PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hsu, SC; Ting, AE; Hazuka, CD; Davanger, S; Kenny, JW; Kee, Y; Scheller, RH				Hsu, SC; Ting, AE; Hazuka, CD; Davanger, S; Kenny, JW; Kee, Y; Scheller, RH			The mammalian brain rsec6/8 complex	NEURON			English	Article							PERMEABILIZED CHROMAFFIN CELLS; GTP-BINDING-PROTEIN; SYNAPTIC VESICLE MEMBRANE; ACTIN-FILAMENTS; YEAST; SECRETION; FUSION; DOCKING; EXOCYTOSIS; RELEASE	rsec6 and rsec8 are two components of a 17S complex in mammalian brain that is homologous to the yeast 834 kDa Sec6/8/15 complex which Ts essential for exocytosis. Purification and partial amino acid sequencing of the mammalian rsec6/8 complex reveals that it is composed of eight novel proteins with a combined molecular weight of 743 kDa. The complex is broadly expressed in brain and displays a plasma membrane localization in nerve terminals. Membrane associated rsec6/8 complex coimmunoprecipitates with syntaxin, a plasma membrane protein critical for neurotransmission. These data suggest a role for the mammalian rsec6/8 complex in neurotransmitter release via interactions with the core vesicle docking and fusion apparatus.	HEWLETT PACKARD CORP,PALO ALTO,CA 94034	Hewlett-Packard	Hsu, SC (corresponding author), STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT CELLULAR & MOL PHYSIOL,STANFORD,CA 94305, USA.		Davanger, Svend/AAN-8754-2020	Ting, Anthony/0000-0002-5058-9576				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1994, ANN NY ACAD SCI, V733, P256, DOI 10.1111/j.1749-6632.1994.tb17275.x; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOWSER R, 1992, J CELL BIOL, V118, P1041, DOI 10.1083/jcb.118.5.1041; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; BURGOYNE RD, 1989, CELL SIGNAL, V1, P323, DOI 10.1016/0898-6568(89)90051-X; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; HWANG BJ, 1996, IN PRESS J CHROMAT B; LANE RD, 1986, METHOD ENZYMOL, V121, P183; LELKES PI, 1986, FEBS LETT, V208, P357, DOI 10.1016/0014-5793(86)81049-3; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PERRIN D, 1987, NATURE, V326, P498, DOI 10.1038/326498a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; PFEFFER SR, 1994, P NATL ACAD SCI USA, V91, P1987, DOI 10.1073/pnas.91.6.1987; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; SCHELLER RH, 1995, NEURON, V14, P893; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; TING AE, 1995, P NATL ACAD SCI USA, V92, P9613, DOI 10.1073/pnas.92.21.9613; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988	37	226	235	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1209	1219		10.1016/S0896-6273(00)80251-2	http://dx.doi.org/10.1016/S0896-6273(00)80251-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982167	Bronze			2022-12-28	WOS:A1996WA24800017
J	Skoulakis, EMC; Davis, RL				Skoulakis, EMC; Davis, RL			Olfactory learning deficits in mutants for leonardo, a Drosophila gene encoding a 14-3-3 protein	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; CALCIUM-DEPENDENT EXOCYTOSIS; MEDIATED ENHANCER DETECTION; C INHIBITOR PROTEINS; KINASE-C; MUSHROOM BODIES; BRAIN 14-3-3; IN-VIVO; PREFERENTIAL EXPRESSION; TRYPTOPHAN-HYDROXYLASE	Studies of Drosophila and other insects have indicated an essential role for the mushroom bodies in learning and memory. The leonardo gene encodes a Drosophila protein highly homologous to the vertebrate 14-3-3 zeta isoform, a protein well studied for biochemical roles but without a well established biological function. The gene is expressed abundantly and preferentially in mushroom body neurons. Mutant alleles that reduce LEONARDO protein levels in the mushroom bodies significantly decrease the capacity for olfactory learning, but do not affect sensory modalities or brain neuroanatomy that are requisite for conditioning. These results establish a biological role for 14-3-3 proteins in mushroom body-mediated learning and memory processes, and suggest that proteins known to interact with them, such as RAF-1 or other protein kinases, may also have this biological function.	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA	Baylor College of Medicine	Skoulakis, EMC (corresponding author), BAYLOR COLL MED, DEPT CELL BIOL, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIGMS NIH HHS [GM15406] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015406] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; BOSTON PF, 1982, J NEUROCHEM, V38, P1466, DOI 10.1111/j.1471-4159.1982.tb07927.x; BOSTON PF, 1982, J NEUROCHEM, V38, P1475, DOI 10.1111/j.1471-4159.1982.tb07928.x; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; CHEN CN, 1986, P NATL ACAD SCI USA, V86, P3599; CHOI KW, 1991, J BIOL CHEM, V266, P15999; CONKLIN DS, 1995, P NATL ACAD SCI USA, V92, P7892, DOI 10.1073/pnas.92.17.7892; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DAVIS RL, 1984, MOL CELL BIOL, V4, P358, DOI 10.1128/MCB.4.2.358; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Davis RL, 1996, CURR BIOL, V6, P146, DOI 10.1016/S0960-9822(02)00447-5; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DUNBAR BS, 1987, 2 DIMENTIONAL ELECTR; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FEANY MB, 1995, SCIENCE, V268, P825; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; FOSTER JL, 1988, J BIOL CHEM, V263, P1676; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.0.CO;2-B; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; ICHIMURA T, 1991, J NEUROCHEM, V56, P1449, DOI 10.1111/j.1471-4159.1991.tb11446.x; ICHIMURA T, 1987, FEBS LETT, V219, P79, DOI 10.1016/0014-5793(87)81194-8; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; ISOBE T, 1992, FEBS LETT, V308, P121, DOI 10.1016/0014-5793(92)81257-M; ISOBE T, 1991, J MOL BIOL, V217, P125, DOI 10.1016/0022-2836(91)90616-E; JONES DH, 1995, FEBS LETT, V368, P55, DOI 10.1016/0014-5793(95)00598-4; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MAKITA Y, 1990, FEBS LETT, V268, P185, DOI 10.1016/0014-5793(90)81004-8; MARTIN H, 1993, FEBS LETT, V331, P296, DOI 10.1016/0014-5793(93)80356-Y; MENZEL R, 1991, NEUROBIOLOGY LEARNIN; MOORE BW, 1968, PHYSL BIOCH ASPECTS, P345; MORGAN A, 1992, BIOCHEM J, V286, P807, DOI 10.1042/bj2860807; MORGAN A, 1992, NATURE, V355, P833, DOI 10.1038/355833a0; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; PALLAS DC, 1994, SCIENCE, V265, P535, DOI 10.1126/science.8036498; PATEL Y, 1994, BBA-MOL CELL RES, V1222, P405, DOI 10.1016/0167-4889(94)90048-5; QUI Y, 1991, J MOL BIOL, V222, P553; REUTHER GW, 1994, SCIENCE, V266, P129, DOI 10.1126/science.7939633; ROSEBOOM PH, 1994, DNA CELL BIOL, V13, P629, DOI 10.1089/dna.1994.13.629; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; ROTH D, 1995, FEBS LETT, V374, P77, DOI 10.1016/0014-5793(95)01080-X; SCHWARTZ JH, 1993, P NATL ACAD SCI USA, V90, P8310, DOI 10.1073/pnas.90.18.8310; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; SKOULAKIS EMC, 1993, INT CONGR SER, V1036, P99; Sokal R. R., 1981, BIOMETRY; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; SWANSON KD, 1992, GENE, V113, P183, DOI 10.1016/0378-1119(92)90394-5; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TANJI M, 1994, J NEUROCHEM, V63, P1908; TOKER A, 1992, EUR J BIOCHEM, V206, P453, DOI 10.1111/j.1432-1033.1992.tb16946.x; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; WATANABE M, 1991, MOL BRAIN RES, V10, P151, DOI 10.1016/0169-328X(91)90105-7; WATANABE M, 1993, MOL BRAIN RES, V17, P135, DOI 10.1016/0169-328X(93)90082-Z; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; YAMAMORI B, 1995, J BIOL CHEM, V270, P11723, DOI 10.1074/jbc.270.20.11723; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	73	188	193	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV	1996	17	5					931	944		10.1016/S0896-6273(00)80224-X	http://dx.doi.org/10.1016/S0896-6273(00)80224-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938125	Bronze			2022-12-28	WOS:A1996VV15100015
J	Narasimhan, K; Linden, DJ				Narasimhan, K; Linden, DJ			Defining a minimal computational unit for cerebellar long-term depression	NEURON			English	Article							PROTEIN-KINASE-C; DENDRITIC SPINES; PURKINJE-CELLS; NITRIC-OXIDE; GLUTAMATE SENSITIVITY; SYNAPTIC PLASTICITY; CALCIUM CHANNELS; CA2+ TRANSIENTS; CLIMBING FIBER; NEURONS	In cerebellar long-term depression (LTD), conjunctive stimulation of parallel and climbing fiber inputs to a Purkinje neuron (PN) results in a selective depression of parallel fiber-PH synaptic strength. A similar phenomenon may be induced in the cultured PN when glutamate pulses and PH depolarization, which mimic the effects of parallel and climbing fibers, respectively, are coapplied. Here, we show that LTD can be induced in two very reduced preparations of the postsynaptic neuron; an acutely dissociated preparation and a perforated outside-out macropatch of dendritic membrane. LTD in these preparations retains properties of that seen in an intact cultured PH in that it is not induced by either glutamate pulses or depolarization alone and requires calcium influx, mGluR activation, and PKC activation for induction. As both of these preparations lack dendritic spine compartments, these findings suggest that the associative nature of LTD induction does not require this level of morphological organization.			Narasimhan, K (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, R37MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham W.C., 1991, KINDLING SYNAPTIC PL, P92; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; CHANG HT, 1952, COLD SPRING HARB SYM, V17, P189, DOI 10.1101/SQB.1952.017.01.019; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; COSS RG, 1985, BEHAV NEURAL BIOL, V44, P151, DOI 10.1016/S0163-1047(85)90170-0; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; DESCHUTTER E, 1995, TRENDS NEUROSCI, V18, P291, DOI 10.1016/0166-2236(95)93916-L; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; HOLMES WR, 1990, BRAIN RES, V519, P338, DOI 10.1016/0006-8993(90)90098-V; HOMER CH, 1993, PROG NEUROBIOL, V41, P281; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; JAFFE DB, 1994, J NEUROBIOL, V25, P220, DOI 10.1002/neu.480250303; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KOCH C, 1993, J NEUROSCI, V13, P413; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LEVITAN ES, 1990, NATURE, V348, P545, DOI 10.1038/348545a0; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Tanzi E., 1893, RIV SPER FRENIAT MED, V19, P419; TAUBE JS, 1987, BRAIN RES, V419, P32, DOI 10.1016/0006-8993(87)90565-8; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; WALLACE CS, 1991, LONG TERM POTENTIATI, P189; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; ZILBERTER YI, 1990, NEURON, V5, P597, DOI 10.1016/0896-6273(90)90214-Z	65	32	33	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					333	341		10.1016/S0896-6273(00)80164-6	http://dx.doi.org/10.1016/S0896-6273(00)80164-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780656	Bronze			2022-12-28	WOS:A1996VE84000015
J	Miller, AG; Aldrich, RW				Miller, AG; Aldrich, RW			Conversion of a delayed rectifier K+ channel to a voltage-gated inward rectifier K+ channel by three amino acid substitutions	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; TEA BLOCKADE; INACTIVATION; MUTATIONS; REGION; EXPRESSION; CELLS; S4-SEQUENCE	Single, double, and triple mutations progressively shift Shaker activation to more hyperpolarized potentials, resulting in an increase in the fraction of inactivated channels at negative resting voltages. The most negatively shifted mutation, the triple mutant, behaves like an inward rectifier. What is usually considered activation for an inward rectifier is, for the triple mutant, recovery from inactivation, and what is usually considered deactivation is inactivation. This conversion from outward rectifier to inward rectifier does not rely on a difference in sign or direction of charge movement of the voltage sensor, since activation of the Shaker outward rectifier is due to a different gate than activation of the triple mutant inward rectifier. Other voltage-dependent inward rectifiers in the Shaker family may work by a similar mechanism.	STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University	Miller, AG (corresponding author), STANFORD UNIV,DEPT MOLEC & CELL PHYSIOL,STANFORD,CA 94305, USA.							ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Chandy K. G., 1995, LIGAND VOLTAGE GATED; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GOMEZLAGUNAS F, 1994, BIOPHYS J, V67, P1806, DOI 10.1016/S0006-3495(94)80662-9; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MULLERROBER B, 1995, EMBO J, V14, P2409, DOI 10.1002/j.1460-2075.1995.tb07238.x; NICHOLS CG, 1994, J PHYSIOL-LONDON, V476, P399, DOI 10.1113/jphysiol.1994.sp020141; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SHIBASAKI T, 1987, J PHYSIOL-LONDON, V387, P227, DOI 10.1113/jphysiol.1987.sp016571; SILVER MR, 1990, J GEN PHYSIOL, V96, P109, DOI 10.1085/jgp.96.1.109; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	40	54	55	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					853	858		10.1016/S0896-6273(00)80105-1	http://dx.doi.org/10.1016/S0896-6273(00)80105-1			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608003	Bronze			2022-12-28	WOS:A1996UG61100018
J	Shi, GY; Nakahira, K; Hammond, S; Rhodes, KJ; Schechter, LE; Trimmer, JS				Shi, GY; Nakahira, K; Hammond, S; Rhodes, KJ; Schechter, LE; Trimmer, JS			beta Subunits promote K+ channel surface expression through effects early in biosynthesis	NEURON			English	Article							BRAIN POTASSIUM-CHANNEL; RAT-BRAIN; ENDOPLASMIC-RETICULUM; XENOPUS OOCYTES; BOVINE BRAIN; CLONING; PROTEIN; IDENTIFICATION; DIVERSITY; NEURONS	Voltage-gated K+ channels are protein complexes composed of ion-conducting integral membrane alpha subunits and cytoplasmic beta subunits. Here, we show that, in transfected mammalian cells, the predominant beta subunit isoform in brain, Kv beta 2, associates with the Kv1.2 alpha subunit early in channel biosynthesis and that KvPP exerts multiple chaperone-like effects on associated Kv1.2 including promotion of cotranslational N-linked glycosylation of the nascent Kv1.2 polypeptide, increased stability of Kv beta 2/Kv1.2 complexes, and increased efficiency of cell surface expression of Kv1.2. Taken together, these results indicate that while some cytoplasmic K+ channel beta subunits affect the inactivation kinetics of alpha subunits, a more general, and perhaps more fundamental, role is to mediate the biosynthetic maturation and surface expression of voltage-gated K+ channel complexes. These findings provide a molecular basis for recent genetic studies indicating that beta subunits are key determinants of neuronal excitability.	SUNY STONY BROOK,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794; WYETH AYERST RES,CNS DISORDERS,PRINCETON,NJ 08543	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pfizer					NINDS NIH HHS [NS34383] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034383, R37NS034383] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; Heinemann SH, 1995, FEBS LETT, V377, P383, DOI 10.1016/0014-5793(95)01377-6; Hille B., 1992, IONIC CHANNELS EXCIT; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; HURST RS, 1991, MOL PHARMACOL, V40, P572; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MORALES MJ, 1995, J BIOL CHEM, V270, P6272, DOI 10.1074/jbc.270.11.6272; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; PAULMICHL M, 1991, P NATL ACAD SCI USA, V88, P7892, DOI 10.1073/pnas.88.17.7892; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RHODES KJ, 1995, J NEUROSCI, V15, P5360; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHEN NV, 1993, NEURON, V11, P67; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHI GY, 1994, J BIOL CHEM, V269, P23204; STERN M, 1989, J NEUROGENET, V5, P215, DOI 10.3109/01677068909066209; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TRIMMER JS, 1985, CELL, V40, P697, DOI 10.1016/0092-8674(85)90218-1; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8	47	322	328	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					843	852		10.1016/S0896-6273(00)80104-X	http://dx.doi.org/10.1016/S0896-6273(00)80104-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608002	Bronze			2022-12-28	WOS:A1996UG61100017
J	Marty, S; Berninger, B; Carroll, P; Thoenen, H				Marty, S; Berninger, B; Carroll, P; Thoenen, H			GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor	NEURON			English	Article							FACTOR MESSENGER-RNA; NEURONS; CELLS	gamma-Aminobutyric acid (GABA) switches from enhancing to repressing brain-derived neurotrophic factor (BDNF) mRNA synthesis during the maturation of hippocampal neurons in vitro. Interneurons do not produce BDNF themselves, but BDNF enhances their differentiation. Therefore, the question arose whether hippocampal interneurons regulate their phenotype by regulating BDNF expression and release from adjacent cells. The GABA(A) receptor agonist muscimol and BDNF increased the size and neuropeptide Y (NPY) immunoreactivity of hippocampal interneurons. However, GABAergic stimulation failed to increase NPY immunoreactivity in cultures from BDNF knockout embryos. At later developmental stages, when GABA represses BDNF synthesis, treatment with muscimol induced a decrease in cell size and NPY immunoreactivity of interneurons. Interneurons might thus control their phenotype through the regulation of BDNF synthesis in, and release from, their target neurons.			Marty, S (corresponding author), MAX PLANCK INST PSYCHIAT, DEPT NEUROCHEM, KLOPFERSPITZ 18A, D-82152 MARTINSRIED, GERMANY.		Carroll, Patrick/AAL-7773-2021; Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782				ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; EINS S, 1983, CELL TISSUE RES, V229, P457; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GALL C, 1990, PROG BRAIN RES, V83, P371; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOSOKAWA Y, 1994, EUR J NEUROSCI, V6, P805, DOI 10.1111/j.1460-9568.1994.tb00991.x; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KATER SB, 1991, J NEUROSCI, V11, P891; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; MARTY S, 1996, IN PRESS J NEUROSCI; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; NAWA H, 1994, J NEUROSCI, V14, P3751; SCHOUSBOE A, 1995, J NEUROSCI RES, V41, P1, DOI 10.1002/jnr.490410102; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; ZAFRA F, 1992, J NEUROSCI, V12, P4793	18	226	233	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1996	16	3					565	570		10.1016/S0896-6273(00)80075-6	http://dx.doi.org/10.1016/S0896-6273(00)80075-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785053	Bronze			2022-12-28	WOS:A1996UC16800012
J	Airaksinen, MS; Koltzenburg, M; Lewin, GR; Masu, Y; Helbig, C; Wolf, E; Brem, G; Toyka, KV; Thoenen, H; Meyer, M				Airaksinen, MS; Koltzenburg, M; Lewin, GR; Masu, Y; Helbig, C; Wolf, E; Brem, G; Toyka, KV; Thoenen, H; Meyer, M			Specific subtypes of cutaneous mechanoreceptors require neurotrophin-3 following peripheral target innervation	NEURON			English	Article							NERVE GROWTH-FACTOR; SENSORY NEURONS; MYELINATED NOCICEPTORS; MESSENGER-RNA; TOUCH DOMES; RAT; FIBERS; INVIVO; RECEPTORS; SURVIVAL	Neurotrophin-3 (NT-3) is required for the development of most sensory neurons of the dorsal root ganglia. Using electrophysiological techniques in mice with null mutations of the NT-3 gene, we show that two functionally specific subsets of cutaneous afferents differentially require this factor: D-hair receptors and slowly adapting mechanoreceptors; other cutaneous receptors were unaffected. Merkel cells, which are the end organs of slowly adapting mechanoreceptors, are virtually absent in 14-day-old homozygous mutants and are severely reduced in adult NT-3 heterozygous animals. This loss of Merkel cells, together with their innervation, happens in the first postnatal weeks of life, in contrast to muscle spindles and afferents, which are never formed in the absence of NT-3. Thus, NT-3 is essential for the maintenance of specific cutaneous afferents known to subserve fine tactile discrimination in humans.	MAX PLANCK INST PSYCHIAT,DEPT NEUROBIOCHEM,D-82152 PLANEGG,GERMANY; UNIV WURZBURG,DEPT NEUROL,D-97080 WURZBURG,GERMANY; INST MOL ANIM BREEDING,D-81375 MUNICH,GERMANY	Max Planck Society; University of Wurzburg	Airaksinen, MS (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROCHEM,AM KLOPFERSPITZ 18A,D-82152 PLANEGG,GERMANY.		Lewin, Gary R/B-8028-2011	Wolf, Eckhard/0000-0002-0430-9510; Lewin, Gary/0000-0002-2890-6352; Airaksinen, Matti/0000-0002-7199-4984				BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Boyd I.A., 1968, COMPOSITION PERIPHER; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V92, P385, DOI 10.1007/BF00492495; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FORSTER C, 1990, J NEUROSCI METH, V31, P109, DOI 10.1016/0165-0270(90)90155-9; GAESE F, 1994, DEVELOPMENT, V120, P1613; HANDWERKER HO, 1991, J PHYSIOL-LONDON, V435, P229, DOI 10.1113/jphysiol.1991.sp018507; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; JOHNSON EM, 1986, TRENDS NEUROSCI, V9, P33, DOI 10.1016/0166-2236(86)90012-3; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; KUCERA J, 1995, J COMP NEUROL, V363, P307, DOI 10.1002/cne.903630211; LEWIN GR, 1992, J NEUROSCI, V12, P1896; LEWIN GR, 1991, J NEUROPHYSIOL, V66, P1205, DOI 10.1152/jn.1991.66.4.1205; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LEWIN GR, 1994, J NEUROPHYSIOL, V71, P941, DOI 10.1152/jn.1994.71.3.941; LISNEY SJW, 1989, Q J EXP PHYSIOL CMS, V74, P757, DOI 10.1113/expphysiol.1989.sp003348; LOPRESTI P, 1994, J NEUROBIOL, V25, P1613, DOI 10.1002/neu.480251212; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MILLS LR, 1989, DEV BIOL, V136, P61, DOI 10.1016/0012-1606(89)90130-9; NURSE CA, 1984, NEUROSCIENCE, V11, P521, DOI 10.1016/0306-4522(84)90042-3; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; PASCHE F, 1990, J INVEST DERMATOL, V95, P247, DOI 10.1111/1523-1747.ep12484847; PERL ER, 1973, HDB SENSORY PHYSL, V2, P29; Perl ER, 1992, SENSORY NEURONS DIVE, P3; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; TOJO H, 1995, BRAIN RES, V669, P163, DOI 10.1016/0006-8993(94)01219-8; VALLBO AB, 1979, PHYSIOL REV, V59, P919, DOI 10.1152/physrev.1979.59.4.919	41	189	193	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					287	295		10.1016/S0896-6273(00)80047-1	http://dx.doi.org/10.1016/S0896-6273(00)80047-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789944	Bronze			2022-12-28	WOS:A1996TW95700009
J	French, RJ; PrusakSochaczewski, E; Zamponi, GW; Becker, S; Kularatna, AS; Horn, R				French, RJ; PrusakSochaczewski, E; Zamponi, GW; Becker, S; Kularatna, AS; Horn, R			Interactions between a pore-blocking peptide and the voltage sensor of the sodium channel: An electrostatic approach to channel geometry	NEURON			English	Article							MU-CONOTOXIN-GIIIA; SKELETAL-MUSCLE; NA+ CHANNELS; RAT-BRAIN; BATRACHOTOXIN; INSENSITIVITY; CHARYBDOTOXIN; TETRODOTOXIN; SAXITOXIN; CALCIUM	Few experimental data illuminate the relationship between the molecular structures that mediate ion conduction through voltage-dependent ion channels and the structures responsible for sensing transmembrane voltage and controlling gating. To fill this void, we have used a strongly cationic, mutated mu-conotoxin peptide, which only partially blocks current through voltage-dependent sodium channels, to study voltage-dependent activation gating in both bound and unbound channels. When the peptide binds to the ion-conducting pore, it inhibits channel opening, necessitating stronger depolarization for channel activation. We show that this activation shift could result entirely from electrostatic inhibition of the movement of the voltage-sensing S4 charges and estimate the approximate physical distance through which the S4 charges move.	MAX PLANCK INST BIOPHYS, W-6000 FRANKFURT, GERMANY; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT PHYSIOL, PHILADELPHIA, PA 19107 USA	Max Planck Society; Jefferson University	French, RJ (corresponding author), UNIV CALGARY, FAC MED, DEPT MED PHYSIOL, NEUROSCI RES GRP, CALGARY, AB T2N 4N1, CANADA.			Zamponi, Gerald W./0000-0002-0644-9066	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041691] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41691] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CORREA AM, 1991, J GEN PHYSIOL, V97, P605, DOI 10.1085/jgp.97.3.605; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; CUKIERMAN S, 1988, J GEN PHYSIOL, V92, P431, DOI 10.1085/jgp.92.4.431; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; DURELL SR, 1992, BIOPHYS J, V62, P243; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUO XT, 1987, BIOCHEMISTRY-US, V26, P7546, DOI 10.1021/bi00398a003; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; HUANG LYM, 1982, P NATL ACAD SCI-BIOL, V79, P2082, DOI 10.1073/pnas.79.6.2082; KHODOROV BI, 1985, PROG BIOPHYS MOL BIO, V45, P57, DOI 10.1016/0079-6107(85)90005-7; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MATHIAS RT, 1992, NATO ADV SCI I C-MAT, V335, P473; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MINTZ IM, 1994, J NEUROSCI, V14, P2844; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; QUANDT FN, 1982, P NATL ACAD SCI-BIOL, V79, P6732, DOI 10.1073/pnas.79.21.6732; SATO K, 1991, J BIOL CHEM, V266, P16989; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1993, Q REV BIOPHYS, V27, P1; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STEPHAN MM, 1994, J MEMBRANE BIOL, V137, P1; STILLINGER F, 1961, J CHEM PHYS, V35, P1584, DOI 10.1063/1.1732113; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; ZAMPONI GW, 1993, BIOPHYS J, V65, P2335, DOI 10.1016/S0006-3495(93)81292-X	40	83	84	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB	1996	16	2					407	413		10.1016/S0896-6273(00)80058-6	http://dx.doi.org/10.1016/S0896-6273(00)80058-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789955	Bronze			2022-12-28	WOS:A1996TW95700020
J	Raman, IM; Tong, G; Jahr, CE				Raman, IM; Tong, G; Jahr, CE			beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; NORADRENALINE; ENHANCEMENT; ACTIVATION; CHANNELS; CALCIUM; DESENSITIZATION; PHOSPHORYLATION	To identify the protein kinases regulating synaptic NMDA receptors, as well as the conditions favoring enhancement of NMDA receptor-mediated excitatory postsynaptic currents (EPSCs) by phosphorylation, we studied the effects of kinase activation and inhibition in hippocampal neurons. Inhibition of cAMP-dependent protein kinase (PKA) prevented recovery of NMDA receptors from calcineurin-mediated dephosphorylation induced by synaptic activity, suggesting that tonically active PKA phosphorylates receptors during quiescent periods. Conversely, elevation of PKA activity by forskolin, cAMP analogs, or the beta-adrenergic receptor agonists norepinephrine and isoproterenol overcame the ability of calcineurin to depress the amplitude of NMDA EPSCs. Thus, stimulation of beta-adrenergic receptors during excitatory synaptic transmission can increase charge transfer and Ca2+ influx through NMDA receptors.			Raman, IM (corresponding author), OREGON HLTH SCI UNIV,PORTLAND,OR 97201, USA.		Tong, Gary/AAC-9426-2022		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021419] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21419] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE R, 1993, NEURON, V10, P83, DOI 10.1016/0896-6273(93)90244-L; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; DOZE VA, 1991, NEURON, V6, P889, DOI 10.1016/0896-6273(91)90229-S; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; DUNWIDDIE TV, 1992, J NEUROSCI, V12, P506; GEREAU RW, 1994, J NEUROSCI, V14, P3310; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; LIMAN ER, 1989, BRAIN RES, V481, P399, DOI 10.1016/0006-8993(89)90822-6; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OLPE HR, 1986, NEUROSCI LETT, V65, P11, DOI 10.1016/0304-3940(86)90112-6; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SCANZIANI M, 1993, J NEUROSCI, V13, P5393, DOI 10.1523/JNEUROSCI.13-12-05393.1993; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; SHARMA RK, 1986, J BIOL CHEM, V261, P1322; SHARMA RK, 1985, P NATL ACAD SCI USA, V82, P2603, DOI 10.1073/pnas.82.9.2603; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0	45	247	252	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					415	421		10.1016/S0896-6273(00)80059-8	http://dx.doi.org/10.1016/S0896-6273(00)80059-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789956	Bronze			2022-12-28	WOS:A1996TW95700021
J	Oliet, SHR; Bourque, CW				Oliet, SHR; Bourque, CW			Gadolinium uncouples mechanical detection and osmoreceptor potential in supraoptic neurons	NEURON			English	Article							ACTIVATED ION CHANNELS; CULTURED CHICK HEART; MECHANOSENSITIVE CURRENTS; SINGLE-CHANNEL; MDX-MYOTUBES; ADULT-RAT; STRETCH; BLOCK; ELECTROPHYSIOLOGY; OSMOSENSITIVITY	Stretch-sensitive ion channels are ubiquitous, yet evidence of their role in mechanotransduction remains scarce. The presence of stretch-inactivated cation channels in supraoptic neurons is consistent with the osmoreceptor potentials regulating vasopressin release. However, whether osmosensitivity depends on mechanical gating and ion flux through stretch-inactivated channels is unknown. Here we report that changes in channel open probability associated either with modification of pipette pressure or with external osmolality selectively result from variations in closed time. While channel mechanosensitivity and osmotically evoked changes in cell volume are not affected by gadolinium, similar concentrations of the lanthanide inhibit cation permeation through the single channels and macroscopic osmoreceptor potentials. Mechanotransduction through stretch-inactivated channels is therefore necessary for osmoreception in supraoptic neurons.	MCGILL UNIV,MONTREAL GEN HOSP,CTR RES NEUROSCI,MONTREAL,PQ H3G 1A4,CANADA	McGill University				Bourque, Charles/0000-0002-1594-742X; Oliet, Stephane/0000-0003-0595-9029				ABE H, 1982, J PHYSIOL-LONDON, V327, P157, DOI 10.1113/jphysiol.1982.sp014225; [Anonymous], [No title captured]; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; BOURQUE CW, 1984, J PHYSIOL-LONDON, V349, P631, DOI 10.1113/jphysiol.1984.sp015178; BOURQUE CW, 1994, FRONT NEUROENDOCRIN, V15, P231, DOI 10.1006/frne.1994.1010; BOURQUE CW, 1990, FRONT NEUROENDOCRIN, V11, P183; BOURQUE CW, 1989, J PHYSIOL-LONDON, V417, P263, DOI 10.1113/jphysiol.1989.sp017800; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; ELINDER F, 1994, BIOPHYS J, V67, P71, DOI 10.1016/S0006-3495(94)80456-4; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; FRANCO A, 1991, BIOPHYS J, V59, P1164, DOI 10.1016/S0006-3495(91)82332-3; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; FRIEDMAN JE, 1993, J NEUROSCI, V13, P63; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; GUSTIN MC, 1988, SCIENCE, V242, P762, DOI 10.1126/science.2460920; GUSTIN MC, 1991, SCIENCE, V253, P800, DOI 10.1126/science.253.5021.800; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KULLBERG R, 1987, TRENDS NEUROSCI, V10, P387, DOI 10.1016/0166-2236(87)90001-4; MASON WT, 1980, NATURE, V287, P154, DOI 10.1038/287154a0; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; MORRIS CE, 1991, SCIENCE, V251, P1246, DOI 10.1126/science.1706535; MORRIS CE, 1992, EXPERIENTIA, V48, P852, DOI 10.1007/BF02118418; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; OLIET SHR, 1993, AM J PHYSIOL, V265, pR1475, DOI 10.1152/ajpregu.1993.265.6.R1475; OLIET SHR, 1992, J PHYSIOL-LONDON, V455, P291, DOI 10.1113/jphysiol.1992.sp019302; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; OLIET SHR, 1994, TRENDS NEUROSCI, V17, P340, DOI 10.1016/0166-2236(94)90177-5; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; RICHARD D, 1992, NEUROENDOCRINOLOGY, V55, P609, DOI 10.1159/000126174; RUKNUDIN A, 1993, AM J PHYSIOL, V264, pH960, DOI 10.1152/ajpheart.1993.264.3.H960; SACHS F, 1992, SENSORY TRANSDUCTION, P242; SAKIN H, 1993, CELLULAR MOL PHYSL C, P215; SIGURDSON W, 1992, AM J PHYSIOL, V262, pH1110, DOI 10.1152/ajpheart.1992.262.4.H1110; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; SOKABE M, 1992, ADV COMP ENV PHYSL, V10, P55; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333	37	63	64	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					175	181		10.1016/S0896-6273(00)80034-3	http://dx.doi.org/10.1016/S0896-6273(00)80034-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562082	Bronze			2022-12-28	WOS:A1996TT30700020
J	Campagna, JA; Ruegg, MA; Bixby, JL				Campagna, JA; Ruegg, MA; Bixby, JL			Agrin is a differentiation-inducing ''stop signal'' for motoneurons in vitro	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; NEUROMUSCULAR-JUNCTIONS INVITRO; BASAL LAMINA; CULTURED MYOTUBES; CHICK-EMBRYO; MUSCLE; PROTEINS; EXPRESSION; OUTGROWTH; NEURONS	Proteins of the synaptic basal lamina are important in directing the differentiation of motor nerve terminals. One synaptic basal lamina protein, agrin, which influences postsynaptic muscle differentiation, has been suggested to influence nerve terminals as well. To test this hypothesis, we cocultured chick ciliary ganglion neurons with agrin-expressing CHO cells. Ciliary ganglion neurons, but not sensory neurons, adhered five times as well to agrin-expressing cells as to untransfected cells. Further, ciliary ganglion neurites were growth inhibited upon contact with agrin-expressing cells. Finally, the synaptic vesicle protein synaptotagmin became concentrated at contacts between ciliary ganglion neurites and agrin-expressing cells. These activities were shared by neuronal and muscle-derived agrin isoforms, consistent with the hypothesis that muscle agrin may influence the presynaptic axon. Our results suggest that agrin influences the growth and differentiation of motoneurons in vivo.	UNIV BASEL,BIOZENTRUM,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND	University of Basel	Campagna, JA (corresponding author), UNIV MIAMI,SCH MED,DEPT MOLEC & CELLULAR PHARMACOL,R-189,1600 NW 10 AVE,MIAMI,FL 33136, USA.		Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Bixby, John/0000-0003-1633-5318	NICHD NIH HHS [HD25154] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025154] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BETZ W, 1976, J PHYSIOL-LONDON, V254, P75, DOI 10.1113/jphysiol.1976.sp011222; BIXBY JL, 1985, J NEUROSCI, V5, P3070; BIXBY JL, 1995, J NEUROBIOL, V26, P262, DOI 10.1002/neu.480260210; BIXBY JL, 1987, DEV BIOL, V119, P363, DOI 10.1016/0012-1606(87)90041-8; BIXBY JL, 1989, NEURON, V3, P287, DOI 10.1016/0896-6273(89)90253-5; BURG MA, 1995, J NEUROSCI RES, V41, P49, DOI 10.1002/jnr.490410107; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CHIU AY, 1984, DEV BIOL, V103, P456, DOI 10.1016/0012-1606(84)90333-6; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; HUNTER DD, 1991, J NEUROSCI, V11, P3960; JAMES DW, 1969, Z ZELLFORSCH MIK ANA, V100, P126, DOI 10.1007/BF00343826; LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F; LIETH E, 1993, J NEUROSCI, V13, P2509, DOI 10.1523/JNEUROSCI.13-06-02509.1993; LOU XJ, 1995, MOL CELL NEUROSCI, V6, P252, DOI 10.1006/mcne.1995.1020; LUPA MT, 1990, DEV BIOL, V142, P31, DOI 10.1016/0012-1606(90)90148-C; LUPA MT, 1989, J NEUROSCI, V9, P3937; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; NAKAJIMA Y, 1980, DEV BIOL, V77, P52, DOI 10.1016/0012-1606(80)90456-X; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; SMITH MA, 1994, NEURON, V12, P795, DOI 10.1016/0896-6273(94)90332-8; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094	43	109	111	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1365	1374		10.1016/0896-6273(95)90014-4	http://dx.doi.org/10.1016/0896-6273(95)90014-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845159	Bronze			2022-12-28	WOS:A1995TL67800014
J	Wang, LC; Dani, J; Godement, P; Marcus, RC; Mason, CA				Wang, LC; Dani, J; Godement, P; Marcus, RC; Mason, CA			Crossed and uncrossed retinal axons respond differently to cells of the optic chiasm midline in vitro	NEURON			English	Article							GROWTH CONE GUIDANCE; SPINAL-CORD; RADIAL GLIA; GANGLION-CELLS; NERVOUS-SYSTEM; CHICK-EMBRYO; FLOOR PLATE; INVITRO; MOUSE; PROJECTIONS	In mouse, retinal axon divergence takes place within a cellular specialization localized at the midline of the optic chiasm. To test whether the cells in this locus present cues for differential retinal axon growth, retinal explants were cocultured with cells dissociated from the chiasmatic midline, both taken from day 14-15 embryos, during the principal period of retinal axon divergence. Compared with crossed axons from other retinal regions, arena from ventrotemporal retina, the sole source of uncrossed axons, were shorter, more fasciculated, and fewer in number when growing on chiasm cells. Furthermore, uncrossed axons avoided clusters of chiasm neurons and glia having the composition and arrangement of the midline specialization, but crossed axons readily grew over them. In contrast to the clusters of chiasm cells, however, individual neurons and glia. did not elicit differential retinal axon growth. These data demonstrate that cues for divergence derive from cells resident to the chiasm and suggest that cellular interactions among resident midline cells are required to produce these cues.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, DEPT ANAT & CELL BIOL, NEW YORK, NY 10032 USA; INST ALFRED FESSARD, CNRS, UPR 2212, F-91198 GIF SUR YVETTE, FRANCE	Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Wang, LC (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, 630 W 168TH ST, NEW YORK, NY 10032 USA.				NEI NIH HHS [EY06510] Funding Source: Medline; NINDS NIH HHS [NS/EY 27615, NS30522] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027615] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BAIRD DH, 1992, J NEUROSCI, V12, P619; BAIRD DH, 1994, NEUROPROTOCOLS, V4, P106; BAKER GE, 1993, J COMP NEUROL, V330, P95, DOI 10.1002/cne.903300108; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BURDENGULLEY SM, 1995, J NEUROSCI, V15, P4370; BURMEISTER DW, 1988, J NEUROSCI, V8, P3151; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHANG WS, 1993, DEVELOPMENT, V118, P651; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; COLELLO RJ, 1992, J COMP NEUROL, V317, P357, DOI 10.1002/cne.903170404; CULICAN SM, 1990, J NEUROSCI, V10, P684; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; Gierer Alfred, 1995, Current Opinion in Neurobiology, V5, P91, DOI 10.1016/0959-4388(95)80092-1; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GODEMENT P, 1989, DEVELOPMENT, V106, P313; GODEMENT P, 1994, J NEUROSCI, V14, P7024; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; GUILLERY RW, 1991, P RET RES F, V3, P153; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; GUILLERY RW, 1987, J COMP NEUROL, V265, P203, DOI 10.1002/cne.902650205; HAMRE KM, 1995, J COMP NEUROL, V352, P421, DOI 10.1002/cne.903520308; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1984, J CELL BIOL, V98, P193, DOI 10.1083/jcb.98.1.193; HO RK, 1982, NATURE, V297, P44; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; JEFFERY G, 1992, J COMP NEUROL, V325, P57, DOI 10.1002/cne.903250106; Jhaveri S, 1993, Perspect Dev Neurobiol, V1, P237; JOHNSTON AR, 1991, DEVELOPMENT, V113, P409; KAPRIELIAN Z, 1994, BIOESSAYS, V16, P1, DOI 10.1002/bies.950160102; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KESHISHIAN H, 1983, DEV BIOL, V96, P89, DOI 10.1016/0012-1606(83)90314-7; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; KNOWLES BB, 1982, DEV BIOL, V93, P54, DOI 10.1016/0012-1606(82)90238-X; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KUHN TB, 1995, NEURON, V14, P275, DOI 10.1016/0896-6273(95)90285-6; LEMMON V, 1992, J NEUROSCI, V12, P818; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; MARCUS RC, 1995, J NEUROSCI, V15, P3716; MARCUS RC, 1995, J NEUROSCI, V15, P6389; MCCABE CF, 1992, DEV BRAIN RES, V66, P11, DOI 10.1016/0165-3806(92)90135-J; MCKANNA JA, 1992, DEV DYNAM, V195, P75, DOI 10.1002/aja.1001950202; MCLOON SC, 1991, J NEUROSCI, V11, P1470; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; NORRIS CR, 1991, J NEUROSCI, V11, P3481; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Polyak S., 1957, VERTEBRATE VISUAL SY; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RABACCHI SA, 1990, DEVELOPMENT, V109, P521; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; REESE BE, 1994, J COMP NEUROL, V349, P303, DOI 10.1002/cne.903490211; RUTISHAUSER U, 1980, J CELL BIOL, V87, P370, DOI 10.1083/jcb.87.2.370; SAVITT JW, 1995, NEURON, V14, P253, DOI 10.1016/0896-6273(95)90283-X; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHEFFIELD JB, 1970, DEV BIOL, V23, P36, DOI 10.1016/S0012-1606(70)80006-9; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; SRETAVAN DW, 1995, SCIENCE, V269, P98, DOI 10.1126/science.7541558; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; TAYLOR JSH, 1994, J COMP NEUROL, V350, P109, DOI 10.1002/cne.903500108; THEITER K, 1972, HOUSE MOUSE; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; VANSELOW J, 1989, DEV BRAIN RES, V45, P15, DOI 10.1016/0165-3806(89)90003-5; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WANG LC, 1994, J NEUROSCI, V14, P3195; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107	81	77	78	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC	1995	15	6					1349	1364		10.1016/0896-6273(95)90013-6	http://dx.doi.org/10.1016/0896-6273(95)90013-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845158	Bronze			2022-12-28	WOS:A1995TL67800013
J	PUIA, G; COSTA, E; VICINI, S				PUIA, G; COSTA, E; VICINI, S			FUNCTIONAL DIVERSITY OF GABA-ACTIVATED CL- CURRENTS IN PURKINJE VERSUS GRANULE NEURONS IN RAT CEREBELLAR SLICES	NEURON			English	Article							INHIBITORY SYNAPTIC CURRENTS; SUBUNIT MESSENGER-RNAS; CENTRAL-NERVOUS-SYSTEM; RECEPTOR SUBUNIT; HIPPOCAMPAL-NEURONS; PATCH-CLAMP; BENZODIAZEPINE RECEPTORS; POSTSYNAPTIC CURRENTS; MOLECULAR-BIOLOGY; ALPHA-6 SUBUNIT	In rat cerebellar slices, we compared whole-cell recordings of spontaneous inhibitory postsynaptic currents (sIPSCs) with Cl- currents resulting from pulses of GABA (1 mM, <2 ms) to outside-out patches from Purkinje and granule neurons. sIPSCs in Purkinje cells decayed with a single fast exponential, as previously reported, whereas in granule cells sIPSC decay was best described by the sum of a fast and a slow exponential curve, with a variable contribution of the slow component to the peak current. GABA pulses to nucleated patches from granule cells elicited Cl- currents with decays similar to sIPSC decays, whereas in patches from Purkinje neurons GABA pulses produced Cl- currents decaying largely with a fast component, but often followed by a slower exponential. GABA concentration steps produced rapidly desensitizing currents in patches from both cerebellar neurons. In distinct cerebellar neurons, specific functional properties of GABA(A) receptors may relate to the presence of distinct receptor subtypes.			PUIA, G (corresponding author), GEORGETOWN UNIV,SCH MED,GEORGETOWN INST NEUROSCI,FIDIA,WASHINGTON,DC 20007, USA.		Puja, Giulia/C-3540-2015	Puja, Giulia/0000-0001-8385-6020; Ribeiro, Jessyca/0000-0003-0068-0061; Vicini, Stefano/0000-0001-8671-5194	NIMH NIH HHS [NIMH R01 MH49486-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049486] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAUDE A, 1992, NEUROSCIENCE, V51, P739, DOI 10.1016/0306-4522(92)90513-2; BOVOLIN P, 1992, P NATL ACAD SCI USA, V89, P9344, DOI 10.1073/pnas.89.19.9344; BURT DR, 1991, FASEB J, V5, P2916, DOI 10.1096/fasebj.5.14.1661244; CACECI MS, 1984, BYTE, V9, P340; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; COSTA E, 1989, NEUROPSYCHOPHARMACOL, V2, P167, DOI 10.1016/0893-133X(89)90020-1; COSTA E, 1975, MECHANISM ACTION BEN, P113; CULLCANDY SG, 1987, BRAIN RES, V402, P182, DOI 10.1016/0006-8993(87)91065-1; DOBLE A, 1992, TRENDS PHARMACOL SCI, V13, P76, DOI 10.1016/0165-6147(92)90027-4; DUCIC I, 1993, EUR J PHARM-MOLEC PH, V244, P29, DOI 10.1016/0922-4106(93)90056-F; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; FROSCH MP, 1992, J NEUROSCI, V12, P3042, DOI 10.1523/JNEUROSCI.12-08-03042.1992; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMORI J, 1989, EXP BRAIN RES, V74, P471; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Ito M, 1984, CEREBELLUM NEURAL CO; KLEINGOOR C, 1991, NEUROSCI LETT, V130, P169, DOI 10.1016/0304-3940(91)90389-B; KLEINGOOR C, 1993, NEUROREPORT, V4, P187, DOI 10.1097/00001756-199302000-00018; KORPI ER, 1993, NATURE, V361, P356, DOI 10.1038/361356a0; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MIERLAK D, 1988, J NEUROSCI, V8, P814; OH DJ, 1992, NEUROSCIENCE, V49, P571, DOI 10.1016/0306-4522(92)90227-S; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; OTIS TS, 1992, NEUROSCIENCE, V49, P13, DOI 10.1016/0306-4522(92)90073-B; Palay S. L., 1974, CEREBELLAR CORTEX CY; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; PUIA G, 1991, MOL PHARMACOL, V39, P691; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SCHNEGGENBURGER R, 1992, J PHYSIOL-LONDON, V445, P261, DOI 10.1113/jphysiol.1992.sp018923; SEGAL M, 1984, J NEUROPHYSIOL, V52, P469, DOI 10.1152/jn.1984.52.3.469; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGEL RE, 1988, NEURON, V1, P579, DOI 10.1016/0896-6273(88)90107-9; SIEGHART W, 1992, TRENDS PHARMACOL SCI, V13, P446, DOI 10.1016/0165-6147(92)90142-S; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SOMOGYI P, 1989, J NEUROSCI, V9, P2197; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; THOMPSON CL, 1992, NEUROSCI LETT, V144, P53, DOI 10.1016/0304-3940(92)90714-I; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VICINI S, 1985, J NEUROSCI, V5, P2212; VICINI S, 1986, P NATL ACAD SCI USA, V83, P9269, DOI 10.1073/pnas.83.23.9269; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; WISDEN W, 1992, J NEUROSCI, V12, P1040; YMER S, 1989, FEBS LETT, V258, P119, DOI 10.1016/0014-5793(89)81630-8	58	133	133	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					117	126		10.1016/0896-6273(94)90157-0	http://dx.doi.org/10.1016/0896-6273(94)90157-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292357				2022-12-28	WOS:A1994MU49300011
J	TANG, LH; AIZENMAN, E				TANG, LH; AIZENMAN, E			ALLOSTERIC MODULATION OF THE NMDA RECEPTOR BY DIHYDROLIPOIC AND LIPOIC ACID IN RAT CORTICAL-NEURONS IN-VITRO	NEURON			English	Article							MICROSOMAL LIPID-PEROXIDATION; OXIDIZED GLUTATHIONE; REDOX MODULATION; HUMAN-SERUM; MEMBRANE; BIOSYNTHESIS; LIPOAMIDASE; REDUCTION; SITE; ENHANCEMENT	The mitochondrial cofactor dihydrolipoic acid (DHLA) was observed to potentiate N-methyl-D-aspartate (NMDA), but not non-NMDA, receptor-mediated whole-cell responses in cultured neurons. This potentiation was readily reversed by the oxidizing agent 5,5'-dithio-bis-(2-nitro-benzoic acid) (DTNB). DHLA was unable to increase NMDA responses previously potentiated by dithiothreitol, nor did it have an effect on NMDA receptors alkylated with N-ethylmaleimide. Single-channel recordings revealed that DHLA produced an increase in NMDA channel open frequency, with no change in single-channel conductance or open time. In contrast, lipoic acid reversed the potentiation of NMDA-evoked responses produced by dithiothreitol and had no effect on NMDA receptors previously oxidized by DTNB. DHLA and lipoic acid are pervasively found substances that readily permeate cellular membranes and thus may influence NMDA receptor activity in vivo by modifying its redox site.			TANG, LH (corresponding author), UNIV PITTSBURGH,SCH MED,DEPT NEUROBIOL,PITTSBURGH,PA 15261, USA.			Aizenman, Elias/0000-0001-9610-4194	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029365] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29365] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIZENMAN E, 1992, J NEUROSCI, V12, P2362; AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; AIZENMAN E, 1992, BRAIN RES, V585, P28, DOI 10.1016/0006-8993(92)91187-J; BACKMANGULLERS B, 1990, CLIN CHIM ACTA, V191, P49, DOI 10.1016/0009-8981(90)90057-Y; BAST A, 1988, BIOCHIM BIOPHYS ACTA, V963, P558, DOI 10.1016/0005-2760(88)90326-8; BERTL A, 1990, P NATL ACAD SCI USA, V87, P7824, DOI 10.1073/pnas.87.20.7824; BUSSE E, 1992, ARZNEIMITTELFORSCH, V42-1, P829; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DUPRE S, 1980, ARCH BIOCHEM BIOPHYS, V202, P361, DOI 10.1016/0003-9861(80)90438-5; GILBERT KR, 1991, NEUROSCI LETT, V133, P11, DOI 10.1016/0304-3940(91)90045-U; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYDEN MA, 1992, J BIOL CHEM, V267, P9512; KAGAN VE, 1992, BIOCHEM PHARMACOL, V44, P1637, DOI 10.1016/0006-2952(92)90482-X; KOIKE M, 1975, METABOLISM SULFUR CO, P87; LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4; Mascio P.D., 1991, AM J CLIN NUTR, V53, p194S; MURPHY ME, 1992, EUR J BIOCHEM, V210, P139, DOI 10.1111/j.1432-1033.1992.tb17401.x; NOWAK LM, 1992, NEURON, V8, P181, DOI 10.1016/0896-6273(92)90119-X; OIZUMI J, 1989, BIOCHEM BIOPH RES CO, V162, P658, DOI 10.1016/0006-291X(89)92361-9; OIZUMI J, 1992, MOL CELL BIOCHEM, V115, P11; PAGANI S, 1989, BIOCHEM INT, V18, P923; PARRY RJ, 1977, J AM CHEM SOC, V99, P6464, DOI 10.1021/ja00461a061; ROJAS L, 1991, BRAIN RES, V551, P10, DOI 10.1016/0006-8993(91)90906-C; SCHOLICH H, 1989, BIOCHIM BIOPHYS ACTA, V1001, P256, DOI 10.1016/0005-2760(89)90108-2; SHIH JCH, 1981, ANAL BIOCHEM, V116, P65, DOI 10.1016/0003-2697(81)90322-5; SINGH R, 1991, J ORG CHEM, V56, P2332, DOI 10.1021/jo00007a018; SPECTOR A, 1988, BIOCHEM BIOPH RES CO, V150, P156, DOI 10.1016/0006-291X(88)90499-8; STRYER L, 1988, BIOCHEMISTRY-US, P373; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; SUZUKI YJ, 1991, FREE RADICAL RES COM, V15, P255, DOI 10.3109/10715769109105221; TANG LH, 1993, MOL PHARMACOL, V44, P473; TANG LH, 1993, J PHYSIOL-LONDON, V465, P303, DOI 10.1113/jphysiol.1993.sp019678; TAUCK DL, 1990, BRAIN RES, V519, P129, DOI 10.1016/0006-8993(90)90070-R; WOODWARD JJ, 1991, J NEUROCHEM, V57, P2059, DOI 10.1111/j.1471-4159.1991.tb06422.x; [No title captured]	37	45	46	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					857	863		10.1016/0896-6273(93)90115-8	http://dx.doi.org/10.1016/0896-6273(93)90115-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240809				2022-12-28	WOS:A1993MJ04100007
J	DAVIES, AM; LEE, KF; JAENISCH, R				DAVIES, AM; LEE, KF; JAENISCH, R			P75-DEFICIENT TRIGEMINAL SENSORY NEURONS HAVE AN ALTERED RESPONSE TO NGF BUT NOT TO OTHER NEUROTROPHINS	NEURON			English	Article							NERVE GROWTH-FACTOR; TRK PROTOONCOGENE PRODUCT; TYROSINE PROTEIN-KINASE; MOLECULAR-CLONING; FACTOR RECEPTOR; FACTOR FAMILY; GENE-TRANSFER; HIGH-AFFINITY; SYMPATHETIC NEURONS; BIOLOGICAL-ACTIVITY	The role of the common low affinity neurotrophin receptor, p75, is controversial. Studies using cell lines suggest that p75 is either essential or dispensable for neurotrophin responsiveness. To resolve this issue, we studied the survival response of developing neurons obtained from normal mouse embyros and embryos with a null mutation in the p75 gene. Embryonic cranial sensory and sympathetic neurons from mutant embryos responded normally to NGF, BDNF, NT-3, and NT-4/5 at saturating concentrations. Dose responses of sympathetic and visceral sensory neurons from mutant embryos were also normal. In contrast, embryonic cutaneous sensory trigeminal neurons isolated from mutant embryos displayed a consistent displacement in the NGF dose response. Compared with wild-type neurons, the concentration of NGF that promoted half-maximal survival was 3- to 4-fold higher for neurons from homozygous embryos and was 2-fold higher for neurons from heterozygous embryos. These findings indicate that p75 enhances the sensitivity of NGF-dependent cutaneous sensory neurons to NGF and may explain, at least in part, the cutaneous sensory abnormalities of mice homozygous for the p75 mutation.	WHITEHEAD INST MED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	DAVIES, AM (corresponding author), UNIV ST ANDREWS, SCH BIOL & MED SCI, ST ANDREWS KY16 9AJ, FIFE, SCOTLAND.		Davies, Alun M/A-4334-2010	Davies, Alun M/0000-0001-5841-8176	NCI NIH HHS [5 R35 CA44339-05] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA044339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP T, 1993, IN PRESS J CELL BIOL; ANDERSON D J, 1992, Current Biology, V2, P461, DOI 10.1016/0960-9822(92)90651-P; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BUCHMAN VL, 1993, IN PRESS DEVELOPMENT; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHUN LLY, 1977, J CELL BIOL, V75, P705, DOI 10.1083/jcb.75.3.705; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; DAVIES AM, 1987, DEVELOPMENT, V100, P307; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1985, DEV BIOL, V111, P62, DOI 10.1016/0012-1606(85)90435-X; DAVIES AM, 1987, DEVELOPMENT, V101, P185; DAVIES AM, 1988, TRENDS GENET, V4, P139, DOI 10.1016/0168-9525(88)90137-0; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DAVIES AM, 1986, J COMP NEUROL, V253, P13, DOI 10.1002/cne.902530103; DAVIES AM, 1993, IN PRESS J NEUROSCI; DRINKWATER CC, 1991, P ROY SOC B-BIOL SCI, V246, P307, DOI 10.1098/rspb.1991.0159; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GOEDERT M, 1984, P NATL ACAD SCI-BIOL, V81, P1580, DOI 10.1073/pnas.81.5.1580; GREENE LA, 1977, DEV BIOL, V58, P96, DOI 10.1016/0012-1606(77)90076-8; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HALLBOOK F, 1990, DEVELOPMENT, V108, P693; HARPER S, 1990, DEVELOPMENT, V110, P515; HATANAKA H, 1988, DEV BRAIN RES, V39, P85, DOI 10.1016/0165-3806(88)90069-7; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KESSLER JA, 1985, J NEUROSCI, V5, P2719; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KORSCHING S, 1988, DEV BIOL, V126, P40, DOI 10.1016/0012-1606(88)90236-9; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDSAY RM, 1989, NEUROSCIENCE, V33, P53, DOI 10.1016/0306-4522(89)90310-2; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MALLETT S, 1991, IMMUNOL TODAY, V12, P220, DOI 10.1016/0167-5699(91)90033-P; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MAYER N, 1982, NEUROSCI LETT, V29, P47, DOI 10.1016/0304-3940(82)90362-7; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCOTT SA, 1993, IN PRESS J COMP NEUR; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; Theiler K., 1972, HOUSE MOUSE; THOENEN H, 1971, P NATL ACAD SCI USA, V68, P1598, DOI 10.1073/pnas.68.7.1598; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; WYATT S, 1990, NEURON, V4, P421, DOI 10.1016/0896-6273(90)90054-J; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; YASUDA T, 1990, BRAIN RES, V524, P54, DOI 10.1016/0006-8993(90)90491-S	78	310	318	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1993	11	4					565	574		10.1016/0896-6273(93)90069-4	http://dx.doi.org/10.1016/0896-6273(93)90069-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398147				2022-12-28	WOS:A1993MD06800002
J	FUNTE, LR; HAYDON, PG				FUNTE, LR; HAYDON, PG			SYNAPTIC TARGET CONTACT ENHANCES PRESYNAPTIC CALCIUM INFLUX BY ACTIVATING CAMP-DEPENDENT PROTEIN-KINASE DURING SYNAPTOGENESIS	NEURON			English	Article							APLYSIA SENSORY NEURONS; BAG CELL NEURONS; TRANSMITTER RELEASE; CYCLIC-AMP; ACTION-POTENTIALS; OMEGA-CONOTOXIN; GROWTH CONES; CHANNELS; MODULATION; ACETYLCHOLINE	Individual dissociated supralateral radular tensor (SLT) muscle fibers were manipulated into contact with fura-2-filled neurites of presynaptic buccal motoneuron 19 from Helisoma in cell culture. Within 30 min of contact, action potential-evoked calcium accumulation was reversibly augmented from 228 +/- 82 nM to 803 +/- 212 nM, an action that was blocked by H-7 (40-100 muM). Calcium accumulation was not augmented when buccal motoneuron 19 contacted muscle or neuronal targets with which it does not form chemical synapses. Addition of pCPTcAMP (500 muM) to cultures reversibly enhanced calcium accumulation. Injection of IP20, a peptide inhibitor of cAMP-dependent protein kinase, prevented pCPTcAMP and SLT muscle from enhancing calcium accumulation. These data demonstrate that SLT muscle target retrogradely regulates calcium accumulation in presynaptic nerve terminals by locally activating presynaptic cAMP-dependent protein kinase.			FUNTE, LR (corresponding author), IOWA STATE UNIV SCI & TECHNOL,DEPT ZOOL & GENET,SIGNAL TRANSDUCT TRAINING GRP,AMES,IA 50011, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024233] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24233] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BEVAN S, 1977, J PHYSIOL-LONDON, V267, P195, DOI 10.1113/jphysiol.1977.sp011808; BLUMENFELD H, 1990, NEURON, V5, P487, DOI 10.1016/0896-6273(90)90088-W; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CHENG HC, 1986, J BIOL CHEM, V261, P989; COHAN CS, 1987, J NEUROSCI, V7, P3588; COHEN MW, 1991, J NEUROSCI, V11, P1032; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAYDON PG, 1988, J NEUROBIOL, V19, P636, DOI 10.1002/neu.480190706; HAYDON PG, 1989, NEURON, V2, P1483, DOI 10.1016/0896-6273(89)90194-3; HAYDON PG, 1985, J NEUROSCI RES, V13, P285; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; JONES OT, 1989, SCIENCE, V244, P1189, DOI 10.1126/science.2543080; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KANDEL ER, 1992, SCIENCE, V258, P243, DOI 10.1126/science.1411522; KANDEL ER, 1986, FIDIA RES F NEUROSCI, P7; Katz B., 1969, RELEASE NEURAL TRANS; KLEIN M, 1982, P NATL ACAD SCI-BIOL, V79, P5713, DOI 10.1073/pnas.79.18.5713; KNOX RJ, 1992, NEURON, V8, P883, DOI 10.1016/0896-6273(92)90202-O; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MATTSON MP, 1988, J NEUROSCI, V8, P1704; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; PERIONI JP, 1992, J NEUROSCI, V12, P2633; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7068; ZORAN MJ, 1989, J EXP BIOL, V142, P225; ZORAN MJ, 1993, IN PRESS DEV BIOL; ZORAN MJ, 1990, NEURON, V6, P145; ZORAN MJ, 1989, DEV BIOL, V138, P202	43	53	53	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1069	1078		10.1016/0896-6273(93)90055-V	http://dx.doi.org/10.1016/0896-6273(93)90055-V			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8391279				2022-12-28	WOS:A1993LK37300007
J	LOGOTHETIS, DE; KAMMEN, BF; LINDPAINTNER, K; BISBAS, D; NADALGINARD, B				LOGOTHETIS, DE; KAMMEN, BF; LINDPAINTNER, K; BISBAS, D; NADALGINARD, B			GATING CHARGE DIFFERENCES BETWEEN 2 VOLTAGE-GATED K+ CHANNELS ARE DUE TO THE SPECIFIC CHARGE CONTENT OF THEIR RESPECTIVE S4 REGIONS	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNELS; DROSOPHILA; S4-SEQUENCE; MUTATIONS; CURRENTS; MOVEMENT; RESIDUES; OOCYTES; BRAIN	Voltage-gated ion channels that differ in their primary amino acid sequence in the putative voltage sensor, the S4 region, show distinct voltage-sensing characteristics. In this study, we directly compared two voltage-gated K+ channels, the mammalian RCK1 with the Drosophila Shab11, and correlated the specific amino acid content of their respective S4 regions with the distinct voltage-sensing properties they exhibit. We find that specific differences in the charge content of the S4 region are sufficient to account for the distinct gating valence of each channel. However, differences in residues inside the S4 region are not sufficient to account for each channel's characteristic voltage range of activation.	HARVARD UNIV,CHILDRENS HOSP,MED CTR,SCH MED,DEPT CARDIOL,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School								Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KEYNES RD, 1974, J PHYSIOL-LONDON, V239, P393, DOI 10.1113/jphysiol.1974.sp010575; KOREN G, 1990, NEURON, V2, P39; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAK MD, 1991, J NEUROSCI, V11, P869; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; STEVENS CF, 1987, PROTEINS EXCITABLE M, P99; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; STUEHMER W, 1989, EMBO (European Molecular Biology Organization) Journal, V8, P3235; STUEHMER W, 1989, Nature (London), V339, P597; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P9	37	47	47	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1121	1129		10.1016/0896-6273(93)90060-5	http://dx.doi.org/10.1016/0896-6273(93)90060-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318233				2022-12-28	WOS:A1993LK37300012
J	VALENZUELA, DM; MAISONPIERRE, PC; GLASS, DJ; ROJAS, E; NUNEZ, L; KONG, Y; GIES, DR; STITT, TN; IP, NY; YANCOPOULOS, GD				VALENZUELA, DM; MAISONPIERRE, PC; GLASS, DJ; ROJAS, E; NUNEZ, L; KONG, Y; GIES, DR; STITT, TN; IP, NY; YANCOPOULOS, GD			ALTERNATIVE FORMS OF RAT TRKC WITH DIFFERENT FUNCTIONAL CAPABILITIES	NEURON			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; NEUROTROPHIC FACTOR; PROTOONCOGENE PRODUCT; FACTOR FAMILY; RECEPTOR; NGF; EXPRESSION; MEMBER; ENCODES	We have identified transcripts encoding several different forms of rat TrkC, a member of the Trk family of receptor tyrosine kinases that serves as a receptor for neurotrophin-3. Some forms of TrkC lack the intracytoplasmic kinase domain and thus resemble previously defined truncated variants of TrkB. Other forms of TrkC contain variable-sized amino acid insertions within the tyrosine kinase domain. Transcripts encoding all forms of TrkC can be detected throughout the nervous system, displaying substantial overlap as well as mutually exclusive distribution patterns with transcripts for TrkB. Strikingly, only transcripts encoding the truncated forms of TrkB and TrkC are found in astrocytes, peripheral nerve, and nonneural tissues. Finally, forms of TrkC containing insertions within the kinase domain retain their ability to autophosphorylate in response to neurotrophin-3, but cannot mediate proliferation in fibroblasts or neuronal differentiation in PC12 cells.			VALENZUELA, DM (corresponding author), REGENERON PHARMACEUT INC, 777 OLD SAW MILL RIVER RD, TARRYTOWN, NY 10591 USA.		Glass, David/AAI-3910-2021; Glass, David/C-4782-2012	Glass, David/0000-0001-6187-4164; Ip, Nancy Yuk-Yu/0000-0002-2763-8907				BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BOTHWELL M, 1991, CURR TOP MICROBIOL, V165, P55; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; IP NY, 1993, IN PRESS J NEUROSCI; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MAISONPIERRE PC, 1993, IN PRESS ONCOGENE; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; RUDGE JS, 1992, EUR J NEUROSCI, V4, P459, DOI 10.1111/j.1460-9568.1992.tb00896.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; VAZQUEZ ME, 1991, NEUROREPORT, V2, P593, DOI 10.1097/00001756-199110000-00010; WILDEN PA, 1992, J BIOL CHEM, V267, P16660; WILDEN PA, 1992, J BIOL CHEM, V267, P13719	44	367	385	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1993	10	5					963	974		10.1016/0896-6273(93)90211-9	http://dx.doi.org/10.1016/0896-6273(93)90211-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494647				2022-12-28	WOS:A1993LD32200018
J	Ebens, A; Brose, K; Leonardo, ED; Hanson, MG; Bladt, F; Birchmeier, C; Barres, BA; TessierLavigne, M				Ebens, A; Brose, K; Leonardo, ED; Hanson, MG; Bladt, F; Birchmeier, C; Barres, BA; TessierLavigne, M			Hepatocyte growth factor scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons	NEURON			English	Article							MACROPHAGE-STIMULATING PROTEIN; JAPANESE MEDAKA FISH; C-MET RECEPTOR; CHICK-EMBRYO; TYROSINE KINASE; NERVE GROWTH; MONOCLONAL-ANTIBODY; PATHWAY SELECTION; MAMMALIAN BRAIN; SCHWANN-CELLS	In the embryonic nervous system, developing axons can be guided to their targets by diffusible factors secreted by their intermediate and final cellular targets. To date only one family of chemoattractants for developing axons has been identified. Grafting and ablation experiments in fish, amphibians, and birds have suggested that spinal motor axons are guided to their targets in the limb in part by a succession of chemoattractants made by the sclerotome and by the limb mesenchyme, two intermediate targets that these axons encounter en route to their target muscles. Here we identify the limb mesenchyme-derived chemoattractant as hepatocyte growth factor/scatter factor (HGF/SF), a diffusible ligand for the c-Met receptor tyrosine kinase, and we also implicate HGF/SF at later stages as a muscle-derived survival factor for motoneurons. These results indicate that, in addition to functioning as a mitogen, a motogen, and a morphogen in nonneural systems, HGF/SF can function as a guidance and survival factor in the developing nervous system.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA; STANFORD UNIV, SCH MED, DEPT NEUROBIOL, STANFORD, CA 94305 USA; MAX DELBRUCK CTR MOL MED, D-13122 BERLIN, GERMANY	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Stanford University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ebens, A (corresponding author), UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM CELL & DEV BIOL, SAN FRANCISCO, CA 94143 USA.		Leonardo, Eduardo/AAH-1525-2020	Leonardo, Eduardo/0000-0001-7426-0217				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; CAMU W, 1992, J NEUROSCI METH, V44, P59, DOI 10.1016/0165-0270(92)90114-S; CHARLWOOD KA, 1972, NERVE GROWTH FACTOR, P102; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Detwiler SR, 1934, J EXP ZOOL, V67, P395, DOI 10.1002/jez.1400670303; EISEN JS, 1994, ANNU REV NEUROSCI, V17, P1; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gilliland G., 1990, PCR PROTOCOLS GUIDE, P60; GORHAM JD, 1990, DEV BRAIN RES, V57, P235, DOI 10.1016/0165-3806(90)90049-5; Hamburger V, 1934, J EXP ZOOL, V68, P449, DOI 10.1002/jez.1400680305; Hamburger V, 1939, J EXP ZOOL, V80, P347, DOI 10.1002/jez.1400800302; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; Hotary KB, 1996, DEV BIOL, V176, P22, DOI 10.1006/dbio.1996.9997; Huff JL, 1996, ONCOGENE, V12, P299; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; Kochhar KS, 1996, CANCER LETT, V104, P163, DOI 10.1016/0304-3835(96)04244-9; KRASNOSELSKY A, 1994, J NEUROSCI, V14, P7284; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; LANSER ME, 1984, J NEUROSCI, V4, P2043; LEWIS J, 1981, J EMBRYOL EXP MORPH, V64, P211; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUMSDEN AGS, 1988, MAKING NERVOUS SYSTE, P168; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P39, DOI 10.1113/jphysiol.1986.sp016104; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; OKAMOTO H, 1991, DEV BIOL, V146, P62, DOI 10.1016/0012-1606(91)90446-A; OKAMOTO H, 1991, DEV BIOL, V146, P49, DOI 10.1016/0012-1606(91)90445-9; OPPENHEIM RW, 1978, J COMP NEUROL, V177, P87, DOI 10.1002/cne.901770107; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; PHELAN KA, 1990, J NEUROSCI, V10, P2699; PIATT J, 1956, J EXP ZOOL, V131, P173, DOI 10.1002/jez.1401310109; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PLACZEK M, 1990, DEVELOPMENT, V110, P19; POLLACK ED, 1977, SCIENCE, V197, P899, DOI 10.1126/science.302031; Pourquie O, 1996, CELL, V84, P461, DOI 10.1016/S0092-8674(00)81291-X; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RONSIN C, 1993, ONCOGENE, V8, P1195; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; STERN CD, 1990, DEVELOPMENT, V110, P1271; STERN CD, 1986, J EMBRYOL EXP MORPH, V91, P209; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; STREIT A, 1995, DEVELOPMENT, V121, P813; Takayama H, 1996, P NATL ACAD SCI USA, V93, P5866, DOI 10.1073/pnas.93.12.5866; Tessier-Lavigne M, 1992, Curr Opin Neurobiol, V2, P60, DOI 10.1016/0959-4388(92)90163-F; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THERY C, 1995, DEV GENET, V17, P90, DOI 10.1002/dvg.1020170110; TOSNEY KW, 1987, DEV BIOL, V122, P540, DOI 10.1016/0012-1606(87)90318-6; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TOSNEY KW, 1991, BIOESSAYS, V13, P17; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; WANG MH, 1995, P NATL ACAD SCI USA, V92, P3933, DOI 10.1073/pnas.92.9.3933; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; YAMAGATA T, 1995, BIOCHEM BIOPH RES CO, V210, P231, DOI 10.1006/bbrc.1995.1651; YAN Q, 1988, J NEUROSCI, V8, P3481; YANG XM, 1993, DEV BIOL, V157, P308, DOI 10.1006/dbio.1993.1137	74	361	372	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1157	1172		10.1016/S0896-6273(00)80247-0	http://dx.doi.org/10.1016/S0896-6273(00)80247-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982163	Bronze			2022-12-28	WOS:A1996WA24800013
J	Jia, ZP; Agopyan, N; Miu, P; Xiong, ZG; Henderson, J; Gerlai, R; Taverna, FA; Velumian, A; MacDonald, J; Carlen, P; AbramowNewerly, W; Roder, J				Jia, ZP; Agopyan, N; Miu, P; Xiong, ZG; Henderson, J; Gerlai, R; Taverna, FA; Velumian, A; MacDonald, J; Carlen, P; AbramowNewerly, W; Roder, J			Enhanced LTP in mice deficient in the AMPA receptor GluR2	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; CALCIUM-PERMEABLE AMPA; GLUTAMATE RECEPTORS; STRUCTURAL DETERMINANTS; METABOTROPIC RECEPTORS; HIPPOCAMPAL-NEURONS; KAINATE RECEPTORS; RAT HIPPOCAMPUS; MURINE NEURONS	AMPA receptors (AMPARs) are not thought to be involved in the induction of long-term potentiation (LTP), but may be involved in its expression via second messenger pathways. However, one subunit of the AMPARs, GluR2, is also known to control Ca2+ influx. To test whether GluR2 plays any role in the induction of LTP, we generated mice that lacked this subunit. In GluR2 mutants, LTP in the CA1 region of hippocampal slices was markedly enhanced (2-fold) and nonsaturating, whereas neuronal excitability and paired-pulse facilitation were normal. The 9-fold increase in Ca2+ permeability, in response to kainate application, suggests one possible mechanism for enhanced LTP. Mutant mice exhibited increased mortality, and those surviving showed reduced exploration and impaired motor coordination. These results suggest an important role for GluR2 in regulating synaptic plasticity and behavior.	TORONTO HOSP,PLAYFAIR NEUROSCI UNIT,TORONTO,ON M5T 2S8,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Jia, ZP (corresponding author), MT SINAI HOSP,SAMUEL LUNENFELD RES INST,600 UNIV AVE,TORONTO,ON M5G 1X5,CANADA.		Jia, zhengping/AAZ-4190-2021; Roder, John/G-6468-2013	Carlen, Peter/0000-0002-3339-8102				ANDERSEN P, 1978, BRAIN RES, V144, P11, DOI 10.1016/0006-8993(78)90431-6; ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; BARRETT EF, 1976, BIOL CHOLINERGIC FUN, P29; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BLANTON M, 1990, J NEUROSCI METH, V30, P203; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; CHIAIA NL, 1992, NEUROSCIENCE, V49, P141, DOI 10.1016/0306-4522(92)90082-D; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; EHLERS MD, 1996, CELL, V84, P746; GELGER JRP, 1995, NEURON, V15, P193; GERBER G, 1989, J NEUROSCI, V9, P3606; GERLAI R, 1993, BEHAV BRAIN RES, V55, P51, DOI 10.1016/0166-4328(93)90006-C; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; GROVER LM, 1990, BRAIN RES, V506, P53, DOI 10.1016/0006-8993(90)91198-P; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1991, SCIENCE, V52, P81; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MACDONALD JF, 1982, CAN J PHYSIOL PHARM, V60, P282, DOI 10.1139/y82-039; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; PURPURA D P, 1968, Brain Research, V7, P310, DOI 10.1016/0006-8993(68)90109-1; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; TURNER RW, 1982, NEUROSCIENCE, V7, P1411, DOI 10.1016/0306-4522(82)90254-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I	58	417	423	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					945	956		10.1016/S0896-6273(00)80225-1	http://dx.doi.org/10.1016/S0896-6273(00)80225-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938126	Bronze			2022-12-28	WOS:A1996VV15100016
J	Li, XJ; Greenwald, I				Li, XJ; Greenwald, I			Membrane topology of the C-elegans SEL-12 presenilin	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; MISSENSE MUTATIONS; GENE; PROTEINS; CHROMOSOME-1; SEQUENCE; RESOLUTION; MODEL	Mutant presenilins cause Alzheimer's disease. Presenilins have multiple hydrophobic regions that could theoretically span a membrane, and a knowledge of the membrane topology is crucial for deducing,the mechanism of presenilin function. By analyzing the activity of beta-galactosidase hybrid proteins expressed in C. elegans, we show that the C. elegans SEL-12 presenilin has eight transmembrane domains and that there is a cleavage site after the sixth transmembrane domain. We examine the presenilin sequence in view of the predicted topology and discuss possible mechanisms for presenilin function.	COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOL BIOPHYS,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Howard Hughes Medical Institute	Li, XJ (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,INTEGRATED PROGRAM CELLULAR MOL & BIOPHYS STUDIES,NEW YORK,NY 10032, USA.							BRENNER S, 1974, GENETICS, V77, P71; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; FIRE A, 1992, GENET ANAL-BIOMOL E, V9, P151, DOI 10.1016/1050-3862(92)90042-4; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVITAN D, 1996, IN PRESS P NATL ACAD; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li JH, 1995, P NATL ACAD SCI USA, V92, P12180, DOI 10.1073/pnas.92.26.12180; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; PerezTur J, 1995, NEUROREPORT, V7, P297; PERRY MD, 1993, GENE DEV, V7, P216, DOI 10.1101/gad.7.2.216; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; REITHMEIER RAF, 1995, CURR OPIN STRUC BIOL, V5, P491, DOI 10.1016/0959-440X(95)80034-4; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SILHAVY TJ, 1985, MICROBIOL REV, V49, P398, DOI 10.1128/MMBR.49.4.398-418.1985; SONG L, 1996, IN PRESS SCIENCE; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; TRAXLER B, 1993, J MEMBRANE BIOL, V132, P1; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	35	185	192	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					1015	1021		10.1016/S0896-6273(00)80231-7	http://dx.doi.org/10.1016/S0896-6273(00)80231-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938132	hybrid			2022-12-28	WOS:A1996VV15100022
J	Brunet, LJ; Gold, GH; Ngai, J				Brunet, LJ; Gold, GH; Ngai, J			General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel	NEURON			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; 2ND MESSENGER PATHWAYS; EMBRYONIC STEM-CELLS; FUNCTIONAL EXPRESSION; ODORANT RECEPTORS; ACTIVATED CHANNEL; ROD PHOTORECEPTOR; ADENYLATE-CYCLASE; INDUCED CURRENTS; MARKER PROTEIN	Olfactory neurons transduce the binding of odorants into membrane depolarization. Two intracellular messengers, cyclic AMP (cAMP) and inositol trisphosphate (IP3), are thought to mediate this process, with cAMP generating responses to some odorants and IP3 mediating responses to others. cAMP causes membrane depolarization by activating a cation-selective cyclic nucleotide-gated (CNG) channel. We created a mutant ''knockout'' mouse lacking functional olfactory CNG channels to assess the roles of different second messenger pathways in olfactory transduction. Using an electrophysiological assay, we find that excitatory responses to both cAMP- and IP3-producing odorants are undetectable in knockout mice. Our results provide direct evidence that the CNG channel subserves excitatory olfactory signal transduction, and further suggest that cAMP is the sole second messenger mediating this process.	MONELL CHEM SENSES CTR,PHILADELPHIA,PA 19104	Monell Chemical Senses Center	Brunet, LJ (corresponding author), UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.				NIDCD NIH HHS [R01 DC-00505, R01 DC-02253] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002253, R01DC000505] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANHOLT RRH, 1990, BIOCHEMISTRY-US, V29, P4049, DOI 10.1021/bi00469a004; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BORISY FF, 1992, J NEUROSCI, V12, P915; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; BREER H, 1991, CHEM SENSES, V16, P19, DOI 10.1093/chemse/16.1.19; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; CUNNINGHAM AM, 1993, NEUROSCIENCE, V57, P339, DOI 10.1016/0306-4522(93)90067-P; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; DAVIS DE, 1956, MANUAL ANAL RODENT P; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; EZEH PI, 1995, J NEUROPHYSIOL, V73, P2207, DOI 10.1152/jn.1995.73.6.2207; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; FRINGS S, 1991, J GEN PHYSIOL, V97, P1, DOI 10.1085/jgp.97.1.1; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; FRINGS S, 1990, BIOPHYS J, V57, P1091, DOI 10.1016/S0006-3495(90)82627-8; FRINGS S, 1993, J GEN PHYSIOL, V101, P1; GORDON SE, 1995, BIOPHYS J, V69, P409, DOI 10.1016/S0006-3495(95)79913-1; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUDSON R, 1986, PHYSIOL BEHAV, V37, P123, DOI 10.1016/0031-9384(86)90394-X; HUQUE T, 1986, BIOCHEM BIOPH RES CO, V137, P36, DOI 10.1016/0006-291X(86)91172-1; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KALINOSKI DL, 1992, BIOCHEM J, V281, P449, DOI 10.1042/bj2810449; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1994, J EXP BIOL, V195, P307; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; KRAMER RH, 1992, NEURON, V9, P897, DOI 10.1016/0896-6273(92)90242-6; KURAHASHI T, 1993, J PHYSIOL-LONDON, V466, P287; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; LYNCH JW, 1989, BIOPHYS J, V55, P755, DOI 10.1016/S0006-3495(89)82874-7; MARGOLIS FL, 1985, TRENDS NEUROSCI, V8, P542, DOI 10.1016/0166-2236(85)90192-4; MIYAMOTO T, 1992, J MEMBRANE BIOL, V127, P173; Nakamura T, 1996, BIOPHYS J, V70, P813, DOI 10.1016/S0006-3495(96)79625-X; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; OKADA Y, 1994, J NEUROPHYSIOL, V71, P595, DOI 10.1152/jn.1994.71.2.595; OKANO M, 1974, J PHYSIOL-LONDON, V242, P353, DOI 10.1113/jphysiol.1974.sp010711; OTTOSON D, 1956, ACTA PHYSIOL SC S122, V35, P1; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; RESTREPO D, 1993, AM J PHYSIOL, V264, P906; RISSER JM, 1987, PHYSIOL BEHAV, V40, P545, DOI 10.1016/0031-9384(87)90042-4; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHILD D, 1995, J NEUROPHYSIOL, V73, P862, DOI 10.1152/jn.1995.73.2.862; SIDAR PB, 1986, J BIOL CHEM, V261, P15538; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; SZABO P, 1994, DEVELOPMENT, V120, P1651; TEICHER MH, 1977, SCIENCE, V198, P635, DOI 10.1126/science.918660; THOMMESEN G, 1977, ACTA PHYSIOL SCAND, V99, P270, DOI 10.1111/j.1748-1716.1977.tb10380.x; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; ZHAINAZAROV AB, 1995, J NEUROPHYSIOL, V74, P479, DOI 10.1152/jn.1995.74.1.479	74	384	399	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					681	693		10.1016/S0896-6273(00)80200-7	http://dx.doi.org/10.1016/S0896-6273(00)80200-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893025	Bronze			2022-12-28	WOS:A1996VP74300013
J	Sheng, M				Sheng, M			PDZs and receptor/channel clustering: Rounding up the latest suspects	NEURON			English	Review							TUMOR-SUPPRESSOR GENE; PROTEIN; HOMOLOG; SAP90; DLG		MASSACHUSETTS GEN HOSP,DEPT NEUROBIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheng, M (corresponding author), MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02114, USA.			Sheng, Morgan/0000-0002-8703-5366				Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Hata Y, 1996, J NEUROSCI, V16, P2488; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Niethammer M, 1996, J NEUROSCI, V16, P2157; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	17	296	304	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					575	578		10.1016/S0896-6273(00)80190-7	http://dx.doi.org/10.1016/S0896-6273(00)80190-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893015	Bronze			2022-12-28	WOS:A1996VP74300003
J	Choe, SY				Choe, SY			Packing of myelin protein zero	NEURON			English	Review							ADHESION MOLECULE; PERIPHERAL MYELIN; CELL-ADHESION; NERVE; GENE				Choe, SY (corresponding author), SALK INST BIOL STUDIES,STRUCT BIOL LAB,10010 N TORREY PINES RD,LA JOLLA,CA 92037, USA.							DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GABRIEL G, 1986, J ANAT, V146, P153; JONES EY, 1995, NATURE, V373, P303; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; NELIS E, 1994, HUM GENET, V94, P653, DOI 10.1007/BF00206959; RITCHIE JM, 1982, PROC R SOC SER B-BIO, V217, P29, DOI 10.1098/rspb.1982.0092; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; WELLS CA, 1993, J NEUROCHEM, V61, P1987, DOI 10.1111/j.1471-4159.1993.tb07434.x; Yoshida M, 1996, NEURON, V16, P1115, DOI 10.1016/S0896-6273(00)80138-5	14	9	10	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					363	365		10.1016/S0896-6273(00)80167-1	http://dx.doi.org/10.1016/S0896-6273(00)80167-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816698	Bronze			2022-12-28	WOS:A1996VJ44000001
J	Shapiro, L; Doyle, JP; Hensley, P; Colman, DR; Hendrickson, WA				Shapiro, L; Doyle, JP; Hensley, P; Colman, DR; Hendrickson, WA			Crystal structure of the extracellular domain from P-0, the major structural protein of peripheral nerve myelin	NEURON			English	Article							TOOTH NEUROPATHY TYPE-1; CELL-ADHESION MOLECULE; FREEZE-FRACTURE; MEMBRANE INTERACTIONS; SURFACE-CHARGE; SOLUBLE FORM; HUMAN CD4; PO GENE; RESOLUTION; FRAGMENT	P-0, the major protein of peripheral nerve myelin, mediates membrane adhesion in the spiral wraps of the myelin sheath. We have determined the crystal structure of the extracellular domain from P-0 (P(0)ex) at 1.9 Angstrom resolution. P(0)ex is folded like a typical immunoglobulin variable-like domain; five residues at the C-terminus are disordered, suggesting a flexible linkage to the membrane. The requirements for crystallization of P(0)ex are similar to those for maintaining the native extracellular spacing of adjacent myelin lamellae; thus, given the self-adhesive character of P(0)ex, the crystal itself may reveal some of the natural interactions that occur between P-0 molecules in myelin. The structure leads to the suggestion that P-0 extracellular domains may emanate from the membrane surface as tetramers that link to tetramers on the opposing membrane surface, to result in the formation of networks of molecules. We report analytical ultracentrifugation data for P(0)ex that support this idea.	COLUMBIA UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA; CUNY MT SINAI SCH MED, BROOKDALE CTR MOL BIOL, NEW YORK, NY 10029 USA; SMITHKLINE BEECHAM PHARMACEUT, DEPT MACROMOL SCI, KING OF PRUSSIA, PA 19406 USA	Columbia University; Howard Hughes Medical Institute; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; GlaxoSmithKline	Shapiro, L (corresponding author), COLUMBIA UNIV, DEPT BIOCHEM & MOL BIOPHYS, 630 W 168TH ST, NEW YORK, NY 10032 USA.		Shapiro, Lawrence/AAE-7172-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, R37GM034102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34102] Funding Source: Medline; NINDS NIH HHS [NS20147] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOLLENSEN E, 1987, NEUROSCI LETT, V82, P77, DOI 10.1016/0304-3940(87)90174-1; BROOKS I, 1994, METHOD ENZYMOL, V240, P459; BROOKS I, 1994, MODERN ANAL ULTRACEN, P15; DEISENHOFER J, 1991, ANNU REV BIOPHYS BIO, V20, P247; DING YG, 1994, J BIOL CHEM, V269, P10764; Doyle JP, 1993, CURR OPIN CELL BIOL, V5, P779, DOI 10.1016/0955-0674(93)90025-L; DOYLE JP, 1995, J CELL BIOL, V131, P465, DOI 10.1083/jcb.131.2.465; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FILBIN MT, 1991, NEURON, V7, P845, DOI 10.1016/0896-6273(91)90286-9; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GABRIEL G, 1986, J ANAT, V146, P153; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GRIFFITH LS, 1992, J NEUROSCI RES, V33, P639, DOI 10.1002/jnr.490330417; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; HENDRICKSON WA, 1979, ACTA CRYSTALLOGR A, V35, P158, DOI 10.1107/S0567739479000279; HIMORO M, 1993, BIOCHEM MOL BIOL INT, V31, P169; INOUYE H, 1988, BIOPHYS J, V53, P247, DOI 10.1016/S0006-3495(88)83086-8; INOUYE H, 1988, BIOPHYS J, V53, P235, DOI 10.1016/S0006-3495(88)83085-6; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KILBY PM, 1995, BIOCHEM J, V305, P935, DOI 10.1042/bj3050935; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; Kirschner Daniel A., 1992, P3; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; MINTON AP, 1981, BIOPHYS CHEM, V14, P317, DOI 10.1016/0301-4622(81)85033-8; NELIS E, 1994, HUM GENET, V94, P653, DOI 10.1007/BF00206959; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OWENS GC, 1991, DEVELOPMENT, V112, P639; PANAGOPOULOS G, 1989, J COMP NEUROL, V286, P337, DOI 10.1002/cne.902860304; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PINTODASILVA P, 1975, P NATL ACAD SCI USA, V72, P4046; Raine C., 1984, MYELIN, P1, DOI 10.1007/978-1-4757-1830-0_1; RANVIER ML, 1878, LECONS HISTOLOGIE SY; RITCHIE JM, 1982, PROC R SOC SER B-BIO, V217, P29, DOI 10.1098/rspb.1982.0092; ROSSMANN MG, 1975, J BIOL CHEM, V250, P3910; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SAAVEDRA RA, 1989, J MOL EVOL, V29, P149, DOI 10.1007/BF02100113; SAUL FA, 1992, PROTEINS, V14, P363, DOI 10.1002/prot.340140305; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; STOLINSKI C, 1982, J NEUROL SCI, V57, P1, DOI 10.1016/0022-510X(82)90107-1; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; WELLS CA, 1993, J NEUROCHEM, V61, P1987, DOI 10.1111/j.1471-4159.1993.tb07434.x; WIMLEY WC, 1993, BIOCHEMISTRY-US, V32, P6307, DOI 10.1021/bi00076a001	58	318	319	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					435	449		10.1016/S0896-6273(00)80176-2	http://dx.doi.org/10.1016/S0896-6273(00)80176-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816707	hybrid			2022-12-28	WOS:A1996VJ44000010
J	Rothstein, JD; DykesHoberg, M; Pardo, CA; Bristol, LA; Jin, L; Kuncl, RW; Kanai, Y; Hediger, MA; Wang, YF; Schielke, JP; Welty, DF				Rothstein, JD; DykesHoberg, M; Pardo, CA; Bristol, LA; Jin, L; Kuncl, RW; Kanai, Y; Hediger, MA; Wang, YF; Schielke, JP; Welty, DF			Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate	NEURON			English	Article							RAT-BRAIN; AMINO-ACIDS; LOCALIZATION; ASTROCYTES; SYNTHETASE; EXPRESSION; INHIBITION; RELEASE; DAMAGE	Three glutamate transporters have been identified in rat, including astroglial transporters GLAST and GLT-1 and a neuronal transporter EAAC1. Here we demonstrate that inhibition of the synthesis of each glutamate transporter subtype using chronic antisense oligonucleotide administration, in vitro and in vivo, selectively and specifically reduced the protein expression and function of glutamate transporters. The loss of glial glutamate transporters GLAST or GLT-1 produced elevated extracellular glutamate levels, neurodegeneration characteristic of excitotoxicity, and a progressive paralysis. The loss of the neuronal glutamate transporter EAAC1 did not elevate extracellular glutamate in the striatum but did produce mild neurotoxicity and resulted in epilepsy. These studies suggest that glial glutamate transporters provide the majority of functional glutamate transport and are essential for maintaining low extracellular glutamate and for preventing chronic glutamate neurotoxicity.	JOHNS HOPKINS UNIV HOSP,DEPT NEUROPATHOL,BALTIMORE,MD 21287; KYORIN UNIV,SCH MED,DEPT PHARMACOL,MITAKA,TOKYO 181,JAPAN; HARVARD UNIV,SCH MED,BRIGHAM & WOMENS HOSP,DEPT MED,RENAL DIV,BOSTON,MA 02115; WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,DEPT PHARMACOKINET & DRUG METAB,ANN ARBOR,MI 48105; WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,DEPT NEUROSCI PHARMACOL,ANN ARBOR,MI 48105	Johns Hopkins University; Johns Hopkins Medicine; Kyorin University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pfizer; Pfizer	Rothstein, JD (corresponding author), JOHNS HOPKINS UNIV HOSP,DEPT NEUROL,BALTIMORE,MD 21287, USA.		rothstein, jeffrey d/C-9470-2013; Pardo, Carlos A./A-5192-2008	Pardo, Carlos A./0000-0002-4128-5335; Hediger, Matthias/0000-0003-1946-027X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012992] Funding Source: NIH RePORTER; NIA NIH HHS [AG12992] Funding Source: Medline; NINDS NIH HHS [NS33958] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BARKS JDE, 1994, MOL CHEM NEUROPATHOL, V23, P201, DOI 10.1007/BF02815412; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; HAJOS F, 1986, NEUROSCIENCE, V18, P417, DOI 10.1016/0306-4522(86)90163-6; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; Kanai Y, 1995, NEUROREPORT, V6, P2357, DOI 10.1097/00001756-199511270-00020; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANAI Y, 1995, EXCITATORY AMINO ACI; LEHRE KP, 1995, J NEUROSCI, V15, P1835; MAKI R, 1994, J NEUROSCI, V14, P6754; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Merlis JK, 1940, AM J PHYSIOL, V131, P0067, DOI 10.1152/ajplegacy.1940.131.1.67; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; OLNEY JW, 1969, J NEUROPATH EXP NEUR, V28, P455, DOI 10.1097/00005072-196907000-00007; OLNEY JW, 1983, BRAIN RES BULL, V10, P699, DOI 10.1016/0361-9230(83)90038-2; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; POW DV, 1994, NEUROSCIENCE, V60, P355, DOI 10.1016/0306-4522(94)90249-6; RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0; ROBINSON MB, 1993, J NEUROCHEM, V61, P2099, DOI 10.1111/j.1471-4159.1993.tb07447.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SHAW PJ, 1994, BRAIN RES, V655, P195, DOI 10.1016/0006-8993(94)91614-4; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WHITESELL L, 1993, P NATL ACAD SCI USA, V90, P4665, DOI 10.1073/pnas.90.10.4665	35	2011	2062	1	86	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					675	686		10.1016/S0896-6273(00)80086-0	http://dx.doi.org/10.1016/S0896-6273(00)80086-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785064	hybrid			2022-12-28	WOS:A1996UC16800023
J	Zou, DJ; Cline, HT				Zou, DJ; Cline, HT			Expression of constitutively active CaMKII in target tissue modifies presynaptic axon arbor growth	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; EYE-SPECIFIC STRIPES; SQUID GIANT SYNAPSE; II MUTANT MICE; VISUAL-CORTEX; RETINOTECTAL SYSTEM; STRIATE CORTEX; MAP FORMATION; CALMODULIN	Calcium/calmodulin-dependent protein kinase II (CaMKII) can be regulated by synaptic activity and could therefore be involved in activity-dependent control of neuronal growth. We tested whether increased CaMKII activity in postsynaptic optic tectal neurons can modify the development of retinotectal axons in Xenopus. The elaboration of individual presynaptic retinal axons was observed in vivo before and up to 3 days after infecting the tectal cells with vaccinia virus carrying the gene for constitutively active truncated CaMKII (tCaMKII). Elevated postsynaptic CaMKII activity prevented the axons from developing the complexity of normal arbors by increasing the normal rate of branch retractions. Some effects of tCaMKII on arbor morphology were seen 1 day after infection, but they became more dramatic by the third day. The results suggest that postsynaptic CaMKII plays a role in the development of presynaptic arbor structure.			Zou, DJ (corresponding author), COLD SPRING HARBOR LAB,POB 100,COLD SPRING HARBOR,NY 11724, USA.							ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BENTLEY D, 1991, J NEUROSCI, V11, P1300; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CABELL L, 1993, INT J DEV NEUROSCI, V11, P357, DOI 10.1016/0736-5748(93)90007-Z; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1990, J NEUROSCI, V10, P1197; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; CLINE HT, 1990, NEURON, V4, P899, DOI 10.1016/0896-6273(90)90143-4; CYPHER C, 1992, Current Opinion in Cell Biology, V4, P4, DOI 10.1016/0955-0674(92)90051-D; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; DAVIS GW, 1994, J NEUROBIOL, V25, P740, DOI 10.1002/neu.480250612; DIAMOND J, 1962, J PHYSIOL-LONDON, V162, P393, DOI 10.1113/jphysiol.1962.sp006941; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOSHIMA Y, 1993, J NEUROSCI, V13, P559; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10041; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HENDRY SHC, 1986, P NATL ACAD SCI USA, V83, P1536, DOI 10.1073/pnas.83.5.1536; JEFFERSON AB, 1991, J BIOL CHEM, V266, P346; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P4050, DOI 10.1073/pnas.88.9.4050; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; JIA WG, 1992, DEV NEUROSCI-BASEL, V14, P238, DOI 10.1159/000111668; JIAN X, 1994, J NEUROBIOL, V25, P1310, DOI 10.1002/neu.480251011; KATER SB, 1994, PROG BRAIN RES, V102, P49; KATZ LC, 1992, ANNU REV NEUROSCI, V15, P31; KENNEDY MB, 1983, J NEUROSCI, V3, P818; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MCGLADEMCULLOCH E, 1992, NATURE, V362, P640; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NAKANE M, 1991, BIOCHEM BIOPH RES CO, V180, P1696; NEVE RL, 1989, P NATL ACAD SCI USA, V86, P4781, DOI 10.1073/pnas.86.12.4781; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SCHERER WJ, 1989, J NEUROSCI, V9, P3837; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; Scott J D, 1992, Curr Opin Neurobiol, V2, P289, DOI 10.1016/0959-4388(92)90117-4; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; Uylings H. B., 1989, COMPUTER TECHNIQUES, P215, DOI 10.1007/978-1-4684-5691-2_11; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; YEN LH, 1993, J NEUROSCI, V13, P4949; YEN LS, 1995, J NEUROSCI, V15, P4712; ZHONG Y, 1992, J NEUROSCI, V12, P644	60	68	70	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					529	539		10.1016/S0896-6273(00)80072-0	http://dx.doi.org/10.1016/S0896-6273(00)80072-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785050	Bronze			2022-12-28	WOS:A1996UC16800009
J	Patel, M; Day, BJ; Crapo, JD; Fridovich, I; McNamara, JO				Patel, M; Day, BJ; Crapo, JD; Fridovich, I; McNamara, JO			Requirement for superoxide in excitotoxic cell death	NEURON			English	Article							GLUTAMATE NEUROTOXICITY; NITRIC-OXIDE; MEDIATED NEUROTOXICITY; ESCHERICHIA-COLI; CULTURES; INACTIVATION; DISMUTASE; ACONITASE; INJURY; NMDA	We tested the pathogenic role of O-2(-) radicals in excitotoxic injury. Inactivation of the TCA cycle enzyme, aconitase, was used as a marker of intracellular O-2(-) levels, and a porphyrin SOD mimetic was used to scavenge O-2(-). The selective, reversible, and SOD-sensitive inactivation of aconitase by known O-2(-) generators was used to validate aconitase activity as a marker of O-2(-) generation. Treatment of rat cortical cultures with NMDA, KA, or the intracellular O-2(-) generator PQ(2+) produced a selective and reversible inactivation of aconitase, which closely correlated with subsequent cell death produced by these agents. The SOD mimetic, but not its less active congener, attenuated both aconitase inactivation and cell death produced by NMDA, KA, and pQ(2+). These results provide direct evidence implicating O-2(-) generation in the pathway to excitotoxic injury.	DUKE UNIV,DEPT BIOCHEM,DURHAM 27710,ENGLAND; DUKE UNIV,DEPT NEUROBIOL,DURHAM 27710,ENGLAND; DUKE UNIV,DEPT PHARMACOL,DURHAM 27710,ENGLAND; VET ADM MED CTR,DURHAM,NC 27710	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Patel, M (corresponding author), DUKE UNIV,DEPT MED,DURHAM 27710,ENGLAND.				NHLBI NIH HHS [HL 31992] Funding Source: Medline; NINDS NIH HHS [NS 32334] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; CHAN PH, 1990, STROKE, V21, P80; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; DUMIUS A, 1988, NATURE, V336, P68; DYKENS JA, 1987, J NEUROCHEM, V49, P1222, DOI 10.1111/j.1471-4159.1987.tb10014.x; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARTHWAITE G, 1986, NEUROSCI LETT, V66, P193, DOI 10.1016/0304-3940(86)90189-8; GHADE GDJ, 1995, MOL PHARMACOL, V47, P1095; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Halliwell B, 1989, FREE RADICAL BIO MED, P22; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; KOH JY, 1990, J NEUROSCI, V10, P693; KREBS HA, 1952, BIOCHEM J, V52, P527, DOI 10.1042/bj0520527; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; LIOCHEV SI, 1995, ARCH BIOCHEM BIOPHYS, V321, P271, DOI 10.1006/abbi.1995.1395; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; OLNEY JW, 1989, BIOL PSYCHIAT, V26, P505, DOI 10.1016/0006-3223(89)90072-3; OLNEY JW, 1986, ADV EXPT MED BIOL, V203, P632; PATEL MN, 1992, TOXICOL APPL PHARM, V115, P124, DOI 10.1016/0041-008X(92)90375-3; PATEL MN, 1993, NEUROTOXICOLOGY, V14, P35; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RACKER E, 1950, BIOCHIM BIOPHYS ACTA, V4, P211, DOI 10.1016/0006-3002(50)90026-6; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1994, P NATL ACAD SCI USA, V91, P4155, DOI 10.1073/pnas.91.10.4155; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; Vassault A, 1984, METHODS ENZYM ANAL, V3, P118	47	390	399	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					345	355		10.1016/S0896-6273(00)80052-5	http://dx.doi.org/10.1016/S0896-6273(00)80052-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789949	Bronze			2022-12-28	WOS:A1996TW95700014
J	TANG, SQ; YATANI, A; BAHINSKI, A; MORI, Y; SCHWARTZ, A				TANG, SQ; YATANI, A; BAHINSKI, A; MORI, Y; SCHWARTZ, A			MOLECULAR LOCALIZATION OF REGIONS IN THE L-TYPE CALCIUM-CHANNEL CRITICAL FOR DIHYDROPYRIDINE ACTION	NEURON			English	Article							FUNCTIONAL EXPRESSION; ALPHA-1 SUBUNIT; OMEGA-CONOTOXIN; MESSENGER-RNAS; CA2+ CHANNELS; BETA-SUBUNIT; SODIUM-CHANNELS; SKELETAL-MUSCLE; CARDIAC-CELLS; K+ CHANNELS	Sensitivity to dihydropyridines (DHPs) is a distinct characteristic that differentiates L-type Ca2+ channels from T-, N-, and P-type Ca2+ channels. To identify regions necessary for the functional effects of DHPs, chimeric Ca2+ channels were constructed in which portions of motif III or motif IV of a DHP-insensitive brain Ca2+ channel, BI-2, were introduced into the DHP-sensitive cardiac L-type Ca2+ channel. The resultant chimeric Ca2+ channels were expressed in Xenopus oocytes, and the effects of a DHP agonist and antagonist were studied. The results show that the linker region between S5 and S6 in motif IV of the L-type Ca2+ channel is a major site for DHP action. The DHP agonist and antagonist molecules interact with distinct sites on the alpha1 subunit of the L-type Ca2+ channel. The data further show that the SS2-S6 region of motif III is not involved in DHP action but may be an important structural component of inactivation.			TANG, SQ (corresponding author), UNIV CINCINNATI, DEPT PHARMACOL & CELL BIOPHYS, CINCINNATI, OH 45267 USA.				NHLBI NIH HHS [P01 HL22619-15, 5R37 HL43231-04, T32 HL07382-16] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL043231, P01HL022619, T32HL007382] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABE T, 1987, J BIOL CHEM, V262, P9877; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; BROWN AM, 1986, J PHYSIOL-LONDON, V379, P495, DOI 10.1113/jphysiol.1986.sp016266; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; COLLIN T, 1993, CIRC RES, V72, P1337, DOI 10.1161/01.RES.72.6.1337; DUBE GP, 1985, BIOCHEM BIOPH RES CO, V128, P1259; EHRLICH HA, 1989, PCR TECHNOLOGY; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FUJITA Y, 1993, NEURON, V10, P1; GLOSSMANN H, 1985, BAYER S, V6, P11; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLE B, 1982, IONIC CHANNELS EXCIT; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; ITAGAKI K, 1992, FEBS LETT, V297, P221, DOI 10.1016/0014-5793(92)80542-O; JANIS RA, 1984, BIOCHEM BIOPH RES CO, V121, P317, DOI 10.1016/0006-291X(84)90725-3; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 1991, J GEN PHYSIOL, V98, P63, DOI 10.1085/jgp.98.1.63; KING SM, 1991, METHOD ENZYMOL, V196, P449; KOKUBUN S, 1986, MOL PHARMACOL, V30, P571; KOKUBUN S, 1984, P NATL ACAD SCI-BIOL, V81, P4824, DOI 10.1073/pnas.81.15.4824; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LORY P, 1993, FEBS LETT, V315, P167, DOI 10.1016/0014-5793(93)81156-T; LORY P, 1991, NEWS PHYSIOL SCI, V6, P277; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NAKAYAMA H, 1991, P NATL ACAD SCI USA, V88, P9203, DOI 10.1073/pnas.88.20.9203; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; REGULLA S, 1991, EMBO J, V10, P45, DOI 10.1002/j.1460-2075.1991.tb07919.x; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHNEIDER T, 1988, EUR J BIOCHEM, V174, P369, DOI 10.1111/j.1432-1033.1988.tb14107.x; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; SLISH DF, 1989, FEBS LETT, V250, P509, DOI 10.1016/0014-5793(89)80786-0; STRIESSNIG J, 1991, P NATL ACAD SCI USA, V88, P10769, DOI 10.1073/pnas.88.23.10769; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TANG SQ, 1993, J BIOL CHEM, V268, P13026; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; VAGHY PL, 1985, FED PROC, V44, P714; VAGHY PL, 1985, BAYER S, V9, P156; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	51	95	95	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1013	1021		10.1016/0896-6273(93)90215-D	http://dx.doi.org/10.1016/0896-6273(93)90215-D			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274273				2022-12-28	WOS:A1993MP54800003
J	LI, SH; SCHILLING, G; YOUNG, WS; LI, XJ; MARGOLIS, RL; STINE, OC; WAGSTER, MV; ABBOTT, MH; FRANZ, ML; RANEN, NG; FOLSTEIN, SE; HEDREEN, JC; ROSS, CA				LI, SH; SCHILLING, G; YOUNG, WS; LI, XJ; MARGOLIS, RL; STINE, OC; WAGSTER, MV; ABBOTT, MH; FRANZ, ML; RANEN, NG; FOLSTEIN, SE; HEDREEN, JC; ROSS, CA			HUNTINGTONS-DISEASE GENE (IT-15) IS WIDELY EXPRESSED IN HUMAN AND RAT-TISSUES	NEURON			English	Article							BULBAR MUSCULAR-ATROPHY; STRIATAL NEURONS; REPEAT; PROTEIN; CORTEX	Huntington's Disease (HD) is notable for selective neuronal vulnerability in the basal ganglia and cerebral cortex. We have investigated in human and rodent tissues the expression of the gene (IT15) whose mutation causes HD. IT15 is widely expressed, with highest levels of expression in brain, but also in lung, testis, ovary, and other tissues. Within the brain, expression is widespread with a neuronal pattern and is not enriched in the basal ganglia. Expression of IT15 is not reduced in the brain of HD patients when corrected for actin (though it is slightly decreased in the striatum when uncorrected, consistent with neuronal loss). Thus, the widespread distribution of IT15 expression does not correspond with the restricted distribution of neuropathologic changes in HD. We suggest that pathophysiology may relate to abnormal cell type-specific protein interactions of the HD protein.	JOHNS HOPKINS UNIV,SCH MED,MOLEC NEUROBIOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; NIMH,CELL BIOL LAB,BETHESDA,MD 20892	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			Young, W Scott/N-3716-2019; Young, W Scott Scott/A-9333-2009; Ross, Christopher A/H-8395-2013	Young, W Scott/0000-0001-6614-5112; Young, W Scott Scott/0000-0001-6614-5112; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016375, P01NS016375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 16375] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; ADLER AJ, 1992, P NATL ACAD SCI USA, V89, P11660, DOI 10.1073/pnas.89.24.11660; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; APPEL SH, 1991, CURRENT NEUROLOGY, V11, P287; Battey, 1986, BASIC METHODS MOL BI; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BERGER FG, 1989, ANNU REV PHYSIOL, V51, P51, DOI 10.1146/annurev.ph.51.030189.000411; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUYN GW, 1986, HDB CLIN NEUROLOGY, V49, P267; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FERRANTE RJ, 1987, J NEUROPATH EXP NEUR, V46, P12, DOI 10.1097/00005072-198701000-00002; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; JANNE OA, 1993, ANN MED, V25, P83, DOI 10.3109/07853899309147863; LAM EWF, 1992, ONCOGENE, V7, P1885; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; ROWLAND LP, 1984, TRENDS NEUROSCI, V7, P110, DOI 10.1016/S0166-2236(84)80236-2; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; 1993, CELL, V72, P971	38	262	268	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					985	993		10.1016/0896-6273(93)90127-D	http://dx.doi.org/10.1016/0896-6273(93)90127-D			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240819				2022-12-28	WOS:A1993MJ04100019
J	SHACKLEFORD, GM; WILLERT, K; WANG, JW; VARMUS, HE				SHACKLEFORD, GM; WILLERT, K; WANG, JW; VARMUS, HE			THE WNT-1 PROTOONCOGENE INDUCES CHANGES IN MORPHOLOGY, GENE-EXPRESSION, AND GROWTH-FACTOR RESPONSIVENESS IN PC12 CELLS	NEURON			English	Article							FACTOR-INDUCED DIFFERENTIATION; EMBRYONAL CARCINOMA-CELLS; MAMMARY-TUMOR VIRUS; PHEOCHROMOCYTOMA CELLS; XENOPUS EMBRYOS; TRANSGENIC MICE; NEURONAL DIFFERENTIATION; DEVELOPMENTAL EXPRESSION; TRANSIENT EXPRESSION; INT-1 PROTOONCOGENE	The product of the Wnt-1 proto-oncogene is a secreted glycoprotein that is normally produced in regions of the embryonic neural tube. We show here that expression of mouse Wnt-1 cDNA in the rat PC12 pheochromocytoma cell line causes a dramatic conversion from a round to a flat cell morphology. In addition, PC12 cells expressing Wnt-1 (PC12/Wnt-1) fail to extend neurites after treatment with NGF, despite the presence and activation of high affinity NGF receptors encoded by the trk gene and the induction of early response genes. Furthermore, PC12/Wnt-1 cells fail to express several neuron- and chromaffin-specific genes, indicating that PC12/Wnt-1 cells have assumed a new phenotype. Although NGF and FGF utilize similar signal transduction pathways in PC12 cells, only FGF is capable of inducing a morphological response and synthesis of transin mRNA in PC12/Wnt-1 cells.	UNIV SO CALIF,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90033; UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143	University of Southern California; University of Southern California; University of California System; University of California San Francisco; University of California System; University of California San Francisco	SHACKLEFORD, GM (corresponding author), CHILDRENS HOSP LOS ANGELES,DIV HEMATOL ONCOL,LOS ANGELES,CA 90027, USA.							ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; ANDERSEN JK, 1990, J NEUROCHEM, V55, P559, DOI 10.1111/j.1471-4159.1990.tb04170.x; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BOULUKOS KE, 1993, ONCOGENE, V8, P237; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BROWN AMC, 1987, MOL CELL BIOL, V7, P3971, DOI 10.1128/MCB.7.11.3971; BROWN AMC, 1986, CELL, V46, P1001, DOI 10.1016/0092-8674(86)90699-9; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; CHRISTIAN JL, 1991, DEV BIOL, V143, P230, DOI 10.1016/0012-1606(91)90073-C; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; EDWARDS PAW, 1992, ONCOGENE, V7, P2041; FILLMORE HL, 1992, J NEUROSCI RES, V31, P662, DOI 10.1002/jnr.490310410; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KIMELMAN D, 1992, DEVELOPMENT, V116, P1; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KWAN H, 1992, MOL CELL BIOL, V12, P147, DOI 10.1128/MCB.12.1.147; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; LIN TP, 1992, CANCER RES, V52, P4413; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; MACHIDA CM, 1989, NEURON, V2, P1587, DOI 10.1016/0896-6273(89)90047-0; MARUYAMA K, 1987, ONCOGENE, V1, P361; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; MATRISIAN LM, 1986, P NATL ACAD SCI USA, V83, P9413, DOI 10.1073/pnas.83.24.9413; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MCCLAY DR, 1987, ANNU REV CELL BIOL, V3, P319, DOI 10.1146/annurev.cellbio.3.1.319; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MCGUIRE JC, 1978, CELL, V15, P357, DOI 10.1016/0092-8674(78)90004-1; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; MCMAHON JA, 1989, DEVELOPMENT, V107, P643; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; NOORDERMEER J, 1989, NUCLEIC ACIDS RES, V17, P11, DOI 10.1093/nar/17.1.11; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; OLSON DJ, 1992, DEV BIOL, V151, P204, DOI 10.1016/0012-1606(92)90227-8; OLSON DJ, 1991, SCIENCE, V252, P1173, DOI 10.1126/science.252.5009.1173; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PETERS G, 1986, NATURE, V320, P628, DOI 10.1038/320628a0; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; RIJSEWIJK F, 1987, EMBO J, V6, P127, DOI 10.1002/j.1460-2075.1987.tb04729.x; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SCHUURING E, 1989, MOL CELL BIOL, V9, P1357, DOI 10.1128/MCB.9.3.1357; SHACKLEFORD GM, 1993, ONCOGENE, V8, P1857; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; STARNAUD R, 1989, ONCOGENE, V4, P1077; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; THOMAS SM, 1991, MOL CELL BIOL, V11, P4739, DOI 10.1128/MCB.11.9.4739; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WOLDA SL, 1992, ONCOGENE, V7, P1941	70	53	53	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					865	875		10.1016/0896-6273(93)90116-9	http://dx.doi.org/10.1016/0896-6273(93)90116-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240810				2022-12-28	WOS:A1993MJ04100008
J	SATHER, WA; TANABE, T; ZHANG, JF; MORI, Y; ADAMS, ME; TSIEN, RW				SATHER, WA; TANABE, T; ZHANG, JF; MORI, Y; ADAMS, ME; TSIEN, RW			DISTINCTIVE BIOPHYSICAL AND PHARMACOLOGICAL PROPERTIES OF CLASS-A (BI) CALCIUM-CHANNEL ALPHA(1)-SUBUNITS	NEURON			English	Article							DEPENDENT CA2+ CHANNELS; OMEGA-AGA-IVA; FUNCTIONAL EXPRESSION; BETA-SUBUNIT; SKELETAL-MUSCLE; N-TYPE; P-TYPE; DIHYDROPYRIDINE RECEPTOR; PERIPHERAL NEURONS; MOLECULAR-CLONING	Transcripts for the class A Ca2+ channel alpha1 subunit (also known as BI) are present at high levels in many parts of the mammalian CNS and are widely assumed to encode the P-type Ca2+ channel. To characterize the biophysical and pharmacological properties of alpha1A channels, macroscopic and single-channel recordings were made in Xenopus oocytes injected with alpha1A cRNA. Alpha1-specific properties were identified by making systematic comparisons with the more familiar class C alpha1 subunit under the condition of a standard ancillary subunit (alpha2/delta + beta) makeup. alpha1A currents activate and inactivate more rapidly and display steeper voltage dependence of gating than alpha1C currents. Unlike alpha1C, alpha1A channels are largely insensitive to dihydropyridines and FPL 64176, but respond to the cone snail peptide omega-CTx-MVIIC (SNX-230), a potent and fairly selective inhibitor. In comparison with P-type Ca2+ channels in rat cerebellar Purkinje cells, alpha1A channels in oocytes are approximately 10(2)-fold less sensitive to omega-Aga-IVA and approximately 10-fold more sensitive to omega-CTx-MVIIC. Alpha1A channels are not inhibited by Bay K 8644 and inactivate much more rapidly than P-type Ca2+ channels. Thus, alpha1A is capable of generating a Ca2+ channel phenotype quite different from P-type current.	YALE UNIV,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536; KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN; YALE UNIV,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06536; UNIV CALIF RIVERSIDE,DEPT ENTOMOL,RIVERSIDE,CA 92521; UNIV CALIF RIVERSIDE,DEPT NEUROSCI,RIVERSIDE,CA 92521	Howard Hughes Medical Institute; Yale University; Kyoto University; Yale University; University of California System; University of California Riverside; University of California System; University of California Riverside	SATHER, WA (corresponding author), STANFORD UNIV,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		Adams, Michael/ABF-6728-2020	Adams, Michael/0000-0003-0519-6113; Sather, William/0000-0003-1482-8055	NINDS NIH HHS [NS24067] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS ME, 1992, NEUROTOX 91, P33; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAGIWARA S, 1983, TRENDS NEUROSCI, V6, P189, DOI 10.1016/0166-2236(83)90084-X; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HESS P, 1990, ANNU REV NEUROSCI, V13, P1337; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LEE KS, 1982, NATURE, V297, P498, DOI 10.1038/297498a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1991, P NATL ACAD SCI USA, V88, P6628, DOI 10.1073/pnas.88.15.6628; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NACHSHEN DA, 1984, J GEN PHYSIOL, V83, P941, DOI 10.1085/jgp.83.6.941; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REUTER H, 1977, J PHYSIOL-LONDON, V264, P17, DOI 10.1113/jphysiol.1977.sp011656; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; VENEMA VJ, 1992, J BIOL CHEM, V267, P2610; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; ZHENG W, 1991, MOL PHARMACOL, V40, P734	56	418	430	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					291	303		10.1016/0896-6273(93)90185-T	http://dx.doi.org/10.1016/0896-6273(93)90185-T			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394721				2022-12-28	WOS:A1993LU06500009
J	OLEARY, DDM; KOESTER, SE				OLEARY, DDM; KOESTER, SE			DEVELOPMENT OF PROJECTION NEURON TYPES, AXON PATHWAYS, AND PATTERNED CONNECTIONS OF THE MAMMALIAN CORTEX	NEURON			English	Review							CENTRAL NERVOUS-SYSTEM; REELER MUTANT MOUSE; CAT STRIATE CORTEX; CLUSTERED HORIZONTAL CONNECTIONS; VISUAL CALLOSAL CONNECTIONS; EARLY POSTNATAL-DEVELOPMENT; OCCIPITAL CORTICAL-NEURONS; DEVELOPING CEREBRAL-CORTEX; RECEPTIVE-FIELD PROPERTIES; FETAL RHESUS-MONKEY				OLEARY, DDM (corresponding author), SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA.				NEI NIH HHS [NEI EY07025] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTMAN J, 1990, EXP NEUROL, V107, P23, DOI 10.1016/0014-4886(90)90060-6; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BARBE MF, 1992, P NATL ACAD SCI USA, V89, P3706, DOI 10.1073/pnas.89.9.3706; BARBE MF, 1991, J NEUROSCI, V11, P519; BATES CA, 1984, DEV BRAIN RES, V13, P265, DOI 10.1016/0165-3806(84)90161-5; Bayer S.A., 1991, NEOCORTICAL DEV; BAYER SA, 1990, EXP NEUROL, V107, P48, DOI 10.1016/0014-4886(90)90062-W; BENTIVOGLIO M, 1980, NEUROSCI LETT, V18, P25, DOI 10.1016/0304-3940(80)90208-6; BLAKEMORE C, 1990, COLD SPRING HARB SYM, V55, P491; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; BOLZ J, 1992, J NEUROSCI, V12, P3054, DOI 10.1523/JNEUROSCI.12-08-03054.1992; Brodmann K, 1909, VERGLEICHENDE LOKALI; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; CALLAWAY EM, 1992, J NEUROSCI, V12, P570; CATALANO SM, 1991, P NATL ACAD SCI USA, V88, P2999, DOI 10.1073/pnas.88.8.2999; CAVINESS VS, 1976, J COMP NEUROL, V170, P449, DOI 10.1002/cne.901700405; CAVINESS VS, 1983, J COMP NEUROL, V219, P182, DOI 10.1002/cne.902190205; CAVINESS VS, 1976, J COMP NEUROL, V170, P435, DOI 10.1002/cne.901700404; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; CHALUPA LM, 1989, P NATL ACAD SCI USA, V86, P1076, DOI 10.1073/pnas.86.3.1076; CHANG FLF, 1986, J COMP NEUROL, V244, P401, DOI 10.1002/cne.902440311; CHUN JJM, 1987, NATURE, V325, P617, DOI 10.1038/325617a0; COWAN WM, 1972, BRAIN RES, V37, P21, DOI 10.1016/0006-8993(72)90344-7; CRANDALL JE, 1984, J COMP NEUROL, V228, P542, DOI 10.1002/cne.902280407; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; DeFelipe J., 1988, CAJAL CEREBRAL CORTE; DEHAY C, 1989, NATURE, V337, P265, DOI 10.1038/337265a0; DEHAY C, 1991, DEV BRAIN RES, V62, P137, DOI 10.1016/0165-3806(91)90199-S; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; FRIAUF E, 1990, J NEUROSCI, V10, P2601; FROST DO, 1990, EXP BRAIN RES, V83, P200; FUKUDA T, 1988, BRAIN RES, V441, P185, DOI 10.1016/0006-8993(88)91397-2; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GHOSH A, 1992, J NEUROSCI, V12, P39; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOTZ M, 1992, DEVELOPMENT, V116, P507; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HOHLABRAHAO JC, 1991, EXP BRAIN RES, V87, P283; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; INNOCENTI GM, 1981, SCIENCE, V212, P824, DOI 10.1126/science.7221566; Innocenti GM., 1986, CEREBRAL CORTEX VOL, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; IVY GO, 1981, J COMP NEUROL, V195, P367, DOI 10.1002/cne.901950302; IVY GO, 1982, J NEUROSCI, V2, P735; Jacobson M., 1991, DEV NEUROBIOLOGY; JENSEN KF, 1984, P NATL ACAD SCI-BIOL, V81, P964, DOI 10.1073/pnas.81.3.964; Jones E. G., 1984, CELLULAR COMPONENTS, P521; JONES EG, 1981, DEV BRAIN RES, V2, P425, DOI 10.1016/0165-3806(81)90050-X; KATZ LC, 1991, EUR J NEUROSCI, V3, P1, DOI 10.1111/j.1460-9568.1991.tb00805.x; KATZ LC, 1992, ANNU REV NEUROSCI, V15, P31; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KEIZER K, 1983, EXP BRAIN RES, V51, P179; KELLER F, 1989, NEURON, V3, P551, DOI 10.1016/0896-6273(89)90265-1; Killackey H P, 1990, J Cogn Neurosci, V2, P1, DOI 10.1162/jocn.1990.2.1.1; KILLACKEY HP, 1986, J COMP NEUROL, V244, P331, DOI 10.1002/cne.902440306; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; KORALEK KA, 1990, P NATL ACAD SCI USA, V87, P1396, DOI 10.1073/pnas.87.4.1396; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; KRISTENSSON K, 1971, BRAIN RES, V29, P363, DOI 10.1016/0006-8993(71)90044-8; LASEK RAYMOND, 1968, BRAIN RES, V8, P319, DOI 10.1016/0006-8993(68)90052-8; LAVAIL JH, 1972, SCIENCE, V176, P1416, DOI 10.1126/science.176.4042.1416; LEMMON V, 1981, J NEUROSCI, V1, P83, DOI 10.1523/JNEUROSCI.01-01-00083.1981; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; LUSKIN MB, 1985, J NEUROSCI, V5, P1062; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1982, ANAT EMBRYOL, V164, P161, DOI 10.1007/BF00318504; MARINPADILLA M, 1972, Z ANAT ENTWICKLUNGS, V136, P125, DOI 10.1007/BF00519174; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1985, SCIENCE, V229, P1268, DOI 10.1126/science.4035355; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; METIN C, 1989, P NATL ACAD SCI USA, V86, P357, DOI 10.1073/pnas.86.1.357; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; NAEGELE JR, 1988, J COMP NEUROL, V277, P593, DOI 10.1002/cne.902770411; O'Leary D D, 1992, Curr Opin Neurobiol, V2, P70, DOI 10.1016/0959-4388(92)90165-H; OGAWA M, 1992, 4TH INT FOR FRONT TE; OLEARY DDM, 1992, EXP NEUROL, V115, P121, DOI 10.1016/0014-4886(92)90234-H; OLEARY DDM, 1990, COLD SH Q B, V55, P453; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; OLEARY DDM, 1981, DEV BRAIN RES, V1, P607, DOI 10.1016/0165-3806(81)90012-2; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; OLEARY DDM, 1985, BRAIN RES, V336, P326, DOI 10.1016/0006-8993(85)90661-4; OLEARY DDM, 1991, DEVELOPMENT, P123; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; PLACZEK M, 1990, COLD SPRING HARB SYM, V55, P279; PRICE J, 1988, DEVELOPMENT, V104, P473; Purves, 1985, PRINCIPLES NEURAL DE; RAEDLER A, 1975, ADV ANAT EMBRYOL CEL, V50, P1; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; RAKIC P, 1983, PROG BRAIN RES, V58, P393, DOI 10.1016/S0079-6123(08)60042-4; Ramon y Cajal S, 1892, REV CIENCIAS MED, V18, P457; RICKMANN M, 1977, ANAT EMBRYOL, V151, P285, DOI 10.1007/BF00318931; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SCHWARTZ ML, 1991, P NATL ACAD SCI USA, V88, P1354, DOI 10.1073/pnas.88.4.1354; SHATZ CJ, 1990, COLD SPRING HARB SYM, V55, P469; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHATZ CJ, 1986, J NEUROSCI, V6, P3655; SHEPPARD AM, 1991, J NEUROSCI, V11, P3928; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMMONS PA, 1982, J COMP NEUROL, V211, P295, DOI 10.1002/cne.902110308; SIMMONS PA, 1983, J NEUROPHYSIOL, V50, P838, DOI 10.1152/jn.1983.50.4.838; STANFIELD BB, 1990, BRAIN RES, V531, P219, DOI 10.1016/0006-8993(90)90777-9; STANFIELD BB, 1985, NATURE, V313, P135, DOI 10.1038/313135a0; STANFIELD BB, 1985, J COMP NEUROL, V238, P236, DOI 10.1002/cne.902380210; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; STEWART GR, 1987, J NEUROSCI, V7, P3325; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; TERASHIMA T, 1987, J COMP NEUROL, V257, P405, DOI 10.1002/cne.902570309; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; THONG IG, 1986, DEV BRAIN RES, V25, P227, DOI 10.1016/0165-3806(86)90212-9; TOYAMA K, 1991, NEUROSCI RES, V12, P57, DOI 10.1016/0168-0102(91)90100-D; TUTTLE R, 1993, CURR BIOL, V3, P70, DOI 10.1016/0960-9822(93)90157-J; VALVERDE F, 1989, J COMP NEUROL, V290, P118, DOI 10.1002/cne.902900108; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WALTER J, 1987, DEVELOPMENT, V101, P685; White E. L., 1986, CEREB CORTEX, V5, P271; WOODWARD WR, 1990, NEUROSCIENCE, V36, P393, DOI 10.1016/0306-4522(90)90434-6; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258; YURKEWICZ L, 1984, SOMATOSENS RES, V1, P303, DOI 10.3109/07367228409144553	138	271	273	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1993	10	6					991	1006		10.1016/0896-6273(93)90049-W	http://dx.doi.org/10.1016/0896-6273(93)90049-W			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318235				2022-12-28	WOS:A1993LK37300001
J	ZORUMSKI, CF; YAMADA, KA; PRICE, MT; OLNEY, JW				ZORUMSKI, CF; YAMADA, KA; PRICE, MT; OLNEY, JW			A BENZODIAZEPINE RECOGNITION SITE ASSOCIATED WITH THE NON-NMDA GLUTAMATE RECEPTOR	NEURON			English	Article							AMINO-ACID RECEPTORS; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; DESENSITIZATION; ANTAGONISTS; KYNURENATE; GYKI-52466	GYKI 52466 is a benzodiazepine molecule that has muscle relaxant and anticonvulsant properties not attributable to a gamma-aminobutyric acid receptor-mediated mechanism. Here it is shown that GYKI 52466 exerts no blocking action at N-methyl-D-aspartate (NMDA) glutamate receptors, but acts noncompetitively to block ion currents and associated excitotoxicity, including ischemic neuronal degeneration, mediated through non-NMDA glutamate receptors. The inhibition of non-NMDA responses by GYKI 52466 is antagonized by cyclothiazide, hydrochlorothiazide, and diazoxide, benzothiadiazide drugs that inhibit non-NMDA receptor desensitization. These results suggest that non-NMDA receptor-ion channel complexes may contain a novel benzodiazepine recognition site where receptor desensitization is regulated; this postulated site represents a promising new target for rational development of drugs to treat neurological disorders.	WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PEDIAT, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	ZORUMSKI, CF (corresponding author), WASHINGTON UNIV, SCH MED, DEPT PSYCHIAT, ST LOUIS, MO 63110 USA.				NIMH NIH HHS [MH38894, MH00964] Funding Source: Medline; NINDS NIH HHS [NS01443] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH000964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001443] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRCH PJ, 1988, EUR J PHARMACOL, V151, P313, DOI 10.1016/0014-2999(88)90814-X; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; ELMSLIE KS, 1985, BRAIN RES, V330, P265, DOI 10.1016/0006-8993(85)90685-7; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; OLNEY JW, 1990, ANNU REV PHARMACOL, V30, P47; OLNEY JW, 1988, EXCITATORY AMINO ACI, P337; OLNEY JW, 1991, GLUTAMATE CELL DEATH, P77; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SMITH SE, 1991, EUR J PHARMACOL, V201, P179, DOI 10.1016/0014-2999(91)90342-N; TARNAWA I, 1989, EUR J PHARMACOL, V167, P193, DOI 10.1016/0014-2999(89)90579-7; TARNAWA I, 1990, AMINO ACIDS CHEM BIO, P538; THIO LL, 1991, J NEUROSCI, V11, P3430; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; YAMADA KA, 1989, J NEUROSCI, V9, P3230; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P385; ZORUMSKI CF, 1992, PROG NEUROBIOL, V39, P295, DOI 10.1016/0301-0082(92)90020-F; ZORUMSKI CF, 1992, MOL PHARMACOL, V41, P931	22	201	202	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1993	10	1					61	67		10.1016/0896-6273(93)90242-J	http://dx.doi.org/10.1016/0896-6273(93)90242-J			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427702				2022-12-28	WOS:A1993KK01200007
J	Paas, Y; Eisenstein, M; Medevielle, F; Teichberg, VI; DevillersThiery, A				Paas, Y; Eisenstein, M; Medevielle, F; Teichberg, VI; DevillersThiery, A			Identification of the amino acid subsets accounting for the ligand binding specificity of a glutamate receptor	NEURON			English	Article							TRIPHOSPHATE CONFORMATION; TRANSPORT-SYSTEMS; CRYSTAL-STRUCTURE; N-GLYCOSYLATION; PROTEIN; SITE; MECHANISM; MUTATIONS; TOPOLOGY; DOMAINS	In a situation so far unique among neurotransmitter receptors, glutamate receptors share amino acid sequence similarities with the bacterial periplasmic binding proteins (PBPs). On the basis of the primary structure similarity of two bacterial periplasmic proteins (lysine/arginine/ornithine- and phosphate-binding proteins) with the chick cerebellar kainate-binding protein (KBP), a member of the ionotropic glutamate receptor family, we have generated a three-dimensional model structure of the KBP extracellular domain. By an interplay between homology modeling and site-directed mutagenesis, we have investigated the kainate binding properties of 55 different mutants (corresponding to 43 positions) and studied the interactions of some of these mutants with various glutamatergic ligands. As a result, we present here the subsets of amino acids accounting for the binding free energies and specificities of KBP for kainate, glutamate, and CNQX and propose a three-dimensional model, at the microarchitectural level, of the glutamatergic binding domain.	WEIZMANN INST SCI,DEPT CHEM SCI,IL-76100 REHOVOT,ISRAEL; INST PASTEUR,CNRS,URA D1284,F-75015 PARIS,FRANCE	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Paas, Y (corresponding author), WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BEALL JA, 1986, J IMMUNOL METHODS, V86, P217, DOI 10.1016/0022-1759(86)90456-4; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BERLAND CR, 1995, BIOCHEMISTRY-US, V34, P10153, DOI 10.1021/bi00032a008; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; COCKCROFT VB, 1993, NEUROCHEM INT, V23, P583, DOI 10.1016/0197-0186(93)90107-G; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GORODINSKY A, 1993, NEUROCHEM INT, V23, P285, DOI 10.1016/0197-0186(93)90119-P; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GREGOR P, 1988, EMBO J, V7, P2673, DOI 10.1002/j.1460-2075.1988.tb03120.x; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; KANG CH, 1991, J BIOL CHEM, V266, P23893; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Levitzki A., 1978, QUANTITATIVE ASPECTS; LI F, 1995, MOL PHARMACOL, V47, P148; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OH BH, 1993, J BIOL CHEM, V268, P11348; OH BH, 1994, J BIOL CHEM, V269, P4135; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Paas Y, 1996, EMBO J, V15, P1548, DOI 10.1002/j.1460-2075.1996.tb00499.x; PAAS Y, 1994, J NEUROCHEM S1, V63, pSD1; PAAS Y, 1992, INT J DEV NEUROSCI S, V10, P47; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sutcliffe MJ, 1996, BIOPHYS J, V70, P1575, DOI 10.1016/S0006-3495(96)79724-2; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WANG ZM, 1994, J BIOL CHEM, V269, P25091; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WO ZGL, 1995, J BIOL CHEM, V270, P2000, DOI 10.1074/jbc.270.5.2000; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4	52	67	68	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					979	990		10.1016/S0896-6273(00)80228-7	http://dx.doi.org/10.1016/S0896-6273(00)80228-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938129	Bronze			2022-12-28	WOS:A1996VV15100019
J	Lindsay, RM; Yancopoulos, GD				Lindsay, RM; Yancopoulos, GD			GDNF in a bind with known orphan: Accessory implicated in new twist	NEURON			English	Review							CILIARY NEUROTROPHIC FACTOR; MIDBRAIN DOPAMINERGIC-NEURONS; SURVIVAL FACTOR; CNTF RECEPTOR; EXPRESSION; KINASES				Lindsay, RM (corresponding author), REGENERON PHARMACEUT INC,777 OLD SAW MILL RIVER RD,TARRYTOWN,NY 10591, USA.		Lindsay, Ronald/GQP-8001-2022					BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; DESERIO A, 1995, J MOL BIOL, V254, P795, DOI 10.1006/jmbi.1995.0655; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINDSAY RM, 1995, NATURE, V373, P289, DOI 10.1038/373289a0; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0	25	34	41	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					571	574		10.1016/S0896-6273(00)80189-0	http://dx.doi.org/10.1016/S0896-6273(00)80189-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893014	Bronze			2022-12-28	WOS:A1996VP74300002
J	Alder, J; Cho, NK; Hatten, ME				Alder, J; Cho, NK; Hatten, ME			Embryonic precursor cells from the rhombic lip are specified to a cerebellar granule neuron identity	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT CEREBELLUM; PURKINJE-CELLS; IN-VITRO; DIFFERENTIATION; INVITRO; EXPRESSION; ECTODERM; IDENTIFICATION; ANTIBODIES	The specification of diverse classes of neurons is critical to the development of the cerebellar cortex. Here, we describe the purification of early embryonic precursors of cerebellar granule neurons from the rhombic lip, the dorsal aspect of the midbrain/hindbrain region. Isolation of rhombic lip cells reveals a homogenous population of precursor cells that express general neuronal markers and the granule cell marker RU49, but fail to extend neurites or express differentiation markers. Differentiation is induced by coculture with external germinal layer (EGL) cells, or their membranes, suggesting that a local inducing factor acts after formation of the EGL. Thus, proliferating precursors within the rhombic lip are specified to be granule cells very early, with the availability of an inducing factor increasing over the course of development.			Alder, J (corresponding author), ROCKEFELLER UNIV,DEV NEUROBIOL LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.			Alder, Janet/0000-0002-5694-4946	NINDS NIH HHS [NS30532-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030532] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1985, J COMP NEUROL, V231, P42, DOI 10.1002/cne.902310105; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BRUNETTE DM, 1971, J MEMBRANE BIOL, V5, P215, DOI 10.1007/BF01870550; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CAJAL SR, 1889, REV TRIM HISTOL NORM, V3, P4; CELIO MR, 1990, CELL CALCIUM, V11, P599, DOI 10.1016/0143-4160(90)90014-L; DEHAY C, 1993, NATURE, V366, P464, DOI 10.1038/366464a0; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FISHELL G, 1995, DEVELOPMENT, V121, P803; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1994, DEVELOPMENT, V120, P1059; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1981, J CELL BIOL, V90, P622, DOI 10.1083/jcb.90.3.622; HATTEN ME, 1978, EXP CELL RES, V113, P111, DOI 10.1016/0014-4827(78)90092-7; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; KUHAR SG, 1993, DEVELOPMENT, V117, P97; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Lumsden A, 1995, CURR BIOL, V5, P1347, DOI 10.1016/S0960-9822(95)00266-1; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MIALE IL, 1961, EXP NEUROL, V47, P26; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; OTERO RA, 1993, J COMP NEUROL, V333, P579; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SMITH JC, 1993, CURR BIOL, V3, P582, DOI 10.1016/0960-9822(93)90003-7; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; STEMPLE DL, 1993, DEV BIOL, V159, P12, DOI 10.1006/dbio.1993.1218; STITT TN, 1990, NEURON, V5, P639, DOI 10.1016/0896-6273(90)90218-5; THIERY JP, 1977, J BIOL CHEM, V252, P6841; VOGEL KS, 1993, DEVELOPMENT, V119, P263; Yang XW, 1996, DEVELOPMENT, V122, P555; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417; ZHENG L, 1996, NEURON, V16, P47	48	185	188	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					389	399		10.1016/S0896-6273(00)80172-5	http://dx.doi.org/10.1016/S0896-6273(00)80172-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816703	hybrid			2022-12-28	WOS:A1996VJ44000006
J	Lee, KH; McCormick, DA				Lee, KH; McCormick, DA			Abolition of spindle oscillations by serotonin and norepinephrine in the ferret lateral geniculate and perigeniculate nuclei in vitro	NEURON			English	Article							ACTIVATED CATION CURRENT; THALAMIC RELAY NEURONS; GUINEA-PIG; IN-VITRO; SYNCHRONIZED OSCILLATIONS; RETICULARIS THALAMI; NORADRENERGIC MODULATION; THALAMOCORTICAL NEURONS; CELLULAR MECHANISMS; UNIT-ACTIVITY	The transition from sleep to waking is associated with the abolition of spindle waves in thalamecortical neurons and the GABAergic cells of the thalamic reticular/perigeniculate nuclei. We tested the possibility that norepinephrine (NE) and serotonin (5-HT) may abolish spindle wave generation through an enhancement of the hyperpolarization-activated cation current lh in thalamocortical neurons. Local application of agents known to enhance I-h, including 5-HT, NE, the adenylyl cyclase activator, forskolin, and the beta-adrenergic agonist, isoproterenol, to lamina A1 of the dorsal lateral geniculate nucleus resulted in an abolition of local spindle wave generation in thalamocortical neurons. The abolition of spindle waves was reversed by the local application of the I-h channel blocker, cesium. These results suggest that NE and 5-HT may abolish the generation of spindle waves through the modulation of I-h in thalamocortical neurons.			Lee, KH (corresponding author), YALE UNIV,SCH MED,NEUROBIOL SECT,NEW HAVEN,CT 06510, USA.		McCormick, David A/J-2649-2015; Kobelt, Liza/F-5926-2011	McCormick, David A/0000-0002-9803-8335; 				AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; [Anonymous], [No title captured]; ASTONJONES G, 1981, J NEUROSCI, V1, P878; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; BAL T, 1996, NEURON, V17; COX CL, 1995, J NEUROPHYSIOL, V74, P990, DOI 10.1152/jn.1995.74.3.990; DELIMA AD, 1987, J COMP NEUROL, V259, P92, DOI 10.1002/cne.902590107; DELIMA AD, 1987, J COMP NEUROL, V258, P339, DOI 10.1002/cne.902580303; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; JOUVET M, 1972, ERG PHYSIOL BIOL CH, V64, P166; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCCORMICK DA, 1992, J NEUROSCI, V12, P278; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1991, J PHYSIOL-LONDON, V442, P235, DOI 10.1113/jphysiol.1991.sp018791; MCCORMICK DA, 1988, J NEUROPHYSIOL, V59, P978, DOI 10.1152/jn.1988.59.3.978; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; PAPE HC, 1992, NEURON, V9, P441, DOI 10.1016/0896-6273(92)90182-D; POLLARD H, 1987, TRENDS NEUROSCI, V10, P86, DOI 10.1016/0166-2236(87)90031-2; SCHWARTZ ML, 1992, CEREB CORTEX, V2, P16, DOI 10.1093/cercor/2.1.16; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1991, J NEUROSCI, V11, P3200; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; Steriade M., 1990, BRAINSTEM CONTROL WA; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; ULRICH D, 1995, NEURON, V15, P909, DOI 10.1016/0896-6273(95)90181-7; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750	41	52	54	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					309	321		10.1016/S0896-6273(00)80162-2	http://dx.doi.org/10.1016/S0896-6273(00)80162-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780654	Bronze			2022-12-28	WOS:A1996VE84000013
J	Frantz, GD; McConnell, SK				Frantz, GD; McConnell, SK			Restriction of late cerebral cortical progenitors to an upper-layer fate	NEURON			English	Article							VISUAL-CORTEX; CELL LINEAGE; MIGRATION; NEURONS; NEOCORTEX; INVITRO; FERRET	Early in development, neural progenitors in cerebral cortex normally produce neurons of several layers during successive cell divisions. The laminar fate of their daughters depends on environmental cues encountered just before mitosis. At the close of neurogenesis, however, cortical progenitors normally produce neurons destined only for the upper layers. To assess the developmental potential of these cells, upper-layer progenitors were transplanted into the cerebral colter of younger hosts, in which deep-layer neurons were being generated. These studies reveal that late cortical progenitors are not competent to generate deep-layer neurons and are instead restricted to producing the upper layers.			Frantz, GD (corresponding author), STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305, USA.				NEI NIH HHS [EY06342, EY08411] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008411] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARTINGER KB, 1992, DEV BIOL, V149, P149, DOI 10.1016/0012-1606(92)90271-H; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FISHELL G, 1995, DEVELOPMENT, V121, P803; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; JACKSON CA, 1989, J NEUROSCI, V9, P1242; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; PRICE J, 1988, DEVELOPMENT, V104, P473; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; ROBERTS JS, 1993, DEV BIOL, V155, P396, DOI 10.1006/dbio.1993.1038; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Zigova T, 1996, DEV BIOL, V173, P459, DOI 10.1006/dbio.1996.0040	27	259	265	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					55	61		10.1016/S0896-6273(00)80280-9	http://dx.doi.org/10.1016/S0896-6273(00)80280-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755478	Bronze			2022-12-28	WOS:A1996UY98100007
J	Cantrell, AR; Ma, JY; Scheuer, T; Catterall, WA				Cantrell, AR; Ma, JY; Scheuer, T; Catterall, WA			Muscarinic modulation of sodium current by activation of protein kinase C in rat hippocampal neurons	NEURON			English	Article							ACTIVE-CHEMICAL SYNAPSES; ACETYLCHOLINE-RECEPTOR GENES; FROG SYMPATHETIC NEURONS; CALCIUM CURRENT; NA+-CHANNEL; PHOSPHORYLATION; EXPRESSION; SUBTYPES; CLONING; CELLS	Phosphorylation of brain Na+ channels by protein kinase C (PKC) decreases peak Na+ current and slows macroscopic inactivation, but receptor-activated modulation of Na+ currents via the PKC pathway has not been demonstrated. We have examined modulation of Na+ channels by activation of muscarinic receptors in acutely-isolated hippocampal neurons using whole-cell voltage-clamp recording. Application of the muscarinic agonist carbachol reduced peak Na+ current and slowed macroscopic inactivation at all potentials, without changing the voltage-dependent properties of the channel. These effects were mediated by PKC, since they were eliminated when the specific PKC inhibitor (PKCI19-36) was included in the pipette solution and mimicked by the extracellular application of the PKC activator, GAG. Thus, activation of endogenous muscarinic receptors on hippocampal neurons strongly modulates Na+ channel activity by activation of PKC. Cholinergic input from basal forebrain neurons may have this effect in the hippocampus in vivo.			Cantrell, AR (corresponding author), UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007278] Funding Source: NIH RePORTER; NIDA NIH HHS [T32DA07278] Funding Source: Medline; NINDS NIH HHS [NS15751] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGAS J, 1994, J NEUROSCI, V14, P6667; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BOWLBY MR, 1995, J NEUROPHYSIOL, V73, P2221, DOI 10.1152/jn.1995.73.6.2221; BRANN MR, 1993, PROG BRAIN RES, V98, P121; BRUSSAARD AB, 1991, J PHYSIOL-LONDON, V441, P385, DOI 10.1113/jphysiol.1991.sp018757; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; DASCAL N, 1991, NEURON, V6, P165, DOI 10.1016/0896-6273(91)90131-I; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V451, P229, DOI 10.1113/jphysiol.1992.sp019162; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; HOEHN K, 1993, NEURON, V10, P543, DOI 10.1016/0896-6273(93)90341-N; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HOWE AR, 1995, J NEUROSCI, V15, P458; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; KRNJEVIC K, 1993, PROG BRAIN RES, V98, P285; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LIAO CF, 1989, J BIOL CHEM, V264, P7328; LINDEN DJ, 1989, J PHYSIOL-LONDON, V419, P95, DOI 10.1113/jphysiol.1989.sp017863; MCKINNEY M, 1984, ANNU REV PHARMACOL, V24, P121; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; NICOLL RA, 1985, TRENDS NEUROSCI, V8, P533, DOI 10.1016/0166-2236(85)90190-0; NUMANN R, 1994, J NEUROSCI, V14, P4226; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; PRICE DL, 1993, PROG BRAIN RES, V98, P51; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RENGANATHAN M, 1995, J MEMBRANE BIOL, V144, P59; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; SURMEIER DJ, 1991, NEUROSCI LETT, V122, P41, DOI 10.1016/0304-3940(91)90188-Y; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; TAKANO K, 1995, NEURON, V14, P999, DOI 10.1016/0896-6273(95)90338-0; TAYLOR CP, 1993, TRENDS NEUROSCI, V16, P455, DOI 10.1016/0166-2236(93)90077-Y; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TAYLOR CP, 1984, J NEUROPHYSIOL, V52, P143, DOI 10.1152/jn.1984.52.1.143; Tukey J. W., 1977, EXPLORATORY DATA ANA; WAINER BH, 1993, PROG BRAIN RES, V98, P9; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WU T, 1995, NEUROSCI LETT, V184, P121, DOI 10.1016/0304-3940(94)11185-L; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B	49	140	143	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					1019	1026		10.1016/S0896-6273(00)80125-7	http://dx.doi.org/10.1016/S0896-6273(00)80125-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630240	Bronze			2022-12-28	WOS:A1996UN48000017
J	Itasaki, N; Sharpe, J; Morrison, A; Krumlauf, R				Itasaki, N; Sharpe, J; Morrison, A; Krumlauf, R			Reprogramming Hox expression in the vertebrate hindbrain: Influence of paraxial mesoderm and rhombomere transposition	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYO SPINAL-CORD; ANTEROPOSTERIOR PATTERN; HOMEOBOX GENE; INDUCTION; PROTEIN; PLANAR; SEGMENTATION; CELLS; CODE	The developing vertebrate hindbrain consists of segments known as rhombomeres, which express combinations of Hox genes implicated in specifying segmental identity. Using chick-chick and chick-transgenic mouse graftings, we show that anterior to posterior rhombomere transpositions result in a progressive posterior transformation and coordinate induction of new Hox expression. This shows that hindbrain plasticity is evolutionarily conserved and implies rhombomeres may be undergoing continual assessment of their identities. The nature of the changes is dependent on both the anteroposterior position of the graft and its origin. Transposed somites from specific axial levels and developmental stages have a graded ability to induce changes in Hox expression, indicating that paraxial mesoderm is a source of the environmental signal responsible for the plasticity.			Itasaki, N (corresponding author), NATL INST MED RES,MRC,DIV DEV NEUROBIOL,THE RIDGEWAY,LONDON NW7 1AA,ENGLAND.		Sharpe, James/AAB-7948-2019; Krumlauf, Robb/AAH-5012-2019; Sharpe, James/L-1150-2014	Krumlauf, Robb/0000-0001-9102-7927; Sharpe, James/0000-0002-1434-9743; Itasaki, Nobue/0000-0003-0587-9141				ALTABA ARI, 1992, DEVELOPMENT, V116, P67; ALTABA ARI, 1994, TRENDS NEUROSCI, V17, P233, DOI 10.1016/0166-2236(94)90006-X; ANG SL, 1994, DEVELOPMENT, V120, P2979; APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; BALLYCUIF L, 1992, DEVELOPMENT, V115, P999; CHEVALLIER A, 1975, J EMBRYOL EXP MORPH, V33, P291; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; DONIACH T, 1992, DEVELOPMENT, P183; DONIACH T, 1992, SCIENCE, V257, P542, DOI 10.1126/science.1636091; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; GAPINBOTTON A, 1995, DEVELOPMENT, V121, P2707; GARDNER CA, 1991, DEVELOPMENT, V113, P1037; GUTHRIE S, 1993, DEVELOPMENT, V118, P527; GUTHRIE S, 1992, NATURE, V356, P157, DOI 10.1038/356157a0; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; KINTNER C, 1992, ANNU REV NEUROSCI, V15, P251, DOI 10.1146/annurev.neuro.15.1.251; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KURATANI SC, 1993, DEVELOPMENT, V117, P105; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; LIM TM, 1991, DEVELOPMENT, V113, P227; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MADEN M, 1991, DEVELOPMENT, V111, P35; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T; MARTINEZ S, 1995, MECH DEVELOP, V51, P289, DOI 10.1016/0925-4773(95)00376-2; MORRISON A, 1995, MECH DEVELOP, V53, P47, DOI 10.1016/0925-4773(95)00423-8; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; PRINCE V, 1994, DEVELOPMENT, V120, P911; SASAKI H, 1990, NUCLEIC ACIDS RES, V18, P184, DOI 10.1093/nar/18.1.184; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SIMON H, 1995, CURR BIOL, V5, P205, DOI 10.1016/S0960-9822(95)00041-8; SLACK JMW, 1992, DEVELOPMENT, V114, P285; STERN CD, 1991, DEVELOPMENT, V113, P239; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	42	156	159	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					487	500		10.1016/S0896-6273(00)80069-0	http://dx.doi.org/10.1016/S0896-6273(00)80069-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785047	Bronze			2022-12-28	WOS:A1996UC16800006
J	Finkbeiner, S; Greenberg, ME				Finkbeiner, S; Greenberg, ME			Ca2+-dependent routes to Ras: Mechanisms for neuronal survival, differentiation, and plasticity?	NEURON			English	Review							GROWTH-FACTOR; PC12 CELLS; PROTEIN; SRC; ACTIVATION; ONCOGENES; KINASE; BRAIN		HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard Medical School	Finkbeiner, S (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.							BARNEKOW A, 1990, ONCOGENE, V5, P1019; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FINKBEINER S, 1996, IN PRESS NEUROSCIENT; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; NG NFL, 1993, J BIOL CHEM, V268, P25329; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SEGAL R, 1996, IN PRESS ANN REV NEU; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SUDOL M, 1988, BRAIN RES REV, V13, P391, DOI 10.1016/0165-0173(88)90014-8; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; WASILENKO WJ, 1991, MOL CELL BIOL, V11, P309, DOI 10.1128/MCB.11.1.309	24	250	254	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					233	236		10.1016/S0896-6273(00)80040-9	http://dx.doi.org/10.1016/S0896-6273(00)80040-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789937	Bronze			2022-12-28	WOS:A1996TW95700002
J	Moriyoshi, K; Richards, LJ; Akazawa, C; OLeary, DDM; Nakanishi, S				Moriyoshi, K; Richards, LJ; Akazawa, C; OLeary, DDM; Nakanishi, S			Labeling neural cells using adenoviral gene transfer of membrane-targeted GFP	NEURON			English	Article							NEURONS; VECTOR	We describe an experimental system to visualize the soma and processes of mammalian neurons and glia in living and fixed preparations by using a recombinant adenovirus vector to transfer the jellyfish green fluorescent protein (GFP) into postmitotic neural cells both in vitro and in vivo. We have introduced several modifications of GFP that enhance its fluorescence intensity in mammalian axons and dendrites. This method should be useful for studying the dynamic processes of cell migration and the development of neuronal connections, as well as for analyzing the function of exogenous genes introduced into cells using the adenovirus vector.	SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037	Salk Institute	Moriyoshi, K (corresponding author), KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.		Richards AO, Linda/P-6372-2014	Richards AO, Linda/0000-0002-7590-7390	NINDS NIH HHS [NS 31558] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558, R01NS031558] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Bayer S.A., 1991, NEOCORTICAL DEV; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHROBOCZEK J, 1992, VIROLOGY, V186, P280, DOI 10.1016/0042-6822(92)90082-Z; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LIU YC, 1994, J NEUROSCI, V14, P5807; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; PENNYPACKER K, 1991, EXP NEUROL, V111, P25, DOI 10.1016/0014-4886(91)90047-G; Precious B., 1985, VIROLOGY PRACTICAL A, P193; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2	21	239	248	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					255	260		10.1016/S0896-6273(00)80044-6	http://dx.doi.org/10.1016/S0896-6273(00)80044-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789941	Bronze			2022-12-28	WOS:A1996TW95700006
J	Quinlan, EM; Halpain, S				Quinlan, EM; Halpain, S			Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; LONG-TERM POTENTIATION; RAT HIPPOCAMPAL-NEURONS; KINASE-C; DENDRITIC SPINES; ACTIN-FILAMENTS; OKADAIC ACID; TUBULIN POLYMERIZATION; SYNAPTIC ACTIVATION; NMDA RECEPTORS	Many activity-dependent changes in synaptic efficacy occur through elevations in postsynaptic calcium triggered by glutamate receptor activation. Here, the postsynaptic, neuron-specific microtubule-associated protein MAPS is identified as a target of bidirectional calcium-dependent signaling pathways activated by glutamate. Glutamate produced a biphasic change in MAPS: a rapid, transient increase in phosphorylation mediated by metabotropic receptors and attenuated by inhibitors of calcium/calmodulin-dependent protein kinases and protein kinase C, followed by a persistent dephosphorylation of MAP2 mediated by NMDA receptors and activation of the calcium/calmodulin-dependent protein phosphatase 2B (calcineurin). Thus, a single transmembrane signal, glutamate, and the increased intracellular calcium it evokes can have opposing actions on a postsynaptic target phosphoprotein. The phosphorylation state of MAPS determines its interaction with microtubules and actin filaments, suggesting that glutamatergic regulation of MAPS phosphorylation may transduce neural activity into modifications in dendritic structure.			Quinlan, EM (corresponding author), UNIV VIRGINIA, DEPT NEUROSCI, CTR CELL SIGNALING, HLTH SCI CTR, CHARLOTTESVILLE, VA 22908 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050861, R29MH050861] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50861, R01 MH050861] Funding Source: Medline; NINDS NIH HHS [NS07199] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKIYAMA T, 1986, J BIOL CHEM, V261, P5648; ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; AOKI C, 1985, J NEUROSCI, V5, P2465; ARIAS C, 1993, J NEUROCHEM, V61, P673; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BERLING B, 1994, EUR J CELL BIOL, V64, P120; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BURGOYNE RD, 1982, FEBS LETT, V146, P273, DOI 10.1016/0014-5793(82)80933-2; CHINESTRA P, 1993, J NEUROPHYSIOL, V70, P2684, DOI 10.1152/jn.1993.70.6.2684; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DESMOND NL, 1983, BRAIN RES, V265, P21, DOI 10.1016/0006-8993(83)91329-X; DIAZNIDO J, 1993, EUR J NEUROSCI, V5, P818, DOI 10.1111/j.1460-9568.1993.tb00933.x; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; EATON SA, 1993, EUR J PHARM-MOLEC PH, V244, P195, DOI 10.1016/0922-4106(93)90028-8; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; ENAN E, 1993, BIOCHEM PHARMACOL, V45, P703, DOI 10.1016/0006-2952(93)90146-N; ETOH S, 1991, NEUROSCI LETT, V126, P119, DOI 10.1016/0304-3940(91)90533-Y; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GOLDENRING JR, 1985, J NEUROCHEM, V45, P900, DOI 10.1111/j.1471-4159.1985.tb04078.x; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; Greenough W. T., 1988, CEREB CORTEX, P391, DOI DOI 10.1007/978-1-4615-6619-9_11; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HARTLEY DM, 1989, J PHARMACOL EXP THER, V250, P752; HERZOG W, 1978, EUR J BIOCHEM, V92, P1, DOI 10.1111/j.1432-1033.1978.tb12716.x; HOSHI M, 1988, EUR J BIOCHEM, V174, P225, DOI 10.1111/j.1432-1033.1988.tb14086.x; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JAMESON L, 1981, P NATL ACAD SCI-BIOL, V78, P3413, DOI 10.1073/pnas.78.6.3413; JEFFERSON AB, 1991, J BIOL CHEM, V266, P346; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; KLANN E, 1991, J BIOL CHEM, V266, P24253; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; KUNZ J, 1993, TRENDS BIOCHEM SCI, V18, P334, DOI 10.1016/0968-0004(93)90069-Y; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; LIPINSKI HG, 1987, BRAIN RES, V437, P26, DOI 10.1016/0006-8993(87)91523-X; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MONTORO RJ, 1993, NEUROSCIENCE, V54, P859, DOI 10.1016/0306-4522(93)90580-9; MORALES M, 1989, CELL TISSUE RES, V256, P447; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; NICHOLSON C, 1983, FED PROC, V42, P2865; NISHIDA E, 1981, J BIOCHEM-TOKYO, V90, P575, DOI 10.1093/oxfordjournals.jbchem.a133510; OTANI S, 1993, INT REV NEUROBIOL, V35, P1, DOI 10.1016/S0074-7742(08)60567-X; PENN AA, 1994, J NEUROSCI, V14, P3805; RANDALL RD, 1992, J NEUROSCI, V12, P1882; RECASENS M, 1995, ANN NY ACAD SCI, V757, P418, DOI 10.1111/j.1749-6632.1995.tb17501.x; SANDOVAL IV, 1978, EUR J BIOCHEM, V92, P463, DOI 10.1111/j.1432-1033.1978.tb12768.x; SATTILARO RF, 1986, BIOCHEMISTRY-US, V25, P2003, DOI 10.1021/bi00356a025; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SELDEN SC, 1983, J BIOL CHEM, V258, P7064; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; SLOBODA RD, 1976, BIOCHEMISTRY-US, V15, P4497, DOI 10.1021/bi00665a026; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; TEYLER TJ, 1994, HIPPOCAMPUS, V4, P623, DOI 10.1002/hipo.450040602; TSUYAMA S, 1986, J BIOL CHEM, V261, P4110; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VALLEE R, 1980, P NATL ACAD SCI-BIOL, V77, P3206, DOI 10.1073/pnas.77.6.3206; WALAAS SI, 1989, J MOL NEUROSCI, V1, P117, DOI 10.1007/BF02918897; WATKINS JC, 1981, ANN REV PHARM TOXICO, V21, P265; WOLFF DJ, 1985, J BIOL CHEM, V260, P4195; YAMAMOTO H, 1988, J NEUROCHEM, V50, P1614, DOI 10.1111/j.1471-4159.1988.tb03051.x; YAMAMOTO H, 1985, J NEUROCHEM, V44, P759, DOI 10.1111/j.1471-4159.1985.tb12880.x; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	87	114	114	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					357	368		10.1016/S0896-6273(00)80053-7	http://dx.doi.org/10.1016/S0896-6273(00)80053-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789950	Bronze			2022-12-28	WOS:A1996TW95700015
J	Naranjo, D; Miller, C				Naranjo, D; Miller, C			A strongly interacting pair of residues on the contact surface of charybdotoxin and a Shaker K+ channel	NEURON			English	Article							POTASSIUM CHANNELS; BINDING-SITE; BLOCKING PEPTIDE; TETRAETHYLAMMONIUM; PORE; INACTIVATION; INHIBITOR; MUTANTS; ION	Charybdotoxin, a peptide neurotoxin of known molecular structure, blocks Shaker K+ channels by binding to a receptor at the outer opening of the ion conduction pathway. Analysis of variants of CTX at position 29 and of Shaker at position 449 shows that these two residues interact closely in the channel-toxin complex. The CTX mutation M29I leads to a slight strengthening of block when tested on Shaker-449T; the same CTX mutation weakens block 1700-fold when tested on Shaker-449F. The known position of CTX-29 on the toxin's interaction surface thus locates Shaker-449 within 5 Angstrom of the pore axis of the closed channel. All four subunits must carry the 449F mutation to produce a highly toxin-insensitive channel.			Naranjo, D (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.			Naranjo, David/0000-0003-3482-5126	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031768, R01GM031768] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-31768] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; FERNANDEZ I, 1994, BIOCHEMISTRY-US, V33, P14256, DOI 10.1021/bi00251a038; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JOHNSON BA, 1994, BIOCHEMISTRY-US, V33, P15061, DOI 10.1021/bi00254a015; JOHNSON BA, 1992, BIOCHEMISTRY-US, V31, P8185; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KREZEL AM, 1995, PROTEIN SCI, V4, P1478, DOI 10.1002/pro.5560040805; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509	32	137	138	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					123	130		10.1016/S0896-6273(00)80029-X	http://dx.doi.org/10.1016/S0896-6273(00)80029-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562075	Bronze			2022-12-28	WOS:A1996TT30700015
J	Tucker, T; Fettiplace, R				Tucker, T; Fettiplace, R			Confocal imaging of calcium microdomains and calcium extrusion in turtle hair cells	NEURON			English	Article							K+ CHANNELS; DEPENDENT CONDUCTANCES; FREQUENCY-SELECTIVITY; TRANSMITTER RELEASE; COCHLEA; CHICK; ION; CURRENTS; TRANSDUCTION; ADAPTATION	We have studied spatial Ca2+ distribution in hair cells filled with the low affinity fluorescent indicator Calcium Green 5N using real-time confocal microscopy and whole-cell recording. During depolarizations lasting several hundred milliseconds, Ca2+ fluorescence increased at a number of hotspots around the base of the cell but changed little near the hair bundle. The hotspots required influx of Ca2+ through voltage-dependent channels, and they expanded during the pulse from an initial diameter of <1 mu m. Strong Ca2+ buffers like BAPTA slowed their growth rate. On repolarization, the fluorescence decayed with two time constants: similar to 0.1 s, which may represent Ca2+ diffusion away from the entry sites, and 10 s, probably reflecting Ca2+ extrusion. Extrusion occurs mainly via a CaAT-Pase that can be blocked by vanadate. We suggest the hotspots are microdomains of Ca2+ attaining a concentration of at least 85 mu M near assemblies of synaptic release sites.			Tucker, T (corresponding author), UNIV WISCONSIN,SCH MED,DEPT NEUROPHYSIOL,NEUROSCI TRAINING PROGRAM,MADISON,WI 53706, USA.				NIDCD NIH HHS [5 R01 DC 01362] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ART JJ, 1993, J PHYSIOL-LONDON, V470, P109, DOI 10.1113/jphysiol.1993.sp019850; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; ASHMORE JF, 1990, J PHYSIOL-LONDON, V428, P109, DOI 10.1113/jphysiol.1990.sp018203; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLAUSTEI.MP, 1969, J PHYSIOL-LONDON, V200, P497, DOI 10.1113/jphysiol.1969.sp008704; BLAUSTEIN MP, 1991, ANN NY ACAD SCI, V639, P254, DOI 10.1111/j.1749-6632.1991.tb17315.x; CHABBERT C, 1994, PFLUGERS ARCH, V420, P493; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; EATOCK RA, 1987, J NEUROSCI, V7, P2821; ESCOBAR AL, 1994, NATURE, V367, P739, DOI 10.1038/367739a0; FETTIPLACE R, 1992, SOC GEN PHY, V47, P343; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FUCHS PA, 1988, J NEUROSCI, V8, P2460; FUCHS PA, 1992, J NEUROSCI, V12, P800; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; IKEDA K, 1992, PFLUG ARCH EUR J PHY, V420, P493, DOI 10.1007/BF00374624; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; KASS GEN, 1989, J BIOL CHEM, V264, P15192; LANG DG, 1990, J PHYSIOL-LONDON, V425, P117, DOI 10.1113/jphysiol.1990.sp018095; Lenzi David, 1994, Current Opinion in Neurobiology, V4, P496, DOI 10.1016/0959-4388(94)90049-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Mountcastle V., 1984, HDB PHYSL NERVOUS SY, VIII, P639; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; OHMORI H, 1984, J PHYSIOL-LONDON, V350, P561, DOI 10.1113/jphysiol.1984.sp015218; OLIVA C, 1988, BIOPHYS J, V54, P791, DOI 10.1016/S0006-3495(88)83017-0; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Pawley James, 1995, P19; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SAITO K, 1983, CELL TISSUE RES, V229, P467; SCHATZMANN HJ, 1989, ANNU REV PHYSIOL, V51, P473, DOI 10.1146/annurev.ph.51.030189.002353; SCHULTE BA, 1993, HEARING RES, V65, P262, DOI 10.1016/0378-5955(93)90219-Q; SHIGEMOTO T, 1991, J PHYSIOL-LONDON, V442, P669, DOI 10.1113/jphysiol.1991.sp018814; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SNEARY MG, 1988, J COMP NEUROL, V276, P588, DOI 10.1002/cne.902760411; TSIEN RY, 1980, BIOCHIM BIOPHYS ACTA, V599, P623, DOI 10.1016/0005-2736(80)90205-9; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; YAO Y, 1994, J PHYSIOL-LONDON, V476, P17	46	136	137	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1323	1335		10.1016/0896-6273(95)90011-X	http://dx.doi.org/10.1016/0896-6273(95)90011-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845156	Bronze			2022-12-28	WOS:A1995TL67800011
J	JIN, J; CROUCH, RK; CORSON, DW; KATZ, BM; MACNICHOL, EF; CORNWALL, MC				JIN, J; CROUCH, RK; CORSON, DW; KATZ, BM; MACNICHOL, EF; CORNWALL, MC			NONCOVALENT OCCUPANCY OF THE RETINAL-BINDING POCKET OF OPSIN DIMINISHES BLEACHING ADAPTATION OF RETINAL CONES	NEURON			English	Article							VISUAL PIGMENTS; LIGHT ADAPTATION; SKATE RETINA; RHODOPSIN; PHOTORECEPTORS; SENSITIVITY; SALAMANDER; MEMBRANE; PROTEINS; ANALOGS	Bright light bleaches visual pigment and leads to a persistent desensitization of isolated rod and cone photoreceptors called bleaching adaptation. Bleaching adaptation results from the combined effects of pigment depletion and adaptational modulation of certain cellular reactions in the visual transduction cascade. Here, we present evidence that in solitary cone photoreceptors isolated from the salamander retina, the latter effect is due to the presence of free opsin in the outer segment. Also, we demonstrate that this ''opsin adaptation'' can be reversed by treating the cells with synthetic retinoids similar to 11-cis retinal but having polyene chains too short to form protonated Schiff base attachments to opsin.	MED UNIV S CAROLINA, DEPT OPHTHALMOL, CHARLESTON, SC 29425 USA; MED UNIV S CAROLINA, DEPT PATHOL & LAB MED, CHARLESTON, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	JIN, J (corresponding author), BOSTON UNIV, DEPT PHYSIOL, BOSTON, MA 02118 USA.			Cornwall, M./0000-0002-0847-939X	NATIONAL EYE INSTITUTE [R01EY004939, R01EY001157, R01EY007543] Funding Source: NIH RePORTER; NEI NIH HHS [EY07543, EY04939, EY01157] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; BACKSTROM AC, 1978, J PHYSL, V287, P107; BAUMANN C, 1973, J PHYSIOL-LONDON, V235, P761, DOI 10.1113/jphysiol.1973.sp010415; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1982, J PHYSIOL-LONDON, V328, P49, DOI 10.1113/jphysiol.1982.sp014252; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; BLATZ PE, 1969, J AM CHEM SOC, V91, P5930, DOI 10.1021/ja01049a069; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BRIN KP, 1977, J GEN PHYSIOL, V69, P97, DOI 10.1085/jgp.69.1.97; CATT M, 1982, BIOCHEM SOC T, V10, P343, DOI 10.1042/bst0100343; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; CORSON DW, 1990, P NATL ACAD SCI USA, V87, P6823, DOI 10.1073/pnas.87.17.6823; CROUCH RK, 1992, PHOTOCHEM PHOTOBIOL, V56, P251, DOI 10.1111/j.1751-1097.1992.tb02154.x; CROUCH RK, 1982, VISION RES, V22, P1451, DOI 10.1016/0042-6989(82)90209-7; DAEMEN FJM, 1978, NATURE, V276, P847, DOI 10.1038/276847a0; DALY SJ, 1985, VISION RES, V25, P1197, DOI 10.1016/0042-6989(85)90034-3; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; FINDLAY JBC, 1986, BIOCHEM J, V238, P625, DOI 10.1042/bj2380625; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HOLLINS M, 1973, J GEN PHYSIOL, V62, P430, DOI 10.1085/jgp.62.4.430; HUBBARD R., 1971, Methods in Enzymology, V18C, P615, DOI 10.1016/S0076-6879(71)18045-7; JOHNSON GL, 1989, ENDOCR REV, V10, P317, DOI 10.1210/edrv-10-3-317; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; JONES GJ, 1993, IN PRESS J GEN PHYSL; KROPF A, 1958, ANN NY ACAD SCI, V74, P266, DOI 10.1111/j.1749-6632.1958.tb39550.x; LAMB TD, 1986, MOL MECHANISM PHOTOR, P267; MacNichol E. F.  Jr., 1978, Frontiers in Visual Science, P194; MAKINO CL, 1991, J PHYSIOL-LONDON, V442, P761, DOI 10.1113/jphysiol.1991.sp018818; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; PEPPERBERG DR, 1984, VISION RES, V24, P357, DOI 10.1016/0042-6989(84)90061-0; PEPPERBERG DR, 1978, J GEN PHYSIOL, V71, P369, DOI 10.1085/jgp.71.4.369; PERLMAN JI, 1982, J GEN PHYSIOL, V80, P885, DOI 10.1085/jgp.80.6.885; RIPPS H, 1987, NEUROSCI RES, pS87, DOI 10.1016/0921-8696(87)90010-7; RUSHTON WA, 1961, J PHYSIOL-LONDON, V156, P193, DOI 10.1113/jphysiol.1961.sp006668; RUSHTON WAH, 1965, PROC R SOC SER B-BIO, V162, P20, DOI 10.1098/rspb.1965.0024; STECHER PG, 1968, MERCK INDEX, P574; SZUTS EZ, 1991, ARCH BIOCHEM BIOPHYS, V287, P297, DOI 10.1016/0003-9861(91)90482-X; TOWNER P, 1981, EUR J BIOCHEM, V117, P353, DOI 10.1111/j.1432-1033.1981.tb06345.x; VONISLER O, 1956, HELV CHIM ACTA, V39, P259; YOSHIKAMI S, 1978, SCIENCE, V200, P1393	43	58	64	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1993	11	3					513	522		10.1016/0896-6273(93)90155-K	http://dx.doi.org/10.1016/0896-6273(93)90155-K			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398144				2022-12-28	WOS:A1993LY49800011
J	REGEHR, W; KEHOE, J; ASCHER, P; ARMSTRONG, C				REGEHR, W; KEHOE, J; ASCHER, P; ARMSTRONG, C			SYNAPTICALLY TRIGGERED ACTION-POTENTIALS IN DENDRITES	NEURON			English	Article							NEURONS; RECORDINGS	We tested the hypothesis that action potentials originate in apical dendrites of pyramidal cells. Layer V somata were voltage clamped in thin slices of rat motor cortex. Fibers synapsing in unclamped regions far out on the apical dendrite caused small, slow synaptic currents, as recorded at the soma, and sometimes elicited complex, multicomponent current spikes, beginning with a small first spike. Hyperpolarization, or tetrodotoxin applied to basal dendrites and soma, blocked the later spike components without affecting the synaptic current and the first component, which was a synaptically triggered Na+ spike in the apical dendrite. Similar spikes followed voltage steps or direct stimulation. We conclude that Na+ action potentials are initiated in the apical dendrite in response to synaptic input.	ECOLE NORMALE SUPER,NEUROBIOL LAB,F-75231 PARIS 05,FRANCE	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	REGEHR, W (corresponding author), UNIV PENN,DEPT PHYSIOL,PHILADELPHIA,PA 19104, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012547] Funding Source: NIH RePORTER; NINDS NIH HHS [NS12547] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FATT P, 1957, J NEUROPHYSIOL, V20, P27, DOI 10.1152/jn.1957.20.1.27; FOURTES MGF, 1957, J GEN PHYSIOL, V40, P735; HUGUENARD JR, 1989, P NATL ACAD SCI USA, V86, P2473, DOI 10.1073/pnas.86.7.2473; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; PHILLIPS C. G., 1959, QUART JOUR EXPTL PHYSIOL, V44, P1; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986	16	95	96	1	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					145	151		10.1016/0896-6273(93)90278-Y	http://dx.doi.org/10.1016/0896-6273(93)90278-Y			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338663				2022-12-28	WOS:A1993LP43000013
J	Keynes, R; Cook, GMW				Keynes, R; Cook, GMW			Axons turn as netrins find their receptor	NEURON			English	Review							FLOOR PLATE; C-ELEGANS; GUIDANCE; PROTEIN; GROWTH; UNC-6; CELL				Keynes, R (corresponding author), UNIV CAMBRIDGE,DEPT ANAT,DOWNING ST,CAMBRIDGE CB2 3DY,ENGLAND.							CAJAL SRY, 1909, HIST SYSTEME NERVEUX, P661; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CHO KR, 1995, CURR OPIN GENET DEV, V5, P72, DOI 10.1016/S0959-437X(95)90056-X; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Cooper HM, 1995, ONCOGENE, V11, P2243; CULOTTI JG, 1994, CURR OPIN GENET DEV, V4, P587, DOI 10.1016/0959-437X(94)90077-G; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V2, P61; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MITHCELL KJ, 1996, NEURON, V17, P203; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SERAFINI T, 1996, IN PRESS CELL, V87; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; SHIRASAKI R, 1997, IN PRESS NEURON, V18; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P65912; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TUCKER A, 1997, IN PRESS NEURON, V18; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5	25	11	17	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1031	1034		10.1016/S0896-6273(00)80235-4	http://dx.doi.org/10.1016/S0896-6273(00)80235-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982151	Bronze			2022-12-28	WOS:A1996WA24800001
J	Muller, D; Wang, C; Skibo, G; Toni, N; Cremer, H; Calaora, V; Rougon, G; Kiss, JZ				Muller, D; Wang, C; Skibo, G; Toni, N; Cremer, H; Calaora, V; Rougon, G; Kiss, JZ			PSA-NCAM is required for activity-induced synaptic plasticity	NEURON			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; HIPPOCAMPAL ORGANOTYPIC CULTURES; N-CAM; POLYSIALIC ACID; NEURITE OUTGROWTH; AREA CA1; ADULT; GROWTH; L1	Hippocampal organotypic slice cultures maintained 10-20 days in vitro express a high level of the polysialylated embryonic form of neural cell adhesion molecule (NCAM) (PSA-NCAM). Treatment of the cultures with endoneuraminidase-N selectively removed polysialic acid (PSA) from NCAM and completely prevented induction of long-term potentiation (LTP) and long-term depression (LTD) without affecting cellular or synaptic parameters. Similarly, slices prepared from transgenic mice lacking the NCAM gene exhibited a decaying LTP. No inhibition of N-methyl-D-aspartic acid receptor-dependent synaptic responses was detected. Washout of the enzyme resulted in reexpression of PSA immunoreactivity which correlated with a complete recovery of LTP and LTD. This reexpression was blocked by TTX and low calcium and enhanced by bicuculline. Taken together, these results indicate that neuronal activity regulates the expression of PSA-NCAM at the synapse and that this expression is required for the induction of synaptic plasticity.	AA BOGOMOLETS PHYSIOL INST,UA-252601 KIEV,UKRAINE; UNIV LUMINY,LAB GENET & PHYSIOL DEV,F-13288 MARSEILLE,FRANCE	National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Muller, D (corresponding author), UNIV GENEVA,CTR MED,DEPT MORPHOL,CH-1211 GENEVA 4,SWITZERLAND.		ROUGON, Genevieve/G-2578-2013; Toni, Nicolas/M-2057-2014	Toni, Nicolas/0000-0001-5585-268X; ROUGON, Genevieve/0000-0003-1316-8200; Skibo, Galyna/0000-0003-2187-6178; Cremer, Harold/0000-0002-8673-5176				BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P417, DOI 10.1002/hipo.450030404; Goridis C, 1992, Semin Cell Biol, V3, P189; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; KISS JZ, 1993, NEUROSCIENCE, V53, P213, DOI 10.1016/0306-4522(93)90299-U; KLINZ SG, 1995, J NEUROCHEM, V65, P84; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER D, 1994, NEUROSCIENCE, V61, P441, DOI 10.1016/0306-4522(94)90424-3; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; ROUGON G, 1993, EUR J CELL BIOL, V61, P197; ROUGON G, 1986, J CELL BIOL, V103, P2429, DOI 10.1083/jcb.103.6.2429; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SADOUL R, 1983, NATURE, V304, P347, DOI 10.1038/304347a0; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STOPPINI L, 1993, NEUROSCIENCE, V57, P985, DOI 10.1016/0306-4522(93)90043-F; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; WANG C, 1994, J NEUROSCI, V14, P4446; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; WILLIAMS EJ, 1995, MOL CELL NEUROSCI, V6, P69, DOI 10.1006/mcne.1995.1007; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992; ZUBER C, 1992, J BIOL CHEM, V267, P9965	41	505	519	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					413	422		10.1016/S0896-6273(00)80174-9	http://dx.doi.org/10.1016/S0896-6273(00)80174-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816705	Bronze			2022-12-28	WOS:A1996VJ44000008
J	Sudhof, TC; Rizo, J				Sudhof, TC; Rizo, J			Synaptotagmins: C-2-domain proteins that regulate membrane traffic	NEURON			English	Review							SQUID GIANT SYNAPSE; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; CAENORHABDITIS-ELEGANS; CALCIUM-DEPENDENCE; MESSENGER-RNAS; C2B DOMAIN; KINASE-C; TRANSMISSION; DROSOPHILA		UNIV TEXAS,SW MED CTR,DEPT MOL GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235, USA.							AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1996, IN PRESS BIOCH BIOPH; CRAXTON M, 1995, FEBS LETT, V361, P196, DOI 10.1016/0014-5793(95)00176-A; DAVLETOV BA, 1994, J BIOL CHEM, V269, P28547; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HILBUSH BS, 1994, P NATL ACAD SCI USA, V91, P8195, DOI 10.1073/pnas.91.17.8195; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Kee Y, 1996, J NEUROSCI, V16, P1975; KELLY RB, 1995, CURR BIOL, V5, P257, DOI 10.1016/S0960-9822(95)00054-6; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kwon OJ, 1996, FEBS LETT, V378, P135, DOI 10.1016/0014-5793(95)01430-6; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; MARQUEZE B, 1995, J NEUROSCI, V15, P4906; MARTIN KC, 1995, P NATL ACAD SCI USA, V92, P11307, DOI 10.1073/pnas.92.24.11307; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; NEHER E, 1994, NATURE, V372, P316, DOI 10.1038/372316a0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; PERIN MS, 1994, J BIOL CHEM, V269, P8576; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SASAKAGUCHI G, 1995, BIOCHEM BIOPH RES CO, V217, P1053; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; ULLRICH U, 1994, NEURON, V13, P1281; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	70	393	394	2	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					379	388		10.1016/S0896-6273(00)80171-3	http://dx.doi.org/10.1016/S0896-6273(00)80171-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816702	Bronze			2022-12-28	WOS:A1996VJ44000005
J	Berkowitz, A				Berkowitz, A			Networks of neurons, networks of genes	NEURON			English	Review							BEHAVIOR; COMMAND				Berkowitz, A (corresponding author), UNIV CALIF LOS ANGELES,DEPT PSYCHOL,LOS ANGELES,CA 90024, USA.			Berkowitz, Ari/0000-0001-9002-5874				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; CONNOLLY JB, 1996, SCIENCES, V36, P37; EATON RC, 1985, BRAIN BEHAV EVOLUT, V27, P132, DOI 10.1159/000118726; Eaton RC., 1984, NEURAL MECH STARTLE, DOI [10.1007/978-1-4899-2286-1, DOI 10.1007/978-1-4899-2286-1]; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Getting P.A., 1985, P3; Goodale M A, 1993, Curr Opin Neurobiol, V3, P578, DOI 10.1016/0959-4388(93)90059-8; GROBSTEIN P, 1990, COMPUTATIONAL NEUROS, P19; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hess EJ, 1996, NEURON, V16, P1073, DOI 10.1016/S0896-6273(00)80133-6; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; Lashley KS, 1930, PSYCHOL REV, V37, P1, DOI 10.1037/h0074134; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; Marder E, 1995, CURR OPIN NEUROBIOL, V5, P832, DOI 10.1016/0959-4388(95)80113-8; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; MORTON DW, 1994, TRENDS NEUROSCI, V17, P413, DOI 10.1016/0166-2236(94)90015-9; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; SELVERSTON A, 1982, TRENDS NEUROSCI, V5, P120, DOI 10.1016/0166-2236(82)90071-6; SELVERSTON A, 1995, J COMP PHYSIOL A, V176, P139; SELVERSTON AI, 1980, BEHAV BRAIN SCI, V3, P535, DOI 10.1017/S0140525X00006580; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; SUGA N, 1988, NEUROBIOLOGY NEOCORT, P331; WALLACE SF, 1990, J COMP NEUROL, V296, P222, DOI 10.1002/cne.902960204	26	5	5	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					199	202		10.1016/S0896-6273(00)80152-X	http://dx.doi.org/10.1016/S0896-6273(00)80152-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780644	Bronze			2022-12-28	WOS:A1996VE84000003
J	McFarlane, S; Cornel, E; Amaya, E; Holt, CE				McFarlane, S; Cornel, E; Amaya, E; Holt, CE			Inhibition of FGF receptor activity in retinal ganglion cell axons causes errors in target recognition	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; NEURITE OUTGROWTH; XENOPUS-LAEVIS; VISUAL-SYSTEM; DEVELOPMENTAL EXPRESSION; CONE GUIDANCE; IN-VIVO; NEURONS; DIFFERENTIATION; IDENTIFICATION	Native fibroblast growth factor receptor (FGFR) function was inhibited in developing Xenopus retinal ganglion cells (RGCs) by in vivo transfection of a dominant negative FGFR. Axons expressing the dominant negative protein advanced at 60% of the normal speed, but nevertheless navigated appropriately in the embryonic optic pathway. When they neared the optic tectum, however, many axons made erroneous turns, causing them to bypass rather than enter their target. By contrast, RGC axons expressing nonfunctional FGFR mutants entered the tectum correctly. These findings demonstrate a role for FGFR signaling in the extension and targeting of RGC axons and suggest that receptor tyrosine kinase/growth factor interactions play a critical function in establishing initial connectivity in the vertebrate visual system.	UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	McFarlane, S (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.			Holt, Christine Elizabeth/0000-0003-2829-121X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023780] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23780] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMAYA E, 1993, DEVELOPMENT, V118, P477; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BYERS S, 1992, DEV BIOL, V152, P411, DOI 10.1016/0012-1606(92)90149-B; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Elshamy WM, 1996, DEVELOPMENT, V122, P491; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FRIESEL R, 1991, MOL CELL BIOL, V11, P2481, DOI 10.1128/MCB.11.5.2481; FRIESEL R, 1992, DEVELOPMENT, V116, P1051; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; ISAACS HV, 1995, INT J DEV BIOL, V39, P575; KINOSHITA N, 1995, CELL, V83, P621, DOI 10.1016/0092-8674(95)90102-7; Launay C, 1996, DEVELOPMENT, V122, P869; LILIENBAUM A, 1995, MOL CELL NEUROSCI, V6, P139, DOI 10.1006/mcne.1995.1013; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIPTON SA, 1988, P NATL ACAD SCI USA, V85, P2388, DOI 10.1073/pnas.85.7.2388; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; MUSOI TJ, 1990, P NATL ACAD SCI USA, V87, P8365; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ROU JF, 1996, BIOCHEM BIOPH RES CO, V218, P198; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SHIOZAKI C, 1995, GENE, V152, P215, DOI 10.1016/0378-1119(94)00694-N; TANNAHILL D, 1992, DEVELOPMENT, V115, P695; TCHENG M, 1994, EXP EYE RES, V58, P351, DOI 10.1006/exer.1994.1025; UENO H, 1992, J BIOL CHEM, V267, P1470; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WALLICKE PC, 1986, P NATL ACAD SCI USA, V83, P3012; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1995, J CELL SCI, V108, P3523; Worley T, 1996, J NEUROSCI, V16, P2294; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; ZHANG L, 1994, J NEUROSCI, V14, P5187	51	132	133	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					245	254		10.1016/S0896-6273(00)80156-7	http://dx.doi.org/10.1016/S0896-6273(00)80156-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780648	Bronze			2022-12-28	WOS:A1996VE84000007
J	Dani, JA; Heinemann, S				Dani, JA; Heinemann, S			Molecular and cellular aspects of nicotine abuse	NEURON			English	Review							ACETYLCHOLINE-RECEPTOR; RAT; NEURONS; SYSTEM; HUMANS; DRUGS		SALK INST, MOLEC NEUROBIOL LAB, SAN DIEGO, CA 92186 USA	Salk Institute	Dani, JA (corresponding author), BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA.							BENOWITZ NL, 1989, PROG BRAIN RES, V79, P279; CALABRESI P, 1989, BRIT J PHARMACOL, V98, P135, DOI 10.1111/j.1476-5381.1989.tb16873.x; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; CLARKE PBS, 1991, ADV PHAR SC, P285; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GOLDBERG SR, 1988, PHARMACOL BIOCHEM BE, V30, P227, DOI 10.1016/0091-3057(88)90450-9; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HULIHANGIBLIN BA, 1990, J PHARMACOL EXP THER, V252, P21; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; LESTER RAJ, 1994, NEUROPHARMACOLOGY, V33, P27, DOI 10.1016/0028-3908(94)90093-0; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MARKS MJ, 1993, J PHARMACOL EXP THER, V266, P1268; MARKS MJ, 1992, J NEUROSCI, V12, P2765; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; PENG X, 1994, MOL PHARMACOL, V46, P523; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; RUSSELL MAH, 1989, PROG BRAIN RES, V79, P289; SCHELLING TC, 1992, SCIENCE, V255, P430, DOI 10.1126/science.1734519; SHOAIB M, 1994, PSYCHOPHARMACOLOGY, V113, P445, DOI 10.1007/BF02245221; STOLERMAN IP, 1991, TRENDS PHARMACOL SCI, V12, P467, DOI 10.1016/0165-6147(91)90638-9; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WONNACOTT S, 1990, TRENDS PHARMACOL SCI, V11, P216, DOI 10.1016/0165-6147(90)90242-Z	25	471	483	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					905	908		10.1016/S0896-6273(00)80112-9	http://dx.doi.org/10.1016/S0896-6273(00)80112-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630247	Bronze			2022-12-28	WOS:A1996UN48000004
J	Inagaki, N; Gonoi, T; Clement, JP; Wang, CZ; AguilarBryan, L; Bryan, J; Seino, S				Inagaki, N; Gonoi, T; Clement, JP; Wang, CZ; AguilarBryan, L; Bryan, J; Seino, S			A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels	NEURON			English	Article							BETA-CELL TUMOR; POTASSIUM CHANNELS; VENTRICULAR MYOCYTES; H-3 GLIBENCLAMIDE; GLYBURIDE ANALOG; CARDIAC MYOCYTES; RAT; MUSCLE; BRAIN; PURIFICATION	We have cloned an isoform of the sulfonylurea receptor (SUR), designated SUR2. Coexpression of SUR2 and the inward rectifier K+ channel subunit Kir6.2 in COS1 cells reconstitutes the properties of K-ATP channels described in cardiac and skeletal muscle. The SUR2/Kir6.2 channel is less sensitive than the SUR/Kir6.2 channel (the pancreatic beta cell K-ATP channel) to both ATP and the sulfonylurea glibenclamide and is activated by the cardiac K-ATP channel openers, cromakalim and pinacidil, but not by diazoxide. In addition, SUR2 binds glibenclamide with lower affinity. The present study shows that the ATP sensitivity and pharmacological properties of K-ATP channels are determined by a family of structurally related but functionally distinct sulfonylurea receptors.	CHIBA UNIV,PATHOGEN FUNGI & MICROBIAL TOXICOSES RES CTR,CHUO KU,CHIBA 260,JAPAN; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030	Chiba University; Baylor College of Medicine; Baylor College of Medicine	Inagaki, N (corresponding author), CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOLEC MED,CHUO KU,CHIBA 260,JAPAN.		, gonoi/GRS-0648-2022; gonoi, tohru/AAC-5181-2021	, gonoi/0000-0003-3655-7911; gonoi, tohru/0000-0003-3655-7911; Inagaki, Nobuya/0000-0001-8261-2593				AGUILARBRYAN L, 1990, J BIOL CHEM, V265, P8218; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ammala C, 1996, NATURE, V379, P545, DOI 10.1038/379545a0; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; ASHFORD MLJ, 1988, PFLUG ARCH EUR J PHY, V412, P297, DOI 10.1007/BF00582512; BERNARDI H, 1988, P NATL ACAD SCI USA, V85, P9816, DOI 10.1073/pnas.85.24.9816; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DAVIES NW, 1991, J BIOENERG BIOMEMBR, V23, P509, DOI 10.1007/BF00785809; ESCANDE D, 1988, BIOCHEM BIOPH RES CO, V154, P620, DOI 10.1016/0006-291X(88)90184-2; ESCANDE D, 1989, PFLUG ARCH EUR J PHY, V414, P669, DOI 10.1007/BF00582134; FAN Z, 1990, J PHYSIOL-LONDON, V430, P273, DOI 10.1113/jphysiol.1990.sp018291; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GAINES KL, 1988, J BIOL CHEM, V263, P2589; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; KAUBISCH N, 1982, BIOCHEM PHARMACOL, V31, P1171, DOI 10.1016/0006-2952(82)90363-X; KRAMER W, 1988, FEBS LETT, V229, P355, DOI 10.1016/0014-5793(88)81155-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUPO B, 1987, EUR J PHARMACOL, V140, P157, DOI 10.1016/0014-2999(87)90801-6; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; NELSON DA, 1992, J BIOL CHEM, V267, P14928; NICHOLAS B, 1989, SCIENCE, V245, P177; NICHOLS CG, 1990, J PHYSIOL-LONDON, V423, P91, DOI 10.1113/jphysiol.1990.sp018013; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; QUAST U, 1989, TRENDS PHARMACOL SCI, V10, P431, DOI 10.1016/S0165-6147(89)80003-3; RIORDAN JR, 1989, SCIENCE, V245, P1066; SPRUCE AE, 1985, NATURE, V316, P736, DOI 10.1038/316736a0; STURGESS NC, 1985, LANCET, V2, P474; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251	34	829	859	1	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					1011	1017		10.1016/S0896-6273(00)80124-5	http://dx.doi.org/10.1016/S0896-6273(00)80124-5			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630239	Bronze			2022-12-28	WOS:A1996UN48000016
J	Voyvodic, JT				Voyvodic, JT			Cell death in cortical development: How much? Why? So what?	NEURON			English	Review							RETINA; LINEAGE; SURVIVAL; MOUSE				Voyvodic, JT (corresponding author), UNIV PITTSBURGH,DEPT RADIOL,PITTSBURGH,PA 15213, USA.							BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; FERRER I, 1992, PROG NEUROBIOL, V39, P1, DOI 10.1016/0301-0082(92)90029-E; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOMMA S, 1994, J COMP NEUROL, V345, P377, DOI 10.1002/cne.903450305; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	16	64	66	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					693	696		10.1016/S0896-6273(00)80089-6	http://dx.doi.org/10.1016/S0896-6273(00)80089-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607987	Bronze			2022-12-28	WOS:A1996UG61100002
J	Bonci, A; Williams, JT				Bonci, A; Williams, JT			A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine	NEURON			English	Article							RAT NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; BEHAVIORAL SENSITIZATION; CYCLIC-AMP; EXTRACELLULAR DOPAMINE; RECEPTOR FUNCTION; CEREBRAL-CORTEX; TIME COURSE; RELEASE; ADENOSINE	The mesolimbic system is known to play a role in self-administration of opioids and psychostimulants. Although morphine and cocaine act by separate cellular mechanisms initially, the present study describes a common change in synaptic regulation of dopamine cells in the ventral tegmental area 1 week after termination of chronic treatment with either drug. Normally, D1 receptor activation augmented the amplitude of a gamma-aminobutyric acid type a (GABA(B)) inhibitory postsynaptic potential (IPSP), but in drug-experienced animals, D1 receptor activation caused an inhibition of the GABA(B) IPSP. The inhibition was blocked by adenosine A1 receptor antagonists and by agents that disrupted the metabolism of cAMP. This long-lasting dopamine-adenosine interaction may be one mechanism involved in dopamine-mediated craving and relapse to drug-seeking behaviors.			Bonci, A (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.				NIDA NIH HHS [DA08163, DA04523] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008163, R01DA004523] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ACKERMAN JM, 1992, EUR J PHARMACOL, V218, P171, DOI 10.1016/0014-2999(92)90161-V; BARBER R, 1981, MOL PHARMACOL, V19, P38; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; CAMERON DL, 1993, NATURE, V366, P344, DOI 10.1038/366344a0; CAMERON DL, 1994, J NEUROSCI, V14, P6763; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; CUNHA RA, 1992, J NEUROCHEM, V59, P657, DOI 10.1111/j.1471-4159.1992.tb09420.x; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; DUNWIDDIE TV, 1985, INT REV NEUROBIOL, V27, P63, DOI 10.1016/S0074-7742(08)60556-5; EGAWA M, 1988, BRAIN RES, V458, P303, DOI 10.1016/0006-8993(88)90472-6; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; GEREAU RW, 1994, NEURON, V12, P1121, DOI 10.1016/0896-6273(94)90319-0; HAAS HL, 1988, N-S ARCH PHARMACOL, V337, P561; HENRY DJ, 1995, J NEUROSCI, V15, P6287; HENRY DJ, 1989, J PHARMACOL EXP THER, V251, P833; HENRY DJ, 1991, J PHARMACOL EXP THER, V258, P882; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KALIVAS PW, 1993, J NEUROSCI, V13, P276; KORF J, 1976, NATURE, V260, P257, DOI 10.1038/260257a0; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LAZARENO S, 1985, BRAIN RES, V361, P91, DOI 10.1016/0006-8993(85)91278-8; LINDEN J, 1989, TRENDS PHARMACOL SCI, V10, P260, DOI 10.1016/0165-6147(89)90021-7; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MAYFIELD RD, 1992, BRAIN RES, V573, P331, DOI 10.1016/0006-8993(92)90783-6; MERCURI NB, 1989, BRIT J PHARMACOL, V98, P127, DOI 10.1111/j.1476-5381.1989.tb16872.x; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; NESTLER EJ, 1994, CELL, V79, P923, DOI 10.1016/0092-8674(94)90022-1; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; PADEN C, 1976, LIFE SCI, V19, P1499, DOI 10.1016/0024-3205(76)90094-1; PERIS J, 1990, J PHARMACOL EXP THER, V253, P38; RAGAZZI E, 1991, CIRC RES, V68, P1036; ROBERTSON GS, 1991, J NEUROSCI, V11, P2209; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; ROSEBOOM PH, 1990, J PHARMACOL EXP THER, V255, P197; ROSENBERG PA, 1989, J NEUROSCI, V9, P2654; ROSENBERG PA, 1994, J NEUROSCI, V14, P2953; SCHOEN SW, 1995, NEUROSCIENCE, V65, P37, DOI 10.1016/0306-4522(94)00469-L; SCHWABE U, 1980, N-S ARCH PHARMACOL, V313, P179, DOI 10.1007/BF00505731; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; TIMMERMAN W, 1995, IN PRESS SYNAPSE; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WOOLVERTON WL, 1992, TRENDS PHARMACOL SCI, V13, P193, DOI 10.1016/0165-6147(92)90063-C; WU YN, 1995, J PHARMACOL EXP THER, V273, P576; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; ZIMMERMANN H, 1993, NEUROSCIENCE, V55, P105, DOI 10.1016/0306-4522(93)90458-R	50	186	187	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					631	639		10.1016/S0896-6273(00)80082-3	http://dx.doi.org/10.1016/S0896-6273(00)80082-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785060	Bronze			2022-12-28	WOS:A1996UC16800019
J	Das, A				Das, A			Orientation in visual cortex: A simple mechanism emerges	NEURON			English	Review							CAT STRIATE CORTEX; RECEPTIVE-FIELDS; GENICULOCORTICAL AFFERENTS; SELECTIVITY; CELLS; INHIBITION; RESPONSES; NEURONS				Das, A (corresponding author), ROCKEFELLER UNIV,1230 YORK AVE,NEW YORK,NY 10021, USA.							BISHOP PO, 1973, J PHYSIOL-LONDON, V231, P31, DOI 10.1113/jphysiol.1973.sp010218; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; CREUTZFELDT OD, 1974, EXP BRAIN RES, V21, P251; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1988, NATURE, V332, P642, DOI 10.1038/332642a0; FERSTER D, 1987, TRENDS NEUROSCI, V10, P487, DOI 10.1016/0166-2236(87)90126-3; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1992, J NEUROSCI, V12, P1262; FERSTER D, 1996, IN PRESS NATURE; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; MALPELI JG, 1983, J NEUROPHYSIOL, V49, P595, DOI 10.1152/jn.1983.49.3.595; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; PEI X, 1994, J NEUROSCI, V14, P7130; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SUAREZ H, 1995, J NEUROSCI, V15, P6700; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303	23	27	27	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					477	480		10.1016/S0896-6273(00)80067-7	http://dx.doi.org/10.1016/S0896-6273(00)80067-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785045	Bronze			2022-12-28	WOS:A1996UC16800004
J	Neveu, D; Zucker, RS				Neveu, D; Zucker, RS			Postsynaptic levels of [Ca2+](i) needed to trigger LTD and LTP	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC TRANSMISSION; RAT VISUAL-CORTEX; PROTEIN-KINASE; AREA CA1; BLOCKS INDUCTION; DM-NITROPHEN; DEPRESSION; CALCIUM; HIPPOCAMPUS	Long-term potentiation (LTP) and long-term depression (LTD) in CA1 pyramidal neurons are both triggered by a postsynaptic rise in intracellular Ca2+ concentration ([Ca2+](i)). We used photolysis of postsynaptic caged Ca2+ compounds to search for differential thresholds for activation of these processes. Longlasting potentiation (LLP) resembling LTP, and longlasting depression (LLD) resembling LTD, were evoked by [Ca2+](i) elevations of comparable magnitude and duration in different cells. No distinctions in threshold for these processes were detectable. LLP was occluded by tetanically induced LTP and blocked by calmodulin inhibition, and LLD was occluded by electrically induced LTD and blocked by phosphatase inhibition.			Neveu, D (corresponding author), UNIV CALIF BERKELEY,DIV NEUROBIOL,BERKELEY,CA 94720, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15114] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; HIRSCH JC, 1991, EXP BRAIN RES, V85, P621; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; KAPLAN JH, 1989, TRENDS NEUROSCI, V2, P54; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; Kimura F, 1990, Neuroreport, V1, P65, DOI 10.1097/00001756-199009000-00018; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; LANDO L, 1989, J GEN PHYSIOL, V93, P1017, DOI 10.1085/jgp.93.6.1017; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LIN JH, 1993, BRAIN RES, V603, P117, DOI 10.1016/0006-8993(93)91306-D; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MERAT DL, 1985, J BIOL CHEM, V260, P1053; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEVEU D, 1996, IN PRESS J NEUROPHYS; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; REGEHR WG, 1992, J NEUROSCI, V12, P4202; SCHULMAN H, 1994, CURR OPIN NEUROBIOL, V5, P374; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; YOSHIMURA Y, 1991, NEUROREPORT, V2, P393, DOI 10.1097/00001756-199107000-00010; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER R, 1994, METHOD CELL BIOL, V40, P31; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	57	158	161	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					619	629		10.1016/S0896-6273(00)80081-1	http://dx.doi.org/10.1016/S0896-6273(00)80081-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785059	Bronze			2022-12-28	WOS:A1996UC16800018
J	Cheng, LL; Mudge, AW				Cheng, LL; Mudge, AW			Cultured schwann cells constitutively express the myelin protein P-0	NEURON			English	Article							MAJOR MYELIN; NGF-RECEPTOR; CYCLIC-AMP; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; NERVOUS-SYSTEM; GROWTH-FACTORS; SCIATIC-NERVE; GALACTOCEREBROSIDE; PROLIFERATION	It is widely thought that mammalian Schwann cells do not express P-0, the major glycoprotein in peripheral myelin, unless they are induced to do so by axonal signals that can be mimicked by agents that trigger cAMP signaling pathways. In contrast, we find that cultured Schwann cells make large amounts of P-0 without the addition of any axonal-like signal, provided they have not been exposed to serum during the culture process. We also report that glial growth factor/neuregulin inhibits this constitutive P-0 expression. Myelin basic protein is regulated in a similar way. We suggest that expression of P-0 by Schwann cells before the onset of myelination may be prevented by inhibitory signals within the nerve, rather than by the absence of a positive signal from axons.			Cheng, LL (corresponding author), UNIV LONDON UNIV COLL, DEPT BIOL,MRC,DEV NEUROBIOL PROGRAMME, LAB MOL CELL BIOL, GOWER ST, LONDON WC1E 6BT, ENGLAND.							BARON P, 1994, J NEUROCYTOL, V23, P249, DOI 10.1007/BF01275529; BOLIN LM, 1993, J CELL BIOL, V123, P237, DOI 10.1083/jcb.123.1.237; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BROCKES JP, 1980, J NEUROCYTOL, V9, P67, DOI 10.1007/BF01205227; BRUNDEN KR, 1987, J CELL BIOL, V104, P661, DOI 10.1083/jcb.104.3.661; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; CHENG L, 1995, J CELL BIOL, V129, P789, DOI 10.1083/jcb.129.3.789; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; CLEMENCE A, 1989, J NEUROCYTOL, V18, P185, DOI 10.1007/BF01206661; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; FERNANDEZVALLE C, 1993, DEVELOPMENT, V119, P867; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GOODEARL ADJ, 1993, J BIOL CHEM, V268, P18095; Jessen K R, 1992, Curr Opin Neurobiol, V2, P575, DOI 10.1016/0959-4388(92)90021-C; JESSEN KR, 1985, J CELL BIOL, V101, P1135, DOI 10.1083/jcb.101.3.1135; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; LEBLANC AC, 1990, J NEUROSCI RES, V26, P317, DOI 10.1002/jnr.490260308; LEMKE G, 1988, DEVELOPMENT, V102, P499; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MEWS M, 1993, GLIA, V8, P208, DOI 10.1002/glia.440080308; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MORGAN L, 1994, DEVELOPMENT, V120, P1399; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; MORRISON S, 1991, J NEUROCYTOL, V20, P769, DOI 10.1007/BF01187850; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUDGE AW, 1993, CURR BIOL, V3, P361, DOI 10.1016/0960-9822(93)90201-X; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; PODUSLO JF, 1985, J NEUROSCI RES, V14, P177, DOI 10.1002/jnr.490140203; PODUSLO JF, 1985, J NEUROCHEM, V44, P1194, DOI 10.1111/j.1471-4159.1985.tb08743.x; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; SCHERER SS, 1994, J NEUROSCI, V14, P1930; SOBUE G, 1984, SCIENCE, V224, P72, DOI 10.1126/science.6322307; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; TANIUCHI M, 1985, J CELL BIOL, V101, P1100, DOI 10.1083/jcb.101.3.1100; TRAPP BD, 1981, J CELL BIOL, V90, P1, DOI 10.1083/jcb.90.1.1; TRAPP BD, 1988, J NEUROSCI, V8, P3515; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x	42	85	85	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB	1996	16	2					309	319		10.1016/S0896-6273(00)80049-5	http://dx.doi.org/10.1016/S0896-6273(00)80049-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789946	Bronze			2022-12-28	WOS:A1996TW95700011
J	Chow, RH; Klingauf, J; Heinemann, C; Zucker, RS; Neher, E				Chow, RH; Klingauf, J; Heinemann, C; Zucker, RS; Neher, E			Mechanisms determining the time course of secretion in neuroendocrine cells	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; PATCH-CLAMP TECHNIQUES; TRANSMITTER RELEASE; NERVE-TERMINALS; CALCIUM; BUFFERS; CATECHOLAMINES; MODEL	Transmitter release from chromaffin cells differs from that in synapses in that it persists for a longer time after Ca2+ entry has stopped. This prolonged secretion is not due to a delay between vesicle fusion and transmitter release, nor to slow detection of released substance: step increases in capacitance due to single vesicle fusion precede the release detected by amperometry by only a few milliseconds. The persistence of secretion after a depolarization is reduced by addition of mobile calcium buffer. This suggests that most of the delay is due to diffusion of Ca2+ between channels and release sites, implying that Ca2+ channels and secretory vesicles are not colocalized in chromaffin cells, in contrast to presynaptic active zones.	MAX PLANCK INST EXPTL MED,DEPT MOLEC BIOL NEURONAL SIGNALING,D-37077 GOTTINGEN,GERMANY; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	Max Planck Society; University of California System; University of California Berkeley	Chow, RH (corresponding author), MAX PLANCK INST BIOPHYS CHEM,DEPT MEMBRANE BIOPHYS,HERMANN REIN STR 3,D-37075 GOTTINGEN,GERMANY.		Chow, Robert/B-8155-2013; Neher, Erwin/A-2109-2013; Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343				ALMERS W, 1990, ANNU REV PHYSIOL, V52, P607, DOI 10.1146/annurev.ph.52.030190.003135; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; BURGOYNE RD, 1995, PFLUG ARCH EUR J PHY, V430, P213, DOI 10.1007/BF00374652; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow Robert H., 1995, P245; COUPLAND RE, 1968, NATURE, V217, P384, DOI 10.1038/217384a0; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P453, DOI DOI 10.1111/J.1476-5381.1968.TB08474.X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Katz B., 1969, RELEASE NEURAL TRANS; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	27	118	119	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					369	376		10.1016/S0896-6273(00)80054-9	http://dx.doi.org/10.1016/S0896-6273(00)80054-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789951	Bronze			2022-12-28	WOS:A1996TW95700016
J	Larsson, HP; Baker, OS; Dhillon, DS; Isacoff, EY				Larsson, HP; Baker, OS; Dhillon, DS; Isacoff, EY			Transmembrane movement of the Shaker K+ channel S4	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; INACTIVATION; RECEPTOR; SEQUENCE	We have probed internal and external accessibility of S4 residues to the membrane-impermeant thiol reagent methanethiosulfonate-ethyltrimethylammonium (MTSET) in both open and closed, cysteine-substituted Shaker K+ channels. Our results indicate that S4 traverses the membrane with no more than 5 amino acids in the closed state, and that the distribution of buried residues changes when channels open. This change argues for a displacement of S4 through the plane of the membrane in which an initially intracellular residue moves to within 3 amino acids of the extracellular solution. These results demonstrate that the putative voltage-sensing charges of S4 actually reside in the membrane and that they move outward when channels open. We consider constraints placed on channel structure by these results.	UNIV CALIF BERKELEY,GRAD GRP BIOPHYS,BERKELEY,CA 94720	University of California System; University of California Berkeley	Larsson, HP (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,229 STANLEY HALL,BERKELEY,CA 94720, USA.		isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOFFER AM, 1995, FASEB J, V9, P788; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STRYER L, 1988, NATURE, V339, P597; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	34	448	458	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					387	397		10.1016/S0896-6273(00)80056-2	http://dx.doi.org/10.1016/S0896-6273(00)80056-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789953	Bronze			2022-12-28	WOS:A1996TW95700018
J	Noebels, JL				Noebels, JL			Targeting epilepsy genes	NEURON			English	Review											Noebels, JL (corresponding author), BAYLOR COLL MED,DEPT NEUROL,SECT NEUROPHYSIOL,DEV NEUROGENET LAB,HOUSTON,TX 77030, USA.			Noebels, Jeffrey/0000-0002-2887-0839				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Cain DP, 1995, EPILEPSY RES, V22, P107, DOI 10.1016/0920-1211(95)00029-1; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; CULIAT CT, 1995, NAT GENET, V11, P344, DOI 10.1038/ng1195-344; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Noebels Jeffrey L., 1995, P210; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; RYAN SG, 1995, NAT GENET, V10, P4, DOI 10.1038/ng0595-4; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; TOTH M, 1995, NAT GENET, V11, P71, DOI 10.1038/ng0995-71; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45	20	92	94	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					241	244		10.1016/S0896-6273(00)80042-2	http://dx.doi.org/10.1016/S0896-6273(00)80042-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789939	Bronze			2022-12-28	WOS:A1996TW95700004
J	HUGHES, RA; SENDTNER, M; GOLDFARB, M; LINDHOLM, D; THOENEN, H				HUGHES, RA; SENDTNER, M; GOLDFARB, M; LINDHOLM, D; THOENEN, H			EVIDENCE THAT FIBROBLAST GROWTH FACTOR-5 IS A MAJOR MUSCLE-DERIVED SURVIVAL FACTOR FOR CULTURED SPINAL MOTONEURONS	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; CHOLINE-ACETYLTRANSFERASE ACTIVITY; NEURONAL DIFFERENTIATION FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR RECEPTOR FAMILY; SKELETAL-MUSCLE; MESSENGER-RNA; MOTOR NEURONS; CORD NEURONS; REGIONAL DISTRIBUTION	We examined the potential role of fibroblast growth factor 5 (FGF-5) as a target-derived trophic factor for spinal motoneurons. Northern analysis of total RNA from rat skeletal muscle revealed an FGF-5 mRNA transcript both during the period of embryonic motoneuron death and in the adult. Recombinant human FGF-5 supported the survival of highly enriched cultures of embryonic chick motoneurons. Significant proportions of the motoneuron survival activity of rat skeletal muscle extracts could be immunoprecipitated using an antiserum to FGF-5. The immunoprecipitable activity was present in soluble and matrix-bound forms in embryonic muscle, but bound exclusively to the extracellular matrix in adult muscle. These results, along with the secretory nature of FGF-5, suggest that FGF-5 may act as a target-derived trophic factor for motoneurons.	COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032	Columbia University	HUGHES, RA (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROCHEM,W-8033 MARTINSRIED,GERMANY.		Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014; Lindholm, Dan/B-3777-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; 				ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ALTERIO J, 1990, BIOCHEM BIOPH RES CO, V166, P1205, DOI 10.1016/0006-291X(90)90994-X; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BATES B, 1991, MOL CELL BIOL, V11, P1840, DOI 10.1128/MCB.11.4.1840; BENNETT MR, 1980, BRAIN RES, V190, P537, DOI 10.1016/0006-8993(80)90295-4; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALOF AL, 1984, DEV BIOL, V106, P194, DOI 10.1016/0012-1606(84)90075-7; CASTREN E, 1992, IN PRESS P NATL ACAD; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; FLANIGAN TP, 1985, J NEUROCHEM, V45, P1323, DOI 10.1111/j.1471-4159.1985.tb05563.x; FU YM, 1991, J CELL BIOL, V114, P1261, DOI 10.1083/jcb.114.6.1261; FUKADA K, 1985, P NATL ACAD SCI USA, V82, P8795, DOI 10.1073/pnas.82.24.8795; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; HAMBURGER V, 1958, AM J ANAT, V102, P365, DOI 10.1002/aja.1001020303; HAUB O, 1991, DEVELOPMENT, V112, P397; HAUB O, 1990, P NATL ACAD SCI USA, V87, P8022, DOI 10.1073/pnas.87.20.8022; HEBERT JM, 1990, DEV BIOL, V138, P454, DOI 10.1016/0012-1606(90)90211-Z; HEBERT JM, 1991, DEVELOPMENT, V112, P407; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JEONG SJ, 1991, J NEUROBIOL, V22, P462, DOI 10.1002/neu.480220504; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; JOSEPHSILVERSTEIN J, 1989, J CELL BIOL, V108, P2459, DOI 10.1083/jcb.108.6.2459; KAUFMAN LM, 1985, J NEUROSCI, V5, P160; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; KUCHEREREHRET A, 1990, DEVELOPMENT, V110, P1285; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINDHOLM D, 1988, J BIOL CHEM, V263, P16348; MARTINOU JC, 1989, J NEUROSCI, V9, P3645; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MASIAKOWSKI P, 1991, J NEUROCHEM, V57, P1003, DOI 10.1111/j.1471-4159.1991.tb08250.x; MCMANAMAN J, 1989, J NEUROCHEM, V53, P1763, DOI 10.1111/j.1471-4159.1989.tb09241.x; MCMANAMAN JL, 1991, J NEUROCHEM, V57, P258, DOI 10.1111/j.1471-4159.1991.tb02123.x; MCMANAMAN JL, 1988, J BIOL CHEM, V263, P5890; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; MORROW NG, 1990, J CLIN INVEST, V85, P1816, DOI 10.1172/JCI114640; OBRIEN RJ, 1986, J NEUROSCI, V6, P3265; OPPENHEIM RW, 1986, J COMP NEUROL, V246, P281, DOI 10.1002/cne.902460211; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PASQUALE EB, 1990, P NATL ACAD SCI USA, V87, P5812, DOI 10.1073/pnas.87.15.5812; Patterson P H, 1992, Curr Opin Neurobiol, V2, P94, DOI 10.1016/0959-4388(92)90169-L; PATTERSON PH, 1992, CIBA F SYMP, V167, P125; ROHRER H, 1992, DEVELOPMENT, V114, P689; RUTA M, 1988, ONCOGENE, V3, P9; SCHNAAR RL, 1981, J NEUROSCI, V1, P204; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SMITH RG, 1985, J CELL BIOL, V101, P1608, DOI 10.1083/jcb.101.4.1608; STARK KL, 1991, DEVELOPMENT, V113, P641; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; VACA K, 1989, J NEUROSCI RES, V23, P55, DOI 10.1002/jnr.490230108; WANAKA A, 1991, DEVELOPMENT, V111, P455; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WERNER S, 1991, ONCOGENE, V6, P2137; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; ZHAN X, 1987, ONCOGENE, V1, P369; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	68	127	131	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					369	377		10.1016/0896-6273(93)90327-N	http://dx.doi.org/10.1016/0896-6273(93)90327-N			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461132	Green Published			2022-12-28	WOS:A1993KU90100004
J	WILLIAMS, K; RUSSELL, SL; SHEN, YM; MOLINOFF, PB				WILLIAMS, K; RUSSELL, SL; SHEN, YM; MOLINOFF, PB			DEVELOPMENTAL SWITCH IN THE EXPRESSION OF NMDA RECEPTORS OCCURS INVIVO AND INVITRO	NEURON			English	Article							D-ASPARTATE RECEPTOR; MUSCLE ACETYLCHOLINE-RECEPTOR; CENTRAL NERVOUS-SYSTEM; ANTI-ISCHEMIC AGENTS; ANTICONVULSANT MK-801; XENOPUS OOCYTES; VISUAL-CORTEX; RAT-BRAIN; ANTAGONIST; IFENPRODIL	The properties of many ligand-gated ion channels are altered during development. We have characterized a developmental switch in the sensitivity of NMDA receptors to the novel antagonist ifenprodil using ligand binding assays with rat brain membranes and voltage-clamp recording of Xenopus oocytes expressing NMDA receptors after injection of RNA from rat brain and from cloned subunits of the receptor. In neonatal rat brain, NMDA receptors have a uniformly high affinity for ifenprodil. During postnatal development, a second population of receptors having a 100-fold lower affinity for ifenprodil is expressed and represents 50% of NMDA receptors in adult rat brain. This developmental change also occurred in cortical neurons maintained in primary culture. Ifenprodil potently inhibited responses of homomeric NR1 and heteromeric NR1/NR2B receptors but not NR1/NR2A receptors expressed in oocytes, suggesting that inclusion of different NR2 subunits in native NMDA receptors can control the sensitivity to ifenprodil.			WILLIAMS, K (corresponding author), UNIV PENN, SCH MED, DEPT PHARMACOL, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM034781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030000] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 34781] Funding Source: Medline; NINDS NIH HHS [NS 30000] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANANTHARAM V, 1992, FEBS LETT, V305, P27, DOI 10.1016/0014-5793(92)80648-Z; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BEAR MF, 1990, J NEUROSCI, V10, P909; BENARI Y, 1988, NEUROSCI LETT, V94, P88, DOI 10.1016/0304-3940(88)90275-3; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; CARTER C, 1989, EUR J PHARMACOL, V164, P611, DOI 10.1016/0014-2999(89)90275-6; CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222; CARTER C, 1991, EXCITATORY AMINO ACI, P130; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DAUBAS P, 1990, NEURON, V5, P49, DOI 10.1016/0896-6273(90)90032-B; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FOSTER AC, 1987, BRIT J PHARMACOL, V91, P403, DOI 10.1111/j.1476-5381.1987.tb10295.x; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; HARTMAN DS, 1990, NATURE, V343, P372, DOI 10.1038/343372a0; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; KLECKNER NW, 1991, MOL BRAIN RES, V11, P151; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LEGENDRE P, 1991, MOL PHARMACOL, V40, P289; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MORRISETT RA, 1990, DEV BRAIN RES, V56, P257, DOI 10.1016/0165-3806(90)90090-L; POULTER MO, 1992, J NEUROSCI, V12, P2888, DOI 10.1523/JNEUROSCI.12-08-02888.1992; QUICK M W, 1992, Biotechniques, V13, P362; REYNOLDS IJ, 1988, MOL PHARMACOL, V33, P581; REYNOLDS IJ, 1989, MOL PHARMACOL, V36, P758; REYNOLDS IJ, 1992, J NEUROSCI, V12, P970; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; VERDOORN TA, 1987, SCIENCE, V238, P1114, DOI 10.1126/science.2825347; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; WILLIAMS K, 1991, MOL PHARMACOL, V40, P774; WILLIAMS K, 1991, LIFE SCI, V48, P469, DOI 10.1016/0024-3205(91)90463-L; WILLIAMS K, 1992, MOL PHARMACOL, V42, P147; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	43	390	396	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					267	278		10.1016/0896-6273(93)90317-K	http://dx.doi.org/10.1016/0896-6273(93)90317-K			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439412				2022-12-28	WOS:A1993KP68500014
J	Farinas, I; Yoshida, CK; Backus, C; Reichardt, LF				Farinas, I; Yoshida, CK; Backus, C; Reichardt, LF			Lack of neurotrophin-3 results in death of spinal sensory neurons and premature differentiation of their precursors	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; DORSAL-ROOT GANGLION; NEURAL CREST CELLS; MESSENGER-RNA; REQUIRE NEUROTROPHIN-3; TROPHIC FACTORS; TRK RECEPTORS; IN-VITRO; RAT TRKC; EXPRESSION	To understand mechanisms resulting in the absence of two-thirds of spinal sensory neurons in mice lacking NT-3, we have compared dorsal root ganglia development in normal and mutant embryos. The reduction in neurons, achieved by E13, results from several deficits: first, elevated neuronal apoptosis significantly reduces neuronal numbers; second, elevated neurogenesis between E11 and E12, without changes in rates of precursor proliferation or apoptosis, depletes the precursor pool; consequently, the reduced precursor pool prevents increases in neuronal numbers between E12 and E13, when most neurons are born in normal animals. Although deficits occur before final target innervation, we show that NT-3 is expressed at all stages in regions accessible to these neurons or their axons and is only restricted to final targets after innervation.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Farinas, I (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.		Farinas, Isabel/L-7118-2014	Farinas, Isabel/0000-0003-2903-4960	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 48200] Funding Source: Medline; NINDS NIH HHS [P01 NS016033-20, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; CHALAZONITIS A, 1994, J NEUROSCI, V14, P6571; COCHARD P, 1984, J NEUROSCI, V4, P2080; COGGESHALL RE, 1994, DEV BRAIN RES, V82, P193, DOI 10.1016/0165-3806(94)90163-5; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; EASTER SS, 1993, J NEUROSCI, V13, P285; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; Farinas I, 1996, SEMIN NEUROSCI, V8, P133, DOI 10.1006/smns.1996.0018; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; GAESE F, 1994, DEVELOPMENT, V120, P1613; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Henion PD, 1995, DEV BIOL, V172, P602, DOI 10.1006/dbio.1995.8054; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KARAVANOV A, 1995, P NATL ACAD SCI USA, V92, P11279, DOI 10.1073/pnas.92.24.11279; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KUCERA J, 1995, J COMP NEUROL, V363, P307, DOI 10.1002/cne.903630211; LAMBALLE F, 1994, J NEUROSCI, V14, P14; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Lefcort F, 1996, J NEUROSCI, V16, P3704; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MEMBERG SP, 1995, MOL CELL NEUROSCI, V6, P323, DOI 10.1006/mcne.1995.1025; Minichiello L, 1995, DEVELOPMENT, V121, P4067; MU XJ, 1993, J NEUROSCI, V13, P4029; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; Ockel M, 1996, DEVELOPMENT, V122, P301; PINCO O, 1993, J NEUROBIOL, V24, P1626, DOI 10.1002/neu.480241207; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; Scott SA, 1992, SENSORY NEURONS DIVE; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; TOJO H, 1995, BRAIN RES, V669, P163, DOI 10.1016/0006-8993(94)01219-8; Tojo H, 1996, NEUROSCIENCE, V71, P221, DOI 10.1016/0306-4522(95)00445-9; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; White FA, 1996, J NEUROSCI, V16, P4662; Wilkinson GA, 1996, J NEUROSCI, V16, P7661; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; YOSHIDA Y, 1987, BIOMED RES-TOKYO, V8, P431	54	196	197	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1065	1078		10.1016/S0896-6273(00)80240-8	http://dx.doi.org/10.1016/S0896-6273(00)80240-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982156	Green Accepted, Bronze			2022-12-28	WOS:A1996WA24800006
J	Zhang, ZW; Coggan, JS; Berg, DK				Zhang, ZW; Coggan, JS; Berg, DK			Synaptic currents generated by neuronal acetylcholine receptors sensitive to alpha-bungarotoxin	NEURON			English	Article							CILIARY GANGLION NEURONS; BLOCKS NICOTINIC TRANSMISSION; RAT HIPPOCAMPAL-NEURONS; BINDING-SITES; CHICK; NEUROTOXIN; CALCIUM; LOCALIZATION; SUBTYPES; CULTURE	Nicotinic acetylcholine receptors are widely distributed throughout the nervous system, but their functions remain largely unknown. One of the most abundant is a class of receptors that contains the alpha 7 gene product, has a high relative permeability to calcium, and binds alpha-bungarotoxin. Here, we report that receptors sensitive to alpha-bungarotoxin, though concentrated in perisynaptic clusters on neurons, can generate a large amount of the synaptic current. Residual currents through other nicotinic receptors are sufficient to elicit action potentials, but with slower rise times. This demonstrates a postsynaptic response for alpha-bungarotoxin-sensitive receptors on neurons and suggests that the functional domain of the postsynaptic membrane is broader than previously recognized.	UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego				Coggan, Jay S/0000-0002-2270-1989; Zhang, Zhong-wei/0000-0001-7165-6216	NINDS NIH HHS [R01 NS12601] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; ATKINS PW, 1986, PHYSICAL CHEM; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; CHIAPPINELLI VA, 1978, P NATL ACAD SCI USA, V75, P2999, DOI 10.1073/pnas.75.6.2999; CHIAPPINELLI VA, 1981, BRAIN RES, V211, P107, DOI 10.1016/0006-8993(81)90070-6; CHIAPPINELLI VA, 1978, NEUROCHEM RES, V3, P465, DOI 10.1007/BF00966328; CHIAPPINELLI VA, 1985, PHARMACOL THERAPEUT, V31, P1, DOI 10.1016/0163-7258(85)90035-X; CLARKE P, 1995, ADV PHARM SCI, V2; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CORRIVEAU RA, 1994, J NEUROBIOL, V25, P1579, DOI 10.1002/neu.480251210; COURAUD JY, 1980, J NEUROCHEM, V34, P1209, DOI 10.1111/j.1471-4159.1980.tb09961.x; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DRYER SE, 1985, J NEUROSCI, V5, P2654; FUJII JT, 1987, DEV BIOL, V123, P346, DOI 10.1016/0012-1606(87)90393-9; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; Horch HLW, 1995, J NEUROSCI, V15, P7778; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; JACOB MH, 1983, J NEUROSCI, V3, P260; KATO AC, 1980, DEV BIOL, V76, P222, DOI 10.1016/0012-1606(80)90374-7; LORING RH, 1987, J NEUROSCI, V7, P2153; LORING RH, 1985, NEUROSCIENCE, V14, P645, DOI 10.1016/0306-4522(85)90316-1; LORING RH, 1984, NEUROSCIENCE, V11, P989, DOI 10.1016/0306-4522(84)90209-4; MARGIOTTA JF, 1982, NATURE, V296, P152, DOI 10.1038/296152a0; MARTIN AR, 1964, J PHYSIOL-LONDON, V171, P454, DOI 10.1113/jphysiol.1964.sp007390; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; OLIVIERISANGIACOMO C, 1983, DEV BRAIN RES, V7, P61, DOI 10.1016/0165-3806(83)90081-0; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; PUGH PC, 1995, MOL PHARMACOL, V47, P717; PUGH PC, 1994, J NEUROSCI, V14, P889; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; RATHOUZ MM, 1995, J BIOL CHEM, V270, P14366, DOI 10.1074/jbc.270.24.14366; RAVDIN PM, 1981, J NEUROSCI, V1, P849; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCARSELLA G, 1978, DEV NEUROSCI-BASEL, V1, P133, DOI 10.1159/000112565; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SEGUELA P, 1993, J NEUROSCI, V13, P596; SMITH MA, 1985, J NEUROSCI, V5, P2726; ULLIAN EM, 1995, J NEUROSCI, V15, P7012; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; YAWO H, 1994, J PHYSIOL-LONDON, V477, P437, DOI 10.1113/jphysiol.1994.sp020205; ZHANG ZW, 1995, J PHYSIOL-LONDON, V487, P395, DOI 10.1113/jphysiol.1995.sp020888; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9; ZORUMSKI CF, 1992, MOL PHARMACOL, V41, P931	47	158	158	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1231	1240		10.1016/S0896-6273(00)80253-6	http://dx.doi.org/10.1016/S0896-6273(00)80253-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982169	Bronze			2022-12-28	WOS:A1996WA24800019
J	Jacquin, TD; Borday, V; SchneiderMaunoury, S; Topilko, P; Ghilini, G; Kato, F; Charnay, P; Champagnat, J				Jacquin, TD; Borday, V; SchneiderMaunoury, S; Topilko, P; Ghilini, G; Kato, F; Charnay, P; Champagnat, J			Reorganization of pontine rhythmogenic neuronal networks in Krox-20 knockout mice	NEURON			English	Article							CHICK-EMBRYO HINDBRAIN; ZINC-FINGER GENE; INFANT-DEATH-SYNDROME; NEURAL CREST CELLS; BRAIN-STEM; RESPIRATORY RHYTHM; TRANSCRIPTION FACTOR; RETICULAR-FORMATION; 2 RHOMBOMERES; GUINEA-PIG	We have shown previously that the inactivation of the zinc finger gene Krox-20 affects hindbrain segmentation, resulting in the elimination of rhombomeres 3 and 5. We demonstrate here that Krox-20 homozygous mutant mice exhibit abnormally slow respiratory and jaw opening rhythms, indicating that a modification of hindbrain segmentation influences the function of neuronal networks after birth. Central neuronal networks that control respiratory frequency are made predominantly depressant by the elimination of a previously undescribed rhythm-promoting system. Recordings of rhythmic activity from the isolated hindbrain following progressive tissue transections indicate that the reorganization takes place in the caudal pontine reticular formation. The newborn (P0) Krox-20(-/-) mice, in which apneas are ten times longer than in wild-type animals, may be a valuable model for the study of life-threatening apneas during early infancy.	ECOLE NORMALE SUPER, INSERM, U368, F-75230 PARIS 05, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Jacquin, TD (corresponding author), CNRS, INST ALFRED FESSARD, F-91198 GIF SUR YVETTE, FRANCE.		Schneider-Maunoury, Sylvie/K-6795-2017	Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Charnay, Patrick/0000-0002-3847-6042				ANCH A M, 1981, Electromyography and Clinical Neurophysiology, V21, P317; ARVIDSSON U, 1995, J NEUROSCI, V15, P1215; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; BIRGBAUER E, 1995, DEVELOPMENT, V121, P935; BIRGBAUER E, 1994, DEVELOPMENT, V120, P1347; BRANCHEREAU P, 1992, J PHARMACOL EXP THER, V260, P1433; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; CHAMPAGNAT J, 1994, J PHYSIOL-LONDON, V479, P127, DOI 10.1113/jphysiol.1994.sp020282; CHAMPAGNAT J, 1993, NEUROREPORT, V4, P861, DOI 10.1097/00001756-199307000-00005; CHAMPAGNAT J, 1994, NUCLEUS SOLITARY TRA, P215; CHANDLER SH, 1986, J NEUROSCI, V6, P1831; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Cortez SC, 1996, J NEUROPATH EXP NEUR, V55, P841, DOI 10.1097/00005072-199607000-00009; DAWES GS, 1983, J PHYSIOL-LONDON, V335, P535, DOI 10.1113/jphysiol.1983.sp014549; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; DOLLE P, 1993, P NATL ACAD SCI USA, V90, P7666, DOI 10.1073/pnas.90.16.7666; DONGA R, 1991, J NEUROPHYSIOL, V66, P1564, DOI 10.1152/jn.1991.66.5.1564; ERRCHIDI S, 1991, J PHYSIOL-LONDON, V443, P477, DOI 10.1113/jphysiol.1991.sp018846; FORTIN G, 1995, J PHYSIOL-LONDON, V486, P735, DOI 10.1113/jphysiol.1995.sp020849; FORTIN G, 1994, NEUROREPORT, V5, P1149, DOI 10.1097/00001756-199405000-00032; FORTIN G, 1994, NEUROREPORT, V5, P1137, DOI 10.1097/00001756-199405000-00029; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; HANSON MA, 1988, J PHYSIOL-LONDON, V400, P415, DOI 10.1113/jphysiol.1988.sp017129; HAXHIU MA, 1993, BRAIN RES, V618, P115, DOI 10.1016/0006-8993(93)90435-P; JACQUIN T, 1988, P NATL ACAD SCI USA, V85, P948, DOI 10.1073/pnas.85.3.948; JACQUIN T, 1989, BRAIN RES, V502, P214, DOI 10.1016/0006-8993(89)90616-1; JAEGER CB, 1986, NEUROSCIENCE, V18, P121, DOI 10.1016/0306-4522(86)90183-1; JANSEN AH, 1983, PHYSIOL REV, V63, P437, DOI 10.1152/physrev.1983.63.2.437; JODKOWSKI JS, 1994, NEUROSCI LETT, V172, P67, DOI 10.1016/0304-3940(94)90664-5; KINNEY HC, 1995, SCIENCE, V269, P1446, DOI 10.1126/science.7660131; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LIJOWSKA A, 1995, RESP CRIT CARE MED, V151, pA151; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1994, DEVELOPMENT, V120, P1581; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; LUTKIN T, 1991, CELL, V66, P1105; MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x; MARK M, 1993, DEVELOPMENT, V119, P319; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; MORTOLA JP, 1987, PHYSIOL REV, V67, P187, DOI 10.1152/physrev.1987.67.1.187; Nonchev S, 1996, DEVELOPMENT, V122, P543; NOZAKI S, 1993, J NEUROPHYSIOL, V69, P595, DOI 10.1152/jn.1993.69.2.595; NUNEZABADES PA, 1993, J AUTONOM NERV SYST, V42, P99, DOI 10.1016/0165-1838(93)90042-S; ONIMARU H, 1995, NEUROSCI RES, V21, P183, DOI 10.1016/0168-0102(94)00863-B; PIERREFICHE O, 1995, NEUROSCI LETT, V184, P101, DOI 10.1016/0304-3940(94)11179-M; PINE DS, 1994, AM J PSYCHIAT, V151, P864; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Rekling JC, 1996, J NEUROPHYSIOL, V75, P795, DOI 10.1152/jn.1996.75.2.795; RICHTER DW, 1993, J PHYSIOL-LONDON, V470, P23, DOI 10.1113/jphysiol.1993.sp019844; ROMAGNANO MA, 1991, J NEUROSCI, V11, P3539; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH JC, 1990, J NEUROPHYSIOL, V64, P1149, DOI 10.1152/jn.1990.64.4.1149; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; VERT P, 1994, BIOL NEONATE, V65, P133; Wilkinson D G, 1993, Perspect Dev Neurobiol, V1, P117; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0	67	164	168	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					747	758		10.1016/S0896-6273(00)80206-8	http://dx.doi.org/10.1016/S0896-6273(00)80206-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893031	Bronze			2022-12-28	WOS:A1996VP74300019
J	Linden, DJ				Linden, DJ			A protein synthesis-dependent late phase of cerebellar long-term depression	NEURON			English	Article							APLYSIA SENSORY NEURONS; CAMP-RESPONSIVE ELEMENT; PURKINJE-CELLS; CRITICAL PERIOD; DENTATE GYRUS; NITRIC-OXIDE; HETEROSYNAPTIC INHIBITION; MACROMOLECULAR-SYNTHESIS; SYNAPTIC DEPRESSION; DENDRITIC SPINES	Synthesis of new protein has been shown to be required for establishment of a late phase in hippocampal long-term potentiation. Whether a similar requirement is needed to produce the late phase of long-term depression (LTD) remains to be determined. Application of transcription inhibitors or of the translation inhibitor anisomycin, immediately, but not 30 min after glutamate/depolarization conjunction, attenuated a late phase of cerebellar LTD in culture. LTD, produced in a perforated outside-out amcropatch of Purkinje neuron dendrite, which lacks nuclear material, returned to baseline values with a time course paralleling that observed with protein synthesis inhibitors in intact cultured Purkinje neurons. These findings suggest that there is a distinct late phase of cerebellar LTD that is dependent upon postsynaptic protein synthesis.			Linden, DJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R37MH051106, R29MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham W.C., 1991, KINDLING SYNAPTIC PL, P92; ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1994, MOL CELL MECH NEUROT, P529; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1987, PSYCHOL BULL, V3, P518; DEADWYLER SA, 1987, SYNAPSE, V1, P90, DOI 10.1002/syn.890010112; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DESCHUTTER E, 1995, TRENDS NEUROSCI, V18, P291, DOI 10.1016/0166-2236(95)93916-L; DRAGUNOW M, 1989, NEUROSCI LETT, V101, P274, DOI 10.1016/0304-3940(89)90545-4; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1995, NEUROSCIENCE, V67, P799, DOI 10.1016/0306-4522(95)00117-2; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEBB DO, 1949, ORG BEHAVIOR; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; LAUB O, 1980, P NATL ACAD SCI-BIOL, V77, P3297, DOI 10.1073/pnas.77.6.3297; LEVITAN ES, 1990, NATURE, V348, P545, DOI 10.1038/348545a0; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; Linden DJ, 1995, NEURON, V15, P1393, DOI 10.1016/0896-6273(95)90017-9; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6; MATTHIES H, 1989, ANNU REV PSYCHOL, V40, P381, DOI 10.1146/annurev.ps.40.020189.002121; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTAROLO PG, 1988, NATURE, V333, P171, DOI 10.1038/333171a0; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NGUYEN PV, 1990, J NEUROSCI, V10, P1099; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Osten P, 1996, J NEUROSCI, V16, P2444; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHACHER S, 1993, NEURON, V10, P1079, DOI 10.1016/0896-6273(93)90056-W; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Slack JR, 1995, NEUROSCI LETT, V201, P25, DOI 10.1016/0304-3940(94)12121-6; Sossin WS, 1996, TRENDS NEUROSCI, V19, P215; Squire L.R, 1987, MEMORY BRAIN, P134; STANTON PK, 1984, J NEUROSCI, V4, P3080; STEWARD O, 1988, J NEUROSCI, V8, P176; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; STEWARD O, 1982, J NEUROSCI, V2, P284; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WORLEY PF, 1993, J NEUROSCI, V13, P4776; WU F, 1994, NEURON, V12, P407, DOI 10.1016/0896-6273(94)90281-X; Yamagata K, 1994, Learn Mem, V1, P140; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	75	130	130	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					483	490		10.1016/S0896-6273(00)80180-4	http://dx.doi.org/10.1016/S0896-6273(00)80180-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816711	Bronze			2022-12-28	WOS:A1996VJ44000014
J	Zhang, L; Marcu, MG; NauStaudt, K; Trifaro, JM				Zhang, L; Marcu, MG; NauStaudt, K; Trifaro, JM			Recombinant scinderin enhances exocytosis, an effect blocked by two scinderin-derived actin-binding peptides and PIP2	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; FILAMENT-SEVERING PROTEIN; CATECHOLAMINE SECRETION; KINASE-C; CALCIUM; REORGANIZATION; STIMULATION; GELSOLIN; RELEASE; EXPRESSION	The cortical F-actin cytoskeleton represents a negative control for secretion, and it must be locally disassembled to allow chromaffin vesicle exocytosis. Recombinant scinderin (a Ca2+-dependent F-actin-severing protein) potentiated Ca2+-evoked F-actin disassembly and exocytosis in permeabilized chromaffin cells, an effect blocked by peptides Sc-ABP(1) and Sc-ABP(2) (with sequences corresponding to two actin-binding sites of scinderin), exogenous gamma-actin, or phosphatidylinositol 4,5-bisphosphate (PIP2) PIP2 effect was blocked by peptide Sc-PIP2BP (with sequence corresponding to a PIP2-binding site of scinderin). Truncated scinderin(254-715) (lacking actin-severing domains) did not potentiate exocytosis. Sc-ABP(1), Sc-ABP(2), and gamma-actin also inhibited exocytosis in the absence of recombinant scinderin, suggesting an inhibition of endogenous scinderin. Results suggest that scinderin-evoked cortical F-actin disassembly is required for secretion and that scinderin is an important component of the exocytotic machinery.			Zhang, L (corresponding author), UNIV OTTAWA, FAC MED, DEPT PHARMACOL, SECRETORY PROC RES PROGRAM, OTTAWA, ON K1H 8M5, CANADA.							BADER MF, 1986, J CELL BIOL, V102, P636, DOI 10.1083/jcb.102.2.636; BERNSTEIN BW, 1985, J NEUROSCI, V5, P2565; BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449; BURGOYNE RD, 1989, CELL SIGNAL, V1, P323, DOI 10.1016/0898-6568(89)90051-X; CALDWELL P C, 1970, P10; CHEEK TR, 1987, J BIOL CHEM, V262, P11663; CHEEK TR, 1986, FEBS LETT, V207, P110, DOI 10.1016/0014-5793(86)80022-9; DELCASTILLO AR, 1992, J CELL BIOL, V119, P797, DOI 10.1083/jcb.119.4.797; DELCASTILLO AR, 1990, EMBO J, V9, P43, DOI 10.1002/j.1460-2075.1990.tb08078.x; DOUCET JP, 1988, ANAL BIOCHEM, V168, P265, DOI 10.1016/0003-2697(88)90317-X; DUNN LA, 1983, J BIOL CHEM, V258, P4989; EDMONDS CG, 1990, METHOD ENZYMOL, V193, P412, DOI 10.1016/0076-6879(90)93430-S; HENVICK RM, 1981, J BIOL CHEM, V256, P7990; KENIGSBERG RL, 1980, NEUROSCIENCE, V5, P1547, DOI 10.1016/0306-4522(80)90019-6; LEE RWH, 1981, NEUROSCIENCE, V6, P2087, DOI 10.1016/0306-4522(81)90048-8; MAEKAWA S, 1990, J BIOL CHEM, V265, P10940; MARCU MG, 1994, MOL CELL BIOCHEM, V141, P153, DOI 10.1007/BF00926179; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PERRIN D, 1985, NATURE, V315, P589, DOI 10.1038/315589a0; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; TCHAKAROV L, 1990, FEBS LETT, V268, P209, DOI 10.1016/0014-5793(90)81010-L; TRIFARO JM, 1989, INT CONGR SER, V839, P15; TRIFARO JM, 1985, CAN J BIOCHEM CELL B, V63, P661, DOI 10.1139/o85-084; TRIFARO JM, 1984, CAN J PHYSIOL PHARM, V62, P493, DOI 10.1139/y84-079; TRIFARO JM, 1980, NEUROSCIENCE, V5, P1533, DOI 10.1016/0306-4522(80)90018-4; TRIFARO JM, 1982, ADV BIOSCI, V5, P151; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; VITALE ML, 1992, J NEUROCHEM, V59, P1717, DOI 10.1111/j.1471-4159.1992.tb11003.x; WILSON SP, 1983, J BIOL CHEM, V258, P4994; YIN H, 1981, J CELL BIOL, V19, P901; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0	34	65	68	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG	1996	17	2					287	296		10.1016/S0896-6273(00)80160-9	http://dx.doi.org/10.1016/S0896-6273(00)80160-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780652	Bronze			2022-12-28	WOS:A1996VE84000011
J	Rosenmund, C; Stevens, CF				Rosenmund, C; Stevens, CF			Definition of the readily releasable pool of vesicles at hippocampal synapses	NEURON			English	Article							TRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; QUANTAL ANALYSIS; CALCIUM; NEURONS; NEUROSECRETION; CURRENTS	A readily releasable pool of quanta, tentatively identified with docked synaptic vesicles, has been defined by analysis of the neurotransmitter release caused by application of hypertonic solutions. The goal of this work is to determine the relationship of this functionally defined readily releasable pool to the one drawn upon by action potential-evoked release. We find that hypertonic solutions do not act through changes in intracellular calcium. Since the release produced by action potentials and hypertonic solutions varies in parallel as the pool size is changed, we conclude that the same pool is shared by both mechanisms. This conclusion, taken together with other observations in the literature, means that the synaptic release probability depends on the size of the readily releasable pool.	SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037	Howard Hughes Medical Institute; Salk Institute	Rosenmund, C (corresponding author), MAX PLANCK INST BIOPHYS CHEM,AG ZELLULARE NEUROBIOL,D-37077 GOTTINGEN,GERMANY.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 12961] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bekkers John M., 1992, P150; BLIOCH ZL, 1968, J PHYSIOL-LONDON, V199, P11, DOI 10.1113/jphysiol.1968.sp008637; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; BROSIUS DC, 1992, J NEUROPHYSIOL, V68, P1229, DOI 10.1152/jn.1992.68.4.1229; COHEN I, 1985, INT REV NEUROBIOL, V27, P299, DOI 10.1016/S0074-7742(08)60560-7; DELANEY K, 1991, J NEUROSCI, V11, P2631; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HUBBARD JI, 1968, J PHYSIOL-LONDON, V197, P639, DOI 10.1113/jphysiol.1968.sp008579; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Nicoll R A, 1979, Int Rev Neurobiol, V21, P217; QUASTEL DMJ, 1971, SCIENCE, V172, P1034, DOI 10.1126/science.172.3987.1034; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SHIMONI Y, 1977, NATURE, V267, P170, DOI 10.1038/267170a0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Yu WF, 1995, J NEUROSCI METH, V62, P159, DOI 10.1016/0165-0270(95)00071-2; ZENCHENKO TA, 1995, PROTEIN SCI, V4, P251; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167	28	819	827	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1197	1207		10.1016/S0896-6273(00)80146-4	http://dx.doi.org/10.1016/S0896-6273(00)80146-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663996	Bronze, Green Published			2022-12-28	WOS:A1996UU11800017
J	Hartell, NA				Hartell, NA			Strong activation of parallel fibers produces localized calcium transients and a form of LTD that spreads to distant synapses	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; NITRIC-OXIDE; SYNAPTIC DEPRESSION; CLIMBING FIBER; PROTEIN-KINASE; CURRENTS; INVITRO; SENSITIVITY	The temporal and spatial changes in intracellular calcium levels during separate activation of parallel fiber (PF) and climbing fiber (CF) inputs to cerebellar Purkinje cells were studied. PF stimulation (1 Hz), at relatively high stimulus strengths, led to accumulations of calcium that were similar in peak levels to those following CF stimulation but that remained spatially localized. Such stimuli consistently induced a durable depression of PF synaptic transmission that partially occluded further depression by conventional conjunctive stimuli and that was independent of nitric oxide. This depression was accompanied by a reduction of synaptic efficacy in spatially isolated PF inputs to the same cell that was independent of postsynaptic calcium but that was mediated by nitric oxide. These data indicate that LTD comprises at least two separate processes and that parameters of PF stimulation that are capable of raising calcium levels in Purkinje cell dendrites are also able to induce long-term changes in synaptic efficacy.	RIKEN, FRONTIER RES PROGRAM, LAB SYNAPT FUNCT, WAKO, SAITAMA 35101, JAPAN	RIKEN								AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; AJIMA A, 1991, NEUROSCI RES, V12, P281, DOI 10.1016/0168-0102(91)90117-H; Albus JS, 1971, MATH BIOSCI, V28, P167; BATCHELOR AM, 1993, NEUROPHARMACOLOGY, V32, P11, DOI 10.1016/0028-3908(93)90124-L; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; DANIEL H, 1992, EXP BRAIN RES, V90, P327; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; DESCHUTTER E, 1995, TRENDS NEUROSCI, V18, P291, DOI 10.1016/0166-2236(95)93916-L; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HIRANO T, 1990, NEUROSCI LETT, V119, P145, DOI 10.1016/0304-3940(90)90819-U; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; ITO M, 1992, NEUROSCI RES, V14, P27, DOI 10.1016/S0168-0102(05)80004-5; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KASONO K, 1994, NEUROREPORT, V6, P17, DOI 10.1097/00001756-199412300-00006; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LOHMANN SM, 1981, P NATL ACAD SCI-BIOL, V78, P653, DOI 10.1073/pnas.78.1.653; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MONTGOMERY JC, 1994, NEUROSCI LETT, V174, P145, DOI 10.1016/0304-3940(94)90007-8; OJAKANGAS CL, 1994, J NEUROPHYSIOL, V72, P2617, DOI 10.1152/jn.1994.72.6.2617; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHREURS BG, 1993, BRAIN RES, V631, P223; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SUGIMORI M, 1990, P NATL ACAD SCI USA, V87, P5084, DOI 10.1073/pnas.87.13.5084	48	131	132	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR	1996	16	3					601	610		10.1016/S0896-6273(00)80079-3	http://dx.doi.org/10.1016/S0896-6273(00)80079-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785057	Bronze			2022-12-28	WOS:A1996UC16800016
J	Brustle, O; Maskos, U; McKay, RDG				Brustle, O; Maskos, U; McKay, RDG			Host-guided migration allows targeted introduction of neurons into the embryonic brain	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CORTICAL-NEURONS; INFERIOR COLLICULUS; ASTROCYTE MIGRATION; CORPUS-CALLOSUM; VISUAL-CORTEX; RAT; INDUCTION; ORIGIN; TIME	The stereotyped positions occupied by individual classes of neurons are a fundamental characteristic of CNS cytoarchitecture. To study the regulation of neuronal positioning, we injected genetically labeled neural precursors derived from dorsal and ventral mouse forebrain into the telencephalic vesicles of embryonic rats. Cells from both areas were found to participate in the generation of telencephalic, diencephalic, and mesencephalic brain regions. Donor-derived neurons populated the host brain in distinct patterns and acquired phenotypic features appropriate for their final location. These observations indicate that neuronal migration and differentiation are predominantly regulated by non-cell-autonomous signals. Exploiting this phenomenon, intrauterine transplantation allows generation of controlled chimerism in the mammalian brain.			Brustle, O (corresponding author), NINCDS,MOLEC BIOL LAB,BETHESDA,MD 20892, USA.							ALTABA AR, 1993, J NEUROBIOL, V24, P1276, DOI 10.1002/neu.480241004; ALTMAN J, 1981, EXP BRAIN RES, V42, P411; ALTMAN J, 1981, EXP BRAIN RES, V42, P424; ALTMAN J, 1979, J COMP NEUROL, V188, P455, DOI 10.1002/cne.901880308; ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; Altman J, 1986, DEV RAT HYPOTHALAMUS; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; ALVARADOMALLART RM, 1990, DEV BIOL, V139, P75, DOI 10.1016/0012-1606(90)90280-V; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BARBE MF, 1991, J NEUROSCI, V11, P519; Bayer S.A., 1991, NEOCORTICAL DEV; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; FISHELL G, 1995, DEVELOPMENT, V121, P803; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; HYNES RO, 1994, CURR OPIN GENET DEV, V4, P569, DOI 10.1016/0959-437X(94)90074-D; LAGENAUR C, 1981, J SUPRAMOL STR CELL, V15, P335, DOI 10.1002/jsscb.1981.380150404; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LUND RD, 1993, INT J DEV NEUROSCI, V11, P595, DOI 10.1016/0736-5748(93)90048-I; LUND RD, 1985, NEUROSCI LETT, V61, P221, DOI 10.1016/0304-3940(85)90428-8; MALENKA RC, 1994, NATURE, V372, P218, DOI 10.1038/372218a0; MALMIERCA MS, 1993, J COMP NEUROL, V333, P1, DOI 10.1002/cne.903330102; MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; ROUTTENBERG A, 1995, NATURE, V374, P314, DOI 10.1038/374314b0; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SORIANO P, 1995, ANNU REV NEUROSCI, V18, P1; STANFIELD BB, 1985, NATURE, V313, P135, DOI 10.1038/313135a0; VICARIOABEJON C, 1995, J NEUROSCI, V15, P6351; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; ZHOU HF, 1990, J COMP NEUROL, V292, P320, DOI 10.1002/cne.902920213; ZHOU HF, 1992, J COMP NEUROL, V317, P145, DOI 10.1002/cne.903170204; ZHOU HF, 1993, EXP NEUROL, V122, P155, DOI 10.1006/exnr.1993.1116; ZIMMER A, 1992, ANNU REV NEUROSCI, V15, P115, DOI 10.1146/annurev.neuro.15.1.115	48	177	181	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1275	1285		10.1016/0896-6273(95)90007-1	http://dx.doi.org/10.1016/0896-6273(95)90007-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845152	Bronze			2022-12-28	WOS:A1995TL67800007
J	ANGLESON, JK; WENSEL, TG				ANGLESON, JK; WENSEL, TG			A GTPASE-ACCELERATING FACTOR FOR TRANSDUCIN, DISTINCT FROM ITS EFFECTOR CGMP PHOSPHODIESTERASE, IN ROD OUTER SEGMENT MEMBRANES	NEURON			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; RETINAL RODS; INHIBITORY SUBUNIT; BINDING-SITES; G-PROTEIN; PHOSPHOLIPASE C-BETA-1; MOLECULAR MECHANISM; VISUAL TRANSDUCTION; HYDROLYSIS; BOVINE	Hydrolysis of GTP by the photoreceptor G protein transducin (G(talpha)) was found to occur with kinetics identical to the inactivation of its effector cGMP phosphodiesterase (PDE), but was too slow (tens of seconds) in dilute rod outer segment (ROS) suspensions to account for subsecond recovery of the light response. Raising the concentration of ROS membranes increased the rates of GTP hydrolysis and PDE inactivation in parallel as much as 6-fold. Holo-PDE and its gamma subunit had weak effects on GTPase kinetics (<1.6-fold and <1.3-fold, respectively). ROS membranes stripped of PDE retained approximately 90% of a GTPase accelerating activity that was protease sensitive, indicating that they contain a GTPase-accelerating factor distinct from PDE.			ANGLESON, JK (corresponding author), BAYLOR COLL MED, VERNA & MARRS MCLEAN DEPT BIOCHEM, HOUSTON, TX 77030 USA.			Wensel, Theodore/0000-0003-3518-9352	NEI NIH HHS [EY07001, EY07981] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007981] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONNY B, 1993, BIOCHEMISTRY-US, V32, P8646, DOI 10.1021/bi00084a036; ARSHAVSKY VY, 1989, FEBS LETT, V250, P353, DOI 10.1016/0014-5793(89)80754-9; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; ARSHAVSKY VY, 1987, FEBS LETT, V224, P19, DOI 10.1016/0014-5793(87)80414-3; ARSHAVSKY VY, 1991, J BIOL CHEM, V266, P18530; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BENNETT N, 1989, BIOCHEMISTRY-US, V28, P7418, DOI 10.1021/bi00444a040; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BOURNE HR, 1992, NATURE, V358, P541, DOI 10.1038/358541a0; BRANDT DR, 1986, J BIOL CHEM, V261, P1656; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; BROWN RL, 1989, P NATL ACAD SCI USA, V86, P4922, DOI 10.1073/pnas.86.13.4922; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; CATTY P, 1992, J BIOL CHEM, V267, P19489; CLERC A, 1992, J BIOL CHEM, V267, P6620; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; DRATZ EA, 1987, BIOCHEM BIOPH RES CO, V146, P379, DOI 10.1016/0006-291X(87)90540-7; ERICKSON MA, 1992, SCIENCE, V257, P1255, DOI 10.1126/science.1519062; FUNG BKK, 1983, J BIOL CHEM, V258, P503; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; GUY PM, 1990, BIOCHEMISTRY-US, V29, P6954, DOI 10.1021/bi00482a003; HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P3597; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KAHLERT M, 1991, BIOPHYS J, V59, P375, DOI 10.1016/S0006-3495(91)82231-7; KAUPP UB, 1992, ANNU REV PHYSIOL, V54, P153; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LAMB TD, 1988, J PHYSIOL-LONDON, V407, P463, DOI 10.1113/jphysiol.1988.sp017426; LAMB TD, 1986, J PHYSIOL-LONDON, V372, P315, DOI 10.1113/jphysiol.1986.sp016011; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; NAVON SE, 1984, J BIOL CHEM, V259, P6686; NEAL SE, 1988, J BIOL CHEM, V263, P19718; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; PAGES F, 1992, J BIOL CHEM, V267, P22018; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SITARAMAYYA A, 1988, BIOCHEMISTRY-US, V27, P4880, DOI 10.1021/bi00413a044; STRYER L, 1991, J BIOL CHEM, V266, P10711; TING TD, 1991, BIOCHEMISTRY-US, V30, P8996, DOI 10.1021/bi00101a013; TYMINSKI PN, 1984, BIOCHEMISTRY-US, V23, P3986, DOI 10.1021/bi00312a028; VUONG TM, 1990, NATURE, V346, P71, DOI 10.1038/346071a0; VUONG TM, 1991, P NATL ACAD SCI USA, V88, P9813, DOI 10.1073/pnas.88.21.9813; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; YAMAZAKI A, 1993, J BIOL CHEM, V268, P8899; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; YEE R, 1978, J BIOL CHEM, V253, P8902; ZUCKERMAN R, 1986, FEBS LETT, V207, P35, DOI 10.1016/0014-5793(86)80008-4	63	83	85	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					939	949		10.1016/0896-6273(93)90123-9	http://dx.doi.org/10.1016/0896-6273(93)90123-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240815				2022-12-28	WOS:A1993MJ04100015
J	REBECK, GW; REITER, JS; STRICKLAND, DK; HYMAN, BT				REBECK, GW; REITER, JS; STRICKLAND, DK; HYMAN, BT			APOLIPOPROTEIN-E IN SPORADIC ALZHEIMERS-DISEASE - ALLELIC VARIATION AND RECEPTOR INTERACTIONS	NEURON			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID-BETA-PROTEIN; ALPHA-2-MACROGLOBULIN RECEPTOR; NEUROFIBRILLARY TANGLES; MONOCLONAL-ANTIBODIES; BINDING-PROTEIN; SENILE PLAQUES; CULTURED-CELLS; GENE-MUTATIONS; LOCUS	An increased prevalence of apolipoprotein E (ApoE) epsilon4 allele exists in late onset familial Alzheimer's disease. We found, in sporadic Alzheimer's disease, that 62% of patients possessed an ApoE-epsilon4 allele, compared with 20% of controls. ApoE-epsilon4/4 patients had more senile plaques (SPs) than epsilon3/3 patients. ApoE immunoreactivity of SPs was equivalent in both groups. Two receptors bind ApoE complexes, the low density lipoprotein (LDL) receptor and the LDL receptor-related protein (LRP). In normal brain, anti-LRP antibodies strongly stained neurons and lightly stained astrocytes; anti-LDL receptor antibodies stained only the neuropil and astrocytes. In Alzheimer's disease, SPs and reactive astrocytes were also strongly LRP immunoreactive. Colocalization of ApoE and LRP to SPs implies that these molecules may be involved in metabolism of components of SPs.	AMER RED CROSS,BIOCHEM LAB,ROCKVILLE,MD 20855	American Red Cross	REBECK, GW (corresponding author), MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114, USA.		Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X	NIA NIH HHS [AG05598, AG08487] Funding Source: Medline; NIGMS NIH HHS [GM42581] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005598, R29AG008487, R01AG008487] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; BAUER J, 1991, FEBS LETT, V285, P111, DOI 10.1016/0014-5793(91)80737-N; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DIEDRICH JF, 1991, J VIROL, V65, P4759, DOI 10.1128/JVI.65.9.4759-4768.1991; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HERZ J, 1990, J BIOL CHEM, V265, P21355; HIXSON JE, 1990, J LIPID RES, V31, P545; HYMAN BT, 1992, J NEUROPATH EXP NEUR, V51, P76, DOI 10.1097/00005072-199201000-00009; HYMAN BT, 1993, IN RPESS J NEUROPATH; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MANN DMA, 1989, NEUROPATH APPL NEURO, V15, P317, DOI 10.1111/j.1365-2990.1989.tb01232.x; MUELLERHILL B, 1989, ANNU REV BIOCHEM, V58, P287; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1991, AM J HUM GENET, V49, P511; SCHMECHEL DE, 1993, IN PRESS P NATL ACAD; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SMITH MA, 1993, BIOCHEM BIOPH RES CO, V193, P579, DOI 10.1006/bbrc.1993.1663; SNIPES JG, 1986, P NATL ACAD SCI USA, V83, P1130; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRITTMATTER WJ, 1993, IN PRESS P NATL ACAD; TANZI RE, 1992, AM J HUM GENET, V51, P273; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VANGOOL D, 1993, NEUROBIOL AGING, V14, P233, DOI 10.1016/0197-4580(93)90006-W; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423	45	975	989	1	33	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					575	580						6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398148				2022-12-28	WOS:A1993MD06800003
J	WALTON, KM; MARTELL, KJ; KWAK, SP; DIXON, JE; LARGENT, BL				WALTON, KM; MARTELL, KJ; KWAK, SP; DIXON, JE; LARGENT, BL			A NOVEL RECEPTOR-TYPE PROTEIN-TYROSINE-PHOSPHATASE IS EXPRESSED DURING NEUROGENESIS IN THE OLFACTORY NEUROEPITHELIUM	NEURON			English	Article							CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; LEUKOCYTE-COMMON ANTIGEN; GROWTH CONE MEMBRANES; IMMUNOGLOBULIN SUPERFAMILY; TRK PROTOONCOGENE; NEURAL DEVELOPMENT; DROSOPHILA EMBRYO; MARKER PROTEIN; BINDING-SITE	Tyrosine phosphorylation plays a central role in the control of neuronal cell development and function. Yet, few neuronal protein tyrosine phosphatases (PTPs) have been identified. We examined rat olfactory neuroepithelium for expression of novel PTPs potentially important in neuronal development and regeneration. Using the polymerase chain reaction with degenerate DNA oligomers directed to the conserved tyrosine phosphatase domain, we identified 6 novel tyrosine phosphatases. One of these, PTP NE-3, is a receptor-type PTP expressed selectively in both rat brain and olfactory neuroepithelium. In the olfactory neuroepithelium, PTP NE-3 expression is restricted to neurons and describes a novel pattern of expression with a high level in the immature neurons and a lower level in mature olfactory sensory neurons.	UNIV MICHIGAN, NEUROSCI PROGRAM, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT ANAT & CELL BIOL, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	WALTON, KM (corresponding author), UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R37DK018024] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00042] Funding Source: Medline; NIDCD NIH HHS [DC-01964] Funding Source: Medline; NIDDK NIH HHS [DK-18024] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANHOLT RRH, 1993, CRIT REV NEUROBIOL, V7, P1; ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BENOWITZ LI, 1988, J NEUROSCI, V8, P339; CAMARA CG, 1984, BRAIN RES, V308, P63, DOI 10.1016/0006-8993(84)90917-X; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DELAMONTE SM, 1989, DEV BRAIN RES, V46, P161, DOI 10.1016/0165-3806(89)90279-4; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HARIHARAN IK, 1991, P NATL ACAD SCI USA, V88, P11266, DOI 10.1073/pnas.88.24.11266; HOWARD PK, 1992, CELL, V71, P637, DOI 10.1016/0092-8674(92)90597-6; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JIRIK FR, 1992, CYTOGENET CELL GENET, V61, P266, DOI 10.1159/000133418; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LARGENT BL, 1993, J NEUROSCI, V13, P300; LEBEAU JM, 1991, J NEUROSCI RES, V28, P299, DOI 10.1002/jnr.490280217; LEVEY MS, 1991, J NEUROSCI, V11, P3556; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; MANESS PF, 1990, CIBA F SYMP, V150, P57; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MARGOLIS FL, 1985, TRENDS NEUROSCI, V8, P542, DOI 10.1016/0166-2236(85)90192-4; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATTEN WT, 1990, J CELL BIOL, V111, P1959, DOI 10.1083/jcb.111.5.1959; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P4444, DOI 10.1073/pnas.87.12.4444; MIRAGALL F, 1988, DEV BIOL, V129, P516, DOI 10.1016/0012-1606(88)90397-1; MORRISON EE, 1990, J COMP NEUROL, V297, P1, DOI 10.1002/cne.902970102; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; NEVE RL, 1988, P NATL ACAD SCI USA, V85, P3638, DOI 10.1073/pnas.85.10.3638; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; OAKLEY B, 1992, EXP NEUROL, V115, P50, DOI 10.1016/0014-4886(92)90220-K; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; PATTHY L, 1990, CELL, V61, P13, DOI 10.1016/0092-8674(90)90208-V; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; POT DA, 1991, J BIOL CHEM, V266, P19688; RAMAKERS GJA, 1992, J NEUROCYTOL, V21, P853, DOI 10.1007/BF01191683; RAMAKERS GJA, 1992, J NEUROCYTOL, V8, P205; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RITISHAUSER U, 1908, PHYSIOL REV, V68, P819; RODRIGUEZTEBAR A, 1991, PHILOS T ROY SOC B, V331, P255, DOI 10.1098/rstb.1991.0013; SAMANEN DW, 1984, J COMP NEUROL, V225, P201, DOI 10.1002/cne.902250206; Sambrook J, 1989, MOL CLONING LABORATO; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; SCHWOB JE, 1986, J NEUROSCI, V6, P208; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STJOHNSTON D, 1992, CELL, V68, P201; STREULI M, 1988, J EXP MED, V168, P1523, DOI 10.1084/jem.168.5.1523; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; SWARUP G, 1991, FEBS LETT, V280, P65, DOI 10.1016/0014-5793(91)80205-H; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TROWBRIDGE IS, 1991, J BIOL CHEM, V266, P23517; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; VERHAAGEN J, 1990, J NEUROSCI RES, V26, P31, DOI 10.1002/jnr.490260105; VIERECK C, 1989, J NEUROSCI, V9, P3547; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; YU Q, 1992, ONCOGENE, V7, P1051; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	86	91	93	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					387	400		10.1016/0896-6273(93)90193-U	http://dx.doi.org/10.1016/0896-6273(93)90193-U			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352946	Green Submitted			2022-12-28	WOS:A1993LU06500017
J	OBERDICK, J; SCHILLING, K; SMEYNE, RJ; CORBIN, JG; BOCCHIARO, C; MORGAN, JI				OBERDICK, J; SCHILLING, K; SMEYNE, RJ; CORBIN, JG; BOCCHIARO, C; MORGAN, JI			CONTROL OF SEGMENT-LIKE PATTERNS OF GENE-EXPRESSION IN THE MOUSE CEREBELLUM	NEURON			English	Article							TRANSGENE EXPRESSION; OLIVOCEREBELLAR PROJECTION; PARASAGITTAL ORGANIZATION; VISUAL-CORTEX; PURKINJE; RAT; CAT; TRANSCRIPTION; COMPARTMENTS; PROMOTER	A Purkinje cell-specific transgene, L7-lacZ, is expressed in a series of parasagitally oriented stripes in the mouse cerebellum. This banding pattern can be perturbed by promoter mutation, showing that a combination of positive and negative control elements contributes to the temporal and spatial map of L7 gene expression. In addition to the parasagittal stripes, certain mutations reveal Purkinje cells organized into compartments oriented in the transverse plane of the cerebellum. Transcription factors of the POU or homeobox families appear to be involved in controlling L7 expression in the transverse orientation. Strikingly, some of the domains of gene expression revealed by the mutations appear to correspond to functional compartments of Purkinje cells, thereby suggesting an underlying genetic principle used to orchestrate functional organization in the nervous system.	OHIO STATE UNIV, CTR BIOTECHNOL, COLUMBUS, OH 43210 USA	University System of Ohio; Ohio State University	OBERDICK, J (corresponding author), ROCHE INST MOLEC BIOL, DEPT NEUROSCI, ROCHE RES CTR, NUTLEY, NJ 07110 USA.		Morgan, James/N-8104-2018; Morgan, James/GRO-2905-2022	Morgan, James/0000-0002-8920-1065; Smeyne, Richard/0000-0002-8459-5472	PHS HHS [08-08601] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKAIKE T, 1992, J COMP NEUROL, V320, P398, DOI 10.1002/cne.903200311; ALLEN N D, 1987, P217; ARMSTRONG DM, 1974, J COMP NEUROL, V154, P287, DOI 10.1002/cne.901540305; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; BUISSERETDELMAS C, 1988, NEUROSCI RES, V5, P494, DOI 10.1016/0168-0102(88)90039-9; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; EISENMAN LM, 1989, NEUROSCIENCE, V31, P231, DOI 10.1016/0306-4522(89)90045-6; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRAVEL C, 1987, J COMP NEUROL, V265, P294, DOI 10.1002/cne.902650211; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; GROENEWEGEN HJ, 1977, J COMP NEUROL, V174, P417, DOI 10.1002/cne.901740304; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P255, DOI 10.1098/rstb.1984.0022; INMNIS MA, 1990, PCR PROTOCOLS GUIDE; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KAWAMURA K, 1979, NEUROSCIENCE, V4, P1615, DOI 10.1016/0306-4522(79)90024-1; LECLERC N, 1992, P NATL ACAD SCI USA, V89, P5006, DOI 10.1073/pnas.89.11.5006; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; MARANI E, 1979, ACTA MORPHOL NEER SC, V17, P33; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; OSCARSSON O, 1979, TRENDS NEUROSCI, V2, P143, DOI 10.1016/0166-2236(79)90057-2; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; ROBERTSON LT, 1982, EXP BRAIN RES, V46, P281; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; SOTELO C, 1991, PHILOS T R SOC B, V331, P307, DOI 10.1098/rstb.1991.0022; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Voogd J., 1980, INFERIOR OLIVARY NUC, P207; WASSEF M, 1990, J COMP NEUROL, V294, P223, DOI 10.1002/cne.902940207; WASSEF M, 1992, J COMP NEUROL, V323, P519, DOI 10.1002/cne.903230405; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	40	143	143	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1993	10	6					1007	1018		10.1016/0896-6273(93)90050-2	http://dx.doi.org/10.1016/0896-6273(93)90050-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318226				2022-12-28	WOS:A1993LK37300002
J	BRUNS, D; ENGERT, F; LUX, HD				BRUNS, D; ENGERT, F; LUX, HD			A FAST ACTIVATING PRESYNAPTIC REUPTAKE CURRENT DURING SEROTONERGIC TRANSMISSION IN IDENTIFIED NEURONS OF HIRUDO	NEURON			English	Article							PLASMA-MEMBRANE VESICLES; SQUID GIANT SYNAPSE; LEECH NEURONS; NEUROTRANSMITTER RELEASE; RETZIUS CELLS; TIME COURSE; PLATELET 5-HYDROXYTRYPTAMINE; TRANSMITTER RELEASE; VOLTAGE HYPOTHESIS; SENSORY NEURONS	An electrogenic serotonin (5-HT) uptake process was characterized in the serotonergic Retzius-P cell synapse of the leech, and the simultaneous activation of this presynaptic reuptake and the postsynaptic response was monitored during evoked transmitter release. A presynaptic, Na+-dependent inward current upon application of 5-HT was isolated at membrane potentials between -80 and +60 mV. Its identification as a transmitter uptake current was confirmed by monitoring accumulation of the autofluorescent 5-HT analog 5,7-dihydroxytryptamine during activation of this current. To study the kinetics of 5-HT reuptake in functional synapses, transmitter release was stimulated by flash photolysis of the Ca2+-caging DM-nitrophen. The results demonstrate that re-uptake activates with a minimal delay of less than a millisecond during synaptic transmission. It acts as a rapid transmitter removal system to determine the time course of the postsynaptic response and monitors the kinetics of transmitter clearance at the synaptic site.			BRUNS, D (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROPHYSIOL,KLOPFERSPITZ 18A,W-8033 MARTINSRIED,GERMANY.							Baumgarten H G, 1978, Ann N Y Acad Sci, V305, P3, DOI 10.1111/j.1749-6632.1978.tb31507.x; BLAUSTEIN MP, 1975, J MEMBRANE BIOL, V22, P285, DOI 10.1007/BF01868176; BOGDANSKI DF, 1970, BIOCHIM BIOPHYS ACTA, V219, P189, DOI 10.1016/0005-2736(70)90074-X; BORLINGHAUS R, 1987, J MEMBRANE BIOL, V97, P161, DOI 10.1007/BF01869220; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DEITMER JW, 1981, J EXP BIOL, V91, P87; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DELATORRE JC, 1976, HISTOCHEMISTRY, V49, P81, DOI 10.1007/BF00495672; DIETZEL ID, 1988, DEV BIOL, V128, P277, DOI 10.1016/0012-1606(88)90290-4; DIETZEL ID, 1986, J PHYSIOL-LONDON, V372, P191, DOI 10.1113/jphysiol.1986.sp016004; DRAPEAU P, 1989, J NEUROSCI, V9, P2502; DRAPEAU P, 1988, J NEUROSCI, V8, P4718; DUDEL J, 1988, NEUROMUSCULAR JUNCTI, P149; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; FUCHS PA, 1982, J PHYSIOL-LONDON, V323, P195, DOI 10.1113/jphysiol.1982.sp014068; GERSCHENFELD HM, 1974, J PHYSIOL-LONDON, V243, P427, DOI 10.1113/jphysiol.1974.sp010761; GERSCHENFELD HM, 1978, J PHYSIOL-LONDON, V274, P265; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENDERSON LP, 1983, J PHYSIOL-LONDON, V339, P309, DOI 10.1113/jphysiol.1983.sp014718; HIGASHI H, 1982, J PHYSIOL-LONDON, V323, P543, DOI 10.1113/jphysiol.1982.sp014091; HOFMEIER G, 1981, PFLUG ARCH EUR J PHY, V391, P242, DOI 10.1007/BF00596178; HORN AS, 1973, J NEUROCHEM, V21, P233; IVERSEN LL, 1973, BRIT MED BULL, V29, P130, DOI 10.1093/oxfordjournals.bmb.a070982; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KANNER BI, 1985, BIOCHIM BIOPHYS ACTA, V816, P403, DOI 10.1016/0005-2736(85)90508-5; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; KEYES SR, 1982, J BIOL CHEM, V257, P1172; KUFFLER DP, 1987, J COMP NEUROL, V256, P516, DOI 10.1002/cne.902560404; KUHAR MJ, 1978, J NEUROCHEM, V31, P251, DOI 10.1111/j.1471-4159.1978.tb12456.x; LENT CM, 1984, BRAIN RES, V300, P167, DOI 10.1016/0006-8993(84)91353-2; LESSMANN V, 1991, J NEUROSCI, V11, P800; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LIU Y, 1989, PROC R SOC SER B-BIO, V236, P253, DOI 10.1098/rspb.1989.0023; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MCCAMAN MW, 1973, BRAIN RES, V53, P129, DOI 10.1016/0006-8993(73)90772-5; MORAD M, 1988, SCIENCE, V241, P842, DOI 10.1126/science.2457253; NELSON PJ, 1979, J BIOL CHEM, V254, P84; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; NIGGLI E, 1991, NATURE, V349, P621, DOI 10.1038/349621a0; OREILLY CA, 1988, J BIOL CHEM, V263, P6115; PAN ZZ, 1989, J PHARMACOL EXP THER, V251, P56; PARNAS H, 1986, PFLUG ARCH EUR J PHY, V406, P121, DOI 10.1007/BF00586672; PARNAS I, 1986, J PHYSIOL-PARIS, V81, P289; PARTRIDGE LD, 1988, TRENDS NEUROSCI, V11, P69, DOI 10.1016/0166-2236(88)90167-1; REITH MEA, 1989, BIOCHEM PHARMACOL, V38, P2091, DOI 10.1016/0006-2952(89)90062-2; ROSS SB, 1977, NEUROPHARMACOLOGY, V16, P57, DOI 10.1016/0028-3908(77)90048-X; RUDNICK G, 1980, J BIOL CHEM, V255, P3638; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; SILVA NL, 1988, P NATL ACAD SCI USA, V85, P7346, DOI 10.1073/pnas.85.19.7346; STEWART RR, 1989, J EXP BIOL, V141, P1; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; THOMPSON SM, 1992, J NEUROPHYSIOL, V67, P1698, DOI 10.1152/jn.1992.67.6.1698; ZUCKER RS, 1986, SCIENCE, V231, P574, DOI 10.1126/science.2868525; ZUCKER RS, 1988, NATURE, V335, P360, DOI 10.1038/335360a0	59	66	67	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					559	572		10.1016/0896-6273(93)90159-O	http://dx.doi.org/10.1016/0896-6273(93)90159-O			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386524				2022-12-28	WOS:A1993KY50100001
J	PEARCE, RA				PEARCE, RA			PHYSIOLOGICAL EVIDENCE FOR 2 DISTINCT GABA(A) RESPONSES IN RAT HIPPOCAMPUS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; LACUNOSUM-MOLECULARE INTERNEURONS; CIRCUIT SYNAPTIC-INTERACTIONS; SPINAL-CORD NEURONS; PYRAMIDAL CELLS; RECURRENT INHIBITION; RECEPTOR SUBTYPES; BRAIN-SLICES; CA1 NEURONS; A RECEPTORS	The gamma-aminobutyric acid(A) (GABA(A)) receptor is a ligand-gated ionophore involved in synaptic inhibition. Biochemical and molecular biological studies indicate that considerable receptor heterogeneity exists, but physiological differences between inhibitory GABA(A) synaptic responses have not been identified in the brain. The present report describes two anatomically segregated GABA(A)-mediated synaptic currents in the hippocampal CA1 region that have distinct physiological, pharmacological, and functional properties. GABA(A,fast) enters at or near the cell body, decays rapidly (3-8 ms), is blocked by furosemide, and rapidly curtails the excitatory response. GABA(A,slow) enters far from the cell body, decays slowly (30-70 ms), is not blocked by furosemide, and underlies the conventionally recognized early inhibitory postsynaptic potential. The receptors producing these responses may represent subtypes of the GABA(A) receptor.	UNIV WISCONSIN,DEPT ANAT,MADISON,WI 53706; UNIV WISCONSIN,NEUROSCI TRAINING PROGRAM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	PEARCE, RA (corresponding author), UNIV WISCONSIN,DEPT ANESTHESIOL,MADISON,WI 53706, USA.		Pearce, Robert/B-4044-2011	Pearce, Robert/0000-0002-1516-6260	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001548] Funding Source: NIH RePORTER; NINDS NIH HHS [NS01548] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; BUSCH C, 1990, COLD SH Q B, V55, P69; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; DUNWIDDIE TV, 1986, J PHARMACOL EXP THER, V238, P564; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; HARA M, 1992, NEUROSCI LETT, V143, P135, DOI 10.1016/0304-3940(92)90250-B; INOMATA N, 1988, BRIT J PHARMACOL, V93, P679, DOI 10.1111/j.1476-5381.1988.tb10326.x; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; JOHNSTON D, 1983, J NEUROPHYSIOL, V50, P464, DOI 10.1152/jn.1983.50.2.464; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; KAPUR J, 1989, J NEUROPHYSIOL, V61, P417, DOI 10.1152/jn.1989.61.2.417; KERR DIB, 1988, NEUROSCI LETT, V92, P92, DOI 10.1016/0304-3940(88)90748-3; KERR DIB, 1987, BRAIN RES, V405, P150, DOI 10.1016/0006-8993(87)90999-1; KNOWLES WD, 1981, J NEUROSCI, V1, P318; KRASZEWSKI K, 1992, NEUROSCIENCE, V47, P555, DOI 10.1016/0306-4522(92)90165-X; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LERMA J, 1992, MOL PHARMACOL, V41, P217; MACDONALD RL, 1989, J PHYSIOL-LONDON, V410, P479, DOI 10.1113/jphysiol.1989.sp017545; MATHERS DA, 1988, SYNAPSE, V2, P627, DOI 10.1002/syn.890020608; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MODY I, 1991, BRAIN RES, V538, P319, DOI 10.1016/0006-8993(91)90447-4; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NATHAN T, 1991, J NEUROPHYSIOL, V66, P1704, DOI 10.1152/jn.1991.66.5.1704; NEWBERRY NR, 1984, J PHYSIOL-LONDON, V348, P239, DOI 10.1113/jphysiol.1984.sp015107; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; NICOLL RA, 1972, J PHYSIOL-LONDON, V223, P803, DOI 10.1113/jphysiol.1972.sp009875; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NICOLL RA, 1978, J PHYSIOL-LONDON, V283, P121, DOI 10.1113/jphysiol.1978.sp012491; OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PEARCE RA, 1989, ANESTHESIOLOGY, V71, P591, DOI 10.1097/00000542-198910000-00019; PROCTOR WR, 1986, J NEUROSCI, V6, P3161; RALL W, 1985, VOLTAGE PATCH CLAMPI, P191; ROCK DM, 1986, NEUROSCI LETT, V65, P265, DOI 10.1016/0304-3940(86)90272-7; SIEGHART W, 1989, TRENDS PHARMACOL SCI, V10, P407, DOI 10.1016/0165-6147(89)90189-2; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SOMOGYI P, 1983, BRAIN RES, V259, P137, DOI 10.1016/0006-8993(83)91076-4; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; THOMPSON SM, 1988, J NEUROPHYSIOL, V60, P105, DOI 10.1152/jn.1988.60.1.105; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; VU ET, 1992, SCIENCE, V255, P1710, DOI 10.1126/science.1553559; WILLIAMS S, 1992, SYNAPSE, V11, P249, DOI 10.1002/syn.890110309; WISDEN W, 1992, J NEUROSCI, V12, P1040; WOLF P, 1977, N-S ARCH PHARMACOL, V299, P211, DOI 10.1007/BF00500313	52	286	289	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					189	200		10.1016/0896-6273(93)90310-N	http://dx.doi.org/10.1016/0896-6273(93)90310-N			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382497				2022-12-28	WOS:A1993KP68500007
J	Wang, LC; Rachel, RA; Marcus, RC; Mason, CA				Wang, LC; Rachel, RA; Marcus, RC; Mason, CA			Chemosuppression of retinal axon growth by the mouse optic chiasm	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; FLOOR PLATE; SPINAL-CORD; UNCROSSED AXONS; NEURITE OUTGROWTH; COMMISSURAL AXONS; CROSSED AXONS; MOTOR AXONS; TIME-LAPSE; GUIDANCE	To determine whether diffusible guidance cues direct retinal axon growth and divergence at the optic chiasm, we cocultured mouse retinal and chiasm explants in collagen gels. The chiasm reduced retinal neurite lengths and numbers, but did not affect commissural or pontine neurite growth. This reduction in growth was equal for all retinal quadrants and occurred without reorienting the direction of neurite extension. The floor plate, another midline guidance locus, also suppressed retinal neurite outgrowth, whereas cortex or cerebellum explants did not. Growth suppression was not mediated by netrin-1, which instead enhanced retinal neurite extension. We propose that chemosuppression may be a general guidance mechanism that acts in intermediate targets to prime growth cones to perceive other, more specific cues.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT ANAT & CELL BIOL,NEW YORK,NY 10032	Columbia University	Wang, LC (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT PATHOL,722 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL EYE INSTITUTE [F32EY006510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027615] Funding Source: NIH RePORTER; NEI NIH HHS [NRSA EY06510] Funding Source: Medline; NINDS NIH HHS [P0 NS30522, NS/EY 27615] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIRD DH, 1992, J NEUROSCI, V12, P619; Baird DH, 1996, J NEUROSCI, V16, P2642; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bolz Juergen, 1994, Current Opinion in Neurobiology, V4, P545, DOI 10.1016/0959-4388(94)90055-8; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; ERZURUMLU RS, 1993, P NATL ACAD SCI USA, V90, P7235, DOI 10.1073/pnas.90.15.7235; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; Halfter W, 1996, DEV BIOL, V177, P160, DOI 10.1006/dbio.1996.0153; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HU H, 1996, NEURON, V16, P923; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KUANG RZ, 1994, DEVELOPMENT, V120, P1937; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MARCUS RC, 1995, J NEUROSCI, V15, P3716; MARCUS RC, 1995, J NEUROSCI, V15, P6389; Marcus RC, 1996, DEVELOPMENT, V122, P859; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RICE DS, 1995, J COMP NEUROL, V354, P459, DOI 10.1002/cne.903540312; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; TAMADA A, 1995, NEURON, V14, P1083, DOI 10.1016/0896-6273(95)90347-X; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Theiler K., 1972, HOUSE MOUSE; Tucker A, 1996, EUR J NEUROSCI, V8, P906, DOI 10.1111/j.1460-9568.1996.tb01577.x; VONBOXBERG Y, 1993, NEURON, V10, P345; WANG LC, 1994, J NEUROSCI, V14, P3195; Wang LC, 1995, NEURON, V15, P1349, DOI 10.1016/0896-6273(95)90013-6; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; YAMAGATA M, 1995, DEVELOPMENT, V121, P189	54	61	61	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					849	862		10.1016/S0896-6273(00)80217-2	http://dx.doi.org/10.1016/S0896-6273(00)80217-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938118	Bronze			2022-12-28	WOS:A1996VV15100008
J	Araki, T; Milbrandt, J				Araki, T; Milbrandt, J			Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth	NEURON			English	Article							NEURONAL PROCESS OUTGROWTH; CELL-SURFACE PROTEINS; SCHWANN-CELLS; PERIPHERAL-NERVES; MESSENGER-RNA; N-CAM; SYSTEM; EXPRESSION; REGENERATION; RECEPTORS	Peripheral nerve injury results in axonal degeneration and in phenotypic changes of the surrounding Schwann cells, whose presence is critical for nerve regeneration. Using differential screening strategies, we identified a novel protein, termed ninjurin (for nerve injury-induced protein), that is up-regulated after axotomy in neurons and in Schwann cells surrounding the distal nerve segment. Ninjurin is located on the cell surface, is capable of mediating homophilic adhesion, and promotes neurite extension of dorsal root ganglion neurons in vitro. Ninjurin is also expressed in a number of other tissues, predominantly in epithelial cells. These results suggest that ninjurin plays a role in nerve regeneration and in the formation and function of other tissues.	UNIV WASHINGTON, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	Araki, T (corresponding author), UNIV WASHINGTON, SCH MED, DEPT PATHOL, DIV LAB MED, ST LOUIS, MO 63110 USA.		Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689				Aguayo A.J., 1985, SYNAPTIC PLASTICITY, P457; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BRODKEY JA, 1993, EXP NEUROL, V123, P251, DOI 10.1006/exnr.1993.1158; BUNGE RP, 1992, DIS NERV SYST, P87; CHONCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156; DANILOFF JK, 1986, J CELL BIOL, V103, P929, DOI 10.1083/jcb.103.3.929; DOHERTY P, 1989, J CELL BIOL, V109, P789, DOI 10.1083/jcb.109.2.789; EICHLER ME, 1989, BRAIN RES, V482, P340, DOI 10.1016/0006-8993(89)91197-9; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; FALLON JR, 1985, J NEUROSCI, V5, P3169; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P401, DOI 10.1111/j.1365-2990.1986.tb00151.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MANIATIS T, 1982, MOL CLONING LABORATO, P280; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MARTINI R, 1988, J CELL BIOL, V106, P1746; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; RIEGER F, 1988, J CELL BIOL, V107, P707, DOI 10.1083/jcb.107.2.707; ROST B, 1995, PROTEIN SCI, V4, P521; RUBENSTEIN JLR, 1990, NUCLEIC ACIDS RES, V18, P4833, DOI 10.1093/nar/18.16.4833; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TANIUCHI M, 1988, J NEUROSCI, V8, P664; THOMPSON JA, 1987, BIOCHEMISTRY-US, V26, P743, DOI 10.1021/bi00377a014; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TRAPP BD, 1988, J NEUROSCI, V8, P3515; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WHITE FV, 1989, J NEUROCHEM, V52, P1085, DOI 10.1111/j.1471-4159.1989.tb01851.x	41	158	172	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					353	361		10.1016/S0896-6273(00)80166-X	http://dx.doi.org/10.1016/S0896-6273(00)80166-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780658	Bronze			2022-12-28	WOS:A1996VE84000017
J	Roche, KW; OBrien, RJ; Mammen, AL; Bernhardt, J; Huganir, RL				Roche, KW; OBrien, RJ; Mammen, AL; Bernhardt, J; Huganir, RL			Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; RETINAL HORIZONTAL CELLS; GLUTAMATE-RECEPTOR; HIPPOCAMPAL-NEURONS; FUNCTIONAL EXPRESSION; MODULATION; CHANNELS; ENHANCEMENT; CLONING	We have characterized the phosphorylation of the glutamate receptor subunit GluR1, using biochemical and electrophysiological techniques. GluR1 is phosphorylated on multiple sites that are all located on the C-terminus of the protein. Cyclic AMP-dependent protein kinase specifically phosphorylates SER-845 of GluR1 in transfected HEK cells and in neurons in culture. Phosphorylation of this residue results in a 40% potentiation of the peak current through GluR1 homo-meric channels. In addition, protein kinase C specifically phosphorylates Ser-831 of GluR1 in HEK-293 cells and in cultured neurons. These results are consistent with the recently proposed transmembrane topology models of glutamate receptors, in which the C-terminus is intracellular. In addition, the modulation of GluR1 by PKA phosphorylation of Ser-845 suggests that phosphorylation of this residue may underlie the PKA-induced potentiation of AMPA receptors in neurons.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROL,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University	Roche, KW (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.		Roche, Katherine/W-9893-2019; Mammen, Andrew/AAF-2885-2021	Roche, Katherine/0000-0001-7282-6539	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007368] Funding Source: NIH RePORTER; NINDS NIH HHS [1T32NS07368] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLACKSTONE CD, 1992, ANN NEUROL, V31, P680, DOI 10.1002/ana.410310620; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; ESHHAR N, 1993, NEUROSCIENCE, V57, P943, DOI 10.1016/0306-4522(93)90040-M; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; KELLER BU, 1992, EMBO J, V11, P891, DOI 10.1002/j.1460-2075.1992.tb05127.x; KNAPP AG, 1987, NATURE, V325, P437, DOI 10.1038/325437a0; KREBS EG, 1994, TRENDS BIOCHEM SCI, V19, P439, DOI 10.1016/0968-0004(94)90125-2; LIMAN ER, 1989, BRAIN RES, V481, P399, DOI 10.1016/0006-8993(89)90822-6; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MOORE KR, 1994, BIOTECHNIQUES, V17, P130; MOSS SJ, 1993, NEUROCHEM RES, V18, P105, DOI 10.1007/BF00966929; NAKAZAW AK, 1995, NEURON, V15, P697; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; REIMANN EM, 1983, METHOD ENZYMOL, V99, P51; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TAN SE, 1994, J NEUROSCI, V14, P1123, DOI 10.1523/JNEUROSCI.14-03-01123.1994; TAVERNA FA, 1994, J BIOL CHEM, V269, P14159; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; WOODGETT JR, 1987, J BIOL CHEM, V262, P4836; YAKEL JL, 1995, P NATL ACAD SCI USA, V92, P1376, DOI 10.1073/pnas.92.5.1376	45	638	651	2	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1179	1188		10.1016/S0896-6273(00)80144-0	http://dx.doi.org/10.1016/S0896-6273(00)80144-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663994	Bronze			2022-12-28	WOS:A1996UU11800015
J	Role, LW; Berg, DK				Role, LW; Berg, DK			Nicotinic receptors in the development and modulation of CNS synapses	NEURON			English	Review							RAT INTERPEDUNCULAR NUCLEUS; CILIARY GANGLION NEURONS; H-3 DOPAMINE RELEASE; ACETYLCHOLINE-RECEPTOR; XENOPUS OOCYTES; SYMPATHETIC NEURONS; CHANNEL DOMAIN; BINDING-SITES; PHARMACOLOGICAL CHARACTERIZATION; SYNAPTIC TRANSMISSION		UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego	Role, LW (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, DEPT CELL BIOL & ANAT, 722 W 168TH ST, NEW YORK, NY 10032 USA.		Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X				ALKONDON M, 1995, J PHARMACOL EXP THER, V274, P771; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; AMADOR M, 1995, J NEUROSCI, V15, P4525; ANAND R, 1991, J BIOL CHEM, V266, P11192; ARENELLA LS, 1993, J NEUROSCI, V13, P4525; BALLIVET M, 1988, NEURON, V1, P847, DOI 10.1016/0896-6273(88)90132-8; BELCHER G, 1977, J PHYSIOL-LONDON, V272, P105, DOI 10.1113/jphysiol.1977.sp012036; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bertrand D, 1993, CURR OPIN CELL BIOL, V5, P688, DOI 10.1016/0955-0674(93)90141-C; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BROWN DA, 1983, J PHYSIOL-LONDON, V341, P655, DOI 10.1113/jphysiol.1983.sp014831; BROWN DA, 1984, J PHYSIOL-LONDON, V353, P101, DOI 10.1113/jphysiol.1984.sp015325; BRUSSAARD AB, 1994, PFLUG ARCH EUR J PHY, V429, P27, DOI 10.1007/BF02584027; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; CHARNET P, 1992, J PHYSIOL-LONDON, V450, P375, DOI 10.1113/jphysiol.1992.sp019132; Chiappinelli V., 1991, SNAKE TOXINS, P223; CLARKE P, 1995, ADV PHARM SCI, V2; CLARKE PBS, 1986, J COMP NEUROL, V251, P407, DOI 10.1002/cne.902510311; CLARKE PBS, 1987, NEUROSCIENCE, V23, P1011, DOI 10.1016/0306-4522(87)90176-X; CLARKE PBS, 1993, PROG BRAIN RES, V98, P77; CLARKE PBS, 1985, BRAIN RES, V348, P355, DOI 10.1016/0006-8993(85)90456-1; COHEN BN, 1995, J GEN PHYSIOL, V105, P745, DOI 10.1085/jgp.105.6.745; CONNOLLY JG, 1995, J PHYSIOL-LONDON, V484, P87, DOI 10.1113/jphysiol.1995.sp020650; CONROY WG, 1992, NEURON, V9, P679, DOI 10.1016/0896-6273(92)90031-8; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; CORRIVEAU RA, 1995, J NEUROSCI, V15, P1372; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; COVERNTON PJO, 1994, J PHYSIOL-LONDON, V481, P27, DOI 10.1113/jphysiol.1994.sp020416; DANI JA, 1995, CURR OPIN NEUROBIOL, V5, P310, DOI 10.1016/0959-4388(95)80043-3; DELTORO ED, 1994, J COMP NEUROL, V349, P325, DOI 10.1002/cne.903490302; DENERIS ES, 1991, TRENDS PHARMACOL SCI, V12, P34, DOI 10.1016/0165-6147(91)90486-C; DEVAY P, 1994, DEV BIOL, V162, P56, DOI 10.1006/dbio.1994.1066; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P459; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; ELBIZRI H, 1994, BRIT J PHARMACOL, V111, P414, DOI 10.1111/j.1476-5381.1994.tb14750.x; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P215, DOI 10.1113/jphysiol.1991.sp018466; FUCHS PA, 1992, J NEUROSCI, V12, P800; FUTAMI T, 1995, NEUROSCI RES, V21, P331, DOI 10.1016/0168-0102(94)00869-H; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; GRADY S, 1992, J NEUROCHEM, V59, P848, DOI 10.1111/j.1471-4159.1992.tb08322.x; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; HEINEMANN S, 1990, PROG BRAIN RES, V86, P195; HEINEMANN U, 1990, PROG BRAIN RES, V83, P197; HENLEY JM, 1986, SCIENCE, V232, P1627, DOI 10.1126/science.3715468; Horch HLW, 1995, J NEUROSCI, V15, P7778; HORYLEE F, 1995, J NEUROSCI, V15, P6453; HOWARD MJ, 1995, DEV BIOL, V170, P479, DOI 10.1006/dbio.1995.1231; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; ISHIHARA K, 1995, J PHARMACOL EXP THER, V273, P1471; ITO C, 1989, BRAIN RES, V503, P44, DOI 10.1016/0006-8993(89)91701-0; JACOB MH, 1983, J NEUROSCI, V3, P260; JAMES JR, 1995, BEHAV GENET, V25, P149, DOI 10.1007/BF02196924; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KING WM, 1990, BRAIN RES, V527, P150; LANDMESSER L, 1978, FED PROC, V37, P2016; Langley J N, 1892, J Physiol, V13, P460; LAPCHAK PA, 1989, J NEUROCHEM, V53, P1843, DOI 10.1111/j.1471-4159.1989.tb09251.x; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; LESTER RAJ, 1994, NEUROPHARMACOLOGY, V33, P27, DOI 10.1016/0028-3908(94)90093-0; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; LIVSEY CT, 1990, VISION RES, V30, P853, DOI 10.1016/0042-6989(90)90054-O; LONDON ED, 1989, NEUROCHEM RES, V14, P745, DOI 10.1007/BF00964952; LUETJE CW, 1990, J NEUROCHEM, V55, P632, DOI 10.1111/j.1471-4159.1990.tb04180.x; LUETJE CW, 1993, MOL PHARMACOL, V44, P657; LUETJE CW, 1991, J NEUROSCI, V11, P837; MACNICOL M, 1992, FEBS LETT, V304, P237, DOI 10.1016/0014-5793(92)80627-S; MARGIOTTA JF, 1989, DEV BIOL, V135, P326, DOI 10.1016/0012-1606(89)90183-8; MARKS MJ, 1993, J PHARMACOL EXP THER, V264, P542; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MCMAHON LL, 1994, J NEUROPHYSIOL, V71, P826, DOI 10.1152/jn.1994.71.2.826; MCMAHON LL, 1994, NEUROSCIENCE, V59, P689, DOI 10.1016/0306-4522(94)90187-2; MOSS BL, 1993, J NEUROSCI, V13, P13; MOSS BL, 1989, NEURON, V3, P597, DOI 10.1016/0896-6273(89)90270-5; MULLE C, 1991, J NEUROSCI, V11, P2588; MULLE C, 1992, NEURON, V8, P937, DOI 10.1016/0896-6273(92)90208-U; MULLE C, 1992, NEURON, V8, P135, DOI 10.1016/0896-6273(92)90115-T; NUMA S, 1983, COLD SPRING HARB SYM, V48, P57, DOI 10.1101/SQB.1983.048.01.008; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; PAPKE RL, 1991, J PHYSIOL-LONDON, V440, P95, DOI 10.1113/jphysiol.1991.sp018698; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; PARKINSON D, 1988, EXP BRAIN RES, V73, P553, DOI 10.1007/BF00406614; PATRICK J, 1993, PROG BRAIN RES, V98, P113; PHELAN KD, 1992, SYNAPSE, V10, P349, DOI 10.1002/syn.890100410; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; PUGH PC, 1995, MOL PHARMACOL, V47, P717; PUGH PC, 1994, J NEUROSCI, V14, P889; QUIK M, 1994, BRAIN RES, V655, P161, DOI 10.1016/0006-8993(94)91610-1; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; RAPIER C, 1990, J NEUROCHEM, V54, P937, DOI 10.1111/j.1471-4159.1990.tb02341.x; RAPIER C, 1988, J NEUROCHEM, V50, P1123, DOI 10.1111/j.1471-4159.1988.tb10582.x; RATHOUZ MM, 1994, J NEUROSCI, V14, P6935; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; ROGERS M, 1995, BIOPHYS J, V68, P501, DOI 10.1016/S0006-3495(95)80211-0; SANDS SB, 1992, J PHYSIOL-LONDON, V447, P467, DOI 10.1113/jphysiol.1992.sp019012; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; SCHRODER H, 1995, BRAIN IMAGING NICOTI, P73; SCHULZ DW, 1991, J NEUROSCI, V11, P287; SEGUELA P, 1993, J NEUROSCI, V13, P596; SMITH J, 1979, NATURE, V282, P852, DOI 10.1038/282853a0; SUMMERS KL, 1995, NEUROCHEM RES, V20, P753, DOI 10.1007/BF01705545; TOKIMASA T, 1984, BRAIN RES, V295, P364, DOI 10.1016/0006-8993(84)90987-9; ULLIAN EM, 1995, J NEUROSCI, V15, P7012; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; VERNINO S, 1994, J NEUROSCI, V14, P5514; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; VIDAL C, 1993, NEUROSCIENCE, V56, P23, DOI 10.1016/0306-4522(93)90558-W; VIDAL C, 1989, NEUROSCIENCE, V29, P261, DOI 10.1016/0306-4522(89)90056-0; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; VIZI ES, 1995, ANN NY ACAD SCI, V757, P84, DOI 10.1111/j.1749-6632.1995.tb17466.x; WHITING P, 1987, FEBS LETT, V219, P459, DOI 10.1016/0014-5793(87)80272-7; WHITING P, 1991, MOL PHARMACOL, V40, P463; WHITING PJ, 1987, J NEUROSCI, V7, P4005; WONNACOTT S, 1995, ADV PHARM SCI, V2, P87; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZHANG M, 1993, EXP BRAIN RES, V96, P83, DOI 10.1007/BF00230441; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; ZOLI M, 1995, J NEUROSCI, V15, P1912, DOI 10.1523/JNEUROSCI.15-03-01912.1995	128	674	683	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1077	1085		10.1016/S0896-6273(00)80134-8	http://dx.doi.org/10.1016/S0896-6273(00)80134-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663984	hybrid			2022-12-28	WOS:A1996UU11800005
J	Impey, S; Mark, M; Villacres, EC; Poser, S; Chavkin, C; Storm, DR				Impey, S; Mark, M; Villacres, EC; Poser, S; Chavkin, C; Storm, DR			Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus	NEURON			English	Article							DROSOPHILA LEARNING MUTANT; APLYSIA SENSORY NEURONS; TERM POTENTIATION; CYCLIC-AMP; ADENYLATE-CYCLASE; PROTEIN-SYNTHESIS; SYNAPTIC ACTIVATION; SOMATOSTATIN GENE; PYRAMIDAL CELLS; CA-2+ CHANNELS	Gene expression regulated by the cAMP response element (CRE) has been implicated in synaptic plasticity and long-term memory. It has been proposed that CRE-mediated gene expression is stimulated by signals that induce long-term potentiation (LTP). To test this hypothesis, we made mice transgenic for a CRE-regulated reporter construct. We focused on longlasting long-term potentiation (L-LTP), because it depends on cAMP-dependent protein kinase activity (PKA) and de novo gene expression. CRE-mediated gene expression was markedly increased after L-LTP, but not after decremental LTP (D-LTP). Furthermore, inhibitors of PKA blocked L-LTP and associated increases in CRE-mediated gene expression. These data demonstrate that the signaling required for the generation of L-LTP but not D-LTP is sufficient to stimulate CRE-mediated transcription in the hippocampus.	UNIV WASHINGTON, SCH MED, DEPT PSYCHIAT & BEHAV SCI, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	Impey, S (corresponding author), UNIV WASHINGTON, SCH MED, DEPT PHARMACOL, SEATTLE, WA 98195 USA.		Mark, Melanie/ABF-9102-2020; Chavkin, Charles/G-2797-2010	Mark, Melanie/0000-0002-2788-6003; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20498] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P5637, DOI 10.1073/pnas.91.12.5637; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BARONDES SH, 1968, P NATL ACAD SCI USA, V61, P923, DOI 10.1073/pnas.61.3.923; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CHATTON B, 1994, ONCOGENE, V9, P375; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; CROW T, 1990, P NATL ACAD SCI USA, V87, P4490, DOI 10.1073/pnas.87.12.4490; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DECESARE D, 1995, ONCOGENE, V11, P365; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; FLEXNER LB, 1966, P NATL ACAD SCI USA, V55, P369, DOI 10.1073/pnas.55.2.369; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GRECKSCH G, 1980, PHARM BIOCH BEHAV, V12, P613; GROVER LM, 1994, SYNAPSE, V16, P66, DOI 10.1002/syn.890160108; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HANSE E, 1995, NEUROSCIENCE, V67, P531, DOI 10.1016/0306-4522(95)00090-6; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; HUANG YY, 1993, J NEUROSCI, V13, P568; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; IMPEY S, 1994, MOL CELL BIOL, V14, P8272, DOI 10.1128/MCB.14.12.8272; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KESNER RP, 1972, SCIENCE, V176, P432, DOI 10.1126/science.176.4033.432; KILBOURNE EJ, 1992, J BIOL CHEM, V267, P7563; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIU F, 1993, J BIOL CHEM, V268, P6714; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Matthies H, 1990, Adv Exp Med Biol, V268, P359; MEINKOTH J, 1990, CIBA F SYMP, V150, P47; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; REGEHR WG, 1992, J NEUROSCI, V12, P4202; REYMANN KG, 1989, NEUROSCI LETT, V96, P96, DOI 10.1016/0304-3940(89)90249-8; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; Slack JR, 1995, NEUROSCI LETT, V201, P25, DOI 10.1016/0304-3940(94)12121-6; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; SQUIRE LR, 1988, TRENDS NEUROSCI, V11, P170, DOI 10.1016/0166-2236(88)90144-0; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VANNGUYEN T, 1990, J NEUROSCI, V10, P2825; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; YOVELL Y, 1987, P NATL ACAD SCI USA, V84, P9285, DOI 10.1073/pnas.84.24.9285	85	489	498	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					973	982		10.1016/S0896-6273(00)80120-8	http://dx.doi.org/10.1016/S0896-6273(00)80120-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630255	Bronze			2022-12-28	WOS:A1996UN48000012
J	Nestler, EJ				Nestler, EJ			Under siege: The brain on opiates	NEURON			English	Review							LOCUS-CERULEUS NEURONS; WITHDRAWAL; REWARD				Nestler, EJ (corresponding author), YALE UNIV,SCH MED,LAB MOL PSYCHIAT,NEW HAVEN,CT 06508, USA.							AKAOKA H, 1991, J NEUROSCI, V11, P3830; ALREJA M, 1993, J NEUROSCI, V13, P3525; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; CARLEZON WA, 1993, BRAIN RES, V620, P339, DOI 10.1016/0006-8993(93)90177-O; CHILDERS SR, 1991, LIFE SCI, V48, P1991, DOI 10.1016/0024-3205(91)90154-4; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; HARRIS GC, 1991, J NEUROSCI, V11, P2574; JOHNSON SW, 1992, J NEUROSCI, V12, P483; KALIVAS PW, 1995, DRUG ALCOHOL DEPEN, V37, P95, DOI 10.1016/0376-8716(94)01063-Q; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; KOVOOR A, 1995, TRENDS NEUROSCI, V270, P589; MATSUOKA I, 1994, EUR J PHARM-MOLEC PH, V268, P215, DOI 10.1016/0922-4106(94)90191-0; NESTLER EJ, 1994, BRAIN RES BULL, V35, P521, DOI 10.1016/0361-9230(94)90166-X; OLSEN GA, 1994, PEPTIDES, V15, P1513; PEI G, 1995, MOL PHARMACOL, V48, P173; SELF DW, 1994, J NEUROSCI, V14, P6239; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; SIM LJ, 1996, J NEUROSCI, V16, P2648; TRUJILLO KA, 1995, DRUG ALCOHOL DEPEN, V38, P139, DOI 10.1016/0376-8716(95)01119-J; VONZASTROW M, 1994, REGUL PEPTIDES, V54, P315, DOI 10.1016/0167-0115(94)90516-9; WIDNELL KL, 1994, P NATL ACAD SCI USA, V91, P10947, DOI 10.1073/pnas.91.23.10947; WISE RA, 1990, PSYCHOTROPIC DRUGS A, P23	23	212	226	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					897	900		10.1016/S0896-6273(00)80110-5	http://dx.doi.org/10.1016/S0896-6273(00)80110-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630245	Bronze			2022-12-28	WOS:A1996UN48000002
J	Brandes, C; Plautz, JD; Stanewsky, R; Jamison, CF; Straume, M; Wood, KV; Kay, SA; Hall, JC				Brandes, C; Plautz, JD; Stanewsky, R; Jamison, CF; Straume, M; Wood, KV; Kay, SA; Hall, JC			Novel features of Drosophila period transcription revealed by real-time luciferase reporting	NEURON			English	Article							MESSENGER-RNA LEVELS; CIRCADIAN CLOCK; GENE; MELANOGASTER; EXPRESSION; MUTATIONS	The rapid turnover of luciferase and the sensitive, noninvasive nature of its assay make this reporter gene uniquely situated for temporal gene expression studies. To determine the in vivo regulatory pattern of the Drosophila clock gene period (per), we generated transgenic strains carrying a luciferase cDNA fused to the promoter region of the per gene. This has allowed us to monitor circadian rhythms of bioluminescence from pacemaker cells within the head for several days in individual living adults. These high time-resolution experiments permitted neuronal per transcription to be accurately measured in single animals. This new technology has revealed a novel feature of per transcription and opens the door to vastly simplified experiments in general chronobiology and studies of temporally regulated transcription in a wide range of experimental systems.	UNIV VIRGINIA,DEPT BIOL,CHARLOTTESVILLE,VA 22903; UNIV VIRGINIA,NATL SCI FDN CTR BIOL TIMING,CHARLOTTESVILLE,VA 22903; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; BRANDEIS UNIV,NATL SCI FDN CTR BIOL TIMING,WALTHAM,MA 02254; PROMEGA CORP,MADISON,WI 53711	University of Virginia; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Virginia; Brandeis University; Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; Promega Corporation			Stanewsky, Ralf/ABB-9193-2021; Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Stanewsky, Ralf/0000-0001-8238-6864	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33205] Funding Source: Medline; NIMH NIH HHS [MH-51573] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CARPENTER JM, 1950, DROSOPHILA INFORMATI, V24, P96; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; HALL JC, 1995, TRENDS NEUROSCI, V18, P218; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; Kay S A, 1993, Semin Cell Biol, V4, P81, DOI 10.1006/scel.1993.1010; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; LOCKETT TJ, 1992, GENE, V114, P187, DOI 10.1016/0378-1119(92)90573-8; LORENZ LJ, 1989, DEVELOPMENT, V107, P869; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MONSMA SA, 1988, J EXP ZOOL, V247, P279, DOI 10.1002/jez.1402470312; PLAUTZ JD, 1996, IN PRESS GENE; ROBERTSON HM, 1988, GENETICS, V118, P461; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Straume M, 1991, TOPICS FLUORESCENCE, P177, DOI DOI 10.1007/B112907; THOMPSON EM, 1995, P NATL ACAD SCI USA, V92, P1317, DOI 10.1073/pnas.92.5.1317; Vetterling W.T., 1989, NUMERICAL RECIPES; WASHBURN T, 1992, GENETICS, V130, P585; Wood Keith V., 1995, Current Opinion in Biotechnology, V6, P50, DOI 10.1016/0958-1669(95)80009-3; WRIGHT NJD, 1995, J NEUROSCI, V15, P1025; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; ZWIEBEL LJ, 1991, P NATL ACAD SCI USA, V88, P3882, DOI 10.1073/pnas.88.9.3882	33	133	134	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					687	692		10.1016/S0896-6273(00)80088-4	http://dx.doi.org/10.1016/S0896-6273(00)80088-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607986	Bronze			2022-12-28	WOS:A1996UG61100001
J	Sewing, S; Roeper, J; Pongs, O				Sewing, S; Roeper, J; Pongs, O			Kv beta 1 subunit binding specific for Shaker-related potassium channel alpha subunits	NEURON			English	Article							CALCIUM-CHANNEL; FUNCTIONAL EXPRESSION; K+-CHANNEL; RAT-BRAIN; XENOPUS-OOCYTES; BETA-SUBUNIT; INACTIVATION; PURIFICATION; FAMILY; CDNA	Voltage-activated potassium (Kv) channels from mammalian brain are hetero-oligomers containing alpha and beta subunits. Coexpression of Kv1 alpha and Kv beta 1 subunits confers rapid A-type inactivation on noninactivating potassium channels (delayed rectifiers) in expression systems in vitro. We have delineated a Kv1.5 amino-terminal region of up to 90 amino acids (residues 112-201) that is sufficient for interactions of Kv1.5 alpha and Kv beta 1 subunits. Within this region of the Kv1.5 amino terminus (residues 193-201), a Kv beta 1 interaction site necessary for Kv beta 1-mediated rapid inactivation of Kv1.5 currents was detected. This interaction site motif (FYE/QLGE/DEAM/L) is found exclusively in the Shaker-related subfamily (Kv1). The results show that hetero-oligomerization between alpha and Kv beta 1 subunits is restricted to Shaker-related potassium channel alpha subunits.			Sewing, S (corresponding author), INST NEURALE SIGNALVERARBEITUNG,ZENTRUM MOL NEUROBIOL,MARTINISTR 52,D-20246 HAMBURG,GERMANY.			Roeper, Jochen/0000-0003-2145-8742				BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHANDY G, 1994, HDB RECEPTORS CHANNE, P1; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN S, 1994, J PHYSIOL-PARIS, V88, P173, DOI 10.1016/0928-4257(94)90003-5; Hille B., 1992, IONIC CHANNELS EXCIT; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; IKEDA SR, 1992, PFLUG ARCH EUR J PHY, V422, P201, DOI 10.1007/BF00370422; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MCCORMACK T, 1994, CELL, V79, P1133, DOI 10.1016/0092-8674(94)90004-3; MORALES MJ, 1995, J BIOL CHEM, V270, P6270; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; PARCEJ DN, 1989, BIOCHEM J, V257, P899, DOI 10.1042/bj2570899; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; PONGS O, 1995, SEMIN NEUROSCI, V7, P137, DOI 10.1006/smns.1995.0015; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHEN NV, 1993, NEURON, V11, P67; SHEN V, 1995, NEURON, V14, P625; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	47	165	167	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					455	463		10.1016/S0896-6273(00)80063-X	http://dx.doi.org/10.1016/S0896-6273(00)80063-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789960	Bronze			2022-12-28	WOS:A1996TW95700025
J	HANSON, PI; MEYER, T; STRYER, L; SCHULMAN, H				HANSON, PI; MEYER, T; STRYER, L; SCHULMAN, H			DUAL ROLE OF CALMODULIN IN AUTOPHOSPHORYLATION OF MULTIFUNCTIONAL CAM KINASE MAY UNDERLIE DECODING OF CALCIUM SIGNALS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; CA-2+ CALMODULIN; POSTSYNAPTIC DENSITY; HIPPOCAMPAL SLICES; PEPTIDE COMPLEX; PC12 CELLS; MECHANISM; EXPRESSION; ACTIVATION; BINDING	Autophosphorylation of multifunctional Ca2+/calmodulin-dependent protein kinase makes it Ca2+ independent by trapping bound calmodulin and by enabling the kinase to remain partially active even after calmodulin dissociates. We show that autophosphorylation is an intersubunit reaction between neighbors in the multimeric kinase which requires two molecules of calmodulin. Ca2+/calmodulin acts not only to activate the ''kinase'' subunit but also to present effectively the ''substrate'' subunit for autophosphorylation. Conversion of the kinase to the potentiated or trapped state is a cooperative process that is inefficient at low occupancy of calmodulin. Simulations show that repetitive Ca2+ pulses at limiting calmodulin lead to the recruitment of calmodulin to the holoenzyme, which further stimulates autophosphorylation and trapping. This cooperative, positive feedback loop will potentiate the response of the kinase to sequential Ca2+ transients and establish a threshold frequency at which the enzyme becomes highly active.	STANFORD UNIV,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University			Hanson, Phyllis/E-9420-2012	Meyer, Tobias/0000-0003-4339-3804	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024032, R01GM030179, R37GM024032, R37GM030179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045324] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30179, GM24032] Funding Source: Medline; NIMH NIH HHS [MH45324] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colbran R J, 1990, Curr Top Cell Regul, V31, P181; CRUZALEGUI FH, 1992, P NATL ACAD SCI USA, V89, P12127, DOI 10.1073/pnas.89.24.12127; DUPONT G, 1992, BIOESSAYS, V14, P485, DOI 10.1002/bies.950140711; Estep R P, 1990, Curr Top Cell Regul, V31, P161; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FONG YL, 1989, J BIOL CHEM, V264, P16759; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; GOUGH AH, 1993, J CELL BIOL, V121, P1095, DOI 10.1083/jcb.121.5.1095; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IP NY, 1984, NATURE, V311, P472, DOI 10.1038/311472a0; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; KURET J, 1985, J BIOL CHEM, V260, P6427; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; LOU LL, 1989, J NEUROSCI, V9, P2020; MACNICOL M, 1992, FEBS LETT, V304, P237, DOI 10.1016/0014-5793(92)80627-S; MACNICOL M, 1990, J BIOL CHEM, V265, P18055; MACNICOL M, 1992, J BIOL CHEM, V267, P12197; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; OCORR KA, 1991, NEURON, V6, P907, DOI 10.1016/0896-6273(91)90231-N; PATTON BL, 1990, J BIOL CHEM, V265, P11204; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Skene J H, 1990, Neurosci Res Suppl, V13, pS112, DOI 10.1016/0921-8696(90)90040-A; SMITH MK, 1992, J BIOL CHEM, V267, P1761; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; WAXHAM MN, 1990, P NATL ACAD SCI USA, V87, P1273, DOI 10.1073/pnas.87.4.1273; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YAMAUCHI T, 1989, J BIOL CHEM, V264, P19108	51	381	386	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					943	956		10.1016/0896-6273(94)90306-9	http://dx.doi.org/10.1016/0896-6273(94)90306-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185953				2022-12-28	WOS:A1994NM83100002
J	WILKBLASZCZAK, MA; GUTOWSKI, S; STERNWEIS, PC; BELARDETTI, F				WILKBLASZCZAK, MA; GUTOWSKI, S; STERNWEIS, PC; BELARDETTI, F			BRADYKININ MODULATES POTASSIUM AND CALCIUM CURRENTS IN NEUROBLASTOMA HYBRID-CELLS VIA DIFFERENT PERTUSSIS TOXIN-INSENSITIVE PATHWAYS	NEURON			English	Article							G-PROTEINS; PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE; ALPHA-SUBUNITS; INHIBITION; HYDROLYSIS; ACTIVATION; RESPONSES; RECEPTORS	In NG108-15 cells, bradykinin (BK) activates a potassium current (I(K,BK)) and inhibits the voltage-dependent calcium current(I(Ca,V)). BK also stimulates a phosphatidylinositol-specific phospholipase C (PI-PLC). The subsequent release of inositol 1,4,5-trisphosphate and increase in intracellular calcium contribute to IK,BK, through activation of a calcium-dependent potassium current. In membranes from these cells, stimulation of PI-PLC by BK is mediated by G(q) and/or G11, two homologous, pertussis toxin-insensitive G proteins. Here, we have investigated the role of G(q/11), in the electrical responses to BK. GTPgammaS mimicked and occluded both actions of BK, and both effects were insensitive to pertussis toxin. Perfusion of an anti-G(q/11alpha) antibody into the pipette suppressed I(K,BK), but not the inhibition of I(Ca,V) by BK. Thus, BK couples to I(K,BK) via G(q/11), but coupling to I(Ca,V) is most likely via a different, pertussis toxin-insensitive G protein.			WILKBLASZCZAK, MA (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047721, R01GM031954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS025186] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31954, GM47721] Funding Source: Medline; NINDS NIH HHS [NS25186] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P167, DOI 10.1113/jphysiol.1988.sp016994; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P185, DOI 10.1113/jphysiol.1988.sp016995; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P149, DOI 10.1113/jphysiol.1988.sp016993; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRANDT R, 1986, FEBS LETT, V196, P279, DOI 10.1016/0014-5793(86)80263-0; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; HARLOW E, 1988, ANTIBODIES LABORATOR; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HIGASHIDA H, 1986, P NATL ACAD SCI USA, V83, P942, DOI 10.1073/pnas.83.4.942; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Iniguez-Lluhi Jorge, 1993, Trends in Cell Biology, V3, P230, DOI 10.1016/0962-8924(93)90122-H; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; LAMORTE VJ, 1993, J CELL BIOL, V121, P91, DOI 10.1083/jcb.121.1.91; LLEDO PM, 1992, NEURON, V8, P455, DOI 10.1016/0896-6273(92)90273-G; MCGEHEE DS, 1992, NEURON, V9, P315, DOI 10.1016/0896-6273(92)90170-I; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; RASENICK MM, 1989, BRAIN RES, V488, P105, DOI 10.1016/0006-8993(89)90698-7; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; ROBBINS J, 1992, J PHYSIOL-LONDON, V451, P159, DOI 10.1113/jphysiol.1992.sp019159; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SCHAFER S, 1991, PFLUG ARCH EUR J PHY, V418, P581, DOI 10.1007/BF00370575; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; STERNWEIS PC, 1990, TRENDS NEUROSCI, V13, P122, DOI 10.1016/0166-2236(90)90002-R; TANG JM, 1990, PFLUG ARCH EUR J PHY, V416, P347, DOI 10.1007/BF00392072; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; YANO K, 1984, J BIOL CHEM, V259, P201	38	44	44	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					109	116		10.1016/0896-6273(94)90156-2	http://dx.doi.org/10.1016/0896-6273(94)90156-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292355				2022-12-28	WOS:A1994MU49300010
J	SHAO, XM; PAPAZIAN, DM				SHAO, XM; PAPAZIAN, DM			S4 MUTATIONS ALTER THE SINGLE-CHANNEL GATING KINETICS OF SHAKER K+ CHANNELS	NEURON			English	Article							SODIUM-CHANNEL; POTASSIUM CHANNELS; INACTIVATION GATE; XENOPUS OOCYTES; RECEPTOR; DROSOPHILA; CURRENTS; CHARGE; MUSCLE; CDNA	The S4 sequence comprises at least part of the voltage sensor in Shaker K+ channels. Two site-directed mutations in the Shaker S4 sequence, R368Q and R377K, which decrease the voltage dependence of the whole-cell current, alter voltage-dependent gating at the single-channel level. Compared with the wild-type channel, they increase the latency to first opening, destabilize the open state, and alter the equilibria of voltage-dependent transitions, so that some of the charge movement occurs after the first opening. Whether these changes reflect a new mechanism of activation is a key question. Although the mutations alter the kinetics of many steps in the gating process, we conclude that the mutant channels are likely to activate using the same fundamental mechanism as wild-type channels.	UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles	SHAO, XM (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90024, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043459] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM043459-14, R01 GM043459-17, R01 GM043459-13, R01 GM043459-15, R01 GM043459, R01 GM043459-12, R01 GM043459-10, R01 GM043459-16, R01 GM043459-11, GM43459, R01 GM043459-09, R01 GM043459-15S1] Funding Source: Medline; NINDS NIH HHS [NS07101] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; BENDAT JS, 1971, MEASUREMETN ANAL RAN, P123; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; ZAGOTTA WH, 1989, P NATL ACAD SCI USA, V76, P7243; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	34	27	27	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					343	352		10.1016/0896-6273(93)90189-X	http://dx.doi.org/10.1016/0896-6273(93)90189-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352942				2022-12-28	WOS:A1993LU06500013
J	GILBERTSON, TA; ROPER, SD; KINNAMON, SC				GILBERTSON, TA; ROPER, SD; KINNAMON, SC			PROTON CURRENTS THROUGH AMILORIDE-SENSITIVE NA+ CHANNELS IN ISOLATED HAMSTER TASTE CELLS - ENHANCEMENT BY VASOPRESSIN AND CAMP	NEURON			English	Article							ACTIVE ION-TRANSPORT; SODIUM-CHANNELS; CHORDA TYMPANI; FUNGIFORM PAPILLA; NEURAL RESPONSES; K+ CHANNELS; TRANSDUCTION; INHIBITION; RAT; MEMBRANE	Amiloride has been suggested to inhibit responses to a variety of taste stimuli, including salty, sweet, and sour (acid). To test for the involvement of amiloride-sensitive Na+ channels in the transduction of acid stimuli, fungiform taste receptor cells were examined using patch-clamp techniques. Approximately one-half of all cells had amiloride-sensitive Na+ currents (I(Na)) with a K(i) value near 0.2 muM amiloride. After blocking voltage-gated conductances, cells having amiloride sensitivity were tested for responses to acid stimuli. Over three-fourths of cells showed an inward proton current (I(H+)) with an extrapolated reversal potential near approximately +150 mV, which was completely blocked by amiloride (30 muM). Treatment of isolated taste cells with arginine8-vasopressin caused equivalent increases in both I(Na) and I(H+); each effect was mimicked by 8-Br-cAMP. Taken together, these results indicate that protons permeate amiloride-sensitive Na+ channels in hamster fungiform taste cells and contribute to acid transduction.	UNIV COLORADO, HLTH SCI CTR, ROCKY MT TASTE & SMELL CTR, DENVER, CO 80262 USA; COLORADO STATE UNIV, DEPT ANAT & NEUROBIOL, FT COLLINS, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado State University			Gilbertson, Timothy/G-7147-2011	Gilbertson, Timothy/0000-0003-2569-3096; Roper, Stephen/0000-0001-6049-8320	NIDCD NIH HHS [DC-00374, DC-00766, DC-00244] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000766] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AKABAS M, 1990, J MEMBRANE BIOL, V114, P71, DOI 10.1007/BF01869386; AVENET P, 1988, J MEMBRANE BIOL, V105, P245, DOI 10.1007/BF01871001; AVENET P, 1991, J MEMBRANE BIOL, V124, P33, DOI 10.1007/BF01871362; AVENET P, 1992, SOC GEN PHY, V47, P271; Avenet P, 1991, Curr Opin Neurobiol, V1, P198, DOI 10.1016/0959-4388(91)90078-L; AVENET P, 1992, PENNINGTON CTR NUTRI, V2, P374; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; BEHE P, 1990, 10TH P INT S OLF TAS, P270; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; BESTERMAN JM, 1985, J BIOL CHEM, V260, P1155; BRAND JG, 1985, BRAIN RES, V334, P207, DOI 10.1016/0006-8993(85)90212-4; CUMMINGS TA, 1992, J GEN PHYSIOL, V99, P591, DOI 10.1085/jgp.99.4.591; DESIMONE JA, 1981, SCIENCE, V214, P1039, DOI 10.1126/science.7302576; DESIMONE JA, 1985, AM J PHYSIOL, V249, pR52, DOI 10.1152/ajpregu.1985.249.1.R52; DESIMONE JA, 1984, J GEN PHYSIOL, V83, P633, DOI 10.1085/jgp.83.5.633; FRELIN C, 1988, BIOCHIMIE, V70, P1285, DOI 10.1016/0300-9084(88)90196-4; GARCIA ML, 1990, J BIOL CHEM, V265, P3763; GARTY H, 1983, J GEN PHYSIOL, V81, P785, DOI 10.1085/jgp.81.6.785; GARTY H, 1988, PHYSIOL REV, V68, P309, DOI 10.1152/physrev.1988.68.2.309; GARTY H, 1986, J MEMBRANE BIOL, V90, P193, DOI 10.1007/BF01870126; GILBERTSON TA, 1992, J GEN PHYSIOL, V100, P803, DOI 10.1085/jgp.100.5.803; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HECK GL, 1985, CHEM SENSES, V10, P427; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; HELLEMANN U, 1992, INT J FOOD SCI TECH, V27, P201; HELMAN SI, 1983, J GEN PHYSIOL, V82, P201, DOI 10.1085/jgp.82.2.201; HERNESS MS, 1992, COMP BIOCHEM PHYS A, V103, P269, DOI 10.1016/0300-9629(92)90578-E; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; HILL DL, 1985, DEV BRAIN RES, V20, P310, DOI 10.1016/0165-3806(85)90121-X; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HYMAN AM, 1980, J GEN PHYSIOL, V76, P143, DOI 10.1085/jgp.76.2.143; INOMATA N, 1988, BRIT J PHARMACOL, V93, P679, DOI 10.1111/j.1476-5381.1988.tb10326.x; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; KINNAMON SC, 1988, CHEM SENSES, V13, P115, DOI 10.1093/chemse/13.1.115; KINNAMON SC, 1988, J GEN PHYSIOL, V91, P351, DOI 10.1085/jgp.91.3.351; KINNAMON SC, 1988, TRENDS NEUROSCI, V11, P491, DOI 10.1016/0166-2236(88)90010-0; KINTER LB, 1988, AM J PHYSIOL, V254, pF165, DOI 10.1152/ajprenal.1988.254.2.F165; Korn S.J., 1991, METHODS NEUROSCIENCE, VVolume 4, P364; KOSTEN T, 1985, BEHAV NEUROSCI, V99, P734, DOI 10.1037/0735-7044.99.4.734; LESTER DS, 1988, AM J PHYSIOL, V254, pC802, DOI 10.1152/ajpcell.1988.254.6.C802; MANEV H, 1990, NEUROPHARMACOLOGY, V29, P1103, DOI 10.1016/0028-3908(90)90033-N; MARUNAKA Y, 1991, AM J PHYSIOL, V260, pC1071, DOI 10.1152/ajpcell.1991.260.5.C1071; MCBURNEY DH, 1973, PHYSIOL BEHAV, V10, P1101, DOI 10.1016/0031-9384(73)90194-7; MCCUTCHEON NB, 1986, PHYSIOL BEHAV, V36, P1081, DOI 10.1016/0031-9384(86)90483-X; MCPHEETERS M, 1985, CHEM SENSES, V10, P341, DOI 10.1093/chemse/10.3.341; MENDOZA SA, 1970, AM J PHYSIOL, V219, P1440, DOI 10.1152/ajplegacy.1970.219.5.1440; MIERSON S, 1988, J GEN PHYSIOL, V92, P87, DOI 10.1085/jgp.92.1.87; MIYAMOTO T, 1988, J PHYSIOL-LONDON, V405, P699, DOI 10.1113/jphysiol.1988.sp017356; OKADA Y, 1991, COMP BIOCHEM PHYS A, V100, P693; OKADA Y, 1990, COMP BIOCHEM PHYS A, V97, P535; ORLOFF J, 1962, J CLIN INVEST, V41, P702, DOI 10.1172/JCI104528; OZEKI M, 1971, J GEN PHYSIOL, V58, P688, DOI 10.1085/jgp.58.6.688; PALATY V, 1989, MOL PHARMACOL, V36, P296; Palmer L G, 1981, Ann N Y Acad Sci, V372, P1, DOI 10.1111/j.1749-6632.1981.tb15453.x; PALMER LG, 1982, J MEMBRANE BIOL, V64, P91, DOI 10.1007/BF01870771; PALMER LG, 1992, ANNU REV PHYSIOL, V54, P51, DOI 10.1146/annurev.ph.54.030192.000411; PANGBORN RM, 1967, PERCEPT PSYCHOPHYS, V2, P503, DOI 10.3758/BF03210255; ROPER S, 1983, SCIENCE, V220, P1311, DOI 10.1126/science.6857254; SARIBANSOHRABY S, 1986, AM J PHYSIOL, V250, pC175, DOI 10.1152/ajpcell.1986.250.2.C175; SCHELLENBERG GD, 1983, MOL PHARMACOL, V24, P251; SCHELLENBERG GD, 1985, MOL PHARMACOL, V27, P537; SCHIFFMAN SS, 1983, P NATL ACAD SCI-BIOL, V80, P6136, DOI 10.1073/pnas.80.19.6136; Schulkin J., 1991, SODIUM HUNGER SEARCH; SETTLE RG, 1986, PHYSIOL BEHAV, V36, P619, DOI 10.1016/0031-9384(86)90343-4; SIMON SA, 1986, AM J PHYSIOL, V251, pR598, DOI 10.1152/ajpregu.1986.251.3.R598; STRICKER E M, 1992, P451; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; TEETER JH, 1989, CHEM SENSES, V1, P151; TONASAKI K, 1984, COMP BIOCH PHYSL A, V78, P651; TONASAKI K, 1989, COMP BIOCH PHYSL A, V94, P659; TRAVERS SP, 1984, J GEN PHYSIOL, V84, P221, DOI 10.1085/jgp.84.2.221; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833	72	130	136	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	1993	10	5					931	942		10.1016/0896-6273(93)90208-9	http://dx.doi.org/10.1016/0896-6273(93)90208-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8388226				2022-12-28	WOS:A1993LD32200015
J	LUCAS, JJ; MELLSTROM, B; COLADO, MI; NARANJO, JR				LUCAS, JJ; MELLSTROM, B; COLADO, MI; NARANJO, JR			MOLECULAR MECHANISMS OF PAIN - SEROTONIN(1A) RECEPTOR AGONISTS TRIGGER TRANSACTIVATION BY C-FOS OF THE PRODYNORPHIN GENE IN SPINAL-CORD NEURONS	NEURON			English	Article							DORSAL HORN NEURONS; MULTIPLE SEQUENCE ELEMENTS; PIG HIPPOCAMPAL MEMBRANES; CENTRAL NERVOUS-SYSTEM; CHRONIC ARTHRITIC RATS; IMMEDIATE EARLY GENES; CHI-OPIOID RECEPTOR; ADENYLATE-CYCLASE; MESSENGER-RNA; PHARMACOLOGICAL CHARACTERIZATION	By using spinal cord neurons cultured in chemically defined medium, a double labeling procedure, and blockage with antisense oligonucleotides, we show that induction of c-fos and the subsequent transactivation of the prodynorphin gene are coupled events, triggered by serotonin1A receptor agonists. Addition of the specific 1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) to the culture, at concentrations similar to that needed for transactivation of the prodynorphin gene, also significantly increases cAMP levels. Furthermore, in rats depleted of serotonin by intrathecal administration of 5,7-dihydroxytryptamine, the induction of prodynorphin after noxious stimulation is dramatically decreased compared with the induction in sham-operated rats. These results suggest that the expression of the prodynorphin gene in spinal cord is under the control of the raphe-spinal efferents containing serotonin.	UNIV COMPLUTENSE MADRID, FAC MED, DEPT FARMACOL, MADRID 3, SPAIN	Complutense University of Madrid	LUCAS, JJ (corresponding author), CSIC, INST CAJAL NEUROCIENCIA, AV DR ARCE 37, E-28002 MADRID, SPAIN.		NARANJO, Jose R/K-1950-2014; Lucas, Jose J./U-6543-2019	NARANJO, Jose R/0000-0002-0270-3469; Lucas, Jose J./0000-0003-1597-3916				ALBERT PR, 1990, J BIOL CHEM, V265, P5825; BALSINDE J, 1988, BIOCHEM BIOPH RES CO, V154, P502, DOI 10.1016/0006-291X(88)90168-4; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; Besson J M, 1981, Adv Exp Med Biol, V133, P153; BOCKAERT J, 1990, MOL PHARMACOL, V37, P408; CARTER MS, 1990, J NEUROSCI, V10, P2203; CAUDLE RM, 1988, J PHARMACOL EXP THER, V246, P508; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CIVELLI O, 1985, P NATL ACAD SCI USA, V82, P4291, DOI 10.1073/pnas.82.12.4291; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; CORBETT AD, 1982, NATURE, V299, P79, DOI 10.1038/299079a0; CRAIN SM, 1990, TRENDS PHARMACOL SCI, V11, P77, DOI 10.1016/0165-6147(90)90322-Y; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; DIGBY J, 1985, MUSCLE NERVE, V8, P595, DOI 10.1002/mus.880080709; DOUGLASS J, 1989, MOL ENDOCRINOL, V3, P2070, DOI 10.1210/mend-3-12-2070; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; DUBNER R, 1992, TRENDS NEUROSCI, V15, P96, DOI 10.1016/0166-2236(92)90019-5; DUBUISSON D, 1980, BRAIN RES, V199, P283, DOI 10.1016/0006-8993(80)90690-3; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; EMILSSON A, 1984, J BIOL CHEM, V259, P3111; FIELDS HL, 1977, BRAIN RES, V126, P441, DOI 10.1016/0006-8993(77)90596-0; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FRAZER A, 1990, ANNU REV PHARMACOL, V30, P307; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOZLAN H, 1983, NATURE, V305, P140, DOI 10.1038/305140a0; GREUEL JM, 1992, EUR J PHARMACOL, V211, P211, DOI 10.1016/0014-2999(92)90531-8; HAUN RS, 1990, J BIOL CHEM, V265, P15455; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HOLLT V, 1987, NEUROSCI LETT, V73, P90, DOI 10.1016/0304-3940(87)90037-1; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; HYLDEN JLK, 1992, J NEUROSCI, V12, P1716; HYLDEN JLK, 1991, PAIN, V44, P187, DOI 10.1016/0304-3959(91)90136-L; Iadarola M J, 1986, NIDA Res Monogr, V75, P406; IADAROLA MJ, 1988, BRAIN RES, V455, P205, DOI 10.1016/0006-8993(88)90078-9; IADAROLA MJ, 1988, 5TH P WORLD C PAIN, P61; Jessell TM, 1989, TXB PAIN, P82; JONES SL, 1990, BRAIN RES, V530, P335, DOI 10.1016/0006-8993(90)91306-2; JONES SL, 1990, J COMP NEUROL, V297, P267, DOI 10.1002/cne.902970209; JULIUS D, 1991, ANNU REV NEUROSCI, V14, P335, DOI 10.1146/annurev.neuro.14.1.335; KAKIUCHI S, 1968, MOL PHARMACOL, V4, P367; KNOX RJ, 1987, BRAIN RES, V415, P21, DOI 10.1016/0006-8993(87)90265-4; LEAH J, 1988, NEUROSCIENCE, V24, P195; MAROTEAUX L, 1992, P NATL ACAD SCI USA, V89, P3020, DOI 10.1073/pnas.89.7.3020; MELLSTROM B, 1991, MOL ENDOCRINOL, V5, P1339, DOI 10.1210/mend-5-9-1339; MILLAN MJ, 1985, BRAIN RES, V340, P156, DOI 10.1016/0006-8993(85)90786-3; MILLAN MJ, 1989, NEUROSCI LETT, V107, P227, DOI 10.1016/0304-3940(89)90822-7; MILLAN MJ, 1991, J PHARMACOL EXP THER, V256, P983; MILLER KE, 1987, J COMP NEUROL, V255, P293, DOI 10.1002/cne.902550212; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; MORRIS BJ, 1987, N-S ARCH PHARMACOL, V336, P240, DOI 10.1007/BF00165811; MORRIS BJ, 1988, MOL BRAIN RES, V4, P15, DOI 10.1016/0169-328X(88)90013-7; NARANJO JR, 1989, NEUROPHARMACOLOGY, V28, P291, DOI 10.1016/0028-3908(89)90106-8; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; NARANJO JR, 1991, ONCOGENE, V6, P223; NOGUCHI K, 1992, NEUROSCIENCE, V46, P561, DOI 10.1016/0306-4522(92)90144-Q; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; PRETEL S, 1991, PEPTIDES, V12, P1243, DOI 10.1016/0196-9781(91)90202-Z; PRZEWLOCKI R, 1988, MOL BRAIN RES, V4, P37, DOI 10.1016/0169-328X(88)90016-2; RUDA MA, 1988, P NATL ACAD SCI USA, V85, P622, DOI 10.1073/pnas.85.2.622; SASEK CA, 1984, NEUROSCIENCE, V12, P855, DOI 10.1016/0306-4522(84)90175-1; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SCHMAUSS C, 1984, J PHARMACOL EXP THER, V228, P1; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHENKER A, 1987, MOL PHARMACOL, V31, P357; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; TAKAHASHI O, 1990, PEPTIDES, V11, P1233, DOI 10.1016/0196-9781(90)90157-Z; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WOOLF CJ, 1986, J NEUROSCI, V6, P1433; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9	73	86	86	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1993	10	4					599	611		10.1016/0896-6273(93)90163-L	http://dx.doi.org/10.1016/0896-6273(93)90163-L			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476611				2022-12-28	WOS:A1993KY50100005
J	CANNON, SC; STRITTMATTER, SM				CANNON, SC; STRITTMATTER, SM			FUNCTIONAL EXPRESSION OF SODIUM-CHANNEL MUTATIONS IDENTIFIED IN FAMILIES WITH PERIODIC PARALYSIS	NEURON			English	Article							ADYNAMIA EPISODICA HEREDITARIA; ALPHA-SUBUNIT; MESSENGER-RNA; MUSCLE; INACTIVATION; GENE; MEMBRANE; CELLS; MODES; RAT	Two mutations in the sodium channel alpha subunit that have been implicated as the cause of periodic paralysis were studied by functional expression in a mammalian cell line. Both mutations disrupted inactivation without affecting the time course of the onset of the sodium current or the single-channel conductance. This is the same functional defect that was observed in myotubes cultured from affected patients and proves that these mutations are not benign polymorphisms. Unlike the currents in the myotubes, however, there was no consistent potassium dependence for the noninactivating component. These mutations also define new regions of the sodium channel alpha subunit that are involved in the process of inactivation.	MASSACHUSETTS GEN HOSP E,DEPT NEUROL,BOSTON,MA 02129		CANNON, SC (corresponding author), MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,DEPT NEUROL,BOSTON,MA 02114, USA.		Cannon, Stephen/V-5343-2019; Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092; Cannon, Stephen/0000-0001-8428-3690				ALDRICH RW, 1987, J NEUROSCI, V7, P418; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CANNON SC, 1993, IN PRESS J PHYSL; CREUTZFELDT O, 1963, ELECTROEN CLIN NEURO, V15, P508, DOI 10.1016/0013-4694(63)90071-3; CUMMINS TR, 1993, IN PRESS NEURON; EBERS GC, 1991, ANN NEUROL, V30, P810, DOI 10.1002/ana.410300610; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GAMSTORP I, 1956, ACTA PAEDIATR STOC S, V108, P1; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KRANER SD, 1985, J BIOL CHEM, V260, P6341; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1983, MUSCLE NERVE, V6, P113, DOI 10.1002/mus.880060206; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; WANG JZ, 1992, BIOCHEM BIOPH RES CO, V182, P794, DOI 10.1016/0006-291X(92)91802-W; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	31	190	192	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					317	326		10.1016/0896-6273(93)90321-H	http://dx.doi.org/10.1016/0896-6273(93)90321-H			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382500				2022-12-28	WOS:A1993KP68500018
J	Nieto, MA				Nieto, MA			Molecular biology of axon guidance	NEURON			English	Review							RECEPTOR TYROSINE KINASES; GROWTH CONE GUIDANCE; C-ELEGANS; GUIDES CELL; SPINAL-CORD; PROTEIN; CHEMOREPELLENT; TRANSMEMBRANE; MIGRATIONS; LIGANDS				Nieto, MA (corresponding author), CSIC,INST CAJAL,E-28002 MADRID,SPAIN.		Nieto, M. Angela/A-6531-2008	Nieto, M. Angela/0000-0002-3538-840X				[Anonymous], 1890, GAC SANITBARC; BAMBRILLA R, 1995, EMBO J, V14, P3116; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Cajal SR., 1893, CELLULE, V9, P119; CHANG SSY, 1996, IN PRESS CELL, V87; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; FAN J, 1995, NEURON, V14, P363; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; Friedman GC, 1996, J NEUROSCI, V16, P5498; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Itasaki N, 1996, NEURON, V16, P55, DOI 10.1016/S0896-6273(00)80023-9; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kenny D, 1995, DEV BIOL, V172, P708, DOI 10.1006/dbio.1995.8083; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; KREUGER NX, 1996, CELL, V84, P611; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; PANDEY A, 1994, J BIOL CHEM, V269, P30154; PANDEY A, 1995, J BIOL CHEM, V270, P19201, DOI 10.1074/jbc.270.33.19201; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Ramon y Cajal S, 1890, ANAT ANZEIGER, V5, P609; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SERAFINI T, 1996, IN PRESS CELL, V87; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; WALTER J, 1987, DEVELOPMENT, V101, P685; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xu QL, 1995, DEVELOPMENT, V121, P4005	49	46	47	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1039	1048		10.1016/S0896-6273(00)80237-8	http://dx.doi.org/10.1016/S0896-6273(00)80237-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982153	Bronze			2022-12-28	WOS:A1996WA24800003
J	Cohen, NA; Brenman, JE; Snyder, SH; Bredt, DS				Cohen, NA; Brenman, JE; Snyder, SH; Bredt, DS			Binding of the inward rectifier K+ channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation	NEURON			English	Article							RECTIFYING POTASSIUM CHANNEL; TUMOR-SUPPRESSOR PROTEIN; NITRIC-OXIDE SYNTHASE; FUNCTIONAL EXPRESSION; SEPTATE JUNCTIONS; MESSENGER-RNA; CLONING; RECEPTOR; BRAIN; RECTIFICATION	Dynamic regulation of ion channel interactions with the cytoskeleton mediates aspects of synaptic plasticity, yet mechanisms for this process are largely unknown. Here, we report that two inwardly rectifying K+ channels, Kir 2.1 and 2.3, bind to PSD-95, a cytoskeletal protein of postsynaptic densities that clusters NMDA receptors and voltage-dependent K+ channels. Kir 2.3 colocalizes with PSD-95 in neuronal populations in forebrain, and a PSD-95/Kir 2.3 complex occurs in hippocampus. Within the C-terminal tail of Kir 2.3, a serine residue critical for interaction with PSD-95, is also a substrate for phosphorylation by protein kinase A (PKA). Stimulation of PKA in intact cells causes rapid dissociation of the channel from PSD-95. This work identifies a physiological mechanism for regulating ion channel interactions with the postsynaptic density.	JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & MOL SCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,PROGRAM BIOMED SCI,SAN FRANCISCO,CA 94143	Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cohen, NA (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.			Cohen, Noam/0000-0002-9462-3932	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266] Funding Source: Medline; NIMH NIH HHS [MH-18501] Funding Source: Medline; NINDS NIH HHS [R01NS34822] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AOKI C, 1993, BRAIN RES, V620, P97, DOI 10.1016/0006-8993(93)90275-R; BREDT DS, 1995, P NATL ACAD SCI USA, V92, P6753, DOI 10.1073/pnas.92.15.6753; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BRENMAN JE, 1996, IN PRESS J NEUROSCI; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FALK T, 1995, FEBS LETT, V367, P127, DOI 10.1016/0014-5793(95)00527-G; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONAS AA, 1996, CURR OPIN NEUROBIOL, V6, P318; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KOUMI S, 1995, J PHYSIOL-LONDON, V486, P661, DOI 10.1113/jphysiol.1995.sp020842; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; LAU LF, 1996, J BIOL CHEM, V35, P21622; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1991, ANNU REV PHYSIOL, V53, P289, DOI 10.1146/annurev.ph.53.030191.001445; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MORISHIGE K, 1993, FEBS LETT, V336, P375, DOI 10.1016/0014-5793(93)80840-Q; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; PESSIA M, 1995, NEURON, V14, P1039, DOI 10.1016/0896-6273(95)90342-9; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; Roche WK, 1996, NEURON, V16, P1179; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SASSOON D, 1993, METHOD ENZYMOL, V225, P384; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; WALLACE BG, 1992, J NEUROBIOL, V23, P592, DOI 10.1002/neu.480230512; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; Wischmeyer E, 1996, P NATL ACAD SCI USA, V93, P5819, DOI 10.1073/pnas.93.12.5819; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	62	225	228	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					759	767		10.1016/S0896-6273(00)80207-X	http://dx.doi.org/10.1016/S0896-6273(00)80207-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893032	hybrid			2022-12-28	WOS:A1996VP74300020
J	Citron, M; Diehl, TS; Capell, A; Haass, C; Teplow, DB; Selkoe, DJ				Citron, M; Diehl, TS; Capell, A; Haass, C; Teplow, DB; Selkoe, DJ			Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF	NEURON			English	Article							PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PEPTIDE; IDENTIFICATION; SECRETION; MUTATION; CLEAVAGE; FRAGMENT; TERMINUS; MONKEY	Cerebral deposition of amyloid beta protein (A beta) is an early and critical feature of Alzheimer's disease. A beta production requires the proteolytic release of A beta from the beta-amyloid precursor protein (beta APP). Thus, inhibition of A beta release is a prime therapeutic goal. Here, we show that the broad spectrum, irreversible serine protease inhibitor, AEBSF, inhibits the constitutive production of A beta in five different human cell lines, both neural and nonneural. AEBSF also stabilizes full-length beta APP and enhances alpha-secretion, as shown by an increase in the proteolytic derivative, alpha-APP(s). Further, we demonstrate that the inhibitory effect of AEBSF is specific for A beta proteins starting at Aspartate 1, suggesting that AEBSF directly inhibits beta-secretase, the Methionine-Aspartate (Met-Asp)-cleaving enzyme. These results indicate that specific inhibition of this A beta-generating protease is possible in living human neural cells and provide information about the characteristics of this as yet unidentified enzyme.	UNIV HEIDELBERG,ZENT INST SEEL GESUNDHEIT,D-68159 MANNHEIM,GERMANY; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,BIOPOLYMER LAB,BOSTON,MA 02115	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital					NIA NIH HHS [AG12749, AG05134] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012749] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; EVIN G, 1994, AMYLOID, V1, P263, DOI 10.3109/13506129409146118; FEISENSTEIN KM, 1994, NAT GENET, V6, P251; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1994, J BIOL CHEM, V269, P17741; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4; HUNG AY, 1993, J BIOL CHEM, V268, P22959; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAZMIROWSKI HG, 1971, PHARMAZIE, V26, P390; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; PRASS D, 1992, GES BIOL CHEM, V373, P812; RAZZABONI BL, 1992, BRAIN RES, V589, P207, DOI 10.1016/0006-8993(92)91279-N; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; WAISMANN P, 1972, ACTA BIOL MED GER, V28, P577; WAITER J, 1996, IN PRESS J BIOL CHEM; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	39	81	85	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					171	179		10.1016/S0896-6273(00)80290-1	http://dx.doi.org/10.1016/S0896-6273(00)80290-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755488	Bronze			2022-12-28	WOS:A1996UY98100017
J	Gale, NW; Holland, SJ; Valenzuela, DM; Flenniken, A; Pan, L; Ryan, TE; Henkemeyer, M; Strebhardt, K; Hirai, H; Wilkinson, DG; Pawson, T; Davis, S; Yancopoulos, GD				Gale, NW; Holland, SJ; Valenzuela, DM; Flenniken, A; Pan, L; Ryan, TE; Henkemeyer, M; Strebhardt, K; Hirai, H; Wilkinson, DG; Pawson, T; Davis, S; Yancopoulos, GD			Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis	NEURON			English	Article							PROTEIN-TYROSINE KINASE; PATTERN-FORMATION; LIMB DEVELOPMENT; GENE; EXPRESSION; HINDBRAIN; FAMILY; BRAIN; ECK; ELK	We report that the many Eph-related receptor tyrosine kinases, and their numerous membrane-bound ligands, can each be grouped into only two major specificity subclasses. Receptors in a given subclass bind most members of a corresponding ligand subclass. The physiological relevance of these groupings is suggested by viewing the collective distributions of all members of a subclass. These composite distributions, in contrast with less informative patterns seen with individual members of the family, reveal that the developing embryo is subdivided into domains defined by reciprocal and apparently mutually exclusive expression of a receptor subclass and its corresponding ligands. Receptors seem to encounter their ligands only at the interface between these domains. This reciprocal compartmentalization implicates the Eph family in the formation of spatial boundaries that may help to organize the developing body plan.	REGENERON PHARMACEUT INC,TARRYTOWN,NY 10591; MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO,ON M5G 1X5,CANADA; NATL INST MED RES,MRC,LONDON NW7 1AA,ENGLAND; CHEMOTHERAPEUT FORSCHUNGSINST,D-6000 FRANKFURT,GERMANY; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN	Regeneron; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; MRC National Institute for Medical Research; University of Tokyo			Pawson, Tony J/E-4578-2013; Strebhardt, Klaus/E-8765-2011	Henkemeyer, Mark/0000-0002-7525-1061; Wilkinson, David/0000-0001-6757-7080; Strebhardt, Klaus/0000-0003-2173-9763				BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; BECKMANN MP, 1994, EMBO J, V13, P3757, DOI 10.1002/j.1460-2075.1994.tb06685.x; BENNETT BD, 1995, P NATL ACAD SCI USA, V92, P1866, DOI 10.1073/pnas.92.6.1866; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Cerretti DP, 1995, MOL IMMUNOL, V32, P1197, DOI 10.1016/0161-5890(95)00108-5; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CLOSSEK T, 1995, ONCOGENE, V10, P97; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DEALY CN, 1993, MECH DEVELOP, V43, P175, DOI 10.1016/0925-4773(93)90034-U; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; ELLIS J, 1995, MECH DEVELOP, V52, P319, DOI 10.1016/0925-4773(95)00411-S; ESPESETH A, 1995, MOL CELL NEUROSCI, V6, P199, DOI 10.1006/mcne.1995.1017; GALE NW, 1996, IN PRESS ONCOGENE; GANJU P, 1994, ONCOGENE, V9, P1613; GILARDIHEBENSTREIT P, 1992, ONCOGENE, V7, P2499; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOLZMAN LB, 1990, MOL CELL BIOL, V10, P5830, DOI 10.1128/MCB.10.11.5830; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; Lackmann M, 1996, P NATL ACAD SCI USA, V93, P2523, DOI 10.1073/pnas.93.6.2523; LHOTAK V, 1991, MOL CELL BIOL, V11, P2496, DOI 10.1128/MCB.11.5.2496; LHOTAK V, 1993, MOL CELL BIOL, V13, P7071, DOI 10.1128/MCB.13.11.7071; MAISONPIERRE PC, 1993, ONCOGENE, V8, P3277; NIETO MA, 1992, DEVELOPMENT, V116, P1137; RUIZ JC, 1994, MECH DEVELOP, V46, P87; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHAO HN, 1994, J BIOL CHEM, V269, P26606; SHAO HN, 1995, J BIOL CHEM, V270, P3467, DOI 10.1074/jbc.270.8.3467; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; TAYLOR V, 1994, NEUROSCIENCE, V63, P163, DOI 10.1016/0306-4522(94)90014-0; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TUZI NL, 1994, BRIT J CANCER, V69, P417, DOI 10.1038/bjc.1994.77; VALENZUELA DM, 1995, ONCOGENE, V10, P1573; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xu QL, 1995, DEVELOPMENT, V121, P4005; ZHOU R, 1994, J NEUROSCI RES, V37, P129, DOI 10.1002/jnr.490370117	39	735	759	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					9	19		10.1016/S0896-6273(00)80276-7	http://dx.doi.org/10.1016/S0896-6273(00)80276-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755474	Bronze			2022-12-28	WOS:A1996UY98100003
J	Andreasen, NC				Andreasen, NC			Pieces of the schizophrenia puzzle fall into place	NEURON			English	Review											Andreasen, NC (corresponding author), UNIV IOWA,COLL MED,PET IMAGING CTR,MENTAL HLTH CLIN RES CTR,IOWA CITY,IA 52242, USA.							ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; ANDREASEN NC, 1994, JAMA-J AM MED ASSOC, V272, P1763, DOI 10.1001/jama.272.22.1763; BARTA PE, 1990, AM J PSYCHIAT, V147, P1457; BENES FM, 1995, ARCH GEN PSYCHIAT, V52, P1015; BOGERTS B, 1993, SCHIZOPHRENIA BULL, V19, P431, DOI 10.1093/schbul/19.2.431; CARLSSON M, 1990, SCHIZOPHRENIA BULL, V16, P425, DOI 10.1093/schbul/16.3.425; DOLAN RJ, 1995, NATURE, V378, P180, DOI 10.1038/378180a0; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; LIDDLE PF, 1992, BRIT J PSYCHIAT, V160, P179, DOI 10.1192/bjp.160.2.179; LIEBERMAN JA, 1993, SCHIZOPHRENIA BULL, V19, P371, DOI 10.1093/schbul/19.2.371; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609	14	36	36	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					697	700		10.1016/S0896-6273(00)80090-2	http://dx.doi.org/10.1016/S0896-6273(00)80090-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607988	Bronze			2022-12-28	WOS:A1996UG61100003
J	Barbe, MF				Barbe, MF			Tempting fate and commitment in the developing forebrain	NEURON			English	Review											Barbe, MF (corresponding author), TEMPLE UNIV,DEPT PHYS THERAPY,PHILADELPHIA,PA 19140, USA.							BARBE MF, 1995, J NEUROSCI, V15, P1819, DOI 10.1523/JNEUROSCI.15-03-01819.1995; BARTH TM, 1994, CEREB CORTEX, V4, P271, DOI 10.1093/cercor/4.3.271; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; CATTANEO E, 1994, DEV BRAIN RES, V83, P197, DOI 10.1016/0165-3806(94)00137-5; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; DEACON TW, 1994, EXP NEUROL, V130, P151, DOI 10.1006/exnr.1994.1194; EBRAHIMIGAILLARD A, 1994, DEV BRAIN RES, V77, P271, DOI 10.1016/0165-3806(94)90203-8; FISHELL G, 1995, DEVELOPMENT, V121, P803; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; Levitt P, 1993, Perspect Dev Neurobiol, V1, P65; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863	16	21	21	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					1	4		10.1016/S0896-6273(00)80015-X	http://dx.doi.org/10.1016/S0896-6273(00)80015-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562072	Bronze			2022-12-28	WOS:A1996TT30700001
J	Mainen, ZF; Joerges, J; Huguenard, JR; Sejnowski, TJ				Mainen, ZF; Joerges, J; Huguenard, JR; Sejnowski, TJ			A model of spike initiation in neocortical pyramidal neurons	NEURON			English	Article							DEPENDENT SODIUM-CHANNELS; CEREBELLAR PURKINJE-CELLS; RAT VISUAL-CORTEX; ACTION-POTENTIALS; BRAIN; DENDRITES; AXON; MORPHOLOGY; SLICES; ELECTROPHYSIOLOGY	Neocortical pyramidal cells possess voltage-dependent dendritic sodium channels that promote propagation of action potentials into the dendritic tree but paradoxically may fail to originate dendritic spikes. A biophysical model was constructed to reconcile these observations with known anatomical and physiological properties. When dendritic and somatic sodium channel densities compatible with electrophysiological measurements were combined with much higher densities in the axon initial segment then, regardless of the site of stimulation, spikes initiated at the initial segment and subsequently invaded the dendrites. The lower initial segment threshold arose from high current density and electrical isolation from the soma. Failure of dendritic channels to initiate spikes was due to inactivation and source-load considerations, which were more favorable for conduction of back-propagated spikes.	SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,COMPUTAT NEUROBIOL LAB,LA JOLLA,CA 92037; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,GRAD PROGRAM NEUROSCI,LA JOLLA,CA 92093; STANFORD UNIV,DEPT NEUROL,STANFORD,CA 94305	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University			Huguenard, John/I-5016-2012; Sejnowski, Terrence/AAV-5558-2021; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Mainen, Zachary/0000-0001-7913-9109	NINDS NIH HHS [NS12151, NS06477] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS012151, P50NS012151] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALZHEIMER C, 1993, J NEUROSCI, V13, P660; AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; BEDLACK RS, 1994, NEURON, V13, P1187, DOI 10.1016/0896-6273(94)90056-6; BELLUZZI O, 1986, J PHYSIOL-LONDON, V380, P275, DOI 10.1113/jphysiol.1986.sp016285; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; CHIU SY, 1987, J PHYSIOL-LONDON, V391, P631, DOI 10.1113/jphysiol.1987.sp016760; COOLEY JW, 1966, BIOPHYS J, V6, P583, DOI 10.1016/S0006-3495(66)86679-1; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; CUMMINS TR, 1994, J NEUROPHYSIOL, V71, P1052, DOI 10.1152/jn.1994.71.3.1052; DESCHENES M, 1980, BRAIN RES, V191, P538, DOI 10.1016/0006-8993(80)91302-5; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FARINAS I, 1991, J COMP NEUROL, V304, P70, DOI 10.1002/cne.903040106; FRANK K, 1957, FED PROC, V16, P39; GOGAN P, 1983, J PHYSIOL-LONDON, V335, P205, DOI 10.1113/jphysiol.1983.sp014529; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Haug H, 1968, Brain Res, V11, P65, DOI 10.1016/0006-8993(68)90074-7; HINAS M, 1993, NEURAL SYSTEMS ANAL, P127; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUGUENARD JR, 1989, P NATL ACAD SCI USA, V86, P2473, DOI 10.1073/pnas.86.7.2473; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; KAARS C, 1981, SCIENCE, V212, P1063, DOI 10.1126/science.7233201; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; LARKMAN A, 1990, J NEUROSCI, V10, P1407; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MAJOR G, 1994, J NEUROSCI, V14, P4613; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MASON A, 1990, J NEUROSCI, V10, P1415; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P285, DOI 10.1113/jphysiol.1983.sp014581; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; PALAY SL, 1968, J CELL BIOL, V37, P193; PETERS A, 1968, J CELL BIOL, V39, P604, DOI 10.1083/jcb.39.3.604; PITLER TA, 1994, NEURON, V13, P1447; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; RHODES PA, 1994, NEURAL COMPUT, V6, P1086, DOI 10.1162/neco.1994.6.6.1086; SAH P, 1988, J GEN PHYSIOL, V91, P373, DOI 10.1085/jgp.91.3.373; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SKAUGEN E, 1980, ACTA PHYSIOL SCAND, V109, P377, DOI 10.1111/j.1748-1716.1980.tb06610.x; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Stratford K., 1989, COMPUTING NEURON; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WESTRUM LE, 1970, J COMP NEUROL, V139, P337, DOI 10.1002/cne.901390306; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	65	329	340	2	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1427	1439		10.1016/0896-6273(95)90020-9	http://dx.doi.org/10.1016/0896-6273(95)90020-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845165	Bronze			2022-12-28	WOS:A1995TL67800020
J	DRAIN, P; DUBIN, AE; ALDRICH, RW				DRAIN, P; DUBIN, AE; ALDRICH, RW			REGULATION OF SHAKER K+ CHANNEL INACTIVATION GATING BY THE CAMP-DEPENDENT PROTEIN-KINASE	NEURON			English	Article							APLYSIA SENSORY NEURONS; PATCH-CLAMPED MEMBRANES; NICOTINIC ACETYLCHOLINE-RECEPTOR; BRAIN SODIUM-CHANNELS; POTASSIUM CHANNELS; FUNCTIONAL MODULATION; PHOSPHORYLATION SITE; PEPTIDERGIC NEURONS; DROSOPHILA MUSCLE; XENOPUS OOCYTES	In response to depolarization of the membrane potential, Shaker K+ channels undergo a series of voltage-dependent conformational changes, from resting to open conformations followed by a rapid transition into a long-lived closed conformation, the N-type inactivated state. Application of phosphatases to the cytoplasmic side of Shaker channels in excised inside-out patches slows N-type inactivation gating. Subsequent application of the purified catalytic subunit of the cAMP-dependent protein kinase (PKA) and ATP reverses the effect, accelerating N-type inactivation back to its initial rapid rate. Macroscopic and single-channel experiments indicate that N-type inactivation is selectively modulated. There was little or no effect on the voltage dependence and kinetics of activation. Comparison of site-directed mutant channels shows that a C-terminal consensus site for PKA phosphorylation is responsible for the modulation. Since a cell's integrative characteristics can be determined by the rate of inactivation of its voltage-dependent channels, modulation of these rates by phosphorylation is likely to have functional consequences.			DRAIN, P (corresponding author), STANFORD UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT MOLEC & CELLULAR PHYSIOL, STANFORD, CA 94305 USA.				PHS HHS [23294] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P531, DOI 10.1113/jphysiol.1979.sp012829; ALDRICH RW, 1990, COLD SPRING HARB SYM, V55, P19; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; AUGUSTINE CK, 1990, J GEN PHYSIOL, V95, P245, DOI 10.1085/jgp.95.2.245; BENSON JA, 1983, P NATL ACAD SCI-BIOL, V80, P3522, DOI 10.1073/pnas.80.11.3522; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CAMARDO JS, 1983, COLD SPRING HARB SYM, V48, P213, DOI 10.1101/SQB.1983.048.01.024; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; CONOVER WJ, 1980, PRACTICAL NONPARAMET, P344; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; GOLDSMITH BA, 1992, P NATL ACAD SCI USA, V89, P11481, DOI 10.1073/pnas.89.23.11481; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOCHNER B, 1992, P NATL ACAD SCI USA, V89, P11476, DOI 10.1073/pnas.89.23.11476; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1983, P NATL ACAD SCI-BIOL, V80, P1130, DOI 10.1073/pnas.80.4.1130; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; LEVITAN IB, 1988, ANNU REV NEUROSCI, V11, P119, DOI 10.1146/annurev.neuro.11.1.119; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; LOECHNER KJ, 1990, BRAIN RES, V532, P1, DOI 10.1016/0006-8993(90)91733-W; MORAN O, 1991, FEBS LETT, V279, P256, DOI 10.1016/0014-5793(91)80162-V; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PEROZO E, 1990, NEURON, V5, P685, DOI 10.1016/0896-6273(90)90222-2; PERUTZ MF, 1988, NATURE, V336, P202, DOI 10.1038/336202a0; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; REINHART PH, 1991, J NEUROSCI, V11, P1627; ROGERS KV, 1990, P NATL ACAD SCI USA, V87, P8975, DOI 10.1073/pnas.87.22.8975; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; SCHORDERETSLATKINE S, 1982, P NATL ACAD SCI-BIOL, V79, P850, DOI 10.1073/pnas.79.3.850; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHUSTER MJ, 1985, NATURE, V313, P392, DOI 10.1038/313392a0; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SOKABE M, 1990, J CELL BIOL, V111, P599, DOI 10.1083/jcb.111.2.599; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; SONG Y, 1990, NATURE, V348, P242, DOI 10.1038/348242a0; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; STRONG JA, 1986, J NEUROSCI, V6, P814; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; WANG JX, 1992, NATURE, V359, P739, DOI 10.1038/359739a0; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WEST JW, 1992, P NATL ACAD SCI US, V89; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZHANG B, 1991, J BIOL CHEM, V266, P990; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	68	103	104	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1994	12	5					1097	1109		10.1016/0896-6273(94)90317-4	http://dx.doi.org/10.1016/0896-6273(94)90317-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185946				2022-12-28	WOS:A1994NM83100013
J	PFRIEGER, FW; GOTTMANN, K; LUX, HD				PFRIEGER, FW; GOTTMANN, K; LUX, HD			KINETICS OF GABA(B) RECEPTOR-MEDIATED INHIBITION OF CALCIUM CURRENTS AND EXCITATORY SYNAPTIC TRANSMISSION IN HIPPOCAMPAL-NEURONS IN-VITRO	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; CENTRAL-NERVOUS-SYSTEM; ROOT GANGLION NEURONS; B RECEPTORS; G-PROTEINS; PRESYNAPTIC INHIBITION; SYMPATHETIC NEURONS; RAT HIPPOCAMPUS; PERTUSSIS TOXIN; PHARMACOLOGICAL CHARACTERIZATION	The time courses of the gamma-aminobutyric acid type B (GABA(B)) receptor-mediated inhibition of excitatory synaptic transmission and of action potential-evoked calcium currents were studied in hippocampal neurons in vitro with step-like changes of a saturating baclofen concentration. Inhibition mediated by postsynaptic GABA(B) receptors was excluded pharmacologically. Both presynaptic inhibition and reduction of calcium currents developed and declined exponentially with similar time constants of about 0.2 and 3 s, respectively. The close correlation of the time courses indicates that fast, G protein-mediated depression of voltage-gated calcium channels and thus direct reduction of the presynaptic calcium influx may contribute to the GABA(B) receptor-induced inhibition of excitatory synaptic transmission in hippocampal neurons in vitro.			PFRIEGER, FW (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROPHYSIOL,KLOPFERSPITZ 18A,D-82152 PLANEGG,GERMANY.		Pfrieger, Frank/AAX-3208-2020	Pfrieger, Frank/0000-0001-7085-1431				ALFORD S, 1991, J NEUROSCI, V11, P3718; ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOWERY N, 1989, TRENDS PHARMACOL SCI, V10, P401, DOI 10.1016/0165-6147(89)90188-0; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; BROWN AM, 1984, J GEN PHYSIOL, V83, P751, DOI 10.1085/jgp.83.5.751; BROWN AM, 1993, J MEMBRANE BIOL, V131, P93, DOI 10.1007/BF02791318; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; COLMERS WF, 1989, BRAIN RES, V498, P99, DOI 10.1016/0006-8993(89)90403-4; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DOLPHIN AC, 1990, ANNU REV PHYSIOL, V52, P243; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; FRYER MW, 1993, J PHYSIOL-LONDON, V464, P501, DOI 10.1113/jphysiol.1993.sp019648; GAGE PW, 1992, TRENDS NEUROSCI, V15, P46, DOI 10.1016/0166-2236(92)90025-4; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; GREEN KA, 1988, BRIT J PHARMACOL, V94, P235, DOI 10.1111/j.1476-5381.1988.tb11520.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1990, J PHYSIOL-LONDON, V422, P433, DOI 10.1113/jphysiol.1990.sp017993; HOLZ GG, 1989, J NEUROSCI, V9, P657; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; HOWE JR, 1987, J PHYSIOL-LONDON, V384, P539, DOI 10.1113/jphysiol.1987.sp016469; HUSTON E, 1990, NEUROSCIENCE, V38, P721, DOI 10.1016/0306-4522(90)90065-C; INOMATA N, 1989, AM J PHYSIOL, V257, pC646, DOI 10.1152/ajpcell.1989.257.4.C646; ISAAC JT, 1993, NEUROSCI LETT, V150, P227, DOI 10.1016/0304-3940(93)90542-S; JACKSON MB, 1992, BIOPHYS J, V61, P756, DOI 10.1016/S0006-3495(92)81880-5; JANIGRO D, 1988, DEV BRAIN RES, V41, P171, DOI 10.1016/0165-3806(88)90180-0; JENKS BG, 1991, LIFE SCI, V48, P1633, DOI 10.1016/0024-3205(91)90123-S; JONES SW, 1991, BIOPHYS J, V60, P502, DOI 10.1016/S0006-3495(91)82077-X; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; LAMBERT NA, 1993, J NEUROPHYSIOL, V69, P630, DOI 10.1152/jn.1993.69.2.630; LESSMANN V, 1992, NEUROSCI LETT, V146, P13; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MCCOBB DP, 1991, NEURON, V7, P119, DOI 10.1016/0896-6273(91)90080-J; MILLER RJ, 1990, FASEB J, V4, P3291, DOI 10.1096/fasebj.4.15.1979294; MILLIGAN G, 1988, BIOCHEM J, V255, P1; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MORAD M, 1988, SCIENCE, V241, P842, DOI 10.1126/science.2457253; MORISHITA R, 1990, FEBS LETT, V271, P231, DOI 10.1016/0014-5793(90)80413-D; NARGEOT J, 1982, J GEN PHYSIOL, V79, P657, DOI 10.1085/jgp.79.4.657; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; PFRIEGER FW, 1992, J NEUROSCI, V12, P4347; POLLO A, 1992, PFLUG ARCH EUR J PHY, V422, P75; REKLING JC, 1993, J NEUROSCI, V13, P1954; SAHARA Y, 1993, J NEUROSCI, V13, P3041; SAINT DA, 1990, NEUROSCI LETT, V118, P9, DOI 10.1016/0304-3940(90)90236-3; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SCHULTZ G, 1990, ANNU REV PHYSIOL, V52, P275, DOI 10.1146/annurev.ph.52.030190.001423; SCOTT RH, 1991, PROG NEUROBIOL, V36, P485, DOI 10.1016/0301-0082(91)90014-R; SCROGGS RS, 1992, J NEUROSCI, V12, P1789; SEABROOK GR, 1990, BRIT J PHARMACOL, V101, P949, DOI 10.1111/j.1476-5381.1990.tb14186.x; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SOLIS JM, 1992, J NEUROSCI, V12, P3466; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; STREIT J, 1989, J NEUROSCI, V9, P4190; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; TRAVAGLI RA, 1991, J PHARMACOL EXP THER, V258, P903; UI M, 1984, TRENDS PHARMACOL SCI, V5, P277, DOI 10.1016/0165-6147(84)90444-9; YATANI A, 1987, SCIENCE, V235, P207, DOI 10.1126/science.2432660; YOON KW, 1991, J PHYSIOL-LONDON, V442, P377, DOI 10.1113/jphysiol.1991.sp018798	79	97	99	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					97	107		10.1016/0896-6273(94)90155-4	http://dx.doi.org/10.1016/0896-6273(94)90155-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292363	Green Published			2022-12-28	WOS:A1994MU49300009
J	ARTINGER, KB; BRONNERFRASER, M				ARTINGER, KB; BRONNERFRASER, M			DELAYED FORMATION OF THE FLOOR PLATE AFTER ABLATION OF THE AVIAN NOTOCHORD	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CHICK-EMBRYO; NEURAL-TUBE; DIFFERENTIATION; PATTERN; AXONS; CELLS	We have examined the long-term effects of notochord ablation at chick stages 9-10 on formation of the floor plate and motor neurons. Although missing or reduced 2 days postablation, the floor plate and motor neurons were morphologically normal by 4 postoperative days. When isolated whole or ventral, but not lateral, neural plate fragments from stage 9 embryos were cultured for 4 days in collagen gels, floor plate and neural markers were observed. Our results suggest that floor plate and motor neurons can form in a delayed fashion in vivo after notochord ablation and in vitro from isolated neural plates. This suggests that either there is an early induction of floor plate by the chordamesoderm of Hensen's node, or only limited interactions between the neural plate and notochord immediately after neurulation are required for floor plate determination.			ARTINGER, KB (corresponding author), UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92717, USA.			Bronner, Marianne/0000-0003-4274-1862	NICHD NIH HHS [NICHD NO1-HD-2-3144, HD-25138] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025138] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARTINGER KB, 1992, DEVELOPMENT, V116, P877; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; DARNELL DK, 1992, DEV DYNAM, V193, P389, DOI 10.1002/aja.1001930411; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMILTON HL, 1952, ILLIES DEV CHICK; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; LEDOUARIAN N, 1982, NEURAL CREST; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PLACZEK M, 1993, DEVELOPMENT, V117, P205; SCHOENWOLF GC, 1985, DEV BIOL, V109, P127, DOI 10.1016/0012-1606(85)90353-7; SCHOENWOLF GC, 1989, J EXP ZOOL, V249, P271, DOI 10.1002/jez.1402490305; SCHOENWOLF GC, 1984, DEV BIOL, V105, P257, DOI 10.1016/0012-1606(84)90284-7; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; SMITH G, 1989, FILM COMMENT, V25, P49; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VANSTRAATEN HWM, 1989, DEVELOPMENT, V107, P793; VANSTRAATEN HWM, 1988, ANAT EMBRYOL, V177, P317; VANSTRAATEN HWM, 1991, ANAT EMBRYOL, V184, P55; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	24	45	46	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1147	1161		10.1016/0896-6273(93)90227-I	http://dx.doi.org/10.1016/0896-6273(93)90227-I			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274280				2022-12-28	WOS:A1993MP54800015
J	MURALIDHAR, MG; THOMAS, JB				MURALIDHAR, MG; THOMAS, JB			THE DROSOPHILA BENDLESS GENE ENCODES A NEURAL PROTEIN RELATED TO UBIQUITIN-CONJUGATING ENZYMES	NEURON			English	Article							NEURONAL GROWTH CONES; VISUAL-SYSTEM; IDENTIFIED NEURONS; CELL-ADHESION; MOTO-NEURONS; WHITE GENE; PATHWAY; EMBRYOS; DNA; GLYCOPROTEIN	The bendless (ben) mutation of Drosophila alters synaptic connectivity between a subset of CNS neurons. Here, we show that ben also causes morphological abnormalities within the visual system, suggesting that ben functions in a number of different developmental processes. We show that the ben gene encodes a protein which is closely related to ubiquitin-conjugating enzymes and that a missense mutation in the highly conserved active site region is associated with the ben mutation. High levels of ben expression are restricted to the nervous system during development. These results suggest a role for ubiquitin-mediated protein modification in nervous system development, including, but not exclusive to, the regulation of synaptic connectivity.			MURALIDHAR, MG (corresponding author), SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,SAN DIEGO,CA 92186, USA.							BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BALL E, 1987, CELL, V51, P221, DOI 10.1016/0092-8674(87)90149-8; BASTIANI MJ, 1986, J NEUROSCI, V6, P3518; BENZER S, 1991, DEV VISUAL SYSTEM, P9; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; BUCKLES GR, 1992, NEURON, V8, P1015, DOI 10.1016/0896-6273(92)90124-V; CAMPOS AR, 1992, DEVELOPMENT, V114, P355; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EDGECOMB RS, 1993, IN PRESS J NEUROGENE; FINLEY D, 1985, TRENDS BIOCHEM SCI, V10, P343, DOI 10.1016/0968-0004(85)90108-2; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GREEN SH, 1981, NATURE, V292, P152, DOI 10.1038/292152a0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; HARTE PJ, 1982, GENETICS, V101, P477; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; ITOH N, 1985, DROS INF SERVICE, V61, P89; Jentsch S, 1992, Trends Cell Biol, V2, P98, DOI 10.1016/0962-8924(92)90013-D; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KING DG, 1980, J NEUROCYTOL, V9, P753, DOI 10.1007/BF01205017; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; KOKEN M, 1991, P NATL ACAD SCI USA, V88, P3832, DOI 10.1073/pnas.88.9.3832; KOTO M, 1981, BRAIN RES, V221, P213, DOI 10.1016/0006-8993(81)90772-1; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5864, DOI 10.1093/nar/17.14.5864; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; Lewis E B, 1982, Prog Clin Biol Res, V85 Pt A, P269; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Maniatis T., 1982, MOL CLONING; MEINERTZHAGEN IA, 1983, TRENDS NEUROSCI, V6, P223, DOI 10.1016/0166-2236(83)90099-1; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PAOLINI R, 1993, EMBO J, V12, P779, DOI 10.1002/j.1460-2075.1993.tb05712.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; RAPER JA, 1984, J NEUROSCI, V4, P2329; RATHJEN FG, 1984, EMBO J, V3, P1; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; SIEGELMAN M, 1986, SCIENCE, V231, P823, DOI 10.1126/science.3003913; SINK H, 1991, DEVELOPMENT, V113, P701; SINK H, 1991, DEVELOPMENT, V112, P307; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; STEWART WW, 1978, CELL, V14, P741, DOI 10.1016/0092-8674(78)90256-8; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMAS JB, 1984, DEV BIOL, V102, P531, DOI 10.1016/0012-1606(84)90222-7; THOMAS JB, 1983, TRENDS NEUROSCI, V6, P214, DOI 10.1016/0166-2236(83)90097-8; THOMAS JB, 1982, NATURE, V298, P650, DOI 10.1038/298650a0; THOMAS JB, 1984, J NEUROSCI, V4, P530; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANVACTOR D, 1993, CELL, V73, P1155; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0	71	120	123	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					253	266		10.1016/0896-6273(93)90182-Q	http://dx.doi.org/10.1016/0896-6273(93)90182-Q			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394720				2022-12-28	WOS:A1993LU06500006
J	CALABRESI, P; PISANI, A; MERCURI, NB; BERNARDI, G				CALABRESI, P; PISANI, A; MERCURI, NB; BERNARDI, G			LITHIUM TREATMENT BLOCKS LONG-TERM SYNAPTIC DEPRESSION IN THE STRIATUM	NEURON			English	Article							MUSCARINIC RECEPTOR SUBTYPES; CYCLIC-AMP ACCUMULATION; PHOSPHOINOSITIDE HYDROLYSIS; INOSITOL TRISPHOSPHATE; HIPPOCAMPAL-NEURONS; NEOSTRIATAL NEURONS; MEMBRANE-PROPERTIES; SUPER-SENSITIVITY; RAT NEOSTRIATUM; BASAL GANGLIA	We have studied the effect of acute and chronic lithium treatment on the activity of striatal neurons recorded from corticostriatal slices. Under control conditions, tetanic stimulation of glutamatergic corticostriatal terminals caused long-term depression (LTD) of excitatory synaptic potentials. Acute lithium treatment did not affect the peak of the induction phase, but it reduced the following phases of LTD. LTD was completely blocked in slices obtained from rats chronically injected with LiCl. Lithium treatment failed to affect the intrinsic membrane properties of striatal neurons and the presynaptic inhibitory effects of carbachol and t-ACPD. We suggest that the lithium-induced blockade of LTD may contribute to the therapeutic action of lithium salts in mania and depression.			CALABRESI, P (corresponding author), UNIV ROMA TOR VERGATA,DIPARTIMENTO SANITA,NEUROL CLIN,VIA O RAIMONDO,I-00173 ROME,ITALY.		Mercuri, Nicola Biagio/K-5348-2016; Pisani, Antonio/G-2492-2012; Calabresi, Paolo/G-8496-2011	Mercuri, Nicola Biagio/0000-0001-6700-7491; Pisani, Antonio/0000-0002-8432-594X; Calabresi, Paolo/0000-0003-0326-5509				AKAIKE A, 1988, J PHARMACOL EXP THER, V246, P1129; AKINS PT, 1990, J NEUROCHEM, V54, P266, DOI 10.1111/j.1471-4159.1990.tb13310.x; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALDENHOFF JB, 1985, NEUROSCI LETT, V54, P103, DOI 10.1016/S0304-3940(85)80125-7; ALGER BE, 1976, BRAIN RES, V110, P463, DOI 10.1016/0006-8993(76)90858-1; AMBROSINI A, 1989, J NEUROCHEM, V53, P825; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; ARONICA E, 1991, J NEUROCHEM, V57, P376, DOI 10.1111/j.1471-4159.1991.tb03763.x; AVISSAR S, 1988, NATURE, V331, P440, DOI 10.1038/331440a0; BEAUGE L, 1975, J PHYSIOL-LONDON, V246, P397, DOI 10.1113/jphysiol.1975.sp010896; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BLAUSTEIN MP, 1975, REV PHYSL BIOCH PHAR, V70, P34; BRANCHEY MH, 1976, AM J PSYCHIAT, V133, P444; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; BUNNEY WE, 1987, PSYCHOPHARMACOLOGY 3, P553; CALABRESI P, 1991, J PHYSIOL-LONDON, V440, P581, DOI 10.1113/jphysiol.1991.sp018726; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P663, DOI 10.1152/jn.1990.63.4.663; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; CALABRESI P, 1992, NEUROSCI LETT, V139, P41, DOI 10.1016/0304-3940(92)90852-X; CALABRESI P, 1991, EUR J NEUROSCI, V4, P116; CALDECOTTHAZARD S, 1991, SYNAPSE, V9, P251, DOI 10.1002/syn.890090404; COCKCROFT S, 1987, TRENDS BIOCHEM SCI, V12, P75, DOI 10.1016/0968-0004(87)90035-1; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; EBSTEIN RP, 1980, J PHARMACOL EXP THER, V213, P161; FLORU L, 1979, INT PHARMACOPSYCHIAT, V14, P149, DOI 10.1159/000468373; GALLAGER DW, 1978, NATURE, V273, P309, DOI 10.1038/273309a0; GARCIAMUNOZ M, 1992, NEUROREPORT, V3, P357, DOI 10.1097/00001756-199204000-00017; GEISLER A, 1978, LIFE SCI, V23, P635, DOI 10.1016/0024-3205(78)90045-0; GOTTBERG E, 1988, SYNAPSE, V2, P442, DOI 10.1002/syn.890020412; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GROVES PM, 1983, BRAIN RES REV, V5, P109, DOI 10.1016/0165-0173(83)90011-5; HIRSCH JC, 1990, J PHYSL, V432, P123; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; IZQUIERDO I, 1992, TRENDS PHARMACOL SCI, V13, P7, DOI 10.1016/0165-6147(92)90004-P; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KITA T, 1984, BRAIN RES, V109, P601; KUBA K, 1990, PROG NEUROBIOL, V34, P197, DOI 10.1016/0301-0082(90)90012-6; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LOVINGER DM, 1991, NEUROSCI LETT, V129, P17, DOI 10.1016/0304-3940(91)90710-B; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MULLER W, 1989, NEUROSCI LETT, V100, P135, DOI 10.1016/0304-3940(89)90673-3; NAHORSKI SR, 1991, TRENDS PHARMACOL SCI, V12, P297, DOI 10.1016/0165-6147(91)90581-C; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; PANDEY GN, 1978, J GEN PHYSIOL, V72, P233, DOI 10.1085/jgp.72.2.233; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; SCHORDERET M, 1977, BIOCHEM PHARMACOL, V26, P167, DOI 10.1016/0006-2952(77)90392-6; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SLADECZEK F, 1988, TRENDS NEUROSCI, V11, P545, DOI 10.1016/0166-2236(88)90183-X; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; SUGITA S, 1991, P NATL ACAD SCI USA, V88, P2608, DOI 10.1073/pnas.88.6.2608; SVENSSON A, 1992, J NEURAL TRANSM-GEN, V88, P235, DOI 10.1007/BF01244735; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; TEYLER TJ, 1984, BRAIN RES REV, V7, P15, DOI 10.1016/0165-0173(84)90027-4; TYRER S, 1980, BRIT J PSYCHIAT, V136, P191; WHITWORTH P, 1990, BRIT J PHARMACOL, V101, P39, DOI 10.1111/j.1476-5381.1990.tb12085.x; WHORLEY PF, 1988, SCIENCE, V239, P1428; WOOD AJ, 1987, PSYCHOL MED, V17, P579, DOI 10.1017/S0033291700025836	64	42	42	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					955	962		10.1016/0896-6273(93)90210-I	http://dx.doi.org/10.1016/0896-6273(93)90210-I			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494646				2022-12-28	WOS:A1993LD32200017
J	McAllister, AK; Katz, LC; Lo, DC				McAllister, AK; Katz, LC; Lo, DC			Neurotrophin regulation of cortical dendritic growth requires activity	NEURON			English	Review							RAT VISUAL-CORTEX; MESSENGER-RNA; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; NEURONAL PLASTICITY; MOLECULAR-CLONING; NERVOUS-SYSTEM; TRK FAMILY; NGF; SURVIVAL	Neurotrophins have been proposed to mediate several forms of activity-dependent competition in the central nervous system. A key element of such hypotheses is that neurotrophins act preferentially on active neurons; however, little direct evidence supports this postulate. We therefore examined, in ferret cortical brain slices, the interactions between activity and neurotrophins in regulating dendritic growth of layer 4 pyramidal neurons. Inhibition of spontaneous electrical activity, synaptic transmission, or L-type calcium channels each prevented the otherwise dramatic increase in dendritic arborizations elicited by brain-derived neurotrophic factor. In developing cortex, this requirement for conjoint neurotrophin signaling and activity provides a mechanism for selectively enhancing the growth and connectivity of active neurons.	DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA	Duke University	McAllister, AK (corresponding author), DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DURHAM, NC 27710 USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NEI NIH HHS [EY11553, EY07690] Funding Source: Medline; NINDS NIH HHS [NS32742] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032742, R29NS032742] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BERARDI N, 1994, P NATL ACAD SCI USA, V91, P684, DOI 10.1073/pnas.91.2.684; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; COHENCORY S, 1991, J NEUROSCI, V11, P462; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; FRANKLIN JL, 1994, PHILOS T ROY SOC B, V345, P251, DOI 10.1098/rstb.1994.0102; GALUSKE RAW, 1996, IN PRESS EUR J NEURO; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; GU Q, 1994, P NATL ACAD SCI USA, V91, P8408, DOI 10.1073/pnas.91.18.8408; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; KATZ LC, 1989, J NEUROSCI, V9, P1389; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; PURVES D, 1988, BODY BRAIN; REH TA, 1985, J NEUROSCI, V5, P1132; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SCHOUPS AA, 1995, DEV BRAIN RES, V86, P326, DOI 10.1016/0165-3806(95)00043-D; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; VALVERDE F, 1968, EXP BRAIN RES, V5, P274; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6	51	416	421	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1057	1064		10.1016/S0896-6273(00)80239-1	http://dx.doi.org/10.1016/S0896-6273(00)80239-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982155				2022-12-28	WOS:A1996WA24800005
J	Breiter, HC; Etcoff, NL; Whalen, PJ; Kennedy, WA; Rauch, SL; Buckner, RL; Strauss, MM; Hyman, SE; Rosen, BR				Breiter, HC; Etcoff, NL; Whalen, PJ; Kennedy, WA; Rauch, SL; Buckner, RL; Strauss, MM; Hyman, SE; Rosen, BR			Response and habituation of the human amygdala during visual processing of facial expression	NEURON			English	Article							STIMULUS-REWARD ASSOCIATIONS; HUMAN BRAIN; IMPAIRED RECOGNITION; UNIPOLAR DEPRESSION; SENSORY STIMULATION; OVERLYING AREAS; TEMPORAL CORTEX; MONKEY; NEURONS; FACES	We measured amygdala activity in human volunteers during rapid visual presentations of fearful, happy, and neutral faces using functional magnetic resonance imaging (fMRI). The first experiment involved a fixed order of conditions both within and across runs, while the second one used a fully counterbalanced order in addition to a low level baseline of simple visual stimuli. In both experiments, the amygdala was preferentially activated in response to fearful versus neutral faces. In the counterbalanced experiment, the amygdala also responded preferentially to happy versus neutral faces, suggesting a possible generalized response to emotionally valenced stimuli. Rapid habituation effects were prominent in both experiments. Thus, the human amygdala responds preferentially to emotionally valenced faces and rapidly habituates to them.	MASSACHUSETTS GEN HOSP,DEPT RADIOL,NUCL MAGNET RESONANCE CTR,CHARLESTOWN,MA 02129; HARVARD UNIV,SCH MED,CHARLESTOWN,MA 02129	Harvard University; Massachusetts General Hospital; Harvard University	Breiter, HC (corresponding author), MASSACHUSETTS GEN HOSP,DEPT PSYCHIAT,CHARLESTOWN,MA 02129, USA.		anand, amit/A-7222-2009; Tudusciuc, Oana/C-1339-2011		NHLBI NIH HHS [HL39810] Funding Source: Medline; NIDA NIH HHS [DA00265, DA09467] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039810] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Andreasen NC, 1996, J NEUROPSYCH CLIN N, V8, P139; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BENKELFAT C, 1995, AM J PSYCHIAT, V152, P1180; BORDI F, 1993, BEHAV NEUROSCI, V107, P757, DOI 10.1037/0735-7044.107.5.757; BORDI F, 1992, J NEUROSCI, V12, P2493; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; BREITER HC, 1996, IN PRESS NEUROIMAGE; BUCKNER RL, 1995, J NEUROSCI, V15, P12; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DAVIS M, 1992, P255; DREVETS WC, 1992, J NEUROSCI, V12, P3628; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Ekman P., 1976, PICTURES FACIAL AFFE; EKMAN P, 1988, HDB SOCIAL PSYCHOPHY, P143; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; FEINBERG TE, 1986, ARCH GEN PSYCHIAT, V43, P276; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; FROMM D, 1984, BIOL PSYCHIAT, V19, P55; GAFFAN D, 1987, J NEUROSCI, V7, P2285; GAFFAN EA, 1988, J NEUROSCI, V8, P3144; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; GEORGE MS, 1993, J NEUROPSYCHIAT, V5, P284; GREDEN JF, 1986, ARCH GEN PSYCHIAT, V43, P269; GUR RC, 1992, PSYCHIAT RES, V42, P241, DOI 10.1016/0165-1781(92)90116-K; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Hamann SB, 1996, NATURE, V379, P497, DOI 10.1038/379497a0; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hatfield T, 1996, J NEUROSCI, V16, P5256; HAXBY JV, 1994, J NEUROSCI, V14, P6336; IRWIN W, 1996, IN PRESS HUMAN AMYGD; JAEGER J, 1986, J AFFECT DISORDERS, V11, P43, DOI 10.1016/0165-0327(86)90058-3; JIANG A, 1995, HUM BRAIN MAPP, V3, P1; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KANWISHER N, 1996, IN PRESS COGN BRAIN; KAPP B S, 1992, P229; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LABAR KS, 1995, J NEUROSCI, V15, P6846; LEDOUX J E, 1992, P339; LEDOUX JE, 1993, ANN NY ACAD SCI, V702, P149, DOI 10.1111/j.1749-6632.1993.tb17246.x; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Mikhailova ES, 1996, BIOL PSYCHIAT, V40, P697, DOI 10.1016/0006-3223(96)00032-7; NAKAMURA K, 1992, J NEUROPHYSIOL, V67, P1447, DOI 10.1152/jn.1992.67.6.1447; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; PERRETT DI, 1982, ADV VERTEBRATE NEURO; Puce A, 1996, J NEUROSCI, V16, P5205; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Reese TG, 1995, JMRI-J MAGN RESON IM, V5, P739, DOI 10.1002/jmri.1880050621; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; ROLLS ET, 1985, SCI BASIS CLIN NEURO, P201; ROLLS ET, 1991, PROCESSING IMAGES FA; ROLLS ET, 1981, AMYGDALOID COMPLEX, P383; RUBINOW DR, 1992, BIOL PSYCHIAT, V31, P947, DOI 10.1016/0006-3223(92)90120-O; SCHNEIDER F, 1992, NERVENARZT, V63, P545; Schneider F, 1996, AM J PSYCHIAT, V153, P206; Sergent J., 1994, VIS COGN, V1, P349, DOI [10.1080/13506289408402305, DOI 10.1080/13506289408402305]; SPIEGLER BJ, 1981, BEHAV BRAIN RES, V3, P303, DOI 10.1016/0166-4328(81)90002-4; Talairach J., 1988, COPLANAR STEREOTAXIC; Tomkins, 1963, AFFECT IMAGERY CONSC, V2; Tomkins SS, 1962, AFFECT IMAGERY CONSC, V1; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	71	1291	1309	2	117	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					875	887		10.1016/S0896-6273(00)80219-6	http://dx.doi.org/10.1016/S0896-6273(00)80219-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	VV151	8938120	Bronze			2022-12-28	WOS:A1996VV15100010
J	Hall, JC				Hall, JC			Are cycling gene products as internal zeitgebers no longer the zeitgeist of chronobiology?	NEURON			English	Review							SILKMOTH ANTHERAEA-PERNYI; PERIOD PROTEIN; DROSOPHILA-MELANOGASTER; RHYTHMS; CLOCKS				Hall, JC (corresponding author), BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254, USA.							ASHBURNER M, 1995, SCIENCE, V270, P1941, DOI 10.1126/science.270.5244.1941; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; FISCH B, 1996, IN PRESS CELL TISSUE; GOLDEN SS, 1996, IN PRESS ANN REV PLA; Hall J.C., 1990, Advances in Insect Physiology, V22, P221, DOI 10.1016/S0065-2806(08)60007-7; HALL JC, 1995, TRENDS NEUROSCI, V18, P230, DOI 10.1016/0166-2236(95)93908-G; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; ISHIDA N, 1995, NEUROSCI RES, V23, P232; KAY SA, 1995, CELL, V83, P361, DOI 10.1016/0092-8674(95)90113-2; KONOPKA RJ, 1987, ANNU REV GENET, V21, P227, DOI 10.1146/annurev.genet.21.1.227; KONOPKA RJ, IN PRESS J NEUROGENE; KYRIACOU CP, 1996, IN PRESS SEMIN CELL; LEVINE JD, 1995, NEURON, V15, P147, DOI 10.1016/0896-6273(95)90072-1; LOROS J, 1995, SEMIN NEUROSCI, V7, P313; LOUDON ASI, 1994, ENDOCRINOLOGY, V135, P712, DOI 10.1210/en.135.2.712; PRICE JL, 1995, BIOESSAYS, V17, P583, DOI 10.1002/bies.950170703; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; ROSBASH M, 1996, IN PRESS COLD SPRING, V61; ROSEWELL KL, 1994, BRAIN RES, V659, P231, DOI 10.1016/0006-8993(94)90884-2; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; Sehgal A, 1996, MOL CELL NEUROSCI, V7, P165, DOI 10.1006/mcne.1996.0013; SIWICKI KK, 1989, NEURON, V3, P51, DOI 10.1016/0896-6273(89)90114-1; TRUMAN JW, 1993, INSECT NEUROCHEMISTR, P39	23	36	36	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					799	802		10.1016/S0896-6273(00)80211-1	http://dx.doi.org/10.1016/S0896-6273(00)80211-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938111	Bronze			2022-12-28	WOS:A1996VV15100001
J	Lester, HA; Cao, YW; Mager, S				Lester, HA; Cao, YW; Mager, S			Listening to neurotransmitter transporters	NEURON			English	Review							GABA				Lester, HA (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.							BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; Cammack JN, 1996, P NATL ACAD SCI USA, V93, P723, DOI 10.1073/pnas.93.2.723; CAMMACK JN, 1994, NEURON, V13, P949, DOI 10.1016/0896-6273(94)90260-7; CHEN JG, 1996, IN PRESS BIOCHEMISTR; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; GASLLI A, 1996, P NATL ACAD SCI USA, V93, P8671; Gu HH, 1996, J BIOL CHEM, V271, P6911, DOI 10.1074/jbc.271.12.6911; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Kramer P. D., 1993, LISTENING PROZAC; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; LIN F, 1996, IN PRESS BIOPHYS J; LU CC, 1996, P NATL ACAD SCI USA, V92, P11220; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; SONDERS M, 1996, IN PRESS J NEUROSCI; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Su A, 1996, BIOPHYS J, V70, P762, DOI 10.1016/S0006-3495(96)79616-9; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	21	100	100	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					807	810		10.1016/S0896-6273(00)80213-5	http://dx.doi.org/10.1016/S0896-6273(00)80213-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938113	Bronze			2022-12-28	WOS:A1996VV15100003
J	Kuner, T; Wollmuth, LP; Karlin, A; Seeburg, PH; Sakmann, B				Kuner, T; Wollmuth, LP; Karlin, A; Seeburg, PH; Sakmann, B			Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines	NEURON			English	Article							VOLTAGE-DEPENDENT BLOCK; LONG-TERM POTENTIATION; GLUTAMATE-RECEPTOR; ACTIVATED CHANNELS; N-GLYCOSYLATION; TOPOLOGY; NEURONS; HIPPOCAMPUS; RESIDUES; SUBUNIT	The structure of the NMDA receptor channel M2 segment was investigated by probing the extracellular and cytoplasmic faces of cysteine-substituted NR1-NRPC channels with charged sulfhydryl-specific reagents. The pattern of accessible positions suggests that the M2 segment forms a channel-lining loop originating and ending on the cytoplasmic side of the channel, with the ascending limb in an alpha-helical structure and the descending limb in an extended structure. A functionally critical asparagine (N-site) is positioned at the tip of the loop, and a cluster of hydrophilic residues of the descending limb, adjacent to the tip, forms the narrow constriction of the channel. An apparent asymmetric positioning of the NR1- and NRP-subunit N-site asparagines may account for their unequal role in Ca2+ permeability and Mg2+ block.	MAX PLANCK INST MED RES,ABT MOL NEUROBIOL,D-69120 HEIDELBERG,GERMANY; MAX PLANCK INST MED RES,ZELLPHYSIOL ABT,D-69120 HEIDELBERG,GERMANY; COLUMBIA UNIV COLL PHYS & SURG,CTR MOL RECOGNIT,DEPT BIOCHEM,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR MOL RECOGNIT,DEPT PHYSIOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR MOL RECOGNIT,DEPT NEUROL,NEW YORK,NY 10032	Max Planck Society; Max Planck Society; Columbia University; Columbia University; Columbia University	Kuner, T (corresponding author), UNIV HEIDELBERG,ZENTRUM MOL BIOL,NEUENHEIMER FELD 282,D-69120 HEIDELBERG,GERMANY.			KARLIN, ARTHUR/0000-0002-4813-752X; Wollmuth, Lonnie/0000-0002-8179-1259				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARELLANO RO, 1995, J PHYSIOL-LONDON, V484, P593, DOI 10.1113/jphysiol.1995.sp020689; AUSUBEL FM, 1995, CURRENT PROTOCOLS MO, pCH8; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hilgemann Donald W., 1995, P307; Hille B., 1992, IONIC CHANNELS EXCIT; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; ISHII T, 1993, J BIOL CHEM, V268, P2833; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; Kuner T, 1996, J NEUROSCI, V16, P3549; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; MACDERMOTT AB, 1956, NATURE, V321, P261; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERKEL DJ, 1993, NEURON, V11, P811; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882	33	190	194	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					343	352		10.1016/S0896-6273(00)80165-8	http://dx.doi.org/10.1016/S0896-6273(00)80165-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780657	hybrid			2022-12-28	WOS:A1996VE84000016
J	Kim, E; Cho, KO; Rothschild, A; Sheng, M				Kim, E; Cho, KO; Rothschild, A; Sheng, M			Heteromultimerization and NMDA receptor-clustering activity of chapsyn-110, a member of the PSD-95 family of proteins	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; MOLECULAR CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; CHANNEL PROTEINS; K+ CHANNELS; RAT-BRAIN; SUBUNIT; HOMOLOG; NEURONS; CLONING	Chapsyn-110, a novel membrane-associated putative guanylate kinase (MAGUK) that binds directly to N-methyl-D-aspartate (NMDA) receptor and Shaker K+ channel subunits, is 70%-80% identical to, and shares an identical domain organization with, PSD-95/SAP90 and SAP97. In rat brain, chapsyn-110 protein shows a somatodendritic expression pattern that overlaps partly with PSD-95 but that contrasts with the axonal distribution of SAP97. Chapsyn-110 associates tightly with the postsynaptic density in brain, and mediates the clustering of both NMDA receptors and K+ channels in heterologous cells. Indeed, chapsyn-110 and PSD-95 can heteromultimerize with each other and are recruited into the same NMDA receptor and K, channel clusters. Thus, chapsyn-110 and PSD-95 may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signalling proteins.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor College of Medicine	Kim, E (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT NEUROBIOL,HOWARD HUGHES MED INST,BOSTON,MA 02114, USA.		Cho, Kyung-Ok/C-1705-2011; Kim, Eunjoon/C-1566-2011	Sheng, Morgan/0000-0002-8703-5366; Cho, Kyung-Ok/0000-0002-0760-2560				AOKI C, 1994, J NEUROSCI, V14, P5202; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; HALL ZW, 1993, NEURON S, V10, P99; Hunt CA, 1996, J NEUROSCI, V16, P1380; ISHII T, 1993, J BIOL CHEM, V268, P2836; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1995, SCIENCE, V269, P1737; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1996, J NEUROSCI, V16, P2157; PETRALIA RS, 1994, J NEUROSCI, V14, P667; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SHENG M, 1994, J NEUROSCI, V14, P2408; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; THODES KJ, 1995, J NEUROSCI, V15, P5360; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	36	474	484	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					103	113		10.1016/S0896-6273(00)80284-6	http://dx.doi.org/10.1016/S0896-6273(00)80284-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755482	Bronze			2022-12-28	WOS:A1996UY98100011
J	Gillis, KD; Mossner, R; Neher, E				Gillis, KD; Mossner, R; Neher, E			Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules	NEURON			English	Article							HIGH-VOLTAGE DISCHARGE; PANCREATIC B-CELLS; PHORBOL ESTER; INSULIN-SECRETION; CALCIUM; CA-2+; CA2+; PHOSPHORYLATION; ACTIVATION; CURRENTS	We have used membrane capacitance measurements to assay Ca2+-triggered exocytosis in single bovine adrenal chromaffin cells. Brief application of phorbol ester (PMA) enhances depolarization-evoked exocytosis severalfold while actually decreasing the Ca2+ current. Ca2+ metabolism is unchanged. Three different protocols were used to show that PMA increases the size of the readily releasable pool of secretory granules. PMA treatment leads to a large increase in amplitude, but little change in the time course of the exocytic burst that results from rapid elevation of [Ca2+](i) upon photolysis of DM-Nitrophen. Thus, PKC appears to affect a late step in secretion but not the Ca2+ sensitivity of the final step.			Gillis, KD (corresponding author), MAX PLANCK INST BIOPHYS CHEM, DEPT MEMBRANE BIOPHYS, FASSBERG, D-37077 GOTTINGEN, GERMANY.		Neher, Erwin/A-2109-2013					AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; BARNETT DW, 1994, J MEMBRANE BIOL, V138, P113; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BITTNER MA, 1993, CELL MOL NEUROBIOL, V13, P649, DOI 10.1007/BF00711564; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; GILLIS KD, 1993, PFLUG ARCH EUR J PHY, V424, P195, DOI 10.1007/BF00374612; GILLIS KD, 1991, PFLUG ARCH EUR J PHY, V418, P611, DOI 10.1007/BF00370579; GILLIS KD, 1992, PFLUG ARCH EUR J PHY, V420, P121, DOI 10.1007/BF00378654; Gillis Kevin D., 1995, P155; GOLDBERG AL, 1969, P NATL ACAD SCI USA, V64, P134, DOI 10.1073/pnas.64.1.134; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; JOHNSTONE SA, 1992, J BIOL CHEM, V267, P25976; JONES PM, 1985, FEBS LETT, V191, P102, DOI 10.1016/0014-5793(85)81002-4; JONES PM, 1986, FEBS LETT, V205, P205, DOI 10.1016/0014-5793(86)80898-5; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; KNIGHT DE, 1983, FEBS LETT, V160, P98, DOI 10.1016/0014-5793(83)80944-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LIN LF, 1994, J NEUROCHEM, V63, P1941; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; LLANO I, 1993, J PHYSIOL-LONDON, V468, P201, DOI 10.1113/jphysiol.1993.sp019767; MORGAN A, 1992, BIOCHEM J, V286, P807, DOI 10.1042/bj2860807; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NISHIZAKI T, 1992, J BIOL CHEM, V267, P23972; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PIPELEERS D, 1987, DIABETOLOGIA, V30, P277, DOI 10.1007/BF00299019; POCOTTE SL, 1985, P NATL ACAD SCI USA, V82, P930, DOI 10.1073/pnas.82.3.930; Seward EP, 1996, J NEUROSCI, V16, P553; Sillen L.G., 1971, STABILITY CONSTANTS; TAMAGAWA T, 1985, FEBS LETT, V183, P433, DOI 10.1016/0014-5793(85)80825-5; TERBUSH DR, 1990, J BIOL CHEM, V265, P21179; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TRIFARO JM, 1993, TRENDS NEUROSCI, V16, P466, DOI 10.1016/0166-2236(93)90079-2; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WEI W, 1992, BIOCHEMISTRY-US, V31, P9934, DOI 10.1021/bi00156a011; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	57	345	349	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1209	1220		10.1016/S0896-6273(00)80147-6	http://dx.doi.org/10.1016/S0896-6273(00)80147-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663997	Bronze, Green Published			2022-12-28	WOS:A1996UU11800018
J	Seoh, SA; Sigg, D; Papazian, DM; Bezanilla, F				Seoh, SA; Sigg, D; Papazian, DM; Bezanilla, F			Voltage-sensing residues in the S2 and S4 segments of the Shaker K+ channel	NEURON			English	Article							POTASSIUM-CHANNEL; SODIUM-CHANNEL; GATING CHARGE; INACTIVATION; CURRENTS; REGION; CDNA	The activation of Shaker K+ channels is steeply voltage dependent. To determine whether conserved charged amino acids in putative transmembrane segments S2, S3, and S4 contribute to the gating charge of the channel, the total gating charge movement per channel was measured in channels containing neutralization mutations. Of eight residues tested, four contributed significantly to the gating charge: E293, an acidic residue in S2, and R365, R368, and R371, three basic residues in the S4 segment. The results indicate that these residues are a major component of the voltage sensor. Furthermore, the S4 segment is not solely resposible for gating charge movement in Shaker K+ channels.	UNIV CALIF LOS ANGELES,SCH MED,DEPT ANESTHESIOL,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Seoh, SA (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90095, USA.				NIGMS NIH HHS [R01 GM043459-11, R01 GM043459-14, R01 GM043459-13, R01 GM043459-09, R01 GM043459-17, GM 30376, R01 GM043459-15S1, R01 GM043459-16, R01 GM043459-10, R01 GM043459, R01 GM043459-12, R01 GM043459-15] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030376, R37GM030376, R01GM043459] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CHANDY GK, 1995, HDB RECEPTORS CHANNE, P1; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	33	571	582	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1159	1167		10.1016/S0896-6273(00)80142-7	http://dx.doi.org/10.1016/S0896-6273(00)80142-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663992	Bronze			2022-12-28	WOS:A1996UU11800013
J	Huang, YY; Kandel, ER				Huang, YY; Kandel, ER			Modulation of both the early and the late phase of mossy fiber LTP by the activation of beta-adrenergic receptors	NEURON			English	Article							LONG-TERM POTENTIATION; ADULT-RAT; HIPPOCAMPUS; NOREPINEPHRINE; INNERVATION; RESPONSES; INCREASES; NEURONS; MEMORY; BRAIN	cAMP and the cAMP-dependent protein kinase (PKA) are required in the messy fiber pathway for both the early and the late phase of long-term potentiation (LTP). Since the CA3 region, which is the target of the messy fibers, receives extensive noradrenergic innervation, we examined the role of beta-adrenergic receptors in messy fiber LTP. We found that we could induce an early phase of LTP by pairing isoproterenol, a beta-adrenergic receptor agonist, with a weak train, subthreshold for LTP. This LTP was specific to the messy fiber pathway, was blocked by inhibitors of PKA, and occluded paired-pulse facilitation, suggesting that isoproterenol was acting presynaptically. When isoproterenol was paired with a train that induced only the early phase of LTP, it gave rise to a protein synthesis-dependent late phase. Consistent with these findings, beta-adrenergic antagonists blocked both the late and the early phase of LTP induced by messy fiber stimulation. Thus, beta-adrenegic receptor modulation is important for both phases of messy fiber LTP.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Columbia University	Huang, YY (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32099] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CASTELLANO C, 1991, BEHAV NEURAL BIOL, V56, P283, DOI 10.1016/0163-1047(91)90439-W; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CROW TJ, 1976, NATURE, V259, P42, DOI 10.1038/259042b0; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GEREAU RW, 1994, J NEUROPHYSIOL, V72, P1438, DOI 10.1152/jn.1994.72.3.1438; GEREAU RW, 1994, J NEUROSCI, V14, P3310; GOLD PE, 1978, BEHAV BIOL, V23, P509, DOI 10.1016/S0091-6773(78)91614-0; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2448; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; MONTAGUE PR, 1995, P NATL ACAD SCI USA, V92, P2425; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; MUELLER AL, 1981, BRAIN RES, V214, P113, DOI 10.1016/0006-8993(81)90442-X; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; OLESKEVICH S, 1989, J NEUROSCI, V9, P3803; PARFITT KD, 1992, HIPPOCAMPUS, V2, P59, DOI 10.1002/hipo.450020108; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STANTON PK, 1985, BRAIN RES, V358, P343, DOI 10.1016/0006-8993(85)90981-3; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WINDER DG, 1993, J NEUROSCI, V13, P38; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167	27	162	167	3	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					611	617		10.1016/S0896-6273(00)80080-X	http://dx.doi.org/10.1016/S0896-6273(00)80080-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785058	hybrid			2022-12-28	WOS:A1996UC16800017
J	Wang, KW; Tai, KK; Goldstein, SAN				Wang, KW; Tai, KK; Goldstein, SAN			MinK residues line a potassium channel pore	NEURON			English	Article							DEPENDENT K+ CHANNEL; PROTEIN-KINASE-C; XENOPUS OOCYTES; CYSTEINE-SUBSTITUTION; MEMBRANE-PROTEIN; TEA BLOCKADE; MUTATIONS; CLONING; ISK; EXPRESSION	MinK has neither the P region nor signature sequence that characterizes pore-forming subunits of all known K+ channels. A specific minK region has now been identified that affects external blockade by 2 common probes of K+ channel pores. When mutated to cysteine, residues in this region render minK susceptible to covalent blockade by methanethiosulfonate ethylsulfonate and alter reversible inhibition by tetraethylammonium. The 2 blockers are found to share overlapping binding site determinants and to interact. Since inhibition by external tetraethylammonium is sensitive to voltage and to the internal concentration of permeant ions, we argue that tetraethylammonium blocks by occluding the external end of a water-filled transmembrane pore. These findings support the view that minK is directly involved in forming a K+-selective ion conduction pathway.	YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOYER CTR MOLEC MED,NEW HAVEN,CT 06536	Yale University	Wang, KW (corresponding author), YALE UNIV,SCH MED,DEPT PEDIAT,BOYER CTR MOLEC MED,333 CEDAR ST,NEW HAVEN,CT 06536, USA.		Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ATTALI B, 1993, NATURE, V365, P850, DOI 10.1038/365850a0; BLUMENTHAL EM, 1992, J NEUROSCI, V12, P290; BLUMENTHAL EM, 1994, J NEUROSCI, V14, P3097; BUSCH AE, 1992, J PHYSIOL-LONDON, V450, P491, DOI 10.1113/jphysiol.1992.sp019138; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; BUSCH AE, 1995, J BIOL CHEM, V270, P3638, DOI 10.1074/jbc.270.8.3638; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FREEMAN LC, 1993, CIRC RES, V73, P968, DOI 10.1161/01.RES.73.5.968; FREEMAN LC, 1994, BIOPHYS J, V66, pA143; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; HAUSDORFF SF, 1991, BIOCHEMISTRY-US, V30, P3341, DOI 10.1021/bi00227a025; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hille B., 1992, IONIC CHANNELS EXCIT; HONORE E, 1991, EMBO J, V10, P2805, DOI 10.1002/j.1460-2075.1991.tb07829.x; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LAU YT, 1988, SCIENCE, V240, P1321, DOI 10.1126/science.3375816; LESAGE F, 1993, RECEPTOR CHANNEL, V1, P143; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MARCUS DC, 1994, AM J PHYSIOL, V267, pC857, DOI 10.1152/ajpcell.1994.267.3.C857; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; MURAI T, 1989, BIOCHEM BIOPH RES CO, V161, P176, DOI 10.1016/0006-291X(89)91577-5; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; SAKAGAMI M, 1991, HEARING RES, V56, P168, DOI 10.1016/0378-5955(91)90166-7; Shimbo K, 1995, BIOPHYS J, V69, P1819, DOI 10.1016/S0006-3495(95)80052-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; SWANSON R, 1993, SEMIN NEUROSCI, V5, P117; Tai Kwok-Keung, 1996, Biophysical Journal, V70, pA151; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TZOUNOPOULOS T, 1995, P NATL ACAD SCI USA, V92, P9593, DOI 10.1073/pnas.92.21.9593; TZOUNOPOULOS T, 1995, BIOPHYS J, V69, P904, DOI 10.1016/S0006-3495(95)79964-7; VARNUM MD, 1993, P NATL ACAD SCI USA, V90, P11528, DOI 10.1073/pnas.90.24.11528; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; XU M, 1993, J BIOL CHEM, V268, P21505; YANG UY, 1995, BIOPHYS J, V68, pA22; YEH TS, 1994, BIOPHYS J, V66, pA143; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	42	79	84	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					571	577		10.1016/S0896-6273(00)80076-8	http://dx.doi.org/10.1016/S0896-6273(00)80076-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785054	hybrid, Green Published			2022-12-28	WOS:A1996UC16800013
J	Deisseroth, K; Bito, H; Tsien, RW				Deisseroth, K; Bito, H; Tsien, RW			Signaling from synapse to nucleus: Postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENES; CAMP-RESPONSIVE ELEMENT; APLYSIA SENSORY NEURONS; MESSENGER-RNA; ADENYLATE-CYCLASE; CA1 NEURONS; HAIR-CELLS; AREA CA1; CALCIUM	Phosphorylation of the transcription factor CREB is thought to be important in processes underlying long-term memory. It is unclear whether CREB phosphorylation can carry information about the sign of changes in synaptic strength, whether CREB pathways are equally activated in neurons receiving or providing synaptic input, or how synapse-to-nucleus communication is mediated. We found that Ca2+-dependent nuclear CREB phosphorylation was rapidly evoked by synaptic stimuli including, but not limited to, those that induced potentiation and depression of synaptic strength. In striking contrast, high frequency action potential firing alone failed to trigger CREB phosphorylation. Activation of a submembranous Ca2+ sensor, just beneath sites of Ca2+ entry, appears critical for triggering nuclear CREB phosphorylation via calmodulin and a Ca2+/calmodulin-dependent protein kinase.			Deisseroth, K (corresponding author), STANFORD UNIV,SCH MED,BECKMAN CTR MOLEC & GENET MED,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305, USA.		Bito, Haruhiko/A-8635-2008	Bito, Haruhiko/0000-0001-6315-9594				ABRAHAM WC, 1994, P NATL ACAD SCI USA, V91, P10049, DOI 10.1073/pnas.91.21.10049; ADLER EM, 1991, J NEUROSCI, V11, P1496; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; CACERES A, 1983, NEUROSCIENCE, V10, P449, DOI 10.1016/0306-4522(83)90145-8; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; EBIHARA S, 1993, J PHYSIOL-LONDON, V472, P689, DOI 10.1113/jphysiol.1993.sp019967; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; HUANG CF, 1994, NEURON, V13, P167, DOI 10.1016/0896-6273(94)90467-7; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IMREDY JP, 1992, NEURON, V9, P197, DOI 10.1016/0896-6273(92)90159-B; IRVING AJ, 1992, J PHYSIOL-LONDON, V456, P667, DOI 10.1113/jphysiol.1992.sp019360; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; LALLI E, 1994, J BIOL CHEM, V269, P17359; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; Lisman J, 1995, J NIH RES, V7, P43; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MACKLER SA, 1992, NEURON, V9, P539, DOI 10.1016/0896-6273(92)90191-F; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MAYFORD M, 1995, CURR OPIN NEUROBIOL, V5, P141, DOI 10.1016/0959-4388(95)80019-0; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MELLSTROM B, 1993, NEURON, V10, P655, DOI 10.1016/0896-6273(93)90167-P; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; MORI Y, 1993, J BIOL CHEM, V268, P26482; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Neher E., 1986, EXPT BRAIN RES SERIE, P80; OLSON NJ, 1995, P NATL ACAD SCI USA, V92, P1659, DOI 10.1073/pnas.92.5.1659; PETTIT DL, 1994, SCIENCE, V266, P1081; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIEGELBAUM SA, 1980, J PHYSIOL-LONDON, V299, P485, DOI 10.1113/jphysiol.1980.sp013138; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Silva Alcino J., 1994, Current Opinion in Neurobiology, V4, P413, DOI 10.1016/0959-4388(94)90104-X; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STEVENS CF, 1994, NEURON, V13, P769, DOI 10.1016/0896-6273(94)90244-5; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WORLEY PF, 1993, J NEUROSCI, V13, P4776; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	83	599	641	0	28	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					89	101		10.1016/S0896-6273(00)80026-4	http://dx.doi.org/10.1016/S0896-6273(00)80026-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562094	Bronze			2022-12-28	WOS:A1996TT30700012
J	Marrion, NV				Marrion, NV			Calcineurin regulates M channel modal gating in sympathetic neurons	NEURON			English	Article							M-CURRENTS; PROTEIN-PHOSPHORYLATION; MUSCARINIC SUPPRESSION; POTASSIUM CURRENTS; INTRACELLULAR CA2+; K+-CURRENT; INHIBITION; CELLS; IDENTIFICATION; MODULATION	The M current regulates neuronal excitability, with its amplitude resulting from high open probability modal M channel behavior. The M current is affected by changing intracellular calcium levels. It is proposed that internal calcium acts by regulating M channel modal gating. Intracellular application of a preactivated form of the calcium-dependent phosphatase calcineurin (CaN420) inhibited the macroscopic M current, while its application to excised inside-out patches reduced high open probability M channel activity. Addition of ATP reversed the action of CaN420 on excised patches. The change in M channel gating induced by CaN420 was different from the effect of muscarine. A kinetic model supports the proposition that shifts in channel gating induced by calcium-dependent phosphorylation and dephosphorylation control M current amplitude.			Marrion, NV (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.				NINDS NIH HHS [NS 29806] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029806, R29NS029806, R55NS029806] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; KIRKWOOD A, 1992, BRAIN RES, V580, P281, DOI 10.1016/0006-8993(92)90955-9; KIRKWOOD A, 1991, NEURON, V6, P1009, DOI 10.1016/0896-6273(91)90240-Z; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; MACINTOSH C, 1990, FEBS LETT, V264, P187; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MARRION NV, 1993, NEURON, V11, P77, DOI 10.1016/0896-6273(93)90272-S; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; MARRION NV, 1992, P ROY SOC B-BIOL SCI, V248, P207, DOI 10.1098/rspb.1992.0063; MUNAKATA M, 1993, J PHYSIOL-LONDON, V471, P599, DOI 10.1113/jphysiol.1993.sp019918; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SCHAFER S, 1991, PFLUG ARCH EUR J PHY, V418, P581, DOI 10.1007/BF00370575; SELYANKO AA, 1993, J PHYSIOL-LONDON, V472, P711, DOI 10.1113/jphysiol.1993.sp019968; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STANSFELD CE, 1993, NEURON, V10, P639, DOI 10.1016/0896-6273(93)90166-O; TOKIMASA T, 1995, BRIT J PHARMACOL, V114, P489, DOI 10.1111/j.1476-5381.1995.tb13253.x; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; YU SP, 1994, J NEUROSCI, V14, P3487	41	45	45	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					163	173		10.1016/S0896-6273(00)80033-1	http://dx.doi.org/10.1016/S0896-6273(00)80033-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562080	Bronze			2022-12-28	WOS:A1996TT30700019
J	Wadsworth, WG; Bhatt, H; Hedgecock, EM				Wadsworth, WG; Bhatt, H; Hedgecock, EM			Neuroglia and pioneer neurons express UNC-6 to provide global and local netrin cues for guiding migrations in C-elegans	NEURON			English	Article							CAENORHABDITIS-ELEGANS; AXON MIGRATIONS; NERVOUS-SYSTEM; GUIDES CELL; LAMININ; GUIDANCE; POLYMORPHISMS; GENETICS; PROTEIN; DOMAINS	Netrins are laminin-related proteins that guide circumferential migrations on the ectoderm. To understand how netrin cues direct cell movements, we examined the expression of nematode netrin UNC-6 from embryo to adult. UNC-6 is expressed in 12 types of neuroglia and neurons, creating a hierarchy of netrin cues in the developing nervous system. Comparing gene expression pattern with in vivo phenotypes, we suggest how multiple netrin cues, each with a characteristic role, guide cells and axons during development. We also present the molecular analysis of selective loss-of-function and null alleles. The results indicate that the biological activities of netrins are mediated through distinct protein domains. Subtle mutations in domain VI can produce selective defects in both direction- and tissue-specific guidance. EGF-like module V-2 is essential for dorsal guidance activity; we infer this module is important for interactions between UNC-6 and the dorsal guidance receptor UNC-5.	ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110; JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218	Johns Hopkins University	Wadsworth, WG (corresponding author), ROBERT WOOD JOHNSON MED SCH,DEPT PATHOL,PISCATAWAY,NJ 08854, USA.		Wadsworth, William G/N-7866-2014	Wadsworth, William G/0000-0003-3824-2948	NINDS NIH HHS [NS26295, NS33156] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033156, R56NS033156, R37NS026295, R01NS026295] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BRENNER S, 1974, GENETICS, V77, P71; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DUBBIN R, 1987, THESIS U CAMBRIDGE E; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jacobson M., 1991, DEV NEUROBIOLOGY; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Sambrook J, 1989, MOL CLONING LABORATO; SCHITTNY JC, 1990, J CELL BIOL, V110, P825, DOI 10.1083/jcb.110.3.825; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; STROME S, 1986, J EMBRYOL EXP MORPH, V97, P15; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VILLENEUVE AM, 1987, CELL, V48, P25, DOI 10.1016/0092-8674(87)90352-7; Wadsworth William G., 1992, Current Opinion in Neurobiology, V2, P36, DOI 10.1016/0959-4388(92)90159-I; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286	31	280	288	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					35	46		10.1016/S0896-6273(00)80021-5	http://dx.doi.org/10.1016/S0896-6273(00)80021-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562088	Bronze			2022-12-28	WOS:A1996TT30700007
J	Adelman, JP; Bond, CT; Pessia, M; Maylie, J				Adelman, JP; Bond, CT; Pessia, M; Maylie, J			Episodic ataxia results from voltage-dependent potassium channels with altered functions	NEURON			English	Article							K+ CHANNEL; ACETAZOLAMIDE; RECEPTOR	Episodic ataxia (EA) is an autosomal dominant human disorder that produces persistent myokymia and attacks of generalized ataxia. Recently, familial EA has been linked to the voltage-dependent delayed rectifier, Kv1.1, on chromosome 12. Six EA families have been identified that carry distinct Kv1.1 missense mutations; all individuals are heterozygous. Expression in Xenopus oocytes demonstrates that two of the EA subunits form homomeric channels with altered gating properties. V408A channels have voltage dependence similar to that bf wild-type channels, but with faster kinetics and increased C-type inactivation, while the voltage dependence of F184C channels is shifted 20 mV positive. The other four EA subunits do not produce functional homomeric channels but reduce the potassium current when coassembled with wild-type subunits. The results suggest a cellular mechanism underlying EA in which the affected nerve cells cannot efficiently repolarize following an action potential because of altered delayed rectifier function.	OREGON HLTH SCI UNIV,DEPT OBSTET & GYNECOL,PORTLAND,OR 97201	Oregon Health & Science University	Adelman, JP (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.			Pessia, Mauro/0000-0002-2857-6795				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ASHIZAWA T, 1983, ANN NEUROL, V13, P285, DOI 10.1002/ana.410130310; BOUCHARD JP, 1984, CAN J NEUROL SCI, V11, P550, DOI 10.1017/S0317167100035022; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BROWNE DL, 1995, MOL GENET, V4, P1671; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; IRANI PF, 1977, ACTA NEUROL SCAND, V55, P273, DOI 10.1111/j.1600-0404.1977.tb05647.x; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; SHEN NV, 1993, NEURON, V11, P67; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; TU LW, 1995, BIOPHYS J, V68, P147, DOI 10.1016/S0006-3495(95)80169-4; ZASORIN NL, 1983, NEUROLOGY, V33, P1212, DOI 10.1212/WNL.33.9.1212	15	185	190	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1449	1454		10.1016/0896-6273(95)90022-5	http://dx.doi.org/10.1016/0896-6273(95)90022-5			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845167	Bronze			2022-12-28	WOS:A1995TL67800022
J	QUATTROCKI, EA; MARSHALL, J; KACZMAREK, LK				QUATTROCKI, EA; MARSHALL, J; KACZMAREK, LK			A SHAB POTASSIUM CHANNEL CONTRIBUTES TO ACTION-POTENTIAL BROADENING IN PEPTIDERGIC NEURONS	NEURON			English	Article							DELAYED-RECTIFIER PROPERTIES; PROTEIN-CODING SEQUENCES; ACTIVATED K+ CHANNELS; XENOPUS OOCYTES; RAT-BRAIN; MOLECULAR MECHANISMS; APLYSIA NEURONS; MAMMALIAN BRAIN; CALCIUM CURRENT; MESSENGER-RNAS	We have cloned the gene for a potassium channel, Aplysia Shab, that is expressed in the bag cell neurons of Aplysia. The voltage dependence and kinetics of the Aplysia Shab current in oocytes match those of IK2, one of the two delayed rectifiers in these neurons. Like IK2, but in contrast with other members of the Shab subfamily, the Aplysia Shab current inactivates within several hundred milliseconds. This inactivation occurs by a process whose properties do not match those previously described for C-type and N-type mechanisms. Neither truncation of the N-terminus nor block by tetraethylammonium alters the time course of inactivation. By incorporating the characteristics of Aplysia Shab into a computational model, we have shown how this current contributes to the normal enhancement of action potentials that occurs in the bag cell neurons at the onset of neuropeptide secretion.			QUATTROCKI, EA (corresponding author), YALE UNIV, SCH MED, DEPT PHARMACOL, NEW HAVEN, CT 06510 USA.		Quattrocki, Elizabeth/D-5263-2016	Quattrocki, Elizabeth/0000-0003-1164-8606	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018492] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-18492] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P507, DOI 10.1113/jphysiol.1979.sp012828; ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P531, DOI 10.1113/jphysiol.1979.sp012829; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; BLOCH W, 1991, BIOCHEMISTRY-US, V30, P2735, DOI 10.1021/bi00225a001; BUTLER A, 1990, NUCLEIC ACIDS RES, V18, P2173, DOI 10.1093/nar/18.8.2173; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; CHIU AY, 1979, P NATL ACAD SCI USA, V76, P6656, DOI 10.1073/pnas.76.12.6656; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CONN PJ, 1989, J NEUROSCI, V9, P480; CONN PJ, 1989, MOL NEUROBIOL, V3, P237, DOI 10.1007/BF02740607; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FAWCETT TW, 1991, COMMENTS, V17, P19; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GRIBSKOV M, 1984, NUCLEIC ACIDS RES, V12, P539, DOI 10.1093/nar/12.1Part2.539; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOROWITZ SB, 1989, P NATL ACAD SCI USA, V86, P9652, DOI 10.1073/pnas.86.24.9652; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; IVERSON LE, 1990, J NEUROSCI, V10, P2903; KACZMAREK LK, 1978, P NATL ACAD SCI USA, V75, P5200, DOI 10.1073/pnas.75.10.5200; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KACZMAREK LK, 1982, BRAIN RES, V238, P105, DOI 10.1016/0006-8993(82)90774-0; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOECHNER KJ, 1990, J NEUROPHYSIOL, V63, P738, DOI 10.1152/jn.1990.63.4.738; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Maniatis T., 1982, MOL CLONING; PAK MD, 1991, J NEUROSCI, V11, P869; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; SIGEL E, 1990, J MEMBRANE BIOL, V117, P201, DOI 10.1007/BF01868451; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; STRONG JA, 1986, J NEUROSCI, V6, P814; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	53	45	45	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1994	12	1					73	86		10.1016/0896-6273(94)90153-8	http://dx.doi.org/10.1016/0896-6273(94)90153-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292361				2022-12-28	WOS:A1994MU49300007
J	CAHILL, GM; BESHARSE, JC				CAHILL, GM; BESHARSE, JC			CIRCADIAN CLOCK FUNCTIONS LOCALIZED IN XENOPUS RETINAL PHOTORECEPTORS	NEURON			English	Article							N-ACETYLTRANSFERASE; DOPAMINE-RECEPTORS; MELATONIN; EYE; PINEAL; LIGHT; RHYTHMS; SYSTEM	A circadian oscillator that regulates visual function is located somewhere within the vertebrate eye. To determine whether circadian rhythmicity is generated by retinal photoreceptors, we isolated and cultured photoreceptor layers from Xenopus retina. On average, 94% of the viable cells in these preparations were rod or cone photoreceptors. Photoreceptor layers produced melatonin rhythmically, with an average period of 24.3 hr, in constant darkness. The phase of the melatonin rhythm was reset by in vitro exposure of the photoreceptor layers to cycles of either light or quinpirole, a D2 dopamine receptor agonist. These data indicate that other parts of the eye are not necessary for generation or entrainment of retinal circadian melatonin rhythms and suggest that rod and/or cone photoreceptors are circadian clock cells.			CAHILL, GM (corresponding author), UNIV KANSAS, MED CTR, DEPT ANAT & CELL BIOL, KANSAS CITY, KS 66160 USA.				NEI NIH HHS [R01 EY002414, EY02414] Funding Source: Medline; NIMH NIH HHS [MH49757] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002414] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Besharse J.C., 1988, PROGR RETINAL RES, V7, P21; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; BESHARSE JC, 1983, EXP EYE RES, V36, P567, DOI 10.1016/0014-4835(83)90051-9; BLOCK GD, 1984, J COMP PHYSIOL, V155, P387, DOI 10.1007/BF00610592; BRANN MR, 1986, NEUROSCI LETT, V69, P221, DOI 10.1016/0304-3940(86)90483-0; CAHILL GM, 1992, VISUAL NEUROSCI, V8, P487, DOI 10.1017/S0952523800005009; CAHILL GM, 1991, J NEUROSCI, V11, P2959; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; CAHILL GM, 1990, J NEUROCHEM, V54, P716, DOI 10.1111/j.1471-4159.1990.tb01932.x; DEARRY A, 1986, J NEUROCHEM, V46, P1006, DOI 10.1111/j.1471-4159.1986.tb00612.x; IUVONE PM, 1983, BRAIN RES, V273, P111, DOI 10.1016/0006-8993(83)91099-5; KAPLAN MW, 1990, INVEST OPHTH VIS SCI, V31, P1; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MENAKER M, 1983, P NATL ACAD SCI-BIOL, V80, P6119, DOI 10.1073/pnas.80.19.6119; MURESAN Z, 1993, IN PRESS J COMP NEUR; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; PIERCE ME, 1985, J GEN PHYSIOL, V86, P671, DOI 10.1085/jgp.86.5.671; Pittendrigh C, 1981, HDB BEHAVIORAL NEURO, V4, P57; REME CE, 1991, J BIOL RHYTHM, V6, P5, DOI 10.1177/074873049100600104; SCHUTTE M, 1991, J NEUROCYTOL, V20, P195, DOI 10.1007/BF01186992; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; TAKAHASHI JS, 1989, RECENT PROG HORM RES, V45, P279; UNDERWOOD H, 1990, J BIOL RHYTHM, V5, P257, DOI 10.1177/074873049000500307; WIECHMANN AF, 1986, EXP EYE RES, V42, P507, DOI 10.1016/0014-4835(86)90042-4	24	262	263	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1993	10	4					573	577		10.1016/0896-6273(93)90160-S	http://dx.doi.org/10.1016/0896-6273(93)90160-S			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476609				2022-12-28	WOS:A1993KY50100002
J	GRAYKELLER, MP; POLANS, AS; PALCZEWSKI, K; DETWILER, PB				GRAYKELLER, MP; POLANS, AS; PALCZEWSKI, K; DETWILER, PB			THE EFFECT OF RECOVERIN-LIKE CALCIUM-BINDING PROTEINS ON THE PHOTORESPONSE OF RETINAL RODS	NEURON			English	Article							PHOTORECEPTOR GUANYLATE-CYCLASE; OUTER SEGMENTS; SALAMANDER RODS; PURIFICATION; LIGHT; EXCITATION; CELLS	The rod photoresponse is triggered by an enzyme cascade that stimulates cGMP hydrolysis. The resulting fall in cGMP leads to a decrease in Ca2+, which promotes photoresponse recovery by activating guanylate cyclase, causing cGMP resynthesis. In vitro biochemical studies suggest that Ca2+ activation of guanylate cyclase is mediated by recoverin, a 26 kd Ca2+-binding protein. To evaluate this, exogenous bovine recoverin and two other homologous Ca2+-binding proteins from chicken and Gecko retina were dialyzed into functionally intact Gecko rods using whole-cell recording. All three proteins prolonged the rising phase of the photoresponse without affecting the kinetics of response recovery. These results suggest that recoverin-like proteins affect termination of the transduction cascade, rather than mediate Ca2+-sensitive activation of guanylate cyclase.	GOOD SAMARITAN HOSP, RS DOW NEUROL SCI INST, PORTLAND, OR 97209 USA; UNIV WASHINGTON, SCH MED, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, SCH MED, DEPT PHARMACOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	GRAYKELLER, MP (corresponding author), UNIV WASHINGTON, SCH MED, DEPT PHYSIOL & BIOPHYS, SEATTLE, WA 98195 USA.			Detwiler, Peter/0000-0003-3910-2023	NEI NIH HHS [T32-EY07031, EY08061, EY07089] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY007089, T32EY007031, R29EY008061, R01EY008061, R01EY007089] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; BIERNBAUM MS, 1985, J GEN PHYSIOL, V85, P83, DOI 10.1085/jgp.85.1.83; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; DEDMAN JR, 1983, METHOD ENZYMOL, V102, P1; DIZHOOR AM, 1989, BIOCHEM BIOPH RES CO, V162, P544, DOI 10.1016/0006-291X(89)92031-7; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; HAGINS WA, 1974, EXP EYE RES, V18, P299, DOI 10.1016/0014-4835(74)90157-2; HAKKI S, 1990, BIOCHEMISTRY-US, V29, P1088, DOI 10.1021/bi00456a035; HATAKENAKA S, 1985, BRAIN RES, V331, P209, DOI 10.1016/0006-8993(85)91546-X; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; HAYASHI F, 1993, IN PRESS METH NEUROS; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1992, BIOCHEM BIOPH RES CO, V186, P411, DOI 10.1016/S0006-291X(05)80823-X; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; KUNO T, 1992, BIOCHEM BIOPH RES CO, V184, P1219, DOI 10.1016/S0006-291X(05)80012-9; KUTUZOV MA, 1991, FEBS LETT, V293, P21, DOI 10.1016/0014-5793(91)81143-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; MCNAUGHTON PA, 1986, NATURE, V322, P261, DOI 10.1038/322261a0; MCNAUGHTON PA, 1990, PHYSIOL REV, V70, P847, DOI 10.1152/physrev.1990.70.3.847; MILAM AH, 1992, VISUAL NEUROSCI, V10, P1; OKAZAKI K, 1992, BIOCHEM BIOPH RES CO, V185, P147, DOI 10.1016/S0006-291X(05)80968-4; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; PALCZEWSKI K, 1993, IN PRESS METH NEUROS; PALCZEWSKI K, 1990, BIOCHEMISTRY-US, V29, P6267; PANNBACKER RG, 1973, SCIENCE, V182, P1138, DOI 10.1126/science.182.4117.1138; PEPE IM, 1986, FEBS LETT, V203, P73, DOI 10.1016/0014-5793(86)81439-9; POLANS AS, 1993, INVEST OPHTH VIS SCI, V34, P81; POLANS AS, 1991, J CELL BIOL, V112, P981, DOI 10.1083/jcb.112.5.981; RATTO GM, 1988, J NEUROSCI, V8, P3240; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; RISPOLI G, 1990, NATO ADV SCI I A-LIF, V194, P157; RISPOLI G, 1993, IN PRESS J PHYSL; RISPOLI G, 1992, SIGNAL TRANSDUCTION, P217; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SATHEL WA, 1988, THESIS U WASHINGTON; STRYER L, 1991, J BIOL CHEM, V266, P10711; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TAKAMATSU K, 1992, BIOCHEM BIOPH RES CO, V183, P245, DOI 10.1016/0006-291X(92)91635-4; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; Yoshikami S., 1973, BIOCH PHYSL VISUAL P, P245	49	157	157	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR	1993	10	3					523	531		10.1016/0896-6273(93)90339-S	http://dx.doi.org/10.1016/0896-6273(93)90339-S			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461139				2022-12-28	WOS:A1993KU90100016
J	SEEGER, M; TEAR, G; FERRESMARCO, D; GOODMAN, CS				SEEGER, M; TEAR, G; FERRESMARCO, D; GOODMAN, CS			MUTATIONS AFFECTING GROWTH CONE GUIDANCE IN DROSOPHILA - GENES NECESSARY FOR GUIDANCE TOWARD OR AWAY FROM THE MIDLINE	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; AXON PATHWAYS; EMBRYONIC-DEVELOPMENT; NUCLEAR-PROTEIN; LARVAL CUTICLE; RETINAL AXONS; ZYGOTIC LOCI; FASCICLIN-I; FLOOR PLATE; PATTERN	We performed a large-scale screen for mutations that affect the development of CNS axon pathways in the Drosophila embryo. We screened embryos from over 13,500 balanced lines and saved over 250 mutant lines whose phenotypes suggest possible defects in growth cone guidance. Here we focus on two new genes: commissureless (comm) and roundabout (robo). Mutations in comm lead to an absence of nearly all CNS axon commissures, such that growth cones that normally project across the midline instead now extend only on their own side. Mutations in robo lead to the opposite misrouting, such that some growth cones that normally extend only on their own side instead now project across the midline. The phenotypes of these two genes suggest that they may encode components of attractive and repulsive signaling systems at the midline that either guide growth cones across the midline or keep them on their own side.			SEEGER, M (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.		Tear, Guy/C-5444-2009; Ferres-Marco, Maria/G-8364-2015	Ferres-Marco, Maria/0000-0002-0596-4891	NINDS NIH HHS [NS18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BERNHARDT RR, 1990, J COMP NEUROL, V302, P607; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Bixby J L, 1992, Curr Opin Neurobiol, V2, P66, DOI 10.1016/0959-4388(92)90164-G; BRENNER S, 1974, GENETICS, V77, P71; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GOODMAN CS, 1993, DEV DROSOPHILA; GREENINGLOH G, 1991, CELL, V67, P45; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; JACOBS JR, 1989, NEURON, V2, P1625; JACOBS JR, 1989, J NEUROSCI, V9, P2412; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; Keynes R J, 1992, Curr Opin Neurobiol, V2, P55, DOI 10.1016/0959-4388(92)90162-E; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MOORMAN SJ, 1990, J NEUROSCI, V10, P3158; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PLACZEK M, 1990, DEVELOPMENT, V110, P19; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; ROBERTSON HM, 1988, GENETICS, V118, P461; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; STRETAVAN DW, 1990, J NEUROSCI, V10, P1995; Tessier-Lavigne M, 1992, Curr Opin Neurobiol, V2, P60, DOI 10.1016/0959-4388(92)90163-F; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; WALTER J, 1987, DEVELOPMENT, V101, P909; WIESCHAUS E, 1984, W ROUX ARCH DEV BIOL, V193, P283; YAGINUMA H, 1991, J NEUROSCI, V11, P2598	54	586	600	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					409	426		10.1016/0896-6273(93)90330-T	http://dx.doi.org/10.1016/0896-6273(93)90330-T			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461134				2022-12-28	WOS:A1993KU90100007
J	YANG, J; TSIEN, RW				YANG, J; TSIEN, RW			ENHANCEMENT OF N-TYPE AND L-TYPE CALCIUM-CHANNEL CURRENTS BY PROTEIN-KINASE-C IN FROG SYMPATHETIC NEURONS	NEURON			English	Article							HIPPOCAMPAL-NEURONS; PHORBOL ESTERS; TRANSMITTER RELEASE; PERIPHERAL NEURONS; OMEGA-CONOTOXIN; CA-2+ CHANNELS; RAT; ACTIVATION; MODULATION; PHOSPHORYLATION	The effect of protein kinase C (PKC) stimulation on Ca2+ channels was studied in frog sympathetic neurons. 12,13-Phorbol dibutyrate (PDBu) consistently augmented Ca2+ channel currents in whole-cell recordings. This enhancement was blocked by staurosporine and PKC(19-31), but not produced by 4alpha-phorbol 12,13-didecanoate, indicating that PDBu acts via PKC. Both N- and L-type currents, as isolated pharmacologically, were increased. PKC enhancement was independent of the extent of G protein activation, indicating that it was not caused by removal of tonic G protein inhibition. In unitary recordings PDBu produced dramatic increases in single N- and L-type channel activity by sharply decreasing closed time intervals between adjacent openings, but did not alter the unitary current size or mean open time. This up-modulation by PKC may constitute a positive feedback mechanism in the regulation of neuronal Ca2+ channel activity.			YANG, J (corresponding author), STANFORD UNIV, DEPT MOLEC & CELLULAR PHYSIOL, STANFORD, CA 94305 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS24067] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; ARTALEJO CR, 1990, NATURE, V348, P239, DOI 10.1038/348239a0; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, J NEUROSCI, V10, P1922; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; BOLAND LM, 1991, J NEUROSCI, V11, P1140; BOLAND LM, 1993, IN PRESS J NEUROSCI; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; CHANG CF, 1991, J BIOL CHEM, V266, P16395; DELCOUR A, 1993, IN PRESS SCIENCE; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DOERNER D, 1990, J NEUROSCI, V10, P1699; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FISHER R, 1990, J NEUROPHYSIOL, V64, P1291, DOI 10.1152/jn.1990.64.4.1291; FRIEL DD, 1992, NEURON, V8, P1109, DOI 10.1016/0896-6273(92)90132-W; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; GURNEY AM, 1989, NATURE, V341, P65, DOI 10.1038/341065a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOCKBERGER P, 1989, NATURE, V338, P340, DOI 10.1038/338340a0; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; JAHN H, 1988, EUR J BIOCHEM, V178, P535, DOI 10.1111/j.1432-1033.1988.tb14480.x; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; JONES SW, 1990, J NEUROSCI, V10, P2261; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; KACZMAREK LK, 1987, NEUROMODULATION BIOC, P286; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; LACERDA AE, 1988, NATURE, V335, P249, DOI 10.1038/335249a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MARBAN E, 1982, J PHYSIOL-LONDON, V329, P589, DOI 10.1113/jphysiol.1982.sp014321; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; MCCARRON JG, 1992, NATURE, V357, P74, DOI 10.1038/357074a0; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RYU PD, 1990, J NEUROPHYSIOL, V63, P273, DOI 10.1152/jn.1990.63.2.273; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; SEKIGUCHI K, 1988, J BIOCHEM-TOKYO, V103, P759, DOI 10.1093/oxfordjournals.jbchem.a122343; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VIVAUDOU MB, 1988, FASEB J, V2, P2497, DOI 10.1096/fasebj.2.9.2453389; WAKADE AR, 1985, N-S ARCH PHARMACOL, V331, P122, DOI 10.1007/BF00498863; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753	54	165	171	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1993	10	2					127	136		10.1016/0896-6273(93)90305-B	http://dx.doi.org/10.1016/0896-6273(93)90305-B			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382496				2022-12-28	WOS:A1993KP68500002
J	OMalley, DM; Kao, YH; Fetcho, JR				OMalley, DM; Kao, YH; Fetcho, JR			Imaging the functional organization of zebrafish hindbrain segments during escape behaviors	NEURON			English	Article							CHICK-EMBRYO HINDBRAIN; MAUTHNER CELL; SPINAL-CORD; RETICULOSPINAL NEURONS; CALCIUM TRANSIENTS; GOLDFISH; VISUALIZATION; ACTIVATION; RESPONSES; PATHWAYS	Although vertebrate hindbrains are segmented structures, the functional significance of the segmentation is unknown. In zebrafish, the hindbrain segments contain serially repeated classes of individually identifiable neurons. We took advantage of the transparency of larval zebrafish and used confocal calcium imaging in the intact fish to study the activity of one set of individually identified, serially homologous reticulospinal cells (the Mauthner cell, MiD2cm, and MiD3cm) during behavior. Behavioral studies predicted that differential activity in this set of serially homologous neurons might serve to control the directionality of the escape behavior that fish use to avoid predators. We found that the serially homologous cells are indeed activated during escapes and that the combination of cells activated depends upon the location of the sensory stimulus used to elicit the escape. The patterns of activation we observed were exactly those predicted by behavioral studies. The data suggest that duplication of ancestral hindbrain segments, and subsequent functional diversification, resulted in sets of related neurons whose activity patterns create behavioral variability.	SUNY STONY BROOK,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026539, U24NS109113, F32NS009113, R29NS026539, R01NS026539] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS026539-25, NS26539, R01 NS026539, NS09113] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; CRUCE WLR, 1984, AM ZOOL, V24, P733; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; EATON RC, 1991, J EXP BIOL, V161, P469; EATON RC, 1991, BRAIN BEHAV EVOLUT, V37, P272, DOI 10.1159/000114365; EATON RC, 1975, J NEUROPHYSIOL, V38, P502, DOI 10.1152/jn.1975.38.3.502; EATON RC, 1982, J COMP PHYSIOL, V145, P485, DOI 10.1007/BF00612814; EATON RC, 1984, J COMP PHYSIOL, V155, P813, DOI 10.1007/BF00611598; FABER DS, 1991, BRAIN BEHAV EVOLUT, V37, P286, DOI 10.1159/000114366; FABER DS, 1989, ANN NY ACAD SCI, V563, P11, DOI 10.1111/j.1749-6632.1989.tb42187.x; FEATHERSTONE D, 1991, J EXP BIOL, V158, P583; FETCHO JR, 1988, J NEUROSCI, V8, P4192; FETCHO JR, 1995, J NEUROPHYSIOL, V73, P399, DOI 10.1152/jn.1995.73.1.399; FOREMAN MB, 1993, J NEUROSCI, V13, P4101; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GUTHRIE S, 1995, TRENDS NEUROSCI, V18, P74, DOI 10.1016/0166-2236(95)80027-Y; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; LEE RKK, 1991, J COMP NEUROL, V304, P34; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MCCLELLAN AD, 1994, BRAIN RES, V663, P61, DOI 10.1016/0006-8993(94)90462-6; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; MORTON DW, 1994, TRENDS NEUROSCI, V17, P413, DOI 10.1016/0166-2236(94)90015-9; MULLINS MC, 1993, CURR OPIN GENET DEV, V3, P648, DOI 10.1016/0959-437X(93)90102-U; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; ODONOVAN MJ, 1993, J NEUROSCI METH, V46, P91, DOI 10.1016/0165-0270(93)90145-H; OMALLEY DM, 1994, J NEUROSCI, V14, P5741; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; SOBIERAJSKI LM, 1995, IEEE COMPUT GRAPH, V15, P55, DOI 10.1109/38.391491; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WINE JJ, 1972, J EXP BIOL, V56, P1; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; ZOTTOLI SJ, 1977, J EXP BIOL, V66, P243	38	229	233	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1145	1155		10.1016/S0896-6273(00)80246-9	http://dx.doi.org/10.1016/S0896-6273(00)80246-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982162	Bronze			2022-12-28	WOS:A1996WA24800012
J	Prokop, A; Landgraf, M; Rushton, E; Broadie, K; Bate, M				Prokop, A; Landgraf, M; Rushton, E; Broadie, K; Bate, M			Presynaptic development at the Drosophila neuromuscular junction: Assembly and localization of presynaptic active zones	NEURON			English	Article							CELL-ADHESION MOLECULE; TRANSCRIPTION FACTOR; SYNAPTIC CONNECTIONS; MUSCLE DEVELOPMENT; GROWTH CONES; GENE; RECEPTOR; LARVAL; DIFFERENTIATION; EMBRYOGENESIS	We describe the extent to which presynaptic structures at the embryonic neuromuscular junction of Drosophila can form in mutants where development of postsynaptic somatic muscles is affected. Although twist mutant embryos lack mesoderm, motor axons still grow out of the CNS and form morphologically normal presynaptic active zones, independent of their target cells. In myoblast city mutant embryos, myoblasts do not fuse but form fully differentiated mononucleate muscles, which make functional neuromuscular synapses with correctly localized presynaptic active tones. Myoblasts also fail to fuse but still attract appropriate innervation in mef2 mutant embryos. However, these myoblasts fail to differentiate into muscles and presynaptic active zones fail to localize at neuromuscular contacts. Thus, the process of synapse formation can be genetically separated from the process of target recognition, revealing that localization of presynaptic active zones requires mef2-dependent muscle differentiation.			Prokop, A (corresponding author), UNIV CAMBRIDGE,DEPT ZOOL,DOWNING ST,CAMBRIDGE CB2 3EJ,ENGLAND.			Landgraf, Matthias/0000-0001-5142-1997; Prokop, Andreas/0000-0001-8482-3298	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BALLEY CH, 1993, ANN REV PHYSL, V55, P397; BATE M, 1993, DEVELOPMENT, P149; BATE M, 1995, NEURON, V15, P513, DOI 10.1016/0896-6273(95)90141-8; BATE M, 1990, DEVELOPMENT, V110, P791; Bate Michael, 1993, P1013; BAYLIES MK, 1995, DEVELOPMENT, V121, P3829; BINNINGTON KC, 1982, TISSUE CELL, V14, P463, DOI 10.1016/0040-8166(82)90040-4; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROADIE KS, 1994, J PHYSIOLOGY-PARIS, V88, P123, DOI 10.1016/0928-4257(94)90023-X; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; BURROWS M, 1989, EUR J NEUROSCI, V1, P111, DOI 10.1111/j.1460-9568.1989.tb00778.x; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CASH S, 1992, J NEUROSCI, V12, P2051; CHIBA A, 1993, J NEUROSCI, V13, P714; CURRIE DA, 1995, DEV DYNAM, V203, P311, DOI 10.1002/aja.1002030303; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; GALEY FR, 1966, J ULTRA MOL STRUCT R, V14, P405, DOI 10.1016/S0022-5320(66)80057-6; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Goodman Corey S., 1993, P1131; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HALPERN ME, 1991, J NEUROSCI, V11, P3227; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; KIDOKORO Y, 1994, NEUROSCI RES, V19, P143, DOI 10.1016/0168-0102(94)90137-6; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; MEADOWS LA, 1994, J CELL SCI, V107, P321; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V192, P267; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Prokop Andreas, 1993, P33; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; Schulz RA, 1996, ONCOGENE, V12, P1827; SEECOF RL, 1972, P NATL ACAD SCI USA, V69, P566, DOI 10.1073/pnas.69.3.566; SHAW SR, 1986, P NATL ACAD SCI USA, V83, P7961, DOI 10.1073/pnas.83.20.7961; SIMPSON P, 1983, GENETICS, V105, P615; Stewart BA, 1996, J NEUROSCI, V16, P3877; TAYLOR MV, 1995, CURR BIOL, V5, P740, DOI 10.1016/S0960-9822(95)00149-7; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	57	109	109	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					617	626		10.1016/S0896-6273(00)80195-6	http://dx.doi.org/10.1016/S0896-6273(00)80195-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893020	Bronze			2022-12-28	WOS:A1996VP74300008
J	Renstrom, E; Ding, WG; Bokvist, K; Rorsman, P				Renstrom, E; Ding, WG; Bokvist, K; Rorsman, P			Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin	NEURON			English	Article							PANCREATIC B-CELLS; ADRENAL CHROMAFFIN CELLS; FREE CA-2+ CONCENTRATION; G-PROTEIN; ACTION-POTENTIALS; CALCIUM CURRENTS; CA2+ CHANNELS; OKADAIC ACID; RELEASE; MEMBRANE	Neurotransmitters and hormones such as somatostatin, galanin, and adrenalin reduce insulin secretion. Their inhibitory action involves direct interference with the exocytotic machinery. We have examined the molecular processes underlying this effect using high resolution measurements of cell capacitance. Suppression of exocytosis was maximal at concentrations that did not cause complete inhibition of glucose-stimulated electrical activity. This action was dependent on activation of G proteins but was not associated with inhibition of the voltage-dependent Ca2+ currents or adenylate cyclase activity. The molecular processes initiated by the agonists culminate in the activation of the Ca2+-dependent protein phosphatase calcineurin, and suppression of the activity of this enzyme abolishes their action on exocytosis. We propose that mechanisms similar to those we report here may contribute to adrenergic and peptidergic inhibition of secretion in other neuroendocrine cells and in nerve terminals.			Renstrom, E (corresponding author), NOVO NORDISK AS,DEPT ISLET CELL PHYSIOL,SYMB SCI PK,FRUEBJERGVEJ 3,DK-2100 COPENHAGEN,DENMARK.		Rorsman, Patrik/A-4331-2016; Tuluc, Petronel/C-2527-2011	Rorsman, Patrik/0000-0001-7578-0767; 				AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BOKVIST K, 1991, BIOSCIENCE REP, V11, P147, DOI 10.1007/BF01182483; CHEN C, 1992, GROWTH REGULAT, V2, P167; CHEN C, 1994, TRENDS ENDOCRIN MET, V5, P227, DOI 10.1016/1043-2760(94)P3080-Q; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COOK DL, 1982, DIABETES, V31, P985, DOI 10.2337/diabetes.31.11.985; DEBUYSER A, 1991, PFLUG ARCH EUR J PHY, V419, P131, DOI 10.1007/BF00372998; DREWS G, 1990, ENDOCRINOLOGY, V126, P1646, DOI 10.1210/endo-126-3-1646; DREWS G, 1994, MOL CELL ENDOCRINOL, V105, P97, DOI 10.1016/0303-7207(94)90040-X; ENAN E, 1992, PESTIC SCI, V37, P21; GALINDO E, 1992, P NATL ACAD SCI USA, V89, P7398, DOI 10.1073/pnas.89.16.7398; GILLISON SL, 1994, INSULIN SECRETION PA, P287; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HENQUIN JC, 1984, EXPERIENTIA, V40, P1043, DOI 10.1007/BF01971450; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HOMAIDAN FR, 1991, P NATL ACAD SCI USA, V88, P8744, DOI 10.1073/pnas.88.19.8744; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOWELL SL, 1991, TXB DIABETES, P72; HSU WH, 1991, J BIOL CHEM, V266, P837; ISHIBASHI H, 1995, J NEUROPHYSIOL, V74, P1028, DOI 10.1152/jn.1995.74.3.1028; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KEAHEY HH, 1990, AM J PHYSIOL, V357, pC1171; NEER EJ, 1988, NATURE, V333, P129, DOI 10.1038/333129a0; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; NILSSON T, 1989, J BIOL CHEM, V264, P973; NILSSON T, 1988, J BIOL CHEM, V263, P1855; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RASMUSSEN H, 1990, DIABETES CARE, V13, P655, DOI 10.2337/diacare.13.6.655; RORSMAN P, 1988, J GEN PHYSIOL, V91, P223, DOI 10.1085/jgp.91.2.223; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; RORSMAN P, 1986, J PHYSIOL-LONDON, V374, P531, DOI 10.1113/jphysiol.1986.sp016096; SAKURA H, 1995, DIABETOLOGIA, V38, pA111; SEAQUIST ER, 1992, DIABETES, V41, P1390, DOI 10.2337/diabetes.41.11.1390; SHARP GWG, 1989, J BIOL CHEM, V264, P7302; SWAIN JE, 1991, J NEUROBIOL, V22, P855, DOI 10.1002/neu.480220806; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; ULLRICH S, 1989, FEBS LETT, V247, P401, DOI 10.1016/0014-5793(89)81379-1; ULLRICH S, 1988, J BIOL CHEM, V263, P8615; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WAHLANDER K, 1991, WENNER GREN INT S SE, V8, P237	48	148	149	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					513	522		10.1016/S0896-6273(00)80183-X	http://dx.doi.org/10.1016/S0896-6273(00)80183-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816714	Bronze			2022-12-28	WOS:A1996VJ44000017
J	Muller, BM; Kistner, U; Kindler, S; Chung, WJ; Kuhlendahl, S; Fenster, SD; Lau, LF; Veh, RW; Huganir, RL; Gundelfinger, ED; Garner, CC				Muller, BM; Kistner, U; Kindler, S; Chung, WJ; Kuhlendahl, S; Fenster, SD; Lau, LF; Veh, RW; Huganir, RL; Gundelfinger, ED; Garner, CC			SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; RAT-BRAIN; SYNAPTIC LOCALIZATION; DENSITY FRACTION; K+ CHANNELS; DROSOPHILA; MEMBRANE; HOMOLOG; DOMAINS; SAP90	Synapse-associated proteins (SAPs) are constituents of the pre- and postsynaptic submembraneous cytomatrix. Here, we present SAP102, a novel 102 kDa SAP detected in dendritic shafts and spines of asymmetric type 1 synapses. SAP102 is enriched in preparations of synaptic junctions, where it biochemically behaves as a component of the cortical cytoskeleton. Antibodies directed against NMDA receptors coimmunoprecipitate SAP102 from rat brain synaptosomes. Recombinant proteins containing the carboxy-terminal tail of NMDA receptor subunit NR2B interact with SAP102 from rat brain homogenates. All three PDZ domains in SAP102 bind the cytoplasmic tail of NR2B in vitro. These data represent direct evidence that in vivo SAP102 is involved in linking NMDA receptors to the submembraneous cytomatrix associated with postsynaptic densities at excitatory synapses.	UNIV ALABAMA,NEUROBIOL RES CTR,BIRMINGHAM,AL 35213; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205; UNIV HAMBURG,INST CELLULAR BIOCHEM & CLIN NEUROBIOL,D-22529 HAMBURG,GERMANY; INST NEUROBIOL,D-39008 MAGDEBURG,GERMANY; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510	University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; Johns Hopkins University; University of Hamburg; Leibniz Institut fur Neurobiologie (LIN); Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Muller, BM (corresponding author), UNIV HAMBURG,CTR MOL NEUROBIOL,D-20246 HAMBURG,GERMANY.			Garner, Craig/0000-0003-1970-5417; Fenster, Steven/0000-0002-4470-8145	NICHD NIH HHS [P50 HD32901] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD032901] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CARBONETTO S, 1995, CURR OPIN NEUROBIOL, V5, P596, DOI 10.1016/0959-4388(95)80064-6; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Hunt CA, 1996, J NEUROSCI, V16, P1380; HUNTLEY CW, 1994, TRENDS NEUROSCI, V17, P536; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1995, FEBS LETT, V359, P159, DOI 10.1016/0014-5793(95)00030-D; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1995, SCIENCE, V269, P1737; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LANDIS DMD, 1988, INTRINSIC DETERMINAN, P201; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MCPHERSON PS, 1994, P NATL ACAD SCI USA, V91, P6486, DOI 10.1073/pnas.91.14.6486; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1996, J NEUROSCI, V16, P2157; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; SAHYOUN N, 1985, BIOCHEM BIOPH RES CO, V132, P878, DOI 10.1016/0006-291X(85)91889-3; Sambrook J., 2002, MOL CLONING LAB MANU; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	34	356	359	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					255	265		10.1016/S0896-6273(00)80157-9	http://dx.doi.org/10.1016/S0896-6273(00)80157-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780649	Bronze			2022-12-28	WOS:A1996VE84000008
J	Clapham, DE				Clapham, DE			TRP is cracked but is CRAC TRP?	NEURON			English	Review							CELLS				Clapham, DE (corresponding author), MAYO CLIN & MAYO FDN,200 1ST ST SW,ROCHESTER,MN 55905, USA.		Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428				BENNETT DL, 1995, CURR BIOL, V5, P1225, DOI 10.1016/S0960-9822(95)00243-0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Hardie RC, 1996, J NEUROSCI, V16, P2924; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; PUTNEY JW, 1977, J PHYSIOL-LONDON, V268, P139, DOI 10.1113/jphysiol.1977.sp011851; RANGANATHAN R, 1994, NEURON, V13, P837, DOI 10.1016/0896-6273(94)90250-X; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	15	75	76	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1069	1072		10.1016/S0896-6273(00)80132-4	http://dx.doi.org/10.1016/S0896-6273(00)80132-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663982	Bronze			2022-12-28	WOS:A1996UU11800003
J	ElShamy, WM; Ernfors, P				ElShamy, WM; Ernfors, P			A local action of neurotrophin-3 prevents the death of proliferating sensory neuron precursor cells	NEURON			English	Article							NERVE GROWTH-FACTOR; EXPRESSING MESSENGER-RNA; TYROSINE KINASE RECEPTOR; AFFINITY NGF RECEPTOR; DORSAL-ROOT GANGLION; FACTOR FAMILY; MOLECULAR-CLONING; TRK PROTOONCOGENE; SYMPATHETIC NEURONS; SPINAL GANGLIA	The role of neurotrophin-3 (NT-3) in early development of the dorsal root ganglion was investigated. Excessive cell death in the dorsal root ganglion of mice that carry a deleted NT-3 gene (NT-3(-/-) mice) preceded the period of programmed cell death, detected by the TUNEL method, and caused a reduction in the number of proliferating precursors without altering the proportion of proliferating cells to total number of neurons. Furthermore, the majority of proliferating cells detected by bromodeoxyuridine incorporation also stained with the TUNEL method. NT-3 mRNA was expressed locally in the embryonic, but not the postnatal dorsal root ganglion. Most cultured early embryonic NT-3(-/-) neurons died in the absence of exogenous NT-3 as did the wild-type neurons when cultured with NT-3 neutralizing antibodies, suggesting that NT-3 acts locally to prevent the death of proliferating sensory precursor cells during neurogenesis. Thus, NT-3 may inflict constraints on the number of proliferating precursor cells and thereby affect the number of neurons generated during development of the peripheral nervous system.			ElShamy, WM (corresponding author), KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,MOLEC NEUROBIOL LAB,DOKTORSRINGEN 12A,S-17177 STOCKHOLM,SWEDEN.		ElShamy, Wael M./L-1090-2018; ElShamy, Wael/AAF-2867-2019	Ernfors, Patrik/0000-0002-1140-3986				ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; CARR PA, 1993, BRAIN RES BULL, V30, P209, DOI 10.1016/0361-9230(93)90246-8; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DECHANT G, 1993, J NEUROSCI, V13, P2610, DOI 10.1523/JNEUROSCI.13-06-02610.1993; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; Elshamy WM, 1996, DEVELOPMENT, V122, P491; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; EVAN GI, 1995, CURR OPIN CELL BIOL, V7, P825, DOI 10.1016/0955-0674(95)80066-2; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; GAESE F, 1994, DEVELOPMENT, V120, P1613; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GOLDSTEIN RS, 1990, P NATL ACAD SCI USA, V87, P4476, DOI 10.1073/pnas.87.12.4476; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HAMBURGER V, 1981, J NEUROSCI, V1, P60, DOI 10.1523/JNEUROSCI.01-01-00060.1981; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; IBANEZ CF, 1993, DEVELOPMENT, V117, P1345; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1990, DEVELOPMENT, V109, P845; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MCMILLANCARR V, 1978, J COMP NEUROL, V182, P727; MEMBERG SP, 1995, MOL CELL NEUROSCI, V6, P323, DOI 10.1006/mcne.1995.1025; MU XJ, 1993, J NEUROSCI, V13, P4029; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; OPPENHEIM RW, 1989, DEV BIOL, V133, P468, DOI 10.1016/0012-1606(89)90050-X; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; ROHRER H, 1987, J NEUROSCI, V7, P3739; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHOMCZYSKI P, 1987, ANAL BIOCHEM, V162, P156; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; ZHOU XF, 1994, BRAIN RES, V643, P162, DOI 10.1016/0006-8993(94)90022-1	69	80	80	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					963	972		10.1016/S0896-6273(00)80119-1	http://dx.doi.org/10.1016/S0896-6273(00)80119-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630254	Bronze			2022-12-28	WOS:A1996UN48000011
J	Goldstein, SAN; Colatsky, TJ				Goldstein, SAN; Colatsky, TJ			Ion channels: Too complex for rational drug design?	NEURON			English	Review							GLUTAMATE		WYETH AYERST RES,DIV CARDIOVASC & METAB DIS,ION CHANNEL RES GRP,PRINCETON,NJ 08543	Pfizer	Goldstein, SAN (corresponding author), YALE UNIV,SCH MED,BOYER CTR MOLEC MED,DEPT PEDIAT,DEPT CELLULAR & MOL PHYSIOL,333 CEDAR ST,NEW HAVEN,CT 06536, USA.		Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; Ammala C, 1996, NATURE, V379, P545, DOI 10.1038/379545a0; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; EGEBJERG J, 1994, P NATL ACAD SCI USA, V91, P10270, DOI 10.1073/pnas.91.22.10270; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOCKERMAN GH, 1995, J BIOL CHEM, V270, P22119, DOI 10.1074/jbc.270.38.22119; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; INAGAKI N, 1996, NEURON, V16; INAGAKI N, 1995, SCIENCE, V270, P1160; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; *LQTS SADS FDN TAS, 1996, IN PRESS CIRCULATION; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; Miller AG, 1996, NEURON, V16, P853, DOI 10.1016/S0896-6273(00)80105-1; MITRA AK, 1995, NAT STRUCT BIOL, V2, P726, DOI 10.1038/nsb0995-726; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; NICHOLS CG, 1996, IN PRESS SCIENCE; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; PHILIPSON LH, 1994, J BIOL CHEM, V269, P27787; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; SUN JP, 1995, J PHARMACOL EXP THER, V274, P419; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; WALZ T, 1995, NAT STRUCT BIOL, V2, P730, DOI 10.1038/nsb0995-730; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; WORLEY JF, 1994, J BIOL CHEM, V269, P32055; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	49	18	18	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					913	919		10.1016/S0896-6273(00)80114-2	http://dx.doi.org/10.1016/S0896-6273(00)80114-2			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630249	Green Published, hybrid			2022-12-28	WOS:A1996UN48000006
J	Sereda, M; Griffiths, I; Puhlhofer, A; Stewart, H; Rossner, MJ; Zimmermann, F; Magyar, JP; Schneider, A; Hund, E; Meinck, HM; Suter, U; Nave, KA				Sereda, M; Griffiths, I; Puhlhofer, A; Stewart, H; Rossner, MJ; Zimmermann, F; Magyar, JP; Schneider, A; Hund, E; Meinck, HM; Suter, U; Nave, KA			A transgenic rat model of Charcot-Marie-Tooth disease	NEURON			English	Article							ARREST-SPECIFIC GENE; PERIPHERAL MYELIN; POINT MUTATION; GROWTH ARREST; NERVE-CONDUCTION; SCHWANN-CELLS; PMP22 GENE; TYPE-1A; PROTEIN; DUPLICATION	Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy in humans and has been associated with a partial duplication of chromosome 17 (CMT type 1A). We have generated a transgenic rat model of this disease and provide experimental evidence that CMT1A is caused by increased expression of the gene for peripheral myelin protein-22 (PMP22, gas-3). PMP22-transgenic rats develop gait abnormalities caused by a peripheral hypomyelination, Schwann cell hypertrophy (onion bulb formation), and muscle weakness. Reduced nerve conduction velocities closely resemble recordings in human patients with CMT1A. When bred to homozygosity, transgenic animals completely fail to elaborate myelin. We anticipate that the CMT rat model will facilitate the identification of a cellular disease mechanism and serve in the evaluation of potential treatment strategies.	UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,D-69120 HEIDELBERG,GERMANY; UNIV HEIDELBERG,DEPT NEUROL,D-69120 HEIDELBERG,GERMANY; UNIV GLASGOW,DEPT VET CLIN STUDIES,GLASGOW G61 1QH,LANARK,SCOTLAND; ETH ZURICH,ETH HOENGGERBERG,DEPT CELL BIOL,CH-8093 ZURICH,SWITZERLAND	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Glasgow; Swiss Federal Institutes of Technology Domain; ETH Zurich			Nave, Klaus-Armin/C-8883-2011; Suter, Ueli/A-1624-2010	Rossner, Moritz/0000-0002-0667-3420				ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; BAECHNER D, 1995, J NEUROSCI RES, V42, P735; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dyck PJ, 1993, PERIPHERAL NEUROPATH, V2; FABBRETTI E, 1995, GENE DEV, V9, P1846, DOI 10.1101/gad.9.15.1846; GANTEN D, 1991, HYPERTENSION, V17, P843, DOI 10.1161/01.HYP.17.6.843; GARCIA CA, 1996, IN PRESS NEUROLOGY; HANEMANN CO, 1994, J NEUROSCI RES, V37, P654, DOI 10.1002/jnr.490370513; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HUDSON LD, 1990, SEMIN NEUROSCI, V2, P483; IONASESCU VV, 1995, NEUROLOGY, V45, P1766, DOI 10.1212/WNL.45.9.1766; IONASESCU VV, 1995, MUSCLE NERVE, V18, P257; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KAMHOLZ J, 1994, ANN NEUROL, V36, P451, DOI 10.1002/ana.410360326; KITAMURA K, 1976, BIOCHIM BIOPHYS ACTA, V455, P806, DOI 10.1016/0005-2736(76)90050-X; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; Nave KA, 1996, NEUROSCIENTIST, V2, P33, DOI 10.1177/107385849600200111; Nave Klaus-Armin, 1995, P571; NICHOLSON GA, 1991, NEUROLOGY, V41, P547, DOI 10.1212/WNL.41.4.547; PARMANTIER E, 1995, EUR J NEUROSCI, V7, P1080, DOI 10.1111/j.1460-9568.1995.tb01095.x; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1995, BRAIN PATHOL, V5, P233, DOI 10.1111/j.1750-3639.1995.tb00600.x; SNIPES GJ, 1995, J ANAT, V186, P483; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SUTER U, 1994, J BIOL CHEM, V269, P1; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; WISE CA, 1993, AM J HUM GENET, V53, P853; YOSHIKAWA H, 1994, ANN NEUROL, V35, P445, DOI 10.1002/ana.410350412; ZOIDL G, 1995, EMBO J, V14, P1122, DOI 10.1002/j.1460-2075.1995.tb07095.x	53	280	295	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					1049	1060		10.1016/S0896-6273(00)80128-2	http://dx.doi.org/10.1016/S0896-6273(00)80128-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630243	Bronze			2022-12-28	WOS:A1996UN48000020
J	MacKenzie, PJ; Umemiya, M; Murphy, TH				MacKenzie, PJ; Umemiya, M; Murphy, TH			Ca2+ imaging of CNS axons in culture indicates reliable coupling between single action potentials and distal functional release sites	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; LONG-TERM POTENTIATION; SQUID GIANT SYNAPSE; TRANSMITTER RELEASE; CALCIUM CHANNELS; PRESYNAPTIC CALCIUM; HIPPOCAMPAL SLICES; ENHANCEMENT; PROBABILITY; MECHANISM	A combination of Ca2+ imaging and current-clamp recording in cultured cortical neurons was used to evaluate the reliability of coupling between the action potential and rises in Ca2+ at distal release sites as a possible source of variability in CNS synaptic transmission. Local domains of enhanced Ca2+ influx were observed at varicosities on axon collaterals. Functional assay of vesicle turnover using FM1-43 and parallel electron microscopy confirmed that these varicosities were release sites. Single action potentials reliably (>95% of the time) resulted in a presynaptic Ca2+ transient at all presumed release sites including those on distal collaterals. Variability in the amplitude of presynaptic Ca2+ transients at individual boutons was estimated to be on average less than 20%. We conclude that the coupling of somatic action potentials to distal release sites is generally a reliable process, although nonlinearity in the relationship between Ca2+ influx and neurotransmitter release may amplify the effects of relatively small fluctuations in Ca2+ influx.	UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,KINSMEN LAB,VANCOUVER,BC V6T 1Z3,CANADA	University of British Columbia			Murphy, Timothy/AAW-1975-2021; Murphy, Timothy H/I-4982-2014	Murphy, Timothy/0000-0002-0093-4490; Murphy, Timothy H/0000-0002-0093-4490				ADLER EM, 1991, J NEUROSCI, V11, P1496; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; AUGUSTINE GJ, 1990, CALCIUM ENTRY ACTION, P365; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Cajal R, 1911, HISTOLOGY NERVOUS SY; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; COOPER RL, 1995, J NEUROSCI, V15, P4209; DELANEY K, 1991, J NEUROSCI, V11, P2631; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; FIELDS RD, 1991, J NEUROSCI, V11, P134; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS KM, 1995, TRENDS NEUROSCI, V18, P365, DOI 10.1016/0166-2236(95)93930-V; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HILLE B, 1992, IONIC CHANNELS EXCIT, P321; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LUSCHER C, 1994, J NEUROPHYSIOL, V72, P634, DOI 10.1152/jn.1994.72.2.634; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALINOW R, 1994, SCIENCE, V266, P1195, DOI 10.1126/science.7973700; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MINTA A, 1989, J BIOL CHEM, V264, P8171; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MURPHY TH, 1995, NEURON, V15, P159, DOI 10.1016/0896-6273(95)90073-X; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; MURPHY TH, 1990, DEV BRAIN RES, V57, P146, DOI 10.1016/0165-3806(90)90195-5; Peters A, 1976, FINE STRUCTURE NERVO, P90; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAGU B, 1989, AM J PHYSIOL, V256, pC540; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; REGEHR WG, 1994, J NEUROSCI, V14, P523; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; SORRA KE, 1993, J NEUROSCI, V13, P3736; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; VOLGUSHEV M, 1995, EUR J NEUROSCI, V7, P1751, DOI 10.1111/j.1460-9568.1995.tb00695.x; WALL PD, 1995, TRENDS NEUROSCI, V18, P99, DOI 10.1016/0166-2236(95)93883-Y; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WU LG, 1994, J NEUROSCI, V14, P645; WU LG, 1994, J NEUROSCI, V14, P5613; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zar JH., 1999, BIOSTAT ANAL; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	67	85	85	2	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					783	795		10.1016/S0896-6273(00)80098-7	http://dx.doi.org/10.1016/S0896-6273(00)80098-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607996	Bronze			2022-12-28	WOS:A1996UG61100011
J	Broillet, MC; Firestein, S				Broillet, MC; Firestein, S			Direct activation of the olfactory cyclic nucleotide-gated channel through modification of sulfhydryl groups by NO compounds	NEURON			English	Article							NITRIC-OXIDE; RECEPTOR NEURONS; FUNCTIONAL EXPRESSION; NITROGEN-DIOXIDE; CELLS	The activation of a cyclic nucleotide-gated channel is the final step in sensory transduction in olfaction. Normally, this channel is opened by the intracellular cyclic nucleotide second messenger cAMP or cGMP. However, in single channel recordings we found that donors of nitric oxide, a putative intercellular messenger, could directly activate the native olfactory neuron channel. Its action was independent of the presence of the normal ligand and did not involve the cyclic nucleotide binding site, suggesting an alternate site on the molecule that is critical in channel gating. The biochemical pathway appears to utilize nitric oxide in one of its alternate redox states, the nitrosonium ion, transnitrosylating a free sulfhydryl group belonging to a cysteine residue tentatively identified as being in the region linking the S6 transmembrane domain to the ligand binding domain.			Broillet, MC (corresponding author), COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027, USA.			Broillet, Marie-Christine/0000-0002-0487-6638				BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; BUTLER AR, 1995, TRENDS PHARMACOL SCI, V16, P18, DOI 10.1016/S0165-6147(00)88968-3; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DONNER K, 1990, EXP EYE RES, V51, P97, DOI 10.1016/0014-4835(90)90176-U; DRYER SE, 1991, NATURE, V353, P756, DOI 10.1038/353756a0; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; Firestein Stuart, 1994, Seminars in Cell Biology, V5, P39, DOI 10.1006/scel.1994.1006; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; JOCELYN PC, 1987, SULFUR SULFUR AMINO, P246; JOCELYN PC, 1987, SULFUR SULFUR AMINO, P44; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KENYON GL, 1977, ENZYME STRUCTURE, P407; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LEINDERSZUFALL T, 1995, NEUROREPORT, V6, P45; LIPTON SA, 1994, NEUROPHARMACOLOGY, V33, P1229, DOI 10.1016/0028-3908(94)90021-3; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LISCHKA FW, 1993, NEUROREPORT, V4, P582, DOI 10.1097/00001756-199305000-00031; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MONCADA S, 1991, PHARMACOL REV, V43, P109; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; PRYOR WA, 1981, SCIENCE, V214, P435, DOI 10.1126/science.214.4519.435; PRYOR WA, 1982, J ORG CHEM, V47, P156, DOI 10.1021/jo00340a038; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; ROSKAMS AJ, 1994, NEURON, V13, P289; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SNYDER SH, 1992, SCIENCE, V257, P494, DOI 10.1126/science.1353273; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHITE FHJ, 1972, ENZYME STRUCTURE, P481; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481; ZHAO HQ, 1994, NEUROREPORT, V6, P149, DOI 10.1097/00001756-199412300-00038; ZUFALL F, 1991, J NEUROSCI, V11, P3573; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	42	133	137	3	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					377	385		10.1016/S0896-6273(00)80055-0	http://dx.doi.org/10.1016/S0896-6273(00)80055-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789952	hybrid			2022-12-28	WOS:A1996TW95700017
J	Yu, WF; Xu, J; Li, M				Yu, WF; Xu, J; Li, M			NAB domain is essential for the subunit assembly of both alpha-alpha and alpha-beta and complexes of Shaker-like potassium channels	NEURON			English	Article							HETEROMULTIMERIC K+ CHANNELS; XENOPUS-OOCYTES; ION CHANNELS; BOVINE BRAIN; RAT-BRAIN; A-CURRENT; INACTIVATION; DROSOPHILA; CELLS; PROTEIN	There are at least five subfamilies of Shaker-like K+ channels. The diverse functions of K+ channels are thought to be further modulated by hydrophilic beta subunits. Here we report that Kv beta 1 inactivates RCK4 and Shaker B K+ channels of the Kv1 subfamily, but not Shal2 of the Kv4 subfamily. This correlates the subfamily-specific binding of Kv beta 1 to the cytoplasmic N-terminal domains of Kv1 alpha subunits. We map the Kv beta 1-binding site to a region overlapping NAB(Kv1), a domain that specifies different Kv1 or subunits to form heterotetramers. Using chimeric or subunits, we demonstrate that NAB(Kv1) is essential for the Kv beta 1-mediated inactivation. These results suggest that Kv beta 1 modulates a subset of K+ channels through the specific assembly of alpha-beta complexes and reveal the dual function of the NAB domain in mediating the assembly of both alpha-alpha and alpha-beta complexes.	JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA	Johns Hopkins University	Yu, WF (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PHYSIOL, BALTIMORE, MD 21205 USA.							BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BEIRAO PSL, 1994, J PHYSIOL-LONDON, V474, P269, DOI 10.1113/jphysiol.1994.sp020019; BUTLER A, 1990, NUCLEIC ACIDS RES, V18, P2173, DOI 10.1093/nar/18.8.2173; BYRNE JH, 1980, J NEUROPHYSIOL, V43, P651, DOI 10.1152/jn.1980.43.3.651; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; DREWE JA, 1992, J NEUROSCI, V12, P538; DUBOIS JM, 1993, PROG BIOPHYS MOL BIO, V59, P1, DOI 10.1016/0079-6107(93)90005-5; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FOSTER CD, 1992, NEURON, V9, P229, DOI 10.1016/0896-6273(92)90162-7; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1991, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MILKMAN R, 1994, P NATL ACAD SCI USA, V91, P3510, DOI 10.1073/pnas.91.9.3510; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MORALES MJ, 1995, J BIOL CHEM, V270, P6272, DOI 10.1074/jbc.270.11.6272; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; ROGAWSKI MA, 1985, TRENDS NEUROSCI, V8, P214, DOI 10.1016/0166-2236(85)90082-7; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; STEPHENS GJ, 1995, J PHYSIOL-LONDON, V484, P1; SUMMERS MD, 1987, TEX AGR EXP ST B, V1555; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TORO L, 1992, NEURON, V9, P237, DOI 10.1016/0896-6273(92)90163-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WU J, 1995, J BIOL CHEM, V270, P24761; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZHAO B, 1994, NEURON, V13, P1205, DOI 10.1016/0896-6273(94)90058-2	56	128	132	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					441	453		10.1016/S0896-6273(00)80062-8	http://dx.doi.org/10.1016/S0896-6273(00)80062-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789959	hybrid			2022-12-28	WOS:A1996TW95700024
J	MACONOCHIE, DJ; ZEMPEL, JM; STEINBACH, JH				MACONOCHIE, DJ; ZEMPEL, JM; STEINBACH, JH			HOW QUICKLY CAN GABA(A) RECEPTORS OPEN	NEURON			English	Article							SPINAL-CORD NEURONS; FROG NEUROMUSCULAR-JUNCTION; INDUCED CHLORIDE CURRENT; SINGLE-CHANNEL ANALYSIS; MAIN CONDUCTANCE STATE; ACETYLCHOLINE-RECEPTOR; PATCH-CLAMP; TIME-COURSE; SYNAPTIC TRANSMISSION; STOCHASTIC PROPERTIES	We have examined GABA(A) receptor activation by making rapid applications of GABA to outside-out patches excised from cultured postnatal rat cerebellar neurons. The rate of development of current increases with increasing GABA concentration from a low to a high concentration asymptote. The low concentration asymptote is about 10 s-1 for patches taken from granule cells and 4 s-1 for patches from Purkinje cells. The high concentration asymptote is about 6000 s-1 for patches taken from either granule cells or Purkinje cells. The high concentration asymptote gives an estimate of the fastest rate at which these channels can open and indicates that agonist binding steps are not rate limiting. The concentration dependence of the development of current indicates that more than one GABA molecule is bound to most receptors with open channels and that the final binding step is of low affinity (about 500 muM). A comparison with GABA-mediated postsynaptic currents suggests that the properties of the GABA(A) receptor play a major role in determining the shape of inhibitory synaptic responses and that the cleft concentration of GABA reaches at least 500 muM.			MACONOCHIE, DJ (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANESTHESIOL,ST LOUIS,MO 63110, USA.				NIGMS NIH HHS [P01 GM047969, P01 GM47969] Funding Source: Medline; NINDS NIH HHS [R01 NS22356] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1986, J PHYSIOL-LONDON, V379, P171, DOI 10.1113/jphysiol.1986.sp016246; AUERBACH A, 1992, BIOPHYS J, V62, P72, DOI 10.1016/S0006-3495(92)81783-6; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; BLATZ AL, 1986, BIOPHYS J, V49, P967, DOI 10.1016/S0006-3495(86)83725-0; BORMANN J, 1985, P NATL ACAD SCI USA, V82, P2168, DOI 10.1073/pnas.82.7.2168; CACHELIN AB, 1989, J PHYSIOL-LONDON, V415, P159, DOI 10.1113/jphysiol.1989.sp017717; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; CROUZY SC, 1990, BIOPHYS J, V58, P731, DOI 10.1016/S0006-3495(90)82416-4; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; DILGER JP, 1990, BIOPHYS J, V57, P723, DOI 10.1016/S0006-3495(90)82593-5; DUDEL J, 1990, BIOPHYS J, V57, P533, DOI 10.1016/S0006-3495(90)82569-8; EDMONDS B, 1992, P ROY SOC B-BIOL SCI, V250, P279, DOI 10.1098/rspb.1992.0160; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FELTZ A, 1982, J PHYSIOL-LONDON, V322, P257, DOI 10.1113/jphysiol.1982.sp014036; FRANKE C, 1991, BIOPHYS J, V60, P1008, DOI 10.1016/S0006-3495(91)82138-5; FRANKE C, 1987, NEUROSCI LETT, V88, P405; HAMILL OP, 1983, NATURE, V305, P805, DOI 10.1038/305805a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; JACKSON MB, 1986, BIOPHYS J, V49, P663, DOI 10.1016/S0006-3495(86)83693-1; KANEDA M, 1989, AM J PHYSIOL, V256, pC1153, DOI 10.1152/ajpcell.1989.256.6.C1153; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LINGLE CJ, 1992, J MEMBRANE BIOL, V126, P195; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MACDONALD RL, 1989, J PHYSIOL-LONDON, V410, P479, DOI 10.1113/jphysiol.1989.sp017545; MACDONALD RL, 1992, ION CHANNELS, P315; MACONOCHIE DJ, 1989, PFLUG ARCH EUR J PHY, V414, P589, DOI 10.1007/BF00580996; MACONOCHIE DJ, 1992, J PHYSIOL-LONDON, V454, P129, DOI 10.1113/jphysiol.1992.sp019257; MACONOCHIE DJ, 1992, J PHYSL, V454, P154; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MATHERS DA, 1988, SYNAPSE, V2, P627, DOI 10.1002/syn.890020608; NEHER E, 1975, P NATL ACAD SCI USA, V72, P2140, DOI 10.1073/pnas.72.6.2140; NEWLAND CF, 1991, J PHYSIOL-LONDON, V432, P203, DOI 10.1113/jphysiol.1991.sp018382; ROUX B, 1985, BIOPHYS J, V48, P149, DOI 10.1016/S0006-3495(85)83768-1; Sakmann B, 1983, J Neural Transm Suppl, V18, P83; SCHNEGGENBURGER R, 1992, PFLUG ARCH EUR J PHY, V421, P364, DOI 10.1007/BF00374225; SIEGEL RE, 1988, NEURON, V1, P579, DOI 10.1016/0896-6273(88)90107-9; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; TWYMAN RE, 1990, J PHYSIOL-LONDON, V423, P193, DOI 10.1113/jphysiol.1990.sp018018; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; WEISS DS, 1989, J NEUROSCI, V9, P1314; Wisden W, 1992, Curr Opin Neurobiol, V2, P263, DOI 10.1016/0959-4388(92)90113-Y; [No title captured]	52	207	209	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					61	71		10.1016/0896-6273(94)90152-X	http://dx.doi.org/10.1016/0896-6273(94)90152-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292360				2022-12-28	WOS:A1994MU49300006
J	THOMAS, P; WONG, JG; LEE, AK; ALMERS, W				THOMAS, P; WONG, JG; LEE, AK; ALMERS, W			A LOW-AFFINITY CA2+ RECEPTOR CONTROLS THE FINAL STEPS IN PEPTIDE SECRETION FROM PITUITARY MELANOTROPHS	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; FLUORESCENT INDICATOR; RAT PITUITARY; CALCIUM; EXOCYTOSIS; RELEASE; CURRENTS; TEMPERATURE; ENDOCYTOSIS; MAGNESIUM	Using flash photolysis of caged Ca2+ and the membrane capacitance to monitor exocytosis, we have studied the response of single melanotrophs to a step rise in cytosolic Ca2+ concentration ([Ca2+]i). Exocytosis begins with a rapid burst. This burst is followed by a slower phase, which is inhibited at cytosolic pH 6.2, and an ultraslow phase, which is strongly temperature sensitive. The exocytic burst starts with a delay of 6-11 ms and continues at a rate that grows steeply with [Ca2+]i and is half-maximal at [Ca2+]i = 27 muM. At least 3 Ca2+ ions are required to trigger exocytosis. The rate constant at saturating [Ca2+]i suggests that exocytosis of a dense core vesicle takes 40 ms after all Ca2+ ions have bound to the irregulatory sites. If docked dense core vesicles cause the exocytic burst, they must decorate the plasma membrane at a mean density of 0.5/mum2.	UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195; MAX PLANCK INST MED RES,MOLEK ZELLFORSCH ABT,W-6900 HEIDELBERG 1,GERMANY	University of Washington; University of Washington Seattle; Max Planck Society	THOMAS, P (corresponding author), UNIV CALIF DAVIS,SCH MED,DEPT HUMAN PHYSIOL,DAVIS,CA 95616, USA.		Thomas, Paul/B-1244-2009	Thomas, Paul/0000-0002-0883-9068	NIAMS NIH HHS [AR-17803] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR017803, R37AR017803] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V369, P163; BACK N, 1989, CELL TISSUE RES, V255, P405; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BURGOYNE RD, 1990, ANNU REV PHYSIOL, V52, P647; Chronwall B M, 1988, Peptides, V9 Suppl 1, P169, DOI 10.1016/0196-9781(88)90241-0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; FIDLERLIM N, 1990, NATURE, V344, P449; GRAFENSTEIN HV, 1986, J CELL BIOL, V103, P2343; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Katz B., 1969, RELEASE NEURAL TRANS; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; LATTANZIO FA, 1991, BIOCHEM BIOPH RES CO, V177, P184, DOI 10.1016/0006-291X(91)91966-G; LATTANZIO FA, 1990, BIOCHEM BIOPH RES CO, V171, P102, DOI 10.1016/0006-291X(90)91362-V; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LUNDBERG JM, 1982, ACTA PHYSIOL SCAND, V115, P525, DOI 10.1111/j.1748-1716.1982.tb07117.x; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MARTELL AE, 1974, CRITICAL STABILITY C, V1, P269; MCCRAY JA, 1992, BIOCHEMISTRY-US, V31, P8856, DOI 10.1021/bi00152a023; MIYAMOTO MD, 1975, J PHYSIOL-LONDON, V250, P121, DOI 10.1113/jphysiol.1975.sp011045; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; STACK J, 1991, J PHYSIOL-LONDON, V439, P37, DOI 10.1113/jphysiol.1991.sp018655; Steinbach J.H., 1976, P33; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	43	216	218	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					93	104		10.1016/0896-6273(93)90274-U	http://dx.doi.org/10.1016/0896-6273(93)90274-U			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8393324				2022-12-28	WOS:A1993LP43000009
J	LITMAN, P; BARG, J; RINDZOONSKI, L; GINZBURG, I				LITMAN, P; BARG, J; RINDZOONSKI, L; GINZBURG, I			SUBCELLULAR-LOCALIZATION OF TAU-MESSENGER RNA IN DIFFERENTIATING NEURONAL CELL-CULTURE - IMPLICATIONS FOR NEURONAL POLARITY	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; DEVELOPING RAT-BRAIN; INSITU HYBRIDIZATION; HIPPOCAMPAL-NEURONS; PC12 CELLS; SYNTHETIC MACHINERY; NEURITE OUTGROWTH; GROWTH; EXPRESSION; MAP2	A primary neuronal cell culture derived from whole brains of fetal rats was used to analyze the subcellular localization of tau mRNA, employing nonisotopic detection by in situ hybridization. The culture exhibited a developmental differentiation pattern previously described for neuronal cells in vivo; i.e., a transition from immature to mature tau isoforms as well as segregation of tau into the axons. Our results demonstrate that unlike tubulin mRNA, which is confined to cell bodies, or MAP2 mRNA, which extends into dendrites, tau mRNA was observed to enter the proximal portion of the axon. This sorting of tau mRNA might explain how the tau protein could be selectively delivered to the axon and could have important implications for the development of neuronal polarity.			LITMAN, P (corresponding author), WEIZMANN INST SCI,DEPT NEUROL,IL-76100 REHOVOT,ISRAEL.							BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BINDER LI, 1984, P NATL ACAD SCI-BIOL, V81, P5613, DOI 10.1073/pnas.81.17.5613; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLACK MM, 1982, J CELL BIOL, V95, P379, DOI 10.1083/jcb.95.2.379; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; BRUCKENSTEIN DA, 1990, NEURON, V5, P809, DOI 10.1016/0896-6273(90)90340-L; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CACERES A, 1984, J NEUROSCI, V4, P394; COUCHIE D, 1985, FEBS LETT, V188, P331, DOI 10.1016/0014-5793(85)80397-5; DANIELS M, 1975, ANN NY ACAD SCI, V253, P535, DOI 10.1111/j.1749-6632.1975.tb19227.x; DIRKS RW, 1989, J HISTOCHEM CYTOCHEM, V37, P7, DOI 10.1177/37.1.2642295; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NEUROSCIENCE, V23, P121, DOI 10.1016/0306-4522(87)90276-4; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; FRANCON J, 1982, EUR J BIOCHEM, V129, P465, DOI 10.1111/j.1432-1033.1982.tb07072.x; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GARNER CC, 1988, J CELL BIOL, V106, P779, DOI 10.1083/jcb.106.3.779; GINZBURG I, 1980, NUCLEIC ACIDS RES, V8, P3557; GIUDITTA A, 1990, REGULATION GENE EXPR, P205; HANEMAAIJER R, 1991, J NEUROSCI RES, V30, P163, DOI 10.1002/jnr.490300117; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KEATES RAB, 1988, SCIENCE, V241, P1642, DOI 10.1126/science.3420415; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; KOSIK KS, 1989, ANN NEUROL, V26, P352, DOI 10.1002/ana.410260308; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; LEE G, 1990, CELL MOTIL CYTOSKEL, V15, P199, DOI 10.1002/cm.970150402; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; LIM SS, 1989, J CELL BIOL, V109, P253, DOI 10.1083/jcb.109.1.253; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; MOHR E, 1991, EMBO J, V10, P2419, DOI 10.1002/j.1460-2075.1991.tb07781.x; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; STEWARD O, 1986, J NEUROSCI, V6, P3079; STEWARD O, 1986, J NEUROSCI, V6, P412; TAKEMURA R, 1991, NEUROSCIENCE, V44, P393, DOI 10.1016/0306-4522(91)90064-U; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; YAMADA KM, 1970, P NATL ACAD SCI USA, V66, P1206, DOI 10.1073/pnas.66.4.1206; YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540	51	162	164	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					627	638		10.1016/0896-6273(93)90165-N	http://dx.doi.org/10.1016/0896-6273(93)90165-N			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476613				2022-12-28	WOS:A1993KY50100007
J	Riehl, R; Johnson, K; Bradley, R; Grunwald, GB; Cornel, E; Lilienbaum, A; Holt, CE				Riehl, R; Johnson, K; Bradley, R; Grunwald, GB; Cornel, E; Lilienbaum, A; Holt, CE			Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo	NEURON			English	Article							PURIFIED N-CADHERIN; ADHESION MOLECULES; R-CADHERIN; NEURITE OUTGROWTH; XENOPUS-EMBRYOS; OPTIC-NERVE; CYTOPLASMIC DOMAIN; EXPRESSION; GROWTH; INTEGRINS	The cell-cell adhesion molecule N-cadherin strongly promotes neurite outgrowth in cultured retinal neurons. To test whether cadherins regulate process outgrowth in retinal neurons in vivo, we have blocked cadherin function in single cells by expression of a dominant negative N-cadherin mutant. We report that when cadherin function is inhibited, axon and dendrite outgrowth are severely impaired, particularly in retinal ganglion cells. Laminar migration and cell type specification, by contrast, appear unaffected. Further, expression of the catenin-binding domain of N-cadherin, which blocks cadherin-mediated adhesion in early embryos, does not affect axon outgrowth, suggesting that outgrowth and adhesion are mediated by distinct regions of the cytoplasmic domain. These findings indicate that cadherins play an essential role in the initiation and extension of axons from retinal ganglion cells in vivo.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92037; SALK INST BIOL STUDIES,MOL NEUROBIOL LAB,SAN DIEGO,CA 92138; THOMAS JEFFERSON UNIV,DEPT PATHOL ANAT & CELL BIOL,PHILADELPHIA,PA 19107	University of California System; University of California San Diego; Salk Institute; Jefferson University				Holt, Christine Elizabeth/0000-0003-2829-121X; Johnson, Karl/0000-0003-3931-5985	NCI NIH HHS [1F32CA66313-01] Funding Source: Medline; NEI NIH HHS [EY06658] Funding Source: Medline; NINDS NIH HHS [R01 NS23780] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA066313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023780] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERLE H, 1994, J CELL SCI, V107, P3655; AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; BARAMI K, 1994, NEURON, V13, P567, DOI 10.1016/0896-6273(94)90026-4; BIXBY JL, 1994, J CELL BIOL, V127, P1461, DOI 10.1083/jcb.127.5.1461; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BOLLER K, 1985, J CELL BIOL, V100, P357; CHNG SK, 1992, ANAT EMBRYOL, V186, P175; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; DUFOUR S, 1994, J CELL BIOL, V127, P521, DOI 10.1083/jcb.127.2.521; DUNLOP SA, 1984, VISION RES, V24, P417, DOI 10.1016/0042-6989(84)90040-3; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; GRANT P, 1980, J COMP NEUROL, V189, P671, DOI 10.1002/cne.901890405; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HOLT CE, 1994, P NATL ACAD SCI USA, V91, P10844, DOI 10.1073/pnas.91.23.10844; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; KLJAVIN IJ, 1994, J NEUROSCI, V14, P5035; LEMMON V, 1992, J NEUROSCI, V12, P818; LEVINE E, 1994, DEVELOPMENT, V120, P901; LILIENBAUM A, 1995, MOL CELL NEUROSCI, V6, P139, DOI 10.1006/mcne.1995.1013; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; MULLER HAJ, 1994, MECH DEVELOP, V47, P213, DOI 10.1016/0925-4773(94)90040-X; MURPHYERDOSH C, 1994, DEV BIOL, V161, P107, DOI 10.1006/dbio.1994.1013; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PARADIES NE, 1993, J NEUROSCI RES, V36, P33, DOI 10.1002/jnr.490360105; PAYNE HR, 1992, CELL MOTIL CYTOSKEL, V21, P65, DOI 10.1002/cm.970210108; REDIES C, 1993, GLIA, V8, P161, DOI 10.1002/glia.440080304; REDIES C, 1992, J NEUROSCI, V12, P3525; REDIES C, 1993, J COMP NEUROL, V333, P398, DOI 10.1002/cne.903330307; REICHARDT LF, 1989, DEV NEUROSCI-BASEL, V11, P332, DOI 10.1159/000111910; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; SIMONNEAU L, 1992, DEV DYNAM, V194, P247, DOI 10.1002/aja.1001940402; STIER H, 1995, DEVELOPMENT, V121, P1443; SUZUKI S, 1991, CELL REGUL, V2, P261, DOI 10.1091/mbc.2.4.261	49	238	238	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					837	848		10.1016/S0896-6273(00)80216-0	http://dx.doi.org/10.1016/S0896-6273(00)80216-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938117	Bronze			2022-12-28	WOS:A1996VV15100007
J	Sauman, I; Reppert, SM				Sauman, I; Reppert, SM			Circadian clock neurons in the silkmoth Antheraea pernyi: Novel mechanisms of period protein regulation	NEURON			English	Article							DROSOPHILA-MELANOGASTER; NERVOUS-SYSTEM; GENE-PRODUCT; TIMELESS; EXPRESSION; CLONING; AUTOREGULATION; FEEDBACK; SEQUENCE; REVEALS	We examined Period (PER) protein regulation in the brain of the silkmoth Antheraea pernyi. PER expression is restricted to the cytoplasm and axons of eight neurons, with no evidence of temporal movement into the nucleus. These neurons appear to be circadian clock cells, because PER and per mRNA are colocalized and their levels oscillate in these cells, Timeless protein immunoreactivity is coexpressed in each PER-positive neuron, and clock protein and mRNA oscillations are all suppressed in these neurons by constant light. A per antisense RNA oscillation was detected that is spatially restricted to PER-expressing cells, suggesting a novel mechanism of PER regulation. PER-positive neurons and their projections are strategically positioned for regulating prothoracicotropic hormone and eclosion hormone, two neurohormones under circadian control. Differences in the molecular details of PER expression and regulation between the brains of silkmoths and fruitflies provide insights into the mechanisms of clock gene regulation.	MASSACHUSETTS GEN HOSP,SERV PEDIAT,LAB DEV CHRONOBIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School			Sauman, Ivo/H-2071-2014		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; COLOT HV, 1988, EMBO J, V7, P3929, DOI 10.1002/j.1460-2075.1988.tb03279.x; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DUNLAP JC, 1995, CIBA F SYMP, V183, P1; EWER J, 1992, J NEUROSCI, V12, P3321; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; HALL JC, 1995, TRENDS NEUROSCI, V18, P230, DOI 10.1016/0166-2236(95)93908-G; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; INOUYE M, 1988, GENE, V72, P25, DOI 10.1016/0378-1119(88)90124-2; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; KAY SA, 1995, CELL, V83, P361, DOI 10.1016/0092-8674(95)90113-2; Kimelman D., 1992, Gene regulation: biology of antisense RNA and DNA., P1; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1995, NEURON, V15, P147, DOI 10.1016/0896-6273(95)90072-1; Murashov AK, 1996, MOL BRAIN RES, V37, P85, DOI 10.1016/0169-328X(95)00288-4; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; NIELSEN J, 1994, MOL BIOL EVOL, V11, P839; RAO KR, 1992, PIGM CELL RES, P266, DOI 10.1111/j.1600-0749.1990.tb00383.x; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; Sauman I, 1996, DEV BIOL, V178, P418, DOI 10.1006/dbio.1996.0228; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; TRUMAN JW, 1992, PROG BRAIN RES, V92, P361, DOI 10.1016/S0079-6123(08)61189-9; TRUMAN JW, 1974, J COMP PHYSIOL, V95, P281, DOI 10.1007/BF00609702; TRUMAN JW, 1972, J COMP PHYSIOL, V81, P99, DOI 10.1007/BF00693553; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; TRUMAN JW, 1971, P NATL ACAD SCI USA, V68, P595, DOI 10.1073/pnas.68.3.595; Williams C M, 1969, Symp Soc Exp Biol, V23, P285; WILLIAMS CM, 1964, BIOL BULL, V127, P511, DOI 10.2307/1539252; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	38	186	189	3	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					889	900		10.1016/S0896-6273(00)80220-2	http://dx.doi.org/10.1016/S0896-6273(00)80220-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938121	Bronze			2022-12-28	WOS:A1996VV15100011
J	Raastad, M; Johnson, BR; Kiehn, O				Raastad, M; Johnson, BR; Kiehn, O			The number of postsynaptic currents necessary to produce locomotor-related cyclic information in neurons in the neonatal rat spinal cord	NEURON			English	Article							METHYL-D-ASPARTATE; IN-VITRO; HIPPOCAMPAL SLICES; PYRAMIDAL CELLS; PATCH-CLAMP; INVITRO; MECHANISMS	To understand better how synaptic signaling contributes to network activity, we analyzed the potential contribution of putative unitary postsynaptic currents (PSCs) to locomotor-related information received by spinal interneurons in neonatal rats. The average cyclic modulation of the whole-cell current in 13 neurons was quantified as the difference between the current integral (charge) during the first and second halves of the cyclic locomotor network output. Between 7.6 and 303 average unitary PSCs per second were needed to produce the cyclic modulation. This number is so low that very few (1-5) of the synapses contributing to the cyclic information need to be active simultaneously. This suggests that individual presynaptic cells in a central locomotor network can have a powerful influence on other neurons.			Raastad, M (corresponding author), UNIV COPENHAGEN, DIV NEUROPHYSIOL, DEPT MED PHYSIOL, BLEGDAMSVEJ 3, DK-2200 COPENHAGEN, DENMARK.		Kiehn, Ole/C-4679-2008; kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019	Kiehn, Ole/0000-0002-5954-469X				ANDERSEN P, 1990, PROG BRAIN RES, V83, P215; ARSHAVSKY YI, 1993, TRENDS NEUROSCI, V16, P227, DOI 10.1016/0166-2236(93)90161-E; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; CARR PA, 1995, BRAIN RES BULL, V37, P213, DOI 10.1016/0361-9230(94)00271-2; CAZALETS JR, 1994, J PHYSIOL-LONDON, V474, P173, DOI 10.1113/jphysiol.1994.sp020011; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; COWLEY KC, 1994, NEUROSCI LETT, V171, P147, DOI 10.1016/0304-3940(94)90626-2; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; Feldman J L, 1991, Curr Opin Neurobiol, V1, P590, DOI 10.1016/S0959-4388(05)80033-9; GRILLNER S, 1991, NEURON, V7, P1, DOI 10.1016/0896-6273(91)90069-C; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P565, DOI 10.1152/jn.1994.72.2.565; Kiehn O, 1996, NEUROSCIENCE, V75, P263, DOI 10.1016/0306-4522(96)00250-3; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; KIRKWOOD PA, 1977, J PHYSL, V275, P103; KJAERULFF O, 1994, J PHYSIOL-LONDON, V478, P265, DOI 10.1113/jphysiol.1994.sp020248; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Neher Erwin, 1995, P147; Raastad M, 1996, EUR J NEUROSCI, V8, P1265, DOI 10.1111/j.1460-9568.1996.tb01295.x; Rossignol S, 1996, HDB PHYSL SECTION 12, P173; SMITH JC, 1992, NEUROSCI LETT, V134, P153, DOI 10.1016/0304-3940(92)90504-Z; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; SQALLIHOUSSAINI Y, 1993, J NEUROPHYSIOL, V70, P803, DOI 10.1152/jn.1993.70.2.803; THURBON D, 1994, J NEUROPHYSIOL, V71, P1948, DOI 10.1152/jn.1994.71.5.1948; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208	29	23	24	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					729	738		10.1016/S0896-6273(00)80204-4	http://dx.doi.org/10.1016/S0896-6273(00)80204-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893029	Bronze			2022-12-28	WOS:A1996VP74300017
J	Hsu, SF; Augustine, GJ; Jackson, MB				Hsu, SF; Augustine, GJ; Jackson, MB			Adaptation of Ca2+-triggered exocytosis in presynaptic terminals	NEURON			English	Article							SQUID GIANT SYNAPSE; BOVINE CHROMAFFIN CELLS; TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; CA2+ RELEASE; NEUROTRANSMITTER RELEASE; INTRACELLULAR CALCIUM; FLUORESCENT INDICATOR; PHOTOLABILE CHELATOR; FLASH-PHOTOLYSIS	Rapid increases in Ca2+ concentration, produced by photolysis of caged Ca2+, triggered exocytosis in squid nerve terminals. This exocytosis was transient in nature, decaying with a time constant of approximately 30 ms. The decay could not be explained by a decline in presynaptic Ca2+ concentration, depletion of synaptic vesicles, or desensitization of postsynaptic receptors. Experiments in which Ca2+ was increased either in a series of steps or continuously at different rates suggested that the decay is caused by adaptation of the exocytotic Ca2+ receptor to higher levels of Ca2+. This adjustable sensitivity to Ca2+ represents a novel property of the triggering mechanism that can be used to evaluate molecular models of exocytosis. Adaptation can limit the amount of transmitter released by a nerve terminal and permit the speed of a presynaptic Ca2+ rise to serve as a critical determinant of synaptic efficacy.	DUKE UNIV, SCH MED, DEPT NEUROBIOL, DURHAM, NC 27710 USA; MARINE BIOL LAB, WOODS HOLE, MA 02543 USA	Duke University; Marine Biological Laboratory - Woods Hole	Hsu, SF (corresponding author), UNIV WISCONSIN, SCH MED, DEPT PHYSIOL, MADISON, WI 53706 USA.		Augustine, George James/J-9228-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030016, R01NS021624, R37NS030016] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30016, NS21624] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P143, DOI 10.1113/jphysiol.1985.sp015818; AUGUSTINE GJ, 1984, J PHYSIOL-LONDON, V346, P257, DOI 10.1113/jphysiol.1984.sp015020; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BOWNDS MD, 1995, BEHAV BRAIN SCI, V18, P415, DOI 10.1017/S0140525X00039170; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CHENG HP, 1995, SCIENCE, V267, P2009, DOI 10.1126/science.7701326; CORRIE JET, 1993, J PHYSIOL-LONDON, V465, P1; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; EATOCK RA, 1987, J NEUROSCI, V7, P2821; EllisDavies GCR, 1996, BIOPHYS J, V70, P1006, DOI 10.1016/S0006-3495(96)79644-3; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GYORKE S, 1993, SCIENCE, V260, P807, DOI 10.1126/science.8387229; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HERRINGTON J, 1994, PULSE CONTROL VERSIO; Hodgkin AL., 1964, CONDUCTION NERVOUS I; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Katz B., 1969, RELEASE NEURAL TRANS; KELLY JS, 1969, J NEUROBIOL, V2, P209; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KNOX BE, 1986, P NATL ACAD SCI USA, V83, P2345, DOI 10.1073/pnas.83.8.2345; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; LLINAS R, 1975, P NATL ACAD SCI USA, V72, P187, DOI 10.1073/pnas.72.1.187; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MOORE WJ, 1972, PHYSICAL CHEM; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; PARNAS H, 1989, BIOPHYS J, V55, P859, DOI 10.1016/S0006-3495(89)82885-1; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; SCHELLER RH, 1995, NEURON, V14, P893; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; STUENKEL EL, 1993, J PHYSIOL-LONDON, V468, P335, DOI 10.1113/jphysiol.1993.sp019775; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	57	132	132	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					501	512		10.1016/S0896-6273(00)80182-8	http://dx.doi.org/10.1016/S0896-6273(00)80182-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816713	Bronze			2022-12-28	WOS:A1996VJ44000016
J	Blaxton, TA				Blaxton, TA			Distinguishing false from true in human memory	NEURON			English	Review							POSITRON EMISSION TOMOGRAPHY; EPISODIC MEMORY; HUMAN BRAIN; RETRIEVAL; RECOGNITION; HIPPOCAMPUS				Blaxton, TA (corresponding author), NINCDS,NIH,BETHESDA,MD 20892, USA.							Blaxton TA, 1996, CAN J EXP PSYCHOL, V50, P42, DOI 10.1037/1196-1961.50.1.42; BUCKNER RL, 1995, J NEUROSCI, V15, P12; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; MOSCOVITCH M, 1995, P NATL ACAD SCI USA, V92, P3721, DOI 10.1073/pnas.92.9.3721; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Schacter D. L., 1996, SEARCHING MEMORY BRA; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SCHACTER DL, 1996, NEURON, V17; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Talairach J., 1988, COPLANAR STEREOTAXIC; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2012, DOI 10.1073/pnas.91.6.2012; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030	17	8	8	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					191	194		10.1016/S0896-6273(00)80150-6	http://dx.doi.org/10.1016/S0896-6273(00)80150-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780642	Bronze			2022-12-28	WOS:A1996VE84000001
J	Guo, M; Jan, LY; Jan, YN				Guo, M; Jan, LY; Jan, YN			Control of daughter cell fates during asymmetric division: Interaction of numb and notch	NEURON			English	Article							DROSOPHILA NEUROGENIC GENE; LOOP-HELIX PROTEINS; ORGAN FORMATION; NERVOUS-SYSTEM; FUSHI-TARAZU; MELANOGASTER; LOCUS; EXPRESSION; RECEPTOR; EMBRYOS	During development of the Drosophila peripheral nervous system, a sensory organ precursor (SOP) cell undergoes rounds of asymmetric divisions to generate four distinct cells of a sensory organ. Numb, a membrane-associated protein, is asymmetrically segregated into one daughter cell during SOP division and acts as an inherited determinant of cell fate. Here, we show that Notch, a transmembrane receptor mediating cell-cell communication, functions as a binary switch in cell fate specification during asymmetric divisions of the SOP and its daughter cells in embryogenesis. Moreover, numb negatively regulates Notch, probably through direct protein-protein interaction that requires the phosphotyrosine-binding (PTB) domain of Numb and either the RAM23 region or the very C-terminal end of Notch. Notch then positively regulates a transcription factor encoded by tramtrack (ttk). This leads to Ttk expression in the daughter cell that does not inherit Numb. Thus, the inherited determinant Numb bestows a bias in the machinery for cell-cell communication to allow the specification of distinct daughter cell fates.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Guo, M (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; ASHBURNER M, 1982, GENETICS, V101, P447; Ashburner M., 1989, DROSOPHILA LAB HDB; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BATE CM, 1978, HDB SENSORY PHYSL, P1; BIER E, 1988, SCIENCE, V240, P913, DOI 10.1126/science.3129785; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; BROWN JL, 1991, EMBO J, V10, P665, DOI 10.1002/j.1460-2075.1991.tb07995.x; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GINIGER E, 1993, DEVELOPMENT, V117, P431; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JAN YN, 1995, NEURON, V14, P1; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KNUST E, 1992, GENETICS, V132, P505; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; Laminet AA, 1996, J BIOL CHEM, V271, P264, DOI 10.1074/jbc.271.1.264; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; LYMAN DF, 1995, GENETICS, V141, P1491; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; READ D, 1992, MECH DEVELOP, V38, P183, DOI 10.1016/0925-4773(92)90052-L; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RHYU MS, 1994, THESIS U CALIFORNIA; RUCHOLA H, 1991, CELL, V66, P433; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VAESSIN H, 1987, EMBO (European Molecular Biology Organization) Journal, V6, P3431; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; XU T, 1992, DEVELOPMENT, V115, P913; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	77	534	548	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					27	41		10.1016/S0896-6273(00)80278-0	http://dx.doi.org/10.1016/S0896-6273(00)80278-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755476	Bronze			2022-12-28	WOS:A1996UY98100005
J	Boxall, AR; Lancaster, B; Garthwaite, J				Boxall, AR; Lancaster, B; Garthwaite, J			Tyrosine kinase is required for long-term depression in the cerebellum	NEURON			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; PURKINJE-CELLS; PROTEIN-KINASE; CALCIUM TRANSIENTS; CLIMBING FIBER; LAVENDUSTIN-A; RAT-BRAIN; ACETYLCHOLINE-RECEPTOR; SYNAPTIC CURRENTS; HERBIMYCIN-A	Long-term depression (LTD) at the parallel fiber-Purkinje cell synapse in the cerebellum is a well-known example of synaptic plasticity. Although LTD is thought to reflect an enduring loss of postsynaptic AMPA receptor sensitivity, the underlying mechanisms are unclear. Protein-tyrosine kinases (PTKs) are able to modulate ionotropic receptor function and are enriched in Purkinje cells. Using intracellular recording from Purkinje cells, it is shown that two structurally and mechanistically distinct PTK inhibitors, lavendustin A and herbimycin A, block LTD induced by pairing parallel fiber stimulation with postsynaptic Ca2+ spiking. Intracellular application of the protein kinase C (PKC) activator, (-)-indolactam V, consistently depressed parallel fiber-Purkinje cell EPSPs and occluded pairing-induced LTD. Herbimycin A nullified the run-down produced by (-)-indolactam V. These data suggest that PTKs are necessary for LTD at the parallel fiber-Purkinje cell synapse and that PKC-induced synaptic depression requires PTK activity.	UCL, CRUCIFORM PROJECT, LONDON W1P 91N, ENGLAND	University of London; University College London	Boxall, AR (corresponding author), UCL, RAYNE INST, CRUCIFORM PROJECT, 5 UNIV ST, LONDON WC1E 6JQ, ENGLAND.							ABE K, 1993, BRAIN RES, V621, P167, DOI 10.1016/0006-8993(93)90315-E; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1986, J PHYSIOL-LONDON, V372, P1; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; DANIEL H, 1992, EXP BRAIN RES, V90, P327; DUBOIS PM, 1994, EUR J IMMUNOL, V24, P348, DOI 10.1002/eji.1830240212; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; FALET H, 1994, FEBS LETT, V345, P87, DOI 10.1016/0014-5793(94)00414-5; FUJIKI H, 1984, GANN, V75, P866; FUKUZAWA H, 1994, FEBS LETT, V340, P155; FUKUZAWA H, 1991, BIOCHEM PHARMACOL, V42, P1661; GARTHWAITE J, 1989, NEUROSCI LETT, V107, P151, DOI 10.1016/0304-3940(89)90808-2; GOLARD A, 1993, J NEUROPHYSIOL, V70, P1639, DOI 10.1152/jn.1993.70.4.1639; GRANDALIANO G, 1994, AM J PHYSIOL-RENAL, V267, pF528, DOI 10.1152/ajprenal.1994.267.4.F528; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GRONROOS E, 1995, CELL CALCIUM, V17, P177, DOI 10.1016/0143-4160(95)90032-2; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HSU CYJ, 1991, J BIOL CHEM, V266, P21105; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; HUGANIR RL, 1991, ADV EXP MED BIOL, P279; HUNTER T, 1982, J BIOL CHEM, V257, P4843; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1990, Neuroreport, V1, P129; KANO M, 1988, NEUROSCI RES, V5, P544, DOI 10.1016/0168-0102(88)90041-7; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KASONO K, 1994, NEUROREPORT, V6, P17, DOI 10.1097/00001756-199412300-00006; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KOSE A, 1988, J NEUROSCI, V8, P4262; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LEVY JB, 1993, J BIOL CHEM, V268, P10573; LIEBENHOFF U, 1993, BIOCHEM J, V295, P41, DOI 10.1042/bj2950041; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; MOSS SJ, 1995, NATURE, V377, P344, DOI 10.1038/377344a0; MOSS SJ, 1993, NEUROCHEM RES, V18, P105, DOI 10.1007/BF00966929; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; ONODA T, 1989, J NAT PROD, V52, P1252, DOI 10.1021/np50066a009; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SICILIANO JC, 1994, J NEUROCHEM, V62, P950; SUGRUE MM, 1990, J NEUROSCI, V10, P2513; TERRIAN DM, 1995, J NEUROCHEM, V64, P172; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; UEHARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P803, DOI 10.1016/0006-291X(89)92293-6; VALENZUELA CF, 1995, MOL BRAIN RES, V31, P165, DOI 10.1016/0169-328X(95)00048-W; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; WANG YT, 1994, NATURE, V369, P223; ZHAO YH, 1991, ONCOGENE, V6, P1725; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298	76	60	61	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR	1996	16	4					805	813		10.1016/S0896-6273(00)80100-2	http://dx.doi.org/10.1016/S0896-6273(00)80100-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607998	Bronze			2022-12-28	WOS:A1996UG61100013
J	Inestrosa, NC; Alvarez, A; Perez, CA; Moreno, RD; Vicente, M; Linker, C; Casanueva, OI; Soto, C; Garrido, J				Inestrosa, NC; Alvarez, A; Perez, CA; Moreno, RD; Vicente, M; Linker, C; Casanueva, OI; Soto, C; Garrido, J			Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme	NEURON			English	Article							CORTICAL CHOLINERGIC INNERVATION; HEPARAN-SULFATE PROTEOGLYCANS; MOLECULAR-FORMS; NEURITIC PLAQUES; EXTRACELLULAR-MATRIX; CEREBROSPINAL-FLUID; TORPEDO-CALIFORNICA; SENILE DEMENTIA; CEREBRAL-CORTEX; SELECTIVE LOSS	Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-beta peptide (A beta) deposits of Alzheimer's brain. We report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type A beta and a mutant A beta peptide, which alone produces few amyloid-like fibrils. The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand. Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation. Furthermore, AChE is a potent amyloid-promoting factor when compared with other A beta-associated proteins. Thus, in addition to its role in cholinergic synapses, AChE may function by accelerating A beta formation and could play a role during amyloid deposition in Alzheimer's brain.			Inestrosa, NC (corresponding author), PONTIFICIA UNIV CATOLICA CHILE, FAC CIENCIAS BIOL, DEPT BIOL CELULAR & MOLEC, ALAMEDA 340, SANTIAGO, CHILE.		Perez, Cristian A./A-2341-2008; Moreno, Ricardo R/C-6802-2011	Alvarez Rojas, Alejandra/0000-0002-8129-9280				Alvarez A, 1995, NEUROSCI LETT, V201, P49, DOI 10.1016/0304-3940(94)12127-C; Amitai G, 1991, CHOLINESTERASES STRU, V285; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ATACK JR, 1983, NEUROSCI LETT, V40, P199, DOI 10.1016/0304-3940(83)90302-6; BARAK D, 1994, J BIOL CHEM, V269, P6296; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BEERI R, 1995, CURR BIOL, V5, P1063, DOI 10.1016/S0960-9822(95)00211-9; BERGMANN F, 1950, BIOCHIM BIOPHYS ACTA, V6, P217, DOI 10.1016/0006-3002(50)90094-1; BERGMANN F, 1954, BIOCHEM J, V58, P692, DOI 10.1042/bj0580692; Bondi Mark W., 1994, P41; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; BRANDAN E, 1993, GEN PHARMACOL, V24, P1063, DOI 10.1016/0306-3623(93)90350-7; BRANDAN E, 1985, J CELL BIOL, V101, P985, DOI 10.1083/jcb.101.3.985; CARSON KA, 1991, BRAIN RES, V540, P204, DOI 10.1016/0006-8993(91)90508-S; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DEPREZ PN, 1995, J BIOL CHEM, V270, P11043, DOI 10.1074/jbc.270.19.11043; EICHLER J, 1994, MOL PHARMACOL, V45, P335; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; FISHMAN EB, 1986, ANN NEUROL, V19, P246, DOI 10.1002/ana.410190305; FUENTES ME, 1988, BIOCHEM J, V256, P1047, DOI 10.1042/bj2561047; GEULA C, 1989, BRAIN RES, V498, P185, DOI 10.1016/0006-8993(89)90419-8; Geula Changiz, 1994, P263; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GOMEZRAMOS P, 1992, BRAIN RES, V569, P229, DOI 10.1016/0006-8993(92)90634-L; HALL ZW, 1971, NATURE-NEW BIOL, V232, P62, DOI 10.1038/newbio232062a0; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; HAREL M, 1992, MULTIDISCIPLINARY AP, P233; INESTROSA NC, 1988, NEUROSCI LETT, V90, P186, DOI 10.1016/0304-3940(88)90809-9; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; INESTROSA NC, 1983, EXP CELL RES, V147, P393, DOI 10.1016/0014-4827(83)90221-5; INESTROSA NC, 1990, J MEMBRANE BIOL, V118, P1, DOI 10.1007/BF01872200; INESTROSA NC, 1989, TRENDS PHARMACOL SCI, V10, P325, DOI 10.1016/0165-6147(89)90067-9; IVERSEN LL, 1995, BIOCHEM J, V311, P1; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KALARIA RN, 1991, NEUROPATH APPL NEURO, V17, P189, DOI 10.1111/j.1365-2990.1991.tb00714.x; Katzman Robert, 1994, P105; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; LANSBURY PT, 1992, BIOCHEMISTRY-US, V31, P6865, DOI 10.1021/bi00145a001; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MAIN AR, 1976, BIOL CHOLINERGIC FUN, P269; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MESULAM MM, 1987, ANN NEUROL, V22, P683, DOI 10.1002/ana.410220603; MESULAM MM, 1986, NEUROSCIENCE, V17, P275, DOI 10.1016/0306-4522(86)90242-3; MESULAM MM, 1988, ANN NEUROL, V24, P765, DOI 10.1002/ana.410240611; MORAN MA, 1993, ACTA NEUROPATHOL, V85, P362, DOI 10.1007/BF00334445; NAIKI H, 1991, LAB INVEST, V65, P104; Nakamura S, 1990, J Neural Transm Suppl, V30, P13; NAVARATNAM DS, 1991, LANCET, V337, P447, DOI 10.1016/0140-6736(91)93391-L; PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457; RADIC Z, 1991, MOL PHARMACOL, V39, P98; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHEN ZX, 1994, MED HYPOTHESES, V43, P21, DOI 10.1016/0306-9877(94)90045-0; SILMAN I, 1994, BIOCHEM SOC T, V22, P745, DOI 10.1042/bst0220745; SMITH AD, 1984, LANCET, V1, P513; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SNOW AD, 1988, AM J PATHOL, V133, P456; SOTO C, 1994, J NEUROCHEM, V63, P1191; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; STRUBLE RG, 1982, SCIENCE, V216, P413, DOI 10.1126/science.6803359; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Sussman JL, 1992, CURR OPIN STRUC BIOL, V2, P721; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; Terry Robert D., 1994, P179; VELAN B, 1991, J BIOL CHEM, V266, P23977; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; WEISE C, 1990, EMBO J, V9, P3885, DOI 10.1002/j.1460-2075.1990.tb07607.x; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; WILSON IB, 1958, ARCH BIOCHEM BIOPHYS, V73, P131, DOI 10.1016/0003-9861(58)90248-0; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WRIGHT CI, 1993, P NATL ACAD SCI USA, V90, P683, DOI 10.1073/pnas.90.2.683; YOUNKIN SG, 1986, FASEB J, V45, P2982	86	937	960	4	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					881	891		10.1016/S0896-6273(00)80108-7	http://dx.doi.org/10.1016/S0896-6273(00)80108-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608006	hybrid			2022-12-28	WOS:A1996UG61100021
J	Laurent, G				Laurent, G			Odor images and tunes	NEURON			English	Review							NADPH-DIAPHORASE; NITRIC-OXIDE; MESSENGER				Laurent, G (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X				ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Ache Barry W., 1994, Seminars in Cell Biology, V5, P55, DOI 10.1006/scel.1994.1008; BARRIE JM, 1996, IN PRESS NEUROPHYSIO; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; DIONNE VE, 1994, P NATL ACAD SCI USA, V91, P6253, DOI 10.1073/pnas.91.14.6253; DUBIN AE, 1994, J GEN PHYSIOL, V103, P181, DOI 10.1085/jgp.103.2.181; ELPHICK MR, 1995, J EXP BIOL, V198, P821; EZEH PI, 1995, J NEUROPHYSIOL, V70, P263; GELPERIN A, 1994, NATURE, V369, P61, DOI 10.1038/369061a0; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; KAY LM, 1995, THESIS U CALIFORNIA; Kent PF, 1996, J NEUROSCI, V16, P345; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; MULLER U, 1993, NATURWISSENSCHAFTEN, V80, P524, DOI 10.1007/BF01140811; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YOUNGENTOB SL, 1995, J NEUROPHYSIOL, V73, P387, DOI 10.1152/jn.1995.73.1.387	25	25	25	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					473	476		10.1016/S0896-6273(00)80066-5	http://dx.doi.org/10.1016/S0896-6273(00)80066-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785044	Bronze			2022-12-28	WOS:A1996UC16800003
J	Ranganathan, R; Lewis, JH; MacKinnon, R				Ranganathan, R; Lewis, JH; MacKinnon, R			Spatial localization of the K+ channel selectivity filter by mutant cycle-based structure analysis	NEURON			English	Article							POTASSIUM CHANNEL; 3-DIMENSIONAL STRUCTURE; CHARYBDOTOXIN BLOCK; COMPLEX; VOLTAGE; SHAKER; SITE; PORE	The structurally well-characterized scorpion toxin Agitoxin2 inhibits ion permeation through Shaker K+ channels by binding to the external pore entryway. Scanning mutagenesis identified a set of inhibitor residues critical for making energetic contacts with the channel. Using thermodynamic mutant cycle analysis, we have mapped channel residues relative to the known inhibitor structure. This study constrains the position of multiple channel residues within the pore-forming loops; in one stretch, we have been able to map five out of seven contiguous residues to the inhibitor interaction surface, including those involved in ion selectivity. One interaction in particular, that of K27M on the inhibitor with Y445F on the channel, is unique in that it depends on the K+ ion concentration. These results reveal a shallow vestibule formed by the pore loops at the K+ channel entryway. The selectivity filter is located at the center of the vestibule close to (similar to 5 Angstrom) the extracellular solution.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School					NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; BOTEMS F, 1991, SCIENCE, V254, P1521; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GROSS A, 1996, IN PRESS NEURON; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HIDALGO P, 1995, OBTAINING STRUCTURAL; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JANIN J, 1990, J BIOL CHEM, V265, P16027; JOHNSON BA, 1992, BIOCHEMISTRY-US, V31, P8151, DOI 10.1021/bi00150a006; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KREZEL AM, 1995, PROTEIN SCI, V4, P1478, DOI 10.1002/pro.5560040805; LU Z, 1994, J GEN PHYSIOL, V104, P477, DOI 10.1085/jgp.104.3.477; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	34	280	283	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					131	139		10.1016/S0896-6273(00)80030-6	http://dx.doi.org/10.1016/S0896-6273(00)80030-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562077	Bronze			2022-12-28	WOS:A1996TT30700016
J	Sun, ZP; Akabas, MH; Goulding, EH; Karlin, A; Siegelbaum, SA				Sun, ZP; Akabas, MH; Goulding, EH; Karlin, A; Siegelbaum, SA			Exposure of residues in the cyclic nucleotide-gated channel pore: P region structure and function in gating	NEURON			English	Article							POTASSIUM CHANNELS; ION PERMEATION; K+ CHANNELS; SODIUM-CHANNEL; RECEPTOR; SELECTIVITY; EXPRESSION; DROSOPHILA; MUTATIONS; PATHWAYS	In voltage-gated ion channels and in the homologous cyclic nucleotide-gated (CNG) channels, the loop between the S5 and S6 transmembrane segments (P region) is thought to form the lining of the pore. To investigate the structure and the role in gating of the P region of the bovine retinal CNG channel, we determined the accessibility of 11 cysteine-substituted P region residues to small, charged sulfhydryl reagents applied to the inside and outside of membrane patches in the open and closed states of the channel. The results suggest that the P region forms a loop that extends toward the central axis of the channel, analogous to the L3 loop of bacterial porin channels. Furthermore, the P region, in addition to forming the ion selectivity filter, functions as the channel gate, the structure of which changes when the channel opens.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PHYSIOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR MOLEC RECOGNIT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Sun, ZP (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,630 W 168TH ST,NEW YORK,NY 10032, USA.			Akabas, Myles/0000-0001-8781-7846; KARLIN, ARTHUR/0000-0002-4813-752X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER; NINDS NIH HHS [NS07065, NS30808] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; CATTERALL WA, 1993, TRENDS NEUROSCI, V16, P500, DOI 10.1016/0166-2236(93)90193-P; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; KRAMER RH, 1994, NEURON, V12, P655, DOI 10.1016/0896-6273(94)90220-8; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; ROOT MJ, 1993, NEURON, V11, P459, DOI 10.1016/0896-6273(93)90150-P; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; YELLEN G, 1991, NATURE, V349, P700; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	41	101	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					141	149		10.1016/S0896-6273(00)80031-8	http://dx.doi.org/10.1016/S0896-6273(00)80031-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562078	hybrid			2022-12-28	WOS:A1996TT30700017
J	Freitag, J; Krieger, J; Strotmann, J; Breer, H				Freitag, J; Krieger, J; Strotmann, J; Breer, H			Two grasses of olfactory receptors in Xenopus laevis	NEURON			English	Article							ENCODING ODORANT RECEPTORS; MULTIGENE FAMILY; EXPRESSION; EPITHELIUM; CATFISH; INFORMATION; GENES	Xenopus laevis possess a gene repertoire encoding two distinct classes of olfactory receptors: one class related to receptors of fish and one class similar to receptors of mammals. Sequence comparison indicates that the fish-like receptors represent closely related members of only two subfamilies, whereas mammalian-like receptors are more distantly related, most of them representing a different subfamily. The fishlike receptor genes are exclusively expressed in the lateral diverticulum of the frog's nose, specialized for detecting water-soluble odorants, whereas mammalian-like receptors are expressed in sensory neurons of the main diverticulum, responsible for the reception of volatile odors.			Freitag, J (corresponding author), UNIV STUTTGART HOHENHEIM,INST ZOOPHYSIOL,D-70593 STUTTGART,GERMANY.							ALTNER H, 1962, Z VERGL PHYSIOL, V45, P272, DOI 10.1007/BF00302326; Angerer L.M., 1992, IN SITU HYBRIDIZATIO, P15; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUCK L, 1993, CHEM SENSES, V18, P203, DOI 10.1093/chemse/18.2.203; ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189; Foske H., 1934, Zeitschrift fuer Anatomie Entw Mech, V103, P519, DOI 10.1007/BF02118933; HARA TJ, 1994, ACTA PHYSIOL SCAND, V152, P207, DOI 10.1111/j.1748-1716.1994.tb09800.x; HOFMANN MH, 1991, BRAIN RES, V564, P344, DOI 10.1016/0006-8993(91)91475-G; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; Mayr E, 1942, SYSTEMATICS ORIGIN S; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CHEM SENSES, V18, P209, DOI 10.1093/chemse/18.2.209; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARTZ RM, 1979, ATLAS PROTEIN SEQUEU; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; STROTMANN J, 1994, CELL TISSUE RES, V276, P429; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M	28	202	207	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1383	1392		10.1016/0896-6273(95)90016-0	http://dx.doi.org/10.1016/0896-6273(95)90016-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845161	Bronze			2022-12-28	WOS:A1995TL67800016
J	CHANG, CP; PEARSE, RV; OCONNELL, S; ROSENFELD, MG				CHANG, CP; PEARSE, RV; OCONNELL, S; ROSENFELD, MG			IDENTIFICATION OF A 7 TRANSMEMBRANE HELIX RECEPTOR FOR CORTICOTROPIN-RELEASING FACTOR AND SAUVAGINE IN MAMMALIAN BRAIN	NEURON			English	Article							ADENYLATE-CYCLASE ACTIVITY; ANTERIOR-PITUITARY CELLS; FACTOR CRF RECEPTORS; CALCITONIN GENE; FACTOR-BINDING; MESSENGER-RNA; UROTENSIN-I; CYCLIC-AMP; G-PROTEIN; AUTORADIOGRAPHIC LOCALIZATION	We have identified and characterized cDNAs encoding a novel receptor that is a member of a distinct class of seven transmembrane helix, G(s)-coupled receptors. This receptor mediates ligand-dependent stimulation of intracellular cAMP levels in response to physiologic concentrations of corticotropin-releasing factor (CRF) and to the related frog skin peptide, sauvagine. The pattern of CRF receptor mRNA expression in the brain, pituitary gland, and other organs corresponds precisely to that predicted for the classic CRF receptor, suggesting that this receptor serves to mediate the known biological effects of CRF on behavior, stress, and homeostasis. Alternative splicing events generate a second, relatively abundant gene product expressed in a distinct ontogenic pattern. These findings serve to identify the receptor for an important neuropeptide.	UNIV CALIF SAN DIEGO, GRAD PROGRAM BIOMED, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego	CHANG, CP (corresponding author), UNIV CALIF SAN DIEGO, SCH MED, HOWARD HUGHES MED INST, DEPT MED, EUKARYOT REGULATORY BIOL PROGRAM, LA JOLLA, CA 92093 USA.			Pearse, Richard/0000-0003-3972-1457	NIMH NIH HHS [NIMH MH47137] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aguilera G, 1988, Adv Exp Med Biol, V245, P83; AGUILERA G, 1987, ANN NY ACAD SCI, V512, P48; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; BARINAGA M, 1983, NATURE, V306, P84, DOI 10.1038/306084a0; BATTAGLIA G, 1987, SYNAPSE, V1, P572, DOI 10.1002/syn.890010610; BILEZIKJIAN LM, 1983, ENDOCRINOLOGY, V113, P1726, DOI 10.1210/endo-113-5-1726; BRITTON DR, 1984, BRAIN RES, V304, P201, DOI 10.1016/0006-8993(84)90322-6; BROWN MR, 1982, REGUL PEPTIDES, V4, P107, DOI 10.1016/0167-0115(82)90101-X; CHEN FM, 1986, BRAIN RES, V381, P49; CHENG TC, 1983, ENDOCRINOLOGY, V113, P1669, DOI 10.1210/endo-113-5-1669; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLINS S, 1992, TRENDS BIOCHEM SCI, V17, P37, DOI 10.1016/0968-0004(92)90425-9; De Souza E B, 1986, Methods Enzymol, V124, P560; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; EMESON RB, 1989, NATURE, V341, P76, DOI 10.1038/341076a0; FROHMAN MA, 1989, MOL ENDOCRINOL, V3, P1529, DOI 10.1210/mend-3-10-1529; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; GIGUERE V, 1982, P NATL ACAD SCI-BIOL, V79, P3466, DOI 10.1073/pnas.79.11.3466; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; GRIGORIADIS DE, 1989, PEPTIDES, V10, P179, DOI 10.1016/0196-9781(89)90095-8; GRIGORIADIS DE, 1989, ENDOCRINOLOGY, V125, P1877, DOI 10.1210/endo-125-4-1877; GUILLEMIN R, 1955, ENDOCRINOLOGY, V57, P599, DOI 10.1210/endo-57-5-599; HEN R, 1989, P NATL ACAD SCI USA, V86, P4785, DOI 10.1073/pnas.86.12.4785; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JANSSOJN JO, 1986, SCIENCE, V232, P415; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KOOB GF, 1993, CIBA F SYMP, V172, P277; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEDERIS K, 1983, CAN J BIOCHEM CELL B, V61, P602, DOI 10.1139/o83-076; LEVINE MA, 1988, P NATL ACAD SCI USA, V85, P617, DOI 10.1073/pnas.85.2.617; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V18, P113; NISHIMURA E, 1987, J BIOL CHEM, V262, P12893; OKAWARA Y, 1988, P NATL ACAD SCI USA, V85, P8439, DOI 10.1073/pnas.85.22.8439; OWENS MJ, 1993, CIBA F SYMP, V172, P296; PERRIN MH, 1986, ENDOCRINOLOGY, V118, P1171, DOI 10.1210/endo-118-3-1171; POTTER E, 1991, NATURE, V349, P423, DOI 10.1038/349423a0; POTTER E, 1992, P NATL ACAD SCI USA, V89, P4192, DOI 10.1073/pnas.89.9.4192; RIVIER C, 1983, REGUL PEPTIDES, V5, P139, DOI 10.1016/0167-0115(83)90121-0; ROGER PP, 1983, FEBS LETT, V157, P323, DOI 10.1016/0014-5793(83)80569-9; ROSENDALE BE, 1987, ENDOCRINOLOGY, V120, P2357, DOI 10.1210/endo-120-6-2357; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; SAFFRAN M, 1955, CAN J BIOCHEM PHYS, V33, P408; Sambrook J, 1989, MOL CLONING LABORATO; SAWCHENKO PE, 1993, CIBA F SYMP, V172, P5; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; STANGL D, 1991, BIOCHEMISTRY-US, V30, P8605, DOI 10.1021/bi00099a016; STENZELPOORE MP, 1992, MOL ENDOCRINOL, V6, P1716, DOI 10.1210/me.6.10.1716; THOMPSON RC, 1987, MOL ENDOCRINOL, V1, P363, DOI 10.1210/mend-1-5-363; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; TSANG BK, 1980, J CELL PHYSIOL, V102, P19, DOI 10.1002/jcp.1041020104; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; WEBSTER EL, 1988, ENDOCRINOLOGY, V122, P609, DOI 10.1210/endo-122-2-609; WEBSTER EL, 1989, PEPTIDES, V10, P395, DOI 10.1016/0196-9781(89)90049-1; WEBSTER EL, 1991, STRESS NEUROPEPTIDES, P223; WEI ET, 1993, CIBA F SYMP, V172, P258; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; WIMALAWANSA SJ, 1992, ANN NY ACAD SCI, V657, P70, DOI 10.1111/j.1749-6632.1992.tb22758.x	66	501	512	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1187	1195		10.1016/0896-6273(93)90230-O	http://dx.doi.org/10.1016/0896-6273(93)90230-O			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274282				2022-12-28	WOS:A1993MP54800018
J	BAUERFEIND, R; REGNIERVIGOUROUX, A; FLATMARK, T; HUTTNER, WB				BAUERFEIND, R; REGNIERVIGOUROUX, A; FLATMARK, T; HUTTNER, WB			SELECTIVE STORAGE OF ACETYLCHOLINE, BUT NOT CATECHOLAMINES, IN NEUROENDOCRINE SYNAPTIC-LIKE MICROVESICLES OF EARLY ENDOSOMAL ORIGIN	NEURON			English	Article							VESICULAR MONOAMINE TRANSPORTER; PHEOCHROMOCYTOMA CELL-LINE; IMMATURE SECRETORY GRANULE; CHROMOGRANINS SECRETOGRANINS; BIOCHEMICAL-EVIDENCE; CHROMAFFIN GRANULES; REGULATED PATHWAY; PC12 CELLS; VESICLES; SYNAPTOPHYSIN	We have defined, in the neuroendocrine cell line PC12, the catecholamine- and acetylcholine-storing organelles in the context of the biogenesis of secretory granules and synaptic-like microvesicles (SLMVs). SLMVs were found to originate directly from early endosomes. Both early endosomes and SLMVs exhibited uptake and storage of biosynthetic acetylcholine. Surprisingly, however, despite the presence of a reserpine-sensitive vesicular amine transporter in early endosomes, SLMVs lacked detectable uptake and storage of catecholamines. This was confined to two populations of mature secretory granules, referred to as small and large mature secretory granules, which both derived from immature secretory granules. Our results show that PC 12 cells lack small dense core vesicles, i.e., the catecholamine-storing, but secretory protein-lacking, vesicles found in sympathetic neurons and imply that the biogenesis of these vesicles requires the expression of a distinct type of vesicular amine transporter and/or a change in endosomal protein sorting.			BAUERFEIND, R (corresponding author), UNIV HEIDELBERG, INST NEUROBIOL, NEUENHEIMER FELD 364, D-69120 HEIDELBERG, GERMANY.		Huttner, Wieland B./P-4080-2018					CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; CUTLER DF, 1990, J CELL BIOL, V110, P721, DOI 10.1083/jcb.110.3.721; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; FRIEDERICH E, 1988, J CELL BIOL, V107, P1655, DOI 10.1083/jcb.107.5.1655; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; HELL JW, 1990, J BIOL CHEM, V265, P2111; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; HUTTNER WB, 1991, MARKERS NEURAL ENDOC, P93; ISAMBERT MF, 1989, BIOCHEMISTRY-US, V28, P2265, DOI 10.1021/bi00431a044; JOHNSON RG, 1987, ANN NY ACAD SCI, V493, P162, DOI 10.1111/j.1749-6632.1987.tb27198.x; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KLEIN RL, 1982, NEUROTRANSMITTER VES; LEE RWH, 1983, J BIOL CHEM, V258, P1326; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; MELEGA WP, 1984, P NATL ACAD SCI-BIOL, V81, P6535, DOI 10.1073/pnas.81.20.6535; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NEUMAN B, 1984, NEUROSCIENCE, V13, P921, DOI 10.1016/0306-4522(84)90106-4; NORSETH J, 1982, BIOCHIM BIOPHYS ACTA, V719, P569, DOI 10.1016/0304-4165(82)90247-1; PATZAK A, 1986, J CELL BIOL, V102, P510, DOI 10.1083/jcb.102.2.510; REBOIS RV, 1980, BIOCHEMISTRY-US, V19, P1240, DOI 10.1021/bi00547a031; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; REGNIERVIGOUROUX A, 1993, NEUROCHEM RES, V18, P59, DOI 10.1007/BF00966923; ROSA P, 1989, J CELL BIOL, V109, P17, DOI 10.1083/jcb.109.1.17; ROSA P, 1985, J CELL BIOL, V101, P1999, DOI 10.1083/jcb.101.5.1999; ROSA P, 1992, J HISTOCHEM CYTOCHEM, V40, P523, DOI 10.1177/40.4.1552186; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P5184, DOI 10.1073/pnas.74.11.5184; SLINDE E, 1973, ANAL BIOCHEM, V56, P324, DOI 10.1016/0003-2697(73)90198-X; SLINDE E, 1978, ANAL BIOCHEM, V90, P516, DOI 10.1016/0003-2697(78)90145-8; SMITH AD, 1972, PHARMACOL REV, V24, P435; SMITH AD, 1973, BRIT MED BULL, V29, P123, DOI 10.1093/oxfordjournals.bmb.a070981; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TOOZE J, 1989, EUR J CELL BIOL, V49, P259; TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; TOOZE SA, 1992, METHOD ENZYMOL, V219, P81; TOOZE SA, 1991, FEBS LETT, V285, P220, DOI 10.1016/0014-5793(91)80805-D; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; TOOZE SA, 1993, MECHANISMS INTRACELL, P157; TOUTANT JP, 1988, HDB EXP PHARM, V86, P225; Tuek S., 1988, HDB EXPT PHARM, P125; WAGNER JA, 1985, J NEUROCHEM, V45, P1244, DOI 10.1111/j.1471-4159.1985.tb05549.x; WIEDENMANN B, 1988, FEBS LETT, V240, P71, DOI 10.1016/0014-5793(88)80342-9; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WIEDENMANN B, 1989, VIRCHOWS ARCH B, V58, P95, DOI 10.1007/BF02890062; WINKLER H, 1987, ANN NY ACAD SCI, V493, P3, DOI 10.1111/j.1749-6632.1987.tb27176.x	58	131	132	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1993	11	1					105	121		10.1016/0896-6273(93)90275-V	http://dx.doi.org/10.1016/0896-6273(93)90275-V			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338662				2022-12-28	WOS:A1993LP43000010
J	MARRION, NV				MARRION, NV			SELECTIVE REDUCTION OF ONE-MODE OF M-CHANNEL GATING BY MUSCARINE IN SYMPATHETIC NEURONS	NEURON			English	Article							FREE MEMBRANE PATCHES; POTASSIUM-M-CURRENT; CALCIUM CHANNELS; INTRACELLULAR CALCIUM; GANGLION CELLS; KINETIC STATES; INHIBITION; MODULATION; VOLTAGE; PROTEIN	M-current is widespread in the nervous system. It stabilizes cell excitability, and its suppression by muscarinic receptor activation underlies slow synaptic transmission in sympathetic neurons. Suppression of M-current was one of the first examples of neuromodulation of a potassium current, but the mechanism is not understood. Single-channel recording was used to study this issue. An M-channel with two conductance states, which exhibited appropriate voltage-dependent kinetics with two modes of gating, has been resolved. Mode 1 comprises short open time, low open probability events, and mode 2 openings represent long open time, high open probability behavior. Muscarine decreased M-channel activity by selectively reducing mode 2 M-channel gating through a diffusible second messenger. It is suggested that control of modal gating may be a widespread mechanism for neuromodulation.			MARRION, NV (corresponding author), SUNY,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794, USA.				NINDS NIH HHS [NS 29806] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029806, R29NS029806, R55NS029806] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; ADAMS PR, 1986, J EXP BIOL, V124, P259; ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; AUERBACH A, 1986, J PHYSIOL-LONDON, V378, P119, DOI 10.1113/jphysiol.1986.sp016211; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; GRUNER W, 1991, THESIS SUNY STONY BR; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; JONES SW, 1991, BIOPHYS J, V60, P502, DOI 10.1016/S0006-3495(91)82077-X; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KOYANO K, 1992, J PHYSIOL-LONDON, V454, P231, DOI 10.1113/jphysiol.1992.sp019262; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LOPEZ HS, 1992, NEURON, V8, P725, DOI 10.1016/0896-6273(92)90093-S; LOPEZ HS, 1989, EUR J NEUROSCI, V1, P529, DOI 10.1111/j.1460-9568.1989.tb00360.x; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MARRION NV, 1992, P ROY SOC B-BIOL SCI, V248, P207, DOI 10.1098/rspb.1992.0063; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; NEHER E, 1988, FEBS LETT, V240, P88, DOI 10.1016/0014-5793(88)80345-4; NILIUS B, 1988, BIOPHYS J, V53, P857, DOI 10.1016/S0006-3495(88)83166-7; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; OWEN DG, 1990, J PHYSIOL-LONDON, V431, P269, DOI 10.1113/jphysiol.1990.sp018330; PATLAK JB, 1979, NATURE, V278, P643, DOI 10.1038/278643a0; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753	36	45	45	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					77	84		10.1016/0896-6273(93)90272-S	http://dx.doi.org/10.1016/0896-6273(93)90272-S			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338670				2022-12-28	WOS:A1993LP43000007
J	MOONEY, R; MADISON, DV; SHATZ, CJ				MOONEY, R; MADISON, DV; SHATZ, CJ			ENHANCEMENT OF TRANSMISSION AT THE DEVELOPING RETINOGENICULATE SYNAPSE	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; LONG-TERM POTENTIATION; MEDIATING EXCITATORY INPUT; THALAMIC NEURONS INVITRO; OCULAR DOMINANCE COLUMNS; PRENATAL DEVELOPMENT; NMDA RECEPTORS; VISUAL-CORTEX; HIPPOCAMPAL SLICES; GANGLION-CELLS	Axon terminals from retinal ganglion cells in the left and right eyes initially overlap with each other in the lateral geniculate nucleus of the neonatal ferret, then segregate into eye-specific layers via an activity-dependent process. Brain slices were used to show that, during this period of reorganization, retinal terminals within the lateral geniculate nucleus evoke excitatory postsynaptic currents composed of both NMDA and non-NMDA receptor-mediated currents. The amplitude of these currents could be enhanced for several tens of minutes to more than an hour by several bursts of high frequency synaptic stimulation, and the induction of enhancement appears to depend on NMDA receptor activation. Synaptic enhancement such as this could provide one of the physiological mechanisms by which retinal terminals segregate into eye-specific layers during development.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	MOONEY, R (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		; Madison, Daniel/F-9341-2017	Mooney, Richard/0000-0002-3308-1367; Madison, Daniel/0000-0002-0718-5373	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007158, T32NS007280] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 48108] Funding Source: Medline; NINDS NIH HHS [5 T32 NS07158, 5 T32 NS07280] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARCHER SM, 1982, SCIENCE, V217, P743, DOI 10.1126/science.7100921; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; DESCHENES M, 1984, J NEUROPHYSIOL, V51, P1196, DOI 10.1152/jn.1984.51.6.1196; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; ESGUERRA M, 1992, VISUAL NEUROSCI, V8, P545, DOI 10.1017/S0952523800005642; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; GRAHAM J, 1977, J COMP NEUROL, V173, P629, DOI 10.1002/cne.901730403; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HAHM JO, 1991, NATURE, V351, P368; HARTVEIT E, 1990, J NEUROPHYSIOL, V63, P1361, DOI 10.1152/jn.1990.63.6.1361; HEGGELUND P, 1990, J NEUROPHYSIOL, V63, P1347, DOI 10.1152/jn.1990.63.6.1347; HICKEY TL, 1974, J COMP NEUROL, V156, P239, DOI 10.1002/cne.901560207; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; KANDEL ER, 1992, SCIENCE, V258, P243, DOI 10.1126/science.1411522; KEMP JA, 1982, J PHYSIOL-LONDON, V323, P377, DOI 10.1113/jphysiol.1982.sp014078; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124, DOI 10.1152/jn.1988.59.1.124; KWON YH, 1991, J NEUROPHYSIOL, V66, P414, DOI 10.1152/jn.1991.66.2.414; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; O'Leary JL, 1940, J COMP NEUROL, V73, P405, DOI 10.1002/cne.900730304; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; REH TA, 1985, J NEUROSCI, V5, P1132; SCHARFMAN HE, 1990, P NATL ACAD SCI USA, V87, P4548, DOI 10.1073/pnas.87.12.4548; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILLITO AM, 1990, J NEUROPHYSIOL, V63, P347, DOI 10.1152/jn.1990.63.2.347; SILLITO AM, 1983, BRAIN RES, V280, P299, DOI 10.1016/0006-8993(83)90059-8; SILLITO AM, 1990, NEUROSCIENCE, V34, P273, DOI 10.1016/0306-4522(90)90137-S; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; WHITE CA, 1992, P NATL ACAD SCI USA, V89, P9820; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x	53	85	87	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					815	825		10.1016/0896-6273(93)90198-Z	http://dx.doi.org/10.1016/0896-6273(93)90198-Z			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8388224				2022-12-28	WOS:A1993LD32200005
J	Mooney, R; Penn, AA; Gallego, R; Shatz, CJ				Mooney, R; Penn, AA; Gallego, R; Shatz, CJ			Thalamic relay of spontaneous retinal activity prior to vision	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; VISUAL-CORTEX; RETINOGENICULATE SYNAPSE; POSTNATAL-DEVELOPMENT; ACTION-POTENTIALS; MAMMALIAN RETINA; OCULAR DOMINANCE; NMDA RECEPTORS; GANGLION-CELLS; SEGREGATION	Before vision, retinal ganglion cells produce spontaneous waves of action potentials. A crucial question is whether this spontaneous activity is transmitted to lateral geniculate nucleus (LGN) neurons. Using a novel in vitro preparation, we report that LGN neurons receive periodic barrages of postsynaptic currents from the retina that drive them to fire bursts of action potentials. Groups of LGN neurons are highly correlated in their firing. Experiments in wild-type and NMDAR1 knockout mice show that NMDA receptor activation is not necessary for firing. The transmission of the highly correlated retinal activity to the LGN supports the hypothesis that retinal waves drive retinogeniculate synaptic remodeling. Because LGN neurons are driven to fire action potentials, this spontaneous activity could also act more centrally to influence synaptic modification within the developing visual cortex.	UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,BERKELEY,CA 94720	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley				Mooney, Richard/0000-0002-3308-1367	NIGMS NIH HHS [GM 07365] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CRUNELLI V, 1987, J PHYSIOL-LONDON, V384, P603, DOI 10.1113/jphysiol.1987.sp016472; ESGUERRA M, 1992, VISUAL NEUROSCI, V8, P545, DOI 10.1017/S0952523800005642; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109; Horton JC, 1996, J NEUROSCI, V16, P1791; KALIL RE, 1986, NATURE, V323, P156, DOI 10.1038/323156a0; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8390, DOI 10.1073/pnas.83.21.8390; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MASON CA, 1982, NEUROSCIENCE, V7, P561, DOI 10.1016/0306-4522(82)90064-1; MCCORMICK DA, 1995, J NEUROSCI, V15, P5739; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1992, SEMIN NEUROSCI, V4, P61; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; RAMOA AS, 1994, J NEUROSCI, V14, P2098; SCHARFMAN HE, 1990, P NATL ACAD SCI USA, V87, P4548, DOI 10.1073/pnas.87.12.4548; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SMETTERS DK, 1994, BRAIN RES, V658, P168, DOI 10.1016/S0006-8993(09)90023-3; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STRYKER MP, 1986, J NEUROSCI, V6, P2117; WIESEL TN, 1974, J COMP NEUROL, V158, P301; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0	38	173	175	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					863	874		10.1016/S0896-6273(00)80218-4	http://dx.doi.org/10.1016/S0896-6273(00)80218-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938119	Bronze			2022-12-28	WOS:A1996VV15100009
J	Budnik, V; Koh, YH; Guan, B; Hartmann, B; Hough, C; Woods, D; Gorczyca, M				Budnik, V; Koh, YH; Guan, B; Hartmann, B; Hough, C; Woods, D; Gorczyca, M			Regulation of synapse structure and function by the Drosophila tumor suppressor gene dlg	NEURON			English	Article							NEUROMUSCULAR-JUNCTIONS; MUSCLE; MUTANTS; PROTEIN; INNERVATION; CRAYFISH; RECEPTOR; LARVAE; ULTRASTRUCTURE; EXCITABILITY	Mutations of the tumor suppressor gene discs-large (dlg) lead to postsynaptic structural defects. Here, we report that mutations in dig also result in larger synaptic currents at fly neuromuscular junctions. By selectively targeting DLG protein to either muscles or motorneurons using Gal-4 enhancer trap lines, we were able to rescue substantially the reduced postsynaptic structure in mutants. Rescue of the physiological defect was accomplished by presynaptic, but not postsynaptic targeting, consistent with our finding that miniature excitatory junctional currents were not changed in dig mutants. These results suggest that DLG functions in the regulation of neurotransmitter release and postsynaptic structure. We propose that DLG is an integral part of a mechanism by which changes in both neurotransmitter release and synapse structure are accomplished during development and plasticity.	UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92717	University of California System; University of California Irvine	Budnik, V (corresponding author), UNIV MASSACHUSETTS,DEPT BIOL,AMHERST,MA 01003, USA.				NINDS NIH HHS [K04 NS01786, R01 NS70032, R21 NS070032, R01 NS030072] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS001786, R21NS070032, R01NS030072] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MS, 1988, J NEUROSCI, V8, P242; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; ATWOOD HL, 1976, J NEUROBIOL, V7, P289, DOI 10.1002/neu.480070403; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; ATWOOD HL, 1995, AM ZOOL, V35, P28; BELOTE JM, 1980, NATURE, V285, P573, DOI 10.1038/285573a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1993, DEVELOPMENT, V119, P533; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BUDNIK V, 1996, IN PRESS CURR OPIN N, V6; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; GARNER C, 1996, IN PRESS TRENDS CELL; GENISMAN Y, 1993, HIPPOCAMPUS, V3, P435; GOODMAN CS, 1993, NEURON S, V10, P77; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; HALL ZW, 1993, NEURON S, V10, P99; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KESHISHIAN H, 1993, TRENDS NEUROSCI, V16, P278, DOI 10.1016/0166-2236(93)90182-L; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KIM E, 1996, IN PRESS NEUROPHARMA; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KURDYAK P, 1995, J COMP NEUROL, V348, P1; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LNENICKA GA, 1985, J NEUROSCI, V5, P459; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; WOODS DF, 1996, IN PRESS J CELL BIOL; WU CF, 1985, J NEUROSCI, V5, P2626; ZHONG Y, 1995, J NEUROSCI, V15, P6679	49	313	316	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					627	640		10.1016/S0896-6273(00)80196-8	http://dx.doi.org/10.1016/S0896-6273(00)80196-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893021	Bronze, Green Accepted			2022-12-28	WOS:A1996VP74300009
J	Deckwerth, TL; Elliott, JL; Knudson, CM; Johnson, EM; Snider, WD; Korsmeyer, SJ				Deckwerth, TL; Elliott, JL; Knudson, CM; Johnson, EM; Snider, WD; Korsmeyer, SJ			BAX is required for neuronal death after trophic factor deprivation and during development	NEURON			English	Article							PROGRAMMED CELL-DEATH; NERVE GROWTH-FACTOR; BCL-2 HOMOLOG BAK; SYMPATHETIC NEURONS; IN-VIVO; GENE-EXPRESSION; MOTOR-NEURONS; POLYCYSTIC KIDNEY; TRANSGENIC MICE; DEFICIENT MICE	Members of the BCL2-related family of proteins either promote or repress programmed cell death. BAX, a death-promoting member, heterodimerizes with multiple death-repressing molecules, suggesting that it could prove critical to cell death. We tested whether Bax is required for neuronal death by trophic factor deprivation and during development. Neonatal sympathetic neurons and facial motor neurons from Bax-deficient mice survived nerve growth factor deprivation and disconnection from their targets by axotomy, respectively. These salvaged neurons displayed remarkable soma atrophy and reduced elaboration of neurites; yet they responded to readdition of trophic factor with soma hypertrophy and enhanced neurite outgrowth. Bax-deficient superior cervical ganglia and facial nuclei possessed increased numbers of neurons. Our observations demonstrate that trophic factor deprivation-induced death of sympathetic and motor neurons depends on Bax.	WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT MOL BIOL & PHARMACOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT NEUROL, ST LOUIS, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Deckwerth, TL (corresponding author), WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, DEPT PATHOL & MED, ST LOUIS, MO 63110 USA.			Knudson, Charles Michael/0000-0003-3964-5466	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, R37AG012947] Funding Source: NIH RePORTER; NIA NIH HHS [AG 05681, AG 12947] Funding Source: Medline; NINDS NIH HHS [NS 24679] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberi S, 1996, P NATL ACAD SCI USA, V93, P3978, DOI 10.1073/pnas.93.9.3978; BAKHSHI A, 1985, CELL, V41, P889; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BORNER C, 1994, J CELL BIOL, V126, P1059, DOI 10.1083/jcb.126.4.1059; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; COUGHLIN MD, 1985, DEV BIOL, V110, P392, DOI 10.1016/0012-1606(85)90098-3; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4297; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; FRANKOWSKI H, 1995, NEUROREPORT, V6, P1917, DOI 10.1097/00001756-199510020-00023; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; GORIN PD, 1979, P NATL ACAD SCI USA, V76, P5382, DOI 10.1073/pnas.76.10.5382; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HOUENOU LJ, 1994, PROG BRAIN RES, V102, P217; KAMADA S, 1995, CANCER RES, V55, P354; KIEFER MC, 1995, NATURE, V374, P736, DOI 10.1038/374736a0; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; MARTINOU I, 1995, J CELL BIOL, V128, P201, DOI 10.1083/jcb.128.1.201; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MERRY DE, 1994, DEVELOPMENT, V120, P301; Middleton G, 1996, DEVELOPMENT, V122, P695; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; SAGOT Y, 1995, J NEUROSCI, V15, P7727; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	64	636	645	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					401	411		10.1016/S0896-6273(00)80173-7	http://dx.doi.org/10.1016/S0896-6273(00)80173-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816704	Bronze			2022-12-28	WOS:A1996VJ44000007
J	Schacter, DL; Reiman, E; Curran, T; Yun, LS; Bandy, D; McDermott, KB; Roediger, HL				Schacter, DL; Reiman, E; Curran, T; Yun, LS; Bandy, D; McDermott, KB; Roediger, HL			Neuroanatomical correlates of veridical and illusory recognition memory: Evidence from positron emission tomography	NEURON			English	Article							EPISODIC MEMORY; CEREBELLAR; ACTIVATION; RETRIEVAL; HUMANS; MODEL; TERM; PET	Memory distortions and illusions have been thoroughly documented in psychological studies, but little is known about the neuroanatomical correlates of true and false memories. Vivid but illusory memories can be induced by asking people whether they recall or recognize words that were not previously presented, but are semantically related to other previously presented words. We used positron emission tomography to compare brain regions involved in veridical recognition of printed words that were heard several minutes earlier and illusory recognition of printed words that had not been heard earlier. Veridical and illusory recognition were each associated with blood flow increases in a left medial temporal region previously implicated in episodic memory; veridical recognition was distinguished by additional blood flow increases in a left temporoparietal region previously implicated in the retention of auditory/phonological information. This study reveals similarities and differences in the way the brain processes accurate and illusory memories.	UNIV ARIZONA,DEPT PSYCHIAT,TUCSON,AZ 85721; GOOD SAMARITAN REG MED CTR,POSITRON EMISS TOMOG CTR,PHOENIX,AZ 85006; CASE WESTERN RESERVE UNIV,DEPT PSYCHOL,CLEVELAND,OH 44106; ARIZONA STATE UNIV,DEPT COMP SCI & ENGN,TEMPE,AZ 85287; UNIV WASHINGTON,SCH MED,DEPT RADIOL,ST LOUIS,MO 63110; UNIV WASHINGTON,DEPT PSYCHOL,ST LOUIS,MO 63110	University of Arizona; Case Western Reserve University; Arizona State University; Arizona State University-Tempe; Washington University (WUSTL); Washington University (WUSTL)	Schacter, DL (corresponding author), HARVARD UNIV,DEPT PSYCHOL,CAMBRIDGE,MA 02138, USA.			Schacter, Daniel/0000-0002-2460-6061	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS026985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008441, R01AG008441] Funding Source: NIH RePORTER; NIA NIH HHS [AG08441] Funding Source: Medline; NINDS NIH HHS [NS26985] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREASEN NC, 1995, P NATL ACAD SCI USA, V92, P5111, DOI 10.1073/pnas.92.11.5111; ANISFELD M, 1968, J EXP PSYCHOL, V77, P171, DOI 10.1037/h0025782; Bartlett F. C., 1932, REMEMBERING; Blaxton TA, 1996, CAN J EXP PSYCHOL, V50, P42, DOI 10.1037/1196-1961.50.1.42; BRAINERD CJ, 1995, J MEM LANG, V34, P157, DOI 10.1006/jmla.1995.1008; BRANSFORD JD, 1971, COGNITIVE PSYCHOL, V2, P331, DOI 10.1016/0010-0285(71)90019-3; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; BUCKNER RL, 1995, HDB NEUROPSYCHOLOGY, V10, P439; CAHILL L, 1996, IN PRESS P NATL ACAD; Ceci SJ, 1995, MEMORY DISTORTION, P91; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; CURRAN T, 1996, IN PRESS NEUROPSYCHO; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Fiez JA, 1996, NEURON, V16, P13, DOI 10.1016/S0896-6273(00)80018-5; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; HAYMAN CAG, 1995, MEM COGNITION, V23, P95, DOI 10.3758/BF03210560; HINTZMAN DL, 1988, PSYCHOL REV, V95, P528, DOI 10.1037/0033-295X.95.4.528; HOWARD D, 1992, BRAIN, V115, P1769, DOI 10.1093/brain/115.6.1769; JOHNSON MK, 1988, J EXP PSYCHOL GEN, V117, P371, DOI 10.1037/0096-3445.117.4.371; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McDermott KB, 1996, J MEM LANG, V35, P212, DOI 10.1006/jmla.1996.0012; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; MILNER PM, 1989, NEUROPSYCHOLOGIA, V27, P23, DOI 10.1016/0028-3932(89)90087-0; Moscovitch M, 1995, MEMORY DISTORTION, P226; MOSCOVITCH M, 1995, J CLIN EXP NEUROPSYC, V17, P276, DOI 10.1080/01688639508405123; MOSCOVITCH M, 1995, P NATL ACAD SCI USA, V92, P3721, DOI 10.1073/pnas.92.9.3721; NORMAN KA, 1996, IN PRESS IMPLICIT ME; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Payne DG, 1996, J MEM LANG, V35, P261, DOI 10.1006/jmla.1996.0015; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PHELPS EA, 1992, NEUROPSYCHOLOGIA, V30, P293, DOI 10.1016/0028-3932(92)90006-8; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 1996, J MEM LANG, V35, P76, DOI 10.1006/jmla.1996.0005; ROELTGEN DP, 1985, APPL PSYCHOLINGUIST, V6, P205, DOI 10.1017/S0142716400006184; Russell W. A., 1954, 11 U MINN; Schacter D. L., 1996, SEARCHING MEMORY BRA; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Schacter DL, 1995, MEMORY DISTORTION, P1; Schacter DL, 1996, J MEM LANG, V35, P319, DOI 10.1006/jmla.1996.0018; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SCHACTER DL, IN PRESS NEUROPSYCHO; SCHACTER DL, 1996, IN PRESS P NATL ACAD; SCHOOLER JW, 1986, J EXP PSYCHOL LEARN, V12, P171, DOI 10.1037/0278-7393.12.2.171; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Shimamura Arthur P., 1995, P803; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Squire LR, 1995, MEMORY DISTORTION, P197; SULIN RA, 1974, J EXP PSYCHOL, V103, P255, DOI 10.1037/h0036846; Talairach J., 1988, COPLANAR STEREOTAXIC; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; UNDERWOOD BJ, 1965, J EXP PSYCHOL, V70, P122, DOI 10.1037/h0022014; UNGERLEIDER LG, 1995, SCIENCE, V270, P760; WALLACE WP, 1995, COGNITION, V55, P85, DOI 10.1016/0010-0277(94)00646-3; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	66	232	233	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					267	274		10.1016/S0896-6273(00)80158-0	http://dx.doi.org/10.1016/S0896-6273(00)80158-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	VE840	8780650	Bronze			2022-12-28	WOS:A1996VE84000009
J	Dudek, SM; Friedlander, MJ				Dudek, SM; Friedlander, MJ			Developmental down-regulation of LTD in cortical layer IV and its independence of modulation by inhibition	NEURON			English	Article							LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; OCULAR DOMINANCE COLUMNS; MONOCULARLY DEPRIVED KITTENS; MUSCIMOL BINDING-SITES; STRIATE CORTEX; NMDA RECEPTORS; BINOCULAR COMPETITION; SLICE PREPARATION	For in vitro LTD to remain viable as a model for synaptic weakening in visual cortical plasticity, it is crucial that it display a critical period for its induction within layer IV. A complicating factor, however, is that LTD in layer IV is modulated by inhibitory postsynaptic potentials (IPSPs); postsynaptic responses characterized as containing IPSPs do not depress in response to 1 Hz afferent stimulation. By blocking IPSPs intracellularly, we find that the ability to induce LTD in layer IV neurons is restored in juvenile, but not in mature animals. This developmental down-regulation of LTD induction is specific for layer IV when compared with LTD induction in layers II/III. These data are consistent with the hypothesis that an LTD-like phenomenon is involved in critical period plasticity and is apparently independent of developmental changes in inhibitory circuitry.	UNIV ALABAMA,NEUROBIOL RES CTR,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham			Dudek, Serena/C-6561-2009	Dudek, Serena/0000-0003-4094-8368	NEI NIH HHS [F32 EY06509, EY 05116] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006509] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; ANDERSON JC, 1992, P ROY SOC B-BIOL SCI, V250, P187, DOI 10.1098/rspb.1992.0148; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1985, J NEUROSCI, V5, P1262; BEAR MF, 1990, J NEUROSCI, V10, P909; BEAR MF, 1990, P NATL ACAD SCI USA, V87, P9246, DOI 10.1073/pnas.87.23.9246; BEAR MF, 1992, J NEUROPHYSIOL, V67, P1; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BODEGREUEL KM, 1989, DEV BRAIN RES, V46, P197, DOI 10.1016/0165-3806(89)90283-6; BURGARD EC, 1993, J NEUROPHYSIOL, V69, P230, DOI 10.1152/jn.1993.69.1.230; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CLOTHIAUX EE, 1991, J NEUROPHYSIOL, V399, P301; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dudek SM, 1995, DEV BRAIN RES, V90, P54, DOI 10.1016/0165-3806(96)83486-9; Dudek SM, 1996, J NEUROPHYSIOL, V75, P2167, DOI 10.1152/jn.1996.75.5.2167; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; FOX K, 1992, J NEUROSCI, V12, P2672; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; FREEMAN RD, 1988, J NEUROSCI, V8, P2491; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; FRIEDLANDER MJ, 1984, EXP BRAIN RES, V53, P451; FRIEDLANDER MJ, 1989, J PHYSIOL-LONDON, V416, P183, DOI 10.1113/jphysiol.1989.sp017756; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; HICKEY TL, 1980, J COMP NEUROL, V189, P467, DOI 10.1002/cne.901890304; HIRSCH JA, 1995, J PHYSIOL-LONDON, V483, P183, DOI 10.1113/jphysiol.1995.sp020577; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Johnson RR, 1996, J COMP NEUROL, V368, P335, DOI 10.1002/(SICI)1096-9861(19960506)368:3<335::AID-CNE2>3.0.CO;2-6; KALIL R, 1980, J COMP NEUROL, V189, P483, DOI 10.1002/cne.901890305; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; KIRKWOOD A, 1994, J NEUROSCI, V14, P1534; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KOMATSU Y, 1981, NEUROSCI LETT, V26, P269, DOI 10.1016/0304-3940(81)90144-0; KOMATSU Y, 1983, DEV BRAIN RES, V8, P136, DOI 10.1016/0165-3806(83)90165-7; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P542, DOI 10.1152/jn.1980.43.2.542; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LUHMANN HJ, 1990, DEV BRAIN RES, V54, P287, DOI 10.1016/0165-3806(90)90152-O; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Montague PR, 1991, CEREB CORTEX, V1, P199, DOI 10.1093/cercor/1.3.199; MOWER GD, 1984, BRAIN RES, V309, P168, DOI 10.1016/0006-8993(84)91024-2; MOWER GD, 1985, J COMP NEUROL, V235, P448, DOI 10.1002/cne.902350404; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NEEDLER MC, 1984, BRAIN RES, V308, P347, DOI 10.1016/0006-8993(84)91076-X; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; O'Leary JL, 1941, J COMP NEUROL, V75, P131, DOI 10.1002/cne.900750107; OLSON CR, 1980, EXP BRAIN RES, V39, P17; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; PERKINS AT, 1988, BRAIN RES, V439, P222; PETERS A, 1985, J COMP NEUROL, V238, P263, DOI 10.1002/cne.902380303; REYNOLDS IJ, 1991, EXP BRAIN RES, V85, P611; SHAPLEY R, 1980, EXP BRAIN RES, V39, P41; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHAW C, 1984, BRAIN RES BULL, V13, P331, DOI 10.1016/0361-9230(84)90134-5; SHERMAN SM, 1973, BRAIN RES, V40, P224; SILLITO AM, 1981, NATURE, V291, P318, DOI 10.1038/291318a0; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; TIEMAN SB, 1985, CELL MOL NEUROBIOL, V5, P35, DOI 10.1007/BF00711084; TSUMOTO T, 1978, BRAIN RES, V153, P150, DOI 10.1016/0006-8993(78)91137-X; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978	81	83	83	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1097	1106		10.1016/S0896-6273(00)80136-1	http://dx.doi.org/10.1016/S0896-6273(00)80136-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663986	Bronze			2022-12-28	WOS:A1996UU11800007
J	Zitt, C; Zobel, A; Obukhov, AG; Harteneck, C; Kalkbrenner, F; Luckhoff, A; Schultz, G				Zitt, C; Zobel, A; Obukhov, AG; Harteneck, C; Kalkbrenner, F; Luckhoff, A; Schultz, G			Cloning and functional expression of a human Ca2+-permeable cation channel activated by calcium store depletion	NEURON			English	Article							PHOTOTRANSDUCTION; PROTEIN; CELLS	Depletion of intracellular calcium stores generates a signal that activates Ca2+-permeable channels in the plasma membrane. We have identified a human cDNA, TRPC1A, from a human fetal brain cDNA library. TRPC1A is homologous to the cation channels trp and trpl in Drosophila and is a splice variant of the recently identified cDNA Htrp-1. Expression of TRPC1A in CHO cells induced nonselective cation currents with similar permeabilities for Na+, Ca2+, and Cs+. The currents were activated by intracellular infusion of myo inositol-1,4,5-trisphosphate or thapsigargin. Expression of TRPC1A significantly enhanced increases in the intracellular free calcium concentration induced by Ca2+ restitution after prolonged depletion. Similar results were obtained in Sf9 cells. We conclude that TRPC1A encodes a Ca2+-permeable cation channel activated by depletion of intracellular calcium stores.	FREE UNIV BERLIN,INST PHARMAKOL,D-14195 BERLIN,GERMANY	Free University of Berlin			Obukhov, Alexander G/C-7246-2008	Obukhov, Alexander G/0000-0002-3862-6004				BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dippel E, 1996, P NATL ACAD SCI USA, V93, P1391, DOI 10.1073/pnas.93.4.1391; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARTENECK C, 1995, FEBS LETT, V358, P297, DOI 10.1016/0014-5793(94)01455-A; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; HU YF, 1994, AM J PHYSIOL, V266, pC1736, DOI 10.1152/ajpcell.1994.266.6.C1736; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LUCKHOFF A, 1994, BIOPHYS J, V67, P177, DOI 10.1016/S0006-3495(94)80467-9; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Penner R, 1993, Curr Opin Neurobiol, V3, P368, DOI 10.1016/0959-4388(93)90130-Q; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; ZUCKER CS, 1996, P NATL ACAD SCI USA, V93, P571; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	26	330	343	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1189	1196		10.1016/S0896-6273(00)80145-2	http://dx.doi.org/10.1016/S0896-6273(00)80145-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663995	Bronze			2022-12-28	WOS:A1996UU11800016
J	Kofuji, P; Hofer, M; Millen, KJ; Millonig, JH; Davidson, N; Lester, HA; Hatten, ME				Kofuji, P; Hofer, M; Millen, KJ; Millonig, JH; Davidson, N; Lester, HA; Hatten, ME			Functional analysis of the weaver mutant GIRK2 K+ channel and rescue of weaver granule cells	NEURON			English	Article							NEURONAL DIFFERENTIATION; MOUSE CEREBELLUM; GENE-ACTION; EXPRESSION; MIGRATION; INVITRO; CHIMERAS; PATTERNS; SITE; MICE	In the neurological mutant mouse weaver, granule cell precursors proliferate normally in the external germinal layer of the cerebellar cortex, but fail to differentiate. Granule neurons purified from weaver cerebella have greatly reduced G protein-activated inwardly rectifying K+ currents; instead, they display a constitutive Na+ conductance. Expression of the weaver GIRK2 channel in oocytes confirms that the mutation leads to constitutive activation, loss of monovalent cation selectivity, and increased sensitivity to three channel blockers. Pharmacological blockade of the Na+ influx in weaver granule cells restores their ability to differentiate normally. Thus, Na+ flux through the weaver GIRK2 channel underlies the failure of granule cell development in situ.	ROCKEFELLER UNIV,DEV NEUROBIOL LAB,NEW YORK,NY 10021	Rockefeller University	Kofuji, P (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Kofuji, Paulo/AAR-7835-2021	Kofuji, Paulo/0000-0002-4840-9986; Millen, Kathleen/0000-0001-9978-675X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH049176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034469] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 29836] Funding Source: Medline; NIMH NIH HHS [MH 49176] Funding Source: Medline; NINDS NIH HHS [NS 34469] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; Bormann Joachim, 1992, P136; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; CHAVIS P, 1994, J NEUROSCI, V14, P7067; CHEN Y, 1994, J BIOL CHEM, V269, P7839; CLAPHAM DE, 1994, ANNU REV NEUROSCI, V17, P441; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GOLDOWITZ D, 1989, NEURON, V2, P1565, DOI 10.1016/0896-6273(89)90045-7; GOLDOWITZ D, 1982, J NEUROSCI, V2, P1474; GRAYBIEL AM, 1990, J NEUROSCI, V10, P720; GUPTA M, 1987, BRAIN RES, V402, P379, DOI 10.1016/0006-8993(87)90050-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HATTEN ME, 1981, DEV BIOL, V87, P102, DOI 10.1016/0012-1606(81)90064-6; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1986, J NEUROSCI, V6, P2676; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HERRUP K, 1987, NEUROSCIENCE, V23, P871, DOI 10.1016/0306-4522(87)90164-3; Hille B., 1992, IONIC CHANNELS EXCIT; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KUHAR SG, 1993, DEVELOPMENT, V117, P97; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; KURACHI Y, 1995, AM J PHYSIOL-CELL PH, V269, pC821, DOI 10.1152/ajpcell.1995.269.4.C821; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Millen Kathleen J., 1996, P339; Millen KJ, 1995, DEVELOPMENT, V121, P3935; MILTONIG JH, 1996, IN PRESS MAMMALIAN G; Mjaatvedt AE, 1995, GENOME RES, V5, P453, DOI 10.1101/gr.5.5.453; NICHOLS CG, 1993, TRENDS PHARMACOL SCI, V14, P320; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; RANDALL A, 1995, J NEUROSCI, V15, P2995; REEVES RH, 1989, GENOMICS, V5, P522, DOI 10.1016/0888-7543(89)90018-9; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; REZAI Z, 1972, DEV BIOL, V29, P17, DOI 10.1016/0012-1606(72)90039-5; RofflerTarlov S, 1996, J NEUROSCI, V16, P1819; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SEKIGUCHI M, 1995, BRAIN RES, V696, P262, DOI 10.1016/0006-8993(95)00974-U; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; SOTELO C, 1974, BRAIN RES, V77, P484, DOI 10.1016/0006-8993(74)90636-2; STEWART RR, 1995, J NEUROBIOL, V28, P419, DOI 10.1002/neu.480280403; TAKANO K, 1995, NEURON, V14, P999, DOI 10.1016/0896-6273(95)90338-0; TRIARHOU LC, 1988, EXP BRAIN RES, V70, P256; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; WILLINGER M, 1985, DEV BIOL, V107, P156, DOI 10.1016/0012-1606(85)90384-7; ZERR P, 1993, J PHYSIOL-LONDON, V459, pP281	62	172	174	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					941	952		10.1016/S0896-6273(00)80117-8	http://dx.doi.org/10.1016/S0896-6273(00)80117-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630252	Bronze			2022-12-28	WOS:A1996UN48000009
J	Cash, S; Dan, Y; Poo, MM; Zucker, R				Cash, S; Dan, Y; Poo, MM; Zucker, R			Postsynaptic elevation of calcium induces persistent depression of developing neuromuscular synapses	NEURON			English	Article							LONG-TERM POTENTIATION; NERVE-MUSCLE INTERACTIONS; XENOPUS CELL-CULTURE; SYNAPTIC TRANSMISSION; PROTEIN-KINASE; NITRIC-OXIDE; SKELETAL-MUSCLE; AREA CA1; HIPPOCAMPUS; ACETYLCHOLINE	Synaptic activity is known to modulate neuronal connectivity in the nervous system. At developing Xenopus neuromuscular synapses in culture, repetitive postsynaptic application of ACh near the synapse leads to immediate and persistent synaptic depression, which was shown to be caused by reduction of presyaptic evoked transmitter release. However, little depression was found when ACh was applied to the muscle 20 mu m or further from the synapse. Fluorescence imaging of cytosolic Ca2+ ([Ca2+](i)) showed that each ACh pulse induced a transient elevation of myocyte [Ca2+], that spread approximately 20 mu m. Local photoactivated release of Ca2+ from the caged Ca2+ chelators nitr-5 or nitrophen in the postsynaptic cell was sufficient to induce persistent synaptic depression. These results support a model in which localized Ca2+ influx into the postsynaptic myocyte initiates transsynaptic retrograde modulation of presynaptic secretion mechanisms.	UNIV CALIF BERKELEY,DIV NEUROBIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	Cash, S (corresponding author), COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Dan, Yang/0000-0002-3818-877X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15114] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BETZ WJ, 1990, J NEUROBIOL, V21, P1, DOI 10.1002/neu.480210102; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; Cash Sydney, 1995, Seminars in Developmental Biology, V6, P185, DOI 10.1016/S1044-5781(06)80028-9; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; DAN Y, 1992, NATURE, V359, P733, DOI 10.1038/359733a0; Dan Yang, 1994, Current Opinion in Neurobiology, V4, P95, DOI 10.1016/0959-4388(94)90037-X; DANIEL H, 1992, EXP BRAIN RES, V90, P327; DECKER ER, 1990, J NEUROSCI, V10, P3413; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; EVERS J, 1989, J NEUROSCI, V9, P1523; GIROD R, 1995, J NEUROSCI, V15, P2826; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GORDON T, 1974, CELL TISSUE RES, V155, P13; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HEBB DO, 1949, ORG BEHAVIOR; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KIDOKORO Y, 1982, P NATL ACAD SCI-BIOL, V79, P6727, DOI 10.1073/pnas.79.21.6727; KUFFLER D, 1977, BRAIN RES, V138, P353, DOI 10.1016/0006-8993(77)90752-1; KULLBERG RW, 1977, DEV BIOL, V60, P101, DOI 10.1016/0012-1606(77)90113-0; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; LANDO L, 1989, J GEN PHYSIOL, V93, P1017, DOI 10.1085/jgp.93.6.1017; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LO YJ, 1994, J NEUROSCI, V14, P4684; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MINTA A, 1989, J BIOL CHEM, V264, P8171; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OBRIEN RAD, 1980, NEUROSCIENCE, V5, P1367, DOI 10.1016/0306-4522(80)90209-2; OLIVER MW, 1989, BRAIN RES, V505, P233, DOI 10.1016/0006-8993(89)91448-0; POO MM, 1982, NATURE, V295, P332, DOI 10.1038/295332a0; POO MM, 1995, IN PRESS COLD SPRING, V60; PURVES D, 1985, PRINCIPLES NEURAL DE; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SRIHARI T, 1978, J NEUROCYTOL, V7, P529, DOI 10.1007/BF01260887; STAUBLI U, 1988, BRAIN RES, V444, P153, DOI 10.1016/0006-8993(88)90922-5; STEVENS CF, 1993, NATURE, V364, P147, DOI 10.1038/364147a0; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Tabti N., 1991, CULTURING NERVE CELL, P137; VANESSEN DC, 1990, J NEUROBIOL, V21, P223, DOI 10.1002/neu.480210115; WANG T, 1995, NATURE, V374, P262, DOI 10.1038/374262a0; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	68	33	33	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					745	754		10.1016/S0896-6273(00)80095-1	http://dx.doi.org/10.1016/S0896-6273(00)80095-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607993	Bronze			2022-12-28	WOS:A1996UG61100008
J	Beck, KD; Irwin, I; Valverde, J; Brennan, TJ; Langston, JW; Hefti, F				Beck, KD; Irwin, I; Valverde, J; Brennan, TJ; Langston, JW; Hefti, F			GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis	NEURON			English	Article							IMMUNO-CYTOCHEMICAL LOCALIZATION; VENTRAL TEGMENTAL AREA; DORSAL RAPHE NUCLEUS; SUBSTANTIA NIGRA; TYROSINE-HYDROXYLASE; POSTNATAL-DEVELOPMENT; NEUROTROPHIC FACTOR; FINE-STRUCTURE; NEURONS; BRAIN	To test whether glial cell line-derived neurotrophic factor (GDNF) regulates the development of nigral dopaminergic neurons in vivo, neonatal rats received bilateral injections of GDNF into the striatum. Injections at postnatal day 2 induced a unique transient behavioral pattern characterized by forelimb hyperflexure, clawed toes of all limbs, and a kinked tail. Parallel to the behavioral changes, the levels of striatal and ventral mesencephalic dopamine and serotonin were increased from 60% to 100% with a proportional increase of principal metabolite levels. GDNF increased tyrosine hydroxylase activity in the ventral mesencephalon, but did not affect striatal activity of choline acetyltransferase and GABA uptake. GDNF failed to induce sprouting of dopaminergic neurites. Our findings suggest that during development striatal GDNF regulates the capacity of dopaminergic and of serotonergic neurons for neurotransmitter production and release.	GENENTECH INC,DEPT NEUROSCI,S SAN FRANCISCO,CA 94080; PARKINSONS INST,SUNNYVALE,CA 94086	Roche Holding; Genentech					NATIONAL INSTITUTE ON AGING [P01AG010480] Funding Source: NIH RePORTER; NIA NIH HHS [AG10480] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams R. D., 1993, PRINCIPLES NEUROLOGY; ARBOGAST LA, 1991, DEV BRAIN RES, V63, P151, DOI 10.1016/0165-3806(91)90075-T; AZMITIA E, 1978, J COMP NEUROL, V79, P641; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BECK KD, 1994, PROG NEUROBIOL, V44, P497, DOI 10.1016/0301-0082(94)90009-4; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; BENLOUCIF S, 1991, EUR J PHARMACOL, V200, P1, DOI 10.1016/0014-2999(91)90658-D; BERGMAN J, 1989, J PHARMACOL EXP THER, V251, P150; BROADDUS WC, 1990, DEV BRAIN RES, V52, P265, DOI 10.1016/0165-3806(90)90244-S; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; CHOILUNDBERG DL, 1995, DEV BRAIN RES, V85, P80, DOI 10.1016/0165-3806(94)00197-8; DEWEY SL, 1995, J NEUROSCI, V15, P821; DRAY A, 1976, BRAIN RES, V113, P45, DOI 10.1016/0006-8993(76)90005-6; DRAY A, 1978, BRAIN RES, V151, P431, DOI 10.1016/0006-8993(78)91077-6; EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217; FERRE S, 1994, J NEUROSCI, V14, P4839; GREENBERG D, 1974, SCIENCE, V184, P1243; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HERVE D, 1987, BRAIN RES, V435, P71, DOI 10.1016/0006-8993(87)91588-5; HO A, 1995, NEUROREPORT, V6, P1326; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; HUANG XM, 1993, EUR J PHARMACOL, V238, P291, DOI 10.1016/0014-2999(93)90859-G; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; IRWIN I, 1990, BRAIN RES, V531, P242, DOI 10.1016/0006-8993(90)90780-F; JAVITCH JA, 1984, MOL PHARMACOL, V26, P35; KALEN P, 1988, EXP BRAIN RES, V73, P69, DOI 10.1007/BF00279662; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; KILPATRICK IC, 1986, J NEUROCHEM, V46, P1865; KRIEGLSTEIN K, 1994, NEUROSCIENCE, V63, P1189, DOI 10.1016/0306-4522(94)90583-5; LAPCHAK PA, 1993, NEUROSCIENCE, V53, P639, DOI 10.1016/0306-4522(93)90612-J; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; NEDERGAARD S, 1988, NATURE, V333, P174, DOI 10.1038/333174a0; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PASQUIER DA, 1977, BRAIN RES BULL, V2, P323, DOI 10.1016/0361-9230(77)90066-1; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; SAUER H, 1995, IN PRESS P NATL ACAD; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; SCHMIDTKASTNER R, 1994, MOL BRAIN RES, V26, P325, DOI 10.1016/0169-328X(94)90106-6; SPECHT LA, 1981, BRAIN RES, V218, P49, DOI 10.1016/0006-8993(81)90988-4; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; SPRINGER JE, 1994, EXP NEUROL, V127, P167, DOI 10.1006/exnr.1994.1091; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; SUTERCRAZZOLARA C, 1994, NEUROREPORT, V5, P2486, DOI 10.1097/00001756-199412000-00020; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; TOMAC A, 1995, NATURE, V373, P339; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; VANBOCKSTAELE EJ, 1993, BRAIN RES, V624, P188, DOI 10.1016/0006-8993(93)90077-Z; VANERO JL, 1994, NEUROSCIENCE, V61, P257; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; YADID G, 1994, J PHARMACOL EXP THER, V270, P1158; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZURN AD, 1994, NEUROREPORT, V6, P113, DOI 10.1097/00001756-199412300-00030	53	69	69	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					665	673		10.1016/S0896-6273(00)80085-9	http://dx.doi.org/10.1016/S0896-6273(00)80085-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785063	Bronze			2022-12-28	WOS:A1996UC16800022
J	DiversePierluissi, M; Inglese, J; Stoffel, RH; Lefkowitz, RJ; Dunlap, K				DiversePierluissi, M; Inglese, J; Stoffel, RH; Lefkowitz, RJ; Dunlap, K			G protein-coupled receptor kinase mediates desensitization of norepinephrine-induced Ca2+ channel inhibition	NEURON			English	Article							BETA-GAMMA-SUBUNITS; CALCIUM CURRENTS; N-TYPE; MODULATION; NEURONS; PHOSPHORYLATION; SIGNAL	G protein-coupled receptors are essential signaling molecules at sites of synaptic transmission. Here, we explore the mechanisms responsible for the use-dependent termination of metabotropic receptor signaling in embryonic sensory neurons. We report that the inhibition of voltage-dependent Ca2+ channels mediated by alpha(2)-adrenergic receptors desensitizes slowly with prolonged exposure to the transmitter and that the desensitization is mediated by a G protein-coupled receptor kinase (GRK). Intracellular introduction of recombinant, purified kinases or synthetic blocking peptides into individual neurons demonstrates the specific involvement of a GRK3-like protein. These results suggest that GRK-mediated termination of receptor-G protein coupling is likely to regulate synaptic strength and, as such, may provide one effective mechanism for depression of synaptic transmission.	TUFTS UNIV,SCH MED,DEPT NEUROSCI,BOSTON,MA 02111; PHARMACOPEIA INC,PRINCETON,NJ 08540; DUKE UNIV,SCH MED,DEPT MED,HOWARD HUGHES MED INST,DURHAM,NC 27710; DUKE UNIV,SCH MED,DEPT BIOCHEM,HOWARD HUGHES MED INST,DURHAM,NC 27710	Tufts University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	DiversePierluissi, M (corresponding author), TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111, USA.		Lefkowitz, Robert/AAW-2649-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016483] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16037] Funding Source: Medline; NINDS NIH HHS [NS16483] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIZA JL, 1992, J NEUROSCI, V12, P4045; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; CANFIELD DR, 1984, BRIT J PHARMACOL, V82, P557, DOI 10.1111/j.1476-5381.1984.tb10794.x; CLEMENTS JD, 1992, SCIENCE, V258, P12498; COX DH, 1992, J NEUROSCI, V12, P906; DIVERSEPIERLUIS.M, 1995, NEUROSCIENCE, V65, P47; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; EASON MG, 1992, J BIOL CHEM, V267, P25473; ELMSLIE KS, 1993, PFLUG ARCH EUR J PHY, V423, P472, DOI 10.1007/BF00374943; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; HAGA T, 1994, J NEUROCHEM, V63, P400; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HEADLEY PM, 1978, BRAIN RES, V145, P185, DOI 10.1016/0006-8993(78)90809-0; HOMCY CJ, 1991, ANNU REV PHYSIOL, V53, P137, DOI 10.1146/annurev.physiol.53.1.137; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; INGLESE J, 1993, J BIOL CHEM, V268, P23735; ISHII K, 1994, J BIOL CHEM, V269, P1125; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; KLEIN WL, 1989, FASEB J, V3, P2132, DOI 10.1096/fasebj.3.10.2546848; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KUROSE H, 1994, J BIOL CHEM, V269, P10093; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; MULLER S, 1993, P NATL ACAD SCI USA, V90, P10439, DOI 10.1073/pnas.90.22.10439; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206	40	48	49	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					579	585		10.1016/S0896-6273(00)80077-X	http://dx.doi.org/10.1016/S0896-6273(00)80077-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785055	Bronze			2022-12-28	WOS:A1996UC16800014
J	Hawkins, RD				Hawkins, RD			NO honey, I don't remember	NEURON			English	Review							NITRIC-OXIDE		NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032	New York State Psychiatry Institute	Hawkins, RD (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,722 W 168TH ST,NEW YORK,NY 10032, USA.							BANNERMAN DM, 1994, J NEUROSCI, V14, P7415; BANNERMAN DM, 1994, J NEUROSCI, V14, P7404; BOULTON CL, 1994, EUR J NEUROSCI, V6, P1528, DOI 10.1111/j.1460-9568.1994.tb00543.x; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; DOYLE L, 1996, J NEUROSCI, V16, P418; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; HAWKINS RD, 1994, J NEUROBIOL, V25, P652, DOI 10.1002/neu.480250607; HOLSCHER C, 1994, LEARN MEMORY, V1, P213; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V64, P17, DOI 10.1006/nlme.1995.1040; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V63, P54, DOI 10.1006/nlme.1995.1005; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; PEUNOVA N, 1993, NATURE, V364, P450, DOI 10.1038/364450a0; ZHUO M, 1995, REV NEUROSCIENCE, V6, P259; ZHUO M, 1994, NEUROREPORT, V5, P1033, DOI 10.1097/00001756-199405000-00004	17	79	80	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					465	467		10.1016/S0896-6273(00)80064-1	http://dx.doi.org/10.1016/S0896-6273(00)80064-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785042	hybrid			2022-12-28	WOS:A1996UC16800001
J	Chapman, B; Stone, LS				Chapman, B; Stone, LS			Turning a blind eye to cortical receptive fields	NEURON			English	Review							PRIMARY VISUAL-CORTEX; CAT; REORGANIZATION; RETINA; MAPS		NASA,AMES RES CTR,MOFFETT FIELD,CA 94035	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Chapman, B (corresponding author), UNIV CALIF DAVIS,CTR NEUROSCI,DAVIS,CA 95616, USA.							CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1995, P NATL ACAD SCI USA, V92, P9682, DOI 10.1073/pnas.92.21.9682; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GILBERT CD, 1981, ORG CEREBRAL CORTEX, P163; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; VOLCHAN E, 1994, VISION RES, V35, P1	13	16	16	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					9	12		10.1016/S0896-6273(00)80017-3	http://dx.doi.org/10.1016/S0896-6273(00)80017-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562095	Bronze			2022-12-28	WOS:A1996TT30700003
J	ASENJO, AB; RIM, J; OPRIAN, DD				ASENJO, AB; RIM, J; OPRIAN, DD			MOLECULAR DETERMINANTS OF HUMAN RED/GREEN COLOR DISCRIMINATION	NEURON			English	Article							AMINO-ACID SUBSTITUTIONS; VISUAL PIGMENT GENES; ABSORPTION-SPECTRA; MONOCLONAL-ANTIBODIES; WAVELENGTH REGULATION; CONE PIGMENTS; HUMAN RED; VISION; RHODOPSIN; GREEN	The human red and green color vision pigments are identical at all but 15 of their 364 amino acids, and yet their absorption maxima differ by 31 nm. In an extensive mutagenesis study, including a set of 28 chimeric proteins modeled after pigments in the color-deficient human population and an additional 30 single and multiple point mutants, the spectral difference between these 2 pigments is shown to be determined by 7 and only 7 amino acid residues. In going from the red pigment to the green pigment, the 7 residues are Ser(116) --> Tyr, Ser(180) --> Ala, Ile(230) --> Thr, Ala(233) --> Ser, Tyr(277) --> Phe, Thr(285) --> Ala, and Tyr(309) --> Phe.			ASENJO, AB (corresponding author), BRANDEIS UNIV,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.				NATIONAL EYE INSTITUTE [R01EY009514] Funding Source: NIH RePORTER; NEI NIH HHS [EY09514] Funding Source: Medline; NIGMS NIH HHS [5T32 GM0796] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boynton R. M., 1979, HUMAN COLOR VISION; CHAN T, 1992, J BIOL CHEM, V267, P9478; CHEN JG, 1989, BIOPHYS J, V55, P725, DOI 10.1016/S0006-3495(89)82871-1; CUATRECASAS P, 1970, J BIOL CHEM, V245, P3059; DEEB SS, 1992, AM J HUM GENET, V51, P687; HENDERSON R, 1990, PHILOS T ROY SOC B, V326, P379, DOI 10.1098/rstb.1990.0019; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; LO KM, 1984, P NATL ACAD SCI-BIOL, V81, P2285, DOI 10.1073/pnas.81.8.2285; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; MATHIES R, 1976, P NATL ACAD SCI USA, V73, P2169, DOI 10.1073/pnas.73.7.2169; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; MERBS SL, 1993, PHOTOCHEM PHOTOBIOL, V58, P706, DOI 10.1111/j.1751-1097.1993.tb04956.x; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ J, 1989, NATURE, V342, P679, DOI 10.1038/342679a0; NEITZ J, 1986, NATURE, V323, P623, DOI 10.1038/323623a0; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; POKORNY J., 1979, CONGENITAL ACQUIRED; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; WILLIAMS AJ, 1992, EMBO J, V11, P2039, DOI 10.1002/j.1460-2075.1992.tb05261.x; WINDERICKX J, 1992, NATURE, V356, P431, DOI 10.1038/356431a0; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZHUKOVSKY EA, 1992, BIOCHEMISTRY-US, V31, P10400, DOI 10.1021/bi00157a030	33	347	354	2	41	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1131	1138		10.1016/0896-6273(94)90320-4	http://dx.doi.org/10.1016/0896-6273(94)90320-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185948				2022-12-28	WOS:A1994NM83100016
J	NESTLER, EJ; HOPE, BT; WIDNELL, KL				NESTLER, EJ; HOPE, BT; WIDNELL, KL			DRUG-ADDICTION - A MODEL FOR THE MOLECULAR-BASIS OF NEURAL PLASTICITY	NEURON			English	Review							LOCUS-CERULEUS NEURONS; AMP-REGULATED PHOSPHOPROTEINS; MESOLIMBIC DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; RAT NUCLEUS-ACCUMBENS; PROTEIN KINASE-A; CHRONIC MORPHINE; ADENYLATE-CYCLASE; C-FOS; OPIATE WITHDRAWAL		YALE UNIV, SCH MED, DEPT PHARMACOL, NEW HAVEN, CT 06510 USA; CONNECTICUT MENTAL HLTH CTR, NEW HAVEN, CT 06508 USA	Yale University	NESTLER, EJ (corresponding author), YALE UNIV, SCH MED, DEPT PSYCHIAT, MOLEC PSYCHIAT, NEW HAVEN, CT 06510 USA.		Hope, Bruce T/A-9223-2010	Hope, Bruce T/0000-0001-5804-7061				AGHAJANIAN GK, 1987, NEUROPHARMACOLOGY, V26, P793, DOI 10.1016/0028-3908(87)90054-2; AGHAJANIAN GK, 1978, NATURE, V276, P186, DOI 10.1038/276186a0; ALREJA M, 1991, BRAIN RES, V556, P339, DOI 10.1016/0006-8993(91)90327-R; ALREJA M, 1993, J NEUROSCI, V13, P3525; BEITNER DB, 1989, MOL PHARMACOL, V35, P559; BEITNERJOHNSON D, 1992, J NEUROSCI, V12, P2165; BEITNERJOHNSON D, 1993, NEUROREPORT, V5, P57, DOI 10.1097/00001756-199310000-00014; BEITNERJOHNSON D, 1991, J NEUROCHEM, V57, P344, DOI 10.1111/j.1471-4159.1991.tb02133.x; BEITNERJOHNSON D, 1993, J NEUROCHEM, V61, P1766, DOI 10.1111/j.1471-4159.1993.tb09814.x; BEITNERJOHNSON D, 1992, ANN NY ACAD SCI, V654, P70, DOI 10.1111/j.1749-6632.1992.tb25957.x; BEITNERJOHNSON D, 1991, BRAIN RES, V561, P147, DOI 10.1016/0006-8993(91)90759-O; BOZARTH MA, 1989, CAN J PHYSIOL PHARM, V67, P1158, DOI 10.1139/y89-185; CHILDERS SR, 1991, LIFE SCI, V48, P1991, DOI 10.1016/0024-3205(91)90154-4; CHRISTIE MJ, 1987, MOL PHARMACOL, V32, P633; COLE AJ, 1992, J NEUROCHEM, V58, P1420, DOI 10.1111/j.1471-4159.1992.tb11358.x; COLE BJ, 1990, LIFE SCI, V47, P1715, DOI 10.1016/0024-3205(90)90344-Q; CUNNINGHAM ST, 1993, J NEUROSCI, V13, P2342, DOI 10.1523/JNEUROSCI.13-06-02342.1993; DUMAN RS, 1988, J PHARMACOL EXP THER, V246, P1033; DWORKIN SI, 1993, BIOL BASIS SUBSTANCE, P327; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FIBIGER HC, 1992, CIBA F SYMP, V166, P96; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GUITART X, 1990, BRAIN RES, V516, P57, DOI 10.1016/0006-8993(90)90897-K; GUITART X, 1990, J NEUROSCI, V10, P2649; GUITART X, 1989, J NEUROSCI, V9, P4371; GUITART X, 1992, SYNAPSE, V12, P242, DOI 10.1002/syn.890120310; GUITART X, 1993, BRAIN RES, V611, P7, DOI 10.1016/0006-8993(93)91770-S; GUITART X, 1992, J NEUROCHEM, V58, P1168, DOI 10.1111/j.1471-4159.1992.tb09377.x; HARRIS GC, 1991, J NEUROSCI, V11, P2574; HAYWARD MD, 1990, BRAIN RES, V525, P256, DOI 10.1016/0006-8993(90)90872-9; HENRY DJ, 1991, J PHARMACOL EXP THER, V258, P882; HENTZE MW, 1991, BIOCHIM BIOPHYS ACTA, V1090, P281, DOI 10.1016/0167-4781(91)90191-N; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; HOPE BT, 1994, IN PRESS J NEUROSCI; HYMAN SE, 1993, MOL F PSYCHIATRY; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KOGAN JH, 1992, EUR J PHARMACOL, V211, P47, DOI 10.1016/0014-2999(92)90261-2; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; MAKMAN MH, 1988, BRAIN RES, V445, P303, DOI 10.1016/0006-8993(88)91193-6; MALDONADO R, 1993, BRAIN RES, V605, P128, DOI 10.1016/0006-8993(93)91364-X; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; MISERENDINO MJD, 1993, MOL CELL NEUROSCI, V4, P440, DOI 10.1006/mcne.1993.1055; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NESTLER EJ, 1989, BRAIN RES, V476, P230, DOI 10.1016/0006-8993(89)91243-2; NESTLER EJ, 1990, J NEUROCHEM, V55, P1079, DOI 10.1111/j.1471-4159.1990.tb04602.x; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1988, MOL PHARMACOL, V33, P127; NESTLER EJ, 1993, IN PRESS ANN NY ACAD; NGUYEN TV, 1992, P NATL ACAD SCI USA, V89, P4270, DOI 10.1073/pnas.89.10.4270; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; PIAZZA PV, 1991, P NATL ACAD SCI USA, V88, P2088, DOI 10.1073/pnas.88.6.2088; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; REDMOND DE, 1984, ANNU REV NEUROSCI, V7, P443, DOI 10.1146/annurev.ne.07.030184.002303; ROBINSON TE, 1993, BIOL BASIS SUBSTANCE, P327; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; STEKETEE JD, 1991, BRAIN RES, V545, P287, DOI 10.1016/0006-8993(91)91299-G; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STRIPLIN CD, 1992, BRAIN RES, V579, P181, DOI 10.1016/0006-8993(92)90049-F; SURI C, 1993, J NEUROSCI, V13, P1280; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; VRANA SL, 1993, IN PRESS J NEUROCHEM; WANG YY, 1990, J NEUROSCI, V10, P3335; WISE RA, 1990, PSYCHOTROPIC DRUGS A, P23; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291	70	452	469	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					995	1006		10.1016/0896-6273(93)90213-B	http://dx.doi.org/10.1016/0896-6273(93)90213-B			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274284				2022-12-28	WOS:A1993MP54800001
J	HALL, GF; KOSIK, KS				HALL, GF; KOSIK, KS			AXOTOMY-INDUCED NEUROFILAMENT PHOSPHORYLATION IS INHIBITED INSITU BY MICROINJECTION OF PKA AND PKC INHIBITORS INTO IDENTIFIED LAMPREY NEURONS	NEURON			English	Article							PROTEIN-KINASE-C; NERVE GROWTH-FACTOR; CYTOSKELETAL PROTEINS; SPINAL-CORD; CENTRAL CHROMATOLYSIS; GANGLION NEURONS; GENE-EXPRESSION; CYTOCHALASIN-B; CLOSE AXOTOMY; AXON REACTION	Close axotomy of identified lamprey neurons induces phosphorylation of somatodendritic neurofilaments (NFs), followed by ectopic regeneration of neurofilamentous sprouts from the dendrites. We used in situ intracellular microinjection to study the mechanism of axotomy-induced NF phosphorylation. We found that inhibitors of protein kinase C (PKC) and protein kinase A (PKA) block somatodendritic NF phosphorylation for up to 15 days when injected at the time of axotomy. Injection of PKA catalytic subunit, diacylglycerol, or okadaic acid induces somatodendritic NF phosphorylation in intact neurons with the same time course as close axotomy. These results suggest that transient activation of PKC, PKA, and/or serine phosphatase inhibition by axotomy triggers persistent intracellular changes that may be related to polarity loss in these neurons.	CHILDRENS HOSP MED CTR,DEPT NEUROL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,F13G,CTR NEUROL,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	HALL, GF (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROL NEUROSCI,BOSTON,MA 02115, USA.				NIA NIH HHS [AG 06601] Funding Source: Medline; NINDS NIH HHS [NS 29031, NS 29281] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029031, R29NS029281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENNETT GS, 1985, J CELL BIOL, V100, P1799, DOI 10.1083/jcb.100.5.1799; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BLACK MM, 1986, J NEUROSCI, V6, P1004; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DRAGER UC, 1984, NATURE, V309, P624, DOI 10.1038/309624a0; FINE RE, 1971, NATURE-NEW BIOL, V234, P115, DOI 10.1038/newbio234115a0; GOLDSTEIN ME, 1987, J NEUROSCI, V7, P1586; HALL GF, 1983, SCIENCE, V222, P518, DOI 10.1126/science.6623092; HALL GF, 1989, J NEUROSCI, V9, P588; HALL GF, 1991, P NATL ACAD SCI USA, V88, P5016, DOI 10.1073/pnas.88.11.5016; HALL GF, 1988, J NEUROSCI, V8, P3584; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HEACOCK AM, 1976, P NATL ACAD SCI USA, V73, P828, DOI 10.1073/pnas.73.3.828; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; HISANAGA S, 1990, CELL REGUL, V1, P237, DOI 10.1091/mbc.1.2.237; HOFFMAN PN, 1980, BRAIN RES, V202, P317, DOI 10.1016/0006-8993(80)90144-4; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HOLLIDAY J, 1991, NEURON, V7, P787, DOI 10.1016/0896-6273(91)90281-4; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KLUMPP S, 1990, EMBO J, V9, P685, DOI 10.1002/j.1460-2075.1990.tb08160.x; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KOIZUMI S, 1988, J NEUROSCI, V8, P715; LANNERS HN, 1980, J NEUROCYTOL, V9, P733, DOI 10.1007/BF01205016; LEE VMY, 1986, J NEUROSCI, V6, P850; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LETOURNEAU PC, 1981, DEV BIOL, V85, P113, DOI 10.1016/0012-1606(81)90240-2; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; LINDA H, 1985, BRAIN RES, V358, P329, DOI 10.1016/0006-8993(85)90978-3; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MCKERRACHER L, 1990, J NEUROSCI, V10, P641; MURPHY AD, 1980, BRAIN RES, V186, P251, DOI 10.1016/0006-8993(80)90974-9; NEL AE, 1990, J IMMUNOL, V144, P2683; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; NORDLANDER RH, 1982, DEV BRAIN RES, V4, P181, DOI 10.1016/0165-3806(82)90041-4; OBLINGER MM, 1989, J NEUROSCI, V9, P2645; PLEASURE SJ, 1989, J NEUROSCI, V9, P698; ROEDERER E, 1983, J NEUROSCI, V3, P1835; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SHAW G, 1988, BRAIN RES, V460, P227, DOI 10.1016/0006-8993(88)90367-8; SIHAG RK, 1989, J BIOL CHEM, V264, P457; SINICROPI DV, 1983, J CELL BIOL, V96, P240, DOI 10.1083/jcb.96.1.240; SKOFF RP, 1974, J COMP NEUROL, V153, P107, DOI 10.1002/cne.901530202; SMITH MK, 1990, J BIOL CHEM, V265, P1837; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; SZARO BG, 1991, J COMP NEUROL, V308, P576, DOI 10.1002/cne.903080406; TORVIK A, 1976, NEUROPATH APPL NEURO, V2, P423, DOI 10.1111/j.1365-2990.1976.tb00516.x; WESSELLS NK, 1978, EXP CELL RES, V117, P335, DOI 10.1016/0014-4827(78)90147-7; WICKELGREN WO, 1977, J PHYSIOL-LONDON, V270, P89, DOI 10.1113/jphysiol.1977.sp011940	55	39	39	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					613	625		10.1016/0896-6273(93)90164-M	http://dx.doi.org/10.1016/0896-6273(93)90164-M			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476612				2022-12-28	WOS:A1993KY50100006
J	PENG, YY; ZUCKER, RS				PENG, YY; ZUCKER, RS			RELEASE OF LHRH IS LINEARLY RELATED TO THE TIME INTEGRAL OF PRESYNAPTIC CA2+ ELEVATION ABOVE A THRESHOLD LEVEL IN BULLFROG SYMPATHETIC-GANGLIA	NEURON			English	Article							SQUID GIANT SYNAPSE; TRANSMITTER RELEASE; CALCIUM DIFFUSION; MEDIAN-EMINENCE; NERVE-TERMINALS; CELLS; CA-2+; FROG; FACILITATION; EXOCYTOSIS	To study the Ca2+ dependency of luteinizing hormone-releasing hormone (LHRH) release in the bullfrog sympathetic ganglia, a method was developed to fill the preganglionic nerve terminal boutons with membrane-impermeant fura-2. We found that as stimulation frequency increased from 0.5 to 40 Hz, the peak [Ca2+]i ([Ca2+]p) and the rate of rise in [Ca2+]i increased, the decay of [Ca2+]i, transients followed up to three exponentials, and release of LHRH was linearly related to integral([Ca2+]i - [Ca2+]t)dt. The threshold level of [Ca2+]i for LHRH release for a given set of boutons on a C cell, [Ca2+]t, was estimated by the [Ca2+]p, evoked by 0.5 Hz stimulation that does not induce LHRH release.			PENG, YY (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343	NINDS NIH HHS [NS15114] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BALUK P, 1986, J NEUROCYTOL, V15, P85, DOI 10.1007/BF02057907; BAYLOR SM, 1988, J PHYSIOL-LONDON, V403, P151, DOI 10.1113/jphysiol.1988.sp017244; BELHUMEUR C, 1986, NEUROSCIENCE, V17, P1267, DOI 10.1016/0306-4522(86)90093-X; BUMA P, 1988, CELL TISSUE RES, V252, P107; BUMA P, 1987, NEUROSCI LETT, V74, P151, DOI 10.1016/0304-3940(87)90141-8; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DODD J, 1983, J PHYSIOL-LONDON, V334, P255, DOI 10.1113/jphysiol.1983.sp014493; DODD J, 1983, J PHYSIOL-LONDON, V334, P271, DOI 10.1113/jphysiol.1983.sp014494; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; FENWICK EM, 1978, J CELL BIOL, V76, P12, DOI 10.1083/jcb.76.1.12; FILLENZ M, 1971, PHILOS T ROY SOC B, V261, P319, DOI 10.1098/rstb.1971.0063; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JONES SW, 1984, J NEUROSCI, V4, P420; KAO JPY, 1988, BIOPHYS J, V53, P635, DOI 10.1016/S0006-3495(88)83142-4; LEE CJ, 1992, NEURON, V8, P335, DOI 10.1016/0896-6273(92)90299-S; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MONCK JR, 1988, J BIOL CHEM, V263, P4569; PENG YY, 1991, J NEUROSCI, V11, P85; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; STANLEY EF, 1986, J NEUROSCI, V6, P782; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; TAXI J, 1967, NEURON, P221; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; THURESONKLEIN A, 1981, CHEM NEUROTRANSMISSI, P153; THURESONKLEIN A, 1979, CATECHOLAMINES BASIC, P262; UCHIZONO K, 1964, JPN J PHYSIOL, V14, P210; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6	39	84	87	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					465	473		10.1016/0896-6273(93)90334-N	http://dx.doi.org/10.1016/0896-6273(93)90334-N			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461136				2022-12-28	WOS:A1993KU90100011
J	Emerling, DE; Lander, AD				Emerling, DE; Lander, AD			Inhibitors and promoters of thalamic neuron adhesion and outgrowth in embryonic neocortex: Functional association with chondroitin sulfate	NEURON			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; CELL-ADHESION; GROWTH-FACTORS; CHICK-EMBRYO; PROTEOGLYCAN; GLYCOSAMINOGLYCANS; AXONS; BRAIN	When embryonic thalamic neurons are plated onto living slices of mouse forebrain, cell attachment and neurite outgrowth on different layers of the developing cerebral cortex vary dramatically, in ways that correlate with the timing and pattern of thalamocortical innervation. These layer-specific differences can be eliminated from embryonic day 16 slices by enzymatic removal of chondroitin sulfate (CS). The cortical plate (a zone avoided by thalamic axons in vivo) possesses inhibitory activity (anti-adhesive, neurite repelling) and the intermediate zone and subplate (in which thalamic axons normally grow) possess stimulatory activity (adhesive, neurite promoting), both of which are chondroitinase sensitive. These opposing activities appear not to reflect the presence of different CS proteoglycans (CSPGs) in different zones, but rather the presence of differentially localized CS-binding molecules, which can be competed away by soluble CS. This model reconciles conflicting reports on the actions of CSPGs in neural development, and suggests a role for CSPGs in the organization of matrix-bound cues in the brain.	UNIV CALIF IRVINE,DEPT DEV & CELL BIOL,IRVINE,CA 92697; UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92697	University of California System; University of California Irvine; University of California System; University of California Irvine	Emerling, DE (corresponding author), MIT,DEPT BRAIN & COGNIT SCI,E25-618,CAMBRIDGE,MA 02139, USA.		Lander, Arthur/L-2827-2019; Lander, Arthur D/C-9008-2011	Lander, Arthur/0000-0002-4380-5525; Lander, Arthur D/0000-0002-4380-5525	NINDS NIH HHS [NS26862] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026862] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; BARNEA G, 1994, J BIOL CHEM, V269, P14349; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; BRITTIS PA, 1994, P NATL ACAD SCI USA, V91, P7539, DOI 10.1073/pnas.91.16.7539; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; CARBONETTO S, 1983, J NEUROSCI, V3, P2324; CATALANO SM, 1996, J COMP NEUROL, V366, P36; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CRANDALL JE, 1984, DEV BRAIN RES, V14, P185, DOI 10.1016/0165-3806(84)90305-5; DOU CL, 1994, J NEUROSCI, V14, P7616; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; EMERLING DE, 1994, DEVELOPMENT, V120, P2811; Engel M, 1996, J COMP NEUROL, V366, P34; FAISSNER A, 1995, GLIA, V13, P233, DOI 10.1002/glia.440130402; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FERNAUDESPINOSA I, 1994, J CELL SCI, V107, P1437; FICHARD A, 1991, DEV BIOL, V148, P1, DOI 10.1016/0012-1606(91)90312-Q; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; GREEN SJ, 1988, J CELL SCI, V90, P145; GRUMET M, 1994, J BIOL CHEM, V269, P12142; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; HERNDON ME, 1996, THESIS MIT CAMBRIDGE; IIJIMA N, 1991, J NEUROCHEM, V56, P706, DOI 10.1111/j.1471-4159.1991.tb08207.x; IWATA M, 1993, J BIOL CHEM, V268, P15061; KITAMURA K, 1987, DEVELOPMENT, V100, P501; Klagsbrun M, 1992, Semin Cancer Biol, V3, P81; LAFONT F, 1992, DEVELOPMENT, V114, P17; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; Lander Arthur D., 1993, P341; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; LITWACK ED, 1994, J NEUROSCI, V14, P3713; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; Maeda N, 1996, DEVELOPMENT, V122, P647; MARGOLIS RK, 1975, BIOCHEMISTRY-US, V14, P4797, DOI 10.1021/bi00693a004; MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014; MCADAMS BD, 1995, J COMP NEUROL, V352, P594, DOI 10.1002/cne.903520408; MeyerPuttlitz B, 1996, J COMP NEUROL, V366, P44, DOI 10.1002/(SICI)1096-9861(19960226)366:1<44::AID-CNE4>3.0.CO;2-K; MILLER B, 1995, J COMP NEUROL, V355, P615, DOI 10.1002/cne.903550410; MOSCATELLI D, 1992, J BIOL CHEM, V267, P25803; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PERRIS R, 1991, DEVELOPMENT, V111, P583; PERRIS R, 1987, J CELL BIOL, V105, P2511, DOI 10.1083/jcb.105.6.2511; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; RAUCH U, 1992, J BIOL CHEM, V267, P19536; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; SHEPPARD AM, 1991, J NEUROSCI, V11, P3928; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; SNOW DM, 1991, DEVELOPMENT, V113, P1473; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; Toole BP, 1976, NEURONAL RECOGNITION, P275; TUTTLE R, 1995, J NEUROSCI, V15, P3039; VERNA JM, 1989, INT J DEV NEUROSCI, V7, P389, DOI 10.1016/0736-5748(89)90060-9; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; YAGINUMA H, 1991, J NEUROSCI, V11, P2598; YAMADA H, 1994, J BIOL CHEM, V269, P10119; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	65	111	116	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1089	1100		10.1016/S0896-6273(00)80242-1	http://dx.doi.org/10.1016/S0896-6273(00)80242-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982158	Green Published, Bronze			2022-12-28	WOS:A1996WA24800008
J	Saez, L; Young, MW				Saez, L; Young, MW			Regulation of nuclear entry of the Drosophila clock proteins period and timeless	NEURON			English	Article							CIRCADIAN CLOCK; GENE-PRODUCT; BIOLOGICAL CLOCK; VISUAL-SYSTEM; MUTANTS; EXPRESSION; MELANOGASTER; MUTATION; CLONING; RHYTHMS	Two genes, period (per) and timeless (tim), are essential for circadian rhythmicity in drosophila. The encoded proteins (PER and TIM) physically interact. Here, it is shown that TIM and PER accumulate in the cytoplasm when independently expressed in cultured (S2) Drosophila cells. However, the proteins move to the nuclei of these cells if coexpressed. Domains of PER and TIM have been identified that block nuclear localization of the monomeric proteins. In vitro protein interaction studies indicate that the sequence inhibiting the nuclear accumulation of PER forms a binding site for TIM. The results indicate a mechanism for controlled nuclear localization in which suppression of cytoplasmic localization is accomplished by direct interaction of PER and TIM. No other clock functions are required for nuclear localization. The findings suggest that a checkpoint in the circadian cycle is established by requiring cytoplasmic assembly of a PEW TIM complex as a condition for nuclear transport of either protein.	ROCKEFELLER UNIV,GENET LAB,NEW YORK,NY 10021	Rockefeller University	Saez, L (corresponding author), ROCKEFELLER UNIV,NATL SCI FDN,SCI & TECHNOL CTR BIOL TIMING,HOWARD HUGHES MED INST,1230 YORK AVE,NEW YORK,NY 10021, USA.		, 机智的马小跳和机智的羊不愁/ABC-5169-2020					BARGIELLO TA, 1984, P NATL ACAD SCI-BIOL, V81, P2142, DOI 10.1073/pnas.81.7.2142; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BAYLIES MK, 1993, MOL GENETICS BIOL RH, P123; BRUCE VG, 1972, GENETICS, V70, P537; CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; Edmunds LN, 1988, CELLULAR MOL BASES B; FELDMAN J F, 1973, Genetics, V75, P605; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; ISODA K, 1992, GENE DEV, V6, P619, DOI 10.1101/gad.6.4.619; KAY SA, 1995, CELL, V83, P361, DOI 10.1016/0092-8674(95)90113-2; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LI XX, 1994, J CELL BIOL, V124, P7, DOI 10.1083/jcb.124.1.7; LIU X, 1992, J NEUROSCI, V12, P2735; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; PINES J, 1994, EMBO J, V13, P3777; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; REDDY P, 1984, CELL, V38, P701, DOI 10.1016/0092-8674(84)90265-4; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; RIO DC, 1986, CELL, V44, P21, DOI 10.1016/0092-8674(86)90481-2; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Thummel CS, 1992, DROS INF SERV, V71, P150; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; VOSSHALL LB, 1993, THESIS ROCKEFELLER U; YOUNG MW, 1996, IN PRESS COLD SPRING, V61; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZERR DM, 1990, J NEUROSCI, V10, P2749	44	255	261	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					911	920		10.1016/S0896-6273(00)80222-6	http://dx.doi.org/10.1016/S0896-6273(00)80222-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938123	Bronze			2022-12-28	WOS:A1996VV15100013
J	Salzer, JL; Colman, DR				Salzer, JL; Colman, DR			In memoriam: Richard Paul Bunge	NEURON			English	Item About an Individual									CUNY MT SINAI SCH MED,BROOKDALE CTR MOL BIOL,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Salzer, JL (corresponding author), NYU,MED CTR,DEPT CELL BIOL,NEW YORK,NY 10016, USA.								0	0	0	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					811	812		10.1016/S0896-6273(02)00022-3	http://dx.doi.org/10.1016/S0896-6273(02)00022-3			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938114	Bronze			2022-12-28	WOS:A1996VV15100004
J	Henderson, CE				Henderson, CE			Programmed cell death in the developing nervous system	NEURON			English	Review							GROWTH; SURVIVAL; RECEPTOR; GENE				Henderson, CE (corresponding author), UNIV MEDITERRANEE,INSERM,CNRS,INSERM,U382,IBDM,CAMPUS LUMINY,F-13288 MARSEILLE 09,FRANCE.			Henderson, Christopher/0000-0002-9936-3279				BUREK MJ, 1995, J NEUROBIOL, V27, P85, DOI 10.1002/neu.480270109; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; HARTLAGERUBSAME.M, 1996, J COMP NEUROL, V371, P471; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MICHAELIDIS MT, 1996, NEURON, V17, P75; Middleton G, 1996, DEVELOPMENT, V122, P695; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; Nobes CD, 1996, NEUROSCIENCE, V70, P1067, DOI 10.1016/0306-4522(95)00420-3; Nordeen EJ, 1996, J NEUROBIOL, V30, P531, DOI 10.1002/(SICI)1097-4695(199608)30:4<531::AID-NEU8>3.0.CO;2-4; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; Primi MP, 1996, NEUROREPORT, V7, P473, DOI 10.1097/00001756-199601310-00023; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; Shaham S, 1996, CELL, V86, P201, DOI 10.1016/S0092-8674(00)80092-6; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Troy CM, 1996, J NEUROSCI, V16, P253; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; ZIRPEL L, 1996, IN PRESS J NEUROPHYS	26	91	92	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					579	585		10.1016/S0896-6273(00)80191-9	http://dx.doi.org/10.1016/S0896-6273(00)80191-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893016	Bronze			2022-12-28	WOS:A1996VP74300004
J	Schuster, CM; Davis, GW; Fetter, RD; Goodman, CS				Schuster, CM; Davis, GW; Fetter, RD; Goodman, CS			Genetic dissection of structural and functional components of synaptic plasticity .1. Fasciclin II controls synaptic stabilization and growth	NEURON			English	Article							CELL-ADHESION MOLECULE; CONE GUIDANCE; IMMUNOGLOBULIN SUPERFAMILY; NEURONAL RECOGNITION; DROSOPHILA MUTANTS; LIVING MICE; APLYSIA; EXPRESSION; SYNAPSES; PROTEIN	The glutamatergic neuromuscular synapse in Drosophila forms and differentiates into distinct boutons in the embryo and grows by sprouting new boutons throughout larval life. We demonstrate that two axons form similar to 18 boutons on muscles 7 and 6 by hatching and grow to similar to 180 boutons by third instar. We further show that, after synapse formation, the homophilic cell adhesion molecule Fasciclin II (Fas II) is localized both pre- and postsynaptically where it controls synapse stabilization. In FasII null mutants, synapse formation is normal, but boutons then retract during larval development. Synapse elimination and resulting lethality are rescued by transgenes that drive Fas II expression both pre- and postsynaptically; driving Fas II expression on either side alone is insufficient. Fas II can also control synaptic growth; various FasII alleles lead to either an increase or decrease in sprouting, depending upon the level of Fas II.			Schuster, CM (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOL & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1989, J NEUROBIOL, V20, P356, DOI 10.1002/neu.480200508; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BEYER WH, 1987, CRC HDB MATH SCI, P162; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P144; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Dan Yang, 1994, Current Opinion in Neurobiology, V4, P95, DOI 10.1016/0959-4388(94)90037-X; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; FIELDS DR, 1996, IN PRESS TRENDS NEUR; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; GUAN B, 1996, CURR OPIN NEUROBIOL, V6, P697; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; LICHTMAN JW, 1990, J NEUROBIOL, V21, P99, DOI 10.1002/neu.480210107; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUTHL A, 1994, NATURE, V327, P777; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1986, J NEUROSCI, V6, P1051; Stewart BA, 1996, J NEUROSCI, V16, P3877; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; ZHONG Y, 1995, J NEUROSCI, V15, P6679; ZHONG Y, 1992, J NEUROSCI, V12, P644; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	39	365	370	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					641	654		10.1016/S0896-6273(00)80197-X	http://dx.doi.org/10.1016/S0896-6273(00)80197-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893022	Bronze			2022-12-28	WOS:A1996VP74300010
J	Chen, ML; Hoshi, T; Wu, CF				Chen, ML; Hoshi, T; Wu, CF			Heteromultimeric interactions among K+ channel subunits from Shaker and eag families in Xenopus oocytes	NEURON			English	Article							VOLTAGE-CLAMP ANALYSIS; POTASSIUM-CHANNEL; MOLECULAR MECHANISMS; DROSOPHILA-EAG; INACTIVATION; CURRENTS; LOCUS; MUTATIONS; MUTANTS; MUSCLE	Heteromultimeric interactions of K+ channel subunits across different families have been thought to contribute to the functional diversity of ionic currents, as suggested by previous genetic evidence. We present here direct demonstration in Xenopus oocytes that subunits from distinct eag and Shaker families functionally interact, most likely as heteromultimeric channels. Coexpression with eag accelerates the inactivation and slows the recovery from inactivation of the transient Shaker current. Site-directed mutagenesis indicates that the eag carboxyl terminus is crucial for this interaction, exerting effects preferentially on N-type inactivation. Many members of the eag and Shaker families have now been identified and their human homologs implicated in cardiac and neurological disorders. Studies on channel subunit interactions may prove important in understanding the disease pattern and the complex functions of the brain.	UNIV IOWA, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA	University of Iowa	Chen, ML (corresponding author), UNIV IOWA, DEPT BIOL SCI, IOWA CITY, IA 52242 USA.			Wu, Chun-Fang/0000-0002-4973-2021				ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HAUGLAND FN, 1990, J NEUROSCI, V10, P1357; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SINGH S, 1989, NEURON, V2, P1325, DOI 10.1016/0896-6273(89)90070-6; Tsui L C, 1991, Adv Hum Genet, V20, P153; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wu C F, 1995, Chin J Physiol, V38, P131; Wu C F, 1992, Ion Channels, V3, P261; WU CF, 1985, J NEUROSCI, V5, P2626; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; WU CF, 1986, ION CHANNELS NEURAL, P407; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZHONG Y, 1993, J NEUROSCI, V13, P4669; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864	42	42	43	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					535	542		10.1016/S0896-6273(00)80185-3	http://dx.doi.org/10.1016/S0896-6273(00)80185-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816716	Bronze			2022-12-28	WOS:A1996VJ44000019
J	CamposOrtega, JA				CamposOrtega, JA			Numb diverts notch pathway off the Tramtrack	NEURON			English	Review							DROSOPHILA-MELANOGASTER; EARLY NEUROGENESIS; PROTEIN; MUTANTS; GENE				CamposOrtega, JA (corresponding author), UNIV COLOGNE,INST ENTWICKLUNGSBIOL,D-5000 COLOGNE,GERMANY.							BOVERI T, 1910, W ROUX ARCH ENTWICKL, V30, P101; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HARTENSTEIN V, 1986, ROUX ARCH DEV BIOL, V195, P210, DOI 10.1007/BF02438953; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Poulson DF, 1937, P NATL ACAD SCI USA, V23, P133, DOI 10.1073/pnas.23.3.133; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0	15	41	41	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					1	4		10.1016/S0896-6273(00)80274-3	http://dx.doi.org/10.1016/S0896-6273(00)80274-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755472	Bronze			2022-12-28	WOS:A1996UY98100001
J	Huang, LYM; Neher, E				Huang, LYM; Neher, E			Ca2+-dependent exocytosis in the somata of dorsal root ganglion neurons	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; RAT SENSORY NEURONS; PATCH-CLAMP TECHNIQUES; GENE-RELATED PEPTIDE; SUBSTANCE-P; TRANSMITTER RELEASE; CALCIUM CHANNELS; NERVE-TERMINALS; NEUROTRANSMITTER RELEASE; CAPACITANCE MEASUREMENTS	Using capacitance measurements and the single-cell immunoblot assay to study secretion in dorsal root ganglion neurons, we found that the somata underwent robust exocytosis upon depolarization and released substance P, in response to KCI stimulation. The parallel changes between capacitance responses and intracellular Ca2+ concentration ([Ca2+](i)) at different membrane potentials and the inhibition of exocytosis by Ca2+ chelators suggest that soma release is Ca2+-dependent. We also assessed the level of Ca2+ required for exocytosis by raising the average [Ca2+](i) with the Ca2+ ionophore, ionomycin. Capacitance changes were triggered by cytosolic Ca2+ > 0.6 mu M; the [Ca2+](i) at the release sites during depolarizations was estimated to be 3-10 mu M. These Ca2+ levels are similar to those obtained from neuroendocrine cells, but are at least 10 times lower than those required for transmitter release from nerve terminals.	MAX PLANCK INST BIOPHYS CHEM, ABT MEMBRANBIOPHYS, D-37077 GOTTINGEN, GERMANY	Max Planck Society	Huang, LYM (corresponding author), UNIV TEXAS, MED BRANCH, INST MARINE BIOMED, GALVESTON, TX 77555 USA.		Neher, Erwin/A-2109-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030045] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30045] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; ARITA J, 1991, ENDOCRINOLOGY, V128, P1887, DOI 10.1210/endo-128-4-1887; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BATTAGLIA G, 1988, J COMP NEUROL, V277, P302, DOI 10.1002/cne.902770210; BEAN AJ, 1994, FASEB J, V8, P630, DOI 10.1096/fasebj.8.9.8005390; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; BOOKMAN RJ, 1991, ANN NY ACAD SCI, V635, P352, DOI 10.1111/j.1749-6632.1991.tb36504.x; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHEN GY, 1995, J NEUROSCI, V15, P7747; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; DAN Y, 1994, NEURON, V13, P909, DOI 10.1016/0896-6273(94)90256-9; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; GANDIA L, 1995, PFLUG ARCH EUR J PHY, V430, P55, DOI 10.1007/BF00373839; GIROD R, 1995, J NEUROSCI, V15, P2826; GLUBEKIAN S, 1986, J NEUROCYTOL, V15, P535; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HINGTGEN CM, 1994, BRAIN RES, V655, P51, DOI 10.1016/0006-8993(94)91596-2; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; KAYAHARA T, 1981, BRAIN RES, V216, P277, DOI 10.1016/0006-8993(81)90130-X; KENDALL ME, 1987, ENDOCRINOLOGY, V121, P2260, DOI 10.1210/endo-121-6-2260; LEE KH, 1986, J COMP NEUROL, V243, P335, DOI 10.1002/cne.902430305; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lindau Manfred, 1994, V29, P173; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LOPEZ MG, 1994, PFLUG ARCH EUR J PHY, V427, P348, DOI 10.1007/BF00374544; MERIGHI A, 1988, CELL TISSUE RES, V254, P101; MUDGE AW, 1979, P NATL ACAD SCI USA, V76, P526, DOI 10.1073/pnas.76.1.526; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NEHER E, 1989, NEUROMUSCULAR JUNCTI, P65; Neher E., 1986, EXPT BRAIN RES SERIE, P80; NICOL GD, 1992, J NEUROSCI, V12, P1917; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; PENNER R, 1988, J EXP BIOL, V139, P329; PLENDERLEITH MB, 1990, SYNAPSE, V6, P344, DOI 10.1002/syn.890060406; RENDT J, 1994, ENDOCRINOLOGY, V135, P501, DOI 10.1210/en.135.2.501; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Seward EP, 1996, J NEUROSCI, V16, P553; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; VASKO MR, 1994, J NEUROSCI, V14, P4987; VEDDER H, 1991, J NEUROSCI RES, V30, P288, DOI 10.1002/jnr.490300203; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WAGONER PK, 1993, P NATL ACAD SCI USA, V90, P9145, DOI 10.1073/pnas.90.19.9145; WILLIS WD, 1991, SENSORY MECHANISMS S, P47; WU LG, 1994, J NEUROSCI, V14, P5613; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; ZHOU Z, 1995, P NATL ACAD SCI USA, V92, P6938, DOI 10.1073/pnas.92.15.6938; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; ZHU PC, 1986, NEUROSCIENCE, V19, P43, DOI 10.1016/0306-4522(86)90004-7; ZUCKER RS, 1991, ANN NY ACAD SCI, V635, P191, DOI 10.1111/j.1749-6632.1991.tb36492.x; ZUCKER RS, 1988, NATURE, V335, P360, DOI 10.1038/335360a0	73	245	249	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1996	17	1					135	145		10.1016/S0896-6273(00)80287-1	http://dx.doi.org/10.1016/S0896-6273(00)80287-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755485	Bronze, Green Published			2022-12-28	WOS:A1996UY98100014
J	Brundage, L; Avery, L; Katz, A; Kim, UJ; Mendel, JE; Sternberg, PW; Simon, MI				Brundage, L; Avery, L; Katz, A; Kim, UJ; Mendel, JE; Sternberg, PW; Simon, MI			Mutations in a C-elegans G(q)alpha gene disrupt movement, egg laying, and viability	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PROTEIN ALPHA-SUBUNITS; PHOSPHOLIPASE-C; BETA-GAMMA; WILD-TYPE; RECEPTORS; MUTANTS; CELL; ACTIVATION; DIVERSITY	We find that C. elegans egl-30 encodes a heterotrimeric G protein alpha subunit more than 80% identical to mammalian G(q) alpha family proteins, and which can function as a G(q) alpha subunit in COS-7 cells. We have identified new egl-30 alleles in a selection for genes involved in the C. elegans acetylcholine response. Two egl-30 alleles specify premature termination of G(q) alpha and are essentially lethal in homozygotes. Animals homozygous for six other egl-30 alleles are viable and fertile, but exhibit delayed egg laying and leave flattened tracks. Overexpression of the wild-type egl-30 gene produces the opposite behavior. Analysis of these mutants suggest that their phenotypes reflect defects in the muscle or neuromuscular junction.	CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235	California Institute of Technology; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brundage, L (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Katz, Arieh/F-5836-2012	Sternberg, Paul/0000-0002-7699-0173	NHLBI NIH HHS [R37 HL046154, R01 HL046154, HL46154] Funding Source: Medline; NINDS NIH HHS [F32 NS009541, F32NS09541-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046154, R37HL046154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009541] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFONSO A, 1994, J NEUROSCI, V14, P2290; AROIAN RV, 1993, MOL CELL BIOL, V13, P626, DOI 10.1128/MCB.13.1.626; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1993, J EXP BIOL, V175, P283; BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BRENNER S, 1974, GENETICS, V77, P71; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; CULOTTI JG, 1983, J NEUROSCI, V3, P359; Davignon I, 1996, GENOMICS, V31, P359, DOI 10.1006/geno.1996.0059; EDGERTON MD, 1994, FEBS LETT, V354, P195, DOI 10.1016/0014-5793(94)01101-X; EGLEN RM, 1994, TRENDS PHARMACOL SCI, V15, P114, DOI 10.1016/0165-6147(94)90047-7; GOLLASCH M, 1991, P NATL ACAD SCI USA, V88, P10262, DOI 10.1073/pnas.88.22.10262; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEE CH, 1992, J BIOL CHEM, V267, P16044; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MCKIM KS, 1993, GENETICS, V134, P749; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; OFFERMANNS S, 1991, MOL ENDOCRINOL, V5, P995, DOI 10.1210/mend-5-7-995; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; PARK EC, 1986, GENETICS, V113, P821; RAIZEN DM, 1995, GENETICS, V141, P1365; REINER DJ, 1995, GENETICS, V141, P961; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SILVA IF, 1990, J MOL BIOL, V215, P483, DOI 10.1016/S0022-2836(05)80160-3; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; TRENT C, 1983, GENETICS, V104, P619; VANDERVOORN L, 1990, J MOL BIOL, V213, P17, DOI 10.1016/S0022-2836(05)80118-4; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; Watson S., 1994, G PROTEIN LINKED REC; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; WU DQ, 1992, J BIOL CHEM, V267, P25798	52	152	157	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					999	1009		10.1016/S0896-6273(00)80123-3	http://dx.doi.org/10.1016/S0896-6273(00)80123-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630258	Green Accepted, Bronze			2022-12-28	WOS:A1996UN48000015
J	Shieh, BH; Zhu, MY				Shieh, BH; Zhu, MY			Regulation of the TRP Ca2+ channel by INAD in Drosophila photoreceptors	NEURON			English	Article							CALCIUM-CHANNEL; PROTEIN; PHOTOTRANSDUCTION; GENE; TRANSDUCTION; EXPRESSION	Drosophila vision involves a G protein-coupled phospholipase C-mediated signaling pathway that leads to membrane depolarization through activation of Na+ and Ca2+ channels. InaD mutant flies have a M442K point mutation and display a slow recovery of the Ca2+-dependent current. We report that anti-INAD antibodies coimmunoprecipitate TRP, identified by its electrophoretic mobility, cross reactivity with anti-TRP antibody, and absence in a null allele trp mutant. This interaction is abolished by the InaD point mutation in vitro and in vivo. Interaction was localized to the 19 amino acid C-terminus of TRP by overlay assays, and to the PDZ domain of INAD, encompassing the point mutation. Given the impaired electrophysiology of the InaD mutant, this novel interaction suggests that INAD functions as a regulatory subunit of the TRP Ca2+ channel.			Shieh, BH (corresponding author), VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232, USA.				NEI NIH HHS [EY09743] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009743] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROWN PJ, 1993, J BIOL CHEM, V268, P6668; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; DOOLITTLE RF, 1986, URFS ORFS PRIMER ANA, P561; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; HU YF, 1994, BIOCHEM BIOPH RES CO, V201, P1050, DOI 10.1006/bbrc.1994.1808; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Pak W.L., 1979, P67; Pearn MT, 1996, J BIOL CHEM, V271, P4937; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J., 2002, MOL CLONING LAB MANU; SELINGER Z, 1993, BIOCHIM BIOPHYS ACTA, V1179, P283, DOI 10.1016/0167-4889(93)90084-3; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; STUDIER FW, 1986, J MOL BIOL, V113, P189; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; WOLFNER MF, 1994, DROSOPHILA MELANOGAS, P33; WONG F, 1989, NEURON, V3, P81, DOI 10.1016/0896-6273(89)90117-7	36	228	236	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					991	998		10.1016/S0896-6273(00)80122-1	http://dx.doi.org/10.1016/S0896-6273(00)80122-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630257	Bronze			2022-12-28	WOS:A1996UN48000014
J	Smith, DP				Smith, DP			The sweet, sweet smell of diacetyl	NEURON			English	Review							ODORANT RECEPTORS; C-ELEGANS; NEURONS; SALAMANDER				Smith, DP (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235, USA.							BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SENGUPTA P, 1996, IN PRESS CELL, V84; SINGER MS, 1995, NATURE, V377, P19, DOI 10.1038/377019b0; SULLIVAN SL, 1995, CURR OPIN GENET DEV, V5, P516, DOI 10.1016/0959-437X(95)90057-N; SULLIVAN SL, 1995, NEURON, V15, P779, DOI 10.1016/0896-6273(95)90170-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9	15	1	1	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					469	471		10.1016/S0896-6273(00)80065-3	http://dx.doi.org/10.1016/S0896-6273(00)80065-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785043	Bronze			2022-12-28	WOS:A1996UC16800002
J	Retaux, S; McNeill, L; Harris, WA				Retaux, S; McNeill, L; Harris, WA			Engrailed, retinotectal targeting, and axonal patterning in the midbrain during Xenopus development: An antisense study	NEURON			English	Article							RETINAL AXONS; ROSTROCAUDAL POLARITY; HOMING BEHAVIOR; VISUAL-SYSTEM; GROWTH CONES; EXPRESSION; HOMEOBOX; BRAIN; GENE; DROSOPHILA	Axonal tracts in the vertebrate brain seem to respect domains of homeobox gene expression. To test the role of engrailed in tract formation in the midbrain, we inhibited its expression using antisense (AS) oligo-nucleotides. Phosphorothioate-modified AS oligos caused navigational errors in both the optic projection (OF) and the intertectal commissure (ITC). These oligos, however, also inhibited bFGF binding to the brain. To determine whether these tract phenotypes were due to inhibition of bFGF function or engrailed expression, we used partially phosphorothioate-modified (pp) oligos, which inhibit engrailed expression but do not affect bFGF binding. These ppAS oligos caused the ITC phenotype but had no effect on the OF. Thus, interference with bFGF function correlates with the OP phenotype, while the ITC phenotype is directly related to engrailed expression.			Retaux, S (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL 0366, LA JOLLA, CA 92093 USA.							ALVARADOMALLART RM, 1993, J NEUROBIOL, V24, P1341, DOI 10.1002/neu.480241007; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Boncinelli Edoardo, 1994, Current Opinion in Neurobiology, V4, P29, DOI 10.1016/0959-4388(94)90028-0; BULFONE A, 1993, J NEUROSCI, V13, P3155; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; CHIEN CB, 1995, DEVELOPMENT, V121, P2621; CONDRON BG, 1994, NEURON, V13, P541, DOI 10.1016/0896-6273(94)90024-8; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; DAVIS CA, 1991, DEVELOPMENT, V111, P287; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; GOULD AP, 1992, DEVELOPMENT, V116, P1163; GUVAKOVA MA, 1995, J BIOL CHEM, V270, P2620, DOI 10.1074/jbc.270.6.2620; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HARRIS WA, 1986, NATURE, V320, P266, DOI 10.1038/320266a0; HARRIS WA, 1990, ANNU REV NEUROSCI, V13, P155, DOI 10.1146/annurev.ne.13.030190.001103; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; HEUER JG, 1992, DEVELOPMENT, V115, P35; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; ITASAKI N, 1992, NEURON, V8, P787, DOI 10.1016/0896-6273(92)90099-Y; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; JONES FS, 1990, P NATL ACAD SCI USA, V87, P6497, DOI 10.1073/pnas.87.17.6497; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2091, DOI 10.1073/pnas.89.6.2091; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P2289, DOI 10.1073/pnas.87.6.2289; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; PAPALOPULU N, 1993, DEVELOPMENT, V117, P961; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; RUBENSTEIN JLR, 1994, CURR TOP DEV BIOL, V29, P1, DOI 10.1016/S0070-2153(08)60546-3; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; TAYLOR JSH, 1990, DEVELOPMENT, V108, P147; TAYLOR JSH, 1991, DEVELOPMENT, P95; WAGNER JSH, 1994, DEVELOPMENT S, V372, P333; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WATANABE M, 1993, NUCLEIC ACIDS RES, V21, P2513, DOI 10.1093/nar/21.10.2513; WILSON SW, 1990, DEVELOPMENT, V108, P121; WILSON SW, 1993, TRENDS NEUROSCI, V16, P316, DOI 10.1016/0166-2236(93)90108-X; WURST W, 1994, DEVELOPMENT, V120, P2065	50	28	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					63	75		10.1016/S0896-6273(00)80024-0	http://dx.doi.org/10.1016/S0896-6273(00)80024-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562092	Bronze			2022-12-28	WOS:A1996TT30700010
J	Campbell, K; Olsson, M; Bjorklund, A				Campbell, K; Olsson, M; Bjorklund, A			Regional incorporation and site-specific differentiation of striatal precursors transplanted to the embryonic forebrain ventricle	NEURON			English	Article							CHOLINE-ACETYLTRANSFERASE; RESTRICTED EXPRESSION; CORTICAL-NEURONS; RAT NEOSTRIATUM; BASAL GANGLIA; GLIAL-CELLS; MIGRATION; GENE; PARVALBUMIN; ASTROCYTES	The developmental potential of neural progenitors derived from the E13.5-E14 lateral or medial ganglionic eminences (LGE and MGE, respectively) or the E12 ventral mesencephalon (VM) was examined in a cross-species transplantation model. After injection into the E15 rat forebrain ventricle, mouse LGE progenitors (unlike those of the MGE or VM) were consistently integrated into the host striatum, expressing neurochemical phenotypes and axonal projections characteristic of striatal projection neurons. Additionally, both LGE and MGE precursors displayed widespread incorporation into distinct forebrain and midbrain structures, whereas the more caudally derived VM cells were largely confined to midbrain structures. These results suggest that many LGE precursors are positionally specified for striatal incorporation, while a portion also possess greater potential reflected in more widespread integration following intraventricular injection.	LUND UNIV,DEPT MED CELL RES,S-22362 LUND,SWEDEN	Lund University			Björklund, Anders/ABA-1326-2020; Campbell, Kenneth/ABC-3570-2021	Bjorklund, Anders/0000-0002-5676-6203	NINDS NIH HHS [NS 06701] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKLIN SE, 1993, DEVELOPMENT, V118, P175; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ANDERSON KD, 1991, BRAIN RES, V568, P235, DOI 10.1016/0006-8993(91)91403-N; BARBE MF, 1991, J NEUROSCI, V11, P519; BATCHELOR PE, 1989, J COMP NEUROL, V284, P187, DOI 10.1002/cne.902840204; BAYER SA, 1984, INT J DEV NEUROSCI, V2, P163, DOI 10.1016/0736-5748(84)90008-X; BULFONE A, 1993, J NEUROSCI, V13, P3155; CAMPBELL K, 1995, NEUROSCIENCE, V64, P17, DOI 10.1016/0306-4522(94)00412-X; CATTANEO E, 1994, DEV BRAIN RES, V83, P197, DOI 10.1016/0165-3806(94)00137-5; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; COWAN RL, 1990, J COMP NEUROL, V302, P197, DOI 10.1002/cne.903020202; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; DEACON TW, 1994, EXP NEUROL, V130, P151, DOI 10.1006/exnr.1994.1194; EHRLICH ME, 1990, DEV BRAIN RES, V54, P257, DOI 10.1016/0165-3806(90)90148-R; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; FISHELL G, 1995, DEVELOPMENT, V121, P803; GERFEN CR, 1985, P NATL ACAD SCI USA, V82, P8780, DOI 10.1073/pnas.82.24.8780; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; GOTZ M, 1996, IN PRESS NEURON; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; KISS J, 1990, NEUROSCIENCE, V36, P61, DOI 10.1016/0306-4522(90)90351-4; LAGENAUR C, 1981, J SUPRAMOL STR CELL, V15, P335, DOI 10.1002/jsscb.1981.380150404; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LAMMERS GJ, 1980, ANAT EMBRYOL, V158, P193, DOI 10.1007/BF00315906; LUND RD, 1989, TRANSPLANT P, V21, P3174; LUND RD, 1985, NEUROSCI LETT, V61, P221, DOI 10.1016/0304-3940(85)90428-8; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1985, SCIENCE, V229, P1268, DOI 10.1126/science.4035355; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; NAKAO N, 1994, NEUROREPORT, V5, P1081, DOI 10.1097/00001756-199405000-00015; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; PAKZABAN P, 1993, EXP BRAIN RES, V97, P13; Paxinos G., 2004, J CHEM INF MODEL, V5th; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SMART IHM, 1976, J ANAT, V121, P71; SMART IHM, 1979, NEOSTRIATUM, P127; SOTELO C, 1986, P NATL ACAD SCI USA, V83, P1135, DOI 10.1073/pnas.83.4.1135; VANDERKOOY D, 1987, BRAIN RES, V401, P155, DOI 10.1016/0006-8993(87)91176-0; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WICTORIN K, 1992, PROG NEUROBIOL, V38, P611, DOI 10.1016/0301-0082(92)90044-F; WICTORIN K, 1991, EUR J NEUROSCI, V3, P86, DOI 10.1111/j.1460-9568.1991.tb00814.x; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; ZHOU HF, 1990, J COMP NEUROL, V292, P320, DOI 10.1002/cne.902920213; ZHOU HF, 1992, J COMP NEUROL, V317, P145, DOI 10.1002/cne.903170204	50	160	165	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1259	1273		10.1016/0896-6273(95)90006-3	http://dx.doi.org/10.1016/0896-6273(95)90006-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845151	Bronze			2022-12-28	WOS:A1995TL67800006
J	LoTurco, JJ; Owens, DF; Heath, MJS; Davis, MBE; Kriegstein, AR				LoTurco, JJ; Owens, DF; Heath, MJS; Davis, MBE; Kriegstein, AR			GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis	NEURON			English	Article							RAT CEREBRAL-CORTEX; SUBUNIT MESSENGER-RNAS; CEREBELLAR GRANULE CELLS; GAMMA-AMINOBUTYRIC-ACID; HIPPOCAMPAL-NEURONS; A RECEPTOR; POSTNATAL-DEVELOPMENT; TRANSIENT EXPRESSION; PRENATAL DEVELOPMENT; DEVELOPING NEOCORTEX	We have found that, during the early stages of cortical neurogenesis, both GABA and glutamate depolarize cells in the ventricular zone of rat embryonic neocortex. In the ventricular zone, glutamate acts on AMPA/kainate receptors, while GABA acts on GABA(A) receptors. GABA induces an inward current at resting membrane potentials, presumably owing to a high intracellular Cl- concentration maintained by furosemide-sensitive Cl- transport. GABA and glutamate also produce increases in intracellular Ca2+ in ventricular zone cells, in part through activation of voltage-gated Ca2+ channels. Furthermore, GABA and glutamate decrease the number of embryonic cortical cells synthesizing DNA. Depolarization with K+ similarly decreases DNA synthesis, suggesting that the neurotransmitters act via membrane depolarization. Applied alone, GABAA and AMPAA/kainate receptor antagonists increase DNA synthesis, indicating that endogenously released amino acids influence neocortical progenitors in the cell cycle. These results demonstrate a novel role for amino acid neurotransmitters in regulating neocortical neurogenesis.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT ANESTHESIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA	Columbia University; Columbia University; Columbia University	LoTurco, JJ (corresponding author), UNIV CONNECTICUT, DEPT PHYSIOL & NEUROBIOL, STORRS, CT 06269 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 07280, NS 21223] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE Y, 1994, J NEUROPHYSIOL, V72, P1530, DOI 10.1152/jn.1994.72.4.1530; ALTMAN J, 1990, EXP NEUROL, V107, P23, DOI 10.1016/0014-4886(90)90060-6; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; ARAKI T, 1992, NEUROSCIENCE, V51, P583, DOI 10.1016/0306-4522(92)90298-G; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; BEHAR TN, 1994, J NEUROSCI, V14, P29; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERRY M, 1965, J ANAT, V99, P691; BISCONTE JC, 1975, EXP BRAIN RES, V22, P37; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLANTON MG, 1991, J COMP NEUROL, V310, P550, DOI 10.1002/cne.903100405; BREWER GJ, 1989, NEUROSCI LETT, V99, P268, DOI 10.1016/0304-3940(89)90458-8; BRUCKNER G, 1976, J COMP NEUROL, V166, P245, DOI 10.1002/cne.901660208; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHUN JJM, 1987, NATURE, V325, P617, DOI 10.1038/325617a0; COBAS A, 1991, NEUROSCIENCE, V40, P375, DOI 10.1016/0306-4522(91)90127-A; DICICCOBLOOM E, 1989, BRAIN RES, V491, P403, DOI 10.1016/0006-8993(89)90080-2; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; GHOSH A, 1992, J NEUROSCI, V12, P39; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANSEN GH, 1984, INT J DEV NEUROSCI, V2, P247, DOI 10.1016/0736-5748(84)90019-4; HANSEN GH, 1987, NEUROTROPHIC ACTIVIT, P109; HAZELTON B, 1979, J CELL BIOL, V83, P487, DOI 10.1083/jcb.83.2.487; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; HLADKY SB, 1972, BIOCHIM BIOPHYS ACTA, V274, P294, DOI 10.1016/0005-2736(72)90178-2; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IZANT JG, 1983, CHROMOSOMA, V88, P1, DOI 10.1007/BF00329497; JANIGRO D, 1988, DEV BRAIN RES, V41, P171, DOI 10.1016/0165-3806(88)90180-0; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; KOSTOVIC I, 1980, J NEUROCYTOL, V9, P219, DOI 10.1007/BF01205159; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LAUDER JM, 1986, NEUROSCIENCE, V19, P465, DOI 10.1016/0306-4522(86)90275-7; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; MATTSON MP, 1988, J NEUROSCI, V8, P1704; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MEIER E, 1991, NEUROCHEM INT, V19, P1, DOI 10.1016/0197-0186(91)90113-R; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; MILLER MW, 1988, CEREB CORTEX, V7, P133; MIONE MC, 1994, J NEUROSCI, V14, P107; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOUNT HTJ, 1993, J NEUROSCI, V13, P3173; MUELLER AL, 1984, J NEUROSCI, V4, P860; MUELLER AL, 1983, NEUROSCI LETT, V39, P193, DOI 10.1016/0304-3940(83)90076-9; MURRAY AW, 1991, SCI AM, V264, P56, DOI 10.1038/scientificamerican0391-56; MYERS VB, 1972, BIOCHIM BIOPHYS ACTA, V274, P313, DOI 10.1016/0005-2736(72)90179-4; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; PARNAVELAS JG, 1988, TRENDS NEUROSCI, V11, P92; POULTER MO, 1992, J NEUROSCI, V12, P2888, DOI 10.1523/JNEUROSCI.12-08-02888.1992; RAEDLER A, 1976, ANAT EMBRYOL, V149, P173, DOI 10.1007/BF00317896; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; RAEDLER E, 1980, ANAT EMBRYOL, V158, P253, DOI 10.1007/BF00301816; RAMSDELL JS, 1991, J CELL PHYSIOL, V146, P197, DOI 10.1002/jcp.1041460203; REDBURN D, 1987, NEUROL NEUROBIOL, V32, P1; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; RICKMANN M, 1977, ANAT EMBRYOL, V151, P285, DOI 10.1007/BF00318931; SCHLUMPF M, 1980, J COMP NEUROL, V192, P361, DOI 10.1002/cne.901920210; SCHWARTZ ML, 1992, CEREB CORTEX, V2, P16, DOI 10.1093/cercor/2.1.16; SWANN JW, 1989, NEUROSCIENCE, V28, P551, DOI 10.1016/0306-4522(89)90004-3; TAYLOR J, 1990, J NEUROCHEM, V54, P1689, DOI 10.1111/j.1471-4159.1990.tb01223.x; VALVERDE F, 1989, J COMP NEUROL, V290, P118, DOI 10.1002/cne.902900108; VANEDEN CG, 1989, J COMP NEUROL, V289, P213, DOI 10.1002/cne.902890204; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0	79	890	909	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1287	1298		10.1016/0896-6273(95)90008-X	http://dx.doi.org/10.1016/0896-6273(95)90008-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845153	hybrid			2022-12-28	WOS:A1995TL67800008
J	Rusanescu, G; Qi, HQ; Thomas, SM; Brugge, JS; Halegoua, S				Rusanescu, G; Qi, HQ; Thomas, SM; Brugge, JS; Halegoua, S			Calcium influx induces neurite growth through a Src-Ras signaling cassette	NEURON			English	Article							LONG-TERM POTENTIATION; PC12 CELLS; TYROSINE KINASES; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; MONOCLONAL-ANTIBODIES; ACTIVATED PP60C-SRC; V-SRC; TRANSDUCTION; DEATH	We find that calcium influx through voltage-dependent calcium channels causes extensive neu rite outgrowth in PC12 cells. The calcium signal transduction pathway promoting neurite outgrowth causes the rapid activation of protein tyrosine kinases, which include Src. Protein tyrosine phosphorylation results in the formation of an Shc/Grb2 complex, reading to Ras activation, MAP kinase activation, and the subsequent induction of the immediate early gene NGFI-A. Protein tyrosine phosphorylation, gene induction, and neurite outgrowth are inhibited by the expression of dominant negative forms of both Src and Ras, indicating a requirement for both proto-oncoproteins in calcium signaling. Our results suggest that a signaling cassette which includes Src and Ras is likely to underlie it broad range of calcium actions in the nervous system.	SUNY STONY BROOK, INST CELL & DEV BIOL, STONY BROOK, NY 11794 USA; ARIAD PHARMACEUT INC, CAMBRIDGE, MA 02138 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Takeda Pharmaceutical Company Ltd; Takeda Oncology	Rusanescu, G (corresponding author), SUNY STONY BROOK, DEPT NEUROBIOL & BEHAV, STONY BROOK, NY 11794 USA.				NCI NIH HHS [CA 47572] Funding Source: Medline; NINDS NIH HHS [NS 18218] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018218] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1994, ADV SEC MESS PHOSPH, V29, P139; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BONIECE IR, 1993, J NEUROSCI, V13, P4220; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; CURRAN T, 1987, ONCOGENE, V2, P79; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; Davies Alun M., 1994, Progress in Growth Factor Research, V5, P263, DOI 10.1016/0955-2235(94)90010-8; DEFRANCO C, 1993, MOL ENDOCRINOL, V7, P365, DOI 10.1210/me.7.3.365; FLY CM, 1994, J NEUROCHEM, V62, P923; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HORVATH AR, 1992, EMBO J, V11, P855, DOI 10.1002/j.1460-2075.1992.tb05123.x; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Keegan K, 1993, Curr Opin Neurobiol, V3, P14, DOI 10.1016/0959-4388(93)90029-X; KOIZUMI S, 1988, J NEUROSCI, V8, P715; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; MCTIGUE M, 1985, J BIOL CHEM, V260, P9047; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; SCHLAEPFER DD, 1994, NATURE, V372, P786; SCHRAMM M, 1983, NATURE, V303, P535, DOI 10.1038/303535a0; SEELEY PJ, 1984, J CELL BIOL, V98, P417, DOI 10.1083/jcb.98.2.417; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIEGELBAUM SA, 1994, CURR BIOL, V4, P242, DOI 10.1016/S0960-9822(00)00054-3; Spitzer Nicholas C., 1994, Current Opinion in Neurobiology, V4, P70, DOI 10.1016/0959-4388(94)90034-5; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TENG KK, 1993, J NEUROSCI, V13, P3124; THOMAS SM, 1991, MOL CELL BIOL, V11, P4739, DOI 10.1128/MCB.11.9.4739; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; ZACCHETTI D, 1991, J BIOL CHEM, V266, P20152; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298	60	243	248	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1415	1425		10.1016/0896-6273(95)90019-5	http://dx.doi.org/10.1016/0896-6273(95)90019-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845164	Bronze			2022-12-28	WOS:A1995TL67800019
J	BOWE, MA; DEYST, KA; LESZYK, JD; FALLON, JR				BOWE, MA; DEYST, KA; LESZYK, JD; FALLON, JR			IDENTIFICATION AND PURIFICATION OF AN AGRIN RECEPTOR FROM TORPEDO POSTSYNAPTIC MEMBRANES - A HETEROMERIC COMPLEX RELATED TO THE DYSTROGLYCANS	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; DYSTROPHIN-GLYCOPROTEIN COMPLEX; NEUROMUSCULAR-JUNCTIONS; ELECTRIC ORGAN; BASAL LAMINA; PROTEIN; MUSCLE; MOLECULES; AGGREGATION; BINDING	The selective concentration of neurotransmitter receptors at the postsynaptic membrane is an essential aspect of synaptic differentiation and function. Agrin is an extracellular matrix protein that is likely to direct the accumulation of acetylcholine receptors and several other postsynaptic elements at developing and regenerating neuromuscular junctions. How agrin interacts with the membrane to bring about these changes is unknown. We now report the identification and purification of a protein complex from Torpedo electric organ postsynaptic membranes that is likely to serve as an agrin receptor. The native receptor is a heteromeric complex of two membrane glycoproteins of 190 kDa and 50 kDa. The 190 kDa subunit is sufficient to bind ligand. Peptide sequence analysis revealed that the 190 kDa and 50 kDa subunits are related to the dystrophin-associated glycoproteins alpha- and beta-dystroglycan, respectively. No other candidate agrin receptors were detected. The identification of the agrin receptor opens new avenues toward a mechanistic understanding of synapse differentiation.	WORCESTER FDN EXPTL BIOL INC, WM KECK PROT CHEM FACIL, SHREWSBURY, MA 01545 USA	Worcester Foundation for Biomedical Research	BOWE, MA (corresponding author), WORCESTER FDN EXPTL BIOL INC, NEUROBIOL GRP, 222 MAPLE AVE, SHREWSBURY, MA 01545 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023924] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD023924] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BOWE MA, 1995, IN PRESS ANN REV NEU; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRIADO M, 1984, BIOCHIM BIOPHYS ACTA, V798, P374, DOI 10.1016/0304-4165(84)90112-0; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FALLON JR, 1985, NATURE, V315, P571, DOI 10.1038/315571a0; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; GEE SH, 1993, J BIOL CHEM, V268, P14972; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Harlow E., 1988, ANTIBODIES LAB MANUA, P447; HENDERSON LP, 1984, J NEUROSCI, V4, P3140; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; JESSELL TM, 1993, CELL 72 NEURON S, V10, P1; MA JY, 1993, J BIOL CHEM, V268, P25108; MAIMONE MM, 1993, NEURON, V11, P53, DOI 10.1016/0896-6273(93)90270-2; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MCMAHAN UJ, 1971, PROC R SOC SER B-BIO, V177, P485, DOI 10.1098/rspb.1971.0044; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OCONNOR LT, 1994, J NEUROSCI, V14, P1141, DOI 10.1523/JNEUROSCI.14-03-01141.1994; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SCOTLAND PB, 1993, J CELL BIOL, V123, P719, DOI 10.1083/jcb.123.3.719; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; STJOHN PA, 1982, J CELL BIOL, V92, P333, DOI 10.1083/jcb.92.2.333; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267	48	278	283	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1994	12	5					1173	1180		10.1016/0896-6273(94)90324-7	http://dx.doi.org/10.1016/0896-6273(94)90324-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185951				2022-12-28	WOS:A1994NM83100020
J	GEREAU, RW; CONN, PJ				GEREAU, RW; CONN, PJ			POTENTIATION OF CAMP RESPONSES BY METABOTROPIC GLUTAMATE RECEPTORS DEPRESSES EXCITATORY SYNAPTIC TRANSMISSION BY A KINASE-INDEPENDENT MECHANISM	NEURON			English	Article							CYCLIC-AMP ACCUMULATION; RAT HIPPOCAMPUS; ENDOGENOUS ADENOSINE; CA1 REGION; PHOSPHOINOSITIDE HYDROLYSIS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; ACTIVATION; INCREASES; INHIBITION	Coactivation of metabotropic glutamate receptors (mGluRs) and beta-adrenergic receptors causes a synergistic increase in cAMP formation in the rat hippocampus. Increases in cAMP are known to have many actions in the hippocampus via activation of cAMP-dependent protein kinase. We now report that coactivation of mGluRs and beta-adrenergic receptors induces an acute depression of EPSCs at the Schaffer collateral-CA1 synapse. Interestingly, this depression of EPSCs is dependent upon increases in cAMP levels but independent of protein kinase activity. A series of studies suggests that cAMP-mediated depression of EPSCs is dependent on metabolism of cAMP and release of adenosine or 5'-AMP into the extracellular space with resultant activation of presynaptic adenosine receptors. These studies suggest that cAMP can have local hormone-like effects in the hippocampal formation which are independent of cAMP-dependent protein kinase.	EMORY UNIV,SCH MED,PROGRAM NEUROSCI,ATLANTA,GA 30322	Emory University	GEREAU, RW (corresponding author), EMORY UNIV,SCH MED,DEPT PHARMACOL,ATLANTA,GA 30322, USA.		Conn, Peter/D-7848-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028405, R01NS028405, R01NS031373] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-31373, NS-28405] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOSS V, 1992, J NEUROCHEM, V59, P2340; BRUNS RF, 1990, ANN NY ACAD SCI, V603, P211; CACIAGLLI F, 1993, FUNCT NEUROL SN, V4, P13; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; Conn PJ., 1994, METABOTROPIC GLUTAMA; COSTA M, 1990, N-S ARCH PHARMACOL, V342, P630, DOI 10.1007/BF00175705; DESAI MA, 1992, SYNAPSE, V12, P206, DOI 10.1002/syn.890120305; DESAI MA, 1991, J NEUROPHYSIOL, V66, P40, DOI 10.1152/jn.1991.66.1.40; DESAI MA, 1990, NEUROSCI LETT, V109, P157, DOI 10.1016/0304-3940(90)90555-N; DEVREOTES PN, 1982, DEV DICTYOSTELIUM DI, P117; DIXON D, 1989, J NEUROSCI, V9, P4246; DUNWIDDIE TV, 1980, BRIT J PHARMACOL, V69, P59, DOI 10.1111/j.1476-5381.1980.tb10883.x; DUNWIDDIE TV, 1992, J NEUROSCI, V12, P506; GEREAU RW, 1994, IN PRESS J NEUROSCI; GOLDSMITH BA, 1991, P NATL ACAD SCI USA, V88, P9021, DOI 10.1073/pnas.88.20.9021; GUNTHER T, 1992, FEBS LETT, V307, P333, DOI 10.1016/0014-5793(92)80707-N; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; JOHNSON RD, 1986, EUR J PHARMACOL, V129, P293, DOI 10.1016/0014-2999(86)90439-5; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; POCKETT S, 1993, NEUROSCIENCE, V52, P229, DOI 10.1016/0306-4522(93)90151-5; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; REDDINGTON M, 1982, NEUROSCI LETT, V28, P275, DOI 10.1016/0304-3940(82)90070-2; ROSENBERG PA, 1992, BRAIN RES BULL, V29, P315, DOI 10.1016/0361-9230(92)90062-3; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; SHIMIZU H, 1969, J NEUROCHEM, V16, P1609, DOI 10.1111/j.1471-4159.1969.tb10360.x; SLACK JR, 1991, NEUROSCI LETT, V130, P69, DOI 10.1016/0304-3940(91)90229-M; SUZDAK PD, 1994, IN PRESS METABOTROPI; WINDER DG, 1993, J PHARMACOL EXP THER, V266, P518; WINDER DG, 1992, J NEUROCHEM, V59, P375, DOI 10.1111/j.1471-4159.1992.tb08914.x; WINDER DG, 1993, J NEUROSCI, V13, P38; ZHANG G, 1993, J PHARMACOL EXP THER, V264, P1415	34	67	67	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1121	1129		10.1016/0896-6273(94)90319-0	http://dx.doi.org/10.1016/0896-6273(94)90319-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185947				2022-12-28	WOS:A1994NM83100015
J	MATSUMOTO, H; KURIEN, BT; TAKAGI, Y; KAHN, ES; KINUMI, T; KAMORI, N; YAMADA, T; HAYASHI, F; ISONO, K; PAK, WL; JACKSON, KW; TOBIN, SL				MATSUMOTO, H; KURIEN, BT; TAKAGI, Y; KAHN, ES; KINUMI, T; KAMORI, N; YAMADA, T; HAYASHI, F; ISONO, K; PAK, WL; JACKSON, KW; TOBIN, SL			PHOSRESTIN-I UNDERGOES THE EARLIEST LIGHT-INDUCED PHOSPHORYLATION BY A CALCIUM/CALMODULIN-DEPENDENT PROTEIN-KINASE IN DROSOPHILA PHOTORECEPTORS	NEURON			English	Article							LONG-TERM POTENTIATION; PHOSPHOLIPASE-C; MUTANT MICE; PHOTOTRANSDUCTION MUTANT; INOSITOL TRISPHOSPHATE; LIMULUS PHOTORECEPTORS; PHOTOEXCITED RHODOPSIN; 48-KDA PROTEIN; RNA-POLYMERASE; CLONED GENES	Activation of PI-PLC initiates two independent branches of protein phosphorylation cascades catalyzed by either PKC or Ca2+/calmodulin-dependent protein kinase (CaMK). We find that phosrestin I (PRI), a Drosophila homolog of vertebrate photoreceptor arrestin, undergoes light-induced phosphorylation on a subsecond time scale which is faster than that of any other protein in vivo. We determine that a CaMK activity is responsible for in vitro PRI phosphorylation at Ser(366) in the C-terminal tryptic segment, MetLysSer(P)IleGluGlnHisArg, in which Ser(P) represents phosphoserine(366). We also demonstrate that Ser(366) is the phosphorylation site of PRI in vivo by identifying the molecular species resulting from in-gel tryptic digestion of purified phospho-PRI using HPLC-electrospray ionization tandem quadrupole mass spectroscopy. From these data, we conclude that the CaMK pathway, not the PKC pathway, is responsible for the earliest protein phosphorylation event following activation of PI-PLC in living Drosophila photoreceptors.	PURDUE UNIV, DEPT BIOL SCI, W LAFAYETTE, IN 47907 USA; UNIV OKLAHOMA, HLTH SCI CTR, WILLIAM K WARREN MED RES INST, OKLAHOMA CITY, OK 73190 USA; UNIV OKLAHOMA, HLTH SCI CTR, DEPT MED, OKLAHOMA CITY, OK 73190 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	MATSUMOTO, H (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, OKLAHOMA CITY, OK 73190 USA.		Kurien, Biji T/C-2392-2008; Kinumi, Tomoya/M-1707-2018	Kurien, Biji T/0000-0002-7877-6859; Kinumi, Tomoya/0000-0002-2432-2763	NEI NIH HHS [EY06595] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BACIGALUPO J, 1991, P NATL ACAD SCI USA, V88, P7938, DOI 10.1073/pnas.88.18.7938; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CALMAN BG, 1992, INVEST OPHTH VIS SCI, V33, P874; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; CHOI KW, 1991, J BIOL CHEM, V266, P15999; DELAND MC, 1973, NATURE-NEW BIOL, V244, P184, DOI 10.1038/newbio244184a0; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DOLF PJ, 1993, SCIENCE, V260, P1910; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EDWARDS SC, 1989, VISUAL NEUROSCI, V3, P95, DOI 10.1017/S0952523800004417; FRANK TM, 1991, J GEN PHYSIOL, V97, P697, DOI 10.1085/jgp.97.4.697; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; HYDE DR, 1990, P NATL ACAD SCI USA, V87, P1008, DOI 10.1073/pnas.87.3.1008; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KENNEDY MB, 1992, INTRO MOL NEUROBIOLO, P207; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KOMORI N, 1992, J CELL SCI, V102, P191; KOMORI N, 1991, THESIS U OKLAHOMA CO; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; MASAI I, 1991, J BIOCHEM-TOKYO, V109, P867, DOI 10.1093/oxfordjournals.jbchem.a123472; Matsumoto H., 1985, P398; MATSUMOTO H, 1991, BIOCHEM BIOPH RES CO, V177, P1306, DOI 10.1016/0006-291X(91)90683-X; MATSUMOTO H, 1982, SCIENCE, V217, P839, DOI 10.1126/science.7100927; MATSUMOTO H, 1984, SCIENCE, V223, P184, DOI 10.1126/science.6419348; MCDOWELL JH, 1977, BIOCHEMISTRY-US, V16, P4054, DOI 10.1021/bi00637a018; MEYERTHOLEN EP, 1987, J COMP PHYSIOL A, V161, P793, DOI 10.1007/BF00610221; MINKE B, 1992, PROGR RETINAL RES, P99; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Pak W.L., 1979, P67; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; RICHARD EA, 1992, NATURE, V356, P336, DOI 10.1038/356336a0; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; ROSENTHAL A, 1987, EMBO J, V6, P433, DOI 10.1002/j.1460-2075.1987.tb04773.x; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SELINGER Z, 1988, COLD SPRING HARB SYM, V53, P333, DOI 10.1101/SQB.1988.053.01.040; SHICHI H, 1978, J BIOL CHEM, V253, P7040; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; TOYOSHIMA S, 1990, J BIOL CHEM, V265, P14842; WATSON S, 1992, TRENDS PHARMACOL SCI, V13, P1; WEYAND I, 1990, EUR J BIOCHEM, V193, P459, DOI 10.1111/j.1432-1033.1990.tb19360.x; WIEBE EM, 1989, VISUAL NEUROSCI, V3, P107, DOI 10.1017/S0952523800004429; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671	70	94	95	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1994	12	5					997	1010		10.1016/0896-6273(94)90309-3	http://dx.doi.org/10.1016/0896-6273(94)90309-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185954				2022-12-28	WOS:A1994NM83100005
J	NOTTEBOHM, E; USUI, A; THERIANOS, S; KIMURA, K; DAMBLYCHAUDIERE, C; GHYSEN, A				NOTTEBOHM, E; USUI, A; THERIANOS, S; KIMURA, K; DAMBLYCHAUDIERE, C; GHYSEN, A			THE GENE POXN CONTROLS DIFFERENT STEPS OF THE FORMATION OF CHEMOSENSORY ORGANS IN DROSOPHILA	NEURON			English	Article							MEDIATED ENHANCER DETECTION; SENSE-ORGANS; MELANOGASTER; EXPRESSION; SENSILLA; NEURONS	The gene poxn codes for a transcriptional regulator that specifies poly-innervated (chemosensory), as opposed to mono-innervated (mechanosensory), organs in Drosophila. The ectopic expression of poxn during metamorphosis results in a transformation of the morphology and central projection of adult mechanosensory organs toward those of chemosensory organs. Here we show, by electron microscopy analysis of normal and transformed bristles and by Dil labeling of the innervating neurons, that poxn also controls the number of neurons. To determine whether poxn can transform not only the sense organ precursor cells but also their daughter cells, we examine the effects of the ectopic expression of poxn at different stages of the lineage, and we conclude that poxn can act at a late stage to affect the fate of the undifferentiated neuron.	UNIV LIBRE BRUXELLES,GENET LAB,B-1640 RHODE ST GENESE,BELGIUM; UNIV BASEL,DEPT ZOOL,NEUROBIOL LAB,CH-4051 BASEL,SWITZERLAND; HOKKAIDO UNIV,BIOL LAB,IWAMIZAWA 068,JAPAN	Universite Libre de Bruxelles; University of Basel; Hokkaido University	NOTTEBOHM, E (corresponding author), UNIV LIBRE BRUXELLES,NEUROBIOL LAB,67 RUE CHEVAUX,B-1640 RHODE ST GENESE,BELGIUM.							BATE CM, 1976, HDB SENSORY PHYSL, V11, P8; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; BULLOCK TH, 1965, STRUCTURE FUNCTION N, V2, P1030; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; GHYSEN A, 1993, BIOESSAYS, V15, P293, DOI 10.1002/bies.950150502; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; HUANG F, 1991, DEVELOPMENT, V111, P1087; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NOTTEBOHM E, 1992, NATURE, V359, P829, DOI 10.1038/359829a0; THURM U, 1964, SCIENCE, V145, P1063, DOI 10.1126/science.145.3636.1063; WHITLOCK KE, 1993, DEVELOPMENT, V117, P1251; WIGGLESWORTH VB, 1953, Q J MICROSC SCI, V94, P113; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301	18	48	49	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					25	34		10.1016/0896-6273(94)90149-X	http://dx.doi.org/10.1016/0896-6273(94)90149-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292359				2022-12-28	WOS:A1994MU49300003
J	GENGYOANDO, K; KAMIYA, Y; YAMAKAWA, A; KODAIRA, K; NISHIWAKI, K; MIWA, J; HORI, I; HOSONO, R				GENGYOANDO, K; KAMIYA, Y; YAMAKAWA, A; KODAIRA, K; NISHIWAKI, K; MIWA, J; HORI, I; HOSONO, R			THE C-ELEGANS UNC-18 GENE ENCODES A PROTEIN EXPRESSED IN MOTOR-NEURONS	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CHOLINE-ACETYLTRANSFERASE; ACETYLCHOLINE LEVELS; DEFICIENT MUTANTS; IDENTIFICATION; MUTATIONS; SEQUENCE; YPT1; CORD; RNA	The C. elegans unc-18 gene is required to maintain normal acetylcholine levels. We determined the complete structure of an unc-18 cDNA that encodes a protein of 591 highly charged and hydrophilic amino acids. The protein shows sequence similarity with elements of the secretory pathway in the yeast S. cerevisiae. Antibodies raised against a portion of the unc-18-encoded protein (UNC-18) detected a 68 kd soluble antigen on immunoblots and intensely stained all ventral cord motor neurons in situ. These findings suggest that UNC-18 participates in the axonal transport system and influences the acetylcholine flow in motor neurons.	KANAZAWA UNIV,SCH MED,DEPT BIOCHEM,KANAZAWA,ISHIKAWA 920,JAPAN; KANAZAWA MED UNIV,DEPT BIOCHEM,UCHINADA,ISHIKAWA,JAPAN; KANAZAWA MED UNIV,DEPT BIOL,UCHINADA,ISHIKAWA,JAPAN; TOYAMA UNIV,DEPT TECHNOL,TOYAMA 930,JAPAN; NEC CORP LTD,FUNDAMENTAL RES LABS,TSUKUBA,JAPAN	Kanazawa University; Kanazawa Medical University; Kanazawa Medical University; University of Toyama; NEC Corporation			Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019					AALTO MK, 1992, CELL, V68, P181, DOI 10.1016/0092-8674(92)90462-L; AALTO MK, 1991, YEAST, V7, P643, DOI 10.1002/yea.320070613; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BRENNER S, 1974, GENETICS, V77, P71; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CULOTTI JG, 1981, GENETICS, V97, P281; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; DOOLITTLE RF, 1990, METHOD ENZYMOL, V183, P99; DUNANT Y, 1986, PROG NEUROBIOL, V26, P55, DOI 10.1016/0301-0082(86)90020-1; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; GUAN C, 1987, GENE, V67, P21; HELFMAN DM, 1983, P NATL ACAD SCI-BIOL, V80, P31, DOI 10.1073/pnas.80.1.31; HOSONO R, 1989, ZOOL SCI, V6, P697; HOSONO R, 1987, J NEUROCHEM, V49, P1820, DOI 10.1111/j.1471-4159.1987.tb02442.x; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; HOSONO R, 1991, NEUROSCI LETT, V128, P243, DOI 10.1016/0304-3940(91)90270-4; JOHNSON CD, 1988, NEURON, V1, P165, DOI 10.1016/0896-6273(88)90201-2; KAMIYA Y, 1993, ZOOL SCI, V10, P43; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LEWIS JA, 1987, J NEUROSCI, V7, P3059; Maniatis T, 1989, DECONTAMINATION DILU; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MILVER RJ, 1983, NUCLEIC ACIDS RES, V11, P5497; MOLLARD GFV, 1990, P NATL ACAD SCI USA, V87, P1988; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; RAND JB, 1984, GENETICS, V106, P227; RAND JB, 1989, GENETICS, V122, P73; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASSA T, 1987, NEUROCHEM INT, V11, P323, DOI 10.1016/0197-0186(87)90053-2; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; WADA Y, 1990, MOL CELL BIOL, V10, P2214, DOI 10.1128/MCB.10.5.2214; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	35	95	107	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					703	711		10.1016/0896-6273(93)90080-B	http://dx.doi.org/10.1016/0896-6273(93)90080-B			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398155				2022-12-28	WOS:A1993MD06800013
J	DIAMOND, P; MALLAVARAPU, A; SCHNIPPER, J; BOOTH, J; PARK, L; OCONNOR, TP; JAY, DG				DIAMOND, P; MALLAVARAPU, A; SCHNIPPER, J; BOOTH, J; PARK, L; OCONNOR, TP; JAY, DG			FASCICLIN-I AND FASCICLIN-II HAVE DISTINCT ROLES IN THE DEVELOPMENT OF GRASSHOPPER PIONEER NEURONS	NEURON			English	Article							CELL-ADHESION MOLECULES; ASSISTED LASER INACTIVATION; PERIPHERAL-NERVE PATHWAYS; GROWTH CONE GUIDANCE; GENETIC-ANALYSIS; PROTEIN FUNCTION; AXON PATHWAYS; DROSOPHILA; MEMBRANE; GLYCOPROTEINS	We have used a new technique, micro-CALI (chromophore-assisted laser inactivation), to investigate the function of the neural cell adhesion molecules fasciclin I and II in the development of the grasshopper Ti1 neurons. Micro-CALI of fasciclin I results in defasciculation of the Ti1 axons similar to that achieved using large scale CALI (Jay and Keshishian, 1990). The initial point of axon separation corresponds to the site of laser irradiation, and defasciculation always continues distal to this point. Micro-CALI of fasciclin II prevents the initiation of Ti1 axon outgrowth but has no effect on fasciculation. This effect is restricted to a 3 hr interval between cytokinesis and growth cone emergence.	UNIV CALIF BERKELEY, DEPT CELLULAR BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	DIAMOND, P (corresponding author), HARVARD UNIV, DEPT CELLULAR & DEV BIOL, CAMBRIDGE, MA 02138 USA.							ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; BENTLEY D, 1979, J EMBRYOL EXP MORPH, V54, P47; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BRAY D, 1973, J CELL BIOL, V56, P702, DOI 10.1083/jcb.56.3.702; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; CAUDY M, 1986, J NEUROSCI, V6, P1781; CONDIC ML, 1989, J NEUROSCI, V9, P2678; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAY DG, 1990, NATURE, V348, P548, DOI 10.1038/348548a0; JAY DG, 1988, P NATL ACAD SCI USA, V85, P5454, DOI 10.1073/pnas.85.15.5454; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KESHISHIAN H, 1980, DEV BIOL, V80, P388, DOI 10.1016/0012-1606(80)90413-3; KESHISHIAN H, 1983, DEV BIOL, V96, P103, DOI 10.1016/0012-1606(83)90315-9; KESHISHIAN H, 1983, DEV BIOL, V96, P89, DOI 10.1016/0012-1606(83)90314-7; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LEFCORT F, 1989, J CELL BIOL, V108, P1737, DOI 10.1083/jcb.108.5.1737; LINDEN KG, 1992, BIOPHYS J, V61, P956, DOI 10.1016/S0006-3495(92)81902-1; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; OKABE S, 1992, J CELL BIOL, V117, P105, DOI 10.1083/jcb.117.1.105; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SHEETZ MP, 1990, CELL, V61, P231, DOI 10.1016/0092-8674(90)90804-N; SNOW PM, 1988, P NATL ACAD SCI USA, V85, P5291, DOI 10.1073/pnas.85.14.5291; WHITLOCK KE, 1993, DEVELOPMENT, V117, P1251; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	41	52	54	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1993	11	3					409	421		10.1016/0896-6273(93)90146-I	http://dx.doi.org/10.1016/0896-6273(93)90146-I			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398136				2022-12-28	WOS:A1993LY49800002
J	JASMIN, BJ; LEE, RK; ROTUNDO, RL				JASMIN, BJ; LEE, RK; ROTUNDO, RL			COMPARTMENTALIZATION OF ACETYLCHOLINESTERASE MESSENGER-RNA AND ENZYME AT THE VERTEBRATE NEUROMUSCULAR-JUNCTION	NEURON			English	Article							POLYMERASE CHAIN-REACTION; MULTINUCLEATED MUSCLE-CELLS; CHICK SKELETAL-MUSCLE; RAT SOLEUS MUSCLE; ASYMMETRIC ACETYLCHOLINESTERASE; INSITU HYBRIDIZATION; GENE-EXPRESSION; NUCLEAR DOMAINS; GOLGI-APPARATUS; SINGLE GENE	Acetylcholinesterase (AChE) is concentrated at the vertebrate neuromuscular synapse. To determine whether increased transcript levels could underlie this selective accumulation, we employed a quantitative reverse transcription polymerase chain reaction-based assay to determine mRNA copy number in samples as small as single neuromuscular junctions (NMJs) and a microassay to measure AChE enzyme activity at single synapses. Our results show that AChE mRNA is an intermediate transcript at NMJs, whereas in noninnervated regions of muscle fibers, AChE transcripts are either undetectable or rare. In contrast, alpha-actin transcript levels in the same samples are similar in junctional and extrajunctional regions. However, compared with AChE enzyme activity and alpha-actin mRNA levels, the levels of AChE transcripts at NM)s are highly variable. These results indicate that AChE mRNA and protein expression are compartmentalized at the vertebrate NMJ and provide a direct approach toward dissecting the molecular events leading from synaptic activation to plastic changes in gene expression at single vertebrate synapses.	UNIV MIAMI,SCH MED,DEPT CELL BIOL & ANAT,MIAMI,FL 33101	University of Miami					NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG005917] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BOUABOULA M, 1992, J BIOL CHEM, V267, P21830; BRENNER HR, 1992, DEVELOPMENT, V116, P41; BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVEY B, 1978, EXP NEUROL, V59, P168; DONALDSON SKB, 1975, J GEN PHYSIOL, V66, P427, DOI 10.1085/jgp.66.4.427; FERNANDEZVALLE C, 1989, J BIOL CHEM, V264, P14043; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FUENTES ME, 1993, NEURON, V10, P679, DOI 10.1016/0896-6273(93)90169-R; GETMAN DK, 1992, AM J HUM GENET, V51, P170; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GOLDMAN D, 1991, NEURON, V7, P649, DOI 10.1016/0896-6273(91)90377-C; GOLDMAN D, 1989, NEURON, V3, P219, DOI 10.1016/0896-6273(89)90035-4; GORDON H, 1992, P NATL ACAD SCI USA, V89, P6595, DOI 10.1073/pnas.89.14.6595; HALL ZW, 1989, CELL, V59, P771, DOI 10.1016/0092-8674(89)90597-7; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HARRIS DA, 1989, NATURE, V337, P173, DOI 10.1038/337173a0; HOROVITZ O, 1989, J CELL BIOL, V108, P1823, DOI 10.1083/jcb.108.5.1823; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; JASMIN BJ, 1989, P NATL ACAD SCI USA, V86, P7218, DOI 10.1073/pnas.86.18.7218; JO SA, 1992, DEVELOPMENT, V115, P673; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KLARSFELD A, 1987, BIOCHIMIE, V69, P433, DOI 10.1016/0300-9084(87)90080-0; KLARSFELD A, 1991, EMBO J, V10, P625, DOI 10.1002/j.1460-2075.1991.tb07990.x; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LINKHART TA, 1975, J NEUROL SCI, V26, P193, DOI 10.1016/0022-510X(75)90032-5; MAULET Y, 1990, NEURON, V4, P289, DOI 10.1016/0896-6273(90)90103-M; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; METSIKKO K, 1992, J CELL BIOL, V117, P987, DOI 10.1083/jcb.117.5.987; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RALSTON E, 1989, SCIENCE, V244, P1066, DOI 10.1126/science.2543074; ROSSI SG, 1992, J CELL BIOL, V119, P1657, DOI 10.1083/jcb.119.6.1657; ROTUNDO RL, 1988, P NATL ACAD SCI USA, V85, P7805, DOI 10.1073/pnas.85.20.7805; ROTUNDO RL, 1980, CELL, V22, P595, DOI 10.1016/0092-8674(80)90369-4; ROTUNDO RL, 1990, J CELL BIOL, V110, P715, DOI 10.1083/jcb.110.3.715; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1979, J BIOL CHEM, V254, P4790; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; SALPETER MM, 1967, J CELL BIOL, V32, P379, DOI 10.1083/jcb.32.2.379; SANES JR, 1991, DEVELOPMENT, V113, P1181; SCHUMACHER M, 1988, J BIOL CHEM, V263, P18979; SIKORAV JL, 1988, EMBO J, V7, P2983, DOI 10.1002/j.1460-2075.1988.tb03161.x; SIKORAV JL, 1987, EMBO J, V6, P1865, DOI 10.1002/j.1460-2075.1987.tb02445.x; SIMON AM, 1992, DEVELOPMENT, V114, P545; TSIM KWK, 1992, J CELL BIOL, V118, P1201, DOI 10.1083/jcb.118.5.1201; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WILSON BW, 1973, DEV BIOL, V33, P285, DOI 10.1016/0012-1606(73)90138-3; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125	53	100	104	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					467	477		10.1016/0896-6273(93)90151-G	http://dx.doi.org/10.1016/0896-6273(93)90151-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398140				2022-12-28	WOS:A1993LY49800007
J	RAYMOND, PA; BARTHEL, LK; ROUNSIFER, ME; SULLIVAN, SA; KNIGHT, JK				RAYMOND, PA; BARTHEL, LK; ROUNSIFER, ME; SULLIVAN, SA; KNIGHT, JK			EXPRESSION OF ROD AND CONE VISUAL PIGMENTS IN GOLDFISH AND ZEBRAFISH - A RHODOPSIN-LIKE GENE IS EXPRESSED IN CONES	NEURON			English	Article							COLOR-VISION; MONOCLONAL-ANTIBODIES; POECILIA-RETICULATA; BRACHYDANIO-RERIO; BOVINE RHODOPSIN; OUTER SEGMENTS; PHOTORECEPTORS; SEQUENCE; POLYMORPHISM; EVOLUTION	The primary purpose of the present study was to determine whether a rhodopsin-like gene, which has been postulated to represent the green cone pigment in several species, is in fact expressed in cone photoreceptors instead of rods. The expression patterns of rod opsin and blue and red cone opsins were also examined in both goldfish and zebrafish retinas using colorimetric in situ hybridization. The results demonstrate that the rhodopsin-like gene is expressed in green cones, as predicted. A subset of small cones that do not hybridize with these cRNA probes are tentatively identified as ultraviolet receptors. The results also demonstrate that opsin message in cones is restricted to the perinuclear region, whereas in rods, it is both perinuclear and adjacent to the ellipsoid.	UNIV MICHIGAN,NEUROSCI PROGRAM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	RAYMOND, PA (corresponding author), UNIV MICHIGAN,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109, USA.			KNIGHT, JENNY/0000-0002-0041-5500; Raymond, Pamela/0000-0003-1083-5530				APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; ARAKI M, 1984, CELL STRUCT FUNCT, V9, P1, DOI 10.1247/csf.9.1; ARCHER SN, 1990, VISION RES, V30, P225, DOI 10.1016/0042-6989(90)90038-M; ARCHER SN, 1987, VISION RES, V27, P1243, DOI 10.1016/0042-6989(87)90200-8; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; BOWMAKER JK, 1987, VISION RES, V27, P2101, DOI 10.1016/0042-6989(87)90124-6; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; BRIDGES CDB, 1970, VISION RES, V10, P1315, DOI 10.1016/0042-6989(70)90084-2; COHEN AI, 1972, HDB SENSORY PHYSIOLO, V7, P63; CRESCITELLI F, 1977, J PHYSIOL-LONDON, V268, P559, DOI 10.1113/jphysiol.1977.sp011872; ENGSTROM KJELL, 1960, ACTA ZOOL [STOCKHOLM], V41, P277; FALK JD, 1987, PROGR RETINAL RES, V7, P89; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; HASHRYSHYN CW, 1988, VIS NEUROSCI, V8, P81; HAWRYSHYN CW, 1991, VISION RES, V31, P567, DOI 10.1016/0042-6989(91)90107-G; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; HISATOMI O, 1991, BIOCHEM BIOPH RES CO, V174, P1125, DOI 10.1016/0006-291X(91)91537-M; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; LEVINE JS, 1979, SENS PROCESS, V3, P95; LYALL AH, 1957, Q J MICROSC SCI, V98, P101; MARC RE, 1976, VISION RES, V16, P1211, DOI 10.1016/0042-6989(76)90044-4; MARC RE, 1976, SCIENCE, V191, P487, DOI 10.1126/science.1246634; MCGINNIS JF, 1992, J NEUROSCI RES, V31, P584, DOI 10.1002/jnr.490310325; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; NEUMEYER C, 1985, NATURWISSENSCHAFTEN, V72, P162, DOI 10.1007/BF00490410; NEUMEYER C, 1986, J COMP PHYSIOL A, V158, P203, DOI 10.1007/BF01338563; OHTSUKA T, 1990, EXP EYE RES, V50, P483, DOI 10.1016/0014-4835(90)90036-T; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; RAYMOND PA, 1985, J COMP NEUROL, V236, P90, DOI 10.1002/cne.902360108; Sambrook J, 1989, MOL CLONING LABORATO; STELL WK, 1976, VISION RES, V16, P647, DOI 10.1016/0042-6989(76)90013-4; TABATA M, 1982, COMP BIOCHEM PHYS A, V73, P125; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; TOKUNAGA F, 1990, BIOCHEM BIOPH RES CO, V173, P1212, DOI 10.1016/S0006-291X(05)80915-5; TRAVIS DS, 1988, VISION RES, V28, P481, DOI 10.1016/0042-6989(88)90170-8; TSIN ATC, 1981, VISION RES, V21, P943, DOI 10.1016/0042-6989(81)90196-6; WALLS GL, 1967, VERTEBRATE EYE ITS A; WANG SZ, 1992, BIOCHEMISTRY-US, V31, P3309, DOI 10.1021/bi00128a002; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; YOKOYAMA R, 1990, VISION RES, V30, P807, DOI 10.1016/0042-6989(90)90049-Q; ZILLES K, 1983, CELL TISSUE RES, V229, P423; [No title captured]	53	149	151	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1161	1174		10.1016/0896-6273(93)90064-X	http://dx.doi.org/10.1016/0896-6273(93)90064-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318234	Green Submitted			2022-12-28	WOS:A1993LK37300016
J	BUCHANAN, RL; BENZER, S				BUCHANAN, RL; BENZER, S			DEFECTIVE GLIA IN THE DROSOPHILA BRAIN DEGENERATION MUTANT DROP-DEAD	NEURON			English	Article							RETINAL-DEGENERATION; CELL DEGENERATION; RHODOPSIN GENE; NERVOUS-SYSTEM; FINE-STRUCTURE; OPTIC-LOBES; MELANOGASTER; PROTEIN; DIFFERENTIATION; MOSAICS	To understand better the cellular basis of late-onset neuronal degeneration, we have examined the brain of the drop-dead mutant of Drosophila. This mutant carries an X-chromosomal recessive mutation that causes severe behavioral defects and brain degeneration, manifested a few days after emergence of the adult. Analysis of genetically mosaic flies has indicated that the focus of the drop-dead mutant phenotype is in the brain and that the gene product is non-cell autonomous. We examined the adult drop-dead mutant brain prior to onset of symptoms and found that many glial cells have stunted processes, whereas neuronal morphology is essentially normal. Adult mutant glial cells resemble immature glia found at an earlier stage of normal brain development. These observations suggest that defective glia in the drop-dead brain may disrupt adult nervous system function, contributing to progressive brain degeneration and death. The normal drop-dead gene product may prevent brain degeneration by providing a necessary glial function.			BUCHANAN, RL (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.				NATIONAL EYE INSTITUTE [R01EY009278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM040499] Funding Source: NIH RePORTER; NEI NIH HHS [EYO9278] Funding Source: Medline; NIGMS NIH HHS [GM 40499] Funding Source: Medline; NINDS NIH HHS [5F32NS0881-02] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON DJ, 1989, TRENDS NEUROSCI, V12, P83, DOI 10.1016/0166-2236(89)90160-4; ASHBURNER M, 1989, DROSOPHILA LABORATOR, P179; BARRES BA, 1991, J NEUROSCI, V11, P3685; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOSCHEK CB, 1971, Z ZELLFORSCH MIK ANA, V118, P369; CARLSON SD, 1990, ANNU REV ENTOMOL, V35, P597, DOI 10.1146/annurev.en.35.010190.003121; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; DRISCOLL M, 1992, TRENDS NEUROSCI, V15, P15, DOI 10.1016/0166-2236(92)90343-7; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DUVALL E, 1986, IMMUNOL TODAY, V7, P115, DOI 10.1016/0167-5699(86)90152-0; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FLANAGAN JR, 1977, GENETICS, V85, P587; FREEMANM, 1992, CELL, V69, P963; GASSER UE, 1990, J NEUROSCI, V10, P1276; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; GRIFFITHS GW, 1979, J CELL SCI, V36, P361; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; HEISENBERG M, 1980, DEV NEUROBIOLOGY DRO, P373; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; HOMYK T, 1986, GENETICS, V113, P367; HOTTA Y, 1972, NATURE, V240, P527, DOI 10.1038/240527a0; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; HOYLE G, 1986, J COMP NEUROL, V246, P85, DOI 10.1002/cne.902460106; INOUE H, 1989, J BIOL CHEM, V264, P5996; JACOBS JR, 1989, NEURON, V2, P1625; Kankel D.R., 1980, Genetics and Biology of Drosophila, V2d, P295; KANKEL DR, 1976, DEV BIOL, V48, P1, DOI 10.1016/0012-1606(76)90041-5; KNAPP PE, 1990, DEV NEUROSCI-BASEL, V12, P145, DOI 10.1159/000111844; KUFFLER SW, 1967, PROC R SOC SER B-BIO, V168, P1, DOI 10.1098/rspb.1967.0047; LANE NJ, 1985, COMPREHENSIVE INSECT, V5, P1; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; McKusick VA, 1990, MENDELIAN INHERITANC; MEYER MR, 1987, J NEUROSCI, V7, P512; Miller A, 1965, BIOL DROSOPHILA, P420; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; Nordlander R. H., 1969, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V163, P197, DOI 10.1007/BF00576929; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; PENTREATH VW, 1989, COMP BIOCHEM PHYS A, V93, P77, DOI 10.1016/0300-9629(89)90194-1; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; STEWART BR, 1975, GENETICS, V79, P635; STOCKER RF, 1978, CELL TISSUE RES, V191, P317; Strausfeld NJ., 1980, NEUROANATOMICAL TECH, P132; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; TEI H, 1992, IN PRESS P NATL ACAD; TOLBERT LP, 1990, EXP NEUROL, V109, P19, DOI 10.1016/S0014-4886(05)80005-6; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; Trujillo-Cenoz O., 1985, COMPREHENSIVE INSECT, V6, P171; TSACOPOULOS M, 1988, P NATL ACAD SCI USA, V85, P8727, DOI 10.1073/pnas.85.22.8727; VIHTELIC TS, 1991, GENETICS, V127, P761; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	62	120	121	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					839	850		10.1016/0896-6273(93)90200-B	http://dx.doi.org/10.1016/0896-6273(93)90200-B			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494644				2022-12-28	WOS:A1993LD32200007
J	LAUGWITZ, KL; OFFERMANNS, S; SPICHER, K; SCHULTZ, G				LAUGWITZ, KL; OFFERMANNS, S; SPICHER, K; SCHULTZ, G			MU AND DELTA OPIOID RECEPTORS DIFFERENTIALLY COUPLE TO G-PROTEIN SUBTYPES IN MEMBRANES OF HUMAN NEUROBLASTOMA SH-SY5Y CELLS	NEURON			English	Article							GTP-BINDING PROTEIN; ADENYLATE-CYCLASE ACTIVITY; GUANINE-NUCLEOTIDE; PERTUSSIS TOXIN; ALPHA-SUBUNIT; SIGNAL TRANSDUCTION; MEDIATED INHIBITION; MOLECULAR-CLONING; HYBRID-CELLS; IDENTIFICATION	Opioids are regarded to act via receptors interacting with heterotrimeric pertussis toxin (PTX)-sensitive G proteins. In membranes of SH-SY5Y cells, the mu-selective agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAGO) and the delta-selective agonist [D-Pen2,Pen5]-enkephalin (DPDPE) stimulated incorporation of the photoreactive GTP analog [alpha-P-32]GTP azidoanilide into proteins comigrating with the alpha subunits of G(i1), G(i2), G(i3), G(o1), and another form of G(o), presumably G(o2). In membranes of PTX-treated cells, both agonists were ineffective. Subtype-specific immunoprecipitation of G protein alpha subunits photolabeled in the absence or presence of agonists revealed profound differences between mu and delta opioid receptors in coupling to PTX-sensitive G proteins. Whereas activated delta opioid receptors preferentially coupled to G(i1), activated mu opioid receptors more effectively coupled to G(i3). Additionally, we provide evidence that G(o) subtypes are also differentially activated by the two receptors. Thus, mu and delta opioid receptors appear to discriminate between PTX-sensitive G proteins and lead to activation of distinct G protein subtypes.			LAUGWITZ, KL (corresponding author), FREE UNIV BERLIN, INST PHARMAKOL, THIELALLEE 69-73, W-1000 BERLIN 33, GERMANY.		Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				ATTALI B, 1989, J NEUROCHEM, V52, P360, DOI 10.1111/j.1471-4159.1989.tb09130.x; BERTRAND P, 1990, J BIOL CHEM, V265, P18576; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWN DA, 1990, ANNU REV PHYSIOL, V52, P215; CHILDERS SR, 1991, LIFE SCI, V48, P1991, DOI 10.1016/0024-3205(91)90154-4; CLARK MJ, 1986, LIFE SCI, V39, P1721, DOI 10.1016/0024-3205(86)90090-1; FRANKLIN PH, 1984, J NEUROCHEM, V43, P1132, DOI 10.1111/j.1471-4159.1984.tb12853.x; FREY EA, 1984, ENDOCRINOLOGY, V115, P1797, DOI 10.1210/endo-115-5-1797; GOLDSMITH P, 1988, J BIOL CHEM, V263, P6476; GROSS RA, 1987, P NATL ACAD SCI USA, V84, P5469, DOI 10.1073/pnas.84.15.5469; HATTA S, 1986, P NATL ACAD SCI USA, V83, P5439, DOI 10.1073/pnas.83.15.5439; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HINSCH KD, 1988, FEBS LETT, V238, P191, DOI 10.1016/0014-5793(88)80254-0; HINSCH KD, 1989, BIOCHIM BIOPHYS ACTA, V1013, P60, DOI 10.1016/0167-4889(89)90128-6; HSU WH, 1990, J BIOL CHEM, V265, P11220; JONES DT, 1987, J BIOL CHEM, V262, P14241; KAZMI SMI, 1987, MOL PHARMACOL, V32, P109; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOH HH, 1990, ANNU REV PHARMACOL, V30, P123; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; OFFERMANNS S, 1991, J BIOL CHEM, V266, P3365; OFFERMANNS S, 1991, METHOD ENZYMOL, V195, P286; OFFERMANS S, 1990, FEBS LETT, V260, P14, DOI 10.1016/0014-5793(90)80054-M; PUTTFARCKEN PS, 1988, MOL PHARMACOL, V33, P520; RIBEIRONETO FAP, 1989, P NATL ACAD SCI USA, V86, P2577, DOI 10.1073/pnas.86.8.2577; ROSENTHAL W, 1986, EUR J BIOCHEM, V158, P255, DOI 10.1111/j.1432-1033.1986.tb09745.x; SADEE W, 1987, CANCER RES, V47, P5207; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; SCHULTZ G, 1990, REV PHYSL, V52, P275; SEWARD E, 1991, P ROY SOC B-BIOL SCI, V244, P129, DOI 10.1098/rspb.1991.0061; SEWARD EP, 1989, ADV BIOSCI, V75, P181; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P590, DOI 10.1073/pnas.72.2.590; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SIMONDS WF, 1988, ENDOCR REV, V9, P200, DOI 10.1210/edrv-9-2-200; SPICHER K, 1992, FEBS LETT, V307, P215, DOI 10.1016/0014-5793(92)80770-H; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; SUKI WN, 1987, FEBS LETT, V220, P187, DOI 10.1016/0014-5793(87)80900-6; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; UEDA H, 1988, P NATL ACAD SCI USA, V85, P7013, DOI 10.1073/pnas.85.18.7013; WERLING LL, 1989, N-S ARCH PHARMACOL, V339, P509, DOI 10.1007/BF00167253; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; YU VC, 1988, J PHARMACOL EXP THER, V245, P350	49	172	174	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1993	10	2					233	242		10.1016/0896-6273(93)90314-H	http://dx.doi.org/10.1016/0896-6273(93)90314-H			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382499				2022-12-28	WOS:A1993KP68500011
J	LEVISON, SW; GOLDMAN, JE				LEVISON, SW; GOLDMAN, JE			BOTH OLIGODENDROCYTES AND ASTROCYTES DEVELOP FROM PROGENITORS IN THE SUBVENTRICULAR ZONE OF POSTNATAL RAT FOREBRAIN	NEURON			English	Article							RADIAL GLIAL-CELLS; OPTIC-NERVE; CEREBRAL-CORTEX; RECOMBINANT RETROVIRUS; MACROGLIAL CELLS; DEVELOPMENT INVITRO; CORPUS-CALLOSUM; WHITE MATTER; YOUNG-RATS; ADULT MICE	The developmental fates of subventricular zone (SVZ) cells of the postnatal rat forebrain were determined by retroviral-mediated gene transfer and immunolabeling for glial antigens. A beta-galactosidase-containing retrovirus injected stereotactically into the SVZ infected small, immature cells. By 28 days post-injection labeled cells had appeared in both gray and white matter of the ipsilateral hemisphere. White matter contained labeled oligodendrocytes, but few astrocytes, while neocortex and striatum contained both glial types, often appearing in tightly knit clusters. An analysis after simultaneously injecting alkaline phosphatase- and beta-galactosidase-containing retroviruses showed that cells in each cortical cluster were related. Most clusters contained a single cell type, but approximately 15% contained both astrocytes and oligodendrocytes. These observations strongly suggest that a single SVZ cell can differentiate into both glial types.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Columbia University	LEVISON, SW (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA.		Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309	NIA NIH HHS [AG 00189] Funding Source: Medline; NIMH NIH HHS [MH 15174] Funding Source: Medline; NINDS NIH HHS [NS17125] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017125] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Andriezen W L, 1893, Br Med J, V2, P227; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; BENJELLOUNTOUIMI S, 1985, J NEUROIMMUNOL, V9, P87, DOI 10.1016/S0165-5728(85)80009-6; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CAMMER W, 1988, J NEUROCHEM, V50, P319, DOI 10.1111/j.1471-4159.1988.tb13267.x; CEPKO CL, 1990, COLD SH Q B, V55, P265; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; CULICAN SM, 1990, J NEUROSCI, V10, P684; CURTIS R, 1988, J NEUROCYTOL, V17, P43, DOI 10.1007/BF01735376; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; FFRENCHCONSTANT C, 1986, J CELL BIOL, V102, P844, DOI 10.1083/jcb.102.3.844; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; FRANK E, 1991, DEVELOPMENT, V111, P895; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GRAY GE, 1992, DEVELOPMENT, V114, P271; HALL PA, 1989, DEVELOPMENT, V106, P619; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HARDY R, 1991, DEVELOPMENT, V111, P1061; HELLER A, 1979, J NEUROSCI METH, V1, P41, DOI 10.1016/0165-0270(79)90006-2; IMAMOTO K, 1978, J COMP NEUROL, V180, P115, DOI 10.1002/cne.901800108; KAPLAN MS, 1980, J COMP NEUROL, V193, P711, DOI 10.1002/cne.901930309; KITAMURA T, 1987, BRAIN RES, V423, P189, DOI 10.1016/0006-8993(87)90839-0; KORR H, 1973, J COMP NEUROL, V150, P169, DOI 10.1002/cne.901500205; LEBER SM, 1990, J NEUROSCI, V10, P2451; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, IN PRESS PHARM ASTRO; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; MILLER RH, 1989, ANNU REV NEUROSCI, V12, P517, DOI 10.1146/annurev.ne.12.030189.002505; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; NOBLE M, 1991, GLIA, V4, P157, DOI 10.1002/glia.440040207; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; Polak M., 1982, HISTOL HISTOPATHOL, P363; PRICE J, 1988, DEVELOPMENT, V104, P473; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAMONMOLINER E, 1958, J COMP NEUROL, V110, P157, DOI 10.1002/cne.901100202; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SKOFF RP, 1991, GLIA, V4, P165, DOI 10.1002/glia.440040208; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SKOFF RP, 1976, J COMP NEUROL, V169, P313, DOI 10.1002/cne.901690304; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; STURROCK RR, 1980, J ANAT, V130, P391; TURNER M, 1980, NATURE, V284, P13, DOI 10.1038/284013a0; VAYSSE PJJ, 1990, NEURON, V5, P227, DOI 10.1016/0896-6273(90)90160-H; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WILKIN GP, 1990, TRENDS NEUROSCI, V13, P43, DOI 10.1016/0166-2236(90)90065-I; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9	58	610	615	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1993	10	2					201	212		10.1016/0896-6273(93)90311-E	http://dx.doi.org/10.1016/0896-6273(93)90311-E			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439409				2022-12-28	WOS:A1993KP68500008
J	MOGUL, DJ; ADAMS, ME; FOX, AP				MOGUL, DJ; ADAMS, ME; FOX, AP			DIFFERENTIAL ACTIVATION OF ADENOSINE RECEPTORS DECREASES N-TYPE BUT POTENTIATES P-TYPE CA2+ CURRENT IN HIPPOCAMPAL CA3 NEURONS	NEURON			English	Article							LONG-TERM POTENTIATION; MOUSE SENSORY NEURONS; CALCIUM CHANNELS; GUINEA-PIG; PERIPHERAL NEURONS; RAT HIPPOCAMPUS; OMEGA-CONOTOXIN; MULTIPLE TYPES; RELEASE; NEUROTRANSMISSION	Adenosine is released in the brain in significant quantities in response to increased cellular activity. Adenosine has been shown either to decrease synaptic transmission or to produce an excitatory response in hippocampal synapses, resulting in increased glutamate release. Previous reports have shown that adenosine or its analogs reduced Ca2+ current in dorsal root ganglion and hippocampal neurons. Here we show that the selective activation of adenosine receptor subtypes has different effects on Ca2+ channels from acutely isolated pyramidal neurons from the CA3 region of guinea pig hippocampus. Activation of A1 receptors inhibited primarily N-type Ca2+ current. In contrast, activation of A2b receptors resulted in significant potentiation of P-type but not N-type Ca2+ current. This potentiation could be inhibited by blocking the cAMP-dependent protein kinase. Because of the ubiquity of adenosine, the differential effects on Ca2+ channels of adenosine receptor subtype activation may have significant implications for neuronal excitability.	UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,CHICAGO,IL 60637; UNIV CALIF RIVERSIDE,DEPT ENTOMOL,RIVERSIDE,CA 92521; UNIV CALIF RIVERSIDE,DEPT NEUROSCI,RIVERSIDE,CA 92521	University of Chicago; University of California System; University of California Riverside; University of California System; University of California Riverside			Mogul, David/L-2765-2019					BERNE M, 1982, CEREBRAL HYPOXIA PAT, P82; BOWYER JF, 1990, J PHARMACOL EXP THER, V254, P664; BRUNS RF, 1986, MOL PHARMACOL, V29, P331; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; DOBSON JG, 1971, CIRC RES, V29, P375, DOI 10.1161/01.RES.29.4.375; DOLPHIN AC, 1986, J PHYSIOL-LONDON, V373, P47, DOI 10.1113/jphysiol.1986.sp016034; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; DUNWIDDIE TV, 1984, J PHYSIOL-LONDON, V350, P545, DOI 10.1113/jphysiol.1984.sp015217; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; Fredholm B B, 1983, Acta Physiol Scand Suppl, V515, P7; FREDHOLM BB, 1980, BIOCHEM PHARMACOL, V25, P1583; GINSBORG BL, 1972, J PHYSIOL-LONDON, V224, P629, DOI 10.1113/jphysiol.1972.sp009916; GROSS RA, 1989, J PHYSIOL-LONDON, V411, P585, DOI 10.1113/jphysiol.1989.sp017592; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HENNON BK, 1983, J PHYSL, V336, P607; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KEEN M, 1989, BIOCHEM PHARMACOL, V38, P3827, DOI 10.1016/0006-2952(89)90592-3; KURODA Y, 1978, J PHYSIOL-PARIS, V74, P463; KURODA Y, 1990, JPN J PHARMACOL, V52, P70; LLINAS RR, 1989, ANN NY ACAD SCI, V560, P103, DOI 10.1111/j.1749-6632.1989.tb24084.x; MACDONALD RL, 1986, J PHYSIOL-LONDON, V370, P75, DOI 10.1113/jphysiol.1986.sp015923; MANGANO TJ, 1990, J PHARMACOL EXP THER, V252, P574; MCCARRON JG, 1992, NATURE, V357, P74, DOI 10.1038/357074a0; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; NISHIMURA S, 1990, BRAIN RES, V525, P165, DOI 10.1016/0006-8993(90)91335-E; OKADA Y, 1990, NEUROSCI LETT, V120, P205, DOI 10.1016/0304-3940(90)90039-C; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PROCTOR WR, 1983, NEUROSCI LETT, V35, P197, DOI 10.1016/0304-3940(83)90550-5; PULL I, 1972, BIOCHEM J, V130, P975, DOI 10.1042/bj1300975; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RIBEIRO JA, 1986, PROG NEUROBIOL, V26, P179, DOI 10.1016/0301-0082(86)90015-8; SAKURAI T, 1992, J PHYSIOL-LONDON, V446, pP380; SCHWABE U, 1974, EUR J BIOCHEM, V46, P537, DOI 10.1111/j.1432-1033.1974.tb03647.x; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SNYDER SH, 1985, ANNU REV NEUROSCI, V8, P103; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; UKENA D, 1986, LIFE SCI, V39, P743, DOI 10.1016/0024-3205(86)90023-8; ZHOU QY, 1992, P NATL ACAD SCI USA, V89, P7432, DOI 10.1073/pnas.89.16.7432	43	199	202	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					327	334		10.1016/0896-6273(93)90322-I	http://dx.doi.org/10.1016/0896-6273(93)90322-I			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382501				2022-12-28	WOS:A1993KP68500019
J	WAKAMATSU, Y; WATANABE, Y; SHIMONO, A; KONDOH, H				WAKAMATSU, Y; WATANABE, Y; SHIMONO, A; KONDOH, H			TRANSITION OF LOCALIZATION OF THE N-MYC PROTEIN FROM NUCLEUS TO CYTOPLASM IN DIFFERENTIATING NEURONS	NEURON			English	Article							B TRANSCRIPTION FACTOR; I-KAPPA-B; DNA-BINDING; DORSAL PROTEIN; CELL-LINES; EXPRESSION; ONCOGENE; EMBRYO; MOUSE; AMPLIFICATION	N-myc is a developmentally regulated proto-oncogene encoding a putative sequence-specific DNA-binding protein. Previous studies on tissue distribution of N-myc transcripts indicated that one of the major sites of N-myc expression is the CNS and neural crest derivatives in developing embryos. We investigated N-Myc protein expression in embryonic neural tissues and found that the protein was usually localized in the nucleus, but accumulated in the cytoplasm upon differentiation of specific classes of neurons, e.g., retinal ganglion cells, neurons of spinal ganglia, and Purkinje cells of the cerebellum. The change of localization of N-Myc from the nucleus to the cytoplasm indicates a novel feature of regulation of myc family proteins and suggests functions of N-myc in the cytoplasm of maturing neurons.			WAKAMATSU, Y (corresponding author), NAGOYA UNIV,SCH SCI,DEPT MOLEC BIOL,NAGOYA 46401,JAPAN.							ACESON A, 1991, NEURON, V7, P265; AKESON R, 1990, MOL CELL BIOL, V10, P2012, DOI 10.1128/MCB.10.5.2012; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BERNARDS R, 1986, CELL, V47, P667, DOI 10.1016/0092-8674(86)90509-X; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; COLLUM RG, 1991, MOL CELL BIOL, V11, P1170; DOWNS KM, 1989, GENE DEV, V3, P861; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GUSSE M, 1989, MOL CELL BIOL, V9, P5395, DOI 10.1128/MCB.9.12.5395; JACOBOVITS A, 1985, NATURE, V318, P188; JAFFREDO T, 1989, DEVELOPMENT, V105, P679; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KATO K, 1990, MOL CELL BIOL, V10, P486, DOI 10.1128/MCB.10.2.486; KATO K, 1991, DEV GROWTH DIFFER, V33, P29; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; MAKELA TP, 1992, SCIENCE, V256, P373, DOI 10.1126/science.256.5055.373; MIYATA Y, 1991, J BIOL CHEM, V266, P8779; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SANCHEZ ER, 1992, J BIOL CHEM, V267, P17; SAWAI S, 1990, MOL CELL BIOL, V10, P2017, DOI 10.1128/MCB.10.5.2017; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; SLAMON DJ, 1986, SCIENCE, V232, P768, DOI 10.1126/science.3008339; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; SUEMORI H, 1990, CELL DIFFER DEV, V29, P181, DOI 10.1016/0922-3371(90)90120-L; UENO K, 1988, MOL CELL BIOL, V8, P4529, DOI 10.1128/MCB.8.10.4529; WHITESELL L, 1991, MOL CELL BIOL, V11, P1360, DOI 10.1128/MCB.11.3.1360; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	35	66	66	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1993	10	1					1	9		10.1016/0896-6273(93)90236-K	http://dx.doi.org/10.1016/0896-6273(93)90236-K			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427698				2022-12-28	WOS:A1993KK01200001
J	Wu, LG; Betz, WJ				Wu, LG; Betz, WJ			Nerve activity but not intracellular calcium determines the time course of endocytosis at the frog neuromuscular junction	NEURON			English	Article							TRANSMITTER RELEASE; POSTTETANIC POTENTIATION; PRESYNAPTIC BOUTONS; SYNAPTIC VESICLES; EXOCYTOSIS; TERMINALS; MEMBRANE; CELLS; CA2+; DEPRESSION	We used FM1-43 imaging and intracellular recordings of synaptic potentials to measure the time course of endocytosis in frog motor nerve terminals following tetanic nerve stimulation, and we used fura-2 imaging of intraterminal Ca2+ concentration to compare endocytic rate and [Ca2+](i). Following a 30 Hz tetanus, endocytosis declined exponentially with a time constant that depended on the duration of stimulation. The level of [Ca2+](i) rose from a resting value of about 100 nM to more than 500 nM during 30 Hz stimulation, and rapidly declined to 200-250 nM after stimulation. [Ca2+](i) returned to resting level with a time course that, like endocytosis, depended on the duration of tetanic stimulation. However, the rate of [Ca2+](i) recovery was much slower than the rate of endocytosis, leading to the conclusion that endocytic rate is not determined solely by the instantaneous level of [Ca2+](i).	UNIV COLORADO,SCH MED,DEPT PHYSIOL,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NINDS NIH HHS [NS23466] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023466] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; BURGOYNE RD, 1995, PFLUG ARCH EUR J PHY, V430, P213, DOI 10.1007/BF00374652; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; DELANEY KR, 1989, J NEUROSCI, V9, P3558; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1995, J NEUROSCI, V15, P8246; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; MELDOLESI J, 1981, PHILOS T ROY SOC B, V296, P55, DOI 10.1098/rstb.1981.0171; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; REGEHR WG, 1994, J NEUROSCI, V14, P523; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Tank DW, 1995, J NEUROSCI, V15, P7940; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; ZENGEL JE, 1994, J PHYSIOL-LONDON, V477, P267, DOI 10.1113/jphysiol.1994.sp020189; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	34	143	148	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					769	779		10.1016/S0896-6273(00)80208-1	http://dx.doi.org/10.1016/S0896-6273(00)80208-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893033	Bronze			2022-12-28	WOS:A1996VP74300021
J	Kullmann, DM; Erdemli, G; Asztely, F				Kullmann, DM; Erdemli, G; Asztely, F			LTP of AMPA and NMDA receptor-mediated signals: Evidence for presynaptic expression and extrasynaptic glutamate spill-over	NEURON			English	Article							LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; EXCITATORY SYNAPTIC CURRENTS; TRANSMITTER RELEASE; HIPPOCAMPAL SLICES; CA1 REGION; LASTING POTENTIATION; PYRAMIDAL CELLS; TIME COURSE; COMPONENT	We have addressed the expression of long-term potentiation (LTP) in hippocampal CA1 by comparing AMPA and NMDA receptor-(AMPAR- and NMDAR-) mediated postsynaptic signals. We find that potentiation of NMDAR-mediated signals accompanies LTP of AMPAR-mediated signals, and is associated with a change in variability implying an increase in quantal content. Further, tetanic LTP of NMDAR-mediated signals can be elicited when LTP of AMPAR-mediated signals is prevented. We propose that LTP is mainly expressed presynaptically, and that, while AMPARs respond only to glutamate from immediately apposed terminals, NMDARs also sense glutamate released from terminals presynaptic to neighboring cells. We also find that tetanic LTP increases the rate of depression of NMDAR-mediated signals by the use-dependent blocker MK-801, implying an increase in the glutamate release probability. These findings argue for a presynaptic contribution to LTP and for extrasynaptic spill-over of glutamate onto NMDARs.			Kullmann, DM (corresponding author), UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND.		Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; ASZTELY F, 1992, EUR J NEUROSCI, V4, P681, DOI 10.1111/j.1460-9568.1992.tb00177.x; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERETTA N, 1991, EUR J NEUROSCI, V3, P850; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CORMIER RJ, 1993, NEURON, V10, P907, DOI 10.1016/0896-6273(93)90206-7; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; HESSLER NA, 1993, NATURE, V366, P568; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; KAMIYA H, 1993, SYNAPSE, V13, P186, DOI 10.1002/syn.890130210; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Neveu D, 1996, J NEUROPHYSIOL, V75, P2157, DOI 10.1152/jn.1996.75.5.2157; OCONNOR JJ, 1995, NEUROSCIENCE, V69, P363, DOI 10.1016/0306-4522(95)00295-T; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Stricker C, 1996, J PHYSIOL-LONDON, V490, P443, DOI 10.1113/jphysiol.1996.sp021156; TSIEN RW, 1990, COLD SPRING HARB SYM, V45, P147; VORONIN LL, 1993, NEUROSCIENCE, V56, P275, DOI 10.1016/0306-4522(93)90332-A; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	53	228	231	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					461	474		10.1016/S0896-6273(00)80178-6	http://dx.doi.org/10.1016/S0896-6273(00)80178-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816709	Bronze			2022-12-28	WOS:A1996VJ44000012
J	Aggarwal, SK; MacKinnon, R				Aggarwal, SK; MacKinnon, R			Contribution of the S4 segment to gating charge in the Shaker K+ channel	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; ELECTROPHORUS-ELECTRICUS; COOPERATIVE INTERACTIONS; SUBUNIT STOICHIOMETRY; MOLECULAR-MODEL; RAT-BRAIN; VOLTAGE; EXPRESSION; MOVEMENT	Voltage-activated ion channels respond to changes in membrane voltage by coupling the movement of charges to channel opening. A K+ channel-specific radioligand was designed and used to determine the origin of these gating charges in the Shaker K+ channel. Opening of a Shaker K+ channel is associated with a displacement of 13.6 electron charge units. Gating charge contributions were determined for six of the seven positive charges in the S4 segment, an unusual amino acid sequence in voltage-activated cation channels consisting of repeating basic residues at every third position. Charge-neutralizing mutations of the first four positive charges led to large decreases (similar to 4 electron charge units each) in the gating charge; however, the gating charge of Shaker Delta 10, a Shaker K+ channel with 10 altered nonbasic residues in its S4 segment, was found to be identical to the wild-type channel. These findings show that movement of the NH2-terminal half but not the CO2H-terminal end of the S4 segment underlies gating charge, and that this portion of the S4 segment appears to move across the entire transmembrane voltage difference in association with channel activation.			Aggarwal, SK (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH010989] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 10989] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HURST RS, 1992, J BIOL CHEM, V267, P23742; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KEYNES RD, 1974, J PHYSIOL-LONDON, V239, P393, DOI 10.1113/jphysiol.1974.sp010575; KOSOWER EM, 1985, FEBS LETT, V182, P234, DOI 10.1016/0014-5793(85)80306-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1993, NEURON, V10, P1121, DOI 10.1016/0896-6273(93)90060-5; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MIKA YH, 1994, BIOPHYS J, V67, P1455, DOI 10.1016/S0006-3495(94)80619-8; NEWMAN M, 1995, SCIENCE, V269, P656, DOI 10.1126/science.7624794; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SHIMONY E, 1994, PROTEIN ENG, V7, P503, DOI 10.1093/protein/7.4.503; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	40	570	587	1	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1169	1177		10.1016/S0896-6273(00)80143-9	http://dx.doi.org/10.1016/S0896-6273(00)80143-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663993	Bronze			2022-12-28	WOS:A1996UU11800014
J	Hess, EJ				Hess, EJ			Identification of the weaver mouse mutation: The end of the beginning	NEURON			English	Review							MUTANT MOUSE; GENE; CELL; DOPAMINE; MICE				Hess, EJ (corresponding author), PENN STATE UNIV,COLL MED,DEPT ANAT & NEUROSCI,HERSHEY,PA 17033, USA.							GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GOLDOWITZ D, 1989, NEURON, V2, P1565, DOI 10.1016/0896-6273(89)90045-7; HERRUP K, 1987, NEUROSCIENCE, V23, P871, DOI 10.1016/0306-4522(87)90164-3; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LEVICK V, 1995, BRAIN RES, V676, P325, DOI 10.1016/0006-8993(95)00115-7; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RofflerTarlov S, 1996, J NEUROSCI, V16, P1819; ROFFLERTARLOV S, 1990, J NEUROSCI, V10, P734; SCHMIDT MJ, 1982, J NEUROSCI, V2, P376; SEKIGUCHI M, 1995, BRAIN RES, V696, P262, DOI 10.1016/0006-8993(95)00974-U; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; SMEYNE RJ, 1990, DEV BRAIN RES, V52, P211, DOI 10.1016/0165-3806(90)90237-S; VOGELWEID CM, 1993, J NEUROGENET, V9, P89, DOI 10.3109/01677069309083452; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	19	45	47	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1073	1076		10.1016/S0896-6273(00)80133-6	http://dx.doi.org/10.1016/S0896-6273(00)80133-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663983	Bronze			2022-12-28	WOS:A1996UU11800004
J	Gotz, M; Wizenmann, A; Reinhardt, S; Lumsden, A; Price, J				Gotz, M; Wizenmann, A; Reinhardt, S; Lumsden, A; Price, J			Selective adhesion of cells from different telencephalic regions	NEURON			English	Article							RAT-BRAIN DEVELOPMENT; CEREBRAL-CORTEX; HOMEOBOX GENES; NERVOUS-SYSTEM; REAGGREGATE CULTURES; MAMMALIAN FOREBRAIN; CHICK-EMBRYO; MOUSE-BRAIN; EXPRESSION; MOLECULES	We asked whether specification of different regions of the rodent and avian telencephalon during development involved the acquisition of differential adhesive properties. Cells from different regions were aggregated in a short-term aggregation assay, and their segregation was analyzed. Both neurons and precursor cells from cortex segregate from striatal cells at early, but not later, stages, whereas cells from rodent neocortex and hippocampus segregated only during later stages. Segregation was abolished when Ca2+-dependent but not Ca2+-independent adhesion molecules were selectively removed. Thus, selective adhesion appears to be a conserved mechanism that restricts cellular mixing and might serve to maintain positional information during forebrain development. A candidate for mediating the Ca2+-dependent segregation is the CD15 (Lewis(x)) carbohydrate epitope, which is selectively expressed by mammalian cortex but not striatum.	UNITED MED & DENT SCH,GUYS & ST THOMAS HOSP,SCH MED,MRC,BRAIN DEV PROGRAM,LONDON SE1 9RT,ENGLAND; UNIV MAINZ,INST PHYSIOL CHEM & PATHOBIOCHEM,D-55099 MAINZ,GERMANY	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Johannes Gutenberg University of Mainz	Gotz, M (corresponding author), SMITHKLINE BEECHAM PHARMACEUT,NEW FRONTIERS SCI PK N,3RD AVE,HARLOW CM19 5AD,ESSEX,ENGLAND.		Lumsden, Andrew/C-5146-2009; Price, Jack/G-9510-2011	Gotz, Magdalena/0000-0003-1551-9203	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKAGAWA K, 1987, BRAIN RES, V437, P298, DOI 10.1016/0006-8993(87)91644-1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bayer S.A., 1991, NEOCORTICAL DEV; BAYER SA, 1991, J COMP NEUROL, V307, P499, DOI 10.1002/cne.903070312; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BINDER LI, 1986, ANN NY ACAD SCI, V466, P154; BLASSKAMPMANN S, 1994, J NEUROSCI RES, V37, P359, DOI 10.1002/jnr.490370308; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRACKENBURY R, 1977, J BIOL CHEM, V252, P6835; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; CHALEPAKIS G, 1994, DNA CELL BIOL, V13, P891, DOI 10.1089/dna.1994.13.891; CHUONG CM, 1984, J NEUROSCI, V4, P2354; DEDIEGO I, 1994, EUR J NEUROSCI, V6, P983, DOI 10.1111/j.1460-9568.1994.tb00593.x; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; FISHELL G, 1995, DEVELOPMENT, V121, P803; GANSMULLER A, 1991, GLIA, V4, P580, DOI 10.1002/glia.440040605; GANZLER SII, 1995, J NEUROSCI, V15, P4157; GARBER BB, 1972, DEV BIOL, V27, P217, DOI 10.1016/0012-1606(72)90099-1; GODFRAIND IR, 1991, DEV BRAIN RES, V42, P99; GOTZ M, 1992, DEVELOPMENT, V116, P507; GOTZ M, 1995, IN PRESS EXPERIENTIA; GRAHAM A, 1992, SEMIN NEUROSCI, V4, P307; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; GUTHRIE S, 1993, DEVELOPMENT, V118, P527; HINCK L, 1994, TRENDS BIOCHEM SCI, V19, P538, DOI 10.1016/0968-0004(94)90057-4; Huelsken Joerg, 1994, Current Opinion in Cell Biology, V6, P711; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; Karten H J, 1989, J Cogn Neurosci, V1, P291, DOI 10.1162/jocn.1989.1.4.291; KOJIMA N, 1994, GLYCOCONJUGATE J, V11, P238, DOI 10.1007/BF00731224; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; KRUSHEL LA, 1993, DEV BIOL, V158, P145, DOI 10.1006/dbio.1993.1175; LAMANTIA AS, 1993, NEURON, V10, P1035, DOI 10.1016/0896-6273(93)90052-S; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; LIEPELT U, 1990, DEV BRAIN RES, V51, P267, DOI 10.1016/0165-3806(90)90285-7; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MAURO VP, 1994, P NATL ACAD SCI USA, V91, P2868, DOI 10.1073/pnas.91.7.2868; NAGAFUCHI A, 1994, DEV GROWTH DIFFER, V36, P59; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; PROBSTMEIER R, 1994, J NEUROSCI RES, V37, P324, DOI 10.1002/jnr.490370305; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; RANSCHT B, 1994, CURR OPIN CELL BIOL, V6, P740, DOI 10.1016/0955-0674(94)90102-3; REDIES C, 1993, J COMP NEUROL, V333, P398, DOI 10.1002/cne.903330307; REINHARDTMAELIC.S, 1994, J BRAIN RES, V35, P121; REINHARDTMAELIC.S, 1988, TGHESIS; REINHARDTMAELICKE S, 1990, DEV BRAIN RES, V51, P279, DOI 10.1016/0165-3806(90)90286-8; REYES AA, 1993, MOL BRAIN RES, V17, P201, DOI 10.1016/0169-328X(93)90003-8; SEEDS NW, 1973, TISSUE CULTURE NERVO, P35; SHIMAMURA K, 1992, DEVELOPMENT, V116, P1011; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SMART IHM, 1982, J ANAT, V134, P273; SMART IHM, 1979, ONTOGENY NEOSTRIATUM, P127; SONG DD, 1994, DEV BRAIN RES, V83, P233, DOI 10.1016/0165-3806(94)00144-8; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; TOLE S, 1995, J NEUROSCI, V15, P957; TRAPP BD, 1979, BRAIN RES, V160, P117, DOI 10.1016/0006-8993(79)90605-X; TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207; TUTTLE R, 1995, J NEUROSCI, V15, P3039; URUSHIHARA H, 1979, DEV BIOL, V70, P206, DOI 10.1016/0012-1606(79)90017-4; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WHITESIDES JG, 1995, DEV BIOL, V169, P229, DOI 10.1006/dbio.1995.1140; [No title captured]	79	75	75	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					551	564		10.1016/S0896-6273(00)80074-4	http://dx.doi.org/10.1016/S0896-6273(00)80074-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785052	Bronze			2022-12-28	WOS:A1996UC16800011
J	Verdi, JM; Groves, AK; Farinas, I; Jones, K; Marchionni, MA; Reichardt, LF; Anderson, DJ				Verdi, JM; Groves, AK; Farinas, I; Jones, K; Marchionni, MA; Reichardt, LF; Anderson, DJ			A reciprocal cell-cell interaction mediated by NT-3 and neuregulins controls the early survival and development of sympathetic neuroblasts	NEURON			English	Article							NERVE GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; NEURAL CREST CELLS; SENSORY NEURONS; REGIONAL DISTRIBUTION; FACTOR RECEPTORS; GRANULE NEURONS; CNTF RECEPTOR; MESSENGER-RNA; EXPRESSION	Neurotrophin 3 (NT-3) can support the survival of some embryonic sympathetic neuroblasts before they become nerve growth factor dependent. We show that NT-3 is produced in vivo by nonneuronal cells neighboring embryonic sympathetic ganglia. NT-3 mRNA is produced by these nonneuronal cells in vitro and is up-regulated by platelet-derived growth factor, ciliary neurotrophic factor, and glial growth factor 2 (a neuregulin). Nonneuronal cell-conditioned medium promotes survival and induces TrkA expression in isolated sympathetic neuroblasts, and this activity is blocked by anti-NT-3 antibody. Neuroblasts also enhance NT-3 production by nonneuronal cells. Neuroblasts synthesize several forms of neuregulin, and antibodies to neuregulin attenuate the effect of the neuroblasts on the nonneuronal cells. These data suggest a reciprocal cell-cell interaction, in which neuroblast-derived neuregulins promote NT-3 production by neighboring nonneuronal cells, which in turn promotes neuroblast survival and further differentiation.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; CAMBRIDGE NEUROSCI INC,CAMBRIDGE,MA 02139; AMGEN INST,TORONTO,ON,CANADA; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Verdi, JM (corresponding author), CALTECH,DIV BIOL 21676,PASADENA,CA 91125, USA.		Farinas, Isabel/L-7118-2014	Farinas, Isabel/0000-0003-2903-4960; Groves, Andrew/0000-0002-0784-7998; JONES, KEVIN/0000-0002-3802-7562	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-180014, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; BUJBELLO A, 1994, DEVELOPMENT, V120, P1573; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DAVIES AM, 1994, CURR BIOL, V4, P273, DOI 10.1016/S0960-9822(00)00064-6; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DECHANT G, 1993, J NEUROSCI, V13, P2610, DOI 10.1523/JNEUROSCI.13-06-02610.1993; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; IP NY, 1994, NEURON, V13, P443, DOI 10.1016/0896-6273(94)90359-X; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; LEE KF, 1994, DEVELOPMENT, V120, P1027; LEUNG DW, 1992, NEURON, V8, P1045, DOI 10.1016/0896-6273(92)90126-X; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAO MS, 1993, NEURON, V11, P1175, DOI 10.1016/0896-6273(93)90229-K; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; WESKAMP G, 1991, NEURON, V6, P49; WRIGHT EM, 1992, NEURON, V9, P1; WYATT S, 1993, DEVELOPMENT, V119, P635; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; ZACKENFELS K, 1995, NEURON, V14, P731, DOI 10.1016/0896-6273(95)90217-1	52	125	128	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					515	527		10.1016/S0896-6273(00)80071-9	http://dx.doi.org/10.1016/S0896-6273(00)80071-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785049	Bronze, Green Accepted			2022-12-28	WOS:A1996UC16800008
J	Maren, S; Fanselow, MS				Maren, S; Fanselow, MS			The amygdala and fear conditioning: Has the nut been cracked?	NEURON			English	Review							LATERAL NUCLEUS				Maren, S (corresponding author), UNIV CALIF LOS ANGELES, DEPT PSYCHOL, LOS ANGELES, CA 90095 USA.		Maren, Stephen/A-7091-2009; Maren, Stephen/B-6182-2014	Maren, Stephen/0000-0002-9342-7411; Maren, Stephen/0000-0002-9342-7411				ADOLPHS R, 1995, J NEUROSCI, V15, P5879; APPLEGATE CD, 1982, BRAIN RES, V238, P457, DOI 10.1016/0006-8993(82)90123-8; BARNES CA, 1995, NEURON, V15, P751, DOI 10.1016/0896-6273(95)90166-3; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; CLUGNET MC, 1990, J NEUROSCI, V10, P2818; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; KIM M, 1993, BEHAV NEUROSCI, V107, P1088; Kluaver H., 1937, AM J PHYSIOL, V119, P352; LABAR KS, 1995, J NEUROSCI, V15, P6846; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LI XF, 1995, EXP BRAIN RES, V105, P87; MAREN S, 1991, BRAIN RES, V549, P311, DOI 10.1016/0006-8993(91)90473-9; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; MCGAUGH JL, 1989, ANNU REV NEUROSCI, V12, P265; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Watson JB, 1920, J EXP PSYCHOL, V3, P1, DOI 10.1037/h0069608; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129	25	306	309	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB	1996	16	2					237	240		10.1016/S0896-6273(00)80041-0	http://dx.doi.org/10.1016/S0896-6273(00)80041-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789938	Bronze, Green Published			2022-12-28	WOS:A1996TW95700003
J	Arenas, E; Trupp, M; Akerud, P; Ibanez, CF				Arenas, E; Trupp, M; Akerud, P; Ibanez, CF			GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo	NEURON			English	Article							PARKINSONS-DISEASE; LOCUS-CERULEUS; ALZHEIMERS-DISEASE; SENILE DEMENTIA; CELL LOSS; DOPAMINERGIC-NEURONS; STRIATAL DOPAMINE; BASAL FOREBRAIN; COERULEUS; NEUROPATHOLOGY	The locus coeruleus (LC), the main noradrenergic center in the brain, participates in many neural functions, as diverse as memory and motor output, and is severely affected in several neurodegenerative disorders of the CNS. GDNF, a neurotrophic factor intitially identified as dopaminotrophic, was found to be expressed in several targets of central noradrenergic neurons in the adult rat brain. Grafting of genetically engineered fibroblasts expressing high levels of GDNF prevented >8O% of the 6-hydroxydopamine-induced degeneration of noradrenergic neurons in the LC in vivo. Moreover, GDNF induced a fasciculated sprouting and increased by 2.5-fold both tyrosine hydroxylase levels and the soma size of lesioned LC neurons. These findings reveal a novel and potent neurotrophic activity of GDNF that may have therapeutic applications in neurodegenerative disorders affecting central noradrenergic neurons, such as Alzheimer's, Parkinson's, and Huntington's diseases.			Arenas, E (corresponding author), KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,MOLEC NEUROBIOL LAB,S-17177 STOCKHOLM,SWEDEN.		Arenas, Ernest/AAO-5231-2020	Arenas, Ernest/0000-0003-0197-6577				ARENAS E, 1994, NATURE, V367, P368, DOI 10.1038/367368a0; ARIMA K, 1990, ACTA NEUROPATHOL, V79, P629, DOI 10.1007/BF00294240; BARNES CD, 1991, PROG BRAIN RES, V88, P365; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; CASH R, 1987, NEUROLOGY, V37, P42, DOI 10.1212/WNL.37.1.42; CHANPALAY V, 1989, J COMP NEUROL, V287, P373, DOI 10.1002/cne.902870308; CHANPALAY V, 1991, PROG BRAIN RES, V88, P625; CHUI HC, 1986, ARCH NEUROL-CHICAGO, V43, P991, DOI 10.1001/archneur.1986.00520100013007; DAVIES P, 1976, LANCET, V2, P1403; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FIBIGER HC, 1991, TRENDS NEUROSCI, V14, P220, DOI 10.1016/0166-2236(91)90117-D; FORNO LS, 1966, J NEUROSURG, V24, P266; FRIEDMAN WJ, 1993, EXP NEUROL, V119, P72, DOI 10.1006/exnr.1993.1007; GASPAR P, 1984, ACTA NEUROPATHOL, V64, P43, DOI 10.1007/BF00695605; GASPAR P, 1991, ANN NEUROL, V30, P385; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; HALLIDAY GM, 1990, ANN NEUROL, V27, P373, DOI 10.1002/ana.410270405; HARDY J, 1985, NEUROCHEM INT, V7, P545, DOI 10.1016/0197-0186(85)90050-6; HARLEY C, 1991, PROG BRAIN RES, V88, P307; Hassler R, 1938, J PSYCHOL NEUROL, V48, P387; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hornykiewicz O, 1986, ADV NEUROL, V45, P19; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LOUGHLIN SE, 1985, LOCUS COERULEUS; MANN DMA, 1983, CLIN NEUROPATHOL, V2, P1; MANN DMA, 1983, NEUROPATH APPL NEURO, V9, P3, DOI 10.1111/j.1365-2990.1983.tb00320.x; MARCYNIUK B, 1986, J NEUROL SCI, V76, P335, DOI 10.1016/0022-510X(86)90179-6; MARIEN M, 1993, EUR J PHARMACOL, V236, P487, DOI 10.1016/0014-2999(93)90489-5; MAVRIDIS M, 1991, NEUROSCIENCE, V41, P507, DOI 10.1016/0306-4522(91)90345-O; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PAKKENBERG H., 1965, ACTA NEUROPATHOL, V5, P320; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; SCHNEIDER JS, 1987, NEUROLOGY, V37, P951, DOI 10.1212/WNL.37.6.951; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TOMLINSON BE, 1981, J NEUROL SCI, V49, P419, DOI 10.1016/0022-510X(81)90031-9; TOMONAGA M, 1983, J NEUROL, V230, P231, DOI 10.1007/BF00313699; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZWEIG RM, 1988, ANN NEUROL, V24, P233, DOI 10.1002/ana.410240210; ZWEIG RM, 1993, NEUROLOGY, V43, P986, DOI 10.1212/WNL.43.5.986	51	306	322	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1465	1473		10.1016/0896-6273(95)90024-1	http://dx.doi.org/10.1016/0896-6273(95)90024-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845169	Bronze			2022-12-28	WOS:A1995TL67800024
J	FUJII, H; HAMADA, H				FUJII, H; HAMADA, H			A CNS-SPECIFIC POU TRANSCRIPTION FACTOR, BRN-2, IS REQUIRED FOR ESTABLISHING MAMMALIAN NEURAL CELL LINEAGES	NEURON			English	Article							DEVELOPING NERVOUS-SYSTEM; STEM-CELLS; MOLECULAR CHARACTERIZATION; BINDING-PROTEINS; C-ELEGANS; DOMAIN; GENE; EXPRESSION; BRAIN; OCT-1	The pluripotent embryonal carcinoma cell line P19 can differentiate in vitro into neurons and astrocytes. By employing this neural cell differentiation system, we have studied the expression and function of a POU transcription factor implicated in mammalian neurogenesis. When P19 cells differentiated to the neural cells, one of the CNS-specific POU genes (Brn-2) was selectively induced. The induction of Brn-2 was specific to the neural cell lineages and took place at the early stage of differentiation. When the Brn-2 induction was blocked/delayed by antisense RNA, such cells were unable to differentiate to neurons and astrocytes. Instead they differentiated to nonneural cells, including smooth and skeletal muscle cells. Furthermore, with reduced levels of antisense RNA, differentiation to neural cells occurred. These results indicate that Brn-2 is essential for the neural cell differentiation of P19 cells and suggest that Brn-2 is one of the genes required for establishing neural cell lineages in mammals.	UNIV TOKYO, FAC MED, DEPT BIOCHEM, BUNKYO KU, TOKYO 113, JAPAN	University of Tokyo	FUJII, H (corresponding author), TOKYO METROPOLITAN INST MED SCI, DEPT DEV BIOL & CANC PREVENT, 3-18-22 HONKOMAGOME, BUNKYO KU, TOKYO 113, JAPAN.							AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; AVRAHAM KB, 1993, IN PRESS GENOMICS; BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38; BHAT K, 1988, MOL CELL BIOL, V8, P3251, DOI 10.1128/MCB.8.8.3251; CABRERA CV, 1992, DEVELOPMENT, V115, P893; CAMPOSORTEGA JA, 1991, ANNU REV NEUROSCI, V14, P399, DOI 10.1146/annurev.ne.14.030191.002151; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; HARA Y, 1992, P NATL ACAD SCI USA, V89, P3280, DOI 10.1073/pnas.89.8.3280; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; LEMOINE C, 1992, P NATL ACAD SCI USA, V89, P3285, DOI 10.1073/pnas.89.8.3285; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; MATHIS JM, 1992, EMBO J, V11, P2551, DOI 10.1002/j.1460-2075.1992.tb05320.x; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; OKAMOTO K, 1993, J BIOL CHEM, V268, P7449; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; RUDNICKI M, 1991, TERATOCARCINJOMAS EM, V64, P475; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHIMAZAKI T, 1993, IN PRESS EMBO J; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	31	76	78	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1197	1206		10.1016/0896-6273(93)90231-F	http://dx.doi.org/10.1016/0896-6273(93)90231-F			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274283				2022-12-28	WOS:A1993MP54800019
J	LAMBERT, NA; WILSON, WA				LAMBERT, NA; WILSON, WA			HETEROGENEITY IN PRESYNAPTIC REGULATION OF GABA RELEASE FROM HIPPOCAMPAL INHIBITORY NEURONS	NEURON			English	Article							LACUNOSUM-MOLECULARE INTERNEURONS; GAMMA-AMINOBUTYRIC-ACID; CENTRAL-NERVOUS-SYSTEM; CA3 PYRAMIDAL CELLS; RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; AREA CA1; DENDRITIC INHIBITION; GABAERGIC NEURONS; CEREBRAL-CORTEX	Release of GABA from the terminals of hippocampal inhibitory neurons is inhibited by activation of GABA(B) autoreceptors and mu opioid receptors. However, it is not known whether these presynaptic processes affect all inhibitory synapses equally. We examined the effects of the GABA(B) receptor agonist baclofen and the mu opioid receptor agonist DAGO on postsynaptic currents evoked by minimal stimulation of inhibitory fibers (meIPSCs) in area CA3. Baclofen reversibly depressed approximately half of the meIPSCs evoked in the stratum pyramidale. The remaining meIPSCs were unaffected despite a coincident depression of spontaneous IPSCs. In contrast, all meIPSCs were depressed by DAGO. In addition, minimal stimulation in the stratum radiatum evoked meIPSCs that were always depressed by baclofen. These results indicate that regulation of GABA release by GABA(B) autoreceptors occurs at a subset of inhibitory synapses and that GABA(B)-resistant inhibitory synapses are located on pyramidal neuron somata. Hippocampal inhibitory neurons may be heterogeneous with respect to presynaptic receptor-mediated regulation of GABA release.	VET ADM MED CTR,NEUROBIOL RES LAB,DURHAM,NC 27705	US Department of Veterans Affairs; Veterans Health Administration (VHA)	LAMBERT, NA (corresponding author), DUKE UNIV,DEPT PHARMACOL,DURHAM,NC 27710, USA.				NIMH NIH HHS [MH-15177-5] Funding Source: Medline; NINDS NIH HHS [NS-17771] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017771] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; AULT B, 1982, J PHARMACOL EXP THER, V223, P291; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; DANOS P, 1991, BRAIN RES, V546, P195, DOI 10.1016/0006-8993(91)91481-F; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; DOZE VA, 1991, NEURON, V6, P889, DOI 10.1016/0896-6273(91)90229-S; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; GULYAS AI, 1991, J COMP NEUROL, V312, P371, DOI 10.1002/cne.903120305; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; HARRISON NL, 1990, J PHYSIOL-LONDON, V422, P433, DOI 10.1113/jphysiol.1990.sp017993; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JOHNSTON D, 1983, J NEUROPHYSIOL, V50, P464, DOI 10.1152/jn.1983.50.2.464; KAWAGUCHI Y, 1987, BRAIN RES, V411, P190, DOI 10.1016/0006-8993(87)90700-1; KUNKEL DD, 1988, SYNAPSE, V2, P382, DOI 10.1002/syn.890020405; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; LACAILLE JC, 1989, HIPPOCAMPUS, P287; LAMBERT NA, 1991, EUR J PHARMACOL, V203, P129, DOI 10.1016/0014-2999(91)90801-V; LAMBERT NA, 1993, J NEUROPHYSIOL, V69, P630, DOI 10.1152/jn.1993.69.2.630; LAMBERT NA, 1991, J NEUROPHYSIOL, V66, P1538, DOI 10.1152/jn.1991.66.5.1538; LAMBERT NA, 1991, NEUROSCI LETT, V124, P101, DOI 10.1016/0304-3940(91)90831-D; LANTHORN TH, 1981, BRAIN RES, V225, P171, DOI 10.1016/0006-8993(81)90326-7; MADISON DV, 1988, J PHYSIOL-LONDON, V398, P123, DOI 10.1113/jphysiol.1988.sp017033; MAJOR G, 1993, BIOPHYS J, V65, P469, DOI 10.1016/S0006-3495(93)81039-7; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MOTT DD, 1990, NEUROSCI LETT, V110, P131, DOI 10.1016/0304-3940(90)90800-O; MOTT DD, 1991, SCIENCE, V252, P1718, DOI 10.1126/science.1675489; MOTT DD, 1993, J NEUROPHYSIOL, V69, P674, DOI 10.1152/jn.1993.69.3.674; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NATHAN T, 1991, J NEUROPHYSIOL, V66, P1704, DOI 10.1152/jn.1991.66.5.1704; NEWBERRY NR, 1985, J PHYSIOL-LONDON, V360, P161, DOI 10.1113/jphysiol.1985.sp015610; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; OTIS TS, 1992, J NEUROPHYSIOL, V67, P227, DOI 10.1152/jn.1992.67.1.227; OTIS TS, 1992, NEUROSCIENCE, V49, P13, DOI 10.1016/0306-4522(92)90073-B; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PEARCE RA, 1992, PHARM COMM, V2, P157; PITTALUGA A, 1987, EUR J PHARMACOL, V144, P45, DOI 10.1016/0014-2999(87)90007-0; POTIER B, 1993, EUR J PHARMACOL, V231, P427, DOI 10.1016/0014-2999(93)90120-7; REKLING JC, 1993, J NEUROSCI, V13, P1954; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHWARTZKROIN PA, 1978, BRAIN RES, V157, P1, DOI 10.1016/0006-8993(78)90991-5; SCHWARTZKROIN PA, 1985, J COMP NEUROL, V232, P205, DOI 10.1002/cne.902320206; SEGAL M, 1990, BRAIN RES, V511, P163, DOI 10.1016/0006-8993(90)90236-5; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SOMOGYI P, 1984, J NEUROSCI, V4, P2590; SOMOGYI P, 1983, J NEUROSCI, V3, P1450; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SUGITA S, 1992, NEUROSCI LETT, V134, P207, DOI 10.1016/0304-3940(92)90518-C; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; THOMPSON SM, 1992, J NEUROPHYSIOL, V67, P1698, DOI 10.1152/jn.1992.67.6.1698; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; YOON KW, 1991, J PHYSIOL-LONDON, V442, P377, DOI 10.1113/jphysiol.1991.sp018798	67	83	83	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1057	1067		10.1016/0896-6273(93)90219-H	http://dx.doi.org/10.1016/0896-6273(93)90219-H			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274277				2022-12-28	WOS:A1993MP54800007
J	BUCKANOVICH, RJ; POSNER, JB; DARNELL, RB				BUCKANOVICH, RJ; POSNER, JB; DARNELL, RB			NOVA, THE PARANEOPLASTIC RI ANTIGEN, IS HOMOLOGOUS TO AN RNA-BINDING PROTEIN AND IS SPECIFICALLY EXPRESSED IN THE DEVELOPING MOTOR SYSTEM	NEURON			English	Article							CANCER-ASSOCIATED RETINOPATHY; NEOPLASTIC CEREBELLAR DEGENERATION; NEUROTROPHIC FACTOR PREVENTS; EATON MYASTHENIC SYNDROME; NERVE GROWTH-FACTOR; MESSENGER-RNAS; FLOOR PLATE; CELL-DEATH; DROSOPHILA-MELANOGASTER; RETINAL DEGENERATION	Paraneoplastic opsoclonus-ataxia, a disorder of motor control, develops in breast or lung cancer patients who harbor an antibody (Ri) that recognizes their tumors and a nuclear neuronal protein of 55 kd. We have characterized a gene, Nova, encoding an antigen recognized by the Ri antibody. Nova encodes a novel, highly conserved protein, homologous to the RNA-binding protein hnRNP K, the yeast spicing protein MER1, and a motif in several retroviral proteases. Northern blot analysis detects Nova transcripts only in brain, and several alternatively spliced forms are present in brain and tumor cells. Nova expression is restricted to the ventral brain stem and spinal cord in E18 mice. Since Nova encodes a target antigen in the motor disorder paraneoplastic opsoclonus-ataxia that is expressed in the developing subcortical motor system, it is a likely participant in both the pathogenesis of paraneoplastic opsoclonus-ataxia and the developmental biology of the motor system. The homology between Nova and hnRNP K suggests that Nova regulates RNA splicing or metabolism in a specific subset of developing neurons.	MEM SLOAN KETTERING CANC CTR,DEPT NEUROL,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,COTZIAS LAB NEUROONCOL,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Cornell University	BUCKANOVICH, RJ (corresponding author), ROCKEFELLER UNIV,MOLEC NEUROONCOL LAB,NEW YORK,NY 10021, USA.		Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088	NINDS NIH HHS [NINDS NS 26064, 1 KO8 NS01461-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001461, R01NS026064] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; ANDERSON NE, 1988, ANN NEUROL, V24, P559, DOI 10.1002/ana.410240413; ANDERSON NE, 1988, MEDICINE, V67, P100, DOI 10.1097/00005792-198803000-00003; ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; BUDDESTEFFEN C, 1988, ANN NEUROL, V23, P528, DOI 10.1002/ana.410230518; CHIU IM, 1985, NATURE, V317, P366, DOI 10.1038/317366a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTENSEN ME, 1988, BIOCHEM BIOPH RES CO, V155, P1278, DOI 10.1016/S0006-291X(88)81279-8; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; CRENSHAW EB, 1987, CELL, V49, P389, DOI 10.1016/0092-8674(87)90291-1; CUNNINGHAM JM, 1985, J NEUROCHEM, V45, P159, DOI 10.1111/j.1471-4159.1985.tb05488.x; DALMAU J, 1992, MEDICINE, V71, P59, DOI 10.1097/00005792-199203000-00001; DALMAU J, 1990, ANN NEUROL, V27, P544, DOI 10.1002/ana.410270515; DARNELL RB, 1993, LANCET, V341, P21, DOI 10.1016/0140-6736(93)92485-C; DARNELL RB, 1991, J NEUROSCI, V11, P1224, DOI 10.1523/jneurosci.11-05-01224.1991; DARNELL RB, 1993, IN PRESS CURRENT DIA; DESPOSITO M, 1991, GENOMICS, V10, P43, DOI 10.1016/0888-7543(91)90482-T; DIGRE KB, 1986, ARCH NEUROL-CHICAGO, V43, P1165, DOI 10.1001/archneur.1986.00520110055016; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; DROPCHO EJ, 1987, P NATL ACAD SCI USA, V84, P4552, DOI 10.1073/pnas.84.13.4552; ENGEBRECHT J, 1991, CELL, V66, P1257, DOI 10.1016/0092-8674(91)90047-3; ENGEBRECHT J, 1990, MOL CELL BIOL, V10, P2379, DOI 10.1128/MCB.10.5.2379; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; FATHALLAHSHAYKH H, 1991, P NATL ACAD SCI USA, V88, P3451, DOI 10.1073/pnas.88.8.3451; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; GEADA AMC, 1992, DEVELOPMENT, V116, P497; GRAUS, 1993, NEUROSCI LETT, V150, P212; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; GREENBERG JM, 1990, NATURE, V344, P158, DOI 10.1038/344158a0; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HALL TC, 1974, PARANEOPLASTIC SYNDR, V230; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; JONES CW, 1991, GENETICS, V127, P535; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kingsbury BF, 1930, J COMP NEUROL, V50, P177, DOI 10.1002/cne.900500109; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; KLEIN ES, 1993, GENE DEV, V7, P55, DOI 10.1101/gad.7.1.55; KORNFELD K, 1989, GENE DEV, V3, P243, DOI 10.1101/gad.3.2.243; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LANG B, 1981, LANCET, V2, P224; LAUGHON A, 1985, COLD SPRING HARB SYM, V50, P253, DOI 10.1101/SQB.1985.050.01.032; LEM J, 1992, P NATL ACAD SCI USA, V89, P4422, DOI 10.1073/pnas.89.10.4422; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; LIGHT JD, 1990, NATURE, V346, P76; LUMSDEN A, 1991, CELL, V64, P471, DOI 10.1016/0092-8674(91)90226-O; LUQUE FA, 1991, ANN NEUROL, V29, P241, DOI 10.1002/ana.410290303; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; MOORE R, 1987, J VIROL, V61, P480, DOI 10.1128/JVI.61.2.480-490.1987; NAWA H, 1984, NATURE, V312, P729, DOI 10.1038/312729a0; NEWSOMDAVIS J, 1990, IMMUNOLOGIC MECHANIS; NISHI T, 1991, ONCOGENE, V6, P1555; NOMURA N, 1990, NUCLEIC ACIDS RES, V18, P3047, DOI 10.1093/nar/18.10.3047; ONEILL JH, 1988, BRAIN, V111, P577, DOI 10.1093/brain/111.3.577; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; PATRICK J, 1973, SCIENCE, V180, P821; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; PETRYNIAK B, 1990, P NATL ACAD SCI USA, V87, P1099, DOI 10.1073/pnas.87.3.1099; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; PLACZEK M, 1990, SCIENCE, V250, P985, DOI 10.1126/science.2237443; POLANS AS, 1991, J CELL BIOL, V112, P981, DOI 10.1083/jcb.112.5.981; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; POSNER JB, 1990, IMMUNOLOGIC MECHANIS; RICHTER K, 1990, New Biologist, V2, P556; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; ROSENFELD MR, 1993, ANN NEUROL, V33, P113, DOI 10.1002/ana.410330126; SAKAI K, 1990, ANN NEUROL, V28, P692, DOI 10.1002/ana.410280515; SCHAEFER M, 1985, CELL, V41, P457, DOI 10.1016/S0092-8674(85)80019-2; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shnider B I, 1979, Dis Mon, V25, P1, DOI 10.1016/S0011-5029(79)80013-9; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; SMITH JL, 1989, J EXP ZOOL, V250, P49, DOI 10.1002/jez.1402500107; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; SPRINGER JE, 1985, BRAIN RES BULL, V15, P629, DOI 10.1016/0361-9230(85)90212-6; STEPHENS RM, 1986, SCIENCE, V231, P589, DOI 10.1126/science.3003905; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; THAYER RM, 1987, VIROLOGY, V157, P317, DOI 10.1016/0042-6822(87)90274-1; THIRKILL CE, 1989, NEW ENGL J MED, V321, P1589, DOI 10.1056/NEJM198912073212307; THIRKILL CE, 1992, INVEST OPHTH VIS SCI, V33, P2768; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; WATTERSON RL, 1955, ANAT REC, V122, P539, DOI 10.1002/ar.1091220405; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P5339, DOI 10.1073/pnas.85.14.5339	107	260	269	2	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					657	672		10.1016/0896-6273(93)90077-5	http://dx.doi.org/10.1016/0896-6273(93)90077-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398153				2022-12-28	WOS:A1993MD06800010
J	RYAN, TA; REUTER, H; WENDLAND, B; SCHWEIZER, FE; TSIEN, RW; SMITH, SJ				RYAN, TA; REUTER, H; WENDLAND, B; SCHWEIZER, FE; TSIEN, RW; SMITH, SJ			THE KINETICS OF SYNAPTIC VESICLE RECYCLING MEASURED AT SINGLE PRESYNAPTIC BOUTONS	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; CULTURED HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; MEMBRANE; GLUTAMATE; PROTEINS; EXOCYTOSIS; CELLS	We used the fluorescent membrane probe FM 1-43 to label recycling synaptic vesicles within the presynaptic boutons of dissociated hippocampal neurons in culture. Quantitative time-lapse fluorescence imaging was employed in combination with rapid superfusion techniques to study the dynamics of synaptic vesicles within single boutons. This approach enabled us to measure exocytosis and to analyze the kinetics of endocytosis and the preparation of endocytosed vesicles for re-release (repriming). Our measurements indicate that under sustained membrane depolarization, endocytosis persists much longer than exocytosis, with a t1/2 almost-equal-to 60 s (approximately 24-degrees-C); once internalized, vesicles become reavailable for exocytosis in approximately 30 s. Furthermore, we have shown that endocytosis is not dependent on membrane potential and, unlike exocytosis, that it is independent of extracellular Ca2+.	UNIV BERN,DEPT PHARMACOL,CH-3010 BERN,SWITZERLAND	University of Bern	RYAN, TA (corresponding author), STANFORD UNIV,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548; Smith, Stephen/0000-0002-2290-8701	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067, R01NS028587] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS 24067, NS 28587] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; FORSCHER P, 1987, J NEUROSCI, V7, P3600; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JACOBSON K, 1987, ANNU REV PHYSIOL, V49, P163, DOI 10.1146/annurev.ph.49.030187.001115; Katz B., 1969, RELEASE NEURAL TRANS; KELLY RB, 1993, NEURON S, V10, P43; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V	27	451	457	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					713	724		10.1016/0896-6273(93)90081-2	http://dx.doi.org/10.1016/0896-6273(93)90081-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398156				2022-12-28	WOS:A1993MD06800014
J	FERNS, MJ; CAMPANELLI, JT; HOCH, W; SCHELLER, RH; HALL, Z				FERNS, MJ; CAMPANELLI, JT; HOCH, W; SCHELLER, RH; HALL, Z			THE ABILITY OF AGRIN TO CLUSTER ACHRS DEPENDS ON ALTERNATIVE SPLICING AND ON CELL-SURFACE PROTEOGLYCANS	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; FIBROBLAST GROWTH-FACTOR; HEPARAN-SULFATE; BASAL LAMINA; EXTRACELLULAR-MATRIX; MOTOR NEURONS; CULTURED MYOTUBES; DEVELOPING MUSCLE; MOLECULES; PROTEINS	Agrin, which induces acetylcholine receptor (AChR) clustering at the developing neuromuscular synapse, occurs in multiple forms generated by alternative splicing. Some of these isoforms are specific to the nervous system; others are expressed in both neural and nonneural tissues, including muscle. We have compared the AChR clustering activity of agrin forms varying at each of the three identified splicing sites, denoted x, y, and z. Agrin isoforms were assayed by applying either transfected COS cells, with agrin bound to their surfaces, or soluble agrin to myotubes of the C2 muscle line, or of two variant lines having defective proteoglycans. Dramatic differences in activity were seen between z site isoforms and lesser differences between y site isoforms. The most active agrin forms contained splicing inserts of 4 amino acids at the y site and 8 amino acids at the z site. These forms are found exclusively in neural tissue. All forms were active on C2 myotubes in cell-attached assays, but muscle forms were less active than neural forms. AChR clustering activity of all agrin forms was decreased when assayed on the proteoglycan-deficient lines, suggesting that proteoglycans may help mediate the action of agrin. As neural agrin forms are more active than muscle forms, they are likely to play a primary role in synaptogenesis.	STANFORD UNIV,HOWARD HUGHES MED INST,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University	FERNS, MJ (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.			Ferns, Michael/0000-0002-1545-3024	NIGMS NIH HHS [GM07276] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CAMPANELLI JT, 1993, COLD SPRING HARB SYM, V57, P461; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; GORDON H, 1993, J NEUROSCI, V13, P586; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; HIRANO Y, 1989, J NEUROSCI, V9, P1555; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F; LIETH E, 1993, IN PRESS J NEUROSCI; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; NGSEE JK, 1990, GENE, V86, P251, DOI 10.1016/0378-1119(90)90286-Z; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	37	277	279	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					491	502		10.1016/0896-6273(93)90153-I	http://dx.doi.org/10.1016/0896-6273(93)90153-I			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398142				2022-12-28	WOS:A1993LY49800009
J	YAN, YM; LAGENAUR, C; NARAYANAN, V				YAN, YM; LAGENAUR, C; NARAYANAN, V			MOLECULAR-CLONING OF M6 - IDENTIFICATION OF A PLP/DM20 GENE FAMILY	NEURON			English	Article							MYELIN PROTEOLIPID PROTEIN; CENTRAL NERVOUS-SYSTEM; WHITE MATTER; CELL-DEATH; BRAIN; HYBRIDIZATION; MUTATION; SEQUENCE; NEURONS; MOUSE	M6 is a membrane glycoprotein that is expressed on central neurons and certain polarized epithelia from early developmental stage. Antibodies against M6 interfere with cerebellar neurite outgrowth in vitro. Two closely related cDNAs were obtained by expression cloning, both of which showed high homology with the major CNS myelin protein PLP/DM20. Although M6 and PLP/DM20 share many molecular characteristics, in situ hybridization revealed nonoverlapping distributions of their mRNAs in mouse CNS. The identification of a gene family including neuron-specific M6 and glia-specific PLP/DM20 in CNS suggests a broader functional role for these molecules than myelination.	CHILDRENS HOSP, DEPT PEDIAT, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	YAN, YM (corresponding author), UNIV PITTSBURGH, SCH MED, DEPT NEUROBIOL, PITTSBURGH, PA 15261 USA.			Narayanan, Vinodh/0000-0002-0658-3847	NINDS NIH HHS [CIDA-NS 01282] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001282] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; CAMPAGNONI AT, 1988, J NEUROCHEM, V51, P1, DOI 10.1111/j.1471-4159.1988.tb04827.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P8; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HELYNCK G, 1983, EUR J BIOCHEM, V133, P689, DOI 10.1111/j.1432-1033.1983.tb07518.x; HENIKOFF S, 1984, GENE, V28, P357; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; INOUYE H, 1991, J NEUROSCI RES, V28, P1, DOI 10.1002/jnr.490280102; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KNAPP PE, 1986, J NEUROSCI, V6, P2813; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LARMET Y, 1992, NEURON, V9, P563, DOI 10.1016/0896-6273(92)90193-H; Lees M.B., 1984, PROTEINS MYELIN, P197; LEES MB, 1983, ARCH BIOCHEM BIOPHYS, V226, P643, DOI 10.1016/0003-9861(83)90334-X; LIN LFH, 1982, P NATL ACAD SCI-BIOL, V79, P941, DOI 10.1073/pnas.79.3.941; LUND RD, 1986, J COMP NEUROL, V247, P439, DOI 10.1002/cne.902470404; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERITY AN, 1988, J NEUROSCI RES, V21, P238, DOI 10.1002/jnr.490210216; WAEHNELDT TV, 1987, COMP BIOCHEM PHYS B, V88, P1209, DOI 10.1016/0305-0491(87)90025-3; WAEHNELDT TV, 1990, ANN NY ACAD SCI, V605, P15, DOI 10.1111/j.1749-6632.1990.tb42377.x	37	133	138	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP	1993	11	3					423	431		10.1016/0896-6273(93)90147-J	http://dx.doi.org/10.1016/0896-6273(93)90147-J			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398137				2022-12-28	WOS:A1993LY49800003
J	Coburn, CM; Bargmann, CI				Coburn, CM; Bargmann, CI			A putative cyclic nucleotide-gated channel is required for sensory development and function in C-elegans	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; OLFACTORY RECEPTOR-CELLS; CHEMOSENSORY NEURONS; MOLECULAR MECHANISM; ROD PHOTORECEPTOR; EXPRESSION; MUTANTS; SUBUNIT; CAMP; CONDUCTANCE	In vertebrate visual and olfactory systems, a cyclic nucleotide-gated channel couples receptor activation to electrical activity of the sensory neurons. The Caenorhabditis elegans tax-2 gene is required for some farms of olfaction, for chemosensation of salts, and for thermosensation. We show here that tax-2 encodes a predicted subunit of a cyclic nucleotide-gated channel that is expressed in olfactory, gustatory, and thermosensory neurons, implicating this channel in multiple sensory modalities. Some sensory neurons display axon outgrowth defects in tax-2 mutants. Thus, the channel has an unexpected role in sensory neuron development in addition to its role in sensation. Consistent with this proposed dual function, a Tax-2::GFP fusion protein is present both in sensory cilia and in sensory axons.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,GENET PROGRAM,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Coburn, CM (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT ANAT,PROGRAM DEV BIOL,SAN FRANCISCO,CA 94143, USA.			Bargmann, Cornelia/0000-0002-8484-0618	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001393] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC01393] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AHMAD I, 1994, NEURON, V12, P155, DOI 10.1016/0896-6273(94)90160-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AVENET P, 1988, J MEMBRANE BIOL, V105, P245, DOI 10.1007/BF01871001; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; BRENNER S, 1974, GENETICS, V77, P71; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DUBIN AE, 1994, J GEN PHYSIOL, V103, P181, DOI 10.1085/jgp.103.2.181; DUSENBERY DB, 1975, GENETICS, V80, P297; ELHUSSEINI AED, 1995, NEUROREPORT, V6, P1459, DOI 10.1097/00001756-199507100-00024; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; HERMAN RK, 1990, NATURE, V348, P169, DOI 10.1038/348169a0; HIRAOKA Y, 1990, BIOPHYS J, V57, P325, DOI 10.1016/S0006-3495(90)82534-0; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEIN RD, 1993, CELL, V72, P349, DOI 10.1016/0092-8674(93)90113-5; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHACHER S, 1993, NEURON, V10, P1079, DOI 10.1016/0896-6273(93)90056-W; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; STRYER L, 1991, J BIOL CHEM, V266, P10711; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; VOWELS JJ, 1994, GENETICS, V138, P303; WANG BB, 1993, CELL, V74, P29, DOI 10.1016/0092-8674(93)90292-X; WANG T, 1995, NATURE, V374, P262, DOI 10.1038/374262a0; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; YAO XQ, 1995, P NATL ACAD SCI USA, V92, P11711, DOI 10.1073/pnas.92.25.11711; ZHONG Y, 1992, J NEUROSCI, V12, P644	62	327	336	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					695	706		10.1016/S0896-6273(00)80201-9	http://dx.doi.org/10.1016/S0896-6273(00)80201-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893026	Bronze			2022-12-28	WOS:A1996VP74300014
J	Mochida, S; Sheng, ZH; Baker, C; Kobayashi, H; Catterall, WA				Mochida, S; Sheng, ZH; Baker, C; Kobayashi, H; Catterall, WA			Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels	NEURON			English	Article							RAT SYMPATHETIC NEURONS; SENSITIVE CALCIUM-CHANNEL; TRANSMITTER RELEASE; ACETYLCHOLINE-RELEASE; SYNTAXIN; SYNAPTOTAGMIN; EXOCYTOSIS; SYNAPSES; IDENTIFICATION; COMPLEX	N-type Ca2+ channels bind directly to the synaptic core complex of VAMP/synaptobrevin, syntaxin, and SNAP-25. Peptides containing the synaptic protein interaction (''synprint'') site caused dissociation of N-type Ca2+ channels from the synaptic core complex. Introduction of synprint peptides into presynaptic superior cervical ganglion neurons reversibly inhibited synaptic transmission. Fast EPSPs due to synchronous transmitter release were inhibited, while late EPSPs arising from asynchronous release following a train of action potentials were increased and paired-pulse facilitation was increased. The corresponding peptides from L-type Ca2+ channels had no effect, and the N-type peptides had no effect on Ca2+ currents through N-type Ca2+ channels. These results are consistent with the hypothesis that binding of the synaptic core complex to presynaptic N-type Ca2+ channels is required for Ca2+ influx to elicit rapid, synchronous neurotransmitter release.	UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	Mochida, S (corresponding author), TOKYO MED COLL,DEPT PHYSIOL,TOKYO 160,JAPAN.				NINDS NIH HHS [NS22625] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; INOUE A, 1992, J BIOL CHEM, V267, P10613; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MALLART A, 1968, J PHYSIOL-LONDON, V196, P593, DOI 10.1113/jphysiol.1968.sp008525; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MOCHIDA S, 1995, NEUROSCIENCE, V65, P905, DOI 10.1016/0306-4522(94)00508-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; MOCHIDA S, 1996, IN PRESS NEUROSCIENC; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; OLAGUE PH, 1974, P NATL ACAD SCI USA, V71, P3602, DOI 10.1073/pnas.71.9.3602; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SAISU H, 1991, BIOCHEM BIOPH RES CO, V181, P59, DOI 10.1016/S0006-291X(05)81381-6; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WAKSHULL E, 1979, J NEUROPHYSIOL, V42, P1410, DOI 10.1152/jn.1979.42.5.1410; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WU LG, 1994, J NEUROSCI, V14, P5613; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	40	229	238	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					781	788		10.1016/S0896-6273(00)80209-3	http://dx.doi.org/10.1016/S0896-6273(00)80209-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893034	Bronze			2022-12-28	WOS:A1996VP74300022
J	Hu, HY; Tomasiewicz, H; Magnuson, T; Rutishauser, U				Hu, HY; Tomasiewicz, H; Magnuson, T; Rutishauser, U			The role of polysialic acid in migration of olfactory bulb interneuron precursors in the subventricular zone	NEURON			English	Article							SUBEPENDYMAL LAYER; CELL-MIGRATION; GRANULE CELLS; NEUROGENESIS; BRAIN; NCAM; RAT; ADHESION	Transplantation studies have been used to show that tangential migration of olfactory bulb interneuron precursors is retarded in NCAM-mutant mice, and that this defect reflects loss of NCAM polysialic acid (PSA). In contrast, radial migration of cells within the bulb did not require PSA. Reciprocal transplantations between wild-type and mutant mice have revealed that the mutation affects the in vivo migration environment in the subventricular zone, and not movement of individual cells. However, in vitro migration of the cells into a PSA-negative collagen matrix environment was also PSA-dependent. The surprisingly similar results obtained in the in vivo and in vitro environments is consistent with the observation that migration of subventricular cells occurs as streams of closely apposed cells in which the PSA-positive cells appear to serve as their own migration substrate.	CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University	Hu, HY (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106, USA.				NICHD NIH HHS [HD26722, HD18369] Funding Source: Medline; NINDS NIH HHS [NS32779] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R01HD026722, R37HD018369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS032779] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALCARAZ G, 1991, EUR J CELL BIOL, V55, P165; ALTMAN J, 1966, J COMP NEUROL, V127, P337; BAYER SA, 1983, EXP BRAIN RES, V50, P329; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; FREDETTE B, 1993, J CELL BIOL, V123, P1867, DOI 10.1083/jcb.123.6.1867; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; PRICE JL, 1970, J CELL SCI, V7, P91; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; Rutishauser U., 1992, DEVELOPMENT S, V116, P99; RUTISHAUSER U, 1992, POLYSIALIC ACID, P215; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J	30	314	326	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					735	743		10.1016/S0896-6273(00)80094-X	http://dx.doi.org/10.1016/S0896-6273(00)80094-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607992	Bronze			2022-12-28	WOS:A1996UG61100007
J	Premkumar, LS; Auerbach, A				Premkumar, LS; Auerbach, A			Identification of a high affinity bivalent cation binding site near the entrance of the NMDA receptor channel	NEURON			English	Article							MOUSE CENTRAL NEURONS; D-ASPARTATE RECEPTOR; CALCIUM PERMEABILITY; ACTIVATED CHANNELS; DIVALENT-CATIONS; ION PERMEATION; GLUTAMATE; CELLS; BLOCK; HIPPOCAMPUS	Single channel currents from recombinant N-methyl-D-aspartate (NMDA) receptors having an N-to-Q mutation in M2 reveal a divalent cation binding site that is near the entrance of the pore (similar to 0.2 through the electric field). Ca2+ rapidly binds to this site and readily permeates the channel, while Mg2+ binds more slowly and does not permeate as readily. In wild-type receptors, Mg2+ also blocks the current by occupying a site that is similar to 0.6 through the field. When the more external site is occupied by Ca2+, the conductance of the pore to Na+ is reduced but not abolished, perhaps by an electrostatic blocking mechanism. The site serves to enrich the fraction of NMDA receptor current carried by Ca2+.			Premkumar, LS (corresponding author), SUNY BUFFALO, DEPT BIOPHYS SCI, BUFFALO, NY 14214 USA.							ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; BUTLER JN, 1968, BIOPHYS J, V8, P1426, DOI 10.1016/S0006-3495(68)86564-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHUNG SH, 1990, PHILOS T R SOC B, V329, P265, DOI 10.1098/rstb.1990.0170; CONSTANTINEPATON M, 1990, COLD SPRING HARB SYM, V55, P431; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; Hille B., 1992, IONIC CHANNELS EXCIT; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JAHR CE, 1993, P NATL ACAD SCI USA, V90, P11573, DOI 10.1073/pnas.90.24.11573; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACONOCHIE DJ, 1989, PFLUG ARCH EUR J PHY, V414, P589, DOI 10.1007/BF00580996; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NAKAZAWA K, 1993, J GEN PHYSIOL, V101, P377, DOI 10.1085/jgp.101.3.377; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PAOLETTI P, 1995, NEURON, V15, P1109, DOI 10.1016/0896-6273(95)90099-3; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; RUPPERSBERG JP, 1993, BIOCHEM PHARMACOL, V46, P1877, DOI 10.1016/0006-2952(93)90627-9; SAKURADA K, 1993, J BIOL CHEM, V268, P410; SCHILD L, 1994, BIOPHYS J, V66, P654, DOI 10.1016/S0006-3495(94)80839-2; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; STERN P, 1992, P ROY SOC B-BIOL SCI, V250, P271, DOI 10.1098/rspb.1992.0159; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; ZAREI MM, 1994, J GEN PHYSIOL, V103, P231, DOI 10.1085/jgp.103.2.231; ZAREI MM, 1995, J NEUROSCI, V15, P1446	41	80	80	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					869	880		10.1016/S0896-6273(00)80107-5	http://dx.doi.org/10.1016/S0896-6273(00)80107-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608005	Bronze			2022-12-28	WOS:A1996UG61100020
J	Tear, G; Harris, R; Sutaria, S; Kilomanski, K; Goodman, CS; Seeger, MA				Tear, G; Harris, R; Sutaria, S; Kilomanski, K; Goodman, CS; Seeger, MA			commissureless controls growth cone guidance across the CNS midline in Drosophila and encodes a novel membrane protein	NEURON			English	Article							PIONEER AXON MIGRATIONS; CENTRAL-NERVOUS-SYSTEM; C-ELEGANS; FLOOR PLATE; ESCHERICHIA-COLI; SPINAL-CORD; GUIDES CELL; GENES; EXPRESSION; PURIFICATION	The commissureless (comm) gene was identified previously in a large-scale screen for mutations that disrupt CNS axon pathways in Drosophila. The comm gene has a unique mutant phenotype: the complete absence of most axon commissures, while midline cells and other aspects of CNS fate and patterning are left unchanged. Here, we report on the molecular cloning, characterization, and expression of the comm gene. comm encodes a novel protein of 370 amino acids that lacks a signal sequence, has a transmembrane domain, and biochemically copurifies with membranes. COMM mRNA and COMM protein are dynamically expressed during embryogenesis, including by CNS midline glia during the formation of the axon commissures. Anti-COMM antibodies reveal strong staining of organelles likely to include the Golgi complex and endosomes and weaker staining of the cell surface. As commissural growth cones contact and traverse the CNS midline, COMM protein is apparently transferred from midline glia to commissural axons.	OKLAHOMA MED RES FDN, CELL & MOLEC BIOL PROGRAM, OKLAHOMA CITY, OK 73104 USA	Oklahoma Medical Research Foundation	Tear, G (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOLEC & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA.		Tear, Guy/C-5444-2009		NINDS NIH HHS [NS 32839, NS 18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366, R29NS032839, R01NS032839] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; CAMPBELL RM, 1993, DEVELOPMENT, V119, P1217; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Harlow E., 1988, ANTIBODIES LAB MANUA; HARRISONLAVOIE KJ, 1993, EMBO J, V12, P2847, DOI 10.1002/j.1460-2075.1993.tb05946.x; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HORTSCH M, 1994, METHOD CELL BIOL, V44, P289, DOI 10.1016/S0091-679X(08)60920-6; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; JACOBS JR, 1989, J NEUROSCI, V9, P2412; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MARSHALL BA, 1993, J BIOL CHEM, V268, P26193; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MCKANNA JA, 1989, SCIENCE, V243, P1477, DOI 10.1126/science.2928781; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PARKS AL, 1995, MECH DEVELOP, V50, P201, DOI 10.1016/0925-4773(94)00336-L; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PERIN MS, 1991, J BIOL CHEM, V266, P623; RESTIFO LL, 1986, J MOL BIOL, V188, P517, DOI 10.1016/S0022-2836(86)80002-X; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; RIPOCHE J, 1994, P NATL ACAD SCI USA, V91, P1878, DOI 10.1073/pnas.91.5.1878; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOH S, 1993, J BIOL CHEM, V268, P17820; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMOLLER DA, 1991, CHROMOSOMA, V100, P487, DOI 10.1007/BF00352199; SPINDLER KR, 1984, J VIROL, V49, P132, DOI 10.1128/JVI.49.1.132-141.1984; SWANSON J, 1989, METHOD CELL BIOL, V29, P137; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	56	213	216	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1996	16	3					501	514		10.1016/S0896-6273(00)80070-7	http://dx.doi.org/10.1016/S0896-6273(00)80070-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785048	Bronze			2022-12-28	WOS:A1996UC16800007
J	Gurnett, CA; DeWaard, M; Campbell, KP				Gurnett, CA; DeWaard, M; Campbell, KP			Dual function of the voltage-dependent Ca2+ channel alpha(2)delta subunit in current stimulation and subunit interaction	NEURON			English	Article							SENSITIVE CALCIUM-CHANNEL; MUSCLE DIHYDROPYRIDINE RECEPTOR; SKELETAL-MUSCLE; 1,4-DIHYDROPYRIDINE RECEPTOR; STRUCTURAL CHARACTERIZATION; BETA-SUBUNIT; EXPRESSION; BRAIN; PURIFICATION; DELTA	Voltage-dependent Ca2+ channels are modulated by complex interactions with the alpha(2) delta subunit. In vitro translation was used to demonstrate a single transmembrane topology of the alpha(2) delta subunit in which all but the transmembrane sequence and 5 carboxy-terminal amino acids are extracellular. The glycosylated extracellular domain is required for current stimulation, as shown by coexpression of truncated alpha(2) delta subunits with alpha(1A) and beta(4) subunits in Xenopus oocytes and deglycosylation with peptide-N-glycosidase F. However, coexpression of the transmembrane domain-containing delta subunit reduced the stimulatory effects of full-length alpha(2) delta subunits and substitution of a different transmembrane domain resulted in a loss of current stimulation. These results support a model whereby the alpha(2) delta transmembrane domain mediates subunit interactions and the glycosylated extracellular domain enhances current amplitude.			Gurnett, CA (corresponding author), UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,HOWARD HUGHES MED INST,IOWA CITY,IA 52242, USA.		De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Campbell, Kevin/0000-0003-2066-5889; Gurnett, Christina/0000-0001-9129-315X				BAMBERG K, 1994, J BIOL CHEM, V269, P16909; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BRICKLEY K, 1995, FEBS LETT, V364, P129, DOI 10.1016/0014-5793(95)00371-F; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; CHEN C, 1996, IN PRESS PFLUGERS AR; COOPER CL, 1987, J BIOL CHEM, V262, P509; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; GURNETT CA, 1995, J BIOL CHEM, V270, P9035, DOI 10.1074/jbc.270.16.9035; HAMRICK M, 1993, J BIOL CHEM, V268, P24367; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAY SD, 1991, J BIOL CHEM, V266, P3287; KIM HL, 1992, P NATL ACAD SCI USA, V89, P3251, DOI 10.1073/pnas.89.8.3251; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SCHWALBE RA, 1995, J BIOL CHEM, V270, P15336, DOI 10.1074/jbc.270.25.15336; SHARP AH, 1987, J BIOL CHEM, V262, P12309; SKACH WR, 1993, J BIOL CHEM, V268, P6903; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TAM LY, 1994, J BIOL CHEM, V269, P32542; TANABE T, 1990, NATURE, V346, P467; TOKUMARU H, 1992, EUR J PHARM-MOLEC PH, V227, P363, DOI 10.1016/0922-4106(92)90152-L; WIERZBICKI AS, 1993, ANN NY ACAD SCI, V681, P422, DOI 10.1111/j.1749-6632.1993.tb22926.x; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754	45	234	245	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					431	440		10.1016/S0896-6273(00)80061-6	http://dx.doi.org/10.1016/S0896-6273(00)80061-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789958	Bronze			2022-12-28	WOS:A1996TW95700023
J	Nakao, K; CamposOrtega, JA				Nakao, K; CamposOrtega, JA			Persistent expression of genes of the Enhancer of split complex suppresses neural development in Drosophila	NEURON			English	Article							EARLY NEUROGENESIS; NERVOUS-SYSTEM; NEUROBLAST SEGREGATION; ADJACENT GENES; PRONEURAL GENE; MOTHER CELLS; SCUTE GENES; WING DISK; MELANOGASTER; ACHAETE	The segregation of neural and epidermal progenitors in Drosophila requires the activity of transcription factors encoded by the proneural genes and the genes of the E(SPL)-C. Persistent expression of two genes of the E(SPL)-C suppresses neural development. Embryos exhibit conspicuous central neural hypoplasia and lack sensory organs; imaginal sensory organs are also affected. Suppression of neural development is associated with suppression of the activity of proneural genes. DNA binding is not essential for this effect. Large cells with characteristics of neuroblasts segregate normally in embryos, but these cells fail to express various markers, and the segregated cells and/or their progeny eventually die. These findings indicate that proneural and E(spl) proteins exert antagonistic functions.			Nakao, K (corresponding author), UNIV COLOGNE, INST ENTWICKLUNGSBIOL, D-50923 COLOGNE, GERMANY.							ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ALBERGA A, 1991, DEVELOPMENT, V111, P983; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; BRAND M, 1988, ROUX ARCH DEV BIOL, V197, P457, DOI 10.1007/BF00385679; CABRERA CV, 1987, CELL, V50, P425, DOI 10.1016/0092-8674(87)90496-X; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1992, ROUX ARCH DEV BIOL, V201, P1, DOI 10.1007/BF00188770; CAMPOSORTEGA JA, 1993, DEV DROSOPHILA; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CRONMILLER C, 1993, MECH DEVELOP, V42, P159, DOI 10.1016/0925-4773(93)90005-I; DEDIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731; DELACONCHA A, 1988, GENETICS, V118, P499; DOE CQ, 1992, DEVELOPMENT, V116, P855; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; HARTENSTEIN V, 1994, DEV BIOL, V165, P480, DOI 10.1006/dbio.1994.1269; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; HUANG F, 1991, DEVELOPMENT, V111, P1087; IP YT, 1994, DEVELOPMENT, V120, P199; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; JIMENEZ F, 1990, NEURON, V5, P81, DOI 10.1016/0896-6273(90)90036-F; JIMENEZ F, 1979, NATURE, V282, P310, DOI 10.1038/282310a0; JIMENEZ F, 1987, J NEUROGENET, V4, P179, DOI 10.3109/01677068709102340; JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1987, EMBO J, V6, P4113, DOI 10.1002/j.1460-2075.1987.tb02757.x; KNUST E, 1992, GENETICS, V132, P505; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; LEHMANN R, 1981, ROUX ARCH DEV BIOL, V190, P226, DOI 10.1007/BF00848307; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; OHSAKO S, 1994, GENE DEV, V8, P2743, DOI 10.1101/gad.8.22.2743; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; RUIZGOMEZ M, 1993, EMBO J, V12, P1121, DOI 10.1002/j.1460-2075.1993.tb05753.x; SCHRONS H, 1992, GENETICS, V132, P481; SHEPARD SB, 1989, GENETICS, V122, P429; SIMPSON P, 1990, TRENDS GENET, V6, P343, DOI 10.1016/0168-9525(90)90260-D; SINGSON A, 1994, GENE DEV, V8, P2058, DOI 10.1101/gad.8.17.2058; SKEATH JB, 1994, DEVELOPMENT, V120, P1517; SKEATH JB, 1992, DEVELOPMENT, V114, P939; SKEATH JB, 1992, GENE DEV, V6, P2606, DOI 10.1101/gad.6.12b.2606; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TIETZE K, 1992, P NATL ACAD SCI USA, V89, P6152, DOI 10.1073/pnas.89.13.6152; TREACY MN, 1992, CELL, V68, P491, DOI 10.1016/0092-8674(92)90186-G; USUI K, 1992, DEVELOPMENT, V116, P601; VAESSIN H, 1994, DEVELOPMENT, V120, P935; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; VANDOREN M, 1994, GENE DEV, V8, P2729, DOI 10.1101/gad.8.22.2729; WHITE K, 1980, DEV BIOL, V80, P332, DOI 10.1016/0012-1606(80)90409-1; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	59	115	116	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					275	286		10.1016/S0896-6273(00)80046-X	http://dx.doi.org/10.1016/S0896-6273(00)80046-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789943	Bronze			2022-12-28	WOS:A1996TW95700008
J	Blitzer, RD; Wong, T; Nouranifar, R; Iyengar, R; Landau, EM				Blitzer, RD; Wong, T; Nouranifar, R; Iyengar, R; Landau, EM			Postsynaptic cAMP pathway gates early LTP in hippocampal CA1 region	NEURON			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CALMODULIN-BINDING; ADENYLYL-CYCLASE; MICROCYSTIN-LR; NMDA RECEPTORS; AREA CA1; INHIBITION; CALCIUM; PHOSPHORYLATION	The role of the cAMP pathway in LTP was studied in the CAI region of hippocampus. Widely spaced trains of high frequency stimulation generated cAMP postsynaptically via NMDA receptors and calmodulin, consistent with the Ca2+/calmodulin-mediated stimulation of postsynaptic adenylyl cyclase. The early phase of LTP produced by the same pattern of high frequency stimulation was dependent an postsynaptic cAMP, However, synaptic transmission was not increased by postsynaptic application of cAMP. Early LTP became cAMP-independent when protein phosphatase inhibitors were injected postsynaptically. These observations indicate that in early LTP the cAMP signaling pathway, instead of transmitting signals for the generation of LTP, gates LTP through postsynaptic protein phosphatases.	CUNY MT SINAI SCH MED,DEPT PHARMACOL,NEW YORK,NY 10029; VET ADM MED CTR,PSYCHIAT SERV,BRONX,NY 10468	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Blitzer, RD (corresponding author), CUNY MT SINAI SCH MED,DEPT PSYCHIAT,NEW YORK,NY 10029, USA.				NATIONAL CANCER INSTITUTE [R01CA044998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038761] Funding Source: NIH RePORTER; NCI NIH HHS [CA44998] Funding Source: Medline; NIDDK NIH HHS [DK38761] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; BLAIR SS, 1995, NATURE, V373, P656, DOI 10.1038/373656a0; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLITZER RD, 1994, BRAIN RES, V646, P312, DOI 10.1016/0006-8993(94)90096-5; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CARR DW, 1992, J BIOL CHEM, V267, P16816; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; DOSEMECI A, 1993, J NEUROCHEM, V61, P550; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HAVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761; HOFMANN F, 1985, EUR J BIOCHEM, V150, P85, DOI 10.1111/j.1432-1033.1985.tb08991.x; HONKANEN RE, 1990, J BIOL CHEM, V265, P19401; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; INGLEBRITTSEN TS, 1982, SCIENCE, V221, P331; IYENGAR R, 1993, FASEB J, V7, P768, DOI 10.1096/fasebj.7.9.8330684; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; KELLY PT, 1988, P NATL ACAD SCI USA, V85, P4991, DOI 10.1073/pnas.85.14.4991; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; KENNEDY MB, 1983, P NATL ACAD SCI USA, V80, P945; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MONS N, 1995, IN PRESS P NATL ACAD; MULKEY RM, 1994, NATURE, V369, P488; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NISHIWAKI S, 1990, CARCINOGENESIS, V11, P1837, DOI 10.1093/carcin/11.10.1837; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; PITTALUGA A, 1990, EUR J PHARMACOL, V191, P231, DOI 10.1016/0014-2999(90)94153-O; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SHINOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STONE EA, 1990, BRAIN RES, V530, P295, DOI 10.1016/0006-8993(90)91298-U; THIEMANN W, 1986, BRAIN RES BULL, V17, P1, DOI 10.1016/0361-9230(86)90154-1; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P20; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	70	258	263	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1403	1414		10.1016/0896-6273(95)90018-7	http://dx.doi.org/10.1016/0896-6273(95)90018-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845163	Bronze			2022-12-28	WOS:A1995TL67800018
J	THOMPSON, RC; MANSOUR, A; AKIL, H; WATSON, SJ				THOMPSON, RC; MANSOUR, A; AKIL, H; WATSON, SJ			CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A RAT MU-OPIOID RECEPTOR	NEURON			English	Article							INHIBIT ADENYLATE-CYCLASE; SITE-DIRECTED ALKYLATION; KAPPA-OPIATE AGONISTS; NALORPHINE-LIKE DRUGS; CHRONIC SPINAL DOG; BINDING-SITES; HIGH-AFFINITY; HETEROLOGOUS DESENSITIZATION; EXPRESSION CLONING; MORPHINE-LIKE	We have isolated a rat cDNA clone that displays 75% amino acid homology with the mouse delta and rat kappa opioid receptors. The cDNA (designated pRMuR-12) encodes a protein of 398 amino acids comprising, in part, seven hydrophobic domains similar to those described for other G protein-linked receptors. Data from binding assays conducted with COS-1 cells transiently transfected with a CMV mammalian expression vector containing the full coding region of pRMuR-12 demonstrated mu receptor selectivity. In situ hybridization mRNA analysis revealed an mRNA distribution in rat brain that corresponds well to the distribution of binding sites labeled with mu-selective ligands. Based upon these observations, we conclude that pRMuR-12 encodes a mu opioid receptor.			THOMPSON, RC (corresponding author), UNIV MICHIGAN, MENTAL HLTH RES INST, ANN ARBOR, MI 48109 USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002265] Funding Source: NIH RePORTER; NIADDK NIH HHS [P30-AM34933] Funding Source: Medline; NIDA NIH HHS [NIDA RO1 DA02265] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ATTALI B, 1989, J NEUROCHEM, V52, P360, DOI 10.1111/j.1471-4159.1989.tb09130.x; BARCHFELD CC, 1984, BIOCHEM BIOPH RES CO, V121, P641, DOI 10.1016/0006-291X(84)90230-4; BESSE D, 1990, BRAIN RES, V521, P15, DOI 10.1016/0006-8993(90)91519-M; BESSE D, 1991, BRAIN RES, V548, P287, DOI 10.1016/0006-8993(91)91134-M; BIDLACK JM, 1980, LIFE SCI, V27, P331, DOI 10.1016/0024-3205(80)90201-5; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN C, 1993, MOL CELL BIOL, V44, P8; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CHO TM, 1981, LIFE SCI, V28, P2651, DOI 10.1016/0024-3205(81)90723-2; CHO TM, 1986, P NATL ACAD SCI USA, V83, P4138, DOI 10.1073/pnas.83.12.4138; CHOW T, 1983, MOL PHARMACOL, V24, P203; CLARK RB, 1989, MOL PHARMACOL, V36, P343; DEMOLIOUMASON CD, 1984, FEBS LETT, V170, P378, DOI 10.1016/0014-5793(84)81348-4; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; GILBERT PE, 1976, J PHARMACOL EXP THER, V198, P66; GILLAN MGC, 1982, BRIT J PHARMACOL, V77, P461, DOI 10.1111/j.1476-5381.1982.tb09319.x; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; GOLDSTEIN A, 1984, MOL PHARMACOL, V25, P343; HERLING S, 1981, LIFE SCI, V28, P1571, DOI 10.1016/0024-3205(81)90311-8; HOWELLS RD, 1982, J PHARMACOL EXP THER, V222, P629; HSIA JA, 1984, J BIOL CHEM, V259, P1086; IYENGAR S, 1986, LIFE SCI, V39, P637, DOI 10.1016/0024-3205(86)90045-7; JAMES IF, 1984, MOL PHARMACOL, V25, P337; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; LEANDER JD, 1985, J PHARMACOL EXP THER, V234, P463; LUTZ RA, 1992, J RECEPTOR RES, V12, P267, DOI 10.3109/10799899209074796; MANECKJEE R, 1985, P NATL ACAD SCI USA, V82, P594, DOI 10.1073/pnas.82.2.594; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MANSOUR A, 1993, ANATOMICAL DISTRIBUT; MANZANARES J, 1990, NEUROENDOCRINOLOGY, V52, P200, DOI 10.1159/000125582; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MCLEAN S, 1986, BRAIN RES, V378, P49, DOI 10.1016/0006-8993(86)90285-4; MENG F, 1993, IN PRESS P NATL ACAD; MORLEY JE, 1983, PEPTIDES, V4, P797, DOI 10.1016/0196-9781(83)90069-4; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NOCK B, 1988, EUR J PHARMACOL, V154, P27, DOI 10.1016/0014-2999(88)90359-7; PASTERNAK GW, 1986, LIFE SCI, V38, P1889, DOI 10.1016/0024-3205(86)90217-1; PASTERNAK GW, 1975, NATURE, V253, P563, DOI 10.1038/253563a0; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; PUTTFARCKEN PS, 1988, MOL PHARMACOL, V33, P520; ROCHE PC, 1992, ENDOCRINOLOGY, V131, P268, DOI 10.1210/en.131.1.268; ROTHMAN RB, 1987, PEPTIDES, V8, P1015, DOI 10.1016/0196-9781(87)90130-6; RUEGG UT, 1980, EUR J PHARMACOL, V64, P367, DOI 10.1016/0014-2999(80)90247-2; SCHOFIELD PR, 1989, EMBO J, V8, P489, DOI 10.1002/j.1460-2075.1989.tb03402.x; SIMON EJ, 1991, MED RES REV, V11, P357, DOI 10.1002/med.2610110402; SIMON EJ, 1975, SCIENCE, V190, P389, DOI 10.1126/science.1182043; SIMONDS WF, 1980, P NATL ACAD SCI-BIOL, V77, P4623, DOI 10.1073/pnas.77.8.4623; TEMPEL A, 1987, P NATL ACAD SCI USA, V84, P4308, DOI 10.1073/pnas.84.12.4308; UEDA H, 1987, NEUROSCI LETT, V75, P339, DOI 10.1016/0304-3940(87)90546-5; UNTERWALD EM, 1991, BRAIN RES, V562, P57, DOI 10.1016/0006-8993(91)91186-5; WOLOZIN BL, 1981, P NATL ACAD SCI-BIOL, V78, P6181, DOI 10.1073/pnas.78.10.6181; WOOD PL, 1982, NEUROPHARMACOLOGY, V21, P487, DOI 10.1016/0028-3908(82)90038-7; WOOD PL, 1988, PEPTIDES, V1, P49; XIE GX, 1992, P NATL ACAD SCI USA, V89, P4124, DOI 10.1073/pnas.89.9.4124; XIE YB, 1990, J BIOL CHEM, V265, P21411; YASUDA K, 1993, IN PRESS P NATL ACAD; 1991, PROGRAM MANUAL GCG P	60	396	405	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					903	913		10.1016/0896-6273(93)90120-G	http://dx.doi.org/10.1016/0896-6273(93)90120-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240812	Green Submitted			2022-12-28	WOS:A1993MJ04100012
J	DAVIS, RL				DAVIS, RL			MUSHROOM BODIES AND DROSOPHILA LEARNING	NEURON			English	Review							CYCLIC-AMP PHOSPHODIESTERASE; ADENOSINE 3'-5'-MONOPHOSPHATE PHOSPHODIESTERASE; MEDIATED ENHANCER DETECTION; MUTANT DROSOPHILA; MOLECULAR ANALYSIS; ADENYLATE-CYCLASE; PROTEIN-KINASE; DUNCE GENE; MELANOGASTER; MEMORY				DAVIS, RL (corresponding author), COLD SPRING HARBOR LAB, CTR LEARNING & MEMORY, COLD SPRING HARBOR, NY 11724 USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608				ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; ASZTALOS Z, 1993, J NEUROSCI, V13, P924; BELLEN HJ, 1987, DEV BIOL, V121, P432, DOI 10.1016/0012-1606(87)90180-1; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BOOKER R, 1981, P NATL ACAD SCI-BIOL, V78, P3940, DOI 10.1073/pnas.78.6.3940; BOURNE HR, 1993, NEURON S, V10, P65; BOYNTON S, 1992, GENETICS, V131, P655; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CARLSON J, 1991, TRENDS NEUROSCI, V14, P520, DOI 10.1016/0166-2236(91)90004-E; CHEN CN, 1987, NATURE, V329, P721, DOI 10.1038/329721a0; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; CHOI KW, 1991, J BIOL CHEM, V266, P15999; CORFAS G, 1989, J NEUROSCI, V9, P56; COWAN TM, 1986, J NEUROGENET, V3, P187, DOI 10.3109/01677068609106849; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DELGADO R, 1991, P NATL ACAD SCI USA, V88, P557, DOI 10.1073/pnas.88.2.557; DELGADO R, 1993, IN PRESS P ROY SOC B; DILL M, 1992, RHYTHMOGENESIS NEURO; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DUDAI Y, 1983, P NATL ACAD SCI-BIOL, V80, P5445, DOI 10.1073/pnas.80.17.5445; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Dujardin F, 1850, ANN SCI NATURELLES, V3, P195; DURA JM, 1993, IN PRESS J NEUROGENE; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; FISCHBACH KF, 1979, NATURWISSENSCHAFTEN, V68, P221; FOLKERS E, 1981, J INSECT PHYSIOL, V27, P615, DOI 10.1016/0022-1910(81)90109-8; FOLKERS E, 1993, IN PRESS P NATL ACAD; FORTE M, 1993, IN PRESS GTPASES BIO; FURIA M, 1990, NUCLEIC ACIDS RES, V18, P5837, DOI 10.1093/nar/18.19.5837; FURIA M, 1993, IN PRESS J MOL BIOL; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HEISENBERG M, 1989, FORTS ZOOL, V37, P3; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HUBER F, 1974, PHYSIOL INSECT, V4, P3; KAUVAR LM, 1982, J NEUROSCI, V2, P1347; Kenyon F., 1896, J COMP NEUROL, V6, P133, DOI DOI 10.1002/CNE.910060302; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LANE ME, 1993, IN PRESS GENES DEV; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MANNING A, 1967, NATURE, V216, P338, DOI 10.1038/216338a0; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pirrotta V., 1986, DROSOPHILA PRACTICAL, P83; Power ME, 1943, J MORPHOL, V72, P517, DOI 10.1002/jmor.1050720306; QIU Y, 1993, IN PRESS GENES DEV; QIU YH, 1991, J MOL BIOL, V222, P553, DOI 10.1016/0022-2836(91)90496-S; QUAN F, 1989, P NATL ACAD SCI USA, V86, P4321, DOI 10.1073/pnas.86.11.4321; QUAN F, 1991, P NATL ACAD SCI USA, V18, P1898; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; REES CT, 1989, J NEUROGENET, V5, P105, DOI 10.3109/01677068909066201; SALZ HK, 1982, GENETICS, V100, P587; SCHILDBERGER K, 1984, J COMP PHYSIOL, V154, P71, DOI 10.1007/BF00605392; SCHWARZ TL, 1990, NEURON, V2, P119; SHOTWELL SL, 1983, J NEUROSCI, V3, P739; SKOULAKIS EMC, 1993, IN PRESS NEURON; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STRAUSFELD N J, 1976, P214; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; TULLY T, 1990, COLD SPRING HARB SYM, V55, P203; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1993, IN PRESS J NEUROGENE	76	296	301	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL	1993	11	1					1	14		10.1016/0896-6273(93)90266-T	http://dx.doi.org/10.1016/0896-6273(93)90266-T			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338661				2022-12-28	WOS:A1993LP43000001
J	HOYLE, GW; MERCER, EH; PALMITER, RD; BRINSTER, RL				HOYLE, GW; MERCER, EH; PALMITER, RD; BRINSTER, RL			EXPRESSION OF NGF IN SYMPATHETIC NEURONS LEADS TO EXCESSIVE AXON OUTGROWTH FROM GANGLIA BUT DECREASED TERMINAL INNERVATION WITHIN TISSUES	NEURON			English	Article							NERVE GROWTH-FACTOR; DOPAMINE-BETA-HYDROXYLASE; SUPERIOR CERVICAL-GANGLION; TRANSGENIC MICE; TARGET ORGANS; ADULT-RATS; CELLS; CHICK; PROTEIN; GUANETHIDINE	The effects of nerve growth factor (NGF) on sympathetic axon growth were investigated by generating transgenic mice in which the beta subunit of NGF was expressed in sympathetic neurons using the human dopamine beta-hydroxylase (DBH) promoter. In DBH-NGF mice, the sympathetic trunk and nerves growing to peripheral tissues were enlarged and contained an increased number of sympathetic fibers. Although sympathetic axons reached peripheral tissues, terminal sympathetic innervation within tissues was decreased in DBH-NGF mice. This effect could be reversed in the pancreas by overexpression of NGF in pancreatic islets. The observations are consistent with a model in which NGF gradients are not required to guide sympathetic axons to their targets, but are required for the establishment of the normal density and pattern of sympathetic innervation within target tissues.	UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	HOYLE, GW (corresponding author), UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104, USA.		Mercer, Eric H/AAX-6173-2021	Mercer, Eric H/0000-0002-6737-765X; Brinster, Ralph/0000-0003-1408-7656	NICHD NIH HHS [HD 23657, HD 09172] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD009172, R37HD009172, R37HD023657] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; CROSSLAND WJ, 1979, J COMP NEUROL, V185, P87, DOI 10.1002/cne.901850106; DELATORRE JC, 1980, J NEUROSCI METH, V3, P1, DOI 10.1016/0165-0270(80)90029-1; DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596; EDWARDS RH, 1989, CELL, V58, P161, DOI 10.1016/0092-8674(89)90412-1; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; EMMELIN N, 1961, BRIT J PHARM CHEMOTH, V16, P315, DOI 10.1111/j.1476-5381.1961.tb01090.x; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HAYASHI M, 1985, DEV BIOL, V108, P49, DOI 10.1016/0012-1606(85)90008-9; HENDRY IA, 1976, J NEUROCYTOL, V5, P351, DOI 10.1007/BF01175120; HENDRY IA, 1977, J NEUROCYTOL, V6, P299, DOI 10.1007/BF01175193; JOHNSON EM, 1976, J PHARMACOL EXP THER, V196, P53; JOHNSON EM, 1975, J PHARMACOL EXP THER, V193, P503; KAPUR RP, 1991, NEURON, V7, P717, DOI 10.1016/0896-6273(91)90275-5; KARASEK M, 1983, PINEAL RES REV, V1, P1; KLINGMAN GERDA I., 1967, INT J NEUROPHARMACOL, V6, P501; KORSCHING S, 1988, DEV BIOL, V126, P40, DOI 10.1016/0012-1606(88)90236-9; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Levi-Montalcini R, 1976, Prog Brain Res, V45, P235, DOI 10.1016/S0079-6123(08)60993-0; LEVI-MONTALCINI RITA, 1966, HARVEY LECT, V60, P217; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P373, DOI 10.1073/pnas.46.3.373; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIU YC, 1991, NEURON, V6, P411, DOI 10.1016/0896-6273(91)90249-Y; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; OLSON L, 1967, Z ZELLFORSCH MIK ANA, V81, P155, DOI 10.1007/BF02075968; OWEN DJ, 1989, BRAIN RES, V476, P248, DOI 10.1016/0006-8993(89)91245-6; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; PEARCE FL, 1986, J PHYSIOL-LONDON, V372, P379, DOI 10.1113/jphysiol.1986.sp016014; RUBIN E, 1985, J NEUROSCI, V5, P673; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; STACH RW, 1974, J BIOL CHEM, V249, P6668; TEITELMAN G, 1979, P NATL ACAD SCI USA, V76, P509, DOI 10.1073/pnas.76.1.509; THOENEN H, 1971, P NATL ACAD SCI USA, V68, P1598, DOI 10.1073/pnas.68.7.1598; ULLRICH A, 1983, NATURE, V303, P821, DOI 10.1038/303821a0; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	48	90	95	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1019	1034		10.1016/0896-6273(93)90051-R	http://dx.doi.org/10.1016/0896-6273(93)90051-R			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318227				2022-12-28	WOS:A1993LK37300003
J	CARSON, MJ; BEHRINGER, RR; BRINSTER, RL; MCMORRIS, FA				CARSON, MJ; BEHRINGER, RR; BRINSTER, RL; MCMORRIS, FA			INSULIN-LIKE GROWTH FACTOR-I INCREASES BRAIN GROWTH AND CENTRAL-NERVOUS-SYSTEM MYELINATION IN TRANSGENIC MICE	NEURON			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; SNELL DWARF MOUSE; RAT-BRAIN; OLIGODENDROCYTE DEVELOPMENT; GENE-EXPRESSION; SOMATOMEDIN-C; CEREBRAL MYELINOGENESIS; CHOROID-PLEXUS; GLIAL-CELLS; IGF-I	Insulin-like growth factor I (IGF-I) is a potent regulator of oligodendrocyte development and myelination in vitro, but its effect on myelination in vivo has never been tested directly. Therefore, we examined brain growth and myelination in a transgenic mouse line that overexpresses IGF-I. By postnatal day 55, when brain growth and myelination are essentially complete in normal mice, the brains of transgenic mice were 55% larger than those of controls owing to an increase in cell size and apparently in cell number. Most or all brain structures appeared to be affected. At the same time, total myelin content of the transgenic mice was 130% greater than that of controls. Oligodendrocyte number as a percentage of total cell number was not increased in the transgenic mouse brains; the increase in myelin content was primarily the result of an increase in myelin production per oligodendrocyte. These findings indicate that IGF-I is a potent inducer of brain growth and myelination in vivo.	WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH VET MED,PHILADELPHIA,PA 19104	The Wistar Institute; University of Pennsylvania				Brinster, Ralph/0000-0003-1408-7656	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011036, R01NS026119, F32NS011036] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 11036, NS 26119] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; BALLOTTI R, 1987, EMBO J, V6, P3633, DOI 10.1002/j.1460-2075.1987.tb02695.x; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BASKIN DG, 1988, TRENDS NEUROSCI, V11, P107, DOI 10.1016/0166-2236(88)90155-5; BONDY CA, 1991, J NEUROSCI, V11, P3442; BRAUN PE, 1988, J NEUROSCI, V8, P3057; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; BROWN AL, 1986, J BIOL CHEM, V261, P3144; DELANEY AJ, 1981, J NUTR, V111, P746, DOI 10.1093/jn/111.4.746; DERCOLE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P935, DOI 10.1073/pnas.81.3.935; EGWIM PO, 1986, COMP BIOCHEM PHYS A, V83, P67, DOI 10.1016/0300-9629(86)90089-7; FAGIN JA, 1989, ENDOCRINOLOGY, V125, P2385, DOI 10.1210/endo-125-5-2385; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; GABBOTT PLA, 1987, NEUROSCIENCE, V21, P833, DOI 10.1016/0306-4522(87)90040-6; GHANDOUR MS, 1980, NEUROSCIENCE, V5, P559, DOI 10.1016/0306-4522(80)90053-6; GRANT DB, 1973, ARCH DIS CHILD, V48, P596, DOI 10.1136/adc.48.8.596; HAN VKM, 1987, J NEUROSCI, V7, P501; HINTZ RL, 1978, J PEDIATR-US, V92, P153, DOI 10.1016/S0022-3476(78)80099-7; HODGKINSON SC, 1991, ENDOCRINOLOGY, V129, P2085, DOI 10.1210/endo-129-4-2085; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HYNES MA, 1988, MOL ENDOCRINOL, V2, P47, DOI 10.1210/mend-2-1-47; KING RA, 1988, J ENDOCRINOL, V119, P117, DOI 10.1677/joe.0.1190117; KOMOLY S, 1992, P NATL ACAD SCI USA, V89, P1894, DOI 10.1073/pnas.89.5.1894; KRIGMAN MR, 1976, BRAIN RES, V107, P239, DOI 10.1016/0006-8993(76)90224-9; KURIHARA T, 1967, J NEUROCHEM, V14, P1167, DOI 10.1111/j.1471-4159.1967.tb06164.x; LAMSON G, 1989, ENDOCRINOLOGY, V125, P1100, DOI 10.1210/endo-125-2-1100; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND PK, 1986, J BIOL CHEM, V261, P4539; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MATHEWS LS, 1986, P NATL ACAD SCI USA, V83, P9343, DOI 10.1073/pnas.83.24.9343; MCMORRIS FA, 1983, J NEUROCHEM, V41, P506, DOI 10.1111/j.1471-4159.1983.tb04768.x; MCMORRIS FA, 1990, ANN NY ACAD SCI, V605, P101, DOI 10.1111/j.1749-6632.1990.tb42385.x; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MCMORRIS FA, 1986, P NATL ACAD SCI USA, V83, P822, DOI 10.1073/pnas.83.3.822; MORELL P, 1989, BASIC NEUROCHEMISTRY, P109; MOZELL RL, 1991, J NEUROSCI RES, V30, P382, DOI 10.1002/jnr.490300214; NIELSEN FC, 1991, J NEUROCHEM, V56, P12, DOI 10.1111/j.1471-4159.1991.tb02556.x; NOGUCHI T, 1982, J NEUROCHEM, V38, P257, DOI 10.1111/j.1471-4159.1982.tb10878.x; NOGUCHI T, 1982, J NEUROCHEM, V39, P1693, DOI 10.1111/j.1471-4159.1982.tb08004.x; NOGUCHI T, 1985, NEUROCHEM RES, V10, P1097, DOI 10.1007/BF00965884; Norton W., 1984, OLIGODENDROGLIA; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; OOI GT, 1990, MOL CELL ENDOCRINOL, V71, pC39, DOI 10.1016/0303-7207(90)90243-2; PELTON EW, 1977, NEUROLOGY, V27, P282, DOI 10.1212/WNL.27.3.282; PHILLIPS LS, 1979, AM J CLIN NUTR, V32, P1082, DOI 10.1093/ajcn/32.5.1082; PHILLIPS LS, 1978, ENDOCRINOLOGY, V103, P121, DOI 10.1210/endo-103-1-121; PROHASKA JR, 1973, ANAL BIOCHEM, V56, P275, DOI 10.1016/0003-2697(73)90189-9; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; SHEMER J, 1987, J BIOL CHEM, V262, P7693; Sims N.R., 1978, ADV NEUROCHEMISTRY, V3, P1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STURROCK RR, 1974, J ANAT, V117, P37; STURROCK RR, 1976, J ANAT, V122, P521; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; SUGISAKI T, 1985, NEUROCHEM RES, V10, P767, DOI 10.1007/BF00964534; SWANSON LW, 1985, NATURE, V317, P363, DOI 10.1038/317363a0; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X; WIGGINS RC, 1982, BRAIN RES REV, V4, P151, DOI 10.1016/0165-0173(82)90016-9; WOOD TL, 1990, MOL ENDOCRINOL, V4, P1257, DOI 10.1210/mend-4-8-1257; YOUNG JK, 1991, GLIA, V4, P602, DOI 10.1002/glia.440040607; [No title captured]	63	408	417	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					729	740		10.1016/0896-6273(93)90173-O	http://dx.doi.org/10.1016/0896-6273(93)90173-O			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386530				2022-12-28	WOS:A1993KY50100015
J	FUENTES, ME; TAYLOR, P				FUENTES, ME; TAYLOR, P			CONTROL OF ACETYLCHOLINESTERASE GENE-EXPRESSION DURING MYOGENESIS	NEURON			English	Article							MESSENGER-RNA STABILITY; ALPHA-SUBUNIT GENE; SKELETAL-MUSCLE; RECEPTOR GENES; MOUSE MUSCLE; CELLS; ENHANCER; PROTEIN; IDENTIFICATION; DEGRADATION	Acetylcholinesterase (AChE) and the nicotinic acetylcholine receptor show enhanced expression upon differentiation of C2-C12 myoblasts into myotubes. Northern blots and RNAase protection show substantial increases in the mRNAs encoding both proteins. In contrast to transcriptional control of gene expression of acetylcholine receptor subunits during differentiation, Ache mRNA levels increase through stabilization of the transcript. The transcriptional rate remains unchanged during Ache mRNA accumulation, whereas transcription rate increase for the receptor subunits. Inhibition of protein synthesis produces a dramatic superinduction of Ache mRNA in undifferentiated cells without affecting transcription rates, suggesting the presence of labile proteins that uniquely destabilize the mRNA. Hence, Ache mRNA in myoblasts shows rapid turnover, and upon differentiation, its level is increased by slowing the rate of mRNA degradation.			FUENTES, ME (corresponding author), UNIV CALIF SAN DIEGO,DEPT PHARMACOL 0636,LA JOLLA,CA 92093, USA.		Fuentes, Maria/HGA-8617-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360, R01GM024337, R01GM018360] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-24337, GM-18360] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGLISTER L, 1978, J MOL BIOL, V125, P293, DOI 10.1016/0022-2836(78)90404-7; ATWATER JA, 1990, ANNU REV GENET, V24, P519; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BALDWIN TJ, 1988, J CELL BIOL, V107, P2271, DOI 10.1083/jcb.107.6.2271; BROCK ML, 1983, CELL, V34, P207, DOI 10.1016/0092-8674(83)90151-4; BUONANNO A, 1986, J BIOL CHEM, V261, P1452; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEVELAND D W, 1989, New Biologist, V1, P121; EGYHAZIE E, 1975, P NATL ACAD SCI USA, V72, P946; EISENSTEIN RS, 1988, MOL CELL BIOL, V8, P3183, DOI 10.1128/MCB.8.8.3183; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; EVANS S, 1987, J BIOL CHEM, V262, P4911; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; FUTERMAN AH, 1985, BIOCHEM J, V226, P369, DOI 10.1042/bj2260369; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; GENOVESE C, 1990, MOL IMMUNOL, V27, P733, DOI 10.1016/0161-5890(90)90082-B; GILMOUR BP, 1991, J BIOL CHEM, V266, P19871; HAAS R, 1986, BIOCHEMISTRY-US, V25, P3098, DOI 10.1021/bi00359a005; HASTINGS KEM, 1982, P NATL ACAD SCI-BIOL, V79, P1553, DOI 10.1073/pnas.79.5.1553; HENTZE MW, 1991, BIOCHIM BIOPHYS ACTA, V1090, P281, DOI 10.1016/0167-4781(91)90191-N; HOWE JG, 1986, P NATL ACAD SCI USA, V83, P9006, DOI 10.1073/pnas.83.23.9006; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; INESTROSA NC, 1983, EXP CELL RES, V147, P393, DOI 10.1016/0014-4827(83)90221-5; KHALILI K, 1984, J MOL BIOL, V180, P1007, DOI 10.1016/0022-2836(84)90268-7; KLARSFELD A, 1987, BIOCHIMIE, V69, P433, DOI 10.1016/0300-9084(87)90080-0; LAUFER R, 1989, MOL NEUROBIOL, V3, P1, DOI 10.1007/BF02935587; LI Y, 1993, J BIOL CHEM, V268, P3563; LI Y, 1991, J BIOL CHEM, V266, P23083; LWEBUGAMUKASA JS, 1976, BIOCHEMISTRY-US, V15, P1425, DOI 10.1021/bi00652a012; MASSOULIE J, 1988, HDB EXP PHARM, V86, P167; MERLIE J P, 1986, P75; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; PONTECORVI A, 1988, EMBO J, V7, P1498; PRODY CA, 1991, J BIOL CHEM, V266, P22588; PRODY CA, 1992, NUCLEIC ACIDS RES, V20, P2367, DOI 10.1093/nar/20.9.2367; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; SUBRAMANIAM M, 1989, NATURE, V340, P64, DOI 10.1038/340064a0; TAMM I, 1976, J CELL BIOL, V99, P229; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; TOUTANT JP, 1988, HDB EXP PHARM, V86, P225; WANG Y, 1988, NEURON, V1, P527, DOI 10.1016/0896-6273(88)90183-3; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; YEN TJ, 1988, MOL CELL BIOL, V8, P1224, DOI 10.1128/MCB.8.3.1224	47	70	71	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					679	687		10.1016/0896-6273(93)90169-R	http://dx.doi.org/10.1016/0896-6273(93)90169-R			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386528				2022-12-28	WOS:A1993KY50100011
J	SCHNEIDER, LE; ROBERTS, MS; TAGHERT, PH				SCHNEIDER, LE; ROBERTS, MS; TAGHERT, PH			CELL TYPE-SPECIFIC TRANSCRIPTIONAL REGULATION OF THE DROSOPHILA FMRFAMIDE NEUROPEPTIDE GENE	NEURON			English	Article							DOPA DECARBOXYLASE GENE; INSITU HYBRIDIZATION ANALYSIS; TRANSGENIC MICE; FUSION GENES; EXPRESSION; ELEMENTS; MELANOGASTER; ENHANCER; ORGANIZATION; DIVERSITY	We have used lacZ reporter gene constructs to study the promoter/enhancer regions of the Drosophila FMRFamide neuropeptide gene in germ line transformants. FMRFamide is normally expressed in approximately 60 diverse neurons of the larval CNS that represent approximately 15 distinct cell types. An 8 kb FMRFamide DNA fragment (including 5 kb of 5' upstream sequence) was sufficient to direct a pattern of lacZ expression that mimicked nearly all spatial aspects of the normal pattern. This result indicates that the cell-specific regulation of FMRFamide expression is largely generated by transcriptional mechanisms. Reporter gene expression was lost from selected cell types when smaller fragments were tested, suggesting that multiple control regions are included in the FMRFamide promoter. One region (a 300 bp fragment from -476 to -162) acted as an enhancer for 1 of the approximately 15 FMRFamide-positive cell types, the OL2 neurons. These results suggest that, in the mature nervous system, the complex pattern of FMRFamide neuropeptide gene expression derives from the activity of discrete, cell type-specific enhancers that are independently regulated.	WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110	Washington University (WUSTL)					PHS HHS [21749] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BEALL CJ, 1987, GENE DEV, V1, P510, DOI 10.1101/gad.1.5.510; BOTWELL DDL, 1989, P NATL ACAD SCI USA, V86, P6245; BOTWELL DDL, 1991, P NATL ACAD SCI USA, V88, P6853; BRAY SJ, 1988, EMBO J, V7, P177, DOI 10.1002/j.1460-2075.1988.tb02798.x; CHIN AC, 1990, DNA CELL BIOL, V9, P263, DOI 10.1089/dna.1990.9.263; DUVE H, 1992, P NATL ACAD SCI USA, V89, P2326, DOI 10.1073/pnas.89.6.2326; EVANS PD, 1986, J EXP BIOL, V126, P403; FISHER JA, 1988, CELL, V53, P451; GARABEDIAN MJ, 1986, CELL, V45, P859, DOI 10.1016/0092-8674(86)90560-X; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HAMMER RE, 1987, SCIENCE, V235, P53, DOI 10.1126/science.2432657; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; HEBENER JF, 1989, J BIOL CHEM, V264, P18844; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; HIRSH J, 1989, DEV GENET, V10, P232, DOI 10.1002/dvg.1020100312; HOWARD K, 1988, GENE DEV, V2, P1037, DOI 10.1101/gad.2.8.1037; HOWARD KR, 1990, DEVELOPMENT, V110, P1223; JOHNSON WA, 1989, GENE DEV, V3, P676, DOI 10.1101/gad.3.5.676; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; KITAMOTO T, 1992, J NEUROSCI, V12, P1628; KONDOH H, 1987, DEV BIOL, V120, P177, DOI 10.1016/0012-1606(87)90116-3; LOW MJ, 1986, SCIENCE, V231, P1002, DOI 10.1126/science.2868526; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; NAMBU JR, 1988, NEURON, V1, P55, DOI 10.1016/0896-6273(88)90209-7; OBRIEN MA, 1991, J COMP NEUROL, V304, P623, DOI 10.1002/cne.903040409; PANKRATZ MJ, 1990, CELL, V61, P309, DOI 10.1016/0092-8674(90)90811-R; ROBERTSON HM, 1988, GENETICS, V118, P461; SCHNEIDER LE, 1988, P NATL ACAD SCI USA, V85, P1993, DOI 10.1073/pnas.85.6.1993; SCHNEIDER LE, 1990, J BIOL CHEM, V265, P6890; SCHNEIDER LE, 1991, J COMP NEUROL, V304, P608, DOI 10.1002/cne.903040408; SCHOLNICK SB, 1991, DEV BIOL, V146, P423, DOI 10.1016/0012-1606(91)90244-W; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; SCHOLNICK SB, 1986, SCIENCE, V234, P998, DOI 10.1126/science.3095924; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; STRUHL K, 1991, NEURON, V7, P177, DOI 10.1016/0896-6273(91)90256-Y; SWANSON LW, 1985, NATURE, V317, P363, DOI 10.1038/317363a0; TAGHERT PH, 1990, J NEUROSCI, V10, P1929; TAMURA T, 1985, P NATL ACAD SCI USA, V82, P700; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; WHITE K, 1986, J COMP NEUROL, V247, P430, DOI 10.1002/cne.902470403; YOUNG WS, 1990, J NEUROENDOCRINOL, V2, P917, DOI 10.1111/j.1365-2826.1990.tb00660.x	43	67	67	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					279	291		10.1016/0896-6273(93)90318-L	http://dx.doi.org/10.1016/0896-6273(93)90318-L			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439413				2022-12-28	WOS:A1993KP68500015
J	Chou, WH; Hall, KJ; Wilson, DB; Wideman, CL; Townson, SM; Chadwell, LV; Britt, SG				Chou, WH; Hall, KJ; Wilson, DB; Wideman, CL; Townson, SM; Chadwell, LV; Britt, SG			Identification of a novel Drosophila opsin reveals specific patterning of the R7 and R8 photoreceptor cells	NEURON			English	Article							ELECTRO-PHYSIOLOGICAL ANALYSIS; TYROSINE KINASE DOMAIN; SCHIFF-BASE COUNTERION; HUMAN COLOR-VISION; MOLECULAR-GENETICS; VISUAL PIGMENT; SEVENLESS PROTEIN; BOVINE RHODOPSIN; COMPOUND EYE; EXTRACELLULAR DOMAIN	The function of the compound eye is dependent upon a developmental program that specifies different cell fates and directs the expression of spectrally distinct opsins in different photoreceptor cells. Rh5 is a novel Drosophila opsin gene that encodes a biologically active visual pigment that is expressed in a subset of R8 photoreceptor cells. Rh5 expression in the R8 cell of an individual ommatidium is strictly coordinated with the expression of Rh3, in the overlying R7 cell. In sevenless mutant flies, which lack R7 photoreceptor cells, the expression of the Rh5 protein in R8 cells is disrupted, providing evidence for a specific developmental signal between the R7 and R8 cells that is responsible for the paired expression of opsin genes.	UNIV TEXAS, HLTH SCI CTR, DEPT MOL MED, SAN ANTONIO, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Chou, WH (corresponding author), UNIV TEXAS, HLTH SCI CTR, INST BIOTECHNOL, SAN ANTONIO, TX 78245 USA.		Chou, Wen-Hai/H-1970-2016; Britt, Steven/GVT-1340-2022	Chou, Wen-Hai/0000-0002-7899-1129; Britt, Steven/0000-0001-7656-7984				ALTSCHUL SF, 1990, BASIC LOCAL ALIGNMEN, V216, P403; Ashburner M, 1989, DROSOPHILA LABORATOR, P44; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BASLER K, 1988, CELL, V54, P299; BASLER K, 1989, SCIENCE, V243, P931, DOI 10.1126/science.2493159; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRITT SG, 1993, NEURON, V11, P29, DOI 10.1016/0896-6273(93)90268-V; BURKHARDT D., 1962, SYMPOSIA SOC EXPTL BIOL, V16, P86; CARULLI JP, 1992, GENETICS, V132, P193; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COWMAN AF, 1986, CELL, V44, P705, DOI 10.1016/0092-8674(86)90836-6; Dickson Barry, 1993, P1327; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Gelbart WM, 1996, NUCLEIC ACIDS RES, V24, P53, DOI 10.1093/nar/24.1.53; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1979, J COMP PHYSIOL, V129, P19, DOI 10.1007/BF00679908; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; HARDIE RC, 1979, J COMP PHYSIOL, V133, P23, DOI 10.1007/BF00663107; HARDIE RC, 1983, CELL TISSUE RES, V233, P1, DOI 10.1007/BF00222228; HARDIE RC, 1983, BIOPHYS STRUCT MECH, V9, P171, DOI 10.1007/BF00537814; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HART AC, 1993, NATURE, V361, P732, DOI 10.1038/361732a0; HEISENBERG M, 1971, J EXP BIOL, V55, P85; HEISENBERG M, 1984, VISION DROSOPHILA; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HU KG, 1978, J COMP PHYSIOL, V126, P15, DOI 10.1007/BF01342646; HUBER A, 1990, J BIOL CHEM, V265, P17906; ISONO K, 1988, J GEN PHYSIOL, V92, P587, DOI 10.1085/jgp.92.5.587; Jacobs GH, 1981, COMP COLOR VISION; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V162, P421, DOI 10.1007/BF00612508; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V163, P421, DOI 10.1007/BF00604896; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MEFFERT P, 1976, NATURE, V260, P342, DOI 10.1038/260342a0; MINKE B, 1979, J GEN PHYSIOL, V73, P517, DOI 10.1085/jgp.73.5.517; MONTELL C, 1987, J NEUROSCI, V7, P1558; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NATHANS J, 1992, ANNU REV GENET, V26, P403, DOI 10.1146/annurev.ge.26.120192.002155; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; Ohguro H, 1996, J BIOL CHEM, V271, P5215; OPRIAN DD, 1992, J BIOENERG BIOMEMBR, V24, P211, DOI 10.1007/BF00762679; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; RANGANATHAN R, 1991, TRENDS NEUROSCI, V14, P486, DOI 10.1016/0166-2236(91)90060-8; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; ROBERTSON HM, 1989, GENETICS, V123, P815; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SMOLA U, 1979, J COMP PHYSIOL, V133, P41, DOI 10.1007/BF00663108; STARK WS, 1977, J COMP PHYSIOL, V115, P47, DOI 10.1007/BF00667784; STARK WS, 1977, J COMP PHYSIOL, V121, P289, DOI 10.1007/BF00613010; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Sved J, 1986, DROSOPH INF SERV, V63, P169; SWIMMER C, 1985, NUCLEIC ACIDS RES, V13, P8053, DOI 10.1093/nar/13.22.8053; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VOGT K, 1984, NATURWISSENSCHAFTEN, V71, P211, DOI 10.1007/BF00490436; VOGT K, 1984, Z NATURFORSCH C, V39, P196; Wolff Tanya, 1993, P1277; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373; ZUKER CS, 1987, J NEUROSCI, V7, P1550; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	97	142	146	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1101	1115		10.1016/S0896-6273(00)80243-3	http://dx.doi.org/10.1016/S0896-6273(00)80243-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982159	Bronze			2022-12-28	WOS:A1996WA24800009
J	Liu, FC; Graybiel, AM				Liu, FC; Graybiel, AM			Spatiotemporal dynamics of CREB phosphorylation: Transient versus sustained phosphorylation in the developing striatum	NEURON			English	Article							LONG-TERM-MEMORY; DEPENDENT PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY GENES; MAMMALIAN BRAIN; NERVOUS-SYSTEM; DOPAMINERGIC REGULATION; MOLECULAR MECHANISMS; ORGANOTYPIC CULTURES; PHOSPHATASE CASCADE	The cAMP response element-binding protein (CREB) is a plasticity-associated transcription factor that can potentially integrate cAMP and calcium signals at the gene activation level. We tested for convergent Ser-133 phosphorylation of CREB via dopamine D1/D5 receptors and L-type calcium channels in organotypic cultures of neonatal striatum. We found such convergence only transiently. Sustained CREB phosphorylation by D1/D5 receptor and L-type channel agonists was targeted to opposite (striosome and matrix) cellular phenotypes. Subsequent expression of the CRE-containing gene, c-fos, matched the divergent patterns of sustained CREB phosphorylation, and both divergent patterns could be switched by inhibition of phosphatases, including calcineurin. Control of the duration of CREB phosphorylation may be a critical regulator of CRE-mediated gene expression by dopamine and calcium.	MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139; NATL YANG MING UNIV,INST NEUROSCI,TAIPEI 11221,TAIWAN	Massachusetts Institute of Technology (MIT); National Yang Ming Chiao Tung University				Graybiel, Ann/0000-0002-4326-7720	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028341] Funding Source: NIH RePORTER; NICHD NIH HHS [1-R01-HD28341] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BITO H, 1996, IN PRESS CELL, V87; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; COMB M, 1987, TRENDS NEUROSCI, V10, P473, DOI 10.1016/0166-2236(87)90103-2; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FOSTER GA, 1987, J NEUROSCI, V7, P1994; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOTO S, 1989, EXP BRAIN RES, V77, P442, DOI 10.1007/BF00275004; GOTO S, 1987, NEUROSCIENCE, V22, P189, DOI 10.1016/0306-4522(87)90209-0; GRAYBIEL AM, 1984, NEUROSCIENCE, V13, P1157, DOI 10.1016/0306-4522(84)90293-8; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HEMMINGS HC, 1987, TRENDS NEUROSCI, V10, P377, DOI 10.1016/0166-2236(87)90075-0; HEMMINGS HC, 1984, NATURE, V310, P502; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HUGHES P, 1995, PHARMACOL REV, V47, P133; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; KING MM, 1984, J BIOL CHEM, V259, P8080; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; KRUSHEL LA, 1995, EUR J NEUROSCI, V7, P1210, DOI 10.1111/j.1460-9568.1995.tb01111.x; LIU FC, 1995, J NEUROSCI, V15, P2367, DOI 10.1523/JNEUROSCI.15-03-02367.1995; LIU FC, 1992, J COMP NEUROL, V320, P304, DOI 10.1002/cne.903200304; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MIN BH, 1994, P NATL ACAD SCI USA, V91, P9081, DOI 10.1073/pnas.91.19.9081; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; OUIMET CC, 1984, J NEUROSCI, V4, P111; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; SCHULMAN H, 1995, CURR OPIN NEUROBIOL, V5, P375, DOI 10.1016/0959-4388(95)80051-4; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	52	162	164	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1133	1144		10.1016/S0896-6273(00)80245-7	http://dx.doi.org/10.1016/S0896-6273(00)80245-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982161	Bronze			2022-12-28	WOS:A1996WA24800011
J	Davis, GW; Schuster, CM; Goodman, CS				Davis, GW; Schuster, CM; Goodman, CS			Genetic dissection of structural and functional components of synaptic plasticity .3. CREB is necessary for presynaptic functional plasticity	NEURON			English	Article							CAMP-RESPONSIVE ELEMENT; LONG-TERM FACILITATION; APLYSIA SENSORY NEURONS; CYCLIC-AMP; BEHAVIORAL SENSITIZATION; MACROMOLECULAR-SYNTHESIS; MOTOR AXONS; DROSOPHILA; PROTEIN; MEMORY	Increased cAMP (in dunce mutants) leads to an increase in the structure and function of the Drosophila neuromuscular junction. Synaptic Fasciclin II (Fas II) controls this structural plasticity, but does not alter synaptic function. Here, we show that CREB, the cAMP response element-binding protein, acts in parallel with Fas II to cause an increase in synaptic strength. Expression of the cREB repressor (dCREB2-b) in the dunce mutant blocks functional but not structural plasticity. Expression of the CREB activator (dCREB2-a) increases synaptic strength only in FasII mutants that increase bouton number. This CREB-mediated increase in synaptic strength is due to increased presynaptic transmitter release. Expression of dCREB2-a in a FasII mutant background genetically reconstitutes this cAMP-dependent plasticity. Thus, cAMP initiates parallel changes in CREB and Fas II to achieve long-term synaptic enhancement.			Davis, GW (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOL & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYD IA, 1956, J PHYSIOL-LONDON, V132, P74, DOI 10.1113/jphysiol.1956.sp005503; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; EVENS M, 1993, STAT DISTRIBUTIONS; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Nishikawa K, 1995, J NEUROSCI, V15, P7905; OLSON NJ, 1995, P NATL ACAD SCI USA, V92, P1659, DOI 10.1073/pnas.92.5.1659; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864; ZHONG Y, 1992, J NEUROSCI, V12, P644	32	213	217	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					669	679		10.1016/S0896-6273(00)80199-3	http://dx.doi.org/10.1016/S0896-6273(00)80199-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893024	Bronze			2022-12-28	WOS:A1996VP74300012
J	Hortsch, M				Hortsch, M			The L1 family of neural cell adhesion molecules: Old proteins performing new tricks	NEURON			English	Review							X-LINKED HYDROCEPHALUS; NEURITE OUTGROWTH; N-CAM; MASA-SYNDROME; IMMUNOGLOBULIN SUPERFAMILY; MOUSE LEUKOCYTES; BINDING; EXPRESSION; GLYCOPROTEIN; MUTATIONS				Hortsch, M (corresponding author), UNIV MICHIGAN, DEPT ANAT & CELL BIOL, ANN ARBOR, MI 48109 USA.				NICHD NIH HHS [HD29388] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD029388, R01HD029388] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Burmeister M, 1996, MAMM GENOME, V7, P558, DOI 10.1007/s003359900168; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; Dubreuil RR, 1996, J CELL BIOL, V133, P647, DOI 10.1083/jcb.133.3.647; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FRANSEN E, 1994, HUM MOL GENET, V3, P2255, DOI 10.1093/hmg/3.12.2255; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; GRUMET M, 1993, CELL ADHES COMMUN, V1, P177, DOI 10.3109/15419069309095693; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HORTSCH M, 1995, J BIOL CHEM, V270, P18809, DOI 10.1074/jbc.270.32.18809; HUBBE M, 1993, EUR J IMMUNOL, V23, P2927, DOI 10.1002/eji.1830231130; JOUET M, 1995, AM J HUM GENET, V56, P1304; KAEPERNICK L, 1994, CLIN GENET, V45, P181; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; KLINZ SG, 1995, J NEUROCHEM, V65, P84; KOWITZ A, 1993, CLIN EXP METASTAS, V11, P419, DOI 10.1007/BF00132985; KOWITZ A, 1992, EUR J IMMUNOL, V22, P1199, DOI 10.1002/eji.1830220514; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; KUJAT R, 1995, HISTOCHEM CELL BIOL, V103, P311, DOI 10.1007/BF01457416; Lane RP, 1996, GENOMICS, V35, P456, DOI 10.1006/geno.1996.0385; MAURO VP, 1992, J CELL BIOL, V119, P191, DOI 10.1083/jcb.119.1.191; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475; MORALES G, 1993, NEURON, V11, P1113, DOI 10.1016/0896-6273(93)90224-F; MOSCOSO LM, 1995, J COMP NEUROL, V352, P321, DOI 10.1002/cne.903520302; MUJOO K, 1986, J BIOL CHEM, V261, P299; PROBSTMEIER R, 1990, DIFFERENTIATION, V44, P42, DOI 10.1111/j.1432-0436.1990.tb00535.x; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; RUIZ JC, 1995, J MED GENET, V32, P549, DOI 10.1136/jmg.32.7.549; Ruppert M, 1995, J CELL BIOL, V131, P1881, DOI 10.1083/jcb.131.6.1881; Takeda Y, 1996, J NEUROCHEM, V66, P2338; TONGIORGI E, 1995, J NEUROSCI RES, V42, P547, DOI 10.1002/jnr.490420413; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wong EV, 1995, NEUROSCI LETT, V200, P155, DOI 10.1016/0304-3940(95)12100-I; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6; Zhao X, 1996, J BIOL CHEM, V271, P6563, DOI 10.1074/jbc.271.12.6563; ZHAO XO, 1995, J BIOL CHEM, V270, P29413, DOI 10.1074/jbc.270.49.29413	44	223	228	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					587	593		10.1016/S0896-6273(00)80192-0	http://dx.doi.org/10.1016/S0896-6273(00)80192-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893017	Bronze			2022-12-28	WOS:A1996VP74300005
J	Cummings, JA; Mulkey, RM; Nicoll, RA; Malenka, RC				Cummings, JA; Mulkey, RM; Nicoll, RA; Malenka, RC			Ca2+ signaling requirements for long-term depression in the hippocampus	NEURON			English	Article							EXCITATORY SYNAPTIC TRANSMISSION; RAT VISUAL-CORTEX; AREA CA1; BLOCKS INDUCTION; POTENTIATION; SLICES; MECHANISMS; CHANNELS; MEMORY; LTD	It has been hypothesized that the direction of synaptic weight change elicited by synaptic activity depends on the magnitude of the activity-dependent rise in intracellular Ca2+ concentration. Several aspects of this hypothesis were examined at the Schaffer collateral CA1 synapse, where both long-term depression (LTD) and long-term potentiation (LTP) can be elicited and are Ca2+ dependent. Brief tetanic stimulation, which normally generated LTP, could induce LTD when Ca2+ entry via NMDA receptors was limited either by moderate concentrations of D-APV or by voltage clamping cells at negative membrane potentials. Repetitive activation of voltage-dependent Ca2+ channels in the absence of afferent stimulation could also elicit an LTD that was Ca2+ dependent and was occluded by prior generation of homosynaptic LTD using prolonged low frequency stimulation. These results provide strong evidence that the minimal requirements for inducing LTD involve simply a transient influx of Ca2+ into the postsynaptic cell, via either NMDA receptors or voltage-dependent Ca2+ channels.	UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT CELLULAR & MOLEC PHARMACOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cummings, JA (corresponding author), UNIV CALIF SAN FRANCISCO,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.							ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BASHIR ZI, 1993, EUR J PHARMACOL, V239, P265, DOI 10.1016/0014-2999(93)91009-C; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; CHRISTIE BR, 1994, HIPPOCAMPUS, V4, P127, DOI 10.1002/hipo.450040203; CHRISTIE BR, 1995, J NEUROPHYSIOL, V74, P1244, DOI 10.1152/jn.1995.74.3.1244; CHRISTOFI G, 1993, J NEUROPHYSIOL, V69, P219, DOI 10.1152/jn.1993.69.1.219; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; HANSE E, 1995, NEUROSCIENCE, V67, P531, DOI 10.1016/0306-4522(95)00090-6; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; KERR DS, 1993, SYNAPSE, V14, P305, DOI 10.1002/syn.890140408; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; PAULSEN O, 1993, EUR J NEUROSCI, V5, P1241, DOI 10.1111/j.1460-9568.1993.tb00909.x; POCKETT S, 1990, EXP BRAIN RES, V80, P196; REGEHR WG, 1992, J NEUROSCI, V12, P4202; SCANZIANI M, 1996, IN PRESS NATURE; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; STANTON PK, 1991, NEUROSCI LETT, V127, P61, DOI 10.1016/0304-3940(91)90895-Z; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STEVENS CF, 1990, NATURE, V347, P16, DOI 10.1038/347016a0; TEYLER TJ, 1994, HIPPOCAMPUS, V4, P623, DOI 10.1002/hipo.450040602; VOLGUSHEV M, 1994, NEUROREPORT, V5, P2069, DOI 10.1097/00001756-199410270-00020; WICKENS JR, 1991, NEUROSCI LETT, V130, P128, DOI 10.1016/0304-3940(91)90244-N; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; YANG XD, 1994, J NEUROPHYSIOL, V71, P1586, DOI 10.1152/jn.1994.71.4.1586	41	343	352	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					825	833		10.1016/S0896-6273(00)80102-6	http://dx.doi.org/10.1016/S0896-6273(00)80102-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608000	Bronze			2022-12-28	WOS:A1996UG61100015
J	Tomita, K; Ishibashi, M; Nakahara, K; Ang, SL; Nakanishi, S; Guillemot, F; Kageyama, R				Tomita, K; Ishibashi, M; Nakahara, K; Ang, SL; Nakanishi, S; Guillemot, F; Kageyama, R			Mammalian hairy and Enhancer of split homolog 1 regulates differentiation of retinal neurons and is essential for eye morphogenesis	NEURON			English	Article							C-LIKE IMMUNOREACTIVITY; ROD BIPOLAR CELLS; PHOTORECEPTOR DEVELOPMENT INVITRO; DEVELOPING NERVOUS-SYSTEM; RAT RETINA; MOUSE RETINA; DROSOPHILA-MELANOGASTER; NEUROGENESIS; EXPRESSION; PROTEINS	Mammalian hairy and Enhancer of split homolog 1 (HES1), a basic helix-loop-helix factor gene, is expressed in retinal progenitor cells, and its expression decreases as differentiation proceeds. Retinal progenitor cells infected with HES1-transducing retrovirus did not differentiate into mature retinal cells, suggesting that persistent expression of HES1 blocks retinal development. In contrast, in the retina of HES1-null mutant mice, differentiation was accelerated, and rod and horizontal cells appeared prematurely and formed abnormal rosette-like structures. Lens and cornea development was also severely disturbed. Furthermore, in the mutant retina, bipolar cells extensively died and finally disappeared. These studies provide evidence that HES1 regulates differentiation of retinal neurons and is essential for eye morphogenesis.	UNIV STRASBOURG 1, COLL FRANCE,CNRS,INSERM, INST GENET & BIOL MOLEC & CELLULAIRE, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE; KYOTO UNIV, FAC MED, DEPT ANAT, SAKYO KU, KYOTO 606, JAPAN; KYOTO UNIV, FAC MED, INST IMMUNOL, SAKYO KU, KYOTO 606, JAPAN; RES DEV CORP JAPAN, INHERITANCE & VARIAT, PRESTO, KYOTO 606, JAPAN	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)			Guillemot, Francois/AAV-1482-2021	Nakahara, Kiyoshi/0000-0001-6701-6216				ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; ALTSHULER DM, 1991, P RET RES F, V3, P37; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; BROWN NL, 1995, CELL, V80, P879, DOI 10.1016/0092-8674(95)90291-0; CAFFE AR, 1989, CURR EYE RES, V8, P1083, DOI 10.3109/02713688908997401; CAMPOSORTEGA JA, 1991, ANNU REV NEUROSCI, V14, P399, DOI 10.1146/annurev.ne.14.030191.002151; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; DELAMO FF, 1992, DEVELOPMENT, V115, P737; DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P242; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; DRAGER UC, 1983, NATURE, V303, P169, DOI 10.1038/303169a0; FEDER JN, 1993, MOL CELL BIOL, V13, P105, DOI 10.1128/MCB.13.1.105; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HARRIS WA, 1991, P RET RES F, V3, P95; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; MIYACHI K, 1978, J IMMUNOL, V121, P2228; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; RAYMOND PA, 1991, P RET RES F, V3, P59; REH TA, 1991, P RET RES F, V3, P79; REPKA A, 1992, DEV BIOL, V153, P242, DOI 10.1016/0012-1606(92)90109-T; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SHAW G, 1983, EUR J CELL BIOL, V30, P219; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; Sidman RL, 1961, STRUCTURE EYE, P487; SPARROW JR, 1990, DEV BRAIN RES, V51, P69, DOI 10.1016/0165-3806(90)90259-2; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WATANABE T, 1992, DEVELOPMENT, V114, P899; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; ZHANG DR, 1991, VISUAL NEUROSCI, V6, P429, DOI 10.1017/S0952523800001292	54	286	292	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					723	734		10.1016/S0896-6273(00)80093-8	http://dx.doi.org/10.1016/S0896-6273(00)80093-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607991	Bronze			2022-12-28	WOS:A1996UG61100006
J	Itasaki, N; Nakamura, H				Itasaki, N; Nakamura, H			A role for gradient en expression in positional specification on the optic tectum	NEURON			English	Article							CLONALLY RELATED CELLS; RETINAL AXONS; TOPOGRAPHIC ORDER; RETINOTECTAL PROJECTION; ROSTROCAUDAL POLARITY; NERVOUS-SYSTEM; CHICK; HOMEOBOX; GUIDANCE; INVITRO	The optic tectum, the primary visual center in nonmammalian vertebrates, receives retinal fibers in a topographically ordered manner. en (en-1 and en-2, homologs of the Drosophila segment polarity gene engrailed) is expressed in the tectal primordium in a rostrocaudal gradient, around the stage when the polarity of the retinotectal projection map is being determined. Here we report that scattered en expression, caused by retroviral gene transfer, perturbed the retinotopic order. Nasal retinal fibers, which normally recognize the caudal side of the tectum (strong en expression side) as a target, arborized at ectopic sites, as if they found their targets, or degenerated. Temporal retinal fibers, which normally recognize the rostral side of the tectum (weak en expression side) as a target, were also affected in some cases by degeneration or prevention of innervation in the tectum. These results suggest that gradient en expression defines the positional identity of the tectum along the rostrocaudal axis.			Itasaki, N (corresponding author), TOHOKU UNIV,INST DEV AGING & CANC,DEPT MOLEC NEUROBIOL,AOBA KU,SEIRYO MACHI 4-1,SENDAI,MIYAGI 98077,JAPAN.			Itasaki, Nobue/0000-0003-0587-9141				BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; CEPKO C, 1991, CURR PROT MOL BIOL S, V17; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CROSSLAND WJ, 1979, J COMP NEUROL, V185, P87, DOI 10.1002/cne.901850106; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1991, DEVELOPMENT, V111, P287; FAWCETT JW, 1985, TRENDS NEUROSCI, V8, P201, DOI 10.1016/0166-2236(85)90079-7; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; GARDNER CA, 1988, J NEUROSCI RES, V21, P426, DOI 10.1002/jnr.490210234; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; INGHAM PW, 1992, CELL, V68, P221, DOI 10.1016/0092-8674(92)90467-Q; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; ITASAKI N, 1992, NEURON, V8, P787, DOI 10.1016/0896-6273(92)90099-Y; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KAPRIELIAN Z, 1994, BIOESSAYS, V16, P1, DOI 10.1002/bies.950160102; KOBAYASHI T, 1990, DEV BRAIN RES, V57, P29, DOI 10.1016/0165-3806(90)90181-W; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LOGAN C, 1992, DEV GENET, V13, P345, DOI 10.1002/dvg.1020130505; MARTINEZ S, 1990, DEV BIOL, V139, P432, DOI 10.1016/0012-1606(90)90312-7; MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; NAKAMURA H, 1986, CELL DIFFER DEV, V19, P187, DOI 10.1016/0045-6039(86)90095-3; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; THANOS S, 1987, J COMP NEUROL, V261, P155, DOI 10.1002/cne.902610114; VONBOXBERG Y, 1993, NEURON, V10, P345; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	42	111	114	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					55	62		10.1016/S0896-6273(00)80023-9	http://dx.doi.org/10.1016/S0896-6273(00)80023-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562091	Bronze			2022-12-28	WOS:A1996TT30700009
J	WU, LG; SAGGAU, P				WU, LG; SAGGAU, P			ADENOSINE INHIBITS EVOKED SYNAPTIC TRANSMISSION PRIMARILY BY REDUCING PRESYNAPTIC CALCIUM INFLUX IN AREA CA1 OF HIPPOCAMPUS	NEURON			English	Article							INVITRO RAT HIPPOCAMPUS; CENTRAL-NERVOUS-SYSTEM; PYRAMIDAL NEURONS; GLUTAMATE RELEASE; 8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE DPCPX; POSTTETANIC POTENTIATION; NEUROTRANSMITTER RELEASE; EPILEPTIFORM ACTIVITY; TRANSMITTER RELEASE; ADENYLATE-CYCLASE	Adenosine is a potent modulator of neuronal activity throughout the nervous system. Previous evidence suggests that adenosine presynaptically inhibits synaptic transmission. The mechanism of presynaptic inhibition is uncertain. Adenosine may inhibit transmitter release by reducing voltage-dependent Ca2+ currents, activating K+ currents, or by mechanisms downstream to Ca2+ influx. By simultaneously recording the presynaptic Ca2+ transient ([Ca](t)) and the field excitatory postsynaptic potential (fEPSP) at CA3-CA1 synapses of hippocampal slices, we found that adenosine, through activation of presynaptic A(1) receptors, inhibits the fEPSP primarily by reducing the [Ca](t). Reduced [Ca](t) was due to inhibition of omega-conotoxin GVIA-sensitive and some unidentified Ca2+ channels, probably including Q-type, but not to omega-agatoxin-IVA-sensitive Ca2+ channels. The adenosine A(1) antagonist 8-cyclopentyl-1,3-dipropylxanthine enhanced both the [Ca](t) and the fEPSP, suggesting a tonic inhibition of the [Ca](t) by endogenous adenosine in the hippocampal slice.			WU, LG (corresponding author), BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA.							ALZHEIMER C, 1989, NEUROSCI LETT, V99, P107, DOI 10.1016/0304-3940(89)90273-5; AULT B, 1986, BRIT J PHARMACOL, V87, P695, DOI 10.1111/j.1476-5381.1986.tb14587.x; BROWN TH, 1990, SYNAPTIC ORG BRAIN, P34; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CORRADETTI R, 1984, EUR J PHARMACOL, V104, P19, DOI 10.1016/0014-2999(84)90364-9; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DOLPHIN AC, 1983, NEUROSCI LETT, V43, P49, DOI 10.1016/0304-3940(83)90127-1; DOLPHIN AC, 1985, NATURE, V316, P148, DOI 10.1038/316148a0; DOLPHIN AC, 1986, J PHYSIOL-LONDON, V373, P47, DOI 10.1113/jphysiol.1986.sp016034; DUNWIDDIE TV, 1989, J PHARMACOL EXP THER, V249, P31; DUNWIDDIE TV, 1980, EPILEPSIA, V21, P541, DOI 10.1111/j.1528-1157.1980.tb04305.x; DUNWIDDIE TV, 1980, BRIT J PHARMACOL, V69, P59, DOI 10.1111/j.1476-5381.1980.tb10883.x; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; DUNWIDDIE TV, 1985, INT REV NEUROBIOL, V27, P63, DOI 10.1016/S0074-7742(08)60556-5; DUNWIDDIE TV, 1981, N-S ARCH PHARMACOL, V316, P326, DOI 10.1007/BF00501365; FREDHOLM BB, 1986, ACTA PHYSIOL SCAND, V127, P381, DOI 10.1111/j.1748-1716.1986.tb07918.x; GERBER U, 1989, J PHYSIOL-LONDON, V417, P567, DOI 10.1113/jphysiol.1989.sp017819; GINSBORG BL, 1972, J PHYSIOL-LONDON, V224, P629, DOI 10.1113/jphysiol.1972.sp009916; GREENE RW, 1991, PROG NEUROBIOL, V36, P329, DOI 10.1016/0301-0082(91)90005-L; GREENE RW, 1985, J PHYSIOL-LONDON, V366, P119, DOI 10.1113/jphysiol.1985.sp015788; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; JARVIS MF, 1989, EUR J PHARMACOL, V168, P243, DOI 10.1016/0014-2999(89)90571-2; KAMIYA H, 1991, SYNAPSE, V8, P229, DOI 10.1002/syn.890080309; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; LOHSE MJ, 1987, N-S ARCH PHARMACOL, V336, P204, DOI 10.1007/BF00165806; LUPICA CR, 1992, J NEUROSCI, V12, P3753; MACDONALD RL, 1986, J PHYSIOL-LONDON, V370, P75, DOI 10.1113/jphysiol.1986.sp015923; MALENKA RC, 1988, J NEUROSCI, V8, P3750; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOGUL DJ, 1993, NEURON, V10, P327, DOI 10.1016/0896-6273(93)90322-I; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OKADA Y, 1980, EUR J PHARMACOL, V68, P483; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; PROCTOR WR, 1987, BRAIN RES, V426, P187, DOI 10.1016/0006-8993(87)90441-0; PROCTOR WR, 1983, NEUROSCI LETT, V35, P197, DOI 10.1016/0304-3940(83)90550-5; PULL I, 1972, BIOCHEM J, V130, P975, DOI 10.1042/bj1300975; REDDINGTON M, 1982, NEUROSCI LETT, V28, P275, DOI 10.1016/0304-3940(82)90070-2; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; RIBEIRO JA, 1975, BRIT J PHARMACOL, V54, P213, DOI 10.1111/j.1476-5381.1975.tb06931.x; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLFIELD CN, 1978, BRIT J PHARMACOL, V63, P239, DOI 10.1111/j.1476-5381.1978.tb09752.x; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V435, P373, DOI 10.1113/jphysiol.1991.sp018515; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SCHUBERT P, 1986, BRAIN RES, V376, P382, DOI 10.1016/0006-8993(86)90204-0; SCHUBERT P, 1979, BRAIN RES, V172, P186, DOI 10.1016/0006-8993(79)90910-7; SIGGINS GR, 1981, NEUROSCI LETT, V23, P55, DOI 10.1016/0304-3940(81)90186-5; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SMITH DO, 1991, J PHYSIOL-LONDON, V432, P343, DOI 10.1113/jphysiol.1991.sp018388; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; TRUSSELL LO, 1985, P NATL ACAD SCI USA, V82, P4857, DOI 10.1073/pnas.82.14.4857; WHEELER DB, 1994, IN PRESS SCIENCE; WIERASZKO A, 1989, BRAIN RES, V485, P244, DOI 10.1016/0006-8993(89)90567-2; WU LG, 1994, J NEUROSCI, V14, P645; WU LG, 1994, IN PRESS J NEUROSCI; YAMAMOTO C, 1993, HIPPOCAMPUS, V3, P87, DOI 10.1002/hipo.450030109; YAWO H, 1993, NATURE, V365, P256, DOI 10.1038/365256a0; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	61	315	321	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1994	12	5					1139	1148		10.1016/0896-6273(94)90321-2	http://dx.doi.org/10.1016/0896-6273(94)90321-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185949				2022-12-28	WOS:A1994NM83100017
J	ZIMMERMAN, L; LENDAHL, U; CUNNINGHAM, M; MCKAY, R; PARR, B; GAVIN, B; MANN, J; VASSILEVA, G; MCMAHON, A				ZIMMERMAN, L; LENDAHL, U; CUNNINGHAM, M; MCKAY, R; PARR, B; GAVIN, B; MANN, J; VASSILEVA, G; MCMAHON, A			INDEPENDENT REGULATORY ELEMENTS IN THE NESTIN GENE DIRECT TRANSGENE EXPRESSION TO NEURAL STEM-CELLS OR MUSCLE PRECURSORS	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE FILAMENT PROTEIN; ASTROCYTE-SPECIFIC EXPRESSION; NEUROFILAMENT GENE; DIFFERENTIATION; PROMOTER; ENHANCER; IDENTIFICATION; HYBRIDIZATION; PROLIFERATION	Changes in intermediate filament gene expression occur at key steps in the differentiation of cell types in the mammalian CNS. Neuroepithelial stem cells express the intermediate filament protein nestin and down-regulate it sharply at the transition from proliferating stem cell to postmitotic neuron. Nestin is also expressed in muscle precursors but not in mature muscle cells. We show here that in transgenic mice, independent cell type-specific elements in the first and second introns of the nestin gene consistently direct reporter gene expression to developing muscle and neural precursors, respectively. The second intron contains an enhancer that functions in CNS stem cells, suggesting that there may be a single transcriptional mechanism regulating the CNS stem cell state. This enhancer is much less active in the PNS. The identification of these elements facilitates analysis of mechanisms controlling the switch in gene expression that occurs when muscle and brain precursors terminally differentiate.	MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139; ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110	Massachusetts Institute of Technology (MIT)			Vassileva, Galya/A-6807-2009					BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BESNARD F, 1991, J BIOL CHEM, V266, P18877; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHING GY, 1991, J BIOL CHEM, V266, P19459; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; HAYES TE, 1991, NEW BIOL, V3, P259; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOGAN B, 1986, MANIPULATING MOUSE E; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUNT P, 1991, DEVELOPMENT S, V1, P187; JULIEN JP, 1987, BIOCHIM BIOPHYS ACTA, V909, P10, DOI 10.1016/0167-4781(87)90041-8; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MIURA M, 1990, J NEUROCHEM, V55, P1180, DOI 10.1111/j.1471-4159.1990.tb03123.x; MUCKE L, 1991, NEW BIOL, V3, P465; NAKAHIRA K, 1990, J BIOL CHEM, V265, P19786; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; OSHIMA RG, 1990, GENE DEV, V4, P835, DOI 10.1101/gad.4.5.835; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; Sambrook J, 1989, MOL CLONING LABORATO; TAKEMOTO Y, 1991, NUCLEIC ACIDS RES, V19, P2761, DOI 10.1093/nar/19.10.2761; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; ZENKE M, 1986, EMBO J, V5, P387, DOI 10.1002/j.1460-2075.1986.tb04224.x; ZOPF D, 1990, NUCLEIC ACIDS RES, V18, P521, DOI 10.1093/nar/18.3.521	31	486	526	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					11	24		10.1016/0896-6273(94)90148-1	http://dx.doi.org/10.1016/0896-6273(94)90148-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292356				2022-12-28	WOS:A1994MU49300002
J	TOMASIEWICZ, H; ONO, K; YEE, DL; THOMPSON, C; GORIDIS, C; RUTISHAUSER, U; MAGNUSON, T				TOMASIEWICZ, H; ONO, K; YEE, DL; THOMPSON, C; GORIDIS, C; RUTISHAUSER, U; MAGNUSON, T			GENETIC DELETION OF A NEURAL CELL-ADHESION MOLECULE VARIANT (N-CAM-180) PRODUCES DISTINCT DEFECTS IN THE CENTRAL-NERVOUS-SYSTEM	NEURON			English	Article							EMBRYONIC STEM-CELLS; GERM-LINE TRANSMISSION; N-CAM; NEURITE OUTGROWTH; POLYSIALIC ACID; TRANSMEMBRANE DISPOSITION; RETINOTECTAL PROJECTION; SURFACE MODULATION; CYTOPLASMIC DOMAIN; 180-KD COMPONENT	N-CAM is abundantly expressed in the nervous system in the form of numerous structural variants with characteristic distribution patterns and functional properties. N-CAM-180, the variant having the largest cytoplasmic domain, is expressed by all neurons. The N-CAM-180-specific exon 18 has been deleted to generate homozygous mice unable to express this N-CAM form. The most conspicuous mutant phenotype was in the olfactory bulb, where granule cells were both reduced in number and disorganized. In addition, precursors of these cells were found to be accumulated at their origin in the subependymal zone at the lateral ventricle. Analysis of the mutant in this region suggests that the mutant phenotype involves a defect in cell migration, possibly through specific loss of the polysialylated form of N-CAM-180, which is expressed in the migration pathway. Subtle but distinct abnormalities also were observed in other regions of the brain.	CNRS,CTR IMMUNOL,INSERM,F-13288 MARSEILLE 9,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	TOMASIEWICZ, H (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106, USA.				NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD26722, HD18369] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369, R01HD026722] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006107] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BRONNERFRASER M, 1992, DEV BIOL, V153, P291, DOI 10.1016/0012-1606(92)90114-V; BRUNJES PC, 1986, BRAIN RES REV, V11, P1, DOI 10.1016/0165-0173(86)90008-1; BUSKIRK DR, 1980, NATURE, V285, P488, DOI 10.1038/285488a0; CALEY DW, 1973, AM J ANAT, V133, P179; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CHUONG CM, 1984, J NEUROSCI, V4, P2354; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; DOHERTY P, 1992, J NEUROCHEM, V58, P2338, DOI 10.1111/j.1471-4159.1992.tb10984.x; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FRASER SE, 1988, DEV BIOL, V129, P217, DOI 10.1016/0012-1606(88)90176-5; FREDETTE B, 1993, IN PRESS J CELL BIOL; FREI T, 1992, J CELL BIOL, V118, P177, DOI 10.1083/jcb.118.1.177; GENNARINI G, 1984, EUR J BIOCHEM, V142, P65, DOI 10.1111/j.1432-1033.1984.tb08251.x; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; GENNARINI G, 1986, J NEUROSCI, V6, P1983; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; INOUYE M, 1980, J COMP NEUROL, V190, P357, DOI 10.1002/cne.901900209; KEY B, 1991, NEURON, V6, P381, DOI 10.1016/0896-6273(91)90247-W; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; KOHLER BH, 1989, P NATL ACAD SCI USA, V86, P8927; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MAXWELL IH, 1986, CANCER RES, V46, P4660; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MIRAGALL F, 1990, J NEUROCYTOL, V19, P889; MURRAY BA, 1986, J CELL BIOL, V103, P1431, DOI 10.1083/jcb.103.4.1431; NOBLE M, 1985, NATURE, V316, P725, DOI 10.1038/316725a0; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; RUTISHAUSER U, 1980, J CELL BIOL, V87, P370, DOI 10.1083/jcb.87.2.370; RUTISHAUSER U, 1983, J CELL BIOL, V97, P145, DOI 10.1083/jcb.97.1.145; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; RUTISHAUSER U, 1991, RECEPTORS EXTRACELLU, P132; RUTISHAUSER U, 1993, CURR OPIN NEUROBIOL, V3, P7096; SADOUL R, 1983, NATURE, V304, P347, DOI 10.1038/304347a0; SANTONI MJ, 1987, NUCLEIC ACIDS RES, V15, P8621, DOI 10.1093/nar/15.21.8621; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; SHIGA T, 1983, ANAT EMBRYOL, V167, P203, DOI 10.1007/BF00298511; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SMALL SJ, 1988, NEURON, V1, P1007, DOI 10.1016/0896-6273(88)90158-4; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMPSON J, 1989, GENE DEV, V3, P348, DOI 10.1101/gad.3.3.348; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TOSNEY KW, 1986, DEV BIOL, V114, P468; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992	68	434	446	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1163	1174		10.1016/0896-6273(93)90228-J	http://dx.doi.org/10.1016/0896-6273(93)90228-J			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274281				2022-12-28	WOS:A1993MP54800016
J	TAKEUCHI, J; SHANNON, W; ARONIN, N; SCHWARTZ, WJ				TAKEUCHI, J; SHANNON, W; ARONIN, N; SCHWARTZ, WJ			COMPOSITIONAL CHANGES OF AP-1 DNA-BINDING PROTEINS ARE REGULATED BY LIGHT IN A MAMMALIAN CIRCADIAN CLOCK	NEURON			English	Article							TRANSCRIPTION FACTOR AP-1; EARLY GENE-EXPRESSION; IMMEDIATE EARLY GENES; C-JUN; SUPRACHIASMATIC NUCLEUS; DIFFERENTIAL EXPRESSION; MESSENGER-RNAS; PHOTIC REGULATION; INDUCED SEIZURES; FOS EXPRESSION	Recent reports have shown that the nuclear phosphoprotein Fos is induced by light in a mammalian circadian clock, the suprachiasmatic nucleus. To learn how light and circadian phase affect the binding of Fos to DNA, we analyzed the photic and temporal regulation of immunoreactive Jun protein expression and AP-1 DNA-binding activity in the rat suprachiasmatic nucleus. Immunohistochemistry and gel mobility shift assays suggest that AP-1 activity during the night and after a light pulse consists of constant, as well as variable, protein components; JunD could be identified as a constituent of both dark- and light-activated binding complexes, whereas binding by JunB and Fos could be implicated only after photic stimulation. Since JunD or JunB could be colocalized with Fos in individual suprachiasmatic nucleus cell nuclei, light may be acting in at least some suprachiasmatic nucleus cells by altering AP-1 protein composition rather than binding site occupancy.	UNIV MASSACHUSETTS,SCH MED,DEPT MED,WORCESTER,MA 01655	University of Massachusetts System; University of Massachusetts Worcester	TAKEUCHI, J (corresponding author), UNIV MASSACHUSETTS,SCH MED,DEPT NEUROL,WORCESTER,MA 01655, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024542] Funding Source: NIH RePORTER; NINDS NIH HHS [NINDS R01 NS 24542] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AN G, 1993, ANN NEUROL, V33, P457, DOI 10.1002/ana.410330508; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ARONIN N, 1990, P NATL ACAD SCI USA, V87, P5959, DOI 10.1073/pnas.87.15.5959; ARONIN N, 1991, SUPRACHIASMATIC NUCL, P445; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BENBROOK DM, 1990, ONCOGENE, V5, P295; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRIATA P, 1993, EXP CELL RES, V204, P136, DOI 10.1006/excr.1993.1018; CARTER DA, 1992, MOL BRAIN RES, V16, P111, DOI 10.1016/0169-328X(92)90200-U; CARTER MS, 1990, J NEUROSCI, V10, P2203; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLWELL CS, 1993, J NEUROSCI, V13, P1454; CUTRERA RA, 1993, BRAIN RES, V602, P14, DOI 10.1016/0006-8993(93)90235-F; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EARNEST DJ, 1990, EXP NEUROL, V109, P353, DOI 10.1016/S0014-4886(05)80027-5; GASS P, 1992, NEUROSCIENCE, V48, P315, DOI 10.1016/0306-4522(92)90493-L; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HERDEGEN T, 1991, NEUROSCIENCE, V45, P413, DOI 10.1016/0306-4522(91)90237-I; HERDEGEN T, 1991, J COMP NEUROL, V313, P178, DOI 10.1002/cne.903130113; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; JANIK D, 1992, NEUROREPORT, V3, P575, DOI 10.1097/00001756-199207000-00007; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KILDUFF TS, 1992, MOL BRAIN RES, V16, P47, DOI 10.1016/0169-328X(92)90192-E; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KOBIERSKI LA, 1991, P NATL ACAD SCI USA, V88, P10222, DOI 10.1073/pnas.88.22.10222; KORNHAUSER JM, 1992, SCIENCE, V255, P1581, DOI 10.1126/science.1549784; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Kornhauser JM, 1993, MOL GENETICS BIOL RH, P271; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; MEAD S, 1992, J NEUROSCI, V12, P2516; MELLSTROM B, 1991, ONCOGENE, V6, P1959; MORATALLA R, 1993, J NEUROSCI, V13, P423; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MURPHY TH, 1991, J NEUROCHEM, V57, P1862, DOI 10.1111/j.1471-4159.1991.tb06396.x; NARANJO JR, 1991, ONCOGENE, V6, P223; PENNYPACKER KR, 1992, J BIOL CHEM, V267, P20148; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; REA MA, 1989, BRAIN RES BULL, V23, P577, DOI 10.1016/0361-9230(89)90204-9; ROSEN KM, 1992, P NATL ACAD SCI USA, V89, P5437, DOI 10.1073/pnas.89.12.5437; RUSAK B, 1992, MOL BRAIN RES, V14, P124, DOI 10.1016/0169-328X(92)90019-8; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; RUSAK B, 1992, SCIENCE, V14, P124; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1991, ONCOGENE, V6, P533; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; SONNENBERG JL, 1989, J NEUROSCI RES, V24, P72, DOI 10.1002/jnr.490240111; TAKATSUJI K, 1991, BRAIN RES, V568, P223, DOI 10.1016/0006-8993(91)91401-L; UHL GR, 1991, MOL BRAIN RES, V11, P133, DOI 10.1016/0169-328X(91)90115-E; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y	63	77	78	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					825	836		10.1016/0896-6273(93)90112-5	http://dx.doi.org/10.1016/0896-6273(93)90112-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240806				2022-12-28	WOS:A1993MJ04100004
J	CHANG, GQ; HAO, Y; WONG, F				CHANG, GQ; HAO, Y; WONG, F			APOPTOSIS - FINAL COMMON PATHWAY OF PHOTORECEPTOR DEATH IN RD, RDS, AND RHODOPSIN MUTANT MICE	NEURON			English	Article							PROGRAMMED CELL-DEATH; DEGENERATION SLOW RDS; DOMINANT RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; ENDONUCLEASE ACTIVATION; CGMP-PHOSPHODIESTERASE; BETA-SUBUNIT; MOUSE RETINA; ONE FORM; GENE	Mutations in the retinal degeneration, retinal degeneration slow(/peripherin) and rhodopsin genes cause photoreceptor degeneration in humans and mice. Although the phenotypes arising from these mutations are different, suggesting different mechanisms of pathogenesis, we present evidence that apoptosis may be the final common pathway of the disease process linking genotype to phenotype. We observed internucleosomal cleavage of retinal DNA by gel electrophoresis and fragmented DNA at the single cell level by labeling the nicked DNA ends with biotinylated poly(dU). In retinal degeneration mice, DNA fragmentation occurred during the period of photoreceptor degeneration. In retinal degeneration slow mice and in transgenic mice expressing a mutant (Pro347Ser) rhodopsin gene, DNA fragmentation occurred after normal histogenetic cell death (also apoptosis) had ceased. Since DNA fragmentation by internucleosomal cleavage is a cardinal feature of apoptosis, our data suggest that all three of these genetic mutations lead to apoptosis.	DUKE UNIV, SCH MED, DEPT NEUROBIOL, DURHAM, NC 27710 USA	Duke University	CHANG, GQ (corresponding author), DUKE UNIV, SCH MED, DEPT OPHTHALMOL, DURHAM, NC 27710 USA.				NEI NIH HHS [NEI R55 EY09047, NEI RO1 EY06862] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006862, R55EY009047] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allen T.D., 1987, P39; ALLES A, 1991, FASEB J, V5, P2127, DOI 10.1096/fasebj.5.8.2022310; ARENDS MJ, 1990, AM J PATHOL, V136, P593; Battey, 1986, BASIC METHODS MOL BI; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BRUNE B, 1991, EXP CELL RES, V195, P323, DOI 10.1016/0014-4827(91)90380-D; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CHADER GJ, 1988, RETINAL DISEASES BIO, P80; COHEN JJ, 1991, ADV IMMUNOL, V50, P55; COHEN JJ, 1984, J IMMUNOL, V132, P38; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FINLAY BL, 1992, J NEUROBIOL, V23, P1159, DOI 10.1002/neu.480230908; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GERSCHENSON LE, 1992, FASEB J, V6, P2450, DOI 10.1096/fasebj.6.7.1563596; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; GLUCKSMANN A., 1965, AFCH BIOL, V76, P419; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; HEINTZ N, 1993, TRENDS BIOCHEM SCI, V18, P157, DOI 10.1016/0968-0004(93)90103-T; HOGAN B, 1986, MANIPULATING MOUSE G, P176; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; Kerr J. F., 1991, APOPTOSIS MOL BASIS, V3, P5; Kerr J.F.R., 1987, P93; LOCKSHIN RA, 1992, ANN NY ACAD SCI, V663, P234, DOI 10.1111/j.1749-6632.1992.tb38667.x; Martin Seamus J., 1993, Trends in Cell Biology, V3, P141, DOI 10.1016/0962-8924(93)90128-N; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; MCCONKEY DJ, 1990, FASEB J, V4, P2661, DOI 10.1096/fasebj.4.9.2347464; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; NICOLAOU KC, 1993, P NATL ACAD SCI USA, V90, P3142, DOI 10.1073/pnas.90.8.3142; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; RUBIN LL, 1993, CURR BIOL, V3, P391, DOI 10.1016/0960-9822(93)90211-6; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SCHMIDT SY, 1973, J CELL BIOL, V57, P117, DOI 10.1083/jcb.57.1.117; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; SHAHINFAR S, 1991, CURR EYE RES, V10, P47, DOI 10.3109/02713689109007610; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; WONG F, 1993, ARCH OPHTHALMOL-CHIC, V111, P754, DOI 10.1001/archopht.1993.01090060042020; Wyllie A.H., 1981, CELL DEATH BIOL PATH, P9; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	57	559	578	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1993	11	4					595	605		10.1016/0896-6273(93)90072-Y	http://dx.doi.org/10.1016/0896-6273(93)90072-Y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398150				2022-12-28	WOS:A1993MD06800005
J	LOVENBERG, TW; BARON, BM; DELECEA, L; MILLER, JD; PROSSER, RA; REA, MA; FOYE, PE; RACKE, M; SLONE, AL; SIEGEL, BW; DANIELSON, PE; SUTCLIFFE, JG; ERLANDER, MG				LOVENBERG, TW; BARON, BM; DELECEA, L; MILLER, JD; PROSSER, RA; REA, MA; FOYE, PE; RACKE, M; SLONE, AL; SIEGEL, BW; DANIELSON, PE; SUTCLIFFE, JG; ERLANDER, MG			A NOVEL ADENYLYL CYCLASE-ACTIVATING SEROTONIN RECEPTOR (5-HT7) IMPLICATED IN THE REGULATION OF MAMMALIAN CIRCADIAN-RHYTHMS	NEURON			English	Article							SUPRACHIASMATIC NUCLEI INVITRO; MESSENGER-RNA; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; FIRING RATE; AGONIST; FAMILY; PHASE; GENE; ACID	We report the cloning and characterization of a novel serotonin receptor, designated as 5-HT7, which is coupled to the stimulation of adenylyl cyclase. 5-HT7 mRNA is expressed discretely throughout the CNS, predominantly in the thalamus and hypothalamus. 5-HT7 has a unique pharmacological profile that redefines agonist and antagonist classification of ligands previously thought to be ''selective.'' The circadian phase of spontaneous neuronal activity of the rat suprachiasmatic nucleus of the hypothalamus advances in response to serotonin ligands with a pharmacological profile consistent exclusively with that of 5-HT7. These findings suggest a physiological role in the regulation of circadian rhythms for one subtype of serotonin receptor, 5-HT7, and provide a pharmacological test to evaluate its role in other neuronal systems.	MARION MERRELL DOW RES INST, CINCINNATI, OH 45215 USA; STANFORD UNIV, MED CTR, SCH MED, CTR SLEEP & CIRCADIAN NEUROBIOL, STANFORD, CA 94305 USA; ARMSTRONG LAB, CIRCADIAN NEUROBIOL RES GRP, BROOKS AFB, TX 78235 USA	Dow Chemical Company; Stanford University; United States Department of Defense; United States Air Force	LOVENBERG, TW (corresponding author), Scripps Res Inst, RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA.		de Lecea, Luis/ABE-4005-2021; de Lecea, Luis/B-3171-2009	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942; Prosser, Rebecca/0000-0003-1636-7272	NINDS NIH HHS [NS08905, R01 NS22347] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008905] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADHAM N, 1993, P NATL ACAD SCI USA, V90, P408, DOI 10.1073/pnas.90.2.408; ALBERT PR, 1990, J BIOL CHEM, V265, P5825; AMLAIKY N, 1992, J BIOL CHEM, V267, P19761; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARON BM, 1989, J NEUROCHEM, V53, P602, DOI 10.1111/j.1471-4159.1989.tb07376.x; BARON BM, 1990, MOL PHARMACOL, V38, P348; BOCKAERT J, 1992, TRENDS PHARMACOL SCI, V13, P141, DOI 10.1016/0165-6147(92)90051-7; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EDGAR DM, 1993, J BIOL RHYTHM, V8, P17, DOI 10.1177/074873049300800102; ERLANDER MG, 1993, P NATL ACAD SCI USA, V90, P3452, DOI 10.1073/pnas.90.8.3452; FARGIN A, 1989, J BIOL CHEM, V264, P14848; FOGUET M, 1992, EMBO J, V11, P3481, DOI 10.1002/j.1460-2075.1992.tb05427.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Gillette MU, 1991, SUPRACHIASMATIC NUCL, P125; GLENNON RA, 1988, EUR J PHARMACOL, V154, P339, DOI 10.1016/0014-2999(88)90212-9; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GUAN XM, 1992, MOL PHARMACOL, V41, P695; HUMPHREY PPA, 1993, IN PRESS TRENDS PHAR; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; LOVENBERG TW, 1993, P NATL ACAD SCI USA, V90, P2184, DOI 10.1073/pnas.90.6.2184; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MCALLISTER G, 1992, P NATL ACAD SCI USA, V89, P5517, DOI 10.1073/pnas.89.12.5517; MEDANIC M, 1992, J PHYSIOL-LONDON, V450, P629, DOI 10.1113/jphysiol.1992.sp019147; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MONSMA FJ, 1993, MOL PHARMACOL, V43, P320; PAZOS A, 1984, EUR J PHARMACOL, V106, P539, DOI 10.1016/0014-2999(84)90057-8; PLASSAT JL, 1992, EMBO J, V11, P4779, DOI 10.1002/j.1460-2075.1992.tb05583.x; PRITCHETT DB, 1988, EMBO J, V7, P4135, DOI 10.1002/j.1460-2075.1988.tb03308.x; PROSSER RA, 1990, BRAIN RES, V534, P336, DOI 10.1016/0006-8993(90)90153-3; PROSSER RA, 1993, J BIOL RHYTHM, V8, P1, DOI 10.1177/074873049300800101; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; SCHWARTZ WJ, 1993, ADV INTERNAL MED, V38, P8107; SHIBATA S, 1992, BRAIN RES, V582, P353, DOI 10.1016/0006-8993(92)90156-4; TOMINAGA K, 1992, EUR J PHARMACOL, V214, P79, DOI 10.1016/0014-2999(92)90099-P; TRUMPPKALLMEYER S, 1992, J MED CHEM, V35, P3448, DOI 10.1021/jm00097a002; VOIGT MM, 1991, EMBO J, V10, P4017, DOI 10.1002/j.1460-2075.1991.tb04977.x; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; ZGOMBICK JM, 1991, MOL PHARMACOL, V40, P1036; ZIFA E, 1992, PHARMACOL REV, V44, P401	52	643	677	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					449	458		10.1016/0896-6273(93)90149-L	http://dx.doi.org/10.1016/0896-6273(93)90149-L			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398139				2022-12-28	WOS:A1993LY49800005
J	CHIEN, CB; ROSENTHAL, DE; HARRIS, WA; HOLT, CE				CHIEN, CB; ROSENTHAL, DE; HARRIS, WA; HOLT, CE			NAVIGATIONAL ERRORS MADE BY GROWTH CONES WITHOUT FILOPODIA IN THE EMBRYONIC XENOPUS BRAIN	NEURON			English	Article							APPLIED ELECTRIC-FIELD; CYTOCHALASIN-B; GRASSHOPPER EMBRYOS; ACTIN-FILAMENTS; NEURITE GROWTH; RETINAL AXONS; NERVE GROWTH; AFFINITY; BEHAVIOR; NEURONS	We have developed an exposed brain preparation for observing growth cone pathfinding behavior while performing in vivo pharmacological manipulations, and we used it to test whether Xenopus retinal growth cones need filopodia to navigate. Time-lapse video observation showed that cytochalasin B acted quickly and reversibly when applied; cytochalasin B-treated growth cones lacked filopodia, but had active lamellipodia and continued to advance slowly. Whereas normal retinotectal axons visualized with horseradish peroxidase turn caudally in the mid-diencephalon to reach the tectum, cytochalasin B-treated axons grew past the normal turning point and, instead, continued straight within the diencephalon. In dose-response experiments, pathfinding became abnormal in the same concentration range in which filopodia disappeared. These results suggest that filopodia are necessary for retinal growth cones to respond to guidance signals in the diencephalon.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego	CHIEN, CB (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.			Holt, Christine Elizabeth/0000-0003-2829-121X				BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; BRAY D, 1985, J NEUROSCI, V5, P3204; CAUDY M, 1986, J NEUROSCI, V6, P1781; CAUDY M, 1986, J NEUROSCI, V6, P364; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; DAVENPORT RW, 1992, NEURON, V9, P405, DOI 10.1016/0896-6273(92)90179-H; EASTER SS, 1989, DEVELOPMENT, V107, P553; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; HARRIS WA, 1986, NATURE, V320, P266, DOI 10.1038/320266a0; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HARRIS WA, 1987, DEVELOPMENT, V101, P123; Heidemann S R, 1991, Curr Opin Neurobiol, V1, P339, DOI 10.1016/0959-4388(91)90050-H; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1984, J NEUROSCI, V4, P1130; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; KATZ MJ, 1985, J NEUROSCI, V5, P589; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LETOURNEAU PC, 1991, NERVE GROWTH CONE; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105; MCCAIG CD, 1989, J CELL SCI, V93, P715; NIUWKOOP PD, 1967, NORMAL TABLE XENOPUS; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; RAMPAL AL, 1980, BIOCHEMISTRY-US, V19, P679, DOI 10.1021/bi00545a011; RAPER JA, 1983, J NEUROSCI, V3, P20; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; STRITTMATTER SM, 1991, BIOESSAYS, V13, P127, DOI 10.1002/bies.950130306; SUZUKI N, 1991, J BIOCHEM, V110, P514, DOI 10.1093/oxfordjournals.jbchem.a123612; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; WESSELLS NK, 1978, EXP CELL RES, V115, P111, DOI 10.1016/0014-4827(78)90408-1	38	220	222	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					237	251		10.1016/0896-6273(93)90181-P	http://dx.doi.org/10.1016/0896-6273(93)90181-P			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352941				2022-12-28	WOS:A1993LU06500005
J	LAMANTIA, AS; COLBERT, MC; LINNEY, E				LAMANTIA, AS; COLBERT, MC; LINNEY, E			RETINOIC ACID INDUCTION AND REGIONAL DIFFERENTIATION PREFIGURE OLFACTORY PATHWAY FORMATION IN THE MAMMALIAN FOREBRAIN	NEURON			English	Article							NERVOUS-SYSTEM; MOUSE EMBRYOS; NEURAL-TUBE; FLOOR PLATE; POLARIZING ACTIVITY; BINDING-PROTEINS; EXPRESSION; PATTERN; MORPHOGENESIS; HINDBRAIN	We have used an in vitro assay to identify sources of retinoic acid (RA) and transgenic mice to identify target domains in the developing forebrain. RA participates in a sequence of events that leads to the establishment of the olfactory pathway. First, the lateral cranial mesoderm activates an RA-inducible transgene in neuroepithelial cells in the olfactory placode and the ventrolateral forebrain. Then, neurons and neurites begin to differentiate in these two regions. Finally, olfactory axons grow specifically into the ventrolateral forebrain and subsequently are limited to the olfactory bulb rudiment. The coordination of these events, perhaps by common signals, implies that retinoid induction and retinoid-activated region-specific transcriptional regulation may help to define a forebrain subdivision and the peripheral neurons that provide its primary innervation.	DUKE UNIV, MED CTR, DEPT MICROBIOL, DURHAM, NC 27710 USA	Duke University	LAMANTIA, AS (corresponding author), DUKE UNIV, MED CTR, DEPT CHEM & NUCL ENGN, DURHAM, NC 27710 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD007637, R29HD029178, R01HD029178] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039066] Funding Source: NIH RePORTER; NCI NIH HHS [CA39066] Funding Source: Medline; NICHD NIH HHS [HD07637, HD29178-01A1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTABA ARI, 1991, DEVELOPMENT, V112, P945; BALKAN W, 1992, P NATL ACAD SCI USA, V89, P3347, DOI 10.1073/pnas.89.8.3347; Bartelmez G. W., 1962, CONTRIB EMBRYOL CARN, V37, P13; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; BRYANT SV, 1992, DEV BIOL, V152, P1, DOI 10.1016/0012-1606(92)90152-7; BULFONE A, 1993, IN PRESS J NEUROSCI; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; COLBERT MC, 1993, P NATL ACAD SCI US; CONLON RA, 1992, DEVELOPMENT, V116, P357; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOLLE P, 1990, DEVELOPMENT, V110, P1133; EASTER SS, 1993, J NEUROSCI, V13, P285; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; ESPESETH AS, 1989, GENE DEV, V3, P1647, DOI 10.1101/gad.3.11.1647; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GURDON JB, 1987, DEVELOPMENT, V99, P285; GUSTAFSON AL, 1993, DEVELOPMENT, V117, P451; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; KAPRONBRAS CM, 1985, TERATOLOGY, V32, P87, DOI 10.1002/tera.1420320112; KESSEL M, 1993, NEURON, V10, P379, DOI 10.1016/0896-6273(93)90328-O; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LINNEY E, 1992, CURR TOP DEV BIOL, V27, P309, DOI 10.1016/S0070-2153(08)60538-4; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MADEN M, 1991, DEVELOPMENT, P87; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; MOASE CE, 1991, DEVELOPMENT, V113, P1049; MORRISSKAY GM, 1991, EMBO J, V10, P2985, DOI 10.1002/j.1460-2075.1991.tb07849.x; PAPALOPULU N, 1991, NUCLEIC ACIDS RES, V19, P5497, DOI 10.1093/nar/19.20.5497; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; POPPERL H, 1993, MOL CELL BIOL, V13, P257; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; REYNOLDS K, 1991, MECH DEVELOP, V36, P15, DOI 10.1016/0925-4773(91)90068-H; RICHMAN JM, 1992, DEV BIOL, V154, P299, DOI 10.1016/0012-1606(92)90069-S; RICHMAN JM, 1989, DEV BIOL, V136, P201, DOI 10.1016/0012-1606(89)90142-5; ROSS LS, 1992, J NEUROSCI, V12, P467; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; RUBERTE E, 1991, DEVELOPMENT, V111, P45; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SHARPE CR, 1991, NEURON, V7, P239, DOI 10.1016/0896-6273(91)90262-X; SHENEFELT RE, 1972, TERATOLOGY, V5, P103, DOI 10.1002/tera.1420050115; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SNYDER DC, 1991, J NEUROBIOL, V22, P897, DOI 10.1002/neu.480220903; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; SULIK KK, 1988, DEVELOPMENT, V103, P213; USMANN M, 1989, DEV BIOL, V136, P194; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WAGNER M, 1992, DEVELOPMENT, V116, P55; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILSON SW, 1990, DEVELOPMENT, V108, P121; Windle WF., 1970, EXP NEUROL S, V28, P44; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; ZIMMER A, 1992, DEVELOPMENT, V116, P977	67	136	139	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1993	10	6					1035	1048		10.1016/0896-6273(93)90052-S	http://dx.doi.org/10.1016/0896-6273(93)90052-S			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318228				2022-12-28	WOS:A1993LK37300004
J	FUJITA, Y; MYNLIEFF, M; DIRKSEN, RT; KIM, MS; NIIDOME, T; NAKAI, J; FRIEDRICH, T; IWABE, N; MIYATA, T; FURUICHI, T; FURUTAMA, D; MIKOSHIBA, K; MORI, Y; BEAM, KG				FUJITA, Y; MYNLIEFF, M; DIRKSEN, RT; KIM, MS; NIIDOME, T; NAKAI, J; FRIEDRICH, T; IWABE, N; MIYATA, T; FURUICHI, T; FURUTAMA, D; MIKOSHIBA, K; MORI, Y; BEAM, KG			PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION OF THE OMEGA-CONOTOXIN-SENSITIVE N-TYPE CALCIUM-CHANNEL FROM RABBIT BRAIN	NEURON			English	Article							CHICK SENSORY NEURONS; DYSGENIC SKELETAL-MUSCLE; DIHYDROPYRIDINE RECEPTOR; SODIUM-CHANNEL; BETA-SUBUNIT; ACETYLCHOLINE-RECEPTOR; PERIPHERAL NEURONS; COMPLEMENTARY-DNA; GVIA RECEPTOR; CA2+ CHANNELS	The complete amino acid sequence of a rabbit brain calcium channel (BIII) has been deduced by cloning and sequencing the cDNA. The open reading frame encodes 2339 amino acids, which corresponds to an M(r) of 261,167. A phylogenetic tree representing evolutionary relationships indicates that BIII is grouped together with the other rabbit brain calcium channels, BI and BII, into a subfamily that is distinct from the dihydropyridine-sensitive L-type subfamily. Transient expression in cultured skeletal muscle myotubes derived from muscular dysgenic mice demonstrates that the BIII channel mediates an omega-conotoxin-sensitive calcium current with kinetics and voltage dependence like those previously reported for whole-cell N-type current. Cell-attached patch recordings, with isotonic barium as the charge carrier, revealed distinct single channels with an average slope conductance of 14.3 pS.	KYOTO UNIV, FAC MED, DEPT MOLEC GENET, KYOTO 60601, JAPAN; COLORADO STATE UNIV, COLL VET MED & BIOMED SCI, DEPT PHYSIOL, FT COLLINS, CO 80523 USA; KYOTO UNIV, FAC SCI, DEPT BIOPHYS, KYOTO 60601, JAPAN; UNIV TOKYO, INST MED SCI, DEPT MOLEC NEUROBIOL, TOKYO 108, JAPAN	Kyoto University; Colorado State University; Kyoto University; University of Tokyo	FUJITA, Y (corresponding author), KYOTO UNIV, FAC MED, DEPT MED CHEM, KYOTO 60601, JAPAN.		Nakai, Junichi/GQZ-6415-2022; Mikoshiba, Katsuhiko/N-7943-2015; Furuichi, Teiichi/B-5086-2014	Furuichi, Teiichi/0000-0002-9676-1888	NINDS NIH HHS [NS-26416, NS-24444] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026416, R01NS024444] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE T, 1987, J BIOL CHEM, V262, P9877; ADAMS BA, 1989, J GEN PHYSIOL, V94, P429, DOI 10.1085/jgp.94.3.429; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; ARTALEJO CR, 1992, NEURON, V8, P85, DOI 10.1016/0896-6273(92)90110-Y; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; BEAM KG, 1988, J GEN PHYSIOL, V91, P781, DOI 10.1085/jgp.91.6.781; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHANG FC, 1988, J BIOL CHEM, V263, P18929; CRUZ LJ, 1987, BIOCHEMISTRY-US, V26, P820, DOI 10.1021/bi00377a024; DIRKSEN RT, 1993, IN PRESS BIOPHYS J; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FURUICHI T, 1993, IN PRESS RECEPTORS C; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOFMANN F, 1990, N-S ARCH PHARMACOL, V341, P200; HONG SJ, 1992, NEUROSCIENCE, V48, P727, DOI 10.1016/0306-4522(92)90416-Y; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; ITAGAKI K, 1992, FEBS LETT, V297, P221, DOI 10.1016/0014-5793(92)80542-O; Kimura M, 1983, NEUTRAL THEORY MOL E, P55; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MARQUEZE B, 1988, MOL PHARMACOL, V34, P87; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MYNLIEFF M, 1992, J NEUROPHYSIOL, V68, P85, DOI 10.1152/jn.1992.68.1.85; NIIDOME T, 1992, FEBS LETT, V308, P7, DOI 10.1016/0014-5793(92)81038-N; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; NUMA S, 1986, ANN NY ACAD SCI, V479, P338, DOI 10.1111/j.1749-6632.1986.tb15580.x; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PLUMMER MR, 1991, NATURE, V351, P657, DOI 10.1038/351657a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHNEIDER T, 1988, EUR J BIOCHEM, V174, P369, DOI 10.1111/j.1432-1033.1988.tb14107.x; SCHROEDER JE, 1990, NEURON, V5, P445, DOI 10.1016/0896-6273(90)90083-R; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YOSHIDA A, 1990, J BIOCHEM, V107, P608, DOI 10.1093/oxfordjournals.jbchem.a123094	82	219	223	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1993	10	4					585	598		10.1016/0896-6273(93)90162-K	http://dx.doi.org/10.1016/0896-6273(93)90162-K			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386525				2022-12-28	WOS:A1993KY50100004
J	MELLSTROM, B; NARANJO, JR; FOULKES, NS; LAFARGA, M; SASSONECORSI, P				MELLSTROM, B; NARANJO, JR; FOULKES, NS; LAFARGA, M; SASSONECORSI, P			TRANSCRIPTIONAL RESPONSE TO CAMP IN BRAIN - SPECIFIC DISTRIBUTION AND INDUCTION OF CREM ANTAGONISTS	NEURON			English	Article							MULTIPLE SEQUENCE ELEMENTS; IMMEDIATE EARLY GENES; NUCLEAR FACTOR CREB; FOS MESSENGER-RNA; C-FOS; CYCLIC-AMP; BINDING-PROTEINS; NERVOUS-SYSTEM; SPINAL-CORD; EXPRESSION	Changes in cAMP levels are often associated with the modulation of neuronal function. The CREM gene encodes both antagonists and activators of the cAMP-dependent transcriptional response by alternative splicing. CREM transcripts in rat brain show a characteristic pattern of expression, being specific for the inner layer of the cerebral cortex, anterior thalamus, hippocampus, and hypothalamus. Strikingly, the CREM transcripts correspond to the antagonist isoforms in these areas, suggesting a down-regulatory role for CREM in brain; in contrast, the expression of CREMtau and CREB activators is more diffuse and generalized. In the supraoptic nucleus, CREM expression is induced after osmotic stimulus. Importantly, this demonstrates physiological inducibility of CREM, which is novel within the CRE/ATF family.	FAC MED STRASBOURG,CNRS,UA184,GENET MOLEC EUCARYOTES LAB,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; UNIV CANTABRIA,FAC MED,DEPT ANAT & BIOL CELULAR,E-39011 SANTANDER,SPAIN	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidad de Cantabria	MELLSTROM, B (corresponding author), CSIC,AVE DR ARCE 37,E-28002 MADRID,SPAIN.		Lafarga, Miguel/K-3733-2014; Foulkes, Nicholas S/K-7003-2013; NARANJO, Jose R/K-1950-2014	Foulkes, Nicholas S/0000-0002-1794-9891; NARANJO, Jose R/0000-0002-0270-3469; Lafarga, Miguel/0000-0003-3402-1152				ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; BORRELLI E, 1992, Critical Reviews in Oncogenesis, V3, P321; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; CARTER DA, 1990, CELL MOL NEUROBIOL, V10, P435, DOI 10.1007/BF00711185; CARTER DA, 1989, BRAIN RES, V487, P350, DOI 10.1016/0006-8993(89)90839-1; COMB M, 1987, TRENDS NEUROSCI, V10, P473, DOI 10.1016/0166-2236(87)90103-2; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FOULKES NS, 1991, P NATL ACAD SCI USA, V88, P5448, DOI 10.1073/pnas.88.12.5448; FRAZER A, 1990, ANNU REV PHARMACOL, V30, P307; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GUBITS RM, 1989, MOL BRAIN RES, V6, P39, DOI 10.1016/0169-328X(89)90026-0; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HO YS, 1988, NUCLEIC ACIDS RES, V16, P7746, DOI 10.1093/nar/16.15.7746; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; LAFARGA M, 1992, IN PRESS NEUROSCIENC; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; LEWIN B, 1990, CELL, V61, P1161, DOI 10.1016/0092-8674(90)90675-5; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MELLSTROM B, 1991, ONCOGENE, V6, P1959; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTMAYEUR JP, 1991, P NATL ACAD SCI USA, V88, P3135, DOI 10.1073/pnas.88.8.3135; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; RAYCHAUDHURI P, 1989, GENE DEV, V3, P620, DOI 10.1101/gad.3.5.620; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SASSONECORSI P, 1988, P NATL ACAD SCI USA, V85, P7192, DOI 10.1073/pnas.85.19.7192; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHERMAN TG, 1988, J NEUROSCI, V8, P3785; SHERMAN TG, 1986, J NEUROSCI, V6, P1685; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STRADER CD, 1989, TRENDS PHARMACOL SCI, V89, P26; STRANGE PG, 1990, TRENDS NEUROSCI, V13, P373, DOI 10.1016/0166-2236(90)90022-3; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; VERMA IM, 1986, COLD SPRING HARB SYM, V51, P949, DOI 10.1101/SQB.1986.051.01.108; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOUNG WS, 1987, MOL ENDOCRINOL, V1, P884, DOI 10.1210/mend-1-12-884; [No title captured]	56	85	86	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					655	665		10.1016/0896-6273(93)90167-P	http://dx.doi.org/10.1016/0896-6273(93)90167-P			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386526				2022-12-28	WOS:A1993KY50100009
J	PIERCE, ME; SHESHBERADARAN, H; ZHE, Z; FOX, LE; APPLEBURY, ML; TAKAHASHI, JS				PIERCE, ME; SHESHBERADARAN, H; ZHE, Z; FOX, LE; APPLEBURY, ML; TAKAHASHI, JS			CIRCADIAN REGULATION OF IODOPSIN GENE-EXPRESSION IN EMBRYONIC PHOTORECEPTORS IN RETINAL CELL-CULTURE	NEURON			English	Article							MESSENGER-RNA; CHICK RETINA; CLOCK; TRANSCRIPTION; PROTEIN; RHYTHM; OPSIN; LEVEL; ROD	A circadian clock regulates number of diverse physiological functions in the vertebrate eye. In this study, we show that mRNA for the red-sensitive cone pigment, iodopsin, fluctuates with a circadian rhythm in chicken retina. Transcript levels increase in the late afternoon just prior to the time of cone disc shedding. Furthermore, iodopsin mRNA levels are regulated similarly by a circadian oscillator in primary cultures of dispersed embryonic chick retina. Nuclear run-on experiments show that the circadian regulation of iodopsin transcript abundance occurs at the level of gene transcription. Our results provide a demonstration of clock-regulated gene expression in a vertebrate preparation maintained in cell culture.	NORTHWESTERN UNIV,NSF,CTR BIOL TIMING,EVANSTON,IL 60208; UNIV CHICAGO,CTR VISUAL SCI,CHICAGO,IL 60637; UNIV CHICAGO,COMM NEUROBIOL,CHICAGO,IL 60637	National Science Foundation (NSF); NSF - Center for Biological Timing; Northwestern University; University of Chicago; University of Chicago			Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878	NATIONAL EYE INSTITUTE [R01EY008467, R01EY004801] Funding Source: NIH RePORTER; NEI NIH HHS [EY08467, EY04801, EY06167] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER R, 1986, DEV BIOL, V117, P520, DOI 10.1016/0012-1606(86)90319-2; ADLER R, 1986, RETINA MODEL CELL BI, P111; [Anonymous], MOL GENETICS BIOL RH; ARAKI M, 1990, INVEST OPHTH VIS SCI, V31, P1466; BANERJI SS, 1984, MOL CELL BIOL, V4, P2437, DOI 10.1128/MCB.4.11.2437; Besharse J.C., 1988, PROGR RETINAL RES, V7, P21; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRAFT CM, 1990, J NEUROCHEM, V55, P1461, DOI 10.1111/j.1471-4159.1990.tb04927.x; DARNELL JE, 1982, NATURE, V297, P365, DOI 10.1038/297365a0; DUNLAP JC, 1990, TRENDS GENET, V6, P159, DOI 10.1016/0168-9525(90)90151-U; GIULIANO G, 1988, EMBO J, V7, P3635, DOI 10.1002/j.1460-2075.1988.tb03244.x; HALL JC, 1990, ANNU REV GENET, V24, P659; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; KUWATA O, 1990, FEBS LETT, V272, P128, DOI 10.1016/0014-5793(90)80465-U; LOROS JJ, 1991, MOL CELL BIOL, V11, P558, DOI 10.1128/MCB.11.1.558; MILLAR AJ, 1991, PLANT CELL, V3, P541, DOI 10.1105/tpc.3.5.541; MORSE DS, 1990, TRENDS BIOCHEM SCI, V15, P262, DOI 10.1016/0968-0004(90)90050-L; NAGY F, 1988, GENE DEV, V2, P376, DOI 10.1101/gad.2.4.376; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; REME CE, 1991, J BIOL RHYTHM, V6, P5, DOI 10.1177/074873049100600104; SUGARMAN BJ, 1983, J BIOL CHEM, V258, P9005; Takahashi J S, 1991, Curr Opin Neurobiol, V1, P556, DOI 10.1016/S0959-4388(05)80028-5; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105	28	150	150	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					579	584		10.1016/0896-6273(93)90161-J	http://dx.doi.org/10.1016/0896-6273(93)90161-J			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476610				2022-12-28	WOS:A1993KY50100003
J	WAGNER, KR; COHEN, JB; HUGANIR, RL				WAGNER, KR; COHEN, JB; HUGANIR, RL			THE 87K-POSTSYNAPTIC MEMBRANE-PROTEIN FROM TORPEDO IS A PROTEIN-TYROSINE KINASE SUBSTRATE HOMOLOGOUS TO DYSTROPHIN	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; POSTSYNAPTIC 43-KDA PROTEIN; MARMORATA ELECTRIC ORGAN; CULTURED MUSCLE-CELLS; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; MONOCLONAL-ANTIBODIES; ALKALINE TREATMENT; LEUCINE ZIPPER; RICH MEMBRANES	Postsynaptic peripheral membrane proteins at the neuromuscular junction have been proposed to participate in the immobilization of the nicotinic acetylcholine receptor at the synapse. An 87 kd cytoplasmic peripheral membrane protein has been demonstrated to colocalize with the nicotinic acetylcholine receptor in the Torpedo electric organ and at the mammalian neuromuscular junction. We have cloned the cDNA encoding the 87K protein from Torpedo electric organ, and the predicted protein sequence is homologous to the C-terminal domains of dystrophin, the protein product of the Duchenne muscular dystrophy gene. The 87K protein displays a restricted pattern of expression detected only in electric organ, brain, and skeletal muscle. Analysis of the in vitro and in vivo phosphorylation of the 87K protein indicates that it is multiply phosphorylated on serine, threonine, and tyrosine residues. The 87K protein is in a complex with other proteins associated with the post-synaptic membrane, including dystrophin and a 58 kd protein. These results suggest that the 87K protein is involved in the formation and stability of synapses and is regulated by protein phosphorylation.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	WAGNER, KR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NINDS NIH HHS [NS 24418, NS 29343] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024418, P01NS029343] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; BALDWIN TJ, 1988, DEVELOPMENT, V104, P557; BARRANTES FJ, 1980, FEBS LETT, V112, P73, DOI 10.1016/0014-5793(80)80131-1; BERG JM, 1990, J BIOL CHEM, V265, P6513; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BRIDGMAN PC, 1989, J CELL BIOL, V105, P1829; BUCKLAND R, 1989, NATURE, V338, P547, DOI 10.1038/338547a0; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; CARTAUD J, 1981, J CELL BIOL, V90, P418, DOI 10.1083/jcb.90.2.418; CASNELLIE JE, 1984, P NATL ACAD SCI-BIOL, V81, P6676, DOI 10.1073/pnas.81.21.6676; CHANG HW, 1989, J BIOL CHEM, V264, P20831; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; FOX GQ, 1978, J COMP NEUROL, V179, P677, DOI 10.1002/cne.901790313; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FRAIL DE, 1987, P NATL ACAD SCI USA, V84, P6302, DOI 10.1073/pnas.84.17.6302; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; FROEHNER SC, 1989, FEBS LETT, V249, P229, DOI 10.1016/0014-5793(89)80629-5; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; HARLOW E, 1988, ANTIBODIES LABORATOR; HELLIWELL TR, 1992, AM J HUM GENET, V50, P508; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; HUGANIR RL, 1984, P NATL ACAD SCI USA, V81, P6963; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P5995; KRAMARCY NR, 1990, FEBS LETT, V274, P171, DOI 10.1016/0014-5793(90)81356-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAROCHELLE WJ, 1987, J BIOL CHEM, V262, P8190; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEMAIRE C, 1988, EMBO J, V7, P4517; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P458; MILES K, 1988, MOL NEUROBIOL, V2, P91, DOI 10.1007/BF02935341; MUSIL LS, 1989, J CELL BIOL, V108, P1833, DOI 10.1083/jcb.108.5.1833; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1982, J NEUROSCI, V2, P1760; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; ROUSSELET A, 1981, BIOCHIM BIOPHYS ACTA, V648, P169, DOI 10.1016/0005-2736(81)90032-8; Sambrook J, 1989, MOL CLONING LABORATO; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; SEALOCK R, 1991, J CELL BIOL, V113, P1133, DOI 10.1083/jcb.113.5.1133; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAGNER K, 1991, J BIOL CHEM, V266, P23784; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; YEADON JE, 1991, J CELL BIOL, V115, P1069, DOI 10.1083/jcb.115.4.1069; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	69	148	148	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					511	522		10.1016/0896-6273(93)90338-R	http://dx.doi.org/10.1016/0896-6273(93)90338-R			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461138				2022-12-28	WOS:A1993KU90100015
J	Sauman, I; Tsai, T; Roca, AL; Reppert, SM				Sauman, I; Tsai, T; Roca, AL; Reppert, SM			Period protein is necessary for circadian control of egg hatching behavior in the silkmoth Antheraea pernyi	NEURON			English	Article							CLOCKS	We examined the molecular basis of the circadian control of egg hatching behavior in the silkmoth Antheraea pernyi. Egg hatching is rhythmically gated, persists under constant darkness, and can be entrained by light by midembryogenesis. The time of appearance of photic entrainment by the silkmoth embryo coincides with the appearance of Period (PER) and Timeless (TIM) proteins in eight cells in embryonic brain. Although daily rhythms in PER and/or TIM immunoreactivity in embryonic brain were not detected, a robust circadian oscillation of PER immunoreactivity is present in the nuclei of midgut epithelium. per antisense oligodeoxynucleotide treatment of pharate larvae on the day before hatching consistently abolishes the circadian gate of egg hatching behavior. per antisense treatment also causes a dramatic decrease in PER immunoreactivity in newly hatched larvae. The results provide direct evidence that PER is a necessary element of a circadian system in the silkmoth.	MASSACHUSETTS GEN HOSP,SERV PEDIAT,LAB DEV CHRONOBIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School			Sauman, Ivo/H-2071-2014	Roca, Alfred/0000-0001-9217-5593	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; HALL JC, 1995, TRENDS NEUROSCI, V18, P230, DOI 10.1016/0166-2236(95)93908-G; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KAY SA, 1995, CELL, V83, P361, DOI 10.1016/0092-8674(95)90113-2; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1995, NEURON, V15, P147, DOI 10.1016/0896-6273(95)90072-1; MINIS DH, 1968, SCIENCE, V159, P534, DOI 10.1126/science.159.3814.534; MIZOGUCHI A, 1982, P NATL ACAD SCI-BIOL, V79, P2726, DOI 10.1073/pnas.79.8.2726; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; RIDDIFORD LM, 1971, P 13 INT C ENT MOSC, V1, P431; Saunder DS, 1982, INSECT CLOCKS; WILLIAMS CM, 1964, BIOL BULL, V127, P511, DOI 10.2307/1539252; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	15	54	57	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					901	909		10.1016/S0896-6273(00)80221-4	http://dx.doi.org/10.1016/S0896-6273(00)80221-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938122	Bronze			2022-12-28	WOS:A1996VV15100012
J	Gordon, JA; Cioffi, D; Silva, AJ; Stryker, MP				Gordon, JA; Cioffi, D; Silva, AJ; Stryker, MP			Deficient plasticity in the primary visual cortex of alpha-calcium/calmodulin-dependent protein kinase II mutant mice	NEURON			English	Article							LONG-TERM POTENTIATION; OCULAR DOMINANCE COLUMNS; DISTINCT PATTERNS; RAT-BRAIN; MOUSE; EXPRESSION; LOCALIZATION; EXPERIENCE; NEOCORTEX; RECEPTORS	The recent characterization of plasticity in the mouse visual cortex permits the use of mutant mice to investigate the cellular mechanisms underlying activity-dependent development. As calcium-dependent signaling pathways have been implicated in neuronal plasticity, we examined visual cortical plasticity in mice lacking the alpha-isoform of calcium/calmodulin-dependent protein kinase II (alpha CaMKII). In wild-type mice, brief occlusion of vision in one eye during a critical period reduces responses in the visual cortex. In half of the alpha CaMKII-deficient mice, visual cortical responses developed normally, but visual cortical plasticity was greatly diminished. After intensive training, spatial learning in the Morris water maze was severely impaired in a similar fraction of mutant animals. These data indicate that loss of alpha CaMKII results in a severe but variable defect in neuronal plasticity.	UNIV CALIF SAN FRANCISCO,WM KECK FDN CTR INTEGRAT NEUROSCI,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724	University of California System; University of California San Francisco; Cold Spring Harbor Laboratory	Gordon, JA (corresponding author), UNIV CALIF SAN FRANCISCO,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.		Silva, Alcino/ABD-7684-2021; Gordon, Joshua A/E-6778-2012	Silva, Alcino/0000-0002-1587-4558; Gordon, Joshua A/0000-0002-5488-8266; Silva, Alcino/0000-0001-5525-0494; Stryker, Michael/0000-0003-1546-5831				BEAR MF, 1990, J NEUROSCI, V10, P909; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BRANDT SJ, 1987, CELL, V49, P57, DOI 10.1016/0092-8674(87)90755-0; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BURGIN KE, 1990, J NEUROSCI, V10, P1788; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; FUNAUCHI M, 1992, NEUROREPORT, V3, P173, DOI 10.1097/00001756-199202000-00013; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; GORDON JA, 1996, J NEUROSCI, V126, P3274; GORDON JA, 1995, THESIS U CALIFORNIA; GORDON JA, 1996, IN PRESS GENE TARGET; HENDRY SHC, 1986, P NATL ACAD SCI USA, V83, P1536, DOI 10.1073/pnas.83.5.1536; Hensch TK, 1996, SCIENCE, V272, P554, DOI 10.1126/science.272.5261.554; HUANG FL, 1988, J NEUROSCI, V8, P4734; HUANG FL, 1987, J BIOL CHEM, V262, P15714; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYFORD M, 1995, CURR OPIN NEUROBIOL, V5, P141, DOI 10.1016/0959-4388(95)80019-0; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; Reid SNM, 1996, J PHYSIOL-LONDON, V494, P511, DOI 10.1113/jphysiol.1996.sp021509; Ruthazer ES, 1996, J PHYSIOL-LONDON, V494, P519, DOI 10.1113/jphysiol.1996.sp021510; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; STRYKER MP, 1986, J NEUROSCI, V6, P2117; TSUJINO T, 1990, J NEUROSCI, V10, P870; VIDEEN TO, 1986, BRAIN RES, V371, P1, DOI 10.1016/0006-8993(86)90803-6; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	40	86	86	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					491	499		10.1016/S0896-6273(00)80181-6	http://dx.doi.org/10.1016/S0896-6273(00)80181-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816712	Bronze			2022-12-28	WOS:A1996VJ44000015
J	Oppenheim, RW				Oppenheim, RW			Neurotrophic survival molecules for motoneurons: An embarrassment of riches	NEURON			English	Review							LEUKEMIA INHIBITORY FACTOR; MUSCLE-DERIVED FACTORS; MOTOR-NEURONS; DEATH; CARDIOTROPHIN-1; RECEPTOR; CULTURE; CNTF		WAKE FOREST UNIV,BOWMAN GRAY SCH MED,PROGRAM NEUROSCI,WINSTON SALEM,NC 27157	Wake Forest University; Wake Forest Baptist Medical Center	Oppenheim, RW (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT NEUROBIOL & ANAT,WINSTON SALEM,NC 27157, USA.							ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; DICHIARA TM, 1995, CELL, V83, P313; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; HAMBURGER V, 1958, AM J ANAT, V102, P365, DOI 10.1002/aja.1001020303; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HAMBURGER V, 1993, J NEUROBIOL, V24, P893, DOI 10.1002/neu.480240702; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Oppenheim R. W., 1981, STUDIES DEV NEUROBIO, P74; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1993, J NEUROBIOL, V24, P1065, DOI 10.1002/neu.480240806; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; PURVES D, 1987, TRENDS NEUROSCI, V10, P231, DOI 10.1016/0166-2236(87)90163-9; Sheng ZL, 1996, DEVELOPMENT, V122, P419; Shorey ML, 1909, J EXP ZOOL, V7, P25, DOI 10.1002/jez.1400070103; VARON S, 1982, HUMAN MOTOR NEURON D, P453	23	238	244	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					195	197		10.1016/S0896-6273(00)80151-8	http://dx.doi.org/10.1016/S0896-6273(00)80151-8			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780643	Bronze			2022-12-28	WOS:A1996VE84000002
J	Currie, KPM; Fox, AP				Currie, KPM; Fox, AP			ATP serves as a negative feedback inhibitor of voltage-gated Ca2+ channel currents in cultured bovine adrenal chromaffin cells	NEURON			English	Article							SENSITIVE CALCIUM CHANNELS; EXTRACELLULAR ATP; OMEGA-CONOTOXIN; RECEPTORS; FACILITATION; SECRETION; NEURONS; ACTIVATION; MODULATION; MECHANISM	Modulation of voltage-gated Ca2+ channel current (I-Ca) regulates secretion of catecholamines from adrenal chromaffin cells. Previous work demonstrated that I-Ca can be augmented by phosphorylation to increase secretion or that inhibition of I-Ca results in diminished catecholamine secretion. In the current manuscript, we show that stimulation of chromaffin cells results in the release of an ''endogenous inhibitor'' that suppresses I-Ca. The inhibition is due to the secretion of ATP, which is stored at high concentrations in secretory granules and is coreleased with catecholamines upon stimulation. The ATP exerts its actions through P-2Y purinoceptors and inhibits both N- and P/Q-type Ca2+ channels in a voltage-dependent manner but with different efficacies. Overall, we have identified and characterized a negative feedback pathway that may serve as an important regulatory mechanism for catecholamine secretion in chromaffin cells.			Currie, KPM (corresponding author), UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,947 E 58TH ST,CHICAGO,IL 60637, USA.		Currie, Kevin P/J-9561-2019	Currie, Kevin P/0000-0002-0861-423X				ARTALEJO CR, 1990, NATURE, V348, P239, DOI 10.1038/348239a0; ARTALEJO CR, 1992, NEURON, V8, P85, DOI 10.1016/0896-6273(92)90110-Y; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ARTALEJO CR, 1992, NATURE, V358, P63, DOI 10.1038/358063a0; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEAN BP, 1992, TRENDS PHARMACOL SCI, V13, P87, DOI 10.1016/0165-6147(92)90032-2; BIGORNIA L, 1990, J PHARMACOL EXP THER, V252, P586; BOARDER MR, 1995, TRENDS PHARMACOL SCI, V16, P133, DOI 10.1016/S0165-6147(00)89001-X; BOARDER MR, 1987, BIOCHEM PHARMACOL, V36, P163, DOI 10.1016/0006-2952(87)90394-7; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CARMICHAEL SW, 1985, SCI AM, V253, P40, DOI 10.1038/scientificamerican0885-40; CASTRO E, 1995, J BIOL CHEM, V270, P5098, DOI 10.1074/jbc.270.10.5098; DALZIEL HH, 1994, PHARMACOL REV, V46, P449; DIVERSEPIERLUISSI M, 1991, P NATL ACAD SCI USA, V88, P1261, DOI 10.1073/pnas.88.4.1261; DOLPHIN AC, 1995, EXP PHYSIOL, V80, P1; DOROSHENKO P, 1991, PFLUG ARCH EUR J PHY, V419, P444, DOI 10.1007/BF00370786; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; DOUPNIK CA, 1994, J MEMBRANE BIOL, V140, P47; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; GANDIA L, 1993, J PHYSIOL-LONDON, V470, P55, DOI 10.1113/jphysiol.1993.sp019847; GANDIA L, 1993, BIOCHEM BIOPH RES CO, V194, P671, DOI 10.1006/bbrc.1993.1874; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANS M, 1990, NEUROSCI LETT, V114, P63, DOI 10.1016/0304-3940(90)90429-D; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HOSHI T, 1984, P NATL ACAD SCI-BIOL, V81, P5871, DOI 10.1073/pnas.81.18.5871; HOSHI T, 1987, J NEUROSCI, V7, P571; KLEPPISCH T, 1992, PFLUG ARCH EUR J PHY, V421, P131, DOI 10.1007/BF00374819; LIN LF, 1995, NEUROSCI LETT, V183, P147, DOI 10.1016/0304-3940(94)11136-7; LIN WW, 1994, J PHARMACOL EXP THER, V269, P928; LOPEZ MG, 1994, FEBS LETT, V349, P331, DOI 10.1016/0014-5793(94)00696-2; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; PENINGTON NJ, 1991, J NEUROSCI, V11, P3594, DOI 10.1523/jneurosci.11-11-03594.1991; SASAKAWA N, 1989, J NEUROCHEM, V52, P441, DOI 10.1111/j.1471-4159.1989.tb09140.x; TWITCHELL WA, 1993, NEURON, V10, P701, DOI 10.1016/0896-6273(93)90171-M; TWITCHELL WA, 1994, MOL PHARMACOL, V46, P793; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; WILSON SP, 1988, NEUROPEPTIDES, V11, P17, DOI 10.1016/0143-4179(88)90023-6; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; WINKLER H, 1988, A BENZON S, V25, P347	44	115	116	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					1027	1036		10.1016/S0896-6273(00)80126-9	http://dx.doi.org/10.1016/S0896-6273(00)80126-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630241	Bronze			2022-12-28	WOS:A1996UN48000018
J	Gillespie, SKH; Balasubramanian, S; Fung, ET; Huganir, RL				Gillespie, SKH; Balasubramanian, S; Fung, ET; Huganir, RL			Rapsyn clusters and activates the synapse-specific receptor tyrosine kinase MuSK	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MONOCLONAL-ANTIBODIES; PROTEIN-KINASE; POSTSYNAPTIC PROTEIN; POINT MUTATION; 43K PROTEIN; PHOSPHORYLATION; MEMBRANE; DOMAINS; SUBUNITS	Nerve-induced clustering of the nicotinic acetylcholine receptor (AChR) requires rapsyn, a synaptic peripheral membrane protein, as well as protein-tyrosine kinase activity. Here, we show that rapsyn induces the clustering of the synapse-specific receptor-tyrosine kinase MuSK in transfected QT-6 fibroblasts. Furthermore, rapsyn stimulates the autophosphorylation of MUSK, leading to a subsequent MuSK-dependent increase in cellular tyrosine phosphorylation. Moreover, rapsyn-activated MuSK specifically phosphorylated the AChR beta subunit, the same subunit that is tyrosine phosphorylated during innervation or agrin treatment of muscle. These results suggest rapsyn may mediate the synaptic localization of MUSK in muscle and that MuSK may play an important role in the agrin-induced clustering of the ACI IR.			Gillespie, SKH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024418] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24418] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GANJU P, 1995, ONCOGENE, V11, P281; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; GUITON M, 1994, J BIOL CHEM, V269, P30370; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Hopf C, 1996, J BIOL CHEM, V271, P5231; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; KOPTA C, 1994, J NEUROSCI, V14, P3922; MAIMONE MM, 1993, NEURON, V11, P53, DOI 10.1016/0896-6273(93)90270-2; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MATTHEWS JA, 1985, ANAL BIOCHEM, V151, P205, DOI 10.1016/0003-2697(85)90073-9; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MEIER T, 1995, J CELL BIOL, V131, P441, DOI 10.1083/jcb.131.2.441; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; OHNO S, 1990, J BIOL CHEM, V265, P6296; PENG HB, 1985, J CELL BIOL, V100, P1698, DOI 10.1083/jcb.100.5.1698; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; PHILLIPS WD, 1992, BIOESSAYS, V14, P671, DOI 10.1002/bies.950141005; QU Z, 1994, J NEUROSCI, V14, P6834; QU Z, 1990, NEURON, V2, P367; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; STEINBACH JH, 1981, DEV BIOL, V84, P267, DOI 10.1016/0012-1606(81)90394-8; STJOHNSTON D, 1992, CELL, V68, P201; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; SWOPE SL, 1993, J BIOL CHEM, V268, P25152; SWOPE SL, 1994, J BIOL CHEM, V269, P29817; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WAGNER K, 1991, J BIOL CHEM, V266, P23784; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YU XM, 1994, J NEUROSCI, V14, P785	59	97	97	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					953	962		10.1016/S0896-6273(00)80118-X	http://dx.doi.org/10.1016/S0896-6273(00)80118-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630253	Bronze			2022-12-28	WOS:A1996UN48000010
J	Hu, HY; Rutishauser, U				Hu, HY; Rutishauser, U			A septum-derived chemorepulsive factor for migrating olfactory interneuron precursors	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-TUBULIN ISOTYPE; SUBEPENDYMAL LAYER; NEUROGENESIS; RAT; PROLIFERATION; EXPRESSION; NEURONS; BRAIN; CELLS	During mammalian brain development, immature neurons often migrate considerable distances. A dramatic example is the rostral migration of olfactory interneuron precursors from near the septum to the olfactory bulb via a subventricular pathway. Heterotopic transplantations establish that this migration is unidirectional and that guidance cues operate over a considerable distance. The guidance cues for this translocation have not been identified, and the present studies provide evidence that a diffusible chemorepulsive factor, secreted by caudal septum but not by other tissue regions surrounding the pathway, may be involved. This activity is functionally distinct from that produced by factors that influence vertebrate axon outgrowth, such as netrin-1, netrin-2, and collapsin-1/semaphorin-III. The presence of this activity in the floor plate/ventral spinal cord as well as the septum suggests that it may influence other types of cell migration.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University	Hu, HY (corresponding author), CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369] Funding Source: NIH RePORTER; NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD07104, HD18369] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTMAN J, 1966, J COMP NEUROL, V127, P337; BAYER SA, 1983, EXP BRAIN RES, V50, P329; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; LUSKIN MB, 1993, J NIH RES, V5, P60; MCCONNELL SK, 1990, EXPERIENTIA, V46, P922, DOI 10.1007/BF01939385; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Paxinos G., 1991, ATLAS DEV RAT BRAIN; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106	31	114	121	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					933	940		10.1016/S0896-6273(00)80116-6	http://dx.doi.org/10.1016/S0896-6273(00)80116-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630251	Bronze			2022-12-28	WOS:A1996UN48000008
J	Liu, DT; Tibbs, GR; Siegelbaum, SA				Liu, DT; Tibbs, GR; Siegelbaum, SA			Subunit stoichiometry of cyclic nucleotide-gated channels and effects of subunit order on channel function	NEURON			English	Article							POTASSIUM CHANNELS; ACETYLCHOLINE-RECEPTOR; XENOPUS-OOCYTES; ION CHANNELS; PERMEABILITY; CONDUCTANCE; CATIONS; MUSCLE	Cyclic nucleotide-gated (CNG) ion channels are multimeric structures containing at least two subunits. However, the total number of subunits per functional channel is unknown. To determine the subunit stoichiometry of CNG ion channels, we have coexpressed the 30 pS conductance bovine retinal channel (RET) with an 85 pS conductance chimeric retinal channel containing the catfish olfactory channel P region (R0133). When R0133 and RET monomers are coexpressed, channels with four distinct intermediate conductances are observed. Dimer constructs reveal that two of these conductance levels arise from channels with the same subunit composition (2 R0133:2 RET) but distinct subunit order (like subunits adjacent to each other versus like subunits across from each other). Thus, the data demonstrate that cyclic nucleotide-gated ion channels are tetrameric like the related voltage-gated potassium ion channels; the order of subunits affects the conductance of the channel; and the channel has 4-fold symmetry in which four asymmetric subunits assemble head to tail around a central axis.	COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT PHARMACOL,NEW YORK,NY 10032; COLUMBIA UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Liu, DT (corresponding author), COLUMBIA UNIV,INTEGRATED PROGRAM CELLULAR MOL & BIOPHYS STUDIES,NEW YORK,NY 10032, USA.							BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; EISMANN E, 1993, CELL PHYSIOL BIOCHEM, V3, P332, DOI 10.1159/000154697; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	28	150	153	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					983	990		10.1016/S0896-6273(00)80121-X	http://dx.doi.org/10.1016/S0896-6273(00)80121-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630256	hybrid			2022-12-28	WOS:A1996UN48000013
J	Goda, Y; Stevens, CF				Goda, Y; Stevens, CF			Long-term depression properties in a simple system	NEURON			English	Article							PROTEIN-KINASE; TRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; AREA CA1; CALCIUM; VARIABILITY; PROBABILITY; CURRENTS; BINDING; SYNAPSE	Long-term depression (LTD) in pairs of cultured rodent hippocampal neurons was examined to study the molecular basis of this form of synaptic plasticity. We have previously characterized two components of transmitter release: a synchronous, fast phase that requires synaptotagmin I, and an asynchronous, slow component that persists in the absence of synaptotagmin I. Are these two release components differentially affected by the presynaptic changes of LTD, or is the mechanism of plasticity common to both? We find that LTD is expressed as parallel changes in the fast and slow components of release, and that this form of synaptic plasticity is still seen in the absence of functional synaptotagmin I. Any alterations in the presynaptic release machinery observed during LTD thus involve mechanisms shared by both modes of release.	SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,LA JOLLA,CA 92037	Howard Hughes Medical Institute; Salk Institute	Goda, Y (corresponding author), SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037, USA.		Goda, Yukiko/A-6576-2016; Goda, Yukiko/AAR-5641-2020	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498	NINDS NIH HHS [5 RO1 NS 12961-17] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Katz B., 1969, RELEASE NEURAL TRANS; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NACHSHEN DA, 1982, J GEN PHYSIOL, V79, P1065, DOI 10.1085/jgp.79.6.1065; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x	45	61	63	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					103	111		10.1016/S0896-6273(00)80027-6	http://dx.doi.org/10.1016/S0896-6273(00)80027-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562073	Bronze			2022-12-28	WOS:A1996TT30700013
J	Hen, R				Hen, R			Mean genes	NEURON			English	Review							AGGRESSIVE-BEHAVIOR; MICE; DISORDERS; RATS				Hen, R (corresponding author), COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032, USA.							Bandler R., 1988, PROGR PSYCHOBIOLOGY, V13, P67; BOHMAN M, 1984, ARCH GEN PSYCHIAT, V41, P872; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; CARRASCO JL, 1994, ACTA PSYCHIAT SCAND, V90, P427, DOI 10.1111/j.1600-0447.1994.tb01619.x; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CASES O, 1996, IN PRESS NEURON; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; COCCARO EF, 1993, PSYCHIAT RES, V48, P229, DOI 10.1016/0165-1781(93)90074-Q; COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587; COCCARO EF, 1994, ARCH GEN PSYCHIAT, V51, P318; Conner R. L., 1969, P150; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; EICHELMAN B, 1992, ARCH GEN PSYCHIAT, V49, P488; EICHELMAN BS, 1990, ANNU REV MED, V41, P149; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; GUALTIERI C, 1991, NEUROPSYCHIATRY BEHA; HILAKIVICLARKE LA, 1995, PHARM BIOCH BEHAV, V40, P593; HOYER D, 1994, PHARMACOL REV, V46, P157; ISEL F, 1988, PHARMACOL BIOCHEM BE, V29, P97, DOI 10.1016/0091-3057(88)90281-X; LAGERSPETZ KM, 1971, SCAND J PSYCHOL, V12, P241, DOI 10.1111/j.1467-9450.1971.tb00627.x; LEWIS MH, 1994, NEUROPSYCHOPHARMACOL, V10, P115, DOI 10.1038/npp.1994.13; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; LOEHLIN JC, 1989, AM PSYCHOL, V44, P1285, DOI 10.1037/0003-066X.44.10.1285; Lorenz K., 2005, AGGRESSION; LUCAS JJ, 1995, TRENDS PHARMACOL SCI, V16, P246, DOI 10.1016/S0165-6147(00)89034-3; MAXSON SG, 1996, IN PRESS BEHAV GENET; MEHLMAN PT, 1994, AM J PSYCHIAT, V151, P1485; MICZEK KA, 1994, NEUROSCI BIOBEHAV R, V18, P97, DOI 10.1016/0149-7634(94)90040-X; MINNA JD, 1993, CHEST, V103, pS449, DOI 10.1378/chest.103.4_Supplement.449S; MOLINA V, 1987, PHARMACOL BIOCHEM BE, V27, P123, DOI 10.1016/0091-3057(87)90486-2; MOS J, 1992, DRUG DEVELOP RES, V26, P343, DOI 10.1002/ddr.430260311; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; OLIVIER B, 1989, PSYCHOPHARMACOLOGY, V97, P154, DOI 10.1007/BF00442239; PLOMIN R, 1993, BEHAV GENET, V23, P197, DOI 10.1007/BF01067425; POPOVA NK, 1993, BEHAV GENET, V23, P491, DOI 10.1007/BF01067985; PUCILOWSKI O, 1983, BEHAV BRAIN RES, V9, P33, DOI 10.1016/0166-4328(83)90012-8; RAMBOZ S, 1995, IN PRESS BEHAV BRAIN; ROUBERTOUX PL, 1994, GENETICS, V136, P225; ROUBERTOUX PL, 1995, CR HEBD ACAD SCI, V317, P523; SAAL FSV, 1983, HORMONES AGGRESSIVE, P197; SAUDOU F, 1994, NEUROCHEM INT, V25, P503, DOI 10.1016/0197-0186(94)90150-3; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SIEGEL A, 1988, NEUROBIOLOGY, V31, P261; VALZELLI L, 1979, NEUROPSYCHOBIOLOGY, V5, P129, DOI 10.1159/000117674; VERGNES M, 1986, PHYSIOL BEHAV, V36, P653, DOI 10.1016/0031-9384(86)90349-5; VIRKKUNEN M, 1994, ARCH GEN PSYCHIAT, V51, P20; WEIGER WA, 1988, J PSYCHIAT RES, V22, P85, DOI 10.1016/0022-3956(88)90073-8; WHITAKERAZMITIA PM, 1994, NEUROPSYCHOPHARMACOL, V11, P125, DOI 10.1038/npp.1994.42	50	61	61	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					17	21		10.1016/S0896-6273(00)80019-7	http://dx.doi.org/10.1016/S0896-6273(00)80019-7			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TT307	8562081	Bronze			2022-12-28	WOS:A1996TT30700005
J	Bartsch, U; Bandtlow, CE; Schnell, L; Bartsch, S; Spillmann, AA; Rubin, BP; Hillenbrand, R; Montag, D; Schwab, ME; Schachner, M				Bartsch, U; Bandtlow, CE; Schnell, L; Bartsch, S; Spillmann, AA; Rubin, BP; Hillenbrand, R; Montag, D; Schwab, ME; Schachner, M			Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS	NEURON			English	Article							NEURONAL GROWTH CONES; RAT SPINAL-CORD; NEURITE GROWTH; ADHESION; OLIGODENDROCYTE; ANTIBODIES; OUTGROWTH; COLLAPSE; TENASCIN; PROTEIN	The MAG-deficient mouse was used to test whether MAG acts as a significant inhibitor of axonal regeneration in the adult mammalian CNS, as suggested by cell culture experiments. Cell spreading, neurite elongation, or growth cone collapse of different cell types in vitro was not significantly different when myelin preparations or optic nerve cryosections from either MAG-deficient or wild-type mice were used as a substrate. More importantly, the extent of axonal regrowth in lesioned optic nerve and corticospinal tract in vivo was similarly poor in MAG-deficient and wild-type mice. However, axonal regrowth increased significantly and to a similar extent in both genotypes after application of the IN-1 antibody directed against the neurite growth inhibitors NI-35 and NI-250. These observations do not support the view that MAG is a significant inhibitor of axonal regeneration in the adult CNS.	UNIV ZURICH, BRAIN RES INST, CH-8092 ZURICH, SWITZERLAND	University of Zurich	Bartsch, U (corresponding author), ETH ZURICH, DEPT NEUROBIOL, CH-8093 ZURICH, SWITZERLAND.		Schwab, Martin E/B-6818-2016; Montag, Dirk/D-3925-2014	Montag, Dirk/0000-0002-4964-1330				Aguayo A.J., 1985, SYNAPTIC PLASTICITY, P457; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BARTSCH U, 1995, GLIA, V14, P115, DOI 10.1002/glia.440140206; BARTSCH U, 1992, EUR J NEUROSCI, V4, P338, DOI 10.1111/j.1460-9568.1992.tb00881.x; BEDI KS, 1992, EUR J NEUROSCI, V4, P193, DOI 10.1111/j.1460-9568.1992.tb00867.x; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; HALFTER W, 1987, DEV BIOL, V119, P322, DOI 10.1016/0012-1606(87)90038-8; JOHNSON D, 1986, DEV BRAIN RES, V28, P263, DOI 10.1016/0165-3806(86)90028-3; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; KEIRSTEAD HS, 1992, P NATL ACAD SCI USA, V89, P11664, DOI 10.1073/pnas.89.24.11664; Keynes Roger J., 1995, Current Opinion in Neurobiology, V5, P75, DOI 10.1016/0959-4388(95)80090-5; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RUBIN BP, 1995, IN PRESS EUR J NEURO; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SCHACHNER M, 1994, PERSPECT DEV NEUROBI, V2, P33; SCHNEIDERSCHAULIES J, 1991, NEURON, V7, P995, DOI 10.1016/0896-6273(91)90344-Y; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; SHEWAN D, 1995, J NEUROSCI, V15, P2057, DOI 10.1523/JNEUROSCI.15-03-02057.1995; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; TAYLOR J, 1993, J NEUROSCI RES, V35, P347, DOI 10.1002/jnr.490350402; UNSICKER K, 1985, DEV BRAIN RES, V17, P304, DOI 10.1016/0165-3806(85)90161-0; WEIBEL D, 1994, BRAIN RES, V642, P259, DOI 10.1016/0006-8993(94)90930-X	33	199	203	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1375	1381		10.1016/0896-6273(95)90015-2	http://dx.doi.org/10.1016/0896-6273(95)90015-2			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845160	Bronze			2022-12-28	WOS:A1995TL67800015
J	Linden, DJ				Linden, DJ			Phospholipase A(2) controls the induction of short-term versus long-term depression in the cerebellar Purkinje neuron in culture	NEURON			English	Article							PROTEIN-KINASE-C; UNSATURATED FATTY-ACIDS; ARACHIDONIC-ACID; NITRIC-OXIDE; SYNAPTIC DEPRESSION; GLUTAMATE SENSITIVITY; CLIMBING FIBER; DENTATE GYRUS; AREA CA1; CELLS	Cerebellar long-term depression (LTD) may be reliably induced in the cultured Purkinje neuron when glutamate pulses and Purkinje neuron depolarization are applied together 6 times. When the number of these conjunctive stimuli was reduced to 2, a short-term depression (STD) lasting 20-40 min was induced in 4/12 cells. The enzyme phospholipase A(2) cleaves membrane phospholipids causing liberation of free unsaturated fatty acids, which in turn synergistically activate protein kinase C when present with diacylglycerol and Ca. Application of free unsaturated fatty acids with 2 conjunctive stimuli resulted in an apparent conversion of STD cases to LTD. Application of phospholipase A(2) inhibitors during 6 conjunctions converted LTD to STD. These findings suggest a model in which liberation of unsaturated fatty acids by phospholipase A(2) contributes to a synergistic activation of protein kinase C, the full activation of which results in LTD induction, and the partial activation of which results in STD induction.			Linden, DJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, R37MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ATTWELL D, 1993, SEMIN NEUROSCI, V5, P159, DOI 10.1016/S1044-5765(05)80049-1; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; BRAMHAM CR, 1994, NEUROSCIENCE, V60, P737, DOI 10.1016/0306-4522(94)90501-0; BYRNE JH, 1993, ADV SEC MESS PHOSPH, V27, P47; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHEN SG, 1992, BIOCHEM J, V282, P33, DOI 10.1042/bj2820033; CLEMENTS MP, 1991, NEUROSCIENCE, V45, P379, DOI 10.1016/0306-4522(91)90235-G; COFFEY ET, 1994, J NEUROCHEM, V63, P1303; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; DEFREITAS JC, 1984, EXPERIENTIA, V40, P864; DUMUIS A, 1993, MOL PHARMACOL, V43, P976; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; GLASER KB, 1986, BIOCHEM PHARMACOL, V35, P449, DOI 10.1016/0006-2952(86)90218-2; GLAUM SR, 1992, J NEUROPHYSIOL, V68, P1453, DOI 10.1152/jn.1992.68.4.1453; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; JIN WZ, 1994, BRAIN RES, V642, P237, DOI 10.1016/0006-8993(94)90927-X; KEYSER DO, 1990, NEURON, V5, P545, DOI 10.1016/0896-6273(90)90092-T; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KOVALCHUK Y, 1994, BRAIN RES, V643, P287, DOI 10.1016/0006-8993(94)90035-3; KRUPA M, 1990, EUR J NEUROSCI, V2, P312, DOI 10.1111/j.1460-9568.1990.tb00423.x; LESTER DS, 1991, BIOCHEM BIOPH RES CO, V179, P1522, DOI 10.1016/0006-291X(91)91745-X; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LINDEN DJ, 1986, BRAIN RES, V379, P358, DOI 10.1016/0006-8993(86)90790-0; LINDEN DJ, 1987, J NEUROSCI, V7, P3783; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALLORGA P, 1980, P NATL ACAD SCI-BIOL, V77, P1341, DOI 10.1073/pnas.77.3.1341; MASSICOTTE G, 1990, BRAIN RES, V537, P49, DOI 10.1016/0006-8993(90)90338-C; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; MURAKAMI K, 1985, FEBS LETT, V192, P189, DOI 10.1016/0014-5793(85)80105-8; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; OKADA D, 1989, NEUROSCI LETT, V100, P141, DOI 10.1016/0304-3940(89)90674-5; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHAECHTER JD, 1993, J NEUROSCI, V13, P4361; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; Squire L.R, 1987, MEMORY BRAIN, P134; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; WILLIAMS JH, 1988, NEUROSCI LETT, V88, P81, DOI 10.1016/0304-3940(88)90319-9; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	66	50	51	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1393	1401		10.1016/0896-6273(95)90017-9	http://dx.doi.org/10.1016/0896-6273(95)90017-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845162	hybrid			2022-12-28	WOS:A1995TL67800017
J	WHITE, JA; ALONSO, A; KAY, AR				WHITE, JA; ALONSO, A; KAY, AR			A HEART-LIKE NA+ CURRENT IN THE MEDIAL ENTORHINAL CORTEX	NEURON			English	Article							TETRODOTOXIN-RESISTANT SODIUM; ROOT GANGLION NEURONS; HIPPOCAMPAL REGION; CATION SELECTIVITY; BINDING-SITE; RAT-BRAIN; CHANNELS; CELLS; ZINC; ADULT	Acutely dissociated neurons from the superficial layers of the medial entorhinal cortex of the rat were studied under voltage clamp using the whole-cell patch-clamp configuration. Neurons from the medial entorhinal cortex exhibit a tetrodotoxin (TTX)-resistant Na+ current (I(TTX-R); IC50 almost-equal-to 146 nM), in addition to the normal TTX-sensitive Na+ current (I(TTX-S); IC50 almost-equal-to 6 nM). I(TTX-R) was found in both putative stellate and putative pyramidal neurons from the medial entorhinal cortex. I(TTX-R) is kinetically indistinguishable from I(TTX-S), but can be distinguished from I(TTX-S) based on its enhanced sensitivity to block by Cd2+, La3+, and Zn2+. I(TTX-R) is kinetically and pharmacologically similar to the TTX-resistant Na+ current found in cardiac muscle.	MONTREAL NEUROL HOSP & INST,DEPT NEUROL & NEUROSURG,MONTREAL H3A 2B4,QUEBEC,CANADA	McGill University	WHITE, JA (corresponding author), UNIV IOWA,DEPT BIOL SCI,IOWA CITY,IA 52242, USA.							ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; ALONSO A, 1990, P NATL ACAD SCI USA, V87, P9280, DOI 10.1073/pnas.87.23.9280; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; BENZER TI, 1972, P NATL ACAD SCI USA, V69, P3634, DOI 10.1073/pnas.69.12.3634; BOSSU JL, 1984, NEUROSCI LETT, V51, P241, DOI 10.1016/0304-3940(84)90558-5; BROWN AM, 1981, J PHYSIOL-LONDON, V318, P479; BUSSELBERG D, 1992, BRAIN RES, V593, P77, DOI 10.1016/0006-8993(92)91266-H; CHEMERIS NK, 1980, BIOCHIM BIOPHYS ACTA, V599, P731, DOI 10.1016/0005-2736(80)90213-8; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; DOYLE DD, 1993, J GEN PHYSIOL, V101, P153, DOI 10.1085/jgp.101.2.153; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; FRELIN C, 1986, EUR J PHARMACOL, V122, P245, DOI 10.1016/0014-2999(86)90109-3; FRIEDMAN B, 1984, J COMP NEUROL, V223, P88, DOI 10.1002/cne.902230108; GONOI T, 1989, J PHYSIOL-LONDON, V414, P159, DOI 10.1113/jphysiol.1989.sp017682; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; HARRISON NL, 1993, MOL PHARMACOL, V43, P482; HAUG FMS, 1976, ADV ANAT EMBRYOL CEL, V52, P1; HEINEMANN SH, 1992, PFLUG ARCH EUR J PHY, V422, P90, DOI 10.1007/BF00381519; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOEHN K, 1993, NEURON, V10, P543, DOI 10.1016/0896-6273(93)90341-N; HOLM IE, 1989, J COMP NEUROL, V287, P145, DOI 10.1002/cne.902870202; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; IKEDA SR, 1986, J NEUROPHYSIOL, V55, P527, DOI 10.1152/jn.1986.55.3.527; IKEDA SR, 1987, J PHYSIOL-LONDON, V389, P255, DOI 10.1113/jphysiol.1987.sp016656; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; KANEDA M, 1989, BRAIN RES, V494, P348; KAY AR, 1989, DISSECTION TISSUE CU, P54; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; KOSTYUK PG, 1981, NEUROSCIENCE, V6, P2423, DOI 10.1016/0306-4522(81)90088-9; LEE KS, 1977, NATURE, V265, P751, DOI 10.1038/265751a0; Lehninger A.L, 1975, BIOCHEMISTRY-US; MATZNER O, 1992, BRAIN RES, V597, P92, DOI 10.1016/0006-8993(92)91509-D; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PENINGTON NJ, 1993, J PHYSIOL-LONDON, V464, P33, DOI 10.1113/jphysiol.1993.sp019623; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; RAVINDRAN A, 1991, J GEN PHYSIOL, V97, P89, DOI 10.1085/jgp.97.1.89; RENAUD JF, 1983, J BIOL CHEM, V258, P879; RITCHIE JM, 1977, REV PHYSIOL BIOCH P, V79, P1, DOI 10.1007/BFb0037088; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROY ML, 1992, J NEUROSCI, V12, P2104; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHILD L, 1991, BIOPHYS J, V59, P523, DOI 10.1016/S0006-3495(91)82269-X; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STEINHAUSER C, 1990, PFLUG ARCH EUR J PHY, V415, P756, DOI 10.1007/BF02584017; SWANSON LW, 1986, J NEUROSCI, V6, P3010; VANHOESEN GW, 1982, TRENDS NEUROSCI, V5, P345, DOI 10.1016/0166-2236(82)90201-6; VILLEGAS R, 1973, BIOCHIM BIOPHYS ACTA, V318, P61, DOI 10.1016/0005-2736(73)90336-2; VISENTIN S, 1990, PFLUG ARCH EUR J PHY, V417, P213, DOI 10.1007/BF00370702; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; YAROWSKY PJ, 1991, P NATL ACAD SCI USA, V88, P9453, DOI 10.1073/pnas.88.21.9453; YOSHIDA S, 1978, J NEUROPHYSIOL, V41, P1096, DOI 10.1152/jn.1978.41.5.1096	58	71	71	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1037	1047		10.1016/0896-6273(93)90217-F	http://dx.doi.org/10.1016/0896-6273(93)90217-F			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274275				2022-12-28	WOS:A1993MP54800005
J	YANG, JS; BENNETT, PB; MAKITA, N; GEORGE, AL; BARCHI, RL				YANG, JS; BENNETT, PB; MAKITA, N; GEORGE, AL; BARCHI, RL			EXPRESSION OF THE SODIUM CHANNEL-BETA(1) SUBUNIT IN RAT SKELETAL-MUSCLE IS SELECTIVELY ASSOCIATED WITH THE TETRODOTOXIN-SENSITIVE ALPHA-SUBUNIT ISOFORM	NEURON			English	Article							FUNCTIONAL EXPRESSION; XENOPUS-OOCYTES; NA+ CHANNEL; BRAIN; PROTEIN; PURIFICATION; CDNA	Transcripts homologous to the rat brain sodium channel beta subunit (beta1) are prominently expressed in both innervated and denervated adult skeletal muscle and in heart, but not in neonatal skeletal or cardiac muscle. Regulation of beta1 mRNA expression closely parallels that of SkM1 alpha during development, after denervation in adult muscle, and in primary muscle culture, but does not follow SkM2 expression under any condition examined. In oocytes, beta1 interacts functionally with SkM1 to modulate the abnormally slow inactivation kinetics observed with this alpha subunit expressed alone. We conclude that a common beta1 subunit is expressed in skeletal muscle, heart, and brain and that in skeletal muscle, this subunit is specifically associated with the SkM1, rather than the SkM2, sodium channel isoform.	UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104; VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232	University of Pennsylvania; Vanderbilt University; Vanderbilt University	YANG, JS (corresponding author), UNIV PENN,SCH MED,MAHONEY INST NEUROL SCI,PHILADELPHIA,PA 19104, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS008075, R01NS018013, P01NS008075] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-08075, NS-18013] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGNEW WS, 1980, BIOCHEM BIOPH RES CO, V92, P860, DOI 10.1016/0006-291X(80)90782-2; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BENNETT PB, 1993, IN PRESS FEBS LETT; CANNON SC, 1993, PFLUG ARCH EUR J PHY, V423, P155, DOI 10.1007/BF00374974; CASSADEI JM, 1986, J BIOL CHEM, V261, P4318; Cohen S A, 1993, Int Rev Cytol, V137C, P55; COHEN SA, 1993, IN PRESS CIRC RES; DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KELLY AM, 1991, J NEUROSCI, V11, P1231; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; KRANER SD, 1985, J BIOL CHEM, V260, P6341; MAKITA N, 1993, IN PRESS CIRCULATION; MARTINOU JC, 1991, J NEUROSCI, V11, P1291; MCCLATCHEY AI, 1993, HUM MOL GENET, V2, P745, DOI 10.1093/hmg/2.6.745; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; SATIN J, 1992, J MEMBRANE BIOL, V130, P11; SUTKOWSKI EM, 1990, J BIOL CHEM, V265, P12393; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WHITE MM, 1991, MOL PHARMACOL, V39, P604; YANG J, 1990, J NEUROCHEM, V54, P954, DOI 10.1111/j.1471-4159.1990.tb02343.x; YANG JSJ, 1991, NEURON, V7, P421, DOI 10.1016/0896-6273(91)90294-A; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	31	61	61	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					915	922		10.1016/0896-6273(93)90121-7	http://dx.doi.org/10.1016/0896-6273(93)90121-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240813				2022-12-28	WOS:A1993MJ04100013
J	BOROWSKY, B; MEZEY, E; HOFFMAN, BJ				BOROWSKY, B; MEZEY, E; HOFFMAN, BJ			2 GLYCINE TRANSPORTER VARIANTS WITH DISTINCT LOCALIZATION IN THE CNS AND PERIPHERAL-TISSUES ARE ENCODED BY A COMMON GENE	NEURON			English	Article							MESSENGER-RNAS; RAT-BRAIN; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; GLIAL-CELLS; EXPRESSION; CLONING; NEURONS; NEUROTRANSMITTERS; NORADRENALINE	We have isolated a cDNA encoding a high affinity, Na+/Cl--dependent glycine transporter, GLYT-2, which is distinct from another glycine transporter, GLYT-1. While the 3' sequences of these two cDNAs are identical, the 5' noncoding regions and the N-termini are completely different. GLYT-1 is found only in the white matter of the CNS, while GLYT-2 is found in the gray matter of the CNS as well as in macrophages and mast cells in peripheral tissues. Our findings suggest that tissue-specific alternative splicing or alternative promoter usage from a single gene results in two mRNA products encoding similar but distinct glycine transporters. The anatomic distibution of GLYT-2 mRNA supports the emerging status of glycine as a supraspinal neurotransmitter and suggests that glycine may function as a chemical messenger outside the CNS.	NINCDS,CLIN NEUROSCI BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	BOROWSKY, B (corresponding author), NIMH,CELL BIOL LAB,BETHESDA,MD 20892, USA.		Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691				APRISON MH, 1990, GLYCINE NEUROTRANSMI, P11; AXELROD J, 1971, SCIENCE, V173, P598, DOI 10.1126/science.173.3997.598; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; CHRISTENSEN HN, 1984, BIOCHIM BIOPHYS ACTA, V779, P255, DOI 10.1016/0304-4157(84)90012-1; CHRISTENSEN HN, 1981, BIOCHEM BIOPH RES CO, V98, P102, DOI 10.1016/0006-291X(81)91875-1; CLARK JA, 1992, NEURON, V9, P337, DOI 10.1016/0896-6273(92)90172-A; CURRIE DN, 1981, J EXP BIOL, V95, P181; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FAGG GE, 1983, NEUROSCIENCE, V9, P701, DOI 10.1016/0306-4522(83)90263-4; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HEDGVIST P, 1969, ACTA PHYSL SCAND, V76, P270; HENN FA, 1976, J NEUROSCI RES, V2, P271, DOI 10.1002/jnr.490020404; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HOLOPAINEN I, 1989, J NEUROSCI RES, V24, P374, DOI 10.1002/jnr.490240306; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KILPATRICK DL, 1990, MOL CELL BIOL, V10, P3717, DOI 10.1128/MCB.10.7.3717; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; KITA H, 1982, BRAIN RES, V235, P131, DOI 10.1016/0006-8993(82)90202-5; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIU QR, 1992, FEBS LETT, V305, P110, DOI 10.1016/0014-5793(92)80875-H; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MCGREER EG, 1980, NEUROSCI LETT, V17, P85; MEZEY E, 1991, ENDOCRINOLOGY, V129, P1814, DOI 10.1210/endo-129-4-1814; OHTA M, 1979, BRAIN RES BULL, V4, P231, DOI 10.1016/0361-9230(79)90287-9; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; PURCELL WM, 1990, AGENTS ACTIONS, V30, P38, DOI 10.1007/BF01968992; PYCOCK CJ, 1981, LIFE SCI, V28, P2679, DOI 10.1016/0024-3205(81)90168-5; SATO K, 1992, BRAIN RES, V590, P95, DOI 10.1016/0006-8993(92)91085-S; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHIMADA S, 1991, SCIENCE, V254, P567; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; SNYDER S H, 1970, Biological Psychiatry, V2, P367; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TAKADA M, 1987, J COMP NEUROL, V262, P465, DOI 10.1002/cne.902620402; USDIN TB, 1991, P NATL ACAD SCI USA, V88, P11168, DOI 10.1073/pnas.88.24.11168; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; YOUNG WS, 1986, MOL BRAIN RES, V1, P231, DOI 10.1016/0169-328X(86)90029-X; ZAFRA F, 1989, BIOCHEM J, V258, P403, DOI 10.1042/bj2580403	50	187	191	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					851	863		10.1016/0896-6273(93)90201-2	http://dx.doi.org/10.1016/0896-6273(93)90201-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494645				2022-12-28	WOS:A1993LD32200008
J	CUMMINS, TR; ZHOU, JY; SIGWORTH, FJ; UKOMADU, C; STEPHAN, M; PTACEK, LJ; AGNEW, WS				CUMMINS, TR; ZHOU, JY; SIGWORTH, FJ; UKOMADU, C; STEPHAN, M; PTACEK, LJ; AGNEW, WS			FUNCTIONAL CONSEQUENCES OF A NA+ CHANNEL MUTATION CAUSING HYPERKALEMIC PERIODIC PARALYSIS	NEURON			English	Article							ADYNAMIA EPISODICA HEREDITARIA; SODIUM-CHANNEL; SKELETAL-MUSCLE; INTRACELLULAR PH; ALPHA-SUBUNIT; GATING PROPERTIES; K+ CHANNELS; INACTIVATION; FIBERS; GENE	Hyperkalemic periodic paralysis (HYPP), one of several inheritable myotonic diseases, results from genetic defects in the human skeletal muscle Na+ channel. In some pedigrees, HYPP is correlated with a single base pair substitution resulting in a Met replacing Thr704 in the fifth transmembrane segment of the second domain. This region is totally conserved between the human and rat channels. We have introduced the human mutation into the corresponding region of the rat muscle Na+ channel cDNA and expressed it in human embryonic kidney 293 cells. Patch-clamp recordings show that this mutation shifts the voltage dependence of activation by 10-15 mV in the negative direction. The shift results in a persistent Na+ current that activates near -70 mV; this phenomenon could underlie the abnormal muscle activity observed in patients with HYPP.	UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205	Utah System of Higher Education; University of Utah; Johns Hopkins University	CUMMINS, TR (corresponding author), YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,INTERDEPT NEUROSCI PROGRAM,NEW HAVEN,CT 06510, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000940] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017928] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 38156] Funding Source: Medline; NICHD NIH HHS [K11 HD00940-01] Funding Source: Medline; NINDS NIH HHS [NS 17928] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AICKIN CC, 1977, J PHYSIOL-LONDON, V267, P791; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BIRNBERGER KL, 1979, J NEUROL, V22, P23; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DAVIES NW, 1990, NATURE, V343, P375, DOI 10.1038/343375a0; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1983, MUSCLE NERVE, V6, P113, DOI 10.1002/mus.880060206; LEHMANNHORN F, 1991, PFLUG ARCH EUR J PHY, V418, P297, DOI 10.1007/BF00370530; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; PAN JW, 1988, P NATL ACAD SCI USA, V85, P7836, DOI 10.1073/pnas.85.21.7836; PAPPONE PA, 1980, J PHYSIOL-LONDON, V306, P377, DOI 10.1113/jphysiol.1980.sp013403; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; RENAUD JM, 1989, J PHYSIOL-LONDON, V416, P31, DOI 10.1113/jphysiol.1989.sp017747; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDEL R, 1985, PHYSIOL REV, V65, P310, DOI 10.1152/physrev.1985.65.2.310; Sambrook J, 1989, MOL CLONING LABORATO; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; STREIB EW, 1987, MUSCLE NERVE, V10, P603, DOI 10.1002/mus.880100704; SUBRAMONY SH, 1986, NEUROLOGY, V36, P173, DOI 10.1212/WNL.36.2.173; TRIMMER JS, 1989, NEURON, V3, P333; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; ZAGOTTA WN, 1990, J NEUROSCI, V10, P1799; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	31	131	132	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					667	678		10.1016/0896-6273(93)90168-Q	http://dx.doi.org/10.1016/0896-6273(93)90168-Q			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386527				2022-12-28	WOS:A1993KY50100010
J	MERRITT, DJ; HAWKEN, A; WHITINGTON, PM				MERRITT, DJ; HAWKEN, A; WHITINGTON, PM			THE ROLE OF THE CUT GENE IN THE SPECIFICATION OF CENTRAL PROJECTIONS BY SENSORY AXONS IN DROSOPHILA	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; MANDUCA-SEXTA; CELL FATES; NEURONS; MELANOGASTER; EMBRYO; EXPRESSION; SENSILLA; PATTERN; INSECT	Mutations in the cut gene transform sense organs in Drosophila embryos from external sensory (es) receptors to chordotonal (ch) organs. We have investigated whether their central axonal projections are also transformed. Following Lucifer yellow injection of the sensory neuron, wild-type es and ch organs show characteristic, different projection patterns in the CNS. Transformed es neurons in cut embryos are variable in their projection patterns: some resemble wild-type es neurons, others ch neurons, while yet others are unlike either of these. We conclude that the cut gene influences axonal projections, although its action as a simple modality switch is open to question. Additional genes could be involved in the specification of the central axonal projection of the transformed neurons.			MERRITT, DJ (corresponding author), UNIV NEW ENGLAND, DEPT ZOOL, ARMIDALE, NSW 2351, AUSTRALIA.		Merritt, David J/D-2318-2010	Merritt, David J/0000-0002-8573-7508; Whitington, Paul/0000-0002-9683-0433				BLOCHL R, 1988, CELL TISSUE RES, V252, P669, DOI 10.1007/BF00216655; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BOO K S, 1975, International Journal of Insect Morphology and Embryology, V4, P549, DOI 10.1016/0020-7322(75)90031-8; BOWNES M, 1975, J EMBRYOL EXP MORPH, V33, P789; BURT R, 1982, DEV BIOL, V90, P99, DOI 10.1016/0012-1606(82)90215-9; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CASH S, 1992, J NEUROSCI, V12, P2051; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; GHYSEN A, 1983, DEV BIOL, V99, P7, DOI 10.1016/0012-1606(83)90249-X; HARRELSON AL, 1992, J EXP ZOOL, V261, P310, DOI 10.1002/jez.1402610310; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HIGASHIJIMA S, 1992, GENE DEV, V6, P1005, DOI 10.1101/gad.6.6.1005; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; KENT KS, 1988, J COMP NEUROL, V271, P559, DOI 10.1002/cne.902710407; LAKESHARLAN R, 1991, J COMP NEUROL, V308, P188, DOI 10.1002/cne.903080206; LEVINE RB, 1985, J COMP PHYSIOL A, V157, P1; LIENHARD MC, 1987, J EXP ZOOL, V244, P187, DOI 10.1002/jez.1402440203; LIU S, 1991, GENETICS, V127, P151; McIver S.B., 1985, P71; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; Milliken G. A., 1984, ANAL MESSY DATA; Moulins M., 1976, STRUCTURE FUNCTION P; MURPHEY RK, 1989, J COMP NEUROL, V290, P185, DOI 10.1002/cne.902900203; MURPHEY RK, 1989, J NEUROSCI, V9, P3209; MURPHEY RK, 1985, J COMP PHYSIOL A, V156, P381, DOI 10.1007/BF00610730; NOTTEBOHM E, 1992, NATURE, V359, P829, DOI 10.1038/359829a0; PALKA J, 1982, TRENDS NEUROSCI, V5, P382, DOI 10.1016/0166-2236(82)90218-1; PETERSON BA, 1988, J COMP NEUROL, V275, P128, DOI 10.1002/cne.902750111; PFLUGER HJ, 1988, PHILOS T R SOC B, V321, P1, DOI 10.1098/rstb.1988.0090; SINK H, 1991, DEVELOPMENT, V113, P701; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; WHITINGTON PM, 1984, DEV BIOL, V106, P438, DOI 10.1016/0012-1606(84)90243-4; Wieschaus E., 1986, P199; WOLFRUM U, 1990, CELL TISSUE RES, V261, P85, DOI 10.1007/BF00329441	46	21	21	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1993	10	4					741	752		10.1016/0896-6273(93)90174-P	http://dx.doi.org/10.1016/0896-6273(93)90174-P			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386531				2022-12-28	WOS:A1993KY50100016
J	KILPATRICK, TJ; BARTLETT, PF				KILPATRICK, TJ; BARTLETT, PF			CLONING AND GROWTH OF MULTIPOTENTIAL NEURAL PRECURSORS - REQUIREMENTS FOR PROLIFERATION AND DIFFERENTIATION	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CLONALLY RELATED CELLS; MEDIATED GENE-TRANSFER; CHICKEN OPTIC TECTUM; RECOMBINANT RETROVIRUS; LINEAGE ANALYSIS; CREST CELLS; OLIGODENDROCYTE DEVELOPMENT; NEUROEPITHELIAL CELLS; COMMON PROGENITOR	The importance of intrinsic commitments and epigenetic influence to the development of mature neural cell phenotypes was assessed using embryonic day 10 murine neuroepithelial cells, isolated from telencephalon and mesencephalon. Two types of clones were generated with fibroblast growth factor: type-A clones consisted of large, amorphous cells, and type-B clones contained epithelial-like cells. In many type-B clones, very large numbers of precursor cells were produced. Twenty-four percent of type-B clones contained small numbers of neurons, and 59% of clones containing neurons also contained astrocytes, indicating that this clonal type was derived from a bipotential precursor cell. Neuronal differentiation was enhanced by culturing precursor cells with conditioned medium derived from an immortalized astroglial-like cell line. These results indicate that neuroepithelial precursors have discrete epigenetic requirements for their proliferation and differentiation.			KILPATRICK, TJ (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,ROYAL PARADE,PARKVILLE,VIC 3050,AUSTRALIA.		Bartlett, Perry/F-3813-2012	Kilpatrick, Trevor/0000-0003-3999-085X				ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BARTLETT PF, 1988, P NATL ACAD SCI USA, V85, P3255, DOI 10.1073/pnas.85.9.3255; BARTLETT PF, 1991, TODAYS LIFE SCI, V3, P12; BERNARD O, 1989, J NEUROSCI RES, V24, P9, DOI 10.1002/jnr.490240104; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; COWA WM, 1979, SCI AM, V241, P107; DEVITRY F, 1980, P NATL ACAD SCI-BIOL, V77, P4165, DOI 10.1073/pnas.77.7.4165; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; DRAGO J, 1991, EXP CELL RES, V196, P246, DOI 10.1016/0014-4827(91)90258-V; DRAGO J, 1991, EXP CELL RES, V37, P251; FRANK E, 1991, DEVELOPMENT, V111, P895; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; KILPATRICK TJ, 1993, IN PRESS NEUROSCI RE; LEBER SM, 1990, J NEUROSCI, V10, P2451; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; METCALF D, 1971, HAEMOPOIETIC CELLS, P70; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAFF MC, 1978, NATURE, V274, P813, DOI 10.1038/274813a0; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SIEBERBLUM M, 1989, SCIENCE, V243, P1608, DOI 10.1126/science.2564699; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WATANABE T, 1990, NEURON, V2, P461; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9	49	320	338	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					255	265		10.1016/0896-6273(93)90316-J	http://dx.doi.org/10.1016/0896-6273(93)90316-J			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439411				2022-12-28	WOS:A1993KP68500013
J	TCHELINGERIAN, JL; QUINONERO, J; BOOSS, J; JACQUE, C				TCHELINGERIAN, JL; QUINONERO, J; BOOSS, J; JACQUE, C			LOCALIZATION OF TNF-ALPHA AND IL-1-ALPHA IMMUNOREACTIVITIES IN STRIATAL NEURONS AFTER SURGICAL INJURY TO THE HIPPOCAMPUS	NEURON			English	Article							TUMOR-NECROSIS-FACTOR; ADULT-RAT BRAIN; MOUSE-BRAIN; INTERLEUKIN-1 RECEPTORS; PREFRONTAL CORTEX; CYTO-TOXICITY; ASTROCYTES; REJECTION; MICROGLIA; MACROPHAGES	Since the inflammatory process develops after transplantation to the brain, we sought to determine the presence of cytokines following a surgical trauma to the brain of an adult mouse. We report the early and marked presence of tumor necrosis factor-alpha and interleukin-1alpha in neuronal somata of the striatum following a surgical injury to the hippocampus. The expression of cytokines later extends to neuronal cells of the hippocampus, thalamus, cerebral cortex, brain stem, and cerebellum and to glial cells of the corpus callosum. By contrast, these cytokines are not expressed by neuronal cells following injury to other regions, such as the striatum, cerebellum, and cortex. This study suggests a possible role for certain neurons in the brain's early reaction to a penetrating injury.	YALE UNIV,SCH MED,VET ADM,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT NEUROL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT LAB MED,NEW HAVEN,CT 06510	Yale University; Yale University; Yale University	TCHELINGERIAN, JL (corresponding author), HOP LA PITIE SALPETRIERE,INSERM,U134,F-75651 PARIS 13,FRANCE.							ARBUSTINI E, 1991, AM J PATHOL, V139, P709; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BACKES MG, 1990, J COMP NEUROL, V295, P428, DOI 10.1002/cne.902950307; BALKWILL FR, 1989, IMMUNOL TODAY, V10, P299, DOI 10.1016/0167-5699(89)90085-6; BAN E, 1992, CYTOKINE, V4, P48, DOI 10.1016/1043-4666(92)90036-Q; BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; BARKER CF, 1977, ADV IMMUNOL, V25, P1; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BOOSS J, 1991, J NEUROSCI RES, V30, P455, DOI 10.1002/jnr.490300302; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; CHUNG IY, 1990, J IMMUNOL, V144, P2999; COLLINS VP, 1983, ACTA PATH MICRO IM A, V91, P269; CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DELCERRO M, 1979, NEUROSCIENCE, V4, P1399, DOI 10.1016/0306-4522(79)90167-2; FARRAR WL, 1987, J IMMUNOL, V139, P459; FINSEN BR, 1991, J NEUROIMMUNOL, V32, P159, DOI 10.1016/0165-5728(91)90008-U; FONTANA A, 1982, J IMMUNOL, V129, P2413; FREI K, 1987, EUR J IMMUNOL, V17, P1271, DOI 10.1002/eji.1830170909; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; KLEIN J, 1983, IMMUNOGENETICS, V17, P553, DOI 10.1007/BF00366126; LAWRENCE JM, 1990, NEUROSCIENCE, V37, P431, DOI 10.1016/0306-4522(90)90413-X; LECHAN RM, 1990, BRAIN RES, V514, P135, DOI 10.1016/0006-8993(90)90445-H; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7; NICHOLAS MK, 1987, J NEUROSCI RES, V18, P245, DOI 10.1002/jnr.490180135; NIETOSAMPEDRO M, 1987, NEUROCHEM RES, V12, P723, DOI 10.1007/BF00970528; OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6; PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; POLTORAK M, 1989, EXP NEUROL, V103, P222, DOI 10.1016/0014-4886(89)90046-0; RAGSDALE CW, 1990, P NATL ACAD SCI USA, V87, P6196, DOI 10.1073/pnas.87.16.6196; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; SLOAN DJ, 1991, TRENDS NEUROSCI, V14, P341, DOI 10.1016/0166-2236(91)90159-R; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; SUARD IM, 1989, J NEUROSCI RES, V23, P172, DOI 10.1002/jnr.490230207; SWANSON LW, 1981, BRAIN RES, V217, P150, DOI 10.1016/0006-8993(81)90192-X; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; TAKAO T, 1990, ENDOCRINOLOGY, V127, P3070, DOI 10.1210/endo-127-6-3070; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402	48	164	164	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					213	224		10.1016/0896-6273(93)90312-F	http://dx.doi.org/10.1016/0896-6273(93)90312-F			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439410				2022-12-28	WOS:A1993KP68500009
J	ANDRADE, R				ANDRADE, R			ENHANCEMENT OF BETA-ADRENERGIC RESPONSES BY GI-LINKED RECEPTORS IN RAT HIPPOCAMPUS	NEURON			English	Article							GTP-BINDING PROTEINS; PYRAMIDAL CELLS; ADENYLATE-CYCLASE; CALCIUM CURRENT; GUINEA-PIG; NORADRENALINE; SEROTONIN; CHANNELS; NEURONS; TRANSDUCTION	Many excitable cells express a class of neurotransmitter receptors functionally defined by their ability to increase potassium conductance through G proteins of the G(i)/G(o) class that directly activate the potassium channels. Biochemical studies have shown that these same receptors can also inhibit forskolin-stimulated adenylyl cyclase, although the functional significance of this effect remains unclear. In this study electrophysiological techniques were used to examine how activation of serotonin and gamma-aminobutyric acid receptors belonging to this class affect beta-adrenergic responses signaled through adenylyl cyclase. Surprisingly, activation of these receptors not only failed to inhibit but actually enhanced beta-adrenergic responses. These observations are consistent with evidence indicating that G(i)-linked receptors can enhance the ability of G(s) to stimulate certain adenylyl cyclases.			ANDRADE, R (corresponding author), ST LOUIS UNIV,SCH MED,DEPT PHARMACOL & PHYSIOL SCI,ST LOUIS,MO 63104, USA.				NIMH NIH HHS [MH 43985] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH043985, R01MH043985] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; ANDRADE R, 1991, J PHARMACOL EXP THER, V40, P399; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; DEVIVO M, 1986, J PHARMACOL EXP THER, V238, P248; DOLPHIN AC, 1990, GABAB RECEPTORS IN MAMMALIAN FUNCTION, P259; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FISCHMEISTER R, 1986, J PHYSIOL-LONDON, V376, P183, DOI 10.1113/jphysiol.1986.sp016148; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HIRAYAMA T, 1991, BRAIN RES, V539, P320, DOI 10.1016/0006-8993(91)91637-G; KARBON EW, 1985, MOL PHARMACOL, V27, P53; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MARKSTEIN R, 1986, N-S ARCH PHARMACOL, V333, P335, DOI 10.1007/BF00500006; MCALLISTER G, 1992, P NATL ACAD SCI USA, V89, P5517, DOI 10.1073/pnas.89.12.5517; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; PALMER JM, 1987, J PHYSIOL-LONDON, V387, P371, DOI 10.1113/jphysiol.1987.sp016578; PENINGTON NJ, 1990, NEURON, V4, P751, DOI 10.1016/0896-6273(90)90201-P; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; SCHAAD NC, 1989, J NEUROCHEM, V53, P1941, DOI 10.1111/j.1471-4159.1989.tb09265.x; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TANG WJ, 1991, J BIOL CHEM, V266, P8595; VOIGT MM, 1991, EMBO J, V10, P4017, DOI 10.1002/j.1460-2075.1991.tb04977.x; WOJCIK WJ, 1990, GABAB RECEPTORS IN MAMMALIAN FUNCTION, P141	29	59	59	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1993	10	1					83	88		10.1016/0896-6273(93)90244-L	http://dx.doi.org/10.1016/0896-6273(93)90244-L			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8381289				2022-12-28	WOS:A1993KK01200009
J	Shirasaki, R; Mirzayan, C; TessierLavigne, M; Murakami, F				Shirasaki, R; Mirzayan, C; TessierLavigne, M; Murakami, F			Guidance of circumferentially growing axons by netrin-dependent and -independent floor plate chemotropism in the vertebrate brain	NEURON			English	Article							COMMISSURAL GROWTH CONE; INITIAL TRACT FORMATION; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; CHICK-EMBRYO; C-ELEGANS; SEMAPHORIN-III; MOTOR AXONS; RAT-BRAIN; ZEBRAFISH	Netrin-1, a diffusible signal secreted by floor plate cells at the ventral midline of the vertebrate CNS, can attract ventrally migrating axons and repel a subset of dorsally migrating axons in the spinal cord and rostral hindbrain in vitro. Whether netrin-1 can act as a global cue to guide all circumferentially migrating axons is, however, unknown. Here, we show that netrin-1 can attract alar plate axons that cross the floor plate along its entire rostrocaudal axis. Dorsally directed axons forming the posterior commissure are, however, repelled by the floor plate by a netrin-independent mechanism. These results suggest that netrin-1 functions as a global guidance cue for attraction to the midline. Moreover, floor plate-mediated chemorepulsion may also operate generally to direct dorsal migrations, but its molecular basis may involve both netrin-dependent and -independent mechanisms.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, CELL BIOL PROGRAM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM DEV BIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shirasaki, R (corresponding author), OSAKA UNIV, FAC ENGN SCI, DEPT BIOPHYS ENGN, TOYONAKA, OSAKA 560, JAPAN.			Murakami, Fujio/0000-0002-1519-5096; Shirasaki, Ryuichi/0000-0001-8561-7023	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD07470] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTMAN J, 1981, J COMP NEUROL, V198, P677, DOI 10.1002/cne.901980409; CHEDOTAL A, 1995, EUR J NEUROSCI, V7, P198, DOI 10.1111/j.1460-9568.1995.tb01056.x; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; CHOLLEY B, 1989, DEV BRAIN RES, V45, P185, DOI 10.1016/0165-3806(89)90038-2; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EASTER SS, 1993, J NEUROSCI, V13, P285; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; EDWARDS MA, 1989, DEV BRAIN RES, V49, P185, DOI 10.1016/0165-3806(89)90021-7; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GODEMENT P, 1987, DEVELOPMENT, V101, P697; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; HATTA K, 1994, P NATL ACAD SCI USA, V91, P2061, DOI 10.1073/pnas.91.6.2061; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; LAUDER JM, 1986, NEUROSCIENCE, V19, P465, DOI 10.1016/0306-4522(86)90275-7; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Mastick GS, 1996, DEV BIOL, V173, P79, DOI 10.1006/dbio.1996.0008; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MYERS PZ, 1993, J NEUROSCI, V13, P127; MYERS PZ, 1993, J NEUROSCI, V13, P115; PATEL CK, 1994, J NEUROBIOL, V25, P345, DOI 10.1002/neu.480250402; PHELPS PE, 1993, J COMP NEUROL, V330, P1, DOI 10.1002/cne.903300102; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PRINCE JT, 1992, DEV BRAIN RES, V68, P193, DOI 10.1016/0165-3806(92)90061-Z; PUELLES L, 1977, ANAT EMBRYOL, V150, P187, DOI 10.1007/BF00316650; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; SHEPHERD IT, 1995, J COMP NEUROL, V354, P501, DOI 10.1002/cne.903540403; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; SHIRASAKI R, 1996, NEUROSCI RES       S, V20, pS113; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; TAMADA A, 1995, NEURON, V14, P1083, DOI 10.1016/0896-6273(95)90347-X; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WILSON SW, 1990, DEVELOPMENT, V108, P121; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; YAGINUMA H, 1990, DEVELOPMENT, V108, P705; YAMAMOTO M, 1986, J NEUROSCI, V6, P3576	52	114	115	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1079	1088		10.1016/S0896-6273(00)80241-X	http://dx.doi.org/10.1016/S0896-6273(00)80241-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982157	Bronze			2022-12-28	WOS:A1996WA24800007
J	Firestein, S				Firestein, S			Scentsational ion channels	NEURON			English	Review							OLFACTORY RECEPTOR NEURONS; ADENYLATE-CYCLASE; ODORANTS; TRANSDUCTION; STIMULATION; CONDUCTANCE; ACTIVATION; CILIA; RAT				Firestein, S (corresponding author), COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027, USA.							BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BOEKHOFF I, 1990, J COMP PHYSIOL B, V160, P99, DOI 10.1007/BF00258768; Breer Heinz, 1994, Seminars in Cell Biology, V5, P25, DOI 10.1006/scel.1994.1004; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; GREER CA, 1982, J NEUROSCI, V2, P1744; Lem J, 1996, CURR OPIN NEUROBIOL, V6, P453, DOI 10.1016/S0959-4388(96)80049-3; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; OKADA Y, 1994, J NEUROPHYSIOL, V71, P595, DOI 10.1152/jn.1994.71.2.595; RONNETT GV, 1993, J NEUROSCI, V13, P1751; ROSKAMS AJ, 1994, NEURON, V13, P289; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; Smith DP, 1996, CURR OPIN NEUROBIOL, V6, P500, DOI 10.1016/S0959-4388(96)80056-0; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	19	9	9	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					803	806		10.1016/S0896-6273(00)80212-3	http://dx.doi.org/10.1016/S0896-6273(00)80212-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938112	Bronze			2022-12-28	WOS:A1996VV15100002
J	Komatsu, H; Mori, I; Rhee, JS; Akaike, N; Ohshima, Y				Komatsu, H; Mori, I; Rhee, JS; Akaike, N; Ohshima, Y			Mutations in a cyclic nucleotide-gated channel lead to abnormal thermosensation and chemosensation in C-elegans	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; OLFACTORY RECEPTOR-CELLS; SENSITIVE ADENYLATE-CYCLASE; 2ND MESSENGER PATHWAYS; FUNCTIONAL EXPRESSION; ROD PHOTORECEPTORS; ACTIVATED CHANNELS; GENE-EXPRESSION; NERVOUS-SYSTEM; ION CHANNELS	The C. elegans tax-4 mutants are abnormal in multiple sensory behaviors: they fail to respond to temperature or to water-soluble or volatile chemical attractants. We show that the predicted tax-4 gene product is highly homologous to vertebrate cyclic nucleotide-gated channels. Tax-4 protein expressed in cultured cells functions as a cyclic nucleotide-gated channel. The green fluorescent protein (GFP)-tagged functional Tax-4 protein is expressed in thermosensory, gustatory, and olfactory neurons mediating all the sensory behaviors affected by the tax-4 mutations. The Tax4::GFP fusion is partly localized at the sensory endings of these neurons. The results suggest that a cyclic nucleotide-gated channel is required for thermosensation and chemosensation and that cGMP is an important intracellular messenger in C. elegans sensory transduction.	KYUSHU UNIV, FAC MED, DEPT PHYSIOL, FUKUOKA 81282, JAPAN	Kyushu University	Komatsu, H (corresponding author), KYUSHU UNIV, FAC SCI, DEPT BIOL, FUKUOKA 81281, JAPAN.			Komatsu, Hidetoshi/0000-0003-1630-0537				ALTENHOFEN W, 1991, P NATL ACAD SCI USA, V88, P9868, DOI 10.1073/pnas.88.21.9868; AVERY L, 1993, GENETICS, V134, P454; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; BOEKHOFF I, 1994, J NEUROSCI, V14, P3304; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; DHALLAN RS, 1992, J NEUROSCI, V12, P3248, DOI 10.1523/JNEUROSCI.12-08-03248.1992; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DUSENBERY DB, 1975, GENETICS, V80, P297; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; Imae Y., 1985, SENSING RESPONSE MIC, P73; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; MURASE K, 1990, BRAIN RES, V525, P84, DOI 10.1016/0006-8993(90)91323-9; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NARA T, 1991, J BACTERIOL, V173, P1120, DOI 10.1128/jb.173.3.1120-1124.1991; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NUMA S, 1989, HARVEY LECT, V83, P121; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; Riddle DL., 1988, NEMATODE CAENORHABDI, P393; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS BD, 1992, GENETICS, V131, P609; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481	67	317	329	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					707	718		10.1016/S0896-6273(00)80202-0	http://dx.doi.org/10.1016/S0896-6273(00)80202-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893027	Bronze			2022-12-28	WOS:A1996VP74300015
J	Martin, KC; Kandel, ER				Martin, KC; Kandel, ER			Cell adhesion molecules, CREB, and the formation of new synaptic connections	NEURON			English	Review							LONG-TERM-MEMORY; DROSOPHILA; APLYSIA; PLASTICITY; FASCICULATION; EXPRESSION; MUTANTS; NCAM				Martin, KC (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032, USA.							BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; KELLER F, 1990, J CELL BIOL, V111, P2637, DOI 10.1083/jcb.111.6.2637; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; LANDMESSER I, 1992, NEURON, V4, P655; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; ROSE SPR, 1995, TRENDS NEUROSCI, V18, P502, DOI 10.1016/0166-2236(95)92774-K; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; ZHONG Y, 1992, J NEUROSCI, V12, P644; ZHU H, 1995, J NEUROSCI, V15, P4173	14	156	157	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					567	570		10.1016/S0896-6273(00)80188-9	http://dx.doi.org/10.1016/S0896-6273(00)80188-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893013	hybrid			2022-12-28	WOS:A1996VP74300001
J	Schuster, CM; Davis, GW; Fetter, RD; Goodman, CS				Schuster, CM; Davis, GW; Fetter, RD; Goodman, CS			Genetic dissection of structural and functional components of synaptic plasticity .2. Fasciclin II controls presynaptic structural plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULE; GROWTH CONE GUIDANCE; MACROMOLECULAR-SYNTHESIS; DROSOPHILA MUTANTS; CRITICAL PERIOD; MEMORY MUTANTS; DENTATE GYRUS; LATE-PHASE; APLYSIA	Increased neuronal activity (eag Shaker mutants) and cAMP concentration (dunce mutants) lead to increased synaptic structure and function at the Drosophila neuromuscular junction. Here, we show that the increase in synaptic growth is accompanied by an similar to 50% decrease in synaptic levels of the cell adhesion molecule Fasciclin II (Fas II). This decrease in Fas II is both necessary and sufficient for presynaptic sprouting; FasII mutants that decrease Fas II levels by similar to 50% lead to sprouting similar to eag Shaker and dunce, while transgenes that maintain synaptic Fas II levels suppress sprouting in eag Shaker and dunce. However, FasII mutants that cause a 50% increase in bouton number do not alter synaptic strength; rather, evoked release from single boutons has a reduced quantal content, suggesting that the wild-type amount of release machinery is distributed throughout more boutons.	UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOL & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley					NICHD NIH HHS [HD21294] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYD IA, 1956, J PHYSIOL-LONDON, V132, P74, DOI 10.1113/jphysiol.1956.sp005503; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; CORFAS G, 1990, J NEUROSCI, V10, P491; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; EVENS M, 1993, STAT DISTRIBUTIONS; FAZELI MS, 1994, NEUROSCI LETT, V169, P77, DOI 10.1016/0304-3940(94)90360-3; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; KAPLAN WD, 1969, GENETICS, V61, P399; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MURPHEY RK, 1976, SCIENCE, V191, P564, DOI 10.1126/science.1251189; Nguyen PV, 1996, J NEUROSCI, V16, P3189; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wu C F, 1992, Ion Channels, V3, P261; ZHONG Y, 1995, J NEUROSCI, V15, P6679; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644	43	262	265	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1996	17	4					655	667		10.1016/S0896-6273(00)80198-1	http://dx.doi.org/10.1016/S0896-6273(00)80198-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893023	Bronze			2022-12-28	WOS:A1996VP74300011
J	Trudeau, LE; Emery, DG; Haydon, PG				Trudeau, LE; Emery, DG; Haydon, PG			Direct modulation of the secretory machinery underlies PKA-dependent synaptic facilitation in hippocampal neurons	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-A; CA2+-ACTIVATED SECRETION; TRANSMITTER RELEASE; CALCIUM INFLUX; CYCLIC-AMP; IN-VITRO; PHOSPHORYLATION; TRANSMISSION; ENHANCEMENT	Activation of protein kinase A (PKA) is known to facilitate synaptic transmission. Using synapses established by hippocampal neurons in culture, we show that dialysis of PKA inhibitors in the presynaptic neuron blocks synaptic facilitation produced by the adenylyl cyclase activator forskolin, demonstrating a presynaptic locus of action. Using ruthenium red, a tool that is known to stimulate exocytosis independently of Ca2+ influx, but in a manner sensitive to tetanus toxin, we find that the secretory process is directly up-regulated under conditions where the number of functional terminals remains unchanged, as revealed by imaging of FM1-43, a vital indicator of synaptic vesicle endocytosis. Taken together with our ultrastructural analysis that suggests no enhancement of docking, our data indicate that PKA causes synaptic facilitation by directly elevating the probability of exocytosis of individual vesicles in response to an invariant Ca2+ signal.			Trudeau, LE (corresponding author), IOWA STATE UNIV,DEPT ZOOL & GENET,LAB CELLULAR SIGNALING,AMES,IA 50011, USA.		Trudeau, Louis-Eric/AAE-4782-2020	Trudeau, Louis-Eric/0000-0003-4684-1377	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026650, R01NS024233] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24233, NS26650] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Byrne JH, 1996, J NEUROSCI, V16, P425; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Dittman JS, 1996, J NEUROSCI, V16, P1623; DIXON D, 1989, J NEUROSCI, V9, P4245; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HMUANG CC, 1996, J NEUROSCI, V16, P1026; KLEIN M, 1994, NEURON, V13, P159, DOI 10.1016/0896-6273(94)90466-9; MAIGAROLI A, 1992, NATURE, V357, P134; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHELLER RH, 1995, NEURON, V14, P893; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Trudeau LE, 1996, J NEUROSCI, V16, P46; Voelker D, 1996, BIOPHYS J, V70, P818, DOI 10.1016/S0006-3495(96)79621-2; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482	39	191	194	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					789	797		10.1016/S0896-6273(00)80210-X	http://dx.doi.org/10.1016/S0896-6273(00)80210-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893035	Bronze			2022-12-28	WOS:A1996VP74300023
J	Bal, T; McCormick, DA				Bal, T; McCormick, DA			What stops synchronized thalamocortical oscillations?	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; THALAMIC RELAY NEURONS; ACTIVATED CATION CURRENT; VOLTAGE-CLAMP ANALYSIS; RETICULARIS THALAMI; IN-VITRO; ELECTROPHYSIOLOGICAL PROPERTIES; PERIGENICULATE NUCLEUS; MECHANISMS; MORPHOLOGY	Slow-wave sleep as well as generalized absence seizures are characterized by the occurrence of synchronized oscillations in thalamocortical systems that spontaneously appear and disappear. The spontaneous appearance of synchronized oscillations results from the initiation by one or a small number of cells followed by the progressive recruitment of large numbers of neighboring neurons into the synchronized network activity. Synchronized network oscillations representative of slow-wave sleep, as well as absence seizures, were demonstrated to cease spontaneously at least in part through the persistent activation of a hyperpolarization-activated cation conductance, Block of this conductance resulted in oscillations that, once generalized, occur continuously. These results indicate that the persistent activation of a hyperpolarization-activated cation conductance is a key mechanism through which synchronized oscillations in thalamocortical networks normally terminate.	YALE UNIV, SCH MED, NEUROBIOL SECT, NEW HAVEN, CT 06473 USA	Yale University			Kobelt, Liza/F-5926-2011; McCormick, David A/J-2649-2015	McCormick, David A/0000-0002-9803-8335				[Anonymous], [No title captured]; AVOLI M, 1990, GEN EPILEPSY NEUROBI, P190; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; COX CL, 1996, IN PRESS J COMP NEUR; DESCHENES M, 1984, J NEUROPHYSIOL, V51, P1196, DOI 10.1152/jn.1984.51.6.1196; DESTEXHE A, 1993, BIOPHYS J, V65, P2473, DOI 10.1016/S0006-3495(93)81297-9; DESTEXHE A, 1993, BIOPHYS J, V65, P1538, DOI 10.1016/S0006-3495(93)81190-1; DEXTEXHE A, 1996, IN PRESS J NEUROPHYS; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; HAGIWARA N, 1989, J PHYSIOL-LONDON, V409, P121, DOI 10.1113/jphysiol.1989.sp017488; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HARRIS RM, 1987, J COMP NEUROL, V258, P397, DOI 10.1002/cne.902580308; Jones EG, 1985, THALAMUS; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MULLE C, 1986, J NEUROSCI, V6, P2134; NIEDERMEYER E, 1990, EPILEPSIES DIAGNOSIS; NIEDERMEYER Ernst, 1982, ELECTROEN CLIN NEURO; NUNEZ A, 1992, NEUROSCIENCE, V48, P75, DOI 10.1016/0306-4522(92)90339-4; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SOLTESZ I, 1992, PROG BRAIN RES, V90, P151; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; SPAIN WJ, 1991, J PHYSIOL-LONDON, V434, P609, DOI 10.1113/jphysiol.1991.sp018489; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; UHLRICH DJ, 1991, J NEUROPHYSIOL, V65, P1528, DOI 10.1152/jn.1991.65.6.1528; ULRICH D, 1996, IN PRESS J PHYSL LON; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750	39	162	164	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1996	17	2					297	308		10.1016/S0896-6273(00)80161-0	http://dx.doi.org/10.1016/S0896-6273(00)80161-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780653	hybrid			2022-12-28	WOS:A1996VE84000012
J	Han, KA; Millar, NS; Grotewiel, MS; Davis, RL				Han, KA; Millar, NS; Grotewiel, MS; Davis, RL			DAMB, a novel dopamine receptor expressed specifically in Drosophila mushroom bodies	NEURON			English	Article							ADENYLATE-CYCLASE; PREFERENTIAL EXPRESSION; POINT MUTATIONS; PROTEIN-KINASE; GENE; MEMORY; RUTABAGA; APLYSIA; CLONING; TRANSFORMATION	The modulatory neurotransmitters that trigger biochemical cascades underlying olfactory learning in Drosophila mushroom bodies have remained unknown. To identify molecules that may perform this role, putative biogenic amine receptors were cloned using the polymerase chain reaction (PCR) and single-strand conformation polymorphism analysis. One new receptor, DAMB, was identified as a dopamine D1 receptor by sequence analysis and pharmacological characterization. In situ hybridization and immunohistochemical analyses revealed highly enriched expression of DAMB in mushroom bodies, in a pattern coincident with the rutabaga-encoded adenylyl cyclase. The spatial coexpression of DAMB and the cyclase, along with DAMB's capacity to mediate dopamine-induced increases in cAMP make this receptor an attractive candidate for initiating biochemical cascades underlying learning.	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; UCL, DEPT PHARMACOL, WELLCOME LAB MOL PHARMACOL, LONDON WC1E 6BT, ENGLAND	Baylor College of Medicine; University of London; University College London	Han, KA (corresponding author), BAYLOR COLL MED, DEPT CELL BIOL, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.		Davis, Ronald/J-4998-2013; Grotewiel, Mike/AAX-4094-2020	Davis, Ronald/0000-0002-5986-7608; Grotewiel, Mike/0000-0001-7302-3252	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ARAKAWA S, 1990, NEURON, V4, P343, DOI 10.1016/0896-6273(90)90047-J; BAILEY CH, 1994, ADV SEC MESS PHOSPH, V29, P529; BARD JA, 1993, J BIOL CHEM, V268, P23422; BICKER G, 1989, NATURE, V337, P33, DOI 10.1038/337033a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BYRNE JH, 1993, ADV SEC MESS PHOSPH, V27, P47; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAVIS RL, 1986, MOL CELL BIOL, V6, P1464, DOI 10.1128/MCB.6.5.1464; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Davis RL, 1996, CURR BIOL, V6, P146, DOI 10.1016/S0960-9822(02)00447-5; DAVIS RL, 1996, IN PRESS PHYSL REV, V76; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DUDAI Y, 1987, J COMP PHYSIOL A, V161, P739, DOI 10.1007/BF00605015; DUDAI Y, 1983, P NATL ACAD SCI-BIOL, V80, P5445, DOI 10.1073/pnas.80.17.5445; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FENG G, 1996, IN PRESS J NEUROSCI; FORTE M, 1993, GTPASE BIOL, P319; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; HAN KA, 1992, CANCER RES, V52, P749; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Harlow E., 1988, ANTIBODIES LAB MANUA; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MCGAUGH JL, 1993, BEHAV BRAIN RES, V58, P81, DOI 10.1016/0166-4328(93)90092-5; MILLAR NS, 1994, P ROY SOC B-BIOL SCI, V258, P307, DOI 10.1098/rspb.1994.0178; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; NG GYK, 1994, EUR J PHARM-MOLEC PH, V267, P7, DOI 10.1016/0922-4106(94)90219-4; NIGHORN A, 1994, COMP BIOCHEM PHYS B, V108, P1, DOI 10.1016/0305-0491(94)90157-0; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; ODOWD BF, 1993, J NEUROCHEM, V60, P804, DOI 10.1111/j.1471-4159.1993.tb03224.x; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Restifo L.L., 1990, Advances in Insect Physiology, V22, P115, DOI 10.1016/S0065-2806(08)60006-5; Sambrook J., 2002, MOL CLONING LAB MANU; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Schurmann F.-W., 1987, P231; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; SMITH RF, 1992, PROTEIN ENG, V5, P35, DOI 10.1093/protein/5.1.35; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; STEPHENSON RM, 1994, PHARMACOL BIOCHEM BE, V48, P971, DOI 10.1016/0091-3057(94)90207-0; STRAUSFELD N, 1976, ATLAS INSECT BRAIN, P69; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; VERNIER P, 1993, EXS, V13, P297	52	219	222	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN	1996	16	6					1127	1135		10.1016/S0896-6273(00)80139-7	http://dx.doi.org/10.1016/S0896-6273(00)80139-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663989	Bronze			2022-12-28	WOS:A1996UU11800010
J	Meffert, MK; Calakos, NC; Scheller, RH; Schulman, H				Meffert, MK; Calakos, NC; Scheller, RH; Schulman, H			Nitric oxide modulates synaptic vesicle docking/fusion reactions	NEURON			English	Article							CASEIN KINASE-II; PROTEIN; PHOSPHORYLATION; SYNAPTOTAGMIN; SYNAPTOSOMES; NEUROTOXINS; RELEASE; SNAP-25; TETANUS; FUSION	Nitric oxide (NO) stimulates calcium-independent neurotransmitter release from synaptosomes. NO-stimulated release was found to be inhibited by Botulinum neurotoxins that inactivate the core complex of synaptic proteins involved in the docking and fusion of synaptic vesicles. In experiments using recombinant proteins, NO donors increased formation of the VAMP/SNAP-25/syntaxin 1a core complex and inhibited the binding of n-sec1 to syntaxin 1a. The combined effects of these activities is predicted to promote vesicle docking/fusion. The sulfhydryl reagent NEM inhibited the binding of n-sec1 to syntaxin 1a, while beta-ME could reverse the NO-enhanced association of VAMP/SNAP-25/syntaxin 1a. These data suggest that post-translational modification of sulfhydryl groups by a nitrogen monoxide (likely to be NO+) alters the synaptic protein interactions that regulate neurotransmitter release and synaptic plasticity.	STANFORD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305	Stanford University; Howard Hughes Medical Institute; Stanford University	Meffert, MK (corresponding author), STANFORD UNIV,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Bennett J., 1985, NEUROTRANSMITTER REC, V2nd, P61; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CASELLI A, 1994, J BIOL CHEM, V269, P24878; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; DIMMELER S, 1993, FEBS LETT, V315, P21, DOI 10.1016/0014-5793(93)81124-I; DUHE RJ, 1994, J BIOL CHEM, V269, P7290; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; GOPALAKRISHNA R, 1993, J BIOL CHEM, V268, P27180; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HESS DT, 1994, NEUROPHARMACOLOGY, V33, P1283, DOI 10.1016/0028-3908(94)90028-0; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; KRUSZYNA H, 1993, BIOCHEM PHARMACOL, V46, P95, DOI 10.1016/0006-2952(93)90352-W; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MCDONALD LJ, 1966, P SOC EXP BIOL MED, V211, P1; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; POPOLI M, 1993, FEBS LETT, V317, P85, DOI 10.1016/0014-5793(93)81496-M; PRYOR WA, 1982, J ORG CHEM, V47, P156, DOI 10.1021/jo00340a038; RUBENSTEIN JL, 1993, SYNAPSE, V13, P161, DOI 10.1002/syn.890130207; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; VANDERVLIET A, 1995, ARCH BIOCHEM BIOPHYS, V319, P341, DOI 10.1006/abbi.1995.1303; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764	46	208	211	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1229	1236		10.1016/S0896-6273(00)80149-X	http://dx.doi.org/10.1016/S0896-6273(00)80149-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663999	Bronze			2022-12-28	WOS:A1996UU11800020
J	Yuste, R; Tank, DW				Yuste, R; Tank, DW			Dendritic integration in mammalian neurons, a century after Cajal	NEURON			English	Review							CENTRAL-NERVOUS-SYSTEM; ELECTRON-MICROSCOPIC ANALYSIS; ARBITRARILY BRANCHING CABLES; HIPPOCAMPAL PYRAMIDAL CELLS; ACTION-POTENTIAL DISCHARGE; RAT NEOCORTICAL NEURONS; PATCH-CLAMP RECORDINGS; LONG-TERM POTENTIATION; CAT VISUAL-CORTEX; PURKINJE-CELLS		AT&T BELL LABS, BIOL COMPUTAT RES DEPT, MURRAY HILL, NJ 07974 USA	AT&T; Nokia Corporation; Nokia Bell Labs	Yuste, R (corresponding author), COLUMBIA UNIV, DEPT BIOL SCI, NEW YORK, NY 10027 USA.							ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; ANDERSEN P, 1966, ACTA PHYSIOL SCAND, V66, P461, DOI 10.1111/j.1748-1716.1966.tb03224.x; [Anonymous], CONEXION GEN ELEMENT; ANTIC S, 1995, J NEUROSCI, V15, P1392; BENEDECZKY I, 1994, EXP BRAIN RES, V101, P216, DOI 10.1007/BF00228742; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; BERNARDO LS, 1982, J NEUROSCI, V2, P1614; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BORST A, 1994, TRENDS NEUROSCI, V17, P257, DOI 10.1016/0166-2236(94)90009-4; BORST A, 1992, P NATL ACAD SCI USA, V89, P4139, DOI 10.1073/pnas.89.9.4139; BROCK LG, 1952, J PHYSIOL-LONDON, V117, P431, DOI 10.1113/jphysiol.1952.sp004759; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Bullock Theodore H., 1977, INTRO NERVOUS SYSTEM; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; Cajal SR, 1923, RECUERDOS MI VIDA HI; CAJAL SR, 1897, REV TRIM MICROGR, V1; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; CAULLER LJ, 1994, J NEUROSCI, V14, P751; CAULLER LJ, 1991, EXP BRAIN RES, V84, P607; CAULLER LJ, 1992, SINGLE NEURON COMPUT, P189; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; CONNORS BW, 1983, J NEUROSCI, V3, P773; CONNORS BW, 1986, J NEUROSCI, V6, P164; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P374, DOI 10.1113/jphysiol.1955.sp005413; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P396, DOI 10.1113/jphysiol.1955.sp005414; DE NO R. L., 1959, PROC NATL ACAD SCI, V45, P592; Deiters O, 1865, UNTERSUCHUNGEN GEHIR; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; DEROBERTIS EDP, 1955, J BIOPHYS BIOCHEM CY, V1, P47, DOI 10.1083/jcb.1.1.47; DESCHENES M, 1981, EXP BRAIN RES, V43, P304; DESCHUTTER E, 1994, P NATL ACAD SCI USA, V91, P4736, DOI 10.1073/pnas.91.11.4736; DESCHUTTER E, 1992, TRENDS NEUROSCI, V15, P462, DOI 10.1016/0166-2236(92)90011-V; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; DOWLING JE, 1968, PROC R SOC SER B-BIO, V170, P205, DOI 10.1098/rspb.1968.0034; DUBIN MW, 1970, J COMP NEUROL, V140, P479, DOI 10.1002/cne.901400406; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; ECCLES JC, 1958, J PHYSIOL-LONDON, V143, P11, DOI 10.1113/jphysiol.1958.sp006041; ECCLES JC, 1964, PHYSL SYNAPSES, P104; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FETCHO JR, 1995, J NEUROPHYSIOL, V73, P399, DOI 10.1152/jn.1995.73.1.399; FINE A, 1988, TRENDS NEUROSCI, V11, P346, DOI 10.1016/0166-2236(88)90056-2; FOREHAND CJ, 1984, J NEUROSCI, V4, P1; FROMHERZ P, 1994, P NATL ACAD SCI USA, V91, P4604, DOI 10.1073/pnas.91.10.4604; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GLENN LL, 1988, BRAIN RES, V439, P396, DOI 10.1016/0006-8993(88)91502-8; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; Goppert-Mayer M., 1931, ANN PHYS-LEIPZIG, V401, P273, DOI DOI 10.1002/ANDP.19314010303; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GRINVALD A, 1981, P NATL ACAD SCI-BIOL, V78, P3245, DOI 10.1073/pnas.78.5.3245; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; GUTNICK MJ, 1981, SCIENCE, V211, P67, DOI 10.1126/science.7444449; Haag J, 1996, NATURE, V379, P639, DOI 10.1038/379639a0; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; HEBB DO, 1949, ORG BEHAVIOR; Heiligenberg W., 1991, NEURAL NETS ELECT FI; HERMANN L, 1905, PFLUGERS ARCH, V109, P95; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; HIS W, 1893, BERL KLIN WOCHENSCHR, V40, P41; HODGKIN AL, 1946, PROC R SOC SER B-BIO, V133, P444, DOI 10.1098/rspb.1946.0024; HODGKIN AL, 1957, J PHYSIOL-LONDON, V138, P253, DOI 10.1113/jphysiol.1957.sp005850; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; HOUCHIN J, 1973, J PHYSIOL-LONDON, V232, pP67; HUGUENARD JR, 1989, P NATL ACAD SCI USA, V86, P2473, DOI 10.1073/pnas.86.7.2473; HUME RI, 1981, NATURE, V293, P469, DOI 10.1038/293469a0; Hyde IH, 1921, BIOL BULL-US, V40, P130, DOI 10.2307/1536534; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; KATZ LC, 1988, J NEUROSCI, V8, P3160; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; KISVARDAY ZF, 1987, J COMP NEUROL, V260, P1, DOI 10.1002/cne.902600102; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1993, J NEUROSCI, V13, P413; KOGAN A, 1996, IN PRESS BRAIN RES; KOLLIKER A, 1889, HDB GEWEBELEHRE; KOSAKA T, 1983, BRAIN RES, V277, P347, DOI 10.1016/0006-8993(83)90943-5; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; LAURENT G, 1989, J NEUROSCI, V9, P3030; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LEVY WB, 1985, ELECTRICAL ACTIVITY, P359; LING G, 1949, J CELL COMPAR PHYSL, V34, P383, DOI 10.1002/jcp.1030340304; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2520, DOI 10.1073/pnas.73.7.2520; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1974, J NEUROPHYSIOL, V37, P560, DOI 10.1152/jn.1974.37.3.560; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; Llinas R., 1992, CEREBELLUM REVISITED, P167; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LLINAS RR, 1987, P NATL ACAD SCI USA, V84, P3047, DOI 10.1073/pnas.84.9.3047; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MAJOR G, 1993, BIOPHYS J, V65, P469, DOI 10.1016/S0006-3495(93)81039-7; MAJOR G, 1993, BIOPHYS J, V65, P423, DOI 10.1016/S0006-3495(93)81037-3; MAJOR G, 1994, J NEUROSCI, V14, P4613; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Marvin M., 1961, US Patent, Patent No. [3013467, 3,013,467]; MATSUMURA M, 1988, EXP BRAIN RES, V70, P463; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; MONTANA V, 1989, BIOCHEMISTRY-US, V28, P4536, DOI 10.1021/bi00437a003; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; NUNEZ A, 1993, J NEUROPHYSIOL, V70, P418, DOI 10.1152/jn.1993.70.1.418; NUNEZ A, 1990, EXP NEUROL, V108, P76, DOI 10.1016/0014-4886(90)90010-P; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Peters A., 1991, FINE STRUCTURE NERVO; PHILLIPS CG, 1963, J PHYSIOL-LONDON, V168, P65, DOI 10.1113/jphysiol.1963.sp007178; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; POLLACK GS, 1988, J NEUROSCI, V8, P2635; PURPURA DP, 1964, J NEUROPHYSIOL, V27, P117, DOI 10.1152/jn.1964.27.2.117; Purpura DP., 1967, NEUROSCIENCES A STUD, P372; PURVES D, 1981, J NEUROSCI, V1, P441; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rall W., 1974, CELLULAR MECH SUBSER, P13; Rall W., 1995, THEORETICAL FDN DEND; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Rall W, 1964, NEURAL THEORY MODELI, P73; RAMAN IM, 1992, NEURON, V9, P173, DOI 10.1016/0896-6273(92)90232-3; RAMON P, 1890, THESIS U MADRID; Ramon y Cajal S, 1891, REV CIENCIAS MED, V22, P23; Ramon y Cajal S, 1891, CELLULE, VVII, P1; RAPP M, 1994, J PHYSIOL-LONDON, V474, P101, DOI 10.1113/jphysiol.1994.sp020006; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; REGEHR WG, 1992, J NEUROSCI, V12, P4202; Renshaw B, 1942, J NEUROPHYSIOL, V5, P235, DOI 10.1152/jn.1942.5.3.235; REUVENI I, 1993, J NEUROSCI, V13, P4609; REYHER CKH, 1991, J NEUROSCI, V11, P1485; RHODES PA, 1994, NEURAL COMPUT, V6, P1086, DOI 10.1162/neco.1994.6.6.1086; RICHARDSON TL, 1987, J NEUROPHYSIOL, V58, P981, DOI 10.1152/jn.1987.58.5.981; ROCKLAND KS, 1989, J COMP NEUROL, V285, P54, DOI 10.1002/cne.902850106; ROSE GJ, 1993, J NEUROSCI, V13, P1178; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; ROSS WN, 1986, J NEUROSCI, V6, P1148; Rubel EW, 1988, AUDITORY FUNCTION NE, P3; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SCHADLEN MN, 1994, CURR OPIN NEUROBIOL, V4, P569; SCHARFMAN HE, 1985, BRAIN RES, V331, P267, DOI 10.1016/0006-8993(85)91552-5; SCHWARTZKROIN PA, 1977, BRAIN RES, V135, P157, DOI 10.1016/0006-8993(77)91060-5; SHELTON DP, 1985, NEUROSCIENCE, V14, P111, DOI 10.1016/0306-4522(85)90168-X; SHEPHERD GM, 1985, P NATL ACAD SCI USA, V82, P2192, DOI 10.1073/pnas.82.7.2192; SHEPHERD GM, 1987, NEUROSCIENCE, V21, P151, DOI 10.1016/0306-4522(87)90329-0; SLOPER JJ, 1972, BRAIN RES, V44, P640, DOI 10.1016/0006-8993(72)90327-7; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SOTELO C, 1974, J NEUROPHYSIOL, V37, P541, DOI 10.1152/jn.1974.37.3.541; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; STRATFORD K, 1989, COMP NEUR S, P296; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SUGIHARA I, 1993, J PHYSIOL-LONDON, V470, P243, DOI 10.1113/jphysiol.1993.sp019857; SUTOR B, 1989, J NEUROPHYSIOL, V61, P621, DOI 10.1152/jn.1989.61.3.621; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; THOMSON AM, 1988, J NEUROPHYSIOL, V60, P1896, DOI 10.1152/jn.1988.60.6.1896; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TRAUB RD, 1996, IN PRESS J COMPUT NE; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; TURNER RW, 1991, J NEUROSCI, V11, P2270; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VANGEHUCHTEN A, 1891, CELLULE, V7; WATSON AHD, 1988, J COMP NEUROL, V272, P605, DOI 10.1002/cne.902720411; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; Wilson T., 1984, THEORY PRACTICE SCAN; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; WONG RKS, 1992, J PHYSIOL-LONDON, V457, P675, DOI 10.1113/jphysiol.1992.sp019401; WU K, 1986, MOL BRAIN RES, V1, P167, DOI 10.1016/0169-328X(86)90008-2; YAMAMOTO C, 1972, EXP BRAIN RES, V14, P423; YANG G, 1992, SCIENCE, V258, P1949, DOI 10.1126/science.1470920; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; ZEKI S, 1993, VISION BRAIN, P197; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; [No title captured]	209	280	283	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					701	716		10.1016/S0896-6273(00)80091-4	http://dx.doi.org/10.1016/S0896-6273(00)80091-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607989	hybrid			2022-12-28	WOS:A1996UG61100004
J	Cases, O; Vitalis, T; Seif, I; DeMaeyer, E; Sotelo, C; Gaspar, P				Cases, O; Vitalis, T; Seif, I; DeMaeyer, E; Sotelo, C; Gaspar, P			Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: Role of a serotonin excess during the critical period	NEURON			English	Article							VISUAL CORTICAL PLASTICITY; MOUSE CEREBRAL-CORTEX; POSTNATAL-DEVELOPMENT; NEONATAL RAT; NEOCORTEX; ORGANIZATION; FIELD; INNERVATION; RECEPTORS; NEURONS	In a transgenic mouse line (Tg8) deficient for the gene encoding monoamine oxidase A (MAOA), we show that the primary somatosensory cortex (S1) lacks the characteristic barrel-like clustering of layer IV neurons, whereas normal pattern formation exists in the thalamus and the trigeminal nuclei. No barrel-like patterns were visible with tenascin or serotonin immunostaining or with labeling of thalamocortical axons. An excess of brain serotonin during the critical period of barrel formation appears to have a causal role in these cortical abnormalities, since early administration of parachlorophenylalanine, an inhibitor of serotonin synthesis, in Tg8 pups restored the formation of barrels in S1, whereas inhibition of catecholamine synthesis did not. Transient inactivation of MAOA in normal newborns reproduced a barrelless phenotype in parts of S1.	HOP LA PITIE SALPETRIERE, INSERM, U106, F-75651 PARIS, FRANCE; INST CURIE, CNRS, URA 1343, F-91405 ORSAY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie			Sotelo, Constantino/AAS-5475-2021; De Granzial, Nadine-Tania Vitalis/K-8485-2017; Gaspar, Patricia/G-8892-2011; cases, olivier/G-4882-2017	Sotelo, Constantino/0000-0001-8051-2492; De Granzial, Nadine-Tania Vitalis/0000-0002-5531-3771; Gaspar, Patricia/0000-0003-4217-5717; cases, olivier/0000-0002-5678-7362				AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BELFORD GR, 1979, J COMP NEUROL, V188, P63, DOI 10.1002/cne.901880106; BELFORD GR, 1980, J COMP NEUROL, V193, P335, DOI 10.1002/cne.901930203; BENNETTCLARKE CA, 1993, P NATL ACAD SCI USA, V90, P153, DOI 10.1073/pnas.90.1.153; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; Blue ME, 1991, CEREB CORTEX, V1, P380, DOI 10.1093/cercor/1.5.380; BOSCHERT U, 1994, NEUROSCIENCE, V58, P167, DOI 10.1016/0306-4522(94)90164-3; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CAVINESS VS, 1980, J COMP NEUROL, V194, P335, DOI 10.1002/cne.901940205; CHEN L, 1994, NEUROSCI RES, V19, P111, DOI 10.1016/0168-0102(94)90014-0; CHIAIA NL, 1989, J COMP NEUROL, V285, P325; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; CHUBAKOV AR, 1986, BRAIN RES, V369, P285, DOI 10.1016/0006-8993(86)90537-8; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; CROSSIN KL, 1989, DEV BIOL, V136, P381, DOI 10.1016/0012-1606(89)90264-9; DAMATO RJ, 1987, P NATL ACAD SCI USA, V84, P4322, DOI 10.1073/pnas.84.12.4322; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; GOLDBERG JI, 1991, J NEUROBIOL, V22, P182, DOI 10.1002/neu.480220208; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; HALLMAN H, 1984, MED BIOL, V62, P198; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; HURWITZ BE, 1990, BRAIN RES, V512, P210, DOI 10.1016/0006-8993(90)90628-O; JEANMONOD D, 1981, NEUROSCIENCE, V6, P1503, DOI 10.1016/0306-4522(81)90222-0; JENSEN KF, 1987, J NEUROSCI, V7, P3544; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; KASAMATSU T, 1979, J COMP NEUROL, V185, P163, DOI 10.1002/cne.901850110; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIDOV HGW, 1978, BRAIN RES, V153, P577, DOI 10.1016/0006-8993(78)90341-4; LINDVALL O, 1978, HDB PSYCHOPHARMACOLO, V9, P139; LOEB EP, 1987, BRAIN RES, V403, P113, DOI 10.1016/0006-8993(87)90129-6; MA PM, 1993, J COMP NEUROL, V327, P376, DOI 10.1002/cne.903270306; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OSTERHELDHAAS MC, 1994, DEV BRAIN RES, V77, P189, DOI 10.1016/0165-3806(94)90196-1; RHOADES RW, 1994, J NEUROPHYSIOL, V72, P2438, DOI 10.1152/jn.1994.72.5.2438; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; RIAD M, 1994, DEV BRAIN RES, V82, P245, DOI 10.1016/0165-3806(94)90167-8; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; Roubertoux Pierre L., 1992, V8, P423; SAMSA JM, 1979, BIOL NEONATE, V35, P249; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; STEINDLER DA, 1995, J NEUROSCI, V15, P1971, DOI 10.1523/JNEUROSCI.15-03-01971.1995; STEINDLER DA, 1990, EXP NEUROL, V109, P35, DOI 10.1016/S0014-4886(05)80007-X; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VANDERLOOS H, 1976, NEUROSCI LETT, V2, P1, DOI 10.1016/0304-3940(76)90036-7; VANDERLOOS H, 1991, NATO ADV SCI I A-LIF, V200, P229; VERNEY C, 1982, DEV BRAIN RES, V5, P41, DOI 10.1016/0165-3806(82)90111-0; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; WALLACE MN, 1987, BRAIN RES, V418, P178, DOI 10.1016/0006-8993(87)90977-2; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; WELKER E, 1986, J NEUROSCI, V6, P3355; WEYLER W, 1990, PHARMACOL THERAPEUT, V47, P391, DOI 10.1016/0163-7258(90)90064-9; WHITAKERAZMITIA PM, 1990, ANN NY ACAD SCI, V600, P315, DOI 10.1111/j.1749-6632.1990.tb16892.x; WHITAKERAZMITIA PM, 1989, BRAIN RES, V497, P80, DOI 10.1016/0006-8993(89)90972-4; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; WU HF, 1993, MOL PHARMACOL, V43, P888	64	429	437	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					297	307		10.1016/S0896-6273(00)80048-3	http://dx.doi.org/10.1016/S0896-6273(00)80048-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789945	Bronze			2022-12-28	WOS:A1996TW95700010
J	Gross, A; MacKinnon, R				Gross, A; MacKinnon, R			Agitoxin footprinting the Shaker potassium channel pore	NEURON			English	Article							CA-2+-ACTIVATED K+ CHANNEL; PEPTIDE INHIBITOR; TEA BLOCKADE; CHARYBDOTOXIN; PROTEINS; TETRAETHYLAMMONIUM; INACTIVATION; SIGNALS; BINDING; CHARGE	In voltage-dependent K+ channels, each of the four identical subunits contributes one pore loop to the central ion selectivity unit at the interface between the subunits. The pore loop is also the target for scorpion venom peptide inhibitors. These inhibitors bind at the pore entryway between the four subunits and can assume any one of four orientations. The orientations become distinguishable only if the binding site symmetry is disrupted. We have used mutagenesis and site-directed chemical modification to alter pore loop amino acids in either one or four subunits. The effects of these alterations on inhibitor affinity define the eccentricity of amino acids in the pore entryway and imply a different secondary structure for the amino and carboxyl ends of the pore loop.			Gross, A (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; AQVIST J, 1991, P NATL ACAD SCI USA, V88, P2026, DOI 10.1073/pnas.88.5.2026; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; HARPER ET, 1993, BIOCHEMISTRY-US, V32, P7605, DOI 10.1021/bi00081a001; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; LU Z, 1994, J GEN PHYSIOL, V104, P477, DOI 10.1085/jgp.104.3.477; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8087, DOI 10.1021/bi00446a019; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MRABET NT, 1992, J BIOL CHEM, V261, P5222; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	33	150	153	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					399	406		10.1016/S0896-6273(00)80057-4	http://dx.doi.org/10.1016/S0896-6273(00)80057-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789954	Bronze			2022-12-28	WOS:A1996TW95700019
J	Herrington, J; Park, YB; Babcock, DF; Hille, B				Herrington, J; Park, YB; Babcock, DF; Hille, B			Dominant role of mitochondria in clearance of large Ca2+ loads from rat adrenal chromaffin cells	NEURON			English	Article							INTRACELLULAR CALCIUM; CARDIAC MYOCYTES; SECRETION; TRANSPORT; CA-2+; FLUORESCENCE; MELANOTROPHS; PITUITARY; EXCHANGE; NEURONS	Cytosolic Ca2+ (Ca-c(2+)) clearance from adrenal chromaffin cells was studied by whole-cell patch clamp and indo-1 Ca2+ photometry after influx of Ca2+ through voltage-dependent Ca2+ channels. We isolated the rates of Ca-c(2+) clearance by several mechanisms using combinations of the following agents (with their expected targets): Li+ or TEA substituted for Na+ (Na+-Ca2+ exchange), 1 mM La3+ applied after the depolarization (Na+-Ca2+ exchange and plasma membrane Ca2+-ATPase), 1 mu M thapsigargin (pumping into reticular stores), and 2 mu M carbonyl cyanide m-chlorophenylhydrazone (uptake into mitochondria). Remarkably, whenever [Ca2+](c) rose above similar to 500 nM, Ca-c(2+) clearance by mitochondria exceeded clearance by either Na+-Ca2+ exchange or the Ca2+ pumps of the plasma and reticular membranes. As [Ca2+](c) fell again, Ca2+ re-emerged from mitochondria, prolonging the final return to basal levels.			Herrington, J (corresponding author), UNIV WASHINGTON, DEPT PHYSIOL & BIOPHYS, SEATTLE, WA 98195 USA.			Babcock, Donner/0000-0002-4461-4544	NIAMS NIH HHS [AR17803] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR017803, R37AR017803] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CROMPTON M, 1985, CURR TOP MEMBR TRANS, V25, P231; CROMPTON M, 1990, INTRACELLULAR CALCIU, P181; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P411, DOI 10.1113/jphysiol.1990.sp018074; FRIEL DD, 1995, BIOPHYS J, V68, P1752, DOI 10.1016/S0006-3495(95)80352-8; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GANDIA L, 1995, PFLUG ARCH EUR J PHY, V430, P55, DOI 10.1007/BF00373839; GARRAHAN PJ, 1990, INTRACELLULAR CALCIU, P271; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HERRINGTON J, 1995, J PHYSIOL-LONDON, V485, P297, DOI 10.1113/jphysiol.1995.sp020731; HOLMAN ME, 1994, J PHYSIOL-LONDON, V478, P115, DOI 10.1113/jphysiol.1994.sp020235; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; KLEIN MG, 1991, J PHYSIOL-LONDON, V441, P639, DOI 10.1113/jphysiol.1991.sp018771; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; MALGAROLI A, 1990, J BIOL CHEM, V265, P3005; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; MONCK JR, 1994, BIOPHYS J, V67, P505, DOI 10.1016/S0006-3495(94)80554-5; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; PARK Y, 1994, J PHYSIOL-LONDON, V481, P555, DOI 10.1113/jphysiol.1994.sp020463; PARK YB, 1996, IN PRESS J PHYSL; PEETERS GA, 1989, AM J PHYSIOL, V256, pC351, DOI 10.1152/ajpcell.1989.256.2.C351; POULSEN JCJ, 1995, BIOCHEM J, V307, P749, DOI 10.1042/bj3070749; POWIS DA, 1994, CELL CALCIUM, V16, P377, DOI 10.1016/0143-4160(94)90031-0; POWIS DA, 1991, CELL CALCIUM, V12, P493, DOI 10.1016/0143-4160(91)90031-9; REEVES JP, 1990, INTRACELLULAR CALCIU, P305; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SHEU SS, 1994, J BIOENERG BIOMEMBR, V26, P487, DOI 10.1007/BF00762733; SIPIDO KR, 1991, J PHYSIOL-LONDON, V435, P605, DOI 10.1113/jphysiol.1991.sp018528; Sommer J.R., 1979, HDB PHYSL 2, VVolume 1, P113; TANAKA Y, 1993, BIOCHEMISTRY-US, V32, P12062, DOI 10.1021/bi00096a017; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; THOMAS D, 1994, METHOD CELL BIOL, V40, P65; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TOMLINSON A, 1987, NEUROSCIENCE, V20, P895, DOI 10.1016/0306-4522(87)90250-8; TRIBE RM, 1994, P NATL ACAD SCI USA, V91, P5908, DOI 10.1073/pnas.91.13.5908; TSE A, 1994, J PHYSIOL-LONDON, V477, P511, DOI 10.1113/jphysiol.1994.sp020212; VILLALBA M, 1994, J BIOL CHEM, V269, P2468; WERTH JL, 1994, J NEUROSCI, V14, P348; WHITE RJ, 1995, J NEUROSCI, V15, P1318; WIER WG, 1992, HEART CARDIOVASCULAR, P1223; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	56	311	315	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					219	228		10.1016/S0896-6273(00)80038-0	http://dx.doi.org/10.1016/S0896-6273(00)80038-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562086	Bronze			2022-12-28	WOS:A1996TT30700024
J	Pusch, M; Steinmeyer, K; Koch, MC; Jentsch, TJ				Pusch, M; Steinmeyer, K; Koch, MC; Jentsch, TJ			Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel	NEURON			English	Article							MUSCLE; BECKER; EXPRESSION; CELLS	Autosomal dominant myotonia congenita (Thomsen's disease) is caused by mutations in the muscle chloride channel CIC-1. Several point mutations found in affected families (1290M, R317Q, P480L, and Q552R) dramatically shift gating to positive voltages in mutant/WT heterooligomeric channels, and, when measurable, even more so in mutant homooligomers. These channels can no longer contribute to the repolarization of action potentials, fully explaining why they cause dominant myotonia. Most replacements of the isoleucine at position 290 shift gating toward positive voltages. Mutant/WT heterooligomers can be partially activated by repetitive depolarizations, suggesting a role in shortening myotonic runs. Remarkably, a human mutation affecting an adjacent residue (E291K) is fully recessive. Large shifts in the voltage dependence of gating may be common to many mutations in dominant myotonia congenita.	UNIV MARBURG,MED CTR HUMAN GENET,W-3550 MARBURG,GERMANY	Philipps University Marburg	Pusch, M (corresponding author), UNIV HAMBURG,CTR MOLEC NEUROBIOL,MARTINISTR 52,D-20246 HAMBURG,GERMANY.			Jentsch, Thomas/0000-0002-3509-2553; Pusch, Michael/0000-0002-8644-8847				Becker PE, 1977, MYOTONIA CONGENITA S; FISHER SE, 1994, HUM MOL GENET, V3, P2053; FRANKE C, 1991, MUSCLE NERVE, V14, P762, DOI 10.1002/mus.880140811; FUJITA N, 1994, NUCLEIC ACIDS RES, V22, P1637, DOI 10.1093/nar/22.9.1637; GEORGE AL, 1994, HUM MOL GENET, V3, P2071; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; GRONEMEIER M, 1994, J BIOL CHEM, V269, P5963; HEINE R, 1994, HUM MOL GENET, V3, P1123, DOI 10.1093/hmg/3.7.1123; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482P, pS19; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; JENTSCH TJ, 1995, SOC GEN PHY, V50, P149; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; KOCH MC, 1993, J MED GENET, V30, P914, DOI 10.1136/jmg.30.11.914; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Koty P. P., 1994, American Journal of Human Genetics, V55, pA227; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LEHMANNHORN F, 1995, HUM MOL GENET, V4, P1397, DOI 10.1093/hmg/4.8.1397; LIPICKY RJ, 1971, J CLIN INVEST, V50, P2091, DOI 10.1172/JCI106703; LIPICKY RJ, 1966, J GEN PHYSIOL, V50, P89, DOI 10.1085/jgp.50.1.89; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; MEYERKLEINE C, 1994, HUM MOL GENET, V3, P1015, DOI 10.1093/hmg/3.6.1015; MEYERKLEINE C, 1995, IN PRESS AM J HUM GE; MILLER C, 1982, PHIL T R SOC LOND B, V299, P41; PUSCH M, 1994, BIOPHYS J, V66, P149, DOI 10.1016/S0006-3495(94)80753-2; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RUDEL R, 1988, MUSCLE NERVE, V11, P202, DOI 10.1002/mus.880110303; RUDEL R, 1985, PHYSIOL REV, V65, P310, DOI 10.1152/physrev.1985.65.2.310; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; STEINMEYER K, 1995, IN PRESS J BIOL CHEM; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Thomsen, 1876, ARCH PSYCHIAT NERVEN, V6, P702, DOI DOI 10.1007/BF02164912; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547	36	157	160	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1455	1463		10.1016/0896-6273(95)90023-3	http://dx.doi.org/10.1016/0896-6273(95)90023-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845168	Bronze			2022-12-28	WOS:A1995TL67800023
J	GUMBINER, BM				GUMBINER, BM			PROTEINS ASSOCIATED WITH THE CYTOPLASMIC SURFACE OF ADHESION MOLECULES	NEURON			English	Review							SEGMENT POLARITY GENE; CELL-CELL-ADHESION; UVOMORULIN-CATENIN COMPLEX; E-CADHERIN; TYROSINE PHOSPHORYLATION; BETA-CATENIN; N-CADHERIN; JUNCTIONAL COMMUNICATION; MEMBRANE INTERACTIONS; EXTRACELLULAR-MATRIX				GUMBINER, BM (corresponding author), MEM SLOAN KETTERING CANC CTR, CELLULAR BIOCHEM & BIOPHYS PROGRAM, NEW YORK, NY 10021 USA.				NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037432, R01GM037432] Funding Source: NIH RePORTER; NCI NIH HHS [NCI-P30-CA-08748] Funding Source: Medline; NIGMS NIH HHS [GM37432] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; BRETSCHER A, 1981, P NATL ACAD SCI-BIOL, V78, P6849, DOI 10.1073/pnas.78.11.6849; BURN P, 1988, P NATL ACAD SCI USA, V85, P497, DOI 10.1073/pnas.85.2.497; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; BUTZ S, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142-a; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; DAVIS S, 1991, SCIENCE, V252, P712, DOI 10.1126/science.1708917; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; ENDOW SA, 1992, ANNU REV CELL BIOL, V8, P29; Ervasti JM, 1993, CURR OPIN CELL BIOL, V5, P82, DOI 10.1016/S0955-0674(05)80012-2; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FERNANDEZ JLR, 1992, CELL MOTIL CYTOSKEL, V22, P127, DOI 10.1002/cm.970220206; FLEMING TP, 1988, ANNU REV CELL BIOL, V4, P459, DOI 10.1146/annurev.cellbio.4.1.459; FYRBERG E, 1990, J CELL BIOL, V110, P1999, DOI 10.1083/jcb.110.6.1999; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; GEIGER B, 1987, J CELL SCI, P251; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; GUMBINER B M, 1991, Current Biology, V1, P271, DOI 10.1016/0960-9822(91)90081-7; GUMBINER BM, 1992, CELL, V69, P385, DOI 10.1016/0092-8674(92)90440-N; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; Hedrick Lora, 1993, Trends in Cell Biology, V3, P36, DOI 10.1016/0962-8924(93)90148-T; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; HERZBERG F, 1990, DIFFERENTIATION, V44, P1, DOI 10.1111/j.1432-0436.1990.tb00530.x; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; HORVATH AR, 1990, ONCOGENE, V5, P1349; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kemler R, 1989, CURR OPIN CELL BIOL, V1, P892, DOI 10.1016/0955-0674(89)90055-0; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671; KORMAN NJ, 1989, NEW ENGL J MED, V321, P631, DOI 10.1056/NEJM198909073211002; LANDIS RC, 1993, J CELL BIOL, V120, P1519, DOI 10.1083/jcb.120.6.1519; LARSON RS, 1990, CELL REGUL, V1, P359, DOI 10.1091/mbc.1.4.359; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Magee AI, 1991, CURR OPIN CELL BIOL, V3, P854, DOI 10.1016/0955-0674(91)90060-C; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; MATSUZAKI F, 1990, J CELL BIOL, V110, P1239, DOI 10.1083/jcb.110.4.1239; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MCCREA PD, 1991, J BIOL CHEM, V266, P4514; MCCREA PD, 1993, IN PRESS J CELL BIOL; MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; NUCKOLLS GH, 1992, J CELL SCI, V102, P753; OLSON DJ, 1991, SCIENCE, V252, P1173, DOI 10.1126/science.252.5009.1173; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTTO JJ, 1990, CELL MOTIL CYTOSKEL, V16, P1, DOI 10.1002/cm.970160102; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PEIFER M, 1991, DEVELOPMENT, V111, P1029; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; RINNERTHALER G, 1988, J CELL BIOL, V106, P747, DOI 10.1083/jcb.106.3.747; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; SCHWARZ MA, 1990, ANNU REV CELL BIOL, V6, P461, DOI 10.1146/annurev.cb.06.110190.002333; Shattil SJ, 1991, CURR OPIN CELL BIOL, V3, P869, DOI 10.1016/0955-0674(91)90062-4; SHAW LM, 1990, J CELL BIOL, V110, P2167, DOI 10.1083/jcb.110.6.2167; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAPLEY P, 1989, ONCOGENE, V4, P325; TROYANOVSKY SM, 1993, CELL, V72, P561, DOI 10.1016/0092-8674(93)90075-2; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Turner CE, 1991, CURR OPIN CELL BIOL, V3, P849, DOI 10.1016/0955-0674(91)90059-8; VESTWEBER D, 1987, DEV BIOL, V124, P451, DOI 10.1016/0012-1606(87)90498-2; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; VOLBERG T, 1991, CELL REGUL, V2, P105, DOI 10.1091/mbc.2.2.105; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WESTMEYER A, 1990, EMBO J, V9, P2071, DOI 10.1002/j.1460-2075.1990.tb07374.x; WILLIAMS CL, 1993, J CELL BIOL, V121, P643, DOI 10.1083/jcb.121.3.643; WINKEL GK, 1990, DEV BIOL, V138, P1, DOI 10.1016/0012-1606(90)90171-E; WITKE W, 1992, CELL, V68, P53, DOI 10.1016/0092-8674(92)90205-Q; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; [No title captured]	101	186	194	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1993	11	4					551	564		10.1016/0896-6273(93)90068-3	http://dx.doi.org/10.1016/0896-6273(93)90068-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398146				2022-12-28	WOS:A1993MD06800001
J	WEINBERG, R				WEINBERG, R			TUMOR-SUPPRESSOR GENES	NEURON			English	Review							ADENOVIRUS E1A PROTEINS; RETINOBLASTOMA PROTEIN; P53; CANCER; IMMORTALIZATION; EXPRESSION; ONCOGENE; DELETION; LOCUS		MIT,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	WEINBERG, R (corresponding author), WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142, USA.							BAGCHI S, 1990, CELL, V62, P659, DOI 10.1016/0092-8674(90)90112-R; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; COBRINIK D, 1992, TRENDS BIOCHEM SCI, V17, P312, DOI 10.1016/0968-0004(92)90443-D; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; HANSEN MF, 1987, CANCER RES, V47, P5518; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KASTAN MB, 1991, CANCER RES, V51, P6304; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0	22	50	52	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					191	196		10.1016/0896-6273(93)90177-S	http://dx.doi.org/10.1016/0896-6273(93)90177-S			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352939				2022-12-28	WOS:A1993LU06500001
J	KLEENE, SJ				KLEENE, SJ			ORIGIN OF THE CHLORIDE CURRENT IN OLFACTORY TRANSDUCTION	NEURON			English	Article							SENSITIVE ADENYLATE-CYCLASE; RAT EXOCRINE PANCREAS; RECEPTOR NEURONS; CALCIUM CHANNELS; GATED CHANNELS; CYCLIC-AMP; CILIA; MEMBRANE; CONDUCTANCE; ACTIVATION	In the cilia of amphibian olfactory receptor neurons, odorants elicit a receptor current that has two components: a cationic current through cAMP-gated channels and a Cl- current. Here, a cascade of ciliary currents that accounts for the total receptor current is demonstrated. In isolated olfactory cilia, cAMP sequentially activates two currents. The first is a primary cationic current through channels directly gated by cAMP. Part of this current is carried by Ca2+, which in turn activates a Cl- current. This secondary current is eliminated by the presence of Cl- channel inhibitors, replacement of Cl- with methanesulfonate-, removal of external Ca2+, or blockers of the cAMP-gated cationic channels. When cytoplasmic Ca2+ buffering is low, small cationic currents can activate Cl- currents that are 20 times larger.			KLEENE, SJ (corresponding author), UNIV CINCINNATI,DEPT ANAT & CELL BIOL,CINCINNATI,OH 45267, USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000352, R55DC000926, P01DC000347] Funding Source: NIH RePORTER; NIDCD NIH HHS [P01 DC00347, R55 DC00926, R01 DC00352] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BRUCH RC, 1990, CHEM SENSES, V15, P419, DOI 10.1093/chemse/15.4.419; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DUBIN AE, 1993, J GEN PHYSIOL, V101, P469, DOI 10.1085/jgp.101.4.469; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; GARCIA ML, 1990, J BIOL CHEM, V265, P3763; GOGELEIN H, 1990, FEBS LETT, V268, P79, DOI 10.1016/0014-5793(90)80977-Q; GOGELEIN H, 1989, PFLUG ARCH EUR J PHY, V413, P287, DOI 10.1007/BF00583543; HAGIWARA S, 1982, J PHYSIOL-LONDON, V331, P231, DOI 10.1113/jphysiol.1982.sp014371; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; HIRONO J, 1992, J NEUROSCI METH, V42, P185, DOI 10.1016/0165-0270(92)90098-X; JOSHI H, 1987, NEUROSCI LETT, V82, P321, DOI 10.1016/0304-3940(87)90276-X; KLEENE SJ, 1992, PFLUG ARCH EUR J PHY, V421, P374, DOI 10.1007/BF00374226; KLEENE SJ, 1991, J MEMBRANE BIOL, V120, P75, DOI 10.1007/BF01868593; KLEENE SJ, 1993, J MEMBRANE BIOL, V131, P237, DOI 10.1007/BF02260112; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KOLESNIKOV SS, 1990, FEBS LETT, V266, P96, DOI 10.1016/0014-5793(90)81515-P; KURAHASHI T, 1991, NEUROREPORT, V2, P5, DOI 10.1097/00001756-199101000-00001; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; MCCLINTOCK TS, 1989, P NATL ACAD SCI USA, V86, P8137, DOI 10.1073/pnas.86.20.8137; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NICOL GD, 1987, J GEN PHYSIOL, V90, P651, DOI 10.1085/jgp.90.5.651; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; SHIRLEY SG, 1986, BIOCHEM J, V240, P605, DOI 10.1042/bj2400605; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; TANG JM, 1990, PFLUG ARCH EUR J PHY, V416, P347, DOI 10.1007/BF00392072; WHITE MM, 1990, MOL PHARMACOL, V37, P720; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	37	189	190	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					123	132		10.1016/0896-6273(93)90276-W	http://dx.doi.org/10.1016/0896-6273(93)90276-W			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8393322				2022-12-28	WOS:A1993LP43000011
J	OZAKI, K; NAGATANI, H; OZAKI, M; TOKUNAGA, F				OZAKI, K; NAGATANI, H; OZAKI, M; TOKUNAGA, F			MATURATION OF MAJOR DROSOPHILA RHODOPSIN, NINAE, REQUIRES CHROMOPHORE 3-HYDROXY-RETINAL	NEURON			English	Article							A-BINDING-PROTEIN; VISUAL PIGMENT; MELANOGASTER; GENE; PHOTORECEPTORS; ENCODES; OPSIN; FLY; RHABDOMERES; DEPRIVATION	Opsin expression is extremely suppressed by carotenoid deprivation in Drosophila. Carotenoid replacement in deprived flies promotes the recovery of visual pigment with an increase in opsin, as well as the chromophore 11-cis-3-hydroxyretinal. Here, we show that opsin mRNA and opsin peptide in an intermediate step of posttranslational processing were present in carotenoid-deprived flies. By supplementing chromophore to photoreceptor cells, intermediate opsin was made mature. During this process, opsin peptide underwent multiple modifications involving glycosylation. Based on these results, we present a novel mechanism of protein regulatory expression; that is, chromophore posttranslationally controls the expression of apoprotein by promoting its maturation.			OZAKI, K (corresponding author), OSAKA UNIV,FAC SCI,DEPT BIOL,TOYONAKA,OSAKA 560,JAPAN.		Ozaki, Koichi/O-2798-2015	Ozaki, Koichi/0000-0001-7268-5377				COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; GROENENDIJK GWT, 1980, BIOCHIM BIOPHYS ACTA, V617, P430, DOI 10.1016/0005-2760(80)90009-0; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; HUBER A, 1990, J BIOL CHEM, V265, P17906; ISHIZAKI T, 1989, Zoological Science (Tokyo), V6, P1083; ISONO K, 1988, J GEN PHYSIOL, V92, P587, DOI 10.1085/jgp.92.5.587; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUMOTO H, 1987, P NATL ACAD SCI USA, V84, P985, DOI 10.1073/pnas.84.4.985; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; OTOUSA JE, 1992, VISUAL NEUROSCI, V8, P385, DOI 10.1017/S0952523800004910; OTOUSA JE, 1985, CELL, V40, P439; PAULSEN R, 1983, EUR J BIOCHEM, V137, P609, DOI 10.1111/j.1432-1033.1983.tb07869.x; SAPP RJ, 1991, EXP EYE RES, V53, P73, DOI 10.1016/0014-4835(91)90147-7; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; SCHWEMER J, 1984, CELL TISSUE RES, V236, P293, DOI 10.1007/BF00214230; SEKI T, 1986, VISION RES, V26, P255, DOI 10.1016/0042-6989(86)90020-9; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; STEPHENSON RS, 1983, BIOL PHOTORECEPTION, P477; TANIMURA T, 1986, PHOTOCHEM PHOTOBIOL, V43, P225, DOI 10.1111/j.1751-1097.1986.tb09519.x; VOGT K, 1984, NATURWISSENSCHAFTEN, V71, P211, DOI 10.1007/BF00490436; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; WHITE RH, 1989, CELL TISSUE RES, V257, P519, DOI 10.1007/BF00221461; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	26	77	77	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1113	1119		10.1016/0896-6273(93)90059-Z	http://dx.doi.org/10.1016/0896-6273(93)90059-Z			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318232				2022-12-28	WOS:A1993LK37300011
J	MINTZ, IM; BEAN, BP				MINTZ, IM; BEAN, BP			GABA-B RECEPTOR INHIBITION OF P-TYPE CA2+ CHANNELS IN CENTRAL NEURONS	NEURON			English	Article							CHICK SENSORY NEURONS; GAMMA-AMINOBUTYRIC-ACID; RAT SYMPATHETIC NEURONS; GATED CALCIUM CHANNELS; HIPPOCAMPAL-NEURONS; VERTEBRATE CELLS; NEUROTRANSMITTER MODULATION; CURRENTS; NORADRENALINE; LOCALIZATION	P-type Ca2+ channels in cerebellar Purkinje neurons were inhibited by GABA and the GABA(B) receptor agonist baclofen. Inhibition of P-type Ca2+ channel current involved changes in voltage dependence and kinetics. Baclofen induced a slow phase of activation and altered tail current kinetics, and inhibition could be partly overcome by large depolarizations. These effects were mimicked by internal application of GTPgammaS, which also made the action of baclofen irreversible. In spinal cord neurons, use of selective channel blockers showed that baclofen inhibited both P-type and N-type Ca2+ channels, but not L-type Ca2+ channels; a high threshold current resistant to blockers of P-type, N-type, and L-type channels was also modulated by baclofen. These results show that stimulation of GABA(B) receptors in central neurons can modulate P-type Ca2+ channels through a G protein-mediated mechanism similar to the one linked to N-type Ca2+ channels.			MINTZ, IM (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NHLBI NIH HHS [HL 350334] Funding Source: Medline; NINDS NIH HHS [NS 24472, NS 02253] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024472] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BERNHEIM L, 1991, NEURON, V6, P959; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOWERY N, 1989, TRENDS PHARMACOL SCI, V10, P401, DOI 10.1016/0165-6147(89)90188-0; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; COX DH, 1992, J NEUROSCI, V12, P906; DEISZ RA, 1985, NEUROSCI LETT, V56, P205, DOI 10.1016/0304-3940(85)90130-2; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FISHER R, 1990, J NEUROPHYSIOL, V64, P1291, DOI 10.1152/jn.1990.64.4.1291; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; GREEN KA, 1988, BRIT J PHARMACOL, V94, P235, DOI 10.1111/j.1476-5381.1988.tb11520.x; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDELBERGER R, 1991, P NATL ACAD SCI USA, V88, P7135, DOI 10.1073/pnas.88.16.7135; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; KISKIN NI, 1990, EUR J NEUROSCI, V2, P461, DOI 10.1111/j.1460-9568.1990.tb00437.x; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LOPEZ HS, 1991, NEURON, V7, P1061, DOI 10.1016/0896-6273(91)90350-9; MAGUIRE G, 1989, P NATL ACAD SCI USA, V86, P10144, DOI 10.1073/pnas.86.24.10144; MARCHETTI C, 1989, BIOPHYS J, V56, P1267, DOI 10.1016/S0006-3495(89)82774-2; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; PENNINGTON NJ, 1991, J NEUROSCI, V11, P3594; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; POLLO A, 1992, PFLUG ARCH EUR J PHY, V422, P75; REGAN LJ, 1991, J NEUROSCI, V11, P2259; RYU PD, 1990, J NEUROPHYSIOL, V63, P273, DOI 10.1152/jn.1990.63.2.273; SAH DWY, 1990, J NEUROSCI, V10, P136; SAHARA Y, 1993, IN PRESS J NEUROSCI; SAYER RJ, 1992, J NEUROPHYSIOL, V68, P833, DOI 10.1152/jn.1992.68.3.833; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; SCOTT RH, 1990, NEUROSCIENCE, V38, P285, DOI 10.1016/0306-4522(90)90028-3; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; WILKIN GP, 1981, NATURE, V294, P584, DOI 10.1038/294584a0; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q	72	237	243	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					889	898		10.1016/0896-6273(93)90204-5	http://dx.doi.org/10.1016/0896-6273(93)90204-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8388225				2022-12-28	WOS:A1993LD32200011
J	Kearney, PC; Zhang, HY; Zhong, W; Dougherty, DA; Lester, HA				Kearney, PC; Zhang, HY; Zhong, W; Dougherty, DA; Lester, HA			Determinants of nicotinic receptor gating in natural and unnatural side chain structures at the M2 9' position	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR; DELTA-SUBUNIT; BINDING-SITE; TORPEDO-CALIFORNICA; CHANNEL DOMAIN; LIGAND-BINDING; ION-CHANNEL; ARRANGEMENT; RESIDUES; AFFINITY	A nonsense suppression method was employed to incorporate a total of four natural and six unnatural residues at the 9' position of the M2 region in the beta, gamma, and delta subunits of muscle nicotinic receptors. In 33 pairwise comparisons of functional properties as influenced by structural features including side chain length, branching, and substitution of oxygen for methylene carbons, it is concluded that increased polarity in the side chains at the 9' position consistently increases the sensitivity to acetylcholine. In addition, the stereochemistry of the side chain can have marked influences on the EC(50), primarily because of changes in the single-channel open time. For the case of isoleucine versus allo-isoleucine in the delta subunit, these changes are themselves modified by mutations at the 9' position in other subunits. The data suggest an especially strong interaction between the beta and delta subunits in the pore region, leading in turn to a suggested arrangement of subunits within the pentamer.	CALTECH, DIV PHYS MATH & ASTRON, PASADENA, CA 91125 USA; CALTECH, DIV CHEM & CHEM ENGN, PASADENA, CA 91125 USA	California Institute of Technology; California Institute of Technology	Kearney, PC (corresponding author), CALTECH, DIV BIOL, PASADENA, CA 91125 USA.				NINDS NIH HHS [NS34407, NS11756] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R01NS011756, R37NS034407] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BOULTER J, 1990, J BIOL CHEM, V265, P4472; CHARNET P, 1990, NEURON, V2, P87; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; EVANS DA, 1994, TETRAHEDRON LETT, V35, P7171, DOI 10.1016/0040-4039(94)85352-5; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; HERZ JM, 1989, J BIOL CHEM, V264, P12439; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KARLIN A, 1983, J BIOL CHEM, V258, P6678; Kearney PC, 1996, MOL PHARMACOL, V50, P1401; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; MACHOLD J, 1995, EUR J BIOCHEM, V234, P427, DOI 10.1111/j.1432-1033.1995.427_b.x; MACHOLD J, 1995, P NATL ACAD SCI USA, V92, P7282, DOI 10.1073/pnas.92.16.7282; NASS MM, 1978, BIOPHYS J, V24, P135, DOI 10.1016/S0006-3495(78)85352-1; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; OIKI S, 1995, P NATL ACAD SCI USA, V92, P2121, DOI 10.1073/pnas.92.6.2121; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Saks ME, 1996, J BIOL CHEM, V271, P23169, DOI 10.1074/jbc.271.38.23169; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SINE SM, 1991, J BIOL CHEM, V266, P19369; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; UNWIN N, 1988, J CELL BIOL, V107, P1123, DOI 10.1083/jcb.107.3.1123	30	57	58	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1221	1229		10.1016/S0896-6273(00)80252-4	http://dx.doi.org/10.1016/S0896-6273(00)80252-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982168	Bronze			2022-12-28	WOS:A1996WA24800018
J	Bouron, A; Reuter, H				Bouron, A; Reuter, H			A role of intracellular Na+ in the regulation of synaptic transmission and turnover of the vesicular pool in cultured hippocampal cells	NEURON			English	Article							SODIUM-CALCIUM EXCHANGE; LONG-TERM POTENTIATION; TRANSMITTER RELEASE; NERVE-TERMINALS; PRESYNAPTIC BOUTONS; CENTRAL NEURONS; SYNAPSES; CA2+; VERATRIDINE; CHANNELS	Propagation of action potentials in axons and dendrites increases intracellular Na+ ([Na+](i)) and Ca2+ concentrations ([Ca2+](i)). While the importance of [Ca2+](i) in synaptic transmission is well established, a possible functional role of [Na+](i) is unclear. In cultured hippocampal cells, [Na+](i) was increased by veratridine. We have then measured spontaneous excitatory postsynaptic currents (sEPSCs) and, by means of fluorescent dyes, changes in [Na+](i), in [Ca2+](i), and in the turnover of the vesicular pool of individual boutons. An elevation of [Na+](i) and a concomitant rise in [Ca2+](i) led to a large increase in sEPSC frequency and in the turnover of the presynaptic vesicular pool. Extracellular Ca2+ was essential for these effects of elevated [Na+](i) on synaptic transmission. They probably occur via Na+/Ca2+ exchange.			Bouron, A (corresponding author), UNIV BERN, DEPT PHARMACOL, CH-3010 BERN, SWITZERLAND.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Bouron, Alexandre/0000-0003-4471-7727				ANKRI N, 1994, J NEUROSCI METH, V52, P87, DOI 10.1016/0165-0270(94)90060-4; BARNES S, 1988, J GEN PHYSIOL, V91, P421, DOI 10.1085/jgp.91.3.421; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P617, DOI 10.1113/jphysiol.1975.sp010950; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; Blaustein MP, 1996, ANN NY ACAD SCI, V779, P300, DOI 10.1111/j.1749-6632.1996.tb44803.x; CARVALHO AP, 1991, ANN NY ACAD SCI, V639, P300, DOI 10.1111/j.1749-6632.1991.tb17318.x; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; FRASER DD, 1993, NEURON, V11, P633, DOI 10.1016/0896-6273(93)90075-3; FURMAN I, 1993, FEBS LETT, V319, P105, DOI 10.1016/0014-5793(93)80046-W; GLEASON E, 1994, NEURON, V13, P1109, DOI 10.1016/0896-6273(94)90049-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HILGEMANN DW, 1996, ANN NY ACAD SCI, V779; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Juhaszova M, 1996, ANN NY ACAD SCI, V779, P318, DOI 10.1111/j.1749-6632.1996.tb44804.x; KIEDROWSKI L, 1994, MOL PHARMACOL, V45, P1050; KOCH RA, 1994, J NEUROSCI, V14, P2585; Larkum ME, 1996, J NEUROPHYSIOL, V75, P154, DOI 10.1152/jn.1996.75.1.154; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MINTA A, 1989, J BIOL CHEM, V264, P19449; MULKEY RM, 1992, J NEUROSCI, V12, P4327; NAKAO M, 1989, J GEN PHYSIOL, V94, P539, DOI 10.1085/jgp.94.3.539; NORDMANN JJ, 1991, FEBS LETT, V292, P37, DOI 10.1016/0014-5793(91)80828-Q; REBER BFX, 1991, J PHYSIOL-LONDON, V435, P145, DOI 10.1113/jphysiol.1991.sp018502; REEVES JP, 1985, CURR TOP MEMBR TRANS, V25, P77; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Reuter H, 1996, CURR OPIN NEUROBIOL, V6, P331, DOI 10.1016/S0959-4388(96)80116-4; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SIGEL E, 1987, PFLUG ARCH EUR J PHY, V410, P112, DOI 10.1007/BF00581903; STEVENS CF, 1993, NEURON S, V10, P55; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	39	55	56	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1996	17	5					969	978		10.1016/S0896-6273(00)80227-5	http://dx.doi.org/10.1016/S0896-6273(00)80227-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938128	Bronze			2022-12-28	WOS:A1996VV15100018
J	Thomas, MJ; Moody, TD; Makhinson, M; ODell, TJ				Thomas, MJ; Moody, TD; Makhinson, M; ODell, TJ			Activity-dependent beta-adrenergic modulation of low frequency stimulation induced LTP in the hippocampal CA1 region	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC TRANSMISSION; RECEPTOR ACTIVATION; ADENYLYL-CYCLASE; CYCLIC-AMP; AREA CA1; NEUROMODULATORY SYSTEMS; PROTEIN PHOSPHATASES; RAT HIPPOCAMPUS; GAMMA-SUBUNITS	beta-Adrenergic receptor activation has a central role in the enhancement of memory formation that occurs during heightened states of emotional arousal. Although beta-adrenergic receptor activation may enhance memory formation by modulating long-term potentiation (LTP), a candidate synaptic mechanism involved in memory formation, the cellular basis of this modulation is not fully understood. Here, we report that, in the CA1 region of the hippocampus, beta-adrenergic receptor activation selectively enables the induction of LTP during long trains of 5 Hz synaptic stimulation. Protein phosphatase inhibitors mimic the effects of beta-adrenergic receptor activation on 5 Hz stimulation-induced LTP, suggesting that activation of noradrenergic systems during emotional arousal may enhance memory formation by inhibiting protein phosphatases that normally oppose the induction of LTP.	UNIV CALIF LOS ANGELES,SCH MED,INTERDEPT PHD PROGRAM NEUROSCI,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Thomas, MJ (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,BRAIN RES INST,LOS ANGELES,CA 90024, USA.		Thomas, Mark John/HHC-7509-2022	Thomas, Mark John/0000-0001-5721-5350	NIMH NIH HHS [MH 52876] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH052876] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDRADE R, 1993, NEURON, V10, P83, DOI 10.1016/0896-6273(93)90244-L; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; DAHL D, 1994, NEUROREPORT, V5, P657, DOI 10.1097/00001756-199401000-00032; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GEREAU RW, 1994, NEURON, V12, P1121, DOI 10.1016/0896-6273(94)90319-0; GEREAU RW, 1994, J NEUROPHYSIOL, V72, P1438, DOI 10.1152/jn.1994.72.3.1438; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HEGINBOTHAM LR, 1991, J NEUROSCI, V11, P2519; HERRON CE, 1994, J NEUROSCI, V14, P6013; HOPKINS WF, 1984, SCIENCE, V226, P350, DOI 10.1126/science.6091272; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MCGAUGH JL, 1989, ANNU REV NEUROSCI, V12, P255, DOI 10.1146/annurev.neuro.12.1.255; MCGAUGH JL, 1990, PSYCHOL SCI, V1, P15, DOI 10.1111/j.1467-9280.1990.tb00060.x; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MUSGRAVE MA, 1993, NEUROREPORT, V4, P171, DOI 10.1097/00001756-199302000-00014; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Dell T J, 1994, Learn Mem, V1, P129; PARFITT KD, 1992, HIPPOCAMPUS, V2, P59, DOI 10.1002/hipo.450020108; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; SARVEY JM, 1989, J NEUROSCI METH, V28, P109, DOI 10.1016/0165-0270(89)90016-2; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; THOMAS MJ, 1995, BRAIN RES, V695, P45, DOI 10.1016/0006-8993(95)00757-H; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482	43	243	252	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					475	482		10.1016/S0896-6273(00)80179-8	http://dx.doi.org/10.1016/S0896-6273(00)80179-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816710	Bronze			2022-12-28	WOS:A1996VJ44000013
J	Schafer, M; Fruttiger, M; Montag, D; Schachner, M; Martini, R				Schafer, M; Fruttiger, M; Montag, D; Schachner, M; Martini, R			Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wld(s) mice	NEURON			English	Article							NERVE GROWTH-FACTOR; SCIATIC-NERVE; WALLERIAN DEGENERATION; NEUROTROPHIC FACTOR; PERIPHERAL-NERVES; MESSENGER-RNA; REGENERATION; NGF; LOCALIZATION; MACROPHAGES	The myelin-associated glycoprotein (MAG) has been shown to be inhibitory for certain neurons in vitro (Mukhopadhyay et al., 1994; McKerracher et al., 1994). To investigate whether MAG is an inhibitory component in peripheral myelin in vivo, MAG-deficient mutant mice were cross-bred with C57BL/Wld(s) mice that have delayed lesion-induced myelin degeneration and axon regrowth. While in crushed nerves of C57BL/Wld(s) mice expressing MAG, only 16% of myelin sheaths were associated with regrowing axons, this number was doubled in MAG-deficient C57BL/Wld(s) mice. These observations suggest that the absence of MAG may contribute to the improved axonal regrowth in the double mutants. Therefore, degeneration of MAG-containing myelin might be an important prerequisite to optimize axonal regrowth after peripheral nerve injury.	SWISS FED INST TECHNOL, DEPT NEUROBIOL, CH-8093 ZURICH, SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich			Fruttiger, Marcus/C-1899-2008; Montag, Dirk/D-3925-2014	Montag, Dirk/0000-0002-4964-1330; Martini, Rudolf/0000-0002-5463-5592; Fruttiger, Marcus/0000-0002-6962-5485				ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; BARTSCH U, 1995, GLIA, V14, P115, DOI 10.1002/glia.440140206; BEDI KS, 1992, EUR J NEUROSCI, V4, P193, DOI 10.1111/j.1460-9568.1992.tb00867.x; BROWN MC, 1991, NEURON, V6, P359, DOI 10.1016/0896-6273(91)90245-U; BROWN MC, 1991, EUR J NEUROSCI, V3, P1366, DOI 10.1111/j.1460-9568.1991.tb00069.x; DAVID S, 1995, J NEUROSCI RES, V42, P594, DOI 10.1002/jnr.490420417; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FRUTTIGER M, 1995, J NEUROCYTOL, V24, P1, DOI 10.1007/BF01370156; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; FUNAKOSHI H, 1993, BIOCHEM BIOPH RES CO, V194, P1317; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HALL SM, 1993, J NEUROCYTOL, V22, P480, DOI 10.1007/BF01181567; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; MARTINI R, 1990, J NEUROCYTOL, V19, P601, DOI 10.1007/BF01257247; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; RAIVICH G, 1991, NEURON, V7, P151, DOI 10.1016/0896-6273(91)90083-C; SCHACHNER M, 1994, PERSPECT DEV NEUROBI, V2, P33; SCHERER SS, 1984, J NEUROCYTOL, V13, P519, DOI 10.1007/BF01148079; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202; ZHANG Y, 1995, J COMP NEUROL, V361, P210, DOI 10.1002/cne.903610203	31	148	150	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1107	1113		10.1016/S0896-6273(00)80137-3	http://dx.doi.org/10.1016/S0896-6273(00)80137-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663987	Bronze			2022-12-28	WOS:A1996UU11800008
J	Barth, AL; Justice, NJ; Ngai, J				Barth, AL; Justice, NJ; Ngai, J			Asynchronous onset of odorant receptor expression in the developing zebrafish olfactory system	NEURON			English	Article							BRACHYDANIO-RERIO; EPITHELIUM; CATFISH; NEURONS; FAMILY; GENE; CHANNEL; CELLS	The functional identity of an olfactory neuron is determined in large part by the odorant receptors it expresses. As an approach toward understanding the events that underlie the specification of olfactory neurons, we have examined the patterns of odorant receptor gene expression in the developing zebrafish. Surprisingly, we find that the onset of specific odorant receptor expression occurs asynchronously in the developing olfactory placode. Our results suggest that odorant receptor expression is not strictly stochastic, but rather is governed by temporally regulated cues during development. Moreover, by restricting the number of receptor genes competent for transcription at different times of development, temporal waves of expression may provide a mechanism for simplifying the regulation of the large odorant receptor gene family.			Barth, AL (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002253] Funding Source: NIH RePORTER; NCRR NIH HHS [2-S07-RR07006] Funding Source: Medline; NIDCD NIH HHS [R01 DC-02253] Funding Source: Medline; NIGMS NIH HHS [T32 GM07232-18] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIER H, 1994, J NEUROSCI, V14, P219; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; EISEN JS, 1991, J NEUROSCI, V11, P311; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HANSEN A, 1993, J COMP NEUROL, V333, P289, DOI 10.1002/cne.903330213; HARA T J, 1975, Progress in Neurobiology (Oxford), V5, P271, DOI 10.1016/0301-0082(75)90014-3; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; LEWIN B, 1994, CELL, V79, P935, DOI 10.1016/0092-8674(94)90025-6; Maniatis T., 1982, MOL CLONING; MEISAMI E, 1993, DEV BRAIN RES, V71, P253, DOI 10.1016/0165-3806(93)90177-C; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; NUSSLEINVOLHARD C, 1994, SCIENCE, V266, P572, DOI 10.1126/science.7939708; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; POMEROY SL, 1990, J NEUROSCI, V10, P1952; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; REED RR, 1992, COLD SPRING HARB SYM, V57, P501, DOI 10.1101/SQB.1992.057.01.055; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; STROTMANN J, 1995, EUR J NEUROSCI, V7, P492, DOI 10.1111/j.1460-9568.1995.tb00345.x; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Westerfield M, 1993, ZEBRAFISH BOOK; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; WILSON SW, 1990, DEVELOPMENT, V108, P121	35	120	121	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					23	34		10.1016/S0896-6273(00)80020-3	http://dx.doi.org/10.1016/S0896-6273(00)80020-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562087	Bronze			2022-12-28	WOS:A1996TT30700006
J	SHIN, JH; RICHARD, EA; LISMAN, JE				SHIN, JH; RICHARD, EA; LISMAN, JE			CA2+ IS AN OBLIGATORY INTERMEDIATE IN THE EXCITATION CASCADE OF LIMULUS PHOTORECEPTORS	NEURON			English	Article							VENTRAL PHOTORECEPTORS; INOSITOL-TRISPHOSPHATE; INTRACELLULAR CALCIUM; INVERTEBRATE PHOTORECEPTORS; VISUAL EXCITATION; MICROVILLAR PHOTORECEPTORS; DROSOPHILA PHOTORECEPTORS; DEPENDENT CONDUCTANCES; ENDOPLASMIC-RETICULUM; LIGHT ADAPTATION	We have investigated the role of Ca2+ in the excitation of Limulus photoreceptors by intracellular injection of the Ca2+ buffer, 5,5'-dibromo-BAPTA. Buffer with free Ca2+ of 0.5 or 5 muM slowed the rising edge of the light response over 100-fold and greatly reduced both the transient and plateau phases of the light response, as expected if Ca2+ elevation is necessary for all phases of excitation. Injection of buffers with free Ca2+ of 5 or 45 muM, levels normally reached during light, evoked sustained inward current as expected if Ca2+ is sufficient for excitation. The transduction cascade appears due to a single pathway that sequentially involves 1,4,5-trisphosphate inositol, Ca2+, and cyclic GMP.	BRANDEIS UNIV, CTR COMPLEX SYST, WALTHAM, MA 02254 USA	Brandeis University	SHIN, JH (corresponding author), BRANDEIS UNIV, DEPT BIOL, WALTHAM, MA 02254 USA.				NEI NIH HHS [EY01496] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001496, R37EY001496] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER EM, 1991, J NEUROSCI, V11, P1496; BACIGALUPO J, 1990, SER CENT ES, P27; BACIGALUPO J, 1991, P NATL ACAD SCI USA, V88, P7938, DOI 10.1073/pnas.88.18.7938; BACIGALUPO J, 1992, VISUAL NEUROSCI, V8, P41, DOI 10.1017/S0952523800006477; BAER KM, 1988, J BIOL CHEM, V263, P17; BAUMANN O, 1989, J COMP PHYSIOL A, V165, P627, DOI 10.1007/BF00610994; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BLUMENFELD A, 1985, P NATL ACAD SCI USA, V82, P7116, DOI 10.1073/pnas.82.20.7116; BOLSOVER SR, 1985, J PHYSIOL-LONDON, V364, P381, DOI 10.1113/jphysiol.1985.sp015751; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; BROWN JE, 1984, BIOCHEM BIOPH RES CO, V125, P1137, DOI 10.1016/0006-291X(84)91402-5; BROWN JE, 1974, J GEN PHYSIOL, V64, P643, DOI 10.1085/jgp.64.6.643; DECKERT A, 1992, J PHYSIOL-LONDON, V453, P69, DOI 10.1113/jphysiol.1992.sp019219; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; EDWARDS SC, 1989, VISUAL NEUROSCI, V3, P95, DOI 10.1017/S0952523800004417; FEIN A, 1975, SCIENCE, V187, P1094, DOI 10.1126/science.1114339; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; FEIN A, 1975, J GEN PHYSIOL, V66, P823, DOI 10.1085/jgp.66.6.823; FEIN A, 1986, SCIENCE, V232, P1543, DOI 10.1126/science.3487116; FEIN A, 1975, NATURE, V258, P250, DOI 10.1038/258250a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FRANK TM, 1991, J GEN PHYSIOL, V97, P697, DOI 10.1085/jgp.97.4.697; GRZYWACZ NM, 1992, BIOL CYBERN, V66, P429, DOI 10.1007/BF00197723; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; LEVY S, 1985, J GEN PHYSIOL, V85, P805, DOI 10.1085/jgp.85.6.805; Lino Masamitsu, 1992, Nature (London), V360, P76; LISMAN JE, 1982, J GEN PHYSIOL, V79, P187, DOI 10.1085/jgp.79.2.187; LISMAN JE, 1971, J GEN PHYSIOL, V58, P544, DOI 10.1085/jgp.58.5.544; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; LISMAN JE, 1975, J GEN PHYSIOL, V66, P489, DOI 10.1085/jgp.66.4.489; MILLECCHIA R, 1969, J GEN PHYSIOL, V54, P310, DOI 10.1085/jgp.54.3.310; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; MINKE B, 1992, SOC GEN PHY, V47, P201; NAGY K, 1991, Q REV BIOPHYS, V24, P165, DOI 10.1017/S0033583500003401; NASI E, 1991, J GEN PHYSIOL, V97, P55, DOI 10.1085/jgp.97.1.55; ODAY PM, 1989, J GEN PHYSIOL, V93, P473, DOI 10.1085/jgp.93.3.473; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; PAYNE R, 1988, PHILOS T ROY SOC B, V320, P359, DOI 10.1098/rstb.1988.0082; PAYNE R, 1986, J GEN PHYSIOL, V88, P107, DOI 10.1085/jgp.88.1.107; PAYNE R, 1986, J GEN PHYSIOL, V87, P243, DOI 10.1085/jgp.87.2.243; PAYNE R, 1987, J CELL BIOL, V104, P933, DOI 10.1083/jcb.104.4.933; PAYNE R, 1986, PHOTOBIOCH PHOTOBIOP, V13, P373; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; PAYNE R, 1990, NEURON, V4, P547, DOI 10.1016/0896-6273(90)90112-S; RICHARD EA, 1992, NATURE, V356, P336, DOI 10.1038/356336a0; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STERN J, 1982, J GEN PHYSIOL, V80, P825, DOI 10.1085/jgp.80.6.825; STIEVE H, 1992, VISION RES, V32, P403, DOI 10.1016/0042-6989(92)90232-8; SZUTS EZ, 1986, BIOCHEM J, V240, P929, DOI 10.1042/bj2400929; WIEBE EM, 1989, VISUAL NEUROSCI, V3, P107, DOI 10.1017/S0952523800004429; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671	56	67	67	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					845	855		10.1016/0896-6273(93)90114-7	http://dx.doi.org/10.1016/0896-6273(93)90114-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240808				2022-12-28	WOS:A1993MJ04100006
J	TAKIMOTO, K; FOMINA, AF; GEALY, R; TRIMMER, JS; LEVITAN, ES				TAKIMOTO, K; FOMINA, AF; GEALY, R; TRIMMER, JS; LEVITAN, ES			DEXAMETHASONE RAPIDLY INDUCES KV1.5 K+ CHANNEL GENE-TRANSCRIPTION AND EXPRESSION IN CLONAL PITUITARY-CELLS	NEURON			English	Article							POTASSIUM-CHANNEL; RAT-BRAIN; MESSENGER-RNA; HETEROMULTIMERIC CHANNELS; DEVELOPMENTAL EXPRESSION; MOLECULAR-CLONING; XENOPUS-OOCYTES; DOWN-REGULATION; SUBUNITS; PROTEIN	Glucocorticoids specifically increase Kv1.5 K+ channel mRNA in normal and clonal (GH3) rat pituitary cells. Here, we demonstrate that dexamethasone, a glucocorticoid agonist, rapidly induces Kv1.5 gene transcription, but does not affect Kv1.5 mRNA turnover (t1/2 almost-equal-to 0.5 hr) in GH3 cells. Immunoblots indicate that the steroid also increases the expression of the 76 kd Kv1.5 protein approximately 3-fold within 12 hr without altering its half-life (t1/2 almost-equal-to 4 hr). In contrast, Kv1.4 protein expression is unaffected. Finally, we find that the induction of Kv1.5 protein is associated with an increase in a noninactivating component of the voltage-gated K+ current. Our results indicate that hormones and neurotransmitters may act within hours to regulate excitability by controlling K+ channel gene expression.	SUNY,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; SUNY Maritime College	TAKIMOTO, K (corresponding author), UNIV PITTSBURGH,DEPT PHARMACOL,PITTSBURGH,PA 15261, USA.				NINDS NIH HHS [NS 29804, NS29876] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029804, R55NS029876] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BONINI JA, 1991, BIOTECHNIQUES, V11, P708; BOYLE MB, 1987, NATURE, V330, P373, DOI 10.1038/330373a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; COSLOW ME, 1982, J BIOL CHEM, V257, P9330; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; DREWE JA, 1992, J NEUROSCI, V12, P538; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GANGULY S, 1985, J BIOL CHEM, V260, P2167; GERTZ BJ, 1987, MOL ENDOCRINOL, V1, P933, DOI 10.1210/mend-1-12-933; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; KACZMAREK LK, 1991, NEW BIOL, V3, P315; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; LESAGE F, 1992, FEBS LETT, V310, P162, DOI 10.1016/0014-5793(92)81320-L; LEVITAN ES, 1991, MOL ENDOCRINOL, V5, P1903, DOI 10.1210/mend-5-12-1903; MATSUBARA H, 1991, J BIOL CHEM, V266, P13324; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; MEYERHOF W, 1992, J NEUROENDOCRINOL, V4, P245, DOI 10.1111/j.1365-2826.1992.tb00166.x; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; PASSAFARO M, 1992, J NEUROSCI, V12, P3372; PRAGNELL M, 1990, NEURON, V4, P807, DOI 10.1016/0896-6273(90)90207-V; REHM H, 1989, FEBS LETT, V249, P224, DOI 10.1016/0014-5793(89)80628-3; RIBERA AB, 1990, NEURON, V5, P691, DOI 10.1016/0896-6273(90)90223-3; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; ROBERDS SL, 1991, FEBS LETT, V284, P152, DOI 10.1016/0014-5793(91)80673-Q; RUDY B, 1992, P NATL ACAD SCI USA, V89, P4603, DOI 10.1073/pnas.89.10.4603; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT J, 1985, P NATL ACAD SCI USA, V82, P4847, DOI 10.1073/pnas.82.14.4847; SEQUIER JM, 1990, FEBS LETT, V263, P163, DOI 10.1016/0014-5793(90)80729-3; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SHOLZ KP, 1987, SCIENCE, V235, P685; SIMASKO SM, 1991, AM J PHYSIOL, V261, pE66, DOI 10.1152/ajpendo.1991.261.1.E66; STOLLBERG J, 1987, J NEUROSCI, V7, P1809; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TAKIMOTO K, 1991, BIOCHEM BIOPH RES CO, V180, P953, DOI 10.1016/S0006-291X(05)81158-1; TORRES M, 1992, BIOCHIM BIOPHYS ACTA, V1105, P291, DOI 10.1016/0005-2736(92)90207-3; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WAECHTER CJ, 1983, J BIOL CHEM, V258, P5117	54	97	98	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					359	369		10.1016/0896-6273(93)90191-S	http://dx.doi.org/10.1016/0896-6273(93)90191-S			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352944				2022-12-28	WOS:A1993LU06500015
J	TWITCHELL, WA; RANE, SG				TWITCHELL, WA; RANE, SG			OPIOID PEPTIDE MODULATION OF CA2+-DEPENDENT K+ AND VOLTAGE-ACTIVATED CA2+ CURRENTS IN BOVINE ADRENAL CHROMAFFIN CELLS	NEURON			English	Article							ACTION-POTENTIAL DURATION; POTASSIUM CONDUCTANCE; BINDING-SITES; CATECHOLAMINE SECRETION; OPIATE RECEPTORS; CALCIUM CHANNELS; SENSORY NEURONS; INHIBITION; MEDULLA; RELEASE	Opioid peptides are abundantly expressed in the adrenal medulla, and there is evidence that they may be released presynaptically or as medullary paracrine agents. To assess the physiological relevance of these observations, we investigated opioid effects on ionic currents from cultured bovine adrenal chromaffin cells. Under whole-cell path-clamp conditions, opioid peptides, acting via a mu-type opioid receptor, strongly potentiated the large conductance Ca2+-dependent K+ (BK) channel current. Opioids also inhibited voltage-activated Ca2+ currents. Application of opioid peptides to the extracellular face of outside-out patches also increased opening activity of single BK channels, suggestive of tight receptor-channel coupling. This potentiating effect on BK current, combined with the inhibition of Ca2+ current, indicates that opioids may have an inhibitory influence on secretory activity of the adrenal medulla. The widespread distribution of the BK channel class suggests that the significance of its modulation by opioids could also extend beyond the adrenal gland.			TWITCHELL, WA (corresponding author), PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907, USA.							CASTANAS E, 1985, J NEUROCHEM, V45, P677, DOI 10.1111/j.1471-4159.1985.tb04046.x; CASTANAS E, 1985, J NEUROCHEM, V45, P688, DOI 10.1111/j.1471-4159.1985.tb04047.x; CHAMINADE M, 1984, J PHYSIOL-LONDON, V353, P157, DOI 10.1113/jphysiol.1984.sp015329; CHAVKIN C, 1988, OPIATE RECEPTORS, P273; CHERUBINI E, 1985, P NATL ACAD SCI USA, V82, P1860, DOI 10.1073/pnas.82.6.1860; DEAN DM, 1982, J NEUROCHEM, V38, P606, DOI 10.1111/j.1471-4159.1982.tb08674.x; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; GREENBERG A, 1982, CELL TISSUE RES, V226, P655; GROSS RA, 1990, P NATL ACAD SCI USA, V87, P7025, DOI 10.1073/pnas.87.18.7025; HEYM C, 1988, PROG HISTOCHEM CYTOC, V18, P1; HOLZ GG, 1989, J NEUROSCI, V9, P657; KENNEDY C, 1991, MOL PHARMACOL, V40, P1000; KIDOKORO Y, 1980, J PHYSIOL-LONDON, V307, P199, DOI 10.1113/jphysiol.1980.sp013431; KLEPPISCH T, 1992, PFLUG ARCH EUR J PHY, V421, P131, DOI 10.1007/BF00374819; KUMAKURA K, 1980, NATURE, V283, P489, DOI 10.1038/283489a0; LECHLEITER JD, 1988, NEURON, V1, P227, DOI 10.1016/0896-6273(88)90143-2; LEMAIRE S, 1981, J NEUROCHEM, V36, P886, DOI 10.1111/j.1471-4159.1981.tb01677.x; LIVETT BG, 1984, PHYSIOL REV, V64, P1103, DOI 10.1152/physrev.1984.64.4.1103; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MUDGE AW, 1979, P NATL ACAD SCI USA, V76, P526, DOI 10.1073/pnas.76.1.526; NORTH RA, 1983, BRIT J PHARMACOL, V80, P225, DOI 10.1111/j.1476-5381.1983.tb10023.x; NORTH RA, 1986, TRENDS NEUROSCI, V9, P114; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; SAIANI L, 1982, J NEUROCHEM, V39, P1669, DOI 10.1111/j.1471-4159.1982.tb08001.x; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; SURPRENANT A, 1990, J PHYSIOL-LONDON, V431, P585, DOI 10.1113/jphysiol.1990.sp018349; TORO L, 1990, J GEN PHYSIOL, V96, P373, DOI 10.1085/jgp.96.2.373; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; WAYMIRE JC, 1983, J NEUROSCI METH, V7, P329, DOI 10.1016/0165-0270(83)90026-2; WERZ MA, 1983, NEUROSCI LETT, V42, P173, DOI 10.1016/0304-3940(83)90402-0; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WILSON SP, 1982, J NEUROSCI, V2, P1150; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5	35	49	49	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					701	709		10.1016/0896-6273(93)90171-M	http://dx.doi.org/10.1016/0896-6273(93)90171-M			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476614				2022-12-28	WOS:A1993KY50100013
J	VONBOXBERG, Y; DEISS, S; SCHWARZ, U				VONBOXBERG, Y; DEISS, S; SCHWARZ, U			GUIDANCE AND TOPOGRAPHIC STABILIZATION OF NASAL CHICK RETINAL AXONS ON TARGET-DERIVED COMPONENTS INVITRO	NEURON			English	Article							POSITION-SPECIFIC PROPERTIES; TECTAL CELL-MEMBRANES; RETINOTECTAL PROJECTION; BIOCHEMICAL-CHARACTERIZATION; ADHESION MOLECULES; EMBRYONIC CHICK; NERVOUS-SYSTEM; MAP FORMATION; GROWTH CONES; XENOPUS	We studied mechanisms underlying the generation of topographic order within the developing chick retinotectal connection by combining the recently introduced stripe assay with a novel membrane protein fractionation technique. Our experiments show a preference of temporal and nasal retinal fibers for growing on cell membranes prepared from their proper target area. In addition, membrane preparations from posterior tectum were found to prolong substantially the survival of nasal neurites in vitro. We conclude that tropic as well as trophic interactions contribute to the generation of topographic maps during embryogenesis, in our case to the homing of nasal axons within the posterior tectum.			VONBOXBERG, Y (corresponding author), MAX PLANCK INST ENTWICKLUNGSBIOL,W-7400 TUBINGEN,GERMANY.			von Boxberg, Ysander/0000-0001-5886-6155				BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BONHOEFFER F, 1984, TRENDS NEUROSCI, V7, P378, DOI 10.1016/S0166-2236(84)80060-0; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CHUONG CM, 1984, J NEUROSCI, V4, P2354; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1986, NATURE, V324, P459, DOI 10.1038/324459a0; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EASTER SS, 1984, J NEUROSCI, V4, P1053; FUJISAWA H, 1987, J COMP NEUROL, V260, P127, DOI 10.1002/cne.902600110; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; GIERER A, 1987, DEVELOPMENT, V101, P479; GODEMENT P, 1989, DEVELOPMENT, V106, P313; HALFTER W, 1981, NATURE, V292, P67, DOI 10.1038/292067a0; HANKIN M, 1991, TRENDS NEUROSCI, V14, P224, DOI 10.1016/0166-2236(91)90118-E; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDER AD, 1989, TRENDS NEUROSCI, V12, P189, DOI 10.1016/0166-2236(89)90070-2; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; MARCHASE RB, 1977, J CELL BIOL, V75, P237, DOI 10.1083/jcb.75.1.237; MCLOON SC, 1991, J NEUROSCI, V11, P1470; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NEUKIRCHEN RO, 1982, J BIOL CHEM, V257, P5229; NORRIS CR, 1990, J COMP NEUROL, V293, P268, DOI 10.1002/cne.902930209; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; PATTERSON PH, 1988, NEURON, V1, P263, DOI 10.1016/0896-6273(88)90074-8; RABACCHI SA, 1990, DEVELOPMENT, V109, P521; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; STIRLING RV, 1991, TRENDS NEUROSCI, V14, P509; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; THANOS S, 1987, J COMP NEUROL, V261, P155, DOI 10.1002/cne.902610114; TRISLER D, 1990, J EXP BIOL, V153, P11; TRISLER GD, 1981, P NATL ACAD SCI-BIOL, V78, P2145, DOI 10.1073/pnas.78.4.2145; UDIN SB, 1988, J COMP NEUROL, V203, P575; VIELMETTER J, 1991, J COMP NEUROL, V311, P321, DOI 10.1002/cne.903110303; VIELMETTER J, 1989, NEURON, V2, P1331, DOI 10.1016/0896-6273(89)90071-8; VONBOXBERG Y, 1988, ANAL BIOCHEM, V169, P372; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1990, J PHYSIOL-PARIS, V84, P104; WALTER J, 1990, TRENDS NEUROSCI, V13, P447, DOI 10.1016/0166-2236(90)90097-T	48	42	42	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					345	357						13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461131				2022-12-28	WOS:A1993KU90100002
J	IP, NY; MCCLAIN, J; BARREZUETA, NX; ALDRICH, TH; PAN, L; LI, YP; WIEGAND, SJ; FRIEDMAN, B; DAVIS, S; YANCOPOULOS, GD				IP, NY; MCCLAIN, J; BARREZUETA, NX; ALDRICH, TH; PAN, L; LI, YP; WIEGAND, SJ; FRIEDMAN, B; DAVIS, S; YANCOPOULOS, GD			THE ALPHA COMPONENT OF THE CNTF RECEPTOR IS REQUIRED FOR SIGNALING AND DEFINES POTENTIAL CNTF TARGETS IN THE ADULT AND DURING DEVELOPMENT	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA-INHIBITORY FACTOR; NEURONAL DIFFERENTIATION FACTOR; REGIONAL DISTRIBUTION; MOLECULAR-CLONING; RAT-BRAIN; SYMPATHETIC NEURONS; TROPHIC FACTOR; MESSENGER-RNA; SPINAL-CORD	We recently proposed that ciliary neurotrophic factor (CNTF) shares two receptor components with a generally acting cytokine, leukemia inhibitory factor (LIF), but that CNTF also requires a third receptor component (CNTFRalpha) that is mostly restricted to the nervous system in its expression. Here we demonstrate that a transfected CNTFRalpha gene is sufficient to confer CNTF responsiveness upon hemopoietic cells normally responsive only to LIF, providing evidence that CNTFRalpha is a required receptor component that uniquely characterizes CNTF-responding cells. Consistent with this notion, CNTFRalpha expression could be localized to neurons within all known peripheral targets of CNTF. CNTFRalpha was also widely expressed within neurons of the CNS, suggesting that CNTF has broader CNS actions than previously appreciated. However, in vivo localization of CNTFRalpha, as well as of CNTF itself, is consistent with a particularly important role for CNTF in motor function as well as during neuropoiesis.			IP, NY (corresponding author), REGENERON PHARMACEUT INC, 777 OLD SAW MILL RIVER RD, TARRYTOWN, NY 10591 USA.			Ip, Nancy Yuk-Yu/0000-0002-2763-8907				ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BAUMANN M, 1990, J BIOL CHEM, V265, P19853; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BLOTTNER D, 1989, NEUROSCI LETT, V105, P316, DOI 10.1016/0304-3940(89)90640-X; Bothwell A., 1990, METHODS CLONING ANAL; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DAVIS S, 1993, IN PRESS CURR OPIN N; DAVIS S, 1993, IN PRESS SCIENCE; ECKENSTEIN FP, 1990, NEURON, V4, P623, DOI 10.1016/0896-6273(90)90120-5; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; HAGG T, 1992, NEURON, V8, P145, DOI 10.1016/0896-6273(92)90116-U; HALL AK, 1992, TRENDS NEUROSCI, V15, P35, DOI 10.1016/0166-2236(92)90022-Z; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hughes J T, 1982, Adv Neurol, V36, P61; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IP NY, 1992, IN PRESS PROG GROWTH; IP NY, 1993, IN PRESS EUR J NEURO; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LAVAIL MM, 1992, IN PRESS P NATL ACAD; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAO MS, 1990, DEV BIOL, V139, P65, DOI 10.1016/0012-1606(90)90279-R; RENDE M, 1992, GLIA, V5, P25, DOI 10.1002/glia.440050105; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SKAPER SD, 1986, DEV BRAIN RES, V24, P39, DOI 10.1016/0165-3806(86)90171-9; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546	57	396	408	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					89	102		10.1016/0896-6273(93)90245-M	http://dx.doi.org/10.1016/0896-6273(93)90245-M			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8381290				2022-12-28	WOS:A1993KK01200010
J	Zucker, RS				Zucker, RS			Exocytosis: A molecular and physiological perspective	NEURON			English	Review							BOVINE CHROMAFFIN CELLS; SQUID GIANT SYNAPSE; SACCULAR HAIR-CELLS; TRANSMITTER RELEASE; POSTTETANIC POTENTIATION; TIME-COURSE; N-TYPE; CALCIUM; CA2+; SYNAPTOTAGMIN				Zucker, RS (corresponding author), UNIV CALIF BERKELEY,DIV NEUROBIOL,BERKELEY,CA 94720, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343				ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Atluri PP, 1996, J NEUROSCI, V16, P5661; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Calakos N, 1996, PHYSIOL REV, V76, P1; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1995, NEURON, V16, P359; CONNOR JA, 1986, J PHYSIOL-LONDON, V375, P625, DOI 10.1113/jphysiol.1986.sp016137; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELANEY KR, 1994, J NEUROSCI, V14, P5885; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; FISCHER TM, 1993, J NEUROSCI, V13, P1302; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Henkel AW, 1995, J NEUROSCI, V15, P8246; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; HSU SF, 1996, NEURON, V17, P1; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KRETZ R, 1982, P NATL ACAD SCI-BIOL, V79, P5430, DOI 10.1073/pnas.79.17.5430; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MAGLEBY KL, 1982, J GEN PHYSIOL, V30, P613; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; MILEDI R, 1971, J PHYSIOL-LONDON, V212, P245, DOI 10.1113/jphysiol.1971.sp009320; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; MULKEY RM, 1992, J NEUROSCI, V12, P4327; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; VANDERKLOOT W, 1995, BIOPHYS J, V69, P148, DOI 10.1016/S0006-3495(95)79884-8; Vogel SS, 1996, J CELL BIOL, V134, P329, DOI 10.1083/jcb.134.2.329; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; Zhang L, 1996, NEURON, V17, P287, DOI 10.1016/S0896-6273(00)80160-9	59	278	284	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1049	1055		10.1016/S0896-6273(00)80238-X	http://dx.doi.org/10.1016/S0896-6273(00)80238-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982154	Bronze			2022-12-28	WOS:A1996WA24800004
J	Staley, K; Smith, R; Schaack, J; Wilcox, C; Jentsch, TJ				Staley, K; Smith, R; Schaack, J; Wilcox, C; Jentsch, TJ			Alteration of GABA(A) receptor function following gene transfer of the CLC-2 chloride channel	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; GAMMA-AMINOBUTYRIC ACID; POSTSYNAPTIC INHIBITION; EPILEPTIFORM ACTIVITY; IONIC MECHANISMS; NERVOUS-SYSTEM; SPINAL-CORD; NEURONS; BRAIN; FUROSEMIDE	The effect of GABA(A) receptor activation varies from inhibition to excitation depending on the state of the transmembrane anionic concentration gradient (del(anion)). del(anion) was genetically altered in cultured dorsal root ganglion neurons via adenoviral vector-mediated expression of ClC-2, a Cl- channel postulated to regulate the Cl- concentration in neurons in which GABA(A) receptor activation is predominantly inhibitory. ClC-2 expression was verified by the presence of the appropriate mRNA, protein, and membrane conductance. ClC-2 expression resulted in a large negative shift in the Cl- equilibrium potential (E(Cl)) that attenuated the GABA-mediated membrane depolarization and prevented GABA(A) receptor-mediated action potentials. These results establish that gene transfer of transmembrane ion channels to neurons can be used to demonstrate their physiological function, and that del(anion) can be genetically manipulated to alter the function of neuronal GABA(A) receptors in situ.	UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT B182,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MICROBIOL,DENVER,CO 80262; COLORADO STATE UNIV,DEPT MICROBIOL,FT COLLINS,CO 80523; UNIV HAMBURG,CTR MOL NEUROBIOL,ZMNH,D-20246 HAMBURG,GERMANY	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado State University; University of Hamburg	Staley, K (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT NEUROL,DENVER,CO 80262, USA.			Jentsch, Thomas/0000-0002-3509-2553				ALVAREZLEEFMANS FJ, 1988, J PHYSIOL-LONDON, V406, P225, DOI 10.1113/jphysiol.1988.sp017378; ALVAREZLEEFMANS FJ, 1990, CHLORIDE CHANNELS CA, P133; AULT B, 1994, NEUROPHARMACOLOGY, V33, P109, DOI 10.1016/0028-3908(94)90104-X; AVOLI M, 1990, J NEUROPHYSIOL, V64, P1747, DOI 10.1152/jn.1990.64.6.1747; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Cohen LB, 1977, HDB PHYSL NERVOUS SY, P137; COLLINS JJ, 1995, J PEDIATR-US, V126, P653, DOI 10.1016/S0022-3476(95)70370-5; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; ECCLES JC, 1962, J PHYSIOL-LONDON, V160, P62, DOI 10.1113/jphysiol.1962.sp006835; GALLAGHER JP, 1978, J PHYSIOL-LONDON, V275, P263, DOI 10.1113/jphysiol.1978.sp012189; Golding NL, 1996, J NEUROSCI, V16, P2208; GREGER R, 1990, METHOD ENZYMOL, V191, P793; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; HAHN JS, 1993, PEDIATR NEUROL, V9, P330, DOI 10.1016/0887-8994(93)90076-O; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; JAROLIMEK W, 1996, IN PRESS J NEUROPHYS; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482P, pS19; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LEGENDRE P, 1991, MOL PHARMACOL, V39, P267; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; MICHELSON HB, 1991, SCIENCE, V253, P1420, DOI 10.1126/science.1654594; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MOROTA N, 1995, CHILD NERV SYST, V11, P161, DOI 10.1007/BF00570257; Nicoll R A, 1979, Int Rev Neurobiol, V21, P217; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NICOLL RA, 1978, J PHYSIOL-LONDON, V283, P121, DOI 10.1113/jphysiol.1978.sp012491; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; OLSEN RW, 1994, ANNU REV NEUROSCI, V17, P569; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PUZZAN T, 1996, PHYSIOL REV, V74, P595; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rohrbough J, 1996, J NEUROSCI, V16, P82; SCHAACK J, 1995, J VIROL, V69, P3920, DOI 10.1128/JVI.69.6.3920-3923.1995; SCHER MS, 1993, PEDIATRICS, V91, P128; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH RL, 1995, J NEUROSCI, V15, P4057; SMITH RL, 1994, VIROLOGY, V201, P49; SOLTESZ I, 1994, J NEUROSCI, V14, P2365; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; THOMPSON SM, 1994, PROG NEUROBIOL, V42, P575, DOI 10.1016/0301-0082(94)90044-2; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; WHITE MM, 1990, MOL PHARMACOL, V37, P720; WONG RKS, 1982, J NEUROPHYSIOL, V48, P938, DOI 10.1152/jn.1982.48.4.938; Yancey P.H., 1994, CELLULAR MOL PHYSL C, P81	55	182	183	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					543	551		10.1016/S0896-6273(00)80186-5	http://dx.doi.org/10.1016/S0896-6273(00)80186-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816717	Bronze			2022-12-28	WOS:A1996VJ44000020
J	Pennica, D; Arce, V; Swanson, TA; Vejsada, R; Pollock, RA; Armanini, M; Dudley, K; Phillips, HS; Rosenthal, A; Kato, AC; Henderson, CE				Pennica, D; Arce, V; Swanson, TA; Vejsada, R; Pollock, RA; Armanini, M; Dudley, K; Phillips, HS; Rosenthal, A; Kato, AC; Henderson, CE			Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH-FACTOR; FACTOR PREVENTS; CNTF RECEPTOR; MOTOR NEURONS; CELL-DEATH; BRAIN; EXPRESSION; DEGENERATION	The muscle-derived factors required for survival of embryonic motoneurons are not clearly identified. Cardiotrophin-1 (CT-1), a cytokine related to ciliary neurotrophic factor (CNTF), is expressed at high levels in embryonic limb bud and is secreted by differentiated myotubes. In vitro, CT-1 kept 43% of purified E14 rat motoneurons alive for 2 weeks (ECS(50) = 20 pM). In vivo, CT-1 protected neonatal sciatic motoneurons against the effects of axotomy. CT-1 action on motoneurons was inhibited by phosphatidylinositol-specific phospholipase C (PIPLC), suggesting that CT-1 may act through a GPI-linked component. Since no binding of CT-1 to CNTFR alpha was detected, CT-1 may use a novel cytokine receptor alpha. subunit. CT-1 may be important in normal motoneuron development and as a potential tool for slowing motoneuron degeneration in human diseases.	GENENTECH INC,DEPT NEUROSCI,S SAN FRANCISCO,CA 94080; UNIV MEDITERRANEE,INSERM,CNRS,IBDM,U382,F-13288 MARSEILLE 09,FRANCE; CTR MED UNIV GENEVA,DIV CLIN NEUROMUSCULAR RES,CH-1211 GENEVA 4,SWITZERLAND; CTR MED UNIV GENEVA,DEPT PHARMACOL,CH-1211 GENEVA 4,SWITZERLAND	Roche Holding; Genentech; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva; University of Geneva	Pennica, D (corresponding author), GENENTECH INC,DEPT MOL BIOL,S SAN FRANCISCO,CA 94080, USA.			Henderson, Christopher/0000-0002-9936-3279				ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; CATALA F, 1995, MOL CELL BIOL, V15, P4585; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; HAMBURGER V, 1992, J NEUROBIOL, V23, P1116, DOI 10.1002/neu.480230904; Henderson C.E., 1995, NERVE CELL CULTURE P, P69; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HENDERSON CE, 1993, RESTOR NEUROL NEUROS, V5, P15, DOI 10.3233/RNN-1993-5105; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HENDERSON CE, 1995, ADV NEUROL, V68, P235; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; KWON YW, 1995, J NEUROBIOL, V28, P35, DOI 10.1002/neu.480280105; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; LOW MG, 1986, TRENDS BIOCHEM SCI, V11, P212, DOI 10.1016/0968-0004(86)90009-5; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pennica D, 1996, CYTOKINE, V8, P183, DOI 10.1006/cyto.1996.0026; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; PETERS M, 1995, FEBS LETT, V372, P177, DOI 10.1016/0014-5793(95)00972-C; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PINCONRAYMOND M, 1991, DEV BIOL, V148, P517, DOI 10.1016/0012-1606(91)90270-D; PINSET C, 1991, EMBO J, V10, P2411, DOI 10.1002/j.1460-2075.1991.tb07780.x; SAGOT Y, 1995, EUR J NEUROSCI, V7, P1313, DOI 10.1111/j.1460-9568.1995.tb01122.x; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SENDTNER M, 1992, NATURE, V358, P602; Sheng ZL, 1996, DEVELOPMENT, V122, P419; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; WONG VV, 1995, J BIOL CHEM, V270, P313, DOI 10.1074/jbc.270.1.313; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; YAN Q, 1988, J NEUROSCI, V8, P3481; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	49	194	209	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					63	74		10.1016/S0896-6273(00)80281-0	http://dx.doi.org/10.1016/S0896-6273(00)80281-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755479	Bronze			2022-12-28	WOS:A1996UY98100008
J	LucidiPhillipi, CA; Clary, DO; Reichardt, LF; Gage, FH				LucidiPhillipi, CA; Clary, DO; Reichardt, LF; Gage, FH			TrkA activation is sufficient to rescue axotomized cholinergic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; FIMBRIA-FORNIX TRANSECTION; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; BASAL FOREBRAIN; SENSORY NEURONS; GENE-EXPRESSION; KINASE-ACTIVITY; MESSENGER-RNA	To test the molecular nature of the NGF receptor responsible for the ability of NGF to rescue septal cholinergic neurons following axotomy, we infused polyclonal antibodies that act as specific agonists of trkA (RTA) into the lateral ventricle of fimbria-fornix lesioned animals. Rats receiving chronic intraventricular infusions of RTA showed significantly more low affinity NGF receptor immunoreactive (p75(NGFR-IR)) neurons on the lesioned side than did control animals 2 weeks following unilateral fimbria-fornix lesion. RTA also initiated cholinergic sprouting. Infusions of RTA in combination with an antibody that blocks p75(NGFR) (REX) did not reduce the cell savings effect observed with RTA alone. However, animals infused with RTA plus REX demonstrated significantly less sprouting. These findings suggest that antibody-induced trkA activation is sufficient to mediate NGF-promoted survival of axotomized cholinergic neurons in vivo.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; SUGEN INC,REDWOOD CITY,CA 94063	Howard Hughes Medical Institute; University of California System; University of California San Francisco	LucidiPhillipi, CA (corresponding author), SALK INST BIOL STUDIES,10010 N TORREY PINES RD,LA JOLLA,CA 92037, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006088, R01AG008514, T32AG000216, R37AG008514] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG000216, AG08514, R01 AG008514, AG06088, R37 AG008514, 5T32 AG00216] Funding Source: Medline; NIMH NIH HHS [P50 MH048200-100005] Funding Source: Medline; NINDS NIH HHS [P01 NS028121] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLSOPP TE, 1993, J CELL BIOL, V123, P1555, DOI 10.1083/jcb.123.6.1555; ARIMATSU Y, 1988, DEV BRAIN RES, V45, P297; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BARNETT J, 1990, EXP NEUROL, V110, P11, DOI 10.1016/0014-4886(90)90047-V; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; BATCHELOR PE, 1989, J COMP NEUROL, V284, P187, DOI 10.1002/cne.902840204; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GAGE FH, 1988, J COMP NEUROL, V269, P147, DOI 10.1002/cne.902690112; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; GAGE FH, 1983, BRAIN RES, V268, P27, DOI 10.1016/0006-8993(83)90387-6; GIBBS RB, 1994, J COMP NEUROL, V341, P324, DOI 10.1002/cne.903410304; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; HEFTI F, 1985, NEUROSCIENCE, V14, P55, DOI 10.1016/0306-4522(85)90163-0; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1984, BRAIN RES, V293, P305, DOI 10.1016/0006-8993(84)91237-X; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HIGGINS GA, 1989, NEURON, V3, P247, DOI 10.1016/0896-6273(89)90038-X; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LOEB DM, 1991, CELL, V66, P951; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; MONTERO CN, 1988, J NEUROSCI, V8, P2986; NAUMANN T, 1992, J COMP NEUROL, V325, P219, DOI 10.1002/cne.903250207; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PETERSON DA, 1994, J NEUROSCI, V14, P6872; PETERSON DA, 1993, J NEUROSCI METH, V46, P107, DOI 10.1016/0165-0270(93)90146-I; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RADEKE MJ, 1991, NEURON, V7, P141, DOI 10.1016/0896-6273(91)90082-B; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROVELLI G, 1993, P NATL ACAD SCI USA, V90, P8717, DOI 10.1073/pnas.90.18.8717; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; TUSZYNSKI MH, 1990, BRAIN RES, V508, P241, DOI 10.1016/0006-8993(90)90402-W; VERDI JM, 1994, P NATL ACAD SCI USA, V91, P3949, DOI 10.1073/pnas.91.9.3949; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	61	47	47	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					653	663		10.1016/S0896-6273(00)80084-7	http://dx.doi.org/10.1016/S0896-6273(00)80084-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785062	Bronze, Green Accepted			2022-12-28	WOS:A1996UC16800021
J	Wang, H; Allen, ML; Grigg, JJ; Noebels, JL; Tempel, BL				Wang, H; Allen, ML; Grigg, JJ; Noebels, JL; Tempel, BL			Hypomyelination alters K+ channel expression in mouse mutants shiverer and Trembler	NEURON			English	Article							BASIC-PROTEIN GENE; MYELINATED NERVE-FIBERS; POTASSIUM CHANNELS; SCHWANN-CELL; SODIUM-CHANNELS; MULTIPLE-SCLEROSIS; MEMBRANE CURRENTS; ION CHANNELS; SPINAL-CORD; AXONS	Voltage-gated K+ channels are localized to juxtaparanodal regions of myelinated axons. To begin to understand the role of normal compact myelin in this localization, we examined mKv1.1 and mKv1.2 expression in the dysmyelinating mouse mutants shiverer and Trembler. In neonatal wild-type and shiverer mice, the focal localization of both proteins in axon fiber tracts is similar, suggesting that cues other than mature myelin can direct initial K+ channel localization in shiverer mutants. In contrast, K+ channel localization is altered in hypomyelinated axonal fiber tracts of adult mutants, suggesting that abnormal myelination leads to channel redistribution. In shiverer adult, K+ channel expression is up-regulated in both axons and glia, as revealed by immunocytochemistry, RNase protection, and in situ hybridization studies. This up-regulation of K+ channels in hypomyelinated axon tracts may reflect a compensatory reorganization of ionic currents, allowing impulse conduction to occur in these dysmyelinating mouse mutants.	UNIV WASHINGTON, SCH MED, DEPT PHARMACOL, SEATTLE, WA 98195 USA; VET AFFAIRS MED CTR, CTR GERIATR RES EDUC & CLIN, SEATTLE, WA 98108 USA; BAYLOR COLL MED, DEPT NEUROL, NEUROPHYSIOL SECT, DEV NEUROGENET LAB, HOUSTON, TX 77030 USA	University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine	Wang, H (corresponding author), UNIV WASHINGTON, SCH MED, DEPT OTOLARYNGOL HEAD & NECK SURG, SEATTLE, WA 98195 USA.			Noebels, Jeffrey/0000-0002-2887-0839	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000018] Funding Source: NIH RePORTER; NIDCD NIH HHS [T32-DC00018] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AGARD DA, 1989, METHOD CELL BIOL, V30, P353; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; Barres B A, 1991, Curr Opin Neurobiol, V1, P354, DOI 10.1016/0959-4388(91)90052-9; BEVER CT, 1994, ANN NEUROL, V36, pS118, DOI 10.1002/ana.410360728; BIRD TD, 1978, J NEUROCHEM, V31, P387, DOI 10.1111/j.1471-4159.1978.tb12479.x; BLACK JA, 1991, BRAIN RES, V544, P59, DOI 10.1016/0006-8993(91)90885-Y; BOSMA MM, 1993, J NEUROSCI, V13, P5242, DOI 10.1523/JNEUROSCI.13-12-05242.1993; BOSTOCK H, 1981, J PHYSIOL-LONDON, V313, P301, DOI 10.1113/jphysiol.1981.sp013666; BOWE CM, 1985, PROC R SOC SER B-BIO, V224, P355, DOI 10.1098/rspb.1985.0037; BRISMAR T, 1980, J PHYSIOL-LONDON, V298, P171, DOI 10.1113/jphysiol.1980.sp013074; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; CHIU SY, 1989, J PHYSIOL-LONDON, V408, P199, DOI 10.1113/jphysiol.1989.sp017455; CHIU SY, 1979, J PHYSIOL-LONDON, V292, P149, DOI 10.1113/jphysiol.1979.sp012843; CHIU SY, 1994, GLIA, V12, P1, DOI 10.1002/glia.440120102; CHIU SY, 1991, GLIA, V4, P541, DOI 10.1002/glia.440040602; CHOI BH, 1986, J NEUROPATH EXP NEUR, V45, P513, DOI 10.1097/00005072-198609000-00003; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Hille B., 1992, IONIC CHANNELS EXCIT; HOPKINS WF, 1994, PFLUG ARCH EUR J PHY, V428, P382, DOI 10.1007/BF00724522; MI HY, 1995, J NEUROSCI, V15, P3761; MOLINEAUX SM, 1986, P NATL ACAD SCI USA, V83, P7542, DOI 10.1073/pnas.83.19.7542; MOLL C, 1991, BRAIN RES, V556, P311, DOI 10.1016/0006-8993(91)90321-L; NOEBELS JL, 1991, NATURE, V352, P431, DOI 10.1038/352431a0; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; ROSENBLUTH J, 1980, J COMP NEUROL, V194, P639, DOI 10.1002/cne.901940310; ROSENBLUTH J, 1988, INT J DEV NEUROSCI, V6, P3, DOI 10.1016/0736-5748(88)90025-1; ROSENBLUTH J, 1981, BRAIN RES, V208, P283, DOI 10.1016/0006-8993(81)90558-8; ROSENBLUTH J, 1980, J COMP NEUROL, V193, P729, DOI 10.1002/cne.901930310; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; SCHWARZ JR, 1991, NEUROSCI LETT, V122, P205, DOI 10.1016/0304-3940(91)90859-R; SHRAGER P, 1989, BRAIN RES, V483, P149, DOI 10.1016/0006-8993(89)90046-2; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; STEFOSKI D, 1987, ANN NEUROL, V21, P71, DOI 10.1002/ana.410210113; STERNBERGERLA, 1979, IMMUNOCYTOCHEMISTRY; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TARG EF, 1985, BRAIN RES, V328, P358, DOI 10.1016/0006-8993(85)91049-2; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; WAXMAN SG, 1985, SCIENCE, V228, P1502, DOI 10.1126/science.2409596; WAXMAN SG, 1984, BRAIN RES, V294, P111, DOI 10.1016/0006-8993(84)91314-3; WERKMAN TR, 1992, NEUROSCIENCE, V50, P935, DOI 10.1016/0306-4522(92)90216-O; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WILEYLIVINGSTON CA, 1980, DEV BIOL, V79, P334, DOI 10.1016/0012-1606(80)90120-7; WILSON GF, 1990, J NEUROSCI, V10, P3263	50	72	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1337	1347		10.1016/0896-6273(95)90012-8	http://dx.doi.org/10.1016/0896-6273(95)90012-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845157	Bronze			2022-12-28	WOS:A1995TL67800012
J	Yang, J; Jan, YN; Jan, LY				Yang, J; Jan, YN; Jan, LY			Determination of the subunit stoichiometry of an inwardly rectifying potassium channel	NEURON			English	Article							FUNCTIONAL EXPRESSION; CELLS; RECTIFICATION; RECEPTOR; MG-2+; BLOCK	Inwardly rectifying K+ channels are distantly related to their voltage-gated counterparts and possess a structural motif of only two putative transmembrane segments in each subunit. They are formed by the assembly of an unknown number of subunits. We have examined the subunit stoichiometry oi a strongly rectifying K+ channel, IRK1, by linking together the coding sequence of three or four subunits and distinguishing channels with different numbers of subunits carrying a double mutation that alters inward rectification and single-channel properties. We find that IRK1 channels, like voltage-gated K+ channels, are tetrameric channels. Interestingly, the high sensitivity to Mg2+ and polyamines, cations that produce inward rectification by blocking the channel pore from the cytoplasmic side, is largely retained in a channel containing only one wild-type subunit and three subunits bearing mutations that abolish high affinity Mg2+ and polyamine block.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yang, J (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GLOWATZKI, 1995, P R SOC LOND B, V261, P251; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; ISHIHARA K, 1989, J PHYSIOL-LONDON, V419, P297, DOI 10.1113/jphysiol.1989.sp017874; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MATSUDA H, 1988, J PHYSIOL-LONDON, V397, P237, DOI 10.1113/jphysiol.1988.sp016998; NICHOLS CG, 1994, J PHYSIOL-LONDON, V476, P399, DOI 10.1113/jphysiol.1994.sp020141; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Smith RM, 1974, CRITICAL STABILITY C, V1-6; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	34	196	197	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1441	1447		10.1016/0896-6273(95)90021-7	http://dx.doi.org/10.1016/0896-6273(95)90021-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845166	Bronze			2022-12-28	WOS:A1995TL67800021
J	PATTON, DE; WEST, JW; CATTERALL, WA; GOLDIN, AL				PATTON, DE; WEST, JW; CATTERALL, WA; GOLDIN, AL			A PEPTIDE SEGMENT CRITICAL FOR SODIUM-CHANNEL INACTIVATION FUNCTIONS AS AN INACTIVATION GATE IN A POTASSIUM CHANNEL	NEURON			English	Article							SHAKER K+ CHANNEL; GATING PROPERTIES; GENE; BRAIN; DROSOPHILA; CLONING	The short cytoplasmic peptide segment connecting domains III and IV of voltage-gated sodium channels (III-IV linker) is essential for fast inactivation. To test the functional similarity between the III-IV linker and the potassium channel inactivation particle, we attached the III-IV linker to the amino terminus of a noninactivating potassium channel. This chimeric channel inactivated rapidly and displayed biophysical properties similar to Shaker A-type potassium channels. Recovery f rom inactivation in the chimeric channels was accelerated by high external potassium, consistent with the idea that potassium ions passing through the channel displaced the III-IV linker inactivation particle. A mutation that completely abolishes fast inactivation in rat brain sodium channels also completely abolished inactivation in the chimera. These results demonstrate that the sodium channel III-IV linker can function as a fast inactivation gate and suggest a functional relationship between the fast inactivation processes of sodium and potassium channels.	UNIV CALIF IRVINE,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717; UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195	University of California System; University of California Irvine; University of Washington; University of Washington Seattle			Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026729, R01NS025704, R01NS015751] Funding Source: NIH RePORTER; NINDS NIH HHS [NS25704, NS15751, NS26729] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Barchi R L, 1992, Curr Opin Neurobiol, V2, P631, DOI 10.1016/0959-4388(92)90031-F; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CANNON SC, 1993, NEURON, V10, P3617; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; EATON DC, 1978, NATURE, V271, P473, DOI 10.1038/271473a0; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KIRSCH GE, 1980, J GEN PHYSIOL, V76, P315, DOI 10.1085/jgp.76.3.315; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEHMANNHORN F, 1991, PFLUG ARCH EUR J PHY, V418, P297, DOI 10.1007/BF00370530; MORELLO R, 1980, BIOPHYS J, V31, P435, DOI 10.1016/S0006-3495(80)85071-5; MURRELLLAGNADO RD, 1993, IN PRESS J GEN PHYSL; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PATTON DE, 1991, NEURON, V7, P637, DOI 10.1016/0896-6273(91)90376-B; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10910; PTACEK LJ, 1993, ANN NEUROL, V33, P300, DOI 10.1002/ana.410330312; ROJAS E, 1976, J PHYSIOL-LONDON, V262, P501, DOI 10.1113/jphysiol.1976.sp011608; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10905; YEH JZ, 1977, J GEN PHYSIOL, V69, P293, DOI 10.1085/jgp.69.3.293; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	40	45	45	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					967	974						8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240817				2022-12-28	WOS:A1993MJ04100017
J	BRITT, SG; FEILER, R; KIRSCHFELD, K; ZUKER, CS				BRITT, SG; FEILER, R; KIRSCHFELD, K; ZUKER, CS			SPECTRAL TUNING OF RHODOPSIN AND METARHODOPSIN IN-VIVO	NEURON			English	Article							SCHIFF-BASE COUNTERION; HUMAN COLOR-VISION; BOVINE RHODOPSIN; OPSIN GENE; PHOTORECEPTOR CELL; AMINO-ACIDS; DROSOPHILA-MELANOGASTER; ABSORPTION-SPECTRA; MOLECULAR-GENETICS; VISUAL PIGMENTS	Color vision is dependent upon the expression of spectrally distinct forms of rhodopsin in different photoreceptor cells. To identify the structural features of rhodopsin that regulate spectral sensitivity and absorption in vivo, we have constructed a series of chimeric Drosophila rhodopsin molecules, derived from a blue- and a violet-sensitive rhodopsin, and used P element-mediated germline transformation to generate transgenic flies that express the modified pigments in the R1-R6 photoreceptor cells of the compound eye. Our analysis of these animals indicates that multiple regions of the opsin protein are involved in regulating rhodopsin spectral sensitivity and that the native and photoactivated forms of rhodopsin can be tuned independently of each other. These results demonstrate the feasibility of designing receptor molecules with specifically modified activated states.	UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA; MAX PLANCK INST BIOL CYBERNET, D-72076 TUBINGEN, GERMANY; UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Max Planck Society; University of California System; University of California San Diego	BRITT, SG (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.		Britt, Steven/GVT-1340-2022	Britt, Steven/0000-0001-7656-7984				BIRGE RR, 1981, ANNU REV BIOPHYS BIO, V10, P315, DOI 10.1146/annurev.bb.10.060181.001531; CHAN T, 1992, J BIOL CHEM, V267, P9478; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COWMAN AF, 1986, CELL, V44, P705, DOI 10.1016/0092-8674(86)90836-6; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; FISCHER UC, 1981, PHOTOCHEM PHOTOBIOL, V33, P529, DOI 10.1111/j.1751-1097.1981.tb05456.x; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; HEISENBERG M, 1971, J EXP BIOL, V55, P85; HEISENBERG M, 1984, VISION DROSOPHILA; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; KIRSCHFELD K, 1986, VISION RES, V26, P1771, DOI 10.1016/0042-6989(86)90127-6; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V163, P421, DOI 10.1007/BF00604896; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LEWIS JW, 1992, J BIOENERG BIOMEMBR, V24, P201, DOI 10.1007/BF00762678; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; MINKE B, 1986, MOL MECHANISM PHOTOR, P241; MONTELL C, 1987, J NEUROSCI, V7, P1558; NAKAYAMA TA, 1990, J BIOL CHEM, V265, P15762; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; OPRIAN DD, 1992, J BIOENERG BIOMEMBR, V24, P211, DOI 10.1007/BF00762679; OSAWA S, 1990, CELL, V63, P697, DOI 10.1016/0092-8674(90)90136-3; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; OVCHINNIKOV YA, 1979, FEBS LETT, V100, P219, DOI 10.1016/0014-5793(79)80338-5; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKMAR TP, 1991, P NATL ACAD SCI USA, V88, P3079, DOI 10.1073/pnas.88.8.3079; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Schwemer J., 1989, P112; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; Stavenga DG, 1989, FACETS VISION, P152; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZUKER CS, 1987, J NEUROSCI, V7, P1550; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	54	40	42	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1993	11	1					29	39		10.1016/0896-6273(93)90268-V	http://dx.doi.org/10.1016/0896-6273(93)90268-V			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338666				2022-12-28	WOS:A1993LP43000003
J	YOSHIDA, K; KAWAMURA, K; IMAKI, J				YOSHIDA, K; KAWAMURA, K; IMAKI, J			DIFFERENTIAL EXPRESSION OF C-FOS MESSENGER-RNA IN RAT RETINAL CELLS - REGULATION BY LIGHT-DARK CYCLE	NEURON			English	Article							N-ACETYLTRANSFERASE ACTIVITY; PROTO-ONCOGENE; NERVOUS-SYSTEM; GENE; STIMULATION; NEURONS; IMMUNOREACTIVITY; TRANSCRIPTION; DEGRADATION; ACTIVATION	The distribution and levels of c-fos expression in response to changes in the light/dark cycle were examined in rat retina by in situ hybridization histochemistry. Under a 12 hr light:l 2 hr dark cycle (LD 12:12), c-fos mRNA levels in the inner nuclear layer and the ganglion cell layer increased transiently for 30 min immediately following the onset of the light period, whereas in the outer nuclear layer, c-fos mRNA expression was observed throughout the dark period. During a period of extended darkness following the dark period of LD 12:12, c-fos mRNA levels in the outer nuclear layer remained cyclic-low during the day and higher during the night-suggesting an endogenously generated rhythm. Furthermore, since a 30 min pulse of light during the dark period decreased c-fos expression in the outer nuclear layer, whereas a similar pulse of darkness during the light period resulted in an increase, environmental light/dark cues are also suggested to influence c-fos gene expression.	NIPPON MED COLL,DEPT ANAT,BUNKYO KU,TOKYO 113,JAPAN	Nippon Medical School	YOSHIDA, K (corresponding author), KEIO UNIV,SCH MED,DEPT ANAT,35 SHINANOMACHI,SHINJUKU KU,TOKYO 160,JAPAN.							BINKLEY S, 1979, NATURE, V281, P479, DOI 10.1038/281479a0; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; EHINGER B, 1987, HDB CHEM NEUROANATOM, V5, P389; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; GRIFERATH U, 1990, J COMP NEUROL, V301, P433; IUVONE PM, 1983, BRAIN RES, V273, P111, DOI 10.1016/0006-8993(83)91099-5; JACOBSON L, 1990, ENDOCRINOLOGY, V126, P1709, DOI 10.1210/endo-126-3-1709; KOIBUCHI N, 1991, ENDOCRINOLOGY, V129, P3208, DOI 10.1210/endo-129-6-3208; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; NOWAK JZ, 1990, ADV PINEAL, V4, P81; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; TOMITA T, 1967, VISION RES, V7, P519, DOI 10.1016/0042-6989(67)90061-2; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0	29	110	110	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1049	1054		10.1016/0896-6273(93)90053-T	http://dx.doi.org/10.1016/0896-6273(93)90053-T			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318229				2022-12-28	WOS:A1993LK37300005
J	FORTI, L; PIETROBON, D				FORTI, L; PIETROBON, D			FUNCTIONAL DIVERSITY OF L-TYPE CALCIUM CHANNELS IN RAT CEREBELLAR NEURONS	NEURON			English	Article							CA2+ CHANNELS; PERIPHERAL NEURONS; GATING BEHAVIOR; MULTIPLE TYPES; CARDIAC-CELLS; ACTIVATION; POTENTIATION; LOCALIZATION; FACILITATION; INACTIVATION	Single-channel recordings show that functionally different L-type Ca2+ channels coexist in rat cerebellar granules. Besides two different dihydropyridine (DHP)sensitive gating patterns with properties similar to those of cardiac L-type channels, cerebellar granules contain a third DHP-sensitive gating pattern with unusual voltage-dependent properties and slightly different conductance. This ''anomalous gating'' is characterized, on one hand, by rare, short openings with very low open probability even at high positive voltages and, on the other hand, by long openings with high open probability at negative voltages after a predepolarization. L-type channels with anomalous gating appear suited to generate a surge of Ca2+ influx following strong neuronal activity. The anomalous gating can be explained by a model in which voltage controls the equilibrium between two gating modes.			FORTI, L (corresponding author), UNIV PADUA,CNR,CTR PHYSIOL & MITOCHONDRIA,DEPT BIOMED SCI,I-35100 PADUA,ITALY.		Forti, Lia/AAU-8156-2020	Forti, Lia/0000-0003-3979-0284				AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; ARTALEJO CR, 1990, NATURE, V348, P239, DOI 10.1038/348239a0; ARTALEJO CR, 1991, J PHYSIOL-LONDON, V444, P213, DOI 10.1113/jphysiol.1991.sp018874; ARTALEJO CR, 1992, NATURE, V358, P63, DOI 10.1038/358063a0; BONEV A, 1992, PFLUG ARCH EUR J PHY, V420, P219, DOI 10.1007/BF00374994; CAVALIE A, 1986, PFLUG ARCH EUR J PHY, V406, P241, DOI 10.1007/BF00640910; CHIN H, 1992, FEBS LETT, V299, P69, DOI 10.1016/0014-5793(92)80103-N; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KOKUBUN S, 1984, P NATL ACAD SCI-BIOL, V81, P4824, DOI 10.1073/pnas.81.15.4824; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; PIETROBON D, 1990, NATURE, V346, P651, DOI 10.1038/346651a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RAO CR, 1973, LINEAR STATISTICAL I; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SLESINGER PA, 1991, NEURON, V7, P755, DOI 10.1016/0896-6273(91)90278-8; SLESINGER PA, 1991, J PHYSIOL-LONDON, V439, P301, DOI 10.1113/jphysiol.1991.sp018668; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WICKENS JR, 1991, NEUROSCI LETT, V130, P128, DOI 10.1016/0304-3940(91)90244-N; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753	36	93	93	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					437	450		10.1016/0896-6273(93)90332-L	http://dx.doi.org/10.1016/0896-6273(93)90332-L			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8384858				2022-12-28	WOS:A1993KU90100009
J	Mennerick, S; Matthews, G				Mennerick, S; Matthews, G			Ultrafast exocytosis elicited by calcium current in synaptic terminals of retinal bipolar neurons	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; SQUID GIANT SYNAPSE; RELEASE; KINETICS	Using high resolution capacitance measurements, we have characterized an ultrafast component of transmitter release in ribbon-type synaptic terminals of retinal bipolar neurons. During depolarization, capacitance increases to a plateau of similar to 30 fF with a time constant of similar to 1.5 ms. When not limited by activation kinetics of calcium current, the small pool is depleted even faster, with a time constant of 0.5 ms. After the ultrafast pool is depleted, capacitance rises with a slower time constant of similar to 300 ms. EGTA (5 mM) depresses the slower capacitance rise but leaves the ultrafast phase intact. BAPTA (5 mM) depresses both components of exocytosis. With paired-pulse stimulation, the ultrafast pool recovers from depletion with a time constant of similar to 4 s. The ultrafast component may represent fusion of docked vesicles at the base of the synaptic ribbon, while the slower component represents more distal vesicles on the ribbon.			Mennerick, S (corresponding author), SUNY STONY BROOK,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794, USA.		Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664	NATIONAL EYE INSTITUTE [R01EY003821] Funding Source: NIH RePORTER; NEI NIH HHS [EY03821] Funding Source: Medline; NINDS NIH HHS [NS07371] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HERRINGTON J, 1993, PULSE CONTROL V3 0 I; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; Neher E., 1986, CALCIUM ELECTROGENES, V14, P80; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; USUKURA J, 1987, CELL TISSUE RES, V247, P483, DOI 10.1007/BF00215740; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONGERSDORFF H, 1996, NEURON, V16, P1211; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626	20	210	211	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1241	1249		10.1016/S0896-6273(00)80254-8	http://dx.doi.org/10.1016/S0896-6273(00)80254-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982170	Bronze			2022-12-28	WOS:A1996WA24800020
J	Lebrand, C; Cases, O; Adelbrecht, C; Doye, A; Alvarez, C; ElMestikawy, S; Seif, I; Gaspar, P				Lebrand, C; Cases, O; Adelbrecht, C; Doye, A; Alvarez, C; ElMestikawy, S; Seif, I; Gaspar, P			Transient uptake and storage of serotonin in developing thalamic neurons	NEURON			English	Article							VESICULAR MONOAMINE TRANSPORTER; VISUAL CORTICAL PLASTICITY; SOMATOSENSORY CORTEX; MESSENGER-RNA; RAT-BRAIN; CEREBRAL-CORTEX; CRANIOFACIAL MORPHOGENESIS; ULTRASTRUCTURAL ANALYSIS; TRYPTOPHAN-HYDROXYLASE; POSTNATAL-DEVELOPMENT	Serotonin (5-HT) has been shown to affect the development and patterning of the mouse barrelfield. We show that the dense transient 5-HT innervation of the somatosensory, visual, and auditory cortices originates in the thalamus rather than in the raphe: 5-HT is detected in thalamocortical fibers and most 5-HT cortical labeling disappears after thalamic lesions. Thalamic neurons do not synthesize 5-HT but take up exogenous 5-HT through 5-HT high affinity uptake sites located on thalamocortical axons and terminals. H-3-5-HT injected into the cortex is retrogradely transported to thalamic neurons. In situ hybridization shows a transient expression of the genes encoding the serotonin transporter and the vesicular monoamine transporter in thalamic sensory neurons. In these glutamatergic neurons, internalized 5-HT might thus be stored and used as a ''borrowed transmitter'' for extraneuronal signaling or could exert an intraneuronal control on thalamic maturation.	HOP LA PITIE SALPETRIERE, IFR NEUROSCI, INSERM U288, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, IFR NEUROSCI, INSERM U289, F-75651 PARIS 13, FRANCE; INST CURIE, CNRS UMR 177, F-91405 ORSAY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Lebrand, C (corresponding author), HOP LA PITIE SALPETRIERE, IFR NEUROSCI, INSERM U106, F-75651 PARIS 13, FRANCE.		Lebrand, Cecile/G-1394-2015; cases, olivier/G-4882-2017; Gaspar, Patricia/G-8892-2011	Lebrand, Cecile/0000-0002-2750-3164; cases, olivier/0000-0002-5678-7362; Gaspar, Patricia/0000-0003-4217-5717				AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BENNETTCLARKE CA, 1995, BRAIN RES, V702, P255, DOI 10.1016/0006-8993(95)00867-5; BENNETTCLARKE CA, 1991, NEUROSCIENCE, V43, P163, DOI 10.1016/0306-4522(91)90425-N; BENNETTCLARKE CA, 1993, P NATL ACAD SCI USA, V90, P153, DOI 10.1073/pnas.90.1.153; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; BENNETTCLARKE CA, 1994, J COMP NEUROL, V348, P277, DOI 10.1002/cne.903480209; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; BINA KG, 1995, J COMP NEUROL, V363, P321, DOI 10.1002/cne.903630212; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Blue ME, 1991, CEREB CORTEX, V1, P380, DOI 10.1093/cercor/1.5.380; BLUE ME, 1995, DEV BRAIN RES, V84, P11, DOI 10.1016/0165-3806(94)00147-R; BUZNIKOV GA, 1981, NEUROCHEM RES, V6, P55, DOI 10.1007/BF00963906; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; COHEN Z, 1995, NEUROSCIENCE, V66, P555, DOI 10.1016/0306-4522(94)00625-F; CONSOLAZIONE A, 1981, J HISTOCHEM CYTOCHEM, V29, P1425, DOI 10.1177/29.12.7033368; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364; DAMATO RJ, 1987, P NATL ACAD SCI USA, V84, P4322, DOI 10.1073/pnas.84.12.4322; DARMON MC, 1988, J NEUROCHEM, V51, P312, DOI 10.1111/j.1471-4159.1988.tb04871.x; DECOURCELLES DD, 1990, DEV CARDIOVASC MED, V106, P445; Dori I, 1996, EXP NEUROL, V138, P1, DOI 10.1006/exnr.1996.0041; DOUCET G, 1988, BRAIN RES, V441, P233, DOI 10.1016/0006-8993(88)91403-5; DYCK RH, 1993, J NEUROSCI, V13, P4316; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; FAURE MP, 1995, NEUROSCIENCE, V68, P519, DOI 10.1016/0306-4522(95)00145-9; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; FUJITA M, 1993, NEUROSCI LETT, V162, P59, DOI 10.1016/0304-3940(93)90559-4; FULLER RW, 1988, PHARMACOL BIOCHEM BE, V30, P715, DOI 10.1016/0091-3057(88)90089-5; GERARD A, 1978, CR ACAD SCI D NAT, V286, P891; Gerard C, 1996, SYNAPSE, V23, P164, DOI 10.1002/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2-6; GONZALEZ AM, 1994, MOL BRAIN RES, V22, P219, DOI 10.1016/0169-328X(94)90050-7; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; JENSEN KF, 1987, J NEUROSCI, V7, P3544; JOHNSON RR, 1992, EXP BRAIN RES, V89, P20; KASAMATSU T, 1979, J COMP NEUROL, V185, P163, DOI 10.1002/cne.901850110; KIMELBERG HK, 1985, SCIENCE, V228, P889, DOI 10.1126/science.3890180; KOJIMA T, 1988, J COMP NEUROL, V267, P580, DOI 10.1002/cne.902670410; KREJCI E, 1993, FEBS LETT, V335, P27, DOI 10.1016/0014-5793(93)80432-T; KRISTT DA, 1979, BRAIN RES, V178, P69, DOI 10.1016/0006-8993(79)90088-X; KRISTT DA, 1989, NEUROSCIENCE, V29, P27, DOI 10.1016/0306-4522(89)90330-8; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LESCH KP, 1993, MOL BRAIN RES, V17, P31, DOI 10.1016/0169-328X(93)90069-2; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LOMBARDO A, 1995, NEUROSCIENCE, V65, P997, DOI 10.1016/0306-4522(94)00538-G; MASANA Y, 1993, J NEUROSCI RES, V35, P468, DOI 10.1002/jnr.490350503; MOISEIWITSCH JRD, 1995, P NATL ACAD SCI USA, V92, P7182, DOI 10.1073/pnas.92.16.7182; OSTERHELDHAAS MC, 1994, DEV BRAIN RES, V77, P189, DOI 10.1016/0165-3806(94)90196-1; OsterheldHaas MC, 1996, EXP BRAIN RES, V110, P183; Ottersen OP, 1984, HDB CHEM NEUROANATOM, V3, P141; Ovalle S, 1995, NEUROREPORT, V6, P2353, DOI 10.1097/00001756-199511270-00019; PETER D, 1995, J NEUROSCI, V15, P6179; QIAN Y, 1995, J NEUROSCI, V15, P1261; RHOADES RW, 1994, J NEUROPHYSIOL, V72, P2438, DOI 10.1152/jn.1994.72.5.2438; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHROETER S, 1995, SOC NEUROSCI, P886; SHUEY DL, 1993, ANAT EMBRYOL, V187, P75; SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407; Steinbusch HWM, 1984, HDB CHEM NEUROANATOM, V3, P68; TRAMU G, 1983, CELL TISSUE RES, V228, P297; VANDERLOOS H, 1991, NATO ADV SCI I A-LIF, V200, P229; WALLACE JA, 1982, AM J ANAT, V165, P261, DOI 10.1002/aja.1001650304; WALLACE JA, 1992, HDB CHEM NEUROANATOM, V10, P619	71	271	272	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV	1996	17	5					823	835		10.1016/S0896-6273(00)80215-9	http://dx.doi.org/10.1016/S0896-6273(00)80215-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938116	Bronze			2022-12-28	WOS:A1996VV15100006
J	Rutila, JE; Zeng, HK; Le, M; Curtin, KD; Hall, JC; Rosbash, M				Rutila, JE; Zeng, HK; Le, M; Curtin, KD; Hall, JC; Rosbash, M			The tim(SL) mutant of the Drosophila rhythm gene timeless manifests allele-specific interactions with period gene mutants	NEURON			English	Article							CIRCADIAN BEHAVIORAL RHYTHMS; MESSENGER-RNA LEVELS; CLOCK MUTATION; VISUAL-SYSTEM; PROTEIN; MELANOGASTER; EXPRESSION; PRODUCT; AUTOREGULATION; OSCILLATIONS	To identify new components of the Drosophila circadian clock, we screened chemically mutagenized flies for suppressors or enhancers of the long periods characteristic of the period Goer) mutant allele per(L). We isolated a novel mutant that maps to the rhythm gene timeless (fim). This novel allele, tim(SL), alters the temporal pattern of per(L) protein nuclear localization and restores temperature compensation to per(L) flies. tim(SL) more generally manifests specific interactions with different per alleles. The identification of this first period-altering tim allele provides further evidence that TIM is a major component of the clock, and the allele-specific interactions with PER provide evidence that the PER/TIM heterodimer is a unit of circadian function. Although tim(SL) fails to restore PER-L/TIM temperature insensitivity in yeast, it alters the TIM phosphorylation pattern during the late night The effects on phosphorylation suggest that tim(SL) functions as a partial bypass suppressor of per(L) and provide evidence that the TIM phosphorylation program contributes to the circadian timekeeping mechanism.	BRANDEIS UNIV,NATL SCI FDN,SCI & TECHNOL CTR BIOL TIMING,WALTHAM,MA 02254; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254	Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; Brandeis University	Rutila, JE (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,WALTHAM,MA 02254, USA.				NIGMS NIH HHS [GM-33205] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; EWER J, 1992, J NEUROSCI, V12, P3321; EWER J, 1988, NATURE, V333, P82, DOI 10.1038/333082a0; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1994, J BIOL RHYTHM, V9, P189, DOI 10.1177/074873049400900303; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; LEE C, 1996, SCIENCE, V271, P4740; LIU X, 1992, J NEUROSCI, V12, P2735; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; ZATZ M, 1992, DISCUSS NEUROSCI, V8, P67; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; ZERR DM, 1990, J NEUROSCI, V10, P2749	31	79	80	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					921	929		10.1016/S0896-6273(00)80223-8	http://dx.doi.org/10.1016/S0896-6273(00)80223-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938124	hybrid			2022-12-28	WOS:A1996VV15100014
J	Daston, MM; Koester, SE				Daston, MM; Koester, SE			Transcriptional regulation of axon pathfinding	NEURON			English	Review							DROSOPHILA; EXPRESSION; PATHWAYS; PROSPERO; SUBSETS; NEURONS		NEURON CELL PRESS,CAMBRIDGE,MA 02138		Daston, MM (corresponding author), SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037, USA.							Appel B, 1995, DEVELOPMENT, V121, P4117; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; CHULAGRAFF Q, 1995, NEURON, V15, P1041, DOI 10.1016/0896-6273(95)90093-4; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOE CQ, 1995, NEURON, V15, P991, DOI 10.1016/0896-6273(95)90088-8; HARRIS WA, 1987, DEVELOPMENT, V101, P123; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; TOKUMOTO M, 1995, DEV BIOL, V171, P578, DOI 10.1006/dbio.1995.1306; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8	14	14	14	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					5	8		10.1016/S0896-6273(00)80275-5	http://dx.doi.org/10.1016/S0896-6273(00)80275-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755473	Bronze			2022-12-28	WOS:A1996UY98100002
J	Moratalla, R; Elibol, B; Vallejo, M; Graybiel, AM				Moratalla, R; Elibol, B; Vallejo, M; Graybiel, AM			Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal	NEURON			English	Article							C-FOS; DOPAMINE-RECEPTORS; RAT STRIATUM; INDUCTION; DYNORPHIN; IMMUNOREACTIVITY; SENSITIZATION; AMPHETAMINE; ACTIVATION; SYSTEMS	Repeated exposures to psychomotor stimulants produce long-term changes in behavior ranging from addiction to behavioral sensitization. Many of these behaviors depend on the nigrostriatal system of the basal ganglia. We show here that chronic cocaine exposure not only leads to time-varying alterations in the inducibility of bZIP transcription factors in individual striatal neurons, but also to long-lasting network changes in which ensembles of striatal neurons express these proteins. These network-level adaptations suggest that the behavioral sensitization induced by repeated psychomotor stimulant exposure may reflect an enduring functional reorganization of basal ganglia circuits.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,REPROD ENDOCRINE UNIT,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital	Moratalla, R (corresponding author), MIT,DEPT BRAIN & COGNIT SCI,E25-618,CAMBRIDGE,MA 02139, USA.		Moratalla, Rosario V/H-9280-2015	Moratalla, Rosario V/0000-0002-7623-8010; Graybiel, Ann/0000-0002-4326-7720; Vallejo, Mario/0000-0002-6422-0323	NIDA NIH HHS [DA08037] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008037] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BERRETTA S, 1992, J NEUROPHYSIOL, V68, P767, DOI 10.1152/jn.1992.68.3.767; BHAT RV, 1993, J PHARMACOL EXP THER, V267, P496; CADOR M, 1995, NEUROSCIENCE, V65, P385, DOI 10.1016/0306-4522(94)00524-9; CENCI MA, 1992, EUR J NEUROSCI, V4, P376, DOI 10.1111/j.1460-9568.1992.tb00885.x; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; DAUNAIS JB, 1995, MOL BRAIN RES, V29, P201, DOI 10.1016/0169-328X(94)00246-B; DILTS RP, 1993, SYNAPSE, V13, P251, DOI 10.1002/syn.890130308; EBLEN F, 1995, J NEUROSCI, V15, P5999; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; JOHANSSON B, 1994, NEUROSCIENCE, V59, P837, DOI 10.1016/0306-4522(94)90288-7; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; LAHOSTE GJ, 1993, P NATL ACAD SCI USA, V90, P7451, DOI 10.1073/pnas.90.16.7451; MORATALLA R, 1993, J NEUROSCI, V13, P423; MORATALLA R, 1992, J NEUROSCI, V12, P2609; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; PAUL ML, 1992, J NEUROSCI, V12, P3729, DOI 10.1523/jneurosci.12-10-03729.1992; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; ROSEN JB, 1994, MOL BRAIN RES, V25, P168, DOI 10.1016/0169-328X(94)90295-X; RUSKIN DN, 1994, SYNAPSE, V18, P233, DOI 10.1002/syn.890180309; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; SIVAM SP, 1989, J PHARMACOL EXP THER, V250, P818; SMILEY PL, 1990, J PHARMACOL EXP THER, V253, P938; STEINER H, 1995, J COMP NEUROL, V353, P200, DOI 10.1002/cne.903530204; TORRES G, 1993, BRAIN RES BULL, V30, P173, DOI 10.1016/0361-9230(93)90055-G; WANG JQ, 1994, SYNAPSE, V18, P343, DOI 10.1002/syn.890180410; WIRTSHAFTER D, 1994, BRAIN RES BULL, V35, P85, DOI 10.1016/0361-9230(94)90220-8; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; ZHANG WQ, 1992, BRAIN RES, V577, P312, DOI 10.1016/0006-8993(92)90289-L	41	232	235	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					147	156		10.1016/S0896-6273(00)80288-3	http://dx.doi.org/10.1016/S0896-6273(00)80288-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755486	Bronze			2022-12-28	WOS:A1996UY98100015
J	Subramony, P; Raucher, S; Dryer, L; Dryer, SE				Subramony, P; Raucher, S; Dryer, L; Dryer, SE			Posttranslational regulation of Ca2+-activated K+ currents by a target-derived factor in developing parasympathetic neurons	NEURON			English	Article							CILIARY-GANGLION NEURONS; ACTIVATED POTASSIUM CHANNELS; ACETYLCHOLINE-RECEPTOR; NEUROTROPHIC FACTORS; SYMPATHETIC NEURONS; CELL-SURVIVAL; A-CURRENTS; IN-SITU; DIFFERENTIATION; TRANSMISSION	Macroscopic /(K[Ca) is not expressed at normal levels in chick ciliary ganglion (CG) neurons prior to synapse formation with target tissues, or in neurons developing in vitro or in situ in the absence of target tissues. Here, two chick CG s/o partial cDNAs encoding /(K[Ca) channels were isolated, cloned, and sequenced. Both s/o transcripts were readily detected in developing Co neurons prior to or in the absence of target tissue interactions. When Co neurons developed in vitro in the presence of target tissue (iris) extracts, a normal whole-cell /(K[Ca) was expressed. These effects did not require protein synthesis, and the activity was detectable throughout the stages of synapse formation in the iris. The active component has an apparent molecular weight of 40-60 kDa.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	Subramony, P (corresponding author), FLORIDA STATE UNIV,PROGRAM NEUROSCI & MOL BIOPHYS,TALLAHASSEE,FL 32306, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037348] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37348] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ARENELLA L, 1993, J NEUROSCI, V13, P4625; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHIAPPINELLI VA, 1978, DEV NEUROSCI-BASEL, V1, P191, DOI 10.1159/000112574; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COLLINS F, 1991, J NEUROSCI, V11, P2582; COULOMBE JN, 1991, J NEUROSCI, V11, P553; COULOMBE JN, 1993, NEURON, V10, P899, DOI 10.1016/0896-6273(93)90205-6; DOURADO MM, 1992, J PHYSIOL-LONDON, V449, P411, DOI 10.1113/jphysiol.1992.sp019093; DOURADO MM, 1994, J NEUROSCI, V14, P3156; DOURADO MM, 1994, J PHYSIOL-LONDON, V474, P367, DOI 10.1113/jphysiol.1994.sp020029; DRYER SE, 1991, J PHYSIOL-LONDON, V443, P601, DOI 10.1113/jphysiol.1991.sp018854; DRYER SE, 1994, PROG NEUROBIOL, V43, P281, DOI 10.1016/0301-0082(94)90003-5; ENGISCH KL, 1992, J NEUROSCI, V12, P1115; FURBER S, 1987, J NEUROSCI, V7, P1816; HABECKER BA, 1995, DEV BIOL, V167, P307, DOI 10.1006/dbio.1995.1025; HALVORSEN SW, 1991, J NEUROSCI, V11, P2177; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; JACOB MH, 1991, J NEUROSCI, V11, P1701; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; JONES SM, 1994, J NEUROSCI, V14, P2789; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; LANDIS SC, 1994, PROG BRAIN RES, V100, P19; LANDMESSER L, 1972, J PHYSIOL-LONDON, V222, P691, DOI 10.1113/jphysiol.1972.sp009822; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P737, DOI 10.1113/jphysiol.1974.sp010681; LANDMESSER L, 1978, FED PROC, V37, P2016; LARMET Y, 1992, NEURON, V9, P563, DOI 10.1016/0896-6273(92)90193-H; LEUNG DW, 1992, NEURON, V8, P1045, DOI 10.1016/0896-6273(92)90126-X; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MADERDRUT JL, 1988, BRAIN RES, V444, P189, DOI 10.1016/0006-8993(88)90928-6; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MERINEY SD, 1987, J NEUROSCI, V7, P3827; MERINEY SD, 1987, J NEUROSCI, V7, P3840; NARAYANAN CH, 1978, J EMBRYOL EXP MORPH, V44, P53; NARAYANAN CH, 1981, J EMBRYOL EXP MORPH, V62, P117; NISHI R, 1981, J NEUROSCI, V1, P505; NISHI R, 1981, DEV BIOL, V87, P301, DOI 10.1016/0012-1606(81)90153-6; NISHI R, 1994, J NEUROBIOL, V25, P612, DOI 10.1002/neu.480250604; PILAR G, 1980, J NEUROPHYSIOL, V43, P233, DOI 10.1152/jn.1980.43.1.233; Pilar G, 1982, PROGR CHOLINERGIC BI, P213; RAUCHER S, 1995, J PHYSIOL-LONDON, V486, P605, DOI 10.1113/jphysiol.1995.sp020838; RAUCHER S, 1994, J PHYSIOL-LONDON, V479, P77, DOI 10.1113/jphysiol.1994.sp020279; REINHART PH, 1991, J NEUROSCI, V11, P1627; Sambrook J., 2002, MOL CLONING LAB MANU; SPITZER NC, 1991, J NEUROBIOL, V22, P659, DOI 10.1002/neu.480220702; Spitzer Nicholas C., 1994, Current Opinion in Neurobiology, V4, P70, DOI 10.1016/0959-4388(94)90034-5; Subramony P, 1996, DEV BRAIN RES, V91, P149, DOI 10.1016/0165-3806(95)00174-3; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; WISGIRDA ME, 1994, P NATL ACAD SCI USA, V91, P2858, DOI 10.1073/pnas.91.7.2858; WRIGHT L, 1981, DEV BRAIN RES, V1, P283, DOI 10.1016/0165-3806(81)90114-0	52	36	37	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					115	124		10.1016/S0896-6273(00)80285-8	http://dx.doi.org/10.1016/S0896-6273(00)80285-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755483	Bronze			2022-12-28	WOS:A1996UY98100012
J	Koob, GF				Koob, GF			Drug addiction: The Yin and Yang of hedonic homeostasis	NEURON			English	Review							MOLECULAR MECHANISMS; DEPENDENCE				Koob, GF (corresponding author), SCRIPPS RES INST, DEPT NEUROPHARMACOL, LA JOLLA, CA 92037 USA.							CAINE SB, 1995, BRAIN RES, V692, P47; DANI JA, 1996, NEURON, V16; HEIMER L, 1991, ADV EXP MED BIOL, V295, P1; HEINRICHS SC, 1995, BEHAV PHARMACOL, V6, P74; HYMAN SE, 1996, NEURON, V16; HYTTIA P, 1995, EUR J PHARMACOL, V283, P151; Koob CF, 1996, PHARM TOXIC, P1; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; KOOB GF, 1993, SEMIN NEUROSCI, V5, P351; KOOB GF, 1994, MOL BASIS ALCOHOL US, V7, P221; LITTLETON JM, 1989, PSYCHOACTIVE DRUGS T, P461; MALIN DH, 1990, PEPTIDES, V11, P969, DOI 10.1016/0196-9781(90)90018-Z; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1996, NEURON, V16; OBRIEN CP, 1975, PHARMACOL REV, V27, P533; PICH EM, 1995, J NEUROSCI, V15, P5439; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Russell M. A. H., 1976, DRUGS DRUG DEPENDENC, P182; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Solomon R.L, 1977, PSYCHOPATHOLOGY EXPT, P124; TABAKOFF B, 1996, NEURON, V16; WIKLER A, 1973, ARCH GEN PSYCHIAT, V28, P611; WISE RA, 1988, J ABNORM PSYCHOL, V97, P118, DOI 10.1037/0021-843X.97.2.118	23	279	281	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	1996	16	5					893	896		10.1016/S0896-6273(00)80109-9	http://dx.doi.org/10.1016/S0896-6273(00)80109-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630244	Bronze			2022-12-28	WOS:A1996UN48000001
J	Salin, PA; Malenka, RC; Nicoll, RA				Salin, PA; Malenka, RC; Nicoll, RA			Cyclic AMP mediates a presynaptic form of LTP at cerebellar parallel fiber synapses	NEURON			English	Article							LONG-TERM POTENTIATION; PURKINJE-CELL TRANSMISSION; ADENYLATE-CYCLASE; SYNAPTIC TRANSMISSION; DEPRESSION; SLICES; FACILITATION; EXPRESSION; NEURONS; HIPPOCAMPUS	The N-methyl-D-aspartate receptor-independent form of long-term potentiation (LTP) at hippocampal messy fiber synapses requires presynaptic Ca2+-dependent activation of adenylyl cyclase. To determine whether this form of LTP might occur at other synapses, we examined cerebellar parallel fibers that, like hippocampal messy fiber synapses, express high levels of the Ca2+/calmodulin-sensitive adenylyl cyclase I. Repetitive stimulation of parallel fibers caused a longlasting increase in synaptic strength that was associated with a decrease in paired-pulse facilitation. Blockade of glutamate receptors did not prevent LTP induction, nor did loading of Purkinje cells with a Ca2+ chelator. LTP was occluded by forskolin-induced potentiation and blocked by the protein kinase A inhibitor Rp-8-CPT-cAMPS. These findings suggest that parallel fiber synapses express a form of LTP that is dependent on the activation of a presynaptic adenylyl cyclase and is indistinguishable from LTP at hippocampal messy fiber synapses.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Salin, PA (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT CELLULAR & MOLEC PHARMACOL,SAN FRANCISCO,CA 94143, USA.			Salin, Paul/0000-0001-5221-9109				BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRIGGS CA, 1988, J PHYSIOL-LONDON, V404, P129, DOI 10.1113/jphysiol.1988.sp017282; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; DIXON D, 1989, J NEUROSCI, V9, P4246; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; ECCLES JC, 1966, EXP BRAIN RES, V1, P17; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KUBA K, 1986, J PHYSIOL-LONDON, V374, P515, DOI 10.1113/jphysiol.1986.sp016095; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Llinas R, 1993, Curr Opin Neurobiol, V3, P958, DOI 10.1016/0959-4388(93)90168-X; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; PERRETT SP, 1995, J NEUROSCI, V15, P2074, DOI 10.1523/JNEUROSCI.15-03-02074.1995; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCOTT TRD, 1993, BRIT J PHARMACOL, V110, P461, DOI 10.1111/j.1476-5381.1993.tb13833.x; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4053, DOI 10.1073/pnas.83.11.4053; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	40	325	329	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					797	803		10.1016/S0896-6273(00)80099-9	http://dx.doi.org/10.1016/S0896-6273(00)80099-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607997	Bronze			2022-12-28	WOS:A1996UG61100012
J	Kutsuwada, T; Sakimura, K; Manabe, T; Takayama, C; Katakura, N; Kushiya, E; Natsume, R; Watanabe, M; Inoue, Y; Yagi, T; Aizawa, S; Arakawa, M; Takahashi, T; Nakamura, Y; Mori, H; Mishina, M				Kutsuwada, T; Sakimura, K; Manabe, T; Takayama, C; Katakura, N; Kushiya, E; Natsume, R; Watanabe, M; Inoue, Y; Yagi, T; Aizawa, S; Arakawa, M; Takahashi, T; Nakamura, Y; Mori, H; Mishina, M			Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice	NEURON			English	Article							LONG-TERM POTENTIATION; SPINAL-CORD NEURONS; CYTOCHROME-OXIDASE; AREA CA1; DEVELOPMENTAL-CHANGES; PURKINJE-CELLS; NEONATAL RATS; CHANNEL; ADULT; MOUSE	Multiple epsilon subunits are major determinants of the NMDA receptor channel diversity. Based on their functional properties in vitro and distributions, we have proposed that the epsilon 1 and epsilon 2 subunits play a role in synaptic plasticity. To investigate the physiological significance of the NMDA receptor channel diversity, we generated mutant mice defective in the epsilon 2 subunit. These mice showed no suckling response and died shortly after birth but could survive by hand feeding. The mutation hindered the formation of the whisker-related neuronal barrelette structure and the clustering of primary sensory afferent terminals in the brain-stem trigeminal nucleus. In the hippocampus of the mutant mice, synaptic NMDA responses and long-term depression were abolished. These results suggest that the epsilon 2 subunit plays an essential role in both neuronal pattern formation and synaptic plasticity.	UNIV TOKYO, FAC MED, INST BRAIN RES, DEPT NEUROPHYSIOL, TOKYO 113, JAPAN; HOKKAIDO UNIV, SCH MED, DEPT ANAT, SAPPORO, HOKKAIDO 060, JAPAN; TOKYO MED & DENT UNIV, FAC DENT, DEPT PHYSIOL, TOKYO 113, JAPAN; TSUKUBA LIFE SCI CTR, INST PHYS & CHEM RES, MOLEC ONCOL LAB, IBARAKI, OSAKA 305, JAPAN; UNIV TOKYO, FAC MED, DEPT PHARMACOL, TOKYO 113, JAPAN; NIIGATA UNIV, FAC MED, DEPT INTERNAL MED 2, NIIGATA 951, JAPAN	University of Tokyo; Hokkaido University; Tokyo Medical & Dental University (TMDU); RIKEN; University of Tokyo; Niigata University	Kutsuwada, T (corresponding author), NIIGATA UNIV, BRAIN RES INST, DEPT NEUROPHARMACOL, NIIGATA 951, JAPAN.		Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Arakawa, Masao/0000-0002-2729-8666; Katakura, Nobuo/0000-0002-3495-0886				ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; ASCHER P, 1986, J PHYSIOL-LONDON, V377, pP35; ASHWELL KW, 1982, J ANAT, V135, P531; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BELFORD GR, 1979, J COMP NEUROL, V183, P305, DOI 10.1002/cne.901830207; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BROSE N, 1993, J BIOL CHEM, V268, P22663; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHIAIA NL, 1992, NEUROSCIENCE, V49, P141, DOI 10.1016/0306-4522(92)90082-D; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; ERZURUMLU RS, 1992, J NEUROSCI, V12, P3946; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; IZUMI Y, 1995, SYNAPSE, V20, P19, DOI 10.1002/syn.890200104; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MA PM, 1991, J COMP NEUROL, V309, P161, DOI 10.1002/cne.903090202; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; MISHINA M, 1993, ANN NY ACAD SCI, V707, P136, DOI 10.1111/j.1749-6632.1993.tb38049.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1989, DEV BRAIN RES, V49, P105, DOI 10.1016/0165-3806(89)90063-1; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; QUINLAN JE, 1985, NEUROSCI LETT, V60, P39, DOI 10.1016/0304-3940(85)90378-7; SAKIMURA K, 1980, J NEUROCHEM, V34, P687, DOI 10.1111/j.1471-4159.1980.tb11198.x; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SCHMECHEL D, 1978, SCIENCE, V199, P313, DOI 10.1126/science.339349; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHEN H, 1994, BRAIN RES, V635, P159, DOI 10.1016/0006-8993(94)91435-4; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; WATANABE M, 1994, NEUROSCI LETT, V165, P183, DOI 10.1016/0304-3940(94)90740-4; WESTNEAT MW, 1992, BEHAV NEUROSCI, V106, P539, DOI 10.1037/0735-7044.106.3.539; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I	59	403	408	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					333	344		10.1016/S0896-6273(00)80051-3	http://dx.doi.org/10.1016/S0896-6273(00)80051-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789948	Bronze			2022-12-28	WOS:A1996TW95700013
J	Karlin, A; Akabas, MH				Karlin, A; Akabas, MH			Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins	NEURON			English	Review							SITE-DIRECTED MUTAGENESIS; GAMMA-AMINOBUTYRIC-ACID; AFFINITY BINDING-SITE; GATED ION CHANNELS; ALPHA-SUBUNIT; DELTA-SUBUNIT; AMINO-ACIDS; TORPEDO-CALIFORNICA; H-3 CHLORPROMAZINE; GLYCINE RECEPTOR				Karlin, A (corresponding author), COLUMBIA UNIV, CTR MOLEC RECOGNIT, NEW YORK, NY 10032 USA.			KARLIN, ARTHUR/0000-0002-4813-752X; Akabas, Myles/0000-0001-8781-7846				ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1995, BIOCHEMISTRY-US, V34, P12496, DOI 10.1021/bi00039a002; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; ANAND R, 1991, J BIOL CHEM, V266, P11192; ANAND R, 1993, BIOCHEMISTRY-US, V32, P9975, DOI 10.1021/bi00089a013; ANDERSON DJ, 1981, P NATL ACAD SCI-BIOL, V78, P5598, DOI 10.1073/pnas.78.9.5598; AUERBACH A, 1993, J PHYSIOL-LONDON, V461, P339, DOI 10.1113/jphysiol.1993.sp019517; AYLWIN ML, 1994, MOL PHARMACOL, V46, P1149; BACKUS KH, 1993, NEUROREPORT, V5, P285, DOI 10.1097/00001756-199312000-00026; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; CHATURVEDI V, 1992, BIOCHEMISTRY-US, V31, P1370, DOI 10.1021/bi00120a012; CHAVEZ RA, 1992, J CELL BIOL, V116, P385, DOI 10.1083/jcb.116.2.385; CHAVEZ RA, 1991, J BIOL CHEM, V266, P15532; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; COHEN JB, 1991, J BIOL CHEM, V266, P23354; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; CZAJKOWSKI C, 1995, J BIOL CHEM, V270, P3160, DOI 10.1074/jbc.270.7.3160; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; DAMLE VN, 1978, BIOCHEMISTRY-US, V17, P2039, DOI 10.1021/bi00604a002; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; DANI JA, 1989, J NEUROSCI, V9, P884; DENG L, 1986, BIOCHEM BIOPH RES CO, V138, P1308, DOI 10.1016/S0006-291X(86)80425-9; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; DEVILLERSTHIERY A, 1983, P NATL ACAD SCI-BIOL, V80, P2067, DOI 10.1073/pnas.80.7.2067; DIPAOLA M, 1989, J BIOL CHEM, V264, P15457; DIPAOLA M, 1990, J BIOL CHEM, V265, P11017; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; DOWDING AJ, 1987, BIOCHEMISTRY-US, V26, P6372, DOI 10.1021/bi00394a010; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; FILATOV GN, 1995, IN PRESS MOL PHARM; GALZI JL, 1991, P NATL ACAD SCI USA, V88, P5051, DOI 10.1073/pnas.88.11.5051; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; GIRAUDAT J, 1989, FEBS LETT, V253, P190, DOI 10.1016/0014-5793(89)80957-3; GLOCKSHUBER R, 1991, BIOCHEMISTRY-US, V30, P3049, DOI 10.1021/bi00226a010; GORNETSCHELNOKOW U, 1994, EMBO J, V13, P338, DOI 10.1002/j.1460-2075.1994.tb06266.x; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HANN RM, 1994, BIOCHEMISTRY-US, V33, P14058, DOI 10.1021/bi00251a014; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P5452, DOI 10.1021/bi00292a029; HESS GP, 1993, BIOCHEMISTRY-US, V32, P989, DOI 10.1021/bi00055a001; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUANG LYM, 1978, J GEN PHYSIOL, V71, P397, DOI 10.1085/jgp.71.4.397; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JACKSON MB, 1984, P NATL ACAD SCI-BIOL, V81, P3901, DOI 10.1073/pnas.81.12.3901; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; KAO PN, 1984, J BIOL CHEM, V259, P1662; KAO PN, 1986, J BIOL CHEM, V261, P8085; KARLIN A, 1991, HARVEY LECT, V85, P71; KARLIN A, 1983, J BIOL CHEM, V258, P6678; KARLIN A, 1969, J GEN PHYSIOL, V54, pS245; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; KUROSAKI T, 1987, FEBS LETT, V214, P253, DOI 10.1016/0014-5793(87)80065-0; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LO DC, 1991, NEURON, V6, P31, DOI 10.1016/0896-6273(91)90119-K; LUDDENS H, 1991, J RECEPTOR RES, V11, P535, DOI 10.3109/10799899109066426; MACHOID J, 1995, IN PRESS EUR J BIOCH; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MCCREA PD, 1987, EMBO J, V6, P3619, DOI 10.1002/j.1460-2075.1987.tb02693.x; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NAYEEM N, 1994, J NEUROCHEM, V62, P815; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; NEUBIG RR, 1979, BIOCHEMISTRY-US, V18, P5464, DOI 10.1021/bi00591a032; NEUBIG RR, 1982, BIOCHEMISTRY-US, V21, P3460, DOI 10.1021/bi00257a032; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; PEDERSEN SE, 1992, J BIOL CHEM, V267, P10489; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; POLLARD S, 1995, J BIOL CHEM, V270, P21285, DOI 10.1074/jbc.270.36.21285; REVAH F, 1990, P NATL ACAD SCI USA, V87, P4675, DOI 10.1073/pnas.87.12.4675; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1994, J BIOL CHEM, V269, P8808; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SMITH GB, 1994, J BIOL CHEM, V269, P20380; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; STROUD RM, 1990, BIOCHEMISTRY-US, V29, P11009, DOI 10.1021/bi00502a001; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; TOBIMATSU T, 1987, FEBS LETT, V222, P56, DOI 10.1016/0014-5793(87)80191-6; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VILLARROEL A, 1992, P ROY SOC B-BIOL SCI, V249, P317, DOI 10.1098/rspb.1992.0121; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; WHITE BH, 1992, J BIOL CHEM, V267, P15770; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; XU M, 1993, J BIOL CHEM, V268, P21505; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; YEE GH, 1987, J BIOL CHEM, V262, P16748	134	559	569	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1995	15	6					1231	1244		10.1016/0896-6273(95)90004-7	http://dx.doi.org/10.1016/0896-6273(95)90004-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845149	hybrid			2022-12-28	WOS:A1995TL67800004
J	HUDSPETH, AJ; GILLESPIE, PG				HUDSPETH, AJ; GILLESPIE, PG			PULLING SPRINGS TO TUNE TRANSDUCTION - ADAPTATION BY HAIR-CELLS	NEURON			English	Review							MAMMALIAN MYOSIN-I; GUINEA-PIG COCHLEA; MECHANOELECTRICAL TRANSDUCTION; ACTIN-FILAMENTS; OTOACOUSTIC EMISSIONS; FORCE GENERATION; CROSS-LINKS; MUSCLE; STEREOCILIA; DEPENDENCE		UNIV TEXAS,SW MED CTR,CTR BASIC NEUROSCI RES,DALLAS,TX 75235; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	HUDSPETH, AJ (corresponding author), UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235, USA.			Barr-Gillespie, Peter/0000-0002-9787-5860	NIDCD NIH HHS [DC00317, DC00241] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BARYLKO B, 1992, P NATL ACAD SCI USA, V89, P490, DOI 10.1073/pnas.89.2.490; BENSER ME, 1993, HEARING RES, V68, P243, DOI 10.1016/0378-5955(93)90128-N; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; COLLINS K, 1990, J CELL BIOL, V110, P1137, DOI 10.1083/jcb.110.4.1137; CONZELMAN KA, 1987, J CELL BIOL, V105, P313, DOI 10.1083/jcb.105.1.313; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DALLOS P, 1992, J NEUROSCI, V12, P4575; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FLITNEY FW, 1978, J PHYSIOL-LONDON, V276, P449, DOI 10.1113/jphysiol.1978.sp012246; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P629; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; GOODSON HV, 1993, P NATL ACAD SCI USA, V90, P659, DOI 10.1073/pnas.90.2.659; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HOWARD J, 1987, SENSORY TRANSDUCTION, P138; HOWE CL, 1983, J CELL BIOL, V97, P974, DOI 10.1083/jcb.97.4.974; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; HUDSPETH AJ, 1992, SENSORY TRANSDUCTION, P357; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1990, J BIOL CHEM, V265, P8347; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; KLINKE R, 1977, PSYCHOPHYSICS PHYSL, P101; KUHN HJ, 1981, J MUSCLE RES CELL M, V2, P7, DOI 10.1007/BF00712060; MACARTNEY JC, 1980, NATURE, V288, P491, DOI 10.1038/288491a0; MANLEY GA, 1987, HEARING RES, V26, P257, DOI 10.1016/0378-5955(87)90062-1; MARUTA H, 1981, J BIOL CHEM, V256, P499; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; NARINS PM, 1984, J ACOUST SOC AM, V76, P1384, DOI 10.1121/1.391455; OSBORNE MP, 1988, HEARING RES, V35, P99, DOI 10.1016/0378-5955(88)90044-5; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; PRINGLE J. W. S., 1967, PROGR BIOPHYS MOL BIOL, V17, P1, DOI 10.1016/0079-6107(67)90003-X; REIZES O, 1994, IN PRESS P NATL ACAD; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; SWANLJUNGCOLLINS H, 1991, J BIOL CHEM, V266, P1312; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; VANDIJK P, 1987, J ACOUST SOC AM, V82, P2147, DOI 10.1121/1.395660; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; YAU KW, 1977, NATURE, V269, P78, DOI 10.1038/269078a0	65	212	219	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					1	9		10.1016/0896-6273(94)90147-3	http://dx.doi.org/10.1016/0896-6273(94)90147-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292354	hybrid			2022-12-28	WOS:A1994MU49300001
J	STANLEY, EF				STANLEY, EF			SINGLE CALCIUM CHANNELS AND ACETYLCHOLINE-RELEASE AT A PRESYNAPTIC NERVE-TERMINAL	NEURON			English	Article							SQUID GIANT SYNAPSE; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; ACTIVE ZONES; TIME COURSE; VESICLE; FACILITATION; EXOCYTOSIS; DIFFUSION; CURRENTS	The relationship between calcium influx and the gating of transmitter release was examined at the release face of a cholinergic presynaptic nerve terminal using a technique that allows the simultaneous recording of both calcium channels at the single-channel level and quantal acetylcholine secretion. Acetylcholine release occurred during large inward calcium currents through many simultaneously open channels but was also gated by very small calcium transients, admitting less than 200 ions, when only one channel was open at a time. These findings provide functional support for a highly structured model of the transmitter release face in which the synaptic vesicle release mechanism is closely tethered to one or more presynaptic calcium channels and the opening of only one of these may be sufficient to trigger quantal secretion.			STANLEY, EF (corresponding author), NINCDS, SYNAPT MECH SECT, BETHESDA, MD 20892 USA.							ADLER EM, 1991, J NEUROSCI, V11, P1496; AKIMOTO K, 1990, ANAL BIOCHEM, V189, P182, DOI 10.1016/0003-2697(90)90104-H; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DRYER SE, 1987, NEUROSCIENCE, V20, P905, DOI 10.1016/0306-4522(87)90251-X; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; HORIKAWA HPM, 1993, FEBS LETT, V330, P236, DOI 10.1016/0014-5793(93)80281-X; ISRAEL M, 1981, Neurochemistry International, V3, P81, DOI 10.1016/0197-0186(81)90052-8; KATZ B, 1969, J PHYSIOL-LONDON, V203, P459, DOI 10.1113/jphysiol.1969.sp008875; KOSTYUK PG, 1989, J PHYSIOL-LONDON, V409, P343, DOI 10.1113/jphysiol.1989.sp017501; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MARTIN AR, 1963, J PHYSIOL-LONDON, V168, P443, DOI 10.1113/jphysiol.1963.sp007202; MARTIN AR, 1964, J PHYSIOL-LONDON, V175, P1; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; PARNAS H, 1986, PFLUG ARCH EUR J PHY, V406, P121, DOI 10.1007/BF00586672; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; SILINSKY EM, 1978, J PHYSIOL-LONDON, V274, P157, DOI 10.1113/jphysiol.1978.sp012141; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STANLEY EF, 1992, CAN J PHYSIOL PHARM, V70, pS73, DOI 10.1139/y92-246; STANLEY EF, 1991, J NEUROSCI, V11, P985; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; YAWO H, 1993, J PHYSIOL-LONDON, V460, P153, DOI 10.1113/jphysiol.1993.sp019464; YOSHIKAMI D, 1989, ANN NY ACAD SCI, V560, P230, DOI 10.1111/j.1749-6632.1989.tb24100.x; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032; ZUCKER RS, 1989, PRESYNAPTIC REGULATI, P153	36	217	222	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1007	1011		10.1016/0896-6273(93)90214-C	http://dx.doi.org/10.1016/0896-6273(93)90214-C			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274272				2022-12-28	WOS:A1993MP54800002
J	VOROBJEV, VS; SHARONOVA, IN; WALSH, IB; HAAS, HL				VOROBJEV, VS; SHARONOVA, IN; WALSH, IB; HAAS, HL			HISTAMINE POTENTIATES N-METHYL-D-ASPARTATE RESPONSES IN ACUTELY ISOLATED HIPPOCAMPAL-NEURONS	NEURON			English	Article							RECEPTOR DESENSITIZATION; NMDA RECEPTOR; POTASSIUM CONDUCTANCE; DIVALENT-CATIONS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; XENOPUS-OOCYTES; POLYAMINES; BRAIN; GLYCINE	N-methyl-D-aspartate (NMDA-evoked currents were recorded from acutely isolated rat hippocampal neurons, using the whole-cell patch-clamp technique and a rapid perfusion system. Histamine, at concentrations from 0.5 to 100 muM, reversibly enhanced NMDA currents by up to 50%. The effect cannot be ascribed to activation of the known histamine receptors (H-1, H-2, H-3) but is occluded by spermine. These results suggest an interaction of histamine with the polyamine-binding site on the NMDA receptor complex. This modulatory action could allow the histaminergic system to determine time and loci of NMDA receptor-mediated events, such as memory formation according to behavioral state.			VOROBJEV, VS (corresponding author), HEINRICH HEINE UNIV, INST PHYSIOL 2, D-40001 DUSSELDORF, GERMANY.		Sharonova, Irina/B-5288-2012	Sharonova, Irina/0000-0001-9955-1870				ASCHER P, 1990, PROG CELL R, V1, P149; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BEKKERS JM, 1993, SCIENCE, V261, P104, DOI 10.1126/science.8391168; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BENVENISTE M, 1993, J PHYSIOL-LONDON, V464, P131, DOI 10.1113/jphysiol.1993.sp019627; BERRIDGE MJ, 1987, ANN NY ACAD SCI, V494, P39, DOI 10.1111/j.1749-6632.1987.tb29479.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CLARK GD, 1990, NEUROSCIENCE, V39, P787, DOI 10.1016/0306-4522(90)90261-2; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; FAGE D, 1992, J NEUROCHEM, V58, P2170, DOI 10.1111/j.1471-4159.1992.tb10960.x; GREENE RW, 1990, NEUROSCIENCE, V34, P299, DOI 10.1016/0306-4522(90)90140-Y; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HAAS HL, 1984, AGENTS ACTIONS, V14, P534, DOI 10.1007/BF01973865; HAAS HL, 1992, HISTAMINE RECEPTOR, P161; HAAS HL, 1991, HISTAMINERGIC NEURON, P196; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; INAGAKI N, 1988, J COMP NEUROL, V273, P283, DOI 10.1002/cne.902730302; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KOSTOPOULOS G, 1988, EXP BRAIN RES, V72, P45, DOI 10.1007/BF00248499; KREMZNER LT, 1965, BIOCHEM PHARMACOL, V14, P1189; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; LERMA J, 1990, P NATL ACAD SCI USA, V87, P2354, DOI 10.1073/pnas.87.6.2354; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MARKRAM H, 1992, J PHYSIOL-LONDON, V447, P513, DOI 10.1113/jphysiol.1992.sp019015; MARKRAM H, 1990, J PHYSIOL-LONDON, V427, P381, DOI 10.1113/jphysiol.1990.sp018177; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MCGURK JF, 1990, P NATL ACAD SCI USA, V87, P9971, DOI 10.1073/pnas.87.24.9971; Monnier M, 1970, Int Rev Neurobiol, V12, P265; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; PASCHEN W, 1988, NEUROCHEM PATHOL, V9, P1; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PRELL GD, 1986, ANNU REV NEUROSCI, V9, P209; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; ROCK DM, 1992, MOL PHARMACOL, V42, P157; ROCK DM, 1992, MOL PHARMACOL, V41, P83; SCHWARTZ JC, 1986, TRENDS PHARMACOL SCI, V7, P24, DOI 10.1016/0165-6147(86)90236-1; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SPECIALE C, 1992, MOL NEUROPHARMACOL, V2, P121; VOROBJEV VS, 1991, J NEUROSCI METH, V38, P145, DOI 10.1016/0165-0270(91)90164-U; WADA H, 1991, TRENDS NEUROSCI, V14, P415, DOI 10.1016/0166-2236(91)90034-R; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; WILLIAMS K, 1991, LIFE SCI, V48, P469, DOI 10.1016/0024-3205(91)90463-L; 1992, CHEN L, V356, P521	46	146	153	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					837	844		10.1016/0896-6273(93)90113-6	http://dx.doi.org/10.1016/0896-6273(93)90113-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240807				2022-12-28	WOS:A1993MJ04100005
J	KIRSCH, GE; SHIEH, CC; DREWE, JA; VENER, DF; BROWN, AM				KIRSCH, GE; SHIEH, CC; DREWE, JA; VENER, DF; BROWN, AM			SEGMENTAL EXCHANGES DEFINE 4-AMINOPYRIDINE BINDING AND THE INNER MOUTH OF K+ PORES	NEURON			English	Article							DELAYED-RECTIFIER PROPERTIES; POTASSIUM CHANNEL; SQUID AXON; GATING CURRENTS; BLOCK; AMINOPYRIDINES; CONDUCTANCE; EXPRESSION; DROSOPHILA; REGION	4-Aminopyridine (4AP) blocks the intracellular mouth of voltage-gated K+ channels. We identified critical regions for 4AP binding with chimeric channels in which segments of a low affinity clone (Kv2.1, IC50 = 18 mM) were replaced with those of a high affinity clone (Kv3.1, IC50 = 0.1 mM). 4AP sensitivity was not tranferred with the S5-S6 linker (pore or P region). Instead, a chimera of the cytoplasmic half of S6 increased block 20-fold, without affecting gating. A double chimera of the cytoplasmic halves of S5 and S6 fully transferred 4AP sensitivity. Because 4AP block was inhibited by tetrapentylammonium, we conclude that determinants of 4AP binding lie in the S6 segment that forms the cytoplasmic vestibule of the pore and that this site may overlap a quaternary ammonium site.	BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030	Baylor College of Medicine	KIRSCH, GE (corresponding author), BAYLOR COLL MED,DEPT ANESTHESIOL,HOUSTON,TX 77030, USA.		Vener, David F/AAI-8975-2020		NHLBI NIH HHS [HL37044] Funding Source: Medline; NINDS NIH HHS [NS29473, NS23877] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023877, R01NS029473] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P859; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; DEBIASI M, 1993, PFLUG ARCH EUR J PHY, V422, P354, DOI 10.1007/BF00374291; DREWE JA, IN PRESS METH NEUROS; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; KIRSCH GE, 1991, AM J PHYSIOL, V261, pC583, DOI 10.1152/ajpcell.1991.261.4.C583; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KIRSCH GE, 1992, BIOPHYS J, V62, P136, DOI 10.1016/S0006-3495(92)81800-3; KIRSCH GE, 1986, BIOPHYS J, V50, P637, DOI 10.1016/S0006-3495(86)83503-2; KIRSCH GE, 1983, J PHARMACOL EXP THER, V226, P174; KIRSCH GE, 1978, BIOPHYS J, V22, P507, DOI 10.1016/S0006-3495(78)85503-9; KIRSCH GE, 1993, IN PRESS J GEN PHYSL; KUBO Y, 1993, NATURE, V362, P137; MILLER C, 1982, J GEN PHYSIOL, V79, P869, DOI 10.1085/jgp.79.5.869; PAK MD, 1991, J NEUROSCI, V11, P869; PELHATE M, 1989, Pfluegers Archiv European Journal of Physiology, V414, pS140, DOI 10.1007/BF00582271; Sambrook J, 1989, MOL CLONING LABORATO; SPIRES S, 1989, J GEN PHYSIOL, V93, P263, DOI 10.1085/jgp.93.2.263; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; TAGLIALATELA M, 1992, BIOPHYS J, V62, P34, DOI 10.1016/S0006-3495(92)81770-8; TAGLIALATELA M, 1993, PFLUG ARCH EUR J PHY, V423, P104, DOI 10.1007/BF00374967; TAGLIALATELA M, 1991, MOL PHARMACOL, V40, P299; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; THOMPSON S, 1982, J GEN PHYSIOL, V80, P1, DOI 10.1085/jgp.80.1.1; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; WAGONER PK, 1990, BIOPHYS J, V58, P1481, DOI 10.1016/S0006-3495(90)82493-0; YEH JZ, 1976, J GEN PHYSIOL, V68, P519, DOI 10.1085/jgp.68.5.519; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	35	104	105	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					503	512		10.1016/0896-6273(93)90154-J	http://dx.doi.org/10.1016/0896-6273(93)90154-J			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398143				2022-12-28	WOS:A1993LY49800010
J	KAPLAN, DR; MATSUMOTO, K; LUCARELLI, E; THIELE, CJ				KAPLAN, DR; MATSUMOTO, K; LUCARELLI, E; THIELE, CJ			INDUCTION OF TRKB BY RETINOIC ACID MEDIATES BIOLOGIC RESPONSIVENESS TO BDNF AND DIFFERENTIATION OF HUMAN NEUROBLASTOMA-CELLS	NEURON			English	Article							HUMAN NEURO-BLASTOMA; NERVE GROWTH-FACTOR; ACUTE PROMYELOCYTIC LEUKEMIA; TYROSINE PROTEIN-KINASE; NEUROTROPHIC FACTOR; BINDING PROTEIN; SPINAL-CORD; PROTOONCOGENE PRODUCT; NGF RESPONSIVENESS; MYC GENE	Retinoic acid (RA) induces the neuronal differentiation of many human neuroblastoma cell lines. In this study, we show that RA treatment of neuroblastoma cells induces the expression of TrkB, the receptor for the neurotrophins BDNF, NT-3, and NT-415. BDNF addition to RA-treated SH-SY5Y neuroblastoma cells stimulated the tyrosine phosphorylation of TrkB and neuronal differentiation. RA treatment of KCNR neuroblastoma cells, which constitutively express BDNF mRNA, resulted in the expression of TrkB and differentiation in the absence of added BDNF. Finally, in 15N neuroblastoma cells, which express BDNF mRNA but do not differentiate in response to RA, RA induced only a truncated form of TrkB. 15N cells transfected with full-length TrkB differentiated in the absence of RA. These results indicate that RA induces the neuronal differentiation of neuroblastoma cells by modulating the expression of neurotrophin receptors.	NCI, PEDIAT BRANCH, CELLULAR & MOLEC BIOL SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KAPLAN, DR (corresponding author), NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MMCL, EUKARYOT SIGNAL TRANSDUCT GRP, FREDERICK, MD 21702 USA.		Enrico, Lucarelli/G-3588-2015; Lucarelli, Enrico/AAF-1612-2021	Enrico, Lucarelli/0000-0002-6681-6374; Lucarelli, Enrico/0000-0002-6681-6374	NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABEMAYOR E, 1989, ENVIRON HEALTH PERSP, V80, P3, DOI 10.2307/3430727; AZAR C, 1991, PROG CLIN BIOL RES, V366, P219; BAKER DL, 1989, CANCER RES, V49, P4142; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BIEDLER JL, 1973, CANCER RES, V33, P2643; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; CASTAIGNE S, 1990, BLOOD, V76, P1704; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CICCARONE V, 1989, CANCER RES, V49, P219; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; FELTNER DE, 1989, J IMMUNOL, V143, P4292; FISCHER I, 1986, DEV BRAIN RES, V25, P99, DOI 10.1016/0165-3806(86)90156-2; FOX F, 1959, CANCER, V12, P108, DOI 10.1002/1097-0142(195901/02)12:1<108::AID-CNCR2820120116>3.0.CO;2-H; GAETANO C, 1992, CANCER RES, V52, P4402; GAETANO C, 1991, CELL GROWTH DIFFER, V2, P487; GAETANO C, 1991, ADV NEUROBLASTOMA RE, V3, P165; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HASKELL BE, 1987, CELL TISSUE RES, V247, P67, DOI 10.1007/BF00216548; HEFTI F, 1992, LOCALIZATION FUNCTIO, P25; HELSON L, 1984, CANC DRUG DEL, V1, P303, DOI 10.1089/cdd.1984.1.303; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; HUNTER K, 1991, P NATL ACAD SCI USA, V88, P3666, DOI 10.1073/pnas.88.9.3666; HYATT GA, 1992, P NATL ACAD SCI USA, V89, P8293, DOI 10.1073/pnas.89.17.8293; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MADEN M, 1990, DEVELOPMENT, V109, P75; MADEN M, 1989, DEV BIOL, V135, P124, DOI 10.1016/0012-1606(89)90163-2; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MATSUMOTO K, 1992, ENDOCRINOLOGY, V130, P3669, DOI 10.1210/en.130.6.3669; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MITRA G, 1991, ONCOGENE, V6, P2237; NAKAGAWARA A, 1992, CANCER RES, V52, P1364; ONG DE, 1982, J BIOL CHEM, V257, P13385; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; REYNOLDS CP, 1986, J NATL CANCER I, V76, P375; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; SCHEIBE RJ, 1992, J BIOL CHEM, V267, P17611; SCHWAB M, 1985, NATURE, V316, P160, DOI 10.1038/316160a0; SIDELL N, 1982, J NATL CANCER I, V68, P589; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; THIELE CJ, 1988, ONCOGENE, V3, P281; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; WEST GJ, 1977, CANCER RES, V37, P1372; WUARIN L, 1991, DEV BIOL, V144, P429, DOI 10.1016/0012-1606(91)90435-6; WUARIN L, 1990, INT J DEV NEUROSCI, V8, P317, DOI 10.1016/0736-5748(90)90038-4	72	318	328	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					321	331		10.1016/0896-6273(93)90187-V	http://dx.doi.org/10.1016/0896-6273(93)90187-V			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394722				2022-12-28	WOS:A1993LU06500011
J	SKOULAKIS, EMC; KALDERON, D; DAVIS, RL				SKOULAKIS, EMC; KALDERON, D; DAVIS, RL			PREFERENTIAL EXPRESSION IN MUSHROOM BODIES OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE-A AND ITS ROLE IN LEARNING AND MEMORY	NEURON			English	Article							CYCLIC-AMP PHOSPHODIESTERASE; MEDIATED ENHANCER DETECTION; APLYSIA SENSORY NEURONS; LONG-TERM FACILITATION; DROSOPHILA-MELANOGASTER; GENE; DUNCE; PHOSPHORYLATION; TRANSCRIPTION; SENSITIZATION	Involvement of the cAMP cascade in Drosophila learning and memory is suggested by the aberrant behavioral phenotypes of the mutants dunce (cAMP phosphodiesterase) and rutabaga (adenylyl cyclase). Line DCO581, isolated via an enhancer detector screen for genes preferentially expressed in the mushroom bodies, contains a transposon in the first exon of the catalytic subunit gene (DCO) of protein kinase A (PKA). RNA in situ hybridization and immunohistochemistry show that DCO is preferentially expressed in the mushroom bodies. The DCO581 insertion and an independently isolated hypomorphic allele (DCO(B10)) each produce homozygous lethality and a 40% decrease in PKA activity in heterozygotes. This decrease has mild effects on learning but no effect on memory. However, the 80% reduction in activity obtained by constructing heteroallelic yet viable DCO581/DCO(B10) animals results in a dramatic learning and memory deficit. These results suggest that PKA plays a crucial role in the cAMP cascade in mushroom bodies to mediate learning and memory processes.	COLUMBIA UNIV,FAIRCHILD CTR,DEPT BIOL SCI,NEW YORK,NY 10027	Columbia University	SKOULAKIS, EMC (corresponding author), COLD SPRING HARBOR LAB,CTR LEARNING & MEMORY,COLD SPRING HARBOR,NY 11724, USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIGMS NIH HHS [GM15406, GM 41815] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041815, F32GM015406] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DAVIS RL, 1991, TRENDS GENET, V7, P224, DOI 10.1016/0168-9525(91)90369-2; DELGADO R, 1991, P NATL ACAD SCI USA, V88, P557, DOI 10.1073/pnas.88.2.557; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; FOSTER JL, 1988, J BIOL CHEM, V263, P1676; FOSTER JL, 1988, METHOD ENZYMOL, V159, P215; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HAN PL, 1992, THESIS BAYLOR COLLEG; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEISENBERG M, 1989, FUNDAMENTALS MEMORY, P3; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KANDEL ER, 1983, COLD SPRING HARB SYM, V48, P821, DOI 10.1101/SQB.1983.048.01.085; KOBIERSKI LA, 1991, P NATL ACAD SCI USA, V88, P10222, DOI 10.1073/pnas.88.22.10222; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P67; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MENZEL R, 1991, BEHAVIOR PHYSL BEES; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; QIU YH, 1991, J MOL BIOL, V222, P553, DOI 10.1016/0022-2836(91)90496-S; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHOLZ KP, 1988, SCIENCE, V240, P1664, DOI 10.1126/science.2837826; SCHWARTZ JH, 1983, COLD SPRING HARB SYM, V48, P811, DOI 10.1101/SQB.1983.048.01.084; Sokal R. R., 1981, BIOMETRY; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; TULLY T, 1987, TRENDS NEUROSCI, V10, P330, DOI 10.1016/0166-2236(87)90090-7; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301	44	242	248	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					197	208		10.1016/0896-6273(93)90178-T	http://dx.doi.org/10.1016/0896-6273(93)90178-T			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352940				2022-12-28	WOS:A1993LU06500002
J	SHEN, NV; CHEN, XH; BOYER, MM; PFAFFINGER, PJ				SHEN, NV; CHEN, XH; BOYER, MM; PFAFFINGER, PJ			DELETION ANALYSIS OF K+ CHANNEL ASSEMBLY	NEURON			English	Article							POTASSIUM CHANNEL; XENOPUS-OOCYTES; EXPRESSION; SUBUNITS; SEQUENCE; RECEPTOR	An understanding of K+ channel structure is a critical step in developing an appreciation of the function and regulation of these proteins. We have begun a biochemical analysis of the early steps in K+ channel formation following translation into endoplasmic reticulum membranes. In our experiments, a series of K+ channel subunit protein deletions were constructed and then tested for posttranslational processing and assembly. We find that all deletions containing the S1 domain are inserted into the membrane. The loop between S1 and S2 is glycosylated; thus, this segment is topologically extracellular. Translated subunit proteins mix in the membrane, then assemble into tetramers. This subunit assembly is critically driven by a conserved, self-tetramerizing sequence in the N-terminal cytoplasmic region, which we have named the tetramerization 1 domain.			SHEN, NV (corresponding author), BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030, USA.				NICHD NIH HHS [P30-HD24064] Funding Source: Medline; NINDS NIH HHS [NINDS T32-NS07352] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007352] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; GUY HR, 1990, MONOVALENT CATIONS B, P31; HARLOW E, 1988, ANTIBODIES LABORATOR, P635; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KRIEGLER M, 1990, GENE TANSFER EXPRESS, P213; LAUE TM, 1990, GUIDE PROTEIN PURIFI, P566; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; STRONG M, 1993, IN PRESS MOL BIOL EV; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TITUS DE, 1991, PROMEGA PROTOCOL APP, P155; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; WESSELS HP, 1989, LABORATORY METHODS V, P3	21	220	221	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					67	76						10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338669				2022-12-28	WOS:A1993LP43000006
J	BRAMBLETT, GT; GOEDERT, M; JAKES, R; MERRICK, SE; TROJANOWSKI, JQ; LEE, VMY				BRAMBLETT, GT; GOEDERT, M; JAKES, R; MERRICK, SE; TROJANOWSKI, JQ; LEE, VMY			ABNORMAL TAU-PHOSPHORYLATION AT SER(396) IN ALZHEIMERS-DISEASE RECAPITULATES DEVELOPMENT AND CONTRIBUTES TO REDUCED MICROTUBULE-BINDING	NEURON			English	Article							PAIRED HELICAL FILAMENTS; NERVOUS-SYSTEM; PROTEIN-KINASE; LIVING CELLS; EXPRESSION; ANTIBODIES; TUBULIN; BRAIN; CDNA; CORE	Abnormally phosphorylated tau proteins (A68) are the building blocks of Alzheimer's disease (AD) paired helical filaments. The biological consequences of the conversion of normal adult tau to A68 remain unknown. Here we demonstrate that native A68 does not bind to microtubules (MTs), yet dephosphorylated A68 regains the ability to bind to MTs. Ser396 is phosphorylated in A68, but not in normal adult tau, whereas fetal tau is phosphorylated transiently at this site. Phosphorylation of tau at Ser396 by protein kinases in CHO cells and rat brain produces an electrophoretic mobility similar to that of A68. Using CHO cells transfected with an Ala396 mutant, we show that the phosphorylation of tau at Ser396 reduces its affinity for MTs and its ability to stabilize MTs against nocodazole-induced depolymerization. Our results demonstrate that the abnormal phosphorylation of tau in AD involves Ser396, and we suggest that this may be mediated by the inappropriate activation of fetal kinases or the reduced activity of tau protein phosphatases. Thus, phosphorylation of Ser396 may destabilize MTs in AD, resulting in the degeneration of affected cells.	MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology	BRAMBLETT, GT (corresponding author), UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104, USA.							BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLOSE SH, 1984, J CELL BIOL, V98, P847, DOI 10.1083/jcb.98.3.847; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CROWTHER RA, 1992, FEBS LETT, V309, P199, DOI 10.1016/0014-5793(92)81094-3; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Goedert M, 1991, BRAIN PATHOL, V1, P279, DOI 10.1111/j.1750-3639.1991.tb00671.x; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GOEDERT M, 1993, IN PRESS P NATL ACAD; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEE VMY, 1987, J NEUROSCI, V7, P3474; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; LIU WK, 1991, J BIOL CHEM, V266, P21723; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WILLIAMS RC, 1979, BIOCHEMISTRY-US, V18, P2499, DOI 10.1021/bi00579a010; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; YANG SD, 1991, J PROTEIN CHEM, V10, P171, DOI 10.1007/BF01024781	51	761	788	0	46	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1089	1099		10.1016/0896-6273(93)90057-X	http://dx.doi.org/10.1016/0896-6273(93)90057-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318230				2022-12-28	WOS:A1993LK37300009
J	OTMAKHOV, N; SHIRKE, AM; MALINOW, R				OTMAKHOV, N; SHIRKE, AM; MALINOW, R			MEASURING THE IMPACT OF PROBABILISTIC TRANSMISSION ON NEURONAL OUTPUT	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; GUINEA-PIG HIPPOCAMPUS; PYRAMIDAL CELLS; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; NEURAL NETWORK; INVITRO; SLICES; CONDUCTANCE	We have investigated the impact of stochastic transmission on the input-output relations of neurons in hippocampal slices. A synaptic input that fires a cell has a significant trial-to-trial variability in amplitude, reflecting the probabilistic release of transmitter. By measuring miniature excitatory postsynaptic currents, we estimate that synchronous release of a few vesicles can fire a CA1 cell. The firing threshold and variability can be physiologically modulated. Different cell types have distinct firing thresholds and variabilities. Long-term potentiation (LTP) decreases trial-to-trial variability. If after LTP, the stimulus is reduced to produce a threshold response, the variability returns to that observed before LTP. Thus, for a threshold input, the trial-to-trial variability is maintained with LTP. This may be important for the proper functioning of a plastic nervous system.			OTMAKHOV, N (corresponding author), UNIV IOWA,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242, USA.							AMIT DJ, 1989, P NATL ACAD SCI USA, V86, P7871, DOI 10.1073/pnas.86.20.7871; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; ANDERSEN PO, 1987, SYNAPTIC FUNCTION, P403; BARRIONUEVO G, 1986, J NEUROPHYSIOL, V55, P540, DOI 10.1152/jn.1986.55.3.540; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BRESSLOFF PC, 1990, PHYS REV A, V41, P1126, DOI 10.1103/PhysRevA.41.1126; BUHMANN J, 1987, BIOL CYBERN, V56, P313, DOI 10.1007/BF00319512; BURNOD Y, 1989, P NATL ACAD SCI USA, V86, P352, DOI 10.1073/pnas.86.1.352; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; FERSTER D, 1992, J NEUROSCI, V12, P1262; GIBSON WG, 1991, PHILOS T ROY SOC B, V332, P199, DOI 10.1098/rstb.1991.0050; GUSTAFSSON B, 1988, NEUROSCI LETT, V85, P77, DOI 10.1016/0304-3940(88)90432-6; Hinton GE., 1984, BOLTZMANN MACHINES C; HU GY, 1992, J PHYSIOL-LONDON, V453, P663, DOI 10.1113/jphysiol.1992.sp019250; Katz B., 1969, RELEASE NEURAL TRANS; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Korn H., 1987, SYNAPTIC FUNCTION, P57; KRNJEVIC K, 1982, NEUROSCIENCE, V7, P2165, DOI 10.1016/0306-4522(82)90128-2; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LANGMOEN IA, 1983, J NEUROPHYSIOL, V50, P1320, DOI 10.1152/jn.1983.50.6.1320; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LITTLE WA, 1975, BEHAV BIOL, V14, P115, DOI 10.1016/S0091-6773(75)90122-4; LYNCH JW, 1989, BIOPHYS J, V55, P755, DOI 10.1016/S0006-3495(89)82874-7; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MCBAIN C, 1992, J NEUROPHYSIOL, V68, P16, DOI 10.1152/jn.1992.68.1.16; MCNAUGHTON BL, 1981, J NEUROPHYSIOL, V46, P952, DOI 10.1152/jn.1981.46.5.952; MECKLINGER A, 1992, PSYCHOPHYSIOLOGY, V29, P104, DOI 10.1111/j.1469-8986.1992.tb02021.x; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RICE JA, 1988, MATH STATISTICS DATA; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; ROVIRA C, 1983, EXP BRAIN RES, V49, P151; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SHAW G L, 1974, Mathematical Biosciences, V21, P207, DOI 10.1016/0025-5564(74)90015-7; SIGGINS GR, 1981, NEUROSCI LETT, V23, P55, DOI 10.1016/0304-3940(81)90186-5; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; TAYLOR JG, 1972, J THEOR BIOL, V36, P513, DOI 10.1016/0022-5193(72)90006-9; TRUSSELL LO, 1985, P NATL ACAD SCI USA, V82, P4857, DOI 10.1073/pnas.82.14.4857; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	54	85	86	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1101	1111		10.1016/0896-6273(93)90058-Y	http://dx.doi.org/10.1016/0896-6273(93)90058-Y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318231				2022-12-28	WOS:A1993LK37300010
J	FAHLKE, C; ZACHAR, E; RUDEL, R				FAHLKE, C; ZACHAR, E; RUDEL, R			CHLORIDE CHANNELS WITH REDUCED SINGLE-CHANNEL CONDUCTANCE IN RECESSIVE MYOTONIA-CONGENITA	NEURON			English	Article							MUSCLE-FIBERS; SKELETAL-MUSCLE; MEMBRANE; CURRENTS; BECKER	Myoballs were cultured from muscle biopsies of patients having Becker-type recessive generalized myotonia (RGM). Single-channel recordings showed that the conductance of the ''intermediate'' Cl- channel, the Cl- channel having the highest membrane density and accounting for most of the Cl- conductance in myoballs, was reduced to about 50%. All other channel parameters tested, such as gating properties, ion selectivity, and regulatory pathways, were not different from controls. Two other Cl- channel types were only rarely observed and did not seem different from controls. Also, the macroscopic Cl- conductance measured with tight-seal whole-cell recording was smaller than controls, particularly in the positive membrane potential domain. These results might explain myotonia in RGM on the single-channel level.			FAHLKE, C (corresponding author), UNIV ULM,DEPT GEN PHYSIOL,W-7900 ULM,GERMANY.		Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952				ADRIAN RH, 1976, J PHYSIOL-LONDON, V258, P125, DOI 10.1113/jphysiol.1976.sp011410; Becker PE, 1973, NEW DEV ELECTROMYOGR, P407; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; BRYANT SH, 1980, J PHYSIOL-LONDON, V307, pP31; BURTON F, 1988, MUSCLE NERVE, V11, P1029, DOI 10.1002/mus.880111004; CHUA M, 1991, BIOPHYS J, V59, P1251, DOI 10.1016/S0006-3495(91)82340-2; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; FAHLKE C, 1992, PFLUG ARCH EUR J PHY, V421, P566, DOI 10.1007/BF00375052; FAHLKE C, 1992, PFLUG ARCH EUR J PHY, V421, P108, DOI 10.1007/BF00374816; FAHLKE C, 1992, PFLUG ARCH EUR J PHY, V420, P248, DOI 10.1007/BF00374454; FRANKE C, 1991, MUSCLE NERVE, V14, P762, DOI 10.1002/mus.880140811; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Iaizzo P A, 1991, Neuromuscul Disord, V1, P47, DOI 10.1016/0960-8966(91)90042-Q; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KUNZE DL, 1985, J GEN PHYSIOL, V86, P691, DOI 10.1085/jgp.86.5.691; KUNZELMANN K, 1991, PFLUG ARCH EUR J PHY, V418, P479, DOI 10.1007/BF00497776; Lipicky RJ, 1979, HDB CLIN NEUROLOGY 1, V40, P533; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; PALADE PT, 1977, J GEN PHYSIOL, V69, P325, DOI 10.1085/jgp.69.3.325; PROBSTLE T, 1988, PFLUG ARCH EUR J PHY, V412, P264, DOI 10.1007/BF00582507; RUDEL R, 1988, MUSCLE NERVE, V11, P202, DOI 10.1002/mus.880110303; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Trautmann A, 1983, SINGLE CHANNEL RECOR, P473; ZACHAR E, 1992, PFLUG ARCH EUR J PHY, V421, P101, DOI 10.1007/BF00374815	26	19	19	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					225	232		10.1016/0896-6273(93)90313-G	http://dx.doi.org/10.1016/0896-6273(93)90313-G			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382498				2022-12-28	WOS:A1993KP68500010
J	Liedtke, W; Edelmann, W; Bieri, PL; Chiu, FC; Cowan, NJ; Kucherlapati, R; Raine, CS				Liedtke, W; Edelmann, W; Bieri, PL; Chiu, FC; Cowan, NJ; Kucherlapati, R; Raine, CS			GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; MESSENGER-RNA; OLIGODENDROCYTE DEVELOPMENT; INTERMEDIATE FILAMENTS; ASTROCYTIC PROCESSES; CONDITIONED MEDIUM; CELLS; BRAIN	To investigate the structural role of glial fibrillary acidic protein (GFAP) in vivo, mice carrying a null mutation in GFAP were generated. In 7/14 mutant animals older than 18 months of age, hydrocephalus associated with white matter loss was detected. Mutant mice displayed abnormal myelination including the presence of actively myelinating oligodendrocytes in adults, nonmyelinated axons in optic nerve, and reduced myelin thickness in spinal cord. White matter was poorly vascularized and the blood-brain barrier was structurally and functionally impaired. Astrocytic structure and function were abnormal, consisting of shortened astrocytic cell processes, decreased septation of white matter, and increased CNS extracellular space. Thus, GFAP expression is essential for normal white matter architecture and blood-brain barrier integrity, and its absence leads to late-onset CNS dysmyelination.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOL GENET,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROL,BRONX,NY 10461; NYU,DEPT BIOCHEM,NEW YORK,NY 10016	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University	Liedtke, W (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PATHOL,DIV NEUROPATHOL,1300 MORRIS PK AVE,BRONX,NY 10461, USA.		Kucherlapati, Raju/ABC-8807-2021; Liedtke, Wolfgang/GNH-1878-2022; Liedtke, Wolfgang B/G-4633-2011		NINDS NIH HHS [NS 08952, NS 11920, NS 07098] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098, P50NS011920, P01NS011920, R01NS008952] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNEY ER, 1983, DEV BIOL, V100, P166, DOI 10.1016/0012-1606(83)90207-5; BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BARONVANEVERCOOREN A, 1992, LAB INVEST, V66, P39; BARTLETT WP, 1988, GLIA, V1, P253, DOI 10.1002/glia.440010404; BLAKEMORE WF, 1991, TRENDS NEUROSCI, V14, P323, DOI 10.1016/0166-2236(91)90155-N; BOEGLER O, 1990, P NATL ACAD SCI USA, V87, P6368; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; BUNGE RP, 1965, ANN NY ACAD SCI, V122, P15; CHIU FC, 1989, NEURON, V2, P1435, DOI 10.1016/0896-6273(89)90189-X; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GALLO V, 1995, J NEUROSCI, V15, P394; GARD AL, 1995, DEVELOPMENT, V121, P2187; GOLDMUNTZ EA, 1986, J IMMUNOL, V137, P3444; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; HANDYSIDE AH, 1989, ROUX ARCH DEV BIOL, V198, P48, DOI 10.1007/BF00376370; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kandel ER, 1991, PRINCIPLES NEURAL SC, P22; LANDRY CF, 1990, J NEUROSCI RES, V25, P194, DOI 10.1002/jnr.490250207; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MICHAELSON MD, 1996, IN PRESS DEVELOPMENT; MOORE GRW, 1987, LAB INVEST, V57, P157; MOORE GRW, 1988, LAB INVEST, V59, P641; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Privat Alain, 1995, P3; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Raine C.S, 1991, TXB NEUROPATHOLOGY, P115; RAINE CS, 1984, J NEUROCYTOL, V13, P21, DOI 10.1007/BF01148316; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; SKOFF RP, 1976, NATURE, V264, P560, DOI 10.1038/264560a0; VAUGHN JE, 1967, AM J ANAT, V121, P131, DOI 10.1002/aja.1001210109; Virchow R., 1846, ALLG Z PSYCHIAT, V3, P242; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; WREN DR, 1989, P NATL ACAD SCI USA, V86, P9025, DOI 10.1073/pnas.86.22.9025; WU E, 1992, LAB INVEST, V67, P88; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; YU ACH, 1991, J NEUROSCI RES, V30, P72, DOI 10.1002/jnr.490300109	47	395	404	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					607	615		10.1016/S0896-6273(00)80194-4	http://dx.doi.org/10.1016/S0896-6273(00)80194-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893019	hybrid			2022-12-28	WOS:A1996VP74300007
J	Michaelidis, TM; Sendtner, M; Cooper, JD; Airaksinen, MS; Holtmann, B; Meyer, M; Thoenen, H				Michaelidis, TM; Sendtner, M; Cooper, JD; Airaksinen, MS; Holtmann, B; Meyer, M; Thoenen, H			Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development	NEURON			English	Article							NEUROTROPHIC FACTOR PREVENTS; DEVELOPING NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; MOTOR-NEURONS; TRANSGENIC MICE; PROTOONCOGENE BCL-2; TARGETED DISRUPTION; SEQUENCE SIMILARITY; PROTEIN EXPRESSION; LYMPHOID-TISSUES	Bcl-2 is a major regulator of programmed cell death, a critical process in shaping the developing nervous system. To assess whether Bcl-2 is involved in regulating neuronal survival and in mediating the neuroprotective action of neurotrophic factors, we generated Bcl-5-deficient mice. At birth, the number of facial motoneurons, sensory, and sympathetic neurons was not significantly changed, and axotomy-induced degeneration of facial motoneurons could still be prevented by brain-derived neurotrophic factor (BDNF) or ciliary neurotrophic factor (CNTF). Interestingly, substantial degeneration of motoneurons, sensory, and sympathetic neurons occurred after the physiological cell death period. Accordingly, Bcl-2 is not a permissive factor for the action of neurotrophic factors, and although it does not influence prenatal neuronal survival, it is crucial for the maintenance of specific populations of neurons during the early postnatal period.	UNIV WURZBURG,DEPT NEUROL,CLIN RES UNIT,D-97080 WURZBURG,GERMANY	University of Wurzburg	Michaelidis, TM (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROCHEM,D-82152 PLANEGG,GERMANY.		Sendtner, Michael/M-8137-2014; Cooper, Jonathan/V-9962-2019; Cooper, Jonathan/C-8117-2009; Sendtner, Michael/J-1542-2012	Sendtner, Michael/0000-0002-4737-2974; Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750; Sendtner, Michael/0000-0002-4737-2974; Airaksinen, Matti/0000-0002-7199-4984				ABEDOHMAE S, 1993, BIOCHEM BIOPH RES CO, V191, P915, DOI 10.1006/bbrc.1993.1304; ALLSOPP TE, 1995, EUR J NEUROSCI, V7, P1266, DOI 10.1111/j.1460-9568.1995.tb01116.x; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; ASHWELL KW, 1983, J EMBRYOL EXP MORPH, V77, P117; ASHWELL KW, 1982, J ANAT, V135, P531; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; CHLEQDESCHAMPS CM, 1993, BLOOD, V81, P293; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; COGGESHALL RE, 1994, DEV BRAIN RES, V82, P193, DOI 10.1016/0165-3806(94)90163-5; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; CREWS LL, 1990, J NEUROSCI, V10, P1643; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; DeBilbao F, 1996, NEUROSCIENCE, V71, P1111, DOI 10.1016/0306-4522(95)00505-6; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; FRANKOWSKI H, 1995, NEUROREPORT, V6, P1917, DOI 10.1097/00001756-199510020-00023; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GILLARDON F, 1995, NEUROSCI LETT, V192, P85, DOI 10.1016/0304-3940(95)11619-8; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Hara A, 1996, BRAIN RES, V711, P249, DOI 10.1016/0006-8993(95)01436-5; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; KOLIATSOS VE, 1994, P NATL ACAD SCI USA, V91, P3304, DOI 10.1073/pnas.91.8.3304; KONDO E, 1992, BLOOD, V80, P2044; KOU SY, 1995, J NEUROBIOL, V27, P561, DOI 10.1002/neu.480270410; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; KREUTZBERG GW, 1986, FACIAL NERVE, P75; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; LIN EY, 1993, J IMMUNOL, V151, P1979; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; MAH SP, 1993, J NEUROCHEM, V60, P1183, DOI 10.1111/j.1471-4159.1993.tb03275.x; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MERRY DE, 1994, DEVELOPMENT, V120, P301; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; NEGRINI M, 1987, CELL, V49, P455, DOI 10.1016/0092-8674(87)90448-X; NOBES CD, 1995, EUR J NEUROSCI, V7, P344, DOI 10.1111/j.1460-9568.1995.tb01069.x; Nobes CD, 1996, NEUROSCIENCE, V70, P1067, DOI 10.1016/0306-4522(95)00420-3; NUNEZ G, 1990, J IMMUNOL, V144, P3602; Ohga Y, 1996, NEUROSCIENCE, V73, P913, DOI 10.1016/0306-4522(96)00204-7; OITVAI ZN, 1993, CELL, V74, P609; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; POLLIN MM, 1991, DEVELOPMENT, V112, P83; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMALBRUCH H, 1984, J COMP NEUROL, V224, P252, DOI 10.1002/cne.902240206; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SIEGEL RM, 1992, P NATL ACAD SCI USA, V89, P7003, DOI 10.1073/pnas.89.15.7003; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOENEN H, 1994, INT ACAD B, V7, P197; THOENEN H, 1993, EXP NEUROL, V124, P47, DOI 10.1006/exnr.1993.1173; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TZIMAGIORGIS G, 1995, IN PRESS NUCL ACIDS; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686	92	234	240	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					75	89		10.1016/S0896-6273(00)80282-2	http://dx.doi.org/10.1016/S0896-6273(00)80282-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755480	Bronze			2022-12-28	WOS:A1996UY98100009
J	Thinakaran, G; Borchelt, DR; Lee, MK; Slunt, HH; Spitzer, L; Kim, G; Ratovitsky, T; Davenport, F; Nordstedt, C; Seeger, M; Hardy, J; Levey, AI; Gandy, SE; Jenkins, NA; Copeland, NG; Price, DL; Sisodia, SS				Thinakaran, G; Borchelt, DR; Lee, MK; Slunt, HH; Spitzer, L; Kim, G; Ratovitsky, T; Davenport, F; Nordstedt, C; Seeger, M; Hardy, J; Levey, AI; Gandy, SE; Jenkins, NA; Copeland, NG; Price, DL; Sisodia, SS			Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; PRECURSOR PROTEIN GENE; MUTATION; EXPRESSION	The majority of early-onset cases of familial Alzheimer's disease (FAD) are linked to mutations in two related genes, PS1 and PS2, located on chromosome 14 and 1, respectively. Using two highly specific antibodies against nonoverlapping epitopes of the PS1-encoded polypeptide, termed presenilin 1 (PS1), we document that the preponderant PS1-related species that accumulate in cultured mammalian cells, and in the brains of rodents, primates, and humans are similar to 27-28 kDa N-terminal and similar to 16-17 kDa C-terminal derivatives. Notably, a FAD-linked PS1 variant that lacks exon 9 is not subject to endoproteolytic cleavage. In brains of transgenic mice expressing human PS1, similar to 17 kDa and similar to 27 kDa PS1 derivatives accumulate to saturable levels, and at similar to 1:1 stoichiometry, independent of transgene-derived mRNA. We conclude that PS1 is subject to endoproteolytic processing in vivo.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; KAROLINSKA INST,DEPT CLIN NEUROSCI,S-17176 STOCKHOLM,SWEDEN; CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; NCI,MAMMALIAN GENET LAB,ABL BASIC RES PROGRAM,FREDERICK CANC RES & DEV,FREDERICK,MD 21701; UNIV S FLORIDA,DEPT PSYCHIAT,SUNCOAST ALZHEIMERS DIS LABS,TAMPA,FL 33613	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Cornell University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of South Florida	Thinakaran, G (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205, USA.		Levey, Allan/F-2104-2011; Lee, Michael K/D-9491-2013; Hardy, John/C-2451-2009	Levey, Allan/0000-0002-3153-502X; Lee, Michael K/0000-0001-5865-9682; Hardy, John/0000-0002-3122-0423	NIA NIH HHS [AG05689, AG11508] Funding Source: Medline; NINDS NIH HHS [NS20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011508, R55AG011508] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boteva K, 1996, LANCET, V347, P130, DOI 10.1016/S0140-6736(96)90261-5; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; CHAPMAN J, 1995, LANCET, V346, P1040, DOI 10.1016/S0140-6736(95)91723-3; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; FISCHER M, 1996, IN PRESS EMBO J; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PerezTur J, 1995, NEUROREPORT, V7, P297; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sahara N, 1996, FEBS LETT, V381, P7, DOI 10.1016/0014-5793(96)00054-3; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1995, AMYLOID, V2, P188, DOI 10.3109/13506129509036925; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; SUZUKI T, 1996, BIOCHEM BIOPH RES CO, V219, P706; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; WASCO W, 1995, NAT MED, V1, P848, DOI 10.1038/nm0995-848a; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; 1995, NAT GENET, V11, P219	32	950	976	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					181	190		10.1016/S0896-6273(00)80291-3	http://dx.doi.org/10.1016/S0896-6273(00)80291-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755489	Bronze			2022-12-28	WOS:A1996UY98100018
J	Ziv, NE; Smith, SJ				Ziv, NE; Smith, SJ			Evidence for a role of dendritic filopodia in synaptogenesis and spine formation	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL-NEURONS; GROWTH CONES; FINE-STRUCTURE; VISUAL-CORTEX; POSTNATAL-DEVELOPMENT; ELECTRON-MICROSCOPE; FORM SYNAPSES; CELL-CULTURE; RAT	Axo-dendritic synaptogenesis was examined in live hippocampal cell cultures using the fluorescent dyes DiO to label dendrites and FM 4-64 to label functional presynaptic boutons. As the first functional synaptic boutons appeared in these cultures, numerous filopodia (up to 10 mu m long) were observed to extend transiently (mean lifetime 9.5 min) from dendritic shafts. With progressively increasing numbers of boutons, there were coincident decreases in numbers of transient filopodia and increases in numbers of stable dendritic spines. Dendritic filopodia were observed to initiate physical contacts with nearby axons. This sometimes resulted in filopodial stabilization and formation of functional presynaptic boutons. These findings suggest that dendritic filopodia may actively initiate synaptogenic contacts with nearby (5-10 mu m) axons and thereafter evolve into dendritic spines.			Ziv, NE (corresponding author), STANFORD UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, STANFORD, CA 94305 USA.		Ziv, Noam/ABA-6551-2020	Ziv, Noam/0000-0001-9197-326X; Smith, Stephen/0000-0002-2290-8701	NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS28587] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1993, J PHYSIOLOGY-PARIS, V87, P193, DOI 10.1016/0928-4257(93)90030-W; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CONSTANTINEPATON M, 1990, COLD SPRING HARB SYM, V55, P431; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dailey ME, 1996, J NEUROSCI, V16, P2983; DALVA MB, 1994, J NEUROSCI, V14, P3588; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harris KM., 1989, HIPPOCAMPUS NEW VIST, P33; HAYES BP, 1973, Z ZELLFORSCH MIK ANA, V137, P251, DOI 10.1007/BF00307433; Henkel AW, 1995, J NEUROSCI, V15, P8246; HINDS JW, 1972, J NEUROCYTOL, V1, P169, DOI 10.1007/BF01099183; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; HOSOKAWA T, 1992, NEUROREPORT, V3, P477, DOI 10.1097/00001756-199206000-00005; JURASKA JM, 1979, J COMP NEUROL, V183, P247, DOI 10.1002/cne.901830203; LUND JS, 1977, J COMP NEUROL, V176, P149, DOI 10.1002/cne.901760203; MATTEOLI M, 1995, J PHYSL, V89, P1; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P290, DOI 10.1007/BF00522529; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P271, DOI 10.1007/BF00522528; PAPA M, 1995, J NEUROSCI, V15, P1; PAPPAS GD, 1975, ADV NEUROL, V12, P163; PHELPS PE, 1983, DEV BRAIN RES, V10, P1, DOI 10.1016/0165-3806(83)90116-5; PURPURA DP, 1975, PHYSL PATHOLOGY DEND, P91; RAMOA AS, 1987, SCIENCE, V237, P522, DOI 10.1126/science.3603038; ROCHA M, 1995, P NATL ACAD SCI USA, V92, P8026, DOI 10.1073/pnas.92.17.8026; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; SKOFF RP, 1974, J COMP NEUROL, V153, P107, DOI 10.1002/cne.901530202; SMITH SJ, 1992, NERVE GROWTH CONE, P19; STEWARD O, 1988, MOL NEUROBIOL, V2, P227, DOI 10.1007/BF02935634; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; ULFHAKE B, 1988, J COMP NEUROL, V278, P88, DOI 10.1002/cne.902780106; VAUGHN JE, 1974, J CELL BIOL, V60, P664, DOI 10.1083/jcb.60.3.664; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VERDERIO C, 1995, P NATL ACAD SCI USA, V92, P6449, DOI 10.1073/pnas.92.14.6449; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527	51	669	687	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1996	17	1					91	102		10.1016/S0896-6273(00)80283-4	http://dx.doi.org/10.1016/S0896-6273(00)80283-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755481	Bronze			2022-12-28	WOS:A1996UY98100010
J	Tong, G; Malenka, RC; Nicoll, RA				Tong, G; Malenka, RC; Nicoll, RA			Long-term potentiation in cultures of single hippocampal granule cells: A presynaptic form of plasticity	NEURON			English	Article							MOSSY-FIBER SYNAPSES; CRAYFISH NEUROMUSCULAR-JUNCTION; GUINEA-PIG HIPPOCAMPUS; NEURONS; FACILITATION; ENHANCEMENT; MECHANISMS; RESPONSES	We have explored the mechanisms of messy fiber long-term potentiation (LTP) at autapses in single-cell cultures of guinea pig hippocampal dentate granule cells. L-AP4-sensitive, but not insensitive, cells responded to a brief tetanus with a sustained potentiation in the synaptic responses. The induction of this LTP appeared identical to that observed in hippocampal messy fiber synapses in situ, in that it required a rise in presynaptic Ca2+ and activation of protein kinase A. Its expression also appeared to be presynaptic and was due, at least in part, to events that occurred after the entry of Ca2+ and to the switching on of previously silent release sites.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tong, G (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MOLEC & CELLULAR PHARMACOL,SAN FRANCISCO,CA 94143, USA.		Oka, Yoshitaka/C-9670-2010; Tong, Gary/AAC-9426-2022	Oka, Yoshitaka/0000-0002-3482-3051; 				ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CHARPIER S, 1995, P NATL ACAD SCI USA, V92, P117, DOI 10.1073/pnas.92.1.117; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; DERRICK BE, 1994, P NATL ACAD SCI USA, V91, P10290, DOI 10.1073/pnas.91.22.10290; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SALIN PA, 1995, J NEUROSCI, V15, P6939; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; WOJTOWICZ JM, 1988, J NEUROSCI, V8, P4667; WOJTOWICZ JM, 1988, NEUROSCI LETT, V90, P152, DOI 10.1016/0304-3940(88)90803-8; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; YAMAMOTO C, 1983, EXP BRAIN RES, V51, P128; YAMAMOTO C, 1992, NEUROSCI LETT, V138, P111, DOI 10.1016/0304-3940(92)90484-O; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y	46	125	126	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1147	1157		10.1016/S0896-6273(00)80141-5	http://dx.doi.org/10.1016/S0896-6273(00)80141-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663991	Bronze			2022-12-28	WOS:A1996UU11800012
J	Gesemann, M; Cavalli, V; Denzer, AJ; Brancaccio, A; Schumacher, B; Ruegg, MA				Gesemann, M; Cavalli, V; Denzer, AJ; Brancaccio, A; Schumacher, B; Ruegg, MA			Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR; EXTRACELLULAR-MATRIX; NEUROMUSCULAR-JUNCTION; POSTSYNAPTIC MEMBRANE; ORGANIZING PROTEIN; CULTURED MYOTUBES; MUSCLE; LAMININ; DOMAIN; NERVE	Agrin is a heparan sulfate proteoglycan that induces aggregation of acetylcholine receptors (AChRs) at the neuromuscular synapse. This aggregating activity is modulated by alternative splicing. Here, we compared binding of agrin isoforms to heparin, alpha-dystroglycan, and cultured myotubes. We find that the alternatively spliced 4 amino acid insert (KSRK) is required for heparin binding. The binding affinity of agrin isoforms to alpha-dystroglycan correlates neither with binding to heparin nor with their AChR-aggregating activities. Moreover, the minimal fragment sufficient to induce AChR aggregation does not bind to alpha-dystroglycan. Nevertheless, this fragment still binds to cultured muscle cells. Its binding is competed only by agrin isoforms that are active in AChR aggregation, and therefore this binding site is likely to represent the receptor that initiates AChR clustering.	UNIV BASEL,BIOZENTRUM,DEPT BIOPHYS CHEM,CH-4056 BASEL,SWITZERLAND	University of Basel	Gesemann, M (corresponding author), UNIV BASEL,BIOZENTRUM,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND.		Ruegg, Markus/X-7256-2019; Brancaccio, Andrea/C-5876-2009	Ruegg, Markus/0000-0002-4974-9384; Brancaccio, Andrea/0000-0003-4690-8826				APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; COHEN MW, 1995, J CELL BIOL, V129, P1093, DOI 10.1083/jcb.129.4.1093; DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547; DEYST KA, 1995, J BIOL CHEM, V270, P25956, DOI 10.1074/jbc.270.43.25956; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GORDON H, 1993, J NEUROSCI, V13, P586; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HIRANO Y, 1989, J NEUROSCI, V9, P1555; HOCH W, 1994, EMBO J, V13, P2814, DOI 10.1002/j.1460-2075.1994.tb06575.x; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MA E, 1994, J NEUROSCI, V14, P2943; MA EB, 1995, J NEUROBIOL, V26, P585, DOI 10.1002/neu.480260411; MA JY, 1993, J BIOL CHEM, V268, P25108; MARTIN PT, 1995, NEURON, V14, P743, DOI 10.1016/0896-6273(95)90218-X; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MEIER T, 1995, J CELL BIOL, V131, P441, DOI 10.1083/jcb.131.2.441; NITKIN RM, 1990, J CELL BIOL, V111, P1161, DOI 10.1083/jcb.111.3.1161; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SAITO M, 1993, DEV BRAIN RES, V71, P9, DOI 10.1016/0165-3806(93)90099-V; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SCOTT LJC, 1988, J NEUROSCI, V8, P932; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; THOMAS WS, 1993, DEV BIOL, V158, P523, DOI 10.1006/dbio.1993.1210; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; YURCHENCO PD, 1993, J BIOL CHEM, V268, P8356	68	201	205	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					755	767		10.1016/S0896-6273(00)80096-3	http://dx.doi.org/10.1016/S0896-6273(00)80096-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607994	Bronze, Green Published			2022-12-28	WOS:A1996UG61100009
J	Hedin, KE; Lim, NF; Clapham, DE				Hedin, KE; Lim, NF; Clapham, DE			Cloning of a Xenopus laevis inwardly rectifying K+ channel subunit that permits GIRK1 expression of I-KACh currents in oocytes	NEURON			English	Article							GTP-BINDING PROTEINS; ATRIAL CELLS; ACTIVATION; RECEPTOR; HEART	Xenopus oocytes injected with GIRK1 mRNA express inwardly rectifying K+ channels resembling I-KACh. Yet I-KACh, the atrial G protein-regulated ion channel, is a heteromultimer of GIRK1 and CIR. Reasoning that an oocyte protein might be substituting for CIR, we cloned XIR, a CIR homolog endogenously expressed by Xenopus oocytes. Coinjecting XIR and GIRK1 mRNAs produced large, inwardly rectifying K+ currents responsive to m2-muscarinic receptor stimulation. The m2-stimulated currents of oocytes expressing GIRK1 alone decreased 80% after injecting antisense oligonucleotides specific to the 5' untranslated region of XIR, but GIRK1/CIR currents were unaffected. Thus, GIRK1 without XIR or CIR only ineffectively produces currents in oocytes. This result suggests that GIRK1 does not form native homomultimeric channels.			Hedin, KE (corresponding author), MAYO CLIN & MAYO FDN,DEPT PHARMACOL,200 1ST ST SW,ROCHESTER,MN 55905, USA.		Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Hedin, Karen/0000-0003-1010-923X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049184] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07111-20P] Funding Source: Medline; NIDDK NIH HHS [DK49184-01P3] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Dascal N., 1992, METHODS MOL BIOL VOL, VVolume 13, P205; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; HEDIN KE, 1993, CELL SIGNAL, V5, P505, DOI 10.1016/0898-6568(93)90046-O; HILLE B, 1985, NATURE, V217, P536; KARSCHIN C, 1994, FEBS LETT, V348, P139, DOI 10.1016/0014-5793(94)00590-7; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, IN PRESS J BIOL CHEM; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; PHILIPSON LH, 1995, J BIOL CHEM, V270, P14604, DOI 10.1074/jbc.270.24.14604; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; VELIMIROVIC BM, 1996, IN PRESS FEBS LETT; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	27	161	166	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					423	429		10.1016/S0896-6273(00)80060-4	http://dx.doi.org/10.1016/S0896-6273(00)80060-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789957	Bronze			2022-12-28	WOS:A1996TW95700022
J	Snider, WD; Wright, DE				Snider, WD; Wright, DE			Neurotrophins cause a new sensation	NEURON			English	Review							NERVE GROWTH-FACTOR; MESSENGER-RNA; EXPRESSION; RECEPTOR; NEURONS				Snider, WD (corresponding author), WASHINGTON UNIV,SCH MED,DEPT NEUROL,CTR STUDY NERVOUS SYST INJURY,ST LOUIS,MO 63110, USA.							Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Brown AG, 1981, ORG SPINAL CORD; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KUCERA J, 1995, J COMP NEUROL, V363, P307, DOI 10.1002/cne.903630211; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; MCMAHON SB, 1995, NAT MED, V1, P774, DOI 10.1038/nm0895-774; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MU XJ, 1993, J NEUROSCI, V13, P4029; Perl ER, 1992, SENSORY NEURONS DIVE, P3; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCOTT S, 1992, SENSORY NEURONS; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SNIDER WD, 1996, IN PRESS PHIL T ROY; WRIGHT DE, 1995, J COMP NEUROL, V13, P4029	25	116	117	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					229	232		10.1016/S0896-6273(00)80039-2	http://dx.doi.org/10.1016/S0896-6273(00)80039-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789936	Bronze			2022-12-28	WOS:A1996TW95700001
J	CameronCurry, P; LeDouarin, NM				CameronCurry, P; LeDouarin, NM			Oligodendrocyte precursors originate from both the dorsal and the ventral parts of the spinal cord	NEURON			English	Article							ALPHA-RECEPTOR EXPRESSION; CENTRAL NERVOUS-SYSTEM; CHICK CHIMERA SYSTEM; EMBRYONIC-DEVELOPMENT; BRAIN-DEVELOPMENT; PDGF RECEPTORS; GROWTH-FACTOR; GLIAL-CELLS; LINEAGE; GLIOGENESIS	Oligodendrocytes have been recently claimed to originate from bilateral columns of precursors whose extension is limited to the ventral region of the neuroepithelium. We designed an experiment in which the developmental capabilities of the different regions of the ventricular epithelium could be tested. We exchanged isotopically and isotopically defined sectors of the E2 spinal cord between quail and chick embryos and followed the production and migration of oligodendrocytes by using a quail-specific cDNA probe encoding the oligodendrocyte marker Schwann cell myelin protein. We showed that oligodendrocytes are generated in vivo from bath ventral and dorsal halves of the neural tube. Moreover, extensive ventrodorsal, as well as dorsoventral, migrations of oligodendrogenic cells take place during spinal cord differentiation.	CNRS,INST EMBRYOL CELLULAIRE & MOLEC,F-94736 NOGENT SUR MARNE,FRANCE; COLL FRANCE,F-94736 NOGENT SUR MARNE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France								BALABAN E, 1988, SCIENCE, V241, P1339, DOI 10.1126/science.3413496; CAMERONCURRY P, 1989, DEVELOPMENT, V107, P825; DULAC C, 1992, NEURON, V8, P323, DOI 10.1016/0896-6273(92)90298-R; DULAC C, 1988, NEURON, V1, P211, DOI 10.1016/0896-6273(88)90141-9; EICHMANN A, 1993, MECH DEVELOP, V42, P33, DOI 10.1016/0925-4773(93)90096-G; FUJITA S, 1965, J COMP NEUROL, V124, P51, DOI 10.1002/cne.901240105; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HART IK, 1989, DEVELOPMENT, V105, P595; HIRANO M, 1988, J NEUROSCI RES, V21, P155, DOI 10.1002/jnr.490210208; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; KINUTANI M, 1989, CELL DIFFER DEV, V26, P145, DOI 10.1016/0922-3371(89)90016-6; Le Douarin N., 1969, Bulletin Biologique de la France et de la Belgique, V103, P435; Le Douarin N.M., 1982, NEURAL CREST; LEBER SM, 1995, J NEUROSCI, V15, P1236; LEBER SM, 1990, J NEUROSCI, V10, P2451; LEDOUARIN NM, 1993, TRENDS NEUROSCI, V16, P64, DOI 10.1016/0166-2236(93)90019-I; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LEVINE SM, 1988, J NEUROSCI, V8, P3992; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; NOLL E, 1993, DEVELOPMENT, V118, P563; NORMEE HO, 1974, BRAIN RES, V73, P121; Peters A., 1976, FINE STRUCTURE NERVO; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Richardson WD, 1990, SEMIN NEUROSCI, V2, P445; SCHERER SS, 1994, NEURON, V12, P1363, DOI 10.1016/0896-6273(94)90451-0; TAN K, 1991, ANAT EMBRYOL, V183, P321; TIMSIT S, 1995, J NEUROSCI, V15, P1012; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TROUSSE F, 1995, J NEUROSCI RES, V41, P552, DOI 10.1002/jnr.490410415; WARF BC, 1991, J NEUROSCI, V11, P2477; WENGER EL, 1950, J EXP ZOOL, V114, P51, DOI 10.1002/jez.1401140103; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; ZACCHEI A M, 1961, Arch Ital Anat Embriol, V66, P36	39	75	76	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1299	1310		10.1016/0896-6273(95)90009-8	http://dx.doi.org/10.1016/0896-6273(95)90009-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845154	Bronze			2022-12-28	WOS:A1995TL67800009
J	KAANG, BK; KANDEL, ER; GRANT, SGN				KAANG, BK; KANDEL, ER; GRANT, SGN			ACTIVATION OF CAMP-RESPONSIVE GENES BY STIMULI THAT PRODUCE LONG-TERM FACILITATION IN APLYSIA SENSORY NEURONS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; ELEMENT-BINDING-PROTEIN; GILL-WITHDRAWAL REFLEX; NUCLEAR FACTOR CREB; CYCLIC-AMP; TRANSCRIPTIONAL ACTIVATION; SUBSTRATE-SPECIFICITY; SOMATOSTATIN GENE; ENHANCER ELEMENTS; INDUCIBLE GENES	One of the hallmarks of long-term memory in both vertebrates and invertebrates is the requirement for new protein synthesis. In sensitization of the gill-withdrawal reflex in Aplysia, this requirement can be studied on the cellular level. Here, long-term but not short-term facilitation of the monosynaptic connections between the sensory and motor neurons requires new protein synthesis and is reflected in an altered level of expression of specific proteins regulated through the cAMP second-messenger pathway. Using gene transfer into individual sensory neurons of Aplysia, we find that serotonin (5-HT) induces transcriptional activation of a lacZ reporter gene driven by the cAMP response element (CRE) and that this induction requires CRE-binding proteins (CREBs). The induction by 5-HT does not occur following a single pulse, but becomes progressively more effective following two or more pulses. Moreover, expression of GAL4-CREB fusion genes shows that 5-HT induction requires phosphorylation of CREB on Ser119 by protein kinase A. These data provide direct evidence for CREB-modulated transcriptional activation with long-term facilitation.	COLUMBIA UNIV COLL PHYS & SURG,INTEGRATED PROGRAM CELLULAR MOLEC BIOL & BIOPHYS STUDIES,NEW YORK,NY 10032	Columbia University	KAANG, BK (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.			Grant, Seth/0000-0001-8732-8735				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BACSKAI B, 1993, IN PRESS SCIENCE; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BARONDES SH, 1975, SHORT TERM MEMORY, P379; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; BYRNE JH, 1978, J NEUROPHYSIOL, V41, P418, DOI 10.1152/jn.1978.41.2.418; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; FINK JS, 1991, J BIOL CHEM, V266, P3882; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Higuchi R., 1989, PCR TECHNOLOGY, P61; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KEMP BE, 1977, J BIOL CHEM, V252, P4888; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Macgregor G R, 1991, Methods Mol Biol, V7, P217, DOI 10.1385/0-89603-178-0:217; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; QIAN Z, 1993, IN PRESS NATURE; RAYPORT SG, 1986, J NEUROSCI, V6, P759; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SASSONECORSI P, 1990, ONCOGENE, V5, P427; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SOSSIN WS, 1992, J NEUROSCI, V12, P1160; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	46	266	272	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					427	435		10.1016/0896-6273(93)90331-K	http://dx.doi.org/10.1016/0896-6273(93)90331-K			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8384857				2022-12-28	WOS:A1993KU90100008
J	PEINADO, A; YUSTE, R; KATZ, LC				PEINADO, A; YUSTE, R; KATZ, LC			EXTENSIVE DYE COUPLING BETWEEN RAT NEOCORTICAL NEURONS DURING THE PERIOD OF CIRCUIT FORMATION	NEURON			English	Article							OCULAR DOMINANCE COLUMNS; CAT VISUAL-CORTEX; GAP-JUNCTIONS; PYRAMIDAL NEURONS; SYNAPSE FORMATION; CEREBRAL-CORTEX; MUSCLE-CELLS; INVITRO; CONNECTIONS; BIOCYTIN	A low molecular weight intracellular tracer, Neurobiotin, was injected into single neurons in living slices of rat neocortex made at postnatal days 5-18. Between days 5 and 12, 66% of single-neuron injections labeled clusters of up to 80 neurons surrounding the injected cell. Coupling between neurons occurred primarily through dendrites. Injections done in the presence of halothane, a gap junction blocker, abolished the spread of tracer to surrounding neurons, implying that gap junctions mediate coupling. Injections done after day 16 resulted in little or no dye coupling. We conclude that transient local coupling via gap junctions in developing cortex may provide a pathway for communicating intercellular signals, including subthreshold electrical activity, and thereby enable temporal coordination of local neuronal ensembles during circuit formation.	DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA	Duke University					NATIONAL EYE INSTITUTE [R01EY007960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015177] Funding Source: NIH RePORTER; NEI NIH HHS [EY07960] Funding Source: Medline; NIMH NIH HHS [MH15177] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN F, 1991, NEURON, V6, P101, DOI 10.1016/0896-6273(91)90125-J; [Anonymous], [No title captured]; ARMSTRONG DL, 1983, J NEUROSCI, V3, P1414, DOI 10.1523/jneurosci.03-07-01414.1983; Armstrong-James M., 1988, CEREB CORTEX, V7, p237~ 272; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; ARMSTRONGJAMES M, 1970, Z ZELLFORSCH MIK ANA, V110, P559, DOI 10.1007/BF00330104; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Bennett M., 1977, HDB PHYSL          1, P357; BENNETT MVL, 1963, SCIENCE, V141, P262, DOI 10.1126/science.141.3577.262; BENNETT MVL, 1988, GAP JUNCTIONS, P287; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BURT JM, 1989, CIRC RES, V65, P829, DOI 10.1161/01.RES.65.3.829; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; CONNORS BW, 1983, J NEUROSCI, V3, P773; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Dudek F E, 1986, Adv Neurol, V44, P593; FISCHBACH GD, 1972, DEV BIOL, V28, P407, DOI 10.1016/0012-1606(72)90023-1; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; GUTNICK MJ, 1985, NEUROSCIENCE, V15, P659, DOI 10.1016/0306-4522(85)90067-3; HADLEY RD, 1983, SCIENCE, V221, P466, DOI 10.1126/science.6867723; HAUSWIRTH O, 1968, J PHYSL, V201, pP42; HEBB DO, 1949, ORG BEHAVIOR; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; JURASKA JM, 1979, J COMP NEUROL, V183, P257, DOI 10.1002/cne.901830204; KATZ LC, 1989, J NEUROSCI, V9, P1389; KATZ LC, 1987, J NEUROSCI, V7, P1223; KESSLER JA, 1985, GAP JUNCTIONS, P231; KITA H, 1991, J NEUROSCI METH, V37, P141, DOI 10.1016/0165-0270(91)90124-I; KRIEGSTEIN AR, 1987, DEV BRAIN RES, V34, P161, DOI 10.1016/0165-3806(87)90206-9; KRISTT DA, 1976, BRAIN RES, V108, P180, DOI 10.1016/0006-8993(76)90175-X; LIN CS, 1986, J COMP NEUROL, V244, P369, DOI 10.1002/cne.902440309; LLINAS RR, 1984, GAP JUNCTIONS, P337; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; LOPRESTI V, 1974, P NATL ACAD SCI USA, V71, P1098, DOI 10.1073/pnas.71.4.1098; MATSUMOTO A, 1988, J NEUROSCI, V8, P4177; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; MEINECKE DL, 1987, J COMP NEUROL, V261, P388, DOI 10.1002/cne.902610305; MILLER M, 1981, J NEUROCYTOL, V10, P859, DOI 10.1007/BF01262658; MILLER MW, 1988, CEREB CORTEX, V7, P133; MURPHY AD, 1983, J NEUROSCI, V3, P1422; NELSON PG, 1989, SCIENCE, V244, P585, DOI 10.1126/science.2717942; OLAGUE PH, 1978, DEV BIOL, V67, P404, DOI 10.1016/0012-1606(78)90209-9; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P925, DOI 10.1152/jn.1965.28.5.925; Purves, 1985, PRINCIPLES NEURAL DE; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SLOPER JJ, 1978, PROC R SOC SER B-BIO, V203, P39, DOI 10.1098/rspb.1978.0089; Spray, 1985, GAP JUNCTIONS, P167; SPRAY DC, 1988, GAP JUNCTIONS, P287; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STRYKER MP, 1986, J NEUROSCI, V6, P2117; TERRAR DA, 1988, BRIT J PHARMACOL, V94, P509, DOI 10.1111/j.1476-5381.1988.tb11554.x; TURCO JJL, 1991, SCIENCE, V252, P563; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	61	345	349	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					103	114		10.1016/0896-6273(93)90246-N	http://dx.doi.org/10.1016/0896-6273(93)90246-N			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427699				2022-12-28	WOS:A1993KK01200011
J	Ryan, TA				Ryan, TA			Endocytosis at nerve terminals: Timing is everything	NEURON			English	Review							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLES; MEMBRANE; CELLS; SYNAPTOTAGMIN; EXOCYTOSIS; DYNAMICS; CALCIUM				Ryan, TA (corresponding author), STANFORD UNIV,SCH MED,STANFORD,CA 94305, USA.		Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548				BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KOENIG JH, 1989, J NEUROSCI, V9, P1937; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; SCHELLER RH, 1995, NEURON, V14, P893; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; VALTORTA F, 1988, J CELL BIOL, V107, P2717, DOI 10.1083/jcb.107.6.2717; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	24	21	24	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1035	1037		10.1016/S0896-6273(00)80236-6	http://dx.doi.org/10.1016/S0896-6273(00)80236-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982152	Bronze			2022-12-28	WOS:A1996WA24800002
J	Dudai, Y				Dudai, Y			Consolidation: Fragility on the road to the engram	NEURON			English	Review							LONG-TERM-MEMORY; RETROGRADE-AMNESIA; ANTEROGRADE; LESIONS; SLEEP				Dudai, Y (corresponding author), WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL.							BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Carew TJ, 1996, NEURON, V16, P5, DOI 10.1016/S0896-6273(00)80016-1; CHO YH, 1993, J NEUROSCI, V13, P1759; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dudai Y., 1989, NEUROBIOLOGY MEMORY; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HEBB DO, 1949, ORG BEHAVIOR; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; MAYFORD M, 1995, CURR OPIN NEUROBIOL, V5, P141, DOI 10.1016/0959-4388(95)80019-0; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; ROSE SPR, 1995, BEHAV BRAIN RES, V66, P73, DOI 10.1016/0166-4328(94)00127-2; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1; Sossin WS, 1996, TRENDS NEUROSCI, V19, P215; Squire L. R., 1987, MEMORY BRAIN; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Staubli U, 1996, J NEUROSCI, V16, P853; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	24	93	95	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					367	370		10.1016/S0896-6273(00)80168-3	http://dx.doi.org/10.1016/S0896-6273(00)80168-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816699	Bronze			2022-12-28	WOS:A1996VJ44000002
J	Engel, SA				Engel, SA			Looking into the black box: New directions in neuroimaging	NEURON			English	Review							HUMAN VISUAL-CORTEX; FUNCTIONAL MRI; AREAS				Engel, SA (corresponding author), UNIV CALIF LOS ANGELES,DEPT PSYCHOL,LOS ANGELES,CA 90095, USA.							[Anonymous], 1993, BRAIN ACTIVATION; Bonhoeffer Tobias, 1996, P55; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Cherry Simon R., 1996, P191; Cohen Mark S., 1996, P223; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; ENGEL SA, 1996, IN PRESS CEREB CORTE; HIRSCH J, 1995, P NATL ACAD SCI USA, V92, P6469, DOI 10.1073/pnas.92.14.6469; KANWISHER N, 1996, IN PRESS COG BRAIN R; KARNI A, 1995, NATURE, V377, P155; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; RAICHLE ME, 1994, ANNU REV PSYCHOL, V45, P333, DOI 10.1146/annurev.psych.45.1.333; RAICHLE ME, 1996, CEREB CORTEX, V6, P1; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; TOOTELL RBH, 1996, IN PRESS TRENDS NEUR; UNGERLEIDER LG, 1995, SCIENCE, V270, P759	21	7	7	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					375	378		10.1016/S0896-6273(00)80170-1	http://dx.doi.org/10.1016/S0896-6273(00)80170-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816701	Bronze			2022-12-28	WOS:A1996VJ44000004
J	Goldstein, SAN				Goldstein, SAN			A structural vignette common to voltage sensors and conduction pores: Canaliculi	NEURON			English	Review							SHAKER POTASSIUM CHANNEL; SODIUM-CHANNEL; K+ CHANNEL; INACTIVATION; CHARYBDOTOXIN; MECHANISMS; MUTATIONS; REGION		YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOYER CTR MOLEC MED,NEW HAVEN,CT 06536	Yale University	Goldstein, SAN (corresponding author), YALE UNIV,SCH MED,DEPT PEDIAT,BOYER CTR MOLEC MED,333 CEDAR ST,NEW HAVEN,CT 06536, USA.		Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRONG CM, 1975, QUART REV BIOPH, V7, P179; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; KRAMER RH, 1994, NEURON, V12, P655, DOI 10.1016/0896-6273(94)90220-8; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1991, J BIOENERG BIOMEMBR, V23, P647, DOI 10.1007/BF00785815; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MANUZZU LM, 1996, SCIENCE, V271, P213; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Miller C., 1987, NEUROMODULATION BIOC, P39; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YAO XQ, 1995, P NATL ACAD SCI USA, V92, P11711, DOI 10.1073/pnas.92.25.11711; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	52	43	43	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					717	722		10.1016/S0896-6273(00)80092-6	http://dx.doi.org/10.1016/S0896-6273(00)80092-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607990	Bronze, Green Published			2022-12-28	WOS:A1996UG61100005
J	Eksioglu, YZ; Scheffer, IE; Cardenas, P; Knoll, J; DiMario, F; Ramsby, G; Berg, M; Kamuro, K; Berkovic, SF; Duyk, GM; Parisi, J; Huttenlocher, PR; Walsh, CA				Eksioglu, YZ; Scheffer, IE; Cardenas, P; Knoll, J; DiMario, F; Ramsby, G; Berg, M; Kamuro, K; Berkovic, SF; Duyk, GM; Parisi, J; Huttenlocher, PR; Walsh, CA			Periventricular heterotopia: An X-linked dominant epilepsy locus causing aberrant cerebral cortical development	NEURON			English	Article							JUVENILE MYOCLONIC EPILEPSY; GENERALIZED EPILEPSY; DINUCLEOTIDE REPEAT; NODULAR HETEROTOPIA; LINKAGE ANALYSIS; KB REGION; GENE; MAP; CHILDHOOD; CORTEX	Periventricular heterotopia (PH) involves dramatic malformations of the human cerebral cortex. Here we show that PH is closely linked to markers in distal Xq28 (maximal two-point lod score = 4.77 for F8C at theta = 0; maximal multipoint lod score = 5.37), so that affected females are obligatory mosaics for the mutation; that PH is lethal to at least some affected males; that PH malformations consist of well-differentiated cortical neurons filling the adult subependymal zone; and that individuals with PH are at high risk for epilepsy, though they have no other neurological or external stigmata. The PH gene may represent an important epilepsy susceptibility locus in addition to playing a key role in normal cortical development.	AUSTIN HOSP,DEPT NEUROL,MELBOURNE,VIC 3084,AUSTRALIA; BETH ISRAEL HOSP,CHILDRENS HOSP,DEPT PATHOL,DIV GENET,BOSTON,MA 02215; UNIV CONNECTICUT,DEPT PEDIAT,FARMINGTON,CT; UNIV CONNECTICUT,DEPT RADIOL,FARMINGTON,CT; UNIV ROCHESTER,DEPT NEUROL,ROCHESTER,NY; KOKUBU SEIKYO HOSP,DEPT NEUROL,KAGOSHIMA,JAPAN; MILLENNIUM PHARMACEUT,CAMBRIDGE,MA; MAYO CLIN,DEPT PATHOL ANAT,ROCHESTER,MN; UNIV CHICAGO,DEPT PEDIAT,DEPT NEUROL,CHICAGO,IL 60637	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; University of Connecticut; University of Connecticut; University of Rochester; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Mayo Clinic; University of Chicago	Eksioglu, YZ (corresponding author), HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT NEUROL,DIV NEUROGENET,BOSTON,MA 02115, USA.		jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013	Scheffer, Ingrid E/0000-0002-2311-2174; Berkovic, Samuel/0000-0003-4580-841X; Knoll, Joan/0000-0001-6691-1710				AICARDI J, 1988, EPILEPSIA, V29, pS1, DOI 10.1111/j.1528-1157.1988.tb05803.x; ALZHEIMER A, 1907, ALLG Z PSYCHIAT, V64, P418; BARKOVICH AJ, 1992, RADIOLOGY, V182, P483; BERRYKRAVIS E, 1994, ANN NEUROL, V36, P229, DOI 10.1002/ana.410360216; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; DELGADOESCUETA AV, 1994, EPILEPSIA, V35, pS29, DOI 10.1111/j.1528-1157.1994.tb05926.x; DIMARIO FJ, 1993, NEUROLOGY, V43, P1424, DOI 10.1212/WNL.43.7.1424; DOBYNS WB, 1992, NEUROLOGY, V42, P1375, DOI 10.1212/WNL.42.7.1375; DONNELLY A, 1994, GENOMICS, V20, P363, DOI 10.1006/geno.1994.1189; European Chromosome 16 Tuberous Sclerosis C., 1993, CELL, V75, P1305; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; FARRELL MA, 1992, ACTA NEUROPATHOL, V83, P246, DOI 10.1007/BF00296786; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; Gomez MR, 1988, TUBEROUS SCLEROSIS; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDIMAN O, 1988, NEUROLOGY, V38, P1041, DOI 10.1212/WNL.38.7.1041; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; HICKS AA, 1991, NUCLEIC ACIDS RES, V19, P4016, DOI 10.1093/nar/19.14.4016; HUTTENLOCHER PR, 1994, NEUROLOGY, V44, P51, DOI 10.1212/WNL.44.1.51; HUTTENLOCHER PR, 1991, ANN NEUROL, V30, P461; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; KAMURO K, 1993, BRAIN DEV-JPN, V15, P237, DOI 10.1016/0387-7604(93)90073-H; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LITT M, 1993, BIOTECHNIQUES, V15, P280; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MEENCKE HJ, 1984, EPILEPSIA, V25, P8, DOI 10.1111/j.1528-1157.1984.tb04149.x; NAKATSU Y, 1993, NATURE, V364, P448, DOI 10.1038/364448a0; ODA T, 1993, AM J MED GENET, V47, P268, DOI 10.1002/ajmg.1320470225; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; PINARD JM, 1994, J NEUROL NEUROSUR PS, V57, P914, DOI 10.1136/jnnp.57.8.914; RAYMOND AA, 1994, J NEUROL NEUROSUR PS, V57, P1195, DOI 10.1136/jnnp.57.10.1195; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; RYAN SG, 1995, NAT GENET, V10, P4, DOI 10.1038/ng0595-4; SEDLACEK Z, 1993, HUM MOL GENET, V2, P1865; SEFIANI A, 1991, HUM GENET, V86, P297; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; VITS L, 1994, NAT GENET, V7, P408, DOI 10.1038/ng0794-408; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WANG LH, 1994, GENOMICS, V22, P590, DOI 10.1006/geno.1994.1432; WEHNERT M, 1993, HUM MOL GENET, V2, P1503, DOI 10.1093/hmg/2.9.1503; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEISSENBACH J, 1993, GENE, V135, P275, DOI 10.1016/0378-1119(93)90077-G; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; ZOLLINO M, 1992, AM J MED GENET, V43, P452, DOI 10.1002/ajmg.1320430168	55	251	256	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					77	87		10.1016/S0896-6273(00)80025-2	http://dx.doi.org/10.1016/S0896-6273(00)80025-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562093	hybrid			2022-12-28	WOS:A1996TT30700011
J	Selyanko, AA; Brown, DA				Selyanko, AA; Brown, DA			Intracellular calcium directly inhibits potassium M channels in excised membrane patches from rat sympathetic neurons	NEURON			English	Article							PROTEIN-KINASE-C; M-CURRENTS; GANGLION CELLS; MUSCARINIC SUPPRESSION; K+ CURRENTS; CAFFEINE; DESENSITIZATION; IDENTIFICATION; MODULATION; MESSENGER	Complex effects of altering intracellular [Ca2+] on M-type K+ currents have previously been reported using whole-cell current recording. To study the direct effect of Ca2+ on M-channel activity, we have applied Ca2+ to the inside face of membrane patches excised from rat superior cervical sympathetic ganglion cells. Ca2+ rapidly and reversibly inhibited M-channel activity in 28/44 patches by up to 87%, with a mean IC50 of 100 nM. This effect persisted in the absence of ATP, implying that it was not due to phosphorylation/dephosphorylation. A similar effect was observed in 13/13 cell-attached patches when cells were transiently ''Ca2+-loaded'' by adding 2 mM Ca2+ to a 25 mM K+ solution bathing the extrapatch cell membrane. These observations provide new evidence that Ca2+ can directly inhibit M channels, so supporting the view that Ca2+ might mediate M current inhibition following muscarinic receptor activation.			Selyanko, AA (corresponding author), UCL, DEPT PHARMACOL, GOWER ST, LONDON WC1E 6BT, ENGLAND.		Brown, David A/J-9019-2012					ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P221, DOI 10.1113/jphysiol.1989.sp017612; AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; CHEN HY, 1992, BRIT J PHARMACOL, V105, P329, DOI 10.1111/j.1476-5381.1992.tb14254.x; CONSTANTI A, 1981, NEUROSCI LETT, V24, P289, DOI 10.1016/0304-3940(81)90173-7; DUTAR P, 1988, NEUROSCI LETT, V85, P89, DOI 10.1016/0304-3940(88)90434-X; FILIPPOV AK, 1994, PFLUG ARCH EUR J PHY, V429, P223, DOI 10.1007/BF00374316; FOUCART S, 1995, AM J PHYSIOL-CELL PH, V268, pC829, DOI 10.1152/ajpcell.1995.268.4.C829; FUKUDA K, 1988, NATURE, V335, P355, DOI 10.1038/335355a0; HENKART M, 1980, FED PROC, V39, P2783; HIGASHIDA H, 1995, J PHYSIOL-LONDON, V482, P317, DOI 10.1113/jphysiol.1995.sp020520; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; Jones S. W, 1987, NEUROMODULATION BIOC, P159; KIRKWOOD A, 1991, NEURON, V6, P1009, DOI 10.1016/0896-6273(91)90240-Z; KUBA K, 1994, JPN J PHYSIOL, V44, P613, DOI 10.2170/jjphysiol.44.613; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MARRION NV, 1987, NEUROSCI LETT, V77, P55, DOI 10.1016/0304-3940(87)90606-9; MARRION NV, 1993, NEURON, V11, P77, DOI 10.1016/0896-6273(93)90272-S; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; MARSH SJ, 1995, NEURON, V15, P729, DOI 10.1016/0896-6273(95)90160-4; OWEN DG, 1990, J PHYSIOL-LONDON, V431, P269, DOI 10.1113/jphysiol.1990.sp018330; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; QIN D, 1991, JPN J PHYSIOL, V41, P333, DOI 10.2170/jjphysiol.41.333; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; ROBBINS J, 1992, J PHYSIOL-LONDON, V451, P159, DOI 10.1113/jphysiol.1992.sp019159; SCHMITT H, 1993, PFLUG ARCH EUR J PHY, V425, P134, DOI 10.1007/BF00374513; SELYANKO AA, 1993, J PHYSIOL-LONDON, V472, P711, DOI 10.1113/jphysiol.1993.sp019968; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; SELYANKO AA, 1995, RECEPTOR CHANNEL, V3, P147; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; SIMMONS MA, 1990, NEURON, V4, P557, DOI 10.1016/0896-6273(90)90113-T; SMART TG, 1987, J PHYSIOL-LONDON, V389, P337, DOI 10.1113/jphysiol.1987.sp016660; STANSFELD CE, 1993, NEURON, V10, P639, DOI 10.1016/0896-6273(93)90166-O; THAYER SA, 1988, MOL PHARMACOL, V34, P664; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; TROUSLARD J, 1993, J PHYSIOL-LONDON, V468, P53, DOI 10.1113/jphysiol.1993.sp019759; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; VIANNA AL, 1975, BIOCHIM BIOPHYS ACTA, V410, P389, DOI 10.1016/0005-2744(75)90241-7; WANG HS, 1995, J PHYSIOL-LONDON, V485, P319, DOI 10.1113/jphysiol.1995.sp020732; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; YU SP, 1994, J NEUROSCI, V14, P3487	55	113	116	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN	1996	16	1					151	162		10.1016/S0896-6273(00)80032-X	http://dx.doi.org/10.1016/S0896-6273(00)80032-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562079	Bronze			2022-12-28	WOS:A1996TT30700018
J	Jaramillo, F				Jaramillo, F			Signal transduction in hair cells and its regulation by calcium	NEURON			English	Review							ADAPTATION; CHANNELS; COCHLEA				Jaramillo, F (corresponding author), EMORY UNIV,SCH MED,DEPT PHYSIOL,ATLANTA,GA 30322, USA.							ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; DENK W, 1995, NEURON, V15; FUCHS PA, 1992, J NEUROSCI, V12, P800; GILLESPIE PG, 1995, CURR OPIN NEUROBIOL, V5, P449, DOI 10.1016/0959-4388(95)80004-2; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; KAKEHATA S, 1993, J PHYSIOL-LONDON, V463, P227, DOI 10.1113/jphysiol.1993.sp019592; Lenzi David, 1994, Current Opinion in Neurobiology, V4, P496, DOI 10.1016/0959-4388(94)90049-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; TUCKER T, 1995, NEURON, V15	19	22	22	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1227	1230		10.1016/0896-6273(95)90003-9	http://dx.doi.org/10.1016/0896-6273(95)90003-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845148	Bronze			2022-12-28	WOS:A1995TL67800003
J	KESSLER, JA; LUDLAM, WH; FREIDIN, MM; HALL, DH; MICHAELSON, MD; SPRAY, DC; DOUGHERTY, M; BATTER, DK				KESSLER, JA; LUDLAM, WH; FREIDIN, MM; HALL, DH; MICHAELSON, MD; SPRAY, DC; DOUGHERTY, M; BATTER, DK			CYTOKINE-INDUCED PROGRAMMED DEATH OF CULTURED SYMPATHETIC NEURONS	NEURON			English	Article							NERVE GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; SMOOTH-MUSCLE CELLS; DIFFERENTIAL REGULATION; FACTOR DEPRIVATION; CA-2+; RECEPTOR; GANGLION; INNERVATION	Programmed cell death (PCD) of sympathetic neurons is inhibited by nerve growth factor. However, factors that induce PCD of these cells are unknown. Leukemia inhibitory factor (LIF) and ciliary neurotrophic factor, neuropoietic cytokines known to regulate sympathetic neuron gene expression, were examined for effects on survival of cultured sympathetic neurons. Treatment with LIF or ciliary neurotrophic factor caused neuronal death in a dose-dependent fashion. Inhibition of RNA or protein synthesis, or treatment with potassium, all of which prevent PCD after nerve growth factor deprivation, prevented LIF-induced death. The morphologic and ultrastructural characteristics of the neuronal death induced by LIF and by nerve growth factor deprivation were similar. Furthermore, LIF treatment resulted in DNA fragmentation with a characteristic ''ladder'' on Southern blot analysis. These observations suggest that neuron numbers may be regulated by factors which initiate PCD, as well as by factors which prevent it.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT NEUROSCI, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	KESSLER, JA (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT NEUROL, BRONX, NY 10461 USA.			Spray, David/0000-0001-8368-5073; Freidin, Mona/0000-0002-3162-4858	NINDS NIH HHS [NS20778, NS20013] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020778, R01NS020013] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1992, TRENDS NEUROSCI, V15, P278, DOI 10.1016/0166-2236(92)90076-K; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHRIST GJ, 1992, AM J PHYSIOL, V263, pC373, DOI 10.1152/ajpcell.1992.263.2.C373; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FERRARI G, 1993, J NEUROSCI, V13, P1879; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GOLDMAN WF, 1990, CELL CALCIUM, V11, P221, DOI 10.1016/0143-4160(90)90073-4; GREEN SH, 1986, J BIOL CHEM, V261, P5316; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HENDRY IA, 1976, J NEUROCYTOL, V5, P351, DOI 10.1007/BF01175120; HENDRY IA, 1992, J NEUROSCI, V12, P3427; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; KESSLER JA, 1986, DEV BIOL, V113, P77, DOI 10.1016/0012-1606(86)90109-0; KESSLER JA, 1983, J NEUROSCI, V3, P1301; KESSLER JA, 1985, NEUROSCIENCE, V15, P827, DOI 10.1016/0306-4522(85)90081-8; KESSLER JA, 1985, J NEUROSCI, V5, P2719; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; LAZARUS KJ, 1976, BRAIN RES, V113, P159, DOI 10.1016/0006-8993(76)90013-5; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MOORE EDW, 1990, CELL CALCIUM, V11, P157, DOI 10.1016/0143-4160(90)90068-6; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; NAWA H, 1990, COLD SH Q B, V55, P247; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; OPPENHEIM RW, 1985, TRENDS NEUROSCI, V8, P487, DOI 10.1016/0166-2236(85)90175-4; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SKAPER SD, 1986, DEV BRAIN RES, V24, P39, DOI 10.1016/0165-3806(86)90171-9; SPIEGEL K, 1990, NEURON, V4, P303, DOI 10.1016/0896-6273(90)90104-N; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641	39	100	101	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1123	1132		10.1016/0896-6273(93)90225-G	http://dx.doi.org/10.1016/0896-6273(93)90225-G			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274279				2022-12-28	WOS:A1993MP54800013
J	MORALES, G; HUBERT, M; BRUMMENDORF, T; TREUBERT, U; TARNOK, A; SCHWARZ, U; RATHJEN, FG				MORALES, G; HUBERT, M; BRUMMENDORF, T; TREUBERT, U; TARNOK, A; SCHWARZ, U; RATHJEN, FG			INDUCTION OF AXONAL GROWTH BY HETEROPHILIC INTERACTIONS BETWEEN THE CELL-SURFACE RECOGNITION PROTEIN-F11 AND PROTEIN-NR-CAM/BRAVO	NEURON			English	Article							FIBRONECTIN-TYPE-III; IMMUNOGLOBULIN SUPERFAMILY; ADHESION MOLECULE; NEURITE OUTGROWTH; NERVOUS-SYSTEM; NG-CAM; PHOSPHATIDYLINOSITOL; GLYCOPROTEINS; DOMAINS; F11	F11 and Nr-CAM/Bravo are two axon-associated glycoproteins belonging to different subgroups of the immunoglobulin superfamily. In this report we have investigated the interaction of both proteins using neurite outgrowth and binding assays. Antibody blocking experiments demonstrate that neurite extension of tectal cells on immobilized F11 is mediated by Nr-CAM/Bravo. Binding studies further reveal a direct heterophilic interaction between F11 and Nr-CAM/Bravo. This activity can be mapped to the amino-terminal second or third immunoglobulin-like domain within F11 with domain-specific monoclonal antibodies and deletion mutant proteins expressed on COS cells. Furthermore, perturbation experiments with domain-specific monoclonal antibodies demonstrate that this region is required for adhesion and neurite extension.	MAX PLANCK INST ENTWICKLUNGSBIOL, D-72076 TUBINGEN, GERMANY; ZENTRUM MOLEK NEUROBIOL, D-20246 HAMBURG, GERMANY	Max Planck Society								ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5; BRUMMENDORF T, 1993, J NEUROCHEM, V61, P1207, DOI 10.1111/j.1471-4159.1993.tb13611.x; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BRUMMENDORF T, 1993, NEURON, V10, P711; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; DELAROSA EJ, 1990, J CELL BIOL, V111, P3087, DOI 10.1083/jcb.111.6.3087; FAIVRESARRAILH C, 1992, J NEUROSCI, V12, P257; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; KRUSHEL LA, 1993, NEUROSCIENCE, V53, P797, DOI 10.1016/0306-4522(93)90625-P; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MAURO VP, 1992, J CELL BIOL, V119, P191, DOI 10.1083/jcb.119.1.191; NORENBERG U, 1992, NEURON, V8, P849, DOI 10.1016/0896-6273(92)90199-N; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; RATHJEN FG, 1991, DEVELOPMENT, V113, P151; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WOLFF JM, 1989, BIOCHEM BIOPH RES CO, V161, P931, DOI 10.1016/0006-291X(89)92688-0; WOLFF JM, 1987, EUR J BIOCHEM, V168, P551, DOI 10.1111/j.1432-1033.1987.tb13453.x; WOLFF JM, 1988, THESIS U TUBINGEN TU; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	36	112	114	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1113	1122		10.1016/0896-6273(93)90224-F	http://dx.doi.org/10.1016/0896-6273(93)90224-F			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274278				2022-12-28	WOS:A1993MP54800012
J	WOOD, KA; DIPASQUALE, B; YOULE, RJ				WOOD, KA; DIPASQUALE, B; YOULE, RJ			IN-SITU LABELING OF GRANULE CELLS FOR APOPTOSIS-ASSOCIATED DNA FRAGMENTATION REVEALS DIFFERENT MECHANISMS OF CELL LOSS IN DEVELOPING CEREBELLUM	NEURON			English	Article							QUANTITATIVE-ANALYSIS; MOUSE CHIMERAS; CHICK-EMBRYOS; DEATH; NUMBER; PURKINJE; NEURONS; MICE; DEGRADATION; CORTEX	We have examined the role apoptosis plays during postnatal development of the mouse cerebellum by a new method utilizing T7 DNA polymerase for the in situ detection of DNA fragmentation associated with cell death. Granule cell loss between the third and fifth postnatal weeks, hypothesized to affect the granule cell to Purkinje cell stoichiometry, is not associated with DNA fragmentation. However, cerebellar granule cells undergo extensive nuclear DNA fragmentation between postnatal days 5 and 9. Cell death prior to synaptogenesis may help regulate granule cell number. Our results suggest that different mechanisms of cell death within the same neuronal cell population occur during development.			WOOD, KA (corresponding author), NINCDS,BIOCHEM SECT,SURG NEUROL BRANCH,BETHESDA,MD 20892, USA.							APPLEBY DW, 1977, P NATL ACAD SCI USA, V74, P5579, DOI 10.1073/pnas.74.12.5579; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; BRUSCH W, 1990, BIOCH CELL BIOL, V88, P1071; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CHUN JJM, 1987, NATURE, V325, P617, DOI 10.1038/325617a0; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; COHEN GM, 1992, BIOCHEM J, V286, P331, DOI 10.1042/bj2860331; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; CUNNINGHAM TJ, 1982, INT REV CYTOL, V74, P163, DOI 10.1016/S0074-7696(08)61172-9; DIPASQUALE B, 1991, BIOCHEM BIOPH RES CO, V181, P1442, DOI 10.1016/0006-291X(91)92101-O; DRISCOLL M, 1992, TRENDS NEUROSCI, V15, P15, DOI 10.1016/0166-2236(92)90343-7; FESUS L, 1989, FEBS LETT, V245, P150, DOI 10.1016/0014-5793(89)80210-8; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIORDANO DL, 1980, J NEUROCYTOL, V9, P603, DOI 10.1007/BF01205028; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; HERRUP K, 1987, J NEUROSCI, V7, P829; HERRUP K, 1986, DEV BIOL, V115, P148, DOI 10.1016/0012-1606(86)90236-8; HORNUNG JP, 1989, J COMP NEUROL, V283, P425, DOI 10.1002/cne.902830310; HUBER HE, 1987, ESCHERICHIA COLI THI, V262, P16224; Kerr J.F.R., 1987, P93; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; MODAK DJ, 1977, EXP CELL RES, V75, P307; OPPENHEIM RW, 1985, TRENDS NEUROSCI, V8, P487, DOI 10.1016/0166-2236(85)90175-4; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; SAMBROOK J, 1987, MOL CLONING LABORATO; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; SELLINS KS, 1991, J IMMUNOL, V147, P795; SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610; SONMEZ E, 1984, DEV BRAIN RES, V12, P271, DOI 10.1016/0165-3806(84)90049-X; TABOR S, 1987, J BIOL CHEM, V262, P16212; TOMEI LD, 1991, APOPTOSIS MOL BASIS; WETTS R, 1983, DEV BRAIN RES, V10, P41, DOI 10.1016/0165-3806(83)90119-0; WETTS R, 1982, J NEUROSCI, V2, P1494; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	39	328	332	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					621	632		10.1016/0896-6273(93)90074-2	http://dx.doi.org/10.1016/0896-6273(93)90074-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398151				2022-12-28	WOS:A1993MD06800007
J	TSOULFAS, P; SOPPET, D; ESCANDON, E; TESSAROLLO, L; MENDOZARAMIREZ, JL; ROSENTHAL, A; NIKOLICS, K; PARADA, LF				TSOULFAS, P; SOPPET, D; ESCANDON, E; TESSAROLLO, L; MENDOZARAMIREZ, JL; ROSENTHAL, A; NIKOLICS, K; PARADA, LF			THE RAT TRKC LOCUS ENCODES MULTIPLE NEUROGENIC RECEPTORS THAT EXHIBIT DIFFERENTIAL RESPONSE TO NEUROTROPHIN-3 IN PC12-CELLS	NEURON			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; LEUCINE-RICH ALPHA-2-GLYCOPROTEIN; PLATELET GLYCOPROTEIN-IB; TYROSINE KINASE-ACTIVITY; AMINO-ACID SEQUENCE; MOLECULAR-CLONING; HIGH-AFFINITY; FACTOR FAMILY; PROTOONCOGENE PRODUCT	Members of the Trk tyrosine kinase family have recently been identified as functional receptors of the NGF family of neurotrophins. Here we show the rat trkC locus to be complex, encoding at least four distinct polypeptides. Three of the encoded polypeptides are full-length receptor tyrosine kinases that differ by novel amino acid insertions in the kinase domain. A fourth protein is a truncated receptor that lacks the catalytic domain. Tyrosine phosphorylation, cross-linking, and ligand binding assays indicate that TrkC receptors interact with NT-3 and not with the related neurotrophins NGF, BDNF, xNT-4, or hNT-5. Furthermore, high and low affinity NT-3-binding sites are associated with the TrkC receptors. Stable and transient expression of TrkC receptors in PC12 cells indicates that the neurite outgrowth response elicited by NT-3 is dramatic in receptors lacking the novel kinase insert (gp150trkC) but absent in receptors containing the 14 amino acid insert in the kinase domain (gp150trkC14). These data suggest that the trkC locus encodes receptors that may be capable of mediating different biological responses within the cell. This could have important implications in understanding the role of neurotrophins in the development of the vertebrate nervous system.	GENENTECH INC,S SAN FRANCISCO,CA 94080; UN AM,INST FISIOL CELULAR,MEXICO CITY 04510,DF,MEXICO	Roche Holding; Genentech	TSOULFAS, P (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,MOLEC EMBRYOL SECT,ABL BASIC RES PROGRAM,FREDERICK,MD 21702, USA.		Parada, luis F/B-9400-2014; Tsoulfas, Pantelis/GNH-1922-2022	Tsoulfas, Pantelis/0000-0003-1974-6366	NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BERND P, 1984, J BIOL CHEM, V259, P5509; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIES AM, 1986, J NEUROSCI, V6, P1897; Ebendal T, 1989, Prog Growth Factor Res, V1, P143, DOI 10.1016/0955-2235(89)90008-2; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ESCANONYESCANDON E, 1993, IN PRESS J NEUROSCI; GOEDERT M, 1986, MOL BRAIN RES, V1, P85, DOI 10.1016/0169-328X(86)90023-9; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hanks SK, 1991, CURR OPIN STRUC BIOL, V1, P369, DOI 10.1016/0959-440X(91)90035-R; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HENDERSON CE, 1993, IN PRESS NATURE; HICKEY MJ, 1989, P NATL ACAD SCI USA, V86, P6773, DOI 10.1073/pnas.86.17.6773; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; KRANTZ DD, 1991, J BIOL CHEM, V266, P16801; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; KUMA KI, 1991, P JAPAN ACAD, V10, P181; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; LOPEZ JA, 1988, P NATL ACAD SCI USA, V85, P2135, DOI 10.1073/pnas.85.7.2135; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, MOL CELL BIOL, V8, P176, DOI 10.1128/MCB.8.1.176; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SCHMELZER CH, 1992, J NEUROCHEM, V59, P1675, DOI 10.1111/j.1471-4159.1992.tb10998.x; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SCHNEIDER DS, 1991, ONCOGENE, V6, P1807; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SONNENFELD KH, 1985, J NEUROSCI, V5, P1717; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; TESSAROLLO L, 1992, DEVELOPMENT, V115, P11; TESSAROLLO L, 1993, IN PRESS DEVELOPMENT; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; UENO H, 1992, J BIOL CHEM, V267, P1470; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WHITTEMORE SR, 1986, P NATL ACAD SCI USA, V83, P817, DOI 10.1073/pnas.83.3.817; WILKIE T M, 1991, Methods (Orlando), V2, P32, DOI 10.1016/S1046-2023(05)80123-9; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	88	273	288	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					975	990		10.1016/0896-6273(93)90212-A	http://dx.doi.org/10.1016/0896-6273(93)90212-A			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494648				2022-12-28	WOS:A1993LD32200019
J	GOLA, M; CREST, M				GOLA, M; CREST, M			COLOCALIZATION OF ACTIVE KCA CHANNELS AND CA2+ CHANNELS WITHIN CA2+ DOMAINS IN HELIX NEURONS	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; GENERATING NERVE-CELLS; SQUID GIANT SYNAPSE; POTASSIUM CHANNELS; TRANSMITTER RELEASE; DENDRITIC SPINES; CALCIUM; CURRENTS; VOLTAGE; ACTIVATION	Large conductance Ca2+-activated K+ channels (KCa channels) have to be colocalized with Ca2+ channels to be involved in nerve cell firing regulation. KCa channels were detected in cell-attached patches performed in voltage-clamped Helix neurons. This technique allowed Ca2+ entry to occur either within or around the patch. We observed that the submembrane Ca2+ diffusion was sufficiently limited to prevent the KCa channels from being opened by remote Ca2+ entry. The KCa channels located i n areas devoid of Ca2+ channels remained quiescent during cell firing. These crypto channels were detected following either patch excision or intracellular Ca2+ injection. These data provide direct evidence for the existence of functional Ca2+ domains in a nonspecialized neural membrane.			GOLA, M (corresponding author), CNRS,NEUROBIOL LAB,31 CHEMIN JOSEPH AIGUIER,F-13402 MARSEILLE 9,FRANCE.							AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; CHAGNEUX H, 1989, BRAIN RES, V488, P336, DOI 10.1016/0006-8993(89)90726-9; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CREST M, 1990, BRAIN RES, V518, P299, DOI 10.1016/0006-8993(90)90986-L; CREST M, 1990, J EXP BIOL, V152, P211; CREST M, 1992, J BIOL CHEM, V267, P1640; CREST M, 1993, IN PRESS J PHYSL; FISCHMEISTER R, 1986, PFLUG ARCH EUR J PHY, V406, P73, DOI 10.1007/BF00582957; GOLA M, 1990, J PHYSIOL-LONDON, V420, P73, DOI 10.1113/jphysiol.1990.sp017902; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; HERMANN A, 1987, J GEN PHYSIOL, V90, P27, DOI 10.1085/jgp.90.1.27; HEYER CB, 1976, J PHYSIOL-LONDON, V262, P349, DOI 10.1113/jphysiol.1976.sp011599; IKEMOTO Y, 1989, BIOPHYS J, V56, P2207; IMREDY JP, 1992, NEURON, V9, P197, DOI 10.1016/0896-6273(92)90159-B; KEIZER J, 1992, BIOPHYS J, V63, P291, DOI 10.1016/S0006-3495(92)81576-X; LANCASTER B, 1991, J NEUROSCI, V11, P23; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LANG DG, 1990, J PHYSIOL-LONDON, V425, P117, DOI 10.1113/jphysiol.1990.sp018095; LANG DG, 1987, PFLUG ARCH EUR J PHY, V410, P614, DOI 10.1007/BF00581321; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; LUX HD, 1982, PFLUG ARCH EUR J PHY, V394, P70, DOI 10.1007/BF01108310; MARKWARDT F, 1992, J GEN PHYSIOL, V99, P841, DOI 10.1085/jgp.99.6.841; MAZZANTI M, 1991, J PHYSIOL-LONDON, V443, P307, DOI 10.1113/jphysiol.1991.sp018835; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; MILTON RL, 1990, PFLUG ARCH EUR J PHY, V416, P758, DOI 10.1007/BF00370626; MULLER TH, 1989, J GEN PHYSIOL, V94, P997, DOI 10.1085/jgp.94.6.997; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; PIN T, 1990, J EXP BIOL, V152, P189; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; THOMPSON S, 1988, J NEUROSCI, V8, P1929; VERITY MA, 1992, NEUROTOXICOLOGY, V13, P139; WOOLUM JC, 1981, BIOPHYS J, V36, P297, DOI 10.1016/S0006-3495(81)84729-7; YOSHIDA A, 1991, JPN J PHYSIOL, V41, P297, DOI 10.2170/jjphysiol.41.297	39	90	91	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					689	699		10.1016/0896-6273(93)90170-V	http://dx.doi.org/10.1016/0896-6273(93)90170-V			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386529				2022-12-28	WOS:A1993KY50100012
J	NEHER, E; ZUCKER, RS				NEHER, E; ZUCKER, RS			MULTIPLE CALCIUM-DEPENDENT PROCESSES RELATED TO SECRETION IN BOVINE CHROMAFFIN CELLS	NEURON			English	Article							ADRENAL-MEDULLARY CELLS; FLUORESCENT INDICATOR; EXOCYTOSIS; RELEASE; FURA-2	We have used the caged calcium compound DM-nitrophen to investigate the kinetics of calcium-dependent secretion in bovine chromaffin cells. Perfusion with partially calcium-loaded nitrophen often caused a loading transient-slow secretion for up to 1 min due to displacement of Ca2+ by cytoplasmic Mg2+. Flash photolysis elicited 100 muM [Ca2+]i steps that evoked intense secretion, lasting a few seconds. In cells experiencing a loading transient, [Ca2+]i steps evoked an especially fast secretion. A persistent, slow secretion often followed these fast phases. Distinct kinetic components may reflect secretion from pools that are differentially capable of release. Both secretion and movement of vesicles between pools appear to be [Ca2+]i sensitive. Later [Ca2+]i steps sometimes evoked a rapid capacitance decrease, indicating a fast, [Ca2+]i-dependent phase of endocytosis.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	NEHER, E (corresponding author), MAX PLANCK INST BIOPHYS CHEM, DEPT MEMBRANE BIOPHYS, W-3400 GOTTINGEN, GERMANY.		Neher, Erwin/A-2109-2013; Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343				AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUNIS D, 1988, J EXP BIOL, V139, P253; BAKER PF, 1986, BRIT MED BULL, V42, P399, DOI 10.1093/oxfordjournals.bmb.a072158; BECKER PL, 1987, AM J PHYSIOL, V253, pC613, DOI 10.1152/ajpcell.1987.253.4.C613; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; CHEEK TR, 1989, J CELL BIOL, V109, P1219, DOI 10.1083/jcb.109.3.1219; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; KAPLAN JH, 1990, ANNU REV PHYSIOL, V52, P897; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Katz B., 1969, RELEASE NEURAL TRANS; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KNIGHT DE, 1989, TRENDS NEUROSCI, V12, P451, DOI 10.1016/0166-2236(89)90095-7; KNIGHT DE, 1983, PROC R SOC SER B-BIO, V218, P177, DOI 10.1098/rspb.1983.0033; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NEHER E, 1989, NEUROMUSCULAR JUNCTI, P65; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; ZUCKER RS, 1992, CELL CALCIUM, V13, P29, DOI 10.1016/0143-4160(92)90027-P; ZUCKER RS, 1991, ANN NY ACAD SCI, V635, P191, DOI 10.1111/j.1749-6632.1991.tb36492.x; ZUCKER RS, 1993, IN PRESS CELL CALCIU	28	472	475	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					21	30		10.1016/0896-6273(93)90238-M	http://dx.doi.org/10.1016/0896-6273(93)90238-M			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427700				2022-12-28	WOS:A1993KK01200003
J	Harris, R; Sabatelli, LM; Seeger, MA				Harris, R; Sabatelli, LM; Seeger, MA			Guidance cues at the Drosophila CNS midline: Identification and characterization of two Drosophila Netrin/UNC-6 homologs	NEURON			English	Article							PIONEER AXON MIGRATIONS; CENTRAL-NERVOUS-SYSTEM; GROWTH CONE GUIDANCE; C-ELEGANS; COMMISSURAL AXONS; FLOOR PLATE; GUIDES CELL; EXPRESSION; MELANOGASTER; CHEMOATTRACTANT	Netrins are chemotropic guidance signals that play important roles in circumferential axon guidance in C. elegans and in the developing vertebrate spinal cord. We have identified two Drosophila homologs of this protein family (Netrin-A and Netrin-B). Both Netrins are dynamically expressed throughout embryogenesis, including CNS midline expression at the time of commissure formation. Both Netrin genes map close to each other on the X chromosome, and embryos deficient for this region exhibit defects in commissure formation. This CNS phenotype can be rescued by expression of either Netrin at the CNS midline, confirming an important role for Drosophila Netrins in commissural growth cone guidance. A localized source of Netrin protein at the midline is apparently important for function, since ectopic expression of either Netrin throughout the CNS results in phenotypic defects similar to the loss-of-function phenotype.			Harris, R (corresponding author), OKLAHOMA MED RES FDN,PROGRAM MOL & CELL BIOL,825 NE 13TH ST,OKLAHOMA CITY,OK 73104, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032839, R29NS032839] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32839] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bate Michael, 1993, P1013; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Cohen Stephen M., 1993, P747; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; DRYSDALE R, 1991, GENETICS, V127, P497; Goodman Corey S., 1993, P1131; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HARLOW E, 1988, ANTIBODIES LAB MNAUA; HEDGECOCK EM, 1990, NEURON, V2, P61; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Manning Gerards, 1993, P609; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MITCHELL KJ, 1996, IN PRESS NEURON, V17; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PLACZEK M, 1990, COLD SPRING HARB SYM, V55, P279; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J., 2002, MOL CLONING LAB MANU; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SMOLLER DA, 1991, CHROMOSOMA, V100, P487, DOI 10.1007/BF00352199; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; YAGINUMA H, 1991, J NEUROSCI, V11, P2598; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	44	268	272	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					217	228		10.1016/S0896-6273(00)80154-3	http://dx.doi.org/10.1016/S0896-6273(00)80154-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780646	Bronze			2022-12-28	WOS:A1996VE84000005
J	Spana, EP; Doe, CQ				Spana, EP; Doe, CQ			Numb antagonizes notch signaling to specify sibling neuron cell fates	NEURON			English	Article							NERVOUS-SYSTEM; DROSOPHILA; GENE; PROTEIN; DELTA; SUPPRESSOR; EXPRESSION; HAIRLESS	Asymmetric cell divisions play a key role in establishing neuronal diversity in the mammalian and Drosophila CNS, but the mechanisms involved are mostly unknown. The Drosophila MP2 precursor divides asymmetrically to generate the dMP2/vMP2 interneurons. Delta-Notch signaling is required to specify vMP2 fate, whereas the localized determinant Numb is segregated into dMP2 and is required to specify dMP2 fate. Notch; numb double mutants have two dMP2 neurons; hence, Numb is not required for dMP2 fate, but antagonizes the Delta-Notch ''vMP2'' signal. In vivo Delta expression and in vitro culture experiments show that vMP2 fate is specified by an ''inductive'' signal from outside the MP2 lineage. Thus, intrinsic and extrinsic cues converge to specify binary cell fates in the MP2 cell lineage.			Spana, EP (corresponding author), UNIV ILLINOIS,DEPT CELL & STRUCT BIOL,HOWARD HUGHES MED INST,URBANA,IL 61801, USA.							ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; BATE CM, 1981, J EMBRYOL EXP MORPH, V61, P317; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; Campos-Ortega Jose A., 1993, P1091; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DOE CQ, 1992, DEVELOPMENT, V116, P855; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GREENWALD I, 1989, TRENDS GENET, V5, P237, DOI 10.1016/0168-9525(89)90094-2; GRIMWADE BG, 1985, DEV BIOL, V107, P503, DOI 10.1016/0012-1606(85)90331-8; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; JAN YN, 1995, NEURON, V14, P1; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KOOH PJ, 1993, DEVELOPMENT, V117, P493; KUWADA JY, 1985, DEV BIOL, V110, P114, DOI 10.1016/0012-1606(85)90069-7; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; MENNE TV, 1994, DEVELOPMENT, V120, P123; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; PERRIMON N, 1994, CELL, V76, P781, DOI 10.1016/0092-8674(94)90351-4; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; SEECOF RL, 1971, EXP CELL RES, V69, P161, DOI 10.1016/0014-4827(71)90321-1; SKEATH JB, 1992, DEVELOPMENT, V114, P939; SKEATH JB, 1994, FASEB J, V8, P714, DOI 10.1096/fasebj.8.10.8050670; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0	33	351	359	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					21	26		10.1016/S0896-6273(00)80277-9	http://dx.doi.org/10.1016/S0896-6273(00)80277-9			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755475	Bronze			2022-12-28	WOS:A1996UY98100004
J	Miles, R; Toth, K; Gulyas, AI; Hajos, N; Freund, TF				Miles, R; Toth, K; Gulyas, AI; Hajos, N; Freund, TF			Differences between somatic and dendritic inhibition in the hippocampus	NEURON			English	Article							PYRAMIDAL CELLS; RAT HIPPOCAMPUS; DENTATE GYRUS; RECEPTOR; NEURONS; SYNAPSES; INVITRO; INTERNEURONS; BRAIN	Hippocampal synaptic inhibition is mediated by distinct groups of inhibitory cells. Some contact pyramidal cells perisomatically, while others terminate exclusively on their dendrites. We examined perisomatic and dendritic inhibition by recording from CA3 inhibitory and pyramidal cells and injecting biocytin to visualize both cells in light and electron microscopy. Single perisomatic inhibitory cells made 2-6 terminals clustered around the soma and proximal pyramidal cell processes. Dendritic cells established 5-17 terminals, usually on different dendrites of a pyramidal cell. Perisomatic terminals were larger than those facing dendritic membrane. Perisomatic inhibitory cells initiated the majority of simultaneous IPSPs seen in nearby pyramidal cells. Single IPSPs initiated by perisomatic inhibitory cells could suppress repetitive discharge of sodium-dependent action potentials. Activation of inhibitory fibers terminating on dendrites could suppress calcium-dependent spikes. Thus, distinct inhibitory cells may differentially control dendritic electrogenesis and axonal output of hippocampal pyramidal cells.	HUNGARIAN ACAD SCI,INST EXPTL MED,H-1450 BUDAPEST,HUNGARY	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Miles, R (corresponding author), INST PASTEUR,LAB NEUROBIOL CELLULAIRE,25 RUE DR ROUX,F-75724 PARIS,FRANCE.		Hajos, Norbert/U-2640-2019	Hajos, Norbert/0000-0002-4582-2708; Miles, Richard/0000-0001-7303-0233; Gulyas, Attila/0000-0003-4961-636X				ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; ATWOOD HL, 1983, CELL TISSUE RES, V231, P103; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BLACKSTAD TW, 1963, NATURE, V198, P542, DOI 10.1038/198542a0; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; ECCLES JC, 1969, INHIBITORY PATHWAYS, P101; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; HILL JA, 1993, J NEUROSCI, V13, P1551; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; LAMBERT NA, 1993, NEURON, V11, P1057, DOI 10.1016/0896-6273(93)90219-H; LLINAS R, 1971, J NEUROPHYSIOL, V34, P352; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MICHELSON H, 1991, SCIENCE, V258, P1420; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; MITGAARD J, 1992, J PHYSL, V457, P355; MULLER W, 1990, J NEUROPHYSIOL, V64, P46, DOI 10.1152/jn.1990.64.1.46; NICOLL RA, 1994, NATURE, V368, P808, DOI 10.1038/368808a0; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; SOMOGYI P, 1983, BRAIN RES, V259, P137, DOI 10.1016/0006-8993(83)91076-4; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; WISDEN W, 1992, J NEUROSCI, V12, P1040; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86	39	732	741	1	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					815	823		10.1016/S0896-6273(00)80101-4	http://dx.doi.org/10.1016/S0896-6273(00)80101-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607999	Bronze			2022-12-28	WOS:A1996UG61100014
J	Ashery, U; Penner, R; Spira, ME				Ashery, U; Penner, R; Spira, ME			Acceleration of membrane recycling by axotomy of cultured Aplysia neurons	NEURON			English	Article							FROG NEUROMUSCULAR JUNCTION; PATCH-CLAMP TECHNIQUES; GROWTH CONES; CAPACITANCE MEASUREMENTS; INTRACELLULAR CALCIUM; NERVE REGENERATION; SYNAPTIC VESICLES; MOTOR NEURONS; CELLS; ENDOCYTOSIS	The rapid transition of a stationary axon into a motile growth cone requires the recruitment of membrane and its strategic insertion into the neurolemma. The source of membrane to support the initial rapid growth postaxotomy is not known. Using membrane capacitance measurements, we examined quantitative aspects of membrane dynamics following axotomy of cultured Aplysia neurons. Axotomy activates two processes in parallel: membrane retrieval and exocytosis. Unexpectedly, membrane retrieval is the dominant process in the majority of the experiments. Thus, while a growth cone is vigorously extending, the total neuronal surface area decreases. We suggest that the initial rapid extension phase of the newly formed growth cone postaxotomy is supported by a pool of intracellular membrane that is rapidly retrieved from the neurolemma.	MAX PLANCK INST BIOPHYS CHEM,GOTTINGEN,GERMANY	Max Planck Society	Ashery, U (corresponding author), HEBREW UNIV JERUSALEM,INTRUNIV INST MARINE SCI,INST LIFE SCI,DEPT NEUROBIOL,ELAT,ISRAEL.		Spira, Micha/B-6470-2012	Penner, Reinhold/0000-0002-5366-1537; Ashery, Uri/0000-0001-6338-7888				BAAS PW, 1986, J CELL BIOL, V103, P917, DOI 10.1083/jcb.103.3.917; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BAILEY CH, 1994, SEMIN NEUROSCI, V6, P35; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BENBASSAT D, 1994, EUR J NEUROSCI, V6, P1605, DOI 10.1111/j.1460-9568.1994.tb00551.x; BENBASSAT D, 1993, EXP NEUROL, V122, P295, DOI 10.1006/exnr.1993.1129; BRAY D, 1973, NATURE, V244, P93, DOI 10.1038/244093a0; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; BRAY D, 1992, NERVE GROWTH CONE, P7; BUNGE MB, 1977, J NEUROCYTOL, V6, P407, DOI 10.1007/BF01178226; BURGOYNE RD, 1995, TRENDS NEUROSCI, V18, P191, DOI 10.1016/0166-2236(95)93900-I; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHENG TPO, 1987, J NEUROSCI, V7, P1752; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FELDMAN EL, 1981, J NEUROBIOL, V12, P591, DOI 10.1002/neu.480120607; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FISHMAN HM, 1990, BIOCHIM BIOPHYS ACTA, V1023, P421, DOI 10.1016/0005-2736(90)90135-B; GRIFFIN JW, 1981, J CELL BIOL, V88, P205, DOI 10.1083/jcb.88.1.205; GUNSTREAM JD, 1995, J NEUROSCI, V15, P439; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYDON PG, 1987, J NEUROBIOL, V18, P197, DOI 10.1002/neu.480180206; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HOCHNER B, 1987, J NEUROSCI, V7, P261; HU YH, 1993, NEURON, V10, P921, DOI 10.1016/0896-6273(93)90207-8; Johnston R N, 1980, Curr Top Dev Biol, V16, P165; Kandel ER., 1976, CELLULAR BASIS BEHAV; KATER SB, 1991, J NEUROSCI, V11, P891; Keynes R J, 1992, Curr Opin Neurobiol, V2, P55, DOI 10.1016/0959-4388(92)90162-E; KRAUSE TL, 1994, J NEUROSCI, V1, P6638; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; MARSH M, 1980, J MOL BIOL, V142, P439, DOI 10.1016/0022-2836(80)90281-8; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PENNER R, 1989, TRENDS NEUROSCI, V12, P159, DOI 10.1016/0166-2236(89)90059-3; PFENNINGER KH, 1993, DEV BRAIN RES, V71, P181, DOI 10.1016/0165-3806(93)90170-F; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SHAW G, 1977, EXP CELL RES, V104, P55, DOI 10.1016/0014-4827(77)90068-4; SHELTON DP, 1985, NEUROSCIENCE, V14, P111, DOI 10.1016/0306-4522(85)90168-X; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; WATSON AHD, 1981, CELL TISSUE RES, V215, P325; WESSELLS NK, 1978, EXP CELL RES, V117, P335, DOI 10.1016/0014-4827(78)90147-7; WESSELLS NK, 1974, TISSUE CELL, V6, P757, DOI 10.1016/0040-8166(74)90014-7; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625, DOI 10.1152/jn.1995.74.6.2625	52	26	27	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					641	651		10.1016/S0896-6273(00)80083-5	http://dx.doi.org/10.1016/S0896-6273(00)80083-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785061	Bronze			2022-12-28	WOS:A1996UC16800020
J	DeCamilli, P; Takei, K				DeCamilli, P; Takei, K			Molecular mechanisms in synaptic vesicle endocytosis and recycling	NEURON			English	Review							FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; COATED VESICLES; CLATHRIN; MEMBRANE; PROTEINS; CELLS				DeCamilli, P (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,NEW HAVEN,CT 06510, USA.			Takei, Kohji/0000-0002-6555-9425				Artalejo C. R., 1995, Molecular Biology of the Cell, V6, p296A; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BECK KA, 1991, J BIOL CHEM, V266, P4442; BETZ WJ, 1995, CURR BIOL, V5, P1098, DOI 10.1016/S0960-9822(95)00220-X; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CONIBEAR E, 1995, CELL, V83, P513, DOI 10.1016/0092-8674(95)90088-8; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; LINDNER R, 1992, J BIOL CHEM, V267, P16567; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; PLEY U, 1993, CRIT REV BIOCHEM MOL, V28, P431, DOI 10.3109/10409239309078441; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; ROBINSON PJ, 1994, TRENDS NEUROSCI, V17, P348, DOI 10.1016/0166-2236(94)90179-1; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Schmid Sandra L., 1993, Trends in Cell Biology, V3, P145, DOI 10.1016/0962-8924(93)90129-O; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K., 1995, Molecular Biology of the Cell, V6, p404A; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; VALLEE RB, 1995, TRENDS CELL BIOL, V5, P43, DOI 10.1016/S0962-8924(00)88937-0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564	46	187	189	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					481	486		10.1016/S0896-6273(00)80068-9	http://dx.doi.org/10.1016/S0896-6273(00)80068-9			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785046	Bronze			2022-12-28	WOS:A1996UC16800005
J	BARRES, BA; RAFF, MC				BARRES, BA; RAFF, MC			CONTROL OF OLIGODENDROCYTE NUMBER IN THE DEVELOPING RAT OPTIC-NERVE	NEURON			English	Review							GLIAL PROGENITOR-CELL; GROWTH-FACTOR; GLUCOCORTICOID RECEPTOR; NEGATIVE REGULATION; ASTROCYTE LINEAGES; PDGF RECEPTORS; NULL MUTATION; RETINOIC ACID; AP-1 ACTIVITY; C-FOS		UNIV LONDON UNIV COLL,DEPT BIOL,MRC,DEV NEUROBIOL PROGRAMME,LONDON WC1E 6BT,ENGLAND	University of London; University College London								ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BARRES BA, 1994, IN PRESS DEVELOPMENT; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DUSSAULT JH, 1987, ANNU REV PHYSIOL, V49, P321, DOI 10.1146/annurev.ph.49.030187.001541; FULTON BP, 1992, J NEUROSCI, V12, P4816; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; GILBERT LI, 1981, METAMOPRHOSIS PROBLE; GROVE EA, 1993, DEVELOPMENT, V117, P535; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; HANNSON HA, 1989, EXP EYE RES, V48, P411; HARDY R, 1991, DEVELOPMENT, V111, P1061; HART IK, 1989, DEVELOPMENT, V105, P595; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1990, MOL ASPECTS CELLULAR; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P3782, DOI 10.1128/MCB.13.6.3782; LAM K, 1982, DEV BRAIN RES, V3, P487, DOI 10.1016/0165-3806(82)90014-1; Legrand J, 1986, THYROID HORMONE META, P503; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; MCKINNON RD, 1993, J CELL BIOL, V121, P1397, DOI 10.1083/jcb.121.6.1397; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; MUDHAR HS, 1993, IN PRESS DEVELOPMENT; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; Noble M, 1992, Semin Cell Biol, V3, P413, DOI 10.1016/1043-4682(92)90012-K; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOBLE M, 1984, EMBO J, V3, P2243, DOI 10.1002/j.1460-2075.1984.tb02122.x; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Peters A., 1991, FINE STRUCTURE NERVO; PRINGLE N, 1989, EMBO J, V8, P1049, DOI 10.1002/j.1460-2075.1989.tb03472.x; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; PUYMIRAT J, 1992, PROG NEUROBIOL, V39, P281, DOI 10.1016/0301-0082(92)90019-B; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; RIABOWOL K, 1992, P NATL ACAD SCI USA, V89, P157, DOI 10.1073/pnas.89.1.157; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SAMEL M, 1968, GEN COMP ENDOCR, V10, P229, DOI 10.1016/0016-6480(68)90029-4; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SKOFF RP, 1982, BRAIN RES, V248, P19, DOI 10.1016/0006-8993(82)91143-X; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; TAUBER H, 1980, NEUROSCI LETT, V16, P235, DOI 10.1016/0304-3940(80)90003-8; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; WALTERS SN, 1981, J NEUROCHEM, V36, P1792, DOI 10.1111/j.1471-4159.1981.tb00433.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; WOISWIJK G, 1989, DEVELOPMENT, V105, P387; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; ZHANG XK, 1991, MOL CELL BIOL, V11, P6016, DOI 10.1128/MCB.11.12.6016	68	335	340	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					935	942		10.1016/0896-6273(94)90305-0	http://dx.doi.org/10.1016/0896-6273(94)90305-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185952				2022-12-28	WOS:A1994NM83100001
J	SNOW, AD; SEKIGUCHI, R; NOCHLIN, D; FRASER, P; KIMATA, K; MIZUTANI, A; ARAI, M; SCHREIER, WA; MORGAN, DG				SNOW, AD; SEKIGUCHI, R; NOCHLIN, D; FRASER, P; KIMATA, K; MIZUTANI, A; ARAI, M; SCHREIER, WA; MORGAN, DG			AN IMPORTANT ROLE OF HEPARAN-SULFATE PROTEOGLYCAN (PERLECAN) IN A MODEL SYSTEM FOR THE DEPOSITION AND PERSISTENCE OF FIBRILLAR A-ALPHA-AMYLOID IN RAT-BRAIN	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; SWARM MOUSE-TUMOR; ALZHEIMERS-DISEASE; BASEMENT-MEMBRANE; CHONDROITIN SULFATE; BETA-PROTEIN; P-COMPONENT; NEUROFIBRILLARY TANGLES; PROTEOLYTIC DEGRADATION; MODIFIED BIELSCHOWSKY	A consistent rat model for the study of the consequences of congophilic and fibrillar Abeta-amyloid in brain has been developed. One hundred percent of animals receiving infusions of synthetic beta-amyloid protein (Abeta 1-40) plus a specific heparan sulfate proteoglycan (HSPG) for 1 week or 7 weeks (following 2 week infusions) demonstrated Congo red and thioflavin S-positive deposits adjacent to the infusion site. Extracellular amyloid fibrils were identified by electron microscopy and were immunogold decorated with Abeta antibody. Significant increases in Congo red staining were observed in animals infused with Abeta plus HSPG versus those infused with only Abeta. Infusion of Abeta alone was variable with respect to congophilic amyloid persistence, which occurred in 50% of animals and only when endogenous HSPGs accumulated at Abeta deposition sites. By 7 weeks, only animals infused with Abeta plus HSPG demonstrated compaction of the Congo red material from amorphous, wispy deposits (at 1 week) to stellate deposits resembling a Maltese cross. These spherical amyloid deposits were very similar to Congo red-stained amyloid plaques in human Alzheimer's disease brain, and in vitro data suggest that they were probably formed in vivo following interactions with endogenous brain components.	UNIV TORONTO,CTR RES NEURODEGENERAT DIS,TORONTO M5S 1A8,ONTARIO,CANADA; AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN; SEIKAGAKU CORP,TOKYO INST,TOKYO 103,JAPAN; UNIV SO CALIF,DIV NEUROGERONTOL,LOS ANGELES,CA 90089	University of Toronto; Aichi Medical University; Seikagaku Corporation; University of Southern California	SNOW, AD (corresponding author), UNIV WASHINGTON,DEPT PATHOL,NEUROPATHOL LABS RJ05,SEATTLE,WA 98195, USA.		Morgan, David G/J-5989-2012		NATIONAL INSTITUTE ON AGING [R01AG007892, P50AG005136] Funding Source: NIH RePORTER; NIA NIH HHS [AG05136, AG7892] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; BAUER J, 1991, FEBS LETT, V285, P111, DOI 10.1016/0014-5793(91)80737-N; BEYREUTHER K, 1990, NEUROBIOL AGING, V11, P66, DOI 10.1016/0197-4580(90)90067-A; BUEE L, 1993, BRAIN RES, V601, P154, DOI 10.1016/0006-8993(93)91706-X; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CLEMENS JA, 1992, NEUROBIOL AGING, V13, P581, DOI 10.1016/0197-4580(92)90059-7; CORIA F, 1988, LAB INVEST, V58, P454; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P629, DOI 10.1097/00005072-198811000-00006; DAVIES P, 1992, NEUROBIOL AGING, V13, P613, DOI 10.1016/0197-4580(92)90066-7; DEMEDICINA EP, 1990, BIOCHIM BIOPHYS ACTA, V1053, P135; EIKELENBOOM P, 1989, VIRCHOWS ARCH B, V56, P259; ELGHETANY MT, 1988, STAIN TECHNOL, V63, P201, DOI 10.3109/10520298809107185; EMRE M, 1992, NEUROBIOL AGING, V13, P553, DOI 10.1016/0197-4580(92)90055-3; FLUHARTY AL, 1975, J NEUROCHEM, V25, P429, DOI 10.1111/j.1471-4159.1975.tb04345.x; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; FRAUTSCHY SA, 1992, AM J PATHOL, V140, P1389; FREDERICKSON RCA, 1992, NEUROBIOL AGING, V13, P239, DOI 10.1016/0197-4580(92)90036-W; GAMES D, 1992, NEUROBIOL AGING, V13, P569, DOI 10.1016/0197-4580(92)90057-5; GEULA C, 1989, BRAIN RES, V498, P185, DOI 10.1016/0006-8993(89)90419-8; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; HAMAZAKI H, 1987, J BIOL CHEM, V262, P1456; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; HUSBY G, 1993, B WORLD HEALTH ORGAN, V71, P105; ISEKI E, 1988, NEUROPATH APPL NEURO, V14, P169, DOI 10.1111/j.1365-2990.1988.tb00878.x; ISHIHARA T, 1991, BRAIN RES, V548, P196, DOI 10.1016/0006-8993(91)91122-H; JI ZS, 1993, J BIOL CHEM, V268, P10160; JOACHIM CL, 1989, AM J PATHOL, V135, P309; KALARIA RN, 1991, NEUROPATH APPL NEURO, V17, P189, DOI 10.1111/j.1365-2990.1991.tb00714.x; KATO M, 1988, J CELL BIOL, V106, P2203, DOI 10.1083/jcb.106.6.2203; KATO M, 1987, J BIOL CHEM, V262, P7180; KOLSET SO, 1987, GLYCOCONJUGATE J, V4, P73, DOI 10.1007/BF01048446; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; KOWALL NW, 1992, NEUROBIOL AGING, V13, P537, DOI 10.1016/0197-4580(92)90053-Z; KRUEGER RC, 1987, ANAL BIOCHEM, V167, P295, DOI 10.1016/0003-2697(87)90167-9; MANDYBUR TI, 1990, NEUROLOGY, V40, P635, DOI 10.1212/WNL.40.4.635; MARTIN LJ, 1991, P NATL ACAD SCI USA, V88, P1461, DOI 10.1073/pnas.88.4.1461; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; MORAN MA, 1993, ACTA NEUROPATHOL, V85, P362, DOI 10.1007/BF00334445; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; NOONAN DM, 1988, J BIOL CHEM, V263, P16379; OWENS RT, 1991, ARTERIOSCLER THROMB, V11, P1752, DOI 10.1161/01.ATV.11.6.1752; PIKE CJ, 1991, BRAIN RES, V261, P321; PODLISNY MB, 1992, NEUROBIOL AGING, V13, P561, DOI 10.1016/0197-4580(92)90056-4; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; RUSH DK, 1992, NEUROBIOL AGING, V13, P591, DOI 10.1016/0197-4580(92)90061-2; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SNOW AD, 1989, J NEUROPATH EXP NEUR, V48, P352, DOI 10.1097/00005072-198905000-00160; SNOW AD, 1990, AM J PATHOL, V137, P1253; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; SNOW AD, 1988, AM J PATHOL, V133, P456; SNOW AD, 1989, ALZHEIMERS DISEASE R, P383; SNOW AD, 1994, IN PRESS AM J PATHOL; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; STEINBEHRENS B, 1992, NEUROBIOL AGING, V13, P577, DOI 10.1016/0197-4580(92)90058-6; STRAUSS S, 1992, LAB INVEST, V66, P223; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; SUENAGA T, 1990, ACTA NEUROPATHOL, V80, P280, DOI 10.1007/BF00294646; THRELKELD A, 1989, DEV BIOL, V132, P559, DOI 10.1016/0012-1606(89)90251-0; UNTERBECK A, 1990, REV BIOL RES AGING, V4, P139; VIJAYAN VK, 1991, EXP NEUROL, V112, P72, DOI 10.1016/0014-4886(91)90115-S; WAITE J, 1992, NEUROBIOL AGING, V13, P595, DOI 10.1016/0197-4580(92)90062-3; WEGIEL J, 1990, ACTA NEUROPATHOL, V81, P116, DOI 10.1007/BF00334499; WISNIEWSKI HM, 1991, NEUROBIOL AGING, V12, P593, DOI 10.1016/0197-4580(91)90091-W; WISNIEWSKI HM, 1989, CAN J NEUROL SCI, V16, P535, DOI 10.1017/S0317167100029887; WISNIEWSKI HM, 1990, AM J MED GENET S, V7, P287; WOLOZIN B, 1987, ANN NEUROL, V22, P521, DOI 10.1002/ana.410220412; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x; YANKNER BA, 1992, NEUROBIOL AGING, V13, P615, DOI 10.1016/0197-4580(92)90067-8	82	286	305	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					219	234		10.1016/0896-6273(94)90165-1	http://dx.doi.org/10.1016/0896-6273(94)90165-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292358				2022-12-28	WOS:A1994MU49300019
J	BARBOUR, B				BARBOUR, B			SYNAPTIC CURRENTS EVOKED IN PURKINJE-CELLS BY STIMULATING INDIVIDUAL GRANULE CELLS	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; CEREBELLAR GRANULE; RAT; SLICES; NEURONS; CULTURE; CORTEX; TRANSMISSION; DEPRESSION	Each cerebellar Purkinje cell receives input from about 160,000 glutamatergic granule cells. In anatomically intact preparations this input has hitherto been studied only as a compound synaptic potential or current. Presented here are simultaneous recordings in cerebellar slices of synaptically connected granule cell-Purkinje cell pairs. The mean amplitude of the excitatory synaptic currents evoked by stimulation of individual granule cells ranged from 2 to 60 pA, whereas the great majority of the spontaneous glutamatergic currents in Purkinje cells in the presence of tetrodotoxin were <40 pA. In several cases, stimulation of a single granule cell evoked a disynaptic inhibitory current. It is estimated that on the order of 50 simultaneously active granule cells are sufficient to excite a Purkinje cell.			BARBOUR, B (corresponding author), ECOLE NORMALE SUPER,NEUROBIOL LAB,46 RUE ULM,F-75230 PARIS 05,FRANCE.			Barbour, Boris/0000-0002-1911-0539				ALBUS JS, 1971, MATH BIOSCI, V10, P318; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; CREPEL F, 1978, BRAIN RES, V155, P176, DOI 10.1016/0006-8993(78)90321-9; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; ECCLES JC, 1966, EXP BRAIN RES, V1, P17; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GAHWILER BH, 1984, NEUROSCI LETT, V45, P311, DOI 10.1016/0304-3940(84)90244-1; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; HIRANO T, 1986, P NATL ACAD SCI USA, V83, P4957, DOI 10.1073/pnas.83.13.4957; HIRANO T, 1988, P NATL ACAD SCI USA, V85, P934, DOI 10.1073/pnas.85.3.934; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1984, CEREBELLUM NEURAL CO; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1969, J NEUROPHYSIOL, V32, P847, DOI 10.1152/jn.1969.32.6.847; Llinas R., 1992, CEREBELLUM REVISITED, P167; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; NAPPER RMA, 1988, J COMP NEUROL, V274, P158, DOI 10.1002/cne.902740203; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Palay S. L., 1974, CEREBELLAR CORTEX CY; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346	32	146	146	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					759	769		10.1016/0896-6273(93)90085-6	http://dx.doi.org/10.1016/0896-6273(93)90085-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398158				2022-12-28	WOS:A1993MD06800018
J	CHOI, KL; MOSSMAN, C; AUBE, J; YELLEN, G				CHOI, KL; MOSSMAN, C; AUBE, J; YELLEN, G			THE INTERNAL QUATERNARY AMMONIUM RECEPTOR-SITE OF SHAKER POTASSIUM CHANNELS	NEURON			English	Article							ACTIVATED K+ CHANNELS; TEA BLOCKADE; SQUID AXON; INACTIVATION; CONDUCTANCE; MUTATIONS; REGION; IONS; MECHANISMS; RESIDUES	Quaternary ammonium (QA) compounds inhibit K+ conductance by entering and occluding the open pore of voltage-activated K+ channels. We characterized the effects of a series of alkyl-triethylammonium blockers on the Shaker K+ channel and tested them on a series of site-directed mutants of the channel protein in order to define the structural features of the binding sites. We found that mutations in two regions of the channel protein, the pore (P) region and the last transmembrane sequence (S6), appear to alter QA binding, not through their effects on gating but perhaps through direct effects on the binding site. Several mutations in the P region affect tetraethylammonium binding but have minimal effects on longer blockers, suggesting that the hydrophobic tail contributes to binding in a nonadditive fashion. Binding of the longer blockers can be affected by varying the hydrophobicity of 1 residue within S6 by site-specific substitution, in a manner consistent with a direct hydrophobic interaction between the side chain at this site and the alkyl chains of the blocker.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOPHYS,BALTIMORE,MD 21205; UNIV KANSAS,DEPT MED CHEM,LAWRENCE,KS 66045	Howard Hughes Medical Institute; Johns Hopkins University; University of Kansas	CHOI, KL (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.			Yellen, Gary/0000-0003-4228-7866; Aube, Jeffrey/0000-0003-1049-5767	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029693, NS29693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEYER EJ, 1976, J GEN PHYSIOL, V67, P703, DOI 10.1085/jgp.67.6.703; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KELLETT JC, 1966, J PHARM SCI, V55, P414, DOI 10.1002/jps.2600550413; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MILLER C, 1982, J GEN PHYSIOL, V79, P869, DOI 10.1085/jgp.79.5.869; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO BI, 1977, J GEN PHYSIOL, V69, P897, DOI 10.1085/jgp.69.6.897; SWENSON RP, 1981, J GEN PHYSIOL, V77, P255, DOI 10.1085/jgp.77.3.255; TANFORD C, 1980, HYDROPHOBIC EFFECT; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; YELLEN G, 1984, J GEN PHYSIOL, V84, P187, DOI 10.1085/jgp.84.2.187; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	32	239	241	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					533	541		10.1016/0896-6273(93)90340-W	http://dx.doi.org/10.1016/0896-6273(93)90340-W			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461140				2022-12-28	WOS:A1993KU90100017
J	HOSHINO, M; MATSUZAKI, F; NABESHIMA, Y; HAMA, C				HOSHINO, M; MATSUZAKI, F; NABESHIMA, Y; HAMA, C			HIKARU-GENKI, A CNS-SPECIFIC GENE IDENTIFIED BY ABNORMAL LOCOMOTION IN DROSOPHILA, ENCODES A NOVEL TYPE OF PROTEIN	NEURON			English	Article							CELL-ADHESION MOLECULE; HUMAN INTERLEUKIN-2 RECEPTOR; AMINO-ACID-SEQUENCE; MYELIN-ASSOCIATED GLYCOPROTEIN; MEMBRANE-SPANNING REGION; CENTRAL-NERVOUS-SYSTEM; COMPLEMENT FACTOR-B; IMMUNOGLOBULIN SUPERFAMILY; FASCICLIN-I; TYROSINE KINASE	We have identified a gene, hikaru genki (hig), whose mutant phenotype includes abnormal locomotor behavior. Mutant first instar larvae have uncoordinated movements, and both larvae and adults have reduced locomotion. Sequence analyses revealed that this gene encodes a novel type of protein with a signal sequence, but without transmembrane regions. One of its domains has similarities with immunoglobulin domains; three or four regions are similar to a complement-binding domain found in complement-related proteins and selectins. In situ hybridization to embryos revealed that accumulation of the hig transcripts is restricted to subsets of cells in the CNS. Our data suggest that hig has a role in the development of CNS functions involved in locomotor activity.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROCHEM,NIIGATA 951,JAPAN	Niigata University	HOSHINO, M (corresponding author), NATL INST NEUROSCI,NCNP,DIV MOLEC GENET,4-1-1 OGAWAHIGASHI,KODAIRA,TOKYO 187,JAPAN.							ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BARTHELS D, 1987, EMBO J, V6, P3202; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BEVILACQUA M, 1991, CELL, V67, P233, DOI 10.1016/0092-8674(91)90174-W; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; CAMPBELL RD, 1983, P NATL ACAD SCI-BIOL, V80, P4464, DOI 10.1073/pnas.80.14.4464; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1991, ANNU REV NEUROSCI, V14, P399, DOI 10.1146/annurev.ne.14.030191.002151; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHRISTIE DL, 1983, BIOCHEM J, V209, P61, DOI 10.1042/bj2090061; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; HE HT, 1986, EMBO J, V5, P2489, DOI 10.1002/j.1460-2075.1986.tb04526.x; HEMPERLY JJ, 1986, P NATL ACAD SCI USA, V83, P9822, DOI 10.1073/pnas.83.24.9822; HORTSCH M, 1991, ANNU REV CELL BIOL, V7, P505, DOI 10.1146/annurev.cb.07.110191.002445; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; JACOBS JR, 1989, NEURON, V2, P1625; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KRISTENSEN T, 1987, FASEB J, V46, P2463; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LOZIER J, 1984, P NATL ACAD SCI-BIOL, V81, P3640, DOI 10.1073/pnas.81.12.3640; MOLE JE, 1984, J BIOL CHEM, V259, P3407; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MULLINS MC, 1989, GENE DEV, V3, P729, DOI 10.1101/gad.3.5.729; MUTA T, 1991, J BIOL CHEM, V266, P6554; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PROKOP A, 1991, DEVELOPMENT, V111, P79; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WATSON SR, 1991, J CELL BIOL, V115, P235, DOI 10.1083/jcb.115.1.235; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	65	36	38	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					395	407		10.1016/0896-6273(93)90329-P	http://dx.doi.org/10.1016/0896-6273(93)90329-P			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461133				2022-12-28	WOS:A1993KU90100006
J	MERLIO, JP; ERNFORS, P; KOKAIA, Z; MIDDLEMAS, DS; BENGZON, J; KOKAIA, M; SMITH, ML; SIESJO, BK; HUNTER, T; LINDVALL, O; PERSSON, H				MERLIO, JP; ERNFORS, P; KOKAIA, Z; MIDDLEMAS, DS; BENGZON, J; KOKAIA, M; SMITH, ML; SIESJO, BK; HUNTER, T; LINDVALL, O; PERSSON, H			INCREASED PRODUCTION OF THE TRKB PROTEIN TYROSINE KINASE RECEPTOR AFTER BRAIN INSULTS	NEURON			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; HUMAN NEUROTROPHIC FACTOR; AFFINITY NGF RECEPTOR; MOLECULAR-CLONING; FACTOR FAMILY; PROTOONCOGENE PRODUCT; LIMBIC SEIZURES; RAT HIPPOCAMPUS; EXPRESSION	The protein-tyrosine kinases Trk, TrkB, and TrkC are signal-transducing receptors for a family of neurotrophic factors known as the neurotrophins. Here we show that seizures induced by hippocampal kindling lead to a rapid, transient increase of trkB mRNA and protein in the hippocampus. TrkB is a component of a high affinity receptor for brain-derived neurotrophic factor (BDNF). No change was detected in mRNAs for Trk or TrkC, components of the high affinity nerve growth factor or neurotrophin-3 receptors, respectively. trkB mRNA was also transiently increased in the dentate gyrus following cerebral ischemia and hypoglycemic coma; these treatments had no effect on trk and trkC mRNAs. The increase in trkB mRNA and protein showed the same time course and distribution as the increase in BDNF mRNA. These data suggest that BDNF and its receptor may play a local role within the hippocampus in kindling-associated neural plasticity and in neuronal protection following epileptic, ischemic, and hypoglycemic insults.	KAROLINSKA INST,DEPT MED CHEM,MOLEC NEUROBIOL LAB,S-10401 STOCKHOLM 60,SWEDEN; UNIV LUND HOSP,DEPT NEUROL,RESTORAT NEUROL UNIT,S-22185 LUND,SWEDEN; SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,LA JOLLA,CA 92037; UNIV LUND HOSP,S-22185 LUND,SWEDEN	Karolinska Institutet; Lund University; Skane University Hospital; Salk Institute; Lund University; Skane University Hospital			Kokaia, Zaal/AAL-6009-2020; Kokaia, Merab/A-2133-2010	Kokaia, Zaal/0000-0003-2296-2449; Bengzon, Johan/0000-0001-6536-2107	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS009199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER; NIA NIH HHS [AG 04418] Funding Source: Medline; NINDS NIH HHS [NS 09199] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; BANERJEE SP, 1973, P NATL ACAD SCI USA, V79, P2519; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BENGZON J, 1992, BRAIN RES, V587, P338, DOI 10.1016/0006-8993(92)91016-8; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BUZSAKI G, 1989, EXP BRAIN RES, V78, P268; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; DUGICHDJORDJEVIC MM, 1992, NEUROSCIENCE, V47, P303, DOI 10.1016/0306-4522(92)90246-X; Ebendal T, 1989, Prog Growth Factor Res, V1, P143, DOI 10.1016/0955-2235(89)90008-2; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; HADCOCK JR, 1991, TRENDS NEUROSCI, V14, P242, DOI 10.1016/0166-2236(91)90124-D; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HERRUP K, 1973, P NATL ACAD SCI USA, V70, P3884, DOI 10.1073/pnas.70.12.3884; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KOKAIA M, 1989, BRAIN RES, V491, P398, DOI 10.1016/0006-8993(89)90079-6; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LOTHMAN EW, 1985, BRAIN RES, V360, P83, DOI 10.1016/0006-8993(85)91223-5; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MIDDLEMAS DS, IN PRESS METH NEUROS; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; PERSSON H, 1993, IN PRESS NEUROMETHOD; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWAB ME, 1979, BRAIN RES, V168, P473, DOI 10.1016/0006-8993(79)90303-2; SEILER M, 1984, BRAIN RES, V300, P33, DOI 10.1016/0006-8993(84)91338-6; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIGENO T, 1991, J NEUROSCI, V11, P2914; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	72	251	261	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					151	164		10.1016/0896-6273(93)90307-D	http://dx.doi.org/10.1016/0896-6273(93)90307-D			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439408				2022-12-28	WOS:A1993KP68500004
J	Sontag, E; NunbhakdiCraig, V; Lee, G; Bloom, GS; Mumby, MC				Sontag, E; NunbhakdiCraig, V; Lee, G; Bloom, GS; Mumby, MC			Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A	NEURON			English	Article							PAIRED HELICAL FILAMENTS; CENTRAL NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MONOCLONAL-ANTIBODY; DEPHOSPHORYLATION; SUBUNIT; KINASE; BRAIN; IDENTIFICATION; SITES	Recently, we reported that a pool of protein phosphatase 2A (PP2A) is associated with microtubules. Here, we demonstrate that specific isoforms of PP2A bind and dephosphorylate the neuronal microtubule-associated protein tau. Coexpression of tau and SV40 small t, a specific inhibitor of PP2A, in CV-1, NIH 3T3, or NT2 cells induced the phosphorylation of tau at multiple sites, including Ser-199, Ser-202, Thr-205, Ser-396, and Ser-404. Immunofluorescent and biochemical analyses revealed that hyperphosphorylation correlated with dissociation of tau from microtubules and a loss of tau-induced microtubule stabilization. Taken together, these results support the hypothesis that PP2A controls the phosphorylation state of tau in vivo.	UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT NEUROSCI & CELL BIOL,DALLAS,TX 75235; HARVARD UNIV,SCH MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Sontag, E (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PATHOL,DALLAS,TX 75235, USA.		SONTAG, ESTELLE/AAE-9805-2020	Lee, Gloria/0000-0002-8633-1534	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030485] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL31107] Funding Source: Medline; NINDS NIH HHS [NS30485] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1993, J BIOL CHEM, V268, P3414; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GOEDERT M, 1995, NEUROBIOL AGING, V16, P325, DOI 10.1016/0197-4580(95)00017-9; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1994, FEBS LETT, V341, P94, DOI 10.1016/0014-5793(94)80247-5; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; KAMIBAYASHI C, 1991, J BIOL CHEM, V266, P13251; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; LEE G, 1992, J CELL SCI, V102, P227; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MorishimaKawashima M, 1996, MOL BIOL CELL, V7, P893, DOI 10.1091/mbc.7.6.893; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; MUMBY MC, 1985, J BIOL CHEM, V260, P3763; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; SAITO T, 1995, FEBS LETT, V376, P238, DOI 10.1016/0014-5793(95)01292-0; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; VALLEE RB, 1983, P NATL ACAD SCI-BIOL, V80, P6259, DOI 10.1073/pnas.80.20.6259; YAMAMOTO H, 1995, J BIOCHEM-TOKYO, V118, P1224, DOI 10.1093/oxfordjournals.jbchem.a125011; YANG SI, 1991, MOL CELL BIOL, V64, P1988	35	335	340	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1201	1207		10.1016/S0896-6273(00)80250-0	http://dx.doi.org/10.1016/S0896-6273(00)80250-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982166	Bronze			2022-12-28	WOS:A1996WA24800016
J	Muller, R				Muller, R			A quarter of a century of place cells	NEURON			English	Review							HEAD-DIRECTION CELLS; FREELY-MOVING RATS; COMPLEX-SPIKE CELLS; DENDRITIC SPINE DENSITY; SINGLE UNIT-ACTIVITY; FIRING PROPERTIES; VENTRAL HIPPOCAMPUS; BEHAVING RATS; ENVIRONMENT; NEURONS				Muller, R (corresponding author), SUNY HLTH SCI CTR, DEPT PHYSIOL, BROOKLYN, NY 11203 USA.				NINDS NIH HHS [NS 20686] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020686] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; BREESE CR, 1989, J NEUROSCI, V9, P1097; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Deadwyler SA, 1996, J NEUROSCI, V16, P354; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gothard KM, 1996, J NEUROSCI, V16, P823; HEBB DO, 1949, ORG BEHAVIOR; HETERINGTON PA, IN PRESS BEHAV NEURO; HILL AJ, 1978, EXP NEUROL, V62, P282, DOI 10.1016/0014-4886(78)90058-4; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; JUNG MW, 1994, J NEUROSCI, V14, P7347; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Kubie J L, 1991, Hippocampus, V1, P240, DOI 10.1002/hipo.450010305; KUBIE JL, 1990, J NEUROSCI, V10, P1110; KUBIE JL, 1984, NEUROPSYCHOLOGY MEMO; KUBIE JL, 1985, ELECT ACTIVITY ARCHI; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MCNAUGHTON BL, 1991, J COGNITIVE NEUROSCI, V3, P192, DOI 10.1162/jocn.1991.3.2.190; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MCNAUGHTON BL, 1990, NEUROSCIENCE CONNCTI; Muller R. U., 1991, BRAIN SPACE, P296; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; MULLER RU, 1987, J NEUROSCI, V7, P1951; Muller RU, 1996, CURR OPIN NEUROBIOL, V6, P196, DOI 10.1016/S0959-4388(96)80073-0; MULLER RU, 1994, J NEUROSCI, V14, P7235; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; POUCET B, 1994, NEUROREPORT, V5, P2045, DOI 10.1097/00001756-199410270-00014; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; RECCE M, 1996, IN PRESS HIPPOCAMPUS; Rolls E., 1989, PARALLEL DISTRIBUTED; SHARP PE, 1990, J NEUROSCI, V10, P3093; SHARP PE, 1994, J NEUROSCI, V14, P2339; SHARP PE, 1991, PSYCHOBIOLOGY, V19, P103; SPEAKMAN A, 1990, EUR J NEUROSCI, V2, P544, DOI 10.1111/j.1460-9568.1990.tb00445.x; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; TAUBE JS, 1990, J NEUROSCI, V10, P436; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; WIENER SI, 1995, EUR J NEUROSCI, V7, P2206, DOI 10.1111/j.1460-9568.1995.tb00642.x; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; YOUNG BJ, 1994, J NEUROSCI, V14, P6553	63	245	249	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1996	17	5					813	822		10.1016/S0896-6273(00)80214-7	http://dx.doi.org/10.1016/S0896-6273(00)80214-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938115	Bronze			2022-12-28	WOS:A1996VV15100005
J	Miller, KD				Miller, KD			Synaptic economics: Competition and cooperation in synaptic plasticity	NEURON			English	Review							HRP-EM EVIDENCE; VISUAL-CORTEX; OPTIC FIBERS; NEURONS; REGENERATION; GOLDFISH; NUMBERS		UNIV CALIF SAN FRANCISCO,WM KECK CTR INTEGRAT NEUROSCI,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	Miller, KD (corresponding author), UNIV CALIF SAN FRANCISCO,WM KECK CTR INTEGRAT NEUROSCI,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.							Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BOURGEOIS JP, 1989, P NATL ACAD SCI USA, V86, P4297, DOI 10.1073/pnas.86.11.4297; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HAYES WP, 1988, J COMP NEUROL, V274, P539, DOI 10.1002/cne.902740405; HAYES WP, 1989, J NEUROSCI, V9, P1414; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Miller K.D., 1990, CONNECTIONIST MODELI, P255; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; MILLER KD, 1986, MODELS NEURAL NETWOR, V3, P55; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; XIONG MJ, 1994, J COMP NEUROL, V344, P581, DOI 10.1002/cne.903440407	24	221	228	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1996	17	3					371	374		10.1016/S0896-6273(00)80169-5	http://dx.doi.org/10.1016/S0896-6273(00)80169-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816700	Bronze			2022-12-28	WOS:A1996VJ44000003
J	GrayKeller, MP; Detwiler, PB				GrayKeller, MP; Detwiler, PB			Ca2+ dependence of dark- and light-adapted flash responses in rod photoreceptors	NEURON			English	Article							CYTOPLASMIC CALCIUM-CONCENTRATION; CYCLIC-GMP PHOSPHODIESTERASE; OUTER SEGMENTS; RETINAL RODS; GUANYLATE-CYCLASE; ACTIVATION STEPS; SALAMANDER RODS; VERTEBRATE ROD; GATED CHANNEL; ADAPTATION	Light adaptation is thought to be orchestrated by a Ca2+ feedback signal that desensitizes the response by speeding recovery. To evaluate the role of Ca2+ in adaptation, we compared the effect of lowered Ca2+ on response properties in darkness and during adaptation. Internal Ca2+ was reduced from its normal resting dark level (535 nM) by either background illumination or exposure to Ringer's solution containing low Ca2+ and/or cyclic GMP-gated channel blockers in darkness. Ca2+ reductions in light decreased the activation gain of the transduction process and speeded recovery kinetics, while equivalent Ca2+ reductions in darkness caused similar gain reduction without accelerating recovery. This indicates that adaptational changes in the response are not due purely to feedback effects on recovery.			GrayKeller, MP (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.			Detwiler, Peter/0000-0003-3910-2023	NATIONAL EYE INSTITUTE [R01EY002048] Funding Source: NIH RePORTER; NEI NIH HHS [EY02048] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; FAIN GL, 1990, TRENDS NEUROSCI, V13, P378, DOI 10.1016/0166-2236(90)90023-4; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; JONES GJ, 1995, J PHYSIOL-LONDON, V487, P441, DOI 10.1113/jphysiol.1995.sp020891; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KORENBROT JI, 1989, VISION RES, V29, P939, DOI 10.1016/0042-6989(89)90108-9; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; LAGNADO L, 1994, NATURE, V367, P273, DOI 10.1038/367273a0; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; Matthews HR, 1996, J PHYSIOL-LONDON, V490, P1; MATTHEWS HR, 1995, J PHYSIOL-LONDON, V484, P267, DOI 10.1113/jphysiol.1995.sp020664; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MCCARTHY ST, 1994, BIOPHYS J, V67, P2076, DOI 10.1016/S0006-3495(94)80691-5; MCNAUGHTON PA, 1986, NATURE, V322, P261, DOI 10.1038/322261a0; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NICOL GD, 1989, J GEN PHYSIOL, V94, P233, DOI 10.1085/jgp.94.2.233; PANNBACKER RG, 1973, SCIENCE, V182, P1138, DOI 10.1126/science.182.4117.1138; PEPE IM, 1986, FEBS LETT, V203, P73, DOI 10.1016/0014-5793(86)81439-9; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PEPPERBERG DR, 1994, VISUAL NEUROSCI, V11, P53, DOI 10.1017/S095252380001110X; PUGH E, 1988, NATURE, V334, P16, DOI 10.1038/334016a0; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; QUANDT FN, 1991, NEUROSCIENCE, V42, P629, DOI 10.1016/0306-4522(91)90032-J; RATTO GM, 1988, J NEUROSCI, V8, P3240; RISPOLI G, 1993, J PHYSIOL-LONDON, V465, P513, DOI 10.1113/jphysiol.1993.sp019691; RISPOLI G, 1992, SIGNAL TRANSDUCTION, P217; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SATHER WA, 1988, THESIS U WASHINGTON; TAMURA T, 1991, J GEN PHYSIOL, V98, P95, DOI 10.1085/jgp.98.1.95; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	39	56	57	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					323	331		10.1016/S0896-6273(00)80163-4	http://dx.doi.org/10.1016/S0896-6273(00)80163-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780655	Bronze			2022-12-28	WOS:A1996VE84000014
J	Komuro, H; Rakic, P				Komuro, H; Rakic, P			Intracellular Ca2+ fluctuations modulate the rate of neuronal migration	NEURON			English	Article							CEREBELLAR GRANULE NEURONS; CELL-MIGRATION; ADHESION MOLECULE; HUMAN-NEUTROPHILS; CALCIUM CHANNELS; FURA-RED; INVITRO; GLIA; DIFFERENTIATION; MOTILITY	Transient elevations of intracellular Ca2+ levels play critical roles in neuronal development, but such elevations have not been demonstrated in migrating neurons. Here, we show that the amplitude and frequency components of Ca2+ fluctuations are correlated positively with the rate of granule cell movement in cerebellar microexplant cultures. Moreover, depression of the amplitude and frequency components of Ca2+ fluctuations by blockade of Ca2+ influx across the plasma membrane results in a reversible retardation of cell movement. These results indicate that the combination of amplitude and frequency components of intracellular Ca2+ fluctuations may provide an intracellular signal controlling the rate of neuronal cell migration.			Komuro, H (corresponding author), YALE UNIV, SCH MED, NEUROBIOL SECT, NEW HAVEN, CT 06510 USA.							Anton ES, 1996, J NEUROSCI, V16, P2283; ANTON ES, 1995, J NEUROSCI, V15, P584; ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; BRUNDAGE RA, 1993, AM J PHYSIOL, V265, pC1527, DOI 10.1152/ajpcell.1993.265.6.C1527; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; CAMERON RS, 1994, J NEUROSCI, V14, P3139; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; EDELMAN GM, 1984, ANNU REV NEUROSCI, V7, P339; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; FISHELL G, 1991, DEVELOPMENT, V113, P755; FLOTO RA, 1995, CELL CALCIUM, V18, P377, DOI 10.1016/0143-4160(95)90053-5; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOMEZ TM, 1995, NEURON, V14, P1233, DOI 10.1016/0896-6273(95)90270-8; GREGORY WA, 1988, J NEUROSCI, V8, P1728; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; HATTEN ME, 1984, J NEUROSCI, V4, P1163; HATTEN ME, 1986, J NEUROSCI, V6, P2676; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IVINS JK, 1991, J NEUROSCI, V11, P1597; JACONI MEE, 1991, J CELL BIOL, V112, P1249, DOI 10.1083/jcb.112.6.1249; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KATER SB, 1991, J NEUROSCI, V11, P891; KOMURO H, 1995, J NEUROSCI, V15, P1110; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; LANKFORD KL, 1989, J CELL BIOL, V109, P1229, DOI 10.1083/jcb.109.3.1229; LANKFORD KL, 1995, DEV BRAIN RES, V84, P151, DOI 10.1016/0165-3806(94)00159-W; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; LIPP P, 1993, BIOPHYS J, V65, P2272, DOI 10.1016/S0006-3495(93)81316-X; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; MINTA A, 1989, J BIOL CHEM, V264, P8171; MORAN D, 1991, AM J ANAT, V192, P14, DOI 10.1002/aja.1001920103; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; NELSON EJ, 1994, BIOCHEM J, V302, P147, DOI 10.1042/bj3020147; NEWGREEN DF, 1985, CELL TISSUE RES, V239, P329; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; RAKIC P, 1995, J NEUROBIOL, V26, P299, DOI 10.1002/neu.480260303; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; RAKIC P, 1975, COLD SPRING HARB SYM, V40, P333, DOI 10.1101/SQB.1976.040.01.033; Rakic P, 1985, CELL CONTACT ADHESIO, P67; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; RIVAS RJ, 1995, J NEUROSCI, V15, P981; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; SAWYER DW, 1985, SCIENCE, V230, P663, DOI 10.1126/science.4048951; SCHILD D, 1994, CELL CALCIUM, V15, P341, DOI 10.1016/0143-4160(94)90009-4; SHMIGOL A, 1995, NEUROSCIENCE, V65, P1109, DOI 10.1016/0306-4522(94)00553-H; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; SLATER NT, 1996, EXCITATORY AMINO ACI, P215; SPITZER NC, 1994, TRENDS NEUROSCI, V17, P115, DOI 10.1016/0166-2236(94)90120-1	64	347	353	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1996	17	2					275	285		10.1016/S0896-6273(00)80159-2	http://dx.doi.org/10.1016/S0896-6273(00)80159-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780651	hybrid			2022-12-28	WOS:A1996VE84000010
J	Zhong, WM; Feder, JN; Jiang, MM; Jan, LY; Jan, YN				Zhong, WM; Feder, JN; Jiang, MM; Jan, LY; Jan, YN			Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis	NEURON			English	Article							RAT CEREBRAL-CORTEX; DROSOPHILA EMBRYOS; ORGAN FORMATION; CELL LINEAGE; NOTCH GENE; EXPRESSION; PROTEIN; DISTINCT; PATTERNS; DOMAIN	During Drosophila neurogenesis, differential segregation of Numb is necessary for daughter cells of asymmetric divisions to adopt distinct fates, at least partly by biasing the Notch-mediated cell-cell interaction. We have isolated a highly conserved mammalian homolog of Drosophila numb, m-numb. During mouse cortical neurogenesis, m-Numb is asymmetrically localized to the apical membrane of dividing ventricular neural progenitors. Depending upon the orientation of the cleavage plane, m-Numb may be distributed into one or both of the daughter cells. When expressed in Drosophila embryos, m-Numb is localized asymmetrically in dividing neural precursors and rescues the numb mutant phenotype. Futhermore, m-Numb can physically interact with mouse Notch1. We propose that some shared molecular mechanisms, both cell-intrinsic and cell-extrinsic, generate asymmetric cell divisions during neurogenesis of vertebrates and invertebrates.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zhong, WM (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; DOE CQ, 1992, DEVELOPMENT, V116, P855; GROVE EA, 1993, DEVELOPMENT, V117, P553; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; JAN YN, 1995, NEURON, V14, P1; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KOMACK DR, 1995, NEURON, V15, P311; LANGMAN J, 1966, J COMP NEUROL, V127, P399, DOI 10.1002/cne.901270308; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MARTIN AH, 1967, NATURE, V216, P1133, DOI 10.1038/2161133a0; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MINOE MC, 1994, J NEUROSCI, V14, P107; MUSACCHIO A, 1994, PROG BIOPHYS MOL BIO, V61, P283, DOI 10.1016/0079-6107(94)90003-5; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; PRICE J, 1988, DEVELOPMENT, V104, P473; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; SMART IHM, 1973, J ANAT, V116, P67; SMART IHM, 1985, J ANAT, V140, P397; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SPANA EP, 1995, DEVELOPMENT, V121, P3489; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; ZAMENHOF S, 1987, DEV BRAIN RES, V31, P143, DOI 10.1016/0165-3806(87)90094-0; ZHONG WM, 1994, MOL CELL BIOL, V14, P7276, DOI 10.1128/MCB.14.11.7276; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	52	384	399	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					43	53		10.1016/S0896-6273(00)80279-2	http://dx.doi.org/10.1016/S0896-6273(00)80279-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755477	Bronze			2022-12-28	WOS:A1996UY98100006
J	Hyman, SE				Hyman, SE			Addiction to cocaine and amphetamine	NEURON			English	Review									HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,LAB MOL & DEV NEUROSCI,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital								BROWN EE, 1992, J NEUROSCI, V12, P4112; Carew TJ, 1996, NEURON, V16, P5, DOI 10.1016/S0896-6273(00)80016-1; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; JABER M, 1995, NEUROSCIENCE, V65, P1041, DOI 10.1016/0306-4522(94)00537-F; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; KONRADI C, 1994, J NEUROSCI, V14, P5623; KOOB GF, 1996, NEURON, V16; KOSOFSKY BE, 1995, J COMP NEUROL, V351, P41, DOI 10.1002/cne.903510105; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; STEINER H, 1995, J COMP NEUROL, V353, P200, DOI 10.1002/cne.903530204; WOLF ME, 1994, J NEUROSCI, V14, P1735, DOI 10.1523/JNEUROSCI.14-03-01735.1994; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	18	190	190	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					901	904		10.1016/S0896-6273(00)80111-7	http://dx.doi.org/10.1016/S0896-6273(00)80111-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630246	Bronze			2022-12-28	WOS:A1996UN48000003
J	Lin, CH; Espreafico, EM; Mooseker, MS; Forscher, P				Lin, CH; Espreafico, EM; Mooseker, MS; Forscher, P			Myosin drives retrograde F-actin flow in neuronal growth cones	NEURON			English	Article							RABBIT SKELETAL-MUSCLE; 2,3-BUTANEDIONE MONOXIME; CONTRACTILE ACTIVATION; UNCONVENTIONAL MYOSIN; LEADING-EDGE; NERVE GROWTH; MOTILITY; CELLS; FIBROBLASTS; LOCOMOTION	Actin filaments assembled at the leading edge of neuronal growth cones are centripetally transported via retrograde F-actin flow, a process fundamental to growth cone guidance and other forms of directed cell motility. Here we investigated the role of myosins in retrograde flow, using two distinct modes of myosin inhibition: microinjection of NEM inactivated myosin S1 fragments, or treatment with 2,3-butanedione-2-monoxime, an inhibitor of myosin ATPase. Both treatments resulted in dose-dependent attenuation of retrograde F-actin flow and growth of filopodia. Growth was cytochalasin sensitive and directly proportional to the degree of myosin inhibition, suggesting that retrograde flow results from superimposition of two independent processes: actin assembly and myosin-based filament retraction. These results provide the first direct evidence for myosin involvement in neuronal growth cone function.	FAC MED RIBEIRAO PRETO, DEPT MORPHOL, RIBEIRAO PRETO, SP, BRAZIL; YALE UNIV, DEPT BIOL, NEW HAVEN, CT 06511 USA	Yale University	Lin, CH (corresponding author), NATL YANG MING UNIV, TAIPEI, TAIWAN.		Espreafico, Enilza/O-3053-2016; Espreafico, Enilza/AAW-4658-2021	Espreafico, Enilza/0000-0002-7552-4234; Espreafico, Enilza/0000-0002-7552-4234; Forscher, Paul/0000-0003-1988-5155	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37-DK25387] Funding Source: Medline; NINDS NIH HHS [NS28695] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; ALPERT NR, 1989, J PHYSIOL-LONDON, V414, P433, DOI 10.1113/jphysiol.1989.sp017697; BACKX PH, 1994, J PHYSIOL-LONDON, V476, P487, DOI 10.1113/jphysiol.1994.sp020149; BAHLER M, 1994, J CELL BIOL, V126, P375, DOI 10.1083/jcb.126.2.375; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; CANDE WZ, 1986, METHOD ENZYMOL, V134, P473; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; CHENG TPO, 1992, FEBS LETT, V311, P91, DOI 10.1016/0014-5793(92)81374-U; CRAMER LP, 1994, CURR OPIN CELL BIOL, V6, P82, DOI 10.1016/0955-0674(94)90120-1; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; DETMERS P, 1981, J BIOL CHEM, V256, P99; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; FISHER GW, 1988, CELL MOTIL CYTOSKEL, V11, P235, DOI 10.1002/cm.970110403; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; FORSCHER P, 1990, OPTICAL MICROSCOPY FOR BIOLOGY, P459; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; FRYER MW, 1988, J PHYSIOL-LONDON, V407, P53, DOI 10.1113/jphysiol.1988.sp017403; GRAZI E, 1980, FEBS LETT, V112, P67, DOI 10.1016/0014-5793(80)80129-3; GWATHMEY JK, 1991, CIRC RES, V69, P1280, DOI 10.1161/01.RES.69.5.1280; HEATH JP, 1991, CELL MOTIL CYTOSKEL, V18, P245, DOI 10.1002/cm.970180402; HERRMANN C, 1992, BIOCHEMISTRY-US, V31, P12227, DOI 10.1021/bi00163a036; HIGUCHI H, 1989, J BIOCHEM-TOKYO, V105, P638, DOI 10.1093/oxfordjournals.jbchem.a122717; HORIUTI K, 1988, J MUSCLE RES CELL M, V9, P156, DOI 10.1007/BF01773737; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; KIELLEY WW, 1960, BIOCHIM BIOPHYS ACTA, V41, P401; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCKILLOP DFA, 1994, J MUSCLE RES CELL M, V15, P309; MEEUSEN RL, 1979, J CELL BIOL, V82, P57, DOI 10.1083/jcb.82.1.57; MILLER L, 1988, J BIOL CHEM, V263, P1996; MILLER M, 1992, NEURON, V8, P25, DOI 10.1016/0896-6273(92)90106-N; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; SCHRAMM M, 1994, J PHYSIOL-LONDON, V481, P647, DOI 10.1113/jphysiol.1994.sp020471; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STEELE DS, 1993, AM J PHYSIOL, V265, pH1493, DOI 10.1152/ajpheart.1993.265.5.H1493; STEINEN GJM, 1995, J PHYSL, V482, P109; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tessier-Lavigne M, 1992, Curr Opin Neurobiol, V2, P60, DOI 10.1016/0959-4388(92)90163-F; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Theriot Julie A., 1992, Trends in Cell Biology, V2, P219, DOI 10.1016/0962-8924(92)90298-2; TUNG L, 1985, J PHARMACOL EXP THER, V232, P688; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEST JM, 1989, PFLUG ARCH EUR J PHY, V413, P546, DOI 10.1007/BF00594187; YAMADA KM, 1973, DEV BIOL, V31, P413, DOI 10.1016/0012-1606(73)90276-5; ZHAO Y, 1994, AM J PHYSIOL, V266, pC437, DOI 10.1152/ajpcell.1994.266.2.C437	60	332	332	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					769	782		10.1016/S0896-6273(00)80097-5	http://dx.doi.org/10.1016/S0896-6273(00)80097-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607995	hybrid			2022-12-28	WOS:A1996UG61100010
J	Shibuki, K; Gomi, H; Chen, L; Bao, SW; Kim, JSK; Wakatsuki, H; Fujisaki, T; Fujimoto, J; Katoh, A; Ikeda, T; Chen, C; Thompson, RF; Itohara, S				Shibuki, K; Gomi, H; Chen, L; Bao, SW; Kim, JSK; Wakatsuki, H; Fujisaki, T; Fujimoto, J; Katoh, A; Ikeda, T; Chen, C; Thompson, RF; Itohara, S			Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice	NEURON			English	Article							NICTITATING-MEMBRANE RESPONSE; PURKINJE-CELLS; MEMORY TRACE; RAT-BRAIN; SYNAPTIC DEPRESSION; GLUTAMATE RECEPTORS; MOUSE CEREBELLUM; CLIMBING FIBER; MESSENGER-RNA; LESIONS	Mice devoid of glial fibrillary acidic protein (GFAP), an intermediate filament protein specifically expressed in astrocytes, develop normally and do not show any detectable abnormalities in the anatomy of the brain. In the cerebellum, excitatory synaptic transmission from parallel fibers (PFs) or climbing fibers (CFs) to Purkinje cells is unaltered, and these synapses display normal short-term synaptic plasticity to paired stimuli in GFAP mutant mice. In contrast, long-term depression (LTD) at PF-Purkinje cell synapses is clearly deficient. Furthermore, GFAP mutant mice exhibited a significant impairment of eyeblink conditioning without any detectable deficits in motor coordination tasks. These results suggest that GFAP is required for communications between Bergmann glia and Purkinje cells during LTD induction and maintenance. The data support the notion that cerebellar LTD is a cellular mechanism closely associated with eyeblink conditioning, but is not essential for motor coordination tasks tested.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROPHYSIOL,NIIGATA 951,JAPAN; UNIV SO CALIF,PROGRAM NEURAL INFORMAT & BEHAV SCI,LOS ANGELES,CA 90089; KYOTO UNIV,FAC MED,DEPT ANAT,SAKYO KU,KYOTO 60601,JAPAN; MIT,CTR LEARNING & MEMORY,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139	Niigata University; University of Southern California; Kyoto University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Shibuki, K (corresponding author), KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 60601,JAPAN.		Itohara, Shigeyoshi/I-8769-2012; Katoh, Akira/B-2683-2010	Itohara, Shigeyoshi/0000-0002-2410-9989; Katoh, Akira/0000-0001-7867-2964; Kim, Jeansok/0000-0001-7964-106X; Chen, Lu/0000-0002-8097-2699				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ATTWELL D, 1994, NATURE, V369, P707, DOI 10.1038/369707a0; BAUDE A, 1994, J NEUROSCI, V14, P2830; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CHEN C, 1995, LEARN MEMORY, V185, P185; CLARK RE, 1992, BEHAV NEUROSCI, V106, P879, DOI 10.1037/0735-7044.106.6.879; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; CUENOD M, 1990, TRENDS PHARMACOL SCI, V11, P477; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Goldowitz Dan, 1992, V8, P271; GOMI H, 1995, NEURON, V14, P39; GRANDES P, 1991, EUR J NEUROSCI, V3, P1370, DOI 10.1111/j.1460-9568.1991.tb00070.x; IACOPINO AM, 1990, MOL BRAIN RES, V8, P283, DOI 10.1016/0169-328X(90)90041-B; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 1984, CEREBELLUM NEURAL CO; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; KRUPA DJ, 1993, THESIS U SO CALIFORN; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LAVOND DG, 1989, BEHAV BRAIN RES, V33, P113, DOI 10.1016/S0166-4328(89)80047-6; LAVOND DG, 1987, EXP BRAIN RES, V67, P569; LINCOLN JS, 1982, BRAIN RES, V242, P190, DOI 10.1016/0006-8993(82)90510-8; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LISBERGER SG, 1995, CURR BIOL, V5, P221, DOI 10.1016/S0960-9822(95)00043-1; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MALENKA RC, 1994, NATURE, V372, P218, DOI 10.1038/372218a0; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; MURPHY TH, 1993, J NEUROSCI, V13, P2672, DOI 10.1523/JNEUROSCI.13-06-02672.1993; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Peters A., 1991, FINE STRUCTURE NERVO; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P185, DOI 10.1016/0165-3806(84)90096-8; Polak M., 1982, HISTOL HISTOPATHOL, P363; RACINE RJ, 1986, EXP BRAIN RES, V63, P158; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SKELTON RW, 1988, BEHAV NEUROSCI, V102, P586, DOI 10.1037/0735-7044.102.4.586; STEINMETZ JE, 1992, J NEUROSCI, V12, P4403; TEICHBERG VI, 1991, FASEB J, V5, P3086, DOI 10.1096/fasebj.5.15.1660422; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; THOMPSON RF, 1993, SYNAPTIC PLASTICITY; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; WEISS C, 1991, NEUROBIOL AGING, V12, P249, DOI 10.1016/0197-4580(91)90105-S; WELSH JP, 1989, J NEUROSCI, V9, P299; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	72	281	286	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					587	599		10.1016/S0896-6273(00)80078-1	http://dx.doi.org/10.1016/S0896-6273(00)80078-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785056	Bronze			2022-12-28	WOS:A1996UC16800015
J	Fiez, JA				Fiez, JA			Cerebellar contributions to cognition	NEURON			English	Review							MENTAL SKILLS				Fiez, JA (corresponding author), WASHINGTON UNIV, SCH MED, DEPT NEUROL & NEUROL SURG, DEPT RADIOL, ST LOUIS, MO 63110 USA.							BERNTSON GG, 1982, PHYSIOL PSYCHOL, V10, P2; BLOEDEL JR, 1993, TRENDS NEUROSCI, V16, P451, DOI 10.1016/0166-2236(93)90075-W; BRACKETOLKMITT R, 1989, BEHAV NEUROSCI, V103, P442, DOI 10.1037/0735-7044.103.2.442; Courchesne E, 1995, EEG CL N SU, P315; COURCHESNE E, 1987, ARCH NEUROL-CHICAGO, V44, P335, DOI 10.1001/archneur.1987.00520150073028; DAUM I, 1995, BEHAV BRAIN RES, V67, P201, DOI 10.1016/0166-4328(94)00144-5; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; FILIPEK PA, 1995, CURR OPIN NEUROL, V8, P134, DOI 10.1097/00019052-199504000-00009; GLICKSTEIN M, 1993, TRENDS NEUROSCI, V16, P450, DOI 10.1016/0166-2236(93)90074-V; GRAFMAN J, 1992, NEUROLOGY, V42, P1493, DOI 10.1212/WNL.42.8.1493; ITO M, 1993, TRENDS NEUROSCI, V16, P448, DOI 10.1016/0166-2236(93)90073-U; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; JENKINS IH, 1994, J NEUROSCI, V14, P3775; JUEPTNER M, 1995, NEUROLOGY, V45, P1540, DOI 10.1212/WNL.45.8.1540; KEELE SW, 1990, ANN NY ACAD SCI, V608, P179, DOI 10.1111/j.1749-6632.1990.tb48897.x; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; LEINER HC, 1986, BEHAV NEUROSCI, V100, P443, DOI 10.1037/0735-7044.100.4.443; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Schmahmann JD., 1994, NEUROBIOLOGY AUTISM, P195; THACH WT, 1996, IN PRESS BEHAV BRAIN	23	201	202	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					13	15		10.1016/S0896-6273(00)80018-5	http://dx.doi.org/10.1016/S0896-6273(00)80018-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562076	Bronze			2022-12-28	WOS:A1996TT30700004
J	Grabner, M; Wang, ZY; Hering, S; Striessnig, J; Glossmann, H				Grabner, M; Wang, ZY; Hering, S; Striessnig, J; Glossmann, H			Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels	NEURON			English	Article							SKELETAL-MUSCLE; BETA-SUBUNIT; DIHYDROPYRIDINE RECEPTOR; SMOOTH-MUSCLE; CA2+ CHANNELS; FUNCTIONAL EXPRESSION; DEPENDENT MODULATION; ALPHA-1 SUBUNIT; MESSENGER-RNAS; ACTIVATION	L-type Ca2+ channels are characterized by their unique sensitivity to organic Ca2+ channel modulators like the 1,4-dihydropyridines (DHPs). To identify molecular motifs mediating DHP sensitivity, we transferred this sensitivity from L-type Ca2+ channels to the DHP-insensitive class A brain Ca2+ channel, BI-2. Expression of chimeras revealed minimum sequence stretches conferring DHP sensitivity including segments IIIS5, lllS6, and the connecting linker, as well as the IVS5-IVS6 linker plus segment IVS6. DHP agonist and antagonist effects are determined by different regions within the repeat IV motif. Sequence regions responsible for DHP sensitivity comprise only 9.4% of the overall primary structure of a DHP-sensitive alpha(1A)/alpha(1S) construct. This chimera fully exhibits the DHP sensitivity of channels formed by L-type alpha(1) subunits. In addition, it displays the electrophysiological properties of alpha(1A) as well as its sensitivity toward the peptide toxins omega-agatoxin IVA and omega-conotoxin MVIIC.			Grabner, M (corresponding author), UNIV INNSBRUCK, INST BIOCHEM PHARMAKOL, PETER MAYRSTR 1, A-6020 INNSBRUCK, AUSTRIA.		Striessnig, Joerg/S-9334-2017; Glossmann, Hartmut/AAL-9790-2020	Striessnig, Joerg/0000-0002-9406-7120; glossmann, hartmut h./0000-0002-7392-3266				BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BECHEM M, 1993, PFLUG ARCH EUR J PHY, V424, P343, DOI 10.1007/BF00384362; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; GINAP T, 1993, NEUROSCI LETT, V156, P35, DOI 10.1016/0304-3940(93)90433-L; Glossmann H., 1990, REV PHYSL BIOCH PHAR, V114, P1; GRABNER M, 1994, J BIOL CHEM, V269, P23668; GRABNER M, 1991, P NATL ACAD SCI USA, V88, P727, DOI 10.1073/pnas.88.3.727; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HERING S, 1989, CIRC RES, V64, P928, DOI 10.1161/01.RES.64.5.928; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLE B, 1992, IONIC CHANNELS EXCIT, P83; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUGHES AD, 1990, BRIT J PHARMACOL, V101, P3, DOI 10.1111/j.1476-5381.1990.tb12076.x; KAMP TJ, 1989, CIRC RES, V64, P338, DOI 10.1161/01.RES.64.2.338; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 1991, J GEN PHYSIOL, V98, P63, DOI 10.1085/jgp.98.1.63; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KUNZE DL, 1992, MOL PHARMACOL, V42, P666; LACERDA AE, 1989, J GEN PHYSIOL, V93, P1243, DOI 10.1085/jgp.93.6.1243; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; MARKS TN, 1992, J GEN PHYSIOL, V99, P367, DOI 10.1085/jgp.99.3.367; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MITTERDORFER J, 1995, BIOCHEMISTRY-US, V34, P9350, DOI 10.1021/bi00029a010; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; NAKAYAMA H, 1991, P NATL ACAD SCI USA, V88, P9203, DOI 10.1073/pnas.88.20.9203; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; RANDALL A, 1995, J NEUROSCI, V15, P2995; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANGUINETTI MC, 1986, J GEN PHYSIOL, V88, P369, DOI 10.1085/jgp.88.3.369; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SPRANG S, 1987, SCIENCE, V237, P1012, DOI 10.1126/science.3616621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; STRIESSNIG J, 1991, P NATL ACAD SCI USA, V88, P10769, DOI 10.1073/pnas.88.23.10769; STRUBING C, 1993, BRIT J PHARMACOL, V108, P884, DOI 10.1111/j.1476-5381.1993.tb13482.x; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1991, NATURE, V352, P800, DOI 10.1038/352800a0; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; TRIGGLE DJ, 1991, ANN NY ACAD SCI, V635, P123, DOI 10.1111/j.1749-6632.1991.tb36487.x; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WANG Z, 1995, J PHYSL, P131; WEI XY, 1991, J BIOL CHEM, V266, P21943; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	57	133	133	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					207	218		10.1016/S0896-6273(00)80037-9	http://dx.doi.org/10.1016/S0896-6273(00)80037-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562085	Bronze			2022-12-28	WOS:A1996TT30700023
J	Anderson, DJ				Anderson, DJ			A molecular switch for the neuron-glia developmental decision	NEURON			English	Review							CELL LINEAGE; DROSOPHILA; DIFFERENTIATION; TRANSFORMATION; GENE; CUT				Anderson, DJ (corresponding author), CALTECH,HOWARD HUGHES MED INST,DIV BIOL 21676,PASADENA,CA 91125, USA.							ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; CONDRON BG, 1995, CURR BIOL, V5, P51, DOI 10.1016/S0960-9822(95)00016-9; CONDRON BG, 1994, NEURON, V13, P541, DOI 10.1016/0896-6273(94)90024-8; DOE CQ, 1993, TRENDS NEUROSCI, V16, P510, DOI 10.1016/0166-2236(93)90195-R; DULAC C, 1991, P NATL ACAD SCI USA, V88, P6358, DOI 10.1073/pnas.88.14.6358; GIANGRANDE A, 1994, DEVELOPMENT, V120, P523; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; JAN YN, 1994, ANNU REV GENET, V28, P373, DOI 10.1146/annurev.ge.28.120194.002105; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KANIA A, 1995, GENETICS, V139, P1663; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; PFRIEGER FW, 1995, CELL, V83, P671, DOI 10.1016/0092-8674(95)90178-7; PTASHNE M, 1988, GENETIC SWITCH GENE; RUDEL C, 1992, DEVELOPMENT, V115, P519; SALZBERG A, 1994, NEURON, V13, P269, DOI 10.1016/0896-6273(94)90346-8; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SHANKLAND M, 1992, DETERMINANTS NEURONA; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	25	32	32	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1219	1222		10.1016/0896-6273(95)90001-2	http://dx.doi.org/10.1016/0896-6273(95)90001-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845146	Bronze			2022-12-28	WOS:A1995TL67800001
J	Denk, W; Holt, JR; Shepherd, GMG; Corey, DP				Denk, W; Holt, JR; Shepherd, GMG; Corey, DP			Calcium imaging of single stereocilia in hair cells: Localization of transduction channels at both ends of tip links	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; FLUORESCENCE MICROSCOPY; MECHANICAL STIMULATION; BUNDLE; ADAPTATION; CHICK; SENSITIVITY; DEPENDENCE; CURRENTS; COCHLEA	Mechanically gated ''transduction'' channels in inner ear hair cells are thought to be connected to tip links stretched between adjacent stereocilia. To locate active channels, calcium-green fluorescence in single stereocilia was measured with two-photon laser scanning microscopy. Bundle deflection increased fluorescence in many but not all stereocilia; the increase was blocked by depolarization. The number of stereocilia responding was proportional to the transduction current, consistent with Ca2+ influx through transduction channels. Fluorescence rose first in the tips of stereocilia and then in the bases, in agreement with channel localization at the tips. Some of the shortest stereocilia in a bundle showed a fluorescence increase, as did some of the tallest, indicating that transduction channels can be at either or both ends of tip links.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,NEUROL SERV,PROGRAM NEUROSCI,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,HOWARD HUGHES MED INST,NEUROL SERV,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Denk, W (corresponding author), AT&T BELL LABS,BIOL COMPUTAT RES DEPT,600 MT AVE,MURRAY HILL,NJ 07974, USA.		Shepherd, Gordon/F-2679-2010; denk, winfried/I-6627-2012		NIDCD NIH HHS [DC00304] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; COREY DP, 1980, J NEUROSCI METH, V3, P183, DOI 10.1016/0165-0270(80)90025-4; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DENK W, 1989, PHYS REV LETT, V63, P207, DOI 10.1103/PhysRevLett.63.207; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; Denk W., 1995, 2 PHOTON MOL EXCITAT, P445; EBERHARD M, 1991, BIOCHEM BIOPH RES CO, V180, P209, DOI 10.1016/S0006-291X(05)81278-1; FUCHS PA, 1992, J NEUROSCI, V12, P800; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; HACKNEY CM, 1992, P ROY SOC B-BIOL SCI, V248, P215, DOI 10.1098/rspb.1992.0064; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HIRAOKA Y, 1990, BIOPHYS J, V57, P325, DOI 10.1016/S0006-3495(90)82534-0; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; METCALF AB, 1994, P NATL ACAD SCI USA, V91, P11821, DOI 10.1073/pnas.91.25.11821; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; OHMORI H, 1988, J PHYSIOL-LONDON, V399, P115; OSBORNE MP, 1988, HEARING RES, V35, P99, DOI 10.1016/0378-5955(88)90044-5; PICKLES JO, 1992, TRENDS NEUROSCI, V15, P254, DOI 10.1016/0166-2236(92)90066-H; PICKLES JO, 1993, HEARING RES, V68, P159, DOI 10.1016/0378-5955(93)90120-P; PICKLES JO, 1991, HEARING RES, V54, P153, DOI 10.1016/0378-5955(91)90116-Q; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; RUSCH A, IN PRESS ANN NY ACAD, V781; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SHEPHERD GMG, 1991, J GEN PHYSIOL, V95, pA25; SHEPPARD CJR, 1990, OPTIK, V86, P104; Solc CK, 1994, AUDIT NEUROSCI, V1, P63; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Wilson T., 1984, THEORY PRACTICE SCAN; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	46	208	214	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1311	1321		10.1016/0896-6273(95)90010-1	http://dx.doi.org/10.1016/0896-6273(95)90010-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845155	Bronze			2022-12-28	WOS:A1995TL67800010
J	WONG, ROL; MEISTER, M; SHATZ, CJ				WONG, ROL; MEISTER, M; SHATZ, CJ			TRANSIENT PERIOD OF CORRELATED BURSTING ACTIVITY DURING DEVELOPMENT OF THE MAMMALIAN RETINA	NEURON			English	Article							RECEPTIVE-FIELD CHARACTERISTICS; LATERAL GENICULATE-NUCLEUS; GANGLION-CELLS; AMACRINE CELLS; CAT RETINA; RETINOGENICULATE PATHWAY; PRENATAL DEVELOPMENT; IMPULSE ACTIVITY; LUCIFER YELLOW; RABBIT RETINA	The refinement of early connections in the visual pathway requires electrical activity in the retina before the onset of vision. Using a multielectrode array, we have shown that the spontaneous activity of cells in the neonatal ferret retina is correlated by patterns of periodically generated traveling waves. Here, we examine developmental changes in the characteristics of the waves and show that retinal ganglion cells participate in these patterns of activity, which are seen during the same period as synaptic modification in the lateral geniculate nucleus; that the waves subside gradually as the connectivity in the lateral geniculate nucleus stabilizes; and that their spatial structure allows for refinement of the retinotopic map, as well as for eye-specific segregation in the lateral geniculate nucleus.	STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University				Meister, Markus/0000-0003-2136-6506				AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; BLOOMFIELD SA, 1992, J NEUROPHYSIOL, V68, P711, DOI 10.1152/jn.1992.68.3.711; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CUCCHIARO J, 1984, PROC R SOC SER B-BIO, V223, P141, DOI 10.1098/rspb.1984.0087; DUBIN MW, 1986, J NEUROSCI, V6, P1021; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GREINER JV, 1980, EXP EYE RES, V30, P439, DOI 10.1016/0014-4835(80)90059-7; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MEISTER M, 1993, IN PRESS J NEUROSCI; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; RAPISARDI SC, 1975, EXP BRAIN RES, V22, P295; REDBURN DA, 1992, NEUROCHEM RES, V17, P61, DOI 10.1007/BF00966865; REGEHR WG, 1989, J NEUROSCI METH, V30, P91, DOI 10.1016/0165-0270(89)90055-1; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SINGER W, 1990, J EXP BIOL, V153, P177; SPEAR PD, 1972, BRAIN RES, V45, P67, DOI 10.1016/0006-8993(72)90216-8; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1987, J COMP NEUROL, V255, P386, DOI 10.1002/cne.902550306; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; SUR M, 1984, NATURE, V310, P246, DOI 10.1038/310246a0; TSO DY, 1986, J NEUROSCI, V6, P1160; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VITEK DJ, 1985, J COMP NEUROL, V241, P1, DOI 10.1002/cne.902410102; WASSLE H, 1987, J COMP NEUROL, V265, P391, DOI 10.1002/cne.902650308; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; WINGATE RJT, 1992, J COMP NEUROL, V323, P449, DOI 10.1002/cne.903230402; WONG ROL, 1987, J COMP NEUROL, V255, P159, DOI 10.1002/cne.902550202; YANG G, 1992, SCIENCE, V268, P1949	42	415	417	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					923	938		10.1016/0896-6273(93)90122-8	http://dx.doi.org/10.1016/0896-6273(93)90122-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240814				2022-12-28	WOS:A1993MJ04100014
J	HASHIMOTO, H; ISHIHARA, T; SHIGEMOTO, R; MORI, K; NAGATA, S				HASHIMOTO, H; ISHIHARA, T; SHIGEMOTO, R; MORI, K; NAGATA, S			MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A RECEPTOR FOR PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE	NEURON			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; BINDING-SITES; RAT-BRAIN; EXPRESSION CLONING; HIGH-AFFINITY; PEPTIDE; PACAP; PROTEIN; CELLS; NEUROPEPTIDE	Pituitary adenylate cyclase-activating polypeptide (PACAP) is a polypeptide hormone related to vasoactive intestinal polypeptide (VIP). Rat PACAP receptor cDNA was isolated from a brain cDNA library by cross-hybridization with rat VIP receptor cDNA. The recombinant PACAP receptor expressed in COS cells bound PACAP with about 1000 times higher affinity than VIP, and PACAP stimulated adenylate cyclase through the cloned PACAP receptor. The rat PACAP receptor consists of 495 amino acids, contains seven transmembrane segments, and has a significant similarity with other G(s)-coupled receptors, such as VIP, glucagon, and secretin receptors. PACAP receptor mRNA was abundantly expressed in the brain, but not in the peripheral tissues except for the adrenal gland. In situ hybridization revealed a high level of expression of PACAP receptor mRNA in the hippocampal dentate gyrus, olfactory bulb, and cerebellar cortex.	OSAKA UNIV,FAC PHARMACEUT SCI,DEPT PHARMACOL,SUITA,OSAKA 565,JAPAN; KYOTO UNIV,FAC MED,DEPT MORPHOL BRAIN SCI,KYOTO 606,JAPAN	Osaka University; Kyoto University	HASHIMOTO, H (corresponding author), OSAKA BIOSCI INST,6-2-4 FURUEDAI,SUITA,OSAKA 565,JAPAN.		Hashimoto, Hitoshi/D-1209-2010; Shigemoto, Ryuichi/E-3628-2013; Nagata, Shigekazu/AAG-3203-2019	Hashimoto, Hitoshi/0000-0001-6548-4016; Shigemoto, Ryuichi/0000-0001-8761-9444; Nagata, Shigekazu/0000-0001-9758-8426; Mori, Kensaku/0000-0001-7853-9370				ARIMURA A, 1991, ENDOCRINOLOGY, V129, P2787, DOI 10.1210/endo-129-5-2787; ARIMURA A, 1992, REGUL PEPTIDES, V37, P287; BABA A, 1993, NEUROSCI LETT, V149, P182, DOI 10.1016/0304-3940(93)90766-E; BUSCAIL L, 1990, FEBS LETT, V262, P77, DOI 10.1016/0014-5793(90)80158-F; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; GOTTSCHALL PE, 1991, FASEB J, V5, P194, DOI 10.1096/fasebj.5.2.1848519; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KATADA T, 1982, J BIOL CHEM, V257, P3739; KIMURA C, 1990, BIOCHEM BIOPH RES CO, V166, P81, DOI 10.1016/0006-291X(90)91914-E; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAM HC, 1990, EUR J BIOCHEM, V193, P725, DOI 10.1111/j.1432-1033.1990.tb19392.x; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; MASUO Y, 1992, BRAIN RES, V575, P113, DOI 10.1016/0006-8993(92)90430-H; MASUO Y, 1993, BRAIN RES, V602, P57, DOI 10.1016/0006-8993(93)90241-E; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OGI K, 1990, BIOCHEM BIOPH RES CO, V173, P1271, DOI 10.1016/S0006-291X(05)80924-6; OHTAKI T, 1990, BIOCHEM BIOPH RES CO, V171, P838, DOI 10.1016/0006-291X(90)91222-E; ROBBERECHT P, 1991, FEBS LETT, V286, P133, DOI 10.1016/0014-5793(91)80958-6; ROSELLIN G, 1986, PEPTIDES S1, V7, P89; SAID SI, 1986, J ENDOCRINOL INVEST, V9, P191, DOI 10.1007/BF03348097; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER H, 1991, EUR J BIOCHEM, V202, P951, DOI 10.1111/j.1432-1033.1991.tb16455.x; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHIVERS BD, 1991, ENDOCRINOLOGY, V128, P3055, DOI 10.1210/endo-128-6-3055; SUNDLER F, 1992, NEUROSCIENCE, V46, P439, DOI 10.1016/0306-4522(92)90064-9; TATSUNO I, 1990, BIOCHEM BIOPH RES CO, V168, P1027, DOI 10.1016/0006-291X(90)91132-C; TATSUNO I, 1991, ENDOCRINOLOGY, V129, P1797, DOI 10.1210/endo-129-4-1797; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WATANABE T, 1990, BIOCHEM BIOPH RES CO, V173, P252, DOI 10.1016/S0006-291X(05)81049-6; XIE YB, 1990, J BIOL CHEM, V265, P21411; YOKOTA Y, 1992, EMBO J, V11, P3585, DOI 10.1002/j.1460-2075.1992.tb05442.x	43	248	256	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					333	342		10.1016/0896-6273(93)90188-W	http://dx.doi.org/10.1016/0896-6273(93)90188-W			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394723				2022-12-28	WOS:A1993LU06500012
J	YAMAGATA, K; ANDREASSON, KI; KAUFMANN, WE; BARNES, CA; WORLEY, PF				YAMAGATA, K; ANDREASSON, KI; KAUFMANN, WE; BARNES, CA; WORLEY, PF			EXPRESSION OF A MITOGEN-INDUCIBLE CYCLOOXYGENASE IN BRAIN NEURONS - REGULATION BY SYNAPTIC ACTIVITY AND GLUCOCORTICOIDS	NEURON			English	Article							LONG-TERM POTENTIATION; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; RAT PREOVULATORY FOLLICLES; HORMONE-RELEASING HORMONE; ARACHIDONIC-ACID CASCADE; ANTI-INFLAMMATORY DRUGS; NITRIC-OXIDE SYNTHASE; FACTOR MESSENGER-RNAS; DENTATE GYRUS; LUTEINIZING-HORMONE	Prostaglandins play important and diverse roles in the CNS. The first step in prostaglandin synthesis involves enzymatic oxidation of arachidonic acid, which is catalyzed by prostaglandin H(PGH) synthase, also referred to as cyclooxygenase. We have cloned an inducible form of this enzyme from rat brain that is nearly identical to a murine, mitogen-inducible cyclooxygenase identified from fibroblasts. Our studies indicate that this gene, here termed COX-2, is expressed throughout the forebrain in discrete populations of neurons and is enriched in the cortex and hippocampus. Neuronal expression is rapidly and transiently induced by seizures or NMDA-dependent synaptic activity. No expression is detected in glia or vascular endothelial cells. Basal expression of COX-2 appears to be regulated by natural synaptic activity in the developing and adult brain. Both basal and induced expression of COX-2 are inhibited by glucocorticoids, consistent with COX-2 regulation in peripheral tissues. Our studies indicate that COX-2 expression may be important in regulating prostaglandin signaling in brain. The marked inducibility in neurons by synaptic stimuli suggests a role in activity-dependent plasticity.	JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA; UNIV ARIZONA, DEPT PSYCHOL, TUCSON, AZ 85724 USA; UNIV ARIZONA, DEPT NEUROL, TUCSON, AZ 85724 USA; UNIV ARIZONA, DIV NEURAL SYST MEMORY & AGING, TUCSON, AZ 85724 USA	Johns Hopkins University; University of Arizona; University of Arizona; University of Arizona	YAMAGATA, K (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA.		Snyder, Luann/E-8566-2013		NEI NIH HHS [EY09374, EY08900] Funding Source: Medline; NIA NIH HHS [AG09219] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008900, R01EY009374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009219] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; BREDER CD, 1992, J COMP NEUROL, V322, P409, DOI 10.1002/cne.903220309; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; Campbell W. B., 1990, PHARMACOL BASIS THER, P600; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CECCATELLI S, 1989, P NATL ACAD SCI USA, V86, P9569, DOI 10.1073/pnas.86.23.9569; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DRAGUNOW M, 1989, NEUROSCI LETT, V101, P274, DOI 10.1016/0304-3940(89)90545-4; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; FOSTERMANN U, 1982, PROSTAGLANDINS, V27, P913; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL C, 1992, EPILEPSY RES, P171; GEROZISSIS K, 1983, BRAIN RES, V279, P133, DOI 10.1016/0006-8993(83)90171-3; GREENOUGH WT, 1975, AM SCI, V63, P37; HAYAISHI O, 1988, J BIOL CHEM, V263, P14593; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; HERTTING G, 1989, ANN NY ACAD SCI, V559, P84; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; JEFFERY KJ, 1990, MOL BRAIN RES, V8, P267, DOI 10.1016/0169-328X(90)90039-G; JORDAN CA, 1990, IN SITU HYBRIDIZATIO, P39; KENT RS, 1983, J CLIN INVEST, V72, P455, DOI 10.1172/JCI110993; KIMURA H, 1985, BRAIN RES, V330, P235, DOI 10.1016/0006-8993(85)90682-1; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; LAPETINA EG, 1979, P NATL ACAD SCI USA, V76, P121, DOI 10.1073/pnas.76.1.121; LEE SH, 1992, J BIOL CHEM, V267, P25934; LINZER DIH, 1983, P NATL ACAD SCI-BIOL, V80, P4271, DOI 10.1073/pnas.80.14.4271; LYNCH MA, 1989, NEUROSCIENCE, V30, P693, DOI 10.1016/0306-4522(89)90162-0; MARKEY CM, 1987, J BIOL CHEM, V262, P6266; MARSHALL PJ, 1987, J BIOL CHEM, V262, P3510; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; MCNAUGHTON BL, 1986, J NEUROSCI, V6, P563; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; NARUMIYA S, 1982, LIFE SCI, V31, P2093, DOI 10.1016/0024-3205(82)90101-1; NATHANS D, 1991, ORIGINS OF HUMAN CANCER, P353; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; OGOROCHI T, 1984, J NEUROCHEM, V43, P71, DOI 10.1111/j.1471-4159.1984.tb06680.x; OJEDA SR, 1986, P NATL ACAD SCI USA, V83, P4932, DOI 10.1073/pnas.83.13.4932; OJEDA SR, 1982, ENDOCRINOLOGY, V110, P409, DOI 10.1210/endo-110-2-409; OJEDA SR, 1982, ENDOCRINOLOGY, V50, P89; OSULLIVAN MG, 1992, J BIOL CHEM, V267, P14547; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RAZ A, 1988, J BIOL CHEM, V263, P3022; REED GD, 1991, ANN NY ACAD SCI, V627, P381; RETTORI V, 1992, P NATL ACAD SCI USA, V89, P11543, DOI 10.1073/pnas.89.23.11543; RITTENHOUSE PA, 1992, BRAIN RES, V580, P205, DOI 10.1016/0006-8993(92)90946-7; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; RYSECK RP, 1992, CELL GROWTH DIFFER, V3, P443; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; SIROIS J, 1992, J BIOL CHEM, V267, P11586; SMITH WL, 1991, PHARMACOL THERAPEUT, V49, P153, DOI 10.1016/0163-7258(91)90054-P; STERNBERGER LA, 1986, J HISTOCHEM CYTOCHEM, V34, P599, DOI 10.1177/34.5.3517144; STONE EA, 1993, BRAIN RES, V603, P181, DOI 10.1016/0006-8993(93)91236-L; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TRAPP BD, 1989, J NEUROCYTOL, V18, P47, DOI 10.1007/BF01188423; TSUBOKURA S, 1991, BRAIN RES, V543, P15, DOI 10.1016/0006-8993(91)91043-Z; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; UENO R, 1982, P NATL ACAD SCI-BIOL, V79, P6093, DOI 10.1073/pnas.79.19.6093; URADE Y, 1987, J BIOL CHEM, V262, P15132; VANE J, 1987, FASEB J, V1, P89, DOI 10.1096/fasebj.1.2.3111928; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; WATANABE Y, 1989, BRAIN RES, V478, P143, DOI 10.1016/0006-8993(89)91486-8; WATANABE Y, 1986, BRAIN RES, V378, P216, DOI 10.1016/0006-8993(86)90924-8; WONG WYL, 1989, MOL ENDOCRINOL, V3, P1714, DOI 10.1210/mend-3-11-1714; WONG WYL, 1991, MOL ENDOCRINOL, V5, P1269, DOI 10.1210/mend-5-9-1269; WORLEY PF, 1990, COLD SH Q B, V55, P213, DOI 10.1101/SQB.1990.055.01.023; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; WORLEY PF, 1993, IN PRESS J NEUROSCI; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YAMASHITA A, 1983, P NATL ACAD SCI-BIOL, V80, P6114, DOI 10.1073/pnas.80.19.6114; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0; YOKOYAMA C, 1989, BIOCHEM BIOPH RES CO, V165, P888, DOI 10.1016/S0006-291X(89)80049-X	90	1067	1084	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					371	386		10.1016/0896-6273(93)90192-T	http://dx.doi.org/10.1016/0896-6273(93)90192-T			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352945				2022-12-28	WOS:A1993LU06500016
J	SRETAVAN, DW; REICHARDT, LF				SRETAVAN, DW; REICHARDT, LF			TIME-LAPSE VIDEO ANALYSIS OF RETINAL GANGLION-CELL AXON PATHFINDING AT THE MAMMALIAN OPTIC CHIASM - GROWTH CONE GUIDANCE USING INTRINSIC CHIASM CUES	NEURON			English	Article							PERIPHERAL PIONEER NEURONS; POSTERIOR TECTAL MEMBRANES; CHICK VISUAL-SYSTEM; FASCICLIN-I; NERVOUS-SYSTEM; MOUSE; GRASSHOPPER; PROJECTIONS; COLLAPSE; FIBERS	The specific routing of retinal ganglion cell axons at the mammalian optic chiasm into the ipsilateral or contralateral optic tracts results from axon pathfinding. Using time-lapse microscopy, we show that encounters between axons from opposite eyes at the chiasm induce axon turning, but do not always aim retinal axons into the optic tracts. Following removal of one eye before retinal axons have invaded the chiasm, axons from the remaining eye are still routed into the correct optic tracts. Ipsilaterally projecting axons make turning decisions without pausing over 10-20 min, whereas contralaterally projecting axons occasionally pause before crossing the midline. Thus, initial pathfinding at the chiasm does not depend on binocular axon interactions, but on local cues that trigger differential growth cone responses.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	SRETAVAN, DW (corresponding author), UNIV CALIF SAN FRANCISCO,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.							ANGEVINE JB, 1970, J COMP NEUROL, V139, P129, DOI 10.1002/cne.901390202; BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BERLOT J, 1984, SCIENCE, V223, P493, DOI 10.1126/science.223.4635.493; BONHOEFFER F, 1985, NATURE, V315, P409; BUNT SM, 1981, BRAIN RES, V211, P399, DOI 10.1016/0006-8993(81)90712-5; BUNT SM, 1983, DEV BRAIN RES, V6, P149, DOI 10.1016/0165-3806(83)90093-7; CHALUPA LM, 1991, J NEUROSCI, V11, P191; CHANG WS, 1992, DEVELOPMENT, V114, P507; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GODEMENT P, 1981, CR ACAD SCI III-VIE, V293, P625; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; Grenningloh G, 1992, Curr Opin Neurobiol, V2, P42, DOI 10.1016/0959-4388(92)90160-M; Guillery RW., 1982, SENS PHYSL, V7, P39, DOI [10.1016/B978-0-12-151807-3.50008-2, DOI 10.1016/B978-0-12-151807-3.50008-2]; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; JAY DG, 1990, NATURE, V348, P548, DOI 10.1038/348548a0; KAPFHAMMER J, 1987, J NEUROSCI, V7, P2201; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MYERS PZ, 1993, J NEUROSCI, V13, P127; Niimi K, 1962, TOKUSHIMA J EXP MED, V8, P203; NORRIS WE, 1989, DEVELOPMENT, V105, P541; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; RUGH R, 1990, MOUSE ITS REPROD DEV, P430; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SNOW DM, 1991, DEVELOPMENT, V113, P1473; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; SRETAVAN DW, 1986, J NEUROSCI, V6, P900; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; WALTER J, 1987, DEVELOPMENT, V101, P909	42	109	109	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					761	777		10.1016/0896-6273(93)90176-R	http://dx.doi.org/10.1016/0896-6273(93)90176-R			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386532				2022-12-28	WOS:A1993KY50100018
J	GRIFFITH, LC; VERSELIS, LM; AITKEN, KM; KYRIACOU, CP; DANHO, W; GREENSPAN, RJ				GRIFFITH, LC; VERSELIS, LM; AITKEN, KM; KYRIACOU, CP; DANHO, W; GREENSPAN, RJ			INHIBITION OF CALCIUM CALMODULIN-DEPENDENT PROTEIN-KINASE IN DROSOPHILA DISRUPTS BEHAVIORAL PLASTICITY	NEURON			English	Article							COURTSHIP SONG RHYTHMS; MELANOGASTER AFFECT; ALPHA-SUBUNIT; AUTOPHOSPHORYLATION; MUTATIONS; MUTANTS; MEMORY; BRAIN; PHOSPHORYLATION; EXPRESSION	One of the major mediators of calcium action in neurons is the multifunctional calcium/calmodulin-dependent protein kinase (CaM kinase), an enzyme with the capability of directly regulating its own activity by autophosphorylation. To assess the involvement of CaM kinase in experience-dependent behavior in an intact animal, we have designed a specific peptide inhibitor of CaM kinase and made transgenic Drosophila that express it under control of an inducible promoter. These flies fail to learn normally in two behavioral plasticity paradigms: acoustic priming, a nonassociative measure of sensitization, and courtship conditioning, a measure of associative learning. The magnitude of the learning defect in the associative paradigm appears to be proportional to the level of expression of the peptide gene in the two transgenic lines and can be increased by heat shock induction of gene expression. These results suggest that CaM kinase activity is required for plastic behaviors in an intact animal.	ROCHE INST MOLEC BIOL, DEPT NEUROSCI, NUTLEY, NJ 07110 USA; UNIV LEICESTER, DEPT GENET, LEICESTER LE1 7RH, ENGLAND; HOFFMANN LA ROCHE INC, ROCHE RES CTR, PEPTIDE RES DEPT, NUTLEY, NJ 07110 USA	University of Leicester; Roche Holding				Griffith, Leslie/0000-0003-3164-9876	NINDS NIH HHS [NS08779] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008779] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; BOYNTON S, 1992, GENETICS, V131, P655; CAREW TJ, 1986, ANNU REV NEUROSCI, V9, P435, DOI 10.1146/annurev.ne.09.030186.002251; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; GAILEY DA, 1984, GENETICS, V106, P613; GREENACRE ML, 1993, IN PRESS BEHAV GENET; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; KURET J, 1988, J BIOL CHEM, V263, P9149; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; KYRIACOU CP, 1984, NATURE, V308, P62, DOI 10.1038/308062a0; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; KYRIACOU CP, 1989, ANIM BEHAV, V37, P850, DOI 10.1016/0003-3472(89)90069-9; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MASON PJ, 1982, J MOL BIOL, V156, P21, DOI 10.1016/0022-2836(82)90456-9; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; NICHOLS R, 1992, J MOL NEUROSCI, V3, P213, DOI 10.1007/BF03380141; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; ROBERTSON HM, 1988, GENETICS, V118, P461; SAKAKIBARA M, 1986, BIOPHYS J, V50, P319, DOI 10.1016/S0006-3495(86)83465-8; Sambrook J, 1989, MOL CLONING; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; TULLY T, 1984, BEHAV GENET, V14, P527, DOI 10.1007/BF01065446; WILLMUND R, 1986, P NATL ACAD SCI USA, V83, P9789, DOI 10.1073/pnas.83.24.9789; WOODARD C, 1989, GENETICS, V123, P315; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZIAI R, 1986, P NATL ACAD SCI USA, V83, P8420, DOI 10.1073/pnas.83.21.8420	40	193	198	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1993	10	3					501	509		10.1016/0896-6273(93)90337-Q	http://dx.doi.org/10.1016/0896-6273(93)90337-Q			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8384859				2022-12-28	WOS:A1993KU90100014
J	Fruttiger, M; Calver, AR; Kruger, WH; Mudhar, HS; Michalovich, D; Takakura, N; Nishikawa, SI; Richardson, WD				Fruttiger, M; Calver, AR; Kruger, WH; Mudhar, HS; Michalovich, D; Takakura, N; Nishikawa, SI; Richardson, WD			PDGF mediates a neuron-astrocyte interaction in the developing retina	NEURON			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; FACTOR-A-CHAIN; VASCULAR-PERMEABILITY FACTOR; TRANSGENIC MICE; FACTOR RECEPTOR; OPTIC-NERVE; MONOCLONAL-ANTIBODIES; DIABETIC-RETINOPATHY; PRERETINAL MEMBRANES	Astrocytes invade the developing retina from the optic nerve head, over the axons of retinal ganglion cells (RGCs). RGCs express the platelet-derived growth factor A-chain (PDGF-A) and retinal astrocytes the PDGF alpha-receptor (PDGFR alpha), suggesting that PDGF mediates a paracrine interaction between these cells. To test this, we inhibited PDGF signaling in the eye with a neutralizing anti-PDGFR alpha antibody or a soluble extracellular fragment of PDGFR alpha. These treatments inhibited development of the astrocyte network. We also generated transgenic mice that overexpress PDGF-A in RGCs. This resulted in hyperproliferation of astrocytes, which in turn induced excessive vasculogenesis. Thus, PDGF appears to be a link in the chain of cell-cell interactions responsible for matching numbers of neurons, astrocytes, and blood vessels during retinal development.	UCL, DEPT BIOL, LONDON WC1E 6BT, ENGLAND; UNIV CONNECTICUT, SCH MED, DEPT MICROBIOL, FARMINGTON, CT 06030 USA; UNIV CONNECTICUT, SCH MED, PROGRAM NEUROL SCI, FARMINGTON, CT 06030 USA; KYOTO UNIV, FAC MED, DEPT MOL GENET, SAKYO KU, KYOTO 60601, JAPAN; UNITED MED & DENT SCH, DEPT EXPT PATHOL, LONDON SE1 9RT, ENGLAND	University of London; University College London; University of Connecticut; University of Connecticut; Kyoto University; University of London; King's College London	Fruttiger, M (corresponding author), UCL, MRC, MOL CELL BIOL LAB, MORTIMER ST, LONDON WC1E 6BT, ENGLAND.		Richardson, William/C-1762-2008; Fruttiger, Marcus/C-1899-2008	Richardson, William/0000-0001-7261-2485; Michalovich, David/0000-0003-4452-5776; Fruttiger, Marcus/0000-0002-6962-5485	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABEDI H, 1995, J BIOL CHEM, V270, P11367, DOI 10.1074/jbc.270.19.11367; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; BARINAGA M, 1995, SCIENCE, V267, P452, DOI 10.1126/science.7824943; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; BREITMAN ML, 1989, DEVELOPMENT, V106, P457; CHANLING TL, 1994, PROG RETIN EYE RES, V13, P357, DOI 10.1016/1350-9462(94)90015-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEZARDIN P, 1985, J CHROMATOGR, V319, P67, DOI 10.1016/S0021-9673(01)90540-0; COATS SR, 1994, BIOCHEM J, V297, P379, DOI 10.1042/bj2970379; CONNOLLY DT, 1991, J CELL BIOCHEM, V47, P219, DOI 10.1002/jcb.240470306; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; DAMORE PA, 1993, GROWTH FACTORS, V8, P61, DOI 10.3109/08977199309029135; ENGERMAN RL, 1965, AM J OPHTHALMOL, V60, P628, DOI 10.1016/0002-9394(65)92251-8; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Ferns GAA, 1990, GROWTH FACTORS, V3, P315, DOI 10.3109/08977199009003674; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1989, TRENDS GENET, V5, P108, DOI 10.1016/0168-9525(89)90040-1; HERKEN R, 1990, J ANAT, V169, P189; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOSODA Y, 1993, OPHTHALMIC RES, V25, P289, DOI 10.1159/000267327; IGUCHI I, 1995, CORNEA, V14, P365, DOI 10.1097/00003226-199507000-00004; JERDAN JA, 1986, ARCH OPHTHALMOL-CHIC, V104, P286, DOI 10.1001/archopht.1986.01050140144038; KAUR S, 1989, DEVELOPMENT, V105, P613; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P1660; KLAGSBRUN M, 1993, CURR BIOL, V3, P699, DOI 10.1016/0960-9822(93)90073-W; KOYAMA N, 1994, J CELL PHYSIOL, V158, P1, DOI 10.1002/jcp.1041580102; KOYAMA N, 1994, CIRC RES, V75, P682, DOI 10.1161/01.RES.75.4.682; KOYAMA N, 1992, J BIOL CHEM, V267, P22806; LANDEL CP, 1988, GENE DEV, V2, P1168, DOI 10.1101/gad.2.9.1168; LAROCHELLE WJ, 1991, GENE DEV, V5, P1191, DOI 10.1101/gad.5.7.1191; LATERRA J, 1990, J CELL PHYSIOL, V144, P204, DOI 10.1002/jcp.1041440205; LEE KH, 1990, MOL CELL BIOL, V10, P2237, DOI 10.1128/MCB.10.5.2237; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LING TL, 1989, J COMP NEUROL, V286, P345, DOI 10.1002/cne.902860305; LING TL, 1988, DEV BRAIN RES, V44, P73, DOI 10.1016/0165-3806(88)90119-8; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; OHIRA A, 1990, OPHTHALMOLOGICA, V201, P187, DOI 10.1159/000310150; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; PEER J, 1995, LAB INVEST, V72, P638; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Pollock RA, 1992, GROWTH FACTORS, V7, P267, DOI 10.3109/08977199209046409; PRUSS R, 1979, NATURE, V303, P396; RAINES EW, 1992, J CELL BIOL, V116, P533, DOI 10.1083/jcb.116.2.533; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; SEILER MJ, 1995, EXP BRAIN RES, V105, P59; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SIEGBAHN A, 1990, J CLIN INVEST, V85, P916, DOI 10.1172/JCI114519; Smits A, 1989, GROWTH FACTORS, V2, P1, DOI 10.3109/08977198909069076; SRAMEK SJ, 1989, OPHTHALMOLOGY, V96, P835; STAVRI GT, 1995, FEBS LETT, V358, P311, DOI 10.1016/0014-5793(94)01458-D; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; UCHIHORI Y, 1991, INVEST OPHTH VIS SCI, V32, P2689; UREN A, 1994, BIOCHEM BIOPH RES CO, V204, P628, DOI 10.1006/bbrc.1994.2505; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; YU JC, 1994, J BIOL CHEM, V269, P10668	75	184	188	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1996	17	6					1117	1131		10.1016/S0896-6273(00)80244-5	http://dx.doi.org/10.1016/S0896-6273(00)80244-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982160	Bronze			2022-12-28	WOS:A1996WA24800010
J	Fannon, AM; Colman, DR				Fannon, AM; Colman, DR			A model for central synaptic junctional complex formation based on the differential adhesive specificities of the cadherins	NEURON			English	Article							CELL-CELL-ADHESION; INTERCELLULAR ADHERENS JUNCTIONS; A-CAM; MOLECULE UVOMORULIN; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; EPITHELIAL-CELLS; 135-KD RECEPTOR; R-CADHERIN; N-CADHERIN	Cadherins control critical developmental events through well-documented hemophilic interactions. In epithelia, they are hallmark constituents of junctions that mediate intercellular adhesion. Brain tissue expresses several cadherins, and we now show that two of these, neural (N)- and epithelial (E)-cadherin, are localized to synaptic complexes in mutually exclusive distributions. In cerebellum, N-cadherin is frequently found associated with synapses, some of which are perforated, and in hippocampus, N- and E-cadherin-containing synapses are found aligned along dendritic shafts within the stratum lucidum of CA3. We propose that the cadherins function as primary adhesive moieties between pre- and postsynaptic membranes in the synaptic complex. According to this model, once neurites have been guided to the vicinity of their cognate targets, it is the differential distribution of cadherins along the axonal and dendritic plasma membranes, and ultimately cadherin self-association, that "locks in" nascent synaptic connections.			Fannon, AM (corresponding author), CUNY MT SINAI SCH MED, BROOKDALE CTR MOL BIOL, NEW YORK, NY 10029 USA.				NINDS NIH HHS [NS20147] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; CHANPALAY V, 1971, Z ANAT ENTWICKLUNGS, V133, P274, DOI 10.1007/BF00519303; COHEN RS, 1978, J CELL BIOL, V78, P36, DOI 10.1083/jcb.78.1.36; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; DOTTI CG, 1991, J CELL SCI, P75; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Einheber S, 1996, J COMP NEUROL, V370, P105; Elferink LA, 1995, PROG BRAIN RES, V105, P79; ELLISMAN MH, 1987, ENCY NEUROSCIENCE, V2, P1232; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gaze RM, 1970, FORMATION NERVE CONN; GEIGER B, 1992, ANNU REV CELL BIOL, V8, P307, DOI 10.1146/annurev.cb.08.110192.001515; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GOODWIN L, 1990, BIOCHEM BIOPH RES CO, V173, P1224, DOI 10.1016/S0006-291X(05)80917-9; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; Grunwald GB, 1993, CURR OPIN CELL BIOL, V5, P797, DOI 10.1016/0955-0674(93)90028-O; GUMBINER BM, 1993, NEURON, V11, P551, DOI 10.1016/0896-6273(93)90068-3; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; GURD JW, 1982, J NEUROCHEM, V39, P1117, DOI 10.1111/j.1471-4159.1982.tb11504.x; ICHIMURA T, 1988, J NEUROCYTOL, V17, P3, DOI 10.1007/BF01735373; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; ITARAT W, 1993, J NEUROCYTOL, V22, P753, DOI 10.1007/BF01181321; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; LAGUNOWICH LA, 1992, J NEUROSCI RES, V32, P202, DOI 10.1002/jnr.490320209; Magee AI, 1991, CURR OPIN CELL BIOL, V3, P854, DOI 10.1016/0955-0674(91)90060-C; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Peters A., 1991, FINE STRUCTURE NERVO; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; PHEND KD, 1992, J HISTOCHEM CYTOCHEM, V40, P1011, DOI 10.1177/40.7.1376741; REDIES C, 1993, J COMP NEUROL, V333, P398, DOI 10.1002/cne.903330307; RUTISHAUSER U, 1992, DEVELOPMENT, P99; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Sperry RW, 1943, J COMP NEUROL, V79, P33, DOI 10.1002/cne.900790104; SPERRY RW, 1945, J NEUROPHYSIOL, V8, P15, DOI 10.1152/jn.1945.8.1.15; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sperry RW, 1944, J NEUROPHYSIOL, V7, P57, DOI 10.1152/jn.1944.7.1.57; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUZUKI S, 1991, CELL REGUL, V2, P261, DOI 10.1091/mbc.2.4.261; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TSUKITA S, 1991, J CELL BIOL, V113, P867, DOI 10.1083/jcb.113.4.867; Vaughn DE, 1996, NEURON, V16, P261, DOI 10.1016/S0896-6273(00)80045-8; VOLK T, 1987, CELL, V50, P987, DOI 10.1016/0092-8674(87)90525-3; VOLK T, 1986, J CELL BIOL, V103, P1451, DOI 10.1083/jcb.103.4.1451; VOLK T, 1986, J CELL BIOL, V103, P1441, DOI 10.1083/jcb.103.4.1441; WAGNER G, 1995, SCIENCE, V267, P342, DOI 10.1126/science.7824932; YAMAGATA M, 1995, J NEUROSCI, V15, P4556	65	363	367	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					423	434		10.1016/S0896-6273(00)80175-0	http://dx.doi.org/10.1016/S0896-6273(00)80175-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816706	Bronze			2022-12-28	WOS:A1996VJ44000009
J	Ingi, T; Cheng, J; Ronnett, GV				Ingi, T; Cheng, J; Ronnett, GV			Carbon monoxide: An endogenous modulator of the nitric oxide-cyclic GMP signaling system	NEURON			English	Article							CEREBELLAR GRANULE CELLS; HEME OXYGENASE; MESSENGER-RNA; RAT-BRAIN; INSITU HYBRIDIZATION; GUANYLATE-CYCLASE; ERYTHROID-CELLS; SYNTHASE; GLUTAMATE; LOCALIZATION	Carbon monoxide (GO) is an activator of soluble guanylyl cyclase and is implicated as a neuronal messenger. CO production, nitric oxide synthase (NOS) activity, and guanosine 3',5'-monophosphate (cGMP) levels were quantitated in cerebellar granule cell cultures. Metabolic labeling experiments enabled the direct measurement of neuronal CO production in vitro. CO production is significant, and peaked during early stages of culture. NOS activity and cGMP levels synchronously increased as cells matured. Whereas inhibition of NOS depleted cGMP in mature cultures, inhibitors of CO production potentiated the nitric oxide (NO)-mediated cGMP increase. Exogenous CO at similar concentrations to endogenous levels blocked the NO-mediated cGMP increase. These results directly demonstrate that endogenous neuronal CO production is high and indicate that while NO is the major regulator of cGMP in these neurons, CO may modulate the NO-cGMP signaling system.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University								BESSHO Y, 1993, J NEUROCHEM, V60, P253, DOI 10.1111/j.1471-4159.1993.tb05845.x; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BRUNE B, 1987, MOL PHARMACOL, V32, P497; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; CRUSE I, 1988, J BIOL CHEM, V263, P3348; EBERT PS, 1970, BIOCHIM BIOPHYS ACTA, V208, P236, DOI 10.1016/0304-4165(70)90242-4; EWING JF, 1992, MOL CELL NEUROSCI, V3, P559, DOI 10.1016/1044-7431(92)90068-D; FALK JE, 1975, PROPHYRINS METALLOPO, P808; FREEMAN ME, 1983, J NEUROCHEM, V40, P1441, DOI 10.1111/j.1471-4159.1983.tb13588.x; FURCHGOTT RF, 1991, BLOOD VESSELS, V28, P52; GARDNER LC, 1991, J BIOL CHEM, V266, P22010; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GRISCAVAGE JM, 1994, J BIOL CHEM, V269, P21644; GRISCAVAGE JM, 1993, J IMMUNOL, V151, P6329; HALL PV, 1979, NEUROLOGY, V29, P262, DOI 10.1212/WNL.29.2.262; IGNARRO LJ, 1984, J BIOL CHEM, V259, P6201; Ingi T, 1995, J NEUROSCI, V15, P8214; Jing M, 1994, Adv Pharmacol, V31, P459, DOI 10.1016/S1054-3589(08)60635-3; Jing Ming, 1995, Life Sciences, V56, P19; KHARITONOV VG, 1995, P NATL ACAD SCI USA, V92, P2568, DOI 10.1073/pnas.92.7.2568; KIEDROWSKI L, 1992, J NEUROCHEM, V58, P335, DOI 10.1111/j.1471-4159.1992.tb09315.x; KIM TD, 1994, J BIOL CHEM, V269, P15540; KINGSBURY AE, 1985, DEV BRAIN RES, V17, P17, DOI 10.1016/0165-3806(85)90128-2; KRUSZYNA H, 1993, BIOCHEM PHARMACOL, V46, P95, DOI 10.1016/0006-2952(93)90352-W; LABBE RF, 1957, BIOCHIM BIOPHYS ACTA, V26, P437, DOI 10.1016/0006-3002(57)90033-1; LANDAW SA, 1966, J NUCL MED, V7, P696; LEINDERSZUFALL T, 1995, J NEUROPHYSIOL, V74, P1498, DOI 10.1152/jn.1995.74.4.1498; LINCOLN BC, 1989, BIOCHIM BIOPHYS ACTA, V992, P49, DOI 10.1016/0304-4165(89)90049-4; LUO DS, 1994, EUR J PHARM-MOLEC PH, V267, P263, DOI 10.1016/0922-4106(94)90149-X; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; MEFFERT MK, 1994, NEURON, V13, P1225, DOI 10.1016/0896-6273(94)90060-4; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHANSON JA, 1995, NEURON, V14, P781, DOI 10.1016/0896-6273(95)90222-8; PONKA P, 1985, BLOOD, V65, P850; POSS KD, 1995, NEURON, V15, P867, DOI 10.1016/0896-6273(95)90177-9; SASSA S, 1975, ERYTHROPOIESIS, P383; SCHMIDT HHHW, 1992, FEBS LETT, V307, P102, DOI 10.1016/0014-5793(92)80910-9; SCHWARTZ MB, 1990, J NEUROSCI, V26, P217; STEVENS CF, 1993, NATURE, V364, P147, DOI 10.1038/364147a0; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; SUN Y, 1990, J BIOL CHEM, V265, P8212; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; THOM SR, 1994, TOXICOL APPL PHARM, V128, P105, DOI 10.1006/taap.1994.1186; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VREMAN HJ, 1991, AM J MED SCI, V302, P335, DOI 10.1097/00000441-199112000-00002; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; WYSS PA, 1993, BIOCHIM BIOPHYS ACTA, V1182, P323, DOI 10.1016/0925-4439(93)90076-D; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	55	221	230	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					835	842		10.1016/S0896-6273(00)80103-8	http://dx.doi.org/10.1016/S0896-6273(00)80103-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608001	hybrid			2022-12-28	WOS:A1996UG61100016
J	Muller, U				Muller, U			Inhibition of nitric oxide synthase impairs a distinct form of long-term memory in the honeybee, Apis mellifera	NEURON			English	Article							INTERCELLULAR MESSENGER; GUANYLATE-CYCLASE; POTENTIATION; BRAIN; HIPPOCAMPUS; GLUTAMATE; ENHANCEMENT; CEREBELLUM; ACTIVATION; DEPRESSION	Nitric oxide has been shown to be implicated in neural plasticity that underlies processes of learning and memory. In the honeybee, studies on the role of nitric oxide in associative olfactory learning reveal its specific function in memory formation. Inhibition of nitric oxide synthase during olfactory conditioning impairs a distinct long-term memory that is formed as a consequence of multiple learning trials. Acquisition or retrieval of memory or memory formation induced by a single learning trial is not affected by blocking of nitric oxide synthase. This finding provides a first step toward dissection of molecular mechanisms involved in memory formation, in general, and the special function of nitric oxide synthase, in particular.			Muller, U (corresponding author), FREE UNIV BERLIN,INST NEUROBIOL,KONIGIN LUISE STR 28-30,D-14195 BERLIN,GERMANY.							ALLWEIS C, 1991, NEURAL BEHAV PLASTIC, P351; ALTFELDER K, 1991, INSECT BIOCHEM, V21, P487, DOI 10.1016/0020-1790(91)90102-K; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; BANNERMAN DM, 1994, J NEUROSCI, V14, P7415; BANNERMAN DM, 1994, J NEUROSCI, V14, P7404; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOHME GA, 1993, P NATL ACAD SCI USA, V90, P9191, DOI 10.1073/pnas.90.19.9191; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; CHAPMAN PF, 1992, NEUROREPORT, V3, P567, DOI 10.1097/00001756-199207000-00005; CHETKOVICH DM, 1993, NEUROREPORT, V4, P919, DOI 10.1097/00001756-199307000-00020; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; ELPHICK MR, 1993, BRAIN RES, V619, P344, DOI 10.1016/0006-8993(93)91632-3; ELPHICK MR, 1995, J EXP BIOL, V198, P821; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; ERBER J, 1976, J COMP PHYSIOL PSYCH, V90, P41, DOI 10.1037/h0077258; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GOADSBY PJ, 1992, BRAIN RES, V595, P167, DOI 10.1016/0006-8993(92)91470-Y; GOY MF, 1991, TRENDS NEUROSCI, V14, P293, DOI 10.1016/0166-2236(91)90140-P; GRIBKOFF VK, 1992, J NEUROPHYSIOL, V68, P639, DOI 10.1152/jn.1992.68.2.639; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HALEY JE, 1993, NEUROSCI LETT, V160, P85, DOI 10.1016/0304-3940(93)90919-C; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; HAMMER M, 1994, BEHAV NEURAL BIOL, V62, P210, DOI 10.1016/S0163-1047(05)80019-6; Heisenberg M., 1989, Progress in Zoology, V37, P3; HILDEEBRANDT H, 1994, P 22 GOTT NEUR C, P653; HOLSCHER C, 1992, NEUROSCI LETT, V145, P165, DOI 10.1016/0304-3940(92)90012-V; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Menzel R., 1974, P195; MENZEL R, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P323; Menzel R, 1985, EXPT BEHAV ECOLOGY, P55; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; MULLER U, 1994, J NEUROSCI, V14, P7521; MULLER U, 1995, EUR J NEUROSCI, V7, P2240, DOI 10.1111/j.1460-9568.1995.tb00645.x; MULLER U, 1994, EUR J NEUROSCI, V6, P1382; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Squire L. R., 1987, MEMORY BRAIN; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; WILLIAMS JH, 1993, NEURON, V11, P877, DOI 10.1016/0896-6273(93)90117-A; WITTSTOCK S, 1993, J NEUROSCI, V13, P1379; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368; ZHUO M, 1994, NEUROREPORT, V5, P1033, DOI 10.1097/00001756-199405000-00004	58	172	175	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1996	16	3					541	549		10.1016/S0896-6273(00)80073-2	http://dx.doi.org/10.1016/S0896-6273(00)80073-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC168	8785051	Bronze			2022-12-28	WOS:A1996UC16800010
J	Artalejo, CR; Elhamdani, A; Palfrey, HC				Artalejo, CR; Elhamdani, A; Palfrey, HC			Calmodulin is the divalent cation receptor for rapid endocytosis, but not exocytosis, in adrenal chromaffin cells	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN KINASE; AUTOINHIBITORY DOMAIN; BINDING; PHOSPHORYLATION; SECRETION; CALCINEURIN; ANTIBODIES; VESICLES; PURIFICATION	Exocytosis and the ensuing rapid endocytosis in adrenal chromaffin cells are both Ca2+-dependent phenomena but differ in their divalent cation specificity, implying distinct Ca2+ receptors for the two processes. To ascertain whether calmodulin is the Ca2+ receptor for either process, we blocked its function by introducing calmodulin-binding peptides or anti-calmodulin antibodies into these cells. Exo/endocytosis was followed by measurement of cell membrane capacitance. Rapid endocytosis, but not exocytosis, was abolished by these treatments, indicating that calmodulin is the Ca2+ receptor for rapid endocytosis but is not involved in exocytosis. The principal calmodulin target is not protein phosphatase-as, as antagonism of this enzyme did not inhibit but accelerated rapid endocytosis. Calmodulin may thus regulate both the rate and extent of rapid endocytosis by distinct pathways.	UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,CHICAGO,IL 60637	University of Chicago	Artalejo, CR (corresponding author), NORTHWESTERN UNIV,DEPT NEUROBIOL & PHYSIOL,2153 SHERIDAN RD,EVANSTON,IL 60208, USA.							ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BRADY MJ, 1993, J BIOL CHEM, V268, P17951; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CLAPHAM DE, 1984, J PHYSIOL-LONDON, V353, P541, DOI 10.1113/jphysiol.1984.sp015350; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Fabiato A., 1988, METHOD ENZYMOL, V157, P387; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; GEISOW MJ, 1983, NATURE, V301, P432, DOI 10.1038/301432a0; GROBLEWSKI GE, 1994, J BIOL CHEM, V269, P15111; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HAYCOCK JW, 1988, P NATL ACAD SCI USA, V85, P1677, DOI 10.1073/pnas.85.5.1677; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HIKITA T, 1984, J NEUROCHEM, V43, P1087, DOI 10.1111/j.1471-4159.1984.tb12848.x; HULTSCH T, 1991, P NATL ACAD SCI USA, V88, P6229, DOI 10.1073/pnas.88.14.6229; HUNZIKER W, 1994, J BIOL CHEM, V269, P29003; ITOH T, 1989, NATURE, V338, P164, DOI 10.1038/338164a0; KENIGSBERG RL, 1985, NEUROSCIENCE, V14, P335, DOI 10.1016/0306-4522(85)90183-6; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; KUBLER E, 1994, EMBO J, V13, P5539, DOI 10.1002/j.1460-2075.1994.tb06891.x; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; LEE YC, 1984, J BIOL CHEM, V259, P1226; LITTLETON JT, 1995, TRENDS NEUROSCI, V18, P177; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; MATTHIES HJG, 1988, FEBS LETT, V229, P238, DOI 10.1016/0014-5793(88)81132-3; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MITSUI K, 1993, J BIOL CHEM, V268, P13422; MOMAYEZI M, 1987, J CELL BIOL, V105, P181, DOI 10.1083/jcb.105.1.181; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PEARSON RB, 1986, J BIOL CHEM, V261, P25; PERIN MS, 1991, J BIOL CHEM, V266, P623; REDDY GPV, 1992, BIOCHEMISTRY-US, V31, P10426, DOI 10.1021/bi00158a002; ROBINSON PJ, 1994, TRENDS NEUROSCI, V17, P348, DOI 10.1016/0166-2236(94)90179-1; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; SCHELLER RH, 1995, NEURON, V14, P893; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SMITH MK, 1992, J BIOL CHEM, V267, P1761; SNYDER SH, 1995, NAT MED, V1, P32, DOI 10.1038/nm0195-32; STEINHARDT RA, 1982, NATURE, V295, P154, DOI 10.1038/295154a0; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TRIFARO JM, 1989, NEUROSCIENCE, V29, P1, DOI 10.1016/0306-4522(89)90327-8; VANBELLE H, 1984, ADV CYCLIC NUCL PROT, V17, P557; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONGRAFENSTEIN H, 1992, J PHYSIOL-LONDON, V453, P15, DOI 10.1113/jphysiol.1992.sp019215; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; WOLFF DJ, 1977, J BIOL CHEM, V252, P4108; [No title captured]	57	107	108	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					195	205		10.1016/S0896-6273(00)80036-7	http://dx.doi.org/10.1016/S0896-6273(00)80036-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562084	Bronze			2022-12-28	WOS:A1996TT30700022
J	GILLESPIE, PG; WAGNER, MC; HUDSPETH, AJ				GILLESPIE, PG; WAGNER, MC; HUDSPETH, AJ			IDENTIFICATION OF A 120 KD HAIR-BUNDLE MYOSIN LOCATED NEAR STEREOCILIARY TIPS	NEURON			English	Article							VANADATE-DEPENDENT MODIFICATION; SUBFRAGMENT-1 HEAVY-CHAIN; MUSCLE-CONTRACTION; ACTIN-FILAMENTS; SMOOTH-MUSCLE; INNER-EAR; MECHANOELECTRICAL TRANSDUCTION; ADENOSINE-TRIPHOSPHATASE; CROSS-LINKS; CELLS	By adapting to sustained stimuli, hair cells of the internal ear maintain their optimal sensitivity to minute displacements. Biophysical experiments have suggested that adaptation is mediated by a molecular motor, most likely a member of the myosin family. To provide direct evidence for the presence of myosin isozymes in hair bundles, we used photoaffinity labeling with vanadate-trapped uridine and adenine nucleotides to identify proteins of 120, 160, and 230 kd in a preparation of hair bundles purified from the bullfrog's sacculus. The photoaffinity labeling properties of these proteins, particularly the 120 kd protein, resembled those of other well-characterized myosins. A 120 kd hair-bundle protein was also recognized by a monoclonal antibody directed against a vertebrate myosin I isozyme. Immunofluorescence microscopy localized this protein near the beveled top edge of the hair bundle, the site of mechanoelectrical transduction and adaptation.	UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,CTR BASIC NEUROSCI RES,DEPT PHARMACOL,DALLAS,TX 75235	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Barr-Gillespie, Peter/0000-0002-9787-5860	NIDCD NIH HHS [DC00241] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; ADAMS RJ, 1986, NATURE, V322, P754, DOI 10.1038/322754a0; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; BARYLKO B, 1992, P NATL ACAD SCI USA, V89, P490, DOI 10.1073/pnas.89.2.490; CARBONI JM, 1988, J CELL BIOL, V107, P1749, DOI 10.1083/jcb.107.5.1749; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; CORWIN JT, 1985, P NATL ACAD SCI USA, V82, P3911, DOI 10.1073/pnas.82.11.3911; COUDRIER E, 1983, EMBO J, V2, P469, DOI 10.1002/j.1460-2075.1983.tb01446.x; CREMO CR, 1988, BIOCHEMISTRY-US, V27, P8415, DOI 10.1021/bi00422a018; DANTZIG JA, 1985, J GEN PHYSIOL, V86, P305, DOI 10.1085/jgp.86.3.305; DRENCKHAHN D, 1982, NATURE, V300, P531, DOI 10.1038/300531a0; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; DRENCKHAHN D, 1985, AUDITORY BIOCH, P312; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FATH KR, 1993, J CELL BIOL, V120, P117, DOI 10.1083/jcb.120.1.117; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; FUKAI Y, 1989, NATURE, V341, P328; FULLER SA, 1988, CURRENT PROTOCOLS MO, V2; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GARABEDIAN TE, 1990, J BIOL CHEM, V265, P22547; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; GILLESPIE PG, 1991, P NATL ACAD SCI USA, V88, P2563, DOI 10.1073/pnas.88.6.2563; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; GLENNEY JR, 1980, J BIOL CHEM, V255, P551; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P629; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; GOODSON HV, 1993, P NATL ACAD SCI USA, V90, P659, DOI 10.1073/pnas.90.2.659; GOODY R S, 1980, Journal of Muscle Research and Cell Motility, V1, P101, DOI 10.1007/BF00711928; GRAMMER JC, 1988, BIOCHEMISTRY-US, V27, P8408, DOI 10.1021/bi00422a017; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; HIBBERD MG, 1986, ANNU REV BIOPHYS BIO, V15, P119; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1987, SENSORY TRANSDUCTION, P138; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JACKSON AP, 1988, BIOCHEM J, V251, P515, DOI 10.1042/bj2510515; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; KIEHART DP, 1984, J CELL BIOL, V99, P1002, DOI 10.1083/jcb.99.3.1002; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; LEWIS ER, 1973, J MORPHOL, V39, P351; MACARTNEY JC, 1980, NATURE, V288, P491, DOI 10.1038/288491a0; MARUTA H, 1981, J BIOL CHEM, V256, P499; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; NAKAMAYE KL, 1985, BIOCHEMISTRY-US, V24, P5226, DOI 10.1021/bi00340a041; PATE E, 1991, BIOPHYS J, V59, P598, DOI 10.1016/S0006-3495(91)82275-5; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cb.04.110188.000431; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; SANS A, 1989, HEARING RES, V40, P117, DOI 10.1016/0378-5955(89)90105-6; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; SHERR EH, 1993, J CELL BIOL, V120, P1405, DOI 10.1083/jcb.120.6.1405; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; SLEPECKY N, 1985, HEARING RES, V20, P245, DOI 10.1016/0378-5955(85)90029-2; SLEPECKY NB, 1992, HEARING RES, V57, P201, DOI 10.1016/0378-5955(92)90152-D; SWANLJUNGCOLLINS H, 1991, J BIOL CHEM, V266, P1312; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; WHITE HD, 1976, BIOCHEMISTRY-US, V15, P5818, DOI 10.1021/bi00671a020	72	135	138	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					581	594		10.1016/0896-6273(93)90071-X	http://dx.doi.org/10.1016/0896-6273(93)90071-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398149				2022-12-28	WOS:A1993MD06800004
J	RUPPRECHT, R; REUL, JMHM; TRAPP, T; VANSTEENSEL, B; WETZEL, C; DAMM, K; ZIEGLGANSBERGER, W; HOLSBOER, F				RUPPRECHT, R; REUL, JMHM; TRAPP, T; VANSTEENSEL, B; WETZEL, C; DAMM, K; ZIEGLGANSBERGER, W; HOLSBOER, F			PROGESTERONE RECEPTOR-MEDIATED EFFECTS OF NEUROACTIVE STEROIDS	NEURON			English	Article							HUMAN GLUCOCORTICOID RECEPTOR; GABA-A RECEPTORS; RAT-BRAIN; MINERALOCORTICOID RECEPTOR; MAMMALIAN-CELLS; PITUITARY; NEUROSTEROIDS; EXPRESSION; ACID; DNA	Several 3alpha-hydroxysteroids accumulate in the brain after local synthesis or after metabolization of steroids that are provided by the adrenals. The 3alpha-hydroxy ring A-reduced pregnane steroids allopregnanolone and tetrahydrodeoxycorticosterone are believed not to interact with intracellular receptors, but enhance GABA-mediated chloride currents. The present study shows that these neuroactive steroids can regulate gene expression via the progesterone receptor. The induction of DNA binding and transcriptional activation of the progesterone receptor requires intracellular oxidation of the neuroactive steroids into progesterone receptor active 5alpha-pregnane steroids. Thus, at physiological concentrations, these neuroactive steroids regulate neuronal function through their effects on both transmitter-gated ion channels and steroid receptor-regulated gene expression.	EC SLATER INST, AMSTERDAM, NETHERLANDS		RUPPRECHT, R (corresponding author), MAX PLANCK INST PSYCHIAT, INST CLIN, DEPT NEUROENDOCRINOL, W-8000 MUNICH 40, GERMANY.		Reul, Johannes/B-4132-2019; Jansen, Heiko T./A-5770-2008; Wetzel, Christian/F-1366-2018; Wetzel, Christian/C-2501-2009; Wetzel, Christian H/N-9880-2017	Reul, Johannes/0000-0002-8787-4012; Jansen, Heiko T./0000-0003-0178-396X; Wetzel, Christian/0000-0002-5762-0003; Wetzel, Christian H/0000-0002-5762-0003				ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; CAMPBELL JS, 1990, J STEROID BIOCHEM, V37, P535, DOI 10.1016/0960-0760(90)90398-5; CELOTTI F, 1992, FRONT NEUROENDOCRIN, V13, P163; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CONNEELY OM, 1989, J BIOL CHEM, V264, P14062; CRAWLEY JN, 1986, BRAIN RES, V398, P382, DOI 10.1016/0006-8993(86)91500-3; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5051; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FOX SR, 1990, NEUROENDOCRINOLOGY, V51, P276, DOI 10.1159/000125350; GEE KW, 1988, J PHARMACOL EXP THER, V246, P803; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KARAVOLAS HJ, 1990, CIBA F SYMP, V153, P22; KASTNER P, 1990, J BIOL CHEM, V265, P12163; KRAUSE JE, 1980, J BIOL CHEM, V255, P1807; LAN NC, 1991, J NEUROCHEM, V57, P1818, DOI 10.1111/j.1471-4159.1991.tb06388.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; MELCANGI RC, 1993, ENDOCRINOLOGY, V132, P1252, DOI 10.1210/en.132.3.1252; MENDELSON WB, 1987, PSYCHOPHARMACOLOGY, V93, P226; MORROW AL, 1990, MOL PHARMACOL, V37, P263; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; PERROTAPPLANAT M, 1987, CANCER RES, V47, P2652; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; PURDY RH, 1990, J MED CHEM, V33, P1572, DOI 10.1021/jm00168a008; REUL JMHM, 1990, ENDOCRINOLOGY, V127, P907, DOI 10.1210/endo-127-2-907; RODRIGUEZ R, 1989, MOL ENDOCRINOL, V3, P356, DOI 10.1210/mend-3-2-356; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; SARRIEAU A, 1986, J STEROID BIOCHEM, V25, P717, DOI 10.1016/0022-4731(86)90300-6; SCHUMACHER M, 1990, TRENDS NEUROSCI, V13, P359, DOI 10.1016/0166-2236(90)90016-4; SHINGAI R, 1991, EUR J PHARM-MOLEC PH, V206, P77, DOI 10.1016/0922-4106(91)90149-C; SMITHGALL TE, 1985, BIOCHEM PHARMACOL, V34, P831, DOI 10.1016/0006-2952(85)90763-4	47	264	268	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1993	11	3					523	530		10.1016/0896-6273(93)90156-L	http://dx.doi.org/10.1016/0896-6273(93)90156-L			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398145				2022-12-28	WOS:A1993LY49800012
J	TIMMUSK, T; PALM, K; METSIS, M; REINTAM, T; PAALME, V; SAARMA, M; PERSSON, H				TIMMUSK, T; PALM, K; METSIS, M; REINTAM, T; PAALME, V; SAARMA, M; PERSSON, H			MULTIPLE PROMOTERS DIRECT TISSUE-SPECIFIC EXPRESSION OF THE RAT BDNF-GENE	NEURON			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; FACTOR FAMILY; CHOLINERGIC NEURONS; MOLECULAR-CLONING; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; LIMBIC SEIZURES; BASAL FOREBRAIN	Brain-derived neurotrophic factor (BDNF) supports the survival of a specific set of neurons in the vertebrate nervous system. Here we show that the rat BDNF gene consists of four short 5' exons and one 3' exon encoding the mature BDNF protein. Eight different BDNF mRNAs with four different 5' ends and two alternative polyadenylation sites are transcribed from this gene. BDNF mRNAs containing exons I, II, and III are expressed predominantly in the brain, whereas exon IV transcripts predominate in the lung and heart. mRNAs containing exons I, II, and III increase markedly in the brain after kainic acid-induced seizures, whereas exon IV mRNA increases only slightly. Several transcription initiation sites were mapped upstream of the four 5' exons, and transfection of promoter-reporter gene constructs confirmed that these sequences act as promoters. Combined, the data demonstrate that alternative usage of four promoters within the BDNF gene and differential splicing control tissue-specific and seizure-induced expression of BDNF mRNA.	UNIV HELSINKI,INST BIOTECHNOL,SF-00380 HELSINKI,FINLAND; TALLINN CHEM PHYS & BIOPHYS INST,MOLEC GENET LAB,TALLINN,ESTONIA	University of Helsinki	TIMMUSK, T (corresponding author), KAROLINSKA INST,DEPT MED CHEM 2,MOLEC NEUROBIOL LAB,S-10401 STOCKHOLM 60,SWEDEN.		Metsis, Madis/F-7080-2016; Palm, Kaia/AGF-0479-2022; Timmusk, Tonis/H-4889-2015	Metsis, Madis/0000-0003-1667-677X; Timmusk, Tonis/0000-0002-1015-3348	NIA NIH HHS [AG 04418] Funding Source: Medline; NINDS NIH HHS [NS 09199] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS009199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P102; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BUNNEMANN B, 1990, ADV NEUROSCIENCE, V1, P131; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CSANK C, 1990, NUCLEIC ACIDS RES, V18, P5133, DOI 10.1093/nar/18.17.5133; D'MELLO SR, 1991, MOL BRAIN RES, V11, P255, DOI 10.1016/0169-328X(91)90034-U; D'MELLO SR, 1991, J NEUROCHEM, V57, P1570, DOI 10.1111/j.1471-4159.1991.tb06353.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FOYT HL, 1991, J BIOL CHEM, V266, P7300; FRASER P, 1989, MOL CELL BIOL, V9, P3308, DOI 10.1128/MCB.9.8.3308; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GONZALEZCRESPO S, 1991, P NATL ACAD SCI USA, V88, P8749, DOI 10.1073/pnas.88.19.8749; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HAMMOND DN, 1986, SCIENCE, V234, P1237, DOI 10.1126/science.3775382; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MATHER JP, 1982, ANN NY ACAD SCI, V383, P44, DOI 10.1111/j.1749-6632.1982.tb23161.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; NIELSEN FC, 1990, J BIOL CHEM, V265, P13431; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHIBLER U, 1987, ANNU REV GENET, V21, P237, DOI 10.1146/annurev.ge.21.120187.001321; SELBY MJ, 1987, MOL CELL BIOL, V7, P3057, DOI 10.1128/MCB.7.9.3057; SHAPIRO LH, 1991, J BIOL CHEM, V266, P11999; SHINTANI A, 1992, BIOCHEM BIOPH RES CO, V182, P325, DOI 10.1016/S0006-291X(05)80148-2; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SPAETE RR, 1985, J VIROL, V56, P135, DOI 10.1128/JVI.56.1.135-143.1985; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; XU LC, 1991, NUCLEIC ACIDS RES, V19, P6699, DOI 10.1093/nar/19.24.6699; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	72	713	723	1	38	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					475	489		10.1016/0896-6273(93)90335-O	http://dx.doi.org/10.1016/0896-6273(93)90335-O			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461137				2022-12-28	WOS:A1993KU90100012
J	Zhang, JF; Ellinor, PT; Aldrich, RW; Tsien, RW				Zhang, JF; Ellinor, PT; Aldrich, RW; Tsien, RW			Multiple structural elements in voltage-dependent Ca2+ channels support their inhibition by G proteins	NEURON			English	Article							NEURONAL CALCIUM CHANNELS; CHICK SENSORY NEURONS; BULLFROG SYMPATHETIC NEURONS; GTP-BINDING PROTEIN; N-TYPE; SYNAPTIC TRANSMISSION; BETA-SUBUNIT; NEUROTRANSMITTERS DECREASE; SELECTIVE MODULATION; MEDIATED INHIBITION	Molecular determinants of Ca2+ channel responsiveness to inhibition by receptor-coupled G proteins were investigated in Xenopus oocytes. The inhibitory response of alpha(1B) (N-type) channels was much larger than alpha(1A) (P/Q-type) channels, while alpha(1C) (L-type) channels were unresponsive. Differences in both degree and speed of inhibition were accounted for by variations in inhibitor off-rate. We tested proposals that inhibitory G protein and Ca2+ channel beta subunits compete specifically at the I-II loop. G protein-mediated inhibition remained unaltered in alpha(1B) subunits containing a point mutation in the I-II loop segment critical for Ca2+ channel beta subunit binding, and in chimeras where the I-II loop of alpha(1B) was replaced with counterparts from alpha(1A) or alpha(1C) Full interconversion between modulatory behaviors of alpha(1B) and alpha(1A) was achieved only by swapping both motif I and the C-terminus in combination. Thus, essential structural elements for G protein modulation reside in multiple Ca2+ channel domains.	STANFORD UNIV, DEPT CELLULAR & MOL PHYSIOL, STANFORD, CA 94305 USA; STANFORD UNIV, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University				Ellinor, Patrick/0000-0002-2067-0533	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48638] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS24067] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BITO H, 1994, J BIOL CHEM, V269, P12722; BOLAND LM, 1993, J NEUROSCI, V13, P516; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; CAMPBELL V, 1995, J PHYSIOL-LONDON, V485, P365, DOI 10.1113/jphysiol.1995.sp020735; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Clapham DE, 1996, CURR BIOL, V6, P814, DOI 10.1016/S0960-9822(02)00602-4; COX DH, 1992, J NEUROSCI, V12, P906; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOLPHIN AC, 1995, EXP PHYSIOL, V80, P1; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; ELMSLIE KS, 1994, J PHYSIOL-LONDON, V481, P35, DOI 10.1113/jphysiol.1994.sp020417; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V456, P107, DOI 10.1113/jphysiol.1992.sp019329; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; GOLARD A, 1993, J NEUROSCI, V13, P3884; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; GROSS RA, 1990, P NATL ACAD SCI USA, V87, P7025, DOI 10.1073/pnas.87.18.7025; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HOLZ GG, 1989, J NEUROSCI, V9, P657; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; IKEDA SR, 1992, J PHYSIOL-LONDON, V458, P339, DOI 10.1113/jphysiol.1992.sp019421; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LOPEZ HS, 1991, NEURON, V7, P1061, DOI 10.1016/0896-6273(91)90350-9; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MARCHETTI C, 1989, BIOPHYS J, V56, P1267, DOI 10.1016/S0006-3495(89)82774-2; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; PENINGTON NJ, 1991, J NEUROSCI, V11, P3594, DOI 10.1523/jneurosci.11-11-03594.1991; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; ROCHE JP, 1995, FEBS LETT, V371, P43, DOI 10.1016/0014-5793(95)00860-C; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; TADDESE A, 1995, SCIENCE, V270, P1366, DOI 10.1126/science.270.5240.1366; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toth PT, 1996, J NEUROSCI, V16, P4617; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Wheeler DB, 1996, J NEUROSCI, V16, P2226; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WHEELER DB, 1994, ADV SEC MESS PHOSPH, V29, P155; WU LG, 1994, J NEUROSCI, V14, P5613; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; ZHOU JY, 1995, BIOCHEM BIOPH RES CO, V208, P485, DOI 10.1006/bbrc.1995.1364	67	157	158	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1996	17	5					991	1003		10.1016/S0896-6273(00)80229-9	http://dx.doi.org/10.1016/S0896-6273(00)80229-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938130	Bronze			2022-12-28	WOS:A1996VV15100020
J	Paresce, DM; Ghosh, RN; Maxfield, FR				Paresce, DM; Ghosh, RN; Maxfield, FR			Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor	NEURON			English	Article							HAMSTER OVARY CELLS; LOW-DENSITY-LIPOPROTEIN; PRECURSOR PROTEIN; IMMUNOHISTOCHEMICAL LOCALIZATION; NEUROLOGICAL DISEASE; BINDING-PROPERTIES; AMEBOID MICROGLIA; APOLIPOPROTEIN-E; BRAIN-TISSUE; A-BETA	Microglia are immune system cells associated with Alzheimer's disease plaques containing beta-amyloid (A beta). Murine microglia internalize microaggregates of fluorescently labeled or radioiodinated A beta peptide 1-42. Uptake was confirmed using aggregates of unlabeled A beta detected by immunofluorescence. Uptake of A beta was reduced by coincubation with excess acetyl-low density lipoprotein (Ac-LDL) or other scavenger receptor (SR) ligands, and Dil-labeled Ac-LDL uptake by microglia was blocked by excess A beta. CHO cells transfected with class A or B SRs showed significantly enhanced uptake of A beta. These results show that microglia express SRs that may play a significant role in the clearance of A beta plaques. Binding to SRs could activate inflammation responses that contribute to the pathology of Alzheimer's disease.	COLUMBIA UNIV, DEPT BIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV, ALZHEIMERS DIS RES CTR, NEW YORK, NY 10032 USA; COLUMBIA UNIV, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA; CORNELL UNIV, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA	Columbia University; Columbia University; Columbia University; Cornell University	Paresce, DM (corresponding author), COLUMBIA UNIV, DEPT PATHOL, NEW YORK, NY 10032 USA.		Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027083, R37DK027083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034761] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK27083] Funding Source: Medline; NINDS NIH HHS [NS34761] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; ARAUJO DM, 1992, BRAIN RES, V569, P141, DOI 10.1016/0006-8993(92)90380-R; ASHKENAS J, 1993, J LIPID RES, V34, P983; BELL MD, 1994, J NEUROCYTOL, V23, P605, DOI 10.1007/BF01191555; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; Christie RH, 1996, AM J PATHOL, V148, P399; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; COTMAN CW, 1992, NEUROBIOL AGING, V13, P587, DOI 10.1016/0197-4580(92)90060-B; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Elkabes S, 1996, J NEUROSCI, V16, P2508; FRACKOWIAK J, 1992, ACTA NEUROPATHOL, V84, P225; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1993, ANN NY ACAD SCI, V695, P103, DOI 10.1111/j.1749-6632.1993.tb23036.x; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GOREVIC PD, 1987, BIOCHEM BIOPH RES CO, V147, P854, DOI 10.1016/0006-291X(87)91008-4; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1991, J NEUROSCI, V11, P3783; HERZ J, 1991, J BIOL CHEM, V266, P21232; JOHNSON WJ, 1982, SCIENCE, V218, P574, DOI 10.1126/science.6289443; JOHNSTON PA, 1987, J IMMUNOL, V138, P1551; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KRIEGER M, 1992, TRENDS BIOCHEM SCI, V17, P141, DOI 10.1016/0968-0004(92)90322-Z; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MAXFIELD FR, 1989, METHOD CELL BIOL, V29, P13; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; MCGEER PL, 1992, J NEUROSCI RES, V31, P428, DOI 10.1002/jnr.490310305; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; NAKAJIMA K, 1989, BIOMED RES-TOKYO, V10, P411; PALKAMA T, 1991, IMMUNOLOGY, V74, P432; PENMAN M, 1991, J BIOL CHEM, V266, P23985; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; QUERFURTH HW, 1995, MOL BRAIN RES, V28, P319, DOI 10.1016/0169-328X(94)00224-3; REBECK GW, 1993, NEURON, V11, P575; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J NEUROCHEM, V61, P1916, DOI 10.1111/j.1471-4159.1993.tb09834.x; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; SALZMAN NH, 1988, J CELL BIOL, V106, P1083, DOI 10.1083/jcb.106.4.1083; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHACKELFORD RE, 1995, J BIOL CHEM, V270, P3475, DOI 10.1074/jbc.270.8.3475; SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; WEGIEL J, 1990, ACTA NEUROPATHOL, V81, P116, DOI 10.1007/BF00334499; WISNIEWSKI HM, 1990, AM J MED GENET, P287, DOI 10.1002/ajmg.1320370757; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8	66	550	577	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					553	565		10.1016/S0896-6273(00)80187-7	http://dx.doi.org/10.1016/S0896-6273(00)80187-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816718	hybrid			2022-12-28	WOS:A1996VJ44000021
J	Wong, ROL; Oakley, DM				Wong, ROL; Oakley, DM			Changing patterns of spontaneous bursting activity of on and off retinal ganglion cells during development	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; PRENATAL DEVELOPMENT; MAMMALIAN RETINA; CAT RETINA; ON-CENTER; RETINOGENICULATE PATHWAY; POSTNATAL-DEVELOPMENT; ACTION-POTENTIALS; BETA-CELLS; FERRET	In adult ferrets, retinal ganglion cells (RGCs) responsive to increased (On) or decreased (Off) illumination convey information to different cellular layers of the dorsal lateral geniculate nucleus (dLGN). These dLGN sublaminae emerge during development when RGCs are found to undergo correlated spontaneous bursting activity. Using Ca2+ imaging and intracellular dye-filling techniques, we demonstrate here that in ferret neonates, morphologically identified On and Off beta RGCs have similar burst frequencies prior to the segregation of their inputs in the dLGN, but during the segregation period, they develop distinct burst frequencies. Although the bursts of On cells and Off cells occur synchronously, On cells burst only 25%-35% of the time that Off cells do. This change in the temporal bursting patterns of On and Off RGCs may underlie the segregation of their inputs on dLGN neurons.			Wong, ROL (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.				NATIONAL EYE INSTITUTE [R01EY010699] Funding Source: NIH RePORTER; NEI NIH HHS [EY10699] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; BALDRIDGE WH, 1995, INVEST OPHTH VIS SCI, V36, pS865; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; BODNARENKO SR, 1995, J NEUROSCI, V15, P7037; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; CUCCHIARO J, 1984, PROC R SOC SER B-BIO, V223, P141, DOI 10.1098/rspb.1984.0087; DANN JF, 1988, J NEUROSCI, V8, P1485; DUBIN MW, 1986, J NEUROSCI, V6, P1021; FIELDS RD, 1990, J NEUROSCI, V10, P2950; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HEBB DO, 1949, ORG BEHAVIOR; HENDERSON Z, 1983, J PHYSIOL-LONDON, V345, pP119; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MASLIM J, 1988, DEV BRAIN RES, V44, P87, DOI 10.1016/0165-3806(88)90120-4; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; MILLER KD, 1994, J NEUROSCI, V14, P409; MORGAN J, 1993, VISUAL NEUROSCI, V10, P303, DOI 10.1017/S0952523800003709; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; RAMOA AS, 1988, J NEUROSCI, V8, P4239; RAMOA AS, 1989, P NATL ACAD SCI USA, V86, P2061, DOI 10.1073/pnas.86.6.2061; ROBINSON HPC, 1993, J NEUROPHYSIOL, V70, P1606, DOI 10.1152/jn.1993.70.4.1606; ROE AW, 1989, J COMP NEUROL, V288, P208, DOI 10.1002/cne.902880203; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SKALIORA I, 1993, J NEUROSCI, V13, P313; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STRYKER MP, 1983, J NEUROSCI, V3, P1943; VITEK DJ, 1985, J COMP NEUROL, V241, P1, DOI 10.1002/cne.902410102; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Wassle H., 1982, PROGR RETINAL RES, V1, P125, DOI DOI 10.1016/0278-4327(82)90006-2; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; WINGATE RJT, 1992, J COMP NEUROL, V323, P449, DOI 10.1002/cne.903230402; WINGATE RJT, 1995, EUR J NEUROSCI, V7, P723, DOI 10.1111/j.1460-9568.1995.tb00676.x; Wong R O, 1993, Curr Opin Neurobiol, V3, P595, DOI 10.1016/0959-4388(93)90061-3; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, J NEUROSCI, V15, P2696; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	47	124	125	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1087	1095		10.1016/S0896-6273(00)80135-X	http://dx.doi.org/10.1016/S0896-6273(00)80135-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663985	Bronze			2022-12-28	WOS:A1996UU11800006
J	Tabakoff, B; Hoffman, PL				Tabakoff, B; Hoffman, PL			Alcohol addiction: An enigma among us	NEURON			English	Review							ETHANOL WITHDRAWAL; NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; RAT-BRAIN; NEURONS				Tabakoff, B (corresponding author), UNIV COLORADO,SCH MED,DEPT PHARMACOL,DENVER,CO 80262, USA.		Tabakoff, Boris/AAX-1204-2021					Blevins T, 1995, NEUROSCI LETT, V200, P214, DOI 10.1016/0304-3940(95)12086-J; BRODIE MS, 1990, BRAIN RES, V508, P65, DOI 10.1016/0006-8993(90)91118-Z; BULLER AL, 1995, MOL PHARMACOL, V48, P717; CRISWELL HE, 1995, J PHARMACOL EXP THER, V273, P526; DEVAUD LL, 1994, EUR J PHARM-MOLEC PH, V267, P243, DOI 10.1016/0922-4106(94)90177-5; DIANA M, 1993, P NATL ACAD SCI USA, V90, P7966, DOI 10.1073/pnas.90.17.7966; FOLLESA P, 1995, MOL BRAIN RES, V29, P99, DOI 10.1016/0169-328X(94)00235-7; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; Hodge CW, 1995, ALCOHOL CLIN EXP RES, V19, P1486, DOI 10.1111/j.1530-0277.1995.tb01012.x; HOFFMAN PL, 1996, IN PRESS BRAIN RES; IMPERATO A, 1990, EUR J PHARMACOL, V187, P555, DOI 10.1016/0014-2999(90)90387-L; KOLTCHINE V, 1993, NEUROSCI LETT, V152, P13, DOI 10.1016/0304-3940(93)90471-V; LIN AMY, 1993, J PHARMACOL EXP THER, V265, P426; LOVINGER DM, 1995, J PHARMACOL EXP THER, V274, P164; MHATRE MC, 1993, J NEUROCHEM, V61, P1620, DOI 10.1111/j.1471-4159.1993.tb09795.x; Mihic S.J., 1996, PHARMACOLOGICAL EFFE, P51; SAMSON HH, 1992, TRENDS PHARMACOL SCI, V13, P206, DOI 10.1016/0165-6147(92)90065-E; SIGEL E, 1993, FEBS LETT, V324, P140, DOI 10.1016/0014-5793(93)81380-I; SNELL LD, 1996, IN PRESS MOL BRAIN R; TABAKOFF B, 1996, PHARM TOXIC, P73; TABAKOFF B, 1996, HANDB EXP PHARM, V118, P373; TREVISAN L, 1994, J NEUROCHEM, V62, P1635; Trifunovic RD, 1996, J PHARMACOL EXP THER, V276, P34; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; WHITTINGTON MA, 1992, BRIT J PHARMACOL, V107, P521, DOI 10.1111/j.1476-5381.1992.tb12777.x	25	100	101	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					909	912		10.1016/S0896-6273(00)80113-0	http://dx.doi.org/10.1016/S0896-6273(00)80113-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630248	Bronze			2022-12-28	WOS:A1996UN48000005
J	Zhang, L; Goldman, JE				Zhang, L; Goldman, JE			Generation of cerebellar interneurons from dividing progenitors in white matter	NEURON			English	Article							RAT CEREBELLUM; GLUTAMATE-DECARBOXYLASE; SUBVENTRICULAR ZONE; CELL LINEAGE; MIGRATION; NEURONS; LOCALIZATION; OLIGODENDROCYTES; DIFFERENTIATION; PROLIFERATION	The traditional view of the external granular layer of the cerebellar cortex giving rise to interneurons has been challenged by recent studies with quail-chick chimeras. To clarify the time and site of origins of interneurons, a retrovirus carrying the beta-galactosidase gene was injected into the deep cerebellar tissue or external granular layer of postnatal day 4/5 rats to label dividing progenitors. After deep cerebellar tissue injection, unipolar cells were found initially in white matter at 2 days postinjection and subsequently in the internal granule and molecular layers 4-6 days postinjection. Morphologically defined basket, stellate, and Golgi neurons were clearly identified by 20 days postinjection. In contrast, retroviral labeling of cells in the external granular layer produced only granule neurons in the internal granule layer. Thus, dividing progenitors in the cerebellar white matter migrate through the white matter into the cortex before differentiating into a variety of cortical interneurons.			Zhang, L (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT PATHOL,722 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017125] Funding Source: NIH RePORTER; NINDS NIH HHS [NS17125] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen E, 1912, J COMP NEUROL, V22, P547; ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Cajal SRY., 1995, HISTOLOGY NERVOUS SY, V1; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; GAO WQ, 1994, DEVELOPMENT, V120, P1059; GONYE GE, 1994, J NEUROSCI, V14, P5365; HAJIHOSSEINI M, 1993, EMBO J, V12, P4969, DOI 10.1002/j.1460-2075.1993.tb06190.x; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HANAWAY J, 1968, ANAT REC, V160, P360; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HEINSEN H, 1977, ANAT EMBRYOL, V151, P201, DOI 10.1007/BF00297481; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; His W., 1904, ENTWICKLUNG MENSCHLI; HOKFELT F, 1972, EXP BRAIN RES, V14, P331; Jacobson M., 1991, DEV NEUROBIOLOGY; KELLY JS, 1975, BRAIN RES, V85, P255, DOI 10.1016/0006-8993(75)90078-5; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCGEER PL, 1975, EXP NEUROL, V47, P26, DOI 10.1016/0014-4886(75)90234-4; MCLAUGHLIN BJ, 1974, BRAIN RES, V76, P377, DOI 10.1016/0006-8993(74)90815-4; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; NAKAFUKU M, 1995, J NEUROSCI RES, V41, P153, DOI 10.1002/jnr.490410203; NAPIERALSKI JA, 1993, DEV DYNAM, V197, P244, DOI 10.1002/aja.1001970403; OERTEL WH, 1981, NEUROSCIENCE, V6, P2715, DOI 10.1016/0306-4522(81)90115-9; OTERO RA, 1993, J COMP NEUROL, V333, P597, DOI 10.1002/cne.903330411; PATEL AJ, 1985, BRAIN RES, V237, P203; PRICE J, 1987, DEVELOPMENT, V101, P409; RAKIC P, 1972, J COMP NEUROL, V146, P335, DOI 10.1002/cne.901460304; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1973, J COMP NEUROL, V147, P523, DOI 10.1002/cne.901470407; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; SAITO K, 1974, P NATL ACAD SCI USA, V71, P269, DOI 10.1073/pnas.71.2.269; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SAUER ME, 1959, P SOC EXP BIOL MED, V101, P557; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; SMART I, 1961, J COMP NEUROL, V116, P349, DOI 10.1002/cne.901160307; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; UZMAN LL, 1960, J COMP NEUROL, V114, P137; WARRINGTON AE, 1992, J NEUROSCI RES, V33, P338, DOI 10.1002/jnr.490330218; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WOOD JG, 1976, GABA NERVOUS SYSTEM, P133; ZERLIN M, 1995, J NEUROSCI, V15, P7238	57	205	210	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					47	54		10.1016/S0896-6273(00)80022-7	http://dx.doi.org/10.1016/S0896-6273(00)80022-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562089	hybrid			2022-12-28	WOS:A1996TT30700008
J	PEDARZANI, P; STORM, JF				PEDARZANI, P; STORM, JF			PKA MEDIATES THE EFFECTS OF MONOAMINE TRANSMITTERS ON THE K+ CURRENT UNDERLYING THE SLOW SPIKE FREQUENCY ADAPTATION IN HIPPOCAMPAL-NEURONS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; METABOTROPIC GLUTAMATE RECEPTORS; ACTIVATED POTASSIUM CHANNELS; LOCUS COERULEUS NEURONS; APLYSIA SENSORY NEURONS; CA1 PYRAMIDAL NEURONS; CYCLIC-AMP; RAT-BRAIN; CATALYTIC SUBUNIT	The Ca2+-activated K+ current I(AHP), which underlies spike frequency adaptation in cortical pyramidal cells, can be modulated by multiple transmitters and probably contributes to state control of the forebrain by ascending monoaminergic fibers. Here, we show that the modulation of this current by norepinephrine, serotonin, and histamine is mediated by protein kinase A in hippocampal CA1 neurons. Two specific protein kinase A inhibitors, Rp-cAMPS and Walsh peptide, suppressed the effects of these transmitters on I(AHP) and spike frequency adaptation. The effects of the cyclic AMP analog 8CPT-cAMP were also inhibited, whereas muscarinic and metabotropic glutamate receptor agonists had full effect. Intracellular application of protein kinase A catalytic subunit or a phosphatase inhibitor mimicked the effects of monoamines or 8CPT-cAMP. These results demonstrate that monoaminergic modulation of neuronal excitability in the mammalian CNS is mediated by protein phosphorylation.			PEDARZANI, P (corresponding author), UNIV OSLO,INST NEUROPHYSIOL,PB 1104 BLINDERN,N-0317 OSLO,NORWAY.							ADAMS WB, 1982, P NATL ACAD SCI-BIOL, V79, P3877, DOI 10.1073/pnas.79.12.3877; ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; ANDRADE R, 1993, NEURON, V10, P83, DOI 10.1016/0896-6273(93)90244-L; ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; ANDRADE R, 1991, J PHARMACOL EXP THER, V257, P930; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Azmitia E. C., 1987, PSYCHOPHARMACOLOGY 3, P61; BARBACCIA ML, 1983, J NEUROCHEM, V40, P1671, DOI 10.1111/j.1471-4159.1983.tb08141.x; BASKYS A, 1990, NEUROSCI LETT, V112, P76, DOI 10.1016/0304-3940(90)90325-4; BERNARDO LS, 1982, BRAIN RES, V249, P333; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOCKAERT J, 1992, TRENDS PHARMACOL SCI, V13, P141, DOI 10.1016/0165-6147(92)90051-7; BOLAND LM, 1991, J NEUROSCI, V11, P1140; BOTELHO LHP, 1988, METHOD ENZYMOL, V159, P159; BRUM G, 1983, PFLUG ARCH EUR J PHY, V398, P147, DOI 10.1007/BF00581064; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHAPUT Y, 1990, EUR J PHARMACOL, V182, P441, DOI 10.1016/0014-2999(90)90041-4; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; CHENG HC, 1986, J BIOL CHEM, V261, P989; CHU N, 1973, SCIENCE, V179, P908, DOI 10.1126/science.179.4076.908; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COLE AE, 1983, SCIENCE, V221, P1299, DOI 10.1126/science.6612345; COLINO A, 1987, NATURE, V328, P73, DOI 10.1038/328073a0; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; COSTA MRC, 1982, J BIOL CHEM, V257, P7918; DELGADO R, 1991, P NATL ACAD SCI USA, V88, P557, DOI 10.1073/pnas.88.2.557; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FARLEY J, 1988, BIOPHYS J, V53, P919, DOI 10.1016/S0006-3495(88)83173-4; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FOEHRING RC, 1989, J NEUROPHYSIOL, V61, P245, DOI 10.1152/jn.1989.61.2.245; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GARBARG M, 1974, SCIENCE, V186, P833, DOI 10.1126/science.186.4166.833; GERBER U, 1992, EUR J NEUROSCI, V4, P792, DOI 10.1111/j.1460-9568.1992.tb00189.x; GOLDSMITH BA, 1992, P NATL ACAD SCI USA, V89, P11481, DOI 10.1073/pnas.89.23.11481; GREEN JP, 1983, HDB PSYCHOPHARMACOLO, P385; GREENGARD P, 1978, SCIENCE, V199, P146, DOI 10.1126/science.22932; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HAAS HL, 1985, AGENTS ACTIONS, V16, P234, DOI 10.1007/BF01983148; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HAAS HL, 1986, EXP BRAIN RES, V62, P123; HAAS HL, 1987, NEUROSCI LETT, V78, P171, DOI 10.1016/0304-3940(87)90628-8; HIRAYAMA T, 1991, BRAIN RES, V539, P320, DOI 10.1016/0006-8993(91)91637-G; HOCHNER B, 1992, P NATL ACAD SCI USA, V89, P11476, DOI 10.1073/pnas.89.23.11476; HOGER JH, 1991, NEURON, V6, P227, DOI 10.1016/0896-6273(91)90358-7; HOTSON JR, 1980, J NEUROPHYSIOL, V43, P409, DOI 10.1152/jn.1980.43.2.409; HU GY, 1991, BRAIN RES, V568, P339, DOI 10.1016/0006-8993(91)91423-X; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KLEIN M, 1986, P NATL ACAD SCI USA, V83, P7994, DOI 10.1073/pnas.83.20.7994; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; LANCASTER B, 1991, J NEUROSCI, V11, P23; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LEVITAN IB, 1985, J MEMBRANE BIOL, V87, P177, DOI 10.1007/BF01871217; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MCCORMICK DA, 1989, P NATL ACAD SCI USA, V86, P8098, DOI 10.1073/pnas.86.20.8098; MCCORMICK DA, 1988, J NEUROPHYSIOL, V59, P978, DOI 10.1152/jn.1988.59.3.978; MCCORMICK DA, 1989, TRENDS NEUROSCI, V12, P215, DOI 10.1016/0166-2236(89)90125-2; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; MULLER W, 1992, J NEUROPHYSIOL, V68, P2264, DOI 10.1152/jn.1992.68.6.2264; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; POLLARD H, 1987, TRENDS NEUROSCI, V10, P86, DOI 10.1016/0166-2236(87)90031-2; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; REINHART PH, 1991, J NEUROSCI, V11, P1627; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SAKO T, 1988, CANCER RES, V48, P4646; SCHWARTZKROIN PA, 1980, SCIENCE, V210, P1125, DOI 10.1126/science.6777871; SHABB JB, 1992, J BIOL CHEM, V267, P5723; SIM JA, 1992, EUR J NEUROSCI, V4, P785, DOI 10.1111/j.1460-9568.1992.tb00188.x; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Steriade M., 1990, BRAINSTEM CONTROL WA; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STORM JF, 1987, NEUROSCI LETT, V75, P71, DOI 10.1016/0304-3940(87)90077-2; STRATTON KR, 1989, EUR J PHARMACOL, V173, P235, DOI 10.1016/0014-2999(89)90529-3; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; VANHAASTERT PJM, 1987, BIOPHOSPHATES THEIR, P469; VINTERMYR OK, 1993, EXP CELL RES, V206, P157, DOI 10.1006/excr.1993.1132; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WATANABE T, 1983, NEUROSCI LETT, V39, P249, DOI 10.1016/0304-3940(83)90308-7; ZHANG L, 1992, J NEUROSCI, V12, P4510; ZIFA E, 1992, PHARMACOL REV, V44, P401	101	241	242	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1023	1035		10.1016/0896-6273(93)90216-E	http://dx.doi.org/10.1016/0896-6273(93)90216-E			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274274				2022-12-28	WOS:A1993MP54800004
J	BALICEGORDON, RJ; CHUA, CK; NELSON, CC; LICHTMAN, JW				BALICEGORDON, RJ; CHUA, CK; NELSON, CC; LICHTMAN, JW			GRADUAL LOSS OF SYNAPTIC CARTELS PRECEDES AXON WITHDRAWAL AT DEVELOPING NEUROMUSCULAR-JUNCTIONS	NEURON			English	Article							TRANSVERSUS ABDOMINIS MUSCLE; MAIN IMMUNOGENIC REGION; SKELETAL-MUSCLE; POLYNEURONAL INNERVATION; ACETYLCHOLINE-RECEPTOR; SPONTANEOUS ELIMINATION; MONOCLONAL-ANTIBODIES; INVIVO VISUALIZATION; GARTER SNAKE; RAT	We have studied the spatial deployment of synapses arising from different axons that converge on the same developing neuromuscular junctions. Labeling the competing synaptic ''cartels'' with different dyes in mouse muscle showed that, perinatally, each axon adds similar terminal areas, whereas later, areas occupied by the competing cartels diverged by gradual elimination of one axon's synapses and ongoing addition of synaptic area by the other. Activity-dependent labeling of synapses capable of vesicle recycling in snake muscle also revealed a gradual change in territories occupied by competing inputs, implying that an axon maintained some functional synapses even as others in its cartel were being eliminated. Thus the process of synapse elimination is gradual, with loss of one viable synapse after another, until an axon is left with no synaptic territory and withdraws.			BALICEGORDON, RJ (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.			Balice-Gordon, Rita/0000-0002-9950-7965				Adelson E.H., 1987, Patent No. [4,661,986, 4661986]; Adelson EH., 1984, RCA ENG, V29, P33; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BIXBY JL, 1981, J NEUROCYTOL, V10, P81, DOI 10.1007/BF01181746; COLMAN H, 1993, DEV BIOL, V156, P1, DOI 10.1006/dbio.1993.1054; GODEMENT P, 1987, DEVELOPMENT, V101, P697; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KORNELIUSSEN H, 1976, J NEUROCYTOL, V5, P591, DOI 10.1007/BF01175572; KUFFLER D, 1977, BRAIN RES, V138, P353, DOI 10.1016/0006-8993(77)90752-1; LICHTMAN J W, 1989, New Biologist, V1, P75; LICHTMAN JW, 1987, J PHYSIOL-LONDON, V393, P355, DOI 10.1113/jphysiol.1987.sp016827; LICHTMAN JW, 1985, NATURE, V314, P357, DOI 10.1038/314357a0; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; Purves D, 1985, PRINCIPLES NEURAL DE, P271; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; RILEY DA, 1981, J NEUROCYTOL, V10, P425, DOI 10.1007/BF01262414; RILEY DA, 1977, BRAIN RES, V134, P279, DOI 10.1016/0006-8993(77)91073-3; ROSENTHAL JL, 1977, J PHYSIOL-LONDON, V270, P299, DOI 10.1113/jphysiol.1977.sp011953; STEINBACH JH, 1981, DEV BIOL, V84, P267, DOI 10.1016/0012-1606(81)90394-8; TZARTOS S, 1987, J NEUROIMMUNOL, V15, P185, DOI 10.1016/0165-5728(87)90092-0; TZARTOS SJ, 1980, P NATL ACAD SCI-BIOL, V77, P755, DOI 10.1073/pnas.77.2.755; WILKINSON RS, 1985, J NEUROSCI, V5, P2979	27	102	105	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					801	815		10.1016/0896-6273(93)90110-D	http://dx.doi.org/10.1016/0896-6273(93)90110-D			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240805				2022-12-28	WOS:A1993MJ04100002
J	WIZENMANN, A; THIES, E; KLOSTERMANN, S; BONHOEFFER, F; BAHR, M				WIZENMANN, A; THIES, E; KLOSTERMANN, S; BONHOEFFER, F; BAHR, M			APPEARANCE OF TARGET-SPECIFIC GUIDANCE INFORMATION FOR REGENERATING AXONS AFTER CNS LESIONS	NEURON			English	Article							POSITION-SPECIFIC PROPERTIES; RETINAL GANGLION-CELLS; NERVOUS-SYSTEM; SUPERIOR COLLICULUS; TECTAL MEMBRANES; NEURITE GROWTH; INVITRO; RECOGNITION; INHIBITORS; OUTGROWTH	During development of the vertebrate visual system, an orderly projection of ganglion cells from the retina onto the superior colliculus (SC) is established. Mechanisms that might govern this process include the coordinated action of guidance and corresponding receptor molecules that are specifically distributed on the axons and their targets. In birds and mammals, information for axonal guidance and targeting appears to be confined to the time when the retinocollicular projection is being formed. Here we show that putative guidance activities for temporal and nasal retinal axons, which are not detectable in the normal adult SC, appear after optic nerve transection in adult rats. Both embryonic and adult retinal axons are able to respond to these guiding cues, although the guidance activities detectable in the deafferented adult rat SC might be different from those found during development. These findings imply that it might be possible to reestablish an ordered projection after lesions in the adult mammalian visual system.	UNIV TUBINGEN,NEUROL KLIN,D-72076 TUBINGEN,GERMANY; MAX PLANCK INST ENTWICKLUNGSBIOL,D-72076 TUBINGEN,GERMANY	Eberhard Karls University of Tubingen; Max Planck Society	WIZENMANN, A (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT ANAT,LONDON,ENGLAND.		Baehr, Mathias/K-2188-2014					BAHR M, 1993, J NEUROBIOL, V24, P456, DOI 10.1002/neu.480240405; BAHR M, 1988, EXP BRAIN RES, V73, P393; BAHR M, 1991, NEUROREPORT, V2, P581; BAIER H, 1992, SCUENCE, V255, P474; BONHOEFFER F, 1984, TRENDS NEUROSCI, V7, P378, DOI 10.1016/S0166-2236(84)80060-0; BOXBERG YV, 1993, NEURON, V10, P345; BRAY GM, 1987, J EXP BIOL, V132, P5; BRUMMENDORF T, 1993, J NEUROCHEM, V61, P1; CARONI P, 1988, P R SOC LOND B, V157, P420; GODEMENT P, 1989, DEVELOPMENT, V106, P13; HANKIN M, 1991, TRENDS NEUROSCI, V14, P224, DOI 10.1016/0166-2236(91)90118-E; HANKIN MH, 1990, DEV BIOL, V138, P136, DOI 10.1016/0012-1606(90)90183-J; KAPFHAMMER JP, 1992, J NEUROSCI, V12, P2112; KEIRSTEAD SA, 1989, SCIENCE, V246, P255, DOI 10.1126/science.2799387; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MULLER B, 1990, J EXP BIOL, V153, P29; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; SCHWAB ME, 1990, EXP NEUROL, V109, P2, DOI 10.1016/S0014-4886(05)80003-2; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STAHL B, 1990, NEURON, V5, P737; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; TRISLER D, 1990, J EXP BIOL, V153, P11; VANSELOW J, 1991, VISUAL NEUROSCI, V6, P569, DOI 10.1017/S0952523800002558; VIELMETTER J, 1991, J COMP NEUROL, V311, P321, DOI 10.1002/cne.903110303; VIELMETTER J, 1989, NEURON, V2, P1331, DOI 10.1016/0896-6273(89)90071-8; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1990, J PHYSIOL-PARIS, V84, P104; WALTER J, 1987, DEVELOPMENT, V101, P909	29	97	97	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					975	983		10.1016/0896-6273(93)90126-C	http://dx.doi.org/10.1016/0896-6273(93)90126-C			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240818				2022-12-28	WOS:A1993MJ04100018
J	BIERNAT, J; GUSTKE, N; DREWES, G; MANDELKOW, EM; MANDELKOW, E				BIERNAT, J; GUSTKE, N; DREWES, G; MANDELKOW, EM; MANDELKOW, E			PHOSPHORYLATION OF SER(262) STRONGLY REDUCES BINDING OF TAU-PROTEIN TO MICROTUBULES - DISTINCTION BETWEEN PHF-LIKE IMMUNOREACTIVITY AND MICROTUBULE-BINDING	NEURON			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-LIKE STATE; NEUROFIBRILLARY TANGLES; ABNORMAL PHOSPHORYLATION; NEUROFILAMENT ANTIBODIES; DEPENDENT KINASE; A68 PROTEINS; DISEASE; ISOFORMS; EPITOPES	Tau protein, a component of Alzheimer paired helical filaments, can be phosphorylated by several kinases. Of particular interest is the phosphorylation at Ser/Thr-Pro motifs because the resulting state of tau is similar to that found in Alzheimer's disease, as judged by its immunoreactivity. This state can be mimicked by a brain extract kinase activity and by MAP kinase. We have now studied the effect of these modes of phosphorylation on the interaction between tau and microtubules. Although MAP kinase efficiently phosphorylates many Ser/Thr-Pro motifs of tau, its effect on microtubule binding is only moderate. By contrast, phosphorylation of a single residue, Ser262, has a major effect on binding. Ser262 is not phosphorylated by MAP kinase or other proline-directed kinases, but is phosphorylated by a 35/41 kd kinase in brain, whose purification is described.			BIERNAT, J (corresponding author), DESY,MAX PLANCK UNIT STRUCT MOLEC BIOL,NOTKESTR 85,D-22603 HAMBURG,GERMANY.			Drewes, Gerard/0000-0003-0575-6766				AIZAWA H, 1989, J BIOL CHEM, V264, P5885; BAUDIER J, 1987, J BIOL CHEM, V262, P17577; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRION JP, 1991, BIOCHEM J, V279, P831, DOI 10.1042/bj2790831; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; BURNS RG, 1984, EUR J BIOCHEM, V141, P609, DOI 10.1111/j.1432-1033.1984.tb08236.x; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; CORREAS I, 1992, J BIOL CHEM, V267, P15721; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; GEAHLEN RL, 1986, ANAL BIOCHEM, V153, P151, DOI 10.1016/0003-2697(86)90074-6; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 1991, Curr Opin Neurobiol, V1, P441, DOI 10.1016/0959-4388(91)90067-H; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; HACCARD O, 1990, EUR J BIOCHEM, V192, P633, DOI 10.1111/j.1432-1033.1990.tb19270.x; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; ISHIGURO K, 1991, NEUROSCI LETT, V128, P195, DOI 10.1016/0304-3940(91)90259-V; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; JAMESON L, 1980, BIOCHEMISTRY-US, V19, P2472, DOI 10.1021/bi00552a027; KOSIK KS, 1992, SCIENCE, V256, P780, DOI 10.1126/science.1589757; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KSIEZAKREDING H, 1987, P NATL ACAD SCI USA, V84, P3410, DOI 10.1073/pnas.84.10.3410; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LEDESMA MD, 1992, FEBS LETT, V308, P218, DOI 10.1016/0014-5793(92)81278-T; Lee G, 1993, CURR OPIN CELL BIOL, V5, P88, DOI 10.1016/S0955-0674(05)80013-4; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; RODER HM, 1991, J NEUROSCI, V11, P3325; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; VINCENT IJ, 1992, P NATL ACAD SCI USA, V89, P2878, DOI 10.1073/pnas.89.7.2878; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WIBLE BA, 1989, P NATL ACAD SCI USA, V86, P720, DOI 10.1073/pnas.86.2.720; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040	52	633	664	0	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					153	163		10.1016/0896-6273(93)90279-Z	http://dx.doi.org/10.1016/0896-6273(93)90279-Z			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8393323				2022-12-28	WOS:A1993LP43000014
J	HOEHN, K; WATSON, TWJ; MACVICAR, BA				HOEHN, K; WATSON, TWJ; MACVICAR, BA			A NOVEL TETRODOTOXIN-INSENSITIVE, SLOW SODIUM CURRENT IN STRIATAL AND HIPPOCAMPAL-NEURONS	NEURON			English	Article							ACTIVE-CHEMICAL SYNAPSES; RAT SKELETAL-MUSCLE; ELECTRO-PHYSIOLOGICAL PROPERTIES; NEOSTRIATAL NEURONS; NEOCORTICAL NEURONS; PYRAMIDAL CELLS; RESISTANT SODIUM; GUINEA-PIG; MEMBRANE EXCITABILITY; SYNAPTIC TRANSMISSION	Slow inward currents modulate neuronal firing patterns and may generate depolarizing afterpotentials (DAPs). We report a novel, slow Na+ current (I(NaS) in striatal and hippocampal neurons that can generate DAPs. I(NaS) activated at depolarizations greater than -40 mV, was tetrodotoxin insensitive, and activated and deactivated slowly over hundreds of milliseconds. I(NaS) was dependent upon extracellular Na+, but was not affected by 0 mM extracellular Ca2+ or by Ca2+ channel blockers (Mn2+, Cd2+, or Co2+). A tetrodotoxin-insensitive, Na+-dependent plateau potential that was likely generated by I(NaS) was shown to underlie DAPs during intracellular recordings from hippocampal CA1 pyramidal neurons. Membrane depolarizations and DAPs generated by I(NaS) may contribute to alterations in neuronal firing and epileptiform bursting.			HOEHN, K (corresponding author), UNIV CALGARY,NEUROSCI RES GRP,CALGARY T2N 4N1,AB,CANADA.		MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623				ADACHI S, 1992, BRAIN RES, V573, P349, DOI 10.1016/0006-8993(92)90787-A; AGOPYAN N, 1988, EXP BRAIN RES, V73, P533, DOI 10.1007/BF00406611; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; BERNARDO LS, 1982, J NEUROSCI, V2, P1614; BOSSU JL, 1984, NEUROSCI LETT, V51, P241, DOI 10.1016/0304-3940(84)90558-5; BROWN AM, 1981, J PHYSIOL-LONDON, V318, P455; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P651, DOI 10.1152/jn.1990.63.4.651; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; CALABRESI P, 1987, NEUROSCIENCE, V20, P757, DOI 10.1016/0306-4522(87)90239-9; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P663, DOI 10.1152/jn.1990.63.4.663; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNOR JA, 1984, J PHYSIOL-LONDON, V354, P139, DOI 10.1113/jphysiol.1984.sp015368; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; COULTER DA, 1989, J PHYSIOL-LONDON, V414, P587, DOI 10.1113/jphysiol.1989.sp017705; ECKERT R, 1976, J PHYSIOL-LONDON, V254, P129, DOI 10.1113/jphysiol.1976.sp011225; FRELIN C, 1984, PFLUG ARCH EUR J PHY, V402, P121, DOI 10.1007/BF00583323; FRENCH CR, 1985, NEUROSCI LETT, V56, P289, DOI 10.1016/0304-3940(85)90257-5; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; FRIEDMAN A, 1987, NEUROSCI LETT, V81, P117, DOI 10.1016/0304-3940(87)90350-8; FRIEDMAN A, 1992, NEUROSCI LETT, V135, P13, DOI 10.1016/0304-3940(92)90125-Q; GALLEGO R, 1983, J PHYSIOL-LONDON, V342, P591, DOI 10.1113/jphysiol.1983.sp014870; GRANIT R, 1963, J PHYSIOL-LONDON, V168, P890, DOI 10.1113/jphysiol.1963.sp007229; GREEN DJ, 1983, NATURE, V306, P784, DOI 10.1038/306784a0; HEINEMANN U, 1985, BRAIN RES, V325, P349, DOI 10.1016/0006-8993(85)90338-5; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; HILLE B, 1984, IONIC CHANNELS EXCIT, P46; HOEHN K, 1993, IN PRESS J NEUROSCI; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; IKEDA SR, 1987, J PHYSIOL-LONDON, V389, P255, DOI 10.1113/jphysiol.1987.sp016656; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; KANO M, 1973, J CELL PHYSIOL, V81, P85, DOI 10.1002/jcp.1040810110; KAY AR, 1987, J PHYSIOL-LONDON, V392, P603, DOI 10.1113/jphysiol.1987.sp016799; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; KONNERTH A, 1986, EXPT BRAIN RES, V14, P368; KOSTYUK PG, 1981, NEUROSCIENCE, V6, P2423, DOI 10.1016/0306-4522(81)90088-9; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; LEE KS, 1977, NATURE, V265, P751, DOI 10.1038/265751a0; LEWIS DV, 1984, J NEUROPHYSIOL, V51, P387, DOI 10.1152/jn.1984.51.2.387; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MACVICAR BA, 1985, BRAIN RES, V333, P378, DOI 10.1016/0006-8993(85)91597-5; OGATA N, 1990, PFLUG ARCH EUR J PHY, V416, P594, DOI 10.1007/BF00382695; PARTRIDGE LD, 1979, BRAIN RES, V164, P69; RAGGENBASS M, 1991, NEUROSCIENCE, V11, P1609; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROY ML, 1992, NEUROSCIENCE, V12, P2104; SPITZER NC, 1984, J PHYSIOL-LONDON, V357, P51, DOI 10.1113/jphysiol.1984.sp015488; STAFSTROM CE, 1982, BRAIN RES, V236, P221, DOI 10.1016/0006-8993(82)90050-6; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TAYLOR CP, 1984, J NEUROPHYSIOL, V52, P143, DOI 10.1152/jn.1984.52.1.143; THOMPSON SH, 1976, J NEUROPHYSIOL, V39, P153, DOI 10.1152/jn.1976.39.1.153; TRAUB RD, 1982, NEUROSCIENCE, V7, P1233, DOI 10.1016/0306-4522(82)91130-7; WANG YY, 1990, J NEUROSCI, V10, P3335; WAXMAN SG, 1991, TRENDS NEUROSCI, V14, P461, DOI 10.1016/0166-2236(91)90046-W; WEISS RE, 1986, SCIENCE, V233, P361, DOI 10.1126/science.2425432; WILSON WA, 1974, SCIENCE, V186, P932, DOI 10.1126/science.186.4167.932; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86; YOSHIDA S, 1978, J NEUROPHYSIOL, V41, P1096, DOI 10.1152/jn.1978.41.5.1096	66	84	85	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					543	552		10.1016/0896-6273(93)90341-N	http://dx.doi.org/10.1016/0896-6273(93)90341-N			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461141				2022-12-28	WOS:A1993KU90100018
J	WIERASZKO, A; LI, G; KORNECKI, E; HOGAN, MV; EHRLICH, YH				WIERASZKO, A; LI, G; KORNECKI, E; HOGAN, MV; EHRLICH, YH			LONG-TERM POTENTIATION IN THE HIPPOCAMPUS INDUCED BY PLATELET-ACTIVATING-FACTOR	NEURON			English	Article							CENTRAL NEURONS; NMDA RECEPTORS; BINDING-SITES; INDUCTION; CHANNELS; BRAIN; BLOCK	Platelet-activating factor (PAF) is an ether phospholipid that serves as an autacoid in a wide range of biological processes. We found that when PAF was added to hippocampal slices, it induced a stable and concentration-dependent increase in excitatory postsynaptic potential and population spike recordings (long-term potentiation [LTP]). The PAF effect was blocked by the PAF receptor antagonists BN 52021 and WEB 2086 and the N-methyl-D-aspartate receptor antagonists MK 801 and 2-amino-5-phosphonovalerate. However, these PAF receptor antagonists did not block LTP induced by high frequency stimulation. The facilitation induced by PAF could not be reversed by PAF receptor antagonists. Induction of either PAF- or tetanus-triggered facilitation occluded the subsequent expression of the other, suggesting a common pathway. LTP is a type of synaptic plasticity associated with the formation of memory, and PAF may play an important modulatory role in this process.	NEW YORK STATE INST BASIC RES DEV DISABIL,STATEN ISL,NY 10314; SUNY,HLTH SCI CTR,DEPT ANAT & CELL BIOL,BROOKLYN,NY 11203	Institute for Basic Research in Developmental Disabilities; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College	WIERASZKO, A (corresponding author), CUNY COLL STATEN ISL,CSI IBR CTR DEV NEUROSCI & DEV DISABIL,STATEN ISL,NY 10301, USA.				NINDS NIH HHS [R01 NS27866] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027866] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES PY, 1989, PLATELET ACTIVATING; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOUMANN WJ, 1991, LIPIDS, V26, P945; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; CLAY KL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P309, DOI 10.1016/0005-2760(90)90246-T; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DELCERRO S, 1990, BEHAV NEURAL BIOL, V54, P213, DOI 10.1016/0163-1047(90)90595-W; DOMINGO MT, 1988, BIOCHEM BIOPH RES CO, V151, P730, DOI 10.1016/S0006-291X(88)80341-3; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; KORNECKI E, 1991, LIPIDS, V26, P1243, DOI 10.1007/BF02536540; KORNECKI E, 1988, SCIENCE, V240, P1792, DOI 10.1126/science.3381103; KORNECKI E, 1984, SCIENCE, V226, P1454, DOI 10.1126/science.6150550; KUMAR R, 1988, BIOCHIM BIOPHYS ACTA, V963, P375, DOI 10.1016/0005-2760(88)90304-9; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MARCHESELLI VL, 1990, J BIOL CHEM, V265, P9140; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; TEYLER TJ, 1984, BRAIN RES REV, V7, P15, DOI 10.1016/0165-0173(84)90027-4; WIERASZKO A, 1989, BRAIN RES, V491, P356, DOI 10.1016/0006-8993(89)90070-X	22	141	141	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					553	557		10.1016/0896-6273(93)90342-O	http://dx.doi.org/10.1016/0896-6273(93)90342-O			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461142				2022-12-28	WOS:A1993KU90100019
J	HATA, Y; DAVLETOV, B; PETRENKO, AG; JAHN, R; SUDHOF, TC				HATA, Y; DAVLETOV, B; PETRENKO, AG; JAHN, R; SUDHOF, TC			INTERACTION OF SYNAPTOTAGMIN WITH THE CYTOPLASMIC DOMAINS OF NEUREXINS	NEURON			English	Article							ALPHA-LATROTOXIN RECEPTOR; SYNAPTIC VESICLE PROTEIN; MEMBRANE; P65; CONSERVATION; BINDING; GENE	Synaptotagmin, a major intrinsic membrane protein of synaptic vesicles that binds Ca2+, was purified from bovine brain and immobilized onto Sepharose 4B. Affinity chromatography of brain membrane proteins on immobilized synaptotagmin revealed binding of alpha- and beta-neurexins to synaptotagmin in a Ca2+-independent manner. Using a series of recombinant proteins in which glutathione S-transferase was fused to the cytoplasmic domains of three different neurexins or of control proteins, it was found that synaptotagmin specifically interacts with the cytoplasmic domains of neurexins but not of control proteins. This interaction is dependent on a highly conserved, 40 amino acid sequence that makes up most of the cytoplasmic tails of the neurexins. Our data suggest a direct interaction between the cytoplasmic domains of a plasma membrane protein (the neurexins) and a protein specific for a subcellular organelle (synaptotagmin). Such an interaction could have an important role in the docking and targeting of synaptic vesicles in the nerve terminal.	UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Yale University	HATA, Y (corresponding author), UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235, USA.		Davletov, Bazbek/ABA-8569-2021	Jahn, Reinhard/0000-0003-1542-3498; Davletov, Bazbek/0000-0003-4658-3275; Petrenko, Alexander/0000-0002-6689-6546				BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; INOUE A, 1992, J BIOL CHEM, V267, P10613; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRENKO AG, 1990, EMBO J, V9, P2023, DOI 10.1002/j.1460-2075.1990.tb08331.x; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; PETRENKO AG, 1993, IN PRESS J BIOL CHEM; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; VALTORTA F, 1984, J CELL BIOL, V99, P124, DOI 10.1083/jcb.99.1.124; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V	24	151	153	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					307	315		10.1016/0896-6273(93)90320-Q	http://dx.doi.org/10.1016/0896-6273(93)90320-Q			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439414				2022-12-28	WOS:A1993KP68500017
J	Kaech, S; Ludin, B; Matus, A				Kaech, S; Ludin, B; Matus, A			Cytoskeletal plasticity in cells expressing neuronal microtubule-associated proteins	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; REAL-TIME OBSERVATIONS; DYNAMIC INSTABILITY; LIVING CELLS; TAU-PROTEIN; POSTTRANSLATIONAL MODIFICATION; NONNEURONAL CELLS; CORTICAL-NEURONS; BINDING MOTIF; GROWTH CONES	MAP2 and tau are the two most prominent neuron-specific microtubule-associated proteins. They have been implicated in the stabilization of microtubules and consequently of neurite morphology. To investigate their influence on microtubule dynamics, we have tagged both proteins with green fluorescent protein and expressed them in non-neuronal cells. Time-lapse recordings of living cells showed that MAP2 and tau did not significantly affect the rates of microtubule growth and shrinkage. Longer recordings revealed the growth and disappearance of MAP-induced microtubule bundles coinciding with changes in cell shape. This supports the idea that microtubule dynamics are influenced by the cortical cytoskeleton. The dynamics-preserving stabilization of microtubules by MAP2 and tau thus provides a molecular basis for the morphological plasticity reported to exist in established neurites.			Kaech, S (corresponding author), FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND.			Kaech Petrie, Stefanie/0000-0002-6246-6434				AHMAD FJ, 1993, J NEUROSCI, V13, P856; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; BURTON PR, 1987, BRAIN RES, V409, P71, DOI 10.1016/0006-8993(87)90742-6; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CUMMING R, 1984, J CELL BIOL, V98, P347, DOI 10.1083/jcb.98.1.347; Dailey ME, 1996, J NEUROSCI, V16, P2983; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOLL T, 1993, J CELL SCI, V106, P633; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; DYE RB, 1993, J BIOL CHEM, V268, P6847; EDSON K, 1993, DEVELOPMENT, V117, P689; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; HARRISON RG, 1910, J EXP ZOOL, V17, P521; HEIDEMANN SR, 1990, CELL MOTIL CYTOSKEL, V17, P6, DOI 10.1002/cm.970170103; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HILL TL, 1982, INT REV CYTOL, V78, P1, DOI 10.1016/S0074-7696(08)60105-9; ITOH TJ, 1994, CELL STRUCT FUNCT, V19, P279, DOI 10.1247/csf.19.279; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KURACHI M, 1995, CELL MOTIL CYTOSKEL, V30, P221, DOI 10.1002/cm.970300306; LEE G, 1992, J CELL SCI, V102, P227; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; LUBYPHELPS K, 1988, CELL MOTIL CYTOSKEL, V10, P28, DOI 10.1002/cm.970100107; Ludin B, 1996, GENE, V173, P107, DOI 10.1016/0378-1119(95)00899-3; Ludin B, 1996, J CELL SCI, V109, P91; MANSFIELD SG, 1991, J NEUROCYTOL, V20, P654, DOI 10.1007/BF01187067; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; PRYER NK, 1992, J CELL SCI, V103, P965; Ramon y Cajal S, 1960, STUDIES VERTEBRATE N; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; SAMMAK PJ, 1988, CELL MOTIL CYTOSKEL, V10, P237, DOI 10.1002/cm.970100128; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; SHARMA N, 1994, CELL MOTIL CYTOSKEL, V27, P234, DOI 10.1002/cm.970270305; Sharp DJ, 1996, J NEUROSCI, V16, P4370; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; TAKEMURA R, 1992, J CELL SCI, V103, P953; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; WEEKS PRG, 1991, BIOESSAYS, V13, P235; WEEKS PRG, 1989, DEV BRAIN RES, V49, P305; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WEISSHAAR B, 1992, DEVELOPMENT, V116, P1151; Wordeman Linda, 1994, V13, P287	66	134	141	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1189	1199		10.1016/S0896-6273(00)80249-4	http://dx.doi.org/10.1016/S0896-6273(00)80249-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982165	Bronze			2022-12-28	WOS:A1996WA24800015
J	Borchelt, DR; Thinakaran, G; Eckman, CB; Lee, MK; Davenport, F; Ratovitsky, T; Prada, CM; Kim, G; Seekins, S; Yager, D; Slunt, HH; Wang, R; Seeger, M; Levey, AI; Gandy, SE; Copeland, NG; Jenkins, NA; Price, DL; Younkin, SG				Borchelt, DR; Thinakaran, G; Eckman, CB; Lee, MK; Davenport, F; Ratovitsky, T; Prada, CM; Kim, G; Seekins, S; Yager, D; Slunt, HH; Wang, R; Seeger, M; Levey, AI; Gandy, SE; Copeland, NG; Jenkins, NA; Price, DL; Younkin, SG			Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-PROTEIN; A-BETA; MISSENSE MUTATIONS; SENILE PLAQUES; DOWN-SYNDROME; GENE; A-BETA-42(43); CHROMOSOME-1; PEPTIDE	Mutations in the presenilin 1 (PS1) and presenilin 2 genes cosegregate with the majority of early-onset familial Alzheimer's disease (FAD) pedigrees. We now document that the A beta 1-42(43)/A beta 1-40 ratio in the conditioned media of independent N2a cell lines expressing three FAD-linked PS1 variants is uniformly elevated relative to cells expressing similar levels of wild-type PS1. Similarly, the A beta 1-42(43)/A beta 1-40 ratio is elevated in the brains of young transgenic animals coexpressing a chimeric amyloid precursor protein (APP) and an FAD-linked PS1 variant compared with brains of transgenic mice expressing APP alone or transgenic mice coexpressing wild-type human PS1 and APP. These studies provide compelling support for the view that one mechanism by which these mutant PS1 cause AD is by increasing the extracellular concentration of A beta peptides terminating at 42(43), species that foster A beta deposition.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106; MAYO CLIN JACKSONVILLE,JACKSONVILLE,FL 32224; ROCKEFELLER UNIV,MASS SPECTROMETRY LAB,NEW YORK,NY 10021; CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Case Western Reserve University; Mayo Clinic; Rockefeller University; Cornell University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Borchelt, DR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205, USA.		Lee, Michael K/D-9491-2013; Levey, Allan/F-2104-2011; Wang, Rong/A-8721-2009	Lee, Michael K/0000-0001-5865-9682; Levey, Allan/0000-0002-3153-502X; 	NIA NIH HHS [AG05689, AG05146] Funding Source: Medline; NINDS NIH HHS [NS 20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*ALZH DIS COLL GRO, 1995, NAT GENET, V11, P219; Boteva K, 1996, LANCET, V347, P130, DOI 10.1016/S0140-6736(96)90261-5; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; CHAPMAN J, 1995, LANCET, V346, P1040, DOI 10.1016/S0140-6736(95)91723-3; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; HYMAN BT, 1995, P NATL ACAD SCI USA, V92, P3586, DOI 10.1073/pnas.92.8.3586; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LO ACY, 1994, J BIOL CHEM, V269, P30966; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PerezTur J, 1995, NEUROREPORT, V7, P297; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROHER AE, 1993, J BIOL CHEM, V268, P3072; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SLUNT HH, 1995, AMYLOID, V2, P188, DOI 10.3109/13506129509036925; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; VANNOSTRAND WE, 1989, NATURE, V341, P546; WASCO W, 1995, NAT MED, V1, P848, DOI 10.1038/nm0995-848a	41	1269	1348	3	75	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					1005	1013		10.1016/S0896-6273(00)80230-5	http://dx.doi.org/10.1016/S0896-6273(00)80230-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938131	hybrid			2022-12-28	WOS:A1996VV15100021
J	Lagnado, L; Gomis, A; Job, C				Lagnado, L; Gomis, A; Job, C			Continuous vesicle cycling in the synaptic terminal of retinal bipolar cells	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; BOVINE CHROMAFFIN CELLS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; GOLDFISH RETINA; CALCIUM CURRENT; HAIR-CELLS; ENDOCYTOSIS; EXOCYTOSIS; SECRETION	Endocytosis and exocytosis were investigated in the synaptic terminal of retinal bipolar cells by monitoring the uptake and loss of the fluorescent dye FM1-43. Depolarization in the presence of Ca2+ stimulated a continuous cycle of exocytosis and endocytosis that was approximately balanced at rates up to 3800 vesicles per s. Vesicles became available for exocytosis within 1 min of endocytosis, and about 700,000 releasable vesicles were specifically localized to a region within 2 mu m of the plasma membrane. Release of caged Ca2+ using NP-EGTA while simultaneously monitoring cytosolic Ca2+ with Fura-2 indicated that continuous exocytosis was stimulated by sub-micromolar levels of Ca2+. It has been suggested that the ribbon synapse of bipolar cells only supports transient exocytosis, but our results demonstrate that this synapse is specialized for the continuous secretion of neurotransmitter.			Lagnado, L (corresponding author), MRC,MOL BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.		Gomis, Ana/S-1854-2017	Gomis, Ana/0000-0003-4651-7673				ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, NEURON, V9, P805, DOI 10.1016/0896-6273(92)90235-6; BETZ WJ, 1995, CURR BIOL, V5, P1095; COPENHAGEN DR, 1989, NATURE, V341, P356; DEBELLO WM, 1993, CELL, V74, P947, DOI 10.1016/0092-8674(93)90716-4; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Dowling J. E., 1987, RETINA APPROACHABLE; DOWLING JE, 1973, NATURE, V242, P101, DOI 10.1038/242101a0; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1995, J NEUROSCI, V15, P8246; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; Katz B., 1966, NERVE MUSCLE SYNAPSE; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS RR, 1982, SCI AM, V247, P56, DOI 10.1038/scientificamerican1082-56; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1994, NATURE, V372, P316, DOI 10.1038/372316a0; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PENNER R, 1989, TRENDS NEUROSCI, V12, P159, DOI 10.1016/0166-2236(89)90059-3; RIEKE F, 1996, J PHYSL, P1; RIEKE F, 1994, NEURON, V13, P865; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cb.04.110188.000431; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SAITO T, 1978, VISION RES, V18, P591, DOI 10.1016/0042-6989(78)90208-0; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	50	164	164	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					957	967		10.1016/S0896-6273(00)80226-3	http://dx.doi.org/10.1016/S0896-6273(00)80226-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938127	Bronze			2022-12-28	WOS:A1996VV15100017
J	Gross, RE; Mehler, MF; Mabie, PC; Zang, ZY; Santschi, L; Kessler, JA				Gross, RE; Mehler, MF; Mabie, PC; Zang, ZY; Santschi, L; Kessler, JA			Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; OLIGODENDROCYTES IN-VITRO; FIBRILLARY ACIDIC PROTEIN; RAT CEREBRAL-CORTEX; GROWTH-FACTOR; PRECURSOR CELLS; NEURAL CREST; STEM-CELLS; NEURONAL DIFFERENTIATION; ASTROCYTE DEVELOPMENT	The epigenetic signals that regulate lineage development in the embryonic mammalian brain are poorly understood. Here we demonstrate that a specific subclass of the transforming growth factor beta superfamily, the bone morphogenetic proteins (BMPs), cause the selective, dose-dependent elaboration of the astroglial lineage from murine embryonic subventricular zone (SVZ) multipotent progenitor cells. The astroglial inductive effect is characterized by enhanced morphological complexity and expression of glial fibrillary acidic protein, with concurrent suppression of neuronal and oligodendroglial cell fates. SVZ progenitor cells express transcripts for the appropriate BMP-specific type I and II receptor subunits and selective BMP ligands, suggesting the presence of paracrine or autocrine developmental signaling pathways (or both). These observations suggest that the BMPs have a selective role in determining the cell fate of SVZ multipotent progenitor cells or their more developmentally restricted progeny.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSURG,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,ROSE F KENNEDY CTR RES MENTAL RETARDAT & HUMAN DE,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine					NINDS NIH HHS [NS-20013, NS-34758, NS-20778] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034758, R01NS020013, R01NS020778] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED S, 1995, J NEUROSCI, V15, P5765; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; Anderson DJ, 1995, NEURON, V15, P1219, DOI 10.1016/0896-6273(95)90001-2; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; CAMMER W, 1992, J COMP NEUROL, V321, P33, DOI 10.1002/cne.903210104; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Craig CG, 1996, J NEUROSCI, V16, P2649; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P45, DOI 10.3109/08977199409015050; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FANN MJ, 1994, J NEUROCHEM, V63, P2074; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; GODSAVE SF, 1991, DEVELOPMENT, V111, P523; GREEN JBA, 1994, CELL, V77, P317, DOI 10.1016/0092-8674(94)90145-7; GRUNZ H, 1989, CELL DIFFER DEV, V28, P211, DOI 10.1016/0922-3371(89)90006-3; Heitzler P, 1996, DEVELOPMENT, V122, P161; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; JONES CM, 1991, DEVELOPMENT, V111, P531; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LIU F, 1995, MOL CELL BIOL, V15, P3479; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MAYER M, 1994, DEVELOPMENT, V120, P143; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MEHLER MF, 1995, INT J DEV NEUROSCI, V13, P213, DOI 10.1016/0736-5748(94)00060-G; MEHLER MF, 1994, DEV NEUROSCI-BASEL, V16, P180, DOI 10.1159/000112105; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; NAKAFUKU M, 1995, J NEUROSCI RES, V41, P153, DOI 10.1002/jnr.490410203; PATTERSON PH, 1993, CELL, V72, P123, DOI 10.1016/S0092-8674(05)80032-7; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; PERIDES G, 1992, P NATL ACAD SCI USA, V89, P10326, DOI 10.1073/pnas.89.21.10326; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Pourquie O, 1996, CELL, V84, P461, DOI 10.1016/S0092-8674(00)81291-X; PRIVAT A, 1972, J COMP NEUROL, V146, P277, DOI 10.1002/cne.901460302; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SAKAI Y, 1990, P NATL ACAD SCI USA, V87, P8378, DOI 10.1073/pnas.87.21.8378; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SIMPSON P, 1995, NEURON, V15, P739, DOI 10.1016/0896-6273(95)90163-9; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TOMIZAWA K, 1995, MOL BRAIN RES, V28, P122, DOI 10.1016/0169-328X(94)00199-O; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; WALL NA, 1994, CURR OPIN GENET DEV, V4, P517, DOI 10.1016/0959-437X(94)90066-C; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; YOSHIDA T, 1993, DEV BRAIN RES, V76, P147, DOI 10.1016/0165-3806(93)90132-T; YOSHIDA T, 1993, J NEUROSCI RES, V35, P129, DOI 10.1002/jnr.490350203	83	553	575	4	30	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					595	606		10.1016/S0896-6273(00)80193-2	http://dx.doi.org/10.1016/S0896-6273(00)80193-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893018	Bronze			2022-12-28	WOS:A1996VP74300006
J	Yamoah, EN; Gillespie, PG				Yamoah, EN; Gillespie, PG			Phosphate analogs block adaptation in hair cells by inhibiting adaptation-motor force production	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; BERYLLIUM FLUORIDE; MYOSIN SUBFRAGMENT-1; INORGANIC-PHOSPHATE; BULLFROGS SACCULUS; ALUMINUM FLUORIDE; MUSCLE-FIBERS; VANADATE; EAR; COMPLEXES	To ensure optimal sensitivity for mechanoelectrical transduction, hair cells adapt to prolonged stimuli using active motors. Adaptation motors are thought to employ myosin molecules as their force-producing components. We find that beryllium fluoride, vanadate, and sulfate, phosphate analogs that inhibit the ATPase activity of myosin, inhibit adaptation by abolishing motor force production. Phosphate analogs interact with a 120-kDa bundle protein, most likely myosin I beta, in a manner that coincides with their effects on adaptation. Features of transduction following inhibition of motor force production suggest that the gating and extent springs of the hair cell orient in parallel at rest and that the negative limit of adaptation arises when force in the stretched extent spring matches the force output of the adaptation motor.	JOHNS HOPKINS UNIV, DEPT NEUROSCI, BALTIMORE, MD 21205 USA	Johns Hopkins University	Yamoah, EN (corresponding author), JOHNS HOPKINS UNIV, DEPT PHYSIOL, BALTIMORE, MD 21205 USA.			Barr-Gillespie, Peter/0000-0002-9787-5860	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002368, P60DC000979] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC02368, P60 DC00979] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1992, J NEUROSCI, V12, P3291; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; CHASE PB, 1994, J MUSCLE RES CELL M, V15, P119, DOI 10.1007/BF00130423; CHASE PB, 1993, J PHYSIOL-LONDON, V460, P231, DOI 10.1113/jphysiol.1993.sp019469; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; COREY DP, 1983, J NEUROSCI, V3, P942; DANTZIG JA, 1985, J GEN PHYSIOL, V86, P305, DOI 10.1085/jgp.86.3.305; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FORD LE, 1981, J PHYSIOL-LONDON, V311, P219, DOI 10.1113/jphysiol.1981.sp013582; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; GILLESPIE PG, 1995, CURR OPIN NEUROBIOL, V5, P449, DOI 10.1016/0959-4388(95)80004-2; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; HIROKAWA N, 1982, J CELL BIOL, V95, P249, DOI 10.1083/jcb.95.1.249; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; KOYAMA H, 1982, BRAIN RES, V250, P168, DOI 10.1016/0006-8993(82)90964-7; LEIBLER S, 1993, J CELL BIOL, V121, P1357, DOI 10.1083/jcb.121.6.1357; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; MACARA IG, 1980, TRENDS BIOCHEM SCI, V5, P92, DOI 10.1016/0968-0004(80)90256-X; MARUTA S, 1993, J BIOL CHEM, V268, P7093; METCALF AB, 1994, P NATL ACAD SCI USA, V91, P11821, DOI 10.1073/pnas.91.25.11821; Ostap EM, 1996, J CELL BIOL, V132, P1053, DOI 10.1083/jcb.132.6.1053; PHAN BC, 1993, BIOCHEMISTRY-US, V32, P7712, DOI 10.1021/bi00081a016; PYBUS J, 1975, J PHYSIOL-LONDON, V247, P71, DOI 10.1113/jphysiol.1975.sp010921; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SOLO CF, 1994, AUDIT NEUROSCI, V1, P63; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; TESI C, 1988, FEBS LETT, V236, P256, DOI 10.1016/0014-5793(88)80326-0; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; WILSON GJ, 1995, BIOPHYS J, V68, P216, DOI 10.1016/S0006-3495(95)80177-3	43	48	50	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					523	533		10.1016/S0896-6273(00)80184-1	http://dx.doi.org/10.1016/S0896-6273(00)80184-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816715	hybrid			2022-12-28	WOS:A1996VJ44000018
J	Mitchell, KJ; Doyle, JL; Serafini, T; Kennedy, TE; TessierLavigne, M; Goodman, CS; Dickson, BJ				Mitchell, KJ; Doyle, JL; Serafini, T; Kennedy, TE; TessierLavigne, M; Goodman, CS; Dickson, BJ			Genetic analysis of Netrin genes in Drosophila: Netrins guide CNS commissural axons and peripheral motor axons	NEURON			English	Article							GROWTH CONE GUIDANCE; CENTRAL-NERVOUS-SYSTEM; ABL TYROSINE KINASE; C-ELEGANS; CELL; MIDLINE; EXPRESSION; MUTATIONS; UNC-6; CHEMOATTRACTANT	Two tandem Netrin genes in Drosophila are expressed at the midline of the developing CNS and in different subsets of neurons, muscles, and epidermal patches. In embryos carrying a small deficiency that deletes both genes, CNS axon commissures are partially missing or thinner. This phenotype is rescued by expressing either Netrin gene at the midline. Pan-neural expression of either gene causes disruption of commissural and longitudinal tracts, indicating that the pattern of Netrin expression is crucial and that Netrins function as instructive cues. The double mutant also shows defects in motor axon projections. Expression of either Netrin gene in all muscles also results in aberrant motor projections. Thus, Drosophila Netrins are required for the guidance of commissural axons at the midline, and of motor axons to their target muscles.	UNIV CALIF SAN FRANCISCO,DEPT ANAT,HOWARD HUGHES MED INST,CELL BIOL PROGRAM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT ANAT,HOWARD HUGHES MED INST,PROGRAM DEV BIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT ANAT,HOWARD HUGHES MED INST,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Mitchell, KJ (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT CELL & MOL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.		Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Mitchell, Kevin/0000-0002-3433-4530	NINDS NIH HHS [NS18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOSSING T, 1994, DEVELOPMENT, V120, P1895; BRAND AH, 1993, DEVELOPMENT, V118, P401; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HILL KK, 1995, GENETICS, V141, P595; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MADUENO E, 1995, GENETICS, V139, P1631; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; PLACZEK M, 1990, DEVELOPMENT, V110, P19; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHARP PM, 1993, ATLAS DROSOPHILA GEN, P378; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6	35	374	379	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					203	215		10.1016/S0896-6273(00)80153-1	http://dx.doi.org/10.1016/S0896-6273(00)80153-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780645	Bronze			2022-12-28	WOS:A1996VE84000004
J	ORourke, NA				ORourke, NA			Neuronal chain gangs: Homotypic contacts support migration into the olfactory bulb	NEURON			English	Review							GRANULE CELLS; FOREBRAIN		STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305	Stanford University								CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; KISHI K, 1990, ARCH HISTOL CYTOL, V53, P219, DOI 10.1679/aohc.53.219; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MENEZES JR, 1994, MOL CELL NEUROSCI, V6, P496; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; OROURKE NA, 1992, SCIENCE, V258, P425; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; Rutishauser U., 1992, DEVELOPMENT S, V116, P99; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J	18	37	37	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1061	1064		10.1016/S0896-6273(00)80130-0	http://dx.doi.org/10.1016/S0896-6273(00)80130-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663980	Bronze			2022-12-28	WOS:A1996UU11800001
J	Yoshida, M; Colman, DR				Yoshida, M; Colman, DR			Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; PERIPHERAL MYELIN; BRAIN MYELIN; CNS MYELIN; JIMPY MICE; ADHESION MOLECULE; MESSENGER-RNAS; BASIC-PROTEIN; MUTANT MOUSE; SPLICE SITE	Vertebrate myelin contains two proteins that mediate compaction: protein zero (P-0), an immunoglobulin gene superfamily member, or proteolipid proteins, 4-hydrophobic domain-motif proteins biogenetically unrelated to P-0. The prevailing view has been that expression of P-0 and proteolipid proteins is mutually exclusive; P-0, which mediates myelin compaction in fish, is thought to be completely replaced by the newer proteolipid proteins in the terrestrial vertebrate CNS. However, we now find that proteolipid proteins are actually major myelin constituents in bony fish and amphibia, and so are coexpressed with P-0. Clearly, myelin proteolipids are not new additions to the myelin protein repertoire, but instead were ancestral sheath components, expressed similar to 440 million years ago in the first myelinated fish that existed at least similar to 100 million years before the origin of amphibians. In conclusion, P-0 and the proteolipid proteins are evolving in parallel in myelinating cells of most vertebrate species.			Yoshida, M (corresponding author), CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029, USA.				NINDS NIH HHS [NS20147] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; [Anonymous], MYELIN; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; BOISON D, 1995, J NEUROSCI, V15, P5502; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; BRAUN PE, 1984, MYELIN, P97; CAMPAGNONI CW, 1994, NEUROCHEM RES, V19, P1061, DOI 10.1007/BF00968717; CAPPETTA H, 1987, HDB PALEOICHTHYOLO B, V3, P41; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DAUTIGNY A, 1985, FEBS LETT, V188, P33, DOI 10.1016/0014-5793(85)80869-3; DAUTIGNY A, 1986, NATURE, V321, P867, DOI 10.1038/321867a0; DECOZAR M, 1987, BIOCHEM INT, V14, P833; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; DOYLE JP, 1995, J CELL BIOL, V131, P465, DOI 10.1083/jcb.131.2.465; DUNCAN ID, 1990, ANN NY ACAD SCI, V605, P110, DOI 10.1111/j.1749-6632.1990.tb42386.x; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FRANZ T, 1981, BRAIN RES, V226, P245, DOI 10.1016/0006-8993(81)91097-0; GARDINIER MV, 1986, MOL CELL BIOL, V6, P3755, DOI 10.1128/MCB.6.11.3755; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HELYNCK G, 1983, EUR J BIOCHEM, V133, P689, DOI 10.1111/j.1432-1033.1983.tb07518.x; Hudson Lynn D., 1992, P677; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; Kirschner Daniel A., 1992, P3; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KRONQUIST KE, 1987, J NEUROSCI RES, V18, P395, DOI 10.1002/jnr.490180303; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIN LFH, 1982, P NATL ACAD SCI-BIOL, V79, P941, DOI 10.1073/pnas.79.3.941; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; MACKLIN WB, 1987, FEBS LETT, V223, P417, DOI 10.1016/0014-5793(87)80331-9; MATTHIEU JM, 1986, BRAIN RES, V379, P137, DOI 10.1016/0006-8993(86)90265-9; MEYER A, 1995, TRENDS ECOL EVOL, V10, P111, DOI 10.1016/S0169-5347(00)89004-7; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NAVE KA, 1986, P NATL ACAD SCI USA, V83, P9264, DOI 10.1073/pnas.83.23.9264; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; PETERSON AC, 1984, J COMP NEUROL, V227, P348, DOI 10.1002/cne.902270305; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; ROSENBLUTH J, 1980, J COMP NEUROL, V193, P729, DOI 10.1002/cne.901930310; ROTH G, 1993, BRAIN BEHAV EVOLUT, V42, P137, DOI 10.1159/000114147; SAAVEDRA RA, 1989, J MOL EVOL, V29, P149, DOI 10.1007/BF02100113; SCHAICH M, 1986, BIOL CHEM H-S, V367, P825, DOI 10.1515/bchm3.1986.367.2.825; SCHLIESS F, 1991, BIOL CHEM H-S, V372, P865, DOI 10.1515/bchm3.1991.372.2.865; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SHIRAI S, 1992, COPEIA, V2, P505; SIMONS R, 1987, BIOCHEM BIOPH RES CO, V146, P666, DOI 10.1016/0006-291X(87)90580-8; SINOWAY MP, 1994, J NEUROSCI RES, V37, P551, DOI 10.1002/jnr.490370502; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; STRATMANN A, 1995, J NEUROCHEM, V64, P2427; TAKEI K, 1993, COMP BIOCHEM PHYS B, V106, P873, DOI 10.1016/0305-0491(93)90044-6; TIMSIT S, 1992, J NEUROCHEM, V58, P1936, DOI 10.1111/j.1471-4159.1992.tb10072.x; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TINGBEALL HP, 1979, J MEMBRANE BIOL, V51, P33, DOI 10.1007/BF01869342; WAEHNELDT TV, 1987, COMP BIOCHEM PHYS B, V88, P1209, DOI 10.1016/0305-0491(87)90025-3; WAEHNELDT TV, 1985, NEUROSCI LETT, V57, P97, DOI 10.1016/0304-3940(85)90046-1; WAEHNELDT TV, 1990, ANN NY ACAD SCI, V605, P15, DOI 10.1111/j.1749-6632.1990.tb42377.x; WAEHNELDT TV, 1986, NEUROCHEM INT, V9, P463, DOI 10.1016/0197-0186(86)90136-1; WAEHNELDT TV, 1986, J NEUROCHEM, V46, P1387, DOI 10.1111/j.1471-4159.1986.tb01752.x; WAEHNELDT TV, 1989, J NEUROCHEM, V52, P1941, DOI 10.1111/j.1471-4159.1989.tb07281.x; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J	70	86	86	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1115	1126		10.1016/S0896-6273(00)80138-5	http://dx.doi.org/10.1016/S0896-6273(00)80138-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663988	Bronze			2022-12-28	WOS:A1996UU11800009
J	Katz, PS				Katz, PS			Neurons, networks, and motor behavior	NEURON			English	Editorial Material											Katz, PS (corresponding author), UNIV TEXAS,SCH MED,DEPT NEUROBIOL & ANAT,HOUSTON,TX 77030, USA.			Katz, Paul/0000-0003-0786-1287	NINDS NIH HHS [R01-NS35371] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035371] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Getting P.A., 1986, NEUROBIOLOGY VERTEBR, P231; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; GETTING PA, 1989, METHODS NEURONAL MOD, P171; GRILLNER S, 1986, NEUROBIOLOGY VERTEBR; MARDER E, 1984, TRENDS NEUROSCI, V7, P48, DOI 10.1016/S0166-2236(84)80277-5; MORTON DW, 1994, TRENDS NEUROSCI, V17, P413, DOI 10.1016/0166-2236(94)90015-9; SHIK M. L., 1966, BLOFIZIKA, V11, P659; STEIN PSG, 1996, IN PRESS NEURONS NET; [No title captured]	9	24	24	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					245	253		10.1016/S0896-6273(00)80043-4	http://dx.doi.org/10.1016/S0896-6273(00)80043-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789940	Bronze			2022-12-28	WOS:A1996TW95700005
J	Slesinger, PA; Patil, N; Liao, YJ; Jan, YN; Jan, LY; Cox, DR				Slesinger, PA; Patil, N; Liao, YJ; Jan, YN; Jan, LY; Cox, DR			Functional effects of the mouse weaver mutation on g protein-gated inwardly rectifying K+ channels	NEURON			English	Article							MUTANT MOUSE; GRANULE CELL; CEREBELLAR CORTEX; NEURONAL DIFFERENTIATION; FIBER VULNERABILITY; MESOSTRIATAL SYSTEM; TEA BLOCKADE; GENE-ACTION; MICE; DOPAMINE	The weaver mutation corresponds to a substitution of glycine to serine in the H5 region of a G protein-gated inwardly rectifying K+ channel gene (GIRK2). By studying mutant GIRK2 weaver homomultimeric channels and heteromultimeric channels comprised of GIRK2 weaver and GIRK1 in Xenopus oocytes, we found that GIRK2 weaver homomultimeric channels lose their selectivity for KC ions, giving rise to inappropriate receptor-activated and basally active Na+ currents, whereas heteromultimers of GIRK2 weaver and GIRK1 appeared to have reduced current. Immunohistochemical localization indicates that GIRK2 and GIRK1 proteins are expressed in the cerebellar neurons of mice at postnatal day 4, at a time when these neurons normally undergo differentiation. Thus, the aberrant behavior of mutant GIRK2 weaver channels could affect the development of weaver mice in at least two distinct ways.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT BIOCHEM,SAN FRANCISCO,CA 94143; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Stanford University	Slesinger, PA (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT PHYSIOL,BOX 0444,SAN FRANCISCO,CA 94143, USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024610] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24610] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHFORD MLJ, 1994, NATURE, V370, P456, DOI 10.1038/370456a0; BOND CT, 1995, FEBS LETT, V367, P61, DOI 10.1016/0014-5793(95)00497-W; BRADLEY P, 1978, BRAIN RES, V142, P135, DOI 10.1016/0006-8993(78)90182-8; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; DEPAOLI AM, 1994, MOL CELL NEUROSCI, V5, P515, DOI 10.1006/mcne.1994.1063; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; GALLI C, 1995, J NEUROSCI, V15, P1172; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GASPAR P, 1994, NEUROSCIENCE, V61, P293, DOI 10.1016/0306-4522(94)90232-1; GHETTI B, 1992, NEUROCHEM INT, V20, pS305; GOLDOWITZ D, 1989, NEURON, V2, P1565, DOI 10.1016/0896-6273(89)90045-7; GOLDOWITZ D, 1982, J NEUROSCI, V2, P1474; GRAYBIEL AM, 1990, J NEUROSCI, V10, P720; GUPTA M, 1987, BRAIN RES, V402, P379, DOI 10.1016/0006-8993(87)90050-3; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HATTEN ME, 1984, J NEUROSCI, V4, P1163; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HERRUP K, 1987, NEUROSCIENCE, V23, P871, DOI 10.1016/0306-4522(87)90164-3; Hille B., 1992, IONIC CHANNELS EXCIT; KARSCHIN C, 1994, FEBS LETT, V348, P139, DOI 10.1016/0014-5793(94)00590-7; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAPIVINSKY G, 1995, NATURE, V374, P125; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MIGHELI A, 1995, NEUROSCI LETT, V199, P53, DOI 10.1016/0304-3940(95)12015-V; MURTOMAKI S, 1995, DEV BIOL, V168, P635, DOI 10.1006/dbio.1995.1108; ORRENIUS S, 1994, J NEURAL TRANSM-SUPP, V43, P1; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; REZAI Z, 1972, DEV BIOL, V29, P17, DOI 10.1016/0012-1606(72)90039-5; RICHTER JA, 1992, NEUROCHEM RES, V17, P437, DOI 10.1007/BF00969889; ROFFLERTARLOV S, 1990, J NEUROSCI, V10, P734; ROFFLERTARLOV S, 1984, NATURE, V307, P62, DOI 10.1038/307062a0; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SCHMIDT MJ, 1982, J NEUROSCI, V2, P376; Sidman RL., 1965, CATALOG NEUROLOGICAL, DOI [10.4159/harvard.9780674424326, DOI 10.4159/HARVARD.9780674424326]; SIMON JR, 1994, J NEUROCHEM, V62, P543; SMEYNE RJ, 1989, J NEUROSCI, V9, P1608; SMEYNE RJ, 1990, DEV BRAIN RES, V52, P211, DOI 10.1016/0165-3806(90)90237-S; TAKANO K, 1995, NEURON, V14, P999, DOI 10.1016/0896-6273(95)90338-0; TRIARHOU LC, 1988, EXP BRAIN RES, V70, P256; TSAUR ML, 1995, DIABETES, V44, P592, DOI 10.2337/diabetes.44.5.592; WONG ROL, 1995, P NATL ACAD SCI USA, V92, P1797, DOI 10.1073/pnas.92.6.1797; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; YAMAGUCHI K, 1990, J PHYSIOL-LONDON, V426, P499, DOI 10.1113/jphysiol.1990.sp018151; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	59	235	239	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1996	16	2					321	331		10.1016/S0896-6273(00)80050-1	http://dx.doi.org/10.1016/S0896-6273(00)80050-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789947	Bronze			2022-12-28	WOS:A1996TW95700012
J	Carew, TJ				Carew, TJ			Molecular enhancement of memory formation	NEURON			English	Review							APLYSIA SENSORY NEURONS; DEPENDENT PROTEIN-KINASE; LONG-TERM FACILITATION; CAMP; PHOSPHORYLATION; DYNAMICS; CREB				Carew, TJ (corresponding author), YALE UNIV,DEPT PSYCHOL,DEPT BIOL,NEW HAVEN,CT 06520, USA.							ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YIN JCP, 1995, MOL CELL BIOL, V15, P5123; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	24	149	152	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					5	8		10.1016/S0896-6273(00)80016-1	http://dx.doi.org/10.1016/S0896-6273(00)80016-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562090	hybrid			2022-12-28	WOS:A1996TT30700002
J	Du, HP; Gu, GQ; William, CM; Chalfie, M				Du, HP; Gu, GQ; William, CM; Chalfie, M			Extracellular proteins needed for C-elegans mechanosensation	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EPIDERMAL GROWTH-FACTOR; TOUCH RECEPTOR NEURONS; HAIR-CELLS; MESSENGER-RNA; TRYPSIN-INHIBITOR; STRETCH-RECEPTOR; LEADER SEQUENCE; ALPORT SYNDROME; COLLAGEN GENE	The mec-5 and mec-9 genes encode putative extracellular proteins that allow a set of six touch receptor neurons in C. elegans to respond to gentle touch. MEC-5 is a collagen made by the epidermal cells that surround the touch cells. Mutations causing touch insensitivity affect the Gly-X-Y repeats of this collagen. mec-9 produces two transcripts, the larger of which is expressed in the touch cells and two PVD neurons. This transcript encodes a protein with 5 Kunitz-type protease inhibitor domains, 6 EGF-like repeats (2 of the Ca2+-binding type), and a glutamic acid-rich region. Missense mutations causing touch insensitivity affect both the EGF-like and Kunitz domains. Since mec-9 loss of function mutations dominantly enhance the touch insensitive phenotype of several mec-5 mutations, MEC-5 and MEC-9 may interact. We propose that these proteins provide an extracellular attachment point for the mechanosensory channels of the touch cells.			Du, HP (corresponding author), COLUMBIA UNIV, DEPT BIOL SCI, NEW YORK, NY 10027 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030997, R01GM034775, R37GM030997] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34775, GM30997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BORK P, 1991, FEBS LETT, V286, P47, DOI 10.1016/0014-5793(91)80937-X; BRENNER S, 1974, GENETICS, V77, P71; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHALFIE M, 1993, NATURE, V361, P504, DOI 10.1038/361504a0; CHALFIE M, 1993, J NEUROBIOL, V24, P1433, DOI 10.1002/neu.480241013; CHAN D, 1993, J BIOL CHEM, V268, P15238; COLLINS J, 1987, GENETICS, V120, P987; COREY DP, 1983, J NEUROSCI, V3, P962; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; CULOTTI JG, 1978, GENETICS, V90, P243; DAVIS C G, 1990, New Biologist, V2, P410; DONG LJ, 1995, J BIOL CHEM, V270, P15838, DOI 10.1074/jbc.270.26.15838; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; EDWARDS C, 1981, NEUROSCIENCE, V6, P1455, DOI 10.1016/0306-4522(81)90200-1; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; FERGUSON EL, 1985, GENETICS, V110, P17; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FRENCH AS, 1988, ANNU REV ENTOMOL, V33, P39, DOI 10.1146/annurev.en.33.010188.000351; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; GUSTIN MC, 1988, SCIENCE, V242, P762, DOI 10.1126/science.2460920; HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1, DOI 10.1152/ajpcell.1995.268.1.C1; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HOCHSTRASSER K, 1985, BIOL CHEM H-S, V366, P473, DOI 10.1515/bchm3.1985.366.1.473; HODGKIN J, 1980, GENETICS, V96, P649; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; JOHNSTONE IL, 1994, BIOESSAYS, V16, P171, DOI 10.1002/bies.950160307; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KRAMER JM, 1994, ANNU REV GENET, V28, P95; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LUCCHESI KJ, 1991, J GEN PHYSIOL, V97, P1295, DOI 10.1085/jgp.97.6.1295; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; MANOIL C, 1990, J BACTERIOL, V172, P1035, DOI 10.1128/jb.172.2.1035-1042.1990; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITANI S, 1993, DEVELOPMENT, V119, P773; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; OHSAWA K, 1992, J CHROMATOGR, V597, P285, DOI 10.1016/0021-9673(92)80122-B; OSBORNE MP, 1984, CELL TISSUE RES, V237, P43; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; RAMACHANDRAN GN, 1976, BIOCHEMISTRY COLLAGE; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; Sambrook J, 1989, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382; SIBLEY MH, 1994, EMBO J, V13, P3278, DOI 10.1002/j.1460-2075.1994.tb06629.x; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; TRENT C, 1983, GENETICS, V104, P619; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WILLIAMS BD, 1992, GENETICS, V131, P609; WILSON LJ, 1990, J COMP NEUROL, V296, P343, DOI 10.1002/cne.902960302; Wood W.B, 1988, NEMATODE CAENORHABDI; XUE D, 1992, EMBO J, V11, P4969, DOI 10.1002/j.1460-2075.1992.tb05604.x; ZARKOWER D, 1992, CELL, V70, P237, DOI 10.1016/0092-8674(92)90099-X	90	99	107	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					183	194		10.1016/S0896-6273(00)80035-5	http://dx.doi.org/10.1016/S0896-6273(00)80035-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562083	hybrid			2022-12-28	WOS:A1996TT30700021
J	Sommer, L; Shah, N; Rao, M; Anderson, DJ				Sommer, L; Shah, N; Rao, M; Anderson, DJ			The cellular function of MASH1 in autonomic neurogenesis	NEURON			English	Article							NEURAL CREST CELLS; PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE HOMOLOG-1; INVITRO CLONAL ANALYSIS; NEURONAL DIFFERENTIATION; SYMPATHETIC-GANGLIA; PROGENITOR CELLS; SCHWANN-CELLS; DORSAL-ROOT; GENE FAMILY	Using primary cultures and immortalized multipotential stem cell lines derived from wild-type and MASH1 mutant neural crest cells, we have analyzed the cellular function of MASH1 in autonomic neurogenesis. We present evidence for the existence of a precursor expressing MASH1 and neuronal markers such as neurofilament, neuron-specific tubulin, and tetanus toxin receptor. This cell has a nonneuronal morphology. Differentiation of this precursor to neurons that express markers such as SCG10, peripherin, and neuron-specific enolase is dependent upon MASH1 function. These data imply that the differentiation of autonomic neurons from uncommitted neural crest cells occurs in several sequential steps. Moreover, they suggest that MASH1 does not commit multipotent cells to a neural fate, like its Drosophila achaete-scute counterparts, but rather promotes the differentiation of a committed neuronal precursor.	CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125	California Institute of Technology; Howard Hughes Medical Institute	Sommer, L (corresponding author), CALTECH,DIV BIOL 21676,PASADENA,CA 91125, USA.			Sommer, Lukas/0000-0002-1143-7908				ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BLAUGRUND E, 1996, IN PRESS DEVELOPMENT, V122; BOISSEAU S, 1989, DEVELOPMENT, V106, P665; BRAND M, 1993, DEVELOPMENT, V119, P1; CARNAHAN JF, 1991, J NEUROSCI, V11, P3520; COCHARD P, 1984, J NEUROSCI, V4, P2080; COHEN AM, 1975, DEV BIOL, V46, P262, DOI 10.1016/0012-1606(75)90104-9; CONDRON BG, 1994, J NEUROSCI, V14, P5766; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DUFF RS, 1991, DEV BIOL, V147, P451, DOI 10.1016/0012-1606(91)90303-K; FERREIRO B, 1992, MECH DEVELOP, V40, P25; FRIEDMAN B, 1990, J COMP NEUROL, V295, P43, DOI 10.1002/cne.902950105; GELSERT EE, 1989, NEUROSCI LETT, V102, P137; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GHYSEN A, 1989, DEVELOPMENT, V105, P35; GROVES AK, 1995, DEVELOPMENT, V121, P887; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; ITO K, 1993, DEV BIOL, V157, P517, DOI 10.1006/dbio.1993.1154; JAMEN AP, 1993, DEVELOPMENT, V119, P19; JAN YN, 1994, ANNU REV GENET, V28, P373, DOI 10.1146/annurev.ge.28.120194.002105; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JESSEN KR, 1990, DEVELOPMENT, V109, P91; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; JULIEN JP, 1986, MOL BRAIN RES, V1, P243, DOI 10.1016/0169-328X(86)90030-6; KALCHEIM C, 1986, DEV BIOL, V116, P451, DOI 10.1016/0012-1606(86)90146-6; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN N, 1991, GLIA, V4, P175; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; LO LC, 1994, PERSPECT DEV NEUROBI, V2, P191; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marusich MF, 1991, CURR OPIN GENET DEV, V1, P221, DOI 10.1016/S0959-437X(05)80074-7; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; MICHELSOHN AM, 1992, NEURON, V8, P589, DOI 10.1016/0896-6273(92)90285-L; MORRISONGRAHAM K, 1990, DEV BIOL, V139, P299, DOI 10.1016/0012-1606(90)90299-X; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; RAJU TR, 1982, BRAIN RES, V248, P196, DOI 10.1016/0006-8993(82)91165-9; RAY J, 1994, J NEUROSCI, V14, P3548; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Sieber-Blum M., 1990, Comments on Developmental Neurobiology, V1, P225; SMITHTHOMAS LC, 1989, DEVELOPMENT, V105, P251; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Sternberg Paul W., 1992, P1; TEMPLE S, 1994, DEVELOPMENT, V120, P999; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; UDOLPH G, 1993, DEVELOPMENT, V118, P765; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221	63	217	221	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1245	1258		10.1016/0896-6273(95)90005-5	http://dx.doi.org/10.1016/0896-6273(95)90005-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845150	Bronze			2022-12-28	WOS:A1995TL67800005
J	JONAKAIT, GM; WEI, RT; SHENG, ZL; HART, RP; NI, L				JONAKAIT, GM; WEI, RT; SHENG, ZL; HART, RP; NI, L			INTERFERON-GAMMA PROMOTES CHOLINERGIC DIFFERENTIATION OF EMBRYONIC SEPTAL NUCLEI AND ADJACENT BASAL FOREBRAIN	NEURON			English	Article							NERVE GROWTH-FACTOR; IA-ANTIGEN EXPRESSION; NECROSIS-FACTOR-ALPHA; RAT SPINAL-CORD; NEUROTROPHIC FACTOR; CYTOKINE REGULATION; AMEBOID MICROGLIA; NEURONS INVITRO; SUBSTANCE-P; SYMPATHETIC-GANGLIA	In cultured rat embryonic septal nuclei with adjacent basal forebrain, murine interferon-gamma (IFN gamma) produces a striking increase in choline acetyltransferase (ChAT) activity and mRNA. The effect of IFN gamma on cholinergic differentiation is more potent in E14 cultures than in older cultures. IFN gamma does not cause a change in the affinity of ChAT for choline, nor does it affect cell proliferation. Whereas IFN gamma doubles neuronal cell number, the cholinergic cell number increases more than 7-fold. Ameboid microglia respond to IFN gamma with the translocation of p91 to the nucleus. The action of IFN gamma is not mediated by NGF or bFGF. The enhancement of cholinergic expression that occurs with increased cell density may be partly attributable to an endogenous IFN gamma-like molecule, since antibodies to IFN gamma offset the effects of increased cell density.			JONAKAIT, GM (corresponding author), RUTGERS STATE UNIV,DEPT BIOL SCI,NEWARK,NJ 07102, USA.		Hart, Ronald P/G-6530-2019; Hart, Ronald P/D-5219-2009	Hart, Ronald P/0000-0003-4836-8712; Hart, Ronald P/0000-0003-4836-8712				ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; ALTAR CA, 1991, J NEUROSCI, V11, P828; ARAUJO DM, 1992, J NEUROSCI, V12, P1668; BARISH ME, 1991, DEV BIOL, V144, P412, DOI 10.1016/0012-1606(91)90433-4; Benveniste E N, 1989, Int Immunol, V1, P219, DOI 10.1093/intimm/1.3.219; BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; Bisso G. M., 1992, Brain Dysfunction, V5, P121; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRENNEMAN DE, 1992, J NEUROCHEM, V58, P454, DOI 10.1111/j.1471-4159.1992.tb09743.x; CAVICCHIOLI L, 1991, MOL BRAIN RES, V9, P319, DOI 10.1016/0169-328X(91)90079-D; CHANG JY, 1990, J NEUROCHEM, V55, P436, DOI 10.1111/j.1471-4159.1990.tb04155.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAWFORD GD, 1982, P NATL ACAD SCI-BIOL, V79, P7031, DOI 10.1073/pnas.79.22.7031; DEGROOT CJA, 1991, INT J NEUROSCI, V59, P53, DOI 10.3109/00207459108985449; DREYFUS CF, 1989, TRENDS PHARMACOL SCI, V10, P145, DOI 10.1016/0165-6147(89)90166-1; ENEROTH A, 1992, J NEUROSCI RES, V31, P487, DOI 10.1002/jnr.490310311; ERKMAN L, 1989, DEV BIOL, V132, P375, DOI 10.1016/0012-1606(89)90234-0; FABRY Z, 1992, J NEUROIMMUNOL, V36, P1, DOI 10.1016/0165-5728(92)90026-H; FAGAN AM, 1990, EXP NEUROL, V110, P105, DOI 10.1016/0014-4886(90)90055-W; FIERZ W, 1985, J IMMUNOL, V134, P3785; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; FONTANA A, 1980, J NEUROL SCI, V46, P55, DOI 10.1016/0022-510X(80)90043-X; FREI K, 1987, EUR J IMMUNOL, V17, P1271, DOI 10.1002/eji.1830170909; FREI K, 1985, J IMMUNOL, V135, P4044; FREIDIN M, 1991, P NATL ACAD SCI USA, V88, P3200, DOI 10.1073/pnas.88.8.3200; FROHMAN EM, 1989, J NEUROIMMUNOL, V23, P117, DOI 10.1016/0165-5728(89)90030-1; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1988, J NEUROSCI, V8, P4707; GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4; GRAY CW, 1992, BRAIN RES, V574, P257, DOI 10.1016/0006-8993(92)90825-T; GROTHE C, 1989, NEUROSCIENCE, V31, P649, DOI 10.1016/0306-4522(89)90430-2; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HART RP, 1991, J NEUROSCI RES, V29, P282, DOI 10.1002/jnr.490290303; HARTIKKA J, 1988, J NEUROSCI, V8, P2967; HARTIKKA J, 1988, J NEUROSCI RES, V21, P352, DOI 10.1002/jnr.490210227; HEFTI F, 1985, NEUROSCIENCE, V14, P55, DOI 10.1016/0306-4522(85)90163-0; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; HIRSCH MR, 1983, NEUROSCI LETT, V41, P199, DOI 10.1016/0304-3940(83)90247-1; IMPROTA T, 1988, EXP CELL RES, V179, P1, DOI 10.1016/0014-4827(88)90342-4; JONAKAIT GM, 1985, DEV BIOL, V108, P6, DOI 10.1016/0012-1606(85)90003-X; JONAKAIT GM, 1990, J NEUROSCI RES, V26, P24, DOI 10.1002/jnr.490260104; JONAKAIT GM, 1990, NEUROPEPTIDES IMMUNO, P222; KAMEGAI M, 1990, BRAIN RES, V532, P323, DOI 10.1016/0006-8993(90)91775-C; KAMEGAI M, 1990, NEURON, V2, P429; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KENGAKU M, 1993, MOL BRAIN RES, V18, P71, DOI 10.1016/0169-328X(93)90174-N; KIEFER R, 1990, NEUROSCIENCE, V37, P725, DOI 10.1016/0306-4522(90)90103-B; KNUSEL B, 1990, J NEUROSCI, V10, P558; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P9621; LARSSON J, 1989, NEUROSCI LETT, V100, P326, DOI 10.1016/0304-3940(89)90707-6; LEVEY AI, 1983, NEUROSCIENCE, V9, P9, DOI 10.1016/0306-4522(83)90042-8; LJUNGDAHL A, 1989, J NEUROSCI RES, V24, P451, DOI 10.1002/jnr.490240316; MARTINEZ HJ, 1987, BRAIN RES, V412, P295, DOI 10.1016/0006-8993(87)91136-X; MARTINEZ HJ, 1985, P NATL ACAD SCI USA, V82, P7777, DOI 10.1073/pnas.82.22.7777; MARTINEZ HJ, 1992, J NEUROBIOL, V23, P252; MAUTNER HG, 1981, P NATL ACAD SCI-BIOL, V78, P7449, DOI 10.1073/pnas.78.12.7449; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; ODA Y, 1992, MOL BRAIN RES, V16, P287, DOI 10.1016/0169-328X(92)90237-6; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; PLIOPLYS AV, 1988, J NEUROL SCI, V85, P209, DOI 10.1016/0022-510X(88)90157-8; RUBIN BY, 1980, P NATL ACAD SCI-BIOL, V77, P5928, DOI 10.1073/pnas.77.10.5928; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SANETO RP, 1986, P NATL ACAD SCI USA, V83, P9221, DOI 10.1073/pnas.83.23.9221; SATOH J, 1991, J NEUROSCI RES, V29, P1, DOI 10.1002/jnr.490290102; SATOH JI, 1991, J NEUROPATH EXP NEUR, V50, P215, DOI 10.1097/00005072-199105000-00004; SCARBOROUGH DE, 1989, ENDOCRINOLOGY, V124, P549, DOI 10.1210/endo-124-1-549; SCHMIDT B, 1990, BRAIN RES, V515, P347, DOI 10.1016/0006-8993(90)90621-H; SCHNEIDERSCHAULIES J, 1991, NEURON, V7, P995, DOI 10.1016/0896-6273(91)90344-Y; SHIMOJO M, 1991, NEUROSCI LETT, V123, P229, DOI 10.1016/0304-3940(91)90937-O; STEINIGER B, 1988, J NEUROIMMUNOL, V19, P111, DOI 10.1016/0165-5728(88)90040-9; STORCH E, 1985, ANTIVIR RES, V5, P117, DOI 10.1016/0166-3542(85)90038-5; TEDESCHI B, 1986, J CELL BIOL, V102, P2244, DOI 10.1083/jcb.102.6.2244; TIRONE F, 1989, P NATL ACAD SCI USA, V86, P2088, DOI 10.1073/pnas.86.6.2088; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YONG VW, 1991, P NATL ACAD SCI USA, V88, P7016, DOI 10.1073/pnas.88.16.7016; YOSHIDA K, 1992, J NEUROCHEM, V59, P919, DOI 10.1111/j.1471-4159.1992.tb08331.x; YOSHIDA K, 1991, BRAIN RES, V538, P118, DOI 10.1016/0006-8993(91)90385-9	84	60	61	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1149	1159						11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185950				2022-12-28	WOS:A1994NM83100018
J	KRISHEK, BJ; XIE, XM; BLACKSTONE, C; HUGANIR, RL; MOSS, SJ; SMART, TG				KRISHEK, BJ; XIE, XM; BLACKSTONE, C; HUGANIR, RL; MOSS, SJ; SMART, TG			REGULATION OF GABA(A) RECEPTOR FUNCTION BY PROTEIN-KINASE-C PHOSPHORYLATION	NEURON			English	Article							AMINOBUTYRIC ACIDA RECEPTOR; GABA-A RECEPTORS; MOLECULAR-BIOLOGY; BETA-SUBUNIT; SYNAPTIC PLASTICITY; GAMMA-2 SUBUNIT; ION CHANNELS; 2 FORMS; EXPRESSION; CELLS	GABA(A) receptors possess consensus sequences for phosphorylation by PKC that are located on the presumed intracellular domains of beta and gamma 2 subunits. PKC phosphorylation sites were analyzed using purified receptor subunits and were located on up to 3 serine residues in beta 1 and gamma 2 subunits. The role of phosphorylation in receptor function was studied using recombinant receptors expressed in kidney cells and Xenopus oocytes and was compared with native neuronal GABA(A) receptors. For recombinant and native GABA(A) receptors, PKC phosphorylation caused a reduction in the amplitudes of GABA-activated currents without affecting the time constants for current decay. Selective site-directed mutagenesis of the serine residues reduced the effects of phorbol esters and revealed that serine 343 in the gamma 2 subunit exerted the largest effect on the GABA-activated response. These results indicate that PKC phosphorylation can differentially modulate GABA(A) receptor function.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; UNIV LONDON UNIV COLL,IRC INST MOLEC CELL BIOL,LONDON WC1E 6BT,ENGLAND	Howard Hughes Medical Institute; Johns Hopkins University; University of London; University College London	KRISHEK, BJ (corresponding author), UNIV LONDON,SCH PHARM,DEPT PHARMACOL,29-39 BRUNSWICK SQ,LONDON WC1N 1AX,ENGLAND.			Xie, Xinmin Simon/0000-0002-4049-6499	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANGELOTTI TP, 1993, J NEUROSCI, V13, P1418; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; BATESON AN, 1991, J NEUROCHEM, V56, P1437, DOI 10.1111/j.1471-4159.1991.tb11443.x; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; BROWNING MD, 1990, P NATL ACAD SCI USA, V87, P1315, DOI 10.1073/pnas.87.4.1315; BURT DR, 1991, FASEB J, V5, P2916, DOI 10.1096/fasebj.5.14.1661244; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; GLENCORSE TA, 1992, EUR J NEUROSCI, V4, P271, DOI 10.1111/j.1460-9568.1992.tb00874.x; GYENES M, 1988, MOL PHARMACOL, V34, P719; HADINGHAM KL, 1992, P NATL ACAD SCI USA, V89, P6378, DOI 10.1073/pnas.89.14.6378; HARLOW E, 1988, ANTIBODIES LABORATOR; HARVEY RJ, 1994, J NEUROCHEM, V62, P10; KAIBUCHI K, 1989, J BIOL CHEM, V264, P13489; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KIRKNESS EF, 1989, BIOCHEM J, V259, P613, DOI 10.1042/bj2590613; KOFUJI P, 1991, J NEUROCHEM, V56, P713, DOI 10.1111/j.1471-4159.1991.tb08209.x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEIDENHEIMER NJ, 1992, MOL PHARMACOL, V41, P1116; LEIDENHEIMER NJ, 1991, TRENDS PHARMACOL SCI, V12, P84, DOI 10.1016/0165-6147(91)90509-Q; MILES K, 1989, NEURON, V2, P1517, DOI 10.1016/0896-6273(89)90198-0; MORAN O, 1989, MOL BRAIN RES, V5, P193, DOI 10.1016/0169-328X(89)90035-1; MOSS SJ, 1992, J BIOL CHEM, V267, P14470; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; MOSS SJ, 1991, NEUROSCI LETT, V123, P265, DOI 10.1016/0304-3940(91)90947-R; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PORTER NM, 1990, NEURON, V5, P789, DOI 10.1016/0896-6273(90)90338-G; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIGEL E, 1993, FEBS LETT, V324, P140, DOI 10.1016/0014-5793(93)81380-I; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; SIGEL E, 1991, FEBS LETT, V291, P150, DOI 10.1016/0014-5793(91)81124-Q; SMART TG, 1986, PROC R SOC SER B-BIO, V227, P191, DOI 10.1098/rspb.1986.0019; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; SMART TG, 1992, J PHYSIOL-LONDON, V447, P587, DOI 10.1113/jphysiol.1992.sp019020; Stelzer A, 1992, Ion Channels, V3, P83; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; SWEETNAM PM, 1988, J NEUROCHEM, V51, P1274, DOI 10.1111/j.1471-4159.1988.tb03097.x; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TICKU MK, 1990, MOL PHARMACOL, V38, P719; WAFFORD KA, 1992, FEBS LETT, V313, P113, DOI 10.1016/0014-5793(92)81424-K; WAFFORD KA, 1991, NEURON, V7, P27, DOI 10.1016/0896-6273(91)90071-7; WANG JB, 1992, J MOL NEUROSCI, V3, P177, DOI 10.1007/BF03380136; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x	47	286	300	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1081	1095		10.1016/0896-6273(94)90316-6	http://dx.doi.org/10.1016/0896-6273(94)90316-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185945	hybrid			2022-12-28	WOS:A1994NM83100012
J	LUSKIN, MB				LUSKIN, MB			RESTRICTED PROLIFERATION AND MIGRATION OF POSTNATALLY GENERATED NEURONS DERIVED FROM THE FOREBRAIN SUBVENTRICULAR ZONE	NEURON			English	Article							RAT OLFACTORY-BULB; FETAL MONKEY NEOCORTEX; RECOMBINANT RETROVIRUS; CEREBRAL-CORTEX; CELL-MIGRATION; GRANULE CELLS; SUBEPENDYMAL LAYER; NERVOUS-SYSTEM; MOUSE; LINEAGE	The subventricular zone of the postnatal forebrain produces mainly glia, although it supports limited neurogenesis. To determine whether the subventricular zone is positionally specified, the phenotype and destination of the progeny of subventricular zone cells along the anterior-posterior axis of the lateral ventricles were analyzed. A retroviral lineage tracer containing the E. coli reporter gene lacZ was injected into different parts of the subventricular zone of neonatal rat pups, and at various times thereafter, the expression of beta-galactosidase was detected histochemically or immunohistochemically in the descendants of infected cells. A discrete region of the anterior part of the subventricular zone (SVZa) generated an immense number of neurons that differentiated into granule cells and periglomerular cells of the olfactory bulb-the two major types of interneurons. Thus, the SVZa appears to constitute a specialized source of neuronal progenitor cells. To reach the olfactory bulb, neurons arising in the SVZa migrate several millimeters along a highly restricted route. Guidance cues must be involved to prohibit widespread dispersion of these migrating neurons.			LUSKIN, MB (corresponding author), EMORY UNIV,SCH MED,DEPT ANAT & CELL BIOL,ATLANTA,GA 30322, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028380] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28380] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKESON RA, 1988, MOL NEUROBIOLOGY OLF, P297; ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BRINON JG, 1992, CELL TISSUE RES, V269, P289, DOI 10.1007/BF00319620; CHUNG WW, 1991, J COMP NEUROL, V314, P290, DOI 10.1002/cne.903140207; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; Getchell TV., 1991, SMELL TASTE HLTH DIS, P19; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; KISHI K, 1990, ARCH HISTOL CYTOL, V53, P219, DOI 10.1679/aohc.53.219; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; Lallier T., 1990, Seminars in Developmental Biology, V1, P35; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LING EA, 1973, J COMP NEUROL, V149, P43, DOI 10.1002/cne.901490104; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; LUSKIN MB, 1992, VISUAL SYSTEM GENESI, P111; LUSKIN MB, 1993, J NIH RES, V5, P60; MARES V, 1978, J COMP NEUROL, V177, P519, DOI 10.1002/cne.901770310; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; PATTERSON JA, 1973, J COMP NEUROL, V149, P83; PINCHING AJ, 1971, J CELL SCI, V9, P305; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PRICE JL, 1970, J CELL SCI, V7, P91; PRIVAT A, 1975, INT REV CYTOL, V40, P281, DOI 10.1016/S0074-7696(08)60955-9; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; SKOFF RP, 1980, PATHOL RES PRACT, V168, P279, DOI 10.1016/S0344-0338(80)80270-6; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; 1970, ANAT REC, V166, P257	49	1507	1560	0	29	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					173	189		10.1016/0896-6273(93)90281-U	http://dx.doi.org/10.1016/0896-6273(93)90281-U			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338665				2022-12-28	WOS:A1993LP43000016
J	Doan, A; Thinakaran, G; Borchelt, DR; Slunt, HH; Ratovitsky, T; Podlisny, M; Selkoe, DJ; Seeger, M; Gandy, SE; Price, DL; Sisodia, SS				Doan, A; Thinakaran, G; Borchelt, DR; Slunt, HH; Ratovitsky, T; Podlisny, M; Selkoe, DJ; Seeger, M; Gandy, SE; Price, DL; Sisodia, SS			Protein topology of presenilin 1	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; MISSENSE MUTATIONS; N-GLYCOSYLATION; GENE; CHROMOSOME-1; CELLS; LOCUS	Mutations in a gene encoding a multitransmembrane protein, termed presenilin 1 (PS1), are causative in the majority of early-onset cases of AD. To determine the topology of PS1, we utilized two strategies: first, we tested whether putative transmembranes are sufficient to export a protease-sensitive substrate across a lipid bilayer; and second, we examined the binding of antibodies to specific PS1 epitopes in cultured cells selectively permeabilized with the pore-forming toxin, streptolysin-O. We document that the ''loop,'' N-terminal, and C-terminal domains of PS1 are oriented toward the cytoplasm.	JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115; CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021	Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Cornell University	Doan, A (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NIA NIH HHS [AG05146, AG11508] Funding Source: Medline; NINDS NIH HHS [NS 20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R55AG011508, R01AG011508] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BHAKDI S, 1993, MED MICROBIOL IMMUN, V182, P167; BORCHELT BR, 1996, IN PRESS NEURON, V17; Busfield Frances, 1995, P59, DOI 10.1016/B978-012286965-5/50006-6; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUOVILA AP, 1992, J CELL BIOL, V188, P1305; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; LEE MK, 1996, IN PRESS J NEUROSCI; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LI X, 1996, IN PRESS NEURON, V17; LO ACY, 1994, J BIOL CHEM, V269, P30966; MCGOVERN K, 1991, EMBO J, V10, P2773, DOI 10.1002/j.1460-2075.1991.tb07826.x; PerezTur J, 1995, NEUROREPORT, V7, P297; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1995, AMYLOID, V2, P188, DOI 10.3109/13506129509036925; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Van Broeckhoven C, 1995, NAT GENET, V11, P230; VANNOSTRAND WE, 1989, NATURE, V341, P546; Wisniewski HM., 1973, PROGR NEUROPATHOLOGY, P1; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154	30	358	368	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1996	17	5					1023	1030		10.1016/S0896-6273(00)80232-9	http://dx.doi.org/10.1016/S0896-6273(00)80232-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV151	8938133	hybrid			2022-12-28	WOS:A1996VV15100023
J	MorenoLopez, B; Escudero, M; DelgadoGarcia, JM; Estrada, C				MorenoLopez, B; Escudero, M; DelgadoGarcia, JM; Estrada, C			Nitric oxide production by brain stem neurons is required for normal performance of eye movements in alert animals	NEURON			English	Article							LONG-TERM POTENTIATION; RELAXING FACTOR; INTERCELLULAR MESSENGER; NADPH DIAPHORASE; ABDUCENS NUCLEUS; PREPOSITUS; CAT; SYNTHASE; RELEASE; LOCALIZATION	Although nitric oxide (NO) is produced by discrete groups of neurons in the brain, participation of NO in premotor structures directly involved in reflexively evoked, sensory-motor functions has not been demonstrated so far. We now show that NO is a physiological mediator in the generation of a specific motor response in alert behaving animals. In the oculomotor system, numerous neurons expressing nitric oxide synthase (NOS) are located in the prepositus hypoglossi, a nucleus involved in the control of horizontal eye movements. Unilateral inhibition of NOS within this nucleus results in severe ocular nystagmus with slow phases directed to the contralateral side. Accordingly, local increases of NO or cyclic GMP produced a nystagmus in the opposite direction. It is concluded that a balanced production of NO by prepositus hypoglossi neurons is a necessary condition for the normal performance of eye movements in alert animals.	UNIV AUTONOMA MADRID,FAC MED,DEPT FISIOL,E-28029 MADRID,SPAIN	Autonomous University of Madrid	MorenoLopez, B (corresponding author), UNIV SEVILLA,LAB NEUROCIENCIA,DEPT FISIOL & BIOL ANIM,FAC BIOL,E-41012 SEVILLE,SPAIN.		Delgado-Garcia, Jose M./V-1567-2019; Moreno-López, Bernardo/S-5148-2019; Escudero, Miguel/E-6335-2010	Moreno-López, Bernardo/0000-0003-2897-6227; Escudero, Miguel/0000-0002-0075-8802				BAKER R, 1975, BRAIN RES, V86, P121, DOI 10.1016/0006-8993(75)90643-5; BAKER RG, 1969, BRAIN RES, V15, P577, DOI 10.1016/0006-8993(69)90189-9; Berman A.L., 1968, BRAIN STEM CAT CYTOA; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Buttner-Ennever J. A., 1988, REV OCULOMOTOR RES, V2; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1382; CHERON G, 1986, J PHYSIOL-LONDON, V372, P95, DOI 10.1113/jphysiol.1986.sp015999; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DELGADOGARCIA JM, 1986, NEUROSCIENCE, V17, P929, DOI 10.1016/0306-4522(86)90072-2; DELGADOGARCIA JM, 1989, NEUROSCIENCE, V29, P291, DOI 10.1016/0306-4522(89)90058-4; ESCUDERO M, 1988, EXP BRAIN RES, V71, P218; ESCUDERO M, 1992, J PHYSIOL-LONDON, V458, P539, DOI 10.1113/jphysiol.1992.sp019433; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; MCCREA RA, 1985, J COMP NEUROL, V237, P377, DOI 10.1002/cne.902370308; NAGAO S, 1991, NEUROREPORT, V2, P193, DOI 10.1097/00001756-199104000-00008; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RAPHAN T, 1985, ADAPTIVE PROCESSES V, P285; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Robinson D.A., 1975, BASIC MECH OCULAR MO, P337; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; RODRIGO J, 1994, PHILOS T R SOC B, V345, P175, DOI 10.1098/rstb.1994.0096; ROSKAMS AJ, 1994, NEURON, V13, P289; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; YOKOTA JI, 1993, CONT OCULAR MOTOR VE, P453	33	44	44	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					739	745		10.1016/S0896-6273(00)80205-6	http://dx.doi.org/10.1016/S0896-6273(00)80205-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893030	Bronze			2022-12-28	WOS:A1996VP74300018
J	Ryan, TA; Ziv, NE; Smith, SJ				Ryan, TA; Ziv, NE; Smith, SJ			Potentiation of evoked vesicle turnover at individually resolved synaptic boutons	NEURON			English	Article							LONG-TERM POTENTIATION; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; GLUTAMATE RELEASE; PERFORANT PATH; HIPPOCAMPUS; PROBABILITY; TRANSMISSION; MECHANISM; AREA	We have studied synaptic plasticity in hippocampal cell cultures using a new imaging approach that allows unambiguous discrimination of presynaptic function at the level of single synaptic boutons. Employing a protocol designed to test for use-dependent plasticity resembling N-methyl-D-aspartate receptor-dependent long-term potentiation (NMDA-type LTP), we find that brief tetanic stimuli induce a potentiation of evoked synaptic vesicle turnover that lasts for at least 1 hr. Induction of this clearly presynaptic potentiation is blocked by putative postsynaptic glutamate receptor antagonists, suggesting that a retrograde induction signal might be involved. Potentiation appears to occur approximately equally at boutons of low and high initial release probabilities, and evidently does not involve an increase in the size of the total recycling synaptic vesicle pool.			Ryan, TA (corresponding author), STANFORD UNIV, BECKMAN CTR, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, STANFORD, CA 94305 USA.		Ziv, Noam/ABA-6551-2020; Ryan, Timothy/AAO-8286-2020	Ziv, Noam/0000-0001-9197-326X; Ryan, Timothy/0000-0003-2533-9548; Smith, Stephen/0000-0002-2290-8701	NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS28587] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; EDWARDS F, 1991, NATURE, V350, P271, DOI 10.1038/350271a0; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1994, SCIENCE, V266, P1195, DOI 10.1126/science.7973700; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Snedecor GW, 1980, STATISTICAL METHODS, P98; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; VALTORTA F, 1988, J CELL BIOL, V107, P2717, DOI 10.1083/jcb.107.6.2717	35	92	92	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1996	17	1					125	134		10.1016/S0896-6273(00)80286-X	http://dx.doi.org/10.1016/S0896-6273(00)80286-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755484	Bronze			2022-12-28	WOS:A1996UY98100013
J	Chiamvimonvat, N; PerezGarcia, MT; Ranjan, R; Marban, E; Tomaselli, GF				Chiamvimonvat, N; PerezGarcia, MT; Ranjan, R; Marban, E; Tomaselli, GF			Depth asymmetries of the pore-lining segments of the Na+ channel revealed by cysteine mutagenesis	NEURON			English	Article							SODIUM-CHANNELS; ACETYLCHOLINE-RECEPTOR; MUTATIONS; SITE; PERMEABILITY; EXPRESSION; PERMEATION; CELLS; NERVE	We used serial cysteine mutagenesis to study the structure of the outer vestibule and selectivity region of the voltage-gated Na+ channel. The voltage dependence of Cd2+ block enabled us to determine the locations within the electrical field of cysteine-substituted mutants in the P segments of all four domains. The fractional electrical distances of the substituted cysteines were compared with the differential sensitivity to modification by sulfhydryl-specific modifying reagents. These experiments indicate that the P segment of domain II is external, while the domain IV P segment is displaced internally, compared with the first and third domain P segments. Sulfhydryls with a steep voltage dependence for Cd2+ block produced changes in monovalent cation selectivity; these included substitutions at the presumed selectivity filter, as well as residues in the domain IV P segment not previously recognized as determinants of selectivity. A new structural model is presented in which each of the P segments contribute unique loops that penetrate the membrane to varying depths to form the channel pore.	JOHNS HOPKINS UNIV, SCH MED, DEPT BIOMED ENGN, BALTIMORE, MD 21205 USA	Johns Hopkins University	Chiamvimonvat, N (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT MED, SECT MOL & CELLULAR CARDIOL, BALTIMORE, MD 21205 USA.		Marban, Eduardo/GWC-8514-2022; Perez-Garcia, M. Teresa/F-5173-2015	Perez-Garcia, M. Teresa/0000-0001-8540-8117	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050411, P50HL052307] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL52307, R01 HL50411] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Chiamvimonvat N, 1996, J PHYSIOL-LONDON, V491, P51, DOI 10.1113/jphysiol.1996.sp021195; COLQUHOUN D, 1983, FITTING STAT ANAL SI, P191; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; GUY HR, 1995, SOC GEN PHY, V50, P1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; Hille B, 1992, IONIC CHANNELS EXCIT, P341; HOLLOWAY SF, 1989, PFLUG ARCH EUR J PHY, V414, P613, DOI 10.1007/BF00582125; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KREIG PA, 1984, NUCLEIC ACIDS RES, V12, P7057; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; PUSCH M, 1991, EUR BIOPHYS J, V20, P127, DOI 10.1007/BF01561134; Sather William A., 1994, Current Opinion in Neurobiology, V4, P313, DOI 10.1016/0959-4388(94)90091-4; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHETZ JA, 1993, BIOL BULL, V185, P462, DOI 10.2307/1542486; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; TOMASELLI GF, 1993, CIRC RES, V72, P491, DOI 10.1161/01.RES.72.3.491; TOMASELLI GF, 1995, BIOPHYS J, V68, P1814, DOI 10.1016/S0006-3495(95)80358-9; TRIMMER JS, 1989, NEURON, V3, P38; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0	36	93	97	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	1996	16	5					1037	1047		10.1016/S0896-6273(00)80127-0	http://dx.doi.org/10.1016/S0896-6273(00)80127-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630242	hybrid			2022-12-28	WOS:A1996UN48000019
J	Yang, NB; George, AL; Horn, R				Yang, NB; George, AL; Horn, R			Molecular basis of charge movement in voltage-gated sodium channels	NEURON			English	Article							SHAKER K+-CHANNELS; GATING CHARGE; POTASSIUM CHANNELS; S4 REGION; S4-SEQUENCE; MUTATIONS; RESIDUES; IMPORT	Voltage-dependent movement of a sodium channel S4 segment was examined by cysteine scanning mutagenesis and testing accessibility of the residues to hydrophilic cysteine-modifying reagents. These experiments indicate that 2 charged S4 residues move completely from an internally accessible to an externally accessible location in response to depolarization by passage through a short ''channel'' in the protein. The energetic problems of S4 movement have thus been solved in the same way that many ion channels achieve highly selective and rapid ion permeation through an open pore, by restricting the contact region between the permion and its channel.	VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,DEPT MED,NASHVILLE,TN 37232	Vanderbilt University	Yang, NB (corresponding author), JEFFERSON MED COLL,DEPT PHYSIOL,PHILADELPHIA,PA 19107, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032387, R37NS032387] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41691] Funding Source: Medline; NINDS NIH HHS [NS32387] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRONG CM, 1992, PHYSIOL REV, V72, pS5, DOI 10.1152/physrev.1992.72.suppl_4.S5; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Chahine M, 1995, RECEPTOR CHANNEL, V3, P161; CHAHINE M, 1994, PFLUG ARCH EUR J PHY, V427, P136, DOI 10.1007/BF00585952; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FELIG A, 1994, PFLUGERS ARCH, V427, P406; FRENCH RJ, 1996, IN PRESS NEURON; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Higuchi R., 1989, PCR TECHNOLOGY, P61; HIRSCHBERG B, 1995, IN PRESS J GEN PHYSL; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1993, NEURON, V10, P1121, DOI 10.1016/0896-6273(93)90060-5; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MADUKE M, 1993, SCIENCE, V260, P364, DOI 10.1126/science.8385804; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; MERRILL AR, 1990, BIOCHEMISTRY-US, V29, P8529, DOI 10.1021/bi00489a004; MILLER C, 1982, TRANSPORT BIOL MEMBR, P99; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1993, Q REV BIOPHYS, V27, P1; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TOSTESON MT, 1990, BIOPHYS J, V58, P1367, DOI 10.1016/S0006-3495(90)82483-8; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; ZIZI M, 1995, J MEMBRANE BIOL, V144, P121	40	497	512	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					113	122		10.1016/S0896-6273(00)80028-8	http://dx.doi.org/10.1016/S0896-6273(00)80028-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562074	Bronze			2022-12-28	WOS:A1996TT30700014
J	BESSHO, Y; NAWA, H; NAKANISHI, S				BESSHO, Y; NAWA, H; NAKANISHI, S			SELECTIVE UP-REGULATION OF AN NMDA RECEPTOR SUBUNIT MESSENGER-RNA IN CULTURED CEREBELLAR GRANULE CELLS BY K+-INDUCED DEPOLARIZATION AND NMDA TREATMENT	NEURON			English	Article							GLUTAMATE RECEPTORS; MOLECULAR DIVERSITY; EXPRESSION; DISTINCTION; SURVIVAL; SUBTYPES; NEURONS; BRAIN	High KCl or NMDA treatment promotes the survival of cultured neonatal cerebellar granule cells, and these cells become sensitive to NMDA toxicity after prolonged K+ depolarization. Following both treatments, the NMDA receptor increases, as assessed by fura-2 fluorescence analysis of NMDA receptor-mediated intracellular Ca2+ increase. Northern analysis indicates that both treatments specifically up-regulate NMDAR2A subunit mRNA through an increase in resting intracellular Ca2+ concentration. Antisense oligonucleotide analysis further indicates that NMDAR2A mRNA up-regulation is responsible for NMDA receptor induction. Our results demonstrate that regulation of a specific NMDA receptor subunit mRNA governs NMDA receptor induction, which is thought to play an important role in granule cell survival and death.	COLD SPRING HARBOR LAB,BECKMAN NEUROSCI CTR,COLD SPRING HARBOR,NY 11724	Cold Spring Harbor Laboratory	BESSHO, Y (corresponding author), KYOTO UNIV,FAC MED,DEPT IMMUNOL,KYOTO 606,JAPAN.							BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; BALAZS R, 1992, NEUROSCI LETT, V137, P109, DOI 10.1016/0304-3940(92)90310-4; BESSHO Y, 1993, J NEUROCHEM, V60, P253, DOI 10.1111/j.1471-4159.1993.tb05845.x; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COX JA, 1990, NEURON, V4, P941, DOI 10.1016/0896-6273(90)90147-8; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLO V, 1987, J NEUROSCI, V7, P2203; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harlow E, 1988, ANTIBODIES LABORATOR, P471; ISHII T, 1993, J BIOL CHEM, V268, P2836; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NARAHASHI T, 1974, PHYSIOL REV, V54, P813, DOI 10.1152/physrev.1974.54.4.813; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; VANDERVALK JBF, 1991, EUR J PHARMACOL, V201, P247; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A	28	164	165	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					87	95		10.1016/0896-6273(94)90154-6	http://dx.doi.org/10.1016/0896-6273(94)90154-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292362				2022-12-28	WOS:A1994MU49300008
J	KUHSE, J; LAUBE, B; MAGALEI, D; BETZ, H				KUHSE, J; LAUBE, B; MAGALEI, D; BETZ, H			ASSEMBLY OF THE INHIBITORY GLYCINE RECEPTOR - IDENTIFICATION OF AMINO-ACID-SEQUENCE MOTIFS GOVERNING SUBUNIT STOICHIOMETRY	NEURON			English	Article							MUSCLE ACETYLCHOLINE-RECEPTOR; GATED ION CHANNELS; FUNCTIONAL EXPRESSION; EPSILON SUBUNIT; XENOPUS OOCYTES; ALPHA-SUBUNITS; BETA-SUBUNIT; COS CELLS; LIGAND; BRAIN	The inhibitory glycine receptor (GlyR) is a pentameric protein composed of two types (alpha and beta) of membrane-spanning subunits. Coexpression in Xenopus oocytes of a low affinity mutant of the alpha2 subunit with the alpha1 and beta subunits indicated that GlyRs assembled from alpha1 and alpha2 polypeptides contain variable subunit ratios, whereas alpha/beta hetero-oligomers have an invariant (3:2) stoichiometry. Analysis of different alpha/beta chimeric constructs revealed that this difference in assembly behavior is mediated by the N-terminal extracellular regions of the receptor subunits. Substitution of residues diverging between the alpha and beta subunits identified combinations of sequence motifs determining subunit stoichiometry.			KUHSE, J (corresponding author), MAX PLANCK INST BRAIN RES,DEPT NEUROCHEM,DEUTSCHORDENSTR 46,D-60528 FRANKFURT,GERMANY.		Kuhse, Jochen/T-3864-2019					AKAGI H, 1991, FEBS LETT, V281, P160, DOI 10.1016/0014-5793(91)80383-E; AKAGI H, 1992, NEUROSCI RES, V11, P28; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; CHAVEZ RA, 1992, J BIOL CHEM, V267, P23028; GALZI JL, 1991, P NATL ACAD SCI USA, V88, P5051, DOI 10.1073/pnas.88.11.5051; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; GU Y, 1991, NEURON, V6, P879, DOI 10.1016/0896-6273(91)90228-R; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; Hall Z W, 1992, Trends Cell Biol, V2, P66, DOI 10.1016/0962-8924(92)90058-U; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUHSE J, 1991, FEBS LETT, V283, P73, DOI 10.1016/0014-5793(91)80557-J; KUHSE J, 1990, J BIOL CHEM, V265, P22317; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; MERLIE JP, 1984, CELL, V36, P573, DOI 10.1016/0092-8674(84)90335-0; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; SUMIKAWA K, 1992, MOL BRAIN RES, V13, P349, DOI 10.1016/0169-328X(92)90218-Z; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1764; VERALL S, 1992, CELL, V68, P23; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; Wisden W, 1992, Curr Opin Neurobiol, V2, P263, DOI 10.1016/0959-4388(92)90113-Y; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0	35	155	157	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1049	1056		10.1016/0896-6273(93)90218-G	http://dx.doi.org/10.1016/0896-6273(93)90218-G			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274276				2022-12-28	WOS:A1993MP54800006
J	KANIA, A; HAN, PL; KIM, YT; BELLEN, H				KANIA, A; HAN, PL; KIM, YT; BELLEN, H			NEUROMUSCULIN, A DROSOPHILA GENE EXPRESSED IN PERIPHERAL NEURONAL PRECURSORS AND MUSCLES, ENCODES A CELL-ADHESION MOLECULE	NEURON			English	Article							GROWTH CONE GUIDANCE; MEDIATED ENHANCER DETECTION; CENTRAL-NERVOUS-SYSTEM; IMMUNOGLOBULIN SUPERFAMILY; EXTRACELLULAR-MATRIX; PRIMARY MOTONEURONS; SEX DETERMINATION; FASCICLIN-III; ACHAETE; SEQUENCE	To unravel the molecular mechanisms of peripheral nervous system differentiation in Drosophila, we have screened for and identified genes that are expressed in sensory mother cells. Here, we describe a novel gene, neuromusculin (nrm), that is expressed in sensory mother cells and developing muscles. nrm encodes a member of the immunoglobulin superfamily. Immunoblots of Schneider 2 cells transfected with an nrm cDNA indicate that Nrm is present in a membrane-associated form and a secreted form. Cell aggregation assays suggest that Nrm is a homophilic cell adhesion molecule that is secreted or released after proteolysis, a mechanism that to our knowledge has not been described for immunoglobulin-like molecules. Genetic analyses indicate that nrm is an essential gene required for larval viability. We propose that Nrm may play a role as a cell adhesion molecule in clustering cells of the peripheral nervous system, neuronal fasciculation, and/or pathfinding.			KANIA, A (corresponding author), BAYLOR COLL MED, HOWARD HUGHES MED INST, INST MOLEC GENET, DIV NEUROSCI, HOUSTON, TX 77030 USA.			Kania, Artur/0000-0002-5209-2520; Han, Pyung-Lim/0000-0002-1735-6746; Bellen, Hugo/0000-0001-5992-5989				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASHBURNER M, 1989, DROSOPHILA LABORATOR; BALL EE, 1985, J NEUROSCI, V5, P1808; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Bieber A.J., 1991, Seminars in the Neurosciences, V3, P309, DOI 10.1016/1044-5765(91)90048-S; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BRAND M, 1988, ROUX ARCH DEV BIOL, V197, P457, DOI 10.1007/BF00385679; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CAUDY M, 1986, J NEUROSCI, V6, P1781; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CAUDY M, 1988, GENE DEV, V2, P843, DOI 10.1101/gad.2.7.843; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHIBA A, 1993, J NEUROSCI, V13, P714; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FESSLER JH, 1989, ANNU REV CELL BIOL, V5, P309, DOI 10.1146/annurev.cb.05.110189.001521; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GHYSEN A, 1989, DEVELOPMENT, V105, P35; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; GUAN C, 1988, GENE, V67, P21; HALPERN ME, 1991, J NEUROSCI, V11, P3227; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HORTSCH M, 1991, ANNU REV CELL BIOL, V7, P505, DOI 10.1146/annurev.cb.07.110191.002445; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; JACOBS JR, 1989, J NEUROSCI, V9, P2412; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JOHANSEN J, 1989, J NEUROSCI, V9, P710; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; KEITH FJ, 1990, EMBO J, V9, P4299, DOI 10.1002/j.1460-2075.1990.tb07878.x; KELLERMANN OK, 1982, METHOD ENZYMOL, V90, P459; KEYNES RJ, 1991, DEVELOPMENT, P131; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PIKE SH, 1990, J NEUROSCI, V10, P44; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Purves, 1985, PRINCIPLES NEURAL DE; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; ROEBROEK AJM, 1992, J BIOL CHEM, V267, P17208; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Sambrook J, 1989, MOL CLONING LABORATO; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; SINK H, 1991, DEVELOPMENT, V112, P307; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301	68	42	42	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1993	11	4					673	687		10.1016/0896-6273(93)90078-6	http://dx.doi.org/10.1016/0896-6273(93)90078-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398154				2022-12-28	WOS:A1993MD06800011
J	SLESINGER, PA; JAN, YN; JAN, LY				SLESINGER, PA; JAN, YN; JAN, LY			THE S4-S5 LOOP CONTRIBUTES TO THE ION-SELECTIVE PORE OF POTASSIUM CHANNELS	NEURON			English	Article							ACTIVATED K+ CHANNELS; TEA BLOCKADE; S4 REGION; TETRAETHYLAMMONIUM; MUTATIONS; CELLS; CHARYBDOTOXIN; INACTIVATION; MECHANISMS; CONDUCTION	Mutagenesis experiments on voltage-gated K+ channels have suggested that the ion-selective pore is comprised mostly of H5 segments. To see whether regions outside of the H5 segment might also contribute to the pore structure, we have studied the effect of single amino acid substitutions in the segment that connects the S4 and S5 putative transmembrane segments (S4-S5 loop) on various permeation properties of Shaker K+ channels. Mutations in the S4-S5 loop alter the Rb+ selectivity, the single-channel K+ and Rb+ conductances, and the sensitivity to open channel block produced by intracellular tetraethylammonium ion, Ba2+, and Mg2+. The block of Shaker K+ channels by intracellular Mg2+ is surprising, but is reminiscent of the internal Mg2+ blockade of inward rectifier K+ channels. The results suggest that the S4-S5 loop constitutes part of the ion-selective pore. Thus, the S4-S5 loop and the H5 segment are likely to contribute to the long pore characteristic of voltage-gated K+ channels.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT BIOCHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	SLESINGER, PA (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				ARMSTRONG CM, 1982, J GEN PHYSIOL, V80, P663, DOI 10.1085/jgp.80.5.663; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; EISENMAN G, 1962, BIOPHYS J S, V2, P258; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KIRSCH GE, 1992, BIOPHYS J, V62, P136, DOI 10.1016/S0006-3495(92)81800-3; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MacKinnon R, 1991, Curr Opin Neurobiol, V1, P14, DOI 10.1016/0959-4388(91)90005-R; MATSUDA H, 1988, J PHYSIOL-LONDON, V397, P237, DOI 10.1113/jphysiol.1988.sp016998; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; Miller Christopher, 1992, Current Biology, V2, P573, DOI 10.1016/0960-9822(92)90146-2; NEWLAND CF, 1992, NEURON, V8, P975, DOI 10.1016/0896-6273(92)90212-V; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; RICHARDS JH, 1991, DIRECTED MUTAGENESIS; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIESS MS, 1991, SCIENCE, V254, P1627; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1984, J GEN PHYSIOL, V84, P157, DOI 10.1085/jgp.84.2.157; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; Zar JH., 1999, BIOSTAT ANAL	40	117	117	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					739	749		10.1016/0896-6273(93)90083-4	http://dx.doi.org/10.1016/0896-6273(93)90083-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398157				2022-12-28	WOS:A1993MD06800016
J	SIMON, H; LUMSDEN, A				SIMON, H; LUMSDEN, A			RHOMBOMERE-SPECIFIC ORIGIN OF THE CONTRALATERAL VESTIBULO-ACOUSTIC EFFERENT NEURONS AND THEIR MIGRATION ACROSS THE EMBRYONIC MIDLINE	NEURON			English	Article							CHICK-EMBRYO; HORSERADISH-PEROXIDASE; INNER-EAR; CENTRAL ORGANIZATION; NEURAL CREST; HINDBRAIN; SEGMENTATION; NEUROBLASTS; EXPRESSION; MORPHOLOGY	The bilateral efferent supply to the inner ear receptor fields is located in the hindbrain. In ovo injections of DiI into the common facial/vestibulo-acoustic nerve root at 3 days of chick development (stage 16) followed by analysis at 7 days has revealed the origin of the contralateral efferent neurons of the inner ear and their relation to the transient hindbrain rhombomeres. These neurons have a rhombomere 4-specific origin and form their commissure not by axonal outgrowth but, unusually, by transmedian cell migration into the contralateral rhombomere 4 and rhombomere 5. Neurons first project their axons from the ipsilateral basal plate through the VII/VIIIth nerve exit point and then migrate in the opposite direction, crossing the floor plate at stage 19-21. This rhombomere-specific cell behavior provides evidence at the cellular level that segmentation is intimately involved in establishing the pattern of this region of the CNS.			SIMON, H (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DIV ANAT & CELL BIOL,MRC,LONDON SE1 9RT,ENGLAND.		Lumsden, Andrew/C-5146-2009					ADDENS J. L., 1933, ZEITSCHR GES ANAT ABT I ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V101, P307, DOI 10.1007/BF02118182; ADDENS JL, 1934, PSYCHIATR NEUROL BLA, V3, P1; ALTSCHULER RA, 1985, BRAIN RES, V338, P1, DOI 10.1016/0006-8993(85)90242-2; ARIENSKAPPERS CU, 1921, BRAIN, V44, P125; BONE Q, 1960, J COMP NEUROL, V115, P27, DOI 10.1002/cne.901150105; BONE Q, 1964, INT REV NEUROBIOL, V6, P99, DOI 10.1016/S0074-7742(08)60768-0; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; CASAGRANDE VA, 1990, NEURAL BASES VISUAL, P41; DESMEDT JE, 1961, NATURE, V192, P1263, DOI 10.1038/1921263a0; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; FRITZSCH B, 1984, NEUROSCI LETT, V46, P131, DOI 10.1016/0304-3940(84)90430-0; FRITZSCH B, 1981, NEUROSCI LETT, V26, P191, DOI 10.1016/0304-3940(81)90131-2; FRITZSCH B, 1989, NEUROSCI LETT, V96, P241, DOI 10.1016/0304-3940(89)90385-6; FUCHS PA, 1992, J NEUROSCI, V12, P800; GARCIABELLIDO A, 1979, SCI AM, V241, P102, DOI 10.1038/scientificamerican0779-102; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; GUTHRIE S, 1992, DEVELOPMENT, V114, P663; GUTHRIE S, IN PRESS DEVELOPMENT; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HAMBURGER V, 1951, J MORPHOL, V88, P29; HARKMARK W, 1954, J COMP NEUROL, V100, P115, DOI 10.1002/cne.901000107; HEATON MB, 1980, J COMP NEUROL, V189, P61, DOI 10.1002/cne.901890105; HONIG MG, 1986, J CELL BIOL, V106, P181; HUNT P, 1991, DEVELOPMENT, V112, P43; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; LEVIMONTALCINI R, 1950, J MORPHOL, V86, P253, DOI 10.1002/jmor.1050860203; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MEREDITH GE, 1986, NEUROSCIENCE, V17, P225, DOI 10.1016/0306-4522(86)90238-1; MEREDITH GE, 1988, ACTA BIOL HUNG, V39, P229; MURPHY P, 1991, DEVELOPMENT, V111, P61; Neal HV, 1918, J MORPHOL, V31, P293, DOI 10.1002/jmor.1050310203; PELLEGRINI M, 1985, BRAIN RES, V344, P1, DOI 10.1016/0006-8993(85)91183-7; PUELLES L, 1978, ANAT EMBRYOL, V152, P205, DOI 10.1007/BF00315925; PUELLES L, 1977, ANAT EMBRYOL, V150, P187, DOI 10.1007/BF00316650; RASMUSSEN GL, 1946, J COMP NEUROL, V84, P141, DOI 10.1002/cne.900840204; ROSSI G, 1965, LARYNGOSCOPE, V75, P212; SIMON DK, 1992, J NEUROSCI, V12, P1212; STRUTZ J, 1982, BRAIN RES, V244, P165, DOI 10.1016/0006-8993(82)90914-3; STRUTZ J, 1982, ACTA OTO-LARYNGOL, V94, P45, DOI 10.3109/00016488209128888; TAN K, 1991, ANAT EMBRYOL, V183, P321; Vaage S., 1969, ERG ANAT ENTWICKLU, V41, P1; WARR WB, 1975, J COMP NEUROL, V161, P159, DOI 10.1002/cne.901610203; WILKINSON DG, 1990, TRENDS NEUROSCI, V13, P335, DOI 10.1016/0166-2236(90)90145-Z; WILKINSON DG, 1989, NATURE, V287, P795	48	97	97	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					209	220		10.1016/0896-6273(93)90179-U	http://dx.doi.org/10.1016/0896-6273(93)90179-U			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394719				2022-12-28	WOS:A1993LU06500003
J	MAIMONE, MM; MERLIE, JP				MAIMONE, MM; MERLIE, JP			INTERACTION OF THE 43 KD POSTSYNAPTIC PROTEIN WITH ALL SUBUNITS OF THE MUSCLE NICOTINIC ACETYLCHOLINE-RECEPTOR	NEURON			English	Article							REGULATABLE GLUCOSE TRANSPORTER; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; TORPEDO-MARMORATA; 43-KDA PROTEIN; ALPHA-SUBUNIT; NEUROMUSCULAR-JUNCTIONS; FUNCTIONAL EXPRESSION; MUTATIONAL ANALYSIS; ALKALINE TREATMENT	The 43 kd postsynaptic protein (43K) plays a key role in the aggregation of muscle nicotinic acetylcholine receptors (AChRs) in the postsynaptic membrane of the neuromuscular junction. By transiently coexpressing 43K and a single AChR subunit (alpha, beta, gamma, or delta) in the quail fibroblast cell line, QT-6, we show that 43K interacts with each subunit to form cell surface clusters in which 43K and receptor subunit are precisely colocalized. Although the level of cell surface expression of single subunits is much lower than that of fully assembled receptor, the clustering of both single subunits and fully assembled AChR occurs efficiently. In addition, 43K-induced clustering is specific for AChR subunits. From these results, we conclude that each pentameric AChR has five potential sites for interacting with 43K during cluster formation.			MAIMONE, MM (corresponding author), WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110, USA.							ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BARRANTES FJ, 1980, FEBS LETT, V112, P73, DOI 10.1016/0014-5793(80)80131-1; BLOCH RJ, 1987, J CELL BIOL, V104, P645, DOI 10.1083/jcb.104.3.645; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BLOUNT P, 1991, CURR TOP MEMBR, V39, P277; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BRENNAN C, 1992, DEV BIOL, V149, P100, DOI 10.1016/0012-1606(92)90267-K; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; BURDEN SJ, 1985, P NATL ACAD SCI USA, V82, P8270, DOI 10.1073/pnas.82.23.8270; CARTAUD J, 1981, J CELL BIOL, V90, P418, DOI 10.1083/jcb.90.2.418; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLAUDIO T, 1989, FRONTIERS MOL BIOL M, P63; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GU Y, 1991, NEURON, V6, P879, DOI 10.1016/0896-6273(91)90228-R; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KLAUSNER R D, 1989, New Biologist, V1, P3; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KORDELI E, 1989, J CELL BIOL, V108, P127, DOI 10.1083/jcb.108.1.127; KUROSAKI T, 1987, FEBS LETT, V214, P253, DOI 10.1016/0014-5793(87)80065-0; LAROCHELLE WJ, 1987, J BIOL CHEM, V262, P8190; LAROCHELLE WJ, 1989, DEV BIOL, V132, P130, DOI 10.1016/0012-1606(89)90211-X; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; LAROCHELLE WJ, 1990, J NEUROSCI, V10, P3460; LO MMS, 1980, FEBS LETT, V111, P407, DOI 10.1016/0014-5793(80)80838-6; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MERLIE JP, 1981, J BIOL CHEM, V256, P3605; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PENG HB, 1985, J CELL BIOL, V100, P1698, DOI 10.1083/jcb.100.5.1698; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; PHILLIPS WD, 1992, BIOESSAYS, V14, P671, DOI 10.1002/bies.950141005; PIPER RC, 1992, J CELL BIOL, V117, P729, DOI 10.1083/jcb.117.4.729; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2621, DOI 10.1021/bi00357a051; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROSS AF, 1991, J CELL BIOL, V113, P623, DOI 10.1083/jcb.113.3.623; ROUSSELET A, 1982, EMBO J, V1, P439, DOI 10.1002/j.1460-2075.1982.tb01188.x; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SARGENT PB, 1984, J CELL BIOL, V98, P609, DOI 10.1083/jcb.98.2.609; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; SMITH MM, 1987, J BIOL CHEM, V262, P4367; SUMIKAWA K, 1989, MOL BRAIN RES, V5, P183, DOI 10.1016/0169-328X(89)90034-X; TZARTOS S, 1986, J NEUROIMMUNOL, V10, P235, DOI 10.1016/0165-5728(86)90105-0; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0	69	90	91	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					53	66		10.1016/0896-6273(93)90270-2	http://dx.doi.org/10.1016/0896-6273(93)90270-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338668				2022-12-28	WOS:A1993LP43000005
J	OHARA, PJ; SHEPPARD, PO; THOGERSEN, H; VENEZIA, D; HALDEMAN, BA; MCGRANE, V; HOUAMED, KM; THOMSEN, C; GILBERT, TL; MULVIHILL, ER				OHARA, PJ; SHEPPARD, PO; THOGERSEN, H; VENEZIA, D; HALDEMAN, BA; MCGRANE, V; HOUAMED, KM; THOMSEN, C; GILBERT, TL; MULVIHILL, ER			THE LIGAND-BINDING DOMAIN IN METABOTROPIC GLUTAMATE RECEPTORS IS RELATED TO BACTERIAL PERIPLASMIC BINDING-PROTEINS	NEURON			English	Article							COMPLETE NUCLEOTIDE-SEQUENCES; AMINO-ACID-TRANSPORT; SALMONELLA-TYPHIMURIUM; MOLECULAR-CLONING; NMDA RECEPTOR; FUNCTIONAL EXPRESSION; L-ARABINOSE; GUANYLATE-CYCLASE; ACTIVE-TRANSPORT; LEUCINE-BINDING	Receptors for the major excitatory neurotransmitter glutamate include metabotropic (G protein-coupled) and ionotropic (glutamate-gated ion channel) types. These receptors have large, presumably extracellular, amino-terminal domains. Sensitive sequence analysis techniques indicate that the metabotropic receptor extracellular domain is similar to bacterial periplasmic amino acid binding proteins. A structural model built using the observed similarity predicts a ligand-binding site, and mutants with conservative amino acid substitutions at this site are shown to have reduced ligand affinity. The metabotropic receptor extracellular domain is a member of a family of structural domains linked to a variety of receptor types, including ionotropic glutamate receptors.	NOVO NORDISK,DK-2760 MALOV,DENMARK		OHARA, PJ (corresponding author), ZYMOGENET INC,4225 ROOSEVELT WAY NE,SEATTLE,WA 98105, USA.							AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; ABE T, 1992, J BIOL CHEM, V267, P13361; ADAMS MD, 1989, J BIOL CHEM, V264, P15739; AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2019, DOI 10.1093/nar/20.suppl.2019; BAKER EN, 1992, J INORG BIOCHEM, V47, P147, DOI 10.1016/0162-0134(92)84061-Q; BARNES JM, 1992, PROG NEUROBIOL, V39, P113, DOI 10.1016/0301-0082(92)90007-2; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; BILOFSKY HS, 1986, NUCLEIC ACIDS RES, V14, P1, DOI 10.1093/nar/14.1.1; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; CONNOLLY ML, 1992, BIOPOLYMERS, V32, P1215, DOI 10.1002/bip.360320911; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GEORGE DG, 1986, NUCLEIC ACIDS RES, V14, P11, DOI 10.1093/nar/14.1.11; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; HAMM GH, 1986, NUCLEIC ACIDS RES, V14, P5, DOI 10.1093/nar/14.1.5; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIGGINS CF, 1981, P NATL ACAD SCI-BIOL, V78, P6038, DOI 10.1073/pnas.78.10.6038; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOSHINO T, 1989, J BACTERIOL, V171, P6300, DOI 10.1128/jb.171.11.6300-6306.1989; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; JOHANNESSEN M, 1990, THROMB HAEMOSTASIS, V63, P54; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; KANG CH, 1991, J BIOL CHEM, V266, P23893; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LANDICK R, 1985, J BIOL CHEM, V260, P8257; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOWBRAY SL, 1983, J BIOL CHEM, V258, P7991; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437; OH BH, 1993, IN PRESS J BIOL CHEM; OHNISHI K, 1990, J BIOCHEM-TOKYO, V107, P202, DOI 10.1093/oxfordjournals.jbchem.a123026; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PFLUGRATH JW, 1988, J MOL BIOL, V200, P163, DOI 10.1016/0022-2836(88)90341-5; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RECASENS M, 1992, MOL NEUROPHARMACOL, V2, P15; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SAKIMURA K, 1992, NEURON, V8, P267, DOI 10.1016/0896-6273(92)90293-M; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOLLE A, 1987, MOL GEN GENET, V208, P247, DOI 10.1007/BF00330450; SCHULZ S, 1991, TRENDS PHARMACOL SCI, V12, P116, DOI 10.1016/0165-6147(91)90519-X; SCRIPTURE JB, 1987, J MOL BIOL, V197, P37, DOI 10.1016/0022-2836(87)90607-3; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STODDARD BL, 1992, NATURE, V358, P774, DOI 10.1038/358774a0; SUN W, 1992, P NATL ACAD SCI USA, V89, P1443, DOI 10.1073/pnas.89.4.1443; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; THORPE DS, 1989, J BIOL CHEM, V264, P6545; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VYAS NK, 1991, J BIOL CHEM, V266, P5226; VYAS NK, 1987, NATURE, V327, P635, DOI 10.1038/327635a0; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4	84	603	620	2	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					41	52		10.1016/0896-6273(93)90269-W	http://dx.doi.org/10.1016/0896-6273(93)90269-W			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338667				2022-12-28	WOS:A1993LP43000004
J	MORISHIMAKAWASHIMA, M; HASEGAWA, M; TAKIO, K; SUZUKI, M; TITANI, K; IHARA, Y				MORISHIMAKAWASHIMA, M; HASEGAWA, M; TAKIO, K; SUZUKI, M; TITANI, K; IHARA, Y			UBIQUITIN IS CONJUGATED WITH AMINO-TERMINALLY PROCESSED TAU IN PAIRED HELICAL FILAMENTS	NEURON			English	Article							ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; PROTEIN-TAU; MALLORY BODIES; MULTICATALYTIC PROTEINASE; MULTIUBIQUITIN CHAIN; LEWY BODIES; HUMAN-BRAIN; LOCALIZATION; DEGRADATION	We have investigated ubiquitinated paired helical filaments, which produce a proteinaceous smear in SDS-polyacrylamide gel electrophoresis and immunoblotting. The smear consisted largely of the carboxy-terminal portion of tau and ubiquitin. The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region. Most ubiquitin in paired helical filaments occurred as a monoubiquitinated form, and only a small proportion of ubiquitin formed multiubiquitin chains. There was a ubiquitin-negative smear, in which tau was much less processed in the amino-terminal portion. This strongly suggests that the amino-terminal processing of tau in paired helical filaments precedes its ubiquitination.	INST PHYS & CHEM RES,DIV BIOMOLEC CHARACTERIZAT,WAKO,SAITAMA 351,JAPAN; FUJITA HLTH UNIV,SCH MED,INST COMPREHENS MED SCI,DIV BIOMED POLYMER SCI,TOYOAKE,AICHI 47011,JAPAN	RIKEN; Fujita Health University	MORISHIMAKAWASHIMA, M (corresponding author), UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN.							BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; Brion J. P., 1985, ARCH BIOL BRUX, V95, P229; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DECARLI C, 1992, NEURODEGENERATION, V1, P113; Denk H, 1979, Int Rev Exp Pathol, V20, P77; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GOEDERT M, 1991, NEUROSCI LETT, V126, P149, DOI 10.1016/0304-3940(91)90541-Z; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HASEGAWA M, 1990, NEURON, V4, P909, DOI 10.1016/0896-6273(90)90144-5; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HASEGAWA M, 1993, IN PRESS J NEUROCHEM; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; IHARA Y, 1983, NATURE, V304, P727, DOI 10.1038/304727a0; IHARA Y, 1990, GERONTOLOGY, V36, P15; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; IWATSUBO T, 1992, AM J PATHOL, V140, P277; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P51, DOI 10.1016/0005-2744(81)90107-8; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; MAYER RJ, 1991, BIOCHIM BIOPHYS ACTA, V1089, P141, DOI 10.1016/0167-4781(91)90002-4; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; MORI H, 1989, NEUROSCIENCE YEAR S, V1, P165; MORISHIMAKAWASHIMA M, 1991, BRAIN RES, V554, P316, DOI 10.1016/0006-8993(91)90208-D; NUKINA N, 1985, J BIOCHEM-TOKYO, V98, P1715, DOI 10.1093/oxfordjournals.jbchem.a135443; OHTA M, 1988, LAB INVEST, V59, P848; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; SELKOE DJ, 1985, BANBURY REPORT, V15, P125; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WATANABE N, 1992, J NEUROCHEM, V58, P960, DOI 10.1111/j.1471-4159.1992.tb09349.x; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; YAMAGUCHI H, 1990, BRAIN RES, V537, P318, DOI 10.1016/0006-8993(90)90377-N; ZATLOUKAL K, 1990, HEPATOLOGY, V11, P652, DOI 10.1002/hep.1840110419; ZATLOUKAL K, 1992, LAB INVEST, V66, P774	47	263	271	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1151	1160		10.1016/0896-6273(93)90063-W	http://dx.doi.org/10.1016/0896-6273(93)90063-W			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8391280				2022-12-28	WOS:A1993LK37300015
J	FRANK, E; WENNER, P				FRANK, E; WENNER, P			ENVIRONMENTAL SPECIFICATION OF NEURONAL CONNECTIVITY	NEURON			English	Review							MOTONEURON PROJECTION PATTERNS; SPINAL-CORD; RETINOTECTAL PROJECTION; CELL LINEAGE; CHICK-EMBRYO; PERIPHERAL SPECIFICATION; ACTIVATION PATTERNS; ZEBRAFISH EMBRYOS; PATHWAY SELECTION; IMPULSE ACTIVITY				FRANK, E (corresponding author), UNIV PITTSBURGH, SCH MED, DEPT NEUROBIOL, PITTSBURGH, PA 15261 USA.			Wenner, Peter/0000-0002-7072-2194				ATTARDI DG, 1963, EXP NEUROL, V7, P46, DOI 10.1016/0014-4886(63)90093-1; BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; BONHOEFFER F, 1985, NATURE, V315, P408, DOI 10.1038/315409a0; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; FRANK E, 1982, J PHYSIOL-LONDON, V324, P495, DOI 10.1113/jphysiol.1982.sp014126; FRANK E, 1982, J PHYSIOL-LONDON, V324, P479, DOI 10.1113/jphysiol.1982.sp014125; GAZE RM, 1980, J EMBRYOL EXP MORPH, V55, P143; GLOVER JC, 1986, DEV BIOL, V115, P256, DOI 10.1016/0012-1606(86)90245-9; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HARRIS WA, 1980, J COMP NEUROL, V194, P303, DOI 10.1002/cne.901940203; HOLLYDAY M, 1983, LIMB DEV REGENERAT A, P183; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1984, J NEUROSCI, V4, P1130; JACOBSON M, 1968, DEV BIOL, V17, P202, DOI 10.1016/0012-1606(68)90061-4; JELLIES J, 1988, J NEUROBIOL, V19, P153, DOI 10.1002/neu.480190205; KENYON C, 1985, PHILOS T ROY SOC B, V312, P21, DOI 10.1098/rstb.1985.0175; KIMMEL CB, 1988, TRENDS GENET, V4, P68, DOI 10.1016/0168-9525(88)90043-1; KOBAYASHI T, 1990, DEV BRAIN RES, V57, P29, DOI 10.1016/0165-3806(90)90181-W; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P559; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANCEJONES CC, 1986, DEV BIOL, V116, P387, DOI 10.1016/0012-1606(86)90141-7; LANDMESSER L, 1975, J PHYSIOL-LONDON, V249, P301, DOI 10.1113/jphysiol.1975.sp011017; LANDMESSER LT, 1984, J PHYSIOL-LONDON, V347, P189, DOI 10.1113/jphysiol.1984.sp015061; LANDMESSER LT, 1986, J PHYSIOL-LONDON, V380, P157, DOI 10.1113/jphysiol.1986.sp016278; LEE MT, 1991, J NEUROSCI, V11, P2564; LICHTMAN JW, 1984, J NEUROSCI, V4, P1754; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; LOER CM, 1989, SCIENCE, V244, P64, DOI 10.1126/science.2704990; LOER CM, 1989, J NEUROSCI, V9, P528; MENDELSON B, 1991, J NEUROSCI, V11, P1390; MEYER RL, 1983, DEV BRAIN RES, V6, P293, DOI 10.1016/0165-3806(83)90068-8; OROURKE NA, 1989, DEV BIOL, V132, P251, DOI 10.1016/0012-1606(89)90221-2; PITTMAN RH, 1978, NATURE, V271, P364, DOI 10.1038/271364a0; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SCHMIDT JT, 1983, BRAIN RES, V269, P29, DOI 10.1016/0006-8993(83)90959-9; SCOTT JG, 1976, J NEUROPHYSIOL, V39, P679, DOI 10.1152/jn.1976.39.4.679; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SMITH CL, 1987, J NEUROSCI, V7, P1537; SMITH CL, 1988, BRAIN BEHAV EVOLUT, V31, P227, DOI 10.1159/000116591; STUERMER CAO, 1990, J NEUROSCI, V10, P3615	43	55	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1993	10	5					779	785		10.1016/0896-6273(93)90194-V	http://dx.doi.org/10.1016/0896-6273(93)90194-V			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494643				2022-12-28	WOS:A1993LD32200001
J	Warner, LE; Hilz, MJ; Appel, SH; Killian, JM; Kolodny, EH; Karpati, G; Carpenter, S; Watters, GV; Wheeler, C; Witt, D; Bodell, A; Nelis, E; Van Broeckhoven, C; Lupski, JR				Warner, LE; Hilz, MJ; Appel, SH; Killian, JM; Kolodny, EH; Karpati, G; Carpenter, S; Watters, GV; Wheeler, C; Witt, D; Bodell, A; Nelis, E; Van Broeckhoven, C; Lupski, JR			Clinical phenotypes of different MPZ (P-0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination	NEURON			English	Article							MYELIN PO GENE; PERIPHERAL-NERVE MYELIN; DISEASE TYPE 1B; POINT MUTATION; BASIC-PROTEIN; PMP22 GENE; NEUROPATHY TYPE-1B; ADHESION MOLECULE; GLYCOPROTEIN; DUPLICATION	Hereditary demyelinating peripheral neuropathies consist of a heterogeneous group of genetic disorders that includes hereditary neuropathy with liability to pressure palsies (HNPP), Charcot-Marie-Tooth disease (CMT), Dejerine-Sottas syndrome (DSS), and congenital hypomyelination (CH). The clinical classification of these neuropathies into discrete categories can sometimes be difficult because there can be both clinical and pathologic variation and overlap between these disorders. We have identified five novel mutations in the myelin protein zero (MPZ) gene, encoding the major structural protein (P-0) of peripheral nerve myelin, in patients with either CMT1B, DSS, or CH. This finding suggests that these disorders may not be distinct pathophysiologic entities, but rather represent a spectrum of related ''myelinopathies'' due to an underlying defect in myelination. Furthermore, we hypothesize the differences in clinical severity seen with mutations in MPZ are related to the type of mutation and its subsequent effect on protein function (i.e., loss of function versus dominant negative).	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, CTR HUMAN GENOME, HOUSTON, TX 77030 USA; UNIV ERLANGEN NURNBERG, DEPT NEUROL, D-91054 ERLANGEN, GERMANY; NYU, SCH MED, DEPT NEUROL, NEW YORK, NY 10016 USA; MONTREAL NEUROL HOSP & INST, MONTREAL, PQ H3A 2B4, CANADA; TORONTO HOSP, WESTERN DIV, DEPT NEUROPATHOL, TORONTO, ON M5T 2S8, CANADA; MONTREAL CHILDRENS HOSP, DEPT NEUROL, MONTREAL, PQ H3H 1P3, CANADA; KAISER PERMANENTE CARE PROGRAM NO CALIF, DEPT NEUROL FREMONT, SAN JOSE, CA 95119 USA; KAISER PERMANENTE CARE PROGRAM NO CALIF, DEPT GENET SAN JOSE, SAN JOSE, CA 95119 USA; UNIV ANTWERP VIB, BORN BUNGE FDN, DEPT BIOCHEM,LAB NEUROGENET, B-2610 ANTWERP, BELGIUM	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Erlangen Nuremberg; New York University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McGill University; Kaiser Permanente; Kaiser Permanente; Flanders Institute for Biotechnology (VIB); University of Antwerp	Warner, LE (corresponding author), BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA.		Van Broeckhoven, Christine/M-7853-2019	Van Broeckhoven, Christine/0000-0003-0183-7665	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32-GM08307] Funding Source: Medline; NINDS NIH HHS [R01-NS27042] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALESTRINI MR, 1991, NEUROPEDIATRICS, V22, P65, DOI 10.1055/s-2008-1071419; Bellone E, 1996, HUM MUTAT, V7, P377, DOI 10.1002/humu.1380070403; BIRD TD, 1982, AM J HUM GENET, V34, P388; BLANQUETGROSSAR.F, 1996, IN PRESS HUM MUT; BlanquetGrossard F, 1995, CLIN GENET, V48, P281; BOYLAN KB, 1992, ANN NEUROL, V31, P337, DOI 10.1002/ana.410310318; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; CHARNAS L, 1988, NEUROLOGY, V38, P966, DOI 10.1212/WNL.38.6.966; CHEIFETZ S, 1985, BIOCHEMISTRY-US, V24, P5170, DOI 10.1021/bi00340a032; CHEIFETZ S, 1985, BIOCHEMISTRY-US, V24, P1909, DOI 10.1021/bi00329a016; DING YG, 1994, J BIOL CHEM, V269, P10764; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; Dyck P.J, 1993, PNP, P1094; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GABREELSFESTEN AAW, 1996, IN PRESS NEUROLOGY; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HARATI Y, 1985, J NEUROL NEUROSUR PS, V48, P1269, DOI 10.1136/jnnp.48.12.1269; HAYASAKA K, 1993, GENOMICS, V17, P755, DOI 10.1006/geno.1993.1400; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; HAYASAKA K, 1993, HUM MOL GENET, V2, P1369, DOI 10.1093/hmg/2.9.1369; HIMORO M, 1993, BIOCHEM MOL BIOL INT, V31, P169; Ikegami T, 1996, BIOCHEM BIOPH RES CO, V222, P107, DOI 10.1006/bbrc.1996.0705; IONASESCU VV, 1995, NEUROLOGY, V45, P1766, DOI 10.1212/WNL.45.9.1766; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KENNEDY WR, 1977, ARCH NEUROL-CHICAGO, V34, P337, DOI 10.1001/archneur.1977.00500180031007; KILLIAN JM, 1979, ANN NEUROL, V5, P515, DOI 10.1002/ana.410050604; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LATOUR P, 1995, HUM MUTAT, V6, P50, DOI 10.1002/humu.1380060110; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LYON G, 1969, ACTA NEUROPATHOL, V13, P131, DOI 10.1007/BF00687025; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1995, J NEUROSCI, V15, P4488; NELIS E, 1994, J MED GENET, V31, P811, DOI 10.1136/jmg.31.10.811; NELIS E, 1994, HUM GENET, V94, P653, DOI 10.1007/BF00206959; NELIS E, 1996, IN PRESS EUR J HUM G; ONO J, 1982, EUR J PEDIATR, V138, P265, DOI 10.1007/BF00441215; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; RAUTENSTRAUSS B, 1994, HUM MOL GENET, V3, P1701, DOI 10.1093/hmg/3.9.1701; Roa BB, 1996, HUM MUTAT, V7, P36, DOI 10.1002/(SICI)1098-1004(1996)7:1<36::AID-HUMU5>3.0.CO;2-N; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; SUZUKI M, 1990, J NEUROCHEM, V55, P1966, DOI 10.1111/j.1471-4159.1990.tb05783.x; Tachi N, 1996, NEUROSCI LETT, V204, P173, DOI 10.1016/0304-3940(96)12347-8; THEIN SL, 1990, P NATL ACAD SCI USA, V87, P3924, DOI 10.1073/pnas.87.10.3924; VALENTIJN LJ, 1995, HUM MUTAT, V5, P76, DOI 10.1002/humu.1380050110; WISE CA, 1993, AM J HUM GENET, V53, P853	53	309	312	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1996	17	3					451	460		10.1016/S0896-6273(00)80177-4	http://dx.doi.org/10.1016/S0896-6273(00)80177-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ440	8816708	hybrid			2022-12-28	WOS:A1996VJ44000011
J	Canoll, PD; Musacchio, JM; Hardy, R; Reynolds, R; Marchionni, MA; Salzer, JL				Canoll, PD; Musacchio, JM; Hardy, R; Reynolds, R; Marchionni, MA; Salzer, JL			GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; RAT OPTIC-NERVE; PROTEIN GENE-EXPRESSION; SCHWANN-CELLS; IN-VITRO; MATURE OLIGODENDROCYTES; MESSENGER-RNA; BRAIN; ASTROCYTES	We show that GGF/neuregulin is a mitogen for pro-oligodendrocytes (O4+/O1- cells), oligodendrocytes (O4+/O1+ cells), and type-2 astrocytes. Heregulin beta 1, another neuregulin isoform, is also mitogenic. The proliferative effect of glial growth factor (GGF) does not require, but is greatly potentiated by, serum factors. GGF also promotes the survival of pro-oligodendrocytes under serum-free conditions. High levels of GGF reversibly inhibit the differentiation and lineage commitment of oligodendrocyte progenitors and, in differentiated cultures, result in loss of O1 and myelin basic protein expression. All three erbB receptors are expressed by progenitors and are activated by GGF; the relative abundance of these receptors changes during differentiation. Finally, cortical neurons release a soluble mitogen for pro-oligodendrocytes that is specifically blocked by antibodies to GGF. These results implicate the neuregulins in the neuronal regulation of oligodendrocyte progenitor proliferation, survival, and differentiation.	NYU,SCH MED,DEPT CELL BIOL,NEW YORK,NY 10016; NYU,SCH MED,DEPT NEUROL,NEW YORK,NY 10016; NYU,SCH MED,KAPLAN CANC CTR,NEW YORK,NY 10016; CHARING CROSS & WESTMINSTER COLL,DEPT ANAT,LONDON W6 8RF,ENGLAND; CAMBRIDGE NEUROSCI INC,CAMBRIDGE,MA 02139	New York University; New York University; New York University; Imperial College London	Canoll, PD (corresponding author), NYU,SCH MED,DEPT PHARMACOL,NEW YORK,NY 10016, USA.			Salzer, James/0000-0001-9126-7197	NIGMS NIH HHS [2T32 GM07308] Funding Source: Medline; NINDS NIH HHS [NS26001] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026001] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BOTTENSTEIN J S, 1990, P56; BROCKES JP, 1980, J BIOL CHEM, V255, P8374; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; CHEN SJ, 1989, J NEUROCHEM, V52, P325, DOI 10.1111/j.1471-4159.1989.tb10936.x; Cheng LL, 1996, NEURON, V16, P309, DOI 10.1016/S0896-6273(00)80049-5; COLLARINI EJ, 1992, DEVELOPMENT, V116, P193; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DAVID S, 1984, J NEUROCYTOL, V13, P961, DOI 10.1007/BF01148596; DELOSMONTEROS AE, 1993, P NATL ACAD SCI USA, V90, P50, DOI 10.1073/pnas.90.1.50; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; DUTLY F, 1991, GLIA, V4, P559, DOI 10.1002/glia.440040603; ECCLESTON PA, 1984, BRAIN RES, V210, P315; EDGAR AD, 1985, DEV NEUROSCI-BASEL, V7, P206, DOI 10.1159/000112289; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; FRESSINAUD C, 1995, J NEUROSCI RES, V40, P285, DOI 10.1002/jnr.490400302; FULORAND J, 1977, J COMP NEUROL, V176, P189; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; GOLDMAN JE, 1992, TRENDS NEUROSCI, V15, P359, DOI 10.1016/0166-2236(92)90179-C; GUENARD V, 1995, J NEUROSCI, V15, P419; HARDY R, 1993, J NEUROSCI RES, V36, P121, DOI 10.1002/jnr.490360202; HARDY R, 1993, J NEUROSCI RES, V34, P589, DOI 10.1002/jnr.490340510; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HUNTER SF, 1991, J NEUROSCI RES, V28, P574, DOI 10.1002/jnr.490280415; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; JIN JJ, 1993, CELL GROWTH DIFFER, V4, P227; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; KIDD GJ, 1990, J NEUROSCI RES, V26, P409, DOI 10.1002/jnr.490260403; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; LEVI ADO, 1995, J NEUROSCI, V15, P1329; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LOGAN A, 1986, NEUROSCI LETT, V69, P162, DOI 10.1016/0304-3940(86)90596-3; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MAYER M, 1993, GLIA, V8, P12, DOI 10.1002/glia.440080103; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MCPHILEMY K, 1990, J NEUROCYTOL, V19, P494, DOI 10.1007/BF01257239; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MORGAN L, 1994, DEVELOPMENT, V120, P1399; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Muir DA, 1996, J NEUROSCI RES, V44, P1; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NORDLUND M, 1992, GLIA, V5, P182, DOI 10.1002/glia.440050304; ORRURTREGER A, 1993, P NATL ACAD SCI USA, V90, P1867, DOI 10.1073/pnas.90.5.1867; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; RIVA MA, 1991, DEV BRAIN RES, V62, P45, DOI 10.1016/0165-3806(91)90188-O; ROSENBAUM C, 1996, T AM SOC NEUROCHEM; SANETO RP, 1985, P NATL ACAD SCI USA, V82, P3509, DOI 10.1073/pnas.82.10.3509; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shaw CE, 1996, J NEUROSCI, V16, P1163; SOMMER J, 1980, DEV BIOL, V83, P311; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; WOOD PM, 1986, NATURE, V320, P756, DOI 10.1038/320756a0; WOOD PM, 1991, GLIA, V4, P225, DOI 10.1002/glia.440040214; YASUDA T, 1995, J NEUROSCI RES, V40, P306, DOI 10.1002/jnr.490400304; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; ZAJICEK J, 1994, BRAIN, V117, P1333, DOI 10.1093/brain/117.6.1333	78	316	332	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1996	17	2					229	243		10.1016/S0896-6273(00)80155-5	http://dx.doi.org/10.1016/S0896-6273(00)80155-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE840	8780647	hybrid			2022-12-28	WOS:A1996VE84000006
J	vonGersdorff, H; Vardi, E; Matthews, G; Sterling, P				vonGersdorff, H; Vardi, E; Matthews, G; Sterling, P			Evidence that vesicles on the synaptic ribbon of retinal bipolar neurons can be rapidly released	NEURON			English	Article							FREEZE-SUBSTITUTION; CALCIUM CHANNELS; CELLS; SYNAPSES; CONES; TRANSMISSION; JUNCTIONS; TERMINALS	We relate the ultrastructure of the giant bipolar synapse in goldfish retina to the jump in capacitance that accompanies depolarization-evoked exocytosis. Mean vesicle diameter is 29 +/- 4 nm, giving 26.4 aF/vesicle, so the maximum evoked capacitance (150 fF within 200 ms) represents fusion of about 5700 vesicles. Two terminals contained, respectively, 45 and 65 ribbon-type synaptic outputs, and a fully loaded ribbon tethers about 110 vesicles. Thus, the tethered pool, about 6000 vesicles, corresponds to the rapidly released pool. Further, the difference between small and large terminals in number of tethered vesicles matches their difference in capacitance jump. This suggests, within a ''fire and reload'' model of exocytosis, that the ribbon translocates synaptic vesicles very rapidly to membrane docking sites, supporting a maximum release rate of 500 vesicles/active zone/s, until the population of tethered vesicles is exhausted.	SUNY STONY BROOK, DEPT NEUROBIOL & BEHAV, STONY BROOK, NY 11794 USA; UNIV PENN, DEPT NEUROSCI, PHILADELPHIA, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania					NEI NIH HHS [EY03821, EY00828, EY06506] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003821, R01EY000828] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; BREWER PA, 1986, NEUROSCIENCE, V17, P881, DOI 10.1016/0306-4522(86)90052-7; BUNT AH, 1971, BRAIN RES, V25, P571, DOI 10.1016/0006-8993(71)90461-6; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; COHEN E, 1992, EUR J NEUROSCI, V4, P506, DOI 10.1111/j.1460-9568.1992.tb00901.x; DECAMILLI P, 1995, NATURE, V375, P450, DOI 10.1038/375450a0; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; Eccles, 2013, PHYSL SYNAPSES; FETTIPLACE R, 1971, J MEMBRANE BIOL, V5, P277, DOI 10.1007/BF01870555; FIELDS RD, 1985, SCIENCE, V228, P197, DOI 10.1126/science.3975637; FREED MA, 1994, VISUAL NEUROSCI, V11, P261, DOI 10.1017/S0952523800001620; GETZ WJ, 1995, CURR BIOL, V5, P1098; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; ISHIDA AT, 1980, J COMP NEUROL, V191, P315, DOI 10.1002/cne.901910302; Jackson MB, 1995, INT REV NEUROBIOL, V38, P201, DOI 10.1016/S0074-7742(08)60527-9; KANEKO A, 1985, J PHYSIOL-LONDON, V358, P131, DOI 10.1113/jphysiol.1985.sp015544; KIER CK, 1995, J NEUROSCI, V15, P7673; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Matthews G, 1996, ANNU REV NEUROSCI, V19, P219; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAO R, 1994, BIOPHYS J, V67, P57, DOI 10.1016/S0006-3495(94)80454-0; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SAITO T, 1982, J COMP NEUROL, V205, P161, DOI 10.1002/cne.902050207; SEJNOWSKI TJ, 1982, J NEUROCYTOL, V11, P897, DOI 10.1007/BF01148307; SHERRY DM, 1993, J COMP NEUROL, V329, P188, DOI 10.1002/cne.903290204; SIGWORTH FJ, 1995, J NEUROSCI METH, V56, P203, DOI 10.1016/0165-0270(94)00129-5; SMITH RG, 1987, J NEUROSCI METH, V21, P55, DOI 10.1016/0165-0270(87)90102-6; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; TATSUOKA H, 1989, J COMP NEUROL, V290, P343, DOI 10.1002/cne.902900304; TSUKAMOTO Y, 1992, VISION RES, V32, P1809, DOI 10.1016/0042-6989(92)90042-H; USUKURA J, 1987, CELL TISSUE RES, V247, P483, DOI 10.1007/BF00215740; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1996, J NEUROSCI, V16, P115; YAZULLA S, 1992, J COMP NEUROL, V320, P521, DOI 10.1002/cne.903200409	45	242	243	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1221	1227		10.1016/S0896-6273(00)80148-8	http://dx.doi.org/10.1016/S0896-6273(00)80148-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663998	hybrid			2022-12-28	WOS:A1996UU11800019
J	Liu, Y; Jurman, ME; Yellen, G				Liu, Y; Jurman, ME; Yellen, G			Dynamic rearrangement of the outer mouth of a K+ channel during gating	NEURON			English	Article							POTASSIUM CHANNEL; CYSTEINE-SUBSTITUTION; SENSORY RECEPTOR; BINDING-SITE; TEA BLOCKADE; INACTIVATION; BLOCKING; MUTANTS; REGION; MECHANISMS	With prolonged stimulation, voltage-activated Ki channels close by a gating process called inactivation. This inactivation gating can occur by two distinct molecular mechanisms: N-type, in which a tethered particle blocks the intracellular mouth of the pore, and C-type, which involves a closure of the external mouth. The functional motion involved in C-type inactivation was studied by introducing cysteine residues at the outer mouth of Shaker K+ channels through mutagenesis, and by measuring state-dependent changes in accessibility to chemical modification. Modification of three adjacent residues in the outer mouth was 130-10,000-fold faster in the C-type inactivated state than in the closed state. At one position, state-dependent bridging or disulfide crosslinking between subunits was also possible. These results give a consistent picture in which C-type inactivation promotes a local rearrangement and constriction of the channel at the outer mouth.			Liu, Y (corresponding author), HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02114 USA.			Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [NS09774, NS29693, R01 NS029693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; GRISSMER S, 1989, BIOPHYS J, V55, P203, DOI 10.1016/S0006-3495(89)82793-6; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LORING RH, 1992, MOL BRAIN RES, V15, P113, DOI 10.1016/0169-328X(92)90158-8; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schlief T, 1996, PFLUG ARCH EUR J PHY, V431, P483, DOI 10.1007/BF02191894; SMITH DJ, 1975, BIOCHEMISTRY-US, V14, P766, DOI 10.1021/bi00675a019; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TOTH MS, 1993, PROTEIN SCI, V2, P1024; XU M, 1993, J BIOL CHEM, V268, P21505; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	40	395	404	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					859	867		10.1016/S0896-6273(00)80106-3	http://dx.doi.org/10.1016/S0896-6273(00)80106-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608004	Bronze			2022-12-28	WOS:A1996UG61100019
J	VINCENT, P; MARTY, A				VINCENT, P; MARTY, A			NEIGHBORING CEREBELLAR PURKINJE-CELLS COMMUNICATE VIA RETROGRADE INHIBITION OF COMMON PRESYNAPTIC INTERNEURONS	NEURON			English	Article							SYNAPTIC CURRENTS; NERVOUS-SYSTEM; HIPPOCAMPUS; NEURONS; CALCIUM; INVITRO; CORTEX	Paired tight-seal whole-cell recordings were obtained from neighboring Purkinje cells in cerebellar slices. Under voltage clamp, spontaneous inhibitory postsynaptic currents resulted from the activity of GABAergic interneurons, stellate and basket cells. Up to 80% of inhibitory postsynaptic currents in paired recordings were in register. This correlation was not affected by antagonists of glutamate receptors, faded with distance, and was abolished by tetrodotoxin. Earlier work showed that voltage-gated Ca2+ entry into a Purkinje cell elicits a transient presynaptic inhibition of inhibitory postsynaptic currents. It is now shown that this inhibition is not restricted to the stimulated cell, but that it is transmitted to its neighbors. The results indicate that Purkinje cells exchange information by an unconventional mechanism involving retrograde control of inhibitory synapses.			VINCENT, P (corresponding author), ECOLE NORMALE SUPER,ZENTRUM NEUROBIOL,46 RUE ULM,F-75231 PARIS 05,FRANCE.		Vincent, Pierre/A-1055-2012	Vincent, Pierre/0000-0002-8479-1908				ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1138, DOI 10.1152/jn.1964.27.6.1138; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Ito M, 1984, CEREBELLUM NEURAL CO; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LLANO I, 1993, J PHYSIOL-LONDON, V468, P201, DOI 10.1113/jphysiol.1993.sp019767; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P355, DOI 10.1113/jphysiol.1992.sp019382; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; Palay S. L., 1974, CEREBELLAR CORTEX CY; PITLER TA, 1992, J NEUROSCI, V12, P4122; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SOTELO C, 1972, J CELL BIOL, V53, P271, DOI 10.1083/jcb.53.2.271; STOCKLE H, 1980, NEUROSCIENCE, V5, P893, DOI 10.1016/0306-4522(80)90158-X; TENBRUGGENCATE G, 1976, PFLUG ARCH EUR J PHY, V367, P107, DOI 10.1007/BF00583664; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0	23	112	115	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					885	893		10.1016/0896-6273(93)90118-B	http://dx.doi.org/10.1016/0896-6273(93)90118-B			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240811				2022-12-28	WOS:A1993MJ04100010
J	FRASER, DD; HOEHN, K; WEISS, S; MACVICAR, BA				FRASER, DD; HOEHN, K; WEISS, S; MACVICAR, BA			ARACHIDONIC-ACID INHIBITS SODIUM CURRENTS AND SYNAPTIC TRANSMISSION IN CULTURED STRIATAL NEURONS	NEURON			English	Article							PROTEIN-KINASE-C; LONG-TERM POTENTIATION; CHAIN FATTY-ACIDS; GLUTAMATE RELEASE; LIPOXYGENASE METABOLITES; PRESYNAPTIC INHIBITION; FUNCTIONAL MODULATION; SIGNAL TRANSDUCTION; POTASSIUM CHANNELS; SMOOTH-MUSCLE	In the striatum, dopamine generates arachidonic acid (AA) and induces synaptic depression. Here, we report that Na+ channels are a target for AA in both cultured and acutely isolated striatal neurons. AA depressed veratrine-induced Na+ influx and neurotransmitter release. Whole-cell voltage clamp revealed that peak Na+ currents are depressed, and steady-state inactivation shifts -15 mV in the presence of AA. Furthermore, inactivation was accelerated, and recovery from inactivation was delayed. These actions of AA were not produced by AA metabolites or protein kinase C activation. In addition, AA reduced both the amplitude and frequency of action potentials and depressed spontaneous inhibitory post-synaptic currents without affecting miniature inhibitory postsynaptic currents. These data suggest that AA modulates presynaptic, Na+-dependent action potentials, thereby contributing to striatal synaptic depression.			FRASER, DD (corresponding author), UNIV CALGARY,NEUROSCI RES GRP,CALGARY T2N 4N1,AB,CANADA.		MacVicar, Brian/P-1553-2015; MacVicar, Brian/AAI-7729-2020	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623				AXELROD J, 1990, BIOCHEM SOC T, V18, P503, DOI 10.1042/bst0180503; BARNES S, 1988, J GEN PHYSIOL, V91, P421, DOI 10.1085/jgp.91.3.421; Bashir Z I, 1992, Curr Opin Neurobiol, V2, P328, DOI 10.1016/0959-4388(92)90124-4; BASHIR ZI, 1992, EUR J NEUROSCI, V4, P485, DOI 10.1111/j.1460-9568.1992.tb00898.x; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CAPDEVILA J, 1981, P NATL ACAD SCI-BIOL, V78, P5362, DOI 10.1073/pnas.78.9.5362; CAPDEVILA J, 1988, ARCH BIOCHEM BIOPHYS, V261, P257, DOI 10.1016/0003-9861(88)90340-2; CASS A, 1970, J GEN PHYSIOL, V56, P100, DOI 10.1085/jgp.56.1.100; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHAN PH, 1988, J NEUROCHEM, V50, P1185, DOI 10.1111/j.1471-4159.1988.tb10591.x; CHARLTON MP, 1979, J GEN PHYSIOL, V72, P487; COSTA MRC, 1982, J BIOL CHEM, V257, P7918; DASCAL N, 1991, NEURON, V6, P165, DOI 10.1016/0896-6273(91)90131-I; DRAPEAU C, 1990, NEUROSCI LETT, V115, P286, DOI 10.1016/0304-3940(90)90470-T; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; FREEMAN EJ, 1990, NEUROCHEM RES, V15, P743, DOI 10.1007/BF00973656; HERRERO I, 1991, J NEUROCHEM, V57, P718, DOI 10.1111/j.1471-4159.1991.tb03805.x; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HOEHN K, 1993, J NEUROSCI, V13, P1244; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IZUMI Y, 1992, SCIENCE, V257, P1273, DOI 10.1126/science.1519065; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KEYSER DO, 1990, NEURON, V5, P545, DOI 10.1016/0896-6273(90)90092-T; KHODOROV BI, 1991, ANN NY ACAD SCI, V625, P224, DOI 10.1111/j.1749-6632.1991.tb33843.x; KIM D, 1989, SCIENCE, V244, P1174, DOI 10.1126/science.2727703; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; LINDEN DJ, 1989, J PHYSIOL-LONDON, V419, P95, DOI 10.1113/jphysiol.1989.sp017863; LIU YB, 1993, J NEUROPHYSIOL, V69, P1000, DOI 10.1152/jn.1993.69.3.1000; LOVINGER DM, 1993, J NEUROPHYSIOL, V69, P1236, DOI 10.1152/jn.1993.69.4.1236; LYNCH MA, 1990, J NEUROCHEM, V55, P215, DOI 10.1111/j.1471-4159.1990.tb08841.x; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Marty A., 1983, SINGLE CHANNEL RECOR, P107; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; MINTA A, 1989, J BIOL CHEM, V264, P19449; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; ORDWAY RW, 1989, SCIENCE, V244, P1176, DOI 10.1126/science.2471269; ORDWAY RW, 1991, TRENDS NEUROSCI, V14, P96, DOI 10.1016/0166-2236(91)90069-7; PETROU S, 1993, TRENDS BIOCHEM SCI, V18, P41, DOI 10.1016/0968-0004(93)90050-W; PIN JP, 1986, J NEUROCHEM, V47, P594; PIOMELLI D, 1990, TRENDS PHARMACOL SCI, V11, P367, DOI 10.1016/0165-6147(90)90182-8; PIOMELLI D, 1991, NATURE, V353, P164, DOI 10.1038/353164a0; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SCHUBERT B, 1990, AM J PHYSIOL, V258, pH977, DOI 10.1152/ajpheart.1990.258.4.H977; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHWARTZ RD, 1992, BRAIN RES, V585, P405, DOI 10.1016/0006-8993(92)91246-B; SCHWEITZER P, 1990, NATURE, V346, P464, DOI 10.1038/346464a0; SEKIGUCHI K, 1988, J BIOCHEM-TOKYO, V103, P759, DOI 10.1093/oxfordjournals.jbchem.a122343; SHIMADA T, 1992, J GEN PHYSIOL, V100, P27, DOI 10.1085/jgp.100.1.27; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Stuhmer W, 1992, Curr Opin Neurobiol, V2, P243, DOI 10.1016/0959-4388(92)90110-7; TAKENAKA T, 1988, J MEMBRANE BIOL, V106, P141, DOI 10.1007/BF01871396; WALSH JP, 1993, BRAIN RES, V6308, P123; WEISS S, 1990, J PHARMACOL EXP THER, V252, P380; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; ZONA C, 1993, NEUROREPORT, V4, P359, DOI 10.1097/00001756-199304000-00004	66	93	96	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					633	644		10.1016/0896-6273(93)90075-3	http://dx.doi.org/10.1016/0896-6273(93)90075-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398152				2022-12-28	WOS:A1993MD06800008
J	OKANO, K; MONCK, JR; FERNANDEZ, JM				OKANO, K; MONCK, JR; FERNANDEZ, JM			GTP-GAMMA-S STIMULATES EXOCYTOSIS IN PATCH-CLAMPED RAT MELANOTROPHS	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-C; MAST-CELLS; CAPACITANCE MEASUREMENTS; BINDING PROTEINS; CATECHOLAMINE RELEASE; GUANINE-NUCLEOTIDES; PITUITARY-CELLS; SECRETION; CALCIUM	We investigated the molecular mechanisms regulating exocytosis in patch-clamped melanotrophs by measuring the membrane capacitance. Ca2+-dependent exocytosis could be induced by membrane depolarization or by including solutions containing 2 muM free Ca2+ in the patch pipette. Ca2+-dependent exocytosis was inhibited by GDPbetaS, suggesting involvement of a GTP-binding protein. The hydrolysis-resistant GTP analogs, GTPgammaS and GppNHp, were able to stimulate exocytosis at low free Ca2+ concentrations. The stimulatory response to GTPgammaS was abolished by both GDPbetaS and GTP. The latter suggests that a sustained activation of a GTP-binding protein is necessary for exocytosis. This behavior is similar to the stimulation of exocytosis by guanine nucleotides in mast cells and other nonexcitable cells and suggests a common regulatory mechanism.			OKANO, K (corresponding author), MAYO CLIN & MAYO FDN,DEPT PHYSIOL & BIOPHYS,ROCHESTER,MN 55905, USA.							BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BITTNER MA, 1986, J BIOL CHEM, V261, P182; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; CARROLL AG, 1990, J NEUROCHEM, V55, P930, DOI 10.1111/j.1471-4159.1990.tb04580.x; CHANCE B, 1975, ANAL BIOCHEM, V66, P498, DOI 10.1016/0003-2697(75)90617-X; DEKKER LV, 1991, J NEUROCHEM, V56, P1146, DOI 10.1111/j.1471-4159.1991.tb11404.x; DEMATTEIS MA, 1991, J BIOL CHEM, V266, P10452; DOROSHENKO P, 1991, J PHYSIOL-LONDON, V436, P711, DOI 10.1113/jphysiol.1991.sp018575; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; GOMPERTS BD, 1990, ANNU REV PHYSIOL, V52, P591; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; IYENGAR R, 1980, J BIOL CHEM, V255, P312; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KEJA JA, 1992, J PHYSIOL-LONDON, V450, P409, DOI 10.1113/jphysiol.1992.sp019134; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; LILLIE THW, 1992, BIOCHEM J, V288, P181, DOI 10.1042/bj2880181; LINDAU M, 1991, BIOCHIM BIOPHYS ACTA, V1071, P429, DOI 10.1016/0304-4157(91)90006-I; LUINI A, 1988, CELL MOL NEUROBIOL, V8, P129, DOI 10.1007/BF00712918; MACRAE MB, 1990, BIOCHEM J, V271, P635, DOI 10.1042/bj2710635; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MONCK JR, 1992, J CELL BIOL, V119, P1395, DOI 10.1083/jcb.119.6.1395; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NUSSE O, 1990, J EXP MED, V171, P775, DOI 10.1084/jem.171.3.775; NUSSE O, 1988, J CELL BIOL, V107, P2117, DOI 10.1083/jcb.107.6.2117; OBERHAUSER AF, 1992, NATURE, V360, P270, DOI 10.1038/360270a0; PADFIELD PJ, 1992, P NATL ACAD SCI USA, V89, P1656, DOI 10.1073/pnas.89.5.1656; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; RONNING SA, 1986, J BIOL CHEM, V261, P7834; SENYSHYN J, 1992, FEBS LETT, V309, P41, DOI 10.1016/0014-5793(92)80735-Y; SIKDAR SK, 1990, FEBS LETT, V273, P150, DOI 10.1016/0014-5793(90)81072-V; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; VALLAR L, 1987, J BIOL CHEM, V262, P5049; VANDERMERWE PA, 1989, BIOCHEM J, V264, P901, DOI 10.1042/bj2640901; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	48	42	42	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					165	172		10.1016/0896-6273(93)90280-5	http://dx.doi.org/10.1016/0896-6273(93)90280-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338664				2022-12-28	WOS:A1993LP43000015
J	HAMMANG, JP; BEHRINGER, RR; BAETGE, EE; PALMITER, RD; BRINSTER, RL; MESSING, A				HAMMANG, JP; BEHRINGER, RR; BAETGE, EE; PALMITER, RD; BRINSTER, RL; MESSING, A			ONCOGENE EXPRESSION IN RETINAL HORIZONTAL CELLS OF TRANSGENIC MICE RESULTS IN A CASCADE OF NEURODEGENERATION	NEURON			English	Article							T-ANTIGEN EXPRESSION; RAT RETINA; MOUSE RETINA; IMMUNOHISTOCHEMICAL EVIDENCE; MONOCLONAL-ANTIBODIES; CONTAINING NEURONS; GANGLION-CELLS; AMACRINE CELLS; DIFFERENTIATION; NEOPLASIA	The phenylethanolamine N-methyltransferase promoter directs the expression of the SV40 T antigen to subsets of amacrine and horizontal neurons of the retina in a line of transgenic mice. T antigen expression begins in these cells during the first postnatal week. The horizontal cells appear to develop normally for another week but then begin to die. Subsequently, most of the horizontal cells disappear from the central and mid retina, resulting in loss of the outer plexiform layer and absence of ribbon synapses between the photoreceptors and bipolar cells. Neuronal transformation occurs only in the peripheral retina. These experiments indicate that horizontal neurons are heterogeneous with respect to susceptibility to transformation and that T antigen expression in a subset of horizontal neurons can be a direct cause of neuronal cell death. Furthermore, critical interdependencies exist between horizontal neurons after retinal neurogenesis is complete.	BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,CNS CELL & MOLEC NEUROBIOL,WALLINGFORD,CT 06492; UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104; UNIV WASHINGTON,DEPT BIOCHEM,HOWARD HUGHES MED INST,SEATTLE,WA 98195; UNIV WISCONSIN,SCH VET MED,DEPT PATHOBIOL SCI,MADISON,WI 53706	Bristol-Myers Squibb; University of Pennsylvania; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison				Brinster, Ralph/0000-0003-1408-7656	NCI NIH HHS [CA-38635] Funding Source: Medline; NICHD NIH HHS [HD-09172] Funding Source: Medline; NINDS NIH HHS [NS-22475] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD009172, R37HD009172] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA038635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS JM, 1991, SCIENCE, V254, P1161, DOI 10.1126/science.1957168; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; BAETGE EE, 1988, P NATL ACAD SCI USA, V85, P3648, DOI 10.1073/pnas.85.10.3648; BAETSCHER M, 1991, ONCOGENE, V6, P1133; BEAZLEY LD, 1987, DEV BRAIN RES, V33, P169, DOI 10.1016/0165-3806(87)90151-9; BLANKS JC, 1977, J COMP NEUROL, V174, P317, DOI 10.1002/cne.901740208; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; BOHN MC, 1987, DEV BRAIN RES, V37, P257, DOI 10.1016/0165-3806(87)90247-1; BOYCOTT BB, 1978, PROC R SOC SER B-BIO, V203, P229, DOI 10.1098/rspb.1978.0103; COHEN J, 1987, NEUROSCI LETT, V83, P138, DOI 10.1016/0304-3940(87)90230-8; DRAGER UC, 1983, NATURE, V303, P169, DOI 10.1038/303169a0; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; FOSTER GA, 1985, DEV BRAIN RES, V22, P187, DOI 10.1016/0165-3806(85)90170-1; FOSTER GA, 1985, BRAIN RES, V330, P183, DOI 10.1016/0006-8993(85)90025-3; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HADJICONSTANTINOU M, 1984, NEUROSCIENCE, V13, P547, DOI 10.1016/0306-4522(84)90247-1; HAMMANG JP, 1990, NEURON, V4, P775, DOI 10.1016/0896-6273(90)90204-S; HAMMANG JP, 1992, J COMP NEUROL, V316, P383, DOI 10.1002/cne.903160309; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KEYSER KT, 1987, J NEUROSCI, V7, P3996; LEWIS GP, 1992, J NEUROSCI, V12, P3968; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MESSING A, 1988, ONCOGENE RES, V3, P87; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; ORNITZ DM, 1987, SCIENCE, V238, P188, DOI 10.1126/science.2821617; PARK DH, 1986, J NEUROSCI, V6, P1108; PLEASURE SJ, 1990, J NEUROSCI, V10, P2428; POLLEY EH, 1987, DEV VERTEBRATE RETIN, P3; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; RODERICK TH, 1989, GENETIC VARIANTS STR, P663; SHAW G, 1983, EUR J CELL BIOL, V30, P219; Sidman RL, 1961, STRUCTURE EYE, P487; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VERSAUXBOTTERI C, 1986, J COMP NEUROL, V243, P422, DOI 10.1002/cne.902430311; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	44	42	43	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1197	1209		10.1016/0896-6273(93)90067-2	http://dx.doi.org/10.1016/0896-6273(93)90067-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8391281				2022-12-28	WOS:A1993LK37300019
J	GUTMANN, DH; COLLINS, FS				GUTMANN, DH; COLLINS, FS			THE NEUROFIBROMATOSIS TYPE-1 GENE AND ITS PROTEIN PRODUCT, NEUROFIBROMIN	NEURON			English	Review							GTPASE-ACTIVATING PROTEIN; NERVE GROWTH-FACTOR; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; TUMOR SUPPRESSOR GENES; PC12 CELLS; RAS GTPASE; SACCHAROMYCES-CEREVISIAE; GENOMIC STRUCTURE; CYCLIC-AMP; VONRECKLINGHAUSEN NEUROFIBROMATOSIS		UNIV MICHIGAN, SCH MED, HOWARD HUGHES MED INST, DEPT NEUROL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH MED, HOWARD HUGHES MED INST, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	GUTMANN, DH (corresponding author), UNIV MICHIGAN, SCH MED, HOWARD HUGHES MED INST, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA.			Gutmann, David/0000-0002-3127-5045	NINDS NIH HHS [NS01590, NS23410] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023410, K08NS001590] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aaronson S.A., 1991, GROWTH FACTORS CANC, V254, P1146; ANDERSEN LB, 1993, MOL CELL BIOL, V13, P487, DOI 10.1128/MCB.13.1.487; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; BADER JL, 1986, ANN NY ACAD SCI, V486, P57; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; CAWTHON RM, 1990, GENOMICS, V7, P555, DOI 10.1016/0888-7543(90)90199-5; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CAWTHON RM, 1991, GENOMICS, V9, P446, DOI 10.1016/0888-7543(91)90410-G; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DASTON MM, 1992, NEURON, V8, P415, DOI 10.1016/0896-6273(92)90270-N; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DECLUE JE, 1991, P NATL ACAD SCI USA, V88, P9914, DOI 10.1073/pnas.88.22.9914; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ESTIVILL X, 1991, AM J HUM GENET, V49, pA202; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; GOLUBEVA EE, 1989, FEBS LETT, V247, P232, DOI 10.1016/0014-5793(89)81341-9; GREGORY TE, 1993, IN PRESS SOMAT CELL; GUTMANN DH, 1991, P NATL ACAD SCI USA, V88, P9658, DOI 10.1073/pnas.88.21.9658; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HANSEN MF, 1988, TRENDS GENET, V4, P125, DOI 10.1016/0168-9525(88)90134-5; KAYES LM, 1992, IN PRESS J MED GENET; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; NISHI T, 1991, ONCOGENE, V6, P1555; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; OCONNELL P, 1990, GENOMICS, V7, P547, DOI 10.1016/0888-7543(90)90198-4; OCONNELL P, 1989, SCIENCE, V244, P1087, DOI 10.1126/science.2543077; PAWSON T, 1990, TRENDS GENET, V6, P350, DOI 10.1016/0168-9525(90)90276-C; PONDER BAJ, 1990, TRENDS GENET, V6, P213, DOI 10.1016/0168-9525(90)90181-5; RICCARDI VM, 1991, NEW ENGL J MED, V324, P1283, DOI 10.1056/NEJM199105023241812; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; RICHTERLANDSBERG C, 1986, J CELL BIOL, V102, P821, DOI 10.1083/jcb.102.3.821; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; STANBRIDGE EJ, 1990, ANNU REV GENET, V24, P615; SUGIMOTO Y, 1988, J BIOL CHEM, V263, P12102; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TANAKA K, 1989, MOL CELL BIOL, V9, P757, DOI 10.1128/MCB.9.2.757; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; TIBBLES JAR, 1986, BRIT MED J, V293, P683, DOI 10.1136/bmj.293.6548.683; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; UPADHYAYA M, 1992, IN PRESS J MED GENET; VISKOCHIL D, 1991, MOL CELL BIOL, V11, P906, DOI 10.1128/MCB.11.2.906; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WANG Y, 1991, CELL REGUL, V2, P453, DOI 10.1091/mbc.2.6.453; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; WIGLER MH, 1990, NATURE, V346, P696, DOI 10.1038/346696a0; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	73	128	131	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1993	10	3					335	343		10.1016/0896-6273(93)90324-K	http://dx.doi.org/10.1016/0896-6273(93)90324-K			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461130	Green Submitted			2022-12-28	WOS:A1993KU90100001
J	VERNALLIS, AB; CONROY, WG; BERG, DK				VERNALLIS, AB; CONROY, WG; BERG, DK			NEURONS ASSEMBLE ACETYLCHOLINE-RECEPTORS WITH AS MANY AS 3 KINDS OF SUBUNITS WHILE MAINTAINING SUBUNIT SEGREGATION AMONG RECEPTOR SUBTYPES	NEURON			English	Article							CILIARY GANGLION NEURONS; MONOCLONAL-ANTIBODIES; GENE FAMILY; FUNCTIONAL EXPRESSION; NICOTINIC RECEPTORS; ALPHA-NEUROTOXIN; XENOPUS OOCYTES; BINDING-SITES; CELL-CULTURE; BRAIN	A family of genes encoding neuronal acetylcholine receptor (AChR) subunits has been identified and cloned from vertebrates. Expression studies have implied that as few as one or two kinds of subunits may be sufficient to construct neuronal AChRs and that multiple pair-wise combinations of the gene products are capable of generating functional receptors. We show here that a class of AChRs with a predominantly synaptic location on neurons contains receptors having at least three types of subunits and that the subunits are encoded by the alpha3, beta4, and alpha5 AChR genes. In addition, we show that a class of extrasynaptic AChRs on the same neurons contains the alpha7 subunits but lacks the alpha3, beta4, and alpha5 subunits. The results demonstrate that native AChRs on neurons are more complex in composition than previously appreciated and suggest that constraints on subunit interactions limit the kinds of receptor species produced.			VERNALLIS, AB (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.				NINDS NIH HHS [P01 NS25916, R01 NS12601] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, P01NS025916] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANAND R, 1991, J BIOL CHEM, V266, P11192; BALLIVET M, 1988, NEURON, V1, P847, DOI 10.1016/0896-6273(88)90132-8; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOULTER J, 1990, J BIOL CHEM, V265, P4472; CONROY WG, 1992, NEURON, V9, P679, DOI 10.1016/0896-6273(92)90031-8; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HALVORSEN SW, 1986, J NEUROSCI, V6, P3405; HANKE W, 1986, NATURE, V321, P171, DOI 10.1038/321171a0; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; JACOB MH, 1983, J NEUROSCI, V3, P260; LINDSTROM J, 1981, METHOD ENZYMOL, V74, P452; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; LORING RH, 1987, J NEUROSCI, V7, P2153; LORING RH, 1984, NEUROSCIENCE, V11, P989, DOI 10.1016/0306-4522(84)90209-4; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; MCLANE KE, 1992, J NEUROIMMUNOL, V38, P115, DOI 10.1016/0165-5728(92)90096-4; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NISHI R, 1981, J NEUROSCI, V1, P505; RAVDIN PM, 1979, P NATL ACAD SCI USA, V76, P2072, DOI 10.1073/pnas.76.4.2072; SCHOEPFER R, 1989, FEBS LETT, V257, P393, DOI 10.1016/0014-5793(89)81580-7; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; SMITH MA, 1985, J NEUROSCI, V5, P2726; STOLLBERG J, 1987, J NEUROSCI, V7, P1809; TZARTOS S, 1981, J BIOL CHEM, V250, P8635; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; VIJAYARAGHAVAN S, 1990, J NEUROSCI, V10, P3255; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WHITING P, 1986, J NEUROSCI, V6, P3061; WHITING P, 1991, MOL PHARMACOL, V40, P463; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; WHITING PJ, 1991, MOL BRAIN RES, V10, P61, DOI 10.1016/0169-328X(91)90057-5; WHITING PJ, 1986, BIOCHEMISTRY-US, V25, P2082, DOI 10.1021/bi00356a037; WHITING PJ, 1988, J NEUROSCI, V8, P3395; WHITING PJ, 1987, J NEUROSCI, V7, P4005	45	269	271	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					451	464		10.1016/0896-6273(93)90333-M	http://dx.doi.org/10.1016/0896-6273(93)90333-M			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461135				2022-12-28	WOS:A1993KU90100010
J	Crino, PB; Eberwine, J				Crino, PB; Eberwine, J			Molecular characterization of the dendritic growth cone: Regulated mRNA transport and local protein synthesis	NEURON			English	Article							DEVELOPING RAT-BRAIN; INTERMEDIATE FILAMENT PROTEIN; HIPPOCAMPAL-NEURONS; MESSENGER-RNAS; ALPHA-INTERNEXIN; NERVOUS-SYSTEM; EXPRESSION; CULTURE; CALCIUM; GENE	The molecular mechanisms that regulate growth cone guidance of dendrite outgrowth remain to be elucidated. We hypothesized that mRNA localization in dendritic growth cones and their local protein synthesis may be important for growth cone functioning. The appearance of 23 of 31 growth cone mRNAs was developmentally regulated. Also, alteration of growth cone morphology affected the relative levels of three mRNAs. Finally, using single dendrite transfection, it was shown that local protein synthesis occurs in dendrites and growth cones. A heterogeneous population of mRNAs exists in dendritic growth cones of cultured hippocampal neurons whose relative abundances are developmentally regulated and can vary with changes in growth cone physiology. The demonstration of protein synthesis in growth cones suggests that translation of the localized mRNAs may contribute to regulation of growth cone motility and dendrite outgrowth.	UNIV PENN,SCH MED,DEPT PSYCHIAT,PHILADELPHIA,PA 19104	University of Pennsylvania	Crino, PB (corresponding author), UNIV PENN,SCH MED,DEPT PHARMACOL,36TH & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.		Eberwine, James/B-2247-2010		NIA NIH HHS [AG9900] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009900, R37AG009900] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAAS PW, 1989, J CELL BIOL, V109, P3085, DOI 10.1083/jcb.109.6.3085; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; BUCHHALTER JR, 1991, BRAIN RES BULL, V26, P333, DOI 10.1016/0361-9230(91)90003-3; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; EBERWINE J, 1995, NEUROSCIENTIST, V54, P155; FLIEGNER KH, 1994, J COMP NEUROL, V342, P161, DOI 10.1002/cne.903420202; GARNER C, 1988, NATURE, V336, P374; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; KATER SB, 1990, COLD SH Q B, V55, P359; KATER SB, 1991, J NEUROSCI, V11, P891; KUHN TB, 1995, NEURON, V14, P275, DOI 10.1016/0896-6273(95)90285-6; Lankford K, 1990, CURR OPIN CELL BIOL, V2, P80, DOI 10.1016/S0955-0674(05)80035-3; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LENDAHL U, 1990, CELL, V60, P685; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; LOCKERBIE RO, 1990, BRAIN RES REV, V15, P145, DOI 10.1016/0165-0173(90)90016-H; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MOHR E, 1991, EMBO J, V10, P2419, DOI 10.1002/j.1460-2075.1991.tb07781.x; NEELY MD, 1994, J NEUROSCI, V14, P7511; PALDINO AM, 1979, EXP NEUROL, V64, P620, DOI 10.1016/0014-4886(79)90236-X; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; POULTER M, 1993, J NEUROSCI, V12, P2888; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STEWARD O, 1986, J NEUROSCI, V6, P412; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TAYLOR J, 1989, J NEUROCHEM, V53, P834, DOI 10.1111/j.1471-4159.1989.tb11780.x; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; WEILER IJ, 1994, PROG BRAIN RES, V100, P189; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168	46	217	226	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1996	17	6					1173	1187		10.1016/S0896-6273(00)80248-2	http://dx.doi.org/10.1016/S0896-6273(00)80248-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA248	8982164	hybrid			2022-12-28	WOS:A1996WA24800014
J	Schackwitz, WS; Inoue, T; Thomas, JH				Schackwitz, WS; Inoue, T; Thomas, JH			Chemosensory neurons function in parallel to mediate a pheromone response in C-elegans	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CONTROLLING DAUER FORMATION; GREEN FLUORESCENT PROTEIN; LARVAL DEVELOPMENT; INTERACTING GENES; ENCODES; TEMPERATURE; EXPRESSION; MUTATIONS; MUTANTS	Formation of the C. elegans dauer larva is repressed by the chemosensory neurons ADF, ASI, and ASG. Mutant analysis has defined two parallel genetic pathways that control dauer formation. By killing neurons in these mutants, we show that mutations in one of these genetic pathways disrupt dauer repression by ADF, ASI, and ASG. One gene in this pathway is daf-7, which encodes a TGF beta-related protein. We find that daf-7::GFP fusions are expressed specifically in ASI and that expression is regulated by dauer-inducing sensory stimuli. We also show that a different chemosensory neuron, ASJ, functions in parallel to these neurons to induce dauer formation. Mutations in the second genetic pathway activate dauer formation in an ASJ-dependent manner. Thus, the genetic redundancy in this process is reflected at the neuronal level.			Schackwitz, WS (corresponding author), UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195, USA.		Schackwitz, Wendy/GXH-9536-2022	Schackwitz, Wendy/0000-0002-3013-9180	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007735] Funding Source: NIH RePORTER; NIGMS NIH HHS [R10GM48700, T32GM07735] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHE BW, 1991, SMELL TASTE HLTH DIS, P3; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; LIM CS, 1993, THESIS U MISSOURI CO; MALONE EA, 1994, GENETICS, V136, P879; Malone EA, 1996, GENETICS, V143, P1193; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; SCHILLER PH, 1982, NTURE, V297, P581; SHAKIR MA, 1993, NEUROREPORT, V4, P1151; SOLOMON JM, 1995, GENE DEV, V9, P547, DOI 10.1101/gad.9.5.547; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; TESSIERLAVIGNE M, 1991, PRINCIPLES NEURAL SC; THOMAS JH, 1993, BIOESSAYS, V15, P791, DOI 10.1002/bies.950151204; THOMAS JH, 1993, GENETICS, V134, P1105; VOWELS JJ, 1994, GENETICS, V138, P303; VOWELS JJ, 1992, GENETICS, V130, P105; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	36	229	237	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1996	17	4					719	728		10.1016/S0896-6273(00)80203-2	http://dx.doi.org/10.1016/S0896-6273(00)80203-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP743	8893028	Bronze			2022-12-28	WOS:A1996VP74300016
J	Ohno, K; Wang, HL; Milone, M; Bren, N; Brengman, JM; Nakano, S; Quiram, P; Pruitt, JN; Sine, SM; Engel, AG				Ohno, K; Wang, HL; Milone, M; Bren, N; Brengman, JM; Nakano, S; Quiram, P; Pruitt, JN; Sine, SM; Engel, AG			Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit	NEURON			English	Article							CELL-LINE TE671; GAMMA-SUBUNIT; CHOLINERGIC RECEPTOR; LIGAND-BINDING; MUSCLE-CELLS; KINETICS; FIBROBLASTS; TRANSITIONS; CLONING; MOUSE	We describe the genetic and kinetic defects for a low-affinity fast channel disease of the acetylcholine receptor (AChR) that causes a myasthenic syndrome. In two unrelated patients with very small miniature end plate (EP) potentials, but with normal EP AChR density and normal EP ultrastructure, patch-clamp studies demonstrated infrequent AChR channel events, diminished channel reopenings during ACh occupancy, and resistance to desensitization by ACh. Each patient had two heteroallelic AChR epsilon subunit gene mutations: a common epsilon P121L mutation, a signal peptide mutation (epsilon G-8R) (patient 1), and a glycosylation consensus site mutation (epsilon S143L) (patient 2). AChR expression in HEK fibroblasts was normal with epsilon P121L but was markedly reduced with the other mutations. Therefore, epsilon P121L defines the clinical phenotype. Studies of the engineered epsilon P121L AChR revealed a markedly decreased rate of channel opening, little change in affinity of the resting state for ACh, but reduced affinity of the open channel and desensitized states.	MAYO CLIN & MAYO FDN,DEPT NEUROL,MUSCLE RES LAB,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT PHYSIOL & BIOPHYS,RECEPTOR BIOL LAB,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic			Ohno, Kinji/H-4020-2012	Ohno, Kinji/0000-0002-1529-2750	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744, R01NS006277] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEESON D, 1993, EUR J BIOCHEM, V215, P229, DOI 10.1111/j.1432-1033.1993.tb18027.x; BEESON D, 1989, NUCLEIC ACIDS RES, V17, P4391, DOI 10.1093/nar/17.11.4391; BLOUNT P, 1991, J BIOL CHEM, V266, P14692; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; CHEN J, 1995, BIOPHYS J, V69, P849, DOI 10.1016/S0006-3495(95)79959-3; CHIARA D C, 1992, Biophysical Journal, V61, pA106; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Engel A.G., 1994, MYOLOGY, P1018; ENGEL AG, 1993, MUSCLE NERVE, V16, P1284, DOI 10.1002/mus.880161204; ENGEL AG, 1977, NEUROLOGY, V27, P307, DOI 10.1212/WNL.27.4.307; FU DX, 1994, J BIOL CHEM, V269, P26152; GEHLE VM, 1991, MOL BRAIN RES, V11, P17, DOI 10.1016/0169-328X(91)90016-Q; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HONGYO T, 1993, NUCLEIC ACIDS RES, V21, P3637, DOI 10.1093/nar/21.16.3637; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KATZ B, 1957, J PHYSIOL-LONDON, V137, P267, DOI 10.1113/jphysiol.1957.sp005811; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANG B, 1983, J PHYSIOL-LONDON, V344, P335, DOI 10.1113/jphysiol.1983.sp014943; LEE BS, 1991, J BIOL CHEM, V266, P11448; LUTHER MA, 1989, J NEUROSCI, V9, P1082; MARTIN AR, 1966, PHYSIOL REV, V46, P51, DOI 10.1152/physrev.1966.46.1.51; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHOEPFER R, 1988, FEBS LETT, V226, P235, DOI 10.1016/0014-5793(88)81430-3; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1982, J BIOL CHEM, V257, P8106; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; THOMSEN RH, 1983, J PHARMACOL EXP THER, V227, P260; UCHITEL O, 1993, MUSCLE NERVE, V16, P1293, DOI 10.1002/mus.880161205; UPENDER M, 1995, BIOTECHNIQUES, V18, P29; WEILAND G, 1977, J BIOL CHEM, V252, P7648; ZHANG YN, 1995, J PHYSIOL-LONDON, V486, P189, DOI 10.1113/jphysiol.1995.sp020802; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	47	177	182	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					157	170		10.1016/S0896-6273(00)80289-5	http://dx.doi.org/10.1016/S0896-6273(00)80289-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755487	Bronze			2022-12-28	WOS:A1996UY98100016
J	Chien, CB				Chien, CB			PY in the fly receptor-like tyrosine phosphatases in axonal pathfinding	NEURON			English	Review							DROSOPHILA; GENES				Chien, CB (corresponding author), MAX PLANCK INST ENTWICKLUNGSBIOL,ABT PHYS BIOL,D-72076 TUBINGEN,GERMANY.							BATE M, 1995, NEURON, V15, P513, DOI 10.1016/0896-6273(95)90141-8; BRADYKALNAY SM, 1994, J BIOL CHEM, V269, P28472; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; DESAI CJ, 1994, J NEUROSCI, V14, P7272; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HAMILTON BA, 1995, ROUX ARCH DEV BIOL, V204, P187, DOI 10.1007/BF00241271; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; STOKER AW, 1995, DEVELOPMENT, V121, P1833; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; TIAN SS, 1994, J BIOL CHEM, V269, P28478; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4	18	15	15	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1065	1068		10.1016/S0896-6273(00)80131-2	http://dx.doi.org/10.1016/S0896-6273(00)80131-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663981	Bronze			2022-12-28	WOS:A1996UU11800002
J	Patterson, SL; Abel, T; Deuel, TAS; MArtin, KC; Rose, JC; Kandel, ER				Patterson, SL; Abel, T; Deuel, TAS; MArtin, KC; Rose, JC; Kandel, ER			Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice	NEURON			English	Article							LONG-TERM POTENTIATION; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; MESSENGER-RNA; CYCLIC-AMP; BRAIN; EXPRESSION; RECEPTOR; NEURONS; NT-3	Brain-derived neurotrophic factor (BDNF) is expressed at high levels in hippocampal neurons, and its expression is modulated by neural activity. Knockout mice can be used to study the roles of molecules like BDNF in synaptic plasticity with more molecular specificity than is possible using pharmacological approaches. Because in conventional knockouts the disrupted gene product is absent in all tissues throughout the life of the animal, developmental effects may complicate the interpretation of deficits in the adult. Rescue experiments can help to distinguish between developmental and acute requirements for the missing gene product. We here demonstrate that treatment of hippocampal slices from BDNF knockout mice with recombinant BDNF completely reverses deficits in longterm potentiation and significantly improves deficits in basal synaptic transmission at the Schaffer collateral-CA1 synapse. Thus, BDNF has an acute role in hippocampal synaptic function.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Columbia University	Patterson, SL (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA.		Abel, Ted/AAX-2825-2021	Abel, Ted/0000-0003-2423-4592	NIA NIH HHS [AG 08702] Funding Source: Medline; NIDDK NIH HHS [T32DK07328] Funding Source: Medline; NIMH NIH HHS [1P50 MH 50733] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ANDERSON KD, 1995, J COMP NEUROL, V357, P296, DOI 10.1002/cne.903570209; [Anonymous], [No title captured]; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CARSTEN E, 1993, NEUROREPORT, V4, P895; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; DRAGUNOW M, 1993, NEUROSCI LETT, V160, P232, DOI 10.1016/0304-3940(93)90420-P; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GALL C, 1992, EPILEPSY RES, P171; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; Huang Y Y, 1994, Learn Mem, V1, P74; IP NY, 1993, J NEUROSCI, V13, P3394; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KALMAN D, 1990, NEURON, V4, P355, DOI 10.1016/0896-6273(90)90048-K; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LESSER SS, 1995, J NEUROSCI, V15, P253; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LEVINE ES, 1995, J NEUROSCI, V15, P3084; LINDEFORS N, 1992, EXP BRAIN RES, V88, P78, DOI 10.1007/BF02259130; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOUNT HTJ, 1993, J NEUROSCI, V13, P3173; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VERGE VMK, 1992, J NEUROSCI, V12, P4011; YAN Q, 1994, EXP NEUROL, V127, P23, DOI 10.1006/exnr.1994.1076	51	1010	1021	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1137	1145		10.1016/S0896-6273(00)80140-3	http://dx.doi.org/10.1016/S0896-6273(00)80140-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663990	hybrid			2022-12-28	WOS:A1996UU11800011
J	Yankner, BA				Yankner, BA			Mechanisms of neuronal degeneration in Alzheimer's disease	NEURON			English	Review							AMYLOID-BETA-PROTEIN; NERVE GROWTH-FACTOR; APOLIPOPROTEIN-E; PRECURSOR PROTEIN; MESSENGER-RNA; TAU-PROTEIN; MICROTUBULE-BINDING; CORTICAL-NEURONS; BASAL FOREBRAIN; TRANSGENIC MICE		CHILDRENS HOSP, DIV NEUROSCI, BOSTON, MA 02115 USA	Harvard University; Boston Children's Hospital	Yankner, BA (corresponding author), HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA.							ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; ARAI H, 1990, P NATL ACAD SCI USA, V87, P2249, DOI 10.1073/pnas.87.6.2249; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BLASS JP, 1993, NEUROLOGY, V43, pS25; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; BROWN RH, 1995, CELL, V80, P687, DOI 10.1016/0092-8674(95)90346-1; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUSCIGLIO J, 1992, NEUROBIOL AGING, V13, P609, DOI 10.1016/0197-4580(92)90065-6; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; BUSCIGLIO J, 1993, J NEUROCHEM, V61, P1565, DOI 10.1111/j.1471-4159.1993.tb13658.x; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CHEN M, 1991, NEUROSCI LETT, V125, P223, DOI 10.1016/0304-3940(91)90034-Q; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; COPANI A, 1991, NEUROREPORT, V2, P763, DOI 10.1097/00001756-199112000-00008; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; DAVIES P, 1976, LANCET, V2, P1403; DEKKER AJ, 1994, NEUROSCIENCE, V60, P299, DOI 10.1016/0306-4522(94)90244-5; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; DYRKS T, 1992, J BIOL CHEM, V267, P18210; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FASMAN GD, 1995, P NATL ACAD SCI USA, V92, P369, DOI 10.1073/pnas.92.2.369; FORLONI G, 1993, NEUROREPORT, V4, P523, DOI 10.1097/00001756-199305000-00015; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GIOVANNELLI L, 1995, NEUROSCIENCE, V66, P781, DOI 10.1016/0306-4522(94)00610-H; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GREENBERG SM, 1994, P NATL ACAD SCI USA, V91, P7104, DOI 10.1073/pnas.91.15.7104; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAN SH, 1994, J NEUROPATH EXP NEUR, V53, P535, DOI 10.1097/00005072-199409000-00013; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; HIGGINS LS, 1994, ANN NEUROL, V35, P598, DOI 10.1002/ana.410350514; HOWLETT DR, 1995, NEURODEGENERATION, V4, P23, DOI 10.1006/neur.1995.0003; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KOLIATSOS VE, 1991, ANN NY ACAD SCI, V640, P102; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; LASSMANN H, 1995, ACTA NEUROPATHOL, V89, P35, DOI 10.1007/BF00294257; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; Li JH, 1995, P NATL ACAD SCI USA, V92, P12180, DOI 10.1073/pnas.92.26.12180; LOCKHART BP, 1994, J NEUROSCI RES, V39, P494, DOI 10.1002/jnr.490390416; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; LU Q, 1993, J NEUROSCI, V13, P508; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1; MANTYH PW, 1993, J NEUROCHEM, V61, P1171, DOI 10.1111/j.1471-4159.1993.tb03639.x; MARKOWSKA AL, 1994, J NEUROSCI, V14, P4815; MARTIN LJ, 1994, AM J PATHOL, V145, P1358; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MAY PC, 1992, NEUROBIOL AGING, V13, P605, DOI 10.1016/0197-4580(92)90064-5; MAY PC, 1993, J NEUROCHEM, V61, P2330, DOI 10.1111/j.1471-4159.1993.tb07480.x; MCGEER PL, 1994, ALZ DIS ASSOC DIS, V8, P149, DOI 10.1097/00002093-199408030-00001; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MESULAM MM, 1994, ANN NEUROL, V36, P722, DOI 10.1002/ana.410360506; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; MORRIS JC, 1991, NEUROLOGY, V41, P469, DOI 10.1212/WNL.41.4.469; MUCKE L, 1995, J EXP MED, V181, P1551, DOI 10.1084/jem.181.4.1551; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NELSON PT, 1994, NEUROSCI LETT, V170, P187, DOI 10.1016/0304-3940(94)90270-4; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PODLISNY MB, 1993, AM J PATHOL, V142, P17; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; REBECK GW, 1993, NEURON, V11, P575; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; ROHER AE, 1991, BIOCHEM BIOPH RES CO, V174, P572, DOI 10.1016/0006-291X(91)91455-L; ROHER AE, 1993, J BIOL CHEM, V268, P3072; ROYSTON MC, 1994, NEUROREPORT, V5, P2583, DOI 10.1097/00001756-199412000-00044; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHIN RW, 1993, P NATL ACAD SCI USA, V90, P6825, DOI 10.1073/pnas.90.14.6825; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; SMITH MA, 1995, J NEUROCHEM, V64, P2660; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; SUBBARAO KV, 1990, J NEUROCHEM, V55, P342, DOI 10.1111/j.1471-4159.1990.tb08858.x; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; TUSZYNSKI MH, 1991, ANN NEUROL, V30, P625, DOI 10.1002/ana.410300502; URBANYI Z, 1994, EUR J PHARM-ENVIRON, V270, P375, DOI 10.1016/0926-6917(94)90016-7; VANNOSTRAND WE, 1992, P NATL ACAD SCI USA, V89, P2551, DOI 10.1073/pnas.89.7.2551; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WASCO W, 1995, NAT MED, V1, P948; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WHITSON JS, 1995, NEUROBIOL AGING, V16, P5, DOI 10.1016/0197-4580(95)80002-9; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; YAMAZAKI T, 1992, J NEUROPATH EXP NEUR, V51, P281, DOI 10.1097/00005072-199205000-00006; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020; ZHANG C, 1994, J BIOL CHEM, V269, P25247; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	179	887	941	0	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					921	932		10.1016/S0896-6273(00)80115-4	http://dx.doi.org/10.1016/S0896-6273(00)80115-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630250	Bronze			2022-12-28	WOS:A1996UN48000007
J	Vaughn, DE; Bjorkman, PJ				Vaughn, DE; Bjorkman, PJ			The (Greek) key to structures of neural adhesion molecules	NEURON			English	Review							CRYSTAL-STRUCTURE; IMMUNOGLOBULIN SUPERFAMILY; 3-DIMENSIONAL STRUCTURE; HUMAN CD4; CADHERIN SUPERFAMILY; SURFACE RECOGNITION; NERVOUS-SYSTEM; SOLUBLE FORM; PROTEIN; DOMAIN		CALTECH, HOWARD HUGHES MED INST, PASADENA, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Vaughn, DE (corresponding author), CALTECH, DIV BIOL, PASADENA, CA 91125 USA.							ARULANANDAM ARN, 1993, P NATL ACAD SCI USA, V90, P11613, DOI 10.1073/pnas.90.24.11613; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; BRADY RL, 1993, SCIENCE, V260, P979, DOI 10.1126/science.8493535; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; DAVIES DR, 1983, ANNU REV IMMUNOL, V1, P87, DOI 10.1146/annurev.iy.01.040183.000511; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GEIGER B, 1992, ANNU REV CELL BIOL, V8, P307, DOI 10.1146/annurev.cb.08.110192.001515; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; HOLMGREN A, 1989, NATURE, V342, P248, DOI 10.1038/342248a0; HUBER AH, 1994, NEURON, V12, P717, DOI 10.1016/0896-6273(94)90326-3; HUBER AH, 1994, THESIS CALTECH PASAD; Hynes RO, 1990, FIBRONECTINS; IWAMOTO T, 1993, ONCOGENE, V8, P1087; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; Kabat EA, 1991, SEQUENCES PROTEINS I; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KWONG PD, 1990, P NATL ACAD SCI USA, V87, P6423, DOI 10.1073/pnas.87.16.6423; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; RICHARDSON JS, 1976, J MOL BIOL, V102, P221, DOI 10.1016/S0022-2836(76)80050-2; RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; RYU SE, 1994, STRUCTURE, V2, P59, DOI 10.1016/S0969-2126(00)00008-3; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; TAKEICHI M, 1990, COLD SH Q B, V55, P319; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; WAGNER G, 1994, CURR OPIN STRUC BIOL, V4, P841, DOI 10.1016/0959-440X(94)90265-8; WAGNER G, 1992, ANNU REV BIOPH BIOM, V21, P167, DOI 10.1146/annurev.biophys.21.1.167; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WHEELER GN, 1991, BIOCHEM SOC T, V19, P1060, DOI 10.1042/bst0191060; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YOSHIHARA Y, 1994, NEUROSCI RES, V21, P119, DOI 10.1016/0168-0102(94)90153-8; YOSHIHARA Y, 1991, NEUROSCI RES, V10, P83, DOI 10.1016/0168-0102(91)90033-U	55	97	101	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1996	16	2					261	273		10.1016/S0896-6273(00)80045-8	http://dx.doi.org/10.1016/S0896-6273(00)80045-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW957	8789942	Bronze			2022-12-28	WOS:A1996TW95700007
J	LaMantia, AS				LaMantia, AS			The usual suspects: GABA and glutamate may regulate proliferation in the neocortex	NEURON			English	Review							RAT-BRAIN; RECEPTORS; NEUROTRANSMITTERS; EXPRESSION; NEURONS; SUBUNIT				LaMantia, AS (corresponding author), DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710, USA.							ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BAYER SA, 1991, NEOCORTICAL DEV, P30; BEHAR TN, 1994, J NEUROSCI, V14, P29; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; CHUN JJM, 1987, NATURE, V325, P617, DOI 10.1038/325617a0; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; KILPATRICK TJ, 1995, MOL CELL NEUROSCI, V6, P2, DOI 10.1006/mcne.1995.1002; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; LAUDER JM, 1986, NEUROSCIENCE, V19, P465, DOI 10.1016/0306-4522(86)90275-7; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; LOTURCO JJ, 1995, NEURON, V15; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; NEWPORT JW, 1984, CELL, V37, P731, DOI 10.1016/0092-8674(84)90409-4; PARNAVELAS JG, 1988, TRENDS NEUROSCI, V11, P92; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 1982, Neurosci Res Program Bull, V20, P433; STENSAAS LJ, 1968, Z ZELLFORSCH MIK ANA, V91, P341, DOI 10.1007/BF00440763; 1970, ANAT REC, V166, P257	21	48	48	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1995	15	6					1223	1225		10.1016/0896-6273(95)90002-0	http://dx.doi.org/10.1016/0896-6273(95)90002-0			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL678	8845147	Bronze			2022-12-28	WOS:A1995TL67800002
J	SIMONS, K; ZERIAL, M				SIMONS, K; ZERIAL, M			RAB PROTEINS AND THE ROAD MAPS FOR INTRACELLULAR-TRANSPORT	NEURON			English	Article							GTP-BINDING PROTEIN; GDP DISSOCIATION INHIBITOR; POLARIZED EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; GOLGI-APPARATUS; SMG P25A; HIPPOCAMPAL-NEURONS; VESICULAR TRANSPORT; ENDOCYTIC PATHWAYS				SIMONS, K (corresponding author), EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY.			Simons, Kai/0000-0002-9231-9996				Adler R., 1986, RETINA MODEL CELL BI, P297; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ANTONY C, 1992, J CELL SCI, V103, P785; ARAKI S, 1990, J BIOL CHEM, V265, P13007; BAILDINI G, 1992, P NATL ACADS CI US, V256, P645; Barr F A, 1992, Trends Cell Biol, V2, P91, DOI 10.1016/0962-8924(92)90001-4; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BENETT MK, 1992, SCIENCE, V257, P255; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BRADY ST, 1991, NEURON, V7, P521, DOI 10.1016/0896-6273(91)90365-7; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURTON J, 1993, NATURE, V361, P464, DOI 10.1038/361464a0; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; CHAVRIER P, 1992, GENE, V112, P261, DOI 10.1016/0378-1119(92)90387-5; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; DERETIC D, 1991, J CELL BIOL, V113, P1281, DOI 10.1083/jcb.113.6.1281; DERETIC D, 1993, IN PRESS J CELL SCI; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; ELFERINK LA, 1992, J BIOL CHEM, V267, P5768; GALLWITZ D, 1983, NATURE, V306, P704, DOI 10.1038/306704a0; GEUZE HJ, 1984, CELL, V37, P195, DOI 10.1016/0092-8674(84)90315-5; GOLDENRING JR, 1993, J BIOL CHEM, V268, P18419; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOUD B, 1991, Current Opinion in Cell Biology, V3, P626, DOI 10.1016/0955-0674(91)90033-U; GRUENBERG J, 1992, Current Opinion in Cell Biology, V4, P593, DOI 10.1016/0955-0674(92)90077-P; Gumbiner B, 1990, CURR OPIN CELL BIOL, V2, P881, DOI 10.1016/0955-0674(90)90087-U; HAUBRUCK H, 1990, EMBO J, V9, P1957, DOI 10.1002/j.1460-2075.1990.tb08323.x; HU YH, 1993, NEURON, V10, P921, DOI 10.1016/0896-6273(93)90207-8; HUBBARD AL, 1989, ANNU REV PHYSIOL, V51, P755, DOI 10.1146/annurev.physiol.51.1.755; HUBER LA, 1993, J CELL BIOL, V123, P47, DOI 10.1083/jcb.123.1.47; HUBER LA, 1993, J CELL BIOL, V123, P34; IKONEN E, 1993, IN PRESS CURR BIOL; JONES SM, 1993, IN PRESS J CELL BIOL; KELLY R B, 1991, Current Opinion in Cell Biology, V3, P654, DOI 10.1016/0955-0674(91)90037-Y; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Kraehenbuhl J P, 1992, Trends Cell Biol, V2, P170, DOI 10.1016/0962-8924(92)90036-M; KREIS T E, 1992, Current Opinion in Cell Biology, V4, P609, DOI 10.1016/0955-0674(92)90079-R; KUZNETSOV SA, 1992, NATURE, V356, P722, DOI 10.1038/356722a0; LAVAIL JH, 1987, AXONAL TRANSPORT, P311; LIAN JP, 1993, CELL, V73, P735, DOI 10.1016/0092-8674(93)90253-M; LISANTI MP, 1990, TRENDS BIOCHEM SCI, V15, P113, DOI 10.1016/0968-0004(90)90195-H; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; LUTCKE A, 1993, J CELL BIOL, V121, P553, DOI 10.1083/jcb.121.3.553; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; MARTENSON RE, 1992, MYELIN BIOL CHEM; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MITCHISON TJ, 1992, MOL BIOL CELL, V3, P1309, DOI 10.1091/mbc.3.12.1309; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; Mostov K, 1991, Semin Cell Biol, V2, P411; MOTOIKE T, 1990, DEV BRAIN RES, V57, P279, DOI 10.1016/0165-3806(90)90054-3; MOYA M, 1993, NATURE, V361, P460, DOI 10.1038/361460a0; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; OLKKONEN VM, 1993, IN PRESS J CELL SCI; PAPERMASTER DS, 1985, INVEST OPHTH VIS SCI, V26, P1386; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; PARTON RG, 1993, J NEUROSCI RES, V36; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Riezman Howard, 1993, Trends in Cell Biology, V3, P273, DOI 10.1016/0962-8924(93)90056-7; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SASAKI T, 1991, MOL CELL BIOL, V11, P2909, DOI 10.1128/MCB.11.5.2909; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIMMOLLER A, 1993, IN PRESS J CELL SCI; SCHMIED R, 1989, J NEUROBIOL, V20, P115, DOI 10.1002/neu.480200303; SCHWAB ME, 1979, J CELL BIOL, V82, P798, DOI 10.1083/jcb.82.3.798; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SEWELL JL, 1988, P NATL ACAD SCI USA, V85, P4620, DOI 10.1073/pnas.85.13.4620; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SHIRATAKI H, 1992, J BIOL CHEM, V267, P10946; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; SIMONS K, 1993, COLD SPRING HARB SYM, V57, P611; SOLDATI T, 1992, MOL BIOL CELL, V4, P425; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; STOUTEN PFW, 1993, FEBS LETT, V320, P1, DOI 10.1016/0014-5793(93)81644-F; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; WANDINGERNESS A, 1991, INTRACELLULAR TRAFFI, P575; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	115	278	281	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					789	799		10.1016/0896-6273(93)90109-5	http://dx.doi.org/10.1016/0896-6273(93)90109-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240804				2022-12-28	WOS:A1993MJ04100001
J	VESCOVI, AL; REYNOLDS, BA; FRASER, DD; WEISS, S				VESCOVI, AL; REYNOLDS, BA; FRASER, DD; WEISS, S			BFGF REGULATES THE PROLIFERATIVE FATE OF UNIPOTENT (NEURONAL) AND BIPOTENT (NEURONAL ASTROGLIAL) EGF-GENERATED CNS PROGENITOR CELLS	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; RAT OPTIC-NERVE; CORD ASTROCYTES INVITRO; PRECURSOR CELLS; FACTOR PROMOTES; FACTOR RECEPTOR; ION CHANNELS; SPINAL-CORD; OLIGODENDROCYTE DEVELOPMENT	In cultures of embryonic and adult mouse striatum, we previously demonstrated that EGF induces the proliferation of putative stem cells, which give rise to spheres of undifferentiated cells that can generate neurons and astrocytes. We report here that the spheres of undifferentiated cells contain mRNA and protein for the FGF receptor (FGFR1). Indirect immunocytochemistry demonstrated that many of the cells within the EGF-generated spheres were immunoreactive for FGFR1. Exogenous application of bFGF to the EGF-generated cells induced the proliferation of two progenitor cell types. The first, a bipotent progenitor cell, gave rise to cells with the antigenic and morphological properties of neurons and astrocytes; the other gave rise to cells with neuronal characteristics only. bFGF-generated cells with neuronal morphology exhibited electrophysiological properties indicative of immature central neurons. These results support the hypothesis that sequential actions of growth factors play a role in regulating the generation of neurons and astrocytes in the developing CNS.	UNIV CALGARY, FAC MED, DEPT ANAT, NEUROSCI RES GRP, CALGARY T2N 4N1, AB, CANADA; UNIV CALGARY, FAC MED, DEPT PHARMACOL & THERAPEUT, CALGARY T2N 4N1, AB, CANADA; UNIV CALGARY, FAC MED, GRAD DEPT NEUROSCI, CALGARY T2N 4N1, AB, CANADA	University of Calgary; University of Calgary; University of Calgary			Vescovi, Angelo Luigi/A-4919-2015	Vescovi, Angelo Luigi/0000-0002-1742-4112				ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BARRES BA, 1988, GLIA, V1, P10, DOI 10.1002/glia.440010104; BESNARD F, 1989, INT J DEV NEUROSCI, V7, P401, DOI 10.1016/0736-5748(89)90061-0; BEWSEY KE, 1991, BIOTECHNIQUES, V10, P724; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COULIER F, 1991, ONCOGENE, V6, P1437; DELAUNOY JP, 1988, INT J DEV NEUROSCI, V6, P129, DOI 10.1016/0736-5748(88)90037-8; DELOULME JC, 1991, J NEUROSCI RES, V29, P499, DOI 10.1002/jnr.490290410; DELOULME JC, 1991, NEUROSCIENCE, V42, P561, DOI 10.1016/0306-4522(91)90398-8; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; ECCLESTON PA, 1985, DEV BRAIN RES, V21, P315, DOI 10.1016/0165-3806(85)90221-4; EISEMANN A, 1991, ONCOGENE, V6, P1195; FERRARI G, 1989, DEV BIOL, V133, P140, DOI 10.1016/0012-1606(89)90305-9; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; FREESE A, 1992, BRAIN RES, V575, P351, DOI 10.1016/0006-8993(92)90104-H; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GARCIARILL E, 1991, DEV BRAIN RES, V60, P267, DOI 10.1016/0165-3806(91)90056-O; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GOSPODAROWICZ D, 1975, J BIOL CHEM, V250, P2515; GROTHE C, 1989, NEUROSCIENCE, V31, P649, DOI 10.1016/0306-4522(89)90430-2; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HOCKBERGER PE, 1987, J NEUROSCI, V7, P1370; JOHANSSON S, 1992, J PHYSL, V445, P120; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILLIEN L, 1992, DEVELOPMENT, V115, P253; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MARICS I, 1989, ONCOGENE, V4, P335; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MCMANAMAN J, 1989, J NEUROCHEM, V53, P1763, DOI 10.1111/j.1471-4159.1989.tb09241.x; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MORRISON RS, 1981, P NATL ACAD SCI-BIOL, V78, P7205, DOI 10.1073/pnas.78.11.7205; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PERRAUD F, 1988, GLIA, V1, P124, DOI 10.1002/glia.440010204; PETTMANN B, 1985, FUNKT BIOL MED, V4, P243; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1984, DEV BIOL, V106, P53, DOI 10.1016/0012-1606(84)90060-5; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RITCHIE JM, 1992, TRENDS NEUROSCI, V15, P345; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Sambrook J, 1989, MOL CLONING LABORATO; SENSENBRENNER M, 1985, HORMONES CELL REGULA, V9, P345; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SONTHEIMER H, 1992, J NEUROPHYSIOL, V68, P1001, DOI 10.1152/jn.1992.68.4.1001; SONTHEIMER H, 1992, J NEUROPHYSIOL, V68, P985, DOI 10.1152/jn.1992.68.4.985; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WERNER S, 1993, EMBO J, V12, P2635, DOI 10.1002/j.1460-2075.1993.tb05924.x; WESTERMANN R, 1990, J CELL SCI, P97; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	78	577	616	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					951	966		10.1016/0896-6273(93)90124-A	http://dx.doi.org/10.1016/0896-6273(93)90124-A			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240816				2022-12-28	WOS:A1993MJ04100016
J	HOCH, W; FERNS, M; CAMPANELLI, JT; HALL, ZW; SCHELLER, RH				HOCH, W; FERNS, M; CAMPANELLI, JT; HALL, ZW; SCHELLER, RH			DEVELOPMENTAL REGULATION OF HIGHLY-ACTIVE ALTERNATIVELY SPLICED FORMS OF AGRIN	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; MOTOR NEURONS; BASAL LAMINA; CULTURED MYOTUBES; MOLECULES; MUSCLE; PHOSPHORYLATION; REDISTRIBUTION; COMPONENTS; EXPRESSION	Agrin is an extracellular matrix protein involved in clustering acetylcholine receptors during development of the neuromuscular junction. We have previously shown that alternative splicing at three sites generates multiple forms of rat agrin and that a novel 8 amino acid insert is the most important in determining biological activity. In the present study we have examined the expression of agrin during development with particular emphasis on determining the tissue distribution of the splicing variants at each site. Our principal observation is that the variants containing the sequence most responsible for biological activity are expressed exclusively in neural tissue and that their expression is highly regulated during development. We also show that muscle expresses less active forms and that agrin immunoreactivity during synaptogenesis is initially not limited to synaptic sites, but becomes progressively restricted to the synapse as development proceeds.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	HOCH, W (corresponding author), STANFORD UNIV,BECKMAN CTR MOLEC & GENET MED,HOWARD HUGHES MED INST,STANFORD,CA 94305, USA.			Ferns, Michael/0000-0002-1545-3024	NIGMS NIH HHS [GM07276] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMANO T, 1972, P NATL ACAD SCI USA, V69, P258, DOI 10.1073/pnas.69.1.258; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CAMPANELLI JT, 1993, IN PRESS COLD SPRING; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MANTHORPE M, 1981, J NEUROCHEM, V37, P759; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PURVES D, 1985, PRINCIPLES NEURAL DE; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; ROLE LW, 1985, J NEUROSCI, V5, P2197; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; Sambrook J, 1989, MOL CLONING LABORATO; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1989, J NEUROSCI, V9, P1294; ZISKINDCONHAIM L, 1984, J NEUROSCI, V4, P2346	32	181	190	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					479	490		10.1016/0896-6273(93)90152-H	http://dx.doi.org/10.1016/0896-6273(93)90152-H			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398141				2022-12-28	WOS:A1993LY49800008
J	KITAGAWA, K; SINOWAY, MP; YANG, C; GOULD, RM; COLMAN, DR				KITAGAWA, K; SINOWAY, MP; YANG, C; GOULD, RM; COLMAN, DR			A PROTEOLIPID PROTEIN GENE FAMILY - EXPRESSION IN SHARKS AND RAYS AND POSSIBLE EVOLUTION FROM AN ANCESTRAL GENE ENCODING A PORE-FORMING POLYPEPTIDE	NEURON			English	Article							PELIZAEUS-MERZBACHER DISEASE; NERVOUS-SYSTEM MYELIN; BOVINE BRAIN MYELIN; POINT MUTATION; MESSENGER-RNAS; INSITU HYBRIDIZATION; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; ESCHERICHIA-COLI; CNS MYELIN	The myelin proteolipid proteins (PLP and DM20) are believed to act as ''adhesive struts'' in the extracellular apposition of the CNS myelin sheath. These proteins have been considered late evolutionary developments, which arose de novo in the antecedents of early tetrapods. However, PCR primed with degenerate oligonucleotides corresponding to common segments of rat PLP/DM20 revealed three novel mRNAs in the brains of two elasmobranchs. These mRNAs are closely related to each other and to mammalian DM20, but lack the sequence that distinguishes PLP from DM20. We term the novel proteolipid proteins DM(alpha), DM(beta), and DM(gamma). At least DM(alpha) and DM(gamma) are highly expressed in white matter in myelinating shark brain. The DMs not only are highly homologous to each other, but also contain regions bearing similarities with segments of channel-forming regions of the nicotinic acetylcholine receptor and the glutamate receptor macromolecular complexes. Significantly, we find that across these segments, DM(alpha) and DM(gamma) are more similar to the channel proteins than the two channel proteins are to each other.	OSAKA UNIV, SCH MED, DEPT INTERNAL MED 1, FUKUSHIMA KU, OSAKA 553, JAPAN; COLUMBIA UNIV COLL PHYS & SURG, DEPT ANAT, NEW YORK, NY 10032 USA; OSAKA UNIV, SCH MED, DEPT CELL BIOL, OSAKA 553, JAPAN; NEW YORK STATE INST BASIC RES, MEMBRANE BIOL LAB, STATEN ISL, NY 10314 USA	Osaka University; Columbia University; Osaka University	KITAGAWA, K (corresponding author), CUNY MT SINAI SCH MED, BROOKDALE CTR MOLEC BIOL, NEW YORK, NY 10029 USA.				NINDS NIH HHS [NS 20147, NS 13980] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147, R01NS013980] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLBERG PE, 1992, NATURE, V358, P459, DOI 10.1038/358459a0; BALDINO F, 1989, METHOD ENZYMOL, V168, P761; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; BERNIER L, 1987, J NEUROSCI, V7, P2703; BOISON D, 1989, EMBO J, V8, P3295, DOI 10.1002/j.1460-2075.1989.tb08490.x; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; CAPPETTA H, 1987, HDB PALEOICHTHYOLO B, V3, P41; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DECOZAR M, 1987, BIOCHEM INT, V14, P833; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; FENG DF, 1985, J MOL EVOL, V21, P112, DOI 10.1007/BF02100085; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GARDINIER MV, 1988, J NEUROCHEM, V51, P360; GENCIC S, 1990, J NEUROSCI, V10, P117; GENCIC S, 1989, AM J HUM GENET, V45, P435; GORR T, 1993, AM SCI, V81, P72; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HELYNCK G, 1983, EUR J BIOCHEM, V133, P689, DOI 10.1111/j.1432-1033.1983.tb07518.x; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; HUDSON LD, 1990, ANN NY ACAD SCI, V605, P155, DOI 10.1111/j.1749-6632.1990.tb42390.x; HUDSON LD, 1989, J CELL BIOL, V109, P717, DOI 10.1083/jcb.109.2.717; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kirschner D., 1984, MYELIN, P51; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LAI C, 1987, IMMUNOL REV, V100, P129, DOI 10.1111/j.1600-065X.1987.tb00530.x; LAURSEN RA, 1984, P NATL ACAD SCI-BIOL, V81, P2912, DOI 10.1073/pnas.81.9.2912; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; LIN LFH, 1982, P NATL ACAD SCI-BIOL, V79, P941, DOI 10.1073/pnas.79.3.941; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; Maniatis T., 1982, MOL CLONING; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; NADON NL, 1990, DEVELOPMENT, V110, P529; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SHIRAI S, 1992, COPEIA, P505; SIMONS R, 1987, BIOCHEM BIOPH RES CO, V146, P666, DOI 10.1016/0006-291X(87)90580-8; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; Smeets W. J. A. J., 1983, CENTRAL NERVOUS SYST; SORG BA, 1987, J NEUROCHEM, V49, P1146, DOI 10.1111/j.1471-4159.1987.tb10005.x; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TINGBEALL HP, 1979, J MEMBRANE BIOL, V51, P33, DOI 10.1007/BF01869342; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WAEHNELDT TV, 1990, ANN NY ACAD SCI, V605, P15, DOI 10.1111/j.1749-6632.1990.tb42377.x; WAEHNELDT TV, 1986, J NEUROCHEM, V46, P1387, DOI 10.1111/j.1471-4159.1986.tb01752.x; WAEHNELDT TV, 1989, J NEUROCHEM, V52, P1941, DOI 10.1111/j.1471-4159.1989.tb07281.x; WAEHNELDT TV, 1991, ENVIRON BIOL FISH, V32, P131, DOI 10.1007/BF00007449; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J	78	147	151	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1993	11	3					433	448		10.1016/0896-6273(93)90148-K	http://dx.doi.org/10.1016/0896-6273(93)90148-K			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398138				2022-12-28	WOS:A1993LY49800004
J	PEROZO, E; MACKINNON, R; BEZANILLA, F; STEFANI, E				PEROZO, E; MACKINNON, R; BEZANILLA, F; STEFANI, E			GATING CURRENTS FROM A NONCONDUCTING MUTANT REVEAL OPEN-CLOSED CONFORMATIONS IN SHAKER K+ CHANNELS	NEURON			English	Article							DEPENDENT POTASSIUM CHANNEL; CHARYBDOTOXIN BLOCK; ION CHANNELS; BINDING-SITE; TEA BLOCKADE; VOLTAGE; DROSOPHILA; INACTIVATION; INHIBITOR; TETRAETHYLAMMONIUM	In voltage-dependent ion channels, a voltage sensor region is responsible for channel activation and an aqueous pore is responsible for ion conduction. These two processes have been traditionally considered to be independent. We describe here a mutation in the putative pore region (W434F) that completely abolishes ion conduction without affecting the gating charge of the channel. Gating currents in the nonconductive mutant were found to be identical in their kinetic and steady-state properties to those in conductive channels. Gating current measurements could be performed without subtracting pulses and in the presence of normal physiological solutions. Application of internal tetraethylammonium (an open channel blocker) induced Off charge immobilization for large depolarizations, suggesting that the internal tetraethylammonium-binding site becomes available upon depolarization. We concluded that for this mutant, although the conduction pathway is not functional, the channel can still undergo the closed-open conformation in response to voltage changes.	HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA; UNIV CALIF LOS ANGELES, DEPT CHEM & BIOCHEM, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT PHYSIOL, LOS ANGELES, CA 90024 USA; BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA; UNIV CALIF LOS ANGELES, JERRY LEWIS NEUROMUSCULAR RES INST, LOS ANGELES, CA 90024 USA	Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine; University of California System; University of California Los Angeles	PEROZO, E (corresponding author), UNIV CALIF LOS ANGELES, JULES STEIN EYE INST, LOS ANGELES, CA 90024 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047400, R01GM030376, R37GM030376] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37044] Funding Source: Medline; NIGMS NIH HHS [GM30376, GM47400] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; TAYLOR RE, 1983, J GEN PHYSIOL, V81, P773, DOI 10.1085/jgp.81.6.773; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	30	273	275	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG	1993	11	2					353	358		10.1016/0896-6273(93)90190-3	http://dx.doi.org/10.1016/0896-6273(93)90190-3			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352943				2022-12-28	WOS:A1993LU06500014
J	LEREA, LS; MCNAMARA, JO				LEREA, LS; MCNAMARA, JO			IONOTROPIC GLUTAMATE RECEPTOR SUBTYPES ACTIVATE C-FOS TRANSCRIPTION BY DISTINCT CALCIUM-REQUIRING INTRACELLULAR SIGNALING PATHWAYS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; IMMEDIATE EARLY GENES; HIPPOCAMPAL PYRAMIDAL NEURONS; SENSITIVE ADENYLATE-CYCLASE; CEREBELLAR GRANULE CELLS; LONG-TERM POTENTIATION; EXCITATORY AMINO-ACIDS; ARACHIDONIC-ACID; MESSENGER-RNA; CYCLIC-AMP	N-Methyl-D-aspartate (NMDA) or non-NMDA receptor activation is sufficient to induce transcription of the immediate early gene c-fos in a calcium-requiring manner. We sought to determine whether the calcium-dependent mechanisms inducing c-fos transcription are identical following activation of these two receptor subtypes. We used in situ hybridization and fura-2 imaging to detect c-fos mRNA and intracellular calcium in individual dentate gyrus neurons maintained in vitro. Structurally distinct inhibitors of phospholipase A, and cyclooxygenase abolished NMDA- but not kainic acid-induced increases of c-fos mRNA. Conversely, the calmodulin antagonist calmidazolium markedly inhibited kainic acid- but not NMDA-mediated increases of c-fos mRNA. We propose that the dissociation in the mechanisms transducing the calcium influx signals to the nucleus following NMDA and non-NMDA receptor activation is due to spatially distinct sites of calcium entry, resulting in activation of different enzymes located at distinct sites in the cell.	VET ADM MED CTR, EPILEPSY RES LAB, DURHAM, NC 27705 USA; DUKE UNIV, DEPT PHARMACOL, DURHAM, NC 27710 USA; DUKE UNIV, DEPT NEUROBIOL, DURHAM, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University	LEREA, LS (corresponding author), VET ADM MED CTR, DEPT MED, DIV NEUROL, DURHAM, NC 27705 USA.				NIGMS NIH HHS [GM12049] Funding Source: Medline; NINDS NIH HHS [NS 17771] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM012049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017771] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; ASANO M, 1989, J PHARMACOL EXP THER, V251, P764; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BAZAN NG, 1989, ANN NY ACAD SCI, V559, P1; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BEAR MF, 1990, J NEUROSCI, V10, P909; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BILLAH MM, 1985, J BIOL CHEM, V260, P6899; BITONTI AJ, 1980, J BIOL CHEM, V255, P2026; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; EGAN RW, 1984, PROSTAGLANDINS LEUKO, P593; GINTY DD, 1991, J BIOL CHEM, V266, P17454; GLAUM SR, 1990, J PHARMACOL EXP THER, V253, P1293; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HEADLEY PM, 1990, TRENDS PHARMACOL SCI, V11, P205, DOI 10.1016/0165-6147(90)90116-P; HISANAGA K, 1992, J NEUROCHEM, V58, P1836, DOI 10.1111/j.1471-4159.1992.tb10060.x; HWANG SB, 1985, J BIOL CHEM, V260, P5639; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; IZQUIERDO I, 1991, TRENDS PHARMACOL SCI, V12, P128, DOI 10.1016/0165-6147(91)90527-Y; JONES KA, 1991, NEURON, V7, P593, DOI 10.1016/0896-6273(91)90372-7; KACICH RL, 1988, MOL ENDOCRINOL, V2, P73, DOI 10.1210/mend-2-1-73; LABINER DM, 1993, J NEUROSCI, V13, P744; LAZAREWICZ JW, 1990, J NEUROCHEM, V55, P1875, DOI 10.1111/j.1471-4159.1990.tb05771.x; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; MCCARTHY KD, 1991, NEUROSCIENCE, V41, P325, DOI 10.1016/0306-4522(91)90330-Q; MCNAMARA JO, 1988, NEUROPHARMACOLOGY, V27, P563, DOI 10.1016/0028-3908(88)90176-1; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; NELSON PH, 1987, CRC HDB EICOSANOIDS, V2, P59; PARTINGTON CR, 1980, P NATL ACAD SCI-BIOL, V77, P3024, DOI 10.1073/pnas.77.5.3024; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; ROSENTHAL MD, 1989, BIOCHIM BIOPHYS ACTA, V1001, P1, DOI 10.1016/0005-2760(89)90299-3; ROZENGURT E, 1983, CELL, V34, P265, DOI 10.1016/0092-8674(83)90157-5; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SANFELIU C, 1990, BRAIN RES, V526, P241, DOI 10.1016/0006-8993(90)91228-9; SCHAAD NC, 1987, NATURE, V328, P637, DOI 10.1038/328637a0; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIMONATO M, 1991, MOL BRAIN RES, V11, P115, DOI 10.1016/0169-328X(91)90113-C; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; SZEKELY AM, 1989, MOL PHARMACOL, V35, P401; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VISHWANATH BS, 1988, INFLAMMATION, V12, P549, DOI 10.1007/BF00914317; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; YAMASHITA T, 1986, J BIOL CHEM, V261, P6878; YEAGER RE, 1985, BIOCHEMISTRY-US, V24, P3776, DOI 10.1021/bi00335a054	61	208	210	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					31	41		10.1016/0896-6273(93)90239-N	http://dx.doi.org/10.1016/0896-6273(93)90239-N			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427701				2022-12-28	WOS:A1993KK01200004
